Gene	Variant_Classification	Alteration	Tumor_allele	Reference_allele	dbSNP_RS	bin	Score_bin	Chromosome	Start_position	End_position	Coverage	Allelic_fraction	Number_of_Probes	Segment_Mean	In_Segment	Pathways	COSMIC_overlapping_mutations	COSMIC_total_alterations_in_gene	UniProt_Region	Rationale	Tumor_Sample_Barcode	Clinical_trials	mutation.assessor
NF1	Copy Number	Deleted	NA	NA	NA	0	Investigate Actionability	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA	Biallelic inactivation may predict sensitivity to PI3K pathway inhibitors (PI3K/AKT/MTOR).  Biallelic inactivation mapy predict resistance to RAF and MEK inhibitors.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NF1&recr=Open">Click here</a>	
KDR	Missense_Mutation	p.R1032Q	C	C		0.75	Investigate Actionability	4	55956220	55956220	127	0.283464566929134	NA	NA	NA		p.R1032Q(2)	135	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Activating mutations may predict sensitivity to specific inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,55956220,C,C&fts=all">p.R1032Q</a>
KIT	Missense_Mutation	p.N822Y	A	A		0.75	Investigate Actionability	4	55599338	55599338	4701	0.378642841948522	NA	NA	NA		p.N822Y(5)|p.N822H(1)	6411	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Mutations targetable with TKIs (both FDA approved and novel). Secondary mutations predict resistance to TKIs.  Amplification also associated with resistance to TKIs.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,55599338,A,A&fts=all">p.N822Y</a>
EGFR	Splice_Site		G	G		1	Investigate Actionability	7	55218986	55218986	64	0.15625	NA	NA	NA			14110		Mutations targetable with TKIs (both FDA approved and novel). Other mutations predict resistance to TKIs.  Amplification associated with response to anti-EGFR Abs in colon cancer. Amplification also associated with resistance to TKIs in some cancers.  Rearangement is prognostic in GBM, HNSCC	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGFR&recr=Open">Click here</a>	
ERBB2	Missense_Mutation	p.S310F	C	C		1	Investigate Actionability	17	37868208	37868208	161	0.0496894409937888	NA	NA	NA		p.S310F(6)|p.S310Y(1)	247		Amplifications and mutations predict sensitivity to anti-Her2 therapy.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERBB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,37868208,C,C&fts=all">p.S310F</a>
FLT3	Splice_Site		T	T		1	Investigate Actionability	13	28589395	28589395	90	0.266666666666667	NA	NA	NA			12390		Mutations predict sensitivity to FLT3 inhibitors, sunitinib.  Secondary mutations predict resistance.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLT3&recr=Open">Click here</a>	
PDGFRA	Splice_Site		G	G		1	Investigate Actionability	4	55139703	55139703	411	0.0535279805352798	NA	NA	NA			967		Alterations may predict sensitivity to imatinib and other TKIs	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFRA&recr=Open">Click here</a>	
SMARCA4	Missense_Mutation	p.R966W	C	C		1	Investigate Actionability	19	11134230	11134230	53	0.283018867924528	NA	NA	NA		p.R966W(1)|p.?(1)	163		Inactivation may predict sensitivity to HDAC inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMARCA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,11134230,C,C&fts=all">p.R966W</a>
TP53	Missense_Mutation	p.C176G	A	A		1	Investigate Actionability	17	7578404	7578404	48	0.916666666666667	NA	NA	NA		p.C176S(10)|p.C176R(8)|p.0?(8)|p.C176fs*71(7)|p.C176G(6)|p.C176_R181delCPHHER(3)|p.R174fs*24(3)|p.C176fs*5(3)|p.R175_E180delRCPHHE(3)|p.V173fs*59(2)|p.R174fs*1(2)|p.V157_C176del20(1)|p.C176fs*65(1)|p.C176_P177delCP(1)|p.V173fs*69(1)|p.C176fs*68(1)|p.E171fs*61(1)|p.V173fs*23(1)|p.R174_H178>S(1)|p.V172_E180delVVRRCPHHE(1)|p.R174_H179delRRCPHH(1)|p.E171fs*1(1)|p.R175_H178>X(1)|p.C44G(1)|p.R42fs*24(1)|p.C176fs*72(1)|p.R174_C176delRRC(1)|p.H168fs*69(1)|p.R174fs*70(1)|p.C176del(1)|p.E171_H179delEVVRRCPHH(1)|p.R81fs*24(1)|p.R174_E180>K(1)|p.C83G(1)|p.C176fs*6(1)|p.R174fs*3(1)	24185	Interaction with AXIN1. {ECO:0000250}.|Interaction with HIPK1. {ECO:0000250}.|Required for interaction with FBXO42.|Required for interaction with ZNF385A.	Biallelic inactivation or mutation may be prognostic in some tumor types.  They may also predict sensitivity to some cell cycle inhibitors and p53 specific gene therapies or immunotherapies. May signal the presence of a germline mutation.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TP53&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7578404,A,A&fts=all">p.C176G</a>
ABL1	Missense_Mutation	p.P310S	C	C		1.75	High Priority	9	133748267	133748267	116	0.301724137931034	NA	NA	NA			1195	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Translocations predict sensitivity to tyrosine kinase inhibitors such as imatinib, dasatinib, and nilotinib.  Secondary mutations can cause resistance to these agents.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,133748267,C,C&fts=all">p.P310S</a>
ERBB4	Missense_Mutation	p.G741E	C	C		1.75	High Priority	2	212483981	212483981	128	0.6015625	NA	NA	NA			179	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Mutations may predict sensitivity to Lapatinib and other anti-EGF family inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERBB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,212483981,C,C&fts=all">p.G741E</a>
FGFR2	Splice_Site	p.E769K	C	C		1.75	High Priority	10	123239535	123239535	209	0.167464114832536	NA	NA	NA			181	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Alterations may predict sensitivity to FGFR inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGFR2&recr=Open">Click here</a>	
FGFR2	Missense_Mutation	p.M735I	C	C		1.75	High Priority	10	123243311	123243311	28	0.214285714285714	NA	NA	NA			181	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Alterations may predict sensitivity to FGFR inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGFR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123243311,C,C&fts=all">p.M735I</a>
FGFR2	Missense_Mutation	p.M585I	C	C		1.75	High Priority	10	123256157	123256157	186	0.204301075268817	NA	NA	NA			181	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Alterations may predict sensitivity to FGFR inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGFR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123256157,C,C&fts=all">p.M585I</a>
FLT3	Missense_Mutation	p.F621I	A	A		1.75	High Priority	13	28608105	28608105	197	0.258883248730964	NA	NA	NA		p.A620_F621ins39(1)	12390	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Mutations predict sensitivity to FLT3 inhibitors, sunitinib.  Secondary mutations predict resistance.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,28608105,A,A&fts=all">p.F621I</a>
NTRK3	Missense_Mutation	p.P725L	G	G		1.75	High Priority	15	88423619	88423619	37	0.459459459459459	NA	NA	NA			119	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Fusion with ETS factors (in secretory breast cancer, for example) may predict sensitivity to PI3K pathway inhibitors, SRC inhibitors, and/or IGF1-R inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NTRK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,88423619,G,G&fts=all">p.P725L</a>
ROS1	Splice_Site	p.T2045T	C	C	rs376249709	1.75	High Priority	6	117638306	117638306	80	0.3875	NA	NA	NA			162	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Translocations predict sensitivity to  crizotinib.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROS1&recr=Open">Click here</a>	
ABL1	Missense_Mutation	p.R1013W	C	C		2	High Priority	9	133760714	133760714	58	0.310344827586207	NA	NA	NA			1195	F-actin-binding.|Pro-rich.	Translocations predict sensitivity to tyrosine kinase inhibitors such as imatinib, dasatinib, and nilotinib.  Secondary mutations can cause resistance to these agents.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,133760714,C,C&fts=all">p.R1013W</a>
AKT1	Missense_Mutation	p.E127K	C	C		2	High Priority	14	105237151	105237151	32	0.6875	NA	NA	NA			176		Mutations may predict sensitivity to AKT/MTOR inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,105237151,C,C&fts=all">p.E127K</a>
ALK	Missense_Mutation	p.D305N	C	C		2	High Priority	2	29917755	29917755	104	0.307692307692308	NA	NA	NA			340	MAM 1. {ECO:0000255|PROSITE- ProRule:PRU00128}.	Translocations predict sensitivity to ALK-inhibitors such as crizotinib.  Secondary mutations can cause resistance.  Amplification and activating mutations may also be sensitive to these agents.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,29917755,C,C&fts=all">p.D305N</a>
APC	Missense_Mutation	p.A591V	C	C		2	High Priority	5	112170676	112170676	158	0.0632911392405063	NA	NA	NA		p.?(1)	3261	Leu-rich.	Biallelic inactivation may predict sensitivity to inhibitors of WNT signaling or anti-TRAIL antibodies. May signal the presence of a germline mutation.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,112170676,C,C&fts=all">p.A591V</a>
ATM	Missense_Mutation	p.E71K	G	G		2	High Priority	11	108099930	108099930	194	0.38659793814433	NA	NA	NA			448		Biallelic inactivation may predict sensitivity to PARP inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,108099930,G,G&fts=all">p.E71K</a>
ATM	Nonsense_Mutation	p.R1875*	C	C	rs376603775	2	High Priority	11	108175528	108175528	158	0.39873417721519	NA	NA	NA			448		Biallelic inactivation may predict sensitivity to PARP inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,108175528,C,C&fts=all">p.R1875*</a>
ATR	Missense_Mutation	p.P2271S	G	G		2	High Priority	3	142185252	142185252	166	0.475903614457831	NA	NA	NA			122		Biallelic inactivation may predict sensitivity to PARP inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,142185252,G,G&fts=all">p.P2271S</a>
BRCA1	Missense_Mutation	p.E914K	C	C	rs80357419	2	High Priority	17	41244808	41244808	252	0.392857142857143	NA	NA	NA			120		Biallelic inactivation predict sensitivity to PARP inhibitors. May signal the presence of a germline mutation.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRCA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,41244808,C,C&fts=all">p.E914K</a>
BRCA2	Missense_Mutation	p.L901F	C	C	rs397507637	2	High Priority	13	32911193	32911193	254	0.610236220472441	NA	NA	NA			183	Interaction with NPM1.	Biallelic inactivation predict sensitivity to PARP inhibitors. May signal the presence of a germline mutation.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRCA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,32911193,C,C&fts=all">p.L901F</a>
CCNE1	Missense_Mutation	p.P295S	C	C	rs139792204	2	High Priority	19	30313189	30313189	294	0.207482993197279	NA	NA	NA		p.P295T(1)	20		Amplification may predict sensitivity to CDK2 inhibitors.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCNE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,30313189,C,C&fts=all">p.P295S</a>
CDKN2A	Nonsense_Mutation	p.R29*	G	G	rs121913388	2	High Priority	9	21971120	21971120	23	1	NA	NA	NA		p.0?(1315)|p.R80*(100)|p.?(44)|p.P135L(7)|p.L65fs*38(1)|p.T79fs*37(1)|p.0(1)|p.A76fs*64(1)|p.T79fs*65(1)|p.E61_L94del(1)|p.A68fs*3(1)|p.R80fs*34(1)	4199		Biallelic inactivation may predict sensitivity to CDK4/6 inhibitors.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDKN2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,21971120,G,G&fts=all">p.R29*</a>
EGFR	Nonsense_Mutation	p.E59*	G	G		2	High Priority	7	55210065	55210065	180	0.288888888888889	NA	NA	NA			14110		Mutations targetable with TKIs (both FDA approved and novel). Other mutations predict resistance to TKIs.  Amplification associated with response to anti-EGFR Abs in colon cancer. Amplification also associated with resistance to TKIs in some cancers.  Rearangement is prognostic in GBM, HNSCC	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGFR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,55210065,G,G&fts=all">p.E59*</a>
EPHA3	Missense_Mutation	p.D129H	G	G	rs201357801	2	High Priority	3	89259241	89259241	339	0.209439528023599	NA	NA	NA			139	Eph LBD. {ECO:0000255|PROSITE- ProRule:PRU00883}.	Alterations may predict sensitivity to dasatinib or novel ephrin inhibitors.  Alterations may be prognostic in lung cancer	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,89259241,G,G&fts=all">p.D129H</a>
EPHA3	Missense_Mutation	p.S334F	C	C		2	High Priority	3	89390935	89390935	112	0.196428571428571	NA	NA	NA			139	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.	Alterations may predict sensitivity to dasatinib or novel ephrin inhibitors.  Alterations may be prognostic in lung cancer	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,89390935,C,C&fts=all">p.S334F</a>
EPHA5	Missense_Mutation	p.H664Y	G	G		2	High Priority	4	66231710	66231710	175	0.32	NA	NA	NA			142		Alterations may predict sensitivity to dasatinib or novel ephrin inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,66231710,G,G&fts=all">p.H664Y</a>
EPHA5	Missense_Mutation	p.E633K	C	C		2	High Priority	4	66233102	66233102	142	0.352112676056338	NA	NA	NA		p.E633*(1)	142		Alterations may predict sensitivity to dasatinib or novel ephrin inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,66233102,C,C&fts=all">p.E633K</a>
ERBB4	Missense_Mutation	p.P651L	G	G		2	High Priority	2	212495314	212495314	77	0.636363636363636	NA	NA	NA			179		Mutations may predict sensitivity to Lapatinib and other anti-EGF family inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERBB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,212495314,G,G&fts=all">p.P651L</a>
ERBB4	Missense_Mutation	p.H162Y	G	G		2	High Priority	2	212652822	212652822	146	0.321917808219178	NA	NA	NA			179		Mutations may predict sensitivity to Lapatinib and other anti-EGF family inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERBB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,212652822,G,G&fts=all">p.H162Y</a>
ERBB4	Missense_Mutation	p.S38F	G	G		2	High Priority	2	212989598	212989598	104	0.153846153846154	NA	NA	NA			179		Mutations may predict sensitivity to Lapatinib and other anti-EGF family inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERBB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,212989598,G,G&fts=all">p.S38F</a>
ERBB4	Missense_Mutation	p.G31E	C	C		2	High Priority	2	212989619	212989619	99	0.626262626262626	NA	NA	NA			179		Mutations may predict sensitivity to Lapatinib and other anti-EGF family inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERBB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,212989619,C,C&fts=all">p.G31E</a>
ERG	Missense_Mutation	p.S222F	G	G		2	High Priority	21	39774508	39774508	58	0.155172413793103	NA	NA	NA			4		Fusion with TMPRSS2 shown to potentiate sensitivity to PARP inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,39774508,G,G&fts=all">p.S222F</a>
ETV1	Missense_Mutation	p.R368C	G	G		2	High Priority	7	13940404	13940404	73	0.287671232876712	NA	NA	NA			31		Diagnostic in prostate cancer	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ETV1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,13940404,G,G&fts=all">p.R368C</a>
ETV6	Missense_Mutation	p.A336T	G	G		2	High Priority	12	12022900	12022900	85	0.188235294117647	NA	NA	NA			45		Diagnostic in prostate cancer	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ETV6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,12022900,G,G&fts=all">p.A336T</a>
FGFR2	Missense_Mutation	p.S790F	G	G		2	High Priority	10	123239471	123239471	161	0.136645962732919	NA	NA	NA			181		Alterations may predict sensitivity to FGFR inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGFR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123239471,G,G&fts=all">p.S790F</a>
FGFR2	Missense_Mutation	p.T137I	G	G		2	High Priority	10	123324060	123324060	141	0.304964539007092	NA	NA	NA			181		Alterations may predict sensitivity to FGFR inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGFR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123324060,G,G&fts=all">p.T137I</a>
FLT3	Missense_Mutation	p.S389L	G	G		2	High Priority	13	28622451	28622451	206	0.223300970873786	NA	NA	NA			12390		Mutations predict sensitivity to FLT3 inhibitors, sunitinib.  Secondary mutations predict resistance.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,28622451,G,G&fts=all">p.S389L</a>
GNAQ	Missense_Mutation	p.P127Q	G	G		2	High Priority	9	80430628	80430628	228	0.285087719298246	NA	NA	NA			302		Mutations may predict sensitivity to MAPK pathway inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GNAQ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,80430628,G,G&fts=all">p.P127Q</a>
KRAS	Missense_Mutation	p.F156L	A	A		2	High Priority	12	25368477	25368477	417	0.189448441247002	NA	NA	NA			25349		Mutations may predict resistance to anti-EGFR therapies (cetuximab, ant-EGFR TKIs).  Mutations may predict sensitivity to MEK inhibitors.  Mutations may be directly targetable by some therapies (immunotherapies, viruses).  Prognostic in some cancer types.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRAS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,25368477,A,A&fts=all">p.F156L</a>
MSH6	Missense_Mutation	p.L778F	C	C		2	High Priority	2	48027454	48027454	397	0.307304785894207	NA	NA	NA		p.0?(2)	229		Prognostic / Diagnostic in colon cancer	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSH6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,48027454,C,C&fts=all">p.L778F</a>
MSH6	Missense_Mutation	p.L778P	T	T		2	High Priority	2	48027455	48027455	390	0.307692307692308	NA	NA	NA		p.0?(2)	229		Prognostic / Diagnostic in colon cancer	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSH6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,48027455,T,T&fts=all">p.L778P</a>
MTOR	Missense_Mutation	p.S2035F	G	G		2	High Priority	1	11187793	11187793	296	0.027027027027027	NA	NA	NA			149	Sufficient for interaction with the FKBP1A/rapamycin complex. {ECO:0000250}.	Activating mutations may predict sensitivity to MTOR inhibitors. Secondary mutations may predict resistance to MTOR inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTOR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,11187793,G,G&fts=all">p.S2035F</a>
MTOR	Missense_Mutation	p.R1009W	G	G		2	High Priority	1	11288730	11288730	67	0.0597014925373134	NA	NA	NA			149		Activating mutations may predict sensitivity to MTOR inhibitors. Secondary mutations may predict resistance to MTOR inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTOR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,11288730,G,G&fts=all">p.R1009W</a>
NF1	Nonsense_Mutation	p.Q282*	C	C		2	High Priority	17	29509639	29509639	41	0.731707317073171	NA	NA	NA		p.0?(8)|p.?(4)	599		Biallelic inactivation may predict sensitivity to PI3K pathway inhibitors (PI3K/AKT/MTOR).  Biallelic inactivation mapy predict resistance to RAF and MEK inhibitors.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,29509639,C,C&fts=all">p.Q282*</a>
NOTCH1	Missense_Mutation	p.S2228F	G	G		2	High Priority	9	139391508	139391508	25	0.56	NA	NA	NA		p.K2182fs*61(1)|p.S2163_T2283del(1)	1359		Activating mutations and rearrangements may predict sensitivity to Notch inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOTCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,139391508,G,G&fts=all">p.S2228F</a>
NOTCH1	Missense_Mutation	p.P2222S	G	G		2	High Priority	9	139391527	139391527	36	0.583333333333333	NA	NA	NA		p.K2182fs*61(1)|p.S2163_T2283del(1)	1359		Activating mutations and rearrangements may predict sensitivity to Notch inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOTCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,139391527,G,G&fts=all">p.P2222S</a>
NOTCH1	Missense_Mutation	p.S1911F	G	G		2	High Priority	9	139395206	139395206	49	0.285714285714286	NA	NA	NA			1359		Activating mutations and rearrangements may predict sensitivity to Notch inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOTCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,139395206,G,G&fts=all">p.S1911F</a>
NOTCH1	Missense_Mutation	p.A495V	G	G		2	High Priority	9	139411795	139411795	16	0.4375	NA	NA	NA			1359	EGF-like 13; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.	Activating mutations and rearrangements may predict sensitivity to Notch inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOTCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,139411795,G,G&fts=all">p.A495V</a>
NTRK3	Missense_Mutation	p.D467N	C	C		2	High Priority	15	88483877	88483877	64	0.578125	NA	NA	NA		p.D565H(1)	119		Fusion with ETS factors (in secretory breast cancer, for example) may predict sensitivity to PI3K pathway inhibitors, SRC inhibitors, and/or IGF1-R inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NTRK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,88483877,C,C&fts=all">p.D467N</a>
NTRK3	Missense_Mutation	p.K466N	C	C		2	High Priority	15	88483878	88483878	63	0.587301587301587	NA	NA	NA			119		Fusion with ETS factors (in secretory breast cancer, for example) may predict sensitivity to PI3K pathway inhibitors, SRC inhibitors, and/or IGF1-R inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NTRK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,88483878,C,C&fts=all">p.K466N</a>
PDGFRA	Missense_Mutation	p.K504Q	A	A		2	High Priority	4	55139849	55139849	344	0.0668604651162791	NA	NA	NA			967	Ig-like C2-type 5.	Alterations may predict sensitivity to imatinib and other TKIs	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFRA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,55139849,A,A&fts=all">p.K504Q</a>
PDGFRB	Missense_Mutation	p.P129S	G	G		2	High Priority	5	149514559	149514559	59	0.271186440677966	NA	NA	NA			75	Ig-like C2-type 2.	Alterations may predict sensitivity to imatinib and other TKIs	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFRB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,149514559,G,G&fts=all">p.P129S</a>
PTCH1	Missense_Mutation	p.P1282S	G	G		2	High Priority	9	98209694	98209694	78	0.294871794871795	NA	NA	NA			490		Mutations may predict sensitivity to hedgehog inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,98209694,G,G&fts=all">p.P1282S</a>
RAF1	Missense_Mutation	p.L136F	G	G		2	High Priority	3	12650749	12650749	441	0.183673469387755	NA	NA	NA			32		Alterations may predict sensitivity to RAF inhibitors.  Amplification may predict resistance to mutant-specific RAF inhibitors (like vemurafenib). 	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,12650749,G,G&fts=all">p.L136F</a>
ROS1	Missense_Mutation	p.P1929S	G	G		2	High Priority	6	117641186	117641186	41	0.365853658536585	NA	NA	NA			162		Translocations predict sensitivity to  crizotinib.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,117641186,G,G&fts=all">p.P1929S</a>
ROS1	Missense_Mutation	p.P1710S	G	G		2	High Priority	6	117658455	117658455	124	0.0483870967741935	NA	NA	NA			162	Fibronectin type-III 8. {ECO:0000255|PROSITE-ProRule:PRU00316}.	Translocations predict sensitivity to  crizotinib.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,117658455,G,G&fts=all">p.P1710S</a>
ROS1	Missense_Mutation	p.E1244K	C	C		2	High Priority	6	117679091	117679091	77	0.441558441558442	NA	NA	NA			162		Translocations predict sensitivity to  crizotinib.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,117679091,C,C&fts=all">p.E1244K</a>
ROS1	Missense_Mutation	p.G242E	C	C		2	High Priority	6	117718132	117718132	157	0.305732484076433	NA	NA	NA			162	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.	Translocations predict sensitivity to  crizotinib.	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,117718132,C,C&fts=all">p.G242E</a>
SYK	Missense_Mutation	p.P229L	C	C		2	High Priority	9	93624595	93624595	23	0.304347826086957	NA	NA	NA			26	SH2 2. {ECO:0000255|PROSITE- ProRule:PRU00191}.	Activating mutations may predict sensitivity to Syk inhibitors	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,93624595,C,C&fts=all">p.P229L</a>
TET2	Missense_Mutation	p.P413L	C	C		2	High Priority	4	106156337	106156337	125	0.288	NA	NA	NA			1314	Pro-rich.	Prognostic in MDS 	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TET2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,106156337,C,C&fts=all">p.P413L</a>
FLI1	Splice_Site		G	G		3	Investigate Actionability	11	128651852	128651852	182	0.43956043956044	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLI1&recr=Open">Click here</a>	
PLAG1	Missense_Mutation	p.P431L	G	G		3	Investigate Actionability	8	57079013	57079013	129	0.255813953488372	NA	NA	NA		p.P431L(2)|p.P431H(2)	28	Activates transcription; Inhibition of nuclear import due to lack of NLS and KPNA2 interaction.|Massively activates transcription.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLAG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,57079013,G,G&fts=all">p.P431L</a>
ARNT	Missense_Mutation	p.S673F	G	G		3.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	1	150786642	150786642	214	0.177570093457944	NA	NA	NA	 KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PATHWAYS_IN_CANCER  | 		34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARNT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,150786642,G,G&fts=all">p.S673F</a>
BIRC3	Missense_Mutation	p.P40S	C	C		3.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	11	102195358	102195358	149	0.342281879194631	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BIRC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,102195358,C,C&fts=all">p.P40S</a>
CBLC	Missense_Mutation	p.F139Y	T	T		3.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	19	45284224	45284224	51	0.176470588235294	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		17	4H.|Cbl-PTB. {ECO:0000255|PROSITE- ProRule:PRU00839}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CBLC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,45284224,T,T&fts=all">p.F139Y</a>
MECOM	Missense_Mutation	p.L203F	G	G		3.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	3	168834489	168834489	176	0.306818181818182	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MECOM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,168834489,G,G&fts=all">p.L203F</a>
PAX8	Missense_Mutation	p.G338E	C	C		3.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	2	113993045	113993045	18	0.555555555555556	NA	NA	NA	 KEGG_THYROID_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAX8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,113993045,C,C&fts=all">p.G338E</a>
PAX8	Missense_Mutation	p.G74R	C	C		3.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	2	114002173	114002173	156	0.0641025641025641	NA	NA	NA	 KEGG_THYROID_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		20	Paired. {ECO:0000255|PROSITE- ProRule:PRU00381}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAX8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,114002173,C,C&fts=all">p.G74R</a>
PPARG	Missense_Mutation	p.D200N	G	G		3.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	3	12447443	12447443	102	0.176470588235294	NA	NA	NA	 KEGG_THYROID_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPARG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,12447443,G,G&fts=all">p.D200N</a>
RUNX1T1	Missense_Mutation	p.M365I	C	C		3.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	8	92998536	92998536	156	0.185897435897436	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		86	Important for oligomerization.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RUNX1T1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,92998536,C,C&fts=all">p.M365I</a>
RUNX1T1	Missense_Mutation	p.E339K	C	C		3.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	8	92999177	92999177	242	0.227272727272727	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		86	Important for oligomerization.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RUNX1T1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,92999177,C,C&fts=all">p.E339K</a>
RUNX1T1	Missense_Mutation	p.E261K	C	C		3.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	8	93004077	93004077	120	0.225	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RUNX1T1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,93004077,C,C&fts=all">p.E261K</a>
RUNX1T1	Missense_Mutation	p.D220N	C	C		3.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	8	93017426	93017426	82	0.451219512195122	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RUNX1T1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,93017426,C,C&fts=all">p.D220N</a>
TPR	Missense_Mutation	p.R2145C	G	G		3.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	1	186291478	186291478	281	0.202846975088968	NA	NA	NA	 KEGG_THYROID_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		123			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,186291478,G,G&fts=all">p.R2145C</a>
CREB3L1	Missense_Mutation	p.P455S	C	C		3.04545454545455	Cancer Pathway Linked to: MTOR; RAF1; PDGFRA; PDGFRB; EGFR; FGFR2; KRAS; AKT1; TP53; ERBB2; CCNE1	11	46341919	46341919	13	0.307692307692308	NA	NA	NA	 KEGG_PROSTATE_CANCER  | 		12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CREB3L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,46341919,C,C&fts=all">p.P455S</a>
BUB1B	Missense_Mutation	p.P342L	C	C		3.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	15	40477810	40477810	357	0.263305322128852	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 		36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BUB1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,40477810,C,C&fts=all">p.P342L</a>
BCR	Missense_Mutation	p.S371L	C	C		3.25	Cancer Pathway Linked to: RAF1; AKT1	22	23524259	23524259	37	0.216216216216216	NA	NA	NA	 BIOCARTA_GLEEVEC_PATHWAY  |  KEGG_PATHWAYS_IN_CANCER  | 		35	Binding to ABL SH2-domain.|Kinase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,23524259,C,C&fts=all">p.S371L</a>
WAS	Missense_Mutation	p.E285K	G	G		3.5	Cancer Pathway Linked to: PDGFRA	X	48546764	48546764	24	0.291666666666667	NA	NA	NA	 BIOCARTA_CDC42RAC_PATHWAY  | 		28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WAS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,48546764,G,G&fts=all">p.E285K</a>
ITK	Missense_Mutation	p.E550K	G	G		3.75	Cancer Gene Census	5	156675874	156675874	76	0.342105263157895	NA	NA	NA			70	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,156675874,G,G&fts=all">p.E550K</a>
AFF3	Missense_Mutation	p.G290E	C	C		4	Cancer Gene Census	2	100623098	100623098	104	0.346153846153846	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,100623098,C,C&fts=all">p.G290E</a>
AFF4	Missense_Mutation	p.P346S	G	G		4	Cancer Gene Census	5	132262827	132262827	130	0.315384615384615	NA	NA	NA			43	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFF4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,132262827,G,G&fts=all">p.P346S</a>
AKAP9	Nonsense_Mutation	p.L1350*	T	T		4	Cancer Gene Census	7	91652224	91652224	127	0.456692913385827	NA	NA	NA			155			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,91652224,T,T&fts=all">p.L1350*</a>
ALDH2	Splice_Site	p.P184L	C	C	rs191240032	4	Cancer Gene Census	12	112227737	112227737	40	0.375	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH2&recr=Open">Click here</a>	
ARID1A	Missense_Mutation	p.P1885S	C	C		4	Cancer Gene Census	1	27106693	27106693	112	0.553571428571429	NA	NA	NA			411			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARID1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,27106693,C,C&fts=all">p.P1885S</a>
ATRX	In_Frame_Del	p.H544del	TGA	TGA	rs35738915	4	Cancer Gene Census	X	76939114	76939116	488	0.403688524590164	NA	NA	NA		p.?(1)	145			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATRX&recr=Open">Click here</a>	
BCAR3	Missense_Mutation	p.R381K	C	C		4	Cancer Gene Census	1	94048402	94048402	80	0.925	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCAR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,94048402,C,C&fts=all">p.R381K</a>
BCL10	Missense_Mutation	p.P76S	G	G		4	Cancer Gene Census	1	85736421	85736421	421	0.933491686460808	NA	NA	NA			19	CARD. {ECO:0000255|PROSITE- ProRule:PRU00046}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,85736421,G,G&fts=all">p.P76S</a>
BCL11B	Missense_Mutation	p.P205L	G	G		4	Cancer Gene Census	14	99697708	99697708	11	0.454545454545455	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL11B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,99697708,G,G&fts=all">p.P205L</a>
BMPR1A	Missense_Mutation	p.S185N	G	G		4	Cancer Gene Census	10	88672020	88672020	322	0.0341614906832298	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMPR1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,88672020,G,G&fts=all">p.S185N</a>
BRIP1	Missense_Mutation	p.P368L	G	G		4	Cancer Gene Census	17	59878651	59878651	524	0.196564885496183	NA	NA	NA			55	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRIP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,59878651,G,G&fts=all">p.P368L</a>
CDC73	Missense_Mutation	p.P275L	C	C		4	Cancer Gene Census	1	193117091	193117091	131	0.229007633587786	NA	NA	NA			87	Interaction with POLR2A and PAF1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDC73&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,193117091,C,C&fts=all">p.P275L</a>
CDH11	Nonsense_Mutation	p.Q682*	G	G		4	Cancer Gene Census	16	64981853	64981853	185	0.275675675675676	NA	NA	NA			88			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,64981853,G,G&fts=all">p.Q682*</a>
CHIC2	Copy Number	Amplified	NA	NA	NA	4	Cancer Gene Census	4	54440169	55161441	NA	NA	26	2.27139579394749	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHIC2&recr=Open">Click here</a>	
CIC	Nonsense_Mutation	p.Q1280*	C	C		4	Cancer Gene Census	19	42793219	42793219	136	0.330882352941176	NA	NA	NA			82	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CIC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,42793219,C,C&fts=all">p.Q1280*</a>
CIC	Missense_Mutation	p.P1424S	C	C		4	Cancer Gene Census	19	42794463	42794463	141	0.219858156028369	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CIC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,42794463,C,C&fts=all">p.P1424S</a>
CIITA	Missense_Mutation	p.E406K	G	G		4	Cancer Gene Census	16	11000565	11000565	23	0.304347826086957	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CIITA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,11000565,G,G&fts=all">p.E406K</a>
CIITA	Missense_Mutation	p.K743Q	A	A		4	Cancer Gene Census	16	11001576	11001576	44	0.204545454545455	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CIITA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,11001576,A,A&fts=all">p.K743Q</a>
CLTCL1	Missense_Mutation	p.S989L	G	G		4	Cancer Gene Census	22	19203720	19203720	88	0.25	NA	NA	NA			49	Heavy chain arm.|Proximal segment.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLTCL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,19203720,G,G&fts=all">p.S989L</a>
CLTCL1	Missense_Mutation	p.M99I	C	C		4	Cancer Gene Census	22	19241704	19241704	93	0.225806451612903	NA	NA	NA			49	Globular terminal domain.|WD40-like repeat 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLTCL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,19241704,C,C&fts=all">p.M99I</a>
CRTC1	Missense_Mutation	p.F80S	T	T		4	Cancer Gene Census	19	18853832	18853832	24	0.125	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRTC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,18853832,T,T&fts=all">p.F80S</a>
CYLD	Missense_Mutation	p.H414Y	C	C		4	Cancer Gene Census	16	50813686	50813686	273	0.245421245421245	NA	NA	NA			62	Interaction with TRAF2.|Interaction with TRIP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYLD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,50813686,C,C&fts=all">p.H414Y</a>
DICER1	Missense_Mutation	p.H1767Y	G	G		4	Cancer Gene Census	14	95560290	95560290	194	0.592783505154639	NA	NA	NA			75	RNase III 2. {ECO:0000255|PROSITE- ProRule:PRU00177}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DICER1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,95560290,G,G&fts=all">p.H1767Y</a>
EIF4A2	Missense_Mutation	p.R111K	G	G		4	Cancer Gene Census	3	186502874	186502874	467	0.284796573875803	NA	NA	NA			28	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF4A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,186502874,G,G&fts=all">p.R111K</a>
ELN	Missense_Mutation	p.G89R	G	G		4	Cancer Gene Census	7	73456976	73456976	44	0.772727272727273	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,73456976,G,G&fts=all">p.G89R</a>
EXT2	Missense_Mutation	p.A407V	C	C		4	Cancer Gene Census	11	44193207	44193207	100	0.86	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,44193207,C,C&fts=all">p.A407V</a>
FCRL4	Missense_Mutation	p.E254D	T	T		4	Cancer Gene Census	1	157557151	157557151	325	0.209230769230769	NA	NA	NA			40	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCRL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,157557151,T,T&fts=all">p.E254D</a>
FLI1	Splice_Site	p.G4D	G	G		4	Cancer Gene Census	11	128651853	128651853	182	0.43956043956044	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLI1&recr=Open">Click here</a>	
FLI1	Missense_Mutation	p.R20Q	G	G	rs369164251	4	Cancer Gene Census	11	128651901	128651901	207	0.449275362318841	NA	NA	NA		p.R213Q(1)	31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,128651901,G,G&fts=all">p.R20Q</a>
GATA2	Missense_Mutation	p.G468A	C	C		4	Cancer Gene Census	3	128199902	128199902	10	0.4	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GATA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,128199902,C,C&fts=all">p.G468A</a>
GATA3	Missense_Mutation	p.S162F	C	C		4	Cancer Gene Census	10	8100511	8100511	34	0.205882352941176	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GATA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,8100511,C,C&fts=all">p.S162F</a>
GPC3	Missense_Mutation	p.G253S	C	C		4	Cancer Gene Census	X	132887784	132887784	114	0.403508771929825	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,132887784,C,C&fts=all">p.G253S</a>
GPHN	Missense_Mutation	p.G150R	G	G		4	Cancer Gene Census	14	67382778	67382778	97	0.484536082474227	NA	NA	NA			12	Interaction with GABARAP. {ECO:0000250}.|MPT Mo-transferase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPHN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,67382778,G,G&fts=all">p.G150R</a>
HNRNPA2B1	Missense_Mutation	p.P262L	G	G		4	Cancer Gene Census	7	26233251	26233251	364	0.271978021978022	NA	NA	NA			22	Gly-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNRNPA2B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,26233251,G,G&fts=all">p.P262L</a>
IKZF1	Missense_Mutation	p.L262F	C	C		4	Cancer Gene Census	7	50459495	50459495	76	0.210526315789474	NA	NA	NA		p.?(131)	276			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IKZF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,50459495,C,C&fts=all">p.L262F</a>
IKZF1	Missense_Mutation	p.E304K	G	G		4	Cancer Gene Census	7	50467675	50467675	22	0.227272727272727	NA	NA	NA		p.?(28)	276			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IKZF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,50467675,G,G&fts=all">p.E304K</a>
IL21R	Missense_Mutation	p.G511E	G	G		4	Cancer Gene Census	16	27460519	27460519	49	0.285714285714286	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL21R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,27460519,G,G&fts=all">p.G511E</a>
IL7R	Missense_Mutation	p.R206Q	G	G	rs193922644|rs193922643	4	Cancer Gene Census	5	35873661	35873661	96	0.229166666666667	NA	NA	NA			126	Fibronectin type-III. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL7R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,35873661,G,G&fts=all">p.R206Q</a>
ITK	Missense_Mutation	p.P317S	C	C		4	Cancer Gene Census	5	156667169	156667169	90	0.411111111111111	NA	NA	NA			70	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,156667169,C,C&fts=all">p.P317S</a>
KDM5A	Missense_Mutation	p.S1395L	G	G		4	Cancer Gene Census	12	406257	406257	113	0.247787610619469	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,406257,G,G&fts=all">p.S1395L</a>
LCP1	Missense_Mutation	p.S257N	C	C	rs149807920	4	Cancer Gene Census	13	46725183	46725183	106	0.264150943396226	NA	NA	NA			34	Actin-binding 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,46725183,C,C&fts=all">p.S257N</a>
LIFR	Missense_Mutation	p.S664L	G	G	rs3729744	4	Cancer Gene Census	5	38493782	38493782	204	0.205882352941176	NA	NA	NA			78	Fibronectin type-III 5. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIFR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38493782,G,G&fts=all">p.S664L</a>
LIFR	Missense_Mutation	p.P332L	G	G		4	Cancer Gene Census	5	38506731	38506731	88	0.170454545454545	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIFR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38506731,G,G&fts=all">p.P332L</a>
LIFR	Missense_Mutation	p.E233K	C	C		4	Cancer Gene Census	5	38511931	38511931	160	0.0375	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIFR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38511931,C,C&fts=all">p.E233K</a>
MAML2	Missense_Mutation	p.M907I	C	C		4	Cancer Gene Census	11	95712862	95712862	154	0.454545454545455	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAML2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,95712862,C,C&fts=all">p.M907I</a>
MKL1	Missense_Mutation	p.A802V	G	G		4	Cancer Gene Census	22	40807635	40807635	44	0.477272727272727	NA	NA	NA			30	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,40807635,G,G&fts=all">p.A802V</a>
MLF1	Missense_Mutation	p.P110S	C	C		4	Cancer Gene Census	3	158315947	158315947	189	0.0634920634920635	NA	NA	NA			3	Interaction with COPS3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,158315947,C,C&fts=all">p.P110S</a>
MLLT10	Missense_Mutation	p.P783S	C	C		4	Cancer Gene Census	10	22021956	22021956	409	0.202933985330073	NA	NA	NA			6	Transactivation domain; required for DOT1L-binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLLT10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,22021956,C,C&fts=all">p.P783S</a>
MLLT11	Missense_Mutation	p.S11F	C	C		4	Cancer Gene Census	1	151039732	151039732	432	0.708333333333333	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLLT11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,151039732,C,C&fts=all">p.S11F</a>
MLLT4	Missense_Mutation	p.R44S	A	A		4	Cancer Gene Census	6	168265257	168265257	357	0.439775910364146	NA	NA	NA			65	Ras-associating 1. {ECO:0000255|PROSITE- ProRule:PRU00166}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLLT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,168265257,A,A&fts=all">p.R44S</a>
MN1	Missense_Mutation	p.M835I	C	C		4	Cancer Gene Census	22	28194027	28194027	96	0.270833333333333	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,28194027,C,C&fts=all">p.M835I</a>
MYCN	Missense_Mutation	p.I388S	T	T		4	Cancer Gene Census	2	16085987	16085987	68	0.308823529411765	NA	NA	NA			31	bHLH. {ECO:0000255|PROSITE- ProRule:PRU00981}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,16085987,T,T&fts=all">p.I388S</a>
MYH11	Missense_Mutation	p.T94R	G	G		4	Cancer Gene Census	16	15931829	15931829	98	0.275510204081633	NA	NA	NA			123	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,15931829,G,G&fts=all">p.T94R</a>
NCOA1	Missense_Mutation	p.P1000S	C	C		4	Cancer Gene Census	2	24952481	24952481	164	0.329268292682927	NA	NA	NA	 BIOCARTA_VDR_PATHWAY  | 		53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCOA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,24952481,C,C&fts=all">p.P1000S</a>
NUP98	Missense_Mutation	p.S1006F	G	G		4	Cancer Gene Census	11	3726495	3726495	169	0.881656804733728	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,3726495,G,G&fts=all">p.S1006F</a>
PDE4DIP	Missense_Mutation	p.R1491Q	C	C	rs151134727	4	Cancer Gene Census	1	144879386	144879386	774	0.205426356589147	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE4DIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,144879386,C,C&fts=all">p.R1491Q</a>
PDE4DIP	Missense_Mutation	p.P1335L	G	G		4	Cancer Gene Census	1	144881603	144881603	147	0.115646258503401	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE4DIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,144881603,G,G&fts=all">p.P1335L</a>
PDE4DIP	Missense_Mutation	p.P1335S	G	G		4	Cancer Gene Census	1	144881604	144881604	144	0.125	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE4DIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,144881604,G,G&fts=all">p.P1335S</a>
PDE4DIP	Nonsense_Mutation	p.Q787*	G	G		4	Cancer Gene Census	1	144915477	144915477	893	0.0996640537513998	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE4DIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,144915477,G,G&fts=all">p.Q787*</a>
PDE4DIP	Start_Codon_SNP	p.M1I	C	C		4	Cancer Gene Census	1	145075860	145075860	94	0.0531914893617021	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE4DIP&recr=Open">Click here</a>	
PDGFRA	Copy Number	Amplified	NA	NA	NA	4	Investigate Biological Significance	4	54440169	55161441	NA	NA	26	2.27139579394749	FALSE		NA	NA	NA	Alterations may predict sensitivity to imatinib and other TKIs	MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFRA&recr=Open">Click here</a>	
PHOX2B	Missense_Mutation	p.E183V	T	T		4	Cancer Gene Census	4	41748221	41748221	29	0.413793103448276	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHOX2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,41748221,T,T&fts=all">p.E183V</a>
PLAG1	Missense_Mutation	p.P6S	G	G		4	Cancer Gene Census	8	57080813	57080813	127	0.236220472440945	NA	NA	NA			28	Interacts with KPNA2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLAG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,57080813,G,G&fts=all">p.P6S</a>
PMS1	Nonsense_Mutation	p.Q698*	C	C		4	Cancer Gene Census	2	190728704	190728704	219	0.232876712328767	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PMS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,190728704,C,C&fts=all">p.Q698*</a>
PMS1	Missense_Mutation	p.R919C	C	C	rs145103030	4	Cancer Gene Census	2	190742118	190742118	106	0.547169811320755	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PMS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,190742118,C,C&fts=all">p.R919C</a>
PRDM1	Missense_Mutation	p.M144I	G	G		4	Cancer Gene Census	6	106547303	106547303	89	0.370786516853933	NA	NA	NA			94	SET. {ECO:0000255|PROSITE- ProRule:PRU00190}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,106547303,G,G&fts=all">p.M144I</a>
PRDM16	Missense_Mutation	p.P508S	C	C		4	Cancer Gene Census	1	3328283	3328283	57	0.140350877192982	NA	NA	NA			59	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,3328283,C,C&fts=all">p.P508S</a>
RANBP17	Missense_Mutation	p.P317L	C	C	rs150264798	4	Cancer Gene Census	5	170343584	170343584	279	0.315412186379928	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RANBP17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,170343584,C,C&fts=all">p.P317L</a>
RNF213	Missense_Mutation	p.P2068L	C	C		4	Cancer Gene Census	17	78316998	78316998	152	0.210526315789474	NA	NA	NA			130			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF213&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,78316998,C,C&fts=all">p.P2068L</a>
SETD2	Missense_Mutation	p.P2057L	G	G		4	Cancer Gene Census	3	47103776	47103776	618	0.218446601941748	NA	NA	NA			141			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,47103776,G,G&fts=all">p.P2057L</a>
SETD2	Missense_Mutation	p.S1239F	G	G		4	Cancer Gene Census	3	47162410	47162410	447	0.498881431767338	NA	NA	NA			141			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,47162410,G,G&fts=all">p.S1239F</a>
SETD2	Missense_Mutation	p.P1085S	G	G		4	Cancer Gene Census	3	47162873	47162873	306	0.447712418300654	NA	NA	NA			141			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,47162873,G,G&fts=all">p.P1085S</a>
SLC45A3	Missense_Mutation	p.G487D	C	C		4	Cancer Gene Census	1	205628564	205628564	27	0.259259259259259	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC45A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,205628564,C,C&fts=all">p.G487D</a>
SOX2	Nonsense_Mutation	p.W79*	G	G		4	Cancer Gene Census	3	181430384	181430384	95	0.305263157894737	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,181430384,G,G&fts=all">p.W79*</a>
SRGAP3	Missense_Mutation	p.E706K	C	C		4	Cancer Gene Census	3	9055023	9055023	87	0.195402298850575	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRGAP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,9055023,C,C&fts=all">p.E706K</a>
SRGAP3	Missense_Mutation	p.S399F	G	G		4	Cancer Gene Census	3	9094838	9094838	137	0.211678832116788	NA	NA	NA			54	F-BAR domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRGAP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,9094838,G,G&fts=all">p.S399F</a>
STIL	Missense_Mutation	p.L499P	A	A		4	Cancer Gene Census	1	47746634	47746634	173	0.942196531791908	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STIL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,47746634,A,A&fts=all">p.L499P</a>
TCL1A	Missense_Mutation	p.F91L	G	G		4	Cancer Gene Census	14	96178581	96178581	97	0.247422680412371	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCL1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,96178581,G,G&fts=all">p.F91L</a>
TET1	Nonsense_Mutation	p.L148*	T	T		4	Cancer Gene Census	10	70332538	70332538	169	0.254437869822485	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TET1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,70332538,T,T&fts=all">p.L148*</a>
THRAP3	Missense_Mutation	p.P395L	C	C		4	Cancer Gene Census	1	36754804	36754804	218	0.903669724770642	NA	NA	NA			37	Required for mRNA decay activity.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THRAP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,36754804,C,C&fts=all">p.P395L</a>
TRIM27	Missense_Mutation	p.P358S	G	G		4	Cancer Gene Census	6	28872317	28872317	105	0.2	NA	NA	NA			10	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM27&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28872317,G,G&fts=all">p.P358S</a>
USP6	Missense_Mutation	p.D652N	G	G		4	Cancer Gene Census	17	5048120	5048120	197	0.218274111675127	NA	NA	NA			34	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,5048120,G,G&fts=all">p.D652N</a>
USP6	Missense_Mutation	p.N838S	A	A	rs142811802	4	Cancer Gene Census	17	5051932	5051932	147	0.238095238095238	NA	NA	NA			34	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,5051932,A,A&fts=all">p.N838S</a>
USP6	Missense_Mutation	p.S1148L	C	C	rs375831983	4	Cancer Gene Census	17	5072276	5072276	59	0.644067796610169	NA	NA	NA			34	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,5072276,C,C&fts=all">p.S1148L</a>
WHSC1L1	Missense_Mutation	p.R821K	C	C		4	Cancer Gene Census	8	38162254	38162254	208	0.201923076923077	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WHSC1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,38162254,C,C&fts=all">p.R821K</a>
WRN	Missense_Mutation	p.R225Q	G	G	rs62506077	4	Cancer Gene Census	8	30925793	30925793	131	0.435114503816794	NA	NA	NA			60	3'-5' exonuclease.|Interaction with WRNIP1. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WRN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,30925793,G,G&fts=all">p.R225Q</a>
ZNF521	Missense_Mutation	p.P630L	G	G		4	Cancer Gene Census	18	22805993	22805993	60	0.45	NA	NA	NA			149			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF521&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,22805993,G,G&fts=all">p.P630L</a>
ZNF521	Nonsense_Mutation	p.G102*	C	C		4	Cancer Gene Census	18	22807578	22807578	43	0.418604651162791	NA	NA	NA			149			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF521&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,22807578,C,C&fts=all">p.G102*</a>
ARNT2	Missense_Mutation	p.P465S	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	15	80867331	80867331	122	0.352459016393443	NA	NA	NA	 KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PATHWAYS_IN_CANCER  | 		35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARNT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,80867331,C,C&fts=all">p.P465S</a>
BIRC2	Missense_Mutation	p.P174L	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	11	102221169	102221169	259	0.123552123552124	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BIRC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,102221169,C,C&fts=all">p.P174L</a>
C6	Missense_Mutation	p.M924I	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	5	41142960	41142960	255	0.207843137254902	NA	NA	NA	 KEGG_THYROID_CANCER  |  REACTOME_CELL_CYCLE_CHECKPOINTS  |  KEGG_PATHWAYS_IN_CANCER  | 		96	C5b-binding domain.|Factor I module (FIM) 2.|Kazal-like 2. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41142960,C,C&fts=all">p.M924I</a>
C6	Missense_Mutation	p.H830L	T	T		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	5	41149477	41149477	249	0.21285140562249	NA	NA	NA	 KEGG_THYROID_CANCER  |  REACTOME_CELL_CYCLE_CHECKPOINTS  |  KEGG_PATHWAYS_IN_CANCER  | 		96	C5b-binding domain.|Factor I module (FIM) 1.|Kazal-like 1. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41149477,T,T&fts=all">p.H830L</a>
C6	Missense_Mutation	p.H830Y	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	5	41149478	41149478	250	0.216	NA	NA	NA	 KEGG_THYROID_CANCER  |  REACTOME_CELL_CYCLE_CHECKPOINTS  |  KEGG_PATHWAYS_IN_CANCER  | 		96	C5b-binding domain.|Factor I module (FIM) 1.|Kazal-like 1. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41149478,G,G&fts=all">p.H830Y</a>
C6	Missense_Mutation	p.G566R	C	C	rs372194362	4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	5	41159344	41159344	34	0.235294117647059	NA	NA	NA	 KEGG_THYROID_CANCER  |  REACTOME_CELL_CYCLE_CHECKPOINTS  |  KEGG_PATHWAYS_IN_CANCER  | 	p.G566R(1)	96	TSP type-1 3. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41159344,C,C&fts=all">p.G566R</a>
C6	Missense_Mutation	p.Y285F	T	T		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	5	41181534	41181534	249	0.200803212851406	NA	NA	NA	 KEGG_THYROID_CANCER  |  REACTOME_CELL_CYCLE_CHECKPOINTS  |  KEGG_PATHWAYS_IN_CANCER  | 		96	MACPF. {ECO:0000255|PROSITE- ProRule:PRU00745}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41181534,T,T&fts=all">p.Y285F</a>
COL4A1	Missense_Mutation	p.R715C	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	13	110833689	110833689	78	0.602564102564103	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		105	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,110833689,G,G&fts=all">p.R715C</a>
COL4A2	Missense_Mutation	p.G130E	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	13	111080842	111080842	152	0.157894736842105	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,111080842,G,G&fts=all">p.G130E</a>
COL4A2	Missense_Mutation	p.P877S	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	13	111132608	111132608	140	0.185714285714286	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		80	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,111132608,C,C&fts=all">p.P877S</a>
COL4A2	Missense_Mutation	p.P877L	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	13	111132609	111132609	141	0.177304964539007	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		80	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,111132609,C,C&fts=all">p.P877L</a>
COL4A2	Missense_Mutation	p.P1042S	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	13	111138100	111138100	76	0.184210526315789	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		80	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,111138100,C,C&fts=all">p.P1042S</a>
COL4A4	Missense_Mutation	p.G1639E	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	2	227872198	227872198	129	0.286821705426357	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		98	Collagen IV NC1. {ECO:0000255|PROSITE- ProRule:PRU00736}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,227872198,C,C&fts=all">p.G1639E</a>
COL4A4	Missense_Mutation	p.P1309S	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	2	227895207	227895207	158	0.310126582278481	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		98	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,227895207,G,G&fts=all">p.P1309S</a>
COL4A4	Missense_Mutation	p.P883S	G	G	rs200761108	4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	2	227920730	227920730	28	0.214285714285714	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		98	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,227920730,G,G&fts=all">p.P883S</a>
COL4A4	Missense_Mutation	p.G783R	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	2	227924157	227924157	98	0.295918367346939	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		98	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,227924157,C,C&fts=all">p.G783R</a>
COL4A4	Nonsense_Mutation	p.K772*	T	T		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	2	227924190	227924190	95	0.315789473684211	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		98	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,227924190,T,T&fts=all">p.K772*</a>
COL4A4	Missense_Mutation	p.M499I	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	2	227953495	227953495	99	0.292929292929293	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		98	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,227953495,C,C&fts=all">p.M499I</a>
COL4A6	Missense_Mutation	p.R568C	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	X	107431143	107431143	75	0.4	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		92	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,107431143,G,G&fts=all">p.R568C</a>
CSF2RA	Missense_Mutation	p.Q361L	A	A		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	X	1424377	1424377	93	0.290322580645161	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSF2RA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,1424377,A,A&fts=all">p.Q361L</a>
DVL1	Missense_Mutation	p.E13K	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	1	1284409	1284409	32	0.625	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		13	DIX. {ECO:0000255|PROSITE- ProRule:PRU00069}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DVL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,1284409,C,C&fts=all">p.E13K</a>
DVL3	Missense_Mutation	p.S76F	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	3	183881510	183881510	89	0.224719101123595	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		35	DIX. {ECO:0000255|PROSITE- ProRule:PRU00069}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DVL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,183881510,C,C&fts=all">p.S76F</a>
F10	Missense_Mutation	p.D88N	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	13	113793676	113793676	53	0.377358490566038	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		18	EGF-like 1; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,113793676,G,G&fts=all">p.D88N</a>
F11	Missense_Mutation	p.E487K	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	4	187206946	187206946	155	0.264516129032258	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		32	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,187206946,G,G&fts=all">p.E487K</a>
F8	Missense_Mutation	p.H95Y	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	X	154090028	154090028	208	0.480769230769231	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		120	F5/8 type A 1.|Plastocyanin-like 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,154090028,G,G&fts=all">p.H95Y</a>
F9	Missense_Mutation	p.P177L	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	X	138633230	138633230	98	0.397959183673469	NA	NA	NA	 BIOCARTA_41BB_PATHWAY  |  KEGG_PATHWAYS_IN_CANCER  | 		35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,138633230,C,C&fts=all">p.P177L</a>
FGF12	Missense_Mutation	p.G120R	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	3	192053206	192053206	187	0.0320855614973262	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,192053206,C,C&fts=all">p.G120R</a>
FGF13	Nonsense_Mutation	p.L4*	A	A		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	X	137821421	137821421	73	0.424657534246575	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		24	Mediates targeting to the nucleus. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,137821421,A,A&fts=all">p.L4*</a>
FGF14	Missense_Mutation	p.L133F	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	13	102521086	102521086	142	0.232394366197183	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,102521086,G,G&fts=all">p.L133F</a>
FGF23	Missense_Mutation	p.G104R	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	12	4481765	4481765	81	0.296296296296296	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF23&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,4481765,C,C&fts=all">p.G104R</a>
FGF9	Missense_Mutation	p.P49L	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	13	22246197	22246197	57	0.315789473684211	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,22246197,C,C&fts=all">p.P49L</a>
FN1	Nonsense_Mutation	p.W201*	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	2	216295520	216295520	174	0.28735632183908	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		109	Fibrin- and heparin-binding 1.|Fibronectin type-I 4. {ECO:0000255|PROSITE-ProRule:PRU00478}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,216295520,C,C&fts=all">p.W201*</a>
FZD6	Missense_Mutation	p.L21F	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	8	104312396	104312396	303	0.435643564356436	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		24	FZ. {ECO:0000255|PROSITE- ProRule:PRU00090}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FZD6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,104312396,C,C&fts=all">p.L21F</a>
FZD7	Missense_Mutation	p.L308F	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	2	202900292	202900292	117	0.256410256410256	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FZD7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,202900292,C,C&fts=all">p.L308F</a>
FZD7	Missense_Mutation	p.F424L	T	T		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	2	202900640	202900640	119	0.26890756302521	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FZD7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,202900640,T,T&fts=all">p.F424L</a>
ITGA2B	Missense_Mutation	p.S446F	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	17	42458303	42458303	74	0.297297297297297	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,42458303,G,G&fts=all">p.S446F</a>
ITGA6	Missense_Mutation	p.P303L	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	2	173338915	173338915	149	0.328859060402685	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,173338915,C,C&fts=all">p.P303L</a>
LAMA2	Splice_Site		T	T		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	6	129475830	129475830	108	0.444444444444444	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		194			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA2&recr=Open">Click here</a>	
LAMA2	Missense_Mutation	p.V2294A	T	T		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	6	129781358	129781358	210	0.433333333333333	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		194	Laminin G-like 1. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,129781358,T,T&fts=all">p.V2294A</a>
LAMA3	Missense_Mutation	p.S840L	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	18	21404477	21404477	156	0.416666666666667	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		128	Domain IV 1 (domain IV B).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,21404477,C,C&fts=all">p.S840L</a>
LAMA3	Missense_Mutation	p.A2469V	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	18	21494450	21494450	57	0.491228070175439	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		128	Laminin G-like 1. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,21494450,C,C&fts=all">p.A2469V</a>
LAMA3	Missense_Mutation	p.G2718E	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	18	21501525	21501525	223	0.390134529147982	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		128	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,21501525,G,G&fts=all">p.G2718E</a>
LAMA3	Splice_Site		T	T		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	18	21511167	21511167	175	0.114285714285714	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA3&recr=Open">Click here</a>	
LAMA4	Missense_Mutation	p.G1600E	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	6	112440381	112440381	98	0.387755102040816	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		100	Laminin G-like 4. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,112440381,C,C&fts=all">p.G1600E</a>
LAMA4	Missense_Mutation	p.D501N	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	6	112493863	112493863	80	0.3875	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		100	Domain II and I.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,112493863,C,C&fts=all">p.D501N</a>
LAMB3	Missense_Mutation	p.E996K	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	1	209791317	209791317	152	0.486842105263158	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		45	Domain I.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,209791317,C,C&fts=all">p.E996K</a>
LAMB4	Missense_Mutation	p.P1379L	G	G	rs149396522	4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	7	107688543	107688543	101	0.465346534653465	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		97	Domain alpha.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,107688543,G,G&fts=all">p.P1379L</a>
LAMB4	Missense_Mutation	p.G195D	C	C	rs183493480	4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	7	107748083	107748083	79	0.417721518987342	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		97	Laminin N-terminal. {ECO:0000255|PROSITE- ProRule:PRU00466}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,107748083,C,C&fts=all">p.G195D</a>
LAMC1	Missense_Mutation	p.R359C	C	C	rs147039384	4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	1	183083719	183083719	304	0.457236842105263	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 	p.R359C(2)	76	Laminin EGF-like 2. {ECO:0000255|PROSITE- ProRule:PRU00460}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,183083719,C,C&fts=all">p.R359C</a>
LAMC3	Missense_Mutation	p.P565L	C	C	rs570498707	4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	9	133927941	133927941	120	0.35	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		69	Laminin IV type A. {ECO:0000255|PROSITE- ProRule:PRU00458}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,133927941,C,C&fts=all">p.P565L</a>
LAMC3	Missense_Mutation	p.G678S	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	9	133932408	133932408	163	0.233128834355828	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		69	Laminin EGF-like 5; second part. {ECO:0000255|PROSITE-ProRule:PRU00460}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,133932408,G,G&fts=all">p.G678S</a>
LAMC3	Missense_Mutation	p.S1391F	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	9	133961052	133961052	33	0.545454545454545	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		69	Domain II and I.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,133961052,C,C&fts=all">p.S1391F</a>
NKX3-1	Missense_Mutation	p.E202K	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	8	23538835	23538835	90	0.455555555555556	NA	NA	NA	 KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKX3-1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,23538835,C,C&fts=all">p.E202K</a>
NOS2	Copy Number	Deleted	NA	NA	NA	4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	17	25621463	26370357	NA	NA	46	-1.18672159545669	TRUE	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 	NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOS2&recr=Open">Click here</a>	
STK36	Missense_Mutation	p.T879I	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	2	219561811	219561811	362	0.287292817679558	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK36&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219561811,C,C&fts=all">p.T879I</a>
WNT2	Missense_Mutation	p.D249N	C	C		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	7	116937774	116937774	53	0.509433962264151	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,116937774,C,C&fts=all">p.D249N</a>
WNT3	Missense_Mutation	p.R228C	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	17	44846072	44846072	77	0.285714285714286	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,44846072,G,G&fts=all">p.R228C</a>
WNT9B	Missense_Mutation	p.G235S	G	G		4.02631578947368	Cancer Pathway Linked to: MTOR; MSH6; RAF1; PDGFRA; KIT; APC; PDGFRB; EGFR; CDKN2A; PTCH1; ABL1; FGFR2; KRAS; FLT3; BRCA2; AKT1; TP53; ERBB2; CCNE1	17	44953713	44953713	46	0.347826086956522	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNT9B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,44953713,G,G&fts=all">p.G235S</a>
CREB3L3	Missense_Mutation	p.M10I	G	G		4.04545454545455	Cancer Pathway Linked to: MTOR; RAF1; PDGFRA; PDGFRB; EGFR; FGFR2; KRAS; AKT1; TP53; ERBB2; CCNE1	19	4154898	4154898	50	0.4	NA	NA	NA	 KEGG_PROSTATE_CANCER  | 		24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CREB3L3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4154898,G,G&fts=all">p.M10I</a>
CREB3L3	Missense_Mutation	p.K294M	A	A		4.04545454545455	Cancer Pathway Linked to: MTOR; RAF1; PDGFRA; PDGFRB; EGFR; FGFR2; KRAS; AKT1; TP53; ERBB2; CCNE1	19	4170196	4170196	75	0.213333333333333	NA	NA	NA	 KEGG_PROSTATE_CANCER  | 		24	Leucine-zipper. {ECO:0000255|PROSITE- ProRule:PRU00978}.|bZIP. {ECO:0000255|PROSITE- ProRule:PRU00978}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CREB3L3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4170196,A,A&fts=all">p.K294M</a>
INSRR	Missense_Mutation	p.D1276N	C	C		4.04545454545455	Cancer Pathway Linked to: MTOR; RAF1; PDGFRA; PDGFRB; EGFR; FGFR2; KRAS; AKT1; TP53; ERBB2; CCNE1	1	156810733	156810733	32	0.40625	NA	NA	NA	 KEGG_PROSTATE_CANCER  | 		42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INSRR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,156810733,C,C&fts=all">p.D1276N</a>
PDGFC	Missense_Mutation	p.K264M	T	T		4.04545454545455	Cancer Pathway Linked to: MTOR; RAF1; PDGFRA; PDGFRB; EGFR; FGFR2; KRAS; AKT1; TP53; ERBB2; CCNE1	4	157689055	157689055	225	0.275555555555556	NA	NA	NA	 KEGG_PROSTATE_CANCER  | 		19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,157689055,T,T&fts=all">p.K264M</a>
ALB	Missense_Mutation	p.E15K	G	G		4.0625	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; BRCA2; AKT1; TP53; ERBB2	4	74275082	74275082	157	0.261146496815287	NA	NA	NA	 KEGG_PANCREATIC_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,74275082,G,G&fts=all">p.E15K</a>
ALB	Missense_Mutation	p.D61N	G	G		4.0625	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; BRCA2; AKT1; TP53; ERBB2	4	74276044	74276044	174	0.275862068965517	NA	NA	NA	 KEGG_PANCREATIC_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,74276044,G,G&fts=all">p.D61N</a>
ALB	Missense_Mutation	p.A100V	C	C		4.0625	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; BRCA2; AKT1; TP53; ERBB2	4	74277748	74277748	181	0.303867403314917	NA	NA	NA	 KEGG_PANCREATIC_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,74277748,C,C&fts=all">p.A100V</a>
CTNNA2	Missense_Mutation	p.S408N	G	G		4.07142857142857	Cancer Pathway Linked to: RAF1; APC; EGFR; KRAS; AKT1; TP53; ERBB2	2	80646659	80646659	177	0.169491525423729	NA	NA	NA	 BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,80646659,G,G&fts=all">p.S408N</a>
CTNNA2	Missense_Mutation	p.D480N	G	G		4.07142857142857	Cancer Pathway Linked to: RAF1; APC; EGFR; KRAS; AKT1; TP53; ERBB2	2	80773086	80773086	68	0.0588235294117647	NA	NA	NA	 BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,80773086,G,G&fts=all">p.D480N</a>
CTNNA2	Missense_Mutation	p.F585Y	T	T		4.07142857142857	Cancer Pathway Linked to: RAF1; APC; EGFR; KRAS; AKT1; TP53; ERBB2	2	80801300	80801300	195	0.343589743589744	NA	NA	NA	 BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,80801300,T,T&fts=all">p.F585Y</a>
CTNNA2	Missense_Mutation	p.M722I	G	G		4.07142857142857	Cancer Pathway Linked to: RAF1; APC; EGFR; KRAS; AKT1; TP53; ERBB2	2	80816587	80816587	111	0.207207207207207	NA	NA	NA	 BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,80816587,G,G&fts=all">p.M722I</a>
CTNNA3	Missense_Mutation	p.P838L	G	G		4.07142857142857	Cancer Pathway Linked to: RAF1; APC; EGFR; KRAS; AKT1; TP53; ERBB2	10	67680263	67680263	176	0.0284090909090909	NA	NA	NA	 BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,67680263,G,G&fts=all">p.P838L</a>
CTNNA3	Missense_Mutation	p.L147I	G	G		4.07142857142857	Cancer Pathway Linked to: RAF1; APC; EGFR; KRAS; AKT1; TP53; ERBB2	10	69299281	69299281	93	0.225806451612903	NA	NA	NA	 BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,69299281,G,G&fts=all">p.L147I</a>
CTNNA3	Nonsense_Mutation	p.K96*	T	T		4.07142857142857	Cancer Pathway Linked to: RAF1; APC; EGFR; KRAS; AKT1; TP53; ERBB2	10	69366621	69366621	142	0.211267605633803	NA	NA	NA	 BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,69366621,T,T&fts=all">p.K96*</a>
F5	Splice_Site	p.H1806H	G	G	rs558881342	4.07142857142857	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; AKT1; TP53; ERBB2	1	169498847	169498847	125	0.32	NA	NA	NA	 KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		128	F5/8 type A 3.|Plastocyanin-like 6.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F5&recr=Open">Click here</a>	
F5	Missense_Mutation	p.P1002L	G	G		4.07142857142857	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; AKT1; TP53; ERBB2	1	169511323	169511323	272	0.636029411764706	NA	NA	NA	 KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		128	B.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,169511323,G,G&fts=all">p.P1002L</a>
F5	Missense_Mutation	p.E400K	C	C		4.07142857142857	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; AKT1; TP53; ERBB2	1	169521893	169521893	392	0.227040816326531	NA	NA	NA	 KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		128	F5/8 type A 2.|Plastocyanin-like 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,169521893,C,C&fts=all">p.E400K</a>
PLCG2	Missense_Mutation	p.T736I	C	C		4.07142857142857	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; AKT1; TP53; ERBB2	16	81953241	81953241	94	0.351063829787234	NA	NA	NA	 KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,81953241,C,C&fts=all">p.T736I</a>
PLCG2	Missense_Mutation	p.P971L	C	C		4.07142857142857	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; AKT1; TP53; ERBB2	16	81969843	81969843	65	0.4	NA	NA	NA	 KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		58	PI-PLC Y-box. {ECO:0000255|PROSITE- ProRule:PRU00271}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,81969843,C,C&fts=all">p.P971L</a>
PLCG2	Missense_Mutation	p.R1071C	C	C		4.07142857142857	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; AKT1; TP53; ERBB2	16	81972418	81972418	51	0.274509803921569	NA	NA	NA	 KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		58	C2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,81972418,C,C&fts=all">p.R1071C</a>
PRKCG	Missense_Mutation	p.P319H	C	C		4.07142857142857	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; AKT1; TP53; ERBB2	19	54401229	54401229	69	0.130434782608696	NA	NA	NA	 KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,54401229,C,C&fts=all">p.P319H</a>
RXRA	Missense_Mutation	p.L325P	T	T		4.07142857142857	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; AKT1; TP53; ERBB2	9	137321017	137321017	50	0.3	NA	NA	NA	 BIOCARTA_VDR_PATHWAY  |  KEGG_THYROID_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		19	Ligand-binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RXRA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,137321017,T,T&fts=all">p.L325P</a>
APP	Missense_Mutation	p.D244N	C	C		4.08333333333333	Cancer Pathway Linked to: MSH6; RAF1; APC; KRAS; AKT1; TP53	21	27394291	27394291	17	0.411764705882353	NA	NA	NA	 KEGG_COLORECTAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		22	Asp/Glu-rich (acidic).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,27394291,C,C&fts=all">p.D244N</a>
AXIN1	Splice_Site	p.P372P	G	G		4.08333333333333	Cancer Pathway Linked to: MSH6; RAF1; APC; KRAS; AKT1; TP53	16	359973	359973	20	0.2	NA	NA	NA	 KEGG_ENDOMETRIAL_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 	p.R373fs*41(1)	221	Interaction with GSK3B. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AXIN1&recr=Open">Click here</a>	
DAPK1	Missense_Mutation	p.G621E	G	G		4.08333333333333	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; TP53; ERBB2	9	90272981	90272981	24	0.208333333333333	NA	NA	NA	 KEGG_BLADDER_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAPK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,90272981,G,G&fts=all">p.G621E</a>
DCC	Missense_Mutation	p.H172Y	C	C		4.08333333333333	Cancer Pathway Linked to: MSH6; RAF1; APC; KRAS; AKT1; TP53	18	50432515	50432515	53	0.339622641509434	NA	NA	NA	 KEGG_COLORECTAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		148	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,50432515,C,C&fts=all">p.H172Y</a>
DCC	Missense_Mutation	p.R211Q	G	G		4.08333333333333	Cancer Pathway Linked to: MSH6; RAF1; APC; KRAS; AKT1; TP53	18	50432633	50432633	76	0.447368421052632	NA	NA	NA	 KEGG_COLORECTAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		148	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,50432633,G,G&fts=all">p.R211Q</a>
DCC	Missense_Mutation	p.A864V	C	C		4.08333333333333	Cancer Pathway Linked to: MSH6; RAF1; APC; KRAS; AKT1; TP53	18	50994330	50994330	65	0.384615384615385	NA	NA	NA	 KEGG_COLORECTAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		148	Fibronectin type-III 5. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,50994330,C,C&fts=all">p.A864V</a>
DCC	Missense_Mutation	p.M870I	G	G		4.08333333333333	Cancer Pathway Linked to: MSH6; RAF1; APC; KRAS; AKT1; TP53	18	50994349	50994349	62	0.354838709677419	NA	NA	NA	 KEGG_COLORECTAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		148	Fibronectin type-III 5. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,50994349,G,G&fts=all">p.M870I</a>
F2	Missense_Mutation	p.H479Y	C	C		4.08333333333333	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; TP53; ERBB2	11	46750350	46750350	86	0.430232558139535	NA	NA	NA	 BIOCARTA_41BB_PATHWAY  |  KEGG_BLADDER_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		27	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,46750350,C,C&fts=all">p.H479Y</a>
F3	Missense_Mutation	p.S227F	G	G		4.08333333333333	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; TP53; ERBB2	1	94997948	94997948	153	0.470588235294118	NA	NA	NA	 KEGG_BLADDER_CANCER  |  BIOCARTA_CD40_PATHWAY  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,94997948,G,G&fts=all">p.S227F</a>
F7	Missense_Mutation	p.E275K	G	G		4.08333333333333	Cancer Pathway Linked to: MSH6; RAF1; APC; KRAS; AKT1; TP53	13	113772744	113772744	56	0.267857142857143	NA	NA	NA	 KEGG_THYROID_CANCER  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		16	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,113772744,G,G&fts=all">p.E275K</a>
MMP1	Missense_Mutation	p.R405Q	C	C	rs17879165	4.08333333333333	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; TP53; ERBB2	11	102661520	102661520	158	0.39873417721519	NA	NA	NA	 KEGG_BLADDER_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,102661520,C,C&fts=all">p.R405Q</a>
RAC2	Splice_Site	p.T68T	C	C		4.08333333333333	Cancer Pathway Linked to: MSH6; RAF1; APC; KRAS; AKT1; TP53	22	37628841	37628841	14	0.214285714285714	NA	NA	NA	 KEGG_COLORECTAL_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 	p.T75T(1)	12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAC2&recr=Open">Click here</a>	
THBS1	Missense_Mutation	p.P629L	C	C		4.08333333333333	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; TP53; ERBB2	15	39881515	39881515	92	0.521739130434783	NA	NA	NA	 KEGG_BLADDER_CANCER  | 		53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THBS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,39881515,C,C&fts=all">p.P629L</a>
THBS1	Missense_Mutation	p.D899N	G	G		4.08333333333333	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; TP53; ERBB2	15	39884931	39884931	49	0.36734693877551	NA	NA	NA	 KEGG_BLADDER_CANCER  | 		53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THBS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,39884931,G,G&fts=all">p.D899N</a>
THBS1	Missense_Mutation	p.G969E	G	G		4.08333333333333	Cancer Pathway Linked to: RAF1; EGFR; CDKN2A; KRAS; TP53; ERBB2	15	39885339	39885339	95	0.315789473684211	NA	NA	NA	 KEGG_BLADDER_CANCER  | 		53	TSP C-terminal. {ECO:0000255|PROSITE- ProRule:PRU00635}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THBS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,39885339,G,G&fts=all">p.G969E</a>
TNN	Missense_Mutation	p.G836E	G	G		4.08333333333333	Cancer Pathway Linked to: MSH6; RAF1; APC; KRAS; AKT1; TP53	1	175087817	175087817	91	0.208791208791209	NA	NA	NA	 KEGG_THYROID_CANCER  |  BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		156	Fibronectin type-III 7. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,175087817,G,G&fts=all">p.G836E</a>
TNN	Missense_Mutation	p.E928K	G	G		4.08333333333333	Cancer Pathway Linked to: MSH6; RAF1; APC; KRAS; AKT1; TP53	1	175092667	175092667	76	0.210526315789474	NA	NA	NA	 KEGG_THYROID_CANCER  |  BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		156	Fibronectin type-III 8. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,175092667,G,G&fts=all">p.E928K</a>
TNN	Missense_Mutation	p.E948K	G	G		4.08333333333333	Cancer Pathway Linked to: MSH6; RAF1; APC; KRAS; AKT1; TP53	1	175092727	175092727	79	0.455696202531646	NA	NA	NA	 KEGG_THYROID_CANCER  |  BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		156	Fibronectin type-III 8. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,175092727,G,G&fts=all">p.E948K</a>
TNN	Missense_Mutation	p.G958R	G	G		4.08333333333333	Cancer Pathway Linked to: MSH6; RAF1; APC; KRAS; AKT1; TP53	1	175092757	175092757	90	0.188888888888889	NA	NA	NA	 KEGG_THYROID_CANCER  |  BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 	p.G958R(1)	156	Fibronectin type-III 8. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,175092757,G,G&fts=all">p.G958R</a>
TNN	Missense_Mutation	p.E1022K	G	G		4.08333333333333	Cancer Pathway Linked to: MSH6; RAF1; APC; KRAS; AKT1; TP53	1	175097186	175097186	119	0.470588235294118	NA	NA	NA	 KEGG_THYROID_CANCER  |  BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		156	Fibronectin type-III 9. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,175097186,G,G&fts=all">p.E1022K</a>
CA1	Missense_Mutation	p.R174Q	C	C		4.1	Cancer Pathway Linked to: ATR; ATM; BRCA2; TP53; BRCA1	8	86242066	86242066	24	0.166666666666667	NA	NA	NA	 BIOCARTA_ATRBRCA_PATHWAY  |  REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,86242066,C,C&fts=all">p.R174Q</a>
CA1	Missense_Mutation	p.S88N	C	C		4.1	Cancer Pathway Linked to: ATR; ATM; BRCA2; TP53; BRCA1	8	86249265	86249265	130	0.407692307692308	NA	NA	NA	 BIOCARTA_ATRBRCA_PATHWAY  |  REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,86249265,C,C&fts=all">p.S88N</a>
CA2	Missense_Mutation	p.P180L	C	C		4.1	Cancer Pathway Linked to: ATR; ATM; BRCA2; TP53; BRCA1	8	86389380	86389380	195	0.220512820512821	NA	NA	NA	 BIOCARTA_ATRBRCA_PATHWAY  |  KEGG_HOMOLOGOUS_RECOMBINATION  |  KEGG_PANCREATIC_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,86389380,C,C&fts=all">p.P180L</a>
ANAPC5	Missense_Mutation	p.P498S	G	G		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	12	121758211	121758211	255	0.529411764705882	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 		31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANAPC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,121758211,G,G&fts=all">p.P498S</a>
ANAPC5	Missense_Mutation	p.L407F	G	G		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	12	121766204	121766204	75	0.266666666666667	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 		31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANAPC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,121766204,G,G&fts=all">p.L407F</a>
C7	Missense_Mutation	p.G398E	G	G		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	5	40955588	40955588	212	0.174528301886792	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 			MACPF. {ECO:0000255|PROSITE- ProRule:PRU00745}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,40955588,G,G&fts=all">p.G398E</a>
C7	Missense_Mutation	p.D547N	G	G		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	5	40959700	40959700	48	0.25	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 			CCP 1.|TSP type-1 2. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,40959700,G,G&fts=all">p.D547N</a>
C7	Missense_Mutation	p.P590S	C	C		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	5	40964861	40964861	94	0.223404255319149	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 			CCP 1.|Sushi 1. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,40964861,C,C&fts=all">p.P590S</a>
CDC25C	Missense_Mutation	p.H440Y	G	G		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	5	137621485	137621485	89	0.370786516853933	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 		16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDC25C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,137621485,G,G&fts=all">p.H440Y</a>
CLSPN	Missense_Mutation	p.L1320F	G	G		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	1	36202159	36202159	316	0.560126582278481	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 		56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLSPN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,36202159,G,G&fts=all">p.L1320F</a>
MCM10	Missense_Mutation	p.E795K	G	G		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	10	13246246	13246246	93	0.387096774193548	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 		9	Zinc finger-like 2. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCM10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,13246246,G,G&fts=all">p.E795K</a>
ORC3	Missense_Mutation	p.L241F	C	C		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	6	88321814	88321814	96	0.322916666666667	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 		28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ORC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,88321814,C,C&fts=all">p.L241F</a>
PSMD1	Missense_Mutation	p.D251N	G	G		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	2	231936999	231936999	502	0.282868525896414	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 		31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,231936999,G,G&fts=all">p.D251N</a>
PSMD5	Missense_Mutation	p.P309L	G	G		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	9	123586852	123586852	276	0.213768115942029	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 		10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSMD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,123586852,G,G&fts=all">p.P309L</a>
SMC2	Missense_Mutation	p.K406R	A	A		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	9	106874058	106874058	77	0.233766233766234	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 		48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,106874058,A,A&fts=all">p.K406R</a>
SMC2	Missense_Mutation	p.F622L	T	T		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	9	106880526	106880526	288	0.246527777777778	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 		48	Flexible hinge.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,106880526,T,T&fts=all">p.F622L</a>
UBB	Missense_Mutation	p.R130C	C	C		4.125	Cancer Pathway Linked to: ATR; ATM; TP53; CCNE1	17	16285609	16285609	220	0.236363636363636	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 	p.R130C(1)	16	Ubiquitin-like 2. {ECO:0000255|PROSITE- ProRule:PRU00214}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,16285609,C,C&fts=all">p.R130C</a>
AK7	Missense_Mutation	p.D321E	C	C		4.16666666666667	Cancer Pathway Linked to: RAF1; KRAS; AKT1	14	96917772	96917772	160	0.25	NA	NA	NA	 KEGG_RENAL_CELL_CARCINOMA  | 		31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,96917772,C,C&fts=all">p.D321E</a>
ARC	In_Frame_Del	p.K269del	CTT	CTT		4.16666666666667	Cancer Pathway Linked to: RAF1; KRAS; AKT1	8	143694826	143694828	29	0.482758620689655	NA	NA	NA	 KEGG_RENAL_CELL_CARCINOMA  | 		13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARC&recr=Open">Click here</a>	
ARC	Missense_Mutation	p.E236V	T	T		4.16666666666667	Cancer Pathway Linked to: RAF1; KRAS; AKT1	8	143694926	143694926	22	0.363636363636364	NA	NA	NA	 KEGG_RENAL_CELL_CARCINOMA  | 		13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,143694926,T,T&fts=all">p.E236V</a>
PAK7	Missense_Mutation	p.G291R	C	C		4.16666666666667	Cancer Pathway Linked to: RAF1; KRAS; AKT1	20	9560911	9560911	104	0.211538461538462	NA	NA	NA	 KEGG_RENAL_CELL_CARCINOMA  | 		81	Linker.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,9560911,C,C&fts=all">p.G291R</a>
PAK7	Missense_Mutation	p.P227S	G	G		4.16666666666667	Cancer Pathway Linked to: RAF1; KRAS; AKT1	20	9561103	9561103	49	0.510204081632653	NA	NA	NA	 KEGG_RENAL_CELL_CARCINOMA  | 		81	Linker.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,9561103,G,G&fts=all">p.P227S</a>
ADCY1	Missense_Mutation	p.M274I	G	G		4.25	Cancer Pathway Linked to: RAF1; AKT1	7	45701705	45701705	67	0.313432835820896	NA	NA	NA	 BIOCARTA_IGF1R_PATHWAY  | 		71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,45701705,G,G&fts=all">p.M274I</a>
EGF	Splice_Site	p.R170K	G	G		4.25	Cancer Pathway Linked to: RAF1; EGFR	4	110864591	110864591	239	0.280334728033473	NA	NA	NA	 BIOCARTA_EGF_PATHWAY  |  BIOCARTA_HER2_PATHWAY  |  KEGG_BLADDER_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PATHWAYS_IN_CANCER  | 		50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGF&recr=Open">Click here</a>	
EGF	Missense_Mutation	p.G863E	G	G		4.25	Cancer Pathway Linked to: RAF1; EGFR	4	110909845	110909845	147	0.591836734693878	NA	NA	NA	 BIOCARTA_EGF_PATHWAY  |  BIOCARTA_HER2_PATHWAY  |  KEGG_BLADDER_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PATHWAYS_IN_CANCER  | 		50	EGF-like 6. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,110909845,G,G&fts=all">p.G863E</a>
KL	Missense_Mutation	p.E414K	G	G		4.25	Cancer Pathway Linked to: RAF1; AKT1	13	33628324	33628324	269	0.620817843866171	NA	NA	NA	 BIOCARTA_MET_PATHWAY  |  BIOCARTA_GLEEVEC_PATHWAY  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  |  REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		41	Glycosyl hydrolase-1 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,33628324,G,G&fts=all">p.E414K</a>
KL	Missense_Mutation	p.D598N	G	G		4.25	Cancer Pathway Linked to: RAF1; AKT1	13	33635008	33635008	135	0.385185185185185	NA	NA	NA	 BIOCARTA_MET_PATHWAY  |  BIOCARTA_GLEEVEC_PATHWAY  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  |  REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		41	Glycosyl hydrolase-1 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,33635008,G,G&fts=all">p.D598N</a>
KL	Missense_Mutation	p.R979Q	G	G		4.25	Cancer Pathway Linked to: RAF1; AKT1	13	33638220	33638220	193	0.33160621761658	NA	NA	NA	 BIOCARTA_MET_PATHWAY  |  BIOCARTA_GLEEVEC_PATHWAY  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  |  REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,33638220,G,G&fts=all">p.R979Q</a>
MAP3K1	Missense_Mutation	p.P1053L	C	C		4.25	Cancer Pathway Linked to: RAF1; EGFR	5	56178185	56178185	158	0.215189873417722	NA	NA	NA	 BIOCARTA_41BB_PATHWAY  |  BIOCARTA_CD40_PATHWAY  |  BIOCARTA_EGF_PATHWAY  |  BIOCARTA_GLEEVEC_PATHWAY  | 		57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,56178185,C,C&fts=all">p.P1053L</a>
PIK3CG	Missense_Mutation	p.Y672F	A	A		4.25	Cancer Pathway Linked to: RAF1; AKT1	7	106513001	106513001	226	0.274336283185841	NA	NA	NA	 BIOCARTA_LONGEVITY_PATHWAY  |  BIOCARTA_GLEEVEC_PATHWAY  |  BIOCARTA_HER2_PATHWAY  |  BIOCARTA_MET_PATHWAY  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		132	PIK helical. {ECO:0000255|PROSITE- ProRule:PRU00878}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3CG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,106513001,A,A&fts=all">p.Y672F</a>
PLCG1	Missense_Mutation	p.E587K	G	G		4.25	Cancer Pathway Linked to: RAF1; EGFR	20	39794426	39794426	44	0.977272727272727	NA	NA	NA	 BIOCARTA_EGF_PATHWAY  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		46	SH2 1. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,39794426,G,G&fts=all">p.E587K</a>
TAT	Missense_Mutation	p.M97I	C	C		4.25	Cancer Pathway Linked to: RAF1; EGFR	16	71609874	71609874	117	0.0512820512820513	NA	NA	NA	 KEGG_PROSTATE_CANCER  |  BIOCARTA_GLEEVEC_PATHWAY  |  BIOCARTA_HER2_PATHWAY  |  BIOCARTA_EGF_PATHWAY  |  BIOCARTA_MET_PATHWAY  |  KEGG_PANCREATIC_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,71609874,C,C&fts=all">p.M97I</a>
TAT	Missense_Mutation	p.P31L	G	G		4.25	Cancer Pathway Linked to: RAF1; EGFR	16	71610227	71610227	132	0.295454545454545	NA	NA	NA	 KEGG_PROSTATE_CANCER  |  BIOCARTA_GLEEVEC_PATHWAY  |  BIOCARTA_HER2_PATHWAY  |  BIOCARTA_EGF_PATHWAY  |  BIOCARTA_MET_PATHWAY  |  KEGG_PANCREATIC_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,71610227,G,G&fts=all">p.P31L</a>
C3	Missense_Mutation	p.E822K	C	C		4.5	Cancer Pathway Linked to: PDGFRA	19	6697782	6697782	17	0.235294117647059	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  |  BIOCARTA_CDC42RAC_PATHWAY  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_MISMATCH_REPAIR  |  KEGG_PATHWAYS_IN_CANCER  |  KEGG_HOMOLOGOUS_RECOMBINATION  |  KEGG_COLORECTAL_CANCER  |  KEGG_PANCREATIC_CANCER  |  REACTOME_CELL_CYCLE_CHECKPOINTS  | 		72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,6697782,C,C&fts=all">p.E822K</a>
C5	Missense_Mutation	p.P969S	G	G		4.5	Cancer Pathway Linked to: PDGFRA	9	123753505	123753505	319	0.200626959247649	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  |  BIOCARTA_CDC42RAC_PATHWAY  |  KEGG_COLORECTAL_CANCER  |  KEGG_MISMATCH_REPAIR  |  KEGG_PATHWAYS_IN_CANCER  | 		46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,123753505,G,G&fts=all">p.P969S</a>
DOCK1	Missense_Mutation	p.P249L	C	C		4.5	Cancer Pathway Linked to: RAF1	10	128796492	128796492	285	0.224561403508772	NA	NA	NA	 BIOCARTA_MET_PATHWAY  | 		72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,128796492,C,C&fts=all">p.P249L</a>
EXO1	Missense_Mutation	p.P297L	C	C		4.5	Cancer Pathway Linked to: MSH6	1	242023952	242023952	329	0.437689969604863	NA	NA	NA	 KEGG_MISMATCH_REPAIR  | 		45	Interaction with MSH3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXO1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,242023952,C,C&fts=all">p.P297L</a>
GAB1	Missense_Mutation	p.R58C	C	C		4.5	Cancer Pathway Linked to: RAF1	4	144336729	144336729	131	0.290076335877863	NA	NA	NA	 BIOCARTA_MET_PATHWAY  |  KEGG_RENAL_CELL_CARCINOMA  | 		30	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,144336729,C,C&fts=all">p.R58C</a>
GHR	Missense_Mutation	p.H472Y	C	C		4.5	Cancer Pathway Linked to: AKT1	5	42719023	42719023	112	0.205357142857143	NA	NA	NA	 BIOCARTA_LONGEVITY_PATHWAY  | 		39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GHR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,42719023,C,C&fts=all">p.H472Y</a>
GLI1	Missense_Mutation	p.S607F	C	C		4.5	Cancer Pathway Linked to: PTCH1	12	57864343	57864343	27	0.37037037037037	NA	NA	NA	 BIOCARTA_SHH_PATHWAY  |  KEGG_PATHWAYS_IN_CANCER  | 	p.S607F(1)	69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,57864343,C,C&fts=all">p.S607F</a>
GLI1	Missense_Mutation	p.P1029L	C	C		4.5	Cancer Pathway Linked to: PTCH1	12	57865609	57865609	120	0.441666666666667	NA	NA	NA	 BIOCARTA_SHH_PATHWAY  |  KEGG_PATHWAYS_IN_CANCER  | 		69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,57865609,C,C&fts=all">p.P1029L</a>
GLI2	Missense_Mutation	p.G274R	G	G		4.5	Cancer Pathway Linked to: PTCH1	2	121726466	121726466	22	0.590909090909091	NA	NA	NA	 BIOCARTA_SHH_PATHWAY  |  KEGG_PATHWAYS_IN_CANCER  | 		64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,121726466,G,G&fts=all">p.G274R</a>
GLI2	Missense_Mutation	p.T1545I	C	C		4.5	Cancer Pathway Linked to: PTCH1	2	121748124	121748124	81	0.54320987654321	NA	NA	NA	 BIOCARTA_SHH_PATHWAY  |  KEGG_PATHWAYS_IN_CANCER  | 		64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,121748124,C,C&fts=all">p.T1545I</a>
GLI2	Missense_Mutation	p.S1550F	C	C		4.5	Cancer Pathway Linked to: PTCH1	2	121748139	121748139	66	0.287878787878788	NA	NA	NA	 BIOCARTA_SHH_PATHWAY  |  KEGG_PATHWAYS_IN_CANCER  | 		64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,121748139,C,C&fts=all">p.S1550F</a>
HFM1	Missense_Mutation	p.S1328L	G	G		4.5	Cancer Pathway Linked to: BRCA2	1	91728141	91728141	134	0.395522388059701	NA	NA	NA	 KEGG_HOMOLOGOUS_RECOMBINATION  | 		75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HFM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,91728141,G,G&fts=all">p.S1328L</a>
HFM1	Missense_Mutation	p.R1320K	C	C		4.5	Cancer Pathway Linked to: BRCA2	1	91731589	91731589	181	0.591160220994475	NA	NA	NA	 KEGG_HOMOLOGOUS_RECOMBINATION  | 		75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HFM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,91731589,C,C&fts=all">p.R1320K</a>
HGF	Missense_Mutation	p.G555E	C	C		4.5	Cancer Pathway Linked to: RAF1	7	81335696	81335696	302	0.0364238410596026	NA	NA	NA	 BIOCARTA_MET_PATHWAY  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PATHWAYS_IN_CANCER  | 		75	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HGF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,81335696,C,C&fts=all">p.G555E</a>
HGF	Missense_Mutation	p.M400I	C	C		4.5	Cancer Pathway Linked to: RAF1	7	81350132	81350132	120	0.35	NA	NA	NA	 BIOCARTA_MET_PATHWAY  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PATHWAYS_IN_CANCER  | 		75	Kringle 4. {ECO:0000255|PROSITE- ProRule:PRU00121}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HGF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,81350132,C,C&fts=all">p.M400I</a>
HGF	Missense_Mutation	p.E199K	C	C		4.5	Cancer Pathway Linked to: RAF1	7	81381466	81381466	93	0.0537634408602151	NA	NA	NA	 BIOCARTA_MET_PATHWAY  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PATHWAYS_IN_CANCER  | 	p.E199K(1)	75	Kringle 1. {ECO:0000255|PROSITE- ProRule:PRU00121}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HGF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,81381466,C,C&fts=all">p.E199K</a>
HR	Missense_Mutation	p.R1066C	G	G		4.5	Cancer Pathway Linked to: RAF1	8	21976480	21976480	79	0.253164556962025	NA	NA	NA	 BIOCARTA_CDMAC_PATHWAY  |  BIOCARTA_IGF1R_PATHWAY  |  BIOCARTA_LONGEVITY_PATHWAY  |  KEGG_THYROID_CANCER  |  BIOCARTA_EGF_PATHWAY  |  BIOCARTA_GLEEVEC_PATHWAY  |  BIOCARTA_HER2_PATHWAY  |  BIOCARTA_MET_PATHWAY  |  KEGG_BLADDER_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		27	JmjC. {ECO:0000255|PROSITE- ProRule:PRU00538}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,21976480,G,G&fts=all">p.R1066C</a>
HR	Missense_Mutation	p.P486S	G	G		4.5	Cancer Pathway Linked to: RAF1	8	21983195	21983195	26	0.615384615384615	NA	NA	NA	 BIOCARTA_CDMAC_PATHWAY  |  BIOCARTA_IGF1R_PATHWAY  |  BIOCARTA_LONGEVITY_PATHWAY  |  KEGG_THYROID_CANCER  |  BIOCARTA_EGF_PATHWAY  |  BIOCARTA_GLEEVEC_PATHWAY  |  BIOCARTA_HER2_PATHWAY  |  BIOCARTA_MET_PATHWAY  |  KEGG_BLADDER_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,21983195,G,G&fts=all">p.P486S</a>
HR	Missense_Mutation	p.G481R	C	C		4.5	Cancer Pathway Linked to: RAF1	8	21983210	21983210	34	0.352941176470588	NA	NA	NA	 BIOCARTA_CDMAC_PATHWAY  |  BIOCARTA_IGF1R_PATHWAY  |  BIOCARTA_LONGEVITY_PATHWAY  |  KEGG_THYROID_CANCER  |  BIOCARTA_EGF_PATHWAY  |  BIOCARTA_GLEEVEC_PATHWAY  |  BIOCARTA_HER2_PATHWAY  |  BIOCARTA_MET_PATHWAY  |  KEGG_BLADDER_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,21983210,C,C&fts=all">p.G481R</a>
ITGA1	Missense_Mutation	p.D201N	G	G		4.5	Cancer Pathway Linked to: RAF1	5	52161628	52161628	206	0.359223300970874	NA	NA	NA	 BIOCARTA_MET_PATHWAY  | 		51	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,52161628,G,G&fts=all">p.D201N</a>
MAP2	Missense_Mutation	p.T639I	C	C		4.5	Cancer Pathway Linked to: RAF1	2	210558810	210558810	54	0.277777777777778	NA	NA	NA	 BIOCARTA_CDMAC_PATHWAY  |  BIOCARTA_TGFB_PATHWAY  |  BIOCARTA_IGF1R_PATHWAY  |  KEGG_THYROID_CANCER  |  BIOCARTA_EGF_PATHWAY  |  BIOCARTA_GLEEVEC_PATHWAY  |  BIOCARTA_HER2_PATHWAY  |  BIOCARTA_MET_PATHWAY  |  KEGG_BLADDER_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		124			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,210558810,C,C&fts=all">p.T639I</a>
MAP2	Missense_Mutation	p.R1771C	C	C		4.5	Cancer Pathway Linked to: RAF1	2	210594948	210594948	46	0.217391304347826	NA	NA	NA	 BIOCARTA_CDMAC_PATHWAY  |  BIOCARTA_TGFB_PATHWAY  |  BIOCARTA_IGF1R_PATHWAY  |  KEGG_THYROID_CANCER  |  BIOCARTA_EGF_PATHWAY  |  BIOCARTA_GLEEVEC_PATHWAY  |  BIOCARTA_HER2_PATHWAY  |  BIOCARTA_MET_PATHWAY  |  KEGG_BLADDER_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 	p.R1771C(1)	124			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,210594948,C,C&fts=all">p.R1771C</a>
MAP4	Missense_Mutation	p.P172L	G	G	rs138444567	4.5	Cancer Pathway Linked to: RAF1	3	47963320	47963320	284	0.144366197183099	NA	NA	NA	 BIOCARTA_41BB_PATHWAY  |  BIOCARTA_MET_PATHWAY  | 		32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,47963320,G,G&fts=all">p.P172L</a>
MAP4	Missense_Mutation	p.P172S	G	G		4.5	Cancer Pathway Linked to: RAF1	3	47963321	47963321	286	0.143356643356643	NA	NA	NA	 BIOCARTA_41BB_PATHWAY  |  BIOCARTA_MET_PATHWAY  | 		32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,47963321,G,G&fts=all">p.P172S</a>
MLH3	Missense_Mutation	p.P850S	G	G	rs575583330	4.5	Cancer Pathway Linked to: MSH6	14	75513811	75513811	310	0.374193548387097	NA	NA	NA	 KEGG_MISMATCH_REPAIR  | 		44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,75513811,G,G&fts=all">p.P850S</a>
NFKB1	Missense_Mutation	p.R57C	C	C		4.5	Cancer Pathway Linked to: RAF1	4	103459024	103459024	194	0.257731958762887	NA	NA	NA	 BIOCARTA_CDMAC_PATHWAY  |  BIOCARTA_CD40_PATHWAY  |  BIOCARTA_41BB_PATHWAY  |  KEGG_PANCREATIC_CANCER  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 	p.R57C(1)	27	RHD. {ECO:0000255|PROSITE- ProRule:PRU00265}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFKB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,103459024,C,C&fts=all">p.R57C</a>
NFKB1	Missense_Mutation	p.L517F	C	C		4.5	Cancer Pathway Linked to: RAF1	4	103518730	103518730	171	0.204678362573099	NA	NA	NA	 BIOCARTA_CDMAC_PATHWAY  |  BIOCARTA_CD40_PATHWAY  |  BIOCARTA_41BB_PATHWAY  |  KEGG_PANCREATIC_CANCER  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		27	Interaction with CFLAR.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFKB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,103518730,C,C&fts=all">p.L517F</a>
NFKB1	Missense_Mutation	p.P855L	C	C		4.5	Cancer Pathway Linked to: RAF1	4	103533735	103533735	213	0.286384976525822	NA	NA	NA	 BIOCARTA_CDMAC_PATHWAY  |  BIOCARTA_CD40_PATHWAY  |  BIOCARTA_41BB_PATHWAY  |  KEGG_PANCREATIC_CANCER  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		27	Death.|Interaction with CFLAR.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFKB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,103533735,C,C&fts=all">p.P855L</a>
PLCB1	Missense_Mutation	p.P1198H	C	C		4.5	Cancer Pathway Linked to: RAF1	20	8862438	8862438	108	0.138888888888889	NA	NA	NA	 BIOCARTA_CDMAC_PATHWAY  | 		95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,8862438,C,C&fts=all">p.P1198H</a>
POLD2	Missense_Mutation	p.S323F	G	G		4.5	Cancer Pathway Linked to: BRCA2	7	44155765	44155765	90	0.333333333333333	NA	NA	NA	 KEGG_HOMOLOGOUS_RECOMBINATION  |  KEGG_MISMATCH_REPAIR  | 		12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,44155765,G,G&fts=all">p.S323F</a>
PTK2B	Splice_Site		G	G		4.5	Cancer Pathway Linked to: RAF1	8	27287880	27287880	116	0.198275862068966	NA	NA	NA	 BIOCARTA_MET_PATHWAY  | 		47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTK2B&recr=Open">Click here</a>	
PXN	Missense_Mutation	p.P413S	G	G	rs536359448	4.5	Cancer Pathway Linked to: RAF1	12	120652663	120652663	144	0.0347222222222222	NA	NA	NA	 BIOCARTA_CELL2CELL_PATHWAY  |  BIOCARTA_MET_PATHWAY  | 		19	LIM zinc-binding 1. {ECO:0000255|PROSITE- ProRule:PRU00125}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,120652663,G,G&fts=all">p.P413S</a>
RAD54B	Missense_Mutation	p.R25G	T	T		4.5	Cancer Pathway Linked to: BRCA2	8	95479695	95479695	345	0.231884057971014	NA	NA	NA	 KEGG_HOMOLOGOUS_RECOMBINATION  | 		39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAD54B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,95479695,T,T&fts=all">p.R25G</a>
RAD54L	Missense_Mutation	p.Q203H	G	G		4.5	Cancer Pathway Linked to: BRCA2	1	46726530	46726530	72	0.388888888888889	NA	NA	NA	 KEGG_HOMOLOGOUS_RECOMBINATION  | 		25	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAD54L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,46726530,G,G&fts=all">p.Q203H</a>
RELA	Missense_Mutation	p.P369L	G	G		4.5	Cancer Pathway Linked to: RAF1	11	65422399	65422399	15	0.4	NA	NA	NA	 BIOCARTA_CD40_PATHWAY  |  BIOCARTA_41BB_PATHWAY  |  BIOCARTA_CDMAC_PATHWAY  |  KEGG_PANCREATIC_CANCER  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,65422399,G,G&fts=all">p.P369L</a>
RFC3	Missense_Mutation	p.S219F	C	C		4.5	Cancer Pathway Linked to: MSH6	13	34404938	34404938	205	0.292682926829268	NA	NA	NA	 KEGG_MISMATCH_REPAIR  |  REACTOME_CELL_CYCLE_CHECKPOINTS  | 		3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,34404938,C,C&fts=all">p.S219F</a>
RHOA	Missense_Mutation	p.S73F	G	G		4.5	Cancer Pathway Linked to: PDGFRA	3	49405920	49405920	224	0.21875	NA	NA	NA	 BIOCARTA_CDC42RAC_PATHWAY  |  KEGG_COLORECTAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHOA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49405920,G,G&fts=all">p.S73F</a>
TG	Missense_Mutation	p.P714S	C	C		4.5	Cancer Pathway Linked to: RAF1	8	133899757	133899757	144	0.1875	NA	NA	NA	 BIOCARTA_TGFB_PATHWAY  |  BIOCARTA_MET_PATHWAY  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		168	Thyroglobulin type-1 6. {ECO:0000255|PROSITE-ProRule:PRU00500}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,133899757,C,C&fts=all">p.P714S</a>
TG	Missense_Mutation	p.E1518K	G	G	rs200687678	4.5	Cancer Pathway Linked to: RAF1	8	133935606	133935606	79	0.20253164556962	NA	NA	NA	 BIOCARTA_TGFB_PATHWAY  |  BIOCARTA_MET_PATHWAY  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		168	Thyroglobulin type-1 11. {ECO:0000255|PROSITE-ProRule:PRU00500}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,133935606,G,G&fts=all">p.E1518K</a>
PAK7	Nonsense_Mutation	p.W609*	C	C		4.75	Cancer Pathway	20	9525058	9525058	85	0.188235294117647	NA	NA	NA	 KEGG_RENAL_CELL_CARCINOMA  | 		81	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,9525058,C,C&fts=all">p.W609*</a>
PAK7	Missense_Mutation	p.S594F	G	G		4.75	Cancer Pathway	20	9525104	9525104	99	0.262626262626263	NA	NA	NA	 KEGG_RENAL_CELL_CARCINOMA  | 		81	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,9525104,G,G&fts=all">p.S594F</a>
PRKACG	Missense_Mutation	p.M52I	C	C		4.75	Cancer Pathway	9	71628853	71628853	48	0.291666666666667	NA	NA	NA	 BIOCARTA_SHH_PATHWAY  |  BIOCARTA_IGF1R_PATHWAY  | 		22	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKACG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,71628853,C,C&fts=all">p.M52I</a>
PRKCB	Missense_Mutation	p.Y446H	T	T		4.75	Cancer Pathway	16	24185843	24185843	93	0.182795698924731	NA	NA	NA	 BIOCARTA_CDMAC_PATHWAY  |  BIOCARTA_EGF_PATHWAY  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		9	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,24185843,T,T&fts=all">p.Y446H</a>
PTK2B	Missense_Mutation	p.T673I	C	C		4.75	Cancer Pathway	8	27297937	27297937	55	0.272727272727273	NA	NA	NA	 BIOCARTA_MET_PATHWAY  | 		47	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTK2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,27297937,C,C&fts=all">p.T673I</a>
RPS6KA5	Missense_Mutation	p.Q665L	T	T		4.75	Cancer Pathway	14	91341547	91341547	491	0.29938900203666	NA	NA	NA	 KEGG_BLADDER_CANCER  | 		24	Protein kinase 2. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPS6KA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,91341547,T,T&fts=all">p.Q665L</a>
TGFBR2	Nonsense_Mutation	p.R495*	C	C	rs104893819	4.75	Cancer Pathway	3	30729962	30729962	241	0.427385892116183	NA	NA	NA	 BIOCARTA_TGFB_PATHWAY  |  KEGG_COLORECTAL_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 	p.R495*(2)	53	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGFBR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,30729962,C,C&fts=all">p.R495*</a>
CD19	Missense_Mutation	p.G341R	G	G		5	Cancer Pathway	16	28947858	28947858	51	0.352941176470588	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,28947858,G,G&fts=all">p.G341R</a>
CD200R1	Missense_Mutation	p.P63L	G	G		5	Cancer Pathway	3	112648300	112648300	135	0.318518518518519	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		26	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD200R1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,112648300,G,G&fts=all">p.P63L</a>
CD22	Missense_Mutation	p.S517F	C	C		5	Cancer Pathway	19	35832288	35832288	47	0.25531914893617	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		54	Ig-like C2-type 5.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD22&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,35832288,C,C&fts=all">p.S517F</a>
CD3G	Missense_Mutation	p.E38K	G	G		5	Cancer Pathway	11	118220490	118220490	92	0.304347826086957	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		6	Ig-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD3G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,118220490,G,G&fts=all">p.E38K</a>
CD40	Copy Number	Deleted	NA	NA	NA	5	Cancer Pathway	20	44750539	44751860	NA	NA	4	-1.3521789665987	FALSE	 BIOCARTA_CD40_PATHWAY  |  REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 	NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD40&recr=Open">Click here</a>	
CD8B	Missense_Mutation	p.G127E	C	C		5	Cancer Pathway	2	87085203	87085203	132	0.431818181818182	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		13	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD8B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,87085203,C,C&fts=all">p.G127E</a>
DUSP1	Copy Number	Deleted	NA	NA	NA	5	Cancer Pathway	5	172196137	172362315	NA	NA	9	-1.00404521205795	FALSE	 BIOCARTA_CD40_PATHWAY  | 	NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP1&recr=Open">Click here</a>	
FCGR3A	Missense_Mutation	p.K40Q	T	T		5	Cancer Pathway	1	161518412	161518412	191	0.204188481675393	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 	p.K76*(1)	24	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCGR3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,161518412,T,T&fts=all">p.K40Q</a>
HLA-B	Missense_Mutation	p.P300L	G	G		5	Cancer Pathway	6	31322997	31322997	60	0.2	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		27	Connecting peptide.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HLA-B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31322997,G,G&fts=all">p.P300L</a>
ICAM3	Missense_Mutation	p.G245E	C	C		5	Cancer Pathway	19	10445945	10445945	73	0.219178082191781	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		13	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ICAM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,10445945,C,C&fts=all">p.G245E</a>
IFNG	Missense_Mutation	p.T124A	T	T		5	Cancer Pathway	12	68549264	68549264	65	0.461538461538462	NA	NA	NA	 BIOCARTA_41BB_PATHWAY  | 		12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,68549264,T,T&fts=all">p.T124A</a>
ITGB2	Missense_Mutation	p.E241K	C	C	rs368371881	5	Cancer Pathway	21	46320240	46320240	52	0.192307692307692	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		35	VWFA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,46320240,C,C&fts=all">p.E241K</a>
ITGB2	Missense_Mutation	p.D56N	C	C		5	Cancer Pathway	21	46326992	46326992	39	0.307692307692308	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,46326992,C,C&fts=all">p.D56N</a>
KLRG1	Missense_Mutation	p.S147L	C	C		5	Cancer Pathway	12	9161653	9161653	85	0.211764705882353	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		8	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLRG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,9161653,C,C&fts=all">p.S147L</a>
KLRK1	Splice_Site	p.D144N	C	C		5	Cancer Pathway	12	10530834	10530834	263	0.475285171102662	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		9	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLRK1&recr=Open">Click here</a>	
LILRA1	Missense_Mutation	p.H175Y	C	C		5	Cancer Pathway	19	55106729	55106729	91	0.153846153846154	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		47	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55106729,C,C&fts=all">p.H175Y</a>
LILRA1	Missense_Mutation	p.R196K	G	G		5	Cancer Pathway	19	55106793	55106793	100	0.07	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		47	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55106793,G,G&fts=all">p.R196K</a>
LILRB1	Missense_Mutation	p.P84S	C	C		5	Cancer Pathway	19	55143130	55143130	62	0.161290322580645	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		74	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55143130,C,C&fts=all">p.P84S</a>
LILRB1	Missense_Mutation	p.G139R	G	G		5	Cancer Pathway	19	55143442	55143442	50	0.12	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		74	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55143442,G,G&fts=all">p.G139R</a>
LILRB2	Splice_Site	p.G119E	C	C		5	Cancer Pathway	19	54783502	54783502	45	0.266666666666667	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		44	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRB2&recr=Open">Click here</a>	
MADCAM1	Missense_Mutation	p.G128D	G	G		5	Cancer Pathway	19	498541	498541	28	0.178571428571429	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		10	Ig-like 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MADCAM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,498541,G,G&fts=all">p.G128D</a>
MAP3K5	Missense_Mutation	p.K1264E	T	T		5	Cancer Pathway	6	136883725	136883725	171	0.43859649122807	NA	NA	NA	 BIOCARTA_41BB_PATHWAY  | 		58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,136883725,T,T&fts=all">p.K1264E</a>
MED1	Missense_Mutation	p.P116L	G	G		5	Cancer Pathway	17	37596691	37596691	149	0.429530201342282	NA	NA	NA	 BIOCARTA_VDR_PATHWAY  | 		59	MBD. {ECO:0000255|PROSITE- ProRule:PRU00338}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,37596691,G,G&fts=all">p.P116L</a>
NCOA3	Missense_Mutation	p.R189K	G	G		5	Cancer Pathway	20	46256338	46256338	139	0.0359712230215827	NA	NA	NA	 BIOCARTA_VDR_PATHWAY  | 		52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCOA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,46256338,G,G&fts=all">p.R189K</a>
NCOR1	Nonsense_Mutation	p.Q961*	G	G		5	Cancer Pathway	17	15995312	15995312	188	0.308510638297872	NA	NA	NA	 BIOCARTA_VDR_PATHWAY  | 		107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCOR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,15995312,G,G&fts=all">p.Q961*</a>
NCOR1	Missense_Mutation	p.R581C	G	G		5	Cancer Pathway	17	16024477	16024477	184	0.434782608695652	NA	NA	NA	 BIOCARTA_VDR_PATHWAY  | 		107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCOR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,16024477,G,G&fts=all">p.R581C</a>
PEX1	Missense_Mutation	p.P534S	G	G		5	Cancer Pathway	7	92138713	92138713	89	0.842696629213483	NA	NA	NA	 BIOCARTA_SET_PATHWAY  | 		41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,92138713,G,G&fts=all">p.P534S</a>
RAET1E	Splice_Site	p.D116N	C	C		5	Cancer Pathway	6	150211021	150211021	99	0.434343434343434	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		10	MHC class I alpha-1 like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAET1E&recr=Open">Click here</a>	
SELL	Missense_Mutation	p.P288L	G	G		5	Cancer Pathway	1	169672524	169672524	22	0.409090909090909	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		15	Sushi 2. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SELL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,169672524,G,G&fts=all">p.P288L</a>
TYR	Missense_Mutation	p.M252I	G	G		5	Cancer Pathway	11	88911877	88911877	211	0.464454976303318	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 	p.M252I(1)	48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TYR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,88911877,G,G&fts=all">p.M252I</a>
TYR	Missense_Mutation	p.G253R	G	G	rs61754369	5	Cancer Pathway	11	88911878	88911878	213	0.469483568075117	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TYR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,88911878,G,G&fts=all">p.G253R</a>
VCAM1	Missense_Mutation	p.S346F	C	C		5	Cancer Pathway	1	101194771	101194771	121	0.347107438016529	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		56	Ig-like C2-type 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VCAM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,101194771,C,C&fts=all">p.S346F</a>
VDR	Missense_Mutation	p.S175F	G	G		5	Cancer Pathway	12	48251375	48251375	59	0.406779661016949	NA	NA	NA	 BIOCARTA_VDR_PATHWAY  | 		22	Hinge.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VDR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,48251375,G,G&fts=all">p.S175F</a>
HK1	Missense_Mutation	p.G262E	G	G		5.75	Cancer Pathway	10	71129290	71129290	125	0.232	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  | 		35	Hexokinase type-2 1.|Regulatory.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,71129290,G,G&fts=all">p.G262E</a>
ALDOB	Missense_Mutation	p.F80L	A	A		6	Cancer Pathway	9	104192123	104192123	134	0.238805970149254	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  | 		24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDOB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,104192123,A,A&fts=all">p.F80L</a>
L1CAM	Nonsense_Mutation	p.R558*	G	G		6	Cancer Pathway	X	153133788	153133788	85	0.470588235294118	NA	NA	NA	 REACTOME_BASIGIN_INTERACTIONS  | 		81	Ig-like C2-type 6.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+L1CAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,153133788,G,G&fts=all">p.R558*</a>
L1CAM	Missense_Mutation	p.L11F	G	G		6	Cancer Pathway	X	153141261	153141261	55	0.418181818181818	NA	NA	NA	 REACTOME_BASIGIN_INTERACTIONS  | 		81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+L1CAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,153141261,G,G&fts=all">p.L11F</a>
MAG	Missense_Mutation	p.G319E	G	G		6	Cancer Pathway	19	35791293	35791293	25	0.48	NA	NA	NA	 REACTOME_BASIGIN_INTERACTIONS  | 		34	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,35791293,G,G&fts=all">p.G319E</a>
SI	Missense_Mutation	p.R1655W	G	G		6	Cancer Pathway	3	164709985	164709985	426	0.255868544600939	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  |  REACTOME_BASIGIN_INTERACTIONS  | 		218	Sucrase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164709985,G,G&fts=all">p.R1655W</a>
SI	Missense_Mutation	p.P1652S	G	G		6	Cancer Pathway	3	164709994	164709994	430	0.36046511627907	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  |  REACTOME_BASIGIN_INTERACTIONS  | 		218	Sucrase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164709994,G,G&fts=all">p.P1652S</a>
SI	Missense_Mutation	p.P1638S	G	G		6	Cancer Pathway	3	164710115	164710115	202	0.603960396039604	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  |  REACTOME_BASIGIN_INTERACTIONS  | 	p.P1638T(1)	218	Sucrase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164710115,G,G&fts=all">p.P1638S</a>
SI	Missense_Mutation	p.K1477I	T	T		6	Cancer Pathway	3	164716438	164716438	194	0.0567010309278351	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  |  REACTOME_BASIGIN_INTERACTIONS  | 		218	Sucrase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164716438,T,T&fts=all">p.K1477I</a>
SI	Missense_Mutation	p.E1384K	C	C		6	Cancer Pathway	3	164727096	164727096	156	0.243589743589744	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  |  REACTOME_BASIGIN_INTERACTIONS  | 		218	Sucrase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164727096,C,C&fts=all">p.E1384K</a>
SI	Missense_Mutation	p.E1241K	C	C		6	Cancer Pathway	3	164735374	164735374	147	0.0476190476190476	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  |  REACTOME_BASIGIN_INTERACTIONS  | 		218	Sucrase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164735374,C,C&fts=all">p.E1241K</a>
SI	Missense_Mutation	p.R1240W	G	G		6	Cancer Pathway	3	164735377	164735377	143	0.0559440559440559	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  |  REACTOME_BASIGIN_INTERACTIONS  | 	p.R1240R(1)	218	Sucrase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164735377,G,G&fts=all">p.R1240W</a>
SI	Missense_Mutation	p.R1124Q	C	C	rs201739571	6	Cancer Pathway	3	164737442	164737442	147	0.217687074829932	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  |  REACTOME_BASIGIN_INTERACTIONS  | 		218	Sucrase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164737442,C,C&fts=all">p.R1124Q</a>
SI	Missense_Mutation	p.F323C	A	A		6	Cancer Pathway	3	164780211	164780211	294	0.0442176870748299	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  |  REACTOME_BASIGIN_INTERACTIONS  | 		218	Isomaltase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164780211,A,A&fts=all">p.F323C</a>
SI	Nonsense_Mutation	p.K178*	T	T		6	Cancer Pathway	3	164785231	164785231	393	0.27735368956743	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  |  REACTOME_BASIGIN_INTERACTIONS  | 		218	Isomaltase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164785231,T,T&fts=all">p.K178*</a>
SLC16A1	Missense_Mutation	p.V22L	C	C		6	Cancer Pathway	1	113471867	113471867	196	0.183673469387755	NA	NA	NA	 REACTOME_BASIGIN_INTERACTIONS  | 		20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC16A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,113471867,C,C&fts=all">p.V22L</a>
SLC7A9	Missense_Mutation	p.P482L	G	G	rs146815072	6	Cancer Pathway	19	33321545	33321545	136	0.183823529411765	NA	NA	NA	 REACTOME_BASIGIN_INTERACTIONS  | 		32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,33321545,G,G&fts=all">p.P482L</a>
SLC7A9	Missense_Mutation	p.G173R	C	C		6	Cancer Pathway	19	33353454	33353454	47	0.191489361702128	NA	NA	NA	 REACTOME_BASIGIN_INTERACTIONS  | 		32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,33353454,C,C&fts=all">p.G173R</a>
SLC7A9	Missense_Mutation	p.S51F	G	G		6	Cancer Pathway	19	33355618	33355618	114	0.210526315789474	NA	NA	NA	 REACTOME_BASIGIN_INTERACTIONS  | 		32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,33355618,G,G&fts=all">p.S51F</a>
BLK	Missense_Mutation	p.S420L	C	C		6.75	Cancer Module	8	11420566	11420566	43	0.348837209302326	NA	NA	NA			27	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BLK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,11420566,C,C&fts=all">p.S420L</a>
DLG4	Splice_Site	p.H562Y	G	G		6.75	Cancer Module	17	7096802	7096802	23	0.91304347826087	NA	NA	NA			18	Guanylate kinase-like. {ECO:0000255|PROSITE-ProRule:PRU00100}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLG4&recr=Open">Click here</a>	
EIF2AK3	Missense_Mutation	p.S856F	G	G		6.75	Cancer Module	2	88874434	88874434	370	0.297297297297297	NA	NA	NA			3	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF2AK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,88874434,G,G&fts=all">p.S856F</a>
EPHA7	Missense_Mutation	p.D758N	C	C		6.75	Cancer Module	6	93965656	93965656	118	0.423728813559322	NA	NA	NA			112	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,93965656,C,C&fts=all">p.D758N</a>
EPHA7	Splice_Site	p.G704G	C	C		6.75	Cancer Module	6	93967240	93967240	66	0.318181818181818	NA	NA	NA			112	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA7&recr=Open">Click here</a>	
EPHB2	Missense_Mutation	p.D851N	G	G		6.75	Cancer Module	1	23236920	23236920	67	0.388059701492537	NA	NA	NA			56	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,23236920,G,G&fts=all">p.D851N</a>
FLT4	Missense_Mutation	p.D1065N	C	C		6.75	Cancer Module	5	180043393	180043393	23	0.478260869565217	NA	NA	NA			71	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,180043393,C,C&fts=all">p.D1065N</a>
GCK	Splice_Site	p.V226V	C	C		6.75	Cancer Module	7	44189360	44189360	40	0.5	NA	NA	NA			37	Hexokinase type-2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCK&recr=Open">Click here</a>	
GUCY2C	Missense_Mutation	p.R735K	C	C		6.75	Cancer Module	12	14781625	14781625	218	0.206422018348624	NA	NA	NA			51	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCY2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,14781625,C,C&fts=all">p.R735K</a>
GUCY2F	Missense_Mutation	p.E559K	C	C		6.75	Cancer Module	X	108684606	108684606	120	0.458333333333333	NA	NA	NA			67	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCY2F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,108684606,C,C&fts=all">p.E559K</a>
HK3	Splice_Site	p.R178K	C	C	rs201738990	6.75	Cancer Module	5	176317824	176317824	21	0.333333333333333	NA	NA	NA			47	Glucose-binding. {ECO:0000255}.|Hexokinase type-1 1.|Regulatory.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HK3&recr=Open">Click here</a>	
KSR1	Nonsense_Mutation	p.Q658*	C	C		6.75	Cancer Module	17	25937184	25937184	38	0.657894736842105	NA	NA	NA			28	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KSR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,25937184,C,C&fts=all">p.Q658*</a>
LIMK2	Missense_Mutation	p.A483T	G	G		6.75	Cancer Module	22	31668579	31668579	116	0.0431034482758621	NA	NA	NA			29	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIMK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,31668579,G,G&fts=all">p.A483T</a>
LIMK2	Missense_Mutation	p.S531F	C	C		6.75	Cancer Module	22	31669471	31669471	75	0.186666666666667	NA	NA	NA			29	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIMK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,31669471,C,C&fts=all">p.S531F</a>
MAPK4	Missense_Mutation	p.E82K	G	G		6.75	Cancer Module	18	48190572	48190572	20	0.5	NA	NA	NA			8	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,48190572,G,G&fts=all">p.E82K</a>
MAPK7	Missense_Mutation	p.H149Y	C	C		6.75	Cancer Module	17	19283967	19283967	48	0.270833333333333	NA	NA	NA			30	Necessary for oligomerization. {ECO:0000250}.|Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,19283967,C,C&fts=all">p.H149Y</a>
MAPKAPK3	Missense_Mutation	p.S251F	C	C		6.75	Cancer Module	3	50683618	50683618	155	0.225806451612903	NA	NA	NA			2	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPKAPK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,50683618,C,C&fts=all">p.S251F</a>
MATK	Missense_Mutation	p.T327I	G	G		6.75	Cancer Module	19	3779400	3779400	48	0.208333333333333	NA	NA	NA			26	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MATK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,3779400,G,G&fts=all">p.T327I</a>
MERTK	Missense_Mutation	p.M790I	G	G		6.75	Cancer Module	2	112779855	112779855	125	0.232	NA	NA	NA			46	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MERTK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,112779855,G,G&fts=all">p.M790I</a>
MOS	Missense_Mutation	p.K87Q	T	T		6.75	Cancer Module	8	57026283	57026283	121	0.256198347107438	NA	NA	NA			22	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MOS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,57026283,T,T&fts=all">p.K87Q</a>
MUSK	Missense_Mutation	p.R668C	C	C		6.75	Cancer Module	9	113562660	113562660	103	0.631067961165049	NA	NA	NA			49	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUSK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,113562660,C,C&fts=all">p.R668C</a>
MYT1	Missense_Mutation	p.P192L	C	C		6.75	Cancer Module	20	62839124	62839124	59	0.322033898305085	NA	NA	NA			55	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,62839124,C,C&fts=all">p.P192L</a>
PFKFB4	Missense_Mutation	p.S201F	G	G	rs555739425	6.75	Cancer Module	3	48575961	48575961	78	0.205128205128205	NA	NA	NA			14	6-phosphofructo-2-kinase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PFKFB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,48575961,G,G&fts=all">p.S201F</a>
PRKCI	Missense_Mutation	p.G449E	G	G		6.75	Cancer Module	3	170011225	170011225	229	0.327510917030568	NA	NA	NA			36	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,170011225,G,G&fts=all">p.G449E</a>
PRKCQ	Missense_Mutation	p.P618S	G	G	rs375864699	6.75	Cancer Module	10	6472885	6472885	28	0.214285714285714	NA	NA	NA			45	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCQ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,6472885,G,G&fts=all">p.P618S</a>
ROR2	Missense_Mutation	p.E563K	C	C	rs186571882	6.75	Cancer Module	9	94487089	94487089	20	0.2	NA	NA	NA			71	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,94487089,C,C&fts=all">p.E563K</a>
RPS6KA3	Missense_Mutation	p.D272N	C	C		6.75	Cancer Module	X	20204445	20204445	153	0.895424836601307	NA	NA	NA			41	Protein kinase 1. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPS6KA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,20204445,C,C&fts=all">p.D272N</a>
STK31	Missense_Mutation	p.S718F	C	C		6.75	Cancer Module	7	23825101	23825101	234	0.0555555555555556	NA	NA	NA			67	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,23825101,C,C&fts=all">p.S718F</a>
STK31	Nonsense_Mutation	p.Q926*	C	C		6.75	Cancer Module	7	23854778	23854778	135	0.22962962962963	NA	NA	NA			67	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,23854778,C,C&fts=all">p.Q926*</a>
TRIO	Missense_Mutation	p.P2862L	C	C		6.75	Cancer Module	5	14504675	14504675	172	0.13953488372093	NA	NA	NA			118	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,14504675,C,C&fts=all">p.P2862L</a>
TTN	Missense_Mutation	p.Q32313H	C	C		6.75	Cancer Module	2	179407642	179407642	275	0.352727272727273	NA	NA	NA			1448	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179407642,C,C&fts=all">p.Q32313H</a>
VRK1	Missense_Mutation	p.R103C	C	C		6.75	Cancer Module	14	97313614	97313614	215	0.613953488372093	NA	NA	NA			12	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VRK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,97313614,C,C&fts=all">p.R103C</a>
AANAT	Missense_Mutation	p.E43K	G	G		7	Cancer Module	17	74464955	74464955	57	0.210526315789474	NA	NA	NA			1	N-acetyltransferase. {ECO:0000255|PROSITE-ProRule:PRU00532}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AANAT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,74464955,G,G&fts=all">p.E43K</a>
ABCA1	Missense_Mutation	p.K1052R	T	T		7	Cancer Module	9	107581953	107581953	98	0.316326530612245	NA	NA	NA			115	ABC transporter 1. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,107581953,T,T&fts=all">p.K1052R</a>
ABCA1	Missense_Mutation	p.P1022L	G	G		7	Cancer Module	9	107582246	107582246	87	0.160919540229885	NA	NA	NA			115	ABC transporter 1. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,107582246,G,G&fts=all">p.P1022L</a>
ABCA12	Missense_Mutation	p.R163Q	C	C		7	Cancer Module	2	215917230	215917230	156	0.301282051282051	NA	NA	NA			139			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,215917230,C,C&fts=all">p.R163Q</a>
ABCA12	Missense_Mutation	p.F103Y	A	A		7	Cancer Module	2	215928798	215928798	251	0.278884462151394	NA	NA	NA			139			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,215928798,A,A&fts=all">p.F103Y</a>
ABCA4	Missense_Mutation	p.D1995N	C	C		7	Cancer Module	1	94473212	94473212	90	0.0666666666666667	NA	NA	NA			147	ABC transporter 2. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,94473212,C,C&fts=all">p.D1995N</a>
ABCA4	Missense_Mutation	p.P381S	G	G		7	Cancer Module	1	94544976	94544976	101	0.514851485148515	NA	NA	NA			147			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,94544976,G,G&fts=all">p.P381S</a>
ABCA7	Missense_Mutation	p.P98L	C	C		7	Cancer Module	19	1043167	1043167	57	0.157894736842105	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,1043167,C,C&fts=all">p.P98L</a>
ABCA7	Missense_Mutation	p.P1186S	C	C		7	Cancer Module	19	1055115	1055115	44	0.136363636363636	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,1055115,C,C&fts=all">p.P1186S</a>
ABCA8	Missense_Mutation	p.D1232N	C	C		7	Cancer Module	17	66879945	66879945	167	0.251497005988024	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,66879945,C,C&fts=all">p.D1232N</a>
ABCA8	Missense_Mutation	p.E1094K	C	C		7	Cancer Module	17	66883512	66883512	444	0.682432432432432	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,66883512,C,C&fts=all">p.E1094K</a>
ABCA8	Missense_Mutation	p.P366L	G	G		7	Cancer Module	17	66925218	66925218	86	0.116279069767442	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,66925218,G,G&fts=all">p.P366L</a>
ABCB1	Missense_Mutation	p.N278K	G	G		7	Cancer Module	7	87183242	87183242	72	0.375	NA	NA	NA			111	ABC transmembrane type-1 1. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,87183242,G,G&fts=all">p.N278K</a>
ABCB11	Missense_Mutation	p.K1146I	T	T		7	Cancer Module	2	169783847	169783847	52	0.307692307692308	NA	NA	NA			57	ABC transporter 2. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,169783847,T,T&fts=all">p.K1146I</a>
ABCB11	Missense_Mutation	p.K972R	T	T		7	Cancer Module	2	169791835	169791835	120	0.233333333333333	NA	NA	NA			57	ABC transmembrane type-1 2. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,169791835,T,T&fts=all">p.K972R</a>
ABCB11	Missense_Mutation	p.R487C	G	G		7	Cancer Module	2	169828536	169828536	49	0.653061224489796	NA	NA	NA			57	ABC transporter 1. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,169828536,G,G&fts=all">p.R487C</a>
ABCB9	Missense_Mutation	p.S192F	G	G		7	Cancer Module	12	123444208	123444208	135	0.266666666666667	NA	NA	NA			18	ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,123444208,G,G&fts=all">p.S192F</a>
ABCC2	Missense_Mutation	p.E231G	A	A		7	Cancer Module	10	101556913	101556913	97	0.43298969072165	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,101556913,A,A&fts=all">p.E231G</a>
ABCC3	Missense_Mutation	p.P652S	C	C		7	Cancer Module	17	48746517	48746517	41	0.268292682926829	NA	NA	NA			33	ABC transporter 1. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,48746517,C,C&fts=all">p.P652S</a>
ABCC4	Missense_Mutation	p.E584G	T	T		7	Cancer Module	13	95822859	95822859	89	0.617977528089888	NA	NA	NA			43	ABC transporter 1. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,95822859,T,T&fts=all">p.E584G</a>
ABI3BP	Missense_Mutation	p.E601K	C	C	rs202185024	7	Cancer Module	3	100515259	100515259	56	0.446428571428571	NA	NA	NA			50	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABI3BP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,100515259,C,C&fts=all">p.E601K</a>
ABI3BP	Missense_Mutation	p.P494S	G	G		7	Cancer Module	3	100566488	100566488	204	0.318627450980392	NA	NA	NA			50	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABI3BP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,100566488,G,G&fts=all">p.P494S</a>
ABI3BP	Missense_Mutation	p.P273L	G	G		7	Cancer Module	3	100594372	100594372	76	0.447368421052632	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABI3BP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,100594372,G,G&fts=all">p.P273L</a>
ABI3BP	Missense_Mutation	p.R168Q	C	C		7	Cancer Module	3	100605147	100605147	51	0.313725490196078	NA	NA	NA			50	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABI3BP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,100605147,C,C&fts=all">p.R168Q</a>
ABLIM1	Missense_Mutation	p.M771I	C	C		7	Cancer Module	10	116196043	116196043	192	0.421875	NA	NA	NA			30	HP. {ECO:0000255|PROSITE- ProRule:PRU00595}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABLIM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,116196043,C,C&fts=all">p.M771I</a>
ACADSB	Missense_Mutation	p.P212L	C	C		7	Cancer Module	10	124806765	124806765	190	0.194736842105263	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACADSB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124806765,C,C&fts=all">p.P212L</a>
ACE	Splice_Site	p.E448D	A	A		7	Cancer Module	17	61560391	61560391	183	0.174863387978142	NA	NA	NA			51	Peptidase M2 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACE&recr=Open">Click here</a>	
ACE	Missense_Mutation	p.P522S	C	C		7	Cancer Module	17	61560897	61560897	176	0.210227272727273	NA	NA	NA			51	Peptidase M2 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,61560897,C,C&fts=all">p.P522S</a>
ACE	Missense_Mutation	p.K426N	A	A		7	Cancer Module	17	61570884	61570884	69	0.202898550724638	NA	NA	NA			51	Peptidase M2 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,61570884,A,A&fts=all">p.K426N</a>
ACHE	Missense_Mutation	p.E115K	C	C		7	Cancer Module	7	100491511	100491511	58	0.431034482758621	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACHE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,100491511,C,C&fts=all">p.E115K</a>
ACHE	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	7	100491855	100693918	NA	NA	16	-1.06099915493049	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACHE&recr=Open">Click here</a>	
ACO1	Missense_Mutation	p.P171S	C	C		7	Cancer Module	9	32418362	32418362	56	0.482142857142857	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACO1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,32418362,C,C&fts=all">p.P171S</a>
ACO2	Missense_Mutation	p.P121L	C	C		7	Cancer Module	22	41903983	41903983	53	0.60377358490566	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,41903983,C,C&fts=all">p.P121L</a>
ACOX2	Missense_Mutation	p.H579R	T	T		7	Cancer Module	3	58503005	58503005	118	0.389830508474576	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACOX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,58503005,T,T&fts=all">p.H579R</a>
ACOX2	Missense_Mutation	p.S419F	G	G		7	Cancer Module	3	58512241	58512241	39	0.230769230769231	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACOX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,58512241,G,G&fts=all">p.S419F</a>
ACPT	Missense_Mutation	p.D108N	G	G		7	Cancer Module	19	51294931	51294931	88	0.181818181818182	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACPT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51294931,G,G&fts=all">p.D108N</a>
ACSL4	Missense_Mutation	p.H150Y	G	G		7	Cancer Module	X	108924563	108924563	245	0.473469387755102	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,108924563,G,G&fts=all">p.H150Y</a>
ACSM3	Missense_Mutation	p.R122W	C	C		7	Cancer Module	16	20787305	20787305	155	0.316129032258064	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,20787305,C,C&fts=all">p.R122W</a>
ACSM3	Missense_Mutation	p.E362K	G	G		7	Cancer Module	16	20796370	20796370	178	0.191011235955056	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,20796370,G,G&fts=all">p.E362K</a>
ACTG2	Missense_Mutation	p.R164K	G	G		7	Cancer Module	2	74141813	74141813	151	0.119205298013245	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,74141813,G,G&fts=all">p.R164K</a>
ACTR5	Missense_Mutation	p.F492I	T	T		7	Cancer Module	20	37396147	37396147	204	0.387254901960784	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTR5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,37396147,T,T&fts=all">p.F492I</a>
ADAM10	Nonsense_Mutation	p.E283*	C	C		7	Cancer Module	15	58933141	58933141	228	0.609649122807018	NA	NA	NA			27	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,58933141,C,C&fts=all">p.E283*</a>
ADAM12	Missense_Mutation	p.P685L	G	G		7	Cancer Module	10	127731668	127731668	37	0.297297297297297	NA	NA	NA			69	EGF-like. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,127731668,G,G&fts=all">p.P685L</a>
ADAM2	Missense_Mutation	p.D568N	C	C		7	Cancer Module	8	39603995	39603995	341	0.158357771260997	NA	NA	NA			53	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39603995,C,C&fts=all">p.D568N</a>
ADAM2	Splice_Site	p.G413R	C	C		7	Cancer Module	8	39613339	39613339	302	0.178807947019868	NA	NA	NA			53	Disintegrin. {ECO:0000255|PROSITE- ProRule:PRU00068}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM2&recr=Open">Click here</a>	
ADAM2	Missense_Mutation	p.E131K	C	C		7	Cancer Module	8	39678643	39678643	202	0.420792079207921	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39678643,C,C&fts=all">p.E131K</a>
ADAMTS10	Missense_Mutation	p.G750R	C	C		7	Cancer Module	19	8651597	8651597	46	0.152173913043478	NA	NA	NA			53	Spacer.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8651597,C,C&fts=all">p.G750R</a>
ADAMTS10	Missense_Mutation	p.R233Q	C	C		7	Cancer Module	19	8665924	8665924	23	0.304347826086957	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8665924,C,C&fts=all">p.R233Q</a>
ADAMTS12	Missense_Mutation	p.M1344I	C	C		7	Cancer Module	5	33561225	33561225	100	0.53	NA	NA	NA			216	TSP type-1 5. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,33561225,C,C&fts=all">p.M1344I</a>
ADAMTS13	Missense_Mutation	p.R558Q	G	G		7	Cancer Module	9	136303454	136303454	35	0.285714285714286	NA	NA	NA			36	Spacer.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,136303454,G,G&fts=all">p.R558Q</a>
ADAMTS2	Missense_Mutation	p.R978C	G	G		7	Cancer Module	5	178552000	178552000	22	0.409090909090909	NA	NA	NA			72	TSP type-1 4. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,178552000,G,G&fts=all">p.R978C</a>
ADAMTS3	Missense_Mutation	p.S1038F	G	G	rs201524333	7	Cancer Module	4	73149358	73149358	174	0.275862068965517	NA	NA	NA			76	PLAC. {ECO:0000255|PROSITE- ProRule:PRU00233}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,73149358,G,G&fts=all">p.S1038F</a>
ADAMTS3	Missense_Mutation	p.S774A	A	A		7	Cancer Module	4	73169738	73169738	634	0.302839116719243	NA	NA	NA			76	Spacer.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,73169738,A,A&fts=all">p.S774A</a>
ADAMTS3	Missense_Mutation	p.S296F	G	G		7	Cancer Module	4	73188789	73188789	561	0.586452762923351	NA	NA	NA			76	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,73188789,G,G&fts=all">p.S296F</a>
ADAMTS3	Missense_Mutation	p.G195E	C	C		7	Cancer Module	4	73280609	73280609	347	0.61671469740634	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,73280609,C,C&fts=all">p.G195E</a>
ADAMTS5	Missense_Mutation	p.E651K	C	C		7	Cancer Module	21	28304421	28304421	112	0.294642857142857	NA	NA	NA			72	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,28304421,C,C&fts=all">p.E651K</a>
ADAMTS5	Missense_Mutation	p.K324N	C	C		7	Cancer Module	21	28337739	28337739	115	0.217391304347826	NA	NA	NA			72	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,28337739,C,C&fts=all">p.K324N</a>
ADAMTS5	Missense_Mutation	p.S278F	G	G		7	Cancer Module	21	28337878	28337878	11	0.636363636363636	NA	NA	NA			72	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,28337878,G,G&fts=all">p.S278F</a>
ADAMTSL1	Missense_Mutation	p.E30K	G	G		7	Cancer Module	9	18504851	18504851	73	0.835616438356164	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTSL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,18504851,G,G&fts=all">p.E30K</a>
ADAMTSL1	Missense_Mutation	p.E641K	G	G		7	Cancer Module	9	18721578	18721578	85	0.376470588235294	NA	NA	NA			42	TSP type-1 5. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTSL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,18721578,G,G&fts=all">p.E641K</a>
ADARB1	Missense_Mutation	p.P146S	C	C		7	Cancer Module	21	46596052	46596052	75	0.413333333333333	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADARB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,46596052,C,C&fts=all">p.P146S</a>
ADCY7	Missense_Mutation	p.E837K	G	G		7	Cancer Module	16	50346007	50346007	131	0.290076335877863	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,50346007,G,G&fts=all">p.E837K</a>
ADCY8	Missense_Mutation	p.F836C	A	A	rs368175473	7	Cancer Module	8	131848691	131848691	39	0.179487179487179	NA	NA	NA			134			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,131848691,A,A&fts=all">p.F836C</a>
ADCY8	Missense_Mutation	p.S662F	G	G		7	Cancer Module	8	131896934	131896934	267	0.198501872659176	NA	NA	NA			134			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,131896934,G,G&fts=all">p.S662F</a>
ADCY8	Missense_Mutation	p.A345V	G	G		7	Cancer Module	8	132002715	132002715	233	0.236051502145923	NA	NA	NA			134			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,132002715,G,G&fts=all">p.A345V</a>
ADCYAP1R1	Splice_Site		G	G		7	Cancer Module	7	31126618	31126618	65	0.507692307692308	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCYAP1R1&recr=Open">Click here</a>	
ADH1A	Missense_Mutation	p.S23F	G	G		7	Cancer Module	4	100208773	100208773	159	0.29559748427673	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADH1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,100208773,G,G&fts=all">p.S23F</a>
ADH1B	Missense_Mutation	p.D50N	C	C		7	Cancer Module	4	100239314	100239314	134	0.246268656716418	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADH1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,100239314,C,C&fts=all">p.D50N</a>
ADH1B	Missense_Mutation	p.S23F	G	G		7	Cancer Module	4	100239994	100239994	199	0.266331658291457	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADH1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,100239994,G,G&fts=all">p.S23F</a>
ADORA2A	Missense_Mutation	p.P109S	C	C		7	Cancer Module	22	24829697	24829697	26	0.153846153846154	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADORA2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,24829697,C,C&fts=all">p.P109S</a>
ADORA2A	Missense_Mutation	p.G331E	G	G		7	Cancer Module	22	24837210	24837210	17	0.294117647058824	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADORA2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,24837210,G,G&fts=all">p.G331E</a>
ADORA2B	Missense_Mutation	p.P41L	C	C		7	Cancer Module	17	15848684	15848684	33	0.181818181818182	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADORA2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,15848684,C,C&fts=all">p.P41L</a>
ADRA1A	Missense_Mutation	p.G164S	C	C		7	Cancer Module	8	26721997	26721997	23	0.478260869565217	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADRA1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,26721997,C,C&fts=all">p.G164S</a>
AFM	Missense_Mutation	p.E254K	G	G		7	Cancer Module	4	74354393	74354393	226	0.252212389380531	NA	NA	NA			32	Albumin 2. {ECO:0000255|PROSITE- ProRule:PRU00769}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,74354393,G,G&fts=all">p.E254K</a>
AFM	Missense_Mutation	p.G268E	G	G		7	Cancer Module	4	74354436	74354436	233	0.278969957081545	NA	NA	NA			32	Albumin 2. {ECO:0000255|PROSITE- ProRule:PRU00769}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,74354436,G,G&fts=all">p.G268E</a>
AFP	Missense_Mutation	p.S601L	C	C		7	Cancer Module	4	74320969	74320969	282	0.24822695035461	NA	NA	NA			22	Albumin 3. {ECO:0000255|PROSITE- ProRule:PRU00769}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,74320969,C,C&fts=all">p.S601L</a>
AGBL5	Missense_Mutation	p.R537H	G	G		7	Cancer Module	2	27280245	27280245	164	0.231707317073171	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGBL5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27280245,G,G&fts=all">p.R537H</a>
AGL	Missense_Mutation	p.S603F	C	C		7	Cancer Module	1	100346260	100346260	423	0.539007092198582	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,100346260,C,C&fts=all">p.S603F</a>
AGT	Missense_Mutation	p.E441K	C	C		7	Cancer Module	1	230839024	230839024	140	0.421428571428571	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,230839024,C,C&fts=all">p.E441K</a>
AGTPBP1	Missense_Mutation	p.P521S	G	G		7	Cancer Module	9	88247911	88247911	200	0.2	NA	NA	NA		p.P521S(1)	44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGTPBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,88247911,G,G&fts=all">p.P521S</a>
AHCTF1	Missense_Mutation	p.V151G	A	A		7	Cancer Module	1	247079472	247079472	244	0.184426229508197	NA	NA	NA			74	Necessary for cytoplasmic localization. {ECO:0000250}.|Seven-bladed beta propeller repeats. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHCTF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247079472,A,A&fts=all">p.V151G</a>
AHNAK	Missense_Mutation	p.R3351C	G	G	rs117916864	7	Cancer Module	11	62291838	62291838	94	0.382978723404255	NA	NA	NA			268			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHNAK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,62291838,G,G&fts=all">p.R3351C</a>
AIM1	Missense_Mutation	p.T661S	C	C		7	Cancer Module	6	106968289	106968289	155	0.438709677419355	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AIM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,106968289,C,C&fts=all">p.T661S</a>
AIRE	Missense_Mutation	p.E229K	G	G		7	Cancer Module	21	45709572	45709572	36	0.361111111111111	NA	NA	NA			14	SAND. {ECO:0000255|PROSITE- ProRule:PRU00185}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AIRE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,45709572,G,G&fts=all">p.E229K</a>
AJAP1	Missense_Mutation	p.L396F	C	C		7	Cancer Module	1	4834509	4834509	49	0.469387755102041	NA	NA	NA			24	Targeting signals.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AJAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,4834509,C,C&fts=all">p.L396F</a>
AKAP1	Missense_Mutation	p.S150L	C	C		7	Cancer Module	17	55183274	55183274	71	0.450704225352113	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,55183274,C,C&fts=all">p.S150L</a>
AKAP3	Missense_Mutation	p.P509L	G	G		7	Cancer Module	12	4736542	4736542	36	0.388888888888889	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,4736542,G,G&fts=all">p.P509L</a>
AKAP3	Missense_Mutation	p.D414N	C	C		7	Cancer Module	12	4736828	4736828	237	0.236286919831224	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,4736828,C,C&fts=all">p.D414N</a>
AKAP4	Missense_Mutation	p.E66D	T	T		7	Cancer Module	X	49961593	49961593	114	0.421052631578947	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,49961593,T,T&fts=all">p.E66D</a>
AKAP6	Splice_Site	p.S1125F	C	C		7	Cancer Module	14	33242885	33242885	134	0.328358208955224	NA	NA	NA			122			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP6&recr=Open">Click here</a>	
AKAP6	Missense_Mutation	p.R1500C	C	C	rs74976151	7	Cancer Module	14	33291517	33291517	69	0.376811594202899	NA	NA	NA			122			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,33291517,C,C&fts=all">p.R1500C</a>
AKR1C3	Missense_Mutation	p.F311S	T	T		7	Cancer Module	10	5149655	5149655	130	0.161538461538462	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKR1C3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,5149655,T,T&fts=all">p.F311S</a>
AKR1C4	Missense_Mutation	p.L235F	C	C		7	Cancer Module	10	5254979	5254979	31	0.225806451612903	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKR1C4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,5254979,C,C&fts=all">p.L235F</a>
AKR1C4	Missense_Mutation	p.S320L	C	C		7	Cancer Module	10	5260710	5260710	145	0.262068965517241	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKR1C4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,5260710,C,C&fts=all">p.S320L</a>
ALDH1A3	Missense_Mutation	p.L448F	C	C		7	Cancer Module	15	101447434	101447434	213	0.028169014084507	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH1A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,101447434,C,C&fts=all">p.L448F</a>
ALDH1L1	Missense_Mutation	p.N260S	T	T		7	Cancer Module	3	125872396	125872396	38	0.394736842105263	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,125872396,T,T&fts=all">p.N260S</a>
ALDH3A2	Missense_Mutation	p.P71L	C	C		7	Cancer Module	17	19568346	19568346	95	0.231578947368421	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH3A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,19568346,C,C&fts=all">p.P71L</a>
ALDH6A1	Missense_Mutation	p.G446R	C	C	rs72552258	7	Cancer Module	14	74531952	74531952	134	0.0447761194029851	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH6A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,74531952,C,C&fts=all">p.G446R</a>
ALMS1	Missense_Mutation	p.G3334R	G	G		7	Cancer Module	2	73777489	73777489	218	0.541284403669725	NA	NA	NA			147			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALMS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,73777489,G,G&fts=all">p.G3334R</a>
ALOX5	Missense_Mutation	p.S448F	C	C		7	Cancer Module	10	45938556	45938556	97	0.195876288659794	NA	NA	NA			37	Lipoxygenase. {ECO:0000255|PROSITE- ProRule:PRU00726}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALOX5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,45938556,C,C&fts=all">p.S448F</a>
ALOX5	Missense_Mutation	p.E633K	G	G		7	Cancer Module	10	45941007	45941007	76	0.171052631578947	NA	NA	NA			37	Lipoxygenase. {ECO:0000255|PROSITE- ProRule:PRU00726}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALOX5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,45941007,G,G&fts=all">p.E633K</a>
ALPK2	Missense_Mutation	p.S1194F	G	G		7	Cancer Module	18	56203838	56203838	65	0.384615384615385	NA	NA	NA			84			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,56203838,G,G&fts=all">p.S1194F</a>
ALPK2	Missense_Mutation	p.P1052S	G	G		7	Cancer Module	18	56204265	56204265	56	0.339285714285714	NA	NA	NA		p.P413S(1)|p.P1052S(1)	84			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,56204265,G,G&fts=all">p.P1052S</a>
ALPK2	Missense_Mutation	p.G367D	C	C		7	Cancer Module	18	56246908	56246908	49	0.489795918367347	NA	NA	NA			84			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,56246908,C,C&fts=all">p.G367D</a>
ALPL	Missense_Mutation	p.G343E	G	G		7	Cancer Module	1	21902256	21902256	114	0.315789473684211	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,21902256,G,G&fts=all">p.G343E</a>
AMBP	Missense_Mutation	p.S120F	G	G		7	Cancer Module	9	116836411	116836411	63	0.222222222222222	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,116836411,G,G&fts=all">p.S120F</a>
AMOT	Missense_Mutation	p.P1020L	G	G		7	Cancer Module	X	112022323	112022323	50	0.54	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMOT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,112022323,G,G&fts=all">p.P1020L</a>
AMPD1	Missense_Mutation	p.M485I	C	C		7	Cancer Module	1	115219992	115219992	122	0.352459016393443	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMPD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,115219992,C,C&fts=all">p.M485I</a>
AMPD1	Missense_Mutation	p.E372K	C	C		7	Cancer Module	1	115221019	115221019	234	0.166666666666667	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMPD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,115221019,C,C&fts=all">p.E372K</a>
AMPH	Missense_Mutation	p.E558K	C	C	rs372537853	7	Cancer Module	7	38431555	38431555	91	0.604395604395604	NA	NA	NA		p.E558K(1)	62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMPH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,38431555,C,C&fts=all">p.E558K</a>
AMPH	Missense_Mutation	p.D162H	C	C		7	Cancer Module	7	38516482	38516482	81	0.308641975308642	NA	NA	NA			62	BAR. {ECO:0000255|PROSITE- ProRule:PRU00361}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMPH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,38516482,C,C&fts=all">p.D162H</a>
AMY2B	Missense_Mutation	p.H67Y	C	C		7	Cancer Module	1	104114762	104114762	367	0.196185286103542	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMY2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,104114762,C,C&fts=all">p.H67Y</a>
AMY2B	Splice_Site	p.L335L	C	C		7	Cancer Module	1	104118064	104118064	443	0.0383747178329571	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMY2B&recr=Open">Click here</a>	
AMZ2	Missense_Mutation	p.P238S	C	C		7	Cancer Module	17	66250670	66250670	306	0.0196078431372549	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMZ2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,66250670,C,C&fts=all">p.P238S</a>
ANGEL2	Missense_Mutation	p.S484F	G	G		7	Cancer Module	1	213170529	213170529	317	0.176656151419558	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANGEL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,213170529,G,G&fts=all">p.S484F</a>
ANGPTL2	Missense_Mutation	p.R396Q	C	C		7	Cancer Module	9	129854044	129854044	239	0.271966527196653	NA	NA	NA			18	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANGPTL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,129854044,C,C&fts=all">p.R396Q</a>
ANK1	Missense_Mutation	p.E1556K	C	C		7	Cancer Module	8	41530302	41530302	20	0.2	NA	NA	NA			122	55 kDa regulatory domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,41530302,C,C&fts=all">p.E1556K</a>
ANK1	Missense_Mutation	p.S1509F	G	G		7	Cancer Module	8	41542073	41542073	39	0.435897435897436	NA	NA	NA			122	55 kDa regulatory domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,41542073,G,G&fts=all">p.S1509F</a>
ANK1	Missense_Mutation	p.M1239I	C	C		7	Cancer Module	8	41550307	41550307	149	0.181208053691275	NA	NA	NA			122	UPA domain. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,41550307,C,C&fts=all">p.M1239I</a>
ANK1	Missense_Mutation	p.P1217L	G	G		7	Cancer Module	8	41550374	41550374	79	0.189873417721519	NA	NA	NA			122	ZU5 2. {ECO:0000255|PROSITE- ProRule:PRU00485}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,41550374,G,G&fts=all">p.P1217L</a>
ANK1	Missense_Mutation	p.L655F	G	G		7	Cancer Module	8	41566331	41566331	103	0.203883495145631	NA	NA	NA			122	89 kDa domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,41566331,G,G&fts=all">p.L655F</a>
ANK1	Missense_Mutation	p.A368T	C	C		7	Cancer Module	8	41577184	41577184	131	0.183206106870229	NA	NA	NA			122	89 kDa domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,41577184,C,C&fts=all">p.A368T</a>
ANK2	Missense_Mutation	p.I2832R	T	T		7	Cancer Module	4	114278368	114278368	220	0.290909090909091	NA	NA	NA			248			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,114278368,T,T&fts=all">p.I2832R</a>
ANK2	Missense_Mutation	p.P3123L	C	C		7	Cancer Module	4	114279241	114279241	69	0.246376811594203	NA	NA	NA			248			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,114279241,C,C&fts=all">p.P3123L</a>
ANK3	Missense_Mutation	p.P4334L	G	G		7	Cancer Module	10	61815480	61815480	358	0.189944134078212	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61815480,G,G&fts=all">p.P4334L</a>
ANK3	Missense_Mutation	p.P4196L	G	G		7	Cancer Module	10	61822877	61822877	116	0.189655172413793	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61822877,G,G&fts=all">p.P4196L</a>
ANK3	Missense_Mutation	p.E3526K	C	C		7	Cancer Module	10	61830063	61830063	174	0.14367816091954	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61830063,C,C&fts=all">p.E3526K</a>
ANK3	Missense_Mutation	p.P3201S	G	G		7	Cancer Module	10	61831038	61831038	98	0.163265306122449	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61831038,G,G&fts=all">p.P3201S</a>
ANK3	Missense_Mutation	p.D3067N	C	C	rs568053112	7	Cancer Module	10	61831440	61831440	185	0.221621621621622	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61831440,C,C&fts=all">p.D3067N</a>
ANK3	Missense_Mutation	p.P3045L	G	G		7	Cancer Module	10	61831505	61831505	187	0.491978609625668	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61831505,G,G&fts=all">p.P3045L</a>
ANK3	Missense_Mutation	p.P3045S	G	G		7	Cancer Module	10	61831506	61831506	187	0.491978609625668	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61831506,G,G&fts=all">p.P3045S</a>
ANK3	Missense_Mutation	p.P3037S	G	G		7	Cancer Module	10	61831530	61831530	182	0.208791208791209	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61831530,G,G&fts=all">p.P3037S</a>
ANK3	Missense_Mutation	p.S3020L	G	G		7	Cancer Module	10	61831580	61831580	164	0.268292682926829	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61831580,G,G&fts=all">p.S3020L</a>
ANK3	Missense_Mutation	p.S2282F	G	G		7	Cancer Module	10	61833794	61833794	196	0.331632653061224	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61833794,G,G&fts=all">p.S2282F</a>
ANK3	Missense_Mutation	p.E2226K	C	C		7	Cancer Module	10	61833963	61833963	231	0.194805194805195	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61833963,C,C&fts=all">p.E2226K</a>
ANK3	Missense_Mutation	p.S1848L	G	G		7	Cancer Module	10	61835096	61835096	242	0.210743801652893	NA	NA	NA			196	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61835096,G,G&fts=all">p.S1848L</a>
ANK3	Missense_Mutation	p.S1487F	G	G		7	Cancer Module	10	61836179	61836179	95	0.231578947368421	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61836179,G,G&fts=all">p.S1487F</a>
ANK3	Missense_Mutation	p.A966T	C	C		7	Cancer Module	10	61874035	61874035	184	0.21195652173913	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61874035,C,C&fts=all">p.A966T</a>
ANK3	Missense_Mutation	p.V660G	A	A		7	Cancer Module	10	61946579	61946579	166	0.548192771084337	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61946579,A,A&fts=all">p.V660G</a>
ANK3	Missense_Mutation	p.S450L	G	G		7	Cancer Module	10	61962803	61962803	161	0.267080745341615	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61962803,G,G&fts=all">p.S450L</a>
ANK3	Missense_Mutation	p.A57V	G	G		7	Cancer Module	10	62039342	62039342	350	0.237142857142857	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,62039342,G,G&fts=all">p.A57V</a>
ANKMY1	Missense_Mutation	p.S306L	G	G		7	Cancer Module	2	241463764	241463764	70	0.328571428571429	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKMY1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,241463764,G,G&fts=all">p.S306L</a>
ANKRD1	Missense_Mutation	p.E88K	C	C		7	Cancer Module	10	92678971	92678971	93	0.247311827956989	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,92678971,C,C&fts=all">p.E88K</a>
ANKRD12	Frame_Shift_Del	p.E919fs	AG	AG		7	Cancer Module	18	9256019	9256020	23	0.434782608695652	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD12&recr=Open">Click here</a>	
ANKRD17	Missense_Mutation	p.P1221L	G	G		7	Cancer Module	4	73986785	73986785	178	0.286516853932584	NA	NA	NA			96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,73986785,G,G&fts=all">p.P1221L</a>
ANLN	Missense_Mutation	p.S33F	C	C		7	Cancer Module	7	36435954	36435954	381	0.286089238845144	NA	NA	NA		p.S33C(1)	45	Interaction with CD2AP.|Nuclear localization.|Required for ubiquitination.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANLN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,36435954,C,C&fts=all">p.S33F</a>
ANXA9	Missense_Mutation	p.E138K	G	G		7	Cancer Module	1	150957092	150957092	103	0.41747572815534	NA	NA	NA		p.E138K(1)	8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANXA9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,150957092,G,G&fts=all">p.E138K</a>
ANXA9	Missense_Mutation	p.E216K	G	G		7	Cancer Module	1	150960381	150960381	102	0.245098039215686	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANXA9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,150960381,G,G&fts=all">p.E216K</a>
AOAH	Missense_Mutation	p.V10M	C	C		7	Cancer Module	7	36763726	36763726	103	0.223300970873786	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AOAH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,36763726,C,C&fts=all">p.V10M</a>
AOX1	Nonsense_Mutation	p.E888*	G	G		7	Cancer Module	2	201507339	201507339	67	0.298507462686567	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AOX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,201507339,G,G&fts=all">p.E888*</a>
AOX1	Missense_Mutation	p.E1132G	A	A		7	Cancer Module	2	201526321	201526321	158	0.234177215189873	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AOX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,201526321,A,A&fts=all">p.E1132G</a>
AP2A1	Missense_Mutation	p.L801F	C	C		7	Cancer Module	19	50306624	50306624	61	0.131147540983607	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP2A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50306624,C,C&fts=all">p.L801F</a>
AP3B1	Missense_Mutation	p.D332N	C	C		7	Cancer Module	5	77471476	77471476	39	0.384615384615385	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP3B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,77471476,C,C&fts=all">p.D332N</a>
APBA2	Missense_Mutation	p.E153K	G	G		7	Cancer Module	15	29346544	29346544	21	0.619047619047619	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APBA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,29346544,G,G&fts=all">p.E153K</a>
APBA2	Missense_Mutation	p.A177V	C	C		7	Cancer Module	15	29346617	29346617	24	0.25	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APBA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,29346617,C,C&fts=all">p.A177V</a>
APBA2	Missense_Mutation	p.G725R	G	G		7	Cancer Module	15	29406214	29406214	27	0.296296296296296	NA	NA	NA			59	PDZ 2. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APBA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,29406214,G,G&fts=all">p.G725R</a>
APBB1IP	Missense_Mutation	p.D20N	G	G		7	Cancer Module	10	26781313	26781313	149	0.187919463087248	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APBB1IP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,26781313,G,G&fts=all">p.D20N</a>
APLP1	Missense_Mutation	p.S191L	C	C	rs199660121	7	Cancer Module	19	36362548	36362548	59	0.135593220338983	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APLP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36362548,C,C&fts=all">p.S191L</a>
APLP1	Missense_Mutation	p.E363K	G	G		7	Cancer Module	19	36365436	36365436	108	0.175925925925926	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APLP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36365436,G,G&fts=all">p.E363K</a>
APOA1	Nonsense_Mutation	p.W52*	C	C		7	Cancer Module	11	116707106	116707106	21	0.904761904761905	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,116707106,C,C&fts=all">p.W52*</a>
APOB	Missense_Mutation	p.D3660N	C	C		7	Cancer Module	2	21228762	21228762	62	0.306451612903226	NA	NA	NA			305			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,21228762,C,C&fts=all">p.D3660N</a>
APOB	Missense_Mutation	p.R3059C	G	G	rs146377316	7	Cancer Module	2	21230565	21230565	109	0.302752293577982	NA	NA	NA		p.R3059C(1)	305			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,21230565,G,G&fts=all">p.R3059C</a>
APOB	Missense_Mutation	p.R214C	G	G		7	Cancer Module	2	21260025	21260025	37	0.108108108108108	NA	NA	NA		p.R214C(1)	305	Vitellogenin. {ECO:0000255|PROSITE- ProRule:PRU00557}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,21260025,G,G&fts=all">p.R214C</a>
APOBEC1	Missense_Mutation	p.E22K	C	C		7	Cancer Module	12	7805412	7805412	105	0.438095238095238	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOBEC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7805412,C,C&fts=all">p.E22K</a>
APOH	Missense_Mutation	p.P53S	G	G		7	Cancer Module	17	64224222	64224222	192	0.229166666666667	NA	NA	NA			17	Sushi 1. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,64224222,G,G&fts=all">p.P53S</a>
AQP9	Missense_Mutation	p.P89S	C	C		7	Cancer Module	15	58467200	58467200	130	0.507692307692308	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AQP9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,58467200,C,C&fts=all">p.P89S</a>
AQP9	Missense_Mutation	p.P89L	C	C	rs145164884	7	Cancer Module	15	58467201	58467201	130	0.507692307692308	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AQP9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,58467201,C,C&fts=all">p.P89L</a>
ARFGEF2	Missense_Mutation	p.R1509C	C	C		7	Cancer Module	20	47635436	47635436	83	0.36144578313253	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARFGEF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,47635436,C,C&fts=all">p.R1509C</a>
ARFIP2	Missense_Mutation	p.P330L	G	G		7	Cancer Module	11	6498380	6498380	38	0.421052631578947	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARFIP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,6498380,G,G&fts=all">p.P330L</a>
ARHGAP11A	Missense_Mutation	p.P379S	C	C		7	Cancer Module	15	32928676	32928676	439	0.273348519362187	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP11A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,32928676,C,C&fts=all">p.P379S</a>
ARHGAP20	Missense_Mutation	p.S345F	G	G		7	Cancer Module	11	110451265	110451265	91	0.340659340659341	NA	NA	NA		p.S802Y(1)	60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,110451265,G,G&fts=all">p.S345F</a>
ARHGAP24	Missense_Mutation	p.L446F	C	C		7	Cancer Module	4	86916143	86916143	42	0.238095238095238	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP24&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,86916143,C,C&fts=all">p.L446F</a>
ARHGAP28	Missense_Mutation	p.S629L	C	C		7	Cancer Module	18	6894871	6894871	80	0.5	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP28&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,6894871,C,C&fts=all">p.S629L</a>
ARHGAP29	Missense_Mutation	p.R1133K	C	C		7	Cancer Module	1	94639813	94639813	132	0.424242424242424	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP29&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,94639813,C,C&fts=all">p.R1133K</a>
ARHGEF1	Missense_Mutation	p.P323L	C	C		7	Cancer Module	19	42399467	42399467	121	0.239669421487603	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,42399467,C,C&fts=all">p.P323L</a>
ARHGEF1	Missense_Mutation	p.P790L	C	C		7	Cancer Module	19	42409401	42409401	60	0.533333333333333	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,42409401,C,C&fts=all">p.P790L</a>
ARHGEF1	Missense_Mutation	p.P798S	C	C		7	Cancer Module	19	42409922	42409922	59	0.288135593220339	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,42409922,C,C&fts=all">p.P798S</a>
ARHGEF11	Missense_Mutation	p.P543L	G	G		7	Cancer Module	1	156926255	156926255	257	0.217898832684825	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,156926255,G,G&fts=all">p.P543L</a>
ARHGEF4	Missense_Mutation	p.R623K	G	G		7	Cancer Module	2	131802966	131802966	30	0.7	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,131802966,G,G&fts=all">p.R623K</a>
ARID4A	Missense_Mutation	p.P992L	C	C		7	Cancer Module	14	58831782	58831782	166	0.86144578313253	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARID4A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,58831782,C,C&fts=all">p.P992L</a>
ARID4B	Missense_Mutation	p.P996L	G	G		7	Cancer Module	1	235345247	235345247	368	0.375	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARID4B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,235345247,G,G&fts=all">p.P996L</a>
ARSA	Missense_Mutation	p.P150S	G	G		7	Cancer Module	22	51065611	51065611	49	0.163265306122449	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARSA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,51065611,G,G&fts=all">p.P150S</a>
ARSG	Missense_Mutation	p.F296Y	T	T		7	Cancer Module	17	66364871	66364871	197	0.238578680203046	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARSG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,66364871,T,T&fts=all">p.F296Y</a>
ASB12	Missense_Mutation	p.K36Q	T	T		7	Cancer Module	X	63445425	63445425	16	0.625	NA	NA	NA		p.0?(2)	14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASB12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,63445425,T,T&fts=all">p.K36Q</a>
ASNS	Missense_Mutation	p.S177F	G	G		7	Cancer Module	7	97488605	97488605	127	0.417322834645669	NA	NA	NA			1	Glutamine amidotransferase type-2. {ECO:0000255|PROSITE-ProRule:PRU00609}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASNS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,97488605,G,G&fts=all">p.S177F</a>
ASS1	Missense_Mutation	p.G120E	G	G		7	Cancer Module	9	133333972	133333972	13	0.615384615384615	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,133333972,G,G&fts=all">p.G120E</a>
ASXL2	Nonsense_Mutation	p.Q1349*	G	G		7	Cancer Module	2	25965161	25965161	67	0.313432835820896	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASXL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,25965161,G,G&fts=all">p.Q1349*</a>
ASXL2	Missense_Mutation	p.L322S	A	A		7	Cancer Module	2	25978958	25978958	199	0.311557788944724	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASXL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,25978958,A,A&fts=all">p.L322S</a>
ATAD2	Missense_Mutation	p.H126Y	G	G		7	Cancer Module	8	124358436	124358436	332	0.180722891566265	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATAD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,124358436,G,G&fts=all">p.H126Y</a>
ATE1	Missense_Mutation	p.F279S	A	A		7	Cancer Module	10	123658462	123658462	168	0.25	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123658462,A,A&fts=all">p.F279S</a>
ATF6	Missense_Mutation	p.S631L	C	C		7	Cancer Module	1	161928323	161928323	176	0.426136363636364	NA	NA	NA		p.S631L(1)	34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATF6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,161928323,C,C&fts=all">p.S631L</a>
ATG2A	Missense_Mutation	p.S778F	G	G		7	Cancer Module	11	64676494	64676494	2	1	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATG2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,64676494,G,G&fts=all">p.S778F</a>
ATN1	Missense_Mutation	p.P970S	C	C		7	Cancer Module	12	7048034	7048034	164	0.219512195121951	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7048034,C,C&fts=all">p.P970S</a>
ATP10B	Missense_Mutation	p.E1425A	T	T		7	Cancer Module	5	159992572	159992572	82	0.439024390243902	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP10B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,159992572,T,T&fts=all">p.E1425A</a>
ATP10B	Missense_Mutation	p.E1345D	T	T		7	Cancer Module	5	159992811	159992811	161	0.316770186335404	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP10B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,159992811,T,T&fts=all">p.E1345D</a>
ATP10B	Missense_Mutation	p.N1284K	A	A		7	Cancer Module	5	159996589	159996589	76	0.5	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP10B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,159996589,A,A&fts=all">p.N1284K</a>
ATP10B	Missense_Mutation	p.E965K	C	C		7	Cancer Module	5	160034039	160034039	120	0.316666666666667	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP10B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,160034039,C,C&fts=all">p.E965K</a>
ATP10D	Missense_Mutation	p.R182C	C	C	rs200556408	7	Cancer Module	4	47525087	47525087	109	0.330275229357798	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP10D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,47525087,C,C&fts=all">p.R182C</a>
ATP10D	Missense_Mutation	p.G441E	G	G		7	Cancer Module	4	47538881	47538881	58	0.379310344827586	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP10D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,47538881,G,G&fts=all">p.G441E</a>
ATP1A2	Missense_Mutation	p.S665F	C	C		7	Cancer Module	1	160104964	160104964	37	0.324324324324324	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP1A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,160104964,C,C&fts=all">p.S665F</a>
ATP1A3	Splice_Site	p.R661R	C	C		7	Cancer Module	19	42480718	42480718	43	0.0930232558139535	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP1A3&recr=Open">Click here</a>	
ATP2B1	Missense_Mutation	p.S1140L	G	G		7	Cancer Module	12	89985005	89985005	125	0.376	NA	NA	NA		p.S1140L(1)	45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,89985005,G,G&fts=all">p.S1140L</a>
ATP2B1	Missense_Mutation	p.R1125C	G	G		7	Cancer Module	12	89985051	89985051	85	0.341176470588235	NA	NA	NA			45	Calmodulin-binding subdomain B.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,89985051,G,G&fts=all">p.R1125C</a>
ATP2B2	Missense_Mutation	p.D1072N	C	C		7	Cancer Module	3	10379931	10379931	67	0.194029850746269	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2B2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,10379931,C,C&fts=all">p.D1072N</a>
ATP2B2	Missense_Mutation	p.R185C	G	G		7	Cancer Module	3	10443877	10443877	181	0.187845303867403	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2B2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,10443877,G,G&fts=all">p.R185C</a>
ATP2B2	Missense_Mutation	p.V161G	A	A		7	Cancer Module	3	10443948	10443948	138	0.188405797101449	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2B2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,10443948,A,A&fts=all">p.V161G</a>
ATP5C1	Missense_Mutation	p.S37F	C	C		7	Cancer Module	10	7839028	7839028	198	0.196969696969697	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP5C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,7839028,C,C&fts=all">p.S37F</a>
ATP6V0A1	Missense_Mutation	p.H146Y	C	C		7	Cancer Module	17	40629669	40629669	124	0.370967741935484	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP6V0A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,40629669,C,C&fts=all">p.H146Y</a>
ATP6V1C1	Missense_Mutation	p.R249C	C	C		7	Cancer Module	8	104075373	104075373	322	0.226708074534162	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP6V1C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,104075373,C,C&fts=all">p.R249C</a>
ATP8A1	Missense_Mutation	p.F619C	A	A		7	Cancer Module	4	42524268	42524268	96	0.46875	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,42524268,A,A&fts=all">p.F619C</a>
ATP8A2	Missense_Mutation	p.E241K	G	G		7	Cancer Module	13	26116126	26116126	210	0.257142857142857	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,26116126,G,G&fts=all">p.E241K</a>
ATPAF2	Missense_Mutation	p.R143K	C	C		7	Cancer Module	17	17928013	17928013	155	0.870967741935484	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATPAF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,17928013,C,C&fts=all">p.R143K</a>
ATXN2L	Missense_Mutation	p.P1012L	C	C		7	Cancer Module	16	28847375	28847375	86	0.244186046511628	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATXN2L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,28847375,C,C&fts=all">p.P1012L</a>
ATXN7	Missense_Mutation	p.P181L	C	C		7	Cancer Module	3	63965633	63965633	299	0.220735785953177	NA	NA	NA			35	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATXN7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,63965633,C,C&fts=all">p.P181L</a>
AURKC	Missense_Mutation	p.P33S	C	C		7	Cancer Module	19	57743148	57743148	89	0.179775280898876	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AURKC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57743148,C,C&fts=all">p.P33S</a>
AXL	Missense_Mutation	p.P12S	C	C		7	Cancer Module	19	41725331	41725331	12	0.416666666666667	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AXL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41725331,C,C&fts=all">p.P12S</a>
AXL	Missense_Mutation	p.P301L	C	C		7	Cancer Module	19	41743967	41743967	95	0.147368421052632	NA	NA	NA			48	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AXL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41743967,C,C&fts=all">p.P301L</a>
AXL	Missense_Mutation	p.R308C	C	C		7	Cancer Module	19	41743987	41743987	100	0.32	NA	NA	NA			48	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AXL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41743987,C,C&fts=all">p.R308C</a>
AZU1	Missense_Mutation	p.P176L	C	C		7	Cancer Module	19	830874	830874	31	0.32258064516129	NA	NA	NA			10	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AZU1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,830874,C,C&fts=all">p.P176L</a>
BAHD1	Missense_Mutation	p.L176F	C	C		7	Cancer Module	15	40751189	40751189	25	0.32	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAHD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,40751189,C,C&fts=all">p.L176F</a>
BAI2	Missense_Mutation	p.P95L	G	G		7	Cancer Module	1	32222154	32222154	16	0.3125	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,32222154,G,G&fts=all">p.P95L</a>
BAI2	Missense_Mutation	p.P95S	G	G		7	Cancer Module	1	32222155	32222155	16	0.3125	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,32222155,G,G&fts=all">p.P95S</a>
BAI3	Frame_Shift_Del	p.A584fs	T	T		7	Cancer Module	6	69703677	69703677	214	0.373831775700935	NA	NA	NA			210			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAI3&recr=Open">Click here</a>	
BANK1	Missense_Mutation	p.E183K	G	G		7	Cancer Module	4	102776269	102776269	183	0.289617486338798	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,102776269,G,G&fts=all">p.E183K</a>
BANK1	Missense_Mutation	p.G555E	G	G		7	Cancer Module	4	102951186	102951186	74	0.216216216216216	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,102951186,G,G&fts=all">p.G555E</a>
BANK1	Missense_Mutation	p.E574K	G	G		7	Cancer Module	4	102951242	102951242	69	0.27536231884058	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,102951242,G,G&fts=all">p.E574K</a>
BARD1	Missense_Mutation	p.P315L	G	G	rs148760338	7	Cancer Module	2	215645654	215645654	238	0.23109243697479	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BARD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,215645654,G,G&fts=all">p.P315L</a>
BAZ2B	Missense_Mutation	p.S1467F	G	G		7	Cancer Module	2	160206682	160206682	144	0.215277777777778	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAZ2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,160206682,G,G&fts=all">p.S1467F</a>
BBS7	Missense_Mutation	p.H498Y	G	G		7	Cancer Module	4	122756318	122756318	273	0.534798534798535	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BBS7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,122756318,G,G&fts=all">p.H498Y</a>
BBS7	Missense_Mutation	p.R160C	G	G		7	Cancer Module	4	122780197	122780197	366	0.284153005464481	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BBS7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,122780197,G,G&fts=all">p.R160C</a>
BCAS3	Missense_Mutation	p.S503F	C	C		7	Cancer Module	17	59093133	59093133	551	0.217785843920145	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCAS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,59093133,C,C&fts=all">p.S503F</a>
BCAS3	Missense_Mutation	p.S849T	T	T		7	Cancer Module	17	59445762	59445762	106	0.226415094339623	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCAS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,59445762,T,T&fts=all">p.S849T</a>
BCLAF1	Missense_Mutation	p.H781Y	G	G	rs201815554	7	Cancer Module	6	136589356	136589356	243	0.353909465020576	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCLAF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,136589356,G,G&fts=all">p.H781Y</a>
BCLAF1	Missense_Mutation	p.T661I	G	G		7	Cancer Module	6	136593194	136593194	304	0.348684210526316	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCLAF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,136593194,G,G&fts=all">p.T661I</a>
BCORL1	Missense_Mutation	p.E1172K	G	G		7	Cancer Module	X	129155032	129155032	29	0.448275862068966	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCORL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,129155032,G,G&fts=all">p.E1172K</a>
BCORL1	Missense_Mutation	p.S1204F	C	C		7	Cancer Module	X	129156875	129156875	161	0.46583850931677	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCORL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,129156875,C,C&fts=all">p.S1204F</a>
BEGAIN	Missense_Mutation	p.D461N	C	C		7	Cancer Module	14	101004707	101004707	10	0.4	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BEGAIN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,101004707,C,C&fts=all">p.D461N</a>
BEX1	Missense_Mutation	p.R78K	C	C		7	Cancer Module	X	102317970	102317970	76	0.921052631578947	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BEX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,102317970,C,C&fts=all">p.R78K</a>
BIN2	Missense_Mutation	p.P368Q	G	G	rs376067729	7	Cancer Module	12	51685787	51685787	39	0.435897435897436	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BIN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,51685787,G,G&fts=all">p.P368Q</a>
BLK	Missense_Mutation	p.P39S	C	C	rs535683889	7	Cancer Module	8	11400848	11400848	28	0.464285714285714	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BLK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,11400848,C,C&fts=all">p.P39S</a>
BLK	Missense_Mutation	p.G171E	G	G		7	Cancer Module	8	11412291	11412291	82	0.195121951219512	NA	NA	NA			27	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BLK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,11412291,G,G&fts=all">p.G171E</a>
BLMH	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BLMH&recr=Open">Click here</a>	
BMP1	Missense_Mutation	p.P391L	C	C		7	Cancer Module	8	22049656	22049656	85	0.211764705882353	NA	NA	NA			30	CUB 1. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,22049656,C,C&fts=all">p.P391L</a>
BMP3	Missense_Mutation	p.E452K	G	G		7	Cancer Module	4	81974625	81974625	203	0.310344827586207	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,81974625,G,G&fts=all">p.E452K</a>
BPI	Nonsense_Mutation	p.R198*	C	C		7	Cancer Module	20	36940319	36940319	197	0.147208121827411	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,36940319,C,C&fts=all">p.R198*</a>
BRDT	Missense_Mutation	p.D780N	G	G		7	Cancer Module	1	92467656	92467656	145	0.379310344827586	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRDT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,92467656,G,G&fts=all">p.D780N</a>
BRPF1	Nonsense_Mutation	p.Q399*	C	C		7	Cancer Module	3	9781278	9781278	77	0.181818181818182	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRPF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,9781278,C,C&fts=all">p.Q399*</a>
BSN	Missense_Mutation	p.P1537S	C	C		7	Cancer Module	3	49691598	49691598	59	0.457627118644068	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BSN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49691598,C,C&fts=all">p.P1537S</a>
BSN	Missense_Mutation	p.F2027S	T	T		7	Cancer Module	3	49693069	49693069	105	0.219047619047619	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BSN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49693069,T,T&fts=all">p.F2027S</a>
BSN	Missense_Mutation	p.L2144F	C	C		7	Cancer Module	3	49693419	49693419	58	0.137931034482759	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BSN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49693419,C,C&fts=all">p.L2144F</a>
BSN	Missense_Mutation	p.Y2999N	T	T		7	Cancer Module	3	49698273	49698273	40	0.375	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BSN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49698273,T,T&fts=all">p.Y2999N</a>
BSN	Missense_Mutation	p.P3249S	C	C		7	Cancer Module	3	49699023	49699023	119	0.19327731092437	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BSN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49699023,C,C&fts=all">p.P3249S</a>
BSPRY	Missense_Mutation	p.D270N	G	G		7	Cancer Module	9	116132021	116132021	49	0.183673469387755	NA	NA	NA			8	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BSPRY&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,116132021,G,G&fts=all">p.D270N</a>
BTG3	Missense_Mutation	p.S128F	G	G		7	Cancer Module	21	18971071	18971071	174	0.275862068965517	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTG3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,18971071,G,G&fts=all">p.S128F</a>
BTK	Missense_Mutation	p.P73L	G	G		7	Cancer Module	X	100629546	100629546	348	0.905172413793103	NA	NA	NA			50	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,100629546,G,G&fts=all">p.P73L</a>
BTN3A2	Nonsense_Mutation	p.Q309*	C	C		7	Cancer Module	6	26373512	26373512	436	0.0206422018348624	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTN3A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,26373512,C,C&fts=all">p.Q309*</a>
C1R	Missense_Mutation	p.L521F	G	G		7	Cancer Module	12	7188237	7188237	67	0.417910447761194	NA	NA	NA			16	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7188237,G,G&fts=all">p.L521F</a>
C3AR1	Missense_Mutation	p.E276K	C	C		7	Cancer Module	12	8211956	8211956	116	0.517241379310345	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3AR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,8211956,C,C&fts=all">p.E276K</a>
C4BPB	Missense_Mutation	p.P132L	C	C		7	Cancer Module	1	207265151	207265151	60	0.166666666666667	NA	NA	NA			4	Sushi 2. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C4BPB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,207265151,C,C&fts=all">p.P132L</a>
C8A	Missense_Mutation	p.P147L	C	C		7	Cancer Module	1	57341858	57341858	65	0.4	NA	NA	NA			43	MACPF. {ECO:0000255|PROSITE- ProRule:PRU00745}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,57341858,C,C&fts=all">p.P147L</a>
C8A	Missense_Mutation	p.E352K	G	G		7	Cancer Module	1	57351798	57351798	139	0.0431654676258993	NA	NA	NA			43	MACPF. {ECO:0000255|PROSITE- ProRule:PRU00745}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,57351798,G,G&fts=all">p.E352K</a>
C8A	Missense_Mutation	p.S364F	C	C	rs370785343	7	Cancer Module	1	57351835	57351835	151	0.278145695364238	NA	NA	NA			43	MACPF. {ECO:0000255|PROSITE- ProRule:PRU00745}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,57351835,C,C&fts=all">p.S364F</a>
C8B	Missense_Mutation	p.G510E	C	C		7	Cancer Module	1	57399031	57399031	61	0.327868852459016	NA	NA	NA			52	EGF-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,57399031,C,C&fts=all">p.G510E</a>
C8B	Missense_Mutation	p.G453E	C	C		7	Cancer Module	1	57406562	57406562	54	0.444444444444444	NA	NA	NA			52	MACPF. {ECO:0000255|PROSITE- ProRule:PRU00745}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,57406562,C,C&fts=all">p.G453E</a>
C9	Missense_Mutation	p.D404N	C	C		7	Cancer Module	5	39308362	39308362	259	0.223938223938224	NA	NA	NA			32	MACPF. {ECO:0000255|PROSITE- ProRule:PRU00745}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,39308362,C,C&fts=all">p.D404N</a>
C9	Missense_Mutation	p.E278K	C	C		7	Cancer Module	5	39315915	39315915	194	0.438144329896907	NA	NA	NA			32	MACPF. {ECO:0000255|PROSITE- ProRule:PRU00745}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,39315915,C,C&fts=all">p.E278K</a>
C9	Missense_Mutation	p.D55N	C	C		7	Cancer Module	5	39342213	39342213	232	0.176724137931034	NA	NA	NA			32	TSP type-1. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,39342213,C,C&fts=all">p.D55N</a>
CA11	Missense_Mutation	p.R140C	G	G		7	Cancer Module	19	49143405	49143405	243	0.168724279835391	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CA11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49143405,G,G&fts=all">p.R140C</a>
CABIN1	Missense_Mutation	p.P242L	C	C		7	Cancer Module	22	24451404	24451404	125	0.216	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CABIN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,24451404,C,C&fts=all">p.P242L</a>
CABIN1	Missense_Mutation	p.S853F	C	C		7	Cancer Module	22	24472193	24472193	125	0.224	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CABIN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,24472193,C,C&fts=all">p.S853F</a>
CABIN1	Missense_Mutation	p.S1091F	C	C		7	Cancer Module	22	24483563	24483563	96	0.21875	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CABIN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,24483563,C,C&fts=all">p.S1091F</a>
CACNA1A	Missense_Mutation	p.D1535N	C	C		7	Cancer Module	19	13366061	13366061	22	0.636363636363636	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,13366061,C,C&fts=all">p.D1535N</a>
CACNA1C	Missense_Mutation	p.S314F	C	C		7	Cancer Module	12	2602380	2602380	77	0.155844155844156	NA	NA	NA			132			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,2602380,C,C&fts=all">p.S314F</a>
CACNA1C	Missense_Mutation	p.S916F	C	C		7	Cancer Module	12	2705123	2705123	54	0.185185185185185	NA	NA	NA			132			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,2705123,C,C&fts=all">p.S916F</a>
CACNA1C	Missense_Mutation	p.V923I	G	G		7	Cancer Module	12	2705143	2705143	49	0.408163265306122	NA	NA	NA			132			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,2705143,G,G&fts=all">p.V923I</a>
CACNA1C	Missense_Mutation	p.G1602R	G	G		7	Cancer Module	12	2778135	2778135	78	0.294871794871795	NA	NA	NA			132			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,2778135,G,G&fts=all">p.G1602R</a>
CACNA2D1	Missense_Mutation	p.T539P	T	T		7	Cancer Module	7	81626542	81626542	207	0.0386473429951691	NA	NA	NA			81	Cache.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA2D1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,81626542,T,T&fts=all">p.T539P</a>
CACNA2D1	Nonsense_Mutation	p.Q309*	G	G		7	Cancer Module	7	81667506	81667506	174	0.0517241379310345	NA	NA	NA			81	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA2D1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,81667506,G,G&fts=all">p.Q309*</a>
CACNA2D3	Missense_Mutation	p.S253F	C	C		7	Cancer Module	3	54604001	54604001	89	0.179775280898876	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA2D3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,54604001,C,C&fts=all">p.S253F</a>
CACNA2D3	Missense_Mutation	p.N319D	A	A		7	Cancer Module	3	54615896	54615896	60	0.25	NA	NA	NA			59	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA2D3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,54615896,A,A&fts=all">p.N319D</a>
CACNA2D3	Missense_Mutation	p.G356E	G	G		7	Cancer Module	3	54676168	54676168	52	0.403846153846154	NA	NA	NA			59	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA2D3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,54676168,G,G&fts=all">p.G356E</a>
CACNA2D3	Splice_Site	p.Q749Q	G	G		7	Cancer Module	3	54930776	54930776	183	0.185792349726776	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA2D3&recr=Open">Click here</a>	
CACNB2	Missense_Mutation	p.E620K	G	G		7	Cancer Module	10	18828528	18828528	94	0.265957446808511	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,18828528,G,G&fts=all">p.E620K</a>
CACNB4	Missense_Mutation	p.R30K	C	C		7	Cancer Module	2	152739802	152739802	179	0.29608938547486	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,152739802,C,C&fts=all">p.R30K</a>
CACNG3	Missense_Mutation	p.K171T	A	A		7	Cancer Module	16	24372748	24372748	157	0.292993630573248	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNG3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,24372748,A,A&fts=all">p.K171T</a>
CACNG3	Missense_Mutation	p.R208Q	G	G		7	Cancer Module	16	24372859	24372859	91	0.241758241758242	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNG3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,24372859,G,G&fts=all">p.R208Q</a>
CAD	Missense_Mutation	p.P176S	C	C		7	Cancer Module	2	27445417	27445417	91	0.274725274725275	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27445417,C,C&fts=all">p.P176S</a>
CAD	Missense_Mutation	p.P245S	C	C		7	Cancer Module	2	27445829	27445829	162	0.277777777777778	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27445829,C,C&fts=all">p.P245S</a>
CAD	Missense_Mutation	p.P1059L	C	C		7	Cancer Module	2	27456642	27456642	76	0.0657894736842105	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27456642,C,C&fts=all">p.P1059L</a>
CADM3	Missense_Mutation	p.E178K	G	G		7	Cancer Module	1	159163260	159163260	109	0.422018348623853	NA	NA	NA			55	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CADM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,159163260,G,G&fts=all">p.E178K</a>
CADM4	Missense_Mutation	p.E30K	C	C		7	Cancer Module	19	44131919	44131919	281	0.170818505338078	NA	NA	NA		p.E30*(1)	12	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CADM4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44131919,C,C&fts=all">p.E30K</a>
CADPS	Nonsense_Mutation	p.W536*	C	C		7	Cancer Module	3	62556583	62556583	454	0.42511013215859	NA	NA	NA			92	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CADPS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,62556583,C,C&fts=all">p.W536*</a>
CALB1	Missense_Mutation	p.E190K	C	C		7	Cancer Module	8	91075360	91075360	351	0.179487179487179	NA	NA	NA			11	EF-hand 5. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CALB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,91075360,C,C&fts=all">p.E190K</a>
CALB1	Missense_Mutation	p.M58I	C	C		7	Cancer Module	8	91090658	91090658	378	0.402116402116402	NA	NA	NA			11	EF-hand 2. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CALB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,91090658,C,C&fts=all">p.M58I</a>
CALCRL	Missense_Mutation	p.F308C	A	A		7	Cancer Module	2	188217046	188217046	92	0.217391304347826	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CALCRL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,188217046,A,A&fts=all">p.F308C</a>
CALCRL	Missense_Mutation	p.F16Y	A	A		7	Cancer Module	2	188250276	188250276	212	0.212264150943396	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CALCRL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,188250276,A,A&fts=all">p.F16Y</a>
CALU	Missense_Mutation	p.D221Y	G	G		7	Cancer Module	7	128407527	128407527	134	0.850746268656716	NA	NA	NA			10	EF-hand 4. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CALU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,128407527,G,G&fts=all">p.D221Y</a>
CAMK1G	Nonsense_Mutation	p.R3*	C	C	rs140469539	7	Cancer Module	1	209768335	209768335	106	0.19811320754717	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMK1G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,209768335,C,C&fts=all">p.R3*</a>
CAMK1G	Missense_Mutation	p.R20Q	G	G	rs148219739	7	Cancer Module	1	209768387	209768387	145	0.296551724137931	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMK1G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,209768387,G,G&fts=all">p.R20Q</a>
CAPRIN1	Missense_Mutation	p.P527S	C	C		7	Cancer Module	11	34113477	34113477	120	0.0666666666666667	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPRIN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,34113477,C,C&fts=all">p.P527S</a>
CARD10	Missense_Mutation	p.S642F	G	G		7	Cancer Module	22	37893048	37893048	130	0.261538461538462	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CARD10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,37893048,G,G&fts=all">p.S642F</a>
CASP14	Missense_Mutation	p.A177V	C	C		7	Cancer Module	19	15166250	15166250	76	0.171052631578947	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASP14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,15166250,C,C&fts=all">p.A177V</a>
CASR	Missense_Mutation	p.E602K	G	G		7	Cancer Module	3	122002605	122002605	50	0.38	NA	NA	NA			84			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,122002605,G,G&fts=all">p.E602K</a>
CATSPERB	Nonsense_Mutation	p.E310*	C	C		7	Cancer Module	14	92150224	92150224	187	0.620320855614973	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPERB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,92150224,C,C&fts=all">p.E310*</a>
CCBE1	Splice_Site	p.R71R	C	C		7	Cancer Module	18	57147470	57147470	120	0.375	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCBE1&recr=Open">Click here</a>	
CCDC135	Missense_Mutation	p.P250L	C	C		7	Cancer Module	16	57738837	57738837	59	0.271186440677966	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC135&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,57738837,C,C&fts=all">p.P250L</a>
CCDC40	Missense_Mutation	p.E312K	G	G		7	Cancer Module	17	78023783	78023783	78	0.192307692307692	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,78023783,G,G&fts=all">p.E312K</a>
CCDC40	Missense_Mutation	p.S1029F	C	C		7	Cancer Module	17	78071108	78071108	109	0.238532110091743	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,78071108,C,C&fts=all">p.S1029F</a>
CCDC94	Missense_Mutation	p.R227W	C	C	rs199674678	7	Cancer Module	19	4262082	4262082	48	0.208333333333333	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC94&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4262082,C,C&fts=all">p.R227W</a>
CCNDBP1	Missense_Mutation	p.A95V	C	C		7	Cancer Module	15	43481431	43481431	172	0.319767441860465	NA	NA	NA			13	Interaction with RPLP0.|Interaction with TCF3.|Required for interaction with CCND1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCNDBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43481431,C,C&fts=all">p.A95V</a>
CCNDBP1	Splice_Site	p.K323E	A	A	rs531387107	7	Cancer Module	15	43486658	43486658	168	0.273809523809524	NA	NA	NA			13	Interaction with RPLP0.|Interaction with TCF3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCNDBP1&recr=Open">Click here</a>	
CCNL1	Missense_Mutation	p.R471C	G	G		7	Cancer Module	3	156866200	156866200	462	0.279220779220779	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCNL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,156866200,G,G&fts=all">p.R471C</a>
CCNT1	Missense_Mutation	p.P542L	G	G		7	Cancer Module	12	49087372	49087372	282	0.429078014184397	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCNT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,49087372,G,G&fts=all">p.P542L</a>
CCR1	Missense_Mutation	p.S42F	G	G		7	Cancer Module	3	46245680	46245680	95	0.242105263157895	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,46245680,G,G&fts=all">p.S42F</a>
CD163	Nonsense_Mutation	p.W135*	C	C		7	Cancer Module	12	7653788	7653788	237	0.20253164556962	NA	NA	NA			76	SRCR 1. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7653788,C,C&fts=all">p.W135*</a>
CD163	Missense_Mutation	p.S106F	G	G		7	Cancer Module	12	7653875	7653875	98	0.326530612244898	NA	NA	NA			76	SRCR 1. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7653875,G,G&fts=all">p.S106F</a>
CD163	Missense_Mutation	p.S106T	A	A		7	Cancer Module	12	7653876	7653876	99	0.323232323232323	NA	NA	NA			76	SRCR 1. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7653876,A,A&fts=all">p.S106T</a>
CD1B	Missense_Mutation	p.S300F	G	G		7	Cancer Module	1	158298792	158298792	72	0.333333333333333	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158298792,G,G&fts=all">p.S300F</a>
CD1C	Missense_Mutation	p.S286N	G	G		7	Cancer Module	1	158262632	158262632	53	0.660377358490566	NA	NA	NA			39	Ig-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158262632,G,G&fts=all">p.S286N</a>
CD48	Missense_Mutation	p.S8L	G	G	rs34237772	7	Cancer Module	1	160681531	160681531	76	0.460526315789474	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD48&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,160681531,G,G&fts=all">p.S8L</a>
CD5L	Missense_Mutation	p.D311N	C	C		7	Cancer Module	1	157803090	157803090	65	0.230769230769231	NA	NA	NA			52	SRCR 3. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD5L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,157803090,C,C&fts=all">p.D311N</a>
CD70	Missense_Mutation	p.G187R	C	C		7	Cancer Module	19	6586054	6586054	17	0.352941176470588	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD70&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,6586054,C,C&fts=all">p.G187R</a>
CD86	Nonsense_Mutation	p.Q23*	C	C		7	Cancer Module	3	121822379	121822379	78	0.346153846153846	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD86&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,121822379,C,C&fts=all">p.Q23*</a>
CDC123	Missense_Mutation	p.P174S	C	C		7	Cancer Module	10	12277077	12277077	586	0.223549488054608	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDC123&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,12277077,C,C&fts=all">p.P174S</a>
CDH10	Missense_Mutation	p.R424C	G	G		7	Cancer Module	5	24505344	24505344	141	0.297872340425532	NA	NA	NA			185	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,24505344,G,G&fts=all">p.R424C</a>
CDH10	Missense_Mutation	p.L203H	A	A		7	Cancer Module	5	24535850	24535850	147	0.170068027210884	NA	NA	NA			185	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,24535850,A,A&fts=all">p.L203H</a>
CDH15	Missense_Mutation	p.P62L	C	C		7	Cancer Module	16	89245966	89245966	61	0.327868852459016	NA	NA	NA			18	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,89245966,C,C&fts=all">p.P62L</a>
CDH16	Splice_Site	p.K194K	C	C		7	Cancer Module	16	66949124	66949124	57	0.473684210526316	NA	NA	NA			41	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH16&recr=Open">Click here</a>	
CDH17	Missense_Mutation	p.E562K	C	C		7	Cancer Module	8	95164208	95164208	162	0.222222222222222	NA	NA	NA			52	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,95164208,C,C&fts=all">p.E562K</a>
CDH17	Missense_Mutation	p.P30L	G	G		7	Cancer Module	8	95201476	95201476	207	0.289855072463768	NA	NA	NA			52	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,95201476,G,G&fts=all">p.P30L</a>
CDH18	Missense_Mutation	p.F268L	A	A		7	Cancer Module	5	19612550	19612550	147	0.238095238095238	NA	NA	NA			138	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,19612550,A,A&fts=all">p.F268L</a>
CDH2	Missense_Mutation	p.D854N	C	C		7	Cancer Module	18	25532185	25532185	117	0.35042735042735	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,25532185,C,C&fts=all">p.D854N</a>
CDH2	Missense_Mutation	p.S838F	G	G		7	Cancer Module	18	25532232	25532232	75	0.8	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,25532232,G,G&fts=all">p.S838F</a>
CDH23	Missense_Mutation	p.M1286I	G	G		7	Cancer Module	10	73491871	73491871	54	0.259259259259259	NA	NA	NA			133	Cadherin 12. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH23&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,73491871,G,G&fts=all">p.M1286I</a>
CDH23	Missense_Mutation	p.K1402N	G	G		7	Cancer Module	10	73494083	73494083	22	0.227272727272727	NA	NA	NA			133	Cadherin 13. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH23&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,73494083,G,G&fts=all">p.K1402N</a>
CDH3	Missense_Mutation	p.P690A	C	C		7	Cancer Module	16	68729223	68729223	67	0.567164179104478	NA	NA	NA		p.?(2)	25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,68729223,C,C&fts=all">p.P690A</a>
CDH3	Missense_Mutation	p.P690L	C	C		7	Cancer Module	16	68729224	68729224	66	0.575757575757576	NA	NA	NA		p.?(2)	25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,68729224,C,C&fts=all">p.P690L</a>
CDH4	Missense_Mutation	p.D39N	G	G		7	Cancer Module	20	59829939	59829939	110	0.3	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,59829939,G,G&fts=all">p.D39N</a>
CDH6	Missense_Mutation	p.S526F	C	C		7	Cancer Module	5	31317546	31317546	289	0.183391003460208	NA	NA	NA			77	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,31317546,C,C&fts=all">p.S526F</a>
CDH8	Splice_Site	p.R472R	C	C		7	Cancer Module	16	61761118	61761118	199	0.296482412060302	NA	NA	NA			112	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH8&recr=Open">Click here</a>	
CDH8	Nonsense_Mutation	p.Q333*	G	G		7	Cancer Module	16	61854856	61854856	119	0.235294117647059	NA	NA	NA			112	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,61854856,G,G&fts=all">p.Q333*</a>
CDH9	Missense_Mutation	p.F524L	A	A		7	Cancer Module	5	26886135	26886135	415	0.209638554216867	NA	NA	NA			137	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,26886135,A,A&fts=all">p.F524L</a>
CDH9	Missense_Mutation	p.P452S	G	G		7	Cancer Module	5	26890573	26890573	241	0.195020746887967	NA	NA	NA			137	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,26890573,G,G&fts=all">p.P452S</a>
CDH9	Missense_Mutation	p.S209L	G	G		7	Cancer Module	5	26906845	26906845	178	0.247191011235955	NA	NA	NA			137	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,26906845,G,G&fts=all">p.S209L</a>
CDR1	Missense_Mutation	p.S209F	G	G		7	Cancer Module	X	139865906	139865906	105	0.885714285714286	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,139865906,G,G&fts=all">p.S209F</a>
CDSN	Missense_Mutation	p.E524K	C	C		7	Cancer Module	6	31083822	31083822	135	0.133333333333333	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDSN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31083822,C,C&fts=all">p.E524K</a>
CDSN	Missense_Mutation	p.P309L	G	G		7	Cancer Module	6	31084466	31084466	94	0.24468085106383	NA	NA	NA			10	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDSN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31084466,G,G&fts=all">p.P309L</a>
CDYL	Missense_Mutation	p.G529R	G	G		7	Cancer Module	6	4954240	4954240	59	0.135593220338983	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDYL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,4954240,G,G&fts=all">p.G529R</a>
CEACAM5	Missense_Mutation	p.P14L	C	C		7	Cancer Module	19	42212691	42212691	18	0.166666666666667	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEACAM5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,42212691,C,C&fts=all">p.P14L</a>
CECR2	Missense_Mutation	p.P672S	C	C	rs550266263	7	Cancer Module	22	18022335	18022335	124	0.25	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CECR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,18022335,C,C&fts=all">p.P672S</a>
CELSR1	Splice_Site	p.I2624I	G	G		7	Cancer Module	22	46765589	46765589	27	0.333333333333333	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELSR1&recr=Open">Click here</a>	
CELSR1	Missense_Mutation	p.R1678Q	C	C	rs375665929	7	Cancer Module	22	46805678	46805678	127	0.181102362204724	NA	NA	NA			95	EGF-like 4; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELSR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,46805678,C,C&fts=all">p.R1678Q</a>
CELSR3	Missense_Mutation	p.S3068F	G	G		7	Cancer Module	3	48677815	48677815	128	0.484375	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELSR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,48677815,G,G&fts=all">p.S3068F</a>
CELSR3	Missense_Mutation	p.P2337S	G	G		7	Cancer Module	3	48685394	48685394	168	0.130952380952381	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELSR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,48685394,G,G&fts=all">p.P2337S</a>
CELSR3	Missense_Mutation	p.M873I	C	C		7	Cancer Module	3	48697449	48697449	65	0.230769230769231	NA	NA	NA			83	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELSR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,48697449,C,C&fts=all">p.M873I</a>
CELSR3	Missense_Mutation	p.R855Q	C	C		7	Cancer Module	3	48697504	48697504	188	0.202127659574468	NA	NA	NA			83	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELSR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,48697504,C,C&fts=all">p.R855Q</a>
CELSR3	Missense_Mutation	p.D425N	C	C		7	Cancer Module	3	48698795	48698795	124	0.169354838709677	NA	NA	NA			83	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELSR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,48698795,C,C&fts=all">p.D425N</a>
CENPE	Nonsense_Mutation	p.Q795*	G	G		7	Cancer Module	4	104080310	104080310	290	0.293103448275862	NA	NA	NA			101			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CENPE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,104080310,G,G&fts=all">p.Q795*</a>
CENPE	Nonsense_Mutation	p.R260*	G	G		7	Cancer Module	4	104104413	104104413	260	0.261538461538462	NA	NA	NA			101	Kinesin motor. {ECO:0000255|PROSITE- ProRule:PRU00283}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CENPE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,104104413,G,G&fts=all">p.R260*</a>
CEP135	Missense_Mutation	p.P179L	C	C		7	Cancer Module	4	56823452	56823452	274	0.302919708029197	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP135&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,56823452,C,C&fts=all">p.P179L</a>
CEP192	Missense_Mutation	p.P2251S	C	C		7	Cancer Module	18	13100391	13100391	171	0.327485380116959	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP192&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,13100391,C,C&fts=all">p.P2251S</a>
CER1	Missense_Mutation	p.K231N	C	C		7	Cancer Module	9	14720199	14720199	59	0.796610169491525	NA	NA	NA			11	CTCK. {ECO:0000255|PROSITE- ProRule:PRU00039}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CER1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,14720199,C,C&fts=all">p.K231N</a>
CER1	Missense_Mutation	p.N222S	T	T		7	Cancer Module	9	14720227	14720227	48	0.354166666666667	NA	NA	NA			11	CTCK. {ECO:0000255|PROSITE- ProRule:PRU00039}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CER1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,14720227,T,T&fts=all">p.N222S</a>
CER1	Missense_Mutation	p.L30F	G	G	rs369791843	7	Cancer Module	9	14722583	14722583	60	0.333333333333333	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CER1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,14722583,G,G&fts=all">p.L30F</a>
CFB	Missense_Mutation	p.K650E	A	A		7	Cancer Module	6	31915856	31915856	52	0.192307692307692	NA	NA	NA			21	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31915856,A,A&fts=all">p.K650E</a>
CFH	Splice_Site	p.G117G	G	G		7	Cancer Module	1	196645119	196645119	227	0.422907488986784	NA	NA	NA			101	Sushi 2. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFH&recr=Open">Click here</a>	
CFH	Missense_Mutation	p.M665I	G	G		7	Cancer Module	1	196695721	196695721	244	0.184426229508197	NA	NA	NA			101	Sushi 11. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,196695721,G,G&fts=all">p.M665I</a>
CFH	Missense_Mutation	p.E1003K	G	G		7	Cancer Module	1	196711055	196711055	191	0.424083769633508	NA	NA	NA			101	Sushi 17. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,196711055,G,G&fts=all">p.E1003K</a>
CFHR2	Missense_Mutation	p.R232K	G	G		7	Cancer Module	1	196928092	196928092	286	0.216783216783217	NA	NA	NA			6	Sushi 4. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFHR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,196928092,G,G&fts=all">p.R232K</a>
CFHR4	Missense_Mutation	p.K530I	A	A		7	Cancer Module	1	196887391	196887391	165	0.412121212121212	NA	NA	NA			36	Sushi 9. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFHR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,196887391,A,A&fts=all">p.K530I</a>
CFI	Missense_Mutation	p.Y507N	A	A		7	Cancer Module	4	110663686	110663686	179	0.262569832402235	NA	NA	NA			27	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,110663686,A,A&fts=all">p.Y507N</a>
CFI	Missense_Mutation	p.S115F	G	G		7	Cancer Module	4	110685831	110685831	69	0.536231884057971	NA	NA	NA			27	SRCR. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,110685831,G,G&fts=all">p.S115F</a>
CGN	Missense_Mutation	p.S1022F	C	C		7	Cancer Module	1	151508146	151508146	74	0.472972972972973	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CGN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,151508146,C,C&fts=all">p.S1022F</a>
CHD1L	Missense_Mutation	p.P876S	C	C		7	Cancer Module	1	146767122	146767122	131	0.221374045801527	NA	NA	NA			33	Macro. {ECO:0000255|PROSITE- ProRule:PRU00490}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,146767122,C,C&fts=all">p.P876S</a>
CHD3	Missense_Mutation	p.E427K	G	G		7	Cancer Module	17	7797759	7797759	81	0.308641975308642	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7797759,G,G&fts=all">p.E427K</a>
CHD6	Nonsense_Mutation	p.Q2309*	G	G		7	Cancer Module	20	40043840	40043840	96	0.427083333333333	NA	NA	NA			129			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,40043840,G,G&fts=all">p.Q2309*</a>
CHD6	Missense_Mutation	p.S720F	G	G		7	Cancer Module	20	40113090	40113090	135	0.377777777777778	NA	NA	NA			129	Required for DNA-dependent ATPase activity.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,40113090,G,G&fts=all">p.S720F</a>
CHD7	Missense_Mutation	p.P273S	C	C		7	Cancer Module	8	61654808	61654808	182	0.406593406593407	NA	NA	NA			123			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,61654808,C,C&fts=all">p.P273S</a>
CHD7	Missense_Mutation	p.P1688S	C	C		7	Cancer Module	8	61757820	61757820	64	0.421875	NA	NA	NA			123			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,61757820,C,C&fts=all">p.P1688S</a>
CHFR	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	12	133365878	133779461	NA	NA	33	-1.06793882865658	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHFR&recr=Open">Click here</a>	
CHI3L1	Missense_Mutation	p.S107F	G	G		7	Cancer Module	1	203152914	203152914	91	0.450549450549451	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHI3L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,203152914,G,G&fts=all">p.S107F</a>
CHIT1	Missense_Mutation	p.P17S	G	G		7	Cancer Module	1	203197667	203197667	40	0.1	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHIT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,203197667,G,G&fts=all">p.P17S</a>
CHKB	Missense_Mutation	p.G137R	C	C		7	Cancer Module	22	51020216	51020216	156	0.198717948717949	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHKB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,51020216,C,C&fts=all">p.G137R</a>
CHN2	Missense_Mutation	p.H61Y	C	C		7	Cancer Module	7	29437993	29437993	163	0.54601226993865	NA	NA	NA			23	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,29437993,C,C&fts=all">p.H61Y</a>
CHRNB3	Missense_Mutation	p.S403L	C	C	rs180939079	7	Cancer Module	8	42587658	42587658	137	0.240875912408759	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRNB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,42587658,C,C&fts=all">p.S403L</a>
CILP	Missense_Mutation	p.E832K	C	C		7	Cancer Module	15	65490130	65490130	88	0.272727272727273	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CILP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,65490130,C,C&fts=all">p.E832K</a>
CIT	Missense_Mutation	p.F1391C	A	A	rs528287700	7	Cancer Module	12	120152136	120152136	175	0.502857142857143	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CIT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,120152136,A,A&fts=all">p.F1391C</a>
CLASP2	Missense_Mutation	p.S254T	A	A		7	Cancer Module	3	33686351	33686351	56	0.214285714285714	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLASP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,33686351,A,A&fts=all">p.S254T</a>
CLCN2	Missense_Mutation	p.S104L	G	G		7	Cancer Module	3	184076008	184076008	117	0.273504273504274	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,184076008,G,G&fts=all">p.S104L</a>
CLCN4	Missense_Mutation	p.T459I	C	C		7	Cancer Module	X	10176617	10176617	39	0.82051282051282	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,10176617,C,C&fts=all">p.T459I</a>
CLCN4	Missense_Mutation	p.R481K	G	G		7	Cancer Module	X	10180559	10180559	53	0.452830188679245	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,10180559,G,G&fts=all">p.R481K</a>
CLEC3B	Missense_Mutation	p.E45K	G	G		7	Cancer Module	3	45072342	45072342	13	0.615384615384615	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,45072342,G,G&fts=all">p.E45K</a>
CLGN	Missense_Mutation	p.R281K	C	C		7	Cancer Module	4	141320047	141320047	361	0.301939058171745	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLGN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,141320047,C,C&fts=all">p.R281K</a>
CLIP1	Missense_Mutation	p.A381V	G	G		7	Cancer Module	12	122839723	122839723	134	0.305970149253731	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLIP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,122839723,G,G&fts=all">p.A381V</a>
CLN3	Missense_Mutation	p.G3S	C	C		7	Cancer Module	16	28503074	28503074	28	0.142857142857143	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,28503074,C,C&fts=all">p.G3S</a>
CLPS	Missense_Mutation	p.E65K	C	C	rs369964160	7	Cancer Module	6	35763522	35763522	120	0.075	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLPS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,35763522,C,C&fts=all">p.E65K</a>
CLPTM1	Nonsense_Mutation	p.Q406*	C	C		7	Cancer Module	19	45493778	45493778	141	0.517730496453901	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLPTM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,45493778,C,C&fts=all">p.Q406*</a>
CLSTN3	Missense_Mutation	p.R550W	C	C	rs368510157	7	Cancer Module	12	7295572	7295572	56	0.303571428571429	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLSTN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7295572,C,C&fts=all">p.R550W</a>
CLU	Nonsense_Mutation	p.W350*	C	C		7	Cancer Module	8	27457411	27457411	50	0.28	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,27457411,C,C&fts=all">p.W350*</a>
CLU	Nonsense_Mutation	p.W350*	C	C		7	Cancer Module	8	27457412	27457412	51	0.274509803921569	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,27457412,C,C&fts=all">p.W350*</a>
CLU	Missense_Mutation	p.P208L	G	G		7	Cancer Module	8	27462647	27462647	63	0.238095238095238	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,27462647,G,G&fts=all">p.P208L</a>
CLYBL	Missense_Mutation	p.R87Q	G	G		7	Cancer Module	13	100511125	100511125	89	0.280898876404494	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLYBL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,100511125,G,G&fts=all">p.R87Q</a>
CLYBL	Missense_Mutation	p.E218K	G	G	rs538135354	7	Cancer Module	13	100518511	100518511	192	0.317708333333333	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLYBL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,100518511,G,G&fts=all">p.E218K</a>
CNGA3	Missense_Mutation	p.R225Q	G	G	rs141395850	7	Cancer Module	2	99008422	99008422	44	0.340909090909091	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNGA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,99008422,G,G&fts=all">p.R225Q</a>
CNGA3	Missense_Mutation	p.M406I	G	G		7	Cancer Module	2	99012839	99012839	75	0.266666666666667	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNGA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,99012839,G,G&fts=all">p.M406I</a>
CNGB1	Missense_Mutation	p.E368K	C	C	rs141566950	7	Cancer Module	16	57983276	57983276	37	0.378378378378378	NA	NA	NA			54	Poly-Glu.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNGB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,57983276,C,C&fts=all">p.E368K</a>
CNKSR2	Missense_Mutation	p.S541F	C	C		7	Cancer Module	X	21608703	21608703	106	0.367924528301887	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNKSR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,21608703,C,C&fts=all">p.S541F</a>
CNKSR2	Nonsense_Mutation	p.W591*	G	G		7	Cancer Module	X	21609255	21609255	189	0.46031746031746	NA	NA	NA			61	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNKSR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,21609255,G,G&fts=all">p.W591*</a>
CNTN1	Missense_Mutation	p.N591D	A	A		7	Cancer Module	12	41353003	41353003	99	0.414141414141414	NA	NA	NA			90	Ig-like C2-type 6.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,41353003,A,A&fts=all">p.N591D</a>
CNTN1	Missense_Mutation	p.P891L	C	C		7	Cancer Module	12	41419100	41419100	247	0.0566801619433198	NA	NA	NA			90	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,41419100,C,C&fts=all">p.P891L</a>
CNTN2	Missense_Mutation	p.E365K	G	G		7	Cancer Module	1	205031112	205031112	28	0.464285714285714	NA	NA	NA			54	Ig-like C2-type 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,205031112,G,G&fts=all">p.E365K</a>
CNTN6	Nonsense_Mutation	p.Q93*	C	C	rs541340193	7	Cancer Module	3	1269596	1269596	225	0.226666666666667	NA	NA	NA			90	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,1269596,C,C&fts=all">p.Q93*</a>
CNTN6	Missense_Mutation	p.S572L	C	C		7	Cancer Module	3	1414568	1414568	291	0.18213058419244	NA	NA	NA			90	Ig-like C2-type 6.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,1414568,C,C&fts=all">p.S572L</a>
CNTN6	Missense_Mutation	p.P622L	C	C		7	Cancer Module	3	1415366	1415366	184	0.173913043478261	NA	NA	NA			90	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,1415366,C,C&fts=all">p.P622L</a>
CNTNAP2	Missense_Mutation	p.L364S	T	T		7	Cancer Module	7	146829344	146829344	143	0.356643356643357	NA	NA	NA			188	Laminin G-like 1. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,146829344,T,T&fts=all">p.L364S</a>
CNTNAP2	Missense_Mutation	p.R389Q	G	G	rs548409884	7	Cancer Module	7	146829419	146829419	97	0.793814432989691	NA	NA	NA		p.R389Q(1)	188			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,146829419,G,G&fts=all">p.R389Q</a>
CNTNAP2	Missense_Mutation	p.E535K	G	G	rs76475298	7	Cancer Module	7	147092805	147092805	188	0.345744680851064	NA	NA	NA			188	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,147092805,G,G&fts=all">p.E535K</a>
CNTNAP2	Nonsense_Mutation	p.W798*	G	G		7	Cancer Module	7	147815220	147815220	97	0.391752577319588	NA	NA	NA			188	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,147815220,G,G&fts=all">p.W798*</a>
CNTNAP2	Missense_Mutation	p.G1215E	G	G		7	Cancer Module	7	148080909	148080909	16	0.375	NA	NA	NA			188			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,148080909,G,G&fts=all">p.G1215E</a>
CNTNAP5	Missense_Mutation	p.G414R	G	G		7	Cancer Module	2	125262049	125262049	62	0.258064516129032	NA	NA	NA			176	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,125262049,G,G&fts=all">p.G414R</a>
CNTNAP5	Missense_Mutation	p.D524N	G	G		7	Cancer Module	2	125284957	125284957	95	0.305263157894737	NA	NA	NA			176	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,125284957,G,G&fts=all">p.D524N</a>
CNTNAP5	Missense_Mutation	p.C735S	T	T		7	Cancer Module	2	125504934	125504934	129	0.217054263565891	NA	NA	NA			176	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,125504934,T,T&fts=all">p.C735S</a>
CNTNAP5	Missense_Mutation	p.E903K	G	G		7	Cancer Module	2	125530552	125530552	139	0.251798561151079	NA	NA	NA			176	Laminin G-like 3. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,125530552,G,G&fts=all">p.E903K</a>
COL10A1	Missense_Mutation	p.G446R	C	C		7	Cancer Module	6	116441943	116441943	55	0.290909090909091	NA	NA	NA			13	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL10A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,116441943,C,C&fts=all">p.G446R</a>
COL10A1	Missense_Mutation	p.G229E	C	C	rs202057046	7	Cancer Module	6	116442593	116442593	75	0.0933333333333333	NA	NA	NA			13	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL10A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,116442593,C,C&fts=all">p.G229E</a>
COL11A1	Missense_Mutation	p.E172K	C	C		7	Cancer Module	1	103540311	103540311	162	0.518518518518518	NA	NA	NA			258	Laminin G-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL11A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,103540311,C,C&fts=all">p.E172K</a>
COL11A2	Missense_Mutation	p.P1374S	G	G		7	Cancer Module	6	33134304	33134304	69	0.27536231884058	NA	NA	NA			68	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL11A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,33134304,G,G&fts=all">p.P1374S</a>
COL12A1	Missense_Mutation	p.E2979K	C	C		7	Cancer Module	6	75799832	75799832	77	0.363636363636364	NA	NA	NA			169	Collagen-like 4.|Triple-helical region (COL1) with 2 imperfections.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL12A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,75799832,C,C&fts=all">p.E2979K</a>
COL15A1	Missense_Mutation	p.P977L	C	C		7	Cancer Module	9	101814695	101814695	180	0.561111111111111	NA	NA	NA			107	Nonhelical region 6 (NC6).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL15A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,101814695,C,C&fts=all">p.P977L</a>
COL17A1	Missense_Mutation	p.P1110S	G	G		7	Cancer Module	10	105796340	105796340	46	0.239130434782609	NA	NA	NA			62	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL17A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,105796340,G,G&fts=all">p.P1110S</a>
COL17A1	Missense_Mutation	p.G927R	C	C		7	Cancer Module	10	105799740	105799740	90	0.4	NA	NA	NA			62	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL17A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,105799740,C,C&fts=all">p.G927R</a>
COL17A1	Nonsense_Mutation	p.R584*	G	G		7	Cancer Module	10	105813871	105813871	12	0.416666666666667	NA	NA	NA			62	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL17A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,105813871,G,G&fts=all">p.R584*</a>
COL17A1	Missense_Mutation	p.D335N	C	C		7	Cancer Module	10	105820015	105820015	141	0.234042553191489	NA	NA	NA			62	Nonhelical region (NC16).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL17A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,105820015,C,C&fts=all">p.D335N</a>
COL17A1	Missense_Mutation	p.P186S	G	G		7	Cancer Module	10	105830235	105830235	140	0.185714285714286	NA	NA	NA			62	Necessary for interaction with DST and for the recruitment of DST to hemidesmosome.|Nonhelical region (NC16).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL17A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,105830235,G,G&fts=all">p.P186S</a>
COL19A1	Splice_Site	p.G328R	G	G		7	Cancer Module	6	70672718	70672718	120	0.358333333333333	NA	NA	NA			109	Collagen-like 1.|Triple-helical region 1 (COL1).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL19A1&recr=Open">Click here</a>	
COL19A1	Missense_Mutation	p.P514L	C	C		7	Cancer Module	6	70851937	70851937	40	0.35	NA	NA	NA			109	Collagen-like 4.|Triple-helical region 3 (COL3).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL19A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,70851937,C,C&fts=all">p.P514L</a>
COL19A1	Missense_Mutation	p.P1131L	C	C		7	Cancer Module	6	70916941	70916941	185	0.410810810810811	NA	NA	NA			109			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL19A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,70916941,C,C&fts=all">p.P1131L</a>
COL1A2	Missense_Mutation	p.G112S	G	G		7	Cancer Module	7	94034014	94034014	150	0.766666666666667	NA	NA	NA			115			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL1A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,94034014,G,G&fts=all">p.G112S</a>
COL1A2	Missense_Mutation	p.L452F	C	C		7	Cancer Module	7	94041383	94041383	92	0.380434782608696	NA	NA	NA			115			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL1A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,94041383,C,C&fts=all">p.L452F</a>
COL1A2	Missense_Mutation	p.G496R	G	G		7	Cancer Module	7	94041977	94041977	33	0.454545454545455	NA	NA	NA			115			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL1A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,94041977,G,G&fts=all">p.G496R</a>
COL1A2	Splice_Site		G	G		7	Cancer Module	7	94043205	94043205	33	0.454545454545455	NA	NA	NA			115			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL1A2&recr=Open">Click here</a>	
COL1A2	Missense_Mutation	p.G1294D	G	G		7	Cancer Module	7	94058669	94058669	42	0.380952380952381	NA	NA	NA		p.G1294A(1)	115	Fibrillar collagen NC1. {ECO:0000255|PROSITE-ProRule:PRU00793}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL1A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,94058669,G,G&fts=all">p.G1294D</a>
COL3A1	Missense_Mutation	p.G240E	G	G		7	Cancer Module	2	189854850	189854850	108	0.212962962962963	NA	NA	NA			126	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL3A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,189854850,G,G&fts=all">p.G240E</a>
COL3A1	Missense_Mutation	p.R562Q	G	G		7	Cancer Module	2	189861146	189861146	116	0.310344827586207	NA	NA	NA			126	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL3A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,189861146,G,G&fts=all">p.R562Q</a>
COL3A1	Missense_Mutation	p.G633R	G	G		7	Cancer Module	2	189862453	189862453	105	0.257142857142857	NA	NA	NA			126	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL3A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,189862453,G,G&fts=all">p.G633R</a>
COL4A5	Splice_Site	p.G230S	G	G	rs104886076	7	Cancer Module	X	107821521	107821521	50	0.5	NA	NA	NA			99	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A5&recr=Open">Click here</a>	
COL4A5	Missense_Mutation	p.P578S	C	C		7	Cancer Module	X	107840751	107840751	34	0.5	NA	NA	NA			99	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,107840751,C,C&fts=all">p.P578S</a>
COL4A5	Missense_Mutation	p.P680T	C	C		7	Cancer Module	X	107844712	107844712	54	0.5	NA	NA	NA			99	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,107844712,C,C&fts=all">p.P680T</a>
COL5A1	Missense_Mutation	p.D418N	G	G		7	Cancer Module	9	137623429	137623429	27	0.592592592592593	NA	NA	NA			115	Nonhelical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,137623429,G,G&fts=all">p.D418N</a>
COL5A1	Missense_Mutation	p.P975S	C	C		7	Cancer Module	9	137690278	137690278	26	0.538461538461538	NA	NA	NA			115	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,137690278,C,C&fts=all">p.P975S</a>
COL5A2	Missense_Mutation	p.G498D	C	C		7	Cancer Module	2	189931186	189931186	285	0.23859649122807	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,189931186,C,C&fts=all">p.G498D</a>
COL5A2	Missense_Mutation	p.P454L	G	G		7	Cancer Module	2	189932781	189932781	69	0.289855072463768	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,189932781,G,G&fts=all">p.P454L</a>
COL5A3	Missense_Mutation	p.E927K	C	C		7	Cancer Module	19	10089903	10089903	42	0.119047619047619	NA	NA	NA			116	Collagen-like 4.|Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,10089903,C,C&fts=all">p.E927K</a>
COL5A3	Missense_Mutation	p.P756L	G	G	rs200441833	7	Cancer Module	19	10097076	10097076	15	0.4	NA	NA	NA			116	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,10097076,G,G&fts=all">p.P756L</a>
COL5A3	Missense_Mutation	p.G692R	C	C		7	Cancer Module	19	10100015	10100015	33	0.363636363636364	NA	NA	NA			116	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,10100015,C,C&fts=all">p.G692R</a>
COL5A3	Missense_Mutation	p.P690S	G	G		7	Cancer Module	19	10100021	10100021	31	0.387096774193548	NA	NA	NA			116	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,10100021,G,G&fts=all">p.P690S</a>
COL5A3	Missense_Mutation	p.P639T	G	G		7	Cancer Module	19	10102496	10102496	96	0.229166666666667	NA	NA	NA			116	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,10102496,G,G&fts=all">p.P639T</a>
COL5A3	Missense_Mutation	p.G602R	C	C		7	Cancer Module	19	10103547	10103547	29	0.275862068965517	NA	NA	NA			116	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,10103547,C,C&fts=all">p.G602R</a>
COL6A1	Missense_Mutation	p.L141F	C	C		7	Cancer Module	21	47404376	47404376	25	0.48	NA	NA	NA			33	N-terminal globular domain.|VWFA 1. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,47404376,C,C&fts=all">p.L141F</a>
COL6A2	Missense_Mutation	p.S54L	C	C		7	Cancer Module	21	47531938	47531938	40	0.225	NA	NA	NA			43	Nonhelical region.|VWFA 1. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,47531938,C,C&fts=all">p.S54L</a>
COL6A2	Missense_Mutation	p.R738W	C	C		7	Cancer Module	21	47545941	47545941	38	0.210526315789474	NA	NA	NA		p.R738W(3)	43	Nonhelical region.|VWFA 2. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,47545941,C,C&fts=all">p.R738W</a>
COL6A3	Missense_Mutation	p.W2602R	A	A		7	Cancer Module	2	238249755	238249755	214	0.0280373831775701	NA	NA	NA			217	Nonhelical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,238249755,A,A&fts=all">p.W2602R</a>
COL6A3	Nonsense_Mutation	p.K2272*	T	T		7	Cancer Module	2	238259775	238259775	77	0.272727272727273	NA	NA	NA			217	Collagen-like 4.|Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,238259775,T,T&fts=all">p.K2272*</a>
COL6A3	Nonsense_Mutation	p.R2154*	G	G		7	Cancer Module	2	238267175	238267175	254	0.275590551181102	NA	NA	NA			217	Collagen-like 2.|Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,238267175,G,G&fts=all">p.R2154*</a>
COL6A3	Missense_Mutation	p.G1550R	C	C		7	Cancer Module	2	238277458	238277458	128	0.3125	NA	NA	NA			217	Nonhelical region.|VWFA 8. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,238277458,C,C&fts=all">p.G1550R</a>
COL6A3	Missense_Mutation	p.R1192C	G	G		7	Cancer Module	2	238283160	238283160	34	0.205882352941176	NA	NA	NA			217	Nonhelical region.|VWFA 6. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,238283160,G,G&fts=all">p.R1192C</a>
COL6A3	Missense_Mutation	p.R836Q	C	C		7	Cancer Module	2	238285978	238285978	94	0.680851063829787	NA	NA	NA		p.R836Q(1)	217	Nonhelical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,238285978,C,C&fts=all">p.R836Q</a>
COL6A3	Missense_Mutation	p.P517L	G	G		7	Cancer Module	2	238289905	238289905	279	0.609318996415771	NA	NA	NA			217	Nonhelical region.|VWFA 3. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,238289905,G,G&fts=all">p.P517L</a>
COL7A1	Nonsense_Mutation	p.Q2935*	G	G		7	Cancer Module	3	48602231	48602231	99	0.191919191919192	NA	NA	NA			137	BPTI/Kunitz inhibitor. {ECO:0000255|PROSITE-ProRule:PRU00031}.|Nonhelical region (NC2).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL7A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,48602231,G,G&fts=all">p.Q2935*</a>
COL9A1	Missense_Mutation	p.P865T	G	G		7	Cancer Module	6	70926773	70926773	26	0.384615384615385	NA	NA	NA			80	Collagen-like 10.|Triple-helical region (COL1).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL9A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,70926773,G,G&fts=all">p.P865T</a>
COL9A1	Missense_Mutation	p.P276S	G	G		7	Cancer Module	6	70991143	70991143	27	0.518518518518518	NA	NA	NA			80	Collagen-like 1.|Triple-helical region (COL3).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL9A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,70991143,G,G&fts=all">p.P276S</a>
COL9A2	Missense_Mutation	p.D637N	C	C		7	Cancer Module	1	40767015	40767015	18	0.277777777777778	NA	NA	NA			22	Triple-helical region 1 (COL1).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL9A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,40767015,C,C&fts=all">p.D637N</a>
COL9A3	Splice_Site	p.G62R	G	G		7	Cancer Module	20	61450574	61450574	17	0.470588235294118	NA	NA	NA			28	Triple-helical region 3 (COL3).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL9A3&recr=Open">Click here</a>	
COLEC11	Missense_Mutation	p.G123R	G	G	rs375696847	7	Cancer Module	2	3691072	3691072	49	0.306122448979592	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COLEC11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,3691072,G,G&fts=all">p.G123R</a>
COPS2	Missense_Mutation	p.F294L	A	A		7	Cancer Module	15	49426139	49426139	253	0.304347826086957	NA	NA	NA			18	PCI.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COPS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,49426139,A,A&fts=all">p.F294L</a>
CORIN	Missense_Mutation	p.D607N	C	C		7	Cancer Module	4	47655594	47655594	83	0.409638554216867	NA	NA	NA			79	LDL-receptor class A 5. {ECO:0000255|PROSITE-ProRule:PRU00124}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CORIN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,47655594,C,C&fts=all">p.D607N</a>
CORIN	Missense_Mutation	p.F174L	A	A		7	Cancer Module	4	47765491	47765491	55	0.436363636363636	NA	NA	NA			79	FZ 1. {ECO:0000255|PROSITE- ProRule:PRU00090}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CORIN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,47765491,A,A&fts=all">p.F174L</a>
CORO6	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CORO6&recr=Open">Click here</a>	
CP	Nonsense_Mutation	p.W89*	C	C		7	Cancer Module	3	148930365	148930365	250	0.236	NA	NA	NA			44	F5/8 type A 1.|Plastocyanin-like 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,148930365,C,C&fts=all">p.W89*</a>
CPA3	Missense_Mutation	p.S339L	C	C		7	Cancer Module	3	148603914	148603914	143	0.034965034965035	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,148603914,C,C&fts=all">p.S339L</a>
CPD	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPD&recr=Open">Click here</a>	
CPE	Missense_Mutation	p.E342K	G	G		7	Cancer Module	4	166408640	166408640	191	0.214659685863874	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,166408640,G,G&fts=all">p.E342K</a>
CPN2	Missense_Mutation	p.E187K	C	C		7	Cancer Module	3	194062873	194062873	41	0.268292682926829	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,194062873,C,C&fts=all">p.E187K</a>
CPNE1	Missense_Mutation	p.H245Y	G	G		7	Cancer Module	20	34219258	34219258	174	0.459770114942529	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPNE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,34219258,G,G&fts=all">p.H245Y</a>
CPNE6	Nonsense_Mutation	p.W191*	G	G		7	Cancer Module	14	24543814	24543814	61	0.868852459016393	NA	NA	NA			22	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPNE6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,24543814,G,G&fts=all">p.W191*</a>
CPS1	Missense_Mutation	p.S1395L	C	C		7	Cancer Module	2	211540474	211540474	85	0.270588235294118	NA	NA	NA			142			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,211540474,C,C&fts=all">p.S1395L</a>
CR2	Missense_Mutation	p.K967Q	A	A		7	Cancer Module	1	207649761	207649761	44	0.409090909090909	NA	NA	NA			69	Sushi 15. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,207649761,A,A&fts=all">p.K967Q</a>
CRAT	Missense_Mutation	p.P349S	G	G	rs1044553	7	Cancer Module	9	131862185	131862185	80	0.225	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRAT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,131862185,G,G&fts=all">p.P349S</a>
CRB1	Missense_Mutation	p.E108K	G	G		7	Cancer Module	1	197297803	197297803	179	0.223463687150838	NA	NA	NA			132	EGF-like 2. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,197297803,G,G&fts=all">p.E108K</a>
CRB1	Missense_Mutation	p.G342E	G	G		7	Cancer Module	1	197390319	197390319	146	0.424657534246575	NA	NA	NA			132	EGF-like 9. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,197390319,G,G&fts=all">p.G342E</a>
CRB1	Missense_Mutation	p.E946K	G	G	rs564754426	7	Cancer Module	1	197404165	197404165	202	0.722772277227723	NA	NA	NA		p.E1058K(1)	132	EGF-like 14. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,197404165,G,G&fts=all">p.E946K</a>
CRHBP	Missense_Mutation	p.N191H	A	A	rs529210191	7	Cancer Module	5	76254592	76254592	209	0.382775119617225	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRHBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,76254592,A,A&fts=all">p.N191H</a>
CRHR2	Missense_Mutation	p.I244V	T	T		7	Cancer Module	7	30701800	30701800	45	0.466666666666667	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRHR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,30701800,T,T&fts=all">p.I244V</a>
CRISPLD2	Missense_Mutation	p.S437L	C	C		7	Cancer Module	16	84922840	84922840	126	0.563492063492063	NA	NA	NA			18	LCCL 2. {ECO:0000255|PROSITE- ProRule:PRU00123}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRISPLD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,84922840,C,C&fts=all">p.S437L</a>
CRISPLD2	Missense_Mutation	p.R491W	C	C		7	Cancer Module	16	84940225	84940225	125	0.352	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRISPLD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,84940225,C,C&fts=all">p.R491W</a>
CRLF3	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRLF3&recr=Open">Click here</a>	
CRLS1	Missense_Mutation	p.P229L	C	C		7	Cancer Module	20	6012683	6012683	383	0.281984334203655	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRLS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,6012683,C,C&fts=all">p.P229L</a>
CRNN	Missense_Mutation	p.G267E	C	C		7	Cancer Module	1	152382758	152382758	159	0.679245283018868	NA	NA	NA			35	Gln-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRNN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152382758,C,C&fts=all">p.G267E</a>
CROT	Missense_Mutation	p.R533C	C	C	rs374151013	7	Cancer Module	7	87022054	87022054	118	0.330508474576271	NA	NA	NA		p.R505C(1)	37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CROT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,87022054,C,C&fts=all">p.R533C</a>
CSMD2	Missense_Mutation	p.P474S	G	G		7	Cancer Module	1	34102128	34102128	34	0.470588235294118	NA	NA	NA			246	CUB 3. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,34102128,G,G&fts=all">p.P474S</a>
CSMD3	Missense_Mutation	p.R3695Q	C	C		7	Cancer Module	8	113237040	113237040	293	0.501706484641638	NA	NA	NA			646			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,113237040,C,C&fts=all">p.R3695Q</a>
CSMD3	Missense_Mutation	p.L3147F	G	G		7	Cancer Module	8	113293472	113293472	236	0.203389830508475	NA	NA	NA			646	Sushi 23. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,113293472,G,G&fts=all">p.L3147F</a>
CSMD3	Missense_Mutation	p.G2818E	C	C		7	Cancer Module	8	113308223	113308223	176	0.204545454545455	NA	NA	NA			646	Sushi 18. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,113308223,C,C&fts=all">p.G2818E</a>
CSMD3	Missense_Mutation	p.G2788E	C	C		7	Cancer Module	8	113314099	113314099	188	0.25	NA	NA	NA		p.G2748E(1)|p.G2788E(1)	646	Sushi 17. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,113314099,C,C&fts=all">p.G2788E</a>
CSMD3	Missense_Mutation	p.F2153C	A	A		7	Cancer Module	8	113353900	113353900	69	0.130434782608696	NA	NA	NA			646	CUB 12. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,113353900,A,A&fts=all">p.F2153C</a>
CSMD3	Missense_Mutation	p.G1594E	C	C		7	Cancer Module	8	113519034	113519034	94	0.24468085106383	NA	NA	NA			646	CUB 9. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,113519034,C,C&fts=all">p.G1594E</a>
CSMD3	Missense_Mutation	p.L775F	G	G		7	Cancer Module	8	113697794	113697794	209	0.454545454545455	NA	NA	NA			646	CUB 4. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,113697794,G,G&fts=all">p.L775F</a>
CSMD3	Missense_Mutation	p.E531K	C	C		7	Cancer Module	8	113933898	113933898	227	0.158590308370044	NA	NA	NA		p.E491K(1)|p.E531K(1)	646	Sushi 2. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,113933898,C,C&fts=all">p.E531K</a>
CSMD3	Missense_Mutation	p.E514G	T	T		7	Cancer Module	8	113933948	113933948	199	0.180904522613065	NA	NA	NA			646	Sushi 2. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,113933948,T,T&fts=all">p.E514G</a>
CSMD3	Missense_Mutation	p.S483P	A	A		7	Cancer Module	8	113960080	113960080	282	0.205673758865248	NA	NA	NA			646			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,113960080,A,A&fts=all">p.S483P</a>
CSN2	Missense_Mutation	p.D127N	C	C		7	Cancer Module	4	70823288	70823288	100	0.21	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70823288,C,C&fts=all">p.D127N</a>
CSN2	Missense_Mutation	p.K119R	T	T		7	Cancer Module	4	70823311	70823311	116	0.198275862068966	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70823311,T,T&fts=all">p.K119R</a>
CSNK1G2	Missense_Mutation	p.S410L	C	C		7	Cancer Module	19	1980183	1980183	49	0.142857142857143	NA	NA	NA		p.S410*(1)	8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSNK1G2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,1980183,C,C&fts=all">p.S410L</a>
CSPG5	Missense_Mutation	p.G409R	C	C		7	Cancer Module	3	47614333	47614333	35	0.142857142857143	NA	NA	NA			22	EGF-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSPG5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,47614333,C,C&fts=all">p.G409R</a>
CTAGE1	Missense_Mutation	p.F717Y	A	A		7	Cancer Module	18	19995625	19995625	39	0.282051282051282	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTAGE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,19995625,A,A&fts=all">p.F717Y</a>
CTAGE1	Missense_Mutation	p.P692L	G	G	rs569260453	7	Cancer Module	18	19995700	19995700	90	0.411111111111111	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTAGE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,19995700,G,G&fts=all">p.P692L</a>
CTAGE1	Missense_Mutation	p.P534S	G	G		7	Cancer Module	18	19996175	19996175	74	0.472972972972973	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTAGE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,19996175,G,G&fts=all">p.P534S</a>
CTNNAL1	Missense_Mutation	p.A227V	G	G		7	Cancer Module	9	111746676	111746676	313	0.309904153354633	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNAL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,111746676,G,G&fts=all">p.A227V</a>
CTRC	Missense_Mutation	p.T136I	C	C		7	Cancer Module	1	15769964	15769964	166	0.475903614457831	NA	NA	NA			13	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTRC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,15769964,C,C&fts=all">p.T136I</a>
CUX2	Missense_Mutation	p.E36K	G	G		7	Cancer Module	12	111652046	111652046	195	0.57948717948718	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,111652046,G,G&fts=all">p.E36K</a>
CUX2	Missense_Mutation	p.E328K	G	G		7	Cancer Module	12	111744848	111744848	9	0.777777777777778	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,111744848,G,G&fts=all">p.E328K</a>
CUX2	Missense_Mutation	p.E1485K	G	G		7	Cancer Module	12	111786121	111786121	51	0.450980392156863	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,111786121,G,G&fts=all">p.E1485K</a>
CXCL13	Nonsense_Mutation	p.W68*	G	G		7	Cancer Module	4	78531774	78531774	169	0.57396449704142	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXCL13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,78531774,G,G&fts=all">p.W68*</a>
CXCL14	Missense_Mutation	p.E98K	C	C		7	Cancer Module	5	134907551	134907551	75	0.333333333333333	NA	NA	NA		p.E110K(1)	6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXCL14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,134907551,C,C&fts=all">p.E98K</a>
CXCL5	Missense_Mutation	p.E113K	C	C		7	Cancer Module	4	74863362	74863362	181	0.331491712707182	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXCL5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,74863362,C,C&fts=all">p.E113K</a>
CYBB	Missense_Mutation	p.P56S	C	C		7	Cancer Module	X	37642767	37642767	74	0.432432432432432	NA	NA	NA			32	Ferric oxidoreductase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYBB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,37642767,C,C&fts=all">p.P56S</a>
CYFIP2	Missense_Mutation	p.S632F	C	C		7	Cancer Module	5	156752637	156752637	33	0.363636363636364	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYFIP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,156752637,C,C&fts=all">p.S632F</a>
CYFIP2	Missense_Mutation	p.S942T	T	T		7	Cancer Module	5	156787374	156787374	89	0.314606741573034	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYFIP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,156787374,T,T&fts=all">p.S942T</a>
CYP27A1	Nonsense_Mutation	p.W260*	G	G	rs587778810	7	Cancer Module	2	219677407	219677407	537	0.299813780260708	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP27A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219677407,G,G&fts=all">p.W260*</a>
CYP2A7	Missense_Mutation	p.D382N	C	C		7	Cancer Module	19	41383112	41383112	92	0.173913043478261	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2A7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41383112,C,C&fts=all">p.D382N</a>
CYP2A7	Missense_Mutation	p.F111I	A	A		7	Cancer Module	19	41387506	41387506	51	0.156862745098039	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2A7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41387506,A,A&fts=all">p.F111I</a>
CYP2B6	Missense_Mutation	p.D192N	G	G		7	Cancer Module	19	41512899	41512899	92	0.16304347826087	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2B6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41512899,G,G&fts=all">p.D192N</a>
CYP2B6	Missense_Mutation	p.E474K	G	G		7	Cancer Module	19	41522676	41522676	30	0.2	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2B6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41522676,G,G&fts=all">p.E474K</a>
CYP2C18	Missense_Mutation	p.E148K	G	G		7	Cancer Module	10	96447992	96447992	209	0.200956937799043	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,96447992,G,G&fts=all">p.E148K</a>
CYP2C18	Missense_Mutation	p.S429L	C	C		7	Cancer Module	10	96493190	96493190	233	0.0257510729613734	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,96493190,C,C&fts=all">p.S429L</a>
CYP2C19	Missense_Mutation	p.P220S	C	C		7	Cancer Module	10	96541593	96541593	141	0.205673758865248	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,96541593,C,C&fts=all">p.P220S</a>
CYP2C19	Missense_Mutation	p.F239L	T	T		7	Cancer Module	10	96541652	96541652	239	0.263598326359833	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,96541652,T,T&fts=all">p.F239L</a>
CYP2C19	Missense_Mutation	p.S254L	C	C		7	Cancer Module	10	96541696	96541696	276	0.0289855072463768	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,96541696,C,C&fts=all">p.S254L</a>
CYP2C19	Missense_Mutation	p.P260L	C	C		7	Cancer Module	10	96541714	96541714	285	0.207017543859649	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,96541714,C,C&fts=all">p.P260L</a>
CYP2C8	Splice_Site	p.G431E	C	C		7	Cancer Module	10	96797066	96797066	105	0.485714285714286	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C8&recr=Open">Click here</a>	
CYP2C8	Missense_Mutation	p.D165N	C	C		7	Cancer Module	10	96824706	96824706	292	0.0205479452054795	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,96824706,C,C&fts=all">p.D165N</a>
CYP2E1	Missense_Mutation	p.P213L	C	C		7	Cancer Module	10	135345778	135345778	109	0.357798165137615	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2E1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,135345778,C,C&fts=all">p.P213L</a>
CYP39A1	Missense_Mutation	p.F64I	A	A		7	Cancer Module	6	46610023	46610023	118	0.194915254237288	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP39A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,46610023,A,A&fts=all">p.F64I</a>
CYP3A5	Missense_Mutation	p.G435E	C	C		7	Cancer Module	7	99247805	99247805	223	0.0493273542600897	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP3A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,99247805,C,C&fts=all">p.G435E</a>
CYP3A5	Missense_Mutation	p.E144K	C	C	rs144541701	7	Cancer Module	7	99264577	99264577	66	0.424242424242424	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP3A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,99264577,C,C&fts=all">p.E144K</a>
CYP46A1	Missense_Mutation	p.E376K	G	G		7	Cancer Module	14	100188353	100188353	35	0.571428571428571	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP46A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,100188353,G,G&fts=all">p.E376K</a>
CYP4A11	Missense_Mutation	p.G402E	C	C		7	Cancer Module	1	47399635	47399635	35	0.8	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4A11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,47399635,C,C&fts=all">p.G402E</a>
CYP4A11	Missense_Mutation	p.E71K	C	C		7	Cancer Module	1	47403794	47403794	133	0.443609022556391	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4A11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,47403794,C,C&fts=all">p.E71K</a>
CYP4B1	Nonsense_Mutation	p.Q264*	C	C		7	Cancer Module	1	47279940	47279940	15	0.866666666666667	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,47279940,C,C&fts=all">p.Q264*</a>
CYP4F2	Missense_Mutation	p.P460S	G	G		7	Cancer Module	19	15990175	15990175	118	0.135593220338983	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4F2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,15990175,G,G&fts=all">p.P460S</a>
CYP4F2	Splice_Site	p.G133E	C	C		7	Cancer Module	19	16003246	16003246	41	0.292682926829268	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4F2&recr=Open">Click here</a>	
CYP4F2	Missense_Mutation	p.G93E	C	C		7	Cancer Module	19	16006381	16006381	72	0.166666666666667	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4F2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,16006381,C,C&fts=all">p.G93E</a>
CYP4F3	Nonsense_Mutation	p.Q237*	C	C		7	Cancer Module	19	15760784	15760784	109	0.174311926605505	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4F3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,15760784,C,C&fts=all">p.Q237*</a>
CYP7A1	Missense_Mutation	p.P292S	G	G		7	Cancer Module	8	59409197	59409197	134	0.149253731343284	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP7A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,59409197,G,G&fts=all">p.P292S</a>
CYYR1	Start_Codon_SNP	p.M1I	C	C		7	Cancer Module	21	27945257	27945257	40	0.4	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYYR1&recr=Open">Click here</a>	
DAAM2	Missense_Mutation	p.R696W	C	C		7	Cancer Module	6	39856480	39856480	92	0.16304347826087	NA	NA	NA			49	FH2. {ECO:0000255|PROSITE- ProRule:PRU00774}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAAM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,39856480,C,C&fts=all">p.R696W</a>
DAB2	Missense_Mutation	p.P550L	G	G		7	Cancer Module	5	39377240	39377240	82	0.402439024390244	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,39377240,G,G&fts=all">p.P550L</a>
DAB2	Nonsense_Mutation	p.Q378*	G	G		7	Cancer Module	5	39382929	39382929	97	0.195876288659794	NA	NA	NA			47	Required for localization to clathrin- coated pits. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,39382929,G,G&fts=all">p.Q378*</a>
DCLK1	Missense_Mutation	p.G65R	C	C		7	Cancer Module	13	36700082	36700082	126	0.666666666666667	NA	NA	NA		p.G65R(2)	64	Doublecortin 1. {ECO:0000255|PROSITE- ProRule:PRU00072}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCLK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,36700082,C,C&fts=all">p.G65R</a>
DCT	Missense_Mutation	p.P390L	G	G		7	Cancer Module	13	95112355	95112355	300	0.276666666666667	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,95112355,G,G&fts=all">p.P390L</a>
DDN	Missense_Mutation	p.R210K	C	C		7	Cancer Module	12	49392030	49392030	11	0.454545454545455	NA	NA	NA			8	Interaction with MAGI2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,49392030,C,C&fts=all">p.R210K</a>
DDO	Missense_Mutation	p.P254A	G	G		7	Cancer Module	6	110714328	110714328	69	0.333333333333333	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,110714328,G,G&fts=all">p.P254A</a>
DDR1	Missense_Mutation	p.F586L	C	C		7	Cancer Module	6	30864588	30864588	105	0.104761904761905	NA	NA	NA			29	Gly/Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,30864588,C,C&fts=all">p.F586L</a>
DDX17	Missense_Mutation	p.E151K	C	C		7	Cancer Module	22	38895492	38895492	248	0.451612903225806	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38895492,C,C&fts=all">p.E151K</a>
DDX4	Missense_Mutation	p.E173K	G	G	rs534079199	7	Cancer Module	5	55076914	55076914	226	0.464601769911504	NA	NA	NA		p.E173K(1)	24	Gly-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,55076914,G,G&fts=all">p.E173K</a>
DEFB1	Missense_Mutation	p.H30Y	G	G		7	Cancer Module	8	6728322	6728322	44	0.159090909090909	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEFB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,6728322,G,G&fts=all">p.H30Y</a>
DEPDC5	Missense_Mutation	p.P294S	C	C		7	Cancer Module	22	32194576	32194576	268	0.223880597014925	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEPDC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,32194576,C,C&fts=all">p.P294S</a>
DGCR2	Nonsense_Mutation	p.L184*	A	A		7	Cancer Module	22	19050789	19050789	23	0.260869565217391	NA	NA	NA			18	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGCR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,19050789,A,A&fts=all">p.L184*</a>
DGCR2	Splice_Site	p.L184V	A	A		7	Cancer Module	22	19050790	19050790	23	0.260869565217391	NA	NA	NA			18	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGCR2&recr=Open">Click here</a>	
DGCR8	Missense_Mutation	p.A234V	C	C		7	Cancer Module	22	20074187	20074187	298	0.211409395973154	NA	NA	NA			22	Necessary for interaction with NCL.|Necessary for nuclear localization and retention.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGCR8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,20074187,C,C&fts=all">p.A234V</a>
DGKD	Missense_Mutation	p.L841F	C	C		7	Cancer Module	2	234365915	234365915	87	0.540229885057471	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,234365915,C,C&fts=all">p.L841F</a>
DHRS2	Missense_Mutation	p.E257K	G	G		7	Cancer Module	14	24114377	24114377	50	0.46	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHRS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,24114377,G,G&fts=all">p.E257K</a>
DHX9	Missense_Mutation	p.E638V	A	A		7	Cancer Module	1	182845282	182845282	480	0.458333333333333	NA	NA	NA			49	Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,182845282,A,A&fts=all">p.E638V</a>
DIO1	Missense_Mutation	p.G122R	G	G		7	Cancer Module	1	54370365	54370365	376	0.343085106382979	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIO1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,54370365,G,G&fts=all">p.G122R</a>
DIRAS3	Missense_Mutation	p.R159W	G	G	rs542823739	7	Cancer Module	1	68512506	68512506	192	0.479166666666667	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIRAS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,68512506,G,G&fts=all">p.R159W</a>
DIS3	Missense_Mutation	p.A698G	G	G		7	Cancer Module	13	73336220	73336220	122	0.311475409836066	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,73336220,G,G&fts=all">p.A698G</a>
DLC1	Missense_Mutation	p.L1430S	A	A		7	Cancer Module	8	12945999	12945999	217	0.419354838709677	NA	NA	NA			110	START. {ECO:0000255|PROSITE- ProRule:PRU00197}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,12945999,A,A&fts=all">p.L1430S</a>
DLC1	Missense_Mutation	p.E87K	C	C	rs75294096	7	Cancer Module	8	13357322	13357322	424	0.219339622641509	NA	NA	NA			110			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,13357322,C,C&fts=all">p.E87K</a>
DLEC1	Missense_Mutation	p.D147H	G	G		7	Cancer Module	3	38087061	38087061	83	0.301204819277108	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLEC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38087061,G,G&fts=all">p.D147H</a>
DLEC1	Missense_Mutation	p.P560S	C	C		7	Cancer Module	3	38134293	38134293	160	0.24375	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLEC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38134293,C,C&fts=all">p.P560S</a>
DLEC1	Splice_Site	p.G586E	G	G		7	Cancer Module	3	38135096	38135096	114	0.149122807017544	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLEC1&recr=Open">Click here</a>	
DLEC1	Missense_Mutation	p.G1269E	G	G		7	Cancer Module	3	38156494	38156494	49	0.346938775510204	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLEC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38156494,G,G&fts=all">p.G1269E</a>
DLG1	Missense_Mutation	p.G483R	C	C		7	Cancer Module	3	196842893	196842893	277	0.0433212996389892	NA	NA	NA			26	PDZ 3. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,196842893,C,C&fts=all">p.G483R</a>
DLG1	Missense_Mutation	p.G482E	C	C		7	Cancer Module	3	196842895	196842895	280	0.539285714285714	NA	NA	NA			26	PDZ 3. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,196842895,C,C&fts=all">p.G482E</a>
DLGAP1	Missense_Mutation	p.D756N	C	C		7	Cancer Module	18	3534405	3534405	41	0.439024390243902	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLGAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,3534405,C,C&fts=all">p.D756N</a>
DLGAP1	Missense_Mutation	p.K645E	T	T		7	Cancer Module	18	3581905	3581905	183	0.480874316939891	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLGAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,3581905,T,T&fts=all">p.K645E</a>
DLGAP1	Missense_Mutation	p.E465K	C	C		7	Cancer Module	18	3729333	3729333	66	0.409090909090909	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLGAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,3729333,C,C&fts=all">p.E465K</a>
DLGAP2	Missense_Mutation	p.D345N	G	G		7	Cancer Module	8	1513891	1513891	26	0.115384615384615	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLGAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,1513891,G,G&fts=all">p.D345N</a>
DLGAP2	Missense_Mutation	p.D660N	G	G		7	Cancer Module	8	1624714	1624714	28	0.142857142857143	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLGAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,1624714,G,G&fts=all">p.D660N</a>
DLGAP2	Missense_Mutation	p.P783S	C	C		7	Cancer Module	8	1626678	1626678	10	0.3	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLGAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,1626678,C,C&fts=all">p.P783S</a>
DMBT1	Missense_Mutation	p.L1962F	C	C		7	Cancer Module	10	124390722	124390722	108	0.222222222222222	NA	NA	NA			72	SRCR 14. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMBT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124390722,C,C&fts=all">p.L1962F</a>
DMBT1	Missense_Mutation	p.R2320W	C	C	rs367820947	7	Cancer Module	10	124399958	124399958	27	0.222222222222222	NA	NA	NA			72	ZP. {ECO:0000255|PROSITE- ProRule:PRU00375}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMBT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124399958,C,C&fts=all">p.R2320W</a>
DMD	Missense_Mutation	p.P3390L	G	G		7	Cancer Module	X	31196840	31196840	139	0.467625899280576	NA	NA	NA			77	Interaction with SYNM. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,31196840,G,G&fts=all">p.P3390L</a>
DMD	Missense_Mutation	p.E1992K	C	C		7	Cancer Module	X	32328342	32328342	71	0.52112676056338	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,32328342,C,C&fts=all">p.E1992K</a>
DMD	Missense_Mutation	p.P1990L	G	G		7	Cancer Module	X	32328347	32328347	71	0.929577464788732	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,32328347,G,G&fts=all">p.P1990L</a>
DMXL2	Missense_Mutation	p.A924V	G	G		7	Cancer Module	15	51795224	51795224	57	0.421052631578947	NA	NA	NA			101			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMXL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,51795224,G,G&fts=all">p.A924V</a>
DNAH11	Missense_Mutation	p.M614I	G	G		7	Cancer Module	7	21627813	21627813	38	0.421052631578947	NA	NA	NA			230	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,21627813,G,G&fts=all">p.M614I</a>
DNAH11	Missense_Mutation	p.P705L	C	C		7	Cancer Module	7	21628966	21628966	149	0.503355704697987	NA	NA	NA			230	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,21628966,C,C&fts=all">p.P705L</a>
DNAH11	Missense_Mutation	p.R753K	G	G		7	Cancer Module	7	21630624	21630624	35	0.314285714285714	NA	NA	NA			230	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,21630624,G,G&fts=all">p.R753K</a>
DNAH11	Missense_Mutation	p.E1015K	G	G		7	Cancer Module	7	21640336	21640336	224	0.272321428571429	NA	NA	NA			230	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,21640336,G,G&fts=all">p.E1015K</a>
DNAH11	Missense_Mutation	p.E1063K	G	G		7	Cancer Module	7	21640480	21640480	153	0.222222222222222	NA	NA	NA			230	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,21640480,G,G&fts=all">p.E1063K</a>
DNAH11	Missense_Mutation	p.R1159K	G	G		7	Cancer Module	7	21641064	21641064	89	0.0449438202247191	NA	NA	NA			230	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,21641064,G,G&fts=all">p.R1159K</a>
DNAH11	Missense_Mutation	p.E1685K	G	G		7	Cancer Module	7	21695558	21695558	50	0.24	NA	NA	NA			230	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,21695558,G,G&fts=all">p.E1685K</a>
DNAH11	Missense_Mutation	p.R1949Q	G	G		7	Cancer Module	7	21727067	21727067	60	0.216666666666667	NA	NA	NA			230	AAA 1. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,21727067,G,G&fts=all">p.R1949Q</a>
DNAH11	Missense_Mutation	p.S2650F	C	C		7	Cancer Module	7	21781579	21781579	115	0.339130434782609	NA	NA	NA			230	AAA 3. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,21781579,C,C&fts=all">p.S2650F</a>
DNAH3	Missense_Mutation	p.E4004K	C	C		7	Cancer Module	16	20944817	20944817	74	0.351351351351351	NA	NA	NA			202			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,20944817,C,C&fts=all">p.E4004K</a>
DNAH3	Missense_Mutation	p.S2783L	G	G		7	Cancer Module	16	20981224	20981224	69	0.333333333333333	NA	NA	NA			202	Stalk. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,20981224,G,G&fts=all">p.S2783L</a>
DNAH3	Missense_Mutation	p.R2644Q	C	C		7	Cancer Module	16	20990797	20990797	114	0.526315789473684	NA	NA	NA			202	AAA 4. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,20990797,C,C&fts=all">p.R2644Q</a>
DNAH3	Missense_Mutation	p.E2370D	T	T		7	Cancer Module	16	20996954	20996954	145	0.262068965517241	NA	NA	NA			202			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,20996954,T,T&fts=all">p.E2370D</a>
DNAH3	Missense_Mutation	p.M1531I	C	C		7	Cancer Module	16	21053394	21053394	95	0.326315789473684	NA	NA	NA			202	AAA 1. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,21053394,C,C&fts=all">p.M1531I</a>
DNAH5	Missense_Mutation	p.H4082Y	G	G		7	Cancer Module	5	13721144	13721144	98	0.397959183673469	NA	NA	NA			378	AAA 6. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13721144,G,G&fts=all">p.H4082Y</a>
DNAH5	Missense_Mutation	p.R3599C	G	G	rs202232031	7	Cancer Module	5	13753419	13753419	186	0.220430107526882	NA	NA	NA			378	AAA 5. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13753419,G,G&fts=all">p.R3599C</a>
DNAH5	Missense_Mutation	p.E3376D	T	T		7	Cancer Module	5	13762984	13762984	119	0.38655462184874	NA	NA	NA			378	Stalk. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13762984,T,T&fts=all">p.E3376D</a>
DNAH5	Missense_Mutation	p.G3206E	C	C		7	Cancer Module	5	13769713	13769713	231	0.212121212121212	NA	NA	NA			378	Stalk. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13769713,C,C&fts=all">p.G3206E</a>
DNAH5	Missense_Mutation	p.M3203I	C	C		7	Cancer Module	5	13769721	13769721	192	0.255208333333333	NA	NA	NA			378	Stalk. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13769721,C,C&fts=all">p.M3203I</a>
DNAH5	Nonsense_Mutation	p.Q3147*	G	G		7	Cancer Module	5	13771024	13771024	86	0.267441860465116	NA	NA	NA			378	AAA 4. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13771024,G,G&fts=all">p.Q3147*</a>
DNAH5	Nonsense_Mutation	p.R3000*	G	G		7	Cancer Module	5	13777418	13777418	171	0.233918128654971	NA	NA	NA		p.R3000*(1)	378	AAA 4. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13777418,G,G&fts=all">p.R3000*</a>
DNAH5	Missense_Mutation	p.G2684R	C	C		7	Cancer Module	5	13793798	13793798	137	0.175182481751825	NA	NA	NA			378	AAA 3. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13793798,C,C&fts=all">p.G2684R</a>
DNAH5	Missense_Mutation	p.E1786K	C	C		7	Cancer Module	5	13841929	13841929	173	0.358381502890173	NA	NA	NA			378	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13841929,C,C&fts=all">p.E1786K</a>
DNAH5	Missense_Mutation	p.L1635S	A	A		7	Cancer Module	5	13859607	13859607	237	0.232067510548523	NA	NA	NA			378	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13859607,A,A&fts=all">p.L1635S</a>
DNAH5	Missense_Mutation	p.E912K	C	C		7	Cancer Module	5	13886082	13886082	134	0.253731343283582	NA	NA	NA			378	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13886082,C,C&fts=all">p.E912K</a>
DNAH5	Missense_Mutation	p.E882K	C	C		7	Cancer Module	5	13886172	13886172	60	0.166666666666667	NA	NA	NA			378	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13886172,C,C&fts=all">p.E882K</a>
DNAH5	Missense_Mutation	p.D613N	C	C	rs141072655	7	Cancer Module	5	13901576	13901576	101	0.277227722772277	NA	NA	NA			378	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13901576,C,C&fts=all">p.D613N</a>
DNAH7	Missense_Mutation	p.E3694K	C	C		7	Cancer Module	2	196640692	196640692	121	0.297520661157025	NA	NA	NA			205			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196640692,C,C&fts=all">p.E3694K</a>
DNAH7	Missense_Mutation	p.P3414S	G	G	rs376685120	7	Cancer Module	2	196664133	196664133	176	0.284090909090909	NA	NA	NA			205	AAA 6. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196664133,G,G&fts=all">p.P3414S</a>
DNAH7	Missense_Mutation	p.E2821K	C	C		7	Cancer Module	2	196720669	196720669	306	0.222222222222222	NA	NA	NA			205	Stalk. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196720669,C,C&fts=all">p.E2821K</a>
DNAH7	Missense_Mutation	p.G1924E	C	C		7	Cancer Module	2	196746709	196746709	66	0.348484848484849	NA	NA	NA			205			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196746709,C,C&fts=all">p.G1924E</a>
DNAH7	Missense_Mutation	p.D1825N	C	C	rs376110704	7	Cancer Module	2	196750930	196750930	162	0.296296296296296	NA	NA	NA			205			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196750930,C,C&fts=all">p.D1825N</a>
DNAH7	Missense_Mutation	p.D1219N	C	C		7	Cancer Module	2	196788489	196788489	110	0.281818181818182	NA	NA	NA			205	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196788489,C,C&fts=all">p.D1219N</a>
DNAH7	Missense_Mutation	p.S875F	G	G		7	Cancer Module	2	196825251	196825251	102	0.254901960784314	NA	NA	NA			205	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196825251,G,G&fts=all">p.S875F</a>
DNAH7	Splice_Site	p.K611K	C	C		7	Cancer Module	2	196849356	196849356	176	0.238636363636364	NA	NA	NA			205	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	
DNAH7	Missense_Mutation	p.F312I	A	A		7	Cancer Module	2	196877566	196877566	217	0.225806451612903	NA	NA	NA			205	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196877566,A,A&fts=all">p.F312I</a>
DNAH7	Missense_Mutation	p.F225C	A	A		7	Cancer Module	2	196889222	196889222	59	0.288135593220339	NA	NA	NA			205	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196889222,A,A&fts=all">p.F225C</a>
DNAH9	Missense_Mutation	p.G182E	G	G	rs371187162	7	Cancer Module	17	11511573	11511573	85	0.6	NA	NA	NA			290	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,11511573,G,G&fts=all">p.G182E</a>
DNAH9	Missense_Mutation	p.E755K	G	G		7	Cancer Module	17	11554551	11554551	84	0.297619047619048	NA	NA	NA			290	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,11554551,G,G&fts=all">p.E755K</a>
DNAH9	Missense_Mutation	p.F1633L	T	T		7	Cancer Module	17	11603072	11603072	45	0.155555555555556	NA	NA	NA			290	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,11603072,T,T&fts=all">p.F1633L</a>
DNAH9	Missense_Mutation	p.E2430K	G	G		7	Cancer Module	17	11671887	11671887	31	0.387096774193548	NA	NA	NA			290			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,11671887,G,G&fts=all">p.E2430K</a>
DNAH9	Missense_Mutation	p.H2609Y	C	C		7	Cancer Module	17	11687620	11687620	177	0.0395480225988701	NA	NA	NA			290	AAA 3. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,11687620,C,C&fts=all">p.H2609Y</a>
DNAH9	Missense_Mutation	p.G2819E	G	G		7	Cancer Module	17	11711084	11711084	65	0.630769230769231	NA	NA	NA			290	AAA 4. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,11711084,G,G&fts=all">p.G2819E</a>
DNAH9	Missense_Mutation	p.K3396N	A	A		7	Cancer Module	17	11775049	11775049	102	0.156862745098039	NA	NA	NA			290			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,11775049,A,A&fts=all">p.K3396N</a>
DNAH9	Missense_Mutation	p.S3625F	C	C		7	Cancer Module	17	11786970	11786970	87	0.367816091954023	NA	NA	NA			290	AAA 5. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,11786970,C,C&fts=all">p.S3625F</a>
DNAH9	Missense_Mutation	p.L4100F	C	C		7	Cancer Module	17	11840705	11840705	57	0.210526315789474	NA	NA	NA			290			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,11840705,C,C&fts=all">p.L4100F</a>
DNAJC3	Missense_Mutation	p.R76W	C	C		7	Cancer Module	13	96375528	96375528	256	0.28515625	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,96375528,C,C&fts=all">p.R76W</a>
DNER	Missense_Mutation	p.M189I	C	C	rs267599246	7	Cancer Module	2	230456314	230456314	49	0.26530612244898	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNER&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,230456314,C,C&fts=all">p.M189I</a>
DNM1	Missense_Mutation	p.R601W	C	C		7	Cancer Module	9	131009673	131009673	29	0.620689655172414	NA	NA	NA			32	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,131009673,C,C&fts=all">p.R601W</a>
DNMBP	Missense_Mutation	p.P615L	G	G		7	Cancer Module	10	101715387	101715387	60	0.2	NA	NA	NA			61	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNMBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,101715387,G,G&fts=all">p.P615L</a>
DNTT	Frame_Shift_Ins	p.V380fs	-	-		7	Cancer Module	10	98092132	98092133	126	0.277777777777778	NA	NA	NA			27	Mediates interaction with DNTTIP2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNTT&recr=Open">Click here</a>	
DOCK2	Missense_Mutation	p.F460S	T	T		7	Cancer Module	5	169412836	169412836	145	0.296551724137931	NA	NA	NA			160	DHR-1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,169412836,T,T&fts=all">p.F460S</a>
DPCR1	Missense_Mutation	p.G1293E	G	G		7	Cancer Module	6	30920119	30920119	132	0.265151515151515	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPCR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,30920119,G,G&fts=all">p.G1293E</a>
DPEP2	Missense_Mutation	p.R286G	G	G		7	Cancer Module	16	68024777	68024777	190	0.273684210526316	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPEP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,68024777,G,G&fts=all">p.R286G</a>
DPP6	Missense_Mutation	p.S753F	C	C		7	Cancer Module	7	154679398	154679398	82	0.74390243902439	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,154679398,C,C&fts=all">p.S753F</a>
DPP6	Missense_Mutation	p.G761R	G	G		7	Cancer Module	7	154679421	154679421	87	0.390804597701149	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,154679421,G,G&fts=all">p.G761R</a>
DPP6	Missense_Mutation	p.H796Y	C	C		7	Cancer Module	7	154681175	154681175	10	0.6	NA	NA	NA		p.H732Y(1)	71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,154681175,C,C&fts=all">p.H796Y</a>
DPT	Nonsense_Mutation	p.W92*	C	C		7	Cancer Module	1	168698137	168698137	190	0.157894736842105	NA	NA	NA			12	2 X 53-55 AA tandem repeats.|3 X 6 AA repeats of D-R-[EQ]-W-[NQK]- [FY].		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,168698137,C,C&fts=all">p.W92*</a>
DPYS	Missense_Mutation	p.R475Q	C	C		7	Cancer Module	8	105405031	105405031	490	0.240816326530612	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPYS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,105405031,C,C&fts=all">p.R475Q</a>
DRD1	Missense_Mutation	p.E252K	C	C	rs548677242	7	Cancer Module	5	174869349	174869349	55	0.363636363636364	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DRD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,174869349,C,C&fts=all">p.E252K</a>
DRD1	Missense_Mutation	p.R50K	C	C		7	Cancer Module	5	174869954	174869954	17	0.411764705882353	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DRD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,174869954,C,C&fts=all">p.R50K</a>
DRD3	Missense_Mutation	p.S285F	G	G	rs374601195	7	Cancer Module	3	113850117	113850117	168	0.369047619047619	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DRD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,113850117,G,G&fts=all">p.S285F</a>
DSC3	Missense_Mutation	p.F332S	A	A		7	Cancer Module	18	28598714	28598714	123	0.463414634146341	NA	NA	NA			56	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,28598714,A,A&fts=all">p.F332S</a>
DSCAM	Missense_Mutation	p.P1231S	G	G		7	Cancer Module	21	41496127	41496127	121	0.479338842975207	NA	NA	NA			142	Fibronectin type-III 4. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,41496127,G,G&fts=all">p.P1231S</a>
DSCAM	Missense_Mutation	p.T935A	T	T		7	Cancer Module	21	41550998	41550998	56	0.25	NA	NA	NA			142	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,41550998,T,T&fts=all">p.T935A</a>
DSCAM	Missense_Mutation	p.L370F	G	G		7	Cancer Module	21	41719699	41719699	277	0.205776173285199	NA	NA	NA			142	Ig-like C2-type 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,41719699,G,G&fts=all">p.L370F</a>
DSCAM	Missense_Mutation	p.R284C	G	G	rs267606133	7	Cancer Module	21	41725476	41725476	65	0.2	NA	NA	NA			142	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,41725476,G,G&fts=all">p.R284C</a>
DSCAM	Missense_Mutation	p.S113N	C	C		7	Cancer Module	21	42080403	42080403	146	0.294520547945205	NA	NA	NA			142	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,42080403,C,C&fts=all">p.S113N</a>
DSCAM	Missense_Mutation	p.G109E	C	C		7	Cancer Module	21	42080415	42080415	147	0.272108843537415	NA	NA	NA			142	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,42080415,C,C&fts=all">p.G109E</a>
DSG1	Missense_Mutation	p.G659E	G	G		7	Cancer Module	18	28926037	28926037	67	0.358208955223881	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,28926037,G,G&fts=all">p.G659E</a>
DSG1	Missense_Mutation	p.S1018F	C	C		7	Cancer Module	18	28935212	28935212	23	0.565217391304348	NA	NA	NA		p.S1018F(1)	76	Gly/Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,28935212,C,C&fts=all">p.S1018F</a>
DSG2	Missense_Mutation	p.S671L	C	C		7	Cancer Module	18	29122493	29122493	54	0.425925925925926	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,29122493,C,C&fts=all">p.S671L</a>
DSP	Missense_Mutation	p.R84Q	G	G	rs373736975	7	Cancer Module	6	7556031	7556031	60	0.15	NA	NA	NA			101	Globular 1.|Interacts with plakophilin 1 and junction plakoglobin.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,7556031,G,G&fts=all">p.R84Q</a>
DSP	Missense_Mutation	p.N437S	A	A		7	Cancer Module	6	7568713	7568713	237	0.20253164556962	NA	NA	NA			101	Globular 1.|Interacts with plakophilin 1 and junction plakoglobin.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,7568713,A,A&fts=all">p.N437S</a>
DSP	Missense_Mutation	p.P513L	C	C		7	Cancer Module	6	7569537	7569537	121	0.223140495867769	NA	NA	NA			101	Globular 1.|Interacts with plakophilin 1 and junction plakoglobin.|SH3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,7569537,C,C&fts=all">p.P513L</a>
DST	Missense_Mutation	p.P7451S	G	G		7	Cancer Module	6	56323838	56323838	224	0.651785714285714	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DST&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,56323838,G,G&fts=all">p.P7451S</a>
DST	Missense_Mutation	p.L4508M	G	G		7	Cancer Module	6	56426261	56426261	267	0.655430711610487	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DST&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,56426261,G,G&fts=all">p.L4508M</a>
DST	Missense_Mutation	p.P1470S	G	G		7	Cancer Module	6	56479171	56479171	190	0.226315789473684	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DST&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,56479171,G,G&fts=all">p.P1470S</a>
DST	Missense_Mutation	p.S978F	G	G		7	Cancer Module	6	56498985	56498985	336	0.226190476190476	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DST&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,56498985,G,G&fts=all">p.S978F</a>
DTX1	Nonsense_Mutation	p.W118*	G	G		7	Cancer Module	12	113515323	113515323	80	0.1625	NA	NA	NA			32	WWE 2. {ECO:0000255|PROSITE- ProRule:PRU00248}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DTX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,113515323,G,G&fts=all">p.W118*</a>
DUOX2	Missense_Mutation	p.G949A	C	C		7	Cancer Module	15	45393996	45393996	37	0.324324324324324	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUOX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,45393996,C,C&fts=all">p.G949A</a>
DUSP16	Missense_Mutation	p.H71L	T	T		7	Cancer Module	12	12673821	12673821	266	0.221804511278195	NA	NA	NA			26	Rhodanese. {ECO:0000255|PROSITE- ProRule:PRU00173}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,12673821,T,T&fts=all">p.H71L</a>
DUSP16	Missense_Mutation	p.E36D	T	T		7	Cancer Module	12	12673925	12673925	221	0.271493212669683	NA	NA	NA			26	Rhodanese. {ECO:0000255|PROSITE- ProRule:PRU00173}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,12673925,T,T&fts=all">p.E36D</a>
DUSP27	Missense_Mutation	p.G956E	G	G		7	Cancer Module	1	167097235	167097235	41	0.439024390243902	NA	NA	NA			89	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP27&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,167097235,G,G&fts=all">p.G956E</a>
DUSP27	Missense_Mutation	p.S983F	C	C		7	Cancer Module	1	167097316	167097316	53	0.169811320754717	NA	NA	NA			89	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP27&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,167097316,C,C&fts=all">p.S983F</a>
DUSP27	Missense_Mutation	p.E1135K	G	G		7	Cancer Module	1	167097771	167097771	42	0.452380952380952	NA	NA	NA			89			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP27&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,167097771,G,G&fts=all">p.E1135K</a>
DZIP1	Missense_Mutation	p.S697F	G	G	rs148618215	7	Cancer Module	13	96239921	96239921	76	0.223684210526316	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DZIP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,96239921,G,G&fts=all">p.S697F</a>
E2F8	Missense_Mutation	p.S664F	G	G		7	Cancer Module	11	19247314	19247314	140	0.371428571428571	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+E2F8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,19247314,G,G&fts=all">p.S664F</a>
ECE1	Missense_Mutation	p.R680W	G	G	rs144860890	7	Cancer Module	1	21551745	21551745	63	0.968253968253968	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ECE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,21551745,G,G&fts=all">p.R680W</a>
ECE2	Missense_Mutation	p.G222E	G	G		7	Cancer Module	3	183995087	183995087	60	0.2	NA	NA	NA			49	Endothelin-converting enzyme 2 region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ECE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,183995087,G,G&fts=all">p.G222E</a>
ECE2	Missense_Mutation	p.E401K	G	G		7	Cancer Module	3	184001603	184001603	24	0.208333333333333	NA	NA	NA			49	Endothelin-converting enzyme 2 region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ECE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,184001603,G,G&fts=all">p.E401K</a>
ECE2	Missense_Mutation	p.G737E	G	G		7	Cancer Module	3	184008849	184008849	107	0.0467289719626168	NA	NA	NA			49	Endothelin-converting enzyme 2 region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ECE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,184008849,G,G&fts=all">p.G737E</a>
ECEL1	Splice_Site	p.R395P	C	C		7	Cancer Module	2	233349182	233349182	67	0.253731343283582	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ECEL1&recr=Open">Click here</a>	
ECM1	Missense_Mutation	p.H381Y	C	C		7	Cancer Module	1	150484885	150484885	167	0.125748502994012	NA	NA	NA			22	2 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ECM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,150484885,C,C&fts=all">p.H381Y</a>
ECT2	Missense_Mutation	p.E428K	G	G		7	Cancer Module	3	172486880	172486880	200	0.57	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ECT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,172486880,G,G&fts=all">p.E428K</a>
EDC4	Missense_Mutation	p.P915S	C	C		7	Cancer Module	16	67915274	67915274	125	0.584	NA	NA	NA			41	Sufficient for nuclear localization.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EDC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,67915274,C,C&fts=all">p.P915S</a>
EDC4	Missense_Mutation	p.V1196A	T	T		7	Cancer Module	16	67916726	67916726	53	0.283018867924528	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EDC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,67916726,T,T&fts=all">p.V1196A</a>
EDN3	Missense_Mutation	p.E55K	G	G		7	Cancer Module	20	57876575	57876575	9	0.333333333333333	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EDN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,57876575,G,G&fts=all">p.E55K</a>
EFCAB1	Missense_Mutation	p.G37R	C	C		7	Cancer Module	8	49644012	49644012	343	0.198250728862974	NA	NA	NA		p.G37*(1)	14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFCAB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,49644012,C,C&fts=all">p.G37R</a>
EFCAB6	Splice_Site	p.L1349L	C	C		7	Cancer Module	22	43933258	43933258	195	0.220512820512821	NA	NA	NA			68	Interaction with PARK7.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFCAB6&recr=Open">Click here</a>	
EFEMP1	Missense_Mutation	p.R362Q	C	C	rs369049569	7	Cancer Module	2	56098174	56098174	78	0.217948717948718	NA	NA	NA			28	EGF-like 6; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.|Mediates interaction with TIMP3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFEMP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,56098174,C,C&fts=all">p.R362Q</a>
EFHC2	Splice_Site	p.G475E	C	C		7	Cancer Module	X	44091923	44091923	22	0.363636363636364	NA	NA	NA			29	DM10 3. {ECO:0000255|PROSITE- ProRule:PRU00665}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFHC2&recr=Open">Click here</a>	
EFTUD2	Missense_Mutation	p.S671F	G	G		7	Cancer Module	17	42934476	42934476	142	0.309859154929577	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFTUD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,42934476,G,G&fts=all">p.S671F</a>
EFTUD2	Missense_Mutation	p.L300H	A	A		7	Cancer Module	17	42949909	42949909	126	0.182539682539683	NA	NA	NA			32	tr-type G. {ECO:0000255|PROSITE- ProRule:PRU01059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFTUD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,42949909,A,A&fts=all">p.L300H</a>
EFTUD2	Missense_Mutation	p.L300F	G	G		7	Cancer Module	17	42949910	42949910	124	0.17741935483871	NA	NA	NA			32	tr-type G. {ECO:0000255|PROSITE- ProRule:PRU01059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFTUD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,42949910,G,G&fts=all">p.L300F</a>
EFTUD2	Missense_Mutation	p.I299T	A	A		7	Cancer Module	17	42949912	42949912	131	0.16030534351145	NA	NA	NA			32	tr-type G. {ECO:0000255|PROSITE- ProRule:PRU01059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFTUD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,42949912,A,A&fts=all">p.I299T</a>
EGR2	Missense_Mutation	p.C251Y	C	C		7	Cancer Module	10	64573646	64573646	124	0.217741935483871	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,64573646,C,C&fts=all">p.C251Y</a>
EGR3	Missense_Mutation	p.P157L	G	G		7	Cancer Module	8	22548680	22548680	35	0.114285714285714	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,22548680,G,G&fts=all">p.P157L</a>
EHBP1	Missense_Mutation	p.S742F	C	C		7	Cancer Module	2	63176101	63176101	201	0.129353233830846	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EHBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,63176101,C,C&fts=all">p.S742F</a>
EHBP1	Missense_Mutation	p.S781F	C	C		7	Cancer Module	2	63176218	63176218	189	0.375661375661376	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EHBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,63176218,C,C&fts=all">p.S781F</a>
EHD1	Missense_Mutation	p.T479I	G	G		7	Cancer Module	11	64621974	64621974	42	0.547619047619048	NA	NA	NA			12	EF-hand. {ECO:0000255|PROSITE- ProRule:PRU00448}.|EH. {ECO:0000255|PROSITE- ProRule:PRU00077}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EHD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,64621974,G,G&fts=all">p.T479I</a>
EHF	Missense_Mutation	p.R282Q	G	G		7	Cancer Module	11	34680420	34680420	146	0.438356164383562	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EHF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,34680420,G,G&fts=all">p.R282Q</a>
EHMT2	Missense_Mutation	p.H707Y	G	G		7	Cancer Module	6	31855417	31855417	83	0.180722891566265	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EHMT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31855417,G,G&fts=all">p.H707Y</a>
EIF3B	Missense_Mutation	p.R736C	C	C		7	Cancer Module	7	2418375	2418375	99	0.424242424242424	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,2418375,C,C&fts=all">p.R736C</a>
EIF3D	Missense_Mutation	p.R374C	G	G		7	Cancer Module	22	36912611	36912611	498	0.267068273092369	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF3D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,36912611,G,G&fts=all">p.R374C</a>
EIF4A3	Missense_Mutation	p.R316Q	C	C		7	Cancer Module	17	78111221	78111221	103	0.184466019417476	NA	NA	NA			10	Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF4A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,78111221,C,C&fts=all">p.R316Q</a>
ELAVL1	Missense_Mutation	p.S175F	G	G		7	Cancer Module	19	8032581	8032581	98	0.306122448979592	NA	NA	NA			20	RRM 2. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELAVL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8032581,G,G&fts=all">p.S175F</a>
ELAVL4	Missense_Mutation	p.E73K	G	G		7	Cancer Module	1	50610836	50610836	196	0.0408163265306122	NA	NA	NA			32	RRM 1. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELAVL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,50610836,G,G&fts=all">p.E73K</a>
ELOVL2	Missense_Mutation	p.H146Y	G	G		7	Cancer Module	6	10995309	10995309	218	0.252293577981651	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELOVL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,10995309,G,G&fts=all">p.H146Y</a>
ELOVL6	Missense_Mutation	p.R48W	G	G		7	Cancer Module	4	111026732	111026732	128	0.3671875	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELOVL6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,111026732,G,G&fts=all">p.R48W</a>
EMID1	Missense_Mutation	p.P297L	C	C		7	Cancer Module	22	29629434	29629434	140	0.4	NA	NA	NA			12	Collagen-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMID1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,29629434,C,C&fts=all">p.P297L</a>
EMR1	Missense_Mutation	p.M511I	G	G		7	Cancer Module	19	6919671	6919671	115	0.252173913043478	NA	NA	NA		p.M511I(2)	62	Ser/Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,6919671,G,G&fts=all">p.M511I</a>
EMX2	Missense_Mutation	p.A182V	C	C		7	Cancer Module	10	119305281	119305281	43	0.209302325581395	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,119305281,C,C&fts=all">p.A182V</a>
ENAH	Missense_Mutation	p.P563S	G	G		7	Cancer Module	1	225702570	225702570	110	0.281818181818182	NA	NA	NA			23	EVH2 block C.|EVH2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENAH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,225702570,G,G&fts=all">p.P563S</a>
ENPEP	Missense_Mutation	p.P281A	C	C		7	Cancer Module	4	111412243	111412243	191	0.272251308900524	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPEP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,111412243,C,C&fts=all">p.P281A</a>
ENPEP	Missense_Mutation	p.P281L	C	C		7	Cancer Module	4	111412244	111412244	191	0.272251308900524	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPEP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,111412244,C,C&fts=all">p.P281L</a>
ENPEP	Missense_Mutation	p.G417A	G	G		7	Cancer Module	4	111431456	111431456	160	0.55	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPEP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,111431456,G,G&fts=all">p.G417A</a>
ENPEP	Missense_Mutation	p.P714T	C	C		7	Cancer Module	4	111469471	111469471	99	0.222222222222222	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPEP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,111469471,C,C&fts=all">p.P714T</a>
ENPEP	Missense_Mutation	p.G732E	G	G		7	Cancer Module	4	111470545	111470545	153	0.555555555555556	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPEP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,111470545,G,G&fts=all">p.G732E</a>
ENPEP	Missense_Mutation	p.E922K	G	G		7	Cancer Module	4	111482604	111482604	123	0.357723577235772	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPEP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,111482604,G,G&fts=all">p.E922K</a>
ENPP1	Missense_Mutation	p.P610S	C	C		7	Cancer Module	6	132198236	132198236	55	0.363636363636364	NA	NA	NA			46	Linker. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,132198236,C,C&fts=all">p.P610S</a>
ENPP2	Missense_Mutation	p.G225E	C	C		7	Cancer Module	8	120592367	120592367	895	0.214525139664804	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,120592367,C,C&fts=all">p.G225E</a>
ENPP4	Missense_Mutation	p.E186K	G	G		7	Cancer Module	6	46107876	46107876	283	0.208480565371025	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,46107876,G,G&fts=all">p.E186K</a>
ENPP4	Missense_Mutation	p.S253F	C	C		7	Cancer Module	6	46108078	46108078	187	0.229946524064171	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,46108078,C,C&fts=all">p.S253F</a>
EPB41L1	Missense_Mutation	p.S86L	C	C		7	Cancer Module	20	34763552	34763552	72	0.458333333333333	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPB41L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,34763552,C,C&fts=all">p.S86L</a>
EPB41L2	Missense_Mutation	p.H898Y	G	G		7	Cancer Module	6	131184786	131184786	113	0.486725663716814	NA	NA	NA			44	C-terminal (CTD).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPB41L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,131184786,G,G&fts=all">p.H898Y</a>
EPB42	Missense_Mutation	p.R87Q	C	C	rs370209252	7	Cancer Module	15	43507463	43507463	188	0.313829787234043	NA	NA	NA		p.R117Q(1)	20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPB42&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43507463,C,C&fts=all">p.R87Q</a>
EPHA2	Missense_Mutation	p.P212S	G	G		7	Cancer Module	1	16475062	16475062	54	0.259259259259259	NA	NA	NA			42	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,16475062,G,G&fts=all">p.P212S</a>
EPHA4	Missense_Mutation	p.S907F	G	G		7	Cancer Module	2	222291310	222291310	76	0.276315789473684	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,222291310,G,G&fts=all">p.S907F</a>
EPHA7	Missense_Mutation	p.D397N	C	C		7	Cancer Module	6	94066570	94066570	31	0.483870967741935	NA	NA	NA			112	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,94066570,C,C&fts=all">p.D397N</a>
EPHA7	Missense_Mutation	p.E241K	C	C		7	Cancer Module	6	94120330	94120330	72	0.430555555555556	NA	NA	NA			112	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,94120330,C,C&fts=all">p.E241K</a>
EPHB1	Missense_Mutation	p.R608W	C	C	rs185655852	7	Cancer Module	3	134898764	134898764	119	0.411764705882353	NA	NA	NA		p.R608R(2)	130			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,134898764,C,C&fts=all">p.R608W</a>
EPHB6	Missense_Mutation	p.G304E	G	G		7	Cancer Module	7	142562469	142562469	42	0.142857142857143	NA	NA	NA			87	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHB6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,142562469,G,G&fts=all">p.G304E</a>
EPHB6	Missense_Mutation	p.S371L	C	C		7	Cancer Module	7	142563724	142563724	17	0.352941176470588	NA	NA	NA			87	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHB6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,142563724,C,C&fts=all">p.S371L</a>
EPHX2	Missense_Mutation	p.L44F	C	C		7	Cancer Module	8	27361262	27361262	136	0.161764705882353	NA	NA	NA			27	Phosphatase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,27361262,C,C&fts=all">p.L44F</a>
EPN1	Nonsense_Mutation	p.R409*	C	C		7	Cancer Module	19	56204364	56204364	92	0.108695652173913	NA	NA	NA			17	Ala/Gly/Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56204364,C,C&fts=all">p.R409*</a>
EPS8L3	Missense_Mutation	p.G420R	C	C		7	Cancer Module	1	110294796	110294796	155	0.606451612903226	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPS8L3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,110294796,C,C&fts=all">p.G420R</a>
ERC2	Missense_Mutation	p.R933Q	C	C		7	Cancer Module	3	55733455	55733455	271	0.195571955719557	NA	NA	NA		p.R933Q(2)	31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,55733455,C,C&fts=all">p.R933Q</a>
ERCC6	Nonsense_Mutation	p.R1221*	G	G	rs529174213	7	Cancer Module	10	50678345	50678345	432	0.219907407407407	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERCC6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,50678345,G,G&fts=all">p.R1221*</a>
ERGIC1	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	5	172196137	172362315	NA	NA	9	-1.00404521205795	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERGIC1&recr=Open">Click here</a>	
ESD	Missense_Mutation	p.P113S	G	G		7	Cancer Module	13	47356846	47356846	279	0.265232974910394	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,47356846,G,G&fts=all">p.P113S</a>
ESRRG	Missense_Mutation	p.E346K	C	C	rs267598381	7	Cancer Module	1	216692626	216692626	168	0.172619047619048	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESRRG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,216692626,C,C&fts=all">p.E346K</a>
ESRRG	Missense_Mutation	p.D341N	C	C		7	Cancer Module	1	216692641	216692641	180	0.2	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESRRG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,216692641,C,C&fts=all">p.D341N</a>
ESRRG	Missense_Mutation	p.D107N	C	C		7	Cancer Module	1	216850586	216850586	194	0.231958762886598	NA	NA	NA		p.D102N(1)	49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESRRG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,216850586,C,C&fts=all">p.D107N</a>
ETF1	Missense_Mutation	p.L311F	G	G		7	Cancer Module	5	137846307	137846307	139	0.424460431654676	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ETF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,137846307,G,G&fts=all">p.L311F</a>
ETFDH	Missense_Mutation	p.D171N	G	G		7	Cancer Module	4	159611545	159611545	311	0.321543408360129	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ETFDH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,159611545,G,G&fts=all">p.D171N</a>
EVI2A	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EVI2A&recr=Open">Click here</a>	
EVI2B	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EVI2B&recr=Open">Click here</a>	
EVPL	Missense_Mutation	p.K1322E	T	T		7	Cancer Module	17	74005322	74005322	119	0.0336134453781513	NA	NA	NA			54	Central fibrous rod domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EVPL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,74005322,T,T&fts=all">p.K1322E</a>
EVPL	Missense_Mutation	p.P1246L	G	G	rs370996950	7	Cancer Module	17	74005549	74005549	58	0.224137931034483	NA	NA	NA			54	Central fibrous rod domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EVPL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,74005549,G,G&fts=all">p.P1246L</a>
EXOC2	Missense_Mutation	p.P126S	G	G		7	Cancer Module	6	629881	629881	218	0.192660550458716	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXOC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,629881,G,G&fts=all">p.P126S</a>
EXOC7	Missense_Mutation	p.P298S	G	G	rs200640506	7	Cancer Module	17	74087233	74087233	209	0.22488038277512	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXOC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,74087233,G,G&fts=all">p.P298S</a>
EXPH5	Missense_Mutation	p.R1139G	T	T		7	Cancer Module	11	108382819	108382819	59	0.423728813559322	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXPH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,108382819,T,T&fts=all">p.R1139G</a>
EXPH5	Missense_Mutation	p.D636N	C	C		7	Cancer Module	11	108384328	108384328	165	0.418181818181818	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXPH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,108384328,C,C&fts=all">p.D636N</a>
EXPH5	Missense_Mutation	p.E411K	C	C		7	Cancer Module	11	108385003	108385003	200	0.385	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXPH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,108385003,C,C&fts=all">p.E411K</a>
EXTL3	Splice_Site	p.V760M	G	G		7	Cancer Module	8	28595037	28595037	228	0.192982456140351	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXTL3&recr=Open">Click here</a>	
EYA1	Missense_Mutation	p.P179L	G	G		7	Cancer Module	8	72229807	72229807	179	0.173184357541899	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EYA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,72229807,G,G&fts=all">p.P179L</a>
EYA1	Splice_Site	p.V42I	C	C		7	Cancer Module	8	72267017	72267017	169	0.272189349112426	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EYA1&recr=Open">Click here</a>	
EYA1	Missense_Mutation	p.G39S	C	C		7	Cancer Module	8	72267026	72267026	180	0.233333333333333	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EYA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,72267026,C,C&fts=all">p.G39S</a>
EYA2	Missense_Mutation	p.G147E	G	G		7	Cancer Module	20	45700848	45700848	36	0.75	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EYA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,45700848,G,G&fts=all">p.G147E</a>
EZH1	Missense_Mutation	p.P20S	G	G		7	Cancer Module	17	40876421	40876421	69	0.304347826086957	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EZH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,40876421,G,G&fts=all">p.P20S</a>
F13A1	Missense_Mutation	p.A434V	G	G		7	Cancer Module	6	6196034	6196034	35	0.685714285714286	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F13A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,6196034,G,G&fts=all">p.A434V</a>
F13A1	Missense_Mutation	p.S150P	A	A		7	Cancer Module	6	6266914	6266914	84	0.119047619047619	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F13A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,6266914,A,A&fts=all">p.S150P</a>
F13B	Missense_Mutation	p.F42Y	A	A		7	Cancer Module	1	197032127	197032127	450	0.235555555555556	NA	NA	NA			66	Sushi 1. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F13B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,197032127,A,A&fts=all">p.F42Y</a>
FA2H	Missense_Mutation	p.S92F	G	G		7	Cancer Module	16	74774009	74774009	100	0.31	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FA2H&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,74774009,G,G&fts=all">p.S92F</a>
FABP1	Missense_Mutation	p.S39L	G	G		7	Cancer Module	2	88425819	88425819	386	0.186528497409326	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FABP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,88425819,G,G&fts=all">p.S39L</a>
FAIM2	Missense_Mutation	p.R99C	G	G	rs201425199	7	Cancer Module	12	50291790	50291790	75	0.373333333333333	NA	NA	NA		p.R99C(1)	14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAIM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,50291790,G,G&fts=all">p.R99C</a>
FAIM3	Missense_Mutation	p.S55F	G	G		7	Cancer Module	1	207087313	207087313	346	0.26878612716763	NA	NA	NA		p.S55Y(1)	15	Ig-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAIM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,207087313,G,G&fts=all">p.S55F</a>
FAM129B	Missense_Mutation	p.E368K	C	C		7	Cancer Module	9	130272484	130272484	87	0.666666666666667	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM129B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,130272484,C,C&fts=all">p.E368K</a>
FAM134A	Missense_Mutation	p.L106P	T	T		7	Cancer Module	2	220043679	220043679	391	0.258312020460358	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM134A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,220043679,T,T&fts=all">p.L106P</a>
FAM135B	Missense_Mutation	p.S1073F	G	G		7	Cancer Module	8	139163500	139163500	64	0.28125	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139163500,G,G&fts=all">p.S1073F</a>
FAM135B	Missense_Mutation	p.G872D	C	C		7	Cancer Module	8	139164103	139164103	81	0.271604938271605	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139164103,C,C&fts=all">p.G872D</a>
FAM135B	Nonsense_Mutation	p.L707*	A	A		7	Cancer Module	8	139164598	139164598	29	0.241379310344828	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139164598,A,A&fts=all">p.L707*</a>
FAM135B	Missense_Mutation	p.G621R	C	C		7	Cancer Module	8	139164857	139164857	97	0.185567010309278	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139164857,C,C&fts=all">p.G621R</a>
FAM135B	Nonsense_Mutation	p.Q508*	G	G		7	Cancer Module	8	139165196	139165196	158	0.449367088607595	NA	NA	NA		p.Q508*(2)	238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139165196,G,G&fts=all">p.Q508*</a>
FAM135B	Missense_Mutation	p.E458K	C	C		7	Cancer Module	8	139165346	139165346	126	0.222222222222222	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139165346,C,C&fts=all">p.E458K</a>
FAM135B	Nonsense_Mutation	p.W318*	C	C		7	Cancer Module	8	139190854	139190854	53	0.169811320754717	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139190854,C,C&fts=all">p.W318*</a>
FAM135B	Missense_Mutation	p.S225C	T	T		7	Cancer Module	8	139209909	139209909	65	0.184615384615385	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139209909,T,T&fts=all">p.S225C</a>
FAM135B	Missense_Mutation	p.E208K	C	C		7	Cancer Module	8	139255232	139255232	70	0.342857142857143	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139255232,C,C&fts=all">p.E208K</a>
FAM135B	Missense_Mutation	p.P153L	G	G		7	Cancer Module	8	139263168	139263168	90	0.433333333333333	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139263168,G,G&fts=all">p.P153L</a>
FAM135B	Missense_Mutation	p.P41S	G	G		7	Cancer Module	8	139323120	139323120	115	0.104347826086957	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139323120,G,G&fts=all">p.P41S</a>
FAM135B	Nonsense_Mutation	p.Y27*	A	A		7	Cancer Module	8	139323160	139323160	85	0.458823529411765	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139323160,A,A&fts=all">p.Y27*</a>
FAM49A	Missense_Mutation	p.E177K	C	C		7	Cancer Module	2	16742530	16742530	119	0.285714285714286	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM49A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,16742530,C,C&fts=all">p.E177K</a>
FAM49A	Missense_Mutation	p.E94K	C	C	rs371312049	7	Cancer Module	2	16745275	16745275	110	0.272727272727273	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM49A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,16745275,C,C&fts=all">p.E94K</a>
FAM50A	Missense_Mutation	p.S118F	C	C		7	Cancer Module	X	153674819	153674819	32	0.5	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM50A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,153674819,C,C&fts=all">p.S118F</a>
FAP	Missense_Mutation	p.E325K	C	C		7	Cancer Module	2	163070477	163070477	352	0.582386363636364	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,163070477,C,C&fts=all">p.E325K</a>
FAT2	Missense_Mutation	p.E4118K	C	C		7	Cancer Module	5	150886880	150886880	70	0.485714285714286	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,150886880,C,C&fts=all">p.E4118K</a>
FAT2	Missense_Mutation	p.G2434R	C	C		7	Cancer Module	5	150923388	150923388	54	0.240740740740741	NA	NA	NA			196	Cadherin 21. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,150923388,C,C&fts=all">p.G2434R</a>
FAT2	Missense_Mutation	p.P1687L	G	G		7	Cancer Module	5	150925628	150925628	55	0.327272727272727	NA	NA	NA			196	Cadherin 15. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,150925628,G,G&fts=all">p.P1687L</a>
FAT2	Missense_Mutation	p.P1687S	G	G		7	Cancer Module	5	150925629	150925629	54	0.333333333333333	NA	NA	NA			196	Cadherin 15. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,150925629,G,G&fts=all">p.P1687S</a>
FBL	Missense_Mutation	p.P212L	G	G		7	Cancer Module	19	40328398	40328398	189	0.534391534391534	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,40328398,G,G&fts=all">p.P212L</a>
FBLN2	Missense_Mutation	p.V426D	T	T		7	Cancer Module	3	13613132	13613132	26	0.5	NA	NA	NA			24	N.|Subdomain NB (Cys-free).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBLN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,13613132,T,T&fts=all">p.V426D</a>
FBN1	Missense_Mutation	p.P2198L	G	G		7	Cancer Module	15	48726814	48726814	255	0.294117647058824	NA	NA	NA			139	EGF-like 37; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,48726814,G,G&fts=all">p.P2198L</a>
FBN2	Missense_Mutation	p.P2029L	G	G		7	Cancer Module	5	127636589	127636589	84	0.511904761904762	NA	NA	NA		p.P2029L(2)	197	EGF-like 34; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,127636589,G,G&fts=all">p.P2029L</a>
FBN2	Missense_Mutation	p.G925R	C	C	rs111405756	7	Cancer Module	5	127686599	127686599	68	0.397058823529412	NA	NA	NA			197	TB 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,127686599,C,C&fts=all">p.G925R</a>
FBN3	Missense_Mutation	p.E1435K	C	C	rs376405342	7	Cancer Module	19	8175759	8175759	66	0.212121212121212	NA	NA	NA			132	EGF-like 22; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8175759,C,C&fts=all">p.E1435K</a>
FBXL12	Missense_Mutation	p.P66L	G	G		7	Cancer Module	19	9922283	9922283	78	0.423076923076923	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXL12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9922283,G,G&fts=all">p.P66L</a>
FBXL4	Missense_Mutation	p.L540F	G	G		7	Cancer Module	6	99323375	99323375	126	0.46031746031746	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,99323375,G,G&fts=all">p.L540F</a>
FBXO3	Missense_Mutation	p.P301L	G	G		7	Cancer Module	11	33772115	33772115	147	0.421768707482993	NA	NA	NA			13	ApaG. {ECO:0000255|PROSITE- ProRule:PRU00412}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,33772115,G,G&fts=all">p.P301L</a>
FBXO34	Missense_Mutation	p.E504K	G	G		7	Cancer Module	14	55818618	55818618	129	0.0465116279069767	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO34&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,55818618,G,G&fts=all">p.E504K</a>
FBXO42	Missense_Mutation	p.T680I	G	G		7	Cancer Module	1	16577280	16577280	726	0.0206611570247934	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO42&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,16577280,G,G&fts=all">p.T680I</a>
FBXO42	Missense_Mutation	p.P231L	G	G		7	Cancer Module	1	16582281	16582281	206	0.16504854368932	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO42&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,16582281,G,G&fts=all">p.P231L</a>
FCAR	Nonsense_Mutation	p.Q99*	C	C		7	Cancer Module	19	55396871	55396871	48	0.375	NA	NA	NA		p.Q99*(2)	24	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCAR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55396871,C,C&fts=all">p.Q99*</a>
FCER1A	Missense_Mutation	p.R238S	A	A		7	Cancer Module	1	159277662	159277662	154	0.435064935064935	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCER1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,159277662,A,A&fts=all">p.R238S</a>
FCGBP	Nonsense_Mutation	p.R5317*	G	G	rs545369839	7	Cancer Module	19	40354520	40354520	25	0.48	NA	NA	NA			165	VWFD 13. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCGBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,40354520,G,G&fts=all">p.R5317*</a>
FCGBP	Missense_Mutation	p.H4836Y	G	G		7	Cancer Module	19	40364136	40364136	31	0.290322580645161	NA	NA	NA			165			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCGBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,40364136,G,G&fts=all">p.H4836Y</a>
FCGBP	Missense_Mutation	p.E1452K	C	C		7	Cancer Module	19	40408485	40408485	42	0.238095238095238	NA	NA	NA			165	VWFD 3. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCGBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,40408485,C,C&fts=all">p.E1452K</a>
FCGBP	Missense_Mutation	p.R936Q	C	C		7	Cancer Module	19	40421114	40421114	36	0.194444444444444	NA	NA	NA		p.R936L(1)	165	VWFD 2. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCGBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,40421114,C,C&fts=all">p.R936Q</a>
FCN2	Missense_Mutation	p.P85L	C	C		7	Cancer Module	9	137775187	137775187	45	0.266666666666667	NA	NA	NA			20	Collagen-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,137775187,C,C&fts=all">p.P85L</a>
FCRL1	Missense_Mutation	p.G141E	C	C		7	Cancer Module	1	157772352	157772352	71	0.28169014084507	NA	NA	NA			42	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCRL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,157772352,C,C&fts=all">p.G141E</a>
FDPS	Nonsense_Mutation	p.Q329*	C	C		7	Cancer Module	1	155289645	155289645	265	0.252830188679245	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FDPS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,155289645,C,C&fts=all">p.Q329*</a>
FGG	Missense_Mutation	p.K79I	T	T		7	Cancer Module	4	155533241	155533241	219	0.589041095890411	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155533241,T,T&fts=all">p.K79I</a>
FGL1	Missense_Mutation	p.G152D	C	C		7	Cancer Module	8	17731575	17731575	328	0.149390243902439	NA	NA	NA			13	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,17731575,C,C&fts=all">p.G152D</a>
FGL2	Missense_Mutation	p.R329C	G	G		7	Cancer Module	7	76825931	76825931	173	0.739884393063584	NA	NA	NA			13	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,76825931,G,G&fts=all">p.R329C</a>
FGL2	Missense_Mutation	p.E281K	C	C		7	Cancer Module	7	76826075	76826075	114	0.298245614035088	NA	NA	NA			13	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,76826075,C,C&fts=all">p.E281K</a>
FIG4	Splice_Site	p.S630R	T	T		7	Cancer Module	6	110106173	110106173	211	0.454976303317536	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FIG4&recr=Open">Click here</a>	
FLNC	Missense_Mutation	p.P1234L	C	C		7	Cancer Module	7	128485220	128485220	16	0.1875	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLNC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,128485220,C,C&fts=all">p.P1234L</a>
FLNC	Missense_Mutation	p.S2546F	C	C		7	Cancer Module	7	128497247	128497247	76	0.815789473684211	NA	NA	NA			128	Interaction with INPPL1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLNC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,128497247,C,C&fts=all">p.S2546F</a>
FLNC	Missense_Mutation	p.P2716L	C	C		7	Cancer Module	7	128498546	128498546	46	0.130434782608696	NA	NA	NA			128	Interaction with INPPL1.|Self-association site, tail. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLNC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,128498546,C,C&fts=all">p.P2716L</a>
FLRT2	Missense_Mutation	p.P268S	C	C		7	Cancer Module	14	86088660	86088660	135	0.644444444444444	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLRT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,86088660,C,C&fts=all">p.P268S</a>
FLRT3	Missense_Mutation	p.R341C	G	G		7	Cancer Module	20	14307132	14307132	135	0.42962962962963	NA	NA	NA			17	LRRCT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLRT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,14307132,G,G&fts=all">p.R341C</a>
FMNL2	Missense_Mutation	p.A36V	C	C		7	Cancer Module	2	153192224	153192224	59	0.389830508474576	NA	NA	NA			23	GBD/FH3. {ECO:0000255|PROSITE- ProRule:PRU00579}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMNL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,153192224,C,C&fts=all">p.A36V</a>
FMNL2	Nonsense_Mutation	p.Q71*	C	C		7	Cancer Module	2	153399262	153399262	95	0.168421052631579	NA	NA	NA			23	GBD/FH3. {ECO:0000255|PROSITE- ProRule:PRU00579}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMNL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,153399262,C,C&fts=all">p.Q71*</a>
FMNL2	Missense_Mutation	p.K55R	A	A		7	Cancer Module	2	153483115	153483115	66	0.424242424242424	NA	NA	NA			23	GBD/FH3. {ECO:0000255|PROSITE- ProRule:PRU00579}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMNL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,153483115,A,A&fts=all">p.K55R</a>
FMO1	Missense_Mutation	p.N309Y	A	A		7	Cancer Module	1	171251214	171251214	167	0.449101796407186	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMO1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,171251214,A,A&fts=all">p.N309Y</a>
FMO1	Missense_Mutation	p.F335V	T	T		7	Cancer Module	1	171251292	171251292	213	0.126760563380282	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMO1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,171251292,T,T&fts=all">p.F335V</a>
FMO5	Missense_Mutation	p.G134E	C	C		7	Cancer Module	1	146684961	146684961	339	0.194690265486726	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMO5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,146684961,C,C&fts=all">p.G134E</a>
FMO5	Missense_Mutation	p.R5K	C	C		7	Cancer Module	1	146696608	146696608	240	0.1875	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMO5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,146696608,C,C&fts=all">p.R5K</a>
FMR1	Missense_Mutation	p.R611C	C	C		7	Cancer Module	X	147030296	147030296	121	0.413223140495868	NA	NA	NA			35	Interaction with RANBP9.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,147030296,C,C&fts=all">p.R611C</a>
FNDC3B	Missense_Mutation	p.H352Y	C	C		7	Cancer Module	3	172016570	172016570	204	0.21078431372549	NA	NA	NA			69	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FNDC3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,172016570,C,C&fts=all">p.H352Y</a>
FOLR3	Missense_Mutation	p.P210S	C	C		7	Cancer Module	11	71850645	71850645	76	0.368421052631579	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOLR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,71850645,C,C&fts=all">p.P210S</a>
FOXJ1	Missense_Mutation	p.P109L	G	G		7	Cancer Module	17	74136151	74136151	36	0.527777777777778	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOXJ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,74136151,G,G&fts=all">p.P109L</a>
FPR1	Missense_Mutation	p.F53I	A	A		7	Cancer Module	19	52250091	52250091	55	0.181818181818182	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FPR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,52250091,A,A&fts=all">p.F53I</a>
FRK	Missense_Mutation	p.S153F	G	G		7	Cancer Module	6	116325048	116325048	98	0.295918367346939	NA	NA	NA			27	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,116325048,G,G&fts=all">p.S153F</a>
FSCN3	Missense_Mutation	p.G120S	G	G		7	Cancer Module	7	127235574	127235574	29	0.862068965517241	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSCN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,127235574,G,G&fts=all">p.G120S</a>
FTCD	Missense_Mutation	p.D157N	C	C	rs532226691	7	Cancer Module	21	47571639	47571639	31	0.225806451612903	NA	NA	NA			19	Formiminotransferase N-subdomain. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FTCD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,47571639,C,C&fts=all">p.D157N</a>
FYB	Missense_Mutation	p.P130S	G	G		7	Cancer Module	5	39202675	39202675	265	0.211320754716981	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FYB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,39202675,G,G&fts=all">p.P130S</a>
FYN	Missense_Mutation	p.G106E	C	C		7	Cancer Module	6	112035577	112035577	94	0.340425531914894	NA	NA	NA			30	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FYN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,112035577,C,C&fts=all">p.G106E</a>
G6PC3	Missense_Mutation	p.L154I	C	C		7	Cancer Module	17	42152380	42152380	227	0.343612334801762	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+G6PC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,42152380,C,C&fts=all">p.L154I</a>
GABRA1	Missense_Mutation	p.F42V	T	T		7	Cancer Module	5	161281213	161281213	129	0.317829457364341	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,161281213,T,T&fts=all">p.F42V</a>
GABRA1	Missense_Mutation	p.H129Y	C	C	rs146134200	7	Cancer Module	5	161300252	161300252	56	0.357142857142857	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,161300252,C,C&fts=all">p.H129Y</a>
GABRA2	Missense_Mutation	p.F331I	A	A		7	Cancer Module	4	46264011	46264011	108	0.407407407407407	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,46264011,A,A&fts=all">p.F331I</a>
GABRA5	Missense_Mutation	p.H144Y	C	C		7	Cancer Module	15	27128637	27128637	26	0.269230769230769	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,27128637,C,C&fts=all">p.H144Y</a>
GABRB2	Missense_Mutation	p.K412E	T	T		7	Cancer Module	5	160721393	160721393	98	0.459183673469388	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,160721393,T,T&fts=all">p.K412E</a>
GABRB2	Missense_Mutation	p.D269N	C	C		7	Cancer Module	5	160761786	160761786	47	0.425531914893617	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,160761786,C,C&fts=all">p.D269N</a>
GABRE	Missense_Mutation	p.S288F	G	G		7	Cancer Module	X	151124254	151124254	67	0.492537313432836	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,151124254,G,G&fts=all">p.S288F</a>
GABRG2	Missense_Mutation	p.G76E	G	G		7	Cancer Module	5	161520953	161520953	159	0.29559748427673	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,161520953,G,G&fts=all">p.G76E</a>
GABRG2	Missense_Mutation	p.R82W	C	C	rs146470870	7	Cancer Module	5	161520970	161520970	152	0.282894736842105	NA	NA	NA		p.R82W(1)	62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,161520970,C,C&fts=all">p.R82W</a>
GABRR1	Missense_Mutation	p.S334F	G	G		7	Cancer Module	6	89890156	89890156	46	0.304347826086957	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,89890156,G,G&fts=all">p.S334F</a>
GAD1	Missense_Mutation	p.K318E	A	A	rs17857149	7	Cancer Module	2	171702523	171702523	223	0.282511210762332	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,171702523,A,A&fts=all">p.K318E</a>
GAD2	Missense_Mutation	p.E385K	G	G		7	Cancer Module	10	26562625	26562625	106	0.19811320754717	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,26562625,G,G&fts=all">p.E385K</a>
GALC	Missense_Mutation	p.L413I	G	G		7	Cancer Module	14	88417017	88417017	156	0.282051282051282	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,88417017,G,G&fts=all">p.L413I</a>
GALNT13	Missense_Mutation	p.F206Y	T	T		7	Cancer Module	2	155099349	155099349	89	0.258426966292135	NA	NA	NA			65	Catalytic subdomain A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,155099349,T,T&fts=all">p.F206Y</a>
GBF1	Missense_Mutation	p.P61L	C	C		7	Cancer Module	10	104103826	104103826	358	0.139664804469274	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,104103826,C,C&fts=all">p.P61L</a>
GBF1	Missense_Mutation	p.E304K	G	G		7	Cancer Module	10	104118385	104118385	95	0.347368421052632	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,104118385,G,G&fts=all">p.E304K</a>
GBP1	Missense_Mutation	p.D538N	C	C		7	Cancer Module	1	89520418	89520418	353	0.484419263456091	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,89520418,C,C&fts=all">p.D538N</a>
GBP5	Missense_Mutation	p.G452R	C	C		7	Cancer Module	1	89729427	89729427	192	0.03125	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,89729427,C,C&fts=all">p.G452R</a>
GCKR	Missense_Mutation	p.P448S	C	C		7	Cancer Module	2	27731038	27731038	162	0.290123456790123	NA	NA	NA		p.P448N(1)	29	SIS 2. {ECO:0000255|PROSITE- ProRule:PRU00797}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCKR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27731038,C,C&fts=all">p.P448S</a>
GCM2	Missense_Mutation	p.S316L	G	G		7	Cancer Module	6	10874802	10874802	279	0.236559139784946	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,10874802,G,G&fts=all">p.S316L</a>
GDA	Missense_Mutation	p.P109S	C	C		7	Cancer Module	9	74817599	74817599	307	0.302931596091205	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,74817599,C,C&fts=all">p.P109S</a>
GDA	Missense_Mutation	p.R233C	C	C		7	Cancer Module	9	74838126	74838126	143	0.664335664335664	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,74838126,C,C&fts=all">p.R233C</a>
GDAP1L1	Missense_Mutation	p.G352S	G	G		7	Cancer Module	20	42907890	42907890	62	0.0645161290322581	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDAP1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,42907890,G,G&fts=all">p.G352S</a>
GDF2	Nonsense_Mutation	p.K387*	T	T		7	Cancer Module	10	48413709	48413709	26	0.192307692307692	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,48413709,T,T&fts=all">p.K387*</a>
GDPD5	Missense_Mutation	p.S569F	G	G		7	Cancer Module	11	75146664	75146664	43	0.883720930232558	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDPD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,75146664,G,G&fts=all">p.S569F</a>
GFRA1	Missense_Mutation	p.P388S	G	G		7	Cancer Module	10	117849287	117849287	128	0.1953125	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GFRA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,117849287,G,G&fts=all">p.P388S</a>
GFRA3	Missense_Mutation	p.P33L	G	G		7	Cancer Module	5	137600231	137600231	39	0.512820512820513	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GFRA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,137600231,G,G&fts=all">p.P33L</a>
GGA2	Missense_Mutation	p.A264V	G	G		7	Cancer Module	16	23497343	23497343	72	0.347222222222222	NA	NA	NA			21	GAT. {ECO:0000255|PROSITE- ProRule:PRU00373}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GGA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,23497343,G,G&fts=all">p.A264V</a>
GGT1	Missense_Mutation	p.E432K	G	G	rs373393964	7	Cancer Module	22	25023904	25023904	193	0.238341968911917	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GGT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,25023904,G,G&fts=all">p.E432K</a>
GIMAP5	Nonsense_Mutation	p.W73*	G	G		7	Cancer Module	7	150439446	150439446	29	0.275862068965517	NA	NA	NA			19	AIG1-type G.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIMAP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,150439446,G,G&fts=all">p.W73*</a>
GIPC2	Missense_Mutation	p.L127I	C	C		7	Cancer Module	1	78546497	78546497	125	0.824	NA	NA	NA			20	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIPC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,78546497,C,C&fts=all">p.L127I</a>
GIT2	Missense_Mutation	p.P121S	G	G		7	Cancer Module	12	110426812	110426812	327	0.26605504587156	NA	NA	NA			27	Arf-GAP. {ECO:0000255|PROSITE- ProRule:PRU00288}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,110426812,G,G&fts=all">p.P121S</a>
GJB5	Missense_Mutation	p.G8R	G	G		7	Cancer Module	1	35222953	35222953	45	0.511111111111111	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GJB5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,35222953,G,G&fts=all">p.G8R</a>
GJB5	Missense_Mutation	p.P168S	C	C	rs138854439	7	Cancer Module	1	35223433	35223433	49	0.102040816326531	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GJB5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,35223433,C,C&fts=all">p.P168S</a>
GK2	Missense_Mutation	p.R499C	G	G	rs267600272	7	Cancer Module	4	80327860	80327860	144	0.256944444444444	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,80327860,G,G&fts=all">p.R499C</a>
GK2	Missense_Mutation	p.E95K	C	C		7	Cancer Module	4	80329072	80329072	232	0.310344827586207	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,80329072,C,C&fts=all">p.E95K</a>
GLCCI1	Missense_Mutation	p.S519F	C	C		7	Cancer Module	7	8126080	8126080	295	0.196610169491525	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLCCI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,8126080,C,C&fts=all">p.S519F</a>
GLP1R	Missense_Mutation	p.V150M	G	G		7	Cancer Module	6	39034018	39034018	44	0.681818181818182	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLP1R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,39034018,G,G&fts=all">p.V150M</a>
GLP1R	Missense_Mutation	p.N177S	A	A		7	Cancer Module	6	39040658	39040658	52	0.25	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLP1R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,39040658,A,A&fts=all">p.N177S</a>
GLP1R	Nonsense_Mutation	p.W264*	G	G		7	Cancer Module	6	39041514	39041514	80	0.15	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLP1R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,39041514,G,G&fts=all">p.W264*</a>
GLP1R	Nonsense_Mutation	p.W297*	G	G		7	Cancer Module	6	39046738	39046738	105	0.276190476190476	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLP1R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,39046738,G,G&fts=all">p.W297*</a>
GLRA2	Missense_Mutation	p.P44S	C	C		7	Cancer Module	X	14550422	14550422	171	0.526315789473684	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLRA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,14550422,C,C&fts=all">p.P44S</a>
GLRB	Missense_Mutation	p.L143I	T	T		7	Cancer Module	4	158057750	158057750	245	0.293877551020408	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLRB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,158057750,T,T&fts=all">p.L143I</a>
GLRB	Missense_Mutation	p.S178F	C	C		7	Cancer Module	4	158057961	158057961	121	0.256198347107438	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLRB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,158057961,C,C&fts=all">p.S178F</a>
GLRB	Missense_Mutation	p.K407E	A	A		7	Cancer Module	4	158091605	158091605	140	0.221428571428571	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLRB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,158091605,A,A&fts=all">p.K407E</a>
GLT8D2	Missense_Mutation	p.S101F	G	G		7	Cancer Module	12	104393275	104393275	114	0.447368421052632	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLT8D2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,104393275,G,G&fts=all">p.S101F</a>
GNA15	Missense_Mutation	p.E194K	G	G		7	Cancer Module	19	3151799	3151799	208	0.0288461538461538	NA	NA	NA		p.E194K(1)	18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GNA15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,3151799,G,G&fts=all">p.E194K</a>
GNAT1	Missense_Mutation	p.E241K	G	G		7	Cancer Module	3	50231946	50231946	41	0.292682926829268	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GNAT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,50231946,G,G&fts=all">p.E241K</a>
GNS	Missense_Mutation	p.D194N	C	C		7	Cancer Module	12	65137073	65137073	54	0.407407407407407	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GNS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,65137073,C,C&fts=all">p.D194N</a>
GON4L	Missense_Mutation	p.M73I	C	C		7	Cancer Module	1	155823353	155823353	321	0.236760124610592	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GON4L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,155823353,C,C&fts=all">p.M73I</a>
GOSR1	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOSR1&recr=Open">Click here</a>	
GP5	Missense_Mutation	p.S211L	G	G		7	Cancer Module	3	194118380	194118380	185	0.221621621621622	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,194118380,G,G&fts=all">p.S211L</a>
GPC1	Missense_Mutation	p.E443G	A	A		7	Cancer Module	2	241404949	241404949	31	0.290322580645161	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,241404949,A,A&fts=all">p.E443G</a>
GPC5	Missense_Mutation	p.F162I	T	T		7	Cancer Module	13	92345599	92345599	190	0.273684210526316	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,92345599,T,T&fts=all">p.F162I</a>
GPC5	Missense_Mutation	p.G570E	G	G		7	Cancer Module	13	93518682	93518682	178	0.191011235955056	NA	NA	NA		p.G570V(1)	69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,93518682,G,G&fts=all">p.G570E</a>
GPD1L	Missense_Mutation	p.E181K	G	G		7	Cancer Module	3	32188149	32188149	396	0.421717171717172	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPD1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,32188149,G,G&fts=all">p.E181K</a>
GPLD1	Missense_Mutation	p.L106F	G	G		7	Cancer Module	6	24476423	24476423	31	0.258064516129032	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPLD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,24476423,G,G&fts=all">p.L106F</a>
GPM6A	Missense_Mutation	p.F147C	A	A		7	Cancer Module	4	176573086	176573086	67	0.343283582089552	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPM6A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,176573086,A,A&fts=all">p.F147C</a>
GPM6A	Missense_Mutation	p.E16V	T	T		7	Cancer Module	4	176622909	176622909	59	0.254237288135593	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPM6A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,176622909,T,T&fts=all">p.E16V</a>
GPR1	Missense_Mutation	p.A80V	G	G	rs138835154	7	Cancer Module	2	207041733	207041733	183	0.333333333333333	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,207041733,G,G&fts=all">p.A80V</a>
GPR176	Missense_Mutation	p.E388K	C	C		7	Cancer Module	15	40093719	40093719	201	0.323383084577114	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR176&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,40093719,C,C&fts=all">p.E388K</a>
GPR176	Missense_Mutation	p.P255S	G	G		7	Cancer Module	15	40094118	40094118	101	0.148514851485149	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR176&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,40094118,G,G&fts=all">p.P255S</a>
GPR18	Missense_Mutation	p.R308Q	C	C		7	Cancer Module	13	99907204	99907204	249	0.305220883534137	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,99907204,C,C&fts=all">p.R308Q</a>
GPR35	Missense_Mutation	p.S147F	C	C		7	Cancer Module	2	241569809	241569809	30	0.333333333333333	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR35&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,241569809,C,C&fts=all">p.S147F</a>
GPR39	Missense_Mutation	p.E272K	G	G		7	Cancer Module	2	133175429	133175429	30	0.166666666666667	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,133175429,G,G&fts=all">p.E272K</a>
GPR4	Nonsense_Mutation	p.Q349*	G	G		7	Cancer Module	19	46094080	46094080	128	0.171875	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,46094080,G,G&fts=all">p.Q349*</a>
GPR4	Missense_Mutation	p.S112L	G	G		7	Cancer Module	19	46094790	46094790	84	0.261904761904762	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,46094790,G,G&fts=all">p.S112L</a>
GPR55	Start_Codon_SNP	p.M1I	C	C		7	Cancer Module	2	231775675	231775675	192	0.510416666666667	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR55&recr=Open">Click here</a>	
GPR65	Missense_Mutation	p.S324A	T	T		7	Cancer Module	14	88478161	88478161	115	0.582608695652174	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR65&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,88478161,T,T&fts=all">p.S324A</a>
GPR98	Missense_Mutation	p.V181I	G	G		7	Cancer Module	5	89918501	89918501	17	0.411764705882353	NA	NA	NA			269	Calx-beta 2. {ECO:0000255}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,89918501,G,G&fts=all">p.V181I</a>
GPR98	Missense_Mutation	p.D229N	G	G		7	Cancer Module	5	89923040	89923040	12	0.5	NA	NA	NA			269	Calx-beta 2. {ECO:0000255}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,89923040,G,G&fts=all">p.D229N</a>
GPR98	Nonsense_Mutation	p.Q2557*	C	C		7	Cancer Module	5	89990242	89990242	136	0.573529411764706	NA	NA	NA			269			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,89990242,C,C&fts=all">p.Q2557*</a>
GPR98	Missense_Mutation	p.P2602S	C	C		7	Cancer Module	5	89990377	89990377	208	0.384615384615385	NA	NA	NA			269	Calx-beta 18. {ECO:0000255}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,89990377,C,C&fts=all">p.P2602S</a>
GPR98	Nonsense_Mutation	p.Q3044*	C	C		7	Cancer Module	5	90008191	90008191	37	0.513513513513513	NA	NA	NA			269	Calx-beta 21. {ECO:0000255}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,90008191,C,C&fts=all">p.Q3044*</a>
GPR98	Missense_Mutation	p.G3318D	G	G		7	Cancer Module	5	90020949	90020949	105	0.4	NA	NA	NA			269			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,90020949,G,G&fts=all">p.G3318D</a>
GPR98	Missense_Mutation	p.F3347C	T	T		7	Cancer Module	5	90021036	90021036	24	0.416666666666667	NA	NA	NA			269			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,90021036,T,T&fts=all">p.F3347C</a>
GPR98	Missense_Mutation	p.E3693K	G	G		7	Cancer Module	5	90046470	90046470	194	0.515463917525773	NA	NA	NA			269	Calx-beta 24. {ECO:0000305|PubMed:11606593}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,90046470,G,G&fts=all">p.E3693K</a>
GPR98	Missense_Mutation	p.K3850N	A	A		7	Cancer Module	5	90050972	90050972	33	0.545454545454545	NA	NA	NA			269	Calx-beta 25. {ECO:0000305|PubMed:11606593}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,90050972,A,A&fts=all">p.K3850N</a>
GPR98	Nonsense_Mutation	p.K3968*	A	A		7	Cancer Module	5	90052940	90052940	47	0.297872340425532	NA	NA	NA			269	Calx-beta 26. {ECO:0000255}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,90052940,A,A&fts=all">p.K3968*</a>
GPR98	Splice_Site	p.V4552M	G	G		7	Cancer Module	5	90083888	90083888	30	0.233333333333333	NA	NA	NA			269	Calx-beta 31. {ECO:0000305|PubMed:11606593}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	
GPRASP1	Missense_Mutation	p.N242I	A	A		7	Cancer Module	X	101909566	101909566	150	0.426666666666667	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPRASP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,101909566,A,A&fts=all">p.N242I</a>
GRAMD1A	Missense_Mutation	p.S299F	C	C		7	Cancer Module	19	35505139	35505139	82	0.292682926829268	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRAMD1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,35505139,C,C&fts=all">p.S299F</a>
GRAMD1B	Missense_Mutation	p.P334L	C	C		7	Cancer Module	11	123477423	123477423	25	0.36	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRAMD1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,123477423,C,C&fts=all">p.P334L</a>
GRB14	Nonsense_Mutation	p.Q521*	G	G		7	Cancer Module	2	165349608	165349608	211	0.317535545023697	NA	NA	NA			32	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRB14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,165349608,G,G&fts=all">p.Q521*</a>
GRB14	Missense_Mutation	p.S104L	G	G		7	Cancer Module	2	165476210	165476210	270	0.266666666666667	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRB14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,165476210,G,G&fts=all">p.S104L</a>
GRB7	Missense_Mutation	p.A226V	C	C		7	Cancer Module	17	37900336	37900336	70	0.471428571428571	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRB7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,37900336,C,C&fts=all">p.A226V</a>
GRB7	Missense_Mutation	p.P464S	C	C		7	Cancer Module	17	37902393	37902393	100	0.33	NA	NA	NA			18	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRB7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,37902393,C,C&fts=all">p.P464S</a>
GREB1	Missense_Mutation	p.S1784F	C	C		7	Cancer Module	2	11777846	11777846	35	0.314285714285714	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GREB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,11777846,C,C&fts=all">p.S1784F</a>
GRIA2	Splice_Site		T	T		7	Cancer Module	4	158257901	158257901	287	0.536585365853659	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA2&recr=Open">Click here</a>	
GRIA2	Missense_Mutation	p.S762L	C	C		7	Cancer Module	4	158281289	158281289	108	0.268518518518519	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,158281289,C,C&fts=all">p.S762L</a>
GRIA2	Missense_Mutation	p.V767I	G	G		7	Cancer Module	4	158282169	158282169	63	0.285714285714286	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,158282169,G,G&fts=all">p.V767I</a>
GRIA2	Missense_Mutation	p.G823D	G	G		7	Cancer Module	4	158284012	158284012	109	0.587155963302752	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,158284012,G,G&fts=all">p.G823D</a>
GRIA3	Frame_Shift_Del	p.E294fs	A	A		7	Cancer Module	X	122528949	122528949	119	0.495798319327731	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA3&recr=Open">Click here</a>	
GRIA4	Missense_Mutation	p.G584E	G	G		7	Cancer Module	11	105795399	105795399	65	0.0923076923076923	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,105795399,G,G&fts=all">p.G584E</a>
GRIK1	Splice_Site	p.G638E	C	C		7	Cancer Module	21	30949501	30949501	100	0.54	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK1&recr=Open">Click here</a>	
GRIK2	Missense_Mutation	p.T404A	A	A		7	Cancer Module	6	102266251	102266251	51	0.431372549019608	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,102266251,A,A&fts=all">p.T404A</a>
GRIK2	Nonsense_Mutation	p.W498*	G	G		7	Cancer Module	6	102307337	102307337	82	0.378048780487805	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,102307337,G,G&fts=all">p.W498*</a>
GRIK2	Nonsense_Mutation	p.W498*	G	G		7	Cancer Module	6	102307338	102307338	80	0.375	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,102307338,G,G&fts=all">p.W498*</a>
GRIN1	Missense_Mutation	p.E39K	G	G		7	Cancer Module	9	140034053	140034053	23	0.304347826086957	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,140034053,G,G&fts=all">p.E39K</a>
GRIN2A	Missense_Mutation	p.G889R	C	C		7	Cancer Module	16	9858736	9858736	131	0.33587786259542	NA	NA	NA			198			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,9858736,C,C&fts=all">p.G889R</a>
GRIN2C	Missense_Mutation	p.S661L	G	G		7	Cancer Module	17	72843466	72843466	160	0.25	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72843466,G,G&fts=all">p.S661L</a>
GRM3	Missense_Mutation	p.D374N	G	G		7	Cancer Module	7	86416228	86416228	20	0.45	NA	NA	NA			109			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,86416228,G,G&fts=all">p.D374N</a>
GRM4	Missense_Mutation	p.R393Q	C	C		7	Cancer Module	6	34008516	34008516	36	0.111111111111111	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,34008516,C,C&fts=all">p.R393Q</a>
GRM8	Missense_Mutation	p.G873E	C	C		7	Cancer Module	7	126086239	126086239	117	0.333333333333333	NA	NA	NA			125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,126086239,C,C&fts=all">p.G873E</a>
GSR	Missense_Mutation	p.E281G	T	T		7	Cancer Module	8	30550526	30550526	82	0.0853658536585366	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,30550526,T,T&fts=all">p.E281G</a>
GSR	Nonsense_Mutation	p.E281*	C	C		7	Cancer Module	8	30550527	30550527	82	0.0853658536585366	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,30550527,C,C&fts=all">p.E281*</a>
GSTM5	Missense_Mutation	p.R205Q	G	G		7	Cancer Module	1	110260005	110260005	151	0.529801324503311	NA	NA	NA			21	GST C-terminal.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSTM5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,110260005,G,G&fts=all">p.R205Q</a>
GTF3C1	Missense_Mutation	p.R309C	G	G		7	Cancer Module	16	27539967	27539967	272	0.632352941176471	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTF3C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,27539967,G,G&fts=all">p.R309C</a>
GTF3C2	Missense_Mutation	p.P781S	G	G	rs143734531	7	Cancer Module	2	27550972	27550972	178	0.252808988764045	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTF3C2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27550972,G,G&fts=all">p.P781S</a>
GTPBP1	Missense_Mutation	p.T547I	C	C		7	Cancer Module	22	39124090	39124090	65	0.230769230769231	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTPBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,39124090,C,C&fts=all">p.T547I</a>
GTPBP6	Missense_Mutation	p.R153K	C	C		7	Cancer Module	X	224528	224528	22	0.363636363636364	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTPBP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,224528,C,C&fts=all">p.R153K</a>
GTSE1	Missense_Mutation	p.P568L	C	C		7	Cancer Module	22	46722530	46722530	49	0.142857142857143	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTSE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,46722530,C,C&fts=all">p.P568L</a>
GUCA2B	Missense_Mutation	p.S82L	C	C		7	Cancer Module	1	42620505	42620505	37	0.459459459459459	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCA2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,42620505,C,C&fts=all">p.S82L</a>
GUCY1A3	Missense_Mutation	p.S280L	C	C		7	Cancer Module	4	156632156	156632156	90	0.266666666666667	NA	NA	NA		p.S280W(1)	64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCY1A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,156632156,C,C&fts=all">p.S280L</a>
GUCY1B3	Missense_Mutation	p.S13F	C	C		7	Cancer Module	4	156698739	156698739	234	0.273504273504274	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCY1B3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,156698739,C,C&fts=all">p.S13F</a>
GUCY2C	Missense_Mutation	p.S304F	G	G		7	Cancer Module	12	14829825	14829825	83	0.180722891566265	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCY2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,14829825,G,G&fts=all">p.S304F</a>
GYPA	Missense_Mutation	p.H85Y	G	G		7	Cancer Module	4	145039885	145039885	267	0.307116104868914	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GYPA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,145039885,G,G&fts=all">p.H85Y</a>
GYPB	Missense_Mutation	p.R54C	G	G		7	Cancer Module	4	144920579	144920579	68	0.117647058823529	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GYPB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,144920579,G,G&fts=all">p.R54C</a>
GYPE	Nonsense_Mutation	p.R78*	G	G		7	Cancer Module	4	144797913	144797913	26	0.192307692307692	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GYPE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,144797913,G,G&fts=all">p.R78*</a>
GYS2	Missense_Mutation	p.P143S	G	G	rs376712209	7	Cancer Module	12	21728868	21728868	182	0.241758241758242	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GYS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,21728868,G,G&fts=all">p.P143S</a>
HACL1	Missense_Mutation	p.P363S	G	G		7	Cancer Module	3	15609427	15609427	327	0.0305810397553517	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HACL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,15609427,G,G&fts=all">p.P363S</a>
HADHB	Splice_Site	p.S70L	C	C		7	Cancer Module	2	26486347	26486347	339	0.294985250737463	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HADHB&recr=Open">Click here</a>	
HBB	Missense_Mutation	p.H78Y	G	G	rs63750504|rs33991294	7	Cancer Module	11	5247890	5247890	78	0.461538461538462	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HBB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5247890,G,G&fts=all">p.H78Y</a>
HCRTR2	Missense_Mutation	p.E46K	G	G		7	Cancer Module	6	55039521	55039521	114	0.210526315789474	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCRTR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,55039521,G,G&fts=all">p.E46K</a>
HDC	Missense_Mutation	p.S609F	G	G	rs144259269	7	Cancer Module	15	50534620	50534620	190	0.284210526315789	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HDC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,50534620,G,G&fts=all">p.S609F</a>
HEATR5A	Missense_Mutation	p.S1777L	G	G	rs377132147	7	Cancer Module	14	31771635	31771635	16	0.5	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEATR5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,31771635,G,G&fts=all">p.S1777L</a>
HEATR5A	Nonsense_Mutation	p.Q1629*	G	G		7	Cancer Module	14	31776019	31776019	67	0.791044776119403	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEATR5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,31776019,G,G&fts=all">p.Q1629*</a>
HEPH	Missense_Mutation	p.I579V	A	A		7	Cancer Module	X	65427047	65427047	45	0.933333333333333	NA	NA	NA			89	Plastocyanin-like 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEPH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,65427047,A,A&fts=all">p.I579V</a>
HEPH	Missense_Mutation	p.S875F	C	C		7	Cancer Module	X	65480096	65480096	38	0.315789473684211	NA	NA	NA			89	Plastocyanin-like 5.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEPH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,65480096,C,C&fts=all">p.S875F</a>
HERC2	Missense_Mutation	p.R3023Q	C	C		7	Cancer Module	15	28424128	28424128	133	0.270676691729323	NA	NA	NA			204			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HERC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,28424128,C,C&fts=all">p.R3023Q</a>
HERC4	Missense_Mutation	p.H917Y	G	G		7	Cancer Module	10	69692467	69692467	284	0.204225352112676	NA	NA	NA			27	HECT. {ECO:0000255|PROSITE- ProRule:PRU00104}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HERC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,69692467,G,G&fts=all">p.H917Y</a>
HIF3A	Splice_Site	p.R571R	G	G		7	Cancer Module	19	46834413	46834413	56	0.125	NA	NA	NA			33	ODD.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIF3A&recr=Open">Click here</a>	
HIRA	Missense_Mutation	p.G89R	C	C		7	Cancer Module	22	19394744	19394744	235	0.187234042553191	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIRA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,19394744,C,C&fts=all">p.G89R</a>
HIST1H2AL	Missense_Mutation	p.E92K	G	G		7	Cancer Module	6	27833406	27833406	374	0.211229946524064	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIST1H2AL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,27833406,G,G&fts=all">p.E92K</a>
HIVEP1	Missense_Mutation	p.S167F	C	C		7	Cancer Module	6	12120528	12120528	183	0.207650273224044	NA	NA	NA			90			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIVEP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,12120528,C,C&fts=all">p.S167F</a>
HIVEP2	Missense_Mutation	p.P1335S	G	G		7	Cancer Module	6	143091873	143091873	59	0.491525423728814	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIVEP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,143091873,G,G&fts=all">p.P1335S</a>
HJURP	Missense_Mutation	p.S697F	G	G		7	Cancer Module	2	234749336	234749336	127	0.354330708661417	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HJURP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,234749336,G,G&fts=all">p.S697F</a>
HJURP	Missense_Mutation	p.P679S	G	G		7	Cancer Module	2	234749391	234749391	113	0.256637168141593	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HJURP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,234749391,G,G&fts=all">p.P679S</a>
HLA-DQB1	Missense_Mutation	p.R75Q	C	C	rs9273989	7	Cancer Module	6	32629911	32629911	59	0.203389830508475	NA	NA	NA			4	Beta-1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HLA-DQB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,32629911,C,C&fts=all">p.R75Q</a>
HLA-DRA	Nonsense_Mutation	p.W24*	G	G		7	Cancer Module	6	32407799	32407799	84	0.238095238095238	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HLA-DRA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,32407799,G,G&fts=all">p.W24*</a>
HLTF	Missense_Mutation	p.S598F	G	G		7	Cancer Module	3	148765914	148765914	228	0.289473684210526	NA	NA	NA			47	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HLTF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,148765914,G,G&fts=all">p.S598F</a>
HMGCS2	Missense_Mutation	p.P487S	G	G		7	Cancer Module	1	120293493	120293493	99	0.222222222222222	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMGCS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,120293493,G,G&fts=all">p.P487S</a>
HMGCS2	Missense_Mutation	p.R406K	C	C	rs139620933	7	Cancer Module	1	120295980	120295980	81	0.382716049382716	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMGCS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,120295980,C,C&fts=all">p.R406K</a>
HMGCS2	Missense_Mutation	p.A391V	G	G		7	Cancer Module	1	120298065	120298065	265	0.354716981132075	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMGCS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,120298065,G,G&fts=all">p.A391V</a>
HMGCS2	Nonsense_Mutation	p.Q260*	G	G		7	Cancer Module	1	120301813	120301813	203	0.379310344827586	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMGCS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,120301813,G,G&fts=all">p.Q260*</a>
HMGCS2	Missense_Mutation	p.V61I	C	C		7	Cancer Module	1	120307173	120307173	63	0.301587301587302	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMGCS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,120307173,C,C&fts=all">p.V61I</a>
HNF4A	Splice_Site		G	G		7	Cancer Module	20	43047064	43047064	95	0.452631578947368	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNF4A&recr=Open">Click here</a>	
HNF4G	Missense_Mutation	p.M38I	G	G		7	Cancer Module	8	76456071	76456071	89	0.157303370786517	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNF4G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,76456071,G,G&fts=all">p.M38I</a>
HOMER2	Missense_Mutation	p.S128F	G	G		7	Cancer Module	15	83532923	83532923	66	0.257575757575758	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOMER2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,83532923,G,G&fts=all">p.S128F</a>
HOXA4	Missense_Mutation	p.P308L	G	G		7	Cancer Module	7	27168884	27168884	80	0.7	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,27168884,G,G&fts=all">p.P308L</a>
HOXB13	Missense_Mutation	p.P222S	G	G		7	Cancer Module	17	46804343	46804343	69	0.27536231884058	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXB13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,46804343,G,G&fts=all">p.P222S</a>
HOXB3	Nonsense_Mutation	p.Q350*	G	G		7	Cancer Module	17	46627725	46627725	75	0.24	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,46627725,G,G&fts=all">p.Q350*</a>
HOXD9	Missense_Mutation	p.E257K	G	G		7	Cancer Module	2	176988265	176988265	37	0.594594594594595	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXD9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,176988265,G,G&fts=all">p.E257K</a>
HPD	Splice_Site		C	C		7	Cancer Module	12	122284767	122284767	31	0.225806451612903	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HPD&recr=Open">Click here</a>	
HPGD	Missense_Mutation	p.I174N	A	A		7	Cancer Module	4	175413183	175413183	414	0.270531400966184	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HPGD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,175413183,A,A&fts=all">p.I174N</a>
HPS1	Missense_Mutation	p.P305S	G	G		7	Cancer Module	10	100189354	100189354	116	0.491379310344828	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HPS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,100189354,G,G&fts=all">p.P305S</a>
HRC	Missense_Mutation	p.G505R	C	C		7	Cancer Module	19	49656982	49656982	98	0.244897959183673	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49656982,C,C&fts=all">p.G505R</a>
HRC	Missense_Mutation	p.E195K	C	C		7	Cancer Module	19	49657912	49657912	88	0.556818181818182	NA	NA	NA			34	4 X tandem repeats, acidic.|6 X approximate tandem repeats.|Glu-rich (acidic).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49657912,C,C&fts=all">p.E195K</a>
HRG	Missense_Mutation	p.R182K	G	G		7	Cancer Module	3	186389565	186389565	77	0.194805194805195	NA	NA	NA			37	Cystatin 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,186389565,G,G&fts=all">p.R182K</a>
HRG	Missense_Mutation	p.G189E	G	G		7	Cancer Module	3	186390583	186390583	76	0.263157894736842	NA	NA	NA			37	Cystatin 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,186390583,G,G&fts=all">p.G189E</a>
HRH1	Missense_Mutation	p.G316R	G	G		7	Cancer Module	3	11301669	11301669	92	0.195652173913043	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,11301669,G,G&fts=all">p.G316R</a>
HS3ST2	Missense_Mutation	p.R287Q	G	G	rs142704208	7	Cancer Module	16	22926639	22926639	125	0.336	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HS3ST2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,22926639,G,G&fts=all">p.R287Q</a>
HSD11B1	Missense_Mutation	p.G34R	G	G		7	Cancer Module	1	209879167	209879167	127	0.165354330708661	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD11B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,209879167,G,G&fts=all">p.G34R</a>
HSD17B10	Missense_Mutation	p.R258C	G	G		7	Cancer Module	X	53458366	53458366	42	0.452380952380952	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD17B10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,53458366,G,G&fts=all">p.R258C</a>
HSF2	Missense_Mutation	p.L157F	C	C		7	Cancer Module	6	122737379	122737379	114	0.482456140350877	NA	NA	NA			16	Hydrophobic repeat HR-A/B.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,122737379,C,C&fts=all">p.L157F</a>
HSPB8	Missense_Mutation	p.A77V	C	C		7	Cancer Module	12	119617347	119617347	23	0.478260869565217	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPB8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,119617347,C,C&fts=all">p.A77V</a>
HSPG2	Nonsense_Mutation	p.R3632*	G	G		7	Cancer Module	1	22160044	22160044	62	0.516129032258065	NA	NA	NA			127	Ig-like C2-type 22.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,22160044,G,G&fts=all">p.R3632*</a>
HSPG2	Missense_Mutation	p.T2168I	G	G		7	Cancer Module	1	22179500	22179500	64	0.890625	NA	NA	NA			127	Ig-like C2-type 7.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,22179500,G,G&fts=all">p.T2168I</a>
HSPG2	Missense_Mutation	p.P1661S	G	G		7	Cancer Module	1	22186703	22186703	47	0.531914893617021	NA	NA	NA			127	Laminin EGF-like 11. {ECO:0000255|PROSITE-ProRule:PRU00460}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,22186703,G,G&fts=all">p.P1661S</a>
HTN3	Nonsense_Mutation	p.R41*	C	C	rs372688049	7	Cancer Module	4	70898902	70898902	157	0.24203821656051	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70898902,C,C&fts=all">p.R41*</a>
HTR3A	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	11	113803817	114183201	NA	NA	18	-1.11528487090397	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR3A&recr=Open">Click here</a>	
IBSP	Missense_Mutation	p.E148K	G	G	rs144185482	7	Cancer Module	4	88732550	88732550	62	0.306451612903226	NA	NA	NA			21	Asp/Glu-rich (acidic).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IBSP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,88732550,G,G&fts=all">p.E148K</a>
IDO1	Missense_Mutation	p.D128N	G	G		7	Cancer Module	8	39776412	39776412	136	0.404411764705882	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IDO1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39776412,G,G&fts=all">p.D128N</a>
IER3	Missense_Mutation	p.R85K	C	C		7	Cancer Module	6	30711930	30711930	265	0.20377358490566	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IER3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,30711930,C,C&fts=all">p.R85K</a>
IFI6	Missense_Mutation	p.S74L	G	G		7	Cancer Module	1	27994826	27994826	16	0.5	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFI6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,27994826,G,G&fts=all">p.S74L</a>
IFT122	Missense_Mutation	p.R159Q	G	G		7	Cancer Module	3	129183537	129183537	144	0.0625	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT122&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,129183537,G,G&fts=all">p.R159Q</a>
IFT122	Nonsense_Mutation	p.R400*	C	C	rs369346055	7	Cancer Module	3	129196909	129196909	149	0.395973154362416	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT122&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,129196909,C,C&fts=all">p.R400*</a>
IFT140	Missense_Mutation	p.E173K	C	C	rs146277966	7	Cancer Module	16	1574847	1574847	44	0.204545454545455	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT140&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,1574847,C,C&fts=all">p.E173K</a>
IFT140	Nonsense_Mutation	p.Q385*	G	G		7	Cancer Module	16	1636133	1636133	84	0.214285714285714	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT140&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,1636133,G,G&fts=all">p.Q385*</a>
IFT52	Nonsense_Mutation	p.R274*	C	C		7	Cancer Module	20	42252582	42252582	92	0.41304347826087	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT52&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,42252582,C,C&fts=all">p.R274*</a>
IGF2R	Frame_Shift_Ins	p.-2380fs	-	-	rs372915301	7	Cancer Module	6	160525775	160525776	21	0.428571428571429	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGF2R&recr=Open">Click here</a>	
IGFBP5	Missense_Mutation	p.S199F	G	G		7	Cancer Module	2	217542926	217542926	78	0.294871794871795	NA	NA	NA			5	Thyroglobulin type-1. {ECO:0000255|PROSITE-ProRule:PRU00500}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGFBP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,217542926,G,G&fts=all">p.S199F</a>
IGSF1	Missense_Mutation	p.E1286K	C	C		7	Cancer Module	X	130407898	130407898	82	0.390243902439024	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,130407898,C,C&fts=all">p.E1286K</a>
IGSF1	Missense_Mutation	p.E1198Q	C	C		7	Cancer Module	X	130408705	130408705	122	0.918032786885246	NA	NA	NA			78	Ig-like C2-type 12.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,130408705,C,C&fts=all">p.E1198Q</a>
IGSF3	Missense_Mutation	p.A182V	G	G		7	Cancer Module	1	117156674	117156674	139	0.201438848920863	NA	NA	NA			62	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,117156674,G,G&fts=all">p.A182V</a>
IL10	Missense_Mutation	p.E93K	C	C		7	Cancer Module	1	206944353	206944353	212	0.202830188679245	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,206944353,C,C&fts=all">p.E93K</a>
IL12A	Missense_Mutation	p.P64L	C	C		7	Cancer Module	3	159708026	159708026	57	0.228070175438596	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL12A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,159708026,C,C&fts=all">p.P64L</a>
IL12A	Missense_Mutation	p.S100F	C	C		7	Cancer Module	3	159710833	159710833	245	0.0285714285714286	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL12A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,159710833,C,C&fts=all">p.S100F</a>
IL12RB1	Missense_Mutation	p.E207K	C	C		7	Cancer Module	19	18186640	18186640	95	0.252631578947368	NA	NA	NA			8	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL12RB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,18186640,C,C&fts=all">p.E207K</a>
IL16	Missense_Mutation	p.S867F	C	C		7	Cancer Module	15	81592267	81592267	62	0.580645161290323	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,81592267,C,C&fts=all">p.S867F</a>
IL17B	Missense_Mutation	p.M169I	C	C		7	Cancer Module	5	148753968	148753968	49	0.408163265306122	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL17B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,148753968,C,C&fts=all">p.M169I</a>
IL18R1	Missense_Mutation	p.E34K	G	G		7	Cancer Module	2	102984326	102984326	89	0.325842696629214	NA	NA	NA			34	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL18R1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,102984326,G,G&fts=all">p.E34K</a>
IL1B	Missense_Mutation	p.E87K	C	C		7	Cancer Module	2	113590993	113590993	79	0.177215189873418	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,113590993,C,C&fts=all">p.E87K</a>
IL1R2	Missense_Mutation	p.G188E	G	G		7	Cancer Module	2	102636149	102636149	97	0.288659793814433	NA	NA	NA			28	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1R2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,102636149,G,G&fts=all">p.G188E</a>
IL1RL1	Missense_Mutation	p.R64C	C	C	rs202037442	7	Cancer Module	2	102955425	102955425	234	0.277777777777778	NA	NA	NA		p.R64C(2)	16	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1RL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,102955425,C,C&fts=all">p.R64C</a>
IL1RL1	Missense_Mutation	p.R439Q	G	G	rs150294315	7	Cancer Module	2	102968026	102968026	95	0.336842105263158	NA	NA	NA			16	TIR. {ECO:0000255|PROSITE- ProRule:PRU00204}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1RL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,102968026,G,G&fts=all">p.R439Q</a>
IL1RL2	Missense_Mutation	p.H235Y	C	C		7	Cancer Module	2	102828613	102828613	80	0.3125	NA	NA	NA			26	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1RL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,102828613,C,C&fts=all">p.H235Y</a>
IL1RL2	Missense_Mutation	p.F422L	T	T		7	Cancer Module	2	102849551	102849551	82	0.463414634146341	NA	NA	NA			26	TIR. {ECO:0000255|PROSITE- ProRule:PRU00204}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1RL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,102849551,T,T&fts=all">p.F422L</a>
IL27RA	Missense_Mutation	p.G531R	G	G		7	Cancer Module	19	14162481	14162481	84	0.214285714285714	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL27RA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,14162481,G,G&fts=all">p.G531R</a>
IL2RA	Missense_Mutation	p.E134K	C	C		7	Cancer Module	10	6063624	6063624	61	0.245901639344262	NA	NA	NA			17	Sushi 2. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL2RA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,6063624,C,C&fts=all">p.E134K</a>
IL2RA	Nonsense_Mutation	p.W131*	C	C		7	Cancer Module	10	6063632	6063632	53	0.132075471698113	NA	NA	NA		p.W131*(1)	17	Sushi 2. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL2RA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,6063632,C,C&fts=all">p.W131*</a>
IL2RB	Missense_Mutation	p.R131C	G	G		7	Cancer Module	22	37533773	37533773	29	0.172413793103448	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL2RB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,37533773,G,G&fts=all">p.R131C</a>
IL7	Missense_Mutation	p.E54K	C	C		7	Cancer Module	8	79652305	79652305	268	0.227611940298507	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,79652305,C,C&fts=all">p.E54K</a>
ILF3	Missense_Mutation	p.S873F	C	C		7	Cancer Module	19	10799921	10799921	155	0.232258064516129	NA	NA	NA			31	Interaction with PRMT1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ILF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,10799921,C,C&fts=all">p.S873F</a>
IMPG1	Missense_Mutation	p.H284Y	G	G		7	Cancer Module	6	76720899	76720899	72	0.319444444444444	NA	NA	NA		p.H284N(1)	63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IMPG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,76720899,G,G&fts=all">p.H284Y</a>
INPP5D	Missense_Mutation	p.G754E	G	G		7	Cancer Module	2	234094510	234094510	15	0.2	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INPP5D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,234094510,G,G&fts=all">p.G754E</a>
INPP5F	Missense_Mutation	p.S407L	C	C		7	Cancer Module	10	121563788	121563788	411	0.24330900243309	NA	NA	NA			42	5-phosphatase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INPP5F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,121563788,C,C&fts=all">p.S407L</a>
IQCH	Missense_Mutation	p.R433Q	G	G		7	Cancer Module	15	67664993	67664993	139	0.287769784172662	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,67664993,G,G&fts=all">p.R433Q</a>
IQGAP1	Missense_Mutation	p.R757C	C	C		7	Cancer Module	15	91016162	91016162	240	0.291666666666667	NA	NA	NA			59	IQ 1. {ECO:0000255|PROSITE- ProRule:PRU00116}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQGAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,91016162,C,C&fts=all">p.R757C</a>
IQGAP2	Missense_Mutation	p.N205Y	A	A		7	Cancer Module	5	75885526	75885526	52	0.326923076923077	NA	NA	NA			68			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQGAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,75885526,A,A&fts=all">p.N205Y</a>
IRF1	Missense_Mutation	p.R314W	G	G		7	Cancer Module	5	131819681	131819681	40	0.35	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IRF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,131819681,G,G&fts=all">p.R314W</a>
IRGC	Missense_Mutation	p.A205V	C	C	rs574684743	7	Cancer Module	19	44223324	44223324	49	0.346938775510204	NA	NA	NA			25	IRG-type G.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IRGC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44223324,C,C&fts=all">p.A205V</a>
ISLR	Missense_Mutation	p.S150L	C	C		7	Cancer Module	15	74467648	74467648	30	0.466666666666667	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ISLR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,74467648,C,C&fts=all">p.S150L</a>
ITGA7	Missense_Mutation	p.R541Q	C	C		7	Cancer Module	12	56090810	56090810	18	0.555555555555556	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,56090810,C,C&fts=all">p.R541Q</a>
ITGA8	Missense_Mutation	p.E940K	C	C	rs369955410	7	Cancer Module	10	15590516	15590516	67	0.313432835820896	NA	NA	NA		p.E940Q(1)	96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,15590516,C,C&fts=all">p.E940K</a>
ITGA8	Missense_Mutation	p.R906K	C	C		7	Cancer Module	10	15600122	15600122	86	0.186046511627907	NA	NA	NA			96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,15600122,C,C&fts=all">p.R906K</a>
ITGA8	Missense_Mutation	p.R555Q	C	C	rs140395954	7	Cancer Module	10	15649776	15649776	160	0.2125	NA	NA	NA		p.R555Q(1)	96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,15649776,C,C&fts=all">p.R555Q</a>
ITGA8	Missense_Mutation	p.G400E	C	C		7	Cancer Module	10	15688853	15688853	54	0.12962962962963	NA	NA	NA			96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,15688853,C,C&fts=all">p.G400E</a>
ITGA8	Missense_Mutation	p.L393V	A	A		7	Cancer Module	10	15688875	15688875	69	0.318840579710145	NA	NA	NA			96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,15688875,A,A&fts=all">p.L393V</a>
ITGA8	Missense_Mutation	p.D86N	C	C		7	Cancer Module	10	15760852	15760852	67	0.492537313432836	NA	NA	NA			96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,15760852,C,C&fts=all">p.D86N</a>
ITGAE	Missense_Mutation	p.E317K	C	C		7	Cancer Module	17	3661071	3661071	112	0.357142857142857	NA	NA	NA			41	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGAE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,3661071,C,C&fts=all">p.E317K</a>
ITGAM	Missense_Mutation	p.D264N	G	G		7	Cancer Module	16	31284771	31284771	94	0.329787234042553	NA	NA	NA			56	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,31284771,G,G&fts=all">p.D264N</a>
ITGAM	Splice_Site	p.F765C	T	T		7	Cancer Module	16	31336280	31336280	50	0.22	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGAM&recr=Open">Click here</a>	
ITGAM	Splice_Site	p.S789N	G	G		7	Cancer Module	16	31336352	31336352	48	0.458333333333333	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGAM&recr=Open">Click here</a>	
ITGAX	Splice_Site		G	G		7	Cancer Module	16	31373395	31373395	94	0.265957446808511	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGAX&recr=Open">Click here</a>	
ITGB3	Missense_Mutation	p.T312I	C	C		7	Cancer Module	17	45364593	45364593	130	0.361538461538462	NA	NA	NA			39	VWFA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,45364593,C,C&fts=all">p.T312I</a>
ITGB3	Missense_Mutation	p.R742C	C	C	rs546345692	7	Cancer Module	17	45384961	45384961	62	0.306451612903226	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,45384961,C,C&fts=all">p.R742C</a>
ITGB4	Missense_Mutation	p.T90I	C	C		7	Cancer Module	17	73723736	73723736	13	0.230769230769231	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,73723736,C,C&fts=all">p.T90I</a>
ITGB6	Missense_Mutation	p.K608R	T	T		7	Cancer Module	2	160980334	160980334	348	0.0229885057471264	NA	NA	NA			23	Cysteine-rich tandem repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,160980334,T,T&fts=all">p.K608R</a>
ITGBL1	Missense_Mutation	p.G120E	G	G		7	Cancer Module	13	102220092	102220092	157	0.267515923566879	NA	NA	NA			31	Cysteine-rich tandem repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGBL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,102220092,G,G&fts=all">p.G120E</a>
ITGBL1	Missense_Mutation	p.G198R	G	G		7	Cancer Module	13	102231643	102231643	181	0.215469613259669	NA	NA	NA			31	Cysteine-rich tandem repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGBL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,102231643,G,G&fts=all">p.G198R</a>
ITIH1	Missense_Mutation	p.P283T	C	C		7	Cancer Module	3	52816200	52816200	71	0.380281690140845	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52816200,C,C&fts=all">p.P283T</a>
ITIH2	Missense_Mutation	p.G742E	G	G		7	Cancer Module	10	7786093	7786093	166	0.168674698795181	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,7786093,G,G&fts=all">p.G742E</a>
ITIH3	Missense_Mutation	p.E576K	G	G		7	Cancer Module	3	52837887	52837887	39	0.205128205128205	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52837887,G,G&fts=all">p.E576K</a>
ITM2A	Missense_Mutation	p.D242N	C	C		7	Cancer Module	X	78616654	78616654	64	0.5	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITM2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,78616654,C,C&fts=all">p.D242N</a>
ITPKC	Missense_Mutation	p.D153N	G	G	rs569410899	7	Cancer Module	19	41223497	41223497	148	0.364864864864865	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPKC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41223497,G,G&fts=all">p.D153N</a>
ITPKC	Missense_Mutation	p.D153E	C	C		7	Cancer Module	19	41223499	41223499	149	0.369127516778524	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPKC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41223499,C,C&fts=all">p.D153E</a>
ITPR1	Missense_Mutation	p.D1335N	G	G		7	Cancer Module	3	4735192	4735192	482	0.234439834024896	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,4735192,G,G&fts=all">p.D1335N</a>
ITPR2	Missense_Mutation	p.P548S	G	G		7	Cancer Module	12	26816689	26816689	538	0.228624535315985	NA	NA	NA			125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,26816689,G,G&fts=all">p.P548S</a>
ITPR2	Nonsense_Mutation	p.R440*	G	G		7	Cancer Module	12	26834898	26834898	392	0.219387755102041	NA	NA	NA			125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,26834898,G,G&fts=all">p.R440*</a>
JAKMIP1	Missense_Mutation	p.E494K	C	C		7	Cancer Module	4	6064119	6064119	26	0.346153846153846	NA	NA	NA			42	Mediates interaction with TYK2 and GABBR1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAKMIP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,6064119,C,C&fts=all">p.E494K</a>
JAKMIP1	Missense_Mutation	p.E355K	C	C		7	Cancer Module	4	6083374	6083374	48	0.416666666666667	NA	NA	NA			42	Mediates association with microtubules.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAKMIP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,6083374,C,C&fts=all">p.E355K</a>
JAKMIP2	Missense_Mutation	p.R785C	G	G		7	Cancer Module	5	146991928	146991928	68	0.411764705882353	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAKMIP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,146991928,G,G&fts=all">p.R785C</a>
JAKMIP2	Missense_Mutation	p.E226K	C	C		7	Cancer Module	5	147030062	147030062	102	0.303921568627451	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAKMIP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,147030062,C,C&fts=all">p.E226K</a>
JAM2	Missense_Mutation	p.R229Q	G	G		7	Cancer Module	21	27074570	27074570	123	0.170731707317073	NA	NA	NA			19	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,27074570,G,G&fts=all">p.R229Q</a>
KARS	Missense_Mutation	p.P228S	G	G		7	Cancer Module	16	75669881	75669881	134	0.253731343283582	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KARS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,75669881,G,G&fts=all">p.P228S</a>
KCNA1	Missense_Mutation	p.E139K	G	G		7	Cancer Module	12	5020959	5020959	40	0.25	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,5020959,G,G&fts=all">p.E139K</a>
KCNA1	Missense_Mutation	p.H416Y	C	C		7	Cancer Module	12	5021790	5021790	193	0.227979274611399	NA	NA	NA		p.H416Y(1)	63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,5021790,C,C&fts=all">p.H416Y</a>
KCNA4	Missense_Mutation	p.D337N	C	C		7	Cancer Module	11	30033217	30033217	64	0.390625	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,30033217,C,C&fts=all">p.D337N</a>
KCNA4	Missense_Mutation	p.S313F	G	G		7	Cancer Module	11	30033288	30033288	65	0.353846153846154	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,30033288,G,G&fts=all">p.S313F</a>
KCNA4	Missense_Mutation	p.P300S	G	G		7	Cancer Module	11	30033328	30033328	49	0.26530612244898	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,30033328,G,G&fts=all">p.P300S</a>
KCNA5	Missense_Mutation	p.G136S	G	G		7	Cancer Module	12	5153719	5153719	33	0.212121212121212	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,5153719,G,G&fts=all">p.G136S</a>
KCNB2	Nonsense_Mutation	p.W492*	G	G		7	Cancer Module	8	73849065	73849065	114	0.166666666666667	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,73849065,G,G&fts=all">p.W492*</a>
KCNB2	Missense_Mutation	p.A646V	C	C		7	Cancer Module	8	73849527	73849527	40	0.4	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,73849527,C,C&fts=all">p.A646V</a>
KCNB2	Missense_Mutation	p.T805P	A	A		7	Cancer Module	8	73850003	73850003	36	0.194444444444444	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,73850003,A,A&fts=all">p.T805P</a>
KCNC3	Missense_Mutation	p.G520R	C	C		7	Cancer Module	19	50826652	50826652	46	0.521739130434783	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50826652,C,C&fts=all">p.G520R</a>
KCND3	Missense_Mutation	p.K485N	T	T		7	Cancer Module	1	112322853	112322853	14	0.428571428571429	NA	NA	NA			49	Mediates dendritic targeting. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCND3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,112322853,T,T&fts=all">p.K485N</a>
KCND3	Missense_Mutation	p.G4E	C	C		7	Cancer Module	1	112525338	112525338	8	0.75	NA	NA	NA			49	Interaction with KCNIP2. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCND3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,112525338,C,C&fts=all">p.G4E</a>
KCNJ1	Missense_Mutation	p.R22K	C	C		7	Cancer Module	11	128710074	128710074	169	0.42603550295858	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,128710074,C,C&fts=all">p.R22K</a>
KCNJ12	Missense_Mutation	p.V351A	T	T		7	Cancer Module	17	21319706	21319706	61	0.0983606557377049	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,21319706,T,T&fts=all">p.V351A</a>
KCNJ2	Missense_Mutation	p.S425L	C	C		7	Cancer Module	17	68172454	68172454	109	0.256880733944954	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,68172454,C,C&fts=all">p.S425L</a>
KCNJ3	Missense_Mutation	p.D111N	G	G		7	Cancer Module	2	155555618	155555618	78	0.230769230769231	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,155555618,G,G&fts=all">p.D111N</a>
KCNJ3	Missense_Mutation	p.D111G	A	A		7	Cancer Module	2	155555619	155555619	77	0.233766233766234	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,155555619,A,A&fts=all">p.D111G</a>
KCNJ4	Missense_Mutation	p.R441S	C	C		7	Cancer Module	22	38822815	38822815	106	0.584905660377358	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38822815,C,C&fts=all">p.R441S</a>
KCNJ4	Missense_Mutation	p.E355K	C	C		7	Cancer Module	22	38823075	38823075	43	0.395348837209302	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38823075,C,C&fts=all">p.E355K</a>
KCNJ6	Missense_Mutation	p.P131L	G	G		7	Cancer Module	21	39087068	39087068	145	0.206896551724138	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,39087068,G,G&fts=all">p.P131L</a>
KCNJ6	Missense_Mutation	p.P131S	G	G		7	Cancer Module	21	39087069	39087069	145	0.206896551724138	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,39087069,G,G&fts=all">p.P131S</a>
KCNJ8	Missense_Mutation	p.S326F	G	G		7	Cancer Module	12	21918955	21918955	111	0.18018018018018	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,21918955,G,G&fts=all">p.S326F</a>
KCNK5	Missense_Mutation	p.L148F	G	G		7	Cancer Module	6	39162393	39162393	77	0.220779220779221	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,39162393,G,G&fts=all">p.L148F</a>
KCNK5	Missense_Mutation	p.P106S	G	G		7	Cancer Module	6	39162519	39162519	79	0.215189873417722	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,39162519,G,G&fts=all">p.P106S</a>
KCNMB1	Missense_Mutation	p.A88V	G	G		7	Cancer Module	5	169810726	169810726	52	0.480769230769231	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNMB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,169810726,G,G&fts=all">p.A88V</a>
KCNN1	Missense_Mutation	p.F427Y	T	T		7	Cancer Module	19	18100634	18100634	50	0.2	NA	NA	NA			8	Calmodulin-binding. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,18100634,T,T&fts=all">p.F427Y</a>
KCNN4	Start_Codon_SNP	p.M1I	C	C		7	Cancer Module	19	44285011	44285011	85	0.0705882352941176	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNN4&recr=Open">Click here</a>	
KCNQ3	Missense_Mutation	p.S611L	G	G		7	Cancer Module	8	133144479	133144479	152	0.236842105263158	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNQ3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,133144479,G,G&fts=all">p.S611L</a>
KCNQ3	Missense_Mutation	p.P577S	G	G		7	Cancer Module	8	133146607	133146607	88	0.25	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNQ3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,133146607,G,G&fts=all">p.P577S</a>
KCNQ5	Missense_Mutation	p.S838L	C	C		7	Cancer Module	6	73904851	73904851	58	0.46551724137931	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNQ5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,73904851,C,C&fts=all">p.S838L</a>
KCNV1	Missense_Mutation	p.E175K	C	C		7	Cancer Module	8	110984955	110984955	147	0.224489795918367	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNV1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,110984955,C,C&fts=all">p.E175K</a>
KCNV2	Missense_Mutation	p.E284K	G	G		7	Cancer Module	9	2718589	2718589	27	0.518518518518518	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNV2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,2718589,G,G&fts=all">p.E284K</a>
KIAA0100	Nonsense_Mutation	p.Q1800*	G	G		7	Cancer Module	17	26947000	26947000	80	0.3625	NA	NA	NA			68			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0100&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,26947000,G,G&fts=all">p.Q1800*</a>
KIAA0195	Missense_Mutation	p.R1028C	C	C		7	Cancer Module	17	73492391	73492391	37	0.621621621621622	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0195&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,73492391,C,C&fts=all">p.R1028C</a>
KIAA0368	Nonsense_Mutation	p.Q1612*	G	G		7	Cancer Module	9	114132855	114132855	30	0.333333333333333	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0368&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,114132855,G,G&fts=all">p.Q1612*</a>
KIAA0753	Missense_Mutation	p.P288L	G	G		7	Cancer Module	17	6526854	6526854	84	0.226190476190476	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0753&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,6526854,G,G&fts=all">p.P288L</a>
KIAA0907	Missense_Mutation	p.P244L	G	G		7	Cancer Module	1	155895585	155895585	247	0.214574898785425	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0907&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,155895585,G,G&fts=all">p.P244L</a>
KIAA0907	Missense_Mutation	p.P244S	G	G		7	Cancer Module	1	155895586	155895586	245	0.220408163265306	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0907&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,155895586,G,G&fts=all">p.P244S</a>
KIAA0922	Nonsense_Mutation	p.R1216*	C	C		7	Cancer Module	4	154541986	154541986	318	0.333333333333333	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0922&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,154541986,C,C&fts=all">p.R1216*</a>
KIAA1324	Missense_Mutation	p.E434K	G	G		7	Cancer Module	1	109731768	109731768	62	0.435483870967742	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1324&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,109731768,G,G&fts=all">p.E434K</a>
KIAA1462	Nonsense_Mutation	p.Q689*	G	G		7	Cancer Module	10	30317012	30317012	46	0.130434782608696	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1462&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,30317012,G,G&fts=all">p.Q689*</a>
KIAA1462	Missense_Mutation	p.S495F	G	G		7	Cancer Module	10	30317593	30317593	56	0.196428571428571	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1462&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,30317593,G,G&fts=all">p.S495F</a>
KIF1A	Nonsense_Mutation	p.W619*	C	C		7	Cancer Module	2	241702649	241702649	19	0.210526315789474	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,241702649,C,C&fts=all">p.W619*</a>
KIF1C	Missense_Mutation	p.P1062L	C	C		7	Cancer Module	17	4927319	4927319	34	0.235294117647059	NA	NA	NA			30	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,4927319,C,C&fts=all">p.P1062L</a>
KIF26B	Missense_Mutation	p.P570S	C	C		7	Cancer Module	1	245772624	245772624	45	0.333333333333333	NA	NA	NA			51	Kinesin motor. {ECO:0000255|PROSITE- ProRule:PRU00283}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF26B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,245772624,C,C&fts=all">p.P570S</a>
KIF26B	Missense_Mutation	p.P1148S	C	C		7	Cancer Module	1	245849727	245849727	111	0.288288288288288	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF26B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,245849727,C,C&fts=all">p.P1148S</a>
KIF3B	Missense_Mutation	p.R110C	C	C		7	Cancer Module	20	30897908	30897908	71	0.408450704225352	NA	NA	NA		p.R110C(1)	36	Kinesin motor. {ECO:0000255|PROSITE- ProRule:PRU00283}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,30897908,C,C&fts=all">p.R110C</a>
KIF5A	Missense_Mutation	p.E137K	G	G		7	Cancer Module	12	57958255	57958255	157	0.32484076433121	NA	NA	NA			62	Kinesin motor. {ECO:0000255|PROSITE- ProRule:PRU00283}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,57958255,G,G&fts=all">p.E137K</a>
KIRREL3	Splice_Site		C	C		7	Cancer Module	11	126305162	126305162	43	0.953488372093023	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIRREL3&recr=Open">Click here</a>	
KLHL1	Missense_Mutation	p.Q576R	T	T		7	Cancer Module	13	70314601	70314601	164	0.268292682926829	NA	NA	NA			84			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,70314601,T,T&fts=all">p.Q576R</a>
KLHL4	Missense_Mutation	p.G580E	G	G		7	Cancer Module	X	86890589	86890589	72	0.347222222222222	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,86890589,G,G&fts=all">p.G580E</a>
KLK10	Nonsense_Mutation	p.W268*	C	C		7	Cancer Module	19	51518083	51518083	68	0.308823529411765	NA	NA	NA		p.W268C(1)	13	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLK10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51518083,C,C&fts=all">p.W268*</a>
KLK13	Missense_Mutation	p.G34R	C	C		7	Cancer Module	19	51563829	51563829	98	0.357142857142857	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLK13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51563829,C,C&fts=all">p.G34R</a>
KLK5	Missense_Mutation	p.R216K	C	C		7	Cancer Module	19	51451975	51451975	56	0.160714285714286	NA	NA	NA			15	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51451975,C,C&fts=all">p.R216K</a>
KLKB1	Missense_Mutation	p.H158Y	C	C		7	Cancer Module	4	187158078	187158078	138	0.27536231884058	NA	NA	NA			40	Apple 2. {ECO:0000255|PROSITE- ProRule:PRU00315}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLKB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,187158078,C,C&fts=all">p.H158Y</a>
KLRB1	Nonsense_Mutation	p.W208*	C	C		7	Cancer Module	12	9747924	9747924	249	0.172690763052209	NA	NA	NA			12	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLRB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,9747924,C,C&fts=all">p.W208*</a>
KLRB1	Missense_Mutation	p.L106F	C	C		7	Cancer Module	12	9751191	9751191	443	0.419864559819413	NA	NA	NA			12	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLRB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,9751191,C,C&fts=all">p.L106F</a>
KLRC4	Missense_Mutation	p.S50L	G	G		7	Cancer Module	12	10562026	10562026	357	0.19047619047619	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLRC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,10562026,G,G&fts=all">p.S50L</a>
KNG1	Missense_Mutation	p.D82N	G	G		7	Cancer Module	3	186437942	186437942	142	0.316901408450704	NA	NA	NA			21	Cystatin kininogen-type 1. {ECO:0000255|PROSITE-ProRule:PRU00979}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KNG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,186437942,G,G&fts=all">p.D82N</a>
KNG1	Missense_Mutation	p.S550F	C	C		7	Cancer Module	3	186459834	186459834	96	0.291666666666667	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KNG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,186459834,C,C&fts=all">p.S550F</a>
KRT1	Missense_Mutation	p.D265N	C	C		7	Cancer Module	12	53072339	53072339	69	0.0579710144927536	NA	NA	NA			39	Coil 1B.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,53072339,C,C&fts=all">p.D265N</a>
KRT10	Missense_Mutation	p.S570F	G	G	rs112018671	7	Cancer Module	17	38975078	38975078	60	0.316666666666667	NA	NA	NA			11	Gly-rich.|Ser-rich.|Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,38975078,G,G&fts=all">p.S570F</a>
KRT12	Missense_Mutation	p.E281K	C	C		7	Cancer Module	17	39020083	39020083	31	0.580645161290323	NA	NA	NA			15	Linker 12.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,39020083,C,C&fts=all">p.E281K</a>
KRT12	Missense_Mutation	p.M263I	C	C		7	Cancer Module	17	39021076	39021076	142	0.443661971830986	NA	NA	NA			15	Coil 1B.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,39021076,C,C&fts=all">p.M263I</a>
KRT2	Missense_Mutation	p.G149D	C	C		7	Cancer Module	12	53045481	53045481	38	0.447368421052632	NA	NA	NA			32	Head.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,53045481,C,C&fts=all">p.G149D</a>
KRT33B	Missense_Mutation	p.E186K	C	C		7	Cancer Module	17	39522754	39522754	41	0.268292682926829	NA	NA	NA			21	Coil 1B.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT33B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,39522754,C,C&fts=all">p.E186K</a>
KRT5	Missense_Mutation	p.P152L	G	G	rs60617604	7	Cancer Module	12	52913626	52913626	49	0.326530612244898	NA	NA	NA			35	Head.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,52913626,G,G&fts=all">p.P152L</a>
KSR1	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	25621463	26370357	NA	NA	46	-1.18672159545669	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KSR1&recr=Open">Click here</a>	
KSR2	Missense_Mutation	p.P662S	G	G		7	Cancer Module	12	117962892	117962892	43	0.348837209302326	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KSR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,117962892,G,G&fts=all">p.P662S</a>
KSR2	Missense_Mutation	p.P336L	G	G		7	Cancer Module	12	118105443	118105443	13	0.538461538461538	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KSR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,118105443,G,G&fts=all">p.P336L</a>
KYNU	Missense_Mutation	p.D317N	G	G		7	Cancer Module	2	143787242	143787242	227	0.255506607929515	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KYNU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,143787242,G,G&fts=all">p.D317N</a>
LAIR1	Missense_Mutation	p.D233N	C	C	rs184253479	7	Cancer Module	19	54867583	54867583	84	0.166666666666667	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAIR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,54867583,C,C&fts=all">p.D233N</a>
LAIR1	Splice_Site		C	C		7	Cancer Module	19	54867964	54867964	83	0.204819277108434	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAIR1&recr=Open">Click here</a>	
LAIR1	Splice_Site	p.G195G	C	C		7	Cancer Module	19	54868006	54868006	64	0.203125	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAIR1&recr=Open">Click here</a>	
LAIR1	Splice_Site	p.G195E	C	C		7	Cancer Module	19	54868007	54868007	61	0.19672131147541	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAIR1&recr=Open">Click here</a>	
LCOR	Missense_Mutation	p.L83F	C	C		7	Cancer Module	10	98711868	98711868	190	0.205263157894737	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCOR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,98711868,C,C&fts=all">p.L83F</a>
LECT1	Missense_Mutation	p.E166K	C	C		7	Cancer Module	13	53286977	53286977	142	0.267605633802817	NA	NA	NA			15	BRICHOS. {ECO:0000255|PROSITE- ProRule:PRU00255}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LECT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,53286977,C,C&fts=all">p.E166K</a>
LEPR	Missense_Mutation	p.E873K	G	G		7	Cancer Module	1	66088608	66088608	165	0.4	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LEPR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,66088608,G,G&fts=all">p.E873K</a>
LGALS2	Missense_Mutation	p.S126F	G	G		7	Cancer Module	22	37966292	37966292	143	0.202797202797203	NA	NA	NA			11	Galectin. {ECO:0000255|PROSITE- ProRule:PRU00639}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGALS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,37966292,G,G&fts=all">p.S126F</a>
LGALS4	Missense_Mutation	p.A298V	G	G		7	Cancer Module	19	39292483	39292483	110	0.381818181818182	NA	NA	NA			17	Galectin 2. {ECO:0000255|PROSITE- ProRule:PRU00639}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGALS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39292483,G,G&fts=all">p.A298V</a>
LGALS4	Missense_Mutation	p.R279C	G	G	rs577813567	7	Cancer Module	19	39292541	39292541	119	0.19327731092437	NA	NA	NA			17	Galectin 2. {ECO:0000255|PROSITE- ProRule:PRU00639}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGALS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39292541,G,G&fts=all">p.R279C</a>
LGALS9	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	25621463	26370357	NA	NA	46	-1.18672159545669	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGALS9&recr=Open">Click here</a>	
LGI2	Missense_Mutation	p.R130C	G	G		7	Cancer Module	4	25026467	25026467	85	0.352941176470588	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,25026467,G,G&fts=all">p.R130C</a>
LHCGR	Missense_Mutation	p.L610F	G	G	rs199862871	7	Cancer Module	2	48915108	48915108	151	0.317880794701987	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LHCGR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,48915108,G,G&fts=all">p.L610F</a>
LHCGR	Nonsense_Mutation	p.R554*	G	G	rs121912524	7	Cancer Module	2	48915276	48915276	125	0.296	NA	NA	NA		p.R554*(2)	56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LHCGR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,48915276,G,G&fts=all">p.R554*</a>
LHFPL2	Missense_Mutation	p.G141E	C	C		7	Cancer Module	5	77805615	77805615	230	0.504347826086956	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LHFPL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,77805615,C,C&fts=all">p.G141E</a>
LILRA2	Missense_Mutation	p.G247E	G	G		7	Cancer Module	19	55086843	55086843	59	0.135593220338983	NA	NA	NA			50	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55086843,G,G&fts=all">p.G247E</a>
LILRA2	Missense_Mutation	p.K326R	A	A		7	Cancer Module	19	55087334	55087334	22	0.363636363636364	NA	NA	NA			50	Ig-like C2-type 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55087334,A,A&fts=all">p.K326R</a>
LILRA2	Missense_Mutation	p.E402K	G	G		7	Cancer Module	19	55087561	55087561	53	0.113207547169811	NA	NA	NA			50	Ig-like C2-type 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55087561,G,G&fts=all">p.E402K</a>
LILRA3	Missense_Mutation	p.F318Y	A	A		7	Cancer Module	19	54802043	54802043	78	0.243589743589744	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,54802043,A,A&fts=all">p.F318Y</a>
LIMCH1	Missense_Mutation	p.P520S	C	C		7	Cancer Module	4	41664900	41664900	95	0.326315789473684	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIMCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,41664900,C,C&fts=all">p.P520S</a>
LIMD1	Missense_Mutation	p.S346F	C	C		7	Cancer Module	3	45637408	45637408	133	0.233082706766917	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,45637408,C,C&fts=all">p.S346F</a>
LIN37	Missense_Mutation	p.R158C	C	C		7	Cancer Module	19	36244945	36244945	228	0.144736842105263	NA	NA	NA			6	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIN37&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36244945,C,C&fts=all">p.R158C</a>
LIN7A	Missense_Mutation	p.G147R	C	C		7	Cancer Module	12	81239553	81239553	84	0.392857142857143	NA	NA	NA			15	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIN7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,81239553,C,C&fts=all">p.G147R</a>
LIPC	Nonsense_Mutation	p.Q19*	C	C		7	Cancer Module	15	58724286	58724286	223	0.031390134529148	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIPC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,58724286,C,C&fts=all">p.Q19*</a>
LIPC	Missense_Mutation	p.P443S	C	C		7	Cancer Module	15	58855861	58855861	79	0.265822784810127	NA	NA	NA			31	PLAT. {ECO:0000255|PROSITE- ProRule:PRU00152}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIPC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,58855861,C,C&fts=all">p.P443S</a>
LIPE	Missense_Mutation	p.Q79H	T	T		7	Cancer Module	19	42931065	42931065	463	0.0215982721382289	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIPE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,42931065,T,T&fts=all">p.Q79H</a>
LLGL2	Missense_Mutation	p.R491C	C	C		7	Cancer Module	17	73565207	73565207	10	0.6	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LLGL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,73565207,C,C&fts=all">p.R491C</a>
LMAN1L	Missense_Mutation	p.S130L	C	C		7	Cancer Module	15	75108826	75108826	107	0.252336448598131	NA	NA	NA		p.S130L(1)	19	L-type lectin-like. {ECO:0000255|PROSITE- ProRule:PRU00658}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMAN1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,75108826,C,C&fts=all">p.S130L</a>
LMO7	Missense_Mutation	p.E1091K	G	G		7	Cancer Module	13	76416058	76416058	81	0.283950617283951	NA	NA	NA			56	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMO7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,76416058,G,G&fts=all">p.E1091K</a>
LMO7	Missense_Mutation	p.D1230N	G	G		7	Cancer Module	13	76427250	76427250	131	0.358778625954198	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMO7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,76427250,G,G&fts=all">p.D1230N</a>
LMTK2	Missense_Mutation	p.P1453S	C	C		7	Cancer Module	7	97833372	97833372	70	0.8	NA	NA	NA			59	Poly-Pro.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMTK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,97833372,C,C&fts=all">p.P1453S</a>
LOXL2	Missense_Mutation	p.P427S	G	G		7	Cancer Module	8	23179666	23179666	168	0.178571428571429	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LOXL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,23179666,G,G&fts=all">p.P427S</a>
LOXL2	Missense_Mutation	p.S171L	G	G	rs201211677	7	Cancer Module	8	23217622	23217622	134	0.17910447761194	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LOXL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,23217622,G,G&fts=all">p.S171L</a>
LPA	Missense_Mutation	p.S1061N	C	C		7	Cancer Module	6	161020637	161020637	123	0.349593495934959	NA	NA	NA			107	Kringle 10. {ECO:0000255|PROSITE- ProRule:PRU00121}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,161020637,C,C&fts=all">p.S1061N</a>
LPCAT2	Missense_Mutation	p.P145S	C	C	rs376754389	7	Cancer Module	16	55562410	55562410	357	0.282913165266106	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPCAT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,55562410,C,C&fts=all">p.P145S</a>
LPCAT2	Missense_Mutation	p.P239L	C	C		7	Cancer Module	16	55566748	55566748	278	0.294964028776978	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPCAT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,55566748,C,C&fts=all">p.P239L</a>
LPGAT1	Missense_Mutation	p.G237R	C	C		7	Cancer Module	1	211956589	211956589	231	0.627705627705628	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPGAT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,211956589,C,C&fts=all">p.G237R</a>
LPHN2	Missense_Mutation	p.P357S	C	C		7	Cancer Module	1	82409324	82409324	230	0.31304347826087	NA	NA	NA			119	Olfactomedin-like. {ECO:0000255|PROSITE- ProRule:PRU00446}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPHN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,82409324,C,C&fts=all">p.P357S</a>
LPHN2	Missense_Mutation	p.G854E	G	G		7	Cancer Module	1	82434911	82434911	320	0.2875	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPHN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,82434911,G,G&fts=all">p.G854E</a>
LPHN2	Missense_Mutation	p.P961S	C	C		7	Cancer Module	1	82436157	82436157	180	0.472222222222222	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPHN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,82436157,C,C&fts=all">p.P961S</a>
LPHN3	Missense_Mutation	p.S4L	C	C		7	Cancer Module	4	62363022	62363022	67	0.238805970149254	NA	NA	NA			125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPHN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,62363022,C,C&fts=all">p.S4L</a>
LPHN3	Missense_Mutation	p.S756T	T	T		7	Cancer Module	4	62812682	62812682	295	0.315254237288136	NA	NA	NA			125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPHN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,62812682,T,T&fts=all">p.S756T</a>
LPHN3	Missense_Mutation	p.M762I	G	G		7	Cancer Module	4	62812702	62812702	291	0.319587628865979	NA	NA	NA			125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPHN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,62812702,G,G&fts=all">p.M762I</a>
LPIN2	Missense_Mutation	p.H216Y	G	G		7	Cancer Module	18	2940655	2940655	108	0.37962962962963	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPIN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,2940655,G,G&fts=all">p.H216Y</a>
LPL	Nonsense_Mutation	p.Q16*	C	C		7	Cancer Module	8	19796997	19796997	28	0.571428571428571	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,19796997,C,C&fts=all">p.Q16*</a>
LPL	Nonsense_Mutation	p.R219*	C	C		7	Cancer Module	8	19811744	19811744	256	0.3984375	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,19811744,C,C&fts=all">p.R219*</a>
LPXN	Missense_Mutation	p.P214L	G	G		7	Cancer Module	11	58317480	58317480	95	0.905263157894737	NA	NA	NA			14	LIM zinc-binding 2. {ECO:0000255|PROSITE- ProRule:PRU00125}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPXN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,58317480,G,G&fts=all">p.P214L</a>
LRMP	Splice_Site		G	G		7	Cancer Module	12	25259876	25259876	78	0.179487179487179	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRMP&recr=Open">Click here</a>	
LRP1	Missense_Mutation	p.R1532C	C	C		7	Cancer Module	12	57572374	57572374	47	0.531914893617021	NA	NA	NA			184			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,57572374,C,C&fts=all">p.R1532C</a>
LRP12	Missense_Mutation	p.R746Q	C	C		7	Cancer Module	8	105503244	105503244	135	0.185185185185185	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,105503244,C,C&fts=all">p.R746Q</a>
LRP12	Missense_Mutation	p.S612L	G	G		7	Cancer Module	8	105503646	105503646	187	0.363636363636364	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,105503646,G,G&fts=all">p.S612L</a>
LRP1B	Missense_Mutation	p.P4189S	G	G	rs559377868	7	Cancer Module	2	141079607	141079607	128	0.296875	NA	NA	NA			606	EGF-like 16. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141079607,G,G&fts=all">p.P4189S</a>
LRP1B	Missense_Mutation	p.F3332C	A	A		7	Cancer Module	2	141208199	141208199	143	0.335664335664336	NA	NA	NA			606	LDL-receptor class A 21. {ECO:0000255|PROSITE-ProRule:PRU00124}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141208199,A,A&fts=all">p.F3332C</a>
LRP1B	Missense_Mutation	p.A3308V	G	G		7	Cancer Module	2	141214064	141214064	148	0.256756756756757	NA	NA	NA			606	EGF-like 13. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141214064,G,G&fts=all">p.A3308V</a>
LRP1B	Missense_Mutation	p.P2801S	G	G		7	Cancer Module	2	141264485	141264485	145	0.268965517241379	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141264485,G,G&fts=all">p.P2801S</a>
LRP1B	Missense_Mutation	p.G2485R	C	C		7	Cancer Module	2	141298602	141298602	222	0.328828828828829	NA	NA	NA			606	EGF-like 10. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141298602,C,C&fts=all">p.G2485R</a>
LRP1B	Nonsense_Mutation	p.K2352*	T	T		7	Cancer Module	2	141356340	141356340	160	0.31875	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141356340,T,T&fts=all">p.K2352*</a>
LRP1B	Missense_Mutation	p.G2304E	C	C	rs568309208	7	Cancer Module	2	141359097	141359097	75	0.32	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141359097,C,C&fts=all">p.G2304E</a>
LRP1B	Missense_Mutation	p.G2173R	C	C		7	Cancer Module	2	141458101	141458101	210	0.276190476190476	NA	NA	NA			606	EGF-like 9. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141458101,C,C&fts=all">p.G2173R</a>
LRP1B	Missense_Mutation	p.K1825E	T	T		7	Cancer Module	2	141533694	141533694	167	0.239520958083832	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141533694,T,T&fts=all">p.K1825E</a>
LRP1B	Missense_Mutation	p.E1338G	T	T		7	Cancer Module	2	141641542	141641542	122	0.229508196721311	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141641542,T,T&fts=all">p.E1338G</a>
LRP1B	Missense_Mutation	p.D1084N	C	C		7	Cancer Module	2	141680603	141680603	167	0.305389221556886	NA	NA	NA			606	LDL-receptor class A 8. {ECO:0000255|PROSITE-ProRule:PRU00124}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141680603,C,C&fts=all">p.D1084N</a>
LRP1B	Missense_Mutation	p.D653N	C	C		7	Cancer Module	2	141777504	141777504	183	0.0437158469945355	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141777504,C,C&fts=all">p.D653N</a>
LRP1B	Missense_Mutation	p.G619S	C	C		7	Cancer Module	2	141777606	141777606	189	0.285714285714286	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141777606,C,C&fts=all">p.G619S</a>
LRP1B	Missense_Mutation	p.Q583H	C	C		7	Cancer Module	2	141806595	141806595	210	0.219047619047619	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141806595,C,C&fts=all">p.Q583H</a>
LRP1B	Missense_Mutation	p.L279F	G	G		7	Cancer Module	2	141986767	141986767	168	0.56547619047619	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141986767,G,G&fts=all">p.L279F</a>
LRP1B	Missense_Mutation	p.E148K	C	C		7	Cancer Module	2	142012112	142012112	197	0.289340101522843	NA	NA	NA			606	EGF-like 1. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,142012112,C,C&fts=all">p.E148K</a>
LRP2	Missense_Mutation	p.E4545K	C	C		7	Cancer Module	2	169989179	169989179	182	0.236263736263736	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,169989179,C,C&fts=all">p.E4545K</a>
LRP2	Missense_Mutation	p.H2807Y	G	G		7	Cancer Module	2	170058171	170058171	128	0.3046875	NA	NA	NA			315	LDL-receptor class A 18. {ECO:0000255|PROSITE-ProRule:PRU00124}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,170058171,G,G&fts=all">p.H2807Y</a>
LRP2	Missense_Mutation	p.F2596L	A	A		7	Cancer Module	2	170060711	170060711	285	0.27719298245614	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,170060711,A,A&fts=all">p.F2596L</a>
LRP2	Missense_Mutation	p.R2095Q	C	C		7	Cancer Module	2	170066148	170066148	68	0.235294117647059	NA	NA	NA		p.R2095Q(2)	315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,170066148,C,C&fts=all">p.R2095Q</a>
LRP2	Missense_Mutation	p.P1763S	G	G		7	Cancer Module	2	170083039	170083039	192	0.260416666666667	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,170083039,G,G&fts=all">p.P1763S</a>
LRP2	Missense_Mutation	p.S893F	G	G		7	Cancer Module	2	170103316	170103316	105	0.295238095238095	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,170103316,G,G&fts=all">p.S893F</a>
LRP2	Splice_Site	p.T180I	G	G		7	Cancer Module	2	170150771	170150771	128	0.3359375	NA	NA	NA			315	LDL-receptor class A 4. {ECO:0000255|PROSITE-ProRule:PRU00124}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP2&recr=Open">Click here</a>	
LRRC41	Missense_Mutation	p.P69S	G	G	rs11542622	7	Cancer Module	1	46764037	46764037	183	0.939890710382514	NA	NA	NA		p.P69T(1)	28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC41&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,46764037,G,G&fts=all">p.P69S</a>
LRRC8D	Nonsense_Mutation	p.Q151*	C	C		7	Cancer Module	1	90399078	90399078	182	0.335164835164835	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC8D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,90399078,C,C&fts=all">p.Q151*</a>
LRTM1	Nonsense_Mutation	p.Q159*	G	G		7	Cancer Module	3	54958775	54958775	87	0.218390804597701	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRTM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,54958775,G,G&fts=all">p.Q159*</a>
LSP1	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	11	1860936	1955677	NA	NA	21	-1.13511063553025	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LSP1&recr=Open">Click here</a>	
LSR	Missense_Mutation	p.P86S	C	C		7	Cancer Module	19	35741220	35741220	243	0.296296296296296	NA	NA	NA			13	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LSR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,35741220,C,C&fts=all">p.P86S</a>
LTBP1	Missense_Mutation	p.S183F	C	C		7	Cancer Module	2	33173995	33173995	106	0.283018867924528	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LTBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,33173995,C,C&fts=all">p.S183F</a>
LUM	Missense_Mutation	p.H99Y	G	G		7	Cancer Module	12	91502462	91502462	129	0.310077519379845	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LUM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,91502462,G,G&fts=all">p.H99Y</a>
LY86	Missense_Mutation	p.G52S	G	G		7	Cancer Module	6	6625176	6625176	127	0.188976377952756	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LY86&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,6625176,G,G&fts=all">p.G52S</a>
MACF1	Missense_Mutation	p.L5095F	C	C		7	Cancer Module	1	39853782	39853782	92	0.554347826086957	NA	NA	NA			203			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MACF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,39853782,C,C&fts=all">p.L5095F</a>
MACF1	Missense_Mutation	p.A5257V	C	C		7	Cancer Module	1	39854269	39854269	222	0.324324324324324	NA	NA	NA			203			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MACF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,39854269,C,C&fts=all">p.A5257V</a>
MAGEA4	Missense_Mutation	p.L122F	C	C		7	Cancer Module	X	151092500	151092500	53	0.528301886792453	NA	NA	NA			27	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,151092500,C,C&fts=all">p.L122F</a>
MAGEA4	Missense_Mutation	p.E236K	G	G		7	Cancer Module	X	151092842	151092842	49	0.489795918367347	NA	NA	NA			27	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,151092842,G,G&fts=all">p.E236K</a>
MAGEB2	Missense_Mutation	p.G135E	G	G		7	Cancer Module	X	30237101	30237101	35	0.371428571428571	NA	NA	NA			23	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,30237101,G,G&fts=all">p.G135E</a>
MAGEC1	Splice_Site	p.G2G	G	G		7	Cancer Module	X	140993196	140993196	34	0.382352941176471	NA	NA	NA			127			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC1&recr=Open">Click here</a>	
MAGEC1	Missense_Mutation	p.P369L	C	C		7	Cancer Module	X	140994296	140994296	70	0.371428571428571	NA	NA	NA			127			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,140994296,C,C&fts=all">p.P369L</a>
MAGEC1	Missense_Mutation	p.P569S	C	C		7	Cancer Module	X	140994895	140994895	139	0.431654676258993	NA	NA	NA			127			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,140994895,C,C&fts=all">p.P569S</a>
MAGEC1	Missense_Mutation	p.T983I	C	C		7	Cancer Module	X	140996138	140996138	89	0.471910112359551	NA	NA	NA			127	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,140996138,C,C&fts=all">p.T983I</a>
MAGI1	Missense_Mutation	p.E1105V	T	T		7	Cancer Module	3	65346993	65346993	119	0.453781512605042	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,65346993,T,T&fts=all">p.E1105V</a>
MAGI1	Missense_Mutation	p.D970N	C	C		7	Cancer Module	3	65365023	65365023	15	0.266666666666667	NA	NA	NA			51	Interaction with FCHSD2.|PDZ 5. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,65365023,C,C&fts=all">p.D970N</a>
MAGI1	Missense_Mutation	p.E811K	C	C		7	Cancer Module	3	65369284	65369284	114	0.192982456140351	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,65369284,C,C&fts=all">p.E811K</a>
MAGI1	Missense_Mutation	p.G722E	C	C		7	Cancer Module	3	65415197	65415197	220	0.190909090909091	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,65415197,C,C&fts=all">p.G722E</a>
MAGI1	Missense_Mutation	p.P661S	G	G		7	Cancer Module	3	65415381	65415381	104	0.153846153846154	NA	NA	NA			51	PDZ 3. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,65415381,G,G&fts=all">p.P661S</a>
MAGI1	Missense_Mutation	p.P613L	G	G		7	Cancer Module	3	65415524	65415524	102	0.245098039215686	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,65415524,G,G&fts=all">p.P613L</a>
MAGI1	Missense_Mutation	p.N584D	T	T		7	Cancer Module	3	65415612	65415612	103	0.300970873786408	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,65415612,T,T&fts=all">p.N584D</a>
MAGI1	Missense_Mutation	p.P557S	G	G		7	Cancer Module	3	65415693	65415693	67	0.208955223880597	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,65415693,G,G&fts=all">p.P557S</a>
MAGI1	Missense_Mutation	p.R554Q	C	C		7	Cancer Module	3	65415701	65415701	66	0.212121212121212	NA	NA	NA			51	PDZ 2. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,65415701,C,C&fts=all">p.R554Q</a>
MAGI1	Missense_Mutation	p.H429Y	G	G		7	Cancer Module	3	65422908	65422908	140	0.178571428571429	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,65422908,G,G&fts=all">p.H429Y</a>
MAGI2	Missense_Mutation	p.T1129I	G	G		7	Cancer Module	7	77756551	77756551	102	0.333333333333333	NA	NA	NA			84			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,77756551,G,G&fts=all">p.T1129I</a>
MAGI2	Missense_Mutation	p.P1019S	G	G		7	Cancer Module	7	77762354	77762354	78	0.397435897435897	NA	NA	NA			84	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,77762354,G,G&fts=all">p.P1019S</a>
MAN1A1	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	6	119522514	119670232	NA	NA	6	-1.09018850129166	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAN1A1&recr=Open">Click here</a>	
MAN2A1	Missense_Mutation	p.D972N	G	G		7	Cancer Module	5	109183429	109183429	49	0.469387755102041	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAN2A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,109183429,G,G&fts=all">p.D972N</a>
MAN2A2	Missense_Mutation	p.P699S	C	C		7	Cancer Module	15	91454766	91454766	25	0.6	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAN2A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,91454766,C,C&fts=all">p.P699S</a>
MAN2A2	Missense_Mutation	p.P752L	C	C	rs558084418	7	Cancer Module	15	91455418	91455418	120	0.283333333333333	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAN2A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,91455418,C,C&fts=all">p.P752L</a>
MAN2B1	Missense_Mutation	p.T640I	G	G		7	Cancer Module	19	12763186	12763186	52	0.596153846153846	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAN2B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,12763186,G,G&fts=all">p.T640I</a>
MAP1A	Missense_Mutation	p.P496L	C	C		7	Cancer Module	15	43814444	43814444	69	0.623188405797101	NA	NA	NA			66	9 X 3 AA repeats of K-K-[DE].|Lys-rich (basic).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43814444,C,C&fts=all">p.P496L</a>
MAP1A	Missense_Mutation	p.R1000H	G	G		7	Cancer Module	15	43815956	43815956	28	0.321428571428571	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43815956,G,G&fts=all">p.R1000H</a>
MAP1A	Missense_Mutation	p.P1014S	C	C		7	Cancer Module	15	43815997	43815997	41	0.341463414634146	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43815997,C,C&fts=all">p.P1014S</a>
MAP1A	Missense_Mutation	p.D2087N	G	G		7	Cancer Module	15	43819216	43819216	30	0.166666666666667	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43819216,G,G&fts=all">p.D2087N</a>
MAP1A	Missense_Mutation	p.R2247Q	G	G	rs199600508	7	Cancer Module	15	43819697	43819697	85	0.341176470588235	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43819697,G,G&fts=all">p.R2247Q</a>
MAP1B	Missense_Mutation	p.P2130S	C	C		7	Cancer Module	5	71495570	71495570	54	0.462962962962963	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,71495570,C,C&fts=all">p.P2130S</a>
MAP1LC3A	Missense_Mutation	p.E19K	G	G		7	Cancer Module	20	33147026	33147026	10	1	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP1LC3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,33147026,G,G&fts=all">p.E19K</a>
MAP3K13	Nonsense_Mutation	p.R254*	C	C		7	Cancer Module	3	185161333	185161333	184	0.277173913043478	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,185161333,C,C&fts=all">p.R254*</a>
MAP4K4	Missense_Mutation	p.S1005F	C	C		7	Cancer Module	2	102503632	102503632	73	0.602739726027397	NA	NA	NA			41	CNH. {ECO:0000255|PROSITE- ProRule:PRU00795}.|Mediates interaction with RAP2A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP4K4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,102503632,C,C&fts=all">p.S1005F</a>
MAP6	Missense_Mutation	p.S404L	G	G		7	Cancer Module	11	75316958	75316958	86	0.453488372093023	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,75316958,G,G&fts=all">p.S404L</a>
MAP9	Missense_Mutation	p.K141R	T	T		7	Cancer Module	4	156294347	156294347	123	0.276422764227642	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,156294347,T,T&fts=all">p.K141R</a>
MAP9	Missense_Mutation	p.N98D	T	T	rs74670963	7	Cancer Module	4	156294477	156294477	217	0.253456221198157	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,156294477,T,T&fts=all">p.N98D</a>
MAPK8IP3	Missense_Mutation	p.P281L	C	C	rs371471189	7	Cancer Module	16	1797127	1797127	67	0.208955223880597	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPK8IP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,1797127,C,C&fts=all">p.P281L</a>
MAPK8IP3	Missense_Mutation	p.P823A	C	C		7	Cancer Module	16	1815984	1815984	11	0.727272727272727	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPK8IP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,1815984,C,C&fts=all">p.P823A</a>
MAPT	Missense_Mutation	p.G100R	G	G		7	Cancer Module	17	44051828	44051828	17	0.647058823529412	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,44051828,G,G&fts=all">p.G100R</a>
MAPT	Missense_Mutation	p.A281S	G	G		7	Cancer Module	17	44061011	44061011	41	0.658536585365854	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,44061011,G,G&fts=all">p.A281S</a>
MARCO	Missense_Mutation	p.G193E	G	G		7	Cancer Module	2	119732106	119732106	10	0.3	NA	NA	NA			70	Collagen-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARCO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,119732106,G,G&fts=all">p.G193E</a>
MARCO	Missense_Mutation	p.G349E	G	G		7	Cancer Module	2	119739969	119739969	94	0.223404255319149	NA	NA	NA			70	Collagen-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARCO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,119739969,G,G&fts=all">p.G349E</a>
MBD5	Missense_Mutation	p.E65K	G	G		7	Cancer Module	2	149220230	149220230	227	0.26431718061674	NA	NA	NA			62	MBD. {ECO:0000255|PROSITE- ProRule:PRU00338}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MBD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,149220230,G,G&fts=all">p.E65K</a>
MBD5	Missense_Mutation	p.G204D	G	G		7	Cancer Module	2	149226123	149226123	89	0.269662921348315	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MBD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,149226123,G,G&fts=all">p.G204D</a>
MBD5	Missense_Mutation	p.P402S	C	C		7	Cancer Module	2	149226716	149226716	180	0.305555555555556	NA	NA	NA			62	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MBD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,149226716,C,C&fts=all">p.P402S</a>
MBL2	Missense_Mutation	p.P101L	G	G	rs143562102	7	Cancer Module	10	54530432	54530432	240	0.233333333333333	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MBL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,54530432,G,G&fts=all">p.P101L</a>
MBTPS1	Missense_Mutation	p.P618S	G	G		7	Cancer Module	16	84103574	84103574	298	0.291946308724832	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MBTPS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,84103574,G,G&fts=all">p.P618S</a>
MCF2	Missense_Mutation	p.E838K	C	C		7	Cancer Module	X	138672080	138672080	146	0.486301369863014	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,138672080,C,C&fts=all">p.E838K</a>
MCF2L2	Missense_Mutation	p.R911C	G	G	rs61750384	7	Cancer Module	3	182923984	182923984	167	0.25748502994012	NA	NA	NA		p.R911C(1)	72	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCF2L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,182923984,G,G&fts=all">p.R911C</a>
MCOLN3	Missense_Mutation	p.D173N	C	C		7	Cancer Module	1	85499814	85499814	229	0.877729257641921	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCOLN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,85499814,C,C&fts=all">p.D173N</a>
MDC1	Missense_Mutation	p.A1807V	G	G		7	Cancer Module	6	30671540	30671540	247	0.206477732793522	NA	NA	NA			4	Required for nuclear localization (NLS2).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,30671540,G,G&fts=all">p.A1807V</a>
MED12L	Missense_Mutation	p.P220S	C	C		7	Cancer Module	3	150874049	150874049	137	0.277372262773723	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED12L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,150874049,C,C&fts=all">p.P220S</a>
MED12L	Missense_Mutation	p.P220L	C	C		7	Cancer Module	3	150874050	150874050	137	0.262773722627737	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED12L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,150874050,C,C&fts=all">p.P220L</a>
MED12L	Missense_Mutation	p.S333N	G	G		7	Cancer Module	3	150877779	150877779	192	0.265625	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED12L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,150877779,G,G&fts=all">p.S333N</a>
MED12L	Missense_Mutation	p.I843L	A	A		7	Cancer Module	3	151073798	151073798	261	0.0498084291187739	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED12L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,151073798,A,A&fts=all">p.I843L</a>
MED23	Missense_Mutation	p.K1082N	T	T		7	Cancer Module	6	131914298	131914298	61	0.327868852459016	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED23&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,131914298,T,T&fts=all">p.K1082N</a>
MED24	Missense_Mutation	p.S582A	A	A		7	Cancer Module	17	38182965	38182965	23	0.347826086956522	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED24&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,38182965,A,A&fts=all">p.S582A</a>
MEOX1	Missense_Mutation	p.G231R	C	C		7	Cancer Module	17	41719352	41719352	96	0.270833333333333	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEOX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,41719352,C,C&fts=all">p.G231R</a>
MEP1A	Missense_Mutation	p.E628V	A	A		7	Cancer Module	6	46803085	46803085	35	0.2	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEP1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,46803085,A,A&fts=all">p.E628V</a>
MESDC2	Missense_Mutation	p.L140F	G	G	rs369992727	7	Cancer Module	15	81274319	81274319	136	0.264705882352941	NA	NA	NA			8	Chaperone domain. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MESDC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,81274319,G,G&fts=all">p.L140F</a>
MEST	Missense_Mutation	p.P79S	C	C		7	Cancer Module	7	130137050	130137050	168	0.0833333333333333	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEST&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,130137050,C,C&fts=all">p.P79S</a>
MEST	Missense_Mutation	p.R206Q	G	G		7	Cancer Module	7	130140343	130140343	59	0.338983050847458	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEST&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,130140343,G,G&fts=all">p.R206Q</a>
METTL1	Nonsense_Mutation	p.R257*	G	G	rs200703167	7	Cancer Module	12	58162841	58162841	49	0.36734693877551	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+METTL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,58162841,G,G&fts=all">p.R257*</a>
MGAT3	Missense_Mutation	p.S21F	C	C		7	Cancer Module	22	39883414	39883414	237	0.181434599156118	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGAT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,39883414,C,C&fts=all">p.S21F</a>
MGAT3	Missense_Mutation	p.D230N	G	G		7	Cancer Module	22	39884040	39884040	22	0.636363636363636	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGAT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,39884040,G,G&fts=all">p.D230N</a>
MGMT	Missense_Mutation	p.G208E	G	G		7	Cancer Module	10	131565167	131565167	11	0.363636363636364	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGMT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,131565167,G,G&fts=all">p.G208E</a>
MGST1	Missense_Mutation	p.E11K	G	G		7	Cancer Module	12	16507217	16507217	109	0.174311926605505	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGST1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,16507217,G,G&fts=all">p.E11K</a>
MIB1	Missense_Mutation	p.H535Y	C	C		7	Cancer Module	18	19395700	19395700	118	0.449152542372881	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,19395700,C,C&fts=all">p.H535Y</a>
MIB1	Missense_Mutation	p.R687C	C	C	rs371835384	7	Cancer Module	18	19424062	19424062	115	0.417391304347826	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,19424062,C,C&fts=all">p.R687C</a>
MINK1	Nonsense_Mutation	p.Q914*	C	C		7	Cancer Module	17	4797538	4797538	25	0.32	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MINK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,4797538,C,C&fts=all">p.Q914*</a>
MKI67	Missense_Mutation	p.S2814L	G	G		7	Cancer Module	10	129901663	129901663	113	0.292035398230089	NA	NA	NA			159	16 X 122 AA approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKI67&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,129901663,G,G&fts=all">p.S2814L</a>
MKI67	Missense_Mutation	p.P1114S	G	G		7	Cancer Module	10	129906764	129906764	276	0.297101449275362	NA	NA	NA			159	16 X 122 AA approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKI67&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,129906764,G,G&fts=all">p.P1114S</a>
MLC1	Missense_Mutation	p.P358L	G	G		7	Cancer Module	22	50500073	50500073	42	0.261904761904762	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,50500073,G,G&fts=all">p.P358L</a>
MLPH	Missense_Mutation	p.S259L	C	C		7	Cancer Module	2	238449091	238449091	39	0.282051282051282	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLPH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,238449091,C,C&fts=all">p.S259L</a>
MLPH	Missense_Mutation	p.S411F	C	C		7	Cancer Module	2	238457907	238457907	102	0.323529411764706	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLPH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,238457907,C,C&fts=all">p.S411F</a>
MMD	Missense_Mutation	p.R119C	G	G		7	Cancer Module	17	53481219	53481219	272	0.400735294117647	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,53481219,G,G&fts=all">p.R119C</a>
MME	Missense_Mutation	p.R261K	G	G		7	Cancer Module	3	154855952	154855952	265	0.39622641509434	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MME&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,154855952,G,G&fts=all">p.R261K</a>
MME	Missense_Mutation	p.G721E	G	G		7	Cancer Module	3	154898157	154898157	328	0.231707317073171	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MME&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,154898157,G,G&fts=all">p.G721E</a>
MMP13	Missense_Mutation	p.M116I	C	C		7	Cancer Module	11	102825995	102825995	112	0.339285714285714	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,102825995,C,C&fts=all">p.M116I</a>
MMP16	Missense_Mutation	p.G534E	C	C		7	Cancer Module	8	89053912	89053912	154	0.409090909090909	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,89053912,C,C&fts=all">p.G534E</a>
MMP27	Missense_Mutation	p.S150L	G	G		7	Cancer Module	11	102573742	102573742	214	0.429906542056075	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP27&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,102573742,G,G&fts=all">p.S150L</a>
MMP3	Missense_Mutation	p.P282S	G	G		7	Cancer Module	11	102710930	102710930	89	0.820224719101124	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,102710930,G,G&fts=all">p.P282S</a>
MMP8	Nonsense_Mutation	p.Q269*	G	G		7	Cancer Module	11	102587130	102587130	212	0.858490566037736	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,102587130,G,G&fts=all">p.Q269*</a>
MMRN1	Missense_Mutation	p.A181V	C	C		7	Cancer Module	4	90856147	90856147	234	0.277777777777778	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMRN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,90856147,C,C&fts=all">p.A181V</a>
MMRN1	Missense_Mutation	p.S735C	A	A	rs182758549	7	Cancer Module	4	90857808	90857808	181	0.331491712707182	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMRN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,90857808,A,A&fts=all">p.S735C</a>
MMRN1	Missense_Mutation	p.S735N	G	G		7	Cancer Module	4	90857809	90857809	181	0.331491712707182	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMRN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,90857809,G,G&fts=all">p.S735N</a>
MNDA	Missense_Mutation	p.H21Y	C	C		7	Cancer Module	1	158812004	158812004	128	0.453125	NA	NA	NA		p.H21Y(1)	65	DAPIN. {ECO:0000255|PROSITE- ProRule:PRU00061}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MNDA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158812004,C,C&fts=all">p.H21Y</a>
MNDA	Missense_Mutation	p.K250T	A	A		7	Cancer Module	1	158815555	158815555	127	0.653543307086614	NA	NA	NA			65	HIN-200. {ECO:0000255|PROSITE- ProRule:PRU00106}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MNDA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158815555,A,A&fts=all">p.K250T</a>
MOV10L1	Nonsense_Mutation	p.W168*	G	G		7	Cancer Module	22	50546625	50546625	25	0.16	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MOV10L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,50546625,G,G&fts=all">p.W168*</a>
MOV10L1	Missense_Mutation	p.G409R	G	G	rs549224375	7	Cancer Module	22	50553641	50553641	185	0.232432432432432	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MOV10L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,50553641,G,G&fts=all">p.G409R</a>
MOV10L1	Missense_Mutation	p.G1147E	G	G		7	Cancer Module	22	50599232	50599232	80	0.25	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MOV10L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,50599232,G,G&fts=all">p.G1147E</a>
MOXD1	Missense_Mutation	p.D309N	C	C		7	Cancer Module	6	132649173	132649173	204	0.431372549019608	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MOXD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,132649173,C,C&fts=all">p.D309N</a>
MPO	Nonsense_Mutation	p.Q506*	G	G		7	Cancer Module	17	56350880	56350880	105	0.133333333333333	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56350880,G,G&fts=all">p.Q506*</a>
MPO	Missense_Mutation	p.D461N	C	C		7	Cancer Module	17	56351015	56351015	101	0.217821782178218	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56351015,C,C&fts=all">p.D461N</a>
MPP2	Missense_Mutation	p.P40L	G	G		7	Cancer Module	17	41975712	41975712	41	0.390243902439024	NA	NA	NA			29	L27 1. {ECO:0000255|PROSITE- ProRule:PRU00365}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,41975712,G,G&fts=all">p.P40L</a>
MPP3	Missense_Mutation	p.P268L	G	G		7	Cancer Module	17	41898308	41898308	16	0.25	NA	NA	NA			26	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,41898308,G,G&fts=all">p.P268L</a>
MPP4	Nonsense_Mutation	p.R263*	G	G	rs201910298	7	Cancer Module	2	202545622	202545622	38	0.657894736842105	NA	NA	NA			12	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,202545622,G,G&fts=all">p.R263*</a>
MPPE1	Missense_Mutation	p.L368F	G	G		7	Cancer Module	18	11884533	11884533	77	0.857142857142857	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPPE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,11884533,G,G&fts=all">p.L368F</a>
MPPED2	Nonsense_Mutation	p.W222*	C	C		7	Cancer Module	11	30435876	30435876	114	0.394736842105263	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPPED2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,30435876,C,C&fts=all">p.W222*</a>
MPZ	Missense_Mutation	p.G103E	C	C	rs121913600	7	Cancer Module	1	161276638	161276638	243	0.238683127572016	NA	NA	NA			10	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPZ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,161276638,C,C&fts=all">p.G103E</a>
MRC2	Missense_Mutation	p.S865N	G	G		7	Cancer Module	17	60758281	60758281	31	0.161290322580645	NA	NA	NA			53	C-type lectin 5. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,60758281,G,G&fts=all">p.S865N</a>
MRC2	Missense_Mutation	p.R1096Q	G	G		7	Cancer Module	17	60766274	60766274	43	0.465116279069767	NA	NA	NA			53	C-type lectin 6. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,60766274,G,G&fts=all">p.R1096Q</a>
MRPL23	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	11	1860936	1955677	NA	NA	21	-1.13511063553025	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRPL23&recr=Open">Click here</a>	
MRPS31	Missense_Mutation	p.R219C	G	G		7	Cancer Module	13	41331094	41331094	137	0.240875912408759	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRPS31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,41331094,G,G&fts=all">p.R219C</a>
MSH4	Missense_Mutation	p.R528G	A	A		7	Cancer Module	1	76344718	76344718	208	0.418269230769231	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSH4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,76344718,A,A&fts=all">p.R528G</a>
MSH5	Missense_Mutation	p.L446F	C	C		7	Cancer Module	6	31726883	31726883	187	0.176470588235294	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31726883,C,C&fts=all">p.L446F</a>
MSLN	Missense_Mutation	p.R385C	C	C		7	Cancer Module	16	816413	816413	31	0.193548387096774	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSLN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,816413,C,C&fts=all">p.R385C</a>
MSMB	Missense_Mutation	p.G43R	G	G		7	Cancer Module	10	51556768	51556768	115	0.173913043478261	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSMB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,51556768,G,G&fts=all">p.G43R</a>
MTFR1	Missense_Mutation	p.G69R	G	G		7	Cancer Module	8	66605918	66605918	111	0.234234234234234	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTFR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,66605918,G,G&fts=all">p.G69R</a>
MTMR9	Missense_Mutation	p.S419Y	C	C		7	Cancer Module	8	11180158	11180158	276	0.13768115942029	NA	NA	NA			16	Myotubularin phosphatase. {ECO:0000255|PROSITE-ProRule:PRU00669}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTMR9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,11180158,C,C&fts=all">p.S419Y</a>
MTTP	Missense_Mutation	p.G486E	G	G		7	Cancer Module	4	100527936	100527936	139	0.280575539568345	NA	NA	NA			57	Vitellogenin. {ECO:0000255|PROSITE- ProRule:PRU00557}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTTP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,100527936,G,G&fts=all">p.G486E</a>
MTUS1	Missense_Mutation	p.S47L	G	G	rs201990102	7	Cancer Module	8	17579271	17579271	257	0.229571984435798	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTUS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,17579271,G,G&fts=all">p.S47L</a>
MUC13	Missense_Mutation	p.D368N	C	C		7	Cancer Module	3	124632067	124632067	91	0.0769230769230769	NA	NA	NA			18	EGF-like 3. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,124632067,C,C&fts=all">p.D368N</a>
MUC13	Missense_Mutation	p.F215C	A	A		7	Cancer Module	3	124641141	124641141	102	0.343137254901961	NA	NA	NA			18	SEA. {ECO:0000255|PROSITE- ProRule:PRU00188}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,124641141,A,A&fts=all">p.F215C</a>
MUC16	Missense_Mutation	p.S14310L	G	G		7	Cancer Module	19	8969415	8969415	48	0.354166666666667	NA	NA	NA			590	SEA 15. {ECO:0000255|PROSITE- ProRule:PRU00188}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8969415,G,G&fts=all">p.S14310L</a>
MUC16	Missense_Mutation	p.G13148E	C	C		7	Cancer Module	19	9007525	9007525	39	0.230769230769231	NA	NA	NA			590			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9007525,C,C&fts=all">p.G13148E</a>
MUC16	Missense_Mutation	p.S11662L	G	G		7	Cancer Module	19	9046646	9046646	63	0.142857142857143	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9046646,G,G&fts=all">p.S11662L</a>
MUC16	Missense_Mutation	p.P11593L	G	G		7	Cancer Module	19	9046853	9046853	34	0.0882352941176471	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9046853,G,G&fts=all">p.P11593L</a>
MUC16	Missense_Mutation	p.S11531L	G	G	rs267605782	7	Cancer Module	19	9047039	9047039	50	0.16	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9047039,G,G&fts=all">p.S11531L</a>
MUC16	Missense_Mutation	p.E11484K	C	C		7	Cancer Module	19	9047181	9047181	85	0.552941176470588	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9047181,C,C&fts=all">p.E11484K</a>
MUC16	Missense_Mutation	p.S10611F	G	G		7	Cancer Module	19	9049799	9049799	67	0.164179104477612	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9049799,G,G&fts=all">p.S10611F</a>
MUC16	Missense_Mutation	p.R9277K	C	C		7	Cancer Module	19	9059616	9059616	97	0.257731958762887	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9059616,C,C&fts=all">p.R9277K</a>
MUC16	Missense_Mutation	p.S8615L	G	G		7	Cancer Module	19	9061602	9061602	72	0.138888888888889	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9061602,G,G&fts=all">p.S8615L</a>
MUC16	Missense_Mutation	p.G8545E	C	C		7	Cancer Module	19	9061812	9061812	20	0.35	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9061812,C,C&fts=all">p.G8545E</a>
MUC16	Missense_Mutation	p.G8458E	C	C		7	Cancer Module	19	9062073	9062073	74	0.297297297297297	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9062073,C,C&fts=all">p.G8458E</a>
MUC16	Missense_Mutation	p.G8458R	C	C		7	Cancer Module	19	9062074	9062074	74	0.22972972972973	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9062074,C,C&fts=all">p.G8458R</a>
MUC16	Missense_Mutation	p.P7985L	G	G		7	Cancer Module	19	9063492	9063492	36	0.111111111111111	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9063492,G,G&fts=all">p.P7985L</a>
MUC16	Nonsense_Mutation	p.Q7533*	G	G		7	Cancer Module	19	9064849	9064849	40	0.325	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9064849,G,G&fts=all">p.Q7533*</a>
MUC16	Missense_Mutation	p.E7435K	C	C		7	Cancer Module	19	9065143	9065143	68	0.191176470588235	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9065143,C,C&fts=all">p.E7435K</a>
MUC16	Missense_Mutation	p.K6940T	T	T		7	Cancer Module	19	9066627	9066627	132	0.446969696969697	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9066627,T,T&fts=all">p.K6940T</a>
MUC16	Missense_Mutation	p.S6654F	G	G	rs267605797	7	Cancer Module	19	9067485	9067485	44	0.272727272727273	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9067485,G,G&fts=all">p.S6654F</a>
MUC16	Missense_Mutation	p.S6424F	G	G		7	Cancer Module	19	9068175	9068175	104	0.0961538461538462	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9068175,G,G&fts=all">p.S6424F</a>
MUC16	Missense_Mutation	p.E6314K	C	C		7	Cancer Module	19	9068506	9068506	79	0.189873417721519	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9068506,C,C&fts=all">p.E6314K</a>
MUC16	Missense_Mutation	p.S5996A	A	A		7	Cancer Module	19	9069460	9069460	129	0.170542635658915	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9069460,A,A&fts=all">p.S5996A</a>
MUC16	Missense_Mutation	p.L5609P	A	A		7	Cancer Module	19	9070620	9070620	25	0.16	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9070620,A,A&fts=all">p.L5609P</a>
MUC16	Nonsense_Mutation	p.Y5510*	A	A		7	Cancer Module	19	9070916	9070916	30	0.5	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9070916,A,A&fts=all">p.Y5510*</a>
MUC16	Missense_Mutation	p.E4233K	C	C		7	Cancer Module	19	9074749	9074749	24	0.25	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9074749,C,C&fts=all">p.E4233K</a>
MUC16	Missense_Mutation	p.P4183L	G	G		7	Cancer Module	19	9074898	9074898	54	0.12962962962963	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9074898,G,G&fts=all">p.P4183L</a>
MUC16	Missense_Mutation	p.G2398E	C	C		7	Cancer Module	19	9084622	9084622	49	0.571428571428571	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9084622,C,C&fts=all">p.G2398E</a>
MUC16	Missense_Mutation	p.D2039N	C	C		7	Cancer Module	19	9085700	9085700	70	0.485714285714286	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9085700,C,C&fts=all">p.D2039N</a>
MUC16	Missense_Mutation	p.P1737S	G	G		7	Cancer Module	19	9086606	9086606	65	0.276923076923077	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9086606,G,G&fts=all">p.P1737S</a>
MUC16	Missense_Mutation	p.R1722K	C	C		7	Cancer Module	19	9086650	9086650	92	0.41304347826087	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9086650,C,C&fts=all">p.R1722K</a>
MUC16	Missense_Mutation	p.S1601F	G	G	rs572972579	7	Cancer Module	19	9087013	9087013	86	0.186046511627907	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9087013,G,G&fts=all">p.S1601F</a>
MUC16	Missense_Mutation	p.E1549K	C	C		7	Cancer Module	19	9087170	9087170	108	0.240740740740741	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9087170,C,C&fts=all">p.E1549K</a>
MUC16	Missense_Mutation	p.E1441K	C	C		7	Cancer Module	19	9087494	9087494	53	0.415094339622642	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9087494,C,C&fts=all">p.E1441K</a>
MUC16	Missense_Mutation	p.S1228L	G	G		7	Cancer Module	19	9088132	9088132	112	0.205357142857143	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9088132,G,G&fts=all">p.S1228L</a>
MUC16	Missense_Mutation	p.P1139L	G	G		7	Cancer Module	19	9088399	9088399	22	0.181818181818182	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9088399,G,G&fts=all">p.P1139L</a>
MUC16	Missense_Mutation	p.S829L	G	G		7	Cancer Module	19	9089329	9089329	82	0.219512195121951	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9089329,G,G&fts=all">p.S829L</a>
MUC4	Missense_Mutation	p.L644F	G	G		7	Cancer Module	3	195487965	195487965	57	0.508771929824561	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,195487965,G,G&fts=all">p.L644F</a>
MUC6	Missense_Mutation	p.P2112L	G	G		7	Cancer Module	11	1016466	1016466	34	0.323529411764706	NA	NA	NA			80	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,1016466,G,G&fts=all">p.P2112L</a>
MUM1	Missense_Mutation	p.P424S	C	C		7	Cancer Module	19	1364561	1364561	477	0.333333333333333	NA	NA	NA			18	PWWP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,1364561,C,C&fts=all">p.P424S</a>
MUSK	Missense_Mutation	p.E414K	G	G		7	Cancer Module	9	113538123	113538123	111	0.207207207207207	NA	NA	NA			49	FZ. {ECO:0000255|PROSITE- ProRule:PRU00090}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUSK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,113538123,G,G&fts=all">p.E414K</a>
MUSK	Missense_Mutation	p.G865E	G	G		7	Cancer Module	9	113563252	113563252	20	0.35	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUSK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,113563252,G,G&fts=all">p.G865E</a>
MUT	Missense_Mutation	p.L551F	G	G		7	Cancer Module	6	49412377	49412377	605	0.269421487603306	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,49412377,G,G&fts=all">p.L551F</a>
MX1	Missense_Mutation	p.S81L	C	C		7	Cancer Module	21	42807900	42807900	68	0.323529411764706	NA	NA	NA			27	Dynamin-type G.|GTPase domain (Globular).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,42807900,C,C&fts=all">p.S81L</a>
MX1	Missense_Mutation	p.E437K	G	G		7	Cancer Module	21	42821099	42821099	154	0.24025974025974	NA	NA	NA			27	Middle domain.|Stalk.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,42821099,G,G&fts=all">p.E437K</a>
MX1	Missense_Mutation	p.R441C	C	C		7	Cancer Module	21	42821111	42821111	161	0.236024844720497	NA	NA	NA			27	Middle domain.|Stalk.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,42821111,C,C&fts=all">p.R441C</a>
MXRA5	Missense_Mutation	p.L1404F	G	G		7	Cancer Module	X	3239516	3239516	21	0.285714285714286	NA	NA	NA			157			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MXRA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,3239516,G,G&fts=all">p.L1404F</a>
MXRA5	Missense_Mutation	p.S972F	G	G		7	Cancer Module	X	3240811	3240811	33	0.606060606060606	NA	NA	NA			157			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MXRA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,3240811,G,G&fts=all">p.S972F</a>
MXRA5	Missense_Mutation	p.S900F	G	G		7	Cancer Module	X	3241027	3241027	77	0.87012987012987	NA	NA	NA			157			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MXRA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,3241027,G,G&fts=all">p.S900F</a>
MXRA5	Nonsense_Mutation	p.W227*	C	C		7	Cancer Module	X	3248087	3248087	26	0.346153846153846	NA	NA	NA			157	LRRCT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MXRA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,3248087,C,C&fts=all">p.W227*</a>
MYBPC1	Missense_Mutation	p.G528S	G	G		7	Cancer Module	12	102046916	102046916	106	0.358490566037736	NA	NA	NA			57	Ig-like C2-type 5.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYBPC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,102046916,G,G&fts=all">p.G528S</a>
MYBPC2	Missense_Mutation	p.D354N	G	G	rs377450077	7	Cancer Module	19	50947000	50947000	190	0.121052631578947	NA	NA	NA			1	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYBPC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50947000,G,G&fts=all">p.D354N</a>
MYBPH	Missense_Mutation	p.P269L	G	G		7	Cancer Module	1	203140316	203140316	40	0.1	NA	NA	NA			20	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYBPH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,203140316,G,G&fts=all">p.P269L</a>
MYBPH	Missense_Mutation	p.P269S	G	G		7	Cancer Module	1	203140317	203140317	39	0.102564102564103	NA	NA	NA			20	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYBPH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,203140317,G,G&fts=all">p.P269S</a>
MYCBP2	Missense_Mutation	p.P3480S	G	G		7	Cancer Module	13	77663140	77663140	125	0.248	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,77663140,G,G&fts=all">p.P3480S</a>
MYCBP2	Missense_Mutation	p.P3398S	G	G		7	Cancer Module	13	77667361	77667361	240	0.270833333333333	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,77667361,G,G&fts=all">p.P3398S</a>
MYCBP2	Missense_Mutation	p.P2840S	G	G		7	Cancer Module	13	77672657	77672657	131	0.259541984732824	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,77672657,G,G&fts=all">p.P2840S</a>
MYCBP2	Missense_Mutation	p.S182F	G	G		7	Cancer Module	13	77852982	77852982	132	0.287878787878788	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,77852982,G,G&fts=all">p.S182F</a>
MYCBP2	Missense_Mutation	p.P107S	G	G		7	Cancer Module	13	77862457	77862457	173	0.254335260115607	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,77862457,G,G&fts=all">p.P107S</a>
MYCBPAP	Missense_Mutation	p.E107A	A	A		7	Cancer Module	17	48594045	48594045	55	0.218181818181818	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCBPAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,48594045,A,A&fts=all">p.E107A</a>
MYF6	Missense_Mutation	p.P43H	C	C		7	Cancer Module	12	81101626	81101626	34	0.441176470588235	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYF6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,81101626,C,C&fts=all">p.P43H</a>
MYH1	Missense_Mutation	p.E1930K	C	C		7	Cancer Module	17	10395765	10395765	208	0.274038461538462	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10395765,C,C&fts=all">p.E1930K</a>
MYH1	Missense_Mutation	p.K1532E	T	T		7	Cancer Module	17	10400448	10400448	91	0.252747252747253	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10400448,T,T&fts=all">p.K1532E</a>
MYH1	Splice_Site	p.G1247E	C	C		7	Cancer Module	17	10404068	10404068	164	0.286585365853659	NA	NA	NA		p.G1247E(1)	176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH1&recr=Open">Click here</a>	
MYH1	Splice_Site	p.P530L	G	G		7	Cancer Module	17	10411988	10411988	70	0.0714285714285714	NA	NA	NA			176	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH1&recr=Open">Click here</a>	
MYH14	Missense_Mutation	p.F256V	T	T		7	Cancer Module	19	50728890	50728890	17	0.176470588235294	NA	NA	NA			46	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50728890,T,T&fts=all">p.F256V</a>
MYH14	Nonsense_Mutation	p.Q1379*	C	C		7	Cancer Module	19	50783396	50783396	9	0.666666666666667	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50783396,C,C&fts=all">p.Q1379*</a>
MYH2	Missense_Mutation	p.H701Y	G	G		7	Cancer Module	17	10424623	10424623	183	0.213114754098361	NA	NA	NA		p.H1934D(2)	176	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10424623,G,G&fts=all">p.H701Y</a>
MYH2	Missense_Mutation	p.K552E	T	T		7	Cancer Module	17	10440793	10440793	75	0.146666666666667	NA	NA	NA			176	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10440793,T,T&fts=all">p.K552E</a>
MYH3	Missense_Mutation	p.E1822K	C	C		7	Cancer Module	17	10533507	10533507	84	0.619047619047619	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10533507,C,C&fts=all">p.E1822K</a>
MYH3	Missense_Mutation	p.R1821Q	C	C		7	Cancer Module	17	10533509	10533509	85	0.623529411764706	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10533509,C,C&fts=all">p.R1821Q</a>
MYH8	Missense_Mutation	p.E1542K	C	C		7	Cancer Module	17	10299676	10299676	73	0.246575342465753	NA	NA	NA			134			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10299676,C,C&fts=all">p.E1542K</a>
MYH8	Missense_Mutation	p.D1275N	C	C		7	Cancer Module	17	10302899	10302899	107	0.0467289719626168	NA	NA	NA			134			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10302899,C,C&fts=all">p.D1275N</a>
MYH8	Missense_Mutation	p.E778K	C	C		7	Cancer Module	17	10309458	10309458	102	0.352941176470588	NA	NA	NA			134	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10309458,C,C&fts=all">p.E778K</a>
MYL1	Missense_Mutation	p.E35V	T	T		7	Cancer Module	2	211179663	211179663	272	0.0294117647058824	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,211179663,T,T&fts=all">p.E35V</a>
MYL1	Missense_Mutation	p.E35K	C	C		7	Cancer Module	2	211179664	211179664	269	0.0223048327137546	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,211179664,C,C&fts=all">p.E35K</a>
MYL6B	Missense_Mutation	p.S119L	C	C		7	Cancer Module	12	56549212	56549212	97	0.319587628865979	NA	NA	NA		p.S119L(1)	7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYL6B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,56549212,C,C&fts=all">p.S119L</a>
MYL9	Missense_Mutation	p.S20F	C	C		7	Cancer Module	20	35173346	35173346	67	0.298507462686567	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYL9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,35173346,C,C&fts=all">p.S20F</a>
MYLIP	Missense_Mutation	p.S112F	C	C		7	Cancer Module	6	16141912	16141912	175	0.417142857142857	NA	NA	NA			28	FERM. {ECO:0000255|PROSITE- ProRule:PRU00084}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYLIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,16141912,C,C&fts=all">p.S112F</a>
MYLK	Missense_Mutation	p.R870Q	C	C		7	Cancer Module	3	123419706	123419706	51	0.411764705882353	NA	NA	NA			113	5 X 28 AA approximate tandem repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYLK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,123419706,C,C&fts=all">p.R870Q</a>
MYLK	Missense_Mutation	p.R179Q	C	C		7	Cancer Module	3	123457796	123457796	24	0.291666666666667	NA	NA	NA			113	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYLK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,123457796,C,C&fts=all">p.R179Q</a>
MYNN	Missense_Mutation	p.S289F	C	C		7	Cancer Module	3	169497155	169497155	107	0.233644859813084	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYNN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,169497155,C,C&fts=all">p.S289F</a>
MYO15A	Missense_Mutation	p.G275D	G	G		7	Cancer Module	17	18022938	18022938	39	0.384615384615385	NA	NA	NA			99			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO15A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,18022938,G,G&fts=all">p.G275D</a>
MYO15A	Missense_Mutation	p.D1037N	G	G	rs577502472	7	Cancer Module	17	18025223	18025223	49	0.346938775510204	NA	NA	NA			99			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO15A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,18025223,G,G&fts=all">p.D1037N</a>
MYO15A	Missense_Mutation	p.P1041S	C	C		7	Cancer Module	17	18025235	18025235	59	0.186440677966102	NA	NA	NA			99			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO15A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,18025235,C,C&fts=all">p.P1041S</a>
MYO16	Missense_Mutation	p.P1079S	C	C		7	Cancer Module	13	109707909	109707909	204	0.279411764705882	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,109707909,C,C&fts=all">p.P1079S</a>
MYO16	Missense_Mutation	p.E1328K	G	G		7	Cancer Module	13	109779895	109779895	18	0.277777777777778	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,109779895,G,G&fts=all">p.E1328K</a>
MYO1A	Missense_Mutation	p.P868S	G	G		7	Cancer Module	12	57423646	57423646	34	0.470588235294118	NA	NA	NA			50	Myosin tail. {ECO:0000255}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,57423646,G,G&fts=all">p.P868S</a>
MYO3A	Missense_Mutation	p.E1321K	G	G	rs200190443	7	Cancer Module	10	26463154	26463154	126	0.206349206349206	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,26463154,G,G&fts=all">p.E1321K</a>
MYO3A	Missense_Mutation	p.E1345D	A	A		7	Cancer Module	10	26463228	26463228	83	0.180722891566265	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,26463228,A,A&fts=all">p.E1345D</a>
MYO5B	Missense_Mutation	p.R1275Q	C	C		7	Cancer Module	18	47390530	47390530	20	0.45	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,47390530,C,C&fts=all">p.R1275Q</a>
MYO5B	Missense_Mutation	p.Y707N	A	A		7	Cancer Module	18	47438515	47438515	104	0.836538461538462	NA	NA	NA			87	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,47438515,A,A&fts=all">p.Y707N</a>
MYO5B	Missense_Mutation	p.D489N	C	C		7	Cancer Module	18	47488716	47488716	76	0.315789473684211	NA	NA	NA			87	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,47488716,C,C&fts=all">p.D489N</a>
MYO5B	Missense_Mutation	p.D44N	C	C		7	Cancer Module	18	47581646	47581646	39	0.384615384615385	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,47581646,C,C&fts=all">p.D44N</a>
MYO5C	Missense_Mutation	p.M501I	C	C		7	Cancer Module	15	52545547	52545547	308	0.25	NA	NA	NA			66	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,52545547,C,C&fts=all">p.M501I</a>
MYO9B	Missense_Mutation	p.S323F	C	C		7	Cancer Module	19	17263486	17263486	148	0.189189189189189	NA	NA	NA			39	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO9B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,17263486,C,C&fts=all">p.S323F</a>
MYO9B	Missense_Mutation	p.P1178A	C	C		7	Cancer Module	19	17305768	17305768	61	0.147540983606557	NA	NA	NA			39	Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO9B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,17305768,C,C&fts=all">p.P1178A</a>
MYO9B	Missense_Mutation	p.P1178H	C	C		7	Cancer Module	19	17305769	17305769	60	0.15	NA	NA	NA			39	Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO9B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,17305769,C,C&fts=all">p.P1178H</a>
MYOC	Missense_Mutation	p.E409K	C	C		7	Cancer Module	1	171605355	171605355	160	0.2375	NA	NA	NA			28	Olfactomedin-like. {ECO:0000255|PROSITE- ProRule:PRU00446}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,171605355,C,C&fts=all">p.E409K</a>
MYOM1	Missense_Mutation	p.S470F	G	G		7	Cancer Module	18	3164368	3164368	31	0.387096774193548	NA	NA	NA			77	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,3164368,G,G&fts=all">p.S470F</a>
MYOM2	Missense_Mutation	p.E113K	G	G		7	Cancer Module	8	2005539	2005539	30	0.233333333333333	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2005539,G,G&fts=all">p.E113K</a>
MYOM2	Missense_Mutation	p.G493E	G	G		7	Cancer Module	8	2027656	2027656	249	0.244979919678715	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2027656,G,G&fts=all">p.G493E</a>
MYOM2	Missense_Mutation	p.E934K	G	G		7	Cancer Module	8	2054097	2054097	77	0.181818181818182	NA	NA	NA			104	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2054097,G,G&fts=all">p.E934K</a>
MYOM2	Missense_Mutation	p.G989E	G	G		7	Cancer Module	8	2054355	2054355	102	0.176470588235294	NA	NA	NA			104	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2054355,G,G&fts=all">p.G989E</a>
MYOM2	Missense_Mutation	p.K1298R	A	A		7	Cancer Module	8	2088738	2088738	113	0.176991150442478	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2088738,A,A&fts=all">p.K1298R</a>
MYRIP	Missense_Mutation	p.R523Q	G	G	rs143471880	7	Cancer Module	3	40231857	40231857	85	0.411764705882353	NA	NA	NA			34	Actin-binding.|Myosin-binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYRIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,40231857,G,G&fts=all">p.R523Q</a>
MYT1	Nonsense_Mutation	p.Q615*	C	C		7	Cancer Module	20	62848631	62848631	114	0.315789473684211	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,62848631,C,C&fts=all">p.Q615*</a>
MYT1L	Missense_Mutation	p.S1078F	G	G		7	Cancer Module	2	1805505	1805505	119	0.252100840336134	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYT1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,1805505,G,G&fts=all">p.S1078F</a>
MYT1L	Missense_Mutation	p.R922W	G	G		7	Cancer Module	2	1855417	1855417	89	0.179775280898876	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYT1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,1855417,G,G&fts=all">p.R922W</a>
N4BP2	Missense_Mutation	p.P1363S	C	C		7	Cancer Module	4	40123818	40123818	158	0.411392405063291	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+N4BP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,40123818,C,C&fts=all">p.P1363S</a>
NAGA	Missense_Mutation	p.L310I	A	A		7	Cancer Module	22	42458860	42458860	209	0.186602870813397	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAGA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,42458860,A,A&fts=all">p.L310I</a>
NAP1L3	Missense_Mutation	p.K410I	T	T		7	Cancer Module	X	92927075	92927075	8	0.625	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAP1L3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,92927075,T,T&fts=all">p.K410I</a>
NAPG	Nonsense_Mutation	p.Q178*	C	C		7	Cancer Module	18	10546348	10546348	36	0.333333333333333	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAPG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,10546348,C,C&fts=all">p.Q178*</a>
NAT2	Nonsense_Mutation	p.R9*	A	A		7	Cancer Module	8	18257538	18257538	274	0.22992700729927	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,18257538,A,A&fts=all">p.R9*</a>
NAT2	Missense_Mutation	p.N63S	A	A		7	Cancer Module	8	18257701	18257701	170	0.223529411764706	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,18257701,A,A&fts=all">p.N63S</a>
NAT2	Missense_Mutation	p.K272R	A	A		7	Cancer Module	8	18258328	18258328	195	0.2	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,18258328,A,A&fts=all">p.K272R</a>
NBEA	Missense_Mutation	p.S1259N	G	G		7	Cancer Module	13	35734084	35734084	30	0.5	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NBEA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,35734084,G,G&fts=all">p.S1259N</a>
NBEA	Missense_Mutation	p.K2278E	A	A		7	Cancer Module	13	36129158	36129158	78	0.230769230769231	NA	NA	NA			108	BEACH. {ECO:0000255|PROSITE- ProRule:PRU00026, ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NBEA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,36129158,A,A&fts=all">p.K2278E</a>
NBEA	Missense_Mutation	p.R2510C	C	C		7	Cancer Module	13	36202305	36202305	71	0.295774647887324	NA	NA	NA			108	BEACH. {ECO:0000255|PROSITE- ProRule:PRU00026, ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NBEA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,36202305,C,C&fts=all">p.R2510C</a>
NCALD	Missense_Mutation	p.P10L	G	G	rs557249068	7	Cancer Module	8	102731829	102731829	114	0.385964912280702	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCALD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,102731829,G,G&fts=all">p.P10L</a>
NCAM1	Missense_Mutation	p.P94L	C	C		7	Cancer Module	11	113077989	113077989	42	0.571428571428571	NA	NA	NA			49	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCAM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,113077989,C,C&fts=all">p.P94L</a>
NCAM2	Missense_Mutation	p.E310D	A	A		7	Cancer Module	21	22710740	22710740	126	0.253968253968254	NA	NA	NA			108	Ig-like C2-type 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCAM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,22710740,A,A&fts=all">p.E310D</a>
NCAM2	Missense_Mutation	p.E777K	G	G		7	Cancer Module	21	22906904	22906904	110	0.227272727272727	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCAM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,22906904,G,G&fts=all">p.E777K</a>
NCAN	Missense_Mutation	p.S945F	C	C		7	Cancer Module	19	19339263	19339263	103	0.300970873786408	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCAN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,19339263,C,C&fts=all">p.S945F</a>
NCK1	Missense_Mutation	p.W79R	T	T		7	Cancer Module	3	136664625	136664625	177	0.350282485875706	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,136664625,T,T&fts=all">p.W79R</a>
NCKAP1L	Splice_Site	p.E836E	G	G		7	Cancer Module	12	54925045	54925045	78	0.371794871794872	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCKAP1L&recr=Open">Click here</a>	
NCL	Nonsense_Mutation	p.E268*	C	C		7	Cancer Module	2	232325389	232325389	211	0.246445497630332	NA	NA	NA			35	Asp/Glu-rich (acidic).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,232325389,C,C&fts=all">p.E268*</a>
NCR1	Missense_Mutation	p.G186E	G	G		7	Cancer Module	19	55420805	55420805	69	0.173913043478261	NA	NA	NA			18	Ig-like 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55420805,G,G&fts=all">p.G186E</a>
NDRG2	Missense_Mutation	p.S284L	G	G		7	Cancer Module	14	21486626	21486626	25	0.52	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDRG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,21486626,G,G&fts=all">p.S284L</a>
NDST2	Missense_Mutation	p.R112C	G	G		7	Cancer Module	10	75567813	75567813	105	0.20952380952381	NA	NA	NA			30	Heparan sulfate N-deacetylase 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDST2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,75567813,G,G&fts=all">p.R112C</a>
NEB	Missense_Mutation	p.D6738N	C	C	rs201337732	7	Cancer Module	2	152404198	152404198	79	0.278481012658228	NA	NA	NA		p.D6738N(1)|p.D5037N(1)	301			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,152404198,C,C&fts=all">p.D6738N</a>
NEB	Nonsense_Mutation	p.W2667*	C	C		7	Cancer Module	2	152499823	152499823	94	0.24468085106383	NA	NA	NA			301			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,152499823,C,C&fts=all">p.W2667*</a>
NEB	Missense_Mutation	p.R2448C	G	G	rs576076237	7	Cancer Module	2	152506779	152506779	122	0.245901639344262	NA	NA	NA		p.R2448C(2)	301			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,152506779,G,G&fts=all">p.R2448C</a>
NEB	Nonsense_Mutation	p.E389*	C	C		7	Cancer Module	2	152554150	152554150	108	0.259259259259259	NA	NA	NA			301			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,152554150,C,C&fts=all">p.E389*</a>
NEB	Missense_Mutation	p.S383G	T	T		7	Cancer Module	2	152563400	152563400	25	0.36	NA	NA	NA			301			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,152563400,T,T&fts=all">p.S383G</a>
NEB	Missense_Mutation	p.D156N	C	C		7	Cancer Module	2	152581412	152581412	66	0.212121212121212	NA	NA	NA			301			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,152581412,C,C&fts=all">p.D156N</a>
NECAB3	Missense_Mutation	p.H172Y	G	G		7	Cancer Module	20	32248075	32248075	42	0.404761904761905	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NECAB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,32248075,G,G&fts=all">p.H172Y</a>
NEFH	Missense_Mutation	p.S648F	C	C		7	Cancer Module	22	29885572	29885572	90	0.355555555555556	NA	NA	NA			30	30 X 6 AA repeats of K-S-P-[AEPV]-[EAK]- [AEVK].|Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEFH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,29885572,C,C&fts=all">p.S648F</a>
NEFH	Missense_Mutation	p.K825N	G	G		7	Cancer Module	22	29886104	29886104	28	0.357142857142857	NA	NA	NA			30	30 X 6 AA repeats of K-S-P-[AEPV]-[EAK]- [AEVK].|Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEFH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,29886104,G,G&fts=all">p.K825N</a>
NEFM	Missense_Mutation	p.H166Y	C	C		7	Cancer Module	8	24771802	24771802	12	0.25	NA	NA	NA			36	Coil 1B.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEFM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,24771802,C,C&fts=all">p.H166Y</a>
NEFM	Missense_Mutation	p.E179K	G	G		7	Cancer Module	8	24771841	24771841	15	0.333333333333333	NA	NA	NA			36	Coil 1B.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEFM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,24771841,G,G&fts=all">p.E179K</a>
NEFM	Missense_Mutation	p.E455K	G	G		7	Cancer Module	8	24774731	24774731	92	0.217391304347826	NA	NA	NA			36	Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEFM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,24774731,G,G&fts=all">p.E455K</a>
NEFM	Missense_Mutation	p.E708K	G	G		7	Cancer Module	8	24775490	24775490	19	0.315789473684211	NA	NA	NA			36	Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEFM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,24775490,G,G&fts=all">p.E708K</a>
NEK2	Missense_Mutation	p.H385Y	G	G		7	Cancer Module	1	211836953	211836953	213	0.657276995305164	NA	NA	NA			3	Interaction with PCNT.|Necessary for interaction with MAD1L1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,211836953,G,G&fts=all">p.H385Y</a>
NELL1	Missense_Mutation	p.H378Y	C	C		7	Cancer Module	11	20968942	20968942	146	0.431506849315068	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NELL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,20968942,C,C&fts=all">p.H378Y</a>
NELL2	Missense_Mutation	p.G516E	C	C		7	Cancer Module	12	45004651	45004651	144	0.361111111111111	NA	NA	NA			65	EGF-like 3; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NELL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,45004651,C,C&fts=all">p.G516E</a>
NELL2	Missense_Mutation	p.D246N	C	C		7	Cancer Module	12	45170851	45170851	141	0.368794326241135	NA	NA	NA		p.D246H(1)	65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NELL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,45170851,C,C&fts=all">p.D246N</a>
NEU1	Missense_Mutation	p.R294C	G	G	rs190549838	7	Cancer Module	6	31827960	31827960	115	0.330434782608696	NA	NA	NA		p.R294C(1)	10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEU1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31827960,G,G&fts=all">p.R294C</a>
NFATC2IP	Missense_Mutation	p.R281K	G	G		7	Cancer Module	16	28967654	28967654	29	0.310344827586207	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFATC2IP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,28967654,G,G&fts=all">p.R281K</a>
NFE2	Missense_Mutation	p.E221G	T	T		7	Cancer Module	12	54686618	54686618	32	0.53125	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,54686618,T,T&fts=all">p.E221G</a>
NFIC	Missense_Mutation	p.P390L	C	C		7	Cancer Module	19	3452564	3452564	213	0.450704225352113	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFIC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,3452564,C,C&fts=all">p.P390L</a>
NFKBIL1	Missense_Mutation	p.T114I	C	C		7	Cancer Module	6	31525411	31525411	78	0.0897435897435897	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFKBIL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31525411,C,C&fts=all">p.T114I</a>
NFRKB	Missense_Mutation	p.R573W	G	G		7	Cancer Module	11	129746646	129746646	53	0.773584905660377	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFRKB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,129746646,G,G&fts=all">p.R573W</a>
NFX1	Missense_Mutation	p.G273R	G	G		7	Cancer Module	9	33295209	33295209	58	0.379310344827586	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,33295209,G,G&fts=all">p.G273R</a>
NFX1	Missense_Mutation	p.G273E	G	G		7	Cancer Module	9	33295210	33295210	57	0.385964912280702	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,33295210,G,G&fts=all">p.G273E</a>
NID1	Splice_Site	p.G513E	C	C		7	Cancer Module	1	236193050	236193050	66	0.666666666666667	NA	NA	NA			66	Nidogen G2 beta-barrel. {ECO:0000255|PROSITE-ProRule:PRU00348}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NID1&recr=Open">Click here</a>	
NID2	Missense_Mutation	p.E409K	C	C		7	Cancer Module	14	52520501	52520501	77	0.363636363636364	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,52520501,C,C&fts=all">p.E409K</a>
NINJ1	Missense_Mutation	p.L101H	A	A		7	Cancer Module	9	95888694	95888694	34	0.382352941176471	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NINJ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,95888694,A,A&fts=all">p.L101H</a>
NIPBL	Missense_Mutation	p.F1545C	T	T		7	Cancer Module	5	37014858	37014858	424	0.183962264150943	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIPBL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,37014858,T,T&fts=all">p.F1545C</a>
NIPBL	Missense_Mutation	p.F1838Y	T	T		7	Cancer Module	5	37022431	37022431	235	0.212765957446809	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIPBL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,37022431,T,T&fts=all">p.F1838Y</a>
NIPBL	Missense_Mutation	p.E2696K	G	G		7	Cancer Module	5	37064665	37064665	416	0.237980769230769	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIPBL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,37064665,G,G&fts=all">p.E2696K</a>
NKX2-5	Missense_Mutation	p.E109K	C	C		7	Cancer Module	5	172661762	172661762	15	0.2	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKX2-5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,172661762,C,C&fts=all">p.E109K</a>
NLRC4	Missense_Mutation	p.E409K	C	C	rs144123569	7	Cancer Module	2	32475708	32475708	62	0.306451612903226	NA	NA	NA		p.E409K(2)	16	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.|Winged-helix domain (WHD). {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,32475708,C,C&fts=all">p.E409K</a>
NLRC4	Missense_Mutation	p.G174S	C	C		7	Cancer Module	2	32476413	32476413	82	0.25609756097561	NA	NA	NA			16	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.|Nucleotide-binding domain (NBD). {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,32476413,C,C&fts=all">p.G174S</a>
NLRC5	Missense_Mutation	p.S1398F	C	C		7	Cancer Module	16	57099162	57099162	46	0.260869565217391	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,57099162,C,C&fts=all">p.S1398F</a>
NLRP12	Missense_Mutation	p.E530K	C	C		7	Cancer Module	19	54313325	54313325	68	0.323529411764706	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,54313325,C,C&fts=all">p.E530K</a>
NLRX1	Missense_Mutation	p.R356Q	G	G		7	Cancer Module	11	119045379	119045379	35	0.828571428571429	NA	NA	NA			22	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.|Required for interaction with MAVS.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,119045379,G,G&fts=all">p.R356Q</a>
NNMT	Nonsense_Mutation	p.E22*	G	G		7	Cancer Module	11	114167342	114167342	99	0.333333333333333	NA	NA	NA		p.E22*(1)	16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NNMT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,114167342,G,G&fts=all">p.E22*</a>
NNMT	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	11	113803817	114183201	NA	NA	18	-1.11528487090397	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NNMT&recr=Open">Click here</a>	
NOL6	Missense_Mutation	p.H310Y	G	G		7	Cancer Module	9	33469054	33469054	161	0.385093167701863	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOL6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,33469054,G,G&fts=all">p.H310Y</a>
NOS1	Missense_Mutation	p.D1356N	C	C		7	Cancer Module	12	117660531	117660531	107	0.570093457943925	NA	NA	NA			117			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,117660531,C,C&fts=all">p.D1356N</a>
NOS1	Missense_Mutation	p.D186N	C	C	rs267603328	7	Cancer Module	12	117768319	117768319	67	0.373134328358209	NA	NA	NA			117	Ala-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,117768319,C,C&fts=all">p.D186N</a>
NOS1	Missense_Mutation	p.Q185H	C	C		7	Cancer Module	12	117768320	117768320	67	0.373134328358209	NA	NA	NA			117	Ala-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,117768320,C,C&fts=all">p.Q185H</a>
NOSIP	Missense_Mutation	p.P262S	G	G		7	Cancer Module	19	50059624	50059624	36	0.277777777777778	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOSIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50059624,G,G&fts=all">p.P262S</a>
NOVA1	Missense_Mutation	p.I176N	A	A		7	Cancer Module	14	26918162	26918162	98	0.877551020408163	NA	NA	NA			40	KH 2. {ECO:0000255|PROSITE- ProRule:PRU00117}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOVA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,26918162,A,A&fts=all">p.I176N</a>
NPAS1	Missense_Mutation	p.E244K	G	G		7	Cancer Module	19	47542335	47542335	94	0.138297872340426	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPAS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,47542335,G,G&fts=all">p.E244K</a>
NPC1	Missense_Mutation	p.P691S	G	G		7	Cancer Module	18	21124367	21124367	55	0.436363636363636	NA	NA	NA			38	SSD. {ECO:0000255|PROSITE- ProRule:PRU00199}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,21124367,G,G&fts=all">p.P691S</a>
NPC1	Missense_Mutation	p.P259S	G	G		7	Cancer Module	18	21140301	21140301	64	0.9375	NA	NA	NA			38	Poly-Pro.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,21140301,G,G&fts=all">p.P259S</a>
NPC1	Missense_Mutation	p.S99F	G	G		7	Cancer Module	18	21148954	21148954	97	0.360824742268041	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,21148954,G,G&fts=all">p.S99F</a>
NPC1L1	Missense_Mutation	p.S1297F	G	G		7	Cancer Module	7	44553155	44553155	86	0.209302325581395	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPC1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,44553155,G,G&fts=all">p.S1297F</a>
NPHS1	Missense_Mutation	p.D1144N	C	C		7	Cancer Module	19	36322006	36322006	76	0.171052631578947	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPHS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36322006,C,C&fts=all">p.D1144N</a>
NPR1	Missense_Mutation	p.G394E	G	G		7	Cancer Module	1	153654983	153654983	135	0.192592592592593	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,153654983,G,G&fts=all">p.G394E</a>
NPY2R	Missense_Mutation	p.T85A	A	A		7	Cancer Module	4	156135344	156135344	53	0.320754716981132	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPY2R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,156135344,A,A&fts=all">p.T85A</a>
NR0B2	Missense_Mutation	p.F107L	A	A		7	Cancer Module	1	27240113	27240113	30	0.3	NA	NA	NA			5	Ligand-binding. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NR0B2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,27240113,A,A&fts=all">p.F107L</a>
NR1H4	Missense_Mutation	p.E204K	G	G		7	Cancer Module	12	100928679	100928679	64	0.328125	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NR1H4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,100928679,G,G&fts=all">p.E204K</a>
NR3C2	Missense_Mutation	p.S30F	G	G		7	Cancer Module	4	149357924	149357924	147	0.306122448979592	NA	NA	NA			41	Modulating.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NR3C2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,149357924,G,G&fts=all">p.S30F</a>
NRCAM	Missense_Mutation	p.V238M	C	C		7	Cancer Module	7	107866661	107866661	213	0.356807511737089	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRCAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,107866661,C,C&fts=all">p.V238M</a>
NRF1	Missense_Mutation	p.P194S	C	C		7	Cancer Module	7	129330360	129330360	59	0.440677966101695	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,129330360,C,C&fts=all">p.P194S</a>
NRG1	Missense_Mutation	p.K113I	A	A		7	Cancer Module	8	32463139	32463139	233	0.1931330472103	NA	NA	NA			39	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,32463139,A,A&fts=all">p.K113I</a>
NRG1	Missense_Mutation	p.H295Y	C	C	rs76599953	7	Cancer Module	8	32614009	32614009	131	0.267175572519084	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,32614009,C,C&fts=all">p.H295Y</a>
NRG1	Missense_Mutation	p.S316F	C	C		7	Cancer Module	8	32616849	32616849	199	0.21608040201005	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,32616849,C,C&fts=all">p.S316F</a>
NRG1	Missense_Mutation	p.S411F	C	C		7	Cancer Module	8	32617897	32617897	132	0.196969696969697	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,32617897,C,C&fts=all">p.S411F</a>
NRG1	Missense_Mutation	p.E558K	G	G		7	Cancer Module	8	32621678	32621678	41	0.268292682926829	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,32621678,G,G&fts=all">p.E558K</a>
NRIP2	Missense_Mutation	p.G68E	C	C		7	Cancer Module	12	2943947	2943947	159	0.182389937106918	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRIP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,2943947,C,C&fts=all">p.G68E</a>
NRIP2	Missense_Mutation	p.G68R	C	C		7	Cancer Module	12	2943948	2943948	159	0.188679245283019	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRIP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,2943948,C,C&fts=all">p.G68R</a>
NRK	Missense_Mutation	p.K1421N	A	A		7	Cancer Module	X	105190366	105190366	50	0.38	NA	NA	NA		p.K1421N(1)|p.K1422N(1)	76	CNH. {ECO:0000255|PROSITE- ProRule:PRU00795}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,105190366,A,A&fts=all">p.K1421N</a>
NRP1	Missense_Mutation	p.L557V	G	G	rs190763052	7	Cancer Module	10	33496590	33496590	257	0.214007782101167	NA	NA	NA			48	F5/8 type C 2. {ECO:0000255|PROSITE- ProRule:PRU00081}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,33496590,G,G&fts=all">p.L557V</a>
NRP1	Nonsense_Mutation	p.W411*	C	C		7	Cancer Module	10	33510696	33510696	354	0.403954802259887	NA	NA	NA			48	F5/8 type C 1. {ECO:0000255|PROSITE- ProRule:PRU00081}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,33510696,C,C&fts=all">p.W411*</a>
NRTN	Missense_Mutation	p.S16F	C	C		7	Cancer Module	19	5824223	5824223	53	0.226415094339623	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,5824223,C,C&fts=all">p.S16F</a>
NRXN1	Missense_Mutation	p.D1431N	C	C		7	Cancer Module	2	50170887	50170887	95	0.284210526315789	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,50170887,C,C&fts=all">p.D1431N</a>
NRXN1	Missense_Mutation	p.E1087D	T	T		7	Cancer Module	2	50699539	50699539	79	0.265822784810127	NA	NA	NA			58	EGF-like 3. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,50699539,T,T&fts=all">p.E1087D</a>
NRXN1	Missense_Mutation	p.G507E	C	C		7	Cancer Module	2	50780084	50780084	170	0.247058823529412	NA	NA	NA			58	Laminin G-like 3. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,50780084,C,C&fts=all">p.G507E</a>
NRXN1	Splice_Site	p.G311E	C	C		7	Cancer Module	2	50850753	50850753	29	0.241379310344828	NA	NA	NA			58	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN1&recr=Open">Click here</a>	
NRXN3	Missense_Mutation	p.E34K	G	G		7	Cancer Module	14	79117667	79117667	53	0.264150943396226	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,79117667,G,G&fts=all">p.E34K</a>
NRXN3	Missense_Mutation	p.E120K	G	G	rs148371115	7	Cancer Module	14	79175815	79175815	60	0.2	NA	NA	NA		p.E120K(1)	104	Laminin G-like. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,79175815,G,G&fts=all">p.E120K</a>
NSF	Frame_Shift_Del	p.T646fs	T	T		7	Cancer Module	17	44827168	44827168	193	0.207253886010363	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NSF&recr=Open">Click here</a>	
NSUN7	Missense_Mutation	p.E445K	G	G		7	Cancer Module	4	40800854	40800854	106	0.443396226415094	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NSUN7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,40800854,G,G&fts=all">p.E445K</a>
NTN4	Missense_Mutation	p.C462G	A	A		7	Cancer Module	12	96077284	96077284	21	0.333333333333333	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NTN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,96077284,A,A&fts=all">p.C462G</a>
NTNG1	Missense_Mutation	p.G436E	G	G		7	Cancer Module	1	107979338	107979338	92	0.25	NA	NA	NA			37	Laminin EGF-like 3. {ECO:0000255|PROSITE- ProRule:PRU00460}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NTNG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,107979338,G,G&fts=all">p.G436E</a>
NUFIP2	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUFIP2&recr=Open">Click here</a>	
NUP205	Missense_Mutation	p.R1131C	C	C		7	Cancer Module	7	135300744	135300744	170	0.0588235294117647	NA	NA	NA			93			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP205&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,135300744,C,C&fts=all">p.R1131C</a>
NUP210	Missense_Mutation	p.D1468N	C	C		7	Cancer Module	3	13368822	13368822	33	0.333333333333333	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP210&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,13368822,C,C&fts=all">p.D1468N</a>
NUP210	Missense_Mutation	p.A612V	G	G		7	Cancer Module	3	13407543	13407543	34	0.382352941176471	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP210&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,13407543,G,G&fts=all">p.A612V</a>
NUP210	Missense_Mutation	p.I514F	T	T		7	Cancer Module	3	13415265	13415265	66	0.454545454545455	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP210&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,13415265,T,T&fts=all">p.I514F</a>
NUP210	Missense_Mutation	p.I243N	A	A	rs141026514	7	Cancer Module	3	13427864	13427864	178	0.247191011235955	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP210&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,13427864,A,A&fts=all">p.I243N</a>
NUP210L	Splice_Site	p.E882K	C	C		7	Cancer Module	1	154033522	154033522	163	0.45398773006135	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP210L&recr=Open">Click here</a>	
OAS1	Splice_Site		G	G		7	Cancer Module	12	113355506	113355506	86	0.325581395348837	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OAS1&recr=Open">Click here</a>	
OAS2	Splice_Site	p.P683L	C	C	rs147522268	7	Cancer Module	12	113447044	113447044	178	0.325842696629214	NA	NA	NA			28	OAS domain 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OAS2&recr=Open">Click here</a>	
ODF2	Missense_Mutation	p.A603V	C	C		7	Cancer Module	9	131256859	131256859	55	0.254545454545455	NA	NA	NA		p.A584V(1)	37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ODF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,131256859,C,C&fts=all">p.A603V</a>
OLAH	Missense_Mutation	p.D92N	G	G		7	Cancer Module	10	15103833	15103833	323	0.464396284829721	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OLAH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,15103833,G,G&fts=all">p.D92N</a>
OLAH	Missense_Mutation	p.G235E	G	G		7	Cancer Module	10	15115134	15115134	220	0.495454545454545	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OLAH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,15115134,G,G&fts=all">p.G235E</a>
OLFM4	Missense_Mutation	p.L15F	C	C		7	Cancer Module	13	53603014	53603014	137	0.313868613138686	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OLFM4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,53603014,C,C&fts=all">p.L15F</a>
OLFM4	Missense_Mutation	p.P30S	C	C		7	Cancer Module	13	53603059	53603059	112	0.294642857142857	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OLFM4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,53603059,C,C&fts=all">p.P30S</a>
OLFM4	Missense_Mutation	p.D97N	G	G		7	Cancer Module	13	53608567	53608567	107	0.205607476635514	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OLFM4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,53608567,G,G&fts=all">p.D97N</a>
OLFML2B	Missense_Mutation	p.R580C	G	G		7	Cancer Module	1	161953983	161953983	91	0.450549450549451	NA	NA	NA			48	Olfactomedin-like. {ECO:0000255|PROSITE- ProRule:PRU00446}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OLFML2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,161953983,G,G&fts=all">p.R580C</a>
OMG	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OMG&recr=Open">Click here</a>	
OPHN1	Splice_Site	p.I83I	G	G	rs143598006	7	Cancer Module	X	67518844	67518844	124	0.467741935483871	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPHN1&recr=Open">Click here</a>	
OPTN	Missense_Mutation	p.T450I	C	C		7	Cancer Module	10	13169851	13169851	151	0.417218543046358	NA	NA	NA			22	Interaction with HD.|Interaction with MYO6.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,13169851,C,C&fts=all">p.T450I</a>
OR2F1	Missense_Mutation	p.L86F	C	C		7	Cancer Module	7	143657319	143657319	161	0.0496894409937888	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2F1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,143657319,C,C&fts=all">p.L86F</a>
OSBP	Missense_Mutation	p.P634L	G	G		7	Cancer Module	11	59345781	59345781	117	0.401709401709402	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,59345781,G,G&fts=all">p.P634L</a>
OSBPL10	Nonsense_Mutation	p.R167*	G	G		7	Cancer Module	3	31917963	31917963	291	0.22680412371134	NA	NA	NA			34	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBPL10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,31917963,G,G&fts=all">p.R167*</a>
OSMR	Missense_Mutation	p.S40F	C	C		7	Cancer Module	5	38876348	38876348	276	0.518115942028985	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSMR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38876348,C,C&fts=all">p.S40F</a>
OSMR	Nonsense_Mutation	p.Q273*	C	C		7	Cancer Module	5	38885564	38885564	205	0.190243902439024	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSMR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38885564,C,C&fts=all">p.Q273*</a>
OSMR	Missense_Mutation	p.E532K	G	G		7	Cancer Module	5	38921725	38921725	171	0.198830409356725	NA	NA	NA			46	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSMR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38921725,G,G&fts=all">p.E532K</a>
OTC	Nonsense_Mutation	p.R23*	C	C	rs72552300	7	Cancer Module	X	38212016	38212016	76	0.434210526315789	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,38212016,C,C&fts=all">p.R23*</a>
OTOF	Missense_Mutation	p.E262K	C	C		7	Cancer Module	2	26717923	26717923	39	0.41025641025641	NA	NA	NA			106	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,26717923,C,C&fts=all">p.E262K</a>
OVOL2	Missense_Mutation	p.E21K	C	C		7	Cancer Module	20	18038218	18038218	6	0.5	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OVOL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,18038218,C,C&fts=all">p.E21K</a>
OXR1	Missense_Mutation	p.N113D	A	A		7	Cancer Module	8	107695481	107695481	346	0.176300578034682	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OXR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,107695481,A,A&fts=all">p.N113D</a>
OXR1	Missense_Mutation	p.N113K	C	C	rs537961089	7	Cancer Module	8	107695483	107695483	340	0.164705882352941	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OXR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,107695483,C,C&fts=all">p.N113K</a>
OXR1	Missense_Mutation	p.G481R	G	G		7	Cancer Module	8	107719211	107719211	114	0.228070175438596	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OXR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,107719211,G,G&fts=all">p.G481R</a>
OXT	Missense_Mutation	p.G109S	G	G		7	Cancer Module	20	3053011	3053011	49	0.326530612244898	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OXT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,3053011,G,G&fts=all">p.G109S</a>
P2RY14	Missense_Mutation	p.S226L	G	G		7	Cancer Module	3	150931428	150931428	218	0.325688073394495	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P2RY14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,150931428,G,G&fts=all">p.S226L</a>
P2RY14	Missense_Mutation	p.V204I	C	C	rs138908546	7	Cancer Module	3	150931495	150931495	190	0.547368421052632	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P2RY14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,150931495,C,C&fts=all">p.V204I</a>
P2RY14	Missense_Mutation	p.G44E	C	C		7	Cancer Module	3	150931974	150931974	204	0.0294117647058824	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P2RY14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,150931974,C,C&fts=all">p.G44E</a>
PABPC3	Missense_Mutation	p.P20S	C	C		7	Cancer Module	13	25670394	25670394	53	0.377358490566038	NA	NA	NA			47	RRM 1. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PABPC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,25670394,C,C&fts=all">p.P20S</a>
PABPC4	Missense_Mutation	p.P393L	G	G		7	Cancer Module	1	40030845	40030845	86	0.476744186046512	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PABPC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,40030845,G,G&fts=all">p.P393L</a>
PABPC4	Missense_Mutation	p.P393S	G	G		7	Cancer Module	1	40030846	40030846	85	0.482352941176471	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PABPC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,40030846,G,G&fts=all">p.P393S</a>
PAFAH2	Missense_Mutation	p.R55C	G	G		7	Cancer Module	1	26316020	26316020	29	0.275862068965517	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAFAH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,26316020,G,G&fts=all">p.R55C</a>
PAH	Missense_Mutation	p.P147S	G	G	rs199475649	7	Cancer Module	12	103260429	103260429	69	0.391304347826087	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,103260429,G,G&fts=all">p.P147S</a>
PALLD	Splice_Site	p.E446K	G	G		7	Cancer Module	4	169611754	169611754	151	0.23841059602649	NA	NA	NA			48	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PALLD&recr=Open">Click here</a>	
PALLD	Missense_Mutation	p.E454K	G	G		7	Cancer Module	4	169611778	169611778	159	0.446540880503145	NA	NA	NA			48	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PALLD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,169611778,G,G&fts=all">p.E454K</a>
PALM	Missense_Mutation	p.L156P	T	T		7	Cancer Module	19	736043	736043	94	0.393617021276596	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PALM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,736043,T,T&fts=all">p.L156P</a>
PAM	Missense_Mutation	p.A884V	C	C		7	Cancer Module	5	102361000	102361000	160	0.05625	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,102361000,C,C&fts=all">p.A884V</a>
PAN3	Nonsense_Mutation	p.Y569*	T	T		7	Cancer Module	13	28841453	28841453	178	0.297752808988764	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,28841453,T,T&fts=all">p.Y569*</a>
PANK1	Missense_Mutation	p.S303F	G	G		7	Cancer Module	10	91352982	91352982	196	0.229591836734694	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,91352982,G,G&fts=all">p.S303F</a>
PARVG	Missense_Mutation	p.R324S	G	G		7	Cancer Module	22	44602282	44602282	32	0.375	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PARVG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,44602282,G,G&fts=all">p.R324S</a>
PCDH1	Missense_Mutation	p.G908R	C	C		7	Cancer Module	5	141243174	141243174	60	0.566666666666667	NA	NA	NA		p.G908R(1)	51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,141243174,C,C&fts=all">p.G908R</a>
PCDH1	Missense_Mutation	p.F673I	A	A		7	Cancer Module	5	141243879	141243879	61	0.459016393442623	NA	NA	NA			51	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,141243879,A,A&fts=all">p.F673I</a>
PCDH17	Missense_Mutation	p.E138K	G	G		7	Cancer Module	13	58207092	58207092	13	0.230769230769231	NA	NA	NA			120	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,58207092,G,G&fts=all">p.E138K</a>
PCDH17	Missense_Mutation	p.N266D	A	A		7	Cancer Module	13	58207476	58207476	60	0.2	NA	NA	NA			120	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,58207476,A,A&fts=all">p.N266D</a>
PCDH17	Missense_Mutation	p.P470L	C	C		7	Cancer Module	13	58208089	58208089	34	0.411764705882353	NA	NA	NA			120	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,58208089,C,C&fts=all">p.P470L</a>
PCDH9	Missense_Mutation	p.G1107D	C	C		7	Cancer Module	13	67205362	67205362	143	0.223776223776224	NA	NA	NA			103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,67205362,C,C&fts=all">p.G1107D</a>
PCDH9	Missense_Mutation	p.F1053C	A	A		7	Cancer Module	13	67205524	67205524	46	0.282608695652174	NA	NA	NA			103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,67205524,A,A&fts=all">p.F1053C</a>
PCDHA9	Missense_Mutation	p.G11S	G	G		7	Cancer Module	5	140228111	140228111	94	0.446808510638298	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140228111,G,G&fts=all">p.G11S</a>
PCDHB15	Missense_Mutation	p.S314L	C	C		7	Cancer Module	5	140626087	140626087	125	0.464	NA	NA	NA		p.S314L(2)	61	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140626087,C,C&fts=all">p.S314L</a>
PCDHB15	Missense_Mutation	p.P357S	C	C		7	Cancer Module	5	140626215	140626215	95	0.431578947368421	NA	NA	NA			61	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140626215,C,C&fts=all">p.P357S</a>
PCDHB2	Missense_Mutation	p.P103L	C	C	rs372224200	7	Cancer Module	5	140474682	140474682	73	0.36986301369863	NA	NA	NA			71	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140474682,C,C&fts=all">p.P103L</a>
PCK1	Missense_Mutation	p.G531E	G	G		7	Cancer Module	20	56140583	56140583	38	0.315789473684211	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,56140583,G,G&fts=all">p.G531E</a>
PCLO	Missense_Mutation	p.E3979K	C	C		7	Cancer Module	7	82545367	82545367	228	0.0570175438596491	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82545367,C,C&fts=all">p.E3979K</a>
PCLO	Missense_Mutation	p.K3634R	T	T		7	Cancer Module	7	82579003	82579003	102	0.333333333333333	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82579003,T,T&fts=all">p.K3634R</a>
PCLO	Missense_Mutation	p.Y3600F	T	T		7	Cancer Module	7	82579105	82579105	37	0.351351351351351	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82579105,T,T&fts=all">p.Y3600F</a>
PCLO	Missense_Mutation	p.G2891E	C	C		7	Cancer Module	7	82581597	82581597	104	0.413461538461538	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82581597,C,C&fts=all">p.G2891E</a>
PCLO	Nonsense_Mutation	p.G2311*	C	C		7	Cancer Module	7	82583338	82583338	165	0.309090909090909	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82583338,C,C&fts=all">p.G2311*</a>
PCLO	Missense_Mutation	p.E1871K	C	C	rs369616405	7	Cancer Module	7	82584658	82584658	52	0.269230769230769	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82584658,C,C&fts=all">p.E1871K</a>
PCLO	Missense_Mutation	p.E1840K	C	C		7	Cancer Module	7	82584751	82584751	167	0.0658682634730539	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82584751,C,C&fts=all">p.E1840K</a>
PCLO	Missense_Mutation	p.P779S	G	G		7	Cancer Module	7	82764531	82764531	84	0.0714285714285714	NA	NA	NA		p.P779S(2)|p.P725S(1)	259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82764531,G,G&fts=all">p.P779S</a>
PCLO	Nonsense_Mutation	p.K633*	T	T		7	Cancer Module	7	82764969	82764969	13	0.384615384615385	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82764969,T,T&fts=all">p.K633*</a>
PCLO	Missense_Mutation	p.K246R	T	T		7	Cancer Module	7	82785220	82785220	31	0.387096774193548	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82785220,T,T&fts=all">p.K246R</a>
PCLO	Missense_Mutation	p.D228A	T	T		7	Cancer Module	7	82785274	82785274	26	0.5	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82785274,T,T&fts=all">p.D228A</a>
PCLO	Missense_Mutation	p.D228Y	C	C		7	Cancer Module	7	82785275	82785275	26	0.5	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82785275,C,C&fts=all">p.D228Y</a>
PCNP	Nonsense_Mutation	p.K150*	A	A		7	Cancer Module	3	101311508	101311508	238	0.42436974789916	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCNP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,101311508,A,A&fts=all">p.K150*</a>
PCNT	Missense_Mutation	p.S472F	C	C		7	Cancer Module	21	47771413	47771413	92	0.315217391304348	NA	NA	NA			104	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCNT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,47771413,C,C&fts=all">p.S472F</a>
PCP4	Missense_Mutation	p.E28K	G	G		7	Cancer Module	21	41300929	41300929	99	0.232323232323232	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,41300929,G,G&fts=all">p.E28K</a>
PCSK5	Missense_Mutation	p.E97K	G	G		7	Cancer Module	9	78547391	78547391	50	0.34	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,78547391,G,G&fts=all">p.E97K</a>
PCSK5	Missense_Mutation	p.K113N	G	G		7	Cancer Module	9	78601089	78601089	80	0.25	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,78601089,G,G&fts=all">p.K113N</a>
PCSK5	Missense_Mutation	p.A387T	G	G		7	Cancer Module	9	78722218	78722218	49	0.244897959183673	NA	NA	NA			55	Peptidase S8.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,78722218,G,G&fts=all">p.A387T</a>
PCSK5	Missense_Mutation	p.P947S	C	C		7	Cancer Module	9	78848485	78848485	46	0.173913043478261	NA	NA	NA			55	CRM (Cys-rich motif).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,78848485,C,C&fts=all">p.P947S</a>
PCSK5	Missense_Mutation	p.G1289R	G	G		7	Cancer Module	9	78936399	78936399	82	0.0487804878048781	NA	NA	NA			55	CRM (Cys-rich motif).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,78936399,G,G&fts=all">p.G1289R</a>
PCSK5	Missense_Mutation	p.D1588N	G	G		7	Cancer Module	9	78953240	78953240	31	0.225806451612903	NA	NA	NA			55	CRM (Cys-rich motif).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,78953240,G,G&fts=all">p.D1588N</a>
PDE10A	Missense_Mutation	p.F126Y	A	A		7	Cancer Module	6	165862435	165862435	129	0.356589147286822	NA	NA	NA			71	GAF 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE10A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,165862435,A,A&fts=all">p.F126Y</a>
PDE1B	Nonsense_Mutation	p.Q66*	C	C		7	Cancer Module	12	54963059	54963059	34	0.382352941176471	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,54963059,C,C&fts=all">p.Q66*</a>
PDE1B	Missense_Mutation	p.D495N	G	G		7	Cancer Module	12	54971107	54971107	80	0.4125	NA	NA	NA			31	Catalytic. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,54971107,G,G&fts=all">p.D495N</a>
PDE3B	Missense_Mutation	p.L812R	T	T		7	Cancer Module	11	14880656	14880656	182	0.428571428571429	NA	NA	NA			39	Catalytic. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,14880656,T,T&fts=all">p.L812R</a>
PDE3B	Nonsense_Mutation	p.Q937*	C	C		7	Cancer Module	11	14889127	14889127	95	0.831578947368421	NA	NA	NA			39	Catalytic. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,14889127,C,C&fts=all">p.Q937*</a>
PDE4A	Missense_Mutation	p.R308Q	G	G	rs142958982	7	Cancer Module	19	10568600	10568600	85	0.235294117647059	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE4A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,10568600,G,G&fts=all">p.R308Q</a>
PDE4A	Missense_Mutation	p.A813V	C	C	rs567424183	7	Cancer Module	19	10578074	10578074	131	0.251908396946565	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE4A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,10578074,C,C&fts=all">p.A813V</a>
PDE4B	Splice_Site	p.C94Y	G	G		7	Cancer Module	1	66384518	66384518	144	0.430555555555556	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE4B&recr=Open">Click here</a>	
PDE5A	Missense_Mutation	p.R46C	G	G	rs201554154	7	Cancer Module	4	120528343	120528343	79	0.240506329113924	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,120528343,G,G&fts=all">p.R46C</a>
PDE6A	Missense_Mutation	p.E642K	C	C		7	Cancer Module	5	149264345	149264345	108	0.407407407407407	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE6A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,149264345,C,C&fts=all">p.E642K</a>
PDE6B	Missense_Mutation	p.P345S	C	C		7	Cancer Module	4	649769	649769	14	0.428571428571429	NA	NA	NA			30	GAF 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE6B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,649769,C,C&fts=all">p.P345S</a>
PDE8B	Missense_Mutation	p.R483Q	G	G		7	Cancer Module	5	76704800	76704800	79	0.544303797468354	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE8B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,76704800,G,G&fts=all">p.R483Q</a>
PDGFRL	Missense_Mutation	p.G139D	G	G	rs373464688	7	Cancer Module	8	17478622	17478622	158	0.164556962025316	NA	NA	NA			9	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFRL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,17478622,G,G&fts=all">p.G139D</a>
PDIA4	Missense_Mutation	p.P318S	G	G	rs567343075	7	Cancer Module	7	148708965	148708965	60	0.766666666666667	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDIA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,148708965,G,G&fts=all">p.P318S</a>
PDLIM5	Missense_Mutation	p.F180Y	T	T		7	Cancer Module	4	95506853	95506853	114	0.315789473684211	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDLIM5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,95506853,T,T&fts=all">p.F180Y</a>
PDYN	Missense_Mutation	p.R239W	G	G		7	Cancer Module	20	1961019	1961019	133	0.225563909774436	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDYN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,1961019,G,G&fts=all">p.R239W</a>
PDZD2	Missense_Mutation	p.D435N	G	G		7	Cancer Module	5	32010484	32010484	116	0.25	NA	NA	NA			148			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,32010484,G,G&fts=all">p.D435N</a>
PDZD2	Missense_Mutation	p.K498T	A	A		7	Cancer Module	5	32037422	32037422	52	0.192307692307692	NA	NA	NA			148			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,32037422,A,A&fts=all">p.K498T</a>
PDZD2	Missense_Mutation	p.S568N	G	G		7	Cancer Module	5	32052754	32052754	236	0.398305084745763	NA	NA	NA			148			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,32052754,G,G&fts=all">p.S568N</a>
PDZD2	Missense_Mutation	p.G623E	G	G		7	Cancer Module	5	32053957	32053957	111	0.252252252252252	NA	NA	NA			148	PDZ 3. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,32053957,G,G&fts=all">p.G623E</a>
PEG3	Missense_Mutation	p.M1530I	C	C	rs140891968	7	Cancer Module	19	57325220	57325220	67	0.164179104477612	NA	NA	NA			170			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEG3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57325220,C,C&fts=all">p.M1530I</a>
PEG3	Missense_Mutation	p.G1470R	C	C		7	Cancer Module	19	57325402	57325402	108	0.462962962962963	NA	NA	NA			170	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEG3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57325402,C,C&fts=all">p.G1470R</a>
PEG3	Nonsense_Mutation	p.R1226*	G	G		7	Cancer Module	19	57326134	57326134	54	0.333333333333333	NA	NA	NA		p.R1226>?(2)	170			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEG3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57326134,G,G&fts=all">p.R1226*</a>
PEG3	Missense_Mutation	p.H1185Y	G	G		7	Cancer Module	19	57326257	57326257	152	0.171052631578947	NA	NA	NA			170			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEG3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57326257,G,G&fts=all">p.H1185Y</a>
PEG3	Missense_Mutation	p.E1061K	C	C		7	Cancer Module	19	57326629	57326629	144	0.319444444444444	NA	NA	NA			170			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEG3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57326629,C,C&fts=all">p.E1061K</a>
PEG3	Missense_Mutation	p.E1003K	C	C		7	Cancer Module	19	57326803	57326803	36	0.222222222222222	NA	NA	NA			170			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEG3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57326803,C,C&fts=all">p.E1003K</a>
PEG3	Missense_Mutation	p.H527Y	G	G		7	Cancer Module	19	57328231	57328231	156	0.429487179487179	NA	NA	NA			170			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEG3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57328231,G,G&fts=all">p.H527Y</a>
PEPD	Missense_Mutation	p.S8L	G	G		7	Cancer Module	19	34003677	34003677	77	0.168831168831169	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEPD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,34003677,G,G&fts=all">p.S8L</a>
PER2	Missense_Mutation	p.R290C	G	G		7	Cancer Module	2	239176796	239176796	47	0.361702127659574	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PER2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,239176796,G,G&fts=all">p.R290C</a>
PEX2	Missense_Mutation	p.P226L	G	G		7	Cancer Module	8	77895738	77895738	171	0.181286549707602	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,77895738,G,G&fts=all">p.P226L</a>
PEX5	Missense_Mutation	p.H335Y	C	C		7	Cancer Module	12	7360291	7360291	169	0.171597633136095	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEX5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7360291,C,C&fts=all">p.H335Y</a>
PEX5L	Missense_Mutation	p.K181R	T	T		7	Cancer Module	3	179593229	179593229	98	0.469387755102041	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEX5L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,179593229,T,T&fts=all">p.K181R</a>
PEX5L	Missense_Mutation	p.E53K	C	C		7	Cancer Module	3	179615971	179615971	198	0.242424242424242	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEX5L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,179615971,C,C&fts=all">p.E53K</a>
PEX5L	Missense_Mutation	p.I25L	T	T		7	Cancer Module	3	179689402	179689402	120	0.225	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEX5L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,179689402,T,T&fts=all">p.I25L</a>
PFKFB3	Missense_Mutation	p.S438F	C	C		7	Cancer Module	10	6266148	6266148	68	0.264705882352941	NA	NA	NA			22	Fructose-2,6-bisphosphatase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PFKFB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,6266148,C,C&fts=all">p.S438F</a>
PGC	Missense_Mutation	p.S373F	G	G		7	Cancer Module	6	41704639	41704639	71	0.23943661971831	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,41704639,G,G&fts=all">p.S373F</a>
PGR	Missense_Mutation	p.D371N	C	C		7	Cancer Module	11	100998691	100998691	25	0.8	NA	NA	NA			36	Modulating, Pro-Rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,100998691,C,C&fts=all">p.D371N</a>
PHF10	Splice_Site	p.S319L	G	G		7	Cancer Module	6	170112483	170112483	150	0.46	NA	NA	NA			14	Essential to induce neural progenitor proliferation. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHF10&recr=Open">Click here</a>	
PHF2	Missense_Mutation	p.R107C	C	C		7	Cancer Module	9	96407930	96407930	67	0.26865671641791	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,96407930,C,C&fts=all">p.R107C</a>
PIGQ	Missense_Mutation	p.P39S	C	C		7	Cancer Module	16	624189	624189	20	0.15	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIGQ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,624189,C,C&fts=all">p.P39S</a>
PIGR	Missense_Mutation	p.P485L	G	G		7	Cancer Module	1	207108016	207108016	128	0.65625	NA	NA	NA			45	Ig-like V-type 5.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIGR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,207108016,G,G&fts=all">p.P485L</a>
PIK3C2G	Missense_Mutation	p.S14L	C	C		7	Cancer Module	12	18435056	18435056	28	0.178571428571429	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3C2G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18435056,C,C&fts=all">p.S14L</a>
PIK3C2G	Missense_Mutation	p.E55K	G	G		7	Cancer Module	12	18435178	18435178	98	0.173469387755102	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3C2G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18435178,G,G&fts=all">p.E55K</a>
PIK3C2G	Missense_Mutation	p.K400T	A	A		7	Cancer Module	12	18473957	18473957	66	0.151515151515152	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3C2G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18473957,A,A&fts=all">p.K400T</a>
PIK3C2G	Missense_Mutation	p.G839E	G	G		7	Cancer Module	12	18641517	18641517	45	0.155555555555556	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3C2G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18641517,G,G&fts=all">p.G839E</a>
PIK3C2G	Missense_Mutation	p.K1087I	A	A		7	Cancer Module	12	18691149	18691149	148	0.0405405405405405	NA	NA	NA			66	PI3K/PI4K. {ECO:0000255|PROSITE- ProRule:PRU00269}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3C2G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18691149,A,A&fts=all">p.K1087I</a>
PIK3C2G	Missense_Mutation	p.E1231K	G	G		7	Cancer Module	12	18716344	18716344	55	0.163636363636364	NA	NA	NA			66	PX. {ECO:0000255|PROSITE- ProRule:PRU00147}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3C2G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18716344,G,G&fts=all">p.E1231K</a>
PIK3R4	Splice_Site	p.G978E	C	C		7	Cancer Module	3	130422732	130422732	169	0.42603550295858	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3R4&recr=Open">Click here</a>	
PITPNC1	Missense_Mutation	p.P262L	C	C		7	Cancer Module	17	65688790	65688790	233	0.248927038626609	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PITPNC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,65688790,C,C&fts=all">p.P262L</a>
PITPNC1	Missense_Mutation	p.E286K	G	G		7	Cancer Module	17	65688861	65688861	244	0.704918032786885	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PITPNC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,65688861,G,G&fts=all">p.E286K</a>
PKD1L1	Missense_Mutation	p.R2695K	C	C		7	Cancer Module	7	47840356	47840356	163	0.282208588957055	NA	NA	NA			142			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKD1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,47840356,C,C&fts=all">p.R2695K</a>
PKD1L1	Missense_Mutation	p.L933V	G	G		7	Cancer Module	7	47927627	47927627	156	0.282051282051282	NA	NA	NA			142	REJ. {ECO:0000255|PROSITE- ProRule:PRU00511}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKD1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,47927627,G,G&fts=all">p.L933V</a>
PKP4	Missense_Mutation	p.H359Y	C	C	rs144668119	7	Cancer Module	2	159481861	159481861	82	0.24390243902439	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,159481861,C,C&fts=all">p.H359Y</a>
PLA2G12B	Missense_Mutation	p.R128C	G	G		7	Cancer Module	10	74701011	74701011	263	0.163498098859316	NA	NA	NA		p.R128C(1)	9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2G12B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,74701011,G,G&fts=all">p.R128C</a>
PLA2G12B	Missense_Mutation	p.S30F	G	G		7	Cancer Module	10	74714355	74714355	117	0.196581196581197	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2G12B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,74714355,G,G&fts=all">p.S30F</a>
PLA2G6	Missense_Mutation	p.P714S	G	G		7	Cancer Module	22	38509556	38509556	96	0.28125	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2G6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38509556,G,G&fts=all">p.P714S</a>
PLA2R1	Missense_Mutation	p.R658K	C	C		7	Cancer Module	2	160843731	160843731	96	0.21875	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2R1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,160843731,C,C&fts=all">p.R658K</a>
PLAGL2	Missense_Mutation	p.A177T	C	C		7	Cancer Module	20	30785217	30785217	11	0.636363636363636	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLAGL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,30785217,C,C&fts=all">p.A177T</a>
PLAUR	Missense_Mutation	p.P173S	G	G		7	Cancer Module	19	44159681	44159681	90	0.188888888888889	NA	NA	NA			20	UPAR/Ly6 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLAUR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44159681,G,G&fts=all">p.P173S</a>
PLCB2	Missense_Mutation	p.Q667H	C	C		7	Cancer Module	15	40586527	40586527	59	0.525423728813559	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,40586527,C,C&fts=all">p.Q667H</a>
PLCL1	Missense_Mutation	p.K155T	A	A		7	Cancer Module	2	198948705	198948705	88	0.295454545454545	NA	NA	NA			80	Interaction with PPP1C.|PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,198948705,A,A&fts=all">p.K155T</a>
PLCL1	Nonsense_Mutation	p.R566*	C	C		7	Cancer Module	2	198949937	198949937	197	0.319796954314721	NA	NA	NA			80	Interaction with GABA A beta subunit. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,198949937,C,C&fts=all">p.R566*</a>
PLCL1	Missense_Mutation	p.P827S	C	C		7	Cancer Module	2	198950720	198950720	101	0.336633663366337	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,198950720,C,C&fts=all">p.P827S</a>
PLCL2	Missense_Mutation	p.G917S	G	G		7	Cancer Module	3	17109480	17109480	189	0.153439153439153	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,17109480,G,G&fts=all">p.G917S</a>
PLEKHA4	Missense_Mutation	p.P511S	G	G		7	Cancer Module	19	49351192	49351192	63	0.0952380952380952	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49351192,G,G&fts=all">p.P511S</a>
PLEKHB1	Missense_Mutation	p.G226E	G	G		7	Cancer Module	11	73372592	73372592	73	0.863013698630137	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,73372592,G,G&fts=all">p.G226E</a>
PLEKHB2	Missense_Mutation	p.P131L	C	C		7	Cancer Module	2	131890533	131890533	103	0.194174757281553	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,131890533,C,C&fts=all">p.P131L</a>
PLEKHG1	Missense_Mutation	p.P61L	C	C		7	Cancer Module	6	151054999	151054999	50	0.34	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,151054999,C,C&fts=all">p.P61L</a>
PLEKHG1	Missense_Mutation	p.S567F	C	C		7	Cancer Module	6	151151947	151151947	91	0.428571428571429	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,151151947,C,C&fts=all">p.S567F</a>
PLEKHM2	Missense_Mutation	p.S967F	C	C		7	Cancer Module	1	16059201	16059201	21	0.80952380952381	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,16059201,C,C&fts=all">p.S967F</a>
PLK2	Missense_Mutation	p.F363L	G	G		7	Cancer Module	5	57752839	57752839	287	0.334494773519164	NA	NA	NA		p.F363L(1)	26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,57752839,G,G&fts=all">p.F363L</a>
PLOD2	Missense_Mutation	p.P362L	G	G		7	Cancer Module	3	145804616	145804616	54	0.314814814814815	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLOD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,145804616,G,G&fts=all">p.P362L</a>
PLS1	Missense_Mutation	p.N97T	A	A		7	Cancer Module	3	142389890	142389890	164	0.378048780487805	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,142389890,A,A&fts=all">p.N97T</a>
PLS1	Nonsense_Mutation	p.W131*	G	G		7	Cancer Module	3	142395027	142395027	111	0.36036036036036	NA	NA	NA			27	Actin-binding 1.|CH 1. {ECO:0000255|PROSITE- ProRule:PRU00044}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,142395027,G,G&fts=all">p.W131*</a>
PLXNA2	Missense_Mutation	p.D1828N	C	C		7	Cancer Module	1	208201461	208201461	193	0.238341968911917	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXNA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,208201461,C,C&fts=all">p.D1828N</a>
PLXNA3	Missense_Mutation	p.F278Y	T	T		7	Cancer Module	X	153689677	153689677	71	0.492957746478873	NA	NA	NA			48	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXNA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,153689677,T,T&fts=all">p.F278Y</a>
PLXND1	Missense_Mutation	p.P854L	G	G		7	Cancer Module	3	129293303	129293303	35	0.285714285714286	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXND1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,129293303,G,G&fts=all">p.P854L</a>
PMCH	Missense_Mutation	p.E78A	T	T	rs546386526	7	Cancer Module	12	102591316	102591316	170	0.423529411764706	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PMCH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,102591316,T,T&fts=all">p.E78A</a>
PMCH	Missense_Mutation	p.E78K	C	C		7	Cancer Module	12	102591317	102591317	165	0.412121212121212	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PMCH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,102591317,C,C&fts=all">p.E78K</a>
PNLIPRP1	Missense_Mutation	p.P295L	C	C		7	Cancer Module	10	118359628	118359628	168	0.375	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNLIPRP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,118359628,C,C&fts=all">p.P295L</a>
POF1B	Missense_Mutation	p.F158V	A	A		7	Cancer Module	X	84606424	84606424	101	0.346534653465347	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POF1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,84606424,A,A&fts=all">p.F158V</a>
POLDIP3	Nonsense_Mutation	p.R310*	G	G		7	Cancer Module	22	42988054	42988054	174	0.373563218390805	NA	NA	NA			16	RRM. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLDIP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,42988054,G,G&fts=all">p.R310*</a>
POLE	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	12	133196162	133354393	NA	NA	79	-1.00781166374669	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLE&recr=Open">Click here</a>	
POLQ	Missense_Mutation	p.S2007G	T	T		7	Cancer Module	3	121200611	121200611	150	0.353333333333333	NA	NA	NA			120			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLQ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,121200611,T,T&fts=all">p.S2007G</a>
POLR3B	Missense_Mutation	p.L471R	T	T		7	Cancer Module	12	106824199	106824199	122	0.39344262295082	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,106824199,T,T&fts=all">p.L471R</a>
POSTN	Missense_Mutation	p.H566Y	G	G		7	Cancer Module	13	38153461	38153461	271	0.210332103321033	NA	NA	NA			59	FAS1 4. {ECO:0000255|PROSITE- ProRule:PRU00082, ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POSTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,38153461,G,G&fts=all">p.H566Y</a>
POU2F2	Missense_Mutation	p.P56S	G	G		7	Cancer Module	19	42626298	42626298	92	0.195652173913043	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU2F2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,42626298,G,G&fts=all">p.P56S</a>
POU2F2	Missense_Mutation	p.R35K	C	C		7	Cancer Module	19	42626521	42626521	93	0.21505376344086	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU2F2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,42626521,C,C&fts=all">p.R35K</a>
POU3F4	Nonsense_Mutation	p.S310*	C	C		7	Cancer Module	X	82764261	82764261	14	0.357142857142857	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU3F4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,82764261,C,C&fts=all">p.S310*</a>
POU4F2	Missense_Mutation	p.F136S	T	T		7	Cancer Module	4	147561137	147561137	14	0.5	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU4F2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,147561137,T,T&fts=all">p.F136S</a>
POU6F1	Missense_Mutation	p.R279W	G	G		7	Cancer Module	12	51584101	51584101	68	0.0588235294117647	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU6F1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,51584101,G,G&fts=all">p.R279W</a>
PPA1	Missense_Mutation	p.P256S	G	G		7	Cancer Module	10	71966049	71966049	281	0.0213523131672598	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,71966049,G,G&fts=all">p.P256S</a>
PPARA	Missense_Mutation	p.H274Y	C	C		7	Cancer Module	22	46627797	46627797	73	0.246575342465753	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPARA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,46627797,C,C&fts=all">p.H274Y</a>
PPFIA2	Missense_Mutation	p.R889Q	C	C		7	Cancer Module	12	81693138	81693138	13	0.615384615384615	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPFIA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,81693138,C,C&fts=all">p.R889Q</a>
PPFIA2	Missense_Mutation	p.E379K	C	C		7	Cancer Module	12	81768544	81768544	49	0.36734693877551	NA	NA	NA			85	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPFIA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,81768544,C,C&fts=all">p.E379K</a>
PPM1D	Missense_Mutation	p.R181W	C	C		7	Cancer Module	17	58700950	58700950	412	0.220873786407767	NA	NA	NA			15	PP2C-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPM1D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,58700950,C,C&fts=all">p.R181W</a>
PPM1L	Missense_Mutation	p.D177N	G	G		7	Cancer Module	3	160679653	160679653	233	0.278969957081545	NA	NA	NA			13	PP2C-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPM1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,160679653,G,G&fts=all">p.D177N</a>
PPP1CC	Missense_Mutation	p.V251A	A	A		7	Cancer Module	12	111160070	111160070	141	0.595744680851064	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1CC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,111160070,A,A&fts=all">p.V251A</a>
PPP1R13B	Missense_Mutation	p.R278C	G	G	rs371385581	7	Cancer Module	14	104216268	104216268	200	0.265	NA	NA	NA			33	Gln-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R13B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,104216268,G,G&fts=all">p.R278C</a>
PPP1R3A	Nonsense_Mutation	p.K803*	T	T		7	Cancer Module	7	113518740	113518740	76	0.105263157894737	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,113518740,T,T&fts=all">p.K803*</a>
PPP1R3A	Missense_Mutation	p.H601Y	G	G		7	Cancer Module	7	113519346	113519346	153	0.509803921568627	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,113519346,G,G&fts=all">p.H601Y</a>
PPP1R3A	Missense_Mutation	p.R486Q	C	C		7	Cancer Module	7	113519690	113519690	129	0.310077519379845	NA	NA	NA		p.R486Q(2)	121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,113519690,C,C&fts=all">p.R486Q</a>
PPP2R2C	Missense_Mutation	p.R166K	C	C		7	Cancer Module	4	6374378	6374378	55	0.381818181818182	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2R2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,6374378,C,C&fts=all">p.R166K</a>
PPP2R5C	Missense_Mutation	p.P113S	C	C		7	Cancer Module	14	102348540	102348540	62	0.274193548387097	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2R5C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,102348540,C,C&fts=all">p.P113S</a>
PPP2R5C	Nonsense_Mutation	p.L145*	T	T		7	Cancer Module	14	102349622	102349622	119	0.235294117647059	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2R5C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,102349622,T,T&fts=all">p.L145*</a>
PREP	Missense_Mutation	p.P419L	G	G		7	Cancer Module	6	105771601	105771601	220	0.386363636363636	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,105771601,G,G&fts=all">p.P419L</a>
PRG4	Missense_Mutation	p.P7S	C	C	rs375534473	7	Cancer Module	1	186266026	186266026	201	0.368159203980099	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRG4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,186266026,C,C&fts=all">p.P7S</a>
PRG4	Missense_Mutation	p.E314K	G	G		7	Cancer Module	1	186275791	186275791	209	0.258373205741627	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRG4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,186275791,G,G&fts=all">p.E314K</a>
PRKCI	Missense_Mutation	p.S207F	C	C		7	Cancer Module	3	169991102	169991102	256	0.33203125	NA	NA	NA			36	Regulatory domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,169991102,C,C&fts=all">p.S207F</a>
PRKCQ	Missense_Mutation	p.E317K	C	C		7	Cancer Module	10	6527183	6527183	126	0.198412698412698	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCQ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,6527183,C,C&fts=all">p.E317K</a>
PRKCQ	Missense_Mutation	p.M125I	C	C		7	Cancer Module	10	6549402	6549402	328	0.216463414634146	NA	NA	NA		p.M125I(1)	45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCQ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,6549402,C,C&fts=all">p.M125I</a>
PRKD3	Missense_Mutation	p.P375S	G	G		7	Cancer Module	2	37506938	37506938	403	0.287841191066998	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,37506938,G,G&fts=all">p.P375S</a>
PRKG1	Missense_Mutation	p.P100L	C	C		7	Cancer Module	10	52834649	52834649	23	0.260869565217391	NA	NA	NA			53	Required for dimerization.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,52834649,C,C&fts=all">p.P100L</a>
PRKG2	Missense_Mutation	p.H106Y	G	G		7	Cancer Module	4	82125886	82125886	117	0.256410256410256	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,82125886,G,G&fts=all">p.H106Y</a>
PRLR	Nonsense_Mutation	p.R171*	G	G	rs376188691	7	Cancer Module	5	35072709	35072709	201	0.26865671641791	NA	NA	NA			48	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRLR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,35072709,G,G&fts=all">p.R171*</a>
PROX1	Missense_Mutation	p.S79L	C	C		7	Cancer Module	1	214170114	214170114	109	0.238532110091743	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,214170114,C,C&fts=all">p.S79L</a>
PROX1	Missense_Mutation	p.E122K	G	G		7	Cancer Module	1	214170242	214170242	129	0.209302325581395	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,214170242,G,G&fts=all">p.E122K</a>
PROX1	Missense_Mutation	p.E170K	G	G		7	Cancer Module	1	214170386	214170386	90	0.144444444444444	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,214170386,G,G&fts=all">p.E170K</a>
PROX1	Nonsense_Mutation	p.Q259*	C	C		7	Cancer Module	1	214170653	214170653	47	0.404255319148936	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,214170653,C,C&fts=all">p.Q259*</a>
PRR4	Missense_Mutation	p.E52K	C	C		7	Cancer Module	12	10999913	10999913	211	0.227488151658768	NA	NA	NA			9	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,10999913,C,C&fts=all">p.E52K</a>
PRSS8	Missense_Mutation	p.G32R	C	C	rs201632910	7	Cancer Module	16	31146484	31146484	22	0.227272727272727	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRSS8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,31146484,C,C&fts=all">p.G32R</a>
PRX	Missense_Mutation	p.E73K	C	C		7	Cancer Module	19	40904691	40904691	61	0.245901639344262	NA	NA	NA			47	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,40904691,C,C&fts=all">p.E73K</a>
PSD	Missense_Mutation	p.S313L	G	G		7	Cancer Module	10	104174806	104174806	23	0.260869565217391	NA	NA	NA		p.S98L(1)|p.S313L(1)	34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,104174806,G,G&fts=all">p.S313L</a>
PSD4	Missense_Mutation	p.T73P	A	A		7	Cancer Module	2	113940250	113940250	15	0.4	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,113940250,A,A&fts=all">p.T73P</a>
PSD4	Missense_Mutation	p.R401K	G	G		7	Cancer Module	2	113942970	113942970	132	0.310606060606061	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,113942970,G,G&fts=all">p.R401K</a>
PSD4	Missense_Mutation	p.R555K	G	G		7	Cancer Module	2	113950076	113950076	65	0.307692307692308	NA	NA	NA			29	SEC7. {ECO:0000255|PROSITE- ProRule:PRU00189}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,113950076,G,G&fts=all">p.R555K</a>
PSG11	Missense_Mutation	p.G254E	C	C		7	Cancer Module	19	43519471	43519471	81	0.333333333333333	NA	NA	NA			26	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,43519471,C,C&fts=all">p.G254E</a>
PSG5	Missense_Mutation	p.T245I	G	G		7	Cancer Module	19	43680276	43680276	157	0.254777070063694	NA	NA	NA			35	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,43680276,G,G&fts=all">p.T245I</a>
PSG5	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	19	43702429	43757800	NA	NA	4	-1.36178711457659	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG5&recr=Open">Click here</a>	
PSG9	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	19	43702429	43757800	NA	NA	4	-1.36178711457659	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG9&recr=Open">Click here</a>	
PTGER2	Nonsense_Mutation	p.W296*	G	G		7	Cancer Module	14	52793983	52793983	105	0.4	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGER2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,52793983,G,G&fts=all">p.W296*</a>
PTGER3	Nonsense_Mutation	p.Q283*	G	G		7	Cancer Module	1	71512414	71512414	34	0.323529411764706	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGER3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,71512414,G,G&fts=all">p.Q283*</a>
PTGER3	Missense_Mutation	p.R259C	G	G		7	Cancer Module	1	71512486	71512486	42	0.357142857142857	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGER3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,71512486,G,G&fts=all">p.R259C</a>
PTGIS	Missense_Mutation	p.R245K	C	C		7	Cancer Module	20	48140716	48140716	59	0.338983050847458	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGIS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,48140716,C,C&fts=all">p.R245K</a>
PTGS1	Missense_Mutation	p.P188L	C	C		7	Cancer Module	9	125143716	125143716	32	0.375	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,125143716,C,C&fts=all">p.P188L</a>
PTGS1	Missense_Mutation	p.E404K	G	G	rs200616613	7	Cancer Module	9	125148925	125148925	69	0.144927536231884	NA	NA	NA		p.E404K(1)	8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,125148925,G,G&fts=all">p.E404K</a>
PTH2R	Splice_Site	p.E60G	A	A		7	Cancer Module	2	209302262	209302262	112	0.330357142857143	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTH2R&recr=Open">Click here</a>	
PTH2R	Missense_Mutation	p.M112L	A	A		7	Cancer Module	2	209302529	209302529	183	0.278688524590164	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTH2R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,209302529,A,A&fts=all">p.M112L</a>
PTK7	Missense_Mutation	p.P678L	C	C		7	Cancer Module	6	43110023	43110023	44	0.272727272727273	NA	NA	NA			46	Ig-like C2-type 7.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,43110023,C,C&fts=all">p.P678L</a>
PTPN13	Missense_Mutation	p.E485K	G	G		7	Cancer Module	4	87643432	87643432	171	0.345029239766082	NA	NA	NA			93			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPN13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,87643432,G,G&fts=all">p.E485K</a>
PTPN13	Missense_Mutation	p.S2023L	C	C		7	Cancer Module	4	87705646	87705646	101	0.247524752475248	NA	NA	NA			93			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPN13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,87705646,C,C&fts=all">p.S2023L</a>
PTPN22	Missense_Mutation	p.G743E	C	C		7	Cancer Module	1	114372236	114372236	337	0.181008902077151	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPN22&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,114372236,C,C&fts=all">p.G743E</a>
PTPN3	Missense_Mutation	p.S467F	G	G		7	Cancer Module	9	112172609	112172609	121	0.619834710743802	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,112172609,G,G&fts=all">p.S467F</a>
PTPN3	Missense_Mutation	p.E387K	C	C		7	Cancer Module	9	112182858	112182858	92	0.33695652173913	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,112182858,C,C&fts=all">p.E387K</a>
PTPN6	Missense_Mutation	p.R407W	C	C		7	Cancer Module	12	7067094	7067094	187	0.251336898395722	NA	NA	NA			18	Tyrosine-protein phosphatase. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPN6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7067094,C,C&fts=all">p.R407W</a>
PTPRC	Missense_Mutation	p.S185F	C	C		7	Cancer Module	1	198671630	198671630	212	0.462264150943396	NA	NA	NA			111			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,198671630,C,C&fts=all">p.S185F</a>
PTPRC	Missense_Mutation	p.S1004F	C	C		7	Cancer Module	1	198718617	198718617	157	0.286624203821656	NA	NA	NA			111	Tyrosine-protein phosphatase 2. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,198718617,C,C&fts=all">p.S1004F</a>
PTPRC	Missense_Mutation	p.E1136K	G	G	rs267598281	7	Cancer Module	1	198721798	198721798	163	0.226993865030675	NA	NA	NA		p.E1134K(1)	111	Tyrosine-protein phosphatase 2. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,198721798,G,G&fts=all">p.E1136K</a>
PTPRD	Missense_Mutation	p.G592S	C	C		7	Cancer Module	9	8504309	8504309	89	0.359550561797753	NA	NA	NA			168	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,8504309,C,C&fts=all">p.G592S</a>
PTPRD	Missense_Mutation	p.G327R	C	C		7	Cancer Module	9	8518412	8518412	72	0.597222222222222	NA	NA	NA			168	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,8518412,C,C&fts=all">p.G327R</a>
PTPRE	Splice_Site	p.E242K	G	G		7	Cancer Module	10	129864339	129864339	154	0.538961038961039	NA	NA	NA			22	Tyrosine-protein phosphatase 1. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRE&recr=Open">Click here</a>	
PTPRE	Missense_Mutation	p.R649Q	G	G	rs199816020	7	Cancer Module	10	129877877	129877877	107	0.261682242990654	NA	NA	NA			22	Tyrosine-protein phosphatase 2. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,129877877,G,G&fts=all">p.R649Q</a>
PTPRF	Missense_Mutation	p.R1522Q	G	G	rs70937045	7	Cancer Module	1	44084819	44084819	27	0.814814814814815	NA	NA	NA		p.R1521Q(2)	72	Tyrosine-protein phosphatase 1. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,44084819,G,G&fts=all">p.R1522Q</a>
PTPRG	Nonsense_Mutation	p.W762*	G	G		7	Cancer Module	3	62204655	62204655	179	0.446927374301676	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,62204655,G,G&fts=all">p.W762*</a>
PTPRG	Missense_Mutation	p.E779K	G	G		7	Cancer Module	3	62216945	62216945	123	0.235772357723577	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,62216945,G,G&fts=all">p.E779K</a>
PTPRG	Missense_Mutation	p.A923V	C	C		7	Cancer Module	3	62253388	62253388	438	0.0410958904109589	NA	NA	NA			62	Tyrosine-protein phosphatase 1. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,62253388,C,C&fts=all">p.A923V</a>
PTPRH	Missense_Mutation	p.E253K	C	C		7	Cancer Module	19	55715279	55715279	252	0.202380952380952	NA	NA	NA			67	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55715279,C,C&fts=all">p.E253K</a>
PTPRM	Missense_Mutation	p.P61L	C	C		7	Cancer Module	18	7774255	7774255	196	0.352040816326531	NA	NA	NA			90	MAM. {ECO:0000255|PROSITE- ProRule:PRU00128}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,7774255,C,C&fts=all">p.P61L</a>
PTPRM	Frame_Shift_Del	p.N838fs	T	T		7	Cancer Module	18	8247904	8247904	131	0.847328244274809	NA	NA	NA			90			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRM&recr=Open">Click here</a>	
PTPRN	Missense_Mutation	p.P407L	G	G		7	Cancer Module	2	220164923	220164923	93	0.172043010752688	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,220164923,G,G&fts=all">p.P407L</a>
PTPRO	Missense_Mutation	p.E63K	G	G		7	Cancer Module	12	15637019	15637019	220	0.463636363636364	NA	NA	NA			74	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,15637019,G,G&fts=all">p.E63K</a>
PTPRO	Missense_Mutation	p.G392E	G	G		7	Cancer Module	12	15656911	15656911	344	0.450581395348837	NA	NA	NA			74	Fibronectin type-III 4. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,15656911,G,G&fts=all">p.G392E</a>
PTPRO	Missense_Mutation	p.E408K	G	G		7	Cancer Module	12	15656958	15656958	216	0.430555555555556	NA	NA	NA			74	Fibronectin type-III 4. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,15656958,G,G&fts=all">p.E408K</a>
PTPRS	Missense_Mutation	p.P338S	G	G		7	Cancer Module	19	5244470	5244470	36	0.194444444444444	NA	NA	NA			61	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,5244470,G,G&fts=all">p.P338S</a>
PTPRT	Missense_Mutation	p.F564I	A	A		7	Cancer Module	20	40980796	40980796	44	0.795454545454545	NA	NA	NA			176	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,40980796,A,A&fts=all">p.F564I</a>
PTX3	Missense_Mutation	p.C271Y	G	G		7	Cancer Module	3	157160434	157160434	122	0.540983606557377	NA	NA	NA			10	Pentaxin.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTX3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,157160434,G,G&fts=all">p.C271Y</a>
PVRL3	Nonsense_Mutation	p.Q136*	C	C		7	Cancer Module	3	110831191	110831191	153	0.0718954248366013	NA	NA	NA			19	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PVRL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,110831191,C,C&fts=all">p.Q136*</a>
PWP2	Missense_Mutation	p.H301Y	C	C		7	Cancer Module	21	45537765	45537765	223	0.174887892376682	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PWP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,45537765,C,C&fts=all">p.H301Y</a>
PWP2	Missense_Mutation	p.K773R	A	A		7	Cancer Module	21	45547990	45547990	23	0.260869565217391	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PWP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,45547990,A,A&fts=all">p.K773R</a>
PXMP2	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	12	133196162	133354393	NA	NA	79	-1.00781166374669	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXMP2&recr=Open">Click here</a>	
PZP	Missense_Mutation	p.S1077F	G	G		7	Cancer Module	12	9311080	9311080	242	0.243801652892562	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PZP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,9311080,G,G&fts=all">p.S1077F</a>
PZP	Missense_Mutation	p.E1036K	C	C		7	Cancer Module	12	9312565	9312565	273	0.399267399267399	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PZP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,9312565,C,C&fts=all">p.E1036K</a>
PZP	Missense_Mutation	p.P135S	G	G		7	Cancer Module	12	9355145	9355145	328	0.210365853658537	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PZP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,9355145,G,G&fts=all">p.P135S</a>
RAB3GAP2	Missense_Mutation	p.P394S	G	G		7	Cancer Module	1	220366672	220366672	206	0.266990291262136	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB3GAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,220366672,G,G&fts=all">p.P394S</a>
RABGAP1	Missense_Mutation	p.A266V	C	C		7	Cancer Module	9	125752366	125752366	216	0.662037037037037	NA	NA	NA			41	PID. {ECO:0000255|PROSITE- ProRule:PRU00148}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RABGAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,125752366,C,C&fts=all">p.A266V</a>
RABGAP1	Missense_Mutation	p.P390S	C	C		7	Cancer Module	9	125759604	125759604	106	0.273584905660377	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RABGAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,125759604,C,C&fts=all">p.P390S</a>
RABGAP1	Missense_Mutation	p.R871Q	G	G		7	Cancer Module	9	125852648	125852648	26	0.192307692307692	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RABGAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,125852648,G,G&fts=all">p.R871Q</a>
RAG1	Missense_Mutation	p.P6S	C	C		7	Cancer Module	11	36594870	36594870	121	0.479338842975207	NA	NA	NA			65	Interaction with importin alpha-1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,36594870,C,C&fts=all">p.P6S</a>
RAI1	Nonsense_Mutation	p.Q205*	C	C		7	Cancer Module	17	17696875	17696875	44	0.227272727272727	NA	NA	NA			48	Gln-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,17696875,C,C&fts=all">p.Q205*</a>
RAI1	Missense_Mutation	p.S358F	C	C		7	Cancer Module	17	17697335	17697335	72	0.25	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,17697335,C,C&fts=all">p.S358F</a>
RAI1	Missense_Mutation	p.P1206S	C	C		7	Cancer Module	17	17699878	17699878	40	0.3	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,17699878,C,C&fts=all">p.P1206S</a>
RAI2	Missense_Mutation	p.H417Y	G	G		7	Cancer Module	X	17818882	17818882	64	0.359375	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,17818882,G,G&fts=all">p.H417Y</a>
RANBP2	Missense_Mutation	p.D1041N	G	G		7	Cancer Module	2	109380116	109380116	314	0.315286624203822	NA	NA	NA			129			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RANBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,109380116,G,G&fts=all">p.D1041N</a>
RANBP2	Missense_Mutation	p.H1418Y	C	C		7	Cancer Module	2	109381247	109381247	240	0.320833333333333	NA	NA	NA			129			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RANBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,109381247,C,C&fts=all">p.H1418Y</a>
RARRES3	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	11	63283187	63342520	NA	NA	10	-1.2222962448729	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RARRES3&recr=Open">Click here</a>	
RASGRP3	Missense_Mutation	p.G110E	G	G		7	Cancer Module	2	33745712	33745712	204	0.294117647058824	NA	NA	NA			11	N-terminal Ras-GEF. {ECO:0000255|PROSITE- ProRule:PRU00135}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,33745712,G,G&fts=all">p.G110E</a>
RBBP6	Missense_Mutation	p.S1502F	C	C		7	Cancer Module	16	24582892	24582892	87	0.275862068965517	NA	NA	NA			46	Interaction with p53. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBBP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,24582892,C,C&fts=all">p.S1502F</a>
RBM23	Missense_Mutation	p.R123C	G	G	rs553269433	7	Cancer Module	14	23375438	23375438	55	0.872727272727273	NA	NA	NA			10	Arg-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM23&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,23375438,G,G&fts=all">p.R123C</a>
RBMS3	Missense_Mutation	p.P37S	C	C		7	Cancer Module	3	29476267	29476267	307	0.234527687296417	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBMS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,29476267,C,C&fts=all">p.P37S</a>
RBMXL2	Missense_Mutation	p.E21K	G	G		7	Cancer Module	11	7110412	7110412	11	0.818181818181818	NA	NA	NA			15	RRM. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBMXL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,7110412,G,G&fts=all">p.E21K</a>
RBP2	Missense_Mutation	p.G106D	C	C		7	Cancer Module	3	139173608	139173608	135	0.37037037037037	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,139173608,C,C&fts=all">p.G106D</a>
RCBTB2	Missense_Mutation	p.P302L	G	G		7	Cancer Module	13	49084786	49084786	228	0.258771929824561	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RCBTB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,49084786,G,G&fts=all">p.P302L</a>
RCBTB2	Missense_Mutation	p.P302S	G	G		7	Cancer Module	13	49084787	49084787	227	0.259911894273128	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RCBTB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,49084787,G,G&fts=all">p.P302S</a>
RD3	Missense_Mutation	p.M30I	C	C		7	Cancer Module	1	211654668	211654668	88	0.215909090909091	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,211654668,C,C&fts=all">p.M30I</a>
RECQL	Nonsense_Mutation	p.Q96*	G	G		7	Cancer Module	12	21643241	21643241	411	0.158150851581509	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RECQL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,21643241,G,G&fts=all">p.Q96*</a>
RECQL5	Missense_Mutation	p.E980K	C	C		7	Cancer Module	17	73623540	73623540	151	0.231788079470199	NA	NA	NA		p.E953K(1)	36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RECQL5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,73623540,C,C&fts=all">p.E980K</a>
REEP1	Missense_Mutation	p.G161E	C	C		7	Cancer Module	2	86459861	86459861	46	0.195652173913043	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REEP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,86459861,C,C&fts=all">p.G161E</a>
REG1B	Missense_Mutation	p.A82V	G	G		7	Cancer Module	2	79313569	79313569	132	0.204545454545455	NA	NA	NA			51	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REG1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,79313569,G,G&fts=all">p.A82V</a>
RELN	Nonsense_Mutation	p.Q3254*	G	G		7	Cancer Module	7	103130192	103130192	27	0.407407407407407	NA	NA	NA			227	EGF-like 8. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103130192,G,G&fts=all">p.Q3254*</a>
RELN	Missense_Mutation	p.S3149L	G	G		7	Cancer Module	7	103131274	103131274	24	0.375	NA	NA	NA			227			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103131274,G,G&fts=all">p.S3149L</a>
RELN	Missense_Mutation	p.G2662S	C	C		7	Cancer Module	7	103155767	103155767	19	0.473684210526316	NA	NA	NA			227			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103155767,C,C&fts=all">p.G2662S</a>
RELN	Missense_Mutation	p.G2315E	C	C		7	Cancer Module	7	103179761	103179761	113	0.389380530973451	NA	NA	NA			227			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103179761,C,C&fts=all">p.G2315E</a>
RELN	Missense_Mutation	p.P2038L	G	G		7	Cancer Module	7	103191703	103191703	33	0.484848484848485	NA	NA	NA			227			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103191703,G,G&fts=all">p.P2038L</a>
RELN	Missense_Mutation	p.H605Y	G	G		7	Cancer Module	7	103292187	103292187	54	0.407407407407407	NA	NA	NA			227			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103292187,G,G&fts=all">p.H605Y</a>
RELN	Missense_Mutation	p.S575P	A	A		7	Cancer Module	7	103293038	103293038	67	0.358208955223881	NA	NA	NA			227			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103293038,A,A&fts=all">p.S575P</a>
RELN	Missense_Mutation	p.R334C	G	G		7	Cancer Module	7	103338443	103338443	157	0.0318471337579618	NA	NA	NA			227			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103338443,G,G&fts=all">p.R334C</a>
REM2	Missense_Mutation	p.S93L	C	C		7	Cancer Module	14	23354057	23354057	70	0.914285714285714	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,23354057,C,C&fts=all">p.S93L</a>
REPS2	Missense_Mutation	p.P520S	C	C		7	Cancer Module	X	17121882	17121882	94	0.372340425531915	NA	NA	NA			17	Interaction with RALBP1.|Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REPS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,17121882,C,C&fts=all">p.P520S</a>
RERE	Missense_Mutation	p.R451C	G	G		7	Cancer Module	1	8425968	8425968	70	0.357142857142857	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RERE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,8425968,G,G&fts=all">p.R451C</a>
REV3L	Missense_Mutation	p.P667L	G	G		7	Cancer Module	6	111697558	111697558	122	0.442622950819672	NA	NA	NA			88			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REV3L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,111697558,G,G&fts=all">p.P667L</a>
RFPL3	Missense_Mutation	p.S53F	C	C		7	Cancer Module	22	32754303	32754303	98	0.204081632653061	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFPL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,32754303,C,C&fts=all">p.S53F</a>
RFTN1	Missense_Mutation	p.E230K	C	C		7	Cancer Module	3	16419363	16419363	47	0.319148936170213	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,16419363,C,C&fts=all">p.E230K</a>
RFX3	Missense_Mutation	p.P445S	G	G		7	Cancer Module	9	3270395	3270395	69	0.492753623188406	NA	NA	NA		p.P445S(1)	40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,3270395,G,G&fts=all">p.P445S</a>
RGL1	Missense_Mutation	p.S361F	C	C		7	Cancer Module	1	183857633	183857633	442	0.65158371040724	NA	NA	NA			51	Ras-GEF. {ECO:0000255|PROSITE- ProRule:PRU00168}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,183857633,C,C&fts=all">p.S361F</a>
RGR	Missense_Mutation	p.G208E	G	G		7	Cancer Module	10	86014180	86014180	64	0.234375	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,86014180,G,G&fts=all">p.G208E</a>
RGS10	Missense_Mutation	p.A102V	G	G	rs1802228	7	Cancer Module	10	121275115	121275115	194	0.484536082474227	NA	NA	NA			6	RGS. {ECO:0000255|PROSITE- ProRule:PRU00171}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,121275115,G,G&fts=all">p.A102V</a>
RGS2	Missense_Mutation	p.P145S	C	C		7	Cancer Module	1	192780269	192780269	285	0.252631578947368	NA	NA	NA			5	RGS. {ECO:0000255|PROSITE- ProRule:PRU00171}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,192780269,C,C&fts=all">p.P145S</a>
RGS7	Missense_Mutation	p.D405N	C	C		7	Cancer Module	1	240969496	240969496	156	0.25	NA	NA	NA			76	RGS. {ECO:0000255|PROSITE- ProRule:PRU00171}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,240969496,C,C&fts=all">p.D405N</a>
RGS7	Missense_Mutation	p.R44C	G	G		7	Cancer Module	1	241262011	241262011	159	0.157232704402516	NA	NA	NA		p.R44S(2)	76	DEP. {ECO:0000255|PROSITE- ProRule:PRU00066}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,241262011,G,G&fts=all">p.R44C</a>
RHAG	Missense_Mutation	p.E161K	C	C		7	Cancer Module	6	49585792	49585792	94	0.25531914893617	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHAG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,49585792,C,C&fts=all">p.E161K</a>
RIMS1	Missense_Mutation	p.P114S	C	C		7	Cancer Module	6	72806746	72806746	49	0.387755102040816	NA	NA	NA			102	RabBD. {ECO:0000255|PROSITE- ProRule:PRU00234}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,72806746,C,C&fts=all">p.P114S</a>
RIMS1	Missense_Mutation	p.P114L	C	C		7	Cancer Module	6	72806747	72806747	48	0.354166666666667	NA	NA	NA			102	RabBD. {ECO:0000255|PROSITE- ProRule:PRU00234}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,72806747,C,C&fts=all">p.P114L</a>
RIMS1	Missense_Mutation	p.R1352Q	G	G		7	Cancer Module	6	73023300	73023300	37	0.27027027027027	NA	NA	NA			102	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,73023300,G,G&fts=all">p.R1352Q</a>
RIMS2	Missense_Mutation	p.S289L	C	C		7	Cancer Module	8	104898359	104898359	173	0.219653179190751	NA	NA	NA		p.S289L(1)|p.S547L(1)|p.S319L(1)	144			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,104898359,C,C&fts=all">p.S289L</a>
RIMS2	Missense_Mutation	p.S1337F	C	C		7	Cancer Module	8	105263954	105263954	404	0.163366336633663	NA	NA	NA			144	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,105263954,C,C&fts=all">p.S1337F</a>
RIPK2	Missense_Mutation	p.L303H	T	T		7	Cancer Module	8	90792357	90792357	232	0.254310344827586	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIPK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,90792357,T,T&fts=all">p.L303H</a>
RNASE1	Missense_Mutation	p.E131K	C	C		7	Cancer Module	14	21269837	21269837	97	0.45360824742268	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNASE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,21269837,C,C&fts=all">p.E131K</a>
RNASET2	Splice_Site		C	C		7	Cancer Module	6	167343280	167343280	71	0.338028169014085	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNASET2&recr=Open">Click here</a>	
RND1	Missense_Mutation	p.P72S	G	G		7	Cancer Module	12	49255896	49255896	62	0.435483870967742	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RND1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,49255896,G,G&fts=all">p.P72S</a>
RNF123	Missense_Mutation	p.S92F	C	C		7	Cancer Module	3	49734823	49734823	62	0.258064516129032	NA	NA	NA			38	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF123&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49734823,C,C&fts=all">p.S92F</a>
RNF123	Missense_Mutation	p.R532C	C	C	rs372222420	7	Cancer Module	3	49739803	49739803	292	0.219178082191781	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF123&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49739803,C,C&fts=all">p.R532C</a>
RNF135	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF135&recr=Open">Click here</a>	
RNF216	Splice_Site	p.E23K	C	C		7	Cancer Module	7	5800634	5800634	244	0.25	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF216&recr=Open">Click here</a>	
RNF40	Missense_Mutation	p.G499D	G	G		7	Cancer Module	16	30779488	30779488	98	0.285714285714286	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30779488,G,G&fts=all">p.G499D</a>
RNF40	Missense_Mutation	p.P586L	C	C		7	Cancer Module	16	30779749	30779749	50	0.34	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30779749,C,C&fts=all">p.P586L</a>
RNPEP	Nonsense_Mutation	p.Q632*	C	C		7	Cancer Module	1	201974785	201974785	118	0.186440677966102	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNPEP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,201974785,C,C&fts=all">p.Q632*</a>
ROBO3	Missense_Mutation	p.P642L	C	C		7	Cancer Module	11	124744106	124744106	31	0.258064516129032	NA	NA	NA			35	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROBO3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,124744106,C,C&fts=all">p.P642L</a>
ROBO4	Missense_Mutation	p.G674E	C	C		7	Cancer Module	11	124757664	124757664	11	0.454545454545455	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROBO4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,124757664,C,C&fts=all">p.G674E</a>
ROR2	Splice_Site	p.Q462Q	C	C		7	Cancer Module	9	94488823	94488823	56	0.178571428571429	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROR2&recr=Open">Click here</a>	
ROR2	Missense_Mutation	p.G361R	C	C		7	Cancer Module	9	94493294	94493294	45	0.355555555555556	NA	NA	NA			71	Kringle. {ECO:0000255|PROSITE- ProRule:PRU00121}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,94493294,C,C&fts=all">p.G361R</a>
ROR2	Missense_Mutation	p.D167N	C	C		7	Cancer Module	9	94499796	94499796	59	0.338983050847458	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,94499796,C,C&fts=all">p.D167N</a>
RP1	Missense_Mutation	p.S28N	G	G		7	Cancer Module	8	55533609	55533609	126	0.23015873015873	NA	NA	NA			169			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55533609,G,G&fts=all">p.S28N</a>
RP1	Missense_Mutation	p.E97K	G	G		7	Cancer Module	8	55533815	55533815	76	0.210526315789474	NA	NA	NA			169	Doublecortin 1. {ECO:0000255|PROSITE- ProRule:PRU00072}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55533815,G,G&fts=all">p.E97K</a>
RP1	Nonsense_Mutation	p.W349*	G	G		7	Cancer Module	8	55537488	55537488	98	0.214285714285714	NA	NA	NA			169			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55537488,G,G&fts=all">p.W349*</a>
RP1	Missense_Mutation	p.E490K	G	G		7	Cancer Module	8	55537910	55537910	117	0.247863247863248	NA	NA	NA			169			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55537910,G,G&fts=all">p.E490K</a>
RP1	Missense_Mutation	p.A1176V	C	C		7	Cancer Module	8	55539969	55539969	147	0.272108843537415	NA	NA	NA			169			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55539969,C,C&fts=all">p.A1176V</a>
RP1	Missense_Mutation	p.S1233Y	C	C		7	Cancer Module	8	55540140	55540140	158	0.5	NA	NA	NA			169			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55540140,C,C&fts=all">p.S1233Y</a>
RP1	Missense_Mutation	p.G1383R	G	G		7	Cancer Module	8	55540589	55540589	126	0.0396825396825397	NA	NA	NA			169			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55540589,G,G&fts=all">p.G1383R</a>
RP1	Missense_Mutation	p.L1401F	C	C		7	Cancer Module	8	55540643	55540643	131	0.427480916030534	NA	NA	NA			169			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55540643,C,C&fts=all">p.L1401F</a>
RP1	Missense_Mutation	p.E1421D	A	A		7	Cancer Module	8	55540705	55540705	107	0.252336448598131	NA	NA	NA			169			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55540705,A,A&fts=all">p.E1421D</a>
RP1	Missense_Mutation	p.G1522R	G	G		7	Cancer Module	8	55541006	55541006	79	0.329113924050633	NA	NA	NA			169			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55541006,G,G&fts=all">p.G1522R</a>
RP1	Missense_Mutation	p.E1568K	G	G		7	Cancer Module	8	55541144	55541144	70	0.157142857142857	NA	NA	NA			169			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55541144,G,G&fts=all">p.E1568K</a>
RP1	Missense_Mutation	p.R2080S	A	A		7	Cancer Module	8	55542682	55542682	118	0.152542372881356	NA	NA	NA			169			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55542682,A,A&fts=all">p.R2080S</a>
RP2	Missense_Mutation	p.R211C	C	C	rs398124239	7	Cancer Module	X	46713439	46713439	100	0.4	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,46713439,C,C&fts=all">p.R211C</a>
RPAP1	Missense_Mutation	p.S143L	G	G		7	Cancer Module	15	41827823	41827823	93	0.344086021505376	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,41827823,G,G&fts=all">p.S143L</a>
RPE65	Missense_Mutation	p.E254K	C	C		7	Cancer Module	1	68904972	68904972	164	0.481707317073171	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPE65&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,68904972,C,C&fts=all">p.E254K</a>
RPF1	Missense_Mutation	p.E24K	G	G	rs202113477	7	Cancer Module	1	84945034	84945034	61	0.950819672131147	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,84945034,G,G&fts=all">p.E24K</a>
RPL18	Frame_Shift_Del	p.R91fs	G	G		7	Cancer Module	19	49120009	49120009	373	0.351206434316354	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPL18&recr=Open">Click here</a>	
RPL18	Missense_Mutation	p.R6H	C	C		7	Cancer Module	19	49121121	49121121	209	0.0287081339712919	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPL18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49121121,C,C&fts=all">p.R6H</a>
RRAD	Missense_Mutation	p.S299F	G	G		7	Cancer Module	16	66956010	66956010	37	0.486486486486487	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRAD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,66956010,G,G&fts=all">p.S299F</a>
RRP1	Nonsense_Mutation	p.W56*	G	G		7	Cancer Module	21	45211264	45211264	138	0.289855072463768	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,45211264,G,G&fts=all">p.W56*</a>
RSRC1	Missense_Mutation	p.S75F	C	C		7	Cancer Module	3	157841684	157841684	250	0.24	NA	NA	NA			18	Arg/Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSRC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,157841684,C,C&fts=all">p.S75F</a>
RTN1	Missense_Mutation	p.H91Y	G	G		7	Cancer Module	14	60213170	60213170	57	0.771929824561403	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,60213170,G,G&fts=all">p.H91Y</a>
RTTN	Missense_Mutation	p.A1651V	G	G		7	Cancer Module	18	67725057	67725057	36	0.777777777777778	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RTTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,67725057,G,G&fts=all">p.A1651V</a>
RYBP	Missense_Mutation	p.R183I	C	C		7	Cancer Module	3	72428454	72428454	504	0.0158730158730159	NA	NA	NA			2	Interaction with E4TF1B.|Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,72428454,C,C&fts=all">p.R183I</a>
RYR1	Missense_Mutation	p.D590N	G	G	rs552148844	7	Cancer Module	19	38946368	38946368	43	0.186046511627907	NA	NA	NA			285	B30.2/SPRY 1. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,38946368,G,G&fts=all">p.D590N</a>
RYR1	Missense_Mutation	p.E1175K	G	G		7	Cancer Module	19	38959747	38959747	82	0.195121951219512	NA	NA	NA			285	6 X approximate repeats.|B30.2/SPRY 2. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,38959747,G,G&fts=all">p.E1175K</a>
RYR1	Missense_Mutation	p.H2253Y	C	C		7	Cancer Module	19	38987142	38987142	48	0.125	NA	NA	NA			285	6 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,38987142,C,C&fts=all">p.H2253Y</a>
RYR1	Missense_Mutation	p.E3265G	A	A		7	Cancer Module	19	39008107	39008107	45	0.422222222222222	NA	NA	NA			285			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39008107,A,A&fts=all">p.E3265G</a>
RYR1	Missense_Mutation	p.P4761S	C	C		7	Cancer Module	19	39068666	39068666	28	0.142857142857143	NA	NA	NA			285			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39068666,C,C&fts=all">p.P4761S</a>
RYR2	Missense_Mutation	p.E1648K	G	G		7	Cancer Module	1	237777370	237777370	88	0.215909090909091	NA	NA	NA			586	4 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,237777370,G,G&fts=all">p.E1648K</a>
RYR2	Missense_Mutation	p.E1732K	G	G		7	Cancer Module	1	237777622	237777622	39	0.717948717948718	NA	NA	NA			586	4 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,237777622,G,G&fts=all">p.E1732K</a>
RYR2	Missense_Mutation	p.R2267C	C	C	rs554220274	7	Cancer Module	1	237801663	237801663	128	0.1640625	NA	NA	NA			586	4 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,237801663,C,C&fts=all">p.R2267C</a>
RYR2	Nonsense_Mutation	p.W2741*	G	G		7	Cancer Module	1	237823298	237823298	89	0.0898876404494382	NA	NA	NA			586	4 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,237823298,G,G&fts=all">p.W2741*</a>
RYR2	Nonsense_Mutation	p.L2980*	T	T		7	Cancer Module	1	237843799	237843799	47	0.170212765957447	NA	NA	NA			586			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,237843799,T,T&fts=all">p.L2980*</a>
RYR2	Missense_Mutation	p.S3224F	C	C		7	Cancer Module	1	237870339	237870339	176	0.204545454545455	NA	NA	NA			586			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,237870339,C,C&fts=all">p.S3224F</a>
RYR2	Missense_Mutation	p.P3258S	C	C	rs368028300	7	Cancer Module	1	237870440	237870440	47	0.170212765957447	NA	NA	NA		p.P3256T(1)	586			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,237870440,C,C&fts=all">p.P3258S</a>
RYR3	Missense_Mutation	p.D708N	G	G		7	Cancer Module	15	33895523	33895523	262	0.297709923664122	NA	NA	NA			311	B30.2/SPRY 1. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,33895523,G,G&fts=all">p.D708N</a>
RYR3	Missense_Mutation	p.P1687S	C	C		7	Cancer Module	15	33954790	33954790	91	0.296703296703297	NA	NA	NA			311	4 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,33954790,C,C&fts=all">p.P1687S</a>
RYR3	Missense_Mutation	p.D2722N	G	G	rs376553827	7	Cancer Module	15	34040696	34040696	44	0.5	NA	NA	NA			311	4 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,34040696,G,G&fts=all">p.D2722N</a>
RYR3	Missense_Mutation	p.G2985S	G	G		7	Cancer Module	15	34064257	34064257	44	0.386363636363636	NA	NA	NA			311			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,34064257,G,G&fts=all">p.G2985S</a>
RYR3	Missense_Mutation	p.D3187N	G	G		7	Cancer Module	15	34078153	34078153	164	0.658536585365854	NA	NA	NA			311			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,34078153,G,G&fts=all">p.D3187N</a>
RYR3	Missense_Mutation	p.E3567K	G	G		7	Cancer Module	15	34110878	34110878	42	0.285714285714286	NA	NA	NA			311			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,34110878,G,G&fts=all">p.E3567K</a>
RYR3	Nonsense_Mutation	p.W4211*	G	G		7	Cancer Module	15	34130813	34130813	50	0.38	NA	NA	NA			311			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,34130813,G,G&fts=all">p.W4211*</a>
RYR3	Missense_Mutation	p.E4785K	G	G		7	Cancer Module	15	34152849	34152849	39	0.179487179487179	NA	NA	NA			311			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,34152849,G,G&fts=all">p.E4785K</a>
S100A7	Missense_Mutation	p.S97F	G	G		7	Cancer Module	1	153430298	153430298	80	0.2	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+S100A7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,153430298,G,G&fts=all">p.S97F</a>
SAFB2	Missense_Mutation	p.P174S	G	G		7	Cancer Module	19	5616166	5616166	122	0.278688524590164	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAFB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,5616166,G,G&fts=all">p.P174S</a>
SAGE1	Missense_Mutation	p.S523T	G	G		7	Cancer Module	X	134991149	134991149	91	0.934065934065934	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAGE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,134991149,G,G&fts=all">p.S523T</a>
SAGE1	Missense_Mutation	p.S661L	C	C		7	Cancer Module	X	134992691	134992691	106	0.320754716981132	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAGE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,134992691,C,C&fts=all">p.S661L</a>
SAGE1	Missense_Mutation	p.K857N	A	A		7	Cancer Module	X	134994529	134994529	133	0.413533834586466	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAGE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,134994529,A,A&fts=all">p.K857N</a>
SALL2	Missense_Mutation	p.L980F	G	G		7	Cancer Module	14	21990924	21990924	58	0.379310344827586	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SALL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,21990924,G,G&fts=all">p.L980F</a>
SALL2	Nonsense_Mutation	p.Q34*	G	G		7	Cancer Module	14	21993762	21993762	35	0.8	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SALL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,21993762,G,G&fts=all">p.Q34*</a>
SAMHD1	Missense_Mutation	p.D314N	C	C		7	Cancer Module	20	35545365	35545365	97	0.762886597938144	NA	NA	NA			20	HD.|Substrate binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAMHD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,35545365,C,C&fts=all">p.D314N</a>
SAMSN1	Missense_Mutation	p.L89F	G	G		7	Cancer Module	21	15889227	15889227	138	0.123188405797101	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAMSN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,15889227,G,G&fts=all">p.L89F</a>
SAMSN1	Missense_Mutation	p.R31Q	C	C	rs199748093	7	Cancer Module	21	15893508	15893508	130	0.0615384615384615	NA	NA	NA		p.R31Q(2)|p.R99Q(1)	24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAMSN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,15893508,C,C&fts=all">p.R31Q</a>
SATB1	Missense_Mutation	p.L422M	A	A		7	Cancer Module	3	18428046	18428046	184	0.217391304347826	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SATB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,18428046,A,A&fts=all">p.L422M</a>
SATB1	Missense_Mutation	p.P352S	G	G		7	Cancer Module	3	18436106	18436106	200	0.245	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SATB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,18436106,G,G&fts=all">p.P352S</a>
SATB1	Missense_Mutation	p.G37R	C	C		7	Cancer Module	3	18462351	18462351	252	0.523809523809524	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SATB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,18462351,C,C&fts=all">p.G37R</a>
SC5D	Missense_Mutation	p.S259F	C	C		7	Cancer Module	11	121178097	121178097	144	0.770833333333333	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SC5D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,121178097,C,C&fts=all">p.S259F</a>
SCAP	Missense_Mutation	p.P48L	G	G		7	Cancer Module	3	47476607	47476607	82	0.292682926829268	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,47476607,G,G&fts=all">p.P48L</a>
SCAPER	Missense_Mutation	p.S840F	G	G		7	Cancer Module	15	76958120	76958120	9	0.333333333333333	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAPER&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,76958120,G,G&fts=all">p.S840F</a>
SCAPER	Missense_Mutation	p.R713C	G	G		7	Cancer Module	15	77020964	77020964	259	0.27027027027027	NA	NA	NA			39	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAPER&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,77020964,G,G&fts=all">p.R713C</a>
SCARA3	Missense_Mutation	p.D19N	G	G		7	Cancer Module	8	27507266	27507266	30	0.3	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCARA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,27507266,G,G&fts=all">p.D19N</a>
SCARA3	Missense_Mutation	p.G484R	G	G		7	Cancer Module	8	27528497	27528497	81	0.246913580246914	NA	NA	NA			9	Collagen-like 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCARA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,27528497,G,G&fts=all">p.G484R</a>
SCEL	Missense_Mutation	p.D93E	C	C		7	Cancer Module	13	78138023	78138023	256	0.265625	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCEL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,78138023,C,C&fts=all">p.D93E</a>
SCEL	Missense_Mutation	p.R319K	G	G		7	Cancer Module	13	78176238	78176238	185	0.291891891891892	NA	NA	NA			40	16 X approximate tandem repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCEL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,78176238,G,G&fts=all">p.R319K</a>
SCEL	Splice_Site		G	G		7	Cancer Module	13	78182190	78182190	65	0.353846153846154	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCEL&recr=Open">Click here</a>	
SCEL	Splice_Site	p.G426R	G	G		7	Cancer Module	13	78183251	78183251	144	0.25	NA	NA	NA			40	16 X approximate tandem repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCEL&recr=Open">Click here</a>	
SCG2	Nonsense_Mutation	p.Q459*	G	G		7	Cancer Module	2	224462626	224462626	225	0.275555555555556	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,224462626,G,G&fts=all">p.Q459*</a>
SCN2A	Missense_Mutation	p.H689Y	C	C		7	Cancer Module	2	166183410	166183410	230	0.308695652173913	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,166183410,C,C&fts=all">p.H689Y</a>
SCN4A	Splice_Site		C	C		7	Cancer Module	17	62036624	62036624	60	0.616666666666667	NA	NA	NA			101			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN4A&recr=Open">Click here</a>	
SCN5A	Missense_Mutation	p.F1768Y	A	A		7	Cancer Module	3	38592461	38592461	39	0.205128205128205	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38592461,A,A&fts=all">p.F1768Y</a>
SCN5A	Missense_Mutation	p.E1064K	C	C		7	Cancer Module	3	38622460	38622460	40	0.2	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38622460,C,C&fts=all">p.E1064K</a>
SCN5A	Missense_Mutation	p.D1041N	C	C	rs45491996	7	Cancer Module	3	38622529	38622529	37	0.162162162162162	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38622529,C,C&fts=all">p.D1041N</a>
SCN7A	Missense_Mutation	p.S382F	G	G		7	Cancer Module	2	167313525	167313525	58	0.224137931034483	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,167313525,G,G&fts=all">p.S382F</a>
SCN7A	Missense_Mutation	p.K27Q	T	T		7	Cancer Module	2	167334128	167334128	34	0.382352941176471	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,167334128,T,T&fts=all">p.K27Q</a>
SCN8A	Missense_Mutation	p.S1943F	C	C		7	Cancer Module	12	52201098	52201098	22	0.318181818181818	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN8A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,52201098,C,C&fts=all">p.S1943F</a>
SCN9A	Missense_Mutation	p.E180K	C	C		7	Cancer Module	2	167162360	167162360	107	0.317757009345794	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN9A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,167162360,C,C&fts=all">p.E180K</a>
SCN9A	Missense_Mutation	p.E73K	C	C		7	Cancer Module	2	167168050	167168050	96	0.333333333333333	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN9A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,167168050,C,C&fts=all">p.E73K</a>
SCNN1A	Splice_Site		C	C		7	Cancer Module	12	6464942	6464942	267	0.239700374531835	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCNN1A&recr=Open">Click here</a>	
SCNN1G	Missense_Mutation	p.K570N	G	G		7	Cancer Module	16	23226550	23226550	40	0.175	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCNN1G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,23226550,G,G&fts=all">p.K570N</a>
SCNN1G	Missense_Mutation	p.P625S	C	C		7	Cancer Module	16	23226713	23226713	40	0.35	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCNN1G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,23226713,C,C&fts=all">p.P625S</a>
SCO2	Missense_Mutation	p.K214T	T	T		7	Cancer Module	22	50962200	50962200	211	0.199052132701422	NA	NA	NA			2	Thioredoxin. {ECO:0000255|PROSITE- ProRule:PRU00691}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,50962200,T,T&fts=all">p.K214T</a>
SCTR	Missense_Mutation	p.Q327H	T	T		7	Cancer Module	2	120206297	120206297	52	0.269230769230769	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCTR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,120206297,T,T&fts=all">p.Q327H</a>
SCYL3	Nonsense_Mutation	p.W615*	C	C		7	Cancer Module	1	169823735	169823735	242	0.21900826446281	NA	NA	NA			27	Interaction with EZR.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCYL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,169823735,C,C&fts=all">p.W615*</a>
SEC14L1	Missense_Mutation	p.G499R	G	G		7	Cancer Module	17	75205442	75205442	88	0.170454545454545	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC14L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,75205442,G,G&fts=all">p.G499R</a>
SEC14L1	Missense_Mutation	p.G499E	G	G		7	Cancer Module	17	75205443	75205443	89	0.168539325842697	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC14L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,75205443,G,G&fts=all">p.G499E</a>
SEC16A	Missense_Mutation	p.P1682S	G	G		7	Cancer Module	9	139350591	139350591	80	0.275	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC16A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,139350591,G,G&fts=all">p.P1682S</a>
SEC16A	Missense_Mutation	p.P1056S	G	G		7	Cancer Module	9	139366431	139366431	62	0.306451612903226	NA	NA	NA			51	Required for endoplasmic reticulum localization.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC16A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,139366431,G,G&fts=all">p.P1056S</a>
SEC23A	Missense_Mutation	p.I408L	T	T		7	Cancer Module	14	39536382	39536382	271	0.029520295202952	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC23A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,39536382,T,T&fts=all">p.I408L</a>
SEC23B	Missense_Mutation	p.R313C	C	C	rs111758941	7	Cancer Module	20	18507119	18507119	116	0.275862068965517	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC23B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,18507119,C,C&fts=all">p.R313C</a>
SEC31A	Missense_Mutation	p.R254C	G	G		7	Cancer Module	4	83793119	83793119	173	0.300578034682081	NA	NA	NA			1	Interaction with SEC13.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC31A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,83793119,G,G&fts=all">p.R254C</a>
SEC31B	Missense_Mutation	p.S993F	G	G		7	Cancer Module	10	102249506	102249506	82	0.182926829268293	NA	NA	NA			36	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC31B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,102249506,G,G&fts=all">p.S993F</a>
SEC31B	Missense_Mutation	p.G514E	C	C		7	Cancer Module	10	102258960	102258960	47	0.382978723404255	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC31B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,102258960,C,C&fts=all">p.G514E</a>
SEC31B	Missense_Mutation	p.G514R	C	C		7	Cancer Module	10	102258961	102258961	48	0.416666666666667	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC31B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,102258961,C,C&fts=all">p.G514R</a>
SELE	Missense_Mutation	p.P263S	G	G		7	Cancer Module	1	169698743	169698743	174	0.183908045977011	NA	NA	NA			32	Sushi 2. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SELE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,169698743,G,G&fts=all">p.P263S</a>
SELE	Missense_Mutation	p.S147F	G	G		7	Cancer Module	1	169701065	169701065	59	0.627118644067797	NA	NA	NA		p.S147F(1)	32	EGF-like. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SELE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,169701065,G,G&fts=all">p.S147F</a>
SELP	Missense_Mutation	p.E770K	C	C		7	Cancer Module	1	169562942	169562942	111	0.468468468468468	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SELP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,169562942,C,C&fts=all">p.E770K</a>
SELP	Missense_Mutation	p.P626S	G	G		7	Cancer Module	1	169566244	169566244	163	0.208588957055215	NA	NA	NA		p.P626T(1)	60	Sushi 7. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SELP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,169566244,G,G&fts=all">p.P626S</a>
SELP	Missense_Mutation	p.G543R	C	C		7	Cancer Module	1	169572342	169572342	111	0.279279279279279	NA	NA	NA			60	Sushi 6. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SELP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,169572342,C,C&fts=all">p.G543R</a>
SEMA3A	Missense_Mutation	p.P415S	G	G		7	Cancer Module	7	83634772	83634772	153	0.38562091503268	NA	NA	NA			53	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,83634772,G,G&fts=all">p.P415S</a>
SEMA3A	Missense_Mutation	p.D360N	C	C		7	Cancer Module	7	83636731	83636731	120	0.441666666666667	NA	NA	NA			53	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,83636731,C,C&fts=all">p.D360N</a>
SEMA4D	Missense_Mutation	p.D837N	C	C		7	Cancer Module	9	91993699	91993699	60	0.266666666666667	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA4D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,91993699,C,C&fts=all">p.D837N</a>
SEMA5B	Missense_Mutation	p.G613S	C	C		7	Cancer Module	3	122634438	122634438	8	0.375	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,122634438,C,C&fts=all">p.G613S</a>
SEMA6B	Missense_Mutation	p.P416L	G	G		7	Cancer Module	19	4550159	4550159	27	0.444444444444444	NA	NA	NA			21	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA6B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4550159,G,G&fts=all">p.P416L</a>
SEMA6B	Missense_Mutation	p.E247K	C	C		7	Cancer Module	19	4554432	4554432	46	0.239130434782609	NA	NA	NA			21	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA6B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4554432,C,C&fts=all">p.E247K</a>
SEMA6C	Missense_Mutation	p.S213F	G	G		7	Cancer Module	1	151110491	151110491	49	0.224489795918367	NA	NA	NA			28	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA6C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,151110491,G,G&fts=all">p.S213F</a>
SEMA7A	Missense_Mutation	p.P101S	G	G		7	Cancer Module	15	74711171	74711171	152	0.25	NA	NA	NA			30	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,74711171,G,G&fts=all">p.P101S</a>
SEMG2	Missense_Mutation	p.S37F	C	C		7	Cancer Module	20	43850383	43850383	143	0.398601398601399	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,43850383,C,C&fts=all">p.S37F</a>
SEMG2	Missense_Mutation	p.E294K	G	G		7	Cancer Module	20	43851153	43851153	60	0.8	NA	NA	NA			36	4 X 60 AA tandem repeats, type I.|Repeat-rich region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,43851153,G,G&fts=all">p.E294K</a>
SEMG2	Missense_Mutation	p.R391K	G	G	rs375946828	7	Cancer Module	20	43851445	43851445	77	0.857142857142857	NA	NA	NA			36	4 X 60 AA tandem repeats, type I.|Repeat-rich region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,43851445,G,G&fts=all">p.R391K</a>
SERPINA5	Missense_Mutation	p.S311F	C	C	rs140870466	7	Cancer Module	14	95057127	95057127	66	0.318181818181818	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,95057127,C,C&fts=all">p.S311F</a>
SERPIND1	Missense_Mutation	p.G491E	G	G		7	Cancer Module	22	21141326	21141326	126	0.53968253968254	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPIND1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,21141326,G,G&fts=all">p.G491E</a>
SERPINF1	Missense_Mutation	p.R69Q	G	G	rs151059657	7	Cancer Module	17	1673267	1673267	88	0.238636363636364	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,1673267,G,G&fts=all">p.R69Q</a>
SERPINI1	Missense_Mutation	p.G221E	G	G		7	Cancer Module	3	167510558	167510558	216	0.0324074074074074	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,167510558,G,G&fts=all">p.G221E</a>
SESN2	Missense_Mutation	p.P143L	C	C		7	Cancer Module	1	28598868	28598868	101	0.633663366336634	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SESN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,28598868,C,C&fts=all">p.P143L</a>
SETBP1	Missense_Mutation	p.S305F	C	C		7	Cancer Module	18	42530219	42530219	50	0.88	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,42530219,C,C&fts=all">p.S305F</a>
SEZ6L	Missense_Mutation	p.G37E	G	G		7	Cancer Module	22	26688387	26688387	56	0.125	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEZ6L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,26688387,G,G&fts=all">p.G37E</a>
SEZ6L	Missense_Mutation	p.P204S	C	C		7	Cancer Module	22	26688887	26688887	63	0.111111111111111	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEZ6L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,26688887,C,C&fts=all">p.P204S</a>
SEZ6L	Missense_Mutation	p.P204L	C	C		7	Cancer Module	22	26688888	26688888	62	0.0967741935483871	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEZ6L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,26688888,C,C&fts=all">p.P204L</a>
SEZ6L	Missense_Mutation	p.T898I	C	C		7	Cancer Module	22	26761431	26761431	91	0.285714285714286	NA	NA	NA			80	Sushi 5. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEZ6L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,26761431,C,C&fts=all">p.T898I</a>
SEZ6L2	Missense_Mutation	p.R258W	G	G		7	Cancer Module	16	29906661	29906661	99	0.343434343434343	NA	NA	NA			39	CUB 1. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEZ6L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,29906661,G,G&fts=all">p.R258W</a>
SGSH	Missense_Mutation	p.L348P	A	A		7	Cancer Module	17	78184717	78184717	105	0.780952380952381	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGSH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,78184717,A,A&fts=all">p.L348P</a>
SH3BGR	Missense_Mutation	p.S97F	C	C		7	Cancer Module	21	40883698	40883698	46	0.521739130434783	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3BGR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,40883698,C,C&fts=all">p.S97F</a>
SH3BP1	Missense_Mutation	p.I138L	A	A		7	Cancer Module	22	38039120	38039120	33	0.272727272727273	NA	NA	NA			13	BAR. {ECO:0000255|PROSITE- ProRule:PRU00361}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3BP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38039120,A,A&fts=all">p.I138L</a>
SH3BP4	Missense_Mutation	p.S19L	C	C		7	Cancer Module	2	235943702	235943702	54	0.333333333333333	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3BP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,235943702,C,C&fts=all">p.S19L</a>
SH3BP4	Missense_Mutation	p.A616V	C	C		7	Cancer Module	2	235951260	235951260	43	0.372093023255814	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3BP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,235951260,C,C&fts=all">p.A616V</a>
SH3GL3	Missense_Mutation	p.F110V	T	T		7	Cancer Module	15	84237421	84237421	51	0.352941176470588	NA	NA	NA			30	BAR. {ECO:0000255|PROSITE- ProRule:PRU00361}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3GL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,84237421,T,T&fts=all">p.F110V</a>
SH3GL3	Missense_Mutation	p.G332R	G	G		7	Cancer Module	15	84286989	84286989	127	0.275590551181102	NA	NA	NA			30	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3GL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,84286989,G,G&fts=all">p.G332R</a>
SHBG	Missense_Mutation	p.E355A	A	A	rs5030659	7	Cancer Module	17	7536525	7536525	115	0.321739130434783	NA	NA	NA		p.0?(1)|p.?(1)	10	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHBG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7536525,A,A&fts=all">p.E355A</a>
SIDT2	Splice_Site		G	G		7	Cancer Module	11	117063535	117063535	37	0.864864864864865	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIDT2&recr=Open">Click here</a>	
SIGLEC7	Missense_Mutation	p.G69E	G	G		7	Cancer Module	19	51645832	51645832	58	0.0689655172413793	NA	NA	NA			29	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51645832,G,G&fts=all">p.G69E</a>
SIGLEC7	Missense_Mutation	p.G99E	G	G		7	Cancer Module	19	51645922	51645922	98	0.285714285714286	NA	NA	NA			29	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51645922,G,G&fts=all">p.G99E</a>
SIGLEC7	Missense_Mutation	p.R124C	C	C		7	Cancer Module	19	51645996	51645996	66	0.257575757575758	NA	NA	NA		p.R124C(1)	29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51645996,C,C&fts=all">p.R124C</a>
SIGLEC7	Missense_Mutation	p.P282S	C	C		7	Cancer Module	19	51649195	51649195	101	0.148514851485149	NA	NA	NA			29	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51649195,C,C&fts=all">p.P282S</a>
SIM1	Missense_Mutation	p.G408E	C	C		7	Cancer Module	6	100841710	100841710	44	0.5	NA	NA	NA			79	Single-minded C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00632}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,100841710,C,C&fts=all">p.G408E</a>
SIM1	Missense_Mutation	p.S159F	G	G		7	Cancer Module	6	100897306	100897306	21	0.238095238095238	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,100897306,G,G&fts=all">p.S159F</a>
SIM2	Missense_Mutation	p.P508T	C	C		7	Cancer Module	21	38117383	38117383	24	0.291666666666667	NA	NA	NA			16	Single-minded C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00632}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,38117383,C,C&fts=all">p.P508T</a>
SIPA1L3	Missense_Mutation	p.L602F	C	C		7	Cancer Module	19	38590740	38590740	48	0.1875	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIPA1L3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,38590740,C,C&fts=all">p.L602F</a>
SKAP2	Missense_Mutation	p.F301L	A	A		7	Cancer Module	7	26724441	26724441	217	0.617511520737327	NA	NA	NA			17	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SKAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,26724441,A,A&fts=all">p.F301L</a>
SLC10A2	Missense_Mutation	p.E261K	C	C		7	Cancer Module	13	103701777	103701777	63	0.412698412698413	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC10A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,103701777,C,C&fts=all">p.E261K</a>
SLC12A5	Missense_Mutation	p.E797K	G	G		7	Cancer Module	20	44681607	44681607	4	0.75	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC12A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,44681607,G,G&fts=all">p.E797K</a>
SLC14A2	Missense_Mutation	p.E278K	G	G		7	Cancer Module	18	43217136	43217136	27	0.296296296296296	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC14A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,43217136,G,G&fts=all">p.E278K</a>
SLC14A2	Splice_Site	p.D520N	G	G		7	Cancer Module	18	43246900	43246900	47	0.468085106382979	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC14A2&recr=Open">Click here</a>	
SLC15A1	Missense_Mutation	p.E26Q	C	C	rs558276843	7	Cancer Module	13	99378649	99378649	71	0.267605633802817	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC15A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,99378649,C,C&fts=all">p.E26Q</a>
SLC17A2	Missense_Mutation	p.S352L	G	G		7	Cancer Module	6	25915972	25915972	121	0.198347107438017	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,25915972,G,G&fts=all">p.S352L</a>
SLC17A2	Nonsense_Mutation	p.L337*	A	A		7	Cancer Module	6	25916017	25916017	72	0.486111111111111	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,25916017,A,A&fts=all">p.L337*</a>
SLC17A7	Missense_Mutation	p.M387I	C	C		7	Cancer Module	19	49934695	49934695	30	0.166666666666667	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49934695,C,C&fts=all">p.M387I</a>
SLC17A8	Missense_Mutation	p.M392I	G	G		7	Cancer Module	12	100797938	100797938	75	0.4	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,100797938,G,G&fts=all">p.M392I</a>
SLC18A1	Missense_Mutation	p.P113L	G	G		7	Cancer Module	8	20036782	20036782	173	0.190751445086705	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC18A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,20036782,G,G&fts=all">p.P113L</a>
SLC18A2	Missense_Mutation	p.G205S	G	G		7	Cancer Module	10	119013921	119013921	60	0.166666666666667	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC18A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,119013921,G,G&fts=all">p.G205S</a>
SLC1A3	Missense_Mutation	p.E230K	G	G		7	Cancer Module	5	36677114	36677114	134	0.23134328358209	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC1A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,36677114,G,G&fts=all">p.E230K</a>
SLC1A7	Missense_Mutation	p.P324L	G	G		7	Cancer Module	1	53558286	53558286	24	0.75	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC1A7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,53558286,G,G&fts=all">p.P324L</a>
SLC22A14	Missense_Mutation	p.R241C	C	C	rs546996289	7	Cancer Module	3	38349157	38349157	192	0.473958333333333	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38349157,C,C&fts=all">p.R241C</a>
SLC22A14	Missense_Mutation	p.L567F	C	C		7	Cancer Module	3	38357981	38357981	43	0.441860465116279	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38357981,C,C&fts=all">p.L567F</a>
SLC22A16	Missense_Mutation	p.P400L	G	G		7	Cancer Module	6	110760035	110760035	44	0.477272727272727	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,110760035,G,G&fts=all">p.P400L</a>
SLC22A2	Missense_Mutation	p.G439R	C	C		7	Cancer Module	6	160663399	160663399	107	0.364485981308411	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,160663399,C,C&fts=all">p.G439R</a>
SLC22A2	Missense_Mutation	p.G238E	C	C		7	Cancer Module	6	160670377	160670377	88	0.329545454545455	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,160670377,C,C&fts=all">p.G238E</a>
SLC22A3	Splice_Site	p.W286*	G	G		7	Cancer Module	6	160829953	160829953	71	0.492957746478873	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A3&recr=Open">Click here</a>	
SLC22A3	Splice_Site		T	T		7	Cancer Module	6	160829955	160829955	67	0.477611940298507	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A3&recr=Open">Click here</a>	
SLC25A16	Nonsense_Mutation	p.R297*	G	G	rs139107749	7	Cancer Module	10	70243299	70243299	320	0.221875	NA	NA	NA		p.R297*(1)	7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,70243299,G,G&fts=all">p.R297*</a>
SLC26A3	Missense_Mutation	p.F764S	A	A		7	Cancer Module	7	107406304	107406304	213	0.0375586854460094	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,107406304,A,A&fts=all">p.F764S</a>
SLC26A3	Missense_Mutation	p.G429E	C	C		7	Cancer Module	7	107423267	107423267	93	0.838709677419355	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,107423267,C,C&fts=all">p.G429E</a>
SLC26A3	Missense_Mutation	p.R52K	C	C	rs386833456	7	Cancer Module	7	107434303	107434303	104	0.125	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,107434303,C,C&fts=all">p.R52K</a>
SLC26A8	Missense_Mutation	p.P924S	G	G		7	Cancer Module	6	35911820	35911820	126	0.23015873015873	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,35911820,G,G&fts=all">p.P924S</a>
SLC26A8	Missense_Mutation	p.M310I	C	C		7	Cancer Module	6	35959448	35959448	101	0.198019801980198	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,35959448,C,C&fts=all">p.M310I</a>
SLC27A4	Missense_Mutation	p.F201I	T	T		7	Cancer Module	9	131110868	131110868	66	0.196969696969697	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC27A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,131110868,T,T&fts=all">p.F201I</a>
SLC29A1	Missense_Mutation	p.L201R	T	T		7	Cancer Module	6	44198317	44198317	111	0.72972972972973	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC29A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,44198317,T,T&fts=all">p.L201R</a>
SLC29A1	Missense_Mutation	p.E428D	G	G		7	Cancer Module	6	44201178	44201178	199	0.663316582914573	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC29A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,44201178,G,G&fts=all">p.E428D</a>
SLC29A1	Missense_Mutation	p.T429S	A	A		7	Cancer Module	6	44201179	44201179	198	0.661616161616162	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC29A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,44201179,A,A&fts=all">p.T429S</a>
SLC30A10	Missense_Mutation	p.P416L	G	G		7	Cancer Module	1	220089002	220089002	72	0.333333333333333	NA	NA	NA		p.P416L(1)	13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC30A10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,220089002,G,G&fts=all">p.P416L</a>
SLC30A9	Missense_Mutation	p.S183C	A	A		7	Cancer Module	4	42025338	42025338	176	0.0738636363636364	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC30A9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,42025338,A,A&fts=all">p.S183C</a>
SLC39A6	Missense_Mutation	p.H386Y	G	G		7	Cancer Module	18	33702218	33702218	257	0.910505836575875	NA	NA	NA			41	His-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC39A6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,33702218,G,G&fts=all">p.H386Y</a>
SLC4A1	Missense_Mutation	p.G381S	C	C		7	Cancer Module	17	42335495	42335495	76	0.605263157894737	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,42335495,C,C&fts=all">p.G381S</a>
SLC4A10	Nonsense_Mutation	p.R46*	C	C		7	Cancer Module	2	162660964	162660964	54	0.222222222222222	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,162660964,C,C&fts=all">p.R46*</a>
SLC4A10	Missense_Mutation	p.R135Q	G	G		7	Cancer Module	2	162696425	162696425	137	0.562043795620438	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,162696425,G,G&fts=all">p.R135Q</a>
SLC4A10	Missense_Mutation	p.M301I	G	G		7	Cancer Module	2	162730470	162730470	22	0.272727272727273	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,162730470,G,G&fts=all">p.M301I</a>
SLC4A10	Missense_Mutation	p.D402N	G	G		7	Cancer Module	2	162751198	162751198	34	0.323529411764706	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,162751198,G,G&fts=all">p.D402N</a>
SLC4A1AP	Missense_Mutation	p.S187R	T	T		7	Cancer Module	2	27887180	27887180	63	0.253968253968254	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A1AP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27887180,T,T&fts=all">p.S187R</a>
SLC4A1AP	Missense_Mutation	p.Y188D	T	T		7	Cancer Module	2	27887181	27887181	63	0.26984126984127	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A1AP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27887181,T,T&fts=all">p.Y188D</a>
SLC4A1AP	Missense_Mutation	p.P370L	C	C		7	Cancer Module	2	27890222	27890222	207	0.338164251207729	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A1AP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27890222,C,C&fts=all">p.P370L</a>
SLC4A3	Missense_Mutation	p.S935F	C	C		7	Cancer Module	2	220502923	220502923	24	0.583333333333333	NA	NA	NA			51	Membrane (anion exchange).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,220502923,C,C&fts=all">p.S935F</a>
SLC6A16	Missense_Mutation	p.P218S	G	G		7	Cancer Module	19	49813345	49813345	102	0.57843137254902	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49813345,G,G&fts=all">p.P218S</a>
SLC6A4	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A4&recr=Open">Click here</a>	
SLC6A7	Missense_Mutation	p.G71R	G	G		7	Cancer Module	5	149574468	149574468	47	0.404255319148936	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,149574468,G,G&fts=all">p.G71R</a>
SLC7A2	Missense_Mutation	p.S122L	C	C		7	Cancer Module	8	17401213	17401213	106	0.169811320754717	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,17401213,C,C&fts=all">p.S122L</a>
SLC7A2	Missense_Mutation	p.P548S	C	C		7	Cancer Module	8	17419590	17419590	117	0.230769230769231	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,17419590,C,C&fts=all">p.P548S</a>
SLC8A3	Missense_Mutation	p.I273N	A	A		7	Cancer Module	14	70634322	70634322	37	0.405405405405405	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC8A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,70634322,A,A&fts=all">p.I273N</a>
SLC8A3	Missense_Mutation	p.S69F	G	G		7	Cancer Module	14	70634934	70634934	24	0.291666666666667	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC8A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,70634934,G,G&fts=all">p.S69F</a>
SLC9A3	Missense_Mutation	p.P193S	G	G		7	Cancer Module	5	488529	488529	18	0.611111111111111	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,488529,G,G&fts=all">p.P193S</a>
SLCO2A1	Missense_Mutation	p.R204Q	C	C	rs573944427	7	Cancer Module	3	133670074	133670074	87	0.241379310344828	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO2A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,133670074,C,C&fts=all">p.R204Q</a>
SLIT1	Missense_Mutation	p.P1130S	G	G		7	Cancer Module	10	98766431	98766431	25	0.2	NA	NA	NA			78	EGF-like 6. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,98766431,G,G&fts=all">p.P1130S</a>
SLIT1	Missense_Mutation	p.G694R	C	C		7	Cancer Module	10	98802742	98802742	38	0.368421052631579	NA	NA	NA		p.G694R(2)	78	LRRCT 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,98802742,C,C&fts=all">p.G694R</a>
SLIT1	Nonsense_Mutation	p.K298*	T	T		7	Cancer Module	10	98820446	98820446	36	0.138888888888889	NA	NA	NA			78	LRRNT 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,98820446,T,T&fts=all">p.K298*</a>
SLIT1	Missense_Mutation	p.R118Q	C	C	rs367791664	7	Cancer Module	10	98917635	98917635	256	0.1796875	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,98917635,C,C&fts=all">p.R118Q</a>
SLIT2	Missense_Mutation	p.Q251R	A	A		7	Cancer Module	4	20490582	20490582	78	0.346153846153846	NA	NA	NA			116	LRRCT 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,20490582,A,A&fts=all">p.Q251R</a>
SLIT3	Missense_Mutation	p.E1048K	C	C		7	Cancer Module	5	168119646	168119646	51	0.568627450980392	NA	NA	NA			100	EGF-like 4. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,168119646,C,C&fts=all">p.E1048K</a>
SLIT3	Missense_Mutation	p.G979E	C	C		7	Cancer Module	5	168127593	168127593	16	0.375	NA	NA	NA			100	EGF-like 2. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,168127593,C,C&fts=all">p.G979E</a>
SLIT3	Splice_Site	p.A853T	C	C		7	Cancer Module	5	168138062	168138062	7	0.428571428571429	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT3&recr=Open">Click here</a>	
SLIT3	Splice_Site	p.L852L	C	C		7	Cancer Module	5	168138063	168138063	7	0.428571428571429	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT3&recr=Open">Click here</a>	
SLIT3	Missense_Mutation	p.L774F	G	G		7	Cancer Module	5	168151440	168151440	27	0.259259259259259	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,168151440,G,G&fts=all">p.L774F</a>
SLIT3	Missense_Mutation	p.R525C	G	G	rs267600542	7	Cancer Module	5	168189581	168189581	51	0.196078431372549	NA	NA	NA			100	LRRNT 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,168189581,G,G&fts=all">p.R525C</a>
SLIT3	Missense_Mutation	p.H213Y	G	G		7	Cancer Module	5	168244461	168244461	21	0.238095238095238	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,168244461,G,G&fts=all">p.H213Y</a>
SLITRK1	Missense_Mutation	p.L509F	G	G		7	Cancer Module	13	84454118	84454118	34	0.5	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,84454118,G,G&fts=all">p.L509F</a>
SLITRK1	Missense_Mutation	p.R362K	C	C		7	Cancer Module	13	84454558	84454558	50	0.38	NA	NA	NA			80	LRRNT 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,84454558,C,C&fts=all">p.R362K</a>
SLITRK1	Missense_Mutation	p.H298Y	G	G	rs146746846	7	Cancer Module	13	84454751	84454751	49	0.326530612244898	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,84454751,G,G&fts=all">p.H298Y</a>
SLITRK1	Missense_Mutation	p.F74L	A	A		7	Cancer Module	13	84455423	84455423	66	0.318181818181818	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,84455423,A,A&fts=all">p.F74L</a>
SLITRK3	Missense_Mutation	p.E971K	C	C		7	Cancer Module	3	164905708	164905708	222	0.292792792792793	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164905708,C,C&fts=all">p.E971K</a>
SLITRK3	Missense_Mutation	p.P873S	G	G		7	Cancer Module	3	164906002	164906002	50	0.2	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164906002,G,G&fts=all">p.P873S</a>
SLITRK3	Missense_Mutation	p.S348T	A	A		7	Cancer Module	3	164907577	164907577	232	0.241379310344828	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,164907577,A,A&fts=all">p.S348T</a>
SLITRK5	Missense_Mutation	p.P327L	C	C		7	Cancer Module	13	88328623	88328623	63	0.222222222222222	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,88328623,C,C&fts=all">p.P327L</a>
SLITRK5	Missense_Mutation	p.E947K	G	G		7	Cancer Module	13	88330482	88330482	131	0.549618320610687	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,88330482,G,G&fts=all">p.E947K</a>
SMARCA5	Missense_Mutation	p.S664L	C	C		7	Cancer Module	4	144464749	144464749	220	0.309090909090909	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMARCA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,144464749,C,C&fts=all">p.S664L</a>
SMG5	Missense_Mutation	p.L945F	G	G		7	Cancer Module	1	156220783	156220783	85	0.117647058823529	NA	NA	NA			48	PINc.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMG5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,156220783,G,G&fts=all">p.L945F</a>
SMPDL3B	Missense_Mutation	p.S38F	C	C		7	Cancer Module	1	28271794	28271794	101	0.188118811881188	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMPDL3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,28271794,C,C&fts=all">p.S38F</a>
SMR3B	Missense_Mutation	p.P62S	C	C		7	Cancer Module	4	71255509	71255509	75	0.24	NA	NA	NA			7	Poly-Pro.|Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMR3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,71255509,C,C&fts=all">p.P62S</a>
SMURF2	Nonsense_Mutation	p.Q561*	G	G		7	Cancer Module	17	62551041	62551041	212	0.495283018867925	NA	NA	NA			22	HECT. {ECO:0000255|PROSITE- ProRule:PRU00104}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMURF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,62551041,G,G&fts=all">p.Q561*</a>
SMYD1	Missense_Mutation	p.E355K	G	G		7	Cancer Module	2	88405964	88405964	115	0.139130434782609	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMYD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,88405964,G,G&fts=all">p.E355K</a>
SNAP91	Missense_Mutation	p.G733R	C	C		7	Cancer Module	6	84290271	84290271	73	0.397260273972603	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNAP91&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,84290271,C,C&fts=all">p.G733R</a>
SNRPB	Missense_Mutation	p.P198L	G	G		7	Cancer Module	20	2443374	2443374	59	0.152542372881356	NA	NA	NA			10	Repeat-rich region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNRPB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,2443374,G,G&fts=all">p.P198L</a>
SNRPB	Missense_Mutation	p.P175L	G	G		7	Cancer Module	20	2443770	2443770	165	0.0303030303030303	NA	NA	NA			10	Repeat-rich region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNRPB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,2443770,G,G&fts=all">p.P175L</a>
SNX9	Missense_Mutation	p.A153V	C	C		7	Cancer Module	6	158318016	158318016	35	0.342857142857143	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNX9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,158318016,C,C&fts=all">p.A153V</a>
SOHLH2	Missense_Mutation	p.P229S	G	G		7	Cancer Module	13	36748963	36748963	175	0.297142857142857	NA	NA	NA			26	bHLH. {ECO:0000255|PROSITE- ProRule:PRU00981}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOHLH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,36748963,G,G&fts=all">p.P229S</a>
SORBS1	Missense_Mutation	p.G817R	C	C		7	Cancer Module	10	97101416	97101416	67	0.432835820895522	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORBS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,97101416,C,C&fts=all">p.G817R</a>
SORL1	Missense_Mutation	p.P229S	C	C		7	Cancer Module	11	121459976	121459976	147	0.36734693877551	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,121459976,C,C&fts=all">p.P229S</a>
SORL1	Missense_Mutation	p.G577S	G	G		7	Cancer Module	11	121477604	121477604	81	0.345679012345679	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,121477604,G,G&fts=all">p.G577S</a>
SORL1	Missense_Mutation	p.S995F	C	C		7	Cancer Module	11	121495876	121495876	90	0.355555555555556	NA	NA	NA		p.S2085F(1)	91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,121495876,C,C&fts=all">p.S995F</a>
SORL1	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	11	121340834	121500274	NA	NA	42	-1.1916561403685	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORL1&recr=Open">Click here</a>	
SORT1	Missense_Mutation	p.S550A	A	A		7	Cancer Module	1	109867707	109867707	111	0.423423423423423	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,109867707,A,A&fts=all">p.S550A</a>
SOX30	Missense_Mutation	p.P635L	G	G		7	Cancer Module	5	157053706	157053706	96	0.40625	NA	NA	NA			23	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOX30&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,157053706,G,G&fts=all">p.P635L</a>
SP110	Missense_Mutation	p.S534L	G	G	rs547427992	7	Cancer Module	2	231037665	231037665	40	0.35	NA	NA	NA			29	SAND. {ECO:0000255|PROSITE- ProRule:PRU00185}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SP110&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,231037665,G,G&fts=all">p.S534L</a>
SP140	Missense_Mutation	p.P60L	C	C		7	Cancer Module	2	231101917	231101917	82	0.219512195121951	NA	NA	NA			12	HSR. {ECO:0000255|PROSITE- ProRule:PRU00747}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SP140&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,231101917,C,C&fts=all">p.P60L</a>
SP140	Splice_Site		G	G		7	Cancer Module	2	231115695	231115695	87	0.28735632183908	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SP140&recr=Open">Click here</a>	
SP140	Missense_Mutation	p.R605K	G	G		7	Cancer Module	2	231159011	231159011	135	0.0666666666666667	NA	NA	NA			12	SAND. {ECO:0000255|PROSITE- ProRule:PRU00185}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SP140&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,231159011,G,G&fts=all">p.R605K</a>
SP6	Missense_Mutation	p.A115S	C	C		7	Cancer Module	17	45925453	45925453	28	0.678571428571429	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,45925453,C,C&fts=all">p.A115S</a>
SPARCL1	Missense_Mutation	p.S357F	G	G		7	Cancer Module	4	88411511	88411511	380	0.292105263157895	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPARCL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,88411511,G,G&fts=all">p.S357F</a>
SPARCL1	Missense_Mutation	p.E293K	C	C		7	Cancer Module	4	88412809	88412809	153	0.549019607843137	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPARCL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,88412809,C,C&fts=all">p.E293K</a>
SPEF2	Missense_Mutation	p.K691T	A	A		7	Cancer Module	5	35697841	35697841	180	0.205555555555556	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,35697841,A,A&fts=all">p.K691T</a>
SPEF2	Missense_Mutation	p.D774N	G	G		7	Cancer Module	5	35700791	35700791	215	0.46046511627907	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,35700791,G,G&fts=all">p.D774N</a>
SPEF2	Missense_Mutation	p.P1444S	C	C		7	Cancer Module	5	35779346	35779346	286	0.206293706293706	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,35779346,C,C&fts=all">p.P1444S</a>
SPEF2	Missense_Mutation	p.P1542S	C	C		7	Cancer Module	5	35793345	35793345	180	0.405555555555556	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,35793345,C,C&fts=all">p.P1542S</a>
SPEN	Missense_Mutation	p.P1890L	C	C		7	Cancer Module	1	16258404	16258404	99	0.0505050505050505	NA	NA	NA			149			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,16258404,C,C&fts=all">p.P1890L</a>
SPEN	Missense_Mutation	p.P3257S	C	C	rs200093315	7	Cancer Module	1	16262504	16262504	43	0.558139534883721	NA	NA	NA			149	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,16262504,C,C&fts=all">p.P3257S</a>
SPG11	Missense_Mutation	p.H1658Y	G	G		7	Cancer Module	15	44877983	44877983	275	0.312727272727273	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPG11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,44877983,G,G&fts=all">p.H1658Y</a>
SPINK5	Missense_Mutation	p.D99N	G	G		7	Cancer Module	5	147465980	147465980	179	0.402234636871508	NA	NA	NA			64	Kazal-like 2. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPINK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,147465980,G,G&fts=all">p.D99N</a>
SPINK5	Missense_Mutation	p.G107E	G	G		7	Cancer Module	5	147466005	147466005	201	0.0298507462686567	NA	NA	NA			64	Kazal-like 2. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPINK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,147466005,G,G&fts=all">p.G107E</a>
SPINK5	Missense_Mutation	p.G251S	G	G		7	Cancer Module	5	147474001	147474001	164	0.378048780487805	NA	NA	NA			64	Kazal-like 4. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPINK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,147474001,G,G&fts=all">p.G251S</a>
SPINK5	Missense_Mutation	p.G393R	G	G		7	Cancer Module	5	147480101	147480101	100	0.34	NA	NA	NA			64	Kazal-like 6. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPINK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,147480101,G,G&fts=all">p.G393R</a>
SPINK5	Missense_Mutation	p.G701E	G	G		7	Cancer Module	5	147496019	147496019	64	0.484375	NA	NA	NA			64	Kazal-like 11. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPINK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,147496019,G,G&fts=all">p.G701E</a>
SPINT2	Missense_Mutation	p.S188F	C	C		7	Cancer Module	19	38782600	38782600	31	0.290322580645161	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPINT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,38782600,C,C&fts=all">p.S188F</a>
SPOCK1	Missense_Mutation	p.E219K	C	C		7	Cancer Module	5	136328224	136328224	121	0.388429752066116	NA	NA	NA		p.E219K(1)	18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPOCK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,136328224,C,C&fts=all">p.E219K</a>
SPOCK3	Missense_Mutation	p.E420K	C	C		7	Cancer Module	4	167656125	167656125	63	0.285714285714286	NA	NA	NA			38	Asp-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPOCK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,167656125,C,C&fts=all">p.E420K</a>
SPOCK3	Missense_Mutation	p.G366E	C	C		7	Cancer Module	4	167658662	167658662	247	0.287449392712551	NA	NA	NA		p.G363E(1)	38	Thyroglobulin type-1. {ECO:0000255|PROSITE-ProRule:PRU00500}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPOCK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,167658662,C,C&fts=all">p.G366E</a>
SPRR1B	Missense_Mutation	p.S75L	C	C		7	Cancer Module	1	153005045	153005045	68	0.514705882352941	NA	NA	NA			9	6 X 8 AA approximate tandem repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPRR1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,153005045,C,C&fts=all">p.S75L</a>
SPRY1	Missense_Mutation	p.P245S	C	C		7	Cancer Module	4	124323479	124323479	243	0.288065843621399	NA	NA	NA			11	Cys-rich.|SPR. {ECO:0000255|PROSITE- ProRule:PRU00572}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPRY1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,124323479,C,C&fts=all">p.P245S</a>
SPSB1	Missense_Mutation	p.S176F	C	C		7	Cancer Module	1	9416477	9416477	188	0.457446808510638	NA	NA	NA			13	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPSB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,9416477,C,C&fts=all">p.S176F</a>
SPTA1	Missense_Mutation	p.R1611K	C	C		7	Cancer Module	1	158609703	158609703	191	0.172774869109948	NA	NA	NA			307			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158609703,C,C&fts=all">p.R1611K</a>
SPTA1	Missense_Mutation	p.L1006R	A	A		7	Cancer Module	1	158624420	158624420	106	0.188679245283019	NA	NA	NA			307	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158624420,A,A&fts=all">p.L1006R</a>
SPTA1	Missense_Mutation	p.R356C	G	G		7	Cancer Module	1	158645977	158645977	229	0.423580786026201	NA	NA	NA			307			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158645977,G,G&fts=all">p.R356C</a>
SPTAN1	Nonsense_Mutation	p.Q2149*	C	C		7	Cancer Module	9	131388850	131388850	25	0.36	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTAN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,131388850,C,C&fts=all">p.Q2149*</a>
SPTB	Missense_Mutation	p.E1844D	C	C		7	Cancer Module	14	65239319	65239319	31	0.870967741935484	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,65239319,C,C&fts=all">p.E1844D</a>
SPTB	Missense_Mutation	p.P1613S	G	G	rs375478086	7	Cancer Module	14	65241848	65241848	103	0.427184466019417	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,65241848,G,G&fts=all">p.P1613S</a>
SPTBN1	Missense_Mutation	p.L567V	T	T		7	Cancer Module	2	54855288	54855288	113	0.336283185840708	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTBN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,54855288,T,T&fts=all">p.L567V</a>
SPTLC2	Missense_Mutation	p.R326C	G	G		7	Cancer Module	14	78021843	78021843	59	0.440677966101695	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTLC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,78021843,G,G&fts=all">p.R326C</a>
SQRDL	Missense_Mutation	p.L233F	C	C		7	Cancer Module	15	45968341	45968341	239	0.305439330543933	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SQRDL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,45968341,C,C&fts=all">p.L233F</a>
SRCAP	Nonsense_Mutation	p.Q1035*	C	C		7	Cancer Module	16	30732149	30732149	111	0.216216216216216	NA	NA	NA			136	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRCAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30732149,C,C&fts=all">p.Q1035*</a>
SRRM2	Missense_Mutation	p.R356K	G	G		7	Cancer Module	16	2811596	2811596	157	0.579617834394904	NA	NA	NA			105	Pro-rich.|Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRRM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,2811596,G,G&fts=all">p.R356K</a>
SSH2	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSH2&recr=Open">Click here</a>	
SSR2	Missense_Mutation	p.P75L	G	G		7	Cancer Module	1	155981610	155981610	281	0.227758007117438	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,155981610,G,G&fts=all">p.P75L</a>
SSR2	Missense_Mutation	p.S28L	G	G		7	Cancer Module	1	155989876	155989876	202	0.242574257425743	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,155989876,G,G&fts=all">p.S28L</a>
ST18	Missense_Mutation	p.L852I	G	G		7	Cancer Module	8	53044630	53044630	77	0.493506493506494	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,53044630,G,G&fts=all">p.L852I</a>
ST18	Missense_Mutation	p.E605K	C	C	rs144486751	7	Cancer Module	8	53062531	53062531	180	0.244444444444444	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,53062531,C,C&fts=all">p.E605K</a>
ST18	Nonsense_Mutation	p.Q452*	G	G	rs149497456	7	Cancer Module	8	53076592	53076592	142	0.204225352112676	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,53076592,G,G&fts=all">p.Q452*</a>
ST18	Missense_Mutation	p.E72K	C	C		7	Cancer Module	8	53092745	53092745	202	0.272277227722772	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,53092745,C,C&fts=all">p.E72K</a>
ST6GALNAC1	Missense_Mutation	p.T118S	T	T		7	Cancer Module	17	74625573	74625573	143	0.27972027972028	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST6GALNAC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,74625573,T,T&fts=all">p.T118S</a>
ST7L	Missense_Mutation	p.P17L	G	G		7	Cancer Module	1	113161686	113161686	79	0.40506329113924	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST7L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,113161686,G,G&fts=all">p.P17L</a>
STAB1	Missense_Mutation	p.P295S	C	C		7	Cancer Module	3	52537548	52537548	40	0.225	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52537548,C,C&fts=all">p.P295S</a>
STAB1	Missense_Mutation	p.E549K	G	G		7	Cancer Module	3	52539747	52539747	55	0.218181818181818	NA	NA	NA			76	FAS1 2. {ECO:0000255|PROSITE- ProRule:PRU00082, ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52539747,G,G&fts=all">p.E549K</a>
STAB1	Missense_Mutation	p.G699R	G	G		7	Cancer Module	3	52541989	52541989	102	0.215686274509804	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52541989,G,G&fts=all">p.G699R</a>
STAB1	Missense_Mutation	p.S771L	C	C		7	Cancer Module	3	52543302	52543302	35	0.371428571428571	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52543302,C,C&fts=all">p.S771L</a>
STAB1	Splice_Site	p.R1725R	G	G		7	Cancer Module	3	52553420	52553420	93	0.236559139784946	NA	NA	NA			76	FAS1 6. {ECO:0000255|PROSITE- ProRule:PRU00082, ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB1&recr=Open">Click here</a>	
STARD4	Splice_Site	p.L52F	G	G		7	Cancer Module	5	110842029	110842029	67	0.388059701492537	NA	NA	NA			12	START. {ECO:0000255|PROSITE- ProRule:PRU00197}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STARD4&recr=Open">Click here</a>	
STIP1	Missense_Mutation	p.E410K	G	G		7	Cancer Module	11	63967475	63967475	94	0.425531914893617	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STIP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,63967475,G,G&fts=all">p.E410K</a>
STK31	Missense_Mutation	p.A489T	G	G	rs34414354	7	Cancer Module	7	23808662	23808662	229	0.248908296943231	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,23808662,G,G&fts=all">p.A489T</a>
STK33	Missense_Mutation	p.G432E	C	C	rs377485276	7	Cancer Module	11	8435091	8435091	220	0.877272727272727	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK33&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,8435091,C,C&fts=all">p.G432E</a>
STMN2	Missense_Mutation	p.E133K	G	G		7	Cancer Module	8	80567214	80567214	115	0.0434782608695652	NA	NA	NA			11	SLD. {ECO:0000255|PROSITE- ProRule:PRU00998}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STMN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,80567214,G,G&fts=all">p.E133K</a>
STON2	Missense_Mutation	p.P308S	G	G		7	Cancer Module	14	81744733	81744733	151	0.675496688741722	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STON2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,81744733,G,G&fts=all">p.P308S</a>
STON2	Missense_Mutation	p.E239K	C	C		7	Cancer Module	14	81744940	81744940	86	0.302325581395349	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STON2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,81744940,C,C&fts=all">p.E239K</a>
STRA6	Missense_Mutation	p.E363K	C	C		7	Cancer Module	15	74481459	74481459	20	0.55	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STRA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,74481459,C,C&fts=all">p.E363K</a>
STRN	Missense_Mutation	p.P273L	G	G	rs142776055	7	Cancer Module	2	37121154	37121154	258	0.286821705426357	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STRN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,37121154,G,G&fts=all">p.P273L</a>
STS	Missense_Mutation	p.A19V	C	C		7	Cancer Module	X	7171281	7171281	33	0.454545454545455	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,7171281,C,C&fts=all">p.A19V</a>
STS	Missense_Mutation	p.G100R	G	G		7	Cancer Module	X	7175530	7175530	80	0.3375	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,7175530,G,G&fts=all">p.G100R</a>
SULF1	Missense_Mutation	p.S27F	C	C		7	Cancer Module	8	70476290	70476290	130	0.269230769230769	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,70476290,C,C&fts=all">p.S27F</a>
SULF1	Missense_Mutation	p.K39T	A	A		7	Cancer Module	8	70476326	70476326	138	0.27536231884058	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,70476326,A,A&fts=all">p.K39T</a>
SULF1	Missense_Mutation	p.S353L	C	C		7	Cancer Module	8	70514061	70514061	257	0.0466926070038911	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,70514061,C,C&fts=all">p.S353L</a>
SULT1B1	Missense_Mutation	p.K10Q	T	T		7	Cancer Module	4	70620908	70620908	215	0.26046511627907	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULT1B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70620908,T,T&fts=all">p.K10Q</a>
SULT1E1	Missense_Mutation	p.M283I	C	C		7	Cancer Module	4	70707748	70707748	183	0.207650273224044	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULT1E1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70707748,C,C&fts=all">p.M283I</a>
SULT1E1	Missense_Mutation	p.E55K	C	C		7	Cancer Module	4	70721127	70721127	167	0.18562874251497	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULT1E1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70721127,C,C&fts=all">p.E55K</a>
SULT4A1	Splice_Site		C	C		7	Cancer Module	22	44235824	44235824	13	0.230769230769231	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULT4A1&recr=Open">Click here</a>	
SUPT5H	Splice_Site	p.S347A	T	T		7	Cancer Module	19	39959397	39959397	145	0.16551724137931	NA	NA	NA			51	Interaction with RNA polymerase II.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUPT5H&recr=Open">Click here</a>	
SV2B	Missense_Mutation	p.P217R	C	C		7	Cancer Module	15	91795616	91795616	202	0.188118811881188	NA	NA	NA		p.P217L(1)	42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SV2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,91795616,C,C&fts=all">p.P217R</a>
SV2B	Nonsense_Mutation	p.W263*	G	G		7	Cancer Module	15	91801654	91801654	51	0.254901960784314	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SV2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,91801654,G,G&fts=all">p.W263*</a>
SVEP1	Missense_Mutation	p.E3379K	C	C		7	Cancer Module	9	113148211	113148211	41	0.170731707317073	NA	NA	NA			147	Sushi 33. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SVEP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,113148211,C,C&fts=all">p.E3379K</a>
SVEP1	Missense_Mutation	p.S1060F	G	G		7	Cancer Module	9	113228219	113228219	43	0.255813953488372	NA	NA	NA			147			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SVEP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,113228219,G,G&fts=all">p.S1060F</a>
SVEP1	Nonsense_Mutation	p.W761*	C	C		7	Cancer Module	9	113243536	113243536	29	0.103448275862069	NA	NA	NA			147	Sushi 4. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SVEP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,113243536,C,C&fts=all">p.W761*</a>
SVIL	Missense_Mutation	p.E171K	C	C	rs562741034	7	Cancer Module	10	29839842	29839842	179	0.41340782122905	NA	NA	NA			112	Interaction with MYLK. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SVIL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,29839842,C,C&fts=all">p.E171K</a>
SYCP1	Missense_Mutation	p.T898I	C	C		7	Cancer Module	1	115527479	115527479	233	0.1931330472103	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYCP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,115527479,C,C&fts=all">p.T898I</a>
SYN3	Missense_Mutation	p.R511Q	C	C		7	Cancer Module	22	32914108	32914108	196	0.255102040816327	NA	NA	NA			33	J; Pro-rich linker.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,32914108,C,C&fts=all">p.R511Q</a>
SYNE1	Missense_Mutation	p.F8024Y	A	A		7	Cancer Module	6	152476085	152476085	173	0.341040462427746	NA	NA	NA			524			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,152476085,A,A&fts=all">p.F8024Y</a>
SYNE1	Nonsense_Mutation	p.R6868*	G	G		7	Cancer Module	6	152555026	152555026	70	0.342857142857143	NA	NA	NA			524			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,152555026,G,G&fts=all">p.R6868*</a>
SYNE1	Missense_Mutation	p.H3301Y	G	G		7	Cancer Module	6	152688424	152688424	193	0.481865284974093	NA	NA	NA			524			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,152688424,G,G&fts=all">p.H3301Y</a>
SYNE1	Missense_Mutation	p.R605K	C	C		7	Cancer Module	6	152786511	152786511	138	0.355072463768116	NA	NA	NA			524			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,152786511,C,C&fts=all">p.R605K</a>
SYNGR4	Missense_Mutation	p.P175S	C	C		7	Cancer Module	19	48879393	48879393	149	0.302013422818792	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNGR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,48879393,C,C&fts=all">p.P175S</a>
SYNJ2	Missense_Mutation	p.E609K	G	G		7	Cancer Module	6	158490590	158490590	71	0.408450704225352	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNJ2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,158490590,G,G&fts=all">p.E609K</a>
SYNPO2L	Missense_Mutation	p.A903D	G	G		7	Cancer Module	10	75406702	75406702	107	0.439252336448598	NA	NA	NA			26	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNPO2L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,75406702,G,G&fts=all">p.A903D</a>
SYT1	Missense_Mutation	p.D372N	G	G		7	Cancer Module	12	79842749	79842749	82	0.475609756097561	NA	NA	NA			25	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.|Phospholipid binding. {ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,79842749,G,G&fts=all">p.D372N</a>
SYT4	Missense_Mutation	p.S383F	G	G		7	Cancer Module	18	40850436	40850436	79	0.417721518987342	NA	NA	NA			44	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,40850436,G,G&fts=all">p.S383F</a>
SYT4	Missense_Mutation	p.P363S	G	G		7	Cancer Module	18	40850497	40850497	88	0.409090909090909	NA	NA	NA			44	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,40850497,G,G&fts=all">p.P363S</a>
SYT6	Missense_Mutation	p.E242K	C	C	rs564717037	7	Cancer Module	1	114680464	114680464	123	0.170731707317073	NA	NA	NA			37	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,114680464,C,C&fts=all">p.E242K</a>
SYT7	Missense_Mutation	p.E246K	C	C		7	Cancer Module	11	61295405	61295405	44	0.340909090909091	NA	NA	NA		p.E202K(1)	15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,61295405,C,C&fts=all">p.E246K</a>
SYT8	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	11	1860936	1955677	NA	NA	21	-1.13511063553025	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT8&recr=Open">Click here</a>	
TACC2	Missense_Mutation	p.P220L	C	C		7	Cancer Module	10	123842674	123842674	32	0.3125	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123842674,C,C&fts=all">p.P220L</a>
TACC2	Missense_Mutation	p.G449E	G	G		7	Cancer Module	10	123843361	123843361	62	0.338709677419355	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123843361,G,G&fts=all">p.G449E</a>
TACC2	Missense_Mutation	p.G976E	G	G		7	Cancer Module	10	123844942	123844942	67	0.253731343283582	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123844942,G,G&fts=all">p.G976E</a>
TACC2	Missense_Mutation	p.G1202E	G	G		7	Cancer Module	10	123845620	123845620	32	0.21875	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123845620,G,G&fts=all">p.G1202E</a>
TACC2	Missense_Mutation	p.H1620Y	C	C		7	Cancer Module	10	123846873	123846873	42	0.476190476190476	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123846873,C,C&fts=all">p.H1620Y</a>
TACC2	Missense_Mutation	p.P1937S	C	C		7	Cancer Module	10	123903196	123903196	59	0.457627118644068	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123903196,C,C&fts=all">p.P1937S</a>
TACC2	Missense_Mutation	p.P1937L	C	C		7	Cancer Module	10	123903197	123903197	58	0.46551724137931	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123903197,C,C&fts=all">p.P1937L</a>
TACC2	Missense_Mutation	p.A183V	C	C		7	Cancer Module	10	123970254	123970254	94	0.212765957446809	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123970254,C,C&fts=all">p.A183V</a>
TACC2	Missense_Mutation	p.T225I	C	C		7	Cancer Module	10	123970380	123970380	145	0.303448275862069	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123970380,C,C&fts=all">p.T225I</a>
TAF1	Missense_Mutation	p.P952L	C	C		7	Cancer Module	X	70612432	70612432	71	0.577464788732394	NA	NA	NA			124	Histone acetyltransferase (HAT).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,70612432,C,C&fts=all">p.P952L</a>
TAF1	Missense_Mutation	p.L1232I	C	C		7	Cancer Module	X	70618435	70618435	65	0.907692307692308	NA	NA	NA			124			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,70618435,C,C&fts=all">p.L1232I</a>
TAF7	Missense_Mutation	p.P9S	G	G		7	Cancer Module	5	140699587	140699587	85	0.294117647058824	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140699587,G,G&fts=all">p.P9S</a>
TANC2	Nonsense_Mutation	p.Q1464*	C	C		7	Cancer Module	17	61497733	61497733	97	0.463917525773196	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TANC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,61497733,C,C&fts=all">p.Q1464*</a>
TBC1D19	Splice_Site		G	G		7	Cancer Module	4	26750032	26750032	122	0.377049180327869	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D19&recr=Open">Click here</a>	
TBC1D8B	Missense_Mutation	p.G226E	G	G		7	Cancer Module	X	106066546	106066546	132	0.477272727272727	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D8B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,106066546,G,G&fts=all">p.G226E</a>
TBC1D8B	Missense_Mutation	p.G494R	G	G		7	Cancer Module	X	106083404	106083404	146	0.410958904109589	NA	NA	NA			47	Rab-GAP TBC. {ECO:0000255|PROSITE- ProRule:PRU00163}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D8B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,106083404,G,G&fts=all">p.G494R</a>
TBC1D8B	Missense_Mutation	p.R767Q	G	G	rs374568341	7	Cancer Module	X	106097474	106097474	168	0.44047619047619	NA	NA	NA		p.R767Q(1)	47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D8B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,106097474,G,G&fts=all">p.R767Q</a>
TBL3	Missense_Mutation	p.S170F	C	C		7	Cancer Module	16	2024973	2024973	52	0.25	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,2024973,C,C&fts=all">p.S170F</a>
TBX5	Missense_Mutation	p.E254K	C	C		7	Cancer Module	12	114804192	114804192	50	0.6	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBX5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,114804192,C,C&fts=all">p.E254K</a>
TBX6	Missense_Mutation	p.S80L	G	G		7	Cancer Module	16	30102193	30102193	78	0.294871794871795	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBX6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30102193,G,G&fts=all">p.S80L</a>
TBXAS1	Missense_Mutation	p.L494F	C	C		7	Cancer Module	7	139717586	139717586	47	0.468085106382979	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBXAS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,139717586,C,C&fts=all">p.L494F</a>
TCEA2	Missense_Mutation	p.P202S	C	C		7	Cancer Module	20	62701699	62701699	71	0.366197183098592	NA	NA	NA			12	TFIIS central. {ECO:0000255|PROSITE- ProRule:PRU00651}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCEA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,62701699,C,C&fts=all">p.P202S</a>
TCF4	Missense_Mutation	p.P148S	G	G		7	Cancer Module	18	52937152	52937152	80	0.35	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCF4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,52937152,G,G&fts=all">p.P148S</a>
TCN1	Missense_Mutation	p.E275K	C	C		7	Cancer Module	11	59623456	59623456	155	0.387096774193548	NA	NA	NA			29	Globular N-terminal alpha domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,59623456,C,C&fts=all">p.E275K</a>
TCOF1	Missense_Mutation	p.P975L	C	C		7	Cancer Module	5	149767529	149767529	74	0.297297297297297	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCOF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,149767529,C,C&fts=all">p.P975L</a>
TCOF1	Missense_Mutation	p.T1429I	C	C		7	Cancer Module	5	149777971	149777971	74	0.378378378378378	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCOF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,149777971,C,C&fts=all">p.T1429I</a>
TDGF1	Missense_Mutation	p.G116E	G	G		7	Cancer Module	3	46621449	46621449	80	0.3	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDGF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,46621449,G,G&fts=all">p.G116E</a>
TDO2	Missense_Mutation	p.E252K	G	G		7	Cancer Module	4	156835502	156835502	127	0.354330708661417	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,156835502,G,G&fts=all">p.E252K</a>
TDRKH	Missense_Mutation	p.P105S	G	G		7	Cancer Module	1	151752535	151752535	253	0.478260869565217	NA	NA	NA			26	KH 1. {ECO:0000255|PROSITE- ProRule:PRU00117}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDRKH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,151752535,G,G&fts=all">p.P105S</a>
TEX14	Missense_Mutation	p.E996K	C	C		7	Cancer Module	17	56663264	56663264	289	0.217993079584775	NA	NA	NA		p.E990K(1)|p.E996K(1)	81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56663264,C,C&fts=all">p.E996K</a>
TEX14	Missense_Mutation	p.Y160N	A	A		7	Cancer Module	17	56699087	56699087	63	0.158730158730159	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56699087,A,A&fts=all">p.Y160N</a>
TEX14	Missense_Mutation	p.S99L	G	G		7	Cancer Module	17	56700329	56700329	48	0.6875	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56700329,G,G&fts=all">p.S99L</a>
TEX26	Missense_Mutation	p.R279C	C	C		7	Cancer Module	13	31549009	31549009	105	0.0380952380952381	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,31549009,C,C&fts=all">p.R279C</a>
TFAP2B	Missense_Mutation	p.E445K	G	G		7	Cancer Module	6	50811055	50811055	70	0.128571428571429	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TFAP2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,50811055,G,G&fts=all">p.E445K</a>
TFEC	Missense_Mutation	p.D55E	G	G		7	Cancer Module	7	115624331	115624331	171	0.754385964912281	NA	NA	NA			25	Necessary for transcriptional transactivation.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TFEC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,115624331,G,G&fts=all">p.D55E</a>
TGM2	Missense_Mutation	p.G626E	C	C		7	Cancer Module	20	36759531	36759531	96	0.21875	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,36759531,C,C&fts=all">p.G626E</a>
TGM5	Missense_Mutation	p.R297C	G	G		7	Cancer Module	15	43533162	43533162	122	0.204918032786885	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGM5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43533162,G,G&fts=all">p.R297C</a>
TGM5	Missense_Mutation	p.T94S	G	G		7	Cancer Module	15	43552405	43552405	48	0.208333333333333	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGM5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43552405,G,G&fts=all">p.T94S</a>
TGM7	Splice_Site	p.D658N	C	C		7	Cancer Module	15	43569061	43569061	36	0.777777777777778	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGM7&recr=Open">Click here</a>	
THBS4	Missense_Mutation	p.S73P	T	T		7	Cancer Module	5	79351805	79351805	32	0.46875	NA	NA	NA			34	Laminin G-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THBS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,79351805,T,T&fts=all">p.S73P</a>
THBS4	Missense_Mutation	p.D381N	G	G	rs138775049	7	Cancer Module	5	79366195	79366195	55	0.418181818181818	NA	NA	NA			34	EGF-like 3; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THBS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,79366195,G,G&fts=all">p.D381N</a>
THEG	Missense_Mutation	p.R192C	G	G	rs146544514	7	Cancer Module	19	372692	372692	61	0.180327868852459	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THEG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,372692,G,G&fts=all">p.R192C</a>
TIAF1	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TIAF1&recr=Open">Click here</a>	
TIAM1	Missense_Mutation	p.P1189L	G	G		7	Cancer Module	21	32513732	32513732	128	0.328125	NA	NA	NA			115	DH. {ECO:0000255|PROSITE- ProRule:PRU00062}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TIAM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,32513732,G,G&fts=all">p.P1189L</a>
TIAM2	Missense_Mutation	p.F500I	T	T		7	Cancer Module	6	155458614	155458614	87	0.390804597701149	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TIAM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,155458614,T,T&fts=all">p.F500I</a>
TINAG	Missense_Mutation	p.G330E	G	G		7	Cancer Module	6	54214603	54214603	248	0.205645161290323	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TINAG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,54214603,G,G&fts=all">p.G330E</a>
TJP1	Missense_Mutation	p.E1082K	C	C		7	Cancer Module	15	30010874	30010874	92	0.304347826086957	NA	NA	NA			68			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TJP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,30010874,C,C&fts=all">p.E1082K</a>
TJP3	Missense_Mutation	p.S803F	C	C		7	Cancer Module	19	3747850	3747850	11	0.454545454545455	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TJP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,3747850,C,C&fts=all">p.S803F</a>
TKTL2	Missense_Mutation	p.L179F	G	G		7	Cancer Module	4	164394352	164394352	74	0.243243243243243	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TKTL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,164394352,G,G&fts=all">p.L179F</a>
TLE2	Missense_Mutation	p.P348L	G	G		7	Cancer Module	19	3009670	3009670	13	0.538461538461538	NA	NA	NA			13	Pro/Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,3009670,G,G&fts=all">p.P348L</a>
TLL1	Missense_Mutation	p.R257Q	G	G		7	Cancer Module	4	166924680	166924680	120	0.583333333333333	NA	NA	NA			77	Metalloprotease. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,166924680,G,G&fts=all">p.R257Q</a>
TLL1	Missense_Mutation	p.E521K	G	G	rs150728189	7	Cancer Module	4	166976264	166976264	185	0.243243243243243	NA	NA	NA		p.E521K(1)	77	CUB 2. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,166976264,G,G&fts=all">p.E521K</a>
TLL1	Missense_Mutation	p.P651L	C	C		7	Cancer Module	4	166981285	166981285	147	0.0476190476190476	NA	NA	NA			77	CUB 3. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,166981285,C,C&fts=all">p.P651L</a>
TLL2	Missense_Mutation	p.G386E	C	C		7	Cancer Module	10	98170123	98170123	50	0.22	NA	NA	NA			58	CUB 1. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,98170123,C,C&fts=all">p.G386E</a>
TLN1	Missense_Mutation	p.P1047S	G	G		7	Cancer Module	9	35714060	35714060	100	0.81	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,35714060,G,G&fts=all">p.P1047S</a>
TLR10	Missense_Mutation	p.H464Y	G	G		7	Cancer Module	4	38775822	38775822	187	0.390374331550802	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,38775822,G,G&fts=all">p.H464Y</a>
TLR2	Nonsense_Mutation	p.W9*	G	G		7	Cancer Module	4	154624086	154624086	198	0.262626262626263	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,154624086,G,G&fts=all">p.W9*</a>
TLR3	Missense_Mutation	p.L14F	C	C		7	Cancer Module	4	186997813	186997813	164	0.341463414634146	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,186997813,C,C&fts=all">p.L14F</a>
TLR7	Missense_Mutation	p.E58K	G	G		7	Cancer Module	X	12903799	12903799	121	0.471074380165289	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,12903799,G,G&fts=all">p.E58K</a>
TLR7	Nonsense_Mutation	p.K1005*	A	A		7	Cancer Module	X	12906640	12906640	188	0.441489361702128	NA	NA	NA			44	TIR. {ECO:0000255|PROSITE- ProRule:PRU00204}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,12906640,A,A&fts=all">p.K1005*</a>
TLR9	Missense_Mutation	p.A1010T	C	C		7	Cancer Module	3	52255764	52255764	75	0.453333333333333	NA	NA	NA			30	TIR. {ECO:0000255|PROSITE- ProRule:PRU00204}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52255764,C,C&fts=all">p.A1010T</a>
TLR9	Missense_Mutation	p.R596K	C	C	rs200813049	7	Cancer Module	3	52257005	52257005	91	0.230769230769231	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52257005,C,C&fts=all">p.R596K</a>
TLR9	Nonsense_Mutation	p.Q134*	G	G		7	Cancer Module	3	52263740	52263740	72	0.194444444444444	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52263740,G,G&fts=all">p.Q134*</a>
TLR9	Missense_Mutation	p.P100L	G	G		7	Cancer Module	3	52263978	52263978	39	0.307692307692308	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52263978,G,G&fts=all">p.P100L</a>
TM7SF3	Missense_Mutation	p.S288F	G	G		7	Cancer Module	12	27143388	27143388	155	0.412903225806452	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TM7SF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,27143388,G,G&fts=all">p.S288F</a>
TMC5	Missense_Mutation	p.K367E	A	A		7	Cancer Module	16	19471607	19471607	66	0.378787878787879	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,19471607,A,A&fts=all">p.K367E</a>
TMC5	Missense_Mutation	p.S511F	C	C		7	Cancer Module	16	19477450	19477450	68	0.205882352941176	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,19477450,C,C&fts=all">p.S511F</a>
TMEM190	Splice_Site	p.E74D	A	A		7	Cancer Module	19	55889171	55889171	39	0.205128205128205	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM190&recr=Open">Click here</a>	
TMEM2	Missense_Mutation	p.S1145L	G	G		7	Cancer Module	9	74313064	74313064	203	0.315270935960591	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,74313064,G,G&fts=all">p.S1145L</a>
TMEM62	Missense_Mutation	p.H367Y	C	C		7	Cancer Module	15	43446946	43446946	226	0.327433628318584	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM62&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43446946,C,C&fts=all">p.H367Y</a>
TMPRSS4	Missense_Mutation	p.R73K	G	G		7	Cancer Module	11	117973876	117973876	68	0.647058823529412	NA	NA	NA			19	LDL-receptor class A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,117973876,G,G&fts=all">p.R73K</a>
TNC	Splice_Site		C	C		7	Cancer Module	9	117808962	117808962	77	0.246753246753247	NA	NA	NA			120			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNC&recr=Open">Click here</a>	
TNC	Missense_Mutation	p.R1400Q	C	C	rs189247379	7	Cancer Module	9	117819539	117819539	206	0.320388349514563	NA	NA	NA		p.R1491Q(1)	120	Fibronectin type-III 9. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,117819539,C,C&fts=all">p.R1400Q</a>
TNFAIP2	Missense_Mutation	p.S649F	C	C		7	Cancer Module	14	103601678	103601678	167	0.275449101796407	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFAIP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,103601678,C,C&fts=all">p.S649F</a>
TNFSF11	Missense_Mutation	p.E143K	G	G		7	Cancer Module	13	43174927	43174927	91	0.296703296703297	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFSF11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,43174927,G,G&fts=all">p.E143K</a>
TNFSF11	Missense_Mutation	p.D174N	G	G		7	Cancer Module	13	43175105	43175105	136	0.25	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFSF11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,43175105,G,G&fts=all">p.D174N</a>
TNFSF11	Missense_Mutation	p.P296L	C	C		7	Cancer Module	13	43180987	43180987	190	0.2	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFSF11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,43180987,C,C&fts=all">p.P296L</a>
TNIP1	Missense_Mutation	p.R263Q	C	C	rs139634771	7	Cancer Module	5	150429443	150429443	274	0.368613138686131	NA	NA	NA			23	Interacts with Nef.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNIP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,150429443,C,C&fts=all">p.R263Q</a>
TNNI2	Missense_Mutation	p.R156Q	G	G		7	Cancer Module	11	1862699	1862699	30	0.433333333333333	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNNI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,1862699,G,G&fts=all">p.R156Q</a>
TNNI2	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	11	1860936	1955677	NA	NA	21	-1.13511063553025	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNNI2&recr=Open">Click here</a>	
TNNT3	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	11	1860936	1955677	NA	NA	21	-1.13511063553025	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNNT3&recr=Open">Click here</a>	
TNR	Missense_Mutation	p.G1202E	C	C		7	Cancer Module	1	175304873	175304873	170	0.164705882352941	NA	NA	NA			177	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,175304873,C,C&fts=all">p.G1202E</a>
TNS1	Missense_Mutation	p.M1429K	A	A		7	Cancer Module	2	218682418	218682418	45	0.288888888888889	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,218682418,A,A&fts=all">p.M1429K</a>
TNS1	Missense_Mutation	p.S818F	G	G		7	Cancer Module	2	218712412	218712412	70	0.242857142857143	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,218712412,G,G&fts=all">p.S818F</a>
TNS1	Nonsense_Mutation	p.Q755*	G	G		7	Cancer Module	2	218712602	218712602	23	0.173913043478261	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,218712602,G,G&fts=all">p.Q755*</a>
TNXB	Missense_Mutation	p.E3454K	C	C		7	Cancer Module	6	32014198	32014198	24	0.333333333333333	NA	NA	NA			8	Fibronectin type-III 26. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNXB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,32014198,C,C&fts=all">p.E3454K</a>
TNXB	Missense_Mutation	p.T3006I	G	G		7	Cancer Module	6	32020545	32020545	58	0.189655172413793	NA	NA	NA			8	Fibronectin type-III 22. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNXB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,32020545,G,G&fts=all">p.T3006I</a>
TNXB	Missense_Mutation	p.E2145K	C	C		7	Cancer Module	6	32035549	32035549	87	0.160919540229885	NA	NA	NA			8	Fibronectin type-III 13. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNXB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,32035549,C,C&fts=all">p.E2145K</a>
TNXB	Missense_Mutation	p.G163S	C	C		7	Cancer Module	6	32065143	32065143	48	0.166666666666667	NA	NA	NA			8	EGF-like 1; incomplete. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNXB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,32065143,C,C&fts=all">p.G163S</a>
TOM1	Missense_Mutation	p.P197S	C	C		7	Cancer Module	22	35719848	35719848	107	0.130841121495327	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TOM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,35719848,C,C&fts=all">p.P197S</a>
TOM1	Missense_Mutation	p.F490I	T	T		7	Cancer Module	22	35743191	35743191	53	0.169811320754717	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TOM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,35743191,T,T&fts=all">p.F490I</a>
TOPBP1	Missense_Mutation	p.S805F	G	G		7	Cancer Module	3	133356826	133356826	247	0.45748987854251	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TOPBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,133356826,G,G&fts=all">p.S805F</a>
TOX	Splice_Site		C	C		7	Cancer Module	8	59720343	59720343	142	0.211267605633803	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TOX&recr=Open">Click here</a>	
TP53I13	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TP53I13&recr=Open">Click here</a>	
TP63	Missense_Mutation	p.E158K	G	G		7	Cancer Module	3	189582195	189582195	42	0.166666666666667	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TP63&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,189582195,G,G&fts=all">p.E158K</a>
TP63	Missense_Mutation	p.S271L	C	C	rs147148566	7	Cancer Module	3	189586470	189586470	102	0.254901960784314	NA	NA	NA		p.S365L(3)	61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TP63&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,189586470,C,C&fts=all">p.S271L</a>
TPBG	Missense_Mutation	p.G283D	G	G		7	Cancer Module	6	83075526	83075526	44	0.477272727272727	NA	NA	NA			15	LRRCT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPBG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,83075526,G,G&fts=all">p.G283D</a>
TPK1	Missense_Mutation	p.G58R	C	C		7	Cancer Module	7	144380015	144380015	168	0.321428571428571	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,144380015,C,C&fts=all">p.G58R</a>
TPMT	Missense_Mutation	p.D233Y	C	C		7	Cancer Module	6	18130940	18130940	350	0.168571428571429	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPMT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,18130940,C,C&fts=all">p.D233Y</a>
TPO	Missense_Mutation	p.G254E	G	G		7	Cancer Module	2	1459996	1459996	49	0.183673469387755	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,1459996,G,G&fts=all">p.G254E</a>
TPO	Splice_Site	p.D840N	G	G		7	Cancer Module	2	1507851	1507851	30	0.366666666666667	NA	NA	NA		p.D840Y(1)	95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPO&recr=Open">Click here</a>	
TPTE	Missense_Mutation	p.R524Q	C	C		7	Cancer Module	21	10906990	10906990	88	0.102272727272727	NA	NA	NA			130	C2 tensin-type. {ECO:0000255|PROSITE- ProRule:PRU00589}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPTE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,10906990,C,C&fts=all">p.R524Q</a>
TPTE	Missense_Mutation	p.C492R	A	A		7	Cancer Module	21	10908871	10908871	92	0.152173913043478	NA	NA	NA		p.C474S(1)	130	C2 tensin-type. {ECO:0000255|PROSITE- ProRule:PRU00589}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPTE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,10908871,A,A&fts=all">p.C492R</a>
TPTE	Splice_Site	p.S483L	G	G		7	Cancer Module	21	10910308	10910308	213	0.352112676056338	NA	NA	NA			130	C2 tensin-type. {ECO:0000255|PROSITE- ProRule:PRU00589}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPTE&recr=Open">Click here</a>	
TPTE	Missense_Mutation	p.L408F	G	G	rs267606169	7	Cancer Module	21	10916424	10916424	203	0.177339901477833	NA	NA	NA			130			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPTE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,10916424,G,G&fts=all">p.L408F</a>
TPTE	Missense_Mutation	p.D233N	C	C		7	Cancer Module	21	10942744	10942744	481	0.145530145530146	NA	NA	NA		p.D215N(1)	130	Phosphatase tensin-type. {ECO:0000255|PROSITE-ProRule:PRU00590}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPTE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,10942744,C,C&fts=all">p.D233N</a>
TPTE2	Missense_Mutation	p.R203K	C	C		7	Cancer Module	13	20038609	20038609	245	0.322448979591837	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPTE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,20038609,C,C&fts=all">p.R203K</a>
TRA2A	Missense_Mutation	p.S30L	G	G		7	Cancer Module	7	23561407	23561407	210	0.323809523809524	NA	NA	NA			10	Arg/Ser-rich (RS1 domain).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRA2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,23561407,G,G&fts=all">p.S30L</a>
TRDN	Missense_Mutation	p.G715R	C	C		7	Cancer Module	6	123539769	123539769	65	0.292307692307692	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRDN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,123539769,C,C&fts=all">p.G715R</a>
TRIB2	Missense_Mutation	p.R132Q	G	G		7	Cancer Module	2	12863510	12863510	177	0.27683615819209	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,12863510,G,G&fts=all">p.R132Q</a>
TRIM10	Missense_Mutation	p.H320Y	G	G		7	Cancer Module	6	30122234	30122234	82	0.195121951219512	NA	NA	NA			1	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,30122234,G,G&fts=all">p.H320Y</a>
TRIM15	Missense_Mutation	p.D146N	G	G		7	Cancer Module	6	30135007	30135007	196	0.193877551020408	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,30135007,G,G&fts=all">p.D146N</a>
TRIM6	Missense_Mutation	p.S176F	C	C		7	Cancer Module	11	5632157	5632157	106	0.386792452830189	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5632157,C,C&fts=all">p.S176F</a>
TRIO	Missense_Mutation	p.S1847F	C	C		7	Cancer Module	5	14462907	14462907	178	0.404494382022472	NA	NA	NA			118	Poly-Ser.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,14462907,C,C&fts=all">p.S1847F</a>
TRIO	Missense_Mutation	p.R1926C	C	C		7	Cancer Module	5	14471439	14471439	88	0.306818181818182	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,14471439,C,C&fts=all">p.R1926C</a>
TRIO	Missense_Mutation	p.F2029L	T	T		7	Cancer Module	5	14477006	14477006	206	0.436893203883495	NA	NA	NA			118	DH 2. {ECO:0000255|PROSITE- ProRule:PRU00062}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,14477006,T,T&fts=all">p.F2029L</a>
TRIP12	Nonsense_Mutation	p.R1213*	G	G		7	Cancer Module	2	230654350	230654350	181	0.298342541436464	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIP12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,230654350,G,G&fts=all">p.R1213*</a>
TRPC3	Missense_Mutation	p.M521I	C	C		7	Cancer Module	4	122831538	122831538	77	0.233766233766234	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,122831538,C,C&fts=all">p.M521I</a>
TRPC3	Missense_Mutation	p.S79F	G	G		7	Cancer Module	4	122854177	122854177	27	0.518518518518518	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,122854177,G,G&fts=all">p.S79F</a>
TRPC4	Missense_Mutation	p.E970K	C	C		7	Cancer Module	13	38211066	38211066	159	0.270440251572327	NA	NA	NA		p.E970K(1)	83	Binds to ITPR1, ITPR2 and ITPR3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,38211066,C,C&fts=all">p.E970K</a>
TRPC4	Splice_Site	p.G693G	C	C		7	Cancer Module	13	38225402	38225402	112	0.223214285714286	NA	NA	NA			83	Binds to ITPR1, ITPR2 and ITPR3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPC4&recr=Open">Click here</a>	
TRPC6	Missense_Mutation	p.G356S	C	C		7	Cancer Module	11	101362349	101362349	140	0.407142857142857	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPC6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,101362349,C,C&fts=all">p.G356S</a>
TRPM2	Missense_Mutation	p.P544S	C	C		7	Cancer Module	21	45811344	45811344	33	0.333333333333333	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,45811344,C,C&fts=all">p.P544S</a>
TRPS1	Missense_Mutation	p.E752K	C	C		7	Cancer Module	8	116599674	116599674	199	0.175879396984925	NA	NA	NA			111	Mediates interaction with GLI3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,116599674,C,C&fts=all">p.E752K</a>
TRPS1	Missense_Mutation	p.E176K	C	C		7	Cancer Module	8	116631799	116631799	180	0.144444444444444	NA	NA	NA			111			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,116631799,C,C&fts=all">p.E176K</a>
TRUB1	Missense_Mutation	p.P322L	C	C		7	Cancer Module	10	116735053	116735053	353	0.509915014164306	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRUB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,116735053,C,C&fts=all">p.P322L</a>
TSC22D1	Missense_Mutation	p.P199L	G	G		7	Cancer Module	13	45149615	45149615	80	0.4125	NA	NA	NA			27	His-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSC22D1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,45149615,G,G&fts=all">p.P199L</a>
TSHB	Missense_Mutation	p.S96F	C	C		7	Cancer Module	1	115576718	115576718	329	0.258358662613982	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSHB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,115576718,C,C&fts=all">p.S96F</a>
TSSK1B	Missense_Mutation	p.E317K	C	C		7	Cancer Module	5	112769588	112769588	13	0.230769230769231	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSSK1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,112769588,C,C&fts=all">p.E317K</a>
TST	Missense_Mutation	p.R281C	G	G		7	Cancer Module	22	37407121	37407121	76	0.25	NA	NA	NA			7	Rhodanese 2. {ECO:0000255|PROSITE- ProRule:PRU00173}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TST&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,37407121,G,G&fts=all">p.R281C</a>
TTC14	Missense_Mutation	p.R509C	C	C	rs575420162	7	Cancer Module	3	180327542	180327542	147	0.054421768707483	NA	NA	NA			45	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,180327542,C,C&fts=all">p.R509C</a>
TTF2	Missense_Mutation	p.R497C	C	C	rs367576357	7	Cancer Module	1	117619361	117619361	140	0.171428571428571	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,117619361,C,C&fts=all">p.R497C</a>
TTF2	Nonsense_Mutation	p.R728*	C	C	rs376286717	7	Cancer Module	1	117631444	117631444	266	0.240601503759398	NA	NA	NA			50	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,117631444,C,C&fts=all">p.R728*</a>
TTN	Missense_Mutation	p.R33544K	C	C		7	Cancer Module	2	179400843	179400843	75	0.24	NA	NA	NA			1448	Ig-like 147.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179400843,C,C&fts=all">p.R33544K</a>
TTN	Missense_Mutation	p.E33065K	C	C		7	Cancer Module	2	179403363	179403363	159	0.220125786163522	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179403363,C,C&fts=all">p.E33065K</a>
TTN	Missense_Mutation	p.D31636N	C	C		7	Cancer Module	2	179411152	179411152	69	0.63768115942029	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179411152,C,C&fts=all">p.D31636N</a>
TTN	Missense_Mutation	p.R30988K	C	C		7	Cancer Module	2	179413390	179413390	151	0.245033112582781	NA	NA	NA			1448	Fibronectin type-III 126. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179413390,C,C&fts=all">p.R30988K</a>
TTN	Nonsense_Mutation	p.W29755*	C	C		7	Cancer Module	2	179418468	179418468	90	0.666666666666667	NA	NA	NA			1448	Fibronectin type-III 116. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179418468,C,C&fts=all">p.W29755*</a>
TTN	Missense_Mutation	p.E28924K	C	C		7	Cancer Module	2	179424089	179424089	280	0.221428571428571	NA	NA	NA			1448	Ig-like 133.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179424089,C,C&fts=all">p.E28924K</a>
TTN	Missense_Mutation	p.E27749K	C	C		7	Cancer Module	2	179427614	179427614	49	0.26530612244898	NA	NA	NA			1448	Fibronectin type-III 102. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179427614,C,C&fts=all">p.E27749K</a>
TTN	Missense_Mutation	p.G27313E	C	C	rs199670463	7	Cancer Module	2	179428921	179428921	212	0.287735849056604	NA	NA	NA			1448	Fibronectin type-III 99. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179428921,C,C&fts=all">p.G27313E</a>
TTN	Missense_Mutation	p.E20425K	C	C		7	Cancer Module	2	179455179	179455179	94	0.297872340425532	NA	NA	NA			1448	Fibronectin type-III 48. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179455179,C,C&fts=all">p.E20425K</a>
TTN	Missense_Mutation	p.E19429K	C	C		7	Cancer Module	2	179458835	179458835	123	0.276422764227642	NA	NA	NA			1448	Fibronectin type-III 41. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179458835,C,C&fts=all">p.E19429K</a>
TTN	Missense_Mutation	p.E18115K	C	C		7	Cancer Module	2	179469473	179469473	145	0.248275862068966	NA	NA	NA			1448	Fibronectin type-III 31. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179469473,C,C&fts=all">p.E18115K</a>
TTN	Missense_Mutation	p.D18087N	C	C		7	Cancer Module	2	179469557	179469557	82	0.353658536585366	NA	NA	NA			1448	Fibronectin type-III 31. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179469557,C,C&fts=all">p.D18087N</a>
TTN	Missense_Mutation	p.L17952F	G	G		7	Cancer Module	2	179470168	179470168	88	0.238636363636364	NA	NA	NA			1448	Fibronectin type-III 30. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179470168,G,G&fts=all">p.L17952F</a>
TTN	Missense_Mutation	p.G15888E	C	C		7	Cancer Module	2	179482149	179482149	43	0.418604651162791	NA	NA	NA			1448	Fibronectin type-III 15. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179482149,C,C&fts=all">p.G15888E</a>
TTN	Missense_Mutation	p.D14523N	C	C		7	Cancer Module	2	179497054	179497054	33	0.363636363636364	NA	NA	NA		p.D11955N(2)|p.D5458N(1)|p.D5650N(1)|p.D5583N(1)	1448	Fibronectin type-III 5. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179497054,C,C&fts=all">p.D14523N</a>
TTN	Missense_Mutation	p.P13096S	G	G		7	Cancer Module	2	179516832	179516832	141	0.25531914893617	NA	NA	NA		p.P10662A(1)	1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179516832,G,G&fts=all">p.P13096S</a>
TTN	Missense_Mutation	p.E12050K	C	C		7	Cancer Module	2	179529435	179529435	71	0.169014084507042	NA	NA	NA			1448	Ig-like 80.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179529435,C,C&fts=all">p.E12050K</a>
TTN	Missense_Mutation	p.P10548S	G	G		7	Cancer Module	2	179557260	179557260	20	0.4	NA	NA	NA			1448	Glu-rich.|Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179557260,G,G&fts=all">p.P10548S</a>
TTN	Missense_Mutation	p.P10203S	G	G		7	Cancer Module	2	179565922	179565922	177	0.254237288135593	NA	NA	NA			1448	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179565922,G,G&fts=all">p.P10203S</a>
TTN	Nonsense_Mutation	p.R10051*	G	G		7	Cancer Module	2	179568946	179568946	182	0.263736263736264	NA	NA	NA			1448	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179568946,G,G&fts=all">p.R10051*</a>
TTN	Missense_Mutation	p.N9539S	T	T		7	Cancer Module	2	179574430	179574430	224	0.236607142857143	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179574430,T,T&fts=all">p.N9539S</a>
TTN	Missense_Mutation	p.R8681K	C	C		7	Cancer Module	2	179579871	179579871	254	0.232283464566929	NA	NA	NA			1448	Ig-like 69.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179579871,C,C&fts=all">p.R8681K</a>
TTN	Missense_Mutation	p.G8146E	C	C		7	Cancer Module	2	179583490	179583490	72	0.319444444444444	NA	NA	NA			1448	Ig-like 64.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179583490,C,C&fts=all">p.G8146E</a>
TTN	Missense_Mutation	p.M7898I	C	C		7	Cancer Module	2	179584525	179584525	60	0.266666666666667	NA	NA	NA			1448	Ig-like 61.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179584525,C,C&fts=all">p.M7898I</a>
TTN	Missense_Mutation	p.E7682K	C	C		7	Cancer Module	2	179585702	179585702	111	0.468468468468468	NA	NA	NA			1448	Ig-like 59.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179585702,C,C&fts=all">p.E7682K</a>
TTN	Missense_Mutation	p.G7433W	C	C		7	Cancer Module	2	179587217	179587217	155	0.264516129032258	NA	NA	NA			1448	Ig-like 56.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179587217,C,C&fts=all">p.G7433W</a>
TTN	Missense_Mutation	p.R6240Q	C	C		7	Cancer Module	2	179594164	179594164	117	0.324786324786325	NA	NA	NA			1448	Ig-like 43.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179594164,C,C&fts=all">p.R6240Q</a>
TTN	Missense_Mutation	p.A4962T	C	C		7	Cancer Module	2	179600289	179600289	56	0.25	NA	NA	NA			1448	Ig-like 30.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179600289,C,C&fts=all">p.A4962T</a>
TTN	Missense_Mutation	p.L4625F	G	G		7	Cancer Module	2	179604087	179604087	90	0.333333333333333	NA	NA	NA		p.L4262I(1)|p.L4454I(1)|p.L4387I(1)	1448	Ig-like 26.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179604087,G,G&fts=all">p.L4625F</a>
TTN	Missense_Mutation	p.E4533K	C	C		7	Cancer Module	2	179604363	179604363	93	0.268817204301075	NA	NA	NA			1448	Ig-like 25.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179604363,C,C&fts=all">p.E4533K</a>
TTN	Missense_Mutation	p.E4343V	T	T		7	Cancer Module	2	179604932	179604932	120	0.2	NA	NA	NA			1448	Ig-like 23.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179604932,T,T&fts=all">p.E4343V</a>
TTN	Missense_Mutation	p.E4343K	C	C		7	Cancer Module	2	179604933	179604933	119	0.201680672268908	NA	NA	NA			1448	Ig-like 23.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179604933,C,C&fts=all">p.E4343K</a>
TTN	Missense_Mutation	p.K4254M	T	T		7	Cancer Module	2	179605199	179605199	60	0.283333333333333	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179605199,T,T&fts=all">p.K4254M</a>
TTN	Missense_Mutation	p.E4130K	C	C		7	Cancer Module	2	179605572	179605572	158	0.284810126582278	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179605572,C,C&fts=all">p.E4130K</a>
TTN	Missense_Mutation	p.E3702K	C	C		7	Cancer Module	2	179621099	179621099	74	0.22972972972973	NA	NA	NA			1448	Ig-like 22.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179621099,C,C&fts=all">p.E3702K</a>
TTN	Missense_Mutation	p.S3453L	G	G		7	Cancer Module	2	179622589	179622589	125	0.296	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179622589,G,G&fts=all">p.S3453L</a>
TTN	Missense_Mutation	p.G3412E	C	C		7	Cancer Module	2	179623779	179623779	146	0.287671232876712	NA	NA	NA			1448	Ig-like 20.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179623779,C,C&fts=all">p.G3412E</a>
TTN	Splice_Site		C	C		7	Cancer Module	2	179629253	179629253	218	0.307339449541284	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Missense_Mutation	p.E3275K	C	C		7	Cancer Module	2	179629419	179629419	150	0.3	NA	NA	NA			1448	Ig-like 19.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179629419,C,C&fts=all">p.E3275K</a>
TTN	Missense_Mutation	p.R3224K	C	C		7	Cancer Module	2	179631140	179631140	152	0.546052631578947	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179631140,C,C&fts=all">p.R3224K</a>
TTN	Missense_Mutation	p.R2783K	C	C		7	Cancer Module	2	179635171	179635171	100	0.3	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179635171,C,C&fts=all">p.R2783K</a>
TTN	Nonsense_Mutation	p.W2652*	C	C		7	Cancer Module	2	179636099	179636099	108	0.268518518518519	NA	NA	NA			1448	Ig-like 15.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179636099,C,C&fts=all">p.W2652*</a>
TTN	Missense_Mutation	p.E2642K	C	C		7	Cancer Module	2	179636130	179636130	115	0.573913043478261	NA	NA	NA		p.E2596K(3)|p.E2642K(2)	1448	Ig-like 15.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179636130,C,C&fts=all">p.E2642K</a>
TTN	Nonsense_Mutation	p.W1115*	C	C		7	Cancer Module	2	179646974	179646974	104	0.230769230769231	NA	NA	NA			1448	Ig-like 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179646974,C,C&fts=all">p.W1115*</a>
TTN	Missense_Mutation	p.P942L	G	G		7	Cancer Module	2	179648463	179648463	308	0.305194805194805	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179648463,G,G&fts=all">p.P942L</a>
TTN	Missense_Mutation	p.S528F	G	G		7	Cancer Module	2	179656878	179656878	90	0.211111111111111	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179656878,G,G&fts=all">p.S528F</a>
TTN	Missense_Mutation	p.S153L	G	G		7	Cancer Module	2	179665247	179665247	134	0.67910447761194	NA	NA	NA			1448	Ig-like 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179665247,G,G&fts=all">p.S153L</a>
TTN	Missense_Mutation	p.S57F	G	G		7	Cancer Module	2	179666990	179666990	77	0.376623376623377	NA	NA	NA			1448	Ig-like 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179666990,G,G&fts=all">p.S57F</a>
TTYH2	Missense_Mutation	p.S353F	C	C		7	Cancer Module	17	72246438	72246438	48	0.208333333333333	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTYH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72246438,C,C&fts=all">p.S353F</a>
TUBE1	Missense_Mutation	p.L159F	G	G		7	Cancer Module	6	112397686	112397686	113	0.36283185840708	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TUBE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,112397686,G,G&fts=all">p.L159F</a>
TUFM	Nonsense_Mutation	p.Q190*	G	G		7	Cancer Module	16	28856135	28856135	102	0.284313725490196	NA	NA	NA			13	tr-type G. {ECO:0000255|PROSITE- ProRule:PRU01059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TUFM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,28856135,G,G&fts=all">p.Q190*</a>
TULP3	Missense_Mutation	p.P195S	C	C		7	Cancer Module	12	3040293	3040293	204	0.205882352941176	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TULP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,3040293,C,C&fts=all">p.P195S</a>
U2AF1	Missense_Mutation	p.G223V	C	C		7	Cancer Module	21	44513267	44513267	58	0.310344827586207	NA	NA	NA			126	Arg/Gly/Ser-rich (RS domain).|Poly-Gly.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+U2AF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,44513267,C,C&fts=all">p.G223V</a>
UBA6	Nonsense_Mutation	p.Q561*	G	G		7	Cancer Module	4	68504716	68504716	110	0.590909090909091	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,68504716,G,G&fts=all">p.Q561*</a>
UBAP1	Missense_Mutation	p.G35S	G	G		7	Cancer Module	9	34234282	34234282	271	0.85239852398524	NA	NA	NA			13	UMA. {ECO:0000255|PROSITE- ProRule:PRU00830}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,34234282,G,G&fts=all">p.G35S</a>
UBN1	Missense_Mutation	p.P723S	C	C		7	Cancer Module	16	4924578	4924578	259	0.247104247104247	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,4924578,C,C&fts=all">p.P723S</a>
UBN1	Missense_Mutation	p.S880C	C	C		7	Cancer Module	16	4925050	4925050	51	0.294117647058824	NA	NA	NA			38	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,4925050,C,C&fts=all">p.S880C</a>
UCK2	Missense_Mutation	p.P86S	C	C		7	Cancer Module	1	165859597	165859597	77	0.376623376623377	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UCK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,165859597,C,C&fts=all">p.P86S</a>
UCP3	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	11	73712573	73717426	NA	NA	5	-1.11029284156021	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UCP3&recr=Open">Click here</a>	
UGP2	Missense_Mutation	p.T176K	C	C		7	Cancer Module	2	64111152	64111152	240	0.0208333333333333	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,64111152,C,C&fts=all">p.T176K</a>
UGT2A1	Missense_Mutation	p.E527K	C	C		7	Cancer Module	4	70455095	70455095	175	0.137142857142857	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70455095,C,C&fts=all">p.E527K</a>
UGT2A1	Missense_Mutation	p.G164R	C	C		7	Cancer Module	4	70512873	70512873	162	0.401234567901235	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70512873,C,C&fts=all">p.G164R</a>
UGT2A1	Missense_Mutation	p.E110V	T	T		7	Cancer Module	4	70513034	70513034	231	0.510822510822511	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70513034,T,T&fts=all">p.E110V</a>
UGT2B10	Missense_Mutation	p.M136I	G	G		7	Cancer Module	4	69682145	69682145	117	0.239316239316239	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2B10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,69682145,G,G&fts=all">p.M136I</a>
UGT2B15	Missense_Mutation	p.F517I	A	A		7	Cancer Module	4	69512866	69512866	302	0.235099337748344	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2B15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,69512866,A,A&fts=all">p.F517I</a>
UGT2B4	Missense_Mutation	p.D263N	C	C		7	Cancer Module	4	70359494	70359494	320	0.203125	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2B4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70359494,C,C&fts=all">p.D263N</a>
UGT2B4	Nonsense_Mutation	p.Q234*	G	G		7	Cancer Module	4	70360880	70360880	219	0.452054794520548	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2B4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70360880,G,G&fts=all">p.Q234*</a>
UGT2B4	Missense_Mutation	p.P101S	G	G		7	Cancer Module	4	70361279	70361279	92	0.152173913043478	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2B4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70361279,G,G&fts=all">p.P101S</a>
UGT2B7	Missense_Mutation	p.P190S	C	C		7	Cancer Module	4	69962806	69962806	178	0.51685393258427	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2B7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,69962806,C,C&fts=all">p.P190S</a>
UGT8	Missense_Mutation	p.F77S	T	T		7	Cancer Module	4	115544266	115544266	112	0.321428571428571	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,115544266,T,T&fts=all">p.F77S</a>
UGT8	Missense_Mutation	p.E102K	G	G		7	Cancer Module	4	115544340	115544340	148	0.337837837837838	NA	NA	NA		p.E102K(3)	31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,115544340,G,G&fts=all">p.E102K</a>
UGT8	Missense_Mutation	p.G310E	G	G		7	Cancer Module	4	115585257	115585257	219	0.242009132420091	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,115585257,G,G&fts=all">p.G310E</a>
UGT8	Missense_Mutation	p.F355L	C	C		7	Cancer Module	4	115589263	115589263	210	0.304761904761905	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,115589263,C,C&fts=all">p.F355L</a>
UNC13A	Missense_Mutation	p.S1562A	A	A		7	Cancer Module	19	17720876	17720876	120	0.166666666666667	NA	NA	NA			61	C2 3. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,17720876,A,A&fts=all">p.S1562A</a>
UNC13A	Missense_Mutation	p.L1395F	G	G		7	Cancer Module	19	17735652	17735652	41	0.585365853658537	NA	NA	NA			61	MHD2. {ECO:0000255|PROSITE- ProRule:PRU00588}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,17735652,G,G&fts=all">p.L1395F</a>
UNC5D	Missense_Mutation	p.E269K	G	G		7	Cancer Module	8	35544116	35544116	161	0.192546583850932	NA	NA	NA			112	TSP type-1 1. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC5D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,35544116,G,G&fts=all">p.E269K</a>
UNC5D	Missense_Mutation	p.P454L	C	C		7	Cancer Module	8	35583934	35583934	109	0.220183486238532	NA	NA	NA			112			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC5D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,35583934,C,C&fts=all">p.P454L</a>
UPB1	Nonsense_Mutation	p.W354*	G	G		7	Cancer Module	22	24919732	24919732	123	0.268292682926829	NA	NA	NA			22	CN hydrolase. {ECO:0000255|PROSITE- ProRule:PRU00054}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UPB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,24919732,G,G&fts=all">p.W354*</a>
USH2A	Missense_Mutation	p.R3119C	G	G	rs576236830	7	Cancer Module	1	216011349	216011349	309	0.181229773462783	NA	NA	NA			527	Fibronectin type-III 18. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,216011349,G,G&fts=all">p.R3119C</a>
USH2A	Missense_Mutation	p.P2538S	G	G		7	Cancer Module	1	216062379	216062379	170	0.252941176470588	NA	NA	NA			527	Fibronectin type-III 12. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,216062379,G,G&fts=all">p.P2538S</a>
USH2A	Missense_Mutation	p.P1729L	G	G		7	Cancer Module	1	216256910	216256910	549	0.459016393442623	NA	NA	NA			527	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,216256910,G,G&fts=all">p.P1729L</a>
USH2A	Missense_Mutation	p.P1159S	G	G		7	Cancer Module	1	216373305	216373305	283	0.473498233215548	NA	NA	NA			527	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,216373305,G,G&fts=all">p.P1159S</a>
USH2A	Missense_Mutation	p.Q748P	T	T		7	Cancer Module	1	216420493	216420493	229	0.441048034934498	NA	NA	NA			527	Laminin EGF-like 5. {ECO:0000255|PROSITE- ProRule:PRU00460}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,216420493,T,T&fts=all">p.Q748P</a>
USP36	Missense_Mutation	p.P683L	G	G		7	Cancer Module	17	76803078	76803078	155	0.625806451612903	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP36&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,76803078,G,G&fts=all">p.P683L</a>
USP4	Missense_Mutation	p.G4D	C	C		7	Cancer Module	3	49377447	49377447	64	0.25	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49377447,C,C&fts=all">p.G4D</a>
USP9X	Splice_Site	p.S959L	C	C		7	Cancer Module	X	41029487	41029487	60	0.45	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP9X&recr=Open">Click here</a>	
UST	Missense_Mutation	p.N132Y	A	A		7	Cancer Module	6	149262517	149262517	218	0.412844036697248	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UST&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,149262517,A,A&fts=all">p.N132Y</a>
UTRN	Missense_Mutation	p.L173F	C	C		7	Cancer Module	6	144747534	144747534	53	0.377358490566038	NA	NA	NA			148	Actin-binding.|CH 2. {ECO:0000255|PROSITE- ProRule:PRU00044}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UTRN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,144747534,C,C&fts=all">p.L173F</a>
VAV3	Missense_Mutation	p.R103C	G	G	rs61761613	7	Cancer Module	1	108417537	108417537	113	0.911504424778761	NA	NA	NA			58	CH. {ECO:0000255|PROSITE- ProRule:PRU00044}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VAV3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,108417537,G,G&fts=all">p.R103C</a>
VIL1	Missense_Mutation	p.E269K	G	G		7	Cancer Module	2	219294354	219294354	88	0.306818181818182	NA	NA	NA			41	Core.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VIL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219294354,G,G&fts=all">p.E269K</a>
VIL1	Missense_Mutation	p.D335N	G	G		7	Cancer Module	2	219295502	219295502	57	0.456140350877193	NA	NA	NA			41	Core.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VIL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219295502,G,G&fts=all">p.D335N</a>
VIL1	Missense_Mutation	p.E581K	G	G		7	Cancer Module	2	219300072	219300072	66	0.227272727272727	NA	NA	NA			41	Core.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VIL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219300072,G,G&fts=all">p.E581K</a>
VIM	Missense_Mutation	p.E153K	G	G		7	Cancer Module	10	17271878	17271878	40	0.225	NA	NA	NA			38	Linker 1.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VIM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,17271878,G,G&fts=all">p.E153K</a>
VPS13D	Missense_Mutation	p.G3570R	G	G		7	Cancer Module	1	12429657	12429657	389	0.323907455012853	NA	NA	NA			130			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,12429657,G,G&fts=all">p.G3570R</a>
VPS36	Splice_Site	p.L281L	A	A		7	Cancer Module	13	52992191	52992191	147	0.557823129251701	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS36&recr=Open">Click here</a>	
VWF	Missense_Mutation	p.R2051K	C	C		7	Cancer Module	12	6103685	6103685	163	0.226993865030675	NA	NA	NA			129	VWFD 4. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,6103685,C,C&fts=all">p.R2051K</a>
WASF3	Missense_Mutation	p.S501F	C	C		7	Cancer Module	13	27259975	27259975	37	0.243243243243243	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WASF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,27259975,C,C&fts=all">p.S501F</a>
WDR37	Missense_Mutation	p.G154S	G	G		7	Cancer Module	10	1130406	1130406	125	0.256	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR37&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,1130406,G,G&fts=all">p.G154S</a>
WDR37	Missense_Mutation	p.P273S	C	C		7	Cancer Module	10	1149632	1149632	78	0.282051282051282	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR37&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,1149632,C,C&fts=all">p.P273S</a>
WDR47	Missense_Mutation	p.R83C	G	G	rs140178030	7	Cancer Module	1	109556543	109556543	207	0.48792270531401	NA	NA	NA			20	CTLH. {ECO:0000255|PROSITE- ProRule:PRU00058}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR47&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,109556543,G,G&fts=all">p.R83C</a>
WDR52	Missense_Mutation	p.S138F	G	G		7	Cancer Module	3	113139021	113139021	67	0.447761194029851	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR52&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,113139021,G,G&fts=all">p.S138F</a>
WDR6	Missense_Mutation	p.S107L	C	C		7	Cancer Module	3	49050943	49050943	197	0.233502538071066	NA	NA	NA		p.S659L(1)	26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49050943,C,C&fts=all">p.S107L</a>
WDR78	Missense_Mutation	p.S479F	G	G		7	Cancer Module	1	67306210	67306210	243	0.390946502057613	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR78&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,67306210,G,G&fts=all">p.S479F</a>
WDTC1	Missense_Mutation	p.R437C	C	C		7	Cancer Module	1	27627796	27627796	73	0.520547945205479	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDTC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,27627796,C,C&fts=all">p.R437C</a>
WNK1	Missense_Mutation	p.S1253F	C	C		7	Cancer Module	12	993323	993323	505	0.201980198019802	NA	NA	NA		p.S1253F(1)|p.S1513F(1)	104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,993323,C,C&fts=all">p.S1253F</a>
WNK1	Missense_Mutation	p.P1449L	C	C		7	Cancer Module	12	994316	994316	270	0.225925925925926	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,994316,C,C&fts=all">p.P1449L</a>
WNK1	Missense_Mutation	p.V2354L	G	G		7	Cancer Module	12	1017869	1017869	96	0.177083333333333	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,1017869,G,G&fts=all">p.V2354L</a>
WSB1	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	17	25621463	26370357	NA	NA	46	-1.18672159545669	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WSB1&recr=Open">Click here</a>	
WWC1	Missense_Mutation	p.P536L	C	C		7	Cancer Module	5	167850870	167850870	30	0.3	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WWC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,167850870,C,C&fts=all">p.P536L</a>
WWTR1	Missense_Mutation	p.L331F	G	G		7	Cancer Module	3	149243827	149243827	143	0.244755244755245	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WWTR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,149243827,G,G&fts=all">p.L331F</a>
XPNPEP2	Missense_Mutation	p.D461N	G	G		7	Cancer Module	X	128893169	128893169	54	0.407407407407407	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XPNPEP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,128893169,G,G&fts=all">p.D461N</a>
XRCC6BP1	Missense_Mutation	p.F86Y	T	T		7	Cancer Module	12	58340801	58340801	157	0.45859872611465	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XRCC6BP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,58340801,T,T&fts=all">p.F86Y</a>
XRN1	Missense_Mutation	p.S844F	G	G		7	Cancer Module	3	142102227	142102227	99	0.343434343434343	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XRN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,142102227,G,G&fts=all">p.S844F</a>
XRN1	Missense_Mutation	p.R815C	G	G	rs141258147	7	Cancer Module	3	142103424	142103424	307	0.0521172638436482	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XRN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,142103424,G,G&fts=all">p.R815C</a>
ZBTB10	Missense_Mutation	p.F423V	T	T		7	Cancer Module	8	81412023	81412023	331	0.229607250755287	NA	NA	NA			20	BTB. {ECO:0000255|PROSITE- ProRule:PRU00037}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,81412023,T,T&fts=all">p.F423V</a>
ZBTB16	Copy Number	Deleted	NA	NA	NA	7	Cancer Gene Census	11	113803817	114183201	NA	NA	18	-1.11528487090397	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB16&recr=Open">Click here</a>	
ZBTB20	Nonsense_Mutation	p.Q465*	G	G		7	Cancer Module	3	114069313	114069313	48	0.375	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,114069313,G,G&fts=all">p.Q465*</a>
ZC3H3	Missense_Mutation	p.S69L	G	G	rs370112125	7	Cancer Module	8	144621331	144621331	123	0.398373983739837	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3H3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,144621331,G,G&fts=all">p.S69L</a>
ZDBF2	Missense_Mutation	p.P1257L	C	C		7	Cancer Module	2	207173022	207173022	124	0.201612903225806	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZDBF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,207173022,C,C&fts=all">p.P1257L</a>
ZDHHC2	Missense_Mutation	p.L184H	T	T		7	Cancer Module	8	17063238	17063238	276	0.235507246376812	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZDHHC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,17063238,T,T&fts=all">p.L184H</a>
ZEB1	Missense_Mutation	p.G469E	G	G		7	Cancer Module	10	31809669	31809669	195	0.246153846153846	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZEB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,31809669,G,G&fts=all">p.G469E</a>
ZEB2	Missense_Mutation	p.P906S	G	G	rs375527889	7	Cancer Module	2	145156038	145156038	307	0.302931596091205	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZEB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,145156038,G,G&fts=all">p.P906S</a>
ZEB2	Missense_Mutation	p.P96L	G	G		7	Cancer Module	2	145187380	145187380	237	0.270042194092827	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZEB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,145187380,G,G&fts=all">p.P96L</a>
ZFHX3	Missense_Mutation	p.V2083M	C	C		7	Cancer Module	16	72830334	72830334	74	0.581081081081081	NA	NA	NA			153			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,72830334,C,C&fts=all">p.V2083M</a>
ZFHX3	Missense_Mutation	p.A792V	G	G		7	Cancer Module	16	72991670	72991670	77	0.233766233766234	NA	NA	NA			153			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,72991670,G,G&fts=all">p.A792V</a>
ZFHX3	Missense_Mutation	p.P725L	G	G		7	Cancer Module	16	72991871	72991871	112	0.241071428571429	NA	NA	NA			153			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,72991871,G,G&fts=all">p.P725L</a>
ZFPM2	Missense_Mutation	p.S581F	C	C		7	Cancer Module	8	106814052	106814052	213	0.211267605633803	NA	NA	NA			99			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFPM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,106814052,C,C&fts=all">p.S581F</a>
ZFPM2	Missense_Mutation	p.P717S	C	C		7	Cancer Module	8	106814459	106814459	41	0.146341463414634	NA	NA	NA			99			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFPM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,106814459,C,C&fts=all">p.P717S</a>
ZFPM2	Missense_Mutation	p.R849K	G	G		7	Cancer Module	8	106814856	106814856	24	0.291666666666667	NA	NA	NA			99			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFPM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,106814856,G,G&fts=all">p.R849K</a>
ZFR	Missense_Mutation	p.P616S	G	G		7	Cancer Module	5	32395398	32395398	133	0.195488721804511	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,32395398,G,G&fts=all">p.P616S</a>
ZFYVE1	Missense_Mutation	p.S494F	G	G		7	Cancer Module	14	73444881	73444881	98	0.306122448979592	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFYVE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,73444881,G,G&fts=all">p.S494F</a>
ZKSCAN3	Missense_Mutation	p.G299S	G	G		7	Cancer Module	6	28333340	28333340	85	0.188235294117647	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZKSCAN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28333340,G,G&fts=all">p.G299S</a>
ZMIZ1	Missense_Mutation	p.P841S	C	C		7	Cancer Module	10	81065954	81065954	34	0.205882352941176	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZMIZ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,81065954,C,C&fts=all">p.P841S</a>
ZMIZ2	Missense_Mutation	p.P779L	C	C		7	Cancer Module	7	44805856	44805856	44	0.295454545454545	NA	NA	NA			35	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZMIZ2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,44805856,C,C&fts=all">p.P779L</a>
ZMIZ2	Missense_Mutation	p.S898F	C	C		7	Cancer Module	7	44807152	44807152	56	0.214285714285714	NA	NA	NA			35	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZMIZ2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,44807152,C,C&fts=all">p.S898F</a>
ZMYM5	Missense_Mutation	p.H278Y	G	G	rs116253786	7	Cancer Module	13	20412880	20412880	192	0.291666666666667	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZMYM5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,20412880,G,G&fts=all">p.H278Y</a>
ZMYM6	Missense_Mutation	p.S366L	G	G	rs377596083	7	Cancer Module	1	35476603	35476603	113	0.300884955752212	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZMYM6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,35476603,G,G&fts=all">p.S366L</a>
ZMYND15	Missense_Mutation	p.P674L	C	C		7	Cancer Module	17	4648634	4648634	54	0.351851851851852	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZMYND15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,4648634,C,C&fts=all">p.P674L</a>
ZNF10	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	12	133365878	133779461	NA	NA	33	-1.06793882865658	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF10&recr=Open">Click here</a>	
ZNF107	Missense_Mutation	p.P6S	C	C		7	Cancer Module	7	64152335	64152335	137	0.299270072992701	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF107&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,64152335,C,C&fts=all">p.P6S</a>
ZNF132	Missense_Mutation	p.E288K	C	C		7	Cancer Module	19	58945949	58945949	179	0.17877094972067	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF132&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58945949,C,C&fts=all">p.E288K</a>
ZNF136	Nonsense_Mutation	p.R408*	C	C	rs371730093	7	Cancer Module	19	12298415	12298415	110	0.236363636363636	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF136&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,12298415,C,C&fts=all">p.R408*</a>
ZNF14	Missense_Mutation	p.S371L	G	G		7	Cancer Module	19	19822978	19822978	151	0.364238410596026	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,19822978,G,G&fts=all">p.S371L</a>
ZNF141	Missense_Mutation	p.G251R	G	G		7	Cancer Module	4	366977	366977	146	0.397260273972603	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF141&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,366977,G,G&fts=all">p.G251R</a>
ZNF157	Missense_Mutation	p.A170T	G	G		7	Cancer Module	X	47271980	47271980	51	0.490196078431373	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF157&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,47271980,G,G&fts=all">p.A170T</a>
ZNF157	Missense_Mutation	p.R433Q	G	G	rs186660909	7	Cancer Module	X	47272770	47272770	41	0.414634146341463	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF157&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,47272770,G,G&fts=all">p.R433Q</a>
ZNF16	Missense_Mutation	p.P572L	G	G		7	Cancer Module	8	146156458	146156458	90	0.233333333333333	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,146156458,G,G&fts=all">p.P572L</a>
ZNF185	Missense_Mutation	p.R561Q	G	G		7	Cancer Module	X	152128422	152128422	37	0.243243243243243	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF185&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,152128422,G,G&fts=all">p.R561Q</a>
ZNF19	Nonsense_Mutation	p.Q97*	G	G		7	Cancer Module	16	71510035	71510035	163	0.208588957055215	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,71510035,G,G&fts=all">p.Q97*</a>
ZNF195	Missense_Mutation	p.L192V	A	A		7	Cancer Module	11	3381664	3381664	88	0.909090909090909	NA	NA	NA			17	Spacer.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF195&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,3381664,A,A&fts=all">p.L192V</a>
ZNF239	Missense_Mutation	p.P290S	G	G		7	Cancer Module	10	44052660	44052660	169	0.165680473372781	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF239&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,44052660,G,G&fts=all">p.P290S</a>
ZNF25	Missense_Mutation	p.H304Y	G	G		7	Cancer Module	10	38241516	38241516	103	0.16504854368932	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,38241516,G,G&fts=all">p.H304Y</a>
ZNF251	Missense_Mutation	p.H161Y	G	G		7	Cancer Module	8	145948564	145948564	190	0.252631578947368	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF251&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,145948564,G,G&fts=all">p.H161Y</a>
ZNF254	Missense_Mutation	p.P247S	C	C		7	Cancer Module	19	24309541	24309541	95	0.284210526315789	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF254&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,24309541,C,C&fts=all">p.P247S</a>
ZNF26	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	12	133365878	133779461	NA	NA	33	-1.06793882865658	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF26&recr=Open">Click here</a>	
ZNF266	Missense_Mutation	p.S534F	G	G		7	Cancer Module	19	9524000	9524000	148	0.195945945945946	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF266&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9524000,G,G&fts=all">p.S534F</a>
ZNF273	Missense_Mutation	p.G92R	G	G		7	Cancer Module	7	64378619	64378619	159	0.0566037735849057	NA	NA	NA			16	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF273&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,64378619,G,G&fts=all">p.G92R</a>
ZNF273	Missense_Mutation	p.P108L	C	C		7	Cancer Module	7	64378668	64378668	130	0.0461538461538462	NA	NA	NA			16	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF273&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,64378668,C,C&fts=all">p.P108L</a>
ZNF292	Missense_Mutation	p.S1308T	T	T		7	Cancer Module	6	87967269	87967269	22	0.5	NA	NA	NA			89			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF292&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,87967269,T,T&fts=all">p.S1308T</a>
ZNF318	Missense_Mutation	p.P465L	G	G		7	Cancer Module	6	43323678	43323678	269	0.197026022304833	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF318&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,43323678,G,G&fts=all">p.P465L</a>
ZNF32	Missense_Mutation	p.S59F	G	G		7	Cancer Module	10	44140144	44140144	342	0.441520467836257	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF32&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,44140144,G,G&fts=all">p.S59F</a>
ZNF385D	Nonsense_Mutation	p.R358*	G	G		7	Cancer Module	3	21462822	21462822	37	0.189189189189189	NA	NA	NA		p.R358*(1)	46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF385D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,21462822,G,G&fts=all">p.R358*</a>
ZNF395	Missense_Mutation	p.P249L	G	G		7	Cancer Module	8	28210763	28210763	71	0.126760563380282	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF395&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,28210763,G,G&fts=all">p.P249L</a>
ZNF415	Missense_Mutation	p.E14K	C	C		7	Cancer Module	19	53619662	53619662	190	0.142105263157895	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF415&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,53619662,C,C&fts=all">p.E14K</a>
ZNF423	Missense_Mutation	p.K779R	T	T		7	Cancer Module	16	49670727	49670727	38	0.342105263157895	NA	NA	NA			89			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF423&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,49670727,T,T&fts=all">p.K779R</a>
ZNF423	Missense_Mutation	p.S15L	G	G	rs377503772	7	Cancer Module	16	49823430	49823430	21	0.142857142857143	NA	NA	NA			89			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF423&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,49823430,G,G&fts=all">p.S15L</a>
ZNF43	Missense_Mutation	p.H156Y	G	G		7	Cancer Module	19	21992373	21992373	91	0.263736263736264	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF43&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,21992373,G,G&fts=all">p.H156Y</a>
ZNF462	Missense_Mutation	p.H378Y	C	C		7	Cancer Module	9	109690790	109690790	46	0.282608695652174	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF462&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,109690790,C,C&fts=all">p.H378Y</a>
ZNF462	Missense_Mutation	p.F1137S	T	T		7	Cancer Module	9	109734550	109734550	134	0.291044776119403	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF462&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,109734550,T,T&fts=all">p.F1137S</a>
ZNF592	Missense_Mutation	p.P433S	C	C	rs267604351	7	Cancer Module	15	85327203	85327203	42	0.404761904761905	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF592&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,85327203,C,C&fts=all">p.P433S</a>
ZNF592	Missense_Mutation	p.R637C	C	C		7	Cancer Module	15	85327815	85327815	46	0.282608695652174	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF592&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,85327815,C,C&fts=all">p.R637C</a>
ZNF638	Missense_Mutation	p.M956I	G	G		7	Cancer Module	2	71631038	71631038	648	0.37037037037037	NA	NA	NA			63	RRM 2. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF638&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,71631038,G,G&fts=all">p.M956I</a>
ZNF639	Missense_Mutation	p.V187L	G	G		7	Cancer Module	3	179051311	179051311	239	0.476987447698745	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF639&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,179051311,G,G&fts=all">p.V187L</a>
ZNF667	Missense_Mutation	p.E40K	C	C		7	Cancer Module	19	56972100	56972100	70	0.185714285714286	NA	NA	NA			38	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF667&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56972100,C,C&fts=all">p.E40K</a>
ZNF667	Missense_Mutation	p.D37N	C	C		7	Cancer Module	19	56972109	56972109	73	0.452054794520548	NA	NA	NA			38	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF667&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56972109,C,C&fts=all">p.D37N</a>
ZNF76	Missense_Mutation	p.G155E	G	G		7	Cancer Module	6	35258074	35258074	342	0.233918128654971	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF76&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,35258074,G,G&fts=all">p.G155E</a>
ZNF765	Missense_Mutation	p.E501K	G	G		7	Cancer Module	19	53912309	53912309	66	0.272727272727273	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF765&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,53912309,G,G&fts=all">p.E501K</a>
ZNF77	Missense_Mutation	p.P392S	G	G		7	Cancer Module	19	2933951	2933951	140	0.264285714285714	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF77&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,2933951,G,G&fts=all">p.P392S</a>
ZNF777	Missense_Mutation	p.S693F	G	G		7	Cancer Module	7	149129285	149129285	37	0.351351351351351	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF777&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,149129285,G,G&fts=all">p.S693F</a>
ZNF777	Missense_Mutation	p.P605L	G	G		7	Cancer Module	7	149129549	149129549	33	0.333333333333333	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF777&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,149129549,G,G&fts=all">p.P605L</a>
ZNF8	Missense_Mutation	p.F58L	T	T		7	Cancer Module	19	58797188	58797188	158	0.367088607594937	NA	NA	NA			19	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58797188,T,T&fts=all">p.F58L</a>
ZNF93	Missense_Mutation	p.H531Y	C	C		7	Cancer Module	19	20045355	20045355	112	0.205357142857143	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF93&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,20045355,C,C&fts=all">p.H531Y</a>
ZP4	Missense_Mutation	p.L132F	G	G		7	Cancer Module	1	238053173	238053173	185	0.210810810810811	NA	NA	NA		p.L132F(1)	73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,238053173,G,G&fts=all">p.L132F</a>
ZWILCH	Missense_Mutation	p.L339F	C	C		7	Cancer Module	15	66821235	66821235	163	0.263803680981595	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZWILCH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,66821235,C,C&fts=all">p.L339F</a>
ZZZ3	Missense_Mutation	p.P607S	G	G		7	Cancer Module	1	78047550	78047550	181	0.0331491712707182	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZZZ3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,78047550,G,G&fts=all">p.P607S</a>
ADCK5	Missense_Mutation	p.A192T	G	G		7.75	Cancer Gene	8	145616364	145616364	46	0.58695652173913	NA	NA	NA			8	Protein kinase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,145616364,G,G&fts=all">p.A192T</a>
BRSK1	Missense_Mutation	p.E132K	G	G		7.75	Cancer Gene	19	55800924	55800924	133	0.172932330827068	NA	NA	NA			48	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRSK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55800924,G,G&fts=all">p.E132K</a>
C9orf96	Missense_Mutation	p.R246C	C	C	rs199901953	7.75	Cancer Gene	9	136260760	136260760	40	0.625	NA	NA	NA		p.R246C(1)	25	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9orf96&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,136260760,C,C&fts=all">p.R246C</a>
CDK11A	Missense_Mutation	p.S591P	A	A		7.75	Cancer Gene	1	1635373	1635373	57	0.491228070175439	NA	NA	NA			18	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDK11A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,1635373,A,A&fts=all">p.S591P</a>
CDK18	Missense_Mutation	p.L169F	C	C		7.75	Cancer Gene	1	205495241	205495241	22	0.545454545454545	NA	NA	NA			19	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDK18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,205495241,C,C&fts=all">p.L169F</a>
DCLK3	Missense_Mutation	p.K600M	T	T		7.75	Cancer Gene	3	36756967	36756967	249	0.176706827309237	NA	NA	NA			48	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCLK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,36756967,T,T&fts=all">p.K600M</a>
GSK3A	Missense_Mutation	p.L219F	G	G		7.75	Cancer Gene	19	42740769	42740769	148	0.5	NA	NA	NA			19	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSK3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,42740769,G,G&fts=all">p.L219F</a>
HIPK2	Missense_Mutation	p.S386F	G	G		7.75	Cancer Gene	7	139316418	139316418	62	0.0645161290322581	NA	NA	NA			43	Interaction with DAXX.|Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIPK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,139316418,G,G&fts=all">p.S386F</a>
IRAK2	Missense_Mutation	p.D431N	G	G		7.75	Cancer Gene	3	10276161	10276161	72	0.208333333333333	NA	NA	NA			25	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IRAK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,10276161,G,G&fts=all">p.D431N</a>
NEK5	Missense_Mutation	p.G140E	C	C		7.75	Cancer Gene	13	52684524	52684524	261	0.547892720306513	NA	NA	NA			39	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,52684524,C,C&fts=all">p.G140E</a>
PKN3	Missense_Mutation	p.P657S	C	C		7.75	Cancer Gene	9	131479186	131479186	75	0.693333333333333	NA	NA	NA			24	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,131479186,C,C&fts=all">p.P657S</a>
RPS6KA6	Missense_Mutation	p.F347I	A	A		7.75	Cancer Gene	X	83362703	83362703	51	0.352941176470588	NA	NA	NA			46	AGC-kinase C-terminal.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPS6KA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,83362703,A,A&fts=all">p.F347I</a>
RPS6KB1	Missense_Mutation	p.H245Y	C	C		7.75	Cancer Gene	17	58011575	58011575	451	0.190687361419069	NA	NA	NA			14	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPS6KB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,58011575,C,C&fts=all">p.H245Y</a>
STK35	Missense_Mutation	p.S329F	C	C		7.75	Cancer Gene	20	2097405	2097405	127	0.354330708661417	NA	NA	NA			13	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK35&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,2097405,C,C&fts=all">p.S329F</a>
TRPM6	Missense_Mutation	p.P1951L	G	G	rs143161006	7.75	Cancer Gene	9	77343238	77343238	153	0.673202614379085	NA	NA	NA			126	Alpha-type protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00501}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,77343238,G,G&fts=all">p.P1951L</a>
TRPM6	Missense_Mutation	p.E1902K	C	C		7.75	Cancer Gene	9	77353395	77353395	71	0.352112676056338	NA	NA	NA			126	Alpha-type protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00501}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,77353395,C,C&fts=all">p.E1902K</a>
VRK3	Missense_Mutation	p.R369C	G	G		7.75	Cancer Gene	19	50491741	50491741	59	0.220338983050847	NA	NA	NA			23	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VRK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50491741,G,G&fts=all">p.R369C</a>
AADACL4	Missense_Mutation	p.F16L	C	C		8	Cancer Gene	1	12704613	12704613	111	0.936936936936937	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AADACL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,12704613,C,C&fts=all">p.F16L</a>
AATF	Frame_Shift_Del	p.S218fs	T	T		8	Cancer Gene	17	35310556	35310556	258	0.414728682170543	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AATF&recr=Open">Click here</a>	
ABCA13	Missense_Mutation	p.L2495F	C	C		8	Cancer Gene	7	48318274	48318274	444	0.207207207207207	NA	NA	NA			270			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,48318274,C,C&fts=all">p.L2495F</a>
ABCA13	Missense_Mutation	p.M3581I	G	G		8	Cancer Gene	7	48407445	48407445	14	0.428571428571429	NA	NA	NA			270			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,48407445,G,G&fts=all">p.M3581I</a>
ABCA13	Missense_Mutation	p.G4977E	G	G		8	Cancer Gene	7	48682976	48682976	232	0.28448275862069	NA	NA	NA			270			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,48682976,G,G&fts=all">p.G4977E</a>
ABCA9	Missense_Mutation	p.D154N	C	C		8	Cancer Gene	17	67041322	67041322	148	0.128378378378378	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,67041322,C,C&fts=all">p.D154N</a>
ABCC12	Missense_Mutation	p.E1119K	C	C		8	Cancer Gene	16	48122576	48122576	57	0.245614035087719	NA	NA	NA			90			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,48122576,C,C&fts=all">p.E1119K</a>
ABCC9	Missense_Mutation	p.L1072F	G	G		8	Cancer Gene	12	21997732	21997732	251	0.430278884462151	NA	NA	NA			118	ABC transmembrane type-1 2. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,21997732,G,G&fts=all">p.L1072F</a>
ABCC9	Missense_Mutation	p.E922V	T	T		8	Cancer Gene	12	22005035	22005035	194	0.469072164948454	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,22005035,T,T&fts=all">p.E922V</a>
ABCC9	Missense_Mutation	p.F772Y	A	A		8	Cancer Gene	12	22015911	22015911	144	0.222222222222222	NA	NA	NA			118	ABC transporter 1. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,22015911,A,A&fts=all">p.F772Y</a>
ABCC9	Missense_Mutation	p.E736K	C	C		8	Cancer Gene	12	22017404	22017404	244	0.188524590163934	NA	NA	NA			118	ABC transporter 1. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,22017404,C,C&fts=all">p.E736K</a>
ABCC9	Missense_Mutation	p.G727E	C	C		8	Cancer Gene	12	22025577	22025577	263	0.216730038022814	NA	NA	NA			118	ABC transporter 1. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,22025577,C,C&fts=all">p.G727E</a>
ABCC9	Missense_Mutation	p.V596I	C	C		8	Cancer Gene	12	22046982	22046982	91	0.43956043956044	NA	NA	NA			118	ABC transmembrane type-1 1. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,22046982,C,C&fts=all">p.V596I</a>
ABCC9	Missense_Mutation	p.P131S	G	G		8	Cancer Gene	12	22078891	22078891	134	0.276119402985075	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,22078891,G,G&fts=all">p.P131S</a>
ABCG2	Missense_Mutation	p.R191K	C	C		8	Cancer Gene	4	89042904	89042904	106	0.292452830188679	NA	NA	NA			42	ABC transporter. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,89042904,C,C&fts=all">p.R191K</a>
ABCG8	Missense_Mutation	p.D116N	G	G		8	Cancer Gene	2	44078746	44078746	29	0.137931034482759	NA	NA	NA			45	ABC transporter. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCG8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,44078746,G,G&fts=all">p.D116N</a>
ABCG8	Missense_Mutation	p.E340K	G	G		8	Cancer Gene	2	44099168	44099168	75	0.346666666666667	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCG8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,44099168,G,G&fts=all">p.E340K</a>
ABHD11	Missense_Mutation	p.S168F	G	G		8	Cancer Gene	7	73151660	73151660	59	0.813559322033898	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABHD11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,73151660,G,G&fts=all">p.S168F</a>
ABHD15	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABHD15&recr=Open">Click here</a>	
ABHD16B	Nonsense_Mutation	p.W202*	G	G		8	Cancer Gene	20	62493498	62493498	21	0.428571428571429	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABHD16B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,62493498,G,G&fts=all">p.W202*</a>
ABLIM2	Missense_Mutation	p.D480N	C	C		8	Cancer Gene	4	8010815	8010815	68	0.294117647058824	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABLIM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,8010815,C,C&fts=all">p.D480N</a>
ABT1	Missense_Mutation	p.L268F	C	C		8	Cancer Gene	6	26598856	26598856	93	0.258064516129032	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,26598856,C,C&fts=all">p.L268F</a>
ACAD11	Splice_Site	p.E426K	C	C		8	Cancer Gene	3	132337616	132337616	109	0.376146788990826	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACAD11&recr=Open">Click here</a>	
ACAD11	Missense_Mutation	p.S411L	G	G		8	Cancer Gene	3	132338355	132338355	253	0.33201581027668	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACAD11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,132338355,G,G&fts=all">p.S411L</a>
ACAD11	Missense_Mutation	p.S333L	G	G	rs561289192	8	Cancer Gene	3	132347256	132347256	266	0.327067669172932	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACAD11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,132347256,G,G&fts=all">p.S333L</a>
ACAD9	Frame_Shift_Del	p.GEVG287fs	AGAGGTCGGA	AGAGGTCGGA		8	Cancer Gene	3	128620171	128620180	84	0.0833333333333333	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACAD9&recr=Open">Click here</a>	
ACAN	Missense_Mutation	p.P641L	C	C		8	Cancer Gene	15	89392858	89392858	18	0.222222222222222	NA	NA	NA			93	G2-B'.|Link 4. {ECO:0000255|PROSITE- ProRule:PRU00323}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACAN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,89392858,C,C&fts=all">p.P641L</a>
ACAN	Missense_Mutation	p.E786K	G	G		8	Cancer Gene	15	89398172	89398172	15	0.333333333333333	NA	NA	NA			93	12 X 6 AA approximate tandem repeats of E-[GVE]-P-[SFY]-[APT]-[TSP].|KS.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACAN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,89398172,G,G&fts=all">p.E786K</a>
ACAN	Missense_Mutation	p.S861P	T	T		8	Cancer Gene	15	89398397	89398397	31	0.290322580645161	NA	NA	NA			93	CS-1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACAN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,89398397,T,T&fts=all">p.S861P</a>
ACAN	Missense_Mutation	p.G1435E	G	G		8	Cancer Gene	15	89400120	89400120	174	0.660919540229885	NA	NA	NA			93	29 X 19 AA approximate tandem repeats of E-[IVDG]-[LV]-[EV]-[GTI]-[STA]-[ATV]- [SP]-[GA]-[VIFAD]-[GEDL]-[DE]-[LVI]-[SG]- [GERK]-[LV]-P-S-G.|CS-1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACAN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,89400120,G,G&fts=all">p.G1435E</a>
ACER2	Missense_Mutation	p.G182S	G	G		8	Cancer Gene	9	19446319	19446319	61	0.80327868852459	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACER2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,19446319,G,G&fts=all">p.G182S</a>
ACOT11	Missense_Mutation	p.S510L	C	C	rs140228757	8	Cancer Gene	1	55073641	55073641	130	0.330769230769231	NA	NA	NA			17	START. {ECO:0000255|PROSITE- ProRule:PRU00197}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACOT11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,55073641,C,C&fts=all">p.S510L</a>
ACOT9	Missense_Mutation	p.L117F	G	G		8	Cancer Gene	X	23748668	23748668	311	0.459807073954984	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACOT9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,23748668,G,G&fts=all">p.L117F</a>
ACOXL	Missense_Mutation	p.N223S	A	A		8	Cancer Gene	2	111562887	111562887	115	0.31304347826087	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACOXL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,111562887,A,A&fts=all">p.N223S</a>
ACPL2	Missense_Mutation	p.P47S	C	C		8	Cancer Gene	3	140997270	140997270	63	0.380952380952381	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACPL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,140997270,C,C&fts=all">p.P47S</a>
ACPL2	Missense_Mutation	p.S374L	C	C	rs115983278	8	Cancer Gene	3	141011752	141011752	150	0.4	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACPL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,141011752,C,C&fts=all">p.S374L</a>
ACRBP	Missense_Mutation	p.P403S	G	G		8	Cancer Gene	12	6749559	6749559	55	0.163636363636364	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACRBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,6749559,G,G&fts=all">p.P403S</a>
ACRC	Missense_Mutation	p.S532F	C	C		8	Cancer Gene	X	70828951	70828951	88	0.329545454545455	NA	NA	NA			54	SprT-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACRC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,70828951,C,C&fts=all">p.S532F</a>
ACSF3	Nonsense_Mutation	p.R169*	C	C		8	Cancer Gene	16	89199604	89199604	55	0.672727272727273	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,89199604,C,C&fts=all">p.R169*</a>
ACSL5	Missense_Mutation	p.M482I	G	G		8	Cancer Gene	10	114181763	114181763	181	0.25414364640884	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSL5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,114181763,G,G&fts=all">p.M482I</a>
ACSM1	Nonsense_Mutation	p.W271*	C	C		8	Cancer Gene	16	20681249	20681249	58	0.327586206896552	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,20681249,C,C&fts=all">p.W271*</a>
ACTL7A	Nonsense_Mutation	p.W400*	G	G		8	Cancer Gene	9	111625801	111625801	43	0.209302325581395	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTL7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,111625801,G,G&fts=all">p.W400*</a>
ACTL7B	Missense_Mutation	p.P284S	G	G		8	Cancer Gene	9	111617361	111617361	50	0.14	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTL7B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,111617361,G,G&fts=all">p.P284S</a>
ACTL9	Nonsense_Mutation	p.Q210*	G	G		8	Cancer Gene	19	8808424	8808424	29	0.344827586206897	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTL9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8808424,G,G&fts=all">p.Q210*</a>
ACTR10	Missense_Mutation	p.A127V	C	C		8	Cancer Gene	14	58678047	58678047	364	0.815934065934066	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTR10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,58678047,C,C&fts=all">p.A127V</a>
ACTRT1	Missense_Mutation	p.E117K	C	C		8	Cancer Gene	X	127185837	127185837	146	0.554794520547945	NA	NA	NA		p.E117K(1)	34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTRT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,127185837,C,C&fts=all">p.E117K</a>
ACVR1C	Missense_Mutation	p.R388Q	C	C		8	Cancer Gene	2	158397664	158397664	256	0.0234375	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACVR1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,158397664,C,C&fts=all">p.R388Q</a>
ACVR1C	Nonsense_Mutation	p.R139*	G	G		8	Cancer Gene	2	158412734	158412734	58	0.275862068965517	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACVR1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,158412734,G,G&fts=all">p.R139*</a>
ADAD1	Missense_Mutation	p.S48F	C	C		8	Cancer Gene	4	123302171	123302171	83	0.216867469879518	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,123302171,C,C&fts=all">p.S48F</a>
ADAD1	Missense_Mutation	p.P444S	C	C		8	Cancer Gene	4	123336668	123336668	240	0.220833333333333	NA	NA	NA			35	A to I editase. {ECO:0000255|PROSITE- ProRule:PRU00240}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,123336668,C,C&fts=all">p.P444S</a>
ADAD1	Missense_Mutation	p.E510K	G	G		8	Cancer Gene	4	123342510	123342510	130	0.269230769230769	NA	NA	NA			35	A to I editase. {ECO:0000255|PROSITE- ProRule:PRU00240}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,123342510,G,G&fts=all">p.E510K</a>
ADAD2	Missense_Mutation	p.S385L	C	C		8	Cancer Gene	16	84229522	84229522	16	0.375	NA	NA	NA			13	A to I editase. {ECO:0000255|PROSITE- ProRule:PRU00240}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,84229522,C,C&fts=all">p.S385L</a>
ADAD2	Missense_Mutation	p.F523Y	T	T		8	Cancer Gene	16	84230294	84230294	55	0.309090909090909	NA	NA	NA			13	A to I editase. {ECO:0000255|PROSITE- ProRule:PRU00240}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,84230294,T,T&fts=all">p.F523Y</a>
ADAL	Missense_Mutation	p.S169F	C	C		8	Cancer Gene	15	43638132	43638132	306	0.248366013071895	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43638132,C,C&fts=all">p.S169F</a>
ADAM18	Missense_Mutation	p.G61E	G	G		8	Cancer Gene	8	39463875	39463875	355	0.180281690140845	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39463875,G,G&fts=all">p.G61E</a>
ADAM18	Missense_Mutation	p.E187K	G	G		8	Cancer Gene	8	39486929	39486929	354	0.211864406779661	NA	NA	NA			71	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39486929,G,G&fts=all">p.E187K</a>
ADAM18	Missense_Mutation	p.S233F	C	C		8	Cancer Gene	8	39495093	39495093	216	0.236111111111111	NA	NA	NA		p.S233F(1)	71	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39495093,C,C&fts=all">p.S233F</a>
ADAM18	Splice_Site	p.E411K	G	G		8	Cancer Gene	8	39521314	39521314	103	0.174757281553398	NA	NA	NA			71	Disintegrin. {ECO:0000255|PROSITE- ProRule:PRU00068}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM18&recr=Open">Click here</a>	
ADAM18	Splice_Site	p.G509S	G	G		8	Cancer Gene	8	39525715	39525715	230	0.165217391304348	NA	NA	NA			71	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM18&recr=Open">Click here</a>	
ADAM18	Splice_Site		G	G		8	Cancer Gene	8	39525716	39525716	226	0.168141592920354	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM18&recr=Open">Click here</a>	
ADAM18	Missense_Mutation	p.D735N	G	G	rs184662370	8	Cancer Gene	8	39587442	39587442	310	0.0354838709677419	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39587442,G,G&fts=all">p.D735N</a>
ADAM29	Missense_Mutation	p.H726Y	C	C		8	Cancer Gene	4	175898852	175898852	97	0.298969072164948	NA	NA	NA			93			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM29&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,175898852,C,C&fts=all">p.H726Y</a>
ADAM29	Missense_Mutation	p.P747L	C	C		8	Cancer Gene	4	175898916	175898916	119	0.252100840336134	NA	NA	NA			93	9 X 9 AA approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM29&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,175898916,C,C&fts=all">p.P747L</a>
ADAM32	Missense_Mutation	p.S264A	T	T		8	Cancer Gene	8	39022672	39022672	76	0.197368421052632	NA	NA	NA			31	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM32&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39022672,T,T&fts=all">p.S264A</a>
ADAM32	Missense_Mutation	p.P283S	C	C		8	Cancer Gene	8	39027448	39027448	202	0.485148514851485	NA	NA	NA			31	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM32&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39027448,C,C&fts=all">p.P283S</a>
ADAM32	Missense_Mutation	p.G466R	G	G		8	Cancer Gene	8	39080628	39080628	32	0.1875	NA	NA	NA			31	Disintegrin. {ECO:0000255|PROSITE- ProRule:PRU00068}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM32&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39080628,G,G&fts=all">p.G466R</a>
ADAM32	Splice_Site	p.R545R	G	G		8	Cancer Gene	8	39091418	39091418	77	0.155844155844156	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM32&recr=Open">Click here</a>	
ADAM7	Missense_Mutation	p.R177K	G	G		8	Cancer Gene	8	24324452	24324452	296	0.158783783783784	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,24324452,G,G&fts=all">p.R177K</a>
ADAM7	Missense_Mutation	p.P168S	C	C		8	Cancer Gene	8	24346766	24346766	149	0.328859060402685	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,24346766,C,C&fts=all">p.P168S</a>
ADAM7	Nonsense_Mutation	p.K209*	A	A	rs199913777	8	Cancer Gene	8	24348354	24348354	221	0.16289592760181	NA	NA	NA			64	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,24348354,A,A&fts=all">p.K209*</a>
ADAM7	Missense_Mutation	p.K209M	A	A	rs141242902	8	Cancer Gene	8	24348355	24348355	220	0.163636363636364	NA	NA	NA			64	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,24348355,A,A&fts=all">p.K209M</a>
ADAM7	Missense_Mutation	p.G217R	G	G		8	Cancer Gene	8	24348378	24348378	201	0.442786069651741	NA	NA	NA			64	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,24348378,G,G&fts=all">p.G217R</a>
ADAMTS14	Missense_Mutation	p.G868R	G	G		8	Cancer Gene	10	72511399	72511399	38	0.105263157894737	NA	NA	NA			50	TSP type-1 2. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,72511399,G,G&fts=all">p.G868R</a>
ADAMTS14	Splice_Site	p.G869G	G	G		8	Cancer Gene	10	72511852	72511852	25	0.24	NA	NA	NA			50	TSP type-1 2. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS14&recr=Open">Click here</a>	
ADAMTS14	Missense_Mutation	p.P1120L	C	C		8	Cancer Gene	10	72520287	72520287	44	0.204545454545455	NA	NA	NA			50	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,72520287,C,C&fts=all">p.P1120L</a>
ADAMTS14	Missense_Mutation	p.D1159N	G	G		8	Cancer Gene	10	72520403	72520403	31	0.193548387096774	NA	NA	NA			50	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,72520403,G,G&fts=all">p.D1159N</a>
ADAMTS16	Missense_Mutation	p.W189L	G	G		8	Cancer Gene	5	5182221	5182221	183	0.480874316939891	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,5182221,G,G&fts=all">p.W189L</a>
ADAMTS18	Missense_Mutation	p.P1186L	G	G		8	Cancer Gene	16	77317962	77317962	82	0.231707317073171	NA	NA	NA			118	PLAC. {ECO:0000255|PROSITE- ProRule:PRU00233}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,77317962,G,G&fts=all">p.P1186L</a>
ADAMTS18	Missense_Mutation	p.G563E	C	C		8	Cancer Gene	16	77375623	77375623	87	0.264367816091954	NA	NA	NA			118	Disintegrin.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,77375623,C,C&fts=all">p.G563E</a>
ADAMTS18	Missense_Mutation	p.P262L	G	G		8	Cancer Gene	16	77398272	77398272	48	0.3125	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,77398272,G,G&fts=all">p.P262L</a>
ADAMTS20	Missense_Mutation	p.R1806K	C	C		8	Cancer Gene	12	43769211	43769211	57	0.350877192982456	NA	NA	NA			95	GON. {ECO:0000255|PROSITE- ProRule:PRU00383}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,43769211,C,C&fts=all">p.R1806K</a>
ADAMTS20	Missense_Mutation	p.G1214E	C	C		8	Cancer Gene	12	43822451	43822451	14	0.357142857142857	NA	NA	NA			95	TSP type-1 8. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,43822451,C,C&fts=all">p.G1214E</a>
ADAMTS20	Missense_Mutation	p.P1071L	G	G		8	Cancer Gene	12	43825184	43825184	101	0.346534653465347	NA	NA	NA			95	TSP type-1 5. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,43825184,G,G&fts=all">p.P1071L</a>
ADAMTS20	Frame_Shift_Del	p.K209fs	T	T		8	Cancer Gene	12	43896196	43896196	237	0.413502109704641	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS20&recr=Open">Click here</a>	
ADAMTS4	Missense_Mutation	p.P814S	G	G		8	Cancer Gene	1	161161002	161161002	123	0.634146341463415	NA	NA	NA			43	Spacer.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,161161002,G,G&fts=all">p.P814S</a>
ADAMTS4	Missense_Mutation	p.G740D	C	C		8	Cancer Gene	1	161161223	161161223	117	0.487179487179487	NA	NA	NA			43	Spacer.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,161161223,C,C&fts=all">p.G740D</a>
ADAMTS8	Missense_Mutation	p.A444V	G	G		8	Cancer Gene	11	130284661	130284661	18	0.388888888888889	NA	NA	NA			10	Disintegrin.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,130284661,G,G&fts=all">p.A444V</a>
ADAMTS9	Missense_Mutation	p.D1862N	C	C		8	Cancer Gene	3	64524908	64524908	66	0.151515151515152	NA	NA	NA			100	GON. {ECO:0000255|PROSITE- ProRule:PRU00383}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,64524908,C,C&fts=all">p.D1862N</a>
ADAMTS9	Missense_Mutation	p.S1678L	G	G	rs138753923	8	Cancer Gene	3	64532465	64532465	80	0.4625	NA	NA	NA			100	TSP type-1 15. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,64532465,G,G&fts=all">p.S1678L</a>
ADAMTS9	Missense_Mutation	p.R1205K	C	C		8	Cancer Gene	3	64589731	64589731	84	0.226190476190476	NA	NA	NA			100	TSP type-1 7. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,64589731,C,C&fts=all">p.R1205K</a>
ADAMTS9	Missense_Mutation	p.G757E	C	C		8	Cancer Gene	3	64617507	64617507	234	0.175213675213675	NA	NA	NA			100	Spacer.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,64617507,C,C&fts=all">p.G757E</a>
ADAMTS9	Missense_Mutation	p.L723F	G	G		8	Cancer Gene	3	64619156	64619156	104	0.221153846153846	NA	NA	NA			100	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,64619156,G,G&fts=all">p.L723F</a>
ADAMTS9	Missense_Mutation	p.G624R	C	C		8	Cancer Gene	3	64619542	64619542	90	0.188888888888889	NA	NA	NA			100	TSP type-1 1. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,64619542,C,C&fts=all">p.G624R</a>
ADAMTS9	Missense_Mutation	p.G548E	C	C		8	Cancer Gene	3	64633683	64633683	160	0.25625	NA	NA	NA			100	Disintegrin.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,64633683,C,C&fts=all">p.G548E</a>
ADAMTS9	Missense_Mutation	p.S91F	G	G	rs533046395	8	Cancer Gene	3	64672488	64672488	16	0.25	NA	NA	NA			100	Poly-Ser.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,64672488,G,G&fts=all">p.S91F</a>
ADAMTSL5	Missense_Mutation	p.E68K	C	C		8	Cancer Gene	19	1510417	1510417	26	0.192307692307692	NA	NA	NA			10	TSP type-1. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTSL5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,1510417,C,C&fts=all">p.E68K</a>
ADAP2	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAP2&recr=Open">Click here</a>	
ADARB2	Missense_Mutation	p.S146L	G	G		8	Cancer Gene	10	1405863	1405863	36	0.25	NA	NA	NA			41	DRBM 1. {ECO:0000255|PROSITE- ProRule:PRU00266}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADARB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,1405863,G,G&fts=all">p.S146L</a>
ADCK5	Missense_Mutation	p.I139F	A	A		8	Cancer Gene	8	145616128	145616128	78	0.448717948717949	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,145616128,A,A&fts=all">p.I139F</a>
ADCY2	Missense_Mutation	p.S246F	C	C		8	Cancer Gene	5	7690820	7690820	49	0.183673469387755	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,7690820,C,C&fts=all">p.S246F</a>
ADCY2	Missense_Mutation	p.N381S	A	A		8	Cancer Gene	5	7706889	7706889	457	0.431072210065646	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,7706889,A,A&fts=all">p.N381S</a>
ADCY5	Missense_Mutation	p.F655L	A	A		8	Cancer Gene	3	123015005	123015005	34	0.411764705882353	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,123015005,A,A&fts=all">p.F655L</a>
ADCY6	Missense_Mutation	p.R1025Q	C	C	rs140245629	8	Cancer Gene	12	49164731	49164731	29	0.103448275862069	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,49164731,C,C&fts=all">p.R1025Q</a>
ADCY9	Missense_Mutation	p.P1131S	G	G		8	Cancer Gene	16	4016447	4016447	92	0.260869565217391	NA	NA	NA			47	Guanylate cyclase 2. {ECO:0000255|PROSITE-ProRule:PRU00099}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,4016447,G,G&fts=all">p.P1131S</a>
ADH6	Missense_Mutation	p.M363I	C	C		8	Cancer Gene	4	100126096	100126096	150	0.193333333333333	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADH6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,100126096,C,C&fts=all">p.M363I</a>
ADH6	Missense_Mutation	p.S104F	G	G	rs148378840	8	Cancer Gene	4	100131611	100131611	224	0.214285714285714	NA	NA	NA		p.S104Y(2)	20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADH6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,100131611,G,G&fts=all">p.S104F</a>
ADH6	Missense_Mutation	p.G45R	C	C	rs142886780	8	Cancer Gene	4	100134892	100134892	106	0.207547169811321	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADH6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,100134892,C,C&fts=all">p.G45R</a>
AEN	Missense_Mutation	p.A238V	C	C		8	Cancer Gene	15	89172629	89172629	100	0.32	NA	NA	NA			7	Exonuclease.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AEN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,89172629,C,C&fts=all">p.A238V</a>
AFF2	Missense_Mutation	p.G935D	G	G		8	Cancer Gene	X	148044358	148044358	69	0.434782608695652	NA	NA	NA			109			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,148044358,G,G&fts=all">p.G935D</a>
AFMID	Missense_Mutation	p.K294T	A	A		8	Cancer Gene	17	76202112	76202112	80	0.175	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFMID&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,76202112,A,A&fts=all">p.K294T</a>
AGAP1	Missense_Mutation	p.D325N	G	G		8	Cancer Gene	2	236715898	236715898	146	0.232876712328767	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,236715898,G,G&fts=all">p.D325N</a>
AGBL1	Missense_Mutation	p.R748C	C	C		8	Cancer Gene	15	86940602	86940602	29	0.344827586206897	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGBL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,86940602,C,C&fts=all">p.R748C</a>
AGBL2	Missense_Mutation	p.F757Y	A	A		8	Cancer Gene	11	47688572	47688572	74	0.405405405405405	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGBL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,47688572,A,A&fts=all">p.F757Y</a>
AGPAT3	Missense_Mutation	p.P130L	C	C		8	Cancer Gene	21	45389039	45389039	45	0.266666666666667	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGPAT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,45389039,C,C&fts=all">p.P130L</a>
AGPAT4	Missense_Mutation	p.R304Q	C	C	rs201134001	8	Cancer Gene	6	161560585	161560585	51	0.333333333333333	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGPAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,161560585,C,C&fts=all">p.R304Q</a>
AGPAT4	Missense_Mutation	p.R207Q	C	C		8	Cancer Gene	6	161574422	161574422	9	0.666666666666667	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGPAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,161574422,C,C&fts=all">p.R207Q</a>
AIFM3	Missense_Mutation	p.P478S	C	C		8	Cancer Gene	22	21332231	21332231	51	0.176470588235294	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AIFM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,21332231,C,C&fts=all">p.P478S</a>
AKAP11	Missense_Mutation	p.L228V	T	T		8	Cancer Gene	13	42873564	42873564	231	0.229437229437229	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,42873564,T,T&fts=all">p.L228V</a>
AKAP13	Missense_Mutation	p.S2483L	C	C		8	Cancer Gene	15	86278376	86278376	164	0.274390243902439	NA	NA	NA			98	Interaction with ESR1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,86278376,C,C&fts=all">p.S2483L</a>
AKNA	Missense_Mutation	p.P637S	G	G		8	Cancer Gene	9	117124693	117124693	22	0.181818181818182	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKNA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,117124693,G,G&fts=all">p.P637S</a>
AKR1B15	Missense_Mutation	p.R69C	C	C	rs373511828	8	Cancer Gene	7	134252964	134252964	59	0.305084745762712	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKR1B15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,134252964,C,C&fts=all">p.R69C</a>
AKR1E2	Nonsense_Mutation	p.R255*	C	C		8	Cancer Gene	10	4884622	4884622	214	0.350467289719626	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKR1E2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,4884622,C,C&fts=all">p.R255*</a>
ALDH8A1	Missense_Mutation	p.R339K	C	C		8	Cancer Gene	6	135240001	135240001	97	0.412371134020619	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH8A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,135240001,C,C&fts=all">p.R339K</a>
ALG10B	Missense_Mutation	p.T16I	C	C		8	Cancer Gene	12	38710742	38710742	195	0.317948717948718	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALG10B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,38710742,C,C&fts=all">p.T16I</a>
ALG13	Splice_Site	p.R697C	C	C		8	Cancer Gene	X	110970672	110970672	29	0.379310344827586	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALG13&recr=Open">Click here</a>	
ALLC	Missense_Mutation	p.R364Q	G	G		8	Cancer Gene	2	3750068	3750068	19	0.263157894736842	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALLC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,3750068,G,G&fts=all">p.R364Q</a>
ALPK1	Missense_Mutation	p.L456F	C	C		8	Cancer Gene	4	113352069	113352069	130	0.569230769230769	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,113352069,C,C&fts=all">p.L456F</a>
ALPK3	Missense_Mutation	p.R382P	G	G	rs574988897	8	Cancer Gene	15	85383049	85383049	49	0.63265306122449	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,85383049,G,G&fts=all">p.R382P</a>
ALPK3	Missense_Mutation	p.E456K	G	G		8	Cancer Gene	15	85383270	85383270	17	0.470588235294118	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,85383270,G,G&fts=all">p.E456K</a>
ALPK3	Missense_Mutation	p.G924S	G	G		8	Cancer Gene	15	85400133	85400133	81	0.197530864197531	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,85400133,G,G&fts=all">p.G924S</a>
ALS2CL	Missense_Mutation	p.G443E	C	C		8	Cancer Gene	3	46722844	46722844	84	0.226190476190476	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALS2CL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,46722844,C,C&fts=all">p.G443E</a>
ALS2CR11	Missense_Mutation	p.R324W	G	G		8	Cancer Gene	2	202430459	202430459	23	0.391304347826087	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALS2CR11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,202430459,G,G&fts=all">p.R324W</a>
ALX3	Missense_Mutation	p.G279E	C	C		8	Cancer Gene	1	110603551	110603551	18	0.444444444444444	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALX3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,110603551,C,C&fts=all">p.G279E</a>
AMBN	Missense_Mutation	p.P280S	C	C		8	Cancer Gene	4	71471941	71471941	79	0.253164556962025	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMBN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,71471941,C,C&fts=all">p.P280S</a>
AMBN	Missense_Mutation	p.P362S	C	C		8	Cancer Gene	4	71472187	71472187	28	0.428571428571429	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMBN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,71472187,C,C&fts=all">p.P362S</a>
AMBRA1	Missense_Mutation	p.S1084F	G	G		8	Cancer Gene	11	46419376	46419376	22	0.5	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMBRA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,46419376,G,G&fts=all">p.S1084F</a>
AMN	Missense_Mutation	p.C96F	G	G		8	Cancer Gene	14	103394842	103394842	18	0.222222222222222	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,103394842,G,G&fts=all">p.C96F</a>
ANGPTL6	Nonsense_Mutation	p.Q443*	G	G		8	Cancer Gene	19	10203351	10203351	97	0.278350515463918	NA	NA	NA			12	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANGPTL6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,10203351,G,G&fts=all">p.Q443*</a>
ANGPTL7	Missense_Mutation	p.E207K	G	G	rs376924013	8	Cancer Gene	1	11253778	11253778	98	0.336734693877551	NA	NA	NA			10	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANGPTL7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,11253778,G,G&fts=all">p.E207K</a>
ANKFN1	Missense_Mutation	p.R702S	G	G		8	Cancer Gene	17	54559722	54559722	311	0.254019292604502	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKFN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,54559722,G,G&fts=all">p.R702S</a>
ANKK1	Missense_Mutation	p.E491K	G	G		8	Cancer Gene	11	113270162	113270162	10	0.3	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,113270162,G,G&fts=all">p.E491K</a>
ANKLE2	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	12	133196162	133354393	NA	NA	79	-1.00781166374669	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKLE2&recr=Open">Click here</a>	
ANKRD13B	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD13B&recr=Open">Click here</a>	
ANKRD30A	Missense_Mutation	p.G223E	G	G		8	Cancer Gene	10	37430661	37430661	39	0.102564102564103	NA	NA	NA			158			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD30A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,37430661,G,G&fts=all">p.G223E</a>
ANKRD30A	Missense_Mutation	p.G278E	G	G		8	Cancer Gene	10	37430826	37430826	70	0.5	NA	NA	NA			158			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD30A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,37430826,G,G&fts=all">p.G278E</a>
ANKRD30A	Missense_Mutation	p.K344R	A	A		8	Cancer Gene	10	37431024	37431024	174	0.218390804597701	NA	NA	NA			158			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD30A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,37431024,A,A&fts=all">p.K344R</a>
ANKRD30A	Missense_Mutation	p.G356E	G	G		8	Cancer Gene	10	37431060	37431060	148	0.22972972972973	NA	NA	NA			158			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD30A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,37431060,G,G&fts=all">p.G356E</a>
ANKRD30A	Missense_Mutation	p.S595F	C	C		8	Cancer Gene	10	37451726	37451726	427	0.217798594847775	NA	NA	NA			158			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD30A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,37451726,C,C&fts=all">p.S595F</a>
ANKRD30A	Missense_Mutation	p.E1000K	G	G		8	Cancer Gene	10	37506705	37506705	195	0.384615384615385	NA	NA	NA			158			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD30A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,37506705,G,G&fts=all">p.E1000K</a>
ANKRD30A	Missense_Mutation	p.E1085D	A	A		8	Cancer Gene	10	37508063	37508063	351	0.435897435897436	NA	NA	NA			158			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD30A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,37508063,A,A&fts=all">p.E1085D</a>
ANKRD30A	Missense_Mutation	p.K1205N	A	A		8	Cancer Gene	10	37508423	37508423	120	0.175	NA	NA	NA			158			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD30A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,37508423,A,A&fts=all">p.K1205N</a>
ANKRD33	Missense_Mutation	p.P154L	C	C		8	Cancer Gene	12	52282915	52282915	29	0.482758620689655	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD33&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,52282915,C,C&fts=all">p.P154L</a>
ANKRD35	Missense_Mutation	p.D32N	G	G	rs201101382	8	Cancer Gene	1	145555746	145555746	64	0.390625	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD35&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,145555746,G,G&fts=all">p.D32N</a>
ANKRD35	Missense_Mutation	p.E474K	G	G		8	Cancer Gene	1	145561732	145561732	114	0.219298245614035	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD35&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,145561732,G,G&fts=all">p.E474K</a>
ANKS6	Missense_Mutation	p.P263S	G	G	rs190075616	8	Cancer Gene	9	101536290	101536290	57	0.298245614035088	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKS6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,101536290,G,G&fts=all">p.P263S</a>
ANO2	Splice_Site	p.G797R	C	C		8	Cancer Gene	12	5687532	5687532	83	0.144578313253012	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO2&recr=Open">Click here</a>	
ANO4	Missense_Mutation	p.H45Y	C	C		8	Cancer Gene	12	101333170	101333170	113	0.345132743362832	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,101333170,C,C&fts=all">p.H45Y</a>
ANO4	Missense_Mutation	p.G277R	G	G		8	Cancer Gene	12	101433769	101433769	169	0.42603550295858	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,101433769,G,G&fts=all">p.G277R</a>
ANO4	Missense_Mutation	p.E907K	G	G		8	Cancer Gene	12	101520804	101520804	21	0.238095238095238	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,101520804,G,G&fts=all">p.E907K</a>
ANO5	Missense_Mutation	p.D602N	G	G		8	Cancer Gene	11	22284495	22284495	92	0.391304347826087	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,22284495,G,G&fts=all">p.D602N</a>
AP1G1	Missense_Mutation	p.R221C	G	G		8	Cancer Gene	16	71799469	71799469	254	0.236220472440945	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP1G1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,71799469,G,G&fts=all">p.R221C</a>
AP3M1	Missense_Mutation	p.P75L	G	G		8	Cancer Gene	10	75897914	75897914	209	0.38755980861244	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP3M1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,75897914,G,G&fts=all">p.P75L</a>
AP4E1	Missense_Mutation	p.P467L	C	C		8	Cancer Gene	15	51242106	51242106	233	0.0386266094420601	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP4E1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,51242106,C,C&fts=all">p.P467L</a>
APOOL	Missense_Mutation	p.P113L	C	C		8	Cancer Gene	X	84310875	84310875	48	0.4375	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOOL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,84310875,C,C&fts=all">p.P113L</a>
ARAP2	Nonsense_Mutation	p.R1626*	G	G		8	Cancer Gene	4	36069768	36069768	110	0.336363636363636	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,36069768,G,G&fts=all">p.R1626*</a>
ARAP2	Missense_Mutation	p.R1549Q	C	C		8	Cancer Gene	4	36075408	36075408	177	0.0621468926553672	NA	NA	NA		p.R1549Q(1)	82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,36075408,C,C&fts=all">p.R1549Q</a>
ARAP2	Missense_Mutation	p.E1438K	C	C		8	Cancer Gene	4	36093616	36093616	184	0.375	NA	NA	NA			82	PH 5. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,36093616,C,C&fts=all">p.E1438K</a>
ARAP2	Missense_Mutation	p.G1178E	C	C		8	Cancer Gene	4	36130262	36130262	133	0.0601503759398496	NA	NA	NA			82	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,36130262,C,C&fts=all">p.G1178E</a>
ARAP2	Missense_Mutation	p.R550T	C	C	rs187371781	8	Cancer Gene	4	36189102	36189102	126	0.261904761904762	NA	NA	NA			82	PH 1. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,36189102,C,C&fts=all">p.R550T</a>
ARAP2	Missense_Mutation	p.G525E	C	C		8	Cancer Gene	4	36189177	36189177	216	0.0833333333333333	NA	NA	NA			82	PH 1. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,36189177,C,C&fts=all">p.G525E</a>
ARAP3	Missense_Mutation	p.A1107V	G	G		8	Cancer Gene	5	141035806	141035806	118	0.338983050847458	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARAP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,141035806,G,G&fts=all">p.A1107V</a>
ARAP3	Missense_Mutation	p.P1103S	G	G		8	Cancer Gene	5	141035819	141035819	104	0.317307692307692	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARAP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,141035819,G,G&fts=all">p.P1103S</a>
ARFGEF1	Missense_Mutation	p.T1116I	G	G		8	Cancer Gene	8	68145123	68145123	408	0.424019607843137	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARFGEF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,68145123,G,G&fts=all">p.T1116I</a>
ARHGAP12	Missense_Mutation	p.P12S	G	G		8	Cancer Gene	10	32197750	32197750	447	0.203579418344519	NA	NA	NA			31	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,32197750,G,G&fts=all">p.P12S</a>
ARHGAP31	Missense_Mutation	p.L1004P	T	T		8	Cancer Gene	3	119133787	119133787	19	0.421052631578947	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,119133787,T,T&fts=all">p.L1004P</a>
ARHGAP32	Missense_Mutation	p.P508L	G	G	rs150620556	8	Cancer Gene	11	128844480	128844480	121	0.479338842975207	NA	NA	NA			60	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP32&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,128844480,G,G&fts=all">p.P508L</a>
ARHGAP33	Missense_Mutation	p.G236W	G	G		8	Cancer Gene	19	36271487	36271487	65	0.307692307692308	NA	NA	NA			37	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP33&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36271487,G,G&fts=all">p.G236W</a>
ARHGAP33	Missense_Mutation	p.S374F	C	C		8	Cancer Gene	19	36273310	36273310	92	0.358695652173913	NA	NA	NA			37	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP33&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36273310,C,C&fts=all">p.S374F</a>
ARHGAP33	Missense_Mutation	p.S898F	C	C		8	Cancer Gene	19	36278643	36278643	39	0.153846153846154	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP33&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36278643,C,C&fts=all">p.S898F</a>
ARHGAP39	Missense_Mutation	p.P904L	G	G		8	Cancer Gene	8	145758594	145758594	76	0.105263157894737	NA	NA	NA			22	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,145758594,G,G&fts=all">p.P904L</a>
ARHGAP39	Missense_Mutation	p.P345S	G	G		8	Cancer Gene	8	145773437	145773437	18	0.5	NA	NA	NA			22	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,145773437,G,G&fts=all">p.P345S</a>
ARHGAP44	Missense_Mutation	p.A403T	G	G		8	Cancer Gene	17	12859254	12859254	36	0.166666666666667	NA	NA	NA			31	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP44&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,12859254,G,G&fts=all">p.A403T</a>
ARHGAP5	Missense_Mutation	p.H91Y	C	C		8	Cancer Gene	14	32560146	32560146	196	0.862244897959184	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,32560146,C,C&fts=all">p.H91Y</a>
ARHGAP9	Missense_Mutation	p.S256F	G	G		8	Cancer Gene	12	57871042	57871042	53	0.377358490566038	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,57871042,G,G&fts=all">p.S256F</a>
ARHGEF10L	Missense_Mutation	p.L1020H	T	T		8	Cancer Gene	1	18014234	18014234	20	0.2	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF10L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,18014234,T,T&fts=all">p.L1020H</a>
ARHGEF10L	Missense_Mutation	p.P1223S	C	C		8	Cancer Gene	1	18023819	18023819	38	0.447368421052632	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF10L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,18023819,C,C&fts=all">p.P1223S</a>
ARHGEF25	Missense_Mutation	p.S107P	T	T		8	Cancer Gene	12	58006817	58006817	30	0.333333333333333	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,58006817,T,T&fts=all">p.S107P</a>
ARHGEF26	Missense_Mutation	p.P52L	C	C		8	Cancer Gene	3	153839936	153839936	12	0.416666666666667	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,153839936,C,C&fts=all">p.P52L</a>
ARHGEF3	Missense_Mutation	p.E91K	C	C		8	Cancer Gene	3	56789026	56789026	130	0.0461538461538462	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,56789026,C,C&fts=all">p.E91K</a>
ARHGEF37	Missense_Mutation	p.L301F	C	C		8	Cancer Gene	5	148999923	148999923	118	0.423728813559322	NA	NA	NA			17	BAR. {ECO:0000255|PROSITE- ProRule:PRU00361}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF37&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,148999923,C,C&fts=all">p.L301F</a>
ARMC4	Missense_Mutation	p.R836C	G	G	rs369264618	8	Cancer Gene	10	28196696	28196696	109	0.275229357798165	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,28196696,G,G&fts=all">p.R836C</a>
ARMC4	Missense_Mutation	p.E279K	C	C		8	Cancer Gene	10	28270496	28270496	401	0.204488778054863	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,28270496,C,C&fts=all">p.E279K</a>
ARMC6	Missense_Mutation	p.P408L	C	C		8	Cancer Gene	19	19168433	19168433	25	0.6	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMC6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,19168433,C,C&fts=all">p.P408L</a>
ARMS2	Missense_Mutation	p.G18R	G	G		8	Cancer Gene	10	124214295	124214295	131	0.183206106870229	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124214295,G,G&fts=all">p.G18R</a>
ARPP21	Missense_Mutation	p.M165I	G	G		8	Cancer Gene	3	35731582	35731582	173	0.173410404624277	NA	NA	NA			61	R3H. {ECO:0000255|PROSITE- ProRule:PRU00382}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARPP21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,35731582,G,G&fts=all">p.M165I</a>
ARPP21	Missense_Mutation	p.R400K	G	G		8	Cancer Gene	3	35763300	35763300	40	0.3	NA	NA	NA			61	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARPP21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,35763300,G,G&fts=all">p.R400K</a>
ARPP21	Missense_Mutation	p.G694R	G	G		8	Cancer Gene	3	35833921	35833921	193	0.455958549222798	NA	NA	NA			61	Gln-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARPP21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,35833921,G,G&fts=all">p.G694R</a>
ARPP21	Missense_Mutation	p.G694E	G	G		8	Cancer Gene	3	35833922	35833922	192	0.453125	NA	NA	NA			61	Gln-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARPP21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,35833922,G,G&fts=all">p.G694E</a>
ARSD	Missense_Mutation	p.R552W	G	G		8	Cancer Gene	X	2825440	2825440	23	0.478260869565217	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARSD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,2825440,G,G&fts=all">p.R552W</a>
ARSH	Missense_Mutation	p.S266F	C	C		8	Cancer Gene	X	2936607	2936607	122	0.450819672131148	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARSH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,2936607,C,C&fts=all">p.S266F</a>
ARSH	Missense_Mutation	p.P494S	C	C		8	Cancer Gene	X	2951217	2951217	48	0.479166666666667	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARSH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,2951217,C,C&fts=all">p.P494S</a>
ARSI	Missense_Mutation	p.R261Q	C	C		8	Cancer Gene	5	149677705	149677705	40	0.5	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARSI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,149677705,C,C&fts=all">p.R261Q</a>
ASAH2	Missense_Mutation	p.S126F	G	G		8	Cancer Gene	10	52003095	52003095	98	0.26530612244898	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASAH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,52003095,G,G&fts=all">p.S126F</a>
ASAP3	Missense_Mutation	p.S601F	G	G		8	Cancer Gene	1	23761059	23761059	59	0.23728813559322	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASAP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,23761059,G,G&fts=all">p.S601F</a>
ASB11	Missense_Mutation	p.L320F	G	G	rs145057594	8	Cancer Gene	X	15301641	15301641	214	0.929906542056075	NA	NA	NA			16	SOCS box. {ECO:0000255|PROSITE- ProRule:PRU00194}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASB11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,15301641,G,G&fts=all">p.L320F</a>
ASB15	Missense_Mutation	p.G134E	G	G		8	Cancer Gene	7	123257741	123257741	131	0.0610687022900763	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASB15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,123257741,G,G&fts=all">p.G134E</a>
ASNSD1	Missense_Mutation	p.E614K	G	G		8	Cancer Gene	2	190535360	190535360	251	0.302788844621514	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASNSD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,190535360,G,G&fts=all">p.E614K</a>
ASPM	Missense_Mutation	p.L3260F	G	G		8	Cancer Gene	1	197059377	197059377	272	0.386029411764706	NA	NA	NA			165			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASPM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,197059377,G,G&fts=all">p.L3260F</a>
ASPM	Missense_Mutation	p.R2111K	C	C		8	Cancer Gene	1	197072049	197072049	411	0.231143552311436	NA	NA	NA		p.R2111K(1)	165	IQ 16. {ECO:0000255|PROSITE- ProRule:PRU00116}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASPM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,197072049,C,C&fts=all">p.R2111K</a>
ASPM	Missense_Mutation	p.F315I	A	A		8	Cancer Gene	1	197112439	197112439	415	0.696385542168675	NA	NA	NA			165			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASPM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,197112439,A,A&fts=all">p.F315I</a>
ASTE1	Missense_Mutation	p.H151Y	G	G		8	Cancer Gene	3	130743700	130743700	92	0.478260869565217	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,130743700,G,G&fts=all">p.H151Y</a>
ASTN1	Missense_Mutation	p.M794I	C	C		8	Cancer Gene	1	176905502	176905502	80	0.1625	NA	NA	NA			153			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176905502,C,C&fts=all">p.M794I</a>
ASTN1	Missense_Mutation	p.E774K	C	C	rs199599422	8	Cancer Gene	1	176913084	176913084	76	0.236842105263158	NA	NA	NA			153			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176913084,C,C&fts=all">p.E774K</a>
ASTN1	Missense_Mutation	p.P670L	G	G		8	Cancer Gene	1	176918366	176918366	83	0.240963855421687	NA	NA	NA			153	EGF-like 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176918366,G,G&fts=all">p.P670L</a>
ASTN1	Missense_Mutation	p.F656S	A	A		8	Cancer Gene	1	176918408	176918408	50	0.24	NA	NA	NA			153	EGF-like 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176918408,A,A&fts=all">p.F656S</a>
ASTN2	Missense_Mutation	p.S597F	G	G		8	Cancer Gene	9	119625959	119625959	36	0.222222222222222	NA	NA	NA		p.S597C(1)	102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,119625959,G,G&fts=all">p.S597F</a>
ASTN2	Missense_Mutation	p.S309F	G	G		8	Cancer Gene	9	119976726	119976726	39	0.205128205128205	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,119976726,G,G&fts=all">p.S309F</a>
ASTN2	Missense_Mutation	p.S278F	G	G		8	Cancer Gene	9	119976819	119976819	36	0.25	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,119976819,G,G&fts=all">p.S278F</a>
ASXL3	Missense_Mutation	p.L81F	C	C		8	Cancer Gene	18	31224961	31224961	7	0.571428571428571	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASXL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,31224961,C,C&fts=all">p.L81F</a>
ASXL3	Missense_Mutation	p.E488K	G	G		8	Cancer Gene	18	31318830	31318830	21	0.428571428571429	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASXL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,31318830,G,G&fts=all">p.E488K</a>
ASXL3	Missense_Mutation	p.H1826Y	C	C		8	Cancer Gene	18	31325288	31325288	104	0.346153846153846	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASXL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,31325288,C,C&fts=all">p.H1826Y</a>
ATAD5	Missense_Mutation	p.P965L	C	C		8	Cancer Gene	17	29185279	29185279	52	0.711538461538462	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATAD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,29185279,C,C&fts=all">p.P965L</a>
ATAD5	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATAD5&recr=Open">Click here</a>	
ATF7IP2	Missense_Mutation	p.S527L	C	C	rs34834862	8	Cancer Gene	16	10574766	10574766	204	0.240196078431373	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATF7IP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,10574766,C,C&fts=all">p.S527L</a>
ATG2B	Missense_Mutation	p.P1818S	G	G		8	Cancer Gene	14	96758410	96758410	302	0.274834437086093	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATG2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,96758410,G,G&fts=all">p.P1818S</a>
ATL2	Missense_Mutation	p.R443C	G	G	rs116493165	8	Cancer Gene	2	38525591	38525591	472	0.332627118644068	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,38525591,G,G&fts=all">p.R443C</a>
ATP11C	Missense_Mutation	p.P853S	G	G		8	Cancer Gene	X	138844212	138844212	289	0.474048442906574	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP11C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,138844212,G,G&fts=all">p.P853S</a>
ATP13A5	Missense_Mutation	p.G541E	C	C		8	Cancer Gene	3	193042705	193042705	127	0.220472440944882	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP13A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,193042705,C,C&fts=all">p.G541E</a>
ATP13A5	Missense_Mutation	p.P101L	G	G		8	Cancer Gene	3	193081107	193081107	108	0.268518518518519	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP13A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,193081107,G,G&fts=all">p.P101L</a>
ATP1A4	Missense_Mutation	p.P791L	C	C		8	Cancer Gene	1	160145942	160145942	246	0.739837398373984	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP1A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,160145942,C,C&fts=all">p.P791L</a>
ATP1A4	Missense_Mutation	p.R917Q	G	G		8	Cancer Gene	1	160151487	160151487	93	0.161290322580645	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP1A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,160151487,G,G&fts=all">p.R917Q</a>
ATP1B4	Splice_Site	p.Q187Q	G	G		8	Cancer Gene	X	119505064	119505064	120	0.458333333333333	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP1B4&recr=Open">Click here</a>	
ATP6V1C2	Missense_Mutation	p.G45E	G	G		8	Cancer Gene	2	10866632	10866632	151	0.311258278145695	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP6V1C2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,10866632,G,G&fts=all">p.G45E</a>
ATP8B2	Missense_Mutation	p.L185F	C	C		8	Cancer Gene	1	154304445	154304445	256	0.21875	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8B2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,154304445,C,C&fts=all">p.L185F</a>
ATP8B4	Missense_Mutation	p.G837E	C	C		8	Cancer Gene	15	50189676	50189676	248	0.274193548387097	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8B4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,50189676,C,C&fts=all">p.G837E</a>
ATP8B4	Missense_Mutation	p.D697N	C	C		8	Cancer Gene	15	50209183	50209183	147	0.238095238095238	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8B4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,50209183,C,C&fts=all">p.D697N</a>
ATP8B4	Missense_Mutation	p.H465Y	G	G		8	Cancer Gene	15	50226274	50226274	247	0.315789473684211	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8B4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,50226274,G,G&fts=all">p.H465Y</a>
AZI2	Missense_Mutation	p.S83F	G	G	rs200830891	8	Cancer Gene	3	28380075	28380075	221	0.429864253393665	NA	NA	NA			15	Homodimerization. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AZI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,28380075,G,G&fts=all">p.S83F</a>
B3GALTL	Missense_Mutation	p.G26D	G	G		8	Cancer Gene	13	31789194	31789194	231	0.25974025974026	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+B3GALTL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,31789194,G,G&fts=all">p.G26D</a>
B3GALTL	Missense_Mutation	p.G393E	G	G	rs267606675	8	Cancer Gene	13	31891816	31891816	49	0.489795918367347	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+B3GALTL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,31891816,G,G&fts=all">p.G393E</a>
B3GNT4	Missense_Mutation	p.E330K	G	G		8	Cancer Gene	12	122691861	122691861	25	0.64	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+B3GNT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,122691861,G,G&fts=all">p.E330K</a>
B4GALNT2	Missense_Mutation	p.S67T	T	T		8	Cancer Gene	17	47218793	47218793	50	0.26	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+B4GALNT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,47218793,T,T&fts=all">p.S67T</a>
BAI1	Missense_Mutation	p.I632N	T	T		8	Cancer Gene	8	143562681	143562681	57	0.263157894736842	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,143562681,T,T&fts=all">p.I632N</a>
BATF2	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	64708120	64757286	NA	NA	6	-1.01917037924933	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BATF2&recr=Open">Click here</a>	
BAZ2A	Nonsense_Mutation	p.R1069*	G	G		8	Cancer Gene	12	56997318	56997318	97	0.43298969072165	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAZ2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,56997318,G,G&fts=all">p.R1069*</a>
BBS9	Missense_Mutation	p.P183S	C	C		8	Cancer Gene	7	33296952	33296952	215	0.0325581395348837	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BBS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,33296952,C,C&fts=all">p.P183S</a>
BBS9	Missense_Mutation	p.S297P	T	T		8	Cancer Gene	7	33313441	33313441	126	0.587301587301587	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BBS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,33313441,T,T&fts=all">p.S297P</a>
BBS9	Missense_Mutation	p.P689L	C	C		8	Cancer Gene	7	33427707	33427707	336	0.25297619047619	NA	NA	NA			50	Interaction with LZTL1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BBS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,33427707,C,C&fts=all">p.P689L</a>
BBX	Missense_Mutation	p.E484G	A	A		8	Cancer Gene	3	107492019	107492019	91	0.340659340659341	NA	NA	NA			49	Lys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BBX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,107492019,A,A&fts=all">p.E484G</a>
BCMO1	Missense_Mutation	p.S171L	C	C		8	Cancer Gene	16	81298285	81298285	137	0.598540145985402	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCMO1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,81298285,C,C&fts=all">p.S171L</a>
BEND4	Nonsense_Mutation	p.E427*	C	C		8	Cancer Gene	4	42122179	42122179	32	0.4375	NA	NA	NA			26	BEN. {ECO:0000255|PROSITE- ProRule:PRU00784}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BEND4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,42122179,C,C&fts=all">p.E427*</a>
BEND4	Missense_Mutation	p.N255I	T	T		8	Cancer Gene	4	42145735	42145735	32	0.5	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BEND4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,42145735,T,T&fts=all">p.N255I</a>
BIRC6	Missense_Mutation	p.G384R	G	G		8	Cancer Gene	2	32626346	32626346	354	0.293785310734463	NA	NA	NA			172			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BIRC6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,32626346,G,G&fts=all">p.G384R</a>
BIRC6	Missense_Mutation	p.P2195S	C	C		8	Cancer Gene	2	32696183	32696183	22	0.272727272727273	NA	NA	NA			172			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BIRC6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,32696183,C,C&fts=all">p.P2195S</a>
BIRC8	Missense_Mutation	p.R181K	C	C		8	Cancer Gene	19	53793086	53793086	76	0.447368421052632	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BIRC8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,53793086,C,C&fts=all">p.R181K</a>
BLZF1	Missense_Mutation	p.R159C	C	C		8	Cancer Gene	1	169347574	169347574	403	0.362282878411911	NA	NA	NA		p.R159C(1)	14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BLZF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,169347574,C,C&fts=all">p.R159C</a>
BMP15	Missense_Mutation	p.G322E	G	G		8	Cancer Gene	X	50659393	50659393	102	0.872549019607843	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMP15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,50659393,G,G&fts=all">p.G322E</a>
BMPER	Missense_Mutation	p.D476N	G	G		8	Cancer Gene	7	34125385	34125385	60	0.216666666666667	NA	NA	NA		p.D476H(1)	48	VWFD. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMPER&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,34125385,G,G&fts=all">p.D476N</a>
BRD7	Missense_Mutation	p.R254Q	C	C	rs140345367	8	Cancer Gene	16	50368748	50368748	251	0.0239043824701195	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRD7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,50368748,C,C&fts=all">p.R254Q</a>
BRSK1	Missense_Mutation	p.L312F	C	C		8	Cancer Gene	19	55816913	55816913	307	0.149837133550489	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRSK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55816913,C,C&fts=all">p.L312F</a>
BRWD3	Missense_Mutation	p.R219C	G	G		8	Cancer Gene	X	79999689	79999689	148	0.439189189189189	NA	NA	NA		p.R219C(1)	87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRWD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,79999689,G,G&fts=all">p.R219C</a>
BTBD16	Start_Codon_SNP	p.M1I	G	G		8	Cancer Gene	10	124034599	124034599	246	0.223577235772358	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTBD16&recr=Open">Click here</a>	
BTBD16	Missense_Mutation	p.P96L	C	C		8	Cancer Gene	10	124045665	124045665	176	0.284090909090909	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTBD16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124045665,C,C&fts=all">p.P96L</a>
BTBD7	Missense_Mutation	p.S436L	G	G		8	Cancer Gene	14	93730195	93730195	157	0.184713375796178	NA	NA	NA		p.S436L(2)	35	BACK.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTBD7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,93730195,G,G&fts=all">p.S436L</a>
BTBD9	Missense_Mutation	p.P182L	G	G		8	Cancer Gene	6	38560444	38560444	95	0.189473684210526	NA	NA	NA			12	BACK.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTBD9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,38560444,G,G&fts=all">p.P182L</a>
BTNL9	Missense_Mutation	p.R321K	G	G		8	Cancer Gene	5	180485358	180485358	94	0.478723404255319	NA	NA	NA			19	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTNL9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,180485358,G,G&fts=all">p.R321K</a>
C10orf107	Missense_Mutation	p.P128L	C	C		8	Cancer Gene	10	63519911	63519911	464	0.21551724137931	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf107&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,63519911,C,C&fts=all">p.P128L</a>
C10orf111	Missense_Mutation	p.S3F	G	G		8	Cancer Gene	10	15138816	15138816	141	0.226950354609929	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf111&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,15138816,G,G&fts=all">p.S3F</a>
C10orf12	Missense_Mutation	p.P329L	C	C		8	Cancer Gene	10	98742133	98742133	86	0.209302325581395	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,98742133,C,C&fts=all">p.P329L</a>
C10orf12	Nonsense_Mutation	p.R952*	C	C		8	Cancer Gene	10	98744001	98744001	239	0.238493723849372	NA	NA	NA		p.R952*(1)	45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,98744001,C,C&fts=all">p.R952*</a>
C10orf12	Missense_Mutation	p.S1178L	C	C		8	Cancer Gene	10	98744680	98744680	80	0.1875	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,98744680,C,C&fts=all">p.S1178L</a>
C10orf120	Missense_Mutation	p.R210Q	C	C		8	Cancer Gene	10	124457628	124457628	24	0.25	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf120&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124457628,C,C&fts=all">p.R210Q</a>
C10orf120	Nonsense_Mutation	p.W5*	C	C		8	Cancer Gene	10	124459292	124459292	135	0.214814814814815	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf120&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124459292,C,C&fts=all">p.W5*</a>
C10orf53	Missense_Mutation	p.G148R	G	G		8	Cancer Gene	10	50916631	50916631	84	0.30952380952381	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf53&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,50916631,G,G&fts=all">p.G148R</a>
C10orf68	Missense_Mutation	p.S53F	C	C		8	Cancer Gene	10	32974988	32974988	360	0.444444444444444	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf68&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,32974988,C,C&fts=all">p.S53F</a>
C10orf68	Missense_Mutation	p.E269K	G	G		8	Cancer Gene	10	33018340	33018340	204	0.411764705882353	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf68&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,33018340,G,G&fts=all">p.E269K</a>
C10orf76	Missense_Mutation	p.S689F	G	G		8	Cancer Gene	10	103607289	103607289	124	0.443548387096774	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf76&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,103607289,G,G&fts=all">p.S689F</a>
C10orf88	Missense_Mutation	p.S329F	G	G		8	Cancer Gene	10	124697338	124697338	319	0.219435736677116	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf88&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124697338,G,G&fts=all">p.S329F</a>
C10orf90	Missense_Mutation	p.P495L	G	G	rs372678700	8	Cancer Gene	10	128150064	128150064	46	0.239130434782609	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf90&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,128150064,G,G&fts=all">p.P495L</a>
C11orf74	Missense_Mutation	p.V69A	T	T		8	Cancer Gene	11	36654903	36654903	118	0.855932203389831	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C11orf74&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,36654903,T,T&fts=all">p.V69A</a>
C11orf85	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	64708120	64757286	NA	NA	6	-1.01917037924933	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C11orf85&recr=Open">Click here</a>	
C11orf88	Missense_Mutation	p.P167S	C	C		8	Cancer Gene	11	111405155	111405155	188	0.398936170212766	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C11orf88&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,111405155,C,C&fts=all">p.P167S</a>
C12orf40	Nonsense_Mutation	p.K88*	A	A		8	Cancer Gene	12	40040190	40040190	161	0.46583850931677	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,40040190,A,A&fts=all">p.K88*</a>
C12orf40	Nonsense_Mutation	p.K275*	A	A		8	Cancer Gene	12	40076549	40076549	175	0.382857142857143	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,40076549,A,A&fts=all">p.K275*</a>
C12orf40	Missense_Mutation	p.H548Y	C	C		8	Cancer Gene	12	40114736	40114736	109	0.44954128440367	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,40114736,C,C&fts=all">p.H548Y</a>
C12orf55	Missense_Mutation	p.A1944V	C	C		8	Cancer Gene	12	97078833	97078833	36	0.388888888888889	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf55&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,97078833,C,C&fts=all">p.A1944V</a>
C12orf56	Missense_Mutation	p.G507E	C	C		8	Cancer Gene	12	64668745	64668745	104	0.355769230769231	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf56&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,64668745,C,C&fts=all">p.G507E</a>
C12orf66	Missense_Mutation	p.H117Y	G	G		8	Cancer Gene	12	64609630	64609630	22	0.409090909090909	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf66&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,64609630,G,G&fts=all">p.H117Y</a>
C14orf159	Missense_Mutation	p.P218S	C	C		8	Cancer Gene	14	91642337	91642337	97	0.268041237113402	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C14orf159&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,91642337,C,C&fts=all">p.P218S</a>
C14orf183	Missense_Mutation	p.G34E	C	C		8	Cancer Gene	14	50558467	50558467	23	0.260869565217391	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C14orf183&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,50558467,C,C&fts=all">p.G34E</a>
C14orf39	Missense_Mutation	p.S499L	G	G		8	Cancer Gene	14	60921726	60921726	151	0.437086092715232	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C14orf39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,60921726,G,G&fts=all">p.S499L</a>
C14orf39	Missense_Mutation	p.P425S	G	G		8	Cancer Gene	14	60923720	60923720	260	0.430769230769231	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C14orf39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,60923720,G,G&fts=all">p.P425S</a>
C15orf27	Missense_Mutation	p.E70K	G	G		8	Cancer Gene	15	76430217	76430217	55	0.218181818181818	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C15orf27&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,76430217,G,G&fts=all">p.E70K</a>
C15orf39	Missense_Mutation	p.M14L	A	A		8	Cancer Gene	15	75498429	75498429	30	0.4	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C15orf39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,75498429,A,A&fts=all">p.M14L</a>
C16orf13	Missense_Mutation	p.L174F	G	G		8	Cancer Gene	16	684766	684766	29	0.241379310344828	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C16orf13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,684766,G,G&fts=all">p.L174F</a>
C16orf58	Missense_Mutation	p.A457V	G	G		8	Cancer Gene	16	31502193	31502193	66	0.303030303030303	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C16orf58&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,31502193,G,G&fts=all">p.A457V</a>
C16orf59	Missense_Mutation	p.G161R	G	G		8	Cancer Gene	16	2511101	2511101	50	0.2	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C16orf59&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,2511101,G,G&fts=all">p.G161R</a>
C16orf59	Missense_Mutation	p.P403S	C	C		8	Cancer Gene	16	2514574	2514574	30	0.5	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C16orf59&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,2514574,C,C&fts=all">p.P403S</a>
C16orf59	Missense_Mutation	p.P403Q	C	C		8	Cancer Gene	16	2514575	2514575	30	0.5	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C16orf59&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,2514575,C,C&fts=all">p.P403Q</a>
C16orf78	Splice_Site		G	G		8	Cancer Gene	16	49430333	49430333	45	0.244444444444444	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C16orf78&recr=Open">Click here</a>	
C17orf104	Missense_Mutation	p.G291E	G	G		8	Cancer Gene	17	42744151	42744151	80	0.2125	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf104&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,42744151,G,G&fts=all">p.G291E</a>
C17orf42	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf42&recr=Open">Click here</a>	
C17orf47	Missense_Mutation	p.A262V	G	G		8	Cancer Gene	17	56620763	56620763	294	0.19047619047619	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf47&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56620763,G,G&fts=all">p.A262V</a>
C17orf64	Missense_Mutation	p.P190S	C	C	rs371681055	8	Cancer Gene	17	58506861	58506861	79	0.126582278481013	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf64&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,58506861,C,C&fts=all">p.P190S</a>
C17orf70	Missense_Mutation	p.S561F	G	G		8	Cancer Gene	17	79514426	79514426	76	0.144736842105263	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf70&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,79514426,G,G&fts=all">p.S561F</a>
C17orf74	Missense_Mutation	p.R122C	C	C		8	Cancer Gene	17	7329674	7329674	70	0.357142857142857	NA	NA	NA			22	Arg-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf74&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7329674,C,C&fts=all">p.R122C</a>
C17orf74	Missense_Mutation	p.D312N	G	G	rs200993701	8	Cancer Gene	17	7330244	7330244	48	0.125	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf74&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7330244,G,G&fts=all">p.D312N</a>
C17orf79	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf79&recr=Open">Click here</a>	
C1QTNF3	Missense_Mutation	p.H62Y	G	G		8	Cancer Gene	5	34043047	34043047	372	0.196236559139785	NA	NA	NA			17	Collagen-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1QTNF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,34043047,G,G&fts=all">p.H62Y</a>
C1QTNF5	Missense_Mutation	p.G210D	C	C		8	Cancer Gene	11	119210144	119210144	41	0.780487804878049	NA	NA	NA			3	C1q. {ECO:0000255|PROSITE- ProRule:PRU00368}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1QTNF5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,119210144,C,C&fts=all">p.G210D</a>
C1QTNF7	Missense_Mutation	p.G86R	G	G		8	Cancer Gene	4	15443809	15443809	97	0.381443298969072	NA	NA	NA			16	Collagen-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1QTNF7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,15443809,G,G&fts=all">p.G86R</a>
C1orf173	Missense_Mutation	p.P1235L	G	G		8	Cancer Gene	1	75037690	75037690	40	0.375	NA	NA	NA			184	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf173&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,75037690,G,G&fts=all">p.P1235L</a>
C1orf173	Missense_Mutation	p.E491K	C	C		8	Cancer Gene	1	75072303	75072303	174	0.53448275862069	NA	NA	NA			184	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf173&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,75072303,C,C&fts=all">p.E491K</a>
C1orf173	Missense_Mutation	p.P240L	G	G		8	Cancer Gene	1	75097497	75097497	178	0.325842696629214	NA	NA	NA			184			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf173&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,75097497,G,G&fts=all">p.P240L</a>
C1orf216	Missense_Mutation	p.S106T	A	A		8	Cancer Gene	1	36181607	36181607	77	0.493506493506494	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf216&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,36181607,A,A&fts=all">p.S106T</a>
C1orf43	Missense_Mutation	p.R199Q	C	C		8	Cancer Gene	1	154180095	154180095	163	0.650306748466258	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf43&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,154180095,C,C&fts=all">p.R199Q</a>
C1orf94	Missense_Mutation	p.P570S	C	C		8	Cancer Gene	1	34677994	34677994	17	0.529411764705882	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf94&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,34677994,C,C&fts=all">p.P570S</a>
C20orf26	Missense_Mutation	p.E218K	G	G	rs115295521	8	Cancer Gene	20	20071573	20071573	175	0.377142857142857	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C20orf26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,20071573,G,G&fts=all">p.E218K</a>
C20orf26	Missense_Mutation	p.G677E	G	G		8	Cancer Gene	20	20208990	20208990	268	0.317164179104478	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C20orf26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,20208990,G,G&fts=all">p.G677E</a>
C20orf26	Missense_Mutation	p.D1132N	G	G		8	Cancer Gene	20	20279002	20279002	50	0.34	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C20orf26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,20279002,G,G&fts=all">p.D1132N</a>
C22orf29	Nonsense_Mutation	p.Q325*	G	G		8	Cancer Gene	22	19838812	19838812	41	0.195121951219512	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C22orf29&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,19838812,G,G&fts=all">p.Q325*</a>
C2orf16	Missense_Mutation	p.E159K	G	G		8	Cancer Gene	2	27799914	27799914	129	0.271317829457364	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27799914,G,G&fts=all">p.E159K</a>
C2orf16	Missense_Mutation	p.H1910Y	C	C		8	Cancer Gene	2	27805167	27805167	93	0.333333333333333	NA	NA	NA			47	27 X 8 AA approximative tandem repeat of P-S-E-R-S-H-H-S.|Arg-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27805167,C,C&fts=all">p.H1910Y</a>
C2orf49	Missense_Mutation	p.P129S	C	C		8	Cancer Gene	2	105959423	105959423	231	0.238095238095238	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf49&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,105959423,C,C&fts=all">p.P129S</a>
C2orf54	Missense_Mutation	p.R180K	C	C		8	Cancer Gene	2	241831156	241831156	22	0.318181818181818	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf54&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,241831156,C,C&fts=all">p.R180K</a>
C2orf62	Missense_Mutation	p.S2F	C	C		8	Cancer Gene	2	219221612	219221612	86	0.325581395348837	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf62&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219221612,C,C&fts=all">p.S2F</a>
C2orf62	Missense_Mutation	p.R369W	C	C		8	Cancer Gene	2	219232628	219232628	22	0.181818181818182	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf62&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219232628,C,C&fts=all">p.R369W</a>
C2orf71	Missense_Mutation	p.E178K	C	C		8	Cancer Gene	2	29296596	29296596	96	0.552083333333333	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf71&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,29296596,C,C&fts=all">p.E178K</a>
C3orf18	Missense_Mutation	p.R9K	C	C		8	Cancer Gene	3	50603105	50603105	55	0.127272727272727	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3orf18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,50603105,C,C&fts=all">p.R9K</a>
C3orf20	Nonsense_Mutation	p.W465*	G	G		8	Cancer Gene	3	14756876	14756876	43	0.27906976744186	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3orf20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,14756876,G,G&fts=all">p.W465*</a>
C4orf40	Missense_Mutation	p.T80A	A	A		8	Cancer Gene	4	71024207	71024207	190	0.236842105263158	NA	NA	NA			12	Ala/Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C4orf40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,71024207,A,A&fts=all">p.T80A</a>
C4orf50	Missense_Mutation	p.P634S	G	G	rs541909138	8	Cancer Gene	4	5966852	5966852	35	0.285714285714286	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C4orf50&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,5966852,G,G&fts=all">p.P634S</a>
C5orf22	Missense_Mutation	p.P367S	C	C		8	Cancer Gene	5	31551439	31551439	444	0.204954954954955	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C5orf22&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,31551439,C,C&fts=all">p.P367S</a>
C5orf42	Missense_Mutation	p.K3023E	T	T		8	Cancer Gene	5	37120399	37120399	145	0.172413793103448	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C5orf42&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,37120399,T,T&fts=all">p.K3023E</a>
C5orf54	Missense_Mutation	p.P428S	G	G		8	Cancer Gene	5	159821216	159821216	210	0.376190476190476	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C5orf54&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,159821216,G,G&fts=all">p.P428S</a>
C6orf118	Missense_Mutation	p.G421E	C	C		8	Cancer Gene	6	165703415	165703415	273	0.340659340659341	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6orf118&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,165703415,C,C&fts=all">p.G421E</a>
C6orf120	Missense_Mutation	p.D136N	G	G		8	Cancer Gene	6	170102961	170102961	21	0.428571428571429	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6orf120&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,170102961,G,G&fts=all">p.D136N</a>
C6orf165	Missense_Mutation	p.S107F	C	C		8	Cancer Gene	6	88125440	88125440	167	0.377245508982036	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6orf165&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,88125440,C,C&fts=all">p.S107F</a>
C6orf201	Missense_Mutation	p.R20C	C	C	rs369359347	8	Cancer Gene	6	4087933	4087933	282	0.666666666666667	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6orf201&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,4087933,C,C&fts=all">p.R20C</a>
C6orf222	Missense_Mutation	p.S31L	G	G		8	Cancer Gene	6	36298376	36298376	136	0.183823529411765	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6orf222&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,36298376,G,G&fts=all">p.S31L</a>
C7orf10	Missense_Mutation	p.D87N	G	G		8	Cancer Gene	7	40228105	40228105	99	0.151515151515152	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C7orf10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,40228105,G,G&fts=all">p.D87N</a>
C7orf66	Missense_Mutation	p.H83Y	G	G		8	Cancer Gene	7	108524165	108524165	154	0.038961038961039	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C7orf66&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,108524165,G,G&fts=all">p.H83Y</a>
C8orf33	Missense_Mutation	p.A172V	C	C		8	Cancer Gene	8	146278794	146278794	66	0.196969696969697	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8orf33&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,146278794,C,C&fts=all">p.A172V</a>
C8orf34	Missense_Mutation	p.N177H	A	A		8	Cancer Gene	8	69358617	69358617	192	0.21875	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8orf34&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,69358617,A,A&fts=all">p.N177H</a>
C8orf34	Missense_Mutation	p.L230F	C	C		8	Cancer Gene	8	69381007	69381007	89	0.51685393258427	NA	NA	NA		p.L119F(2)|p.L144F(1)	36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8orf34&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,69381007,C,C&fts=all">p.L230F</a>
C8orf34	Missense_Mutation	p.E277K	G	G		8	Cancer Gene	8	69434097	69434097	122	0.180327868852459	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8orf34&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,69434097,G,G&fts=all">p.E277K</a>
C8orf34	Missense_Mutation	p.E487K	G	G		8	Cancer Gene	8	69699681	69699681	71	0.338028169014085	NA	NA	NA		p.E376K(1)	36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8orf34&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,69699681,G,G&fts=all">p.E487K</a>
C8orf47	Missense_Mutation	p.G145E	G	G		8	Cancer Gene	8	99101679	99101679	56	0.285714285714286	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8orf47&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,99101679,G,G&fts=all">p.G145E</a>
C9orf152	Missense_Mutation	p.P36L	G	G		8	Cancer Gene	9	112969753	112969753	43	0.255813953488372	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9orf152&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,112969753,G,G&fts=all">p.P36L</a>
C9orf78	Missense_Mutation	p.H229Y	G	G		8	Cancer Gene	9	132591577	132591577	53	0.245283018867925	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9orf78&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,132591577,G,G&fts=all">p.H229Y</a>
C9orf84	Missense_Mutation	p.D1291N	C	C		8	Cancer Gene	9	114453972	114453972	168	0.636904761904762	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9orf84&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,114453972,C,C&fts=all">p.D1291N</a>
CABLES2	Missense_Mutation	p.A251V	G	G		8	Cancer Gene	20	60968624	60968624	68	0.308823529411765	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CABLES2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,60968624,G,G&fts=all">p.A251V</a>
CABP2	Missense_Mutation	p.R101Q	C	C		8	Cancer Gene	11	67287538	67287538	11	1	NA	NA	NA			9	EF-hand 1. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CABP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,67287538,C,C&fts=all">p.R101Q</a>
CABS1	Missense_Mutation	p.E373K	G	G		8	Cancer Gene	4	71201873	71201873	138	0.253623188405797	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CABS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,71201873,G,G&fts=all">p.E373K</a>
CACNA1B	Missense_Mutation	p.D550N	G	G		8	Cancer Gene	9	140870463	140870463	12	0.25	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,140870463,G,G&fts=all">p.D550N</a>
CACNA1B	Missense_Mutation	p.G1907R	G	G		8	Cancer Gene	9	141010073	141010073	34	0.352941176470588	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,141010073,G,G&fts=all">p.G1907R</a>
CACNA1D	Missense_Mutation	p.P340L	C	C		8	Cancer Gene	3	53700465	53700465	199	0.231155778894472	NA	NA	NA			90			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,53700465,C,C&fts=all">p.P340L</a>
CACNA1E	Missense_Mutation	p.D1431N	G	G		8	Cancer Gene	1	181726224	181726224	78	0.192307692307692	NA	NA	NA			204			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,181726224,G,G&fts=all">p.D1431N</a>
CACNA1E	Missense_Mutation	p.G1687E	G	G		8	Cancer Gene	1	181741288	181741288	97	0.216494845360825	NA	NA	NA			204			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,181741288,G,G&fts=all">p.G1687E</a>
CACNA1E	Missense_Mutation	p.S1988F	C	C		8	Cancer Gene	1	181764064	181764064	53	0.320754716981132	NA	NA	NA			204			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,181764064,C,C&fts=all">p.S1988F</a>
CACNA1F	Missense_Mutation	p.A1353V	G	G		8	Cancer Gene	X	49068433	49068433	59	0.440677966101695	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,49068433,G,G&fts=all">p.A1353V</a>
CACNA1G	Missense_Mutation	p.P616L	C	C		8	Cancer Gene	17	48653610	48653610	11	0.272727272727273	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,48653610,C,C&fts=all">p.P616L</a>
CACNA1G	Missense_Mutation	p.M862I	G	G		8	Cancer Gene	17	48668928	48668928	29	0.310344827586207	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,48668928,G,G&fts=all">p.M862I</a>
CACNA1I	Missense_Mutation	p.G138E	G	G		8	Cancer Gene	22	39996589	39996589	37	0.405405405405405	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1I&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,39996589,G,G&fts=all">p.G138E</a>
CACNA1I	Missense_Mutation	p.S1993F	C	C		8	Cancer Gene	22	40080454	40080454	10	0.3	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1I&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,40080454,C,C&fts=all">p.S1993F</a>
CACNA1S	Splice_Site	p.G743G	C	C	rs368154721	8	Cancer Gene	1	201039531	201039531	70	0.657142857142857	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1S&recr=Open">Click here</a>	
CACNA1S	Missense_Mutation	p.G629E	C	C		8	Cancer Gene	1	201044685	201044685	153	0.183006535947712	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1S&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,201044685,C,C&fts=all">p.G629E</a>
CACNA1S	Missense_Mutation	p.E355K	C	C		8	Cancer Gene	1	201054651	201054651	105	0.0380952380952381	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1S&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,201054651,C,C&fts=all">p.E355K</a>
CACNA1S	Splice_Site	p.G335G	C	C		8	Cancer Gene	1	201054709	201054709	66	0.196969696969697	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1S&recr=Open">Click here</a>	
CACNG6	Missense_Mutation	p.A210T	G	G	rs576293186	8	Cancer Gene	19	54515288	54515288	33	0.242424242424242	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNG6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,54515288,G,G&fts=all">p.A210T</a>
CADPS2	Missense_Mutation	p.E836K	C	C		8	Cancer Gene	7	122056180	122056180	12	0.5	NA	NA	NA			43	Interaction with DRD2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CADPS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,122056180,C,C&fts=all">p.E836K</a>
CADPS2	Nonsense_Mutation	p.Q514*	G	G		8	Cancer Gene	7	122153305	122153305	14	0.428571428571429	NA	NA	NA			43	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CADPS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,122153305,G,G&fts=all">p.Q514*</a>
CALHM1	Missense_Mutation	p.E338K	C	C	rs577920633	8	Cancer Gene	10	105215048	105215048	29	0.517241379310345	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CALHM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,105215048,C,C&fts=all">p.E338K</a>
CAMKK1	Missense_Mutation	p.R439K	C	C		8	Cancer Gene	17	3772806	3772806	51	0.235294117647059	NA	NA	NA			11	Autoinhibitory domain. {ECO:0000250}.|Calmodulin-binding. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMKK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,3772806,C,C&fts=all">p.R439K</a>
CAMTA1	Missense_Mutation	p.E667K	G	G		8	Cancer Gene	1	7724606	7724606	103	0.0485436893203883	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMTA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,7724606,G,G&fts=all">p.E667K</a>
CAMTA1	Missense_Mutation	p.K1589Q	A	A		8	Cancer Gene	1	7811334	7811334	348	0.925287356321839	NA	NA	NA			85	IQ 2. {ECO:0000255|PROSITE- ProRule:PRU00116}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMTA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,7811334,A,A&fts=all">p.K1589Q</a>
CAPN12	Nonsense_Mutation	p.Q542*	G	G		8	Cancer Gene	19	39226144	39226144	53	0.207547169811321	NA	NA	NA			20	Domain IV.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39226144,G,G&fts=all">p.Q542*</a>
CAPN13	Missense_Mutation	p.D368N	C	C		8	Cancer Gene	2	30974103	30974103	59	0.203389830508475	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,30974103,C,C&fts=all">p.D368N</a>
CAPN6	Missense_Mutation	p.R281C	G	G		8	Cancer Gene	X	110494829	110494829	188	0.48936170212766	NA	NA	NA			47	Calpain catalytic. {ECO:0000255|PROSITE- ProRule:PRU00239}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,110494829,G,G&fts=all">p.R281C</a>
CAPN7	Missense_Mutation	p.P786L	C	C		8	Cancer Gene	3	15292682	15292682	378	0.211640211640212	NA	NA	NA			22	Domain N.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,15292682,C,C&fts=all">p.P786L</a>
CAPN9	Missense_Mutation	p.E167K	G	G		8	Cancer Gene	1	230898495	230898495	69	0.231884057971014	NA	NA	NA			25	Calpain catalytic. {ECO:0000255|PROSITE- ProRule:PRU00239}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,230898495,G,G&fts=all">p.E167K</a>
CAPN9	Missense_Mutation	p.G189E	G	G		8	Cancer Gene	1	230903316	230903316	151	0.205298013245033	NA	NA	NA			25	Calpain catalytic. {ECO:0000255|PROSITE- ProRule:PRU00239}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,230903316,G,G&fts=all">p.G189E</a>
CAPN9	Missense_Mutation	p.R617Q	G	G		8	Cancer Gene	1	230928654	230928654	303	0.224422442244224	NA	NA	NA			25	Domain IV.|EF-hand 3. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,230928654,G,G&fts=all">p.R617Q</a>
CAPRIN2	Missense_Mutation	p.K508Q	T	T		8	Cancer Gene	12	30881842	30881842	317	0.192429022082019	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPRIN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,30881842,T,T&fts=all">p.K508Q</a>
CAPSL	Missense_Mutation	p.R112S	T	T		8	Cancer Gene	5	35910157	35910157	135	0.148148148148148	NA	NA	NA			19	EF-hand 3. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPSL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,35910157,T,T&fts=all">p.R112S</a>
CAPZA3	Missense_Mutation	p.D66N	G	G		8	Cancer Gene	12	18891398	18891398	129	0.410852713178295	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPZA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18891398,G,G&fts=all">p.D66N</a>
CAPZA3	Missense_Mutation	p.G168R	G	G		8	Cancer Gene	12	18891704	18891704	181	0.18232044198895	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPZA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18891704,G,G&fts=all">p.G168R</a>
CARD17	Missense_Mutation	p.H82Y	G	G		8	Cancer Gene	11	104971270	104971270	113	0.389380530973451	NA	NA	NA			6	CARD. {ECO:0000255|PROSITE- ProRule:PRU00046}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CARD17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,104971270,G,G&fts=all">p.H82Y</a>
CASC3	Missense_Mutation	p.V88A	T	T		8	Cancer Gene	17	38297826	38297826	336	0.380952380952381	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,38297826,T,T&fts=all">p.V88A</a>
CASQ1	Splice_Site		G	G		8	Cancer Gene	1	160167405	160167405	91	0.142857142857143	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASQ1&recr=Open">Click here</a>	
CASQ1	Missense_Mutation	p.D322N	G	G		8	Cancer Gene	1	160168823	160168823	271	0.025830258302583	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASQ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,160168823,G,G&fts=all">p.D322N</a>
CASQ1	Missense_Mutation	p.D363N	G	G		8	Cancer Gene	1	160171062	160171062	46	0.173913043478261	NA	NA	NA			21	Asp-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASQ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,160171062,G,G&fts=all">p.D363N</a>
CASZ1	Missense_Mutation	p.P373S	G	G		8	Cancer Gene	1	10719982	10719982	29	0.379310344827586	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASZ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,10719982,G,G&fts=all">p.P373S</a>
CATSPERG	Missense_Mutation	p.M875I	G	G		8	Cancer Gene	19	38857807	38857807	46	0.478260869565217	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPERG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,38857807,G,G&fts=all">p.M875I</a>
CATSPERG	Missense_Mutation	p.V876M	G	G		8	Cancer Gene	19	38857808	38857808	47	0.48936170212766	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPERG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,38857808,G,G&fts=all">p.V876M</a>
CCDC102B	Splice_Site		G	G	rs143482676	8	Cancer Gene	18	66564666	66564666	201	0.776119402985075	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC102B&recr=Open">Click here</a>	
CCDC108	Missense_Mutation	p.D804N	C	C		8	Cancer Gene	2	219888922	219888922	66	0.227272727272727	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC108&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219888922,C,C&fts=all">p.D804N</a>
CCDC110	Missense_Mutation	p.E296K	C	C		8	Cancer Gene	4	186380855	186380855	323	0.582043343653251	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC110&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,186380855,C,C&fts=all">p.E296K</a>
CCDC114	Missense_Mutation	p.P238S	G	G		8	Cancer Gene	19	48807240	48807240	139	0.251798561151079	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC114&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,48807240,G,G&fts=all">p.P238S</a>
CCDC122	Missense_Mutation	p.L258S	A	A		8	Cancer Gene	13	44411465	44411465	183	0.240437158469945	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC122&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,44411465,A,A&fts=all">p.L258S</a>
CCDC130	Splice_Site	p.R86R	G	G		8	Cancer Gene	19	13869682	13869682	41	0.268292682926829	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC130&recr=Open">Click here</a>	
CCDC138	Nonsense_Mutation	p.Q186*	C	C		8	Cancer Gene	2	109411157	109411157	118	0.296610169491525	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC138&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,109411157,C,C&fts=all">p.Q186*</a>
CCDC141	Nonsense_Mutation	p.Q791*	G	G		8	Cancer Gene	2	179733867	179733867	195	0.0358974358974359	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC141&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179733867,G,G&fts=all">p.Q791*</a>
CCDC146	Missense_Mutation	p.E649K	G	G		8	Cancer Gene	7	76911899	76911899	35	0.285714285714286	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC146&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,76911899,G,G&fts=all">p.E649K</a>
CCDC147	Missense_Mutation	p.E314K	G	G		8	Cancer Gene	10	106130662	106130662	166	0.126506024096386	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC147&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,106130662,G,G&fts=all">p.E314K</a>
CCDC155	Missense_Mutation	p.R502W	A	A		8	Cancer Gene	19	49920480	49920480	45	0.0888888888888889	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC155&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49920480,A,A&fts=all">p.R502W</a>
CCDC158	Missense_Mutation	p.G992D	C	C		8	Cancer Gene	4	77250076	77250076	136	0.316176470588235	NA	NA	NA			56	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC158&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,77250076,C,C&fts=all">p.G992D</a>
CCDC158	Missense_Mutation	p.E82K	C	C		8	Cancer Gene	4	77317466	77317466	118	0.338983050847458	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC158&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,77317466,C,C&fts=all">p.E82K</a>
CCDC30	Missense_Mutation	p.H497Y	C	C		8	Cancer Gene	1	43076754	43076754	70	0.0714285714285714	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC30&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,43076754,C,C&fts=all">p.H497Y</a>
CCDC36	Missense_Mutation	p.G371S	G	G		8	Cancer Gene	3	49294041	49294041	166	0.283132530120482	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC36&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49294041,G,G&fts=all">p.G371S</a>
CCDC36	Missense_Mutation	p.K439I	A	A		8	Cancer Gene	3	49294246	49294246	229	0.139737991266376	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC36&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49294246,A,A&fts=all">p.K439I</a>
CCDC36	Missense_Mutation	p.D554N	G	G	rs369435918	8	Cancer Gene	3	49294590	49294590	109	0.201834862385321	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC36&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49294590,G,G&fts=all">p.D554N</a>
CCDC38	Missense_Mutation	p.E550K	C	C		8	Cancer Gene	12	96260898	96260898	168	0.392857142857143	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC38&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,96260898,C,C&fts=all">p.E550K</a>
CCDC39	Missense_Mutation	p.M821I	C	C		8	Cancer Gene	3	180334427	180334427	73	0.301369863013699	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,180334427,C,C&fts=all">p.M821I</a>
CCDC39	Missense_Mutation	p.E809K	C	C		8	Cancer Gene	3	180334465	180334465	74	0.22972972972973	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,180334465,C,C&fts=all">p.E809K</a>
CCDC39	Nonsense_Mutation	p.Q619*	G	G		8	Cancer Gene	3	180359800	180359800	198	0.0454545454545455	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,180359800,G,G&fts=all">p.Q619*</a>
CCDC39	Missense_Mutation	p.E49K	C	C		8	Cancer Gene	3	180381720	180381720	345	0.0463768115942029	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,180381720,C,C&fts=all">p.E49K</a>
CCDC47	Splice_Site		C	C		8	Cancer Gene	17	61838712	61838712	449	0.209354120267261	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC47&recr=Open">Click here</a>	
CCDC47	Missense_Mutation	p.E83K	C	C		8	Cancer Gene	17	61843289	61843289	694	0.210374639769452	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC47&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,61843289,C,C&fts=all">p.E83K</a>
CCDC60	Missense_Mutation	p.E93K	G	G		8	Cancer Gene	12	119909905	119909905	127	0.283464566929134	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC60&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,119909905,G,G&fts=all">p.E93K</a>
CCDC66	Missense_Mutation	p.V416A	T	T		8	Cancer Gene	3	56627697	56627697	257	0.459143968871595	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC66&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,56627697,T,T&fts=all">p.V416A</a>
CCDC67	Start_Codon_SNP	p.M1T	T	T	rs376804718	8	Cancer Gene	11	93065427	93065427	27	0.481481481481481	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC67&recr=Open">Click here</a>	
CCDC83	Missense_Mutation	p.E326K	G	G	rs368704693	8	Cancer Gene	11	85627172	85627172	187	0.417112299465241	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC83&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,85627172,G,G&fts=all">p.E326K</a>
CCDC88B	Missense_Mutation	p.P582S	C	C		8	Cancer Gene	11	64111757	64111757	36	0.833333333333333	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC88B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,64111757,C,C&fts=all">p.P582S</a>
CCDC88B	Missense_Mutation	p.R1243G	C	C		8	Cancer Gene	11	64120862	64120862	5	1	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC88B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,64120862,C,C&fts=all">p.R1243G</a>
CCDC88C	Missense_Mutation	p.E167K	C	C		8	Cancer Gene	14	91806353	91806353	13	0.307692307692308	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC88C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,91806353,C,C&fts=all">p.E167K</a>
CCDC92	Missense_Mutation	p.D179N	C	C		8	Cancer Gene	12	124422015	124422015	40	0.425	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC92&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,124422015,C,C&fts=all">p.D179N</a>
CCDC97	Missense_Mutation	p.P213L	C	C		8	Cancer Gene	19	41825614	41825614	88	0.522727272727273	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC97&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41825614,C,C&fts=all">p.P213L</a>
CCR7	Missense_Mutation	p.L15H	A	A		8	Cancer Gene	17	38715161	38715161	68	0.426470588235294	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCR7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,38715161,A,A&fts=all">p.L15H</a>
CD101	Missense_Mutation	p.S544C	A	A		8	Cancer Gene	1	117560795	117560795	162	0.0308641975308642	NA	NA	NA			49	Ig-like C2-type 5.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD101&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,117560795,A,A&fts=all">p.S544C</a>
CD163L1	Missense_Mutation	p.S1310L	G	G		8	Cancer Gene	12	7522093	7522093	92	0.228260869565217	NA	NA	NA			96	SRCR 12. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7522093,G,G&fts=all">p.S1310L</a>
CD163L1	Missense_Mutation	p.G1117E	C	C		8	Cancer Gene	12	7527127	7527127	65	0.230769230769231	NA	NA	NA			96	SRCR 10. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7527127,C,C&fts=all">p.G1117E</a>
CD163L1	Missense_Mutation	p.S554F	G	G		8	Cancer Gene	12	7550958	7550958	172	0.215116279069767	NA	NA	NA			96	SRCR 5. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7550958,G,G&fts=all">p.S554F</a>
CD163L1	Missense_Mutation	p.D230N	C	C	rs188580867	8	Cancer Gene	12	7585120	7585120	96	0.21875	NA	NA	NA			96	SRCR 2. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7585120,C,C&fts=all">p.D230N</a>
CD163L1	Missense_Mutation	p.F36S	A	A		8	Cancer Gene	12	7593767	7593767	220	0.163636363636364	NA	NA	NA			96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7593767,A,A&fts=all">p.F36S</a>
CD163L1	Missense_Mutation	p.P4S	G	G		8	Cancer Gene	12	7596714	7596714	126	0.468253968253968	NA	NA	NA			96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7596714,G,G&fts=all">p.P4S</a>
CD84	Missense_Mutation	p.G66E	C	C		8	Cancer Gene	1	160535385	160535385	351	0.202279202279202	NA	NA	NA			24	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD84&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,160535385,C,C&fts=all">p.G66E</a>
CDAN1	Missense_Mutation	p.S298F	G	G		8	Cancer Gene	15	43027758	43027758	64	0.234375	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDAN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43027758,G,G&fts=all">p.S298F</a>
CDC20B	Missense_Mutation	p.L417F	G	G		8	Cancer Gene	5	54416345	54416345	81	0.54320987654321	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDC20B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,54416345,G,G&fts=all">p.L417F</a>
CDCA3	Missense_Mutation	p.N161T	T	T		8	Cancer Gene	12	6958581	6958581	112	0.276785714285714	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDCA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,6958581,T,T&fts=all">p.N161T</a>
CDH12	Missense_Mutation	p.E484K	C	C		8	Cancer Gene	5	21765152	21765152	216	0.282407407407407	NA	NA	NA			120	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,21765152,C,C&fts=all">p.E484K</a>
CDH19	Missense_Mutation	p.P53L	G	G		8	Cancer Gene	18	64239284	64239284	210	0.0571428571428571	NA	NA	NA			61	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,64239284,G,G&fts=all">p.P53L</a>
CDH7	Missense_Mutation	p.D103N	G	G		8	Cancer Gene	18	63477036	63477036	86	0.348837209302326	NA	NA	NA			80	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,63477036,G,G&fts=all">p.D103N</a>
CDHR1	Missense_Mutation	p.S474F	C	C		8	Cancer Gene	10	85970857	85970857	92	0.41304347826087	NA	NA	NA			36	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDHR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,85970857,C,C&fts=all">p.S474F</a>
CDHR3	Missense_Mutation	p.P491S	C	C		8	Cancer Gene	7	105658336	105658336	16	0.6875	NA	NA	NA			23	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDHR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,105658336,C,C&fts=all">p.P491S</a>
CDK13	Missense_Mutation	p.L646F	C	C	rs560363391	8	Cancer Gene	7	40037157	40037157	437	0.304347826086957	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDK13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,40037157,C,C&fts=all">p.L646F</a>
CDKN2AIP	Missense_Mutation	p.S497F	C	C		8	Cancer Gene	4	184368327	184368327	339	0.300884955752212	NA	NA	NA			6	DRBM. {ECO:0000255|PROSITE- ProRule:PRU00266}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDKN2AIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,184368327,C,C&fts=all">p.S497F</a>
CEACAM18	Missense_Mutation	p.D55N	G	G		8	Cancer Gene	19	51983697	51983697	15	0.266666666666667	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEACAM18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51983697,G,G&fts=all">p.D55N</a>
CEACAM18	Missense_Mutation	p.G70E	G	G		8	Cancer Gene	19	51983743	51983743	14	0.214285714285714	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEACAM18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51983743,G,G&fts=all">p.G70E</a>
CEACAM8	Missense_Mutation	p.L234F	G	G		8	Cancer Gene	19	43093612	43093612	134	0.141791044776119	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEACAM8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,43093612,G,G&fts=all">p.L234F</a>
CELA3B	Missense_Mutation	p.H233Y	C	C		8	Cancer Gene	1	22313078	22313078	49	0.63265306122449	NA	NA	NA			8	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELA3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,22313078,C,C&fts=all">p.H233Y</a>
CEP120	Missense_Mutation	p.P932S	G	G		8	Cancer Gene	5	122682380	122682380	246	0.357723577235772	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP120&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,122682380,G,G&fts=all">p.P932S</a>
CEP120	Splice_Site		A	A		8	Cancer Gene	5	122748091	122748091	260	0.330769230769231	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP120&recr=Open">Click here</a>	
CEP128	Missense_Mutation	p.E1076K	C	C		8	Cancer Gene	14	80963881	80963881	251	0.601593625498008	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP128&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,80963881,C,C&fts=all">p.E1076K</a>
CEP128	Missense_Mutation	p.D526N	C	C		8	Cancer Gene	14	81251874	81251874	60	0.5	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP128&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,81251874,C,C&fts=all">p.D526N</a>
CEP350	Missense_Mutation	p.D1109G	A	A		8	Cancer Gene	1	179991923	179991923	60	0.366666666666667	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP350&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,179991923,A,A&fts=all">p.D1109G</a>
CEP350	Missense_Mutation	p.E2224K	G	G		8	Cancer Gene	1	180061910	180061910	24	0.208333333333333	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP350&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,180061910,G,G&fts=all">p.E2224K</a>
CEP44	Missense_Mutation	p.P89L	C	C		8	Cancer Gene	4	175224882	175224882	159	0.182389937106918	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP44&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,175224882,C,C&fts=all">p.P89L</a>
CEP72	Missense_Mutation	p.M304I	G	G		8	Cancer Gene	5	637639	637639	72	0.236111111111111	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP72&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,637639,G,G&fts=all">p.M304I</a>
CEPT1	Missense_Mutation	p.P42S	C	C		8	Cancer Gene	1	111690460	111690460	197	0.0304568527918782	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEPT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,111690460,C,C&fts=all">p.P42S</a>
CERKL	Missense_Mutation	p.E280K	C	C		8	Cancer Gene	2	182423353	182423353	111	0.288288288288288	NA	NA	NA			32	DAGKc. {ECO:0000255|PROSITE- ProRule:PRU00783}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CERKL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,182423353,C,C&fts=all">p.E280K</a>
CERKL	Missense_Mutation	p.M279I	C	C		8	Cancer Gene	2	182423354	182423354	111	0.297297297297297	NA	NA	NA			32	DAGKc. {ECO:0000255|PROSITE- ProRule:PRU00783}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CERKL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,182423354,C,C&fts=all">p.M279I</a>
CERKL	Missense_Mutation	p.K89T	T	T		8	Cancer Gene	2	182468779	182468779	106	0.594339622641509	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CERKL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,182468779,T,T&fts=all">p.K89T</a>
CES5A	Missense_Mutation	p.G257R	C	C		8	Cancer Gene	16	55899898	55899898	65	0.292307692307692	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CES5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,55899898,C,C&fts=all">p.G257R</a>
CFHR5	Splice_Site		G	G		8	Cancer Gene	1	196953090	196953090	160	0.65625	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFHR5&recr=Open">Click here</a>	
CFTR	Missense_Mutation	p.R555K	G	G		8	Cancer Gene	7	117227872	117227872	73	0.273972602739726	NA	NA	NA			69	ABC transporter 1. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFTR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,117227872,G,G&fts=all">p.R555K</a>
CGNL1	Missense_Mutation	p.E96K	G	G		8	Cancer Gene	15	57730483	57730483	87	0.28735632183908	NA	NA	NA			60	Head.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CGNL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,57730483,G,G&fts=all">p.E96K</a>
CGNL1	Missense_Mutation	p.E171K	G	G	rs143189146	8	Cancer Gene	15	57730708	57730708	166	0.265060240963855	NA	NA	NA			60	Head.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CGNL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,57730708,G,G&fts=all">p.E171K</a>
CGNL1	Missense_Mutation	p.D1192N	G	G		8	Cancer Gene	15	57837863	57837863	22	0.318181818181818	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CGNL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,57837863,G,G&fts=all">p.D1192N</a>
CHAT	Missense_Mutation	p.G357R	G	G	rs61731735	8	Cancer Gene	10	50835789	50835789	44	0.340909090909091	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHAT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,50835789,G,G&fts=all">p.G357R</a>
CHCHD10	Missense_Mutation	p.G76E	C	C		8	Cancer Gene	22	24109595	24109595	18	0.5	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHCHD10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,24109595,C,C&fts=all">p.G76E</a>
CHD5	Missense_Mutation	p.D1191N	C	C		8	Cancer Gene	1	6188946	6188946	27	0.444444444444444	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,6188946,C,C&fts=all">p.D1191N</a>
CHD5	Missense_Mutation	p.R1085K	C	C		8	Cancer Gene	1	6191699	6191699	21	0.666666666666667	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,6191699,C,C&fts=all">p.R1085K</a>
CHD8	Splice_Site	p.P743L	G	G		8	Cancer Gene	14	21878146	21878146	50	0.5	NA	NA	NA			85	Chromo 2. {ECO:0000255|PROSITE- ProRule:PRU00053}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD8&recr=Open">Click here</a>	
CHD9	Missense_Mutation	p.R928C	C	C	rs549002484	8	Cancer Gene	16	53272403	53272403	304	0.0361842105263158	NA	NA	NA			78	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,53272403,C,C&fts=all">p.R928C</a>
CHD9	Missense_Mutation	p.S958P	T	T		8	Cancer Gene	16	53272493	53272493	349	0.315186246418338	NA	NA	NA			78	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,53272493,T,T&fts=all">p.S958P</a>
CHD9	Missense_Mutation	p.L2497F	C	C		8	Cancer Gene	16	53348909	53348909	87	0.344827586206897	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,53348909,C,C&fts=all">p.L2497F</a>
CHDH	Missense_Mutation	p.G331S	C	C		8	Cancer Gene	3	53854630	53854630	83	0.204819277108434	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHDH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,53854630,C,C&fts=all">p.G331S</a>
CHIA	Splice_Site	p.E161K	G	G		8	Cancer Gene	1	111860303	111860303	106	0.349056603773585	NA	NA	NA		p.E161K(1)|p.E53K(1)	23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHIA&recr=Open">Click here</a>	
CHMP6	Missense_Mutation	p.P187S	C	C		8	Cancer Gene	17	78972906	78972906	114	0.210526315789474	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHMP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,78972906,C,C&fts=all">p.P187S</a>
CHRD	Missense_Mutation	p.P801L	C	C	rs149313082	8	Cancer Gene	3	184105216	184105216	55	0.181818181818182	NA	NA	NA		p.P801L(1)	48	VWFC 3. {ECO:0000255|PROSITE- ProRule:PRU00220}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,184105216,C,C&fts=all">p.P801L</a>
CHRM2	Missense_Mutation	p.S7F	C	C		8	Cancer Gene	7	136699632	136699632	77	0.272727272727273	NA	NA	NA			68			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,136699632,C,C&fts=all">p.S7F</a>
CHRM2	Missense_Mutation	p.I159F	A	A		8	Cancer Gene	7	136700087	136700087	106	0.424528301886792	NA	NA	NA			68			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,136700087,A,A&fts=all">p.I159F</a>
CHRNA9	Missense_Mutation	p.E356K	G	G		8	Cancer Gene	4	40356163	40356163	110	0.290909090909091	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRNA9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,40356163,G,G&fts=all">p.E356K</a>
CHST15	Missense_Mutation	p.D538N	C	C		8	Cancer Gene	10	125769739	125769739	41	0.219512195121951	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHST15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,125769739,C,C&fts=all">p.D538N</a>
CHST15	Missense_Mutation	p.K38T	T	T		8	Cancer Gene	10	125805616	125805616	121	0.43801652892562	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHST15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,125805616,T,T&fts=all">p.K38T</a>
CHST8	Missense_Mutation	p.K285M	A	A		8	Cancer Gene	19	34263547	34263547	52	0.0961538461538462	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHST8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,34263547,A,A&fts=all">p.K285M</a>
CIB3	Missense_Mutation	p.M101I	C	C		8	Cancer Gene	19	16278991	16278991	26	0.230769230769231	NA	NA	NA			16	EF-hand 1. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CIB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,16278991,C,C&fts=all">p.M101I</a>
CILP2	Missense_Mutation	p.R543Q	G	G		8	Cancer Gene	19	19654982	19654982	32	0.375	NA	NA	NA		p.R543L(1)	32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CILP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,19654982,G,G&fts=all">p.R543Q</a>
CILP2	Missense_Mutation	p.P913L	C	C		8	Cancer Gene	19	19656092	19656092	14	0.285714285714286	NA	NA	NA		p.P913L(1)	32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CILP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,19656092,C,C&fts=all">p.P913L</a>
CIR1	Missense_Mutation	p.P144L	G	G		8	Cancer Gene	2	175243704	175243704	326	0.288343558282209	NA	NA	NA		p.P144H(1)	15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CIR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,175243704,G,G&fts=all">p.P144L</a>
CLCA4	Missense_Mutation	p.G140E	G	G		8	Cancer Gene	1	87026012	87026012	139	0.489208633093525	NA	NA	NA			44	Metalloprotease domain. {ECO:0000250|UniProtKB:A8K7I4}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,87026012,G,G&fts=all">p.G140E</a>
CLCA4	Missense_Mutation	p.G494R	G	G		8	Cancer Gene	1	87040235	87040235	168	0.547619047619048	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,87040235,G,G&fts=all">p.G494R</a>
CLDN6	Missense_Mutation	p.T33I	G	G		8	Cancer Gene	16	3065925	3065925	56	0.303571428571429	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLDN6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,3065925,G,G&fts=all">p.T33I</a>
CLEC14A	Missense_Mutation	p.G350E	C	C	rs76636891	8	Cancer Gene	14	38724179	38724179	50	0.8	NA	NA	NA		p.G350E(1)	33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC14A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,38724179,C,C&fts=all">p.G350E</a>
CLEC2D	Missense_Mutation	p.G161D	G	G		8	Cancer Gene	12	9845650	9845650	337	0.198813056379822	NA	NA	NA			9	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC2D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,9845650,G,G&fts=all">p.G161D</a>
CLEC4C	Missense_Mutation	p.E126K	C	C		8	Cancer Gene	12	7890030	7890030	193	0.212435233160622	NA	NA	NA			25	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC4C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7890030,C,C&fts=all">p.E126K</a>
CLEC4F	Nonsense_Mutation	p.K289*	T	T		8	Cancer Gene	2	71043648	71043648	407	0.201474201474201	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC4F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,71043648,T,T&fts=all">p.K289*</a>
CLEC4F	Missense_Mutation	p.E211K	C	C		8	Cancer Gene	2	71043882	71043882	159	0.289308176100629	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC4F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,71043882,C,C&fts=all">p.E211K</a>
CLEC6A	Missense_Mutation	p.S82A	T	T		8	Cancer Gene	12	8618100	8618100	224	0.205357142857143	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC6A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,8618100,T,T&fts=all">p.S82A</a>
CLEC6A	Nonsense_Mutation	p.W182*	G	G		8	Cancer Gene	12	8629976	8629976	267	0.0337078651685393	NA	NA	NA			10	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC6A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,8629976,G,G&fts=all">p.W182*</a>
CLIC6	Missense_Mutation	p.P539S	C	C		8	Cancer Gene	21	36081002	36081002	92	0.576086956521739	NA	NA	NA		p.P539A(1)	19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLIC6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,36081002,C,C&fts=all">p.P539S</a>
CLN6	Missense_Mutation	p.N156K	A	A		8	Cancer Gene	15	68504031	68504031	143	0.27972027972028	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLN6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,68504031,A,A&fts=all">p.N156K</a>
CLNK	Missense_Mutation	p.R198K	C	C		8	Cancer Gene	4	10542127	10542127	69	0.405797101449275	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLNK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,10542127,C,C&fts=all">p.R198K</a>
CLSTN2	Missense_Mutation	p.E45K	G	G		8	Cancer Gene	3	139894816	139894816	97	0.34020618556701	NA	NA	NA			87	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLSTN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,139894816,G,G&fts=all">p.E45K</a>
CLSTN2	Missense_Mutation	p.G309S	G	G	rs373799261	8	Cancer Gene	3	140167498	140167498	114	0.403508771929825	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLSTN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,140167498,G,G&fts=all">p.G309S</a>
CLSTN2	Splice_Site	p.K558K	G	G		8	Cancer Gene	3	140265523	140265523	10	0.5	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLSTN2&recr=Open">Click here</a>	
CLSTN2	Splice_Site		G	G		8	Cancer Gene	3	140265524	140265524	9	0.444444444444444	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLSTN2&recr=Open">Click here</a>	
CLVS1	Missense_Mutation	p.S257N	G	G		8	Cancer Gene	8	62370894	62370894	180	0.227777777777778	NA	NA	NA			41	CRAL-TRIO. {ECO:0000255|PROSITE- ProRule:PRU00056}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLVS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,62370894,G,G&fts=all">p.S257N</a>
CMPK2	Nonsense_Mutation	p.Q415*	G	G	rs199510524	8	Cancer Gene	2	6990088	6990088	106	0.349056603773585	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMPK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,6990088,G,G&fts=all">p.Q415*</a>
CMPK2	Nonsense_Mutation	p.Q248*	G	G		8	Cancer Gene	2	7003643	7003643	145	0.289655172413793	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMPK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,7003643,G,G&fts=all">p.Q248*</a>
CMYA5	Missense_Mutation	p.E2086K	G	G		8	Cancer Gene	5	79030844	79030844	74	0.472972972972973	NA	NA	NA		p.E2086K(1)	128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMYA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,79030844,G,G&fts=all">p.E2086K</a>
CMYA5	Missense_Mutation	p.S3855F	C	C		8	Cancer Gene	5	79084802	79084802	116	0.491379310344828	NA	NA	NA			128	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMYA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,79084802,C,C&fts=all">p.S3855F</a>
CNBD1	Missense_Mutation	p.S221R	A	A		8	Cancer Gene	8	88249230	88249230	199	0.185929648241206	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNBD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,88249230,A,A&fts=all">p.S221R</a>
CNDP2	Missense_Mutation	p.S387F	C	C		8	Cancer Gene	18	72185825	72185825	148	0.898648648648649	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNDP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,72185825,C,C&fts=all">p.S387F</a>
CNGB3	Missense_Mutation	p.E722D	T	T		8	Cancer Gene	8	87588296	87588296	50	0.26	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNGB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,87588296,T,T&fts=all">p.E722D</a>
CNGB3	Missense_Mutation	p.R604Q	C	C	rs369526115	8	Cancer Gene	8	87591451	87591451	288	0.211805555555556	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNGB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,87591451,C,C&fts=all">p.R604Q</a>
CNGB3	Missense_Mutation	p.E336K	C	C	rs373862340	8	Cancer Gene	8	87656899	87656899	145	0.151724137931034	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNGB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,87656899,C,C&fts=all">p.E336K</a>
CNNM2	Missense_Mutation	p.P751S	C	C		8	Cancer Gene	10	104835860	104835860	27	0.111111111111111	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNNM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,104835860,C,C&fts=all">p.P751S</a>
CNPY3	Missense_Mutation	p.P148S	C	C		8	Cancer Gene	6	42905524	42905524	303	0.231023102310231	NA	NA	NA			6	Saposin B-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNPY3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,42905524,C,C&fts=all">p.P148S</a>
CNTN4	Splice_Site	p.A314T	G	G		8	Cancer Gene	3	2928908	2928908	113	0.247787610619469	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN4&recr=Open">Click here</a>	
CNTN4	Missense_Mutation	p.P685L	C	C		8	Cancer Gene	3	3078974	3078974	246	0.186991869918699	NA	NA	NA		p.P357H(1)	61	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,3078974,C,C&fts=all">p.P685L</a>
CNTN4	Missense_Mutation	p.D922N	G	G		8	Cancer Gene	3	3085341	3085341	167	0.161676646706587	NA	NA	NA			61	Fibronectin type-III 4. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,3085341,G,G&fts=all">p.D922N</a>
CNTNAP4	Missense_Mutation	p.K214T	A	A		8	Cancer Gene	16	76482002	76482002	142	0.288732394366197	NA	NA	NA			64	Laminin G-like 1. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,76482002,A,A&fts=all">p.K214T</a>
CNTNAP4	Missense_Mutation	p.E710K	G	G		8	Cancer Gene	16	76528845	76528845	252	0.281746031746032	NA	NA	NA			64	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,76528845,G,G&fts=all">p.E710K</a>
CNTNAP4	Missense_Mutation	p.F1098Y	T	T		8	Cancer Gene	16	76573679	76573679	194	0.304123711340206	NA	NA	NA			64	Laminin G-like 4. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,76573679,T,T&fts=all">p.F1098Y</a>
COG1	Missense_Mutation	p.S257L	C	C		8	Cancer Gene	17	71193392	71193392	506	0.723320158102767	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,71193392,C,C&fts=all">p.S257L</a>
COG3	Missense_Mutation	p.P246L	C	C		8	Cancer Gene	13	46057384	46057384	151	0.211920529801325	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COG3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,46057384,C,C&fts=all">p.P246L</a>
COG6	Missense_Mutation	p.A568V	C	C		8	Cancer Gene	13	40298655	40298655	259	0.239382239382239	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COG6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,40298655,C,C&fts=all">p.A568V</a>
COL14A1	Missense_Mutation	p.E688K	G	G		8	Cancer Gene	8	121239516	121239516	124	0.193548387096774	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL14A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,121239516,G,G&fts=all">p.E688K</a>
COL14A1	Missense_Mutation	p.S1403L	C	C		8	Cancer Gene	8	121301977	121301977	220	0.25	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL14A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,121301977,C,C&fts=all">p.S1403L</a>
COL14A1	Missense_Mutation	p.G1524R	G	G		8	Cancer Gene	8	121327790	121327790	114	0.473684210526316	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL14A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,121327790,G,G&fts=all">p.G1524R</a>
COL14A1	Missense_Mutation	p.G1524E	G	G		8	Cancer Gene	8	121327791	121327791	113	0.47787610619469	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL14A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,121327791,G,G&fts=all">p.G1524E</a>
COL14A1	Missense_Mutation	p.H1743Y	C	C		8	Cancer Gene	8	121381640	121381640	125	0.256	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL14A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,121381640,C,C&fts=all">p.H1743Y</a>
COL21A1	Missense_Mutation	p.S789L	G	G		8	Cancer Gene	6	55925580	55925580	199	0.246231155778894	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL21A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,55925580,G,G&fts=all">p.S789L</a>
COL21A1	Missense_Mutation	p.E534K	C	C		8	Cancer Gene	6	55990415	55990415	66	0.121212121212121	NA	NA	NA			41	Collagen-like 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL21A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,55990415,C,C&fts=all">p.E534K</a>
COL21A1	Missense_Mutation	p.E205K	C	C	rs562696627	8	Cancer Gene	6	56044403	56044403	79	0.518987341772152	NA	NA	NA			41	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL21A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,56044403,C,C&fts=all">p.E205K</a>
COL22A1	Missense_Mutation	p.E1337K	C	C		8	Cancer Gene	8	139620202	139620202	88	0.477272727272727	NA	NA	NA			211	Collagen-like 13.|Gly-rich.|Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL22A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139620202,C,C&fts=all">p.E1337K</a>
COL22A1	Splice_Site	p.G499R	C	C		8	Cancer Gene	8	139815177	139815177	92	0.173913043478261	NA	NA	NA			211	Collagen-like 1.|Gly-rich.|Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL22A1&recr=Open">Click here</a>	
COL22A1	Missense_Mutation	p.R420Q	C	C	rs143614201	8	Cancer Gene	8	139825249	139825249	97	0.195876288659794	NA	NA	NA			211	Laminin G-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL22A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139825249,C,C&fts=all">p.R420Q</a>
COL23A1	Missense_Mutation	p.G427R	C	C		8	Cancer Gene	5	177674544	177674544	20	0.4	NA	NA	NA			19	Collagen-like 4.|Gly-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL23A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,177674544,C,C&fts=all">p.G427R</a>
COL24A1	Missense_Mutation	p.G1167E	C	C		8	Cancer Gene	1	86308039	86308039	344	0.0494186046511628	NA	NA	NA			101	Collagen-like 11.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL24A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,86308039,C,C&fts=all">p.G1167E</a>
COL24A1	Missense_Mutation	p.G1137E	C	C		8	Cancer Gene	1	86313400	86313400	336	0.0505952380952381	NA	NA	NA			101	Collagen-like 11.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL24A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,86313400,C,C&fts=all">p.G1137E</a>
COL25A1	Missense_Mutation	p.G634R	C	C		8	Cancer Gene	4	109740431	109740431	112	0.589285714285714	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL25A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,109740431,C,C&fts=all">p.G634R</a>
COL27A1	Nonsense_Mutation	p.Q1801*	C	C		8	Cancer Gene	9	117071723	117071723	37	0.675675675675676	NA	NA	NA			80	Fibrillar collagen NC1. {ECO:0000255|PROSITE-ProRule:PRU00793}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL27A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,117071723,C,C&fts=all">p.Q1801*</a>
COL4A3	Splice_Site	p.G230D	G	G		8	Cancer Gene	2	228118278	228118278	206	0.315533980582524	NA	NA	NA			55	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A3&recr=Open">Click here</a>	
COL4A3	Missense_Mutation	p.P672S	C	C		8	Cancer Gene	2	228141187	228141187	46	0.304347826086957	NA	NA	NA			55	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,228141187,C,C&fts=all">p.P672S</a>
COL4A3	Missense_Mutation	p.G1304R	G	G		8	Cancer Gene	2	228167781	228167781	159	0.30188679245283	NA	NA	NA			55	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,228167781,G,G&fts=all">p.G1304R</a>
COL6A6	Missense_Mutation	p.G1611E	G	G		8	Cancer Gene	3	130340681	130340681	69	0.449275362318841	NA	NA	NA			134	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,130340681,G,G&fts=all">p.G1611E</a>
COL6A6	Missense_Mutation	p.A1861T	G	G		8	Cancer Gene	3	130368254	130368254	18	0.5	NA	NA	NA			134	Nonhelical region.|VWFA 8. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,130368254,G,G&fts=all">p.A1861T</a>
COL8A1	Missense_Mutation	p.G147R	G	G		8	Cancer Gene	3	99513184	99513184	20	0.55	NA	NA	NA			27	Triple-helical region (COL1).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL8A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,99513184,G,G&fts=all">p.G147R</a>
COL8A2	Missense_Mutation	p.R57L	C	C		8	Cancer Gene	1	36565674	36565674	45	0.844444444444444	NA	NA	NA			17	Nonhelical region (NC2).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL8A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,36565674,C,C&fts=all">p.R57L</a>
CORO2A	Missense_Mutation	p.R390Q	C	C	rs201111862	8	Cancer Gene	9	100890454	100890454	188	0.0425531914893617	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CORO2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,100890454,C,C&fts=all">p.R390Q</a>
COX8C	Missense_Mutation	p.G21S	G	G		8	Cancer Gene	14	93813675	93813675	27	0.37037037037037	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COX8C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,93813675,G,G&fts=all">p.G21S</a>
CPAMD8	Missense_Mutation	p.S1579F	G	G		8	Cancer Gene	19	17013549	17013549	21	0.619047619047619	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPAMD8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,17013549,G,G&fts=all">p.S1579F</a>
CPAMD8	Missense_Mutation	p.G941R	C	C		8	Cancer Gene	19	17056472	17056472	104	0.394230769230769	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPAMD8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,17056472,C,C&fts=all">p.G941R</a>
CPAMD8	Missense_Mutation	p.R674K	C	C		8	Cancer Gene	19	17086840	17086840	22	0.363636363636364	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPAMD8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,17086840,C,C&fts=all">p.R674K</a>
CPEB3	Missense_Mutation	p.D688N	C	C		8	Cancer Gene	10	93812004	93812004	30	0.3	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPEB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,93812004,C,C&fts=all">p.D688N</a>
CPLX3	Missense_Mutation	p.E110K	G	G		8	Cancer Gene	15	75122546	75122546	72	0.263888888888889	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPLX3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,75122546,G,G&fts=all">p.E110K</a>
CPPED1	Missense_Mutation	p.A94V	G	G		8	Cancer Gene	16	12875050	12875050	15	0.533333333333333	NA	NA	NA			18	Catalytic.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPPED1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,12875050,G,G&fts=all">p.A94V</a>
CPSF1	Missense_Mutation	p.P530S	G	G		8	Cancer Gene	8	145624219	145624219	144	0.423611111111111	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPSF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,145624219,G,G&fts=all">p.P530S</a>
CPT1C	Splice_Site		G	G		8	Cancer Gene	19	50209165	50209165	93	0.150537634408602	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPT1C&recr=Open">Click here</a>	
CPT1C	Missense_Mutation	p.P371S	C	C		8	Cancer Gene	19	50209312	50209312	24	0.541666666666667	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPT1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50209312,C,C&fts=all">p.P371S</a>
CRB2	Missense_Mutation	p.R275Q	G	G		8	Cancer Gene	9	126129520	126129520	47	0.574468085106383	NA	NA	NA			23	EGF-like 6. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,126129520,G,G&fts=all">p.R275Q</a>
CRB2	Missense_Mutation	p.S1195F	C	C		8	Cancer Gene	9	126137573	126137573	15	0.266666666666667	NA	NA	NA			23	EGF-like 15. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,126137573,C,C&fts=all">p.S1195F</a>
CRELD1	Missense_Mutation	p.R62K	G	G		8	Cancer Gene	3	9976529	9976529	124	0.241935483870968	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRELD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,9976529,G,G&fts=all">p.R62K</a>
CRISP2	Missense_Mutation	p.E230K	C	C		8	Cancer Gene	6	49660530	49660530	183	0.437158469945355	NA	NA	NA			19	ShKT. {ECO:0000255|PROSITE- ProRule:PRU01005}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRISP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,49660530,C,C&fts=all">p.E230K</a>
CRISP2	Missense_Mutation	p.E20K	C	C		8	Cancer Gene	6	49676852	49676852	212	0.216981132075472	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRISP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,49676852,C,C&fts=all">p.E20K</a>
CRISP3	Missense_Mutation	p.K108E	T	T		8	Cancer Gene	6	49701556	49701556	254	0.397637795275591	NA	NA	NA			27	SCP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRISP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,49701556,T,T&fts=all">p.K108E</a>
CRISP3	Splice_Site	p.D38N	C	C		8	Cancer Gene	6	49704220	49704220	331	0.172205438066465	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRISP3&recr=Open">Click here</a>	
CRISPLD1	Splice_Site	p.V391I	G	G		8	Cancer Gene	8	75932148	75932148	354	0.327683615819209	NA	NA	NA			43	LCCL 2. {ECO:0000255|PROSITE- ProRule:PRU00123}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRISPLD1&recr=Open">Click here</a>	
CRYBA1	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRYBA1&recr=Open">Click here</a>	
CSAD	Missense_Mutation	p.S40F	G	G		8	Cancer Gene	12	53567136	53567136	20	0.3	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSAD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,53567136,G,G&fts=all">p.S40F</a>
CSGALNACT1	Missense_Mutation	p.S335Y	G	G		8	Cancer Gene	8	19277979	19277979	338	0.239644970414201	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSGALNACT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,19277979,G,G&fts=all">p.S335Y</a>
CSMD1	Missense_Mutation	p.R3446K	C	C	rs267601885	8	Cancer Gene	8	2806889	2806889	95	0.252631578947368	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2806889,C,C&fts=all">p.R3446K</a>
CSMD1	Missense_Mutation	p.V3386G	A	A		8	Cancer Gene	8	2808683	2808683	40	0.2	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2808683,A,A&fts=all">p.V3386G</a>
CSMD1	Missense_Mutation	p.R3141C	G	G	rs543793837	8	Cancer Gene	8	2820780	2820780	118	0.177966101694915	NA	NA	NA			25	Sushi 25. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2820780,G,G&fts=all">p.R3141C</a>
CSMD1	Missense_Mutation	p.S3118F	G	G		8	Cancer Gene	8	2820848	2820848	158	0.487341772151899	NA	NA	NA		p.S2846Y(1)|p.S3117Y(1)	25	Sushi 25. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2820848,G,G&fts=all">p.S3118F</a>
CSMD1	Missense_Mutation	p.A2880V	G	G		8	Cancer Gene	8	2832077	2832077	19	0.263157894736842	NA	NA	NA			25	Sushi 21. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2832077,G,G&fts=all">p.A2880V</a>
CSMD1	Missense_Mutation	p.S2382F	G	G		8	Cancer Gene	8	2949181	2949181	46	0.195652173913043	NA	NA	NA			25	CUB 14. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2949181,G,G&fts=all">p.S2382F</a>
CSMD1	Missense_Mutation	p.S1188F	G	G		8	Cancer Gene	8	3200887	3200887	97	0.288659793814433	NA	NA	NA			25	CUB 7. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,3200887,G,G&fts=all">p.S1188F</a>
CSMD1	Missense_Mutation	p.P1170L	G	G		8	Cancer Gene	8	3200941	3200941	57	0.228070175438596	NA	NA	NA			25	CUB 7. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,3200941,G,G&fts=all">p.P1170L</a>
CSMD1	Missense_Mutation	p.P948S	G	G		8	Cancer Gene	8	3226836	3226836	40	0.25	NA	NA	NA			25	CUB 6. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,3226836,G,G&fts=all">p.P948S</a>
CSMD1	Missense_Mutation	p.F947Y	A	A		8	Cancer Gene	8	3226838	3226838	38	0.263157894736842	NA	NA	NA			25	CUB 6. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,3226838,A,A&fts=all">p.F947Y</a>
CSMD1	Missense_Mutation	p.E395K	C	C		8	Cancer Gene	8	3443700	3443700	43	0.27906976744186	NA	NA	NA			25	Sushi 2. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,3443700,C,C&fts=all">p.E395K</a>
CSMD1	Splice_Site	p.A204T	C	C		8	Cancer Gene	8	3889427	3889427	31	0.161290322580645	NA	NA	NA			25	Sushi 1. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	
CSMD1	Missense_Mutation	p.P49S	G	G		8	Cancer Gene	8	4495021	4495021	80	0.225	NA	NA	NA			25	CUB 1. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,4495021,G,G&fts=all">p.P49S</a>
CSRNP1	Missense_Mutation	p.P544L	G	G		8	Cancer Gene	3	39184685	39184685	101	0.207920792079208	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSRNP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,39184685,G,G&fts=all">p.P544L</a>
CSRNP3	Missense_Mutation	p.P318L	C	C		8	Cancer Gene	2	166535362	166535362	129	0.124031007751938	NA	NA	NA			33	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSRNP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,166535362,C,C&fts=all">p.P318L</a>
CSRNP3	Missense_Mutation	p.S498L	C	C		8	Cancer Gene	2	166535902	166535902	107	0.355140186915888	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSRNP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,166535902,C,C&fts=all">p.S498L</a>
CST2	Missense_Mutation	p.D61Y	C	C		8	Cancer Gene	20	23807117	23807117	70	0.628571428571429	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CST2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,23807117,C,C&fts=all">p.D61Y</a>
CTNND2	Missense_Mutation	p.D677N	C	C		8	Cancer Gene	5	11159818	11159818	119	0.134453781512605	NA	NA	NA			136			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNND2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,11159818,C,C&fts=all">p.D677N</a>
CTNND2	Missense_Mutation	p.F563S	A	A		8	Cancer Gene	5	11236876	11236876	151	0.205298013245033	NA	NA	NA			136			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNND2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,11236876,A,A&fts=all">p.F563S</a>
CTNND2	Missense_Mutation	p.G494S	C	C	rs34001856	8	Cancer Gene	5	11346632	11346632	75	0.333333333333333	NA	NA	NA			136			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNND2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,11346632,C,C&fts=all">p.G494S</a>
CTNND2	Missense_Mutation	p.S30F	G	G		8	Cancer Gene	5	11732333	11732333	108	0.231481481481481	NA	NA	NA			136			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNND2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,11732333,G,G&fts=all">p.S30F</a>
CTR9	Missense_Mutation	p.R201C	C	C		8	Cancer Gene	11	10781728	10781728	257	0.400778210116732	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTR9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,10781728,C,C&fts=all">p.R201C</a>
CTR9	Missense_Mutation	p.P618L	C	C		8	Cancer Gene	11	10789519	10789519	188	0.457446808510638	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTR9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,10789519,C,C&fts=all">p.P618L</a>
CUBN	Splice_Site		C	C	rs374982220	8	Cancer Gene	10	16870803	16870803	153	0.222222222222222	NA	NA	NA			241			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUBN&recr=Open">Click here</a>	
CUBN	Nonsense_Mutation	p.Q2368*	G	G		8	Cancer Gene	10	16957928	16957928	399	0.0350877192982456	NA	NA	NA			241	CUB 17. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUBN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,16957928,G,G&fts=all">p.Q2368*</a>
CUBN	Missense_Mutation	p.S1999N	C	C		8	Cancer Gene	10	16975214	16975214	137	0.284671532846715	NA	NA	NA			241	CUB 14. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUBN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,16975214,C,C&fts=all">p.S1999N</a>
CWF19L1	Missense_Mutation	p.P201S	G	G	rs146015632	8	Cancer Gene	10	101995440	101995440	183	0.153005464480874	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CWF19L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,101995440,G,G&fts=all">p.P201S</a>
CWF19L1	Missense_Mutation	p.P13S	G	G		8	Cancer Gene	10	102006629	102006629	223	0.242152466367713	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CWF19L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,102006629,G,G&fts=all">p.P13S</a>
CWH43	Missense_Mutation	p.P207L	C	C		8	Cancer Gene	4	48996825	48996825	66	0.378787878787879	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CWH43&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,48996825,C,C&fts=all">p.P207L</a>
CXCR1	Missense_Mutation	p.G294R	C	C		8	Cancer Gene	2	219029055	219029055	63	0.285714285714286	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXCR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219029055,C,C&fts=all">p.G294R</a>
CXCR2	Nonsense_Mutation	p.S353*	C	C		8	Cancer Gene	2	219000582	219000582	102	0.274509803921569	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXCR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219000582,C,C&fts=all">p.S353*</a>
CXorf22	Missense_Mutation	p.L186F	C	C		8	Cancer Gene	X	35966469	35966469	120	0.408333333333333	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXorf22&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,35966469,C,C&fts=all">p.L186F</a>
CXorf22	Missense_Mutation	p.D384N	G	G		8	Cancer Gene	X	35971812	35971812	59	0.949152542372881	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXorf22&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,35971812,G,G&fts=all">p.D384N</a>
CXorf48	Missense_Mutation	p.R173C	G	G		8	Cancer Gene	X	134292144	134292144	76	0.473684210526316	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXorf48&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,134292144,G,G&fts=all">p.R173C</a>
CYB5R4	Missense_Mutation	p.P362S	C	C		8	Cancer Gene	6	84646071	84646071	87	0.32183908045977	NA	NA	NA			23	FAD-binding FR-type. {ECO:0000255|PROSITE-ProRule:PRU00716}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYB5R4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,84646071,C,C&fts=all">p.P362S</a>
CYLC1	Missense_Mutation	p.E417K	G	G		8	Cancer Gene	X	83128965	83128965	23	0.434782608695652	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYLC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,83128965,G,G&fts=all">p.E417K</a>
CYLC1	Missense_Mutation	p.K423N	A	A		8	Cancer Gene	X	83128985	83128985	21	1	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYLC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,83128985,A,A&fts=all">p.K423N</a>
CYP11B1	Missense_Mutation	p.S114L	G	G	rs200318572	8	Cancer Gene	8	143960795	143960795	17	0.235294117647059	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP11B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,143960795,G,G&fts=all">p.S114L</a>
CYP27C1	Missense_Mutation	p.P110L	G	G		8	Cancer Gene	2	127958757	127958757	121	0.28099173553719	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP27C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,127958757,G,G&fts=all">p.P110L</a>
CYP2A13	Missense_Mutation	p.L451F	C	C		8	Cancer Gene	19	41601712	41601712	124	0.17741935483871	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2A13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41601712,C,C&fts=all">p.L451F</a>
CYP8B1	Missense_Mutation	p.S291F	G	G		8	Cancer Gene	3	42916437	42916437	18	0.166666666666667	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP8B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,42916437,G,G&fts=all">p.S291F</a>
CYTH3	Missense_Mutation	p.T289I	G	G		8	Cancer Gene	7	6205399	6205399	114	0.166666666666667	NA	NA	NA			19	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYTH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,6205399,G,G&fts=all">p.T289I</a>
CYTH3	Missense_Mutation	p.R28C	G	G		8	Cancer Gene	7	6230115	6230115	70	0.171428571428571	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYTH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,6230115,G,G&fts=all">p.R28C</a>
CYTH4	Missense_Mutation	p.P202L	C	C		8	Cancer Gene	22	37699352	37699352	57	0.403508771929825	NA	NA	NA			15	SEC7. {ECO:0000255|PROSITE- ProRule:PRU00189}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYTH4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,37699352,C,C&fts=all">p.P202L</a>
CYTIP	Missense_Mutation	p.G155E	C	C		8	Cancer Gene	2	158287083	158287083	97	0.494845360824742	NA	NA	NA			15	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYTIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,158287083,C,C&fts=all">p.G155E</a>
CYTL1	Missense_Mutation	p.V112I	C	C		8	Cancer Gene	4	5016955	5016955	80	0.4125	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYTL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,5016955,C,C&fts=all">p.V112I</a>
DAB1	Missense_Mutation	p.R76C	G	G		8	Cancer Gene	1	57602296	57602296	101	0.316831683168317	NA	NA	NA			64	PID. {ECO:0000255|PROSITE- ProRule:PRU00148}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,57602296,G,G&fts=all">p.R76C</a>
DAB2IP	Missense_Mutation	p.S59F	C	C		8	Cancer Gene	9	124521208	124521208	15	0.2	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAB2IP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,124521208,C,C&fts=all">p.S59F</a>
DACH1	Missense_Mutation	p.P556L	G	G		8	Cancer Gene	13	72063190	72063190	232	0.301724137931034	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DACH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,72063190,G,G&fts=all">p.P556L</a>
DACH1	Missense_Mutation	p.G486E	C	C		8	Cancer Gene	13	72131275	72131275	128	0.328125	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DACH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,72131275,C,C&fts=all">p.G486E</a>
DACH1	Splice_Site		C	C		8	Cancer Gene	13	72146971	72146971	129	0.24031007751938	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DACH1&recr=Open">Click here</a>	
DACH1	Missense_Mutation	p.S300F	G	G		8	Cancer Gene	13	72255998	72255998	88	0.306818181818182	NA	NA	NA			41	Interaction with SIX6 and HDAC3. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DACH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,72255998,G,G&fts=all">p.S300F</a>
DACH2	Missense_Mutation	p.S260G	A	A		8	Cancer Gene	X	85950029	85950029	47	0.468085106382979	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DACH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,85950029,A,A&fts=all">p.S260G</a>
DACH2	Missense_Mutation	p.E522K	G	G		8	Cancer Gene	X	86069717	86069717	80	0.8625	NA	NA	NA			71	DACHbox-C.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DACH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,86069717,G,G&fts=all">p.E522K</a>
DACH2	Splice_Site		A	A		8	Cancer Gene	X	86087107	86087107	42	0.357142857142857	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DACH2&recr=Open">Click here</a>	
DBH	Missense_Mutation	p.L160F	C	C		8	Cancer Gene	9	136505106	136505106	15	0.333333333333333	NA	NA	NA			36	DOMON. {ECO:0000255|PROSITE- ProRule:PRU00246}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DBH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,136505106,C,C&fts=all">p.L160F</a>
DCAF12L1	Missense_Mutation	p.T206P	T	T		8	Cancer Gene	X	125685976	125685976	15	0.8	NA	NA	NA			68			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCAF12L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,125685976,T,T&fts=all">p.T206P</a>
DCAF12L1	Missense_Mutation	p.R49C	G	G		8	Cancer Gene	X	125686447	125686447	21	0.380952380952381	NA	NA	NA			68			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCAF12L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,125686447,G,G&fts=all">p.R49C</a>
DCAF13	Missense_Mutation	p.R255C	C	C		8	Cancer Gene	8	104433239	104433239	345	0.414492753623188	NA	NA	NA		p.R255S(1)	25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCAF13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,104433239,C,C&fts=all">p.R255C</a>
DCAF17	Missense_Mutation	p.P269L	C	C		8	Cancer Gene	2	172314955	172314955	266	0.31203007518797	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCAF17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,172314955,C,C&fts=all">p.P269L</a>
DCHS2	Missense_Mutation	p.D2755N	C	C		8	Cancer Gene	4	155156176	155156176	77	0.324675324675325	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCHS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155156176,C,C&fts=all">p.D2755N</a>
DCHS2	Missense_Mutation	p.M2501I	C	C		8	Cancer Gene	4	155156936	155156936	187	0.224598930481283	NA	NA	NA			176	Cadherin 22. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCHS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155156936,C,C&fts=all">p.M2501I</a>
DCHS2	Missense_Mutation	p.A2485V	G	G		8	Cancer Gene	4	155156985	155156985	162	0.216049382716049	NA	NA	NA			176	Cadherin 22. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCHS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155156985,G,G&fts=all">p.A2485V</a>
DCHS2	Missense_Mutation	p.E2420K	C	C		8	Cancer Gene	4	155157181	155157181	235	0.280851063829787	NA	NA	NA			176	Cadherin 21. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCHS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155157181,C,C&fts=all">p.E2420K</a>
DCHS2	Missense_Mutation	p.R2028K	C	C		8	Cancer Gene	4	155160366	155160366	113	0.345132743362832	NA	NA	NA			176	Cadherin 18. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCHS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155160366,C,C&fts=all">p.R2028K</a>
DCHS2	Missense_Mutation	p.P1587L	G	G	rs371079845	8	Cancer Gene	4	155219341	155219341	156	0.230769230769231	NA	NA	NA			176	Cadherin 14. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCHS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155219341,G,G&fts=all">p.P1587L</a>
DCHS2	Missense_Mutation	p.G924R	C	C		8	Cancer Gene	4	155243524	155243524	157	0.515923566878981	NA	NA	NA			176	Cadherin 7. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCHS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155243524,C,C&fts=all">p.G924R</a>
DCHS2	Missense_Mutation	p.A151V	G	G		8	Cancer Gene	4	155295082	155295082	177	0.27683615819209	NA	NA	NA			176	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCHS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155295082,G,G&fts=all">p.A151V</a>
DCLK3	Missense_Mutation	p.G197R	C	C		8	Cancer Gene	3	36779562	36779562	76	0.434210526315789	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCLK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,36779562,C,C&fts=all">p.G197R</a>
DDX31	Missense_Mutation	p.S848F	G	G		8	Cancer Gene	9	135470266	135470266	167	0.287425149700599	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,135470266,G,G&fts=all">p.S848F</a>
DDX31	Nonsense_Mutation	p.R687*	G	G		8	Cancer Gene	9	135493798	135493798	128	0.3046875	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,135493798,G,G&fts=all">p.R687*</a>
DDX51	Missense_Mutation	p.S453F	G	G		8	Cancer Gene	12	132625458	132625458	99	0.505050505050505	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX51&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,132625458,G,G&fts=all">p.S453F</a>
DDX54	Missense_Mutation	p.T498I	G	G		8	Cancer Gene	12	113603759	113603759	49	0.551020408163265	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX54&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,113603759,G,G&fts=all">p.T498I</a>
DDX60	Missense_Mutation	p.N1710S	T	T		8	Cancer Gene	4	169138094	169138094	128	0.5546875	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX60&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,169138094,T,T&fts=all">p.N1710S</a>
DDX60	Nonsense_Mutation	p.R1028*	G	G		8	Cancer Gene	4	169183896	169183896	246	0.284552845528455	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX60&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,169183896,G,G&fts=all">p.R1028*</a>
DEFB112	Missense_Mutation	p.D91N	C	C	rs267601067	8	Cancer Gene	6	50011359	50011359	193	0.196891191709845	NA	NA	NA		p.D91N(2)	19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEFB112&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,50011359,C,C&fts=all">p.D91N</a>
DENND1A	Missense_Mutation	p.L132F	G	G		8	Cancer Gene	9	126433629	126433629	265	0.249056603773585	NA	NA	NA			43	DENN. {ECO:0000255|PROSITE- ProRule:PRU00304}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DENND1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,126433629,G,G&fts=all">p.L132F</a>
DENND2A	Missense_Mutation	p.P124L	G	G		8	Cancer Gene	7	140301827	140301827	134	0.776119402985075	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DENND2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,140301827,G,G&fts=all">p.P124L</a>
DENND4C	Missense_Mutation	p.R1694C	C	C		8	Cancer Gene	9	19360308	19360308	297	0.434343434343434	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DENND4C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,19360308,C,C&fts=all">p.R1694C</a>
DGAT2L6	Missense_Mutation	p.R74Q	G	G		8	Cancer Gene	X	69419686	69419686	31	0.354838709677419	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGAT2L6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,69419686,G,G&fts=all">p.R74Q</a>
DGAT2L6	Missense_Mutation	p.R83Q	G	G	rs140805163	8	Cancer Gene	X	69419713	69419713	37	0.891891891891892	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGAT2L6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,69419713,G,G&fts=all">p.R83Q</a>
DGKB	Missense_Mutation	p.S594F	G	G		8	Cancer Gene	7	14517843	14517843	50	0.5	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,14517843,G,G&fts=all">p.S594F</a>
DGKB	Missense_Mutation	p.G575E	C	C		8	Cancer Gene	7	14613886	14613886	402	0.199004975124378	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,14613886,C,C&fts=all">p.G575E</a>
DGKB	Missense_Mutation	p.G473E	C	C	rs533895069	8	Cancer Gene	7	14647077	14647077	205	0.209756097560976	NA	NA	NA			72	DAGKc. {ECO:0000255|PROSITE- ProRule:PRU00783}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,14647077,C,C&fts=all">p.G473E</a>
DGKB	Missense_Mutation	p.E453V	T	T		8	Cancer Gene	7	14652968	14652968	24	0.5	NA	NA	NA			72	DAGKc. {ECO:0000255|PROSITE- ProRule:PRU00783}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,14652968,T,T&fts=all">p.E453V</a>
DGKB	Missense_Mutation	p.S384L	G	G		8	Cancer Gene	7	14669880	14669880	27	0.222222222222222	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,14669880,G,G&fts=all">p.S384L</a>
DGKB	Missense_Mutation	p.D170N	C	C		8	Cancer Gene	7	14741314	14741314	148	0.162162162162162	NA	NA	NA			72	EF-hand 1. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,14741314,C,C&fts=all">p.D170N</a>
DGKG	Splice_Site	p.E199K	C	C		8	Cancer Gene	3	185998533	185998533	47	0.170212765957447	NA	NA	NA			42	EF-hand 1. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKG&recr=Open">Click here</a>	
DGKG	Missense_Mutation	p.R185C	G	G		8	Cancer Gene	3	186002490	186002490	68	0.294117647058824	NA	NA	NA			42	EF-hand 1. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,186002490,G,G&fts=all">p.R185C</a>
DGKH	Missense_Mutation	p.P1147L	C	C		8	Cancer Gene	13	42793928	42793928	122	0.336065573770492	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,42793928,C,C&fts=all">p.P1147L</a>
DHDH	Missense_Mutation	p.E133K	G	G		8	Cancer Gene	19	49442736	49442736	270	0.5	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHDH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49442736,G,G&fts=all">p.E133K</a>
DHDH	Missense_Mutation	p.L158F	C	C	rs554003656	8	Cancer Gene	19	49442811	49442811	93	0.365591397849462	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHDH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49442811,C,C&fts=all">p.L158F</a>
DHX32	Nonsense_Mutation	p.G478*	C	C		8	Cancer Gene	10	127530423	127530423	167	0.431137724550898	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX32&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,127530423,C,C&fts=all">p.G478*</a>
DHX35	Nonsense_Mutation	p.Q89*	C	C		8	Cancer Gene	20	37601292	37601292	142	0.0915492957746479	NA	NA	NA			40	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX35&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,37601292,C,C&fts=all">p.Q89*</a>
DHX37	Missense_Mutation	p.P511S	G	G		8	Cancer Gene	12	125441669	125441669	71	0.549295774647887	NA	NA	NA			65	Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX37&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,125441669,G,G&fts=all">p.P511S</a>
DHX37	Missense_Mutation	p.P464L	G	G		8	Cancer Gene	12	125448955	125448955	58	0.327586206896552	NA	NA	NA			65	Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX37&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,125448955,G,G&fts=all">p.P464L</a>
DIRC1	Missense_Mutation	p.C49S	A	A		8	Cancer Gene	2	189599503	189599503	255	0.309803921568627	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIRC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,189599503,A,A&fts=all">p.C49S</a>
DIS3L2	Missense_Mutation	p.P88S	C	C		8	Cancer Gene	2	232889038	232889038	238	0.491596638655462	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIS3L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,232889038,C,C&fts=all">p.P88S</a>
DIS3L2	Missense_Mutation	p.P602L	C	C		8	Cancer Gene	2	233194588	233194588	20	0.3	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIS3L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,233194588,C,C&fts=all">p.P602L</a>
DISP2	Nonsense_Mutation	p.W844*	G	G		8	Cancer Gene	15	40660844	40660844	29	0.448275862068966	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DISP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,40660844,G,G&fts=all">p.W844*</a>
DLL3	Missense_Mutation	p.G280E	G	G		8	Cancer Gene	19	39994897	39994897	94	0.457446808510638	NA	NA	NA			19	EGF-like 2. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39994897,G,G&fts=all">p.G280E</a>
DLL4	Missense_Mutation	p.E438K	G	G		8	Cancer Gene	15	41228497	41228497	15	0.2	NA	NA	NA			4	EGF-like 6. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,41228497,G,G&fts=all">p.E438K</a>
DMBX1	Missense_Mutation	p.S142F	C	C		8	Cancer Gene	1	46976698	46976698	45	0.0888888888888889	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMBX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,46976698,C,C&fts=all">p.S142F</a>
DMP1	Missense_Mutation	p.D377N	G	G		8	Cancer Gene	4	88584059	88584059	133	0.172932330827068	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,88584059,G,G&fts=all">p.D377N</a>
DMRTA1	Missense_Mutation	p.P338S	C	C		8	Cancer Gene	9	22451407	22451407	60	0.9	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMRTA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,22451407,C,C&fts=all">p.P338S</a>
DNAH10	Missense_Mutation	p.H733Y	C	C		8	Cancer Gene	12	124285916	124285916	217	0.645161290322581	NA	NA	NA			52	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,124285916,C,C&fts=all">p.H733Y</a>
DNAH10	Missense_Mutation	p.E805K	G	G		8	Cancer Gene	12	124288360	124288360	211	0.549763033175355	NA	NA	NA			52	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,124288360,G,G&fts=all">p.E805K</a>
DNAH10	Missense_Mutation	p.M936I	G	G		8	Cancer Gene	12	124297728	124297728	91	0.56043956043956	NA	NA	NA			52	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,124297728,G,G&fts=all">p.M936I</a>
DNAH10	Missense_Mutation	p.R1313C	C	C		8	Cancer Gene	12	124311345	124311345	121	0.272727272727273	NA	NA	NA		p.R1313C(1)	52	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,124311345,C,C&fts=all">p.R1313C</a>
DNAH10	Missense_Mutation	p.A1659T	G	G		8	Cancer Gene	12	124326061	124326061	58	0.310344827586207	NA	NA	NA			52	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,124326061,G,G&fts=all">p.A1659T</a>
DNAH10	Missense_Mutation	p.G2117R	G	G		8	Cancer Gene	12	124343769	124343769	57	0.280701754385965	NA	NA	NA			52	AAA 2. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,124343769,G,G&fts=all">p.G2117R</a>
DNAH10	Nonsense_Mutation	p.W2409*	G	G		8	Cancer Gene	12	124354973	124354973	66	0.136363636363636	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,124354973,G,G&fts=all">p.W2409*</a>
DNAH17	Missense_Mutation	p.A3457T	C	C		8	Cancer Gene	17	76450574	76450574	26	0.653846153846154	NA	NA	NA			116	AAA 5. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,76450574,C,C&fts=all">p.A3457T</a>
DNAH17	Missense_Mutation	p.E2886K	C	C		8	Cancer Gene	17	76464806	76464806	91	0.274725274725275	NA	NA	NA			116	AAA 4. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,76464806,C,C&fts=all">p.E2886K</a>
DNAH17	Missense_Mutation	p.V2865M	C	C		8	Cancer Gene	17	76464869	76464869	100	0.49	NA	NA	NA			116	AAA 4. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,76464869,C,C&fts=all">p.V2865M</a>
DNAH17	Missense_Mutation	p.S2611L	G	G	rs200775409	8	Cancer Gene	17	76475620	76475620	73	0.0958904109589041	NA	NA	NA			116	AAA 3. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,76475620,G,G&fts=all">p.S2611L</a>
DNAH17	Missense_Mutation	p.M1748I	C	C		8	Cancer Gene	17	76497893	76497893	94	0.212765957446809	NA	NA	NA			116	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,76497893,C,C&fts=all">p.M1748I</a>
DNAH17	Missense_Mutation	p.F1575I	A	A		8	Cancer Gene	17	76502873	76502873	107	0.158878504672897	NA	NA	NA			116	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,76502873,A,A&fts=all">p.F1575I</a>
DNAH2	Missense_Mutation	p.H196Y	C	C		8	Cancer Gene	17	7636591	7636591	108	0.175925925925926	NA	NA	NA			189	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7636591,C,C&fts=all">p.H196Y</a>
DNAH2	Missense_Mutation	p.E2161K	G	G		8	Cancer Gene	17	7690229	7690229	34	0.205882352941176	NA	NA	NA			189	AAA 2. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7690229,G,G&fts=all">p.E2161K</a>
DNAH8	Missense_Mutation	p.E348K	G	G		8	Cancer Gene	6	38738264	38738264	141	0.177304964539007	NA	NA	NA			260			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,38738264,G,G&fts=all">p.E348K</a>
DNAH8	Missense_Mutation	p.E830K	G	G		8	Cancer Gene	6	38773361	38773361	56	0.232142857142857	NA	NA	NA			260			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,38773361,G,G&fts=all">p.E830K</a>
DNAH8	Missense_Mutation	p.R1085Q	G	G	rs267601013	8	Cancer Gene	6	38793989	38793989	87	0.103448275862069	NA	NA	NA		p.R1085Q(2)	260			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,38793989,G,G&fts=all">p.R1085Q</a>
DNAH8	Missense_Mutation	p.E1446K	G	G		8	Cancer Gene	6	38813491	38813491	202	0.232673267326733	NA	NA	NA			260			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,38813491,G,G&fts=all">p.E1446K</a>
DNAH8	Missense_Mutation	p.L1963P	T	T		8	Cancer Gene	6	38834407	38834407	157	0.248407643312102	NA	NA	NA			260	AAA 1. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,38834407,T,T&fts=all">p.L1963P</a>
DNAH8	Missense_Mutation	p.G2514E	G	G		8	Cancer Gene	6	38851707	38851707	181	0.215469613259669	NA	NA	NA			260	AAA 3. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,38851707,G,G&fts=all">p.G2514E</a>
DNAH8	Nonsense_Mutation	p.W4336*	G	G		8	Cancer Gene	6	38980357	38980357	310	0.241935483870968	NA	NA	NA			260			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,38980357,G,G&fts=all">p.W4336*</a>
DNAH8	Splice_Site	p.G4395E	G	G	rs371583300	8	Cancer Gene	6	38994442	38994442	83	0.578313253012048	NA	NA	NA			260			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	
DNAI2	Missense_Mutation	p.G474E	G	G		8	Cancer Gene	17	72306229	72306229	33	0.242424242424242	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72306229,G,G&fts=all">p.G474E</a>
DNAI2	Missense_Mutation	p.G588E	G	G		8	Cancer Gene	17	72310300	72310300	20	0.3	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72310300,G,G&fts=all">p.G588E</a>
DNAJB11	Missense_Mutation	p.P223S	C	C		8	Cancer Gene	3	186299851	186299851	119	0.218487394957983	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJB11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,186299851,C,C&fts=all">p.P223S</a>
DNAJB8	Missense_Mutation	p.G106D	C	C	rs141309633	8	Cancer Gene	3	128181772	128181772	27	0.333333333333333	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJB8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,128181772,C,C&fts=all">p.G106D</a>
DNAJC16	Missense_Mutation	p.P247S	C	C		8	Cancer Gene	1	15871058	15871058	228	0.0350877192982456	NA	NA	NA			18	Thioredoxin. {ECO:0000255|PROSITE- ProRule:PRU00691}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,15871058,C,C&fts=all">p.P247S</a>
DNAJC21	Missense_Mutation	p.E230V	A	A		8	Cancer Gene	5	34937681	34937681	200	0.145	NA	NA	NA			21	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJC21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,34937681,A,A&fts=all">p.E230V</a>
DNAL4	Missense_Mutation	p.D62N	C	C		8	Cancer Gene	22	39175588	39175588	21	0.142857142857143	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,39175588,C,C&fts=all">p.D62N</a>
DOCK3	Nonsense_Mutation	p.W1922*	G	G		8	Cancer Gene	3	51418663	51418663	69	0.260869565217391	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,51418663,G,G&fts=all">p.W1922*</a>
DOCK3	Missense_Mutation	p.E1926K	G	G		8	Cancer Gene	3	51418673	51418673	80	0.1625	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,51418673,G,G&fts=all">p.E1926K</a>
DOCK4	Missense_Mutation	p.P1929L	G	G		8	Cancer Gene	7	111368445	111368445	26	0.769230769230769	NA	NA	NA			72	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,111368445,G,G&fts=all">p.P1929L</a>
DOCK7	Missense_Mutation	p.G1924R	C	C		8	Cancer Gene	1	62941476	62941476	290	0.924137931034483	NA	NA	NA			92	DHR-2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62941476,C,C&fts=all">p.G1924R</a>
DOCK7	Nonsense_Mutation	p.R755*	G	G		8	Cancer Gene	1	63024828	63024828	138	0.369565217391304	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,63024828,G,G&fts=all">p.R755*</a>
DOCK7	Missense_Mutation	p.S728L	G	G		8	Cancer Gene	1	63027304	63027304	388	0.52319587628866	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,63027304,G,G&fts=all">p.S728L</a>
DOCK9	Missense_Mutation	p.S210F	G	G		8	Cancer Gene	13	99573296	99573296	38	0.368421052631579	NA	NA	NA			59	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,99573296,G,G&fts=all">p.S210F</a>
DOK4	Missense_Mutation	p.T300I	G	G		8	Cancer Gene	16	57507371	57507371	28	0.321428571428571	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,57507371,G,G&fts=all">p.T300I</a>
DOK5	Missense_Mutation	p.S244L	C	C		8	Cancer Gene	20	53227058	53227058	62	0.32258064516129	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,53227058,C,C&fts=all">p.S244L</a>
DPEP3	Missense_Mutation	p.G148S	C	C		8	Cancer Gene	16	68013589	68013589	40	0.25	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPEP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,68013589,C,C&fts=all">p.G148S</a>
DPEP3	Missense_Mutation	p.R108C	G	G		8	Cancer Gene	16	68014037	68014037	67	0.477611940298507	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPEP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,68014037,G,G&fts=all">p.R108C</a>
DPP10	Missense_Mutation	p.G252E	G	G		8	Cancer Gene	2	116497360	116497360	168	0.357142857142857	NA	NA	NA			101			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPP10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,116497360,G,G&fts=all">p.G252E</a>
DPP10	Missense_Mutation	p.S424L	C	C		8	Cancer Gene	2	116534821	116534821	136	0.286764705882353	NA	NA	NA			101			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPP10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,116534821,C,C&fts=all">p.S424L</a>
DPP10	Missense_Mutation	p.S471L	C	C		8	Cancer Gene	2	116538488	116538488	349	0.306590257879656	NA	NA	NA			101			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPP10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,116538488,C,C&fts=all">p.S471L</a>
DPPA3	Missense_Mutation	p.R82K	G	G		8	Cancer Gene	12	7867941	7867941	22	0.272727272727273	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPPA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7867941,G,G&fts=all">p.R82K</a>
DPY19L1	Missense_Mutation	p.S268L	G	G		8	Cancer Gene	7	35006576	35006576	259	0.0540540540540541	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPY19L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,35006576,G,G&fts=all">p.S268L</a>
DPY19L4	Missense_Mutation	p.P319S	C	C		8	Cancer Gene	8	95777495	95777495	583	0.0428816466552316	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPY19L4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,95777495,C,C&fts=all">p.P319S</a>
DRD5	Missense_Mutation	p.E429K	G	G	rs372758943	8	Cancer Gene	4	9784938	9784938	32	0.4375	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DRD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,9784938,G,G&fts=all">p.E429K</a>
DSC1	Missense_Mutation	p.S736L	G	G		8	Cancer Gene	18	28712562	28712562	168	0.363095238095238	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,28712562,G,G&fts=all">p.S736L</a>
DSC1	Missense_Mutation	p.D237N	C	C	rs267605151	8	Cancer Gene	18	28728524	28728524	147	0.0680272108843537	NA	NA	NA		p.D237Y(2)	53	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,28728524,C,C&fts=all">p.D237N</a>
DSC1	Missense_Mutation	p.F92L	A	A		8	Cancer Gene	18	28737409	28737409	55	0.727272727272727	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,28737409,A,A&fts=all">p.F92L</a>
DSCAML1	Missense_Mutation	p.P535S	G	G		8	Cancer Gene	11	117389268	117389268	40	0.475	NA	NA	NA			110	Ig-like C2-type 6.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCAML1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,117389268,G,G&fts=all">p.P535S</a>
DSEL	Missense_Mutation	p.S1185L	G	G		8	Cancer Gene	18	65178322	65178322	68	0.382352941176471	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSEL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,65178322,G,G&fts=all">p.S1185L</a>
DSEL	Missense_Mutation	p.M963I	C	C		8	Cancer Gene	18	65178987	65178987	93	0.376344086021505	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSEL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,65178987,C,C&fts=all">p.M963I</a>
DSEL	Missense_Mutation	p.N483D	T	T		8	Cancer Gene	18	65180429	65180429	91	0.428571428571429	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSEL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,65180429,T,T&fts=all">p.N483D</a>
DSG4	Missense_Mutation	p.E31K	G	G		8	Cancer Gene	18	28966657	28966657	103	0.864077669902913	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSG4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,28966657,G,G&fts=all">p.E31K</a>
DTNA	Missense_Mutation	p.R8K	G	G		8	Cancer Gene	18	32335963	32335963	48	0.354166666666667	NA	NA	NA			29	Interaction with MAGEE1. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DTNA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,32335963,G,G&fts=all">p.R8K</a>
DUPD1	Missense_Mutation	p.D115N	C	C		8	Cancer Gene	10	76803633	76803633	91	0.21978021978022	NA	NA	NA			11	Tyrosine-protein phosphatase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUPD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,76803633,C,C&fts=all">p.D115N</a>
DUSP19	Missense_Mutation	p.G51A	G	G		8	Cancer Gene	2	183943813	183943813	126	0.30952380952381	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,183943813,G,G&fts=all">p.G51A</a>
DUSP22	Missense_Mutation	p.T117I	C	C		8	Cancer Gene	6	348189	348189	148	0.148648648648649	NA	NA	NA			26	Tyrosine-protein phosphatase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP22&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,348189,C,C&fts=all">p.T117I</a>
DUSP26	Missense_Mutation	p.R27Q	C	C	rs200165319	8	Cancer Gene	8	33454954	33454954	62	0.193548387096774	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,33454954,C,C&fts=all">p.R27Q</a>
DUXA	Missense_Mutation	p.G179E	C	C		8	Cancer Gene	19	57666643	57666643	67	0.134328358208955	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUXA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57666643,C,C&fts=all">p.G179E</a>
DUXA	Nonsense_Mutation	p.Q91*	G	G		8	Cancer Gene	19	57670556	57670556	104	0.211538461538462	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUXA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57670556,G,G&fts=all">p.Q91*</a>
DYDC1	Missense_Mutation	p.E42V	T	T		8	Cancer Gene	10	82112233	82112233	173	0.439306358381503	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,82112233,T,T&fts=all">p.E42V</a>
DYSF	Missense_Mutation	p.S1956F	C	C		8	Cancer Gene	2	71901409	71901409	78	0.153846153846154	NA	NA	NA			111			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYSF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,71901409,C,C&fts=all">p.S1956F</a>
DYTN	Missense_Mutation	p.P385L	G	G		8	Cancer Gene	2	207528106	207528106	42	0.357142857142857	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,207528106,G,G&fts=all">p.P385L</a>
DYTN	Missense_Mutation	p.C352R	A	A		8	Cancer Gene	2	207530680	207530680	97	0.247422680412371	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,207530680,A,A&fts=all">p.C352R</a>
E2F6	Missense_Mutation	p.P261L	G	G		8	Cancer Gene	2	11587770	11587770	281	0.284697508896797	NA	NA	NA			8	Transcription repression.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+E2F6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,11587770,G,G&fts=all">p.P261L</a>
EBF3	Missense_Mutation	p.P263S	G	G		8	Cancer Gene	10	131666171	131666171	42	0.261904761904762	NA	NA	NA			44	IPT/TIG.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EBF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,131666171,G,G&fts=all">p.P263S</a>
EEA1	Missense_Mutation	p.D450N	C	C		8	Cancer Gene	12	93221744	93221744	249	0.417670682730924	NA	NA	NA			36	Gln/Glu/Lys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EEA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,93221744,C,C&fts=all">p.D450N</a>
EFCAB5	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFCAB5&recr=Open">Click here</a>	
EFHC1	Missense_Mutation	p.G486D	G	G		8	Cancer Gene	6	52344013	52344013	278	0.661870503597122	NA	NA	NA			27	DM10 3. {ECO:0000255|PROSITE- ProRule:PRU00665}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFHC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,52344013,G,G&fts=all">p.G486D</a>
EFR3A	Missense_Mutation	p.I584V	A	A		8	Cancer Gene	8	132997188	132997188	71	0.154929577464789	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFR3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,132997188,A,A&fts=all">p.I584V</a>
EGFLAM	Missense_Mutation	p.E74K	G	G		8	Cancer Gene	5	38338812	38338812	57	0.210526315789474	NA	NA	NA			85	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGFLAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38338812,G,G&fts=all">p.E74K</a>
EGFLAM	Missense_Mutation	p.M198I	G	G		8	Cancer Gene	5	38370446	38370446	87	0.310344827586207	NA	NA	NA			85	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGFLAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38370446,G,G&fts=all">p.M198I</a>
EGFLAM	Missense_Mutation	p.P208S	C	C		8	Cancer Gene	5	38370474	38370474	59	0.135593220338983	NA	NA	NA			85	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGFLAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38370474,C,C&fts=all">p.P208S</a>
EGFLAM	Missense_Mutation	p.S405F	C	C		8	Cancer Gene	5	38407973	38407973	172	0.168604651162791	NA	NA	NA		p.S405Y(1)	85	Laminin G-like 1. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGFLAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38407973,C,C&fts=all">p.S405F</a>
EGFLAM	Missense_Mutation	p.S992F	C	C		8	Cancer Gene	5	38464033	38464033	64	0.171875	NA	NA	NA			85	Laminin G-like 3. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGFLAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38464033,C,C&fts=all">p.S992F</a>
EHBP1L1	Missense_Mutation	p.S914F	C	C		8	Cancer Gene	11	65350884	65350884	27	0.851851851851852	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EHBP1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,65350884,C,C&fts=all">p.S914F</a>
EHMT1	Missense_Mutation	p.K636M	A	A		8	Cancer Gene	9	140671185	140671185	90	0.677777777777778	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EHMT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,140671185,A,A&fts=all">p.K636M</a>
EIF4G3	Missense_Mutation	p.V700E	A	A		8	Cancer Gene	1	21220014	21220014	193	0.476683937823834	NA	NA	NA			70	eIF3/EIF4A-binding. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF4G3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,21220014,A,A&fts=all">p.V700E</a>
EIF4G3	Missense_Mutation	p.L241F	G	G		8	Cancer Gene	1	21268776	21268776	218	0.527522935779816	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF4G3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,21268776,G,G&fts=all">p.L241F</a>
ELMOD2	Nonsense_Mutation	p.R15*	C	C		8	Cancer Gene	4	141446625	141446625	466	0.246781115879828	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELMOD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,141446625,C,C&fts=all">p.R15*</a>
EMB	Missense_Mutation	p.E99K	C	C		8	Cancer Gene	5	49706738	49706738	83	0.349397590361446	NA	NA	NA			15	Ig-like V-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,49706738,C,C&fts=all">p.E99K</a>
EMCN	Missense_Mutation	p.S122F	G	G		8	Cancer Gene	4	101386591	101386591	237	0.594936708860759	NA	NA	NA		p.S122Y(1)	13	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,101386591,G,G&fts=all">p.S122F</a>
EMILIN2	Missense_Mutation	p.G481E	G	G		8	Cancer Gene	18	2891567	2891567	113	0.345132743362832	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMILIN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,2891567,G,G&fts=all">p.G481E</a>
EML5	Missense_Mutation	p.P607L	G	G		8	Cancer Gene	14	89172608	89172608	143	0.300699300699301	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EML5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,89172608,G,G&fts=all">p.P607L</a>
EML5	Missense_Mutation	p.R188Q	C	C		8	Cancer Gene	14	89206879	89206879	210	0.638095238095238	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EML5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,89206879,C,C&fts=all">p.R188Q</a>
ENAM	Missense_Mutation	p.P580S	C	C		8	Cancer Gene	4	71508881	71508881	260	0.692307692307692	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,71508881,C,C&fts=all">p.P580S</a>
ENAM	Missense_Mutation	p.E756K	G	G		8	Cancer Gene	4	71509409	71509409	91	0.318681318681319	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,71509409,G,G&fts=all">p.E756K</a>
ENGASE	Missense_Mutation	p.R228C	C	C		8	Cancer Gene	17	77076405	77076405	54	0.333333333333333	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENGASE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,77076405,C,C&fts=all">p.R228C</a>
ENPP3	Missense_Mutation	p.G65E	G	G		8	Cancer Gene	6	131971206	131971206	168	0.404761904761905	NA	NA	NA		p.G65V(1)	53	SMB 1. {ECO:0000255|PROSITE- ProRule:PRU00350}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,131971206,G,G&fts=all">p.G65E</a>
ENPP3	Missense_Mutation	p.D72N	G	G		8	Cancer Gene	6	131971226	131971226	211	0.421800947867299	NA	NA	NA			53	SMB 1. {ECO:0000255|PROSITE- ProRule:PRU00350}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,131971226,G,G&fts=all">p.D72N</a>
ENPP3	Splice_Site	p.S472R	A	A		8	Cancer Gene	6	132039813	132039813	205	0.253658536585366	NA	NA	NA			53	Phosphodiesterase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPP3&recr=Open">Click here</a>	
ENTPD4	Missense_Mutation	p.L520F	G	G		8	Cancer Gene	8	23291870	23291870	198	0.242424242424242	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENTPD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,23291870,G,G&fts=all">p.L520F</a>
EP400	Missense_Mutation	p.P2238L	C	C		8	Cancer Gene	12	132529427	132529427	66	0.333333333333333	NA	NA	NA		p.P2237L(1)	161			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EP400&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,132529427,C,C&fts=all">p.P2238L</a>
EP400	Missense_Mutation	p.S2660F	C	C		8	Cancer Gene	12	132546749	132546749	74	0.567567567567568	NA	NA	NA			161	Interaction with ZNF42. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EP400&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,132546749,C,C&fts=all">p.S2660F</a>
EPHA6	Missense_Mutation	p.R275T	G	G		8	Cancer Gene	3	96706547	96706547	202	0.381188118811881	NA	NA	NA			101			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,96706547,G,G&fts=all">p.R275T</a>
EPHX4	Missense_Mutation	p.E115K	G	G		8	Cancer Gene	1	92508405	92508405	165	0.448484848484848	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,92508405,G,G&fts=all">p.E115K</a>
EPPK1	Missense_Mutation	p.R1461K	C	C		8	Cancer Gene	8	144943040	144943040	20	0.25	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPPK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,144943040,C,C&fts=all">p.R1461K</a>
ERAP1	Missense_Mutation	p.S553F	G	G		8	Cancer Gene	5	96124255	96124255	172	0.412790697674419	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,96124255,G,G&fts=all">p.S553F</a>
ERI3	Missense_Mutation	p.T30I	G	G		8	Cancer Gene	1	44820610	44820610	48	0.9375	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERI3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,44820610,G,G&fts=all">p.T30I</a>
ERMN	Missense_Mutation	p.H210Q	A	A		8	Cancer Gene	2	158178008	158178008	142	0.23943661971831	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERMN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,158178008,A,A&fts=all">p.H210Q</a>
ERN2	Missense_Mutation	p.I537N	A	A		8	Cancer Gene	16	23706555	23706555	46	0.304347826086957	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,23706555,A,A&fts=all">p.I537N</a>
ERN2	Nonsense_Mutation	p.L101*	A	A		8	Cancer Gene	16	23721497	23721497	39	0.358974358974359	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,23721497,A,A&fts=all">p.L101*</a>
ERP27	Missense_Mutation	p.E2K	C	C		8	Cancer Gene	12	15091439	15091439	25	0.16	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERP27&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,15091439,C,C&fts=all">p.E2K</a>
ESF1	Missense_Mutation	p.R15Q	C	C	rs552526994	8	Cancer Gene	20	13763743	13763743	319	0.313479623824451	NA	NA	NA		p.R15L(1)	31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,13763743,C,C&fts=all">p.R15Q</a>
ESRP1	Missense_Mutation	p.V477A	T	T		8	Cancer Gene	8	95683877	95683877	83	0.192771084337349	NA	NA	NA			20	RRM 3. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESRP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,95683877,T,T&fts=all">p.V477A</a>
ESYT2	Missense_Mutation	p.S833L	G	G		8	Cancer Gene	7	158528282	158528282	81	0.160493827160494	NA	NA	NA			32	C2 3. {ECO:0000255|PROSITE- ProRule:PRU00041}.|Required for phosphatidylinositol 4,5- bisphosphate-dependent location at the cell membrane.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESYT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,158528282,G,G&fts=all">p.S833L</a>
EVC	Missense_Mutation	p.T75I	C	C		8	Cancer Gene	4	5721024	5721024	119	0.378151260504202	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EVC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,5721024,C,C&fts=all">p.T75I</a>
EXD1	Nonsense_Mutation	p.K282*	T	T		8	Cancer Gene	15	41483660	41483660	159	0.289308176100629	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,41483660,T,T&fts=all">p.K282*</a>
EXOC3	Missense_Mutation	p.P238S	C	C		8	Cancer Gene	5	453832	453832	128	0.265625	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXOC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,453832,C,C&fts=all">p.P238S</a>
EXOG	Missense_Mutation	p.P175S	C	C		8	Cancer Gene	3	38565419	38565419	126	0.238095238095238	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXOG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38565419,C,C&fts=all">p.P175S</a>
EYS	Missense_Mutation	p.P527S	G	G		8	Cancer Gene	6	66053951	66053951	195	0.446153846153846	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EYS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,66053951,G,G&fts=all">p.P527S</a>
EYS	Missense_Mutation	p.G462R	C	C		8	Cancer Gene	6	66063426	66063426	136	0.411764705882353	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EYS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,66063426,C,C&fts=all">p.G462R</a>
FAAH2	Missense_Mutation	p.P257S	C	C		8	Cancer Gene	X	57405110	57405110	108	0.444444444444444	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAAH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,57405110,C,C&fts=all">p.P257S</a>
FAM107B	Missense_Mutation	p.S27F	G	G		8	Cancer Gene	10	14572379	14572379	246	0.540650406504065	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM107B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,14572379,G,G&fts=all">p.S27F</a>
FAM109B	Missense_Mutation	p.P219S	C	C		8	Cancer Gene	22	42473952	42473952	40	0.125	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM109B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,42473952,C,C&fts=all">p.P219S</a>
FAM117A	Missense_Mutation	p.P241L	G	G		8	Cancer Gene	17	47795063	47795063	56	0.232142857142857	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM117A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,47795063,G,G&fts=all">p.P241L</a>
FAM120B	Missense_Mutation	p.F810L	T	T		8	Cancer Gene	6	170697519	170697519	128	0.4140625	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM120B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,170697519,T,T&fts=all">p.F810L</a>
FAM120C	Missense_Mutation	p.E1044K	C	C		8	Cancer Gene	X	54099627	54099627	73	0.438356164383562	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM120C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,54099627,C,C&fts=all">p.E1044K</a>
FAM120C	Missense_Mutation	p.S973F	G	G		8	Cancer Gene	X	54107815	54107815	52	0.442307692307692	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM120C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,54107815,G,G&fts=all">p.S973F</a>
FAM129A	Missense_Mutation	p.R428K	C	C		8	Cancer Gene	1	184777260	184777260	224	0.696428571428571	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM129A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,184777260,C,C&fts=all">p.R428K</a>
FAM13C	Missense_Mutation	p.F539S	A	A		8	Cancer Gene	10	61011353	61011353	414	0.219806763285024	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM13C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61011353,A,A&fts=all">p.F539S</a>
FAM170A	Missense_Mutation	p.S115F	C	C		8	Cancer Gene	5	118969787	118969787	51	0.431372549019608	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM170A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,118969787,C,C&fts=all">p.S115F</a>
FAM171B	Missense_Mutation	p.K439T	A	A		8	Cancer Gene	2	187626385	187626385	112	0.25	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM171B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,187626385,A,A&fts=all">p.K439T</a>
FAM177B	Missense_Mutation	p.E134K	G	G		8	Cancer Gene	1	222923323	222923323	117	0.170940170940171	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM177B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,222923323,G,G&fts=all">p.E134K</a>
FAM177B	Missense_Mutation	p.E134V	A	A		8	Cancer Gene	1	222923324	222923324	115	0.165217391304348	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM177B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,222923324,A,A&fts=all">p.E134V</a>
FAM181A	Missense_Mutation	p.K169I	A	A	rs200507444	8	Cancer Gene	14	94395137	94395137	19	0.473684210526316	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM181A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,94395137,A,A&fts=all">p.K169I</a>
FAM184A	Missense_Mutation	p.H772Y	G	G		8	Cancer Gene	6	119300671	119300671	87	0.448275862068966	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM184A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,119300671,G,G&fts=all">p.H772Y</a>
FAM188A	Splice_Site		C	C		8	Cancer Gene	10	15858915	15858915	283	0.236749116607774	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM188A&recr=Open">Click here</a>	
FAM188B	Missense_Mutation	p.H186Y	C	C		8	Cancer Gene	7	30825501	30825501	97	0.515463917525773	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM188B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,30825501,C,C&fts=all">p.H186Y</a>
FAM193A	Missense_Mutation	p.P332S	C	C		8	Cancer Gene	4	2664620	2664620	154	0.402597402597403	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM193A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,2664620,C,C&fts=all">p.P332S</a>
FAM194A	Missense_Mutation	p.K462E	T	T		8	Cancer Gene	3	150387198	150387198	198	0.262626262626263	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM194A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,150387198,T,T&fts=all">p.K462E</a>
FAM194A	Missense_Mutation	p.S413F	G	G		8	Cancer Gene	3	150396215	150396215	242	0.177685950413223	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM194A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,150396215,G,G&fts=all">p.S413F</a>
FAM198B	Missense_Mutation	p.S326F	G	G		8	Cancer Gene	4	159076911	159076911	154	0.545454545454545	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM198B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,159076911,G,G&fts=all">p.S326F</a>
FAM24A	Missense_Mutation	p.L79F	C	C	rs200724055	8	Cancer Gene	10	124672387	124672387	109	0.422018348623853	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM24A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124672387,C,C&fts=all">p.L79F</a>
FAM26E	Missense_Mutation	p.M48I	G	G		8	Cancer Gene	6	116833003	116833003	130	0.407692307692308	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM26E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,116833003,G,G&fts=all">p.M48I</a>
FAM46C	Missense_Mutation	p.S172F	C	C		8	Cancer Gene	1	118166005	118166005	217	0.202764976958525	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM46C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,118166005,C,C&fts=all">p.S172F</a>
FAM47A	Missense_Mutation	p.P251L	G	G		8	Cancer Gene	X	34149644	34149644	25	0.36	NA	NA	NA			97	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM47A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,34149644,G,G&fts=all">p.P251L</a>
FAM47B	Missense_Mutation	p.K416N	G	G		8	Cancer Gene	X	34962196	34962196	36	0.444444444444444	NA	NA	NA		p.K416N(1)	71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM47B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,34962196,G,G&fts=all">p.K416N</a>
FAM47C	Missense_Mutation	p.S604F	C	C		8	Cancer Gene	X	37028294	37028294	20	0.45	NA	NA	NA			120			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM47C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,37028294,C,C&fts=all">p.S604F</a>
FAM53A	Missense_Mutation	p.P356S	G	G	rs375206644	8	Cancer Gene	4	1643305	1643305	69	0.333333333333333	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM53A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,1643305,G,G&fts=all">p.P356S</a>
FAM57B	Missense_Mutation	p.C202G	A	A		8	Cancer Gene	16	30036725	30036725	25	0.2	NA	NA	NA			14	TLC. {ECO:0000255|PROSITE- ProRule:PRU00205}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM57B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30036725,A,A&fts=all">p.C202G</a>
FAM65A	Missense_Mutation	p.S356F	C	C		8	Cancer Gene	16	67575630	67575630	66	0.303030303030303	NA	NA	NA		p.S342Y(1)	39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM65A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,67575630,C,C&fts=all">p.S356F</a>
FAM65B	Nonsense_Mutation	p.Q70*	G	G		8	Cancer Gene	6	24873921	24873921	206	0.179611650485437	NA	NA	NA			25	Involved in cell filopodia formation.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM65B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,24873921,G,G&fts=all">p.Q70*</a>
FAM65C	Nonsense_Mutation	p.W248*	C	C		8	Cancer Gene	20	49225205	49225205	63	0.841269841269841	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM65C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,49225205,C,C&fts=all">p.W248*</a>
FAM65C	Missense_Mutation	p.S47L	G	G		8	Cancer Gene	20	49236640	49236640	96	0.375	NA	NA	NA		p.S47L(1)	29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM65C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,49236640,G,G&fts=all">p.S47L</a>
FAM71A	Missense_Mutation	p.G374E	G	G		8	Cancer Gene	1	212799340	212799340	33	0.484848484848485	NA	NA	NA			36	Ala-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM71A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,212799340,G,G&fts=all">p.G374E</a>
FAM71F1	Missense_Mutation	p.G208E	G	G		8	Cancer Gene	7	128370028	128370028	112	0.401785714285714	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM71F1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,128370028,G,G&fts=all">p.G208E</a>
FAM78A	Missense_Mutation	p.D202N	C	C		8	Cancer Gene	9	134136457	134136457	45	0.2	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM78A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,134136457,C,C&fts=all">p.D202N</a>
FAM78B	Missense_Mutation	p.I185F	T	T		8	Cancer Gene	1	166039711	166039711	156	0.198717948717949	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM78B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,166039711,T,T&fts=all">p.I185F</a>
FAM83B	Missense_Mutation	p.N1005Y	A	A		8	Cancer Gene	6	54806782	54806782	76	0.157894736842105	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM83B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,54806782,A,A&fts=all">p.N1005Y</a>
FAM91A1	Missense_Mutation	p.P315S	C	C		8	Cancer Gene	8	124797962	124797962	241	0.228215767634855	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM91A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,124797962,C,C&fts=all">p.P315S</a>
FAM98C	Missense_Mutation	p.E7K	G	G		8	Cancer Gene	19	38893812	38893812	26	0.192307692307692	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM98C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,38893812,G,G&fts=all">p.E7K</a>
FAM9C	Missense_Mutation	p.E66K	C	C		8	Cancer Gene	X	13061055	13061055	132	0.356060606060606	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM9C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,13061055,C,C&fts=all">p.E66K</a>
FANCI	Missense_Mutation	p.T163I	C	C	rs574154974	8	Cancer Gene	15	89805094	89805094	210	0.552380952380952	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FANCI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,89805094,C,C&fts=all">p.T163I</a>
FANCI	Missense_Mutation	p.P260S	C	C		8	Cancer Gene	15	89811652	89811652	312	0.246794871794872	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FANCI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,89811652,C,C&fts=all">p.P260S</a>
FAR2	Splice_Site		G	G		8	Cancer Gene	12	29462118	29462118	566	0.450530035335689	NA	NA	NA		p.?(1)	29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAR2&recr=Open">Click here</a>	
FAT1	Missense_Mutation	p.S3469Y	G	G		8	Cancer Gene	4	187525673	187525673	37	0.324324324324324	NA	NA	NA			228	Cadherin 32. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,187525673,G,G&fts=all">p.S3469Y</a>
FAT1	Missense_Mutation	p.R1535Q	C	C		8	Cancer Gene	4	187549514	187549514	20	0.2	NA	NA	NA			228	Cadherin 13. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,187549514,C,C&fts=all">p.R1535Q</a>
FAT3	Missense_Mutation	p.P390L	C	C		8	Cancer Gene	11	92086897	92086897	192	0.359375	NA	NA	NA			85	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,92086897,C,C&fts=all">p.P390L</a>
FAT3	Missense_Mutation	p.K863R	A	A		8	Cancer Gene	11	92088316	92088316	43	0.325581395348837	NA	NA	NA			85	Cadherin 8. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,92088316,A,A&fts=all">p.K863R</a>
FAT3	Missense_Mutation	p.D2295N	G	G		8	Cancer Gene	11	92533512	92533512	71	0.76056338028169	NA	NA	NA			85	Cadherin 21. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,92533512,G,G&fts=all">p.D2295N</a>
FAT3	Missense_Mutation	p.N2818K	C	C		8	Cancer Gene	11	92538326	92538326	39	0.794871794871795	NA	NA	NA			85	Cadherin 26. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,92538326,C,C&fts=all">p.N2818K</a>
FAT3	Missense_Mutation	p.R3126W	C	C		8	Cancer Gene	11	92565132	92565132	4	0.75	NA	NA	NA			85	Cadherin 28. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,92565132,C,C&fts=all">p.R3126W</a>
FAT4	Nonsense_Mutation	p.Q863*	C	C		8	Cancer Gene	4	126240153	126240153	86	0.27906976744186	NA	NA	NA			355	Cadherin 8. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126240153,C,C&fts=all">p.Q863*</a>
FAT4	Missense_Mutation	p.E1308K	G	G		8	Cancer Gene	4	126241488	126241488	182	0.21978021978022	NA	NA	NA		p.E1308K(2)	355	Cadherin 12. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126241488,G,G&fts=all">p.E1308K</a>
FAT4	Missense_Mutation	p.D1939N	G	G		8	Cancer Gene	4	126329844	126329844	242	0.0495867768595041	NA	NA	NA			355	Cadherin 18. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126329844,G,G&fts=all">p.D1939N</a>
FAT4	Missense_Mutation	p.E2680V	A	A		8	Cancer Gene	4	126370210	126370210	233	0.540772532188841	NA	NA	NA			355	Cadherin 26. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126370210,A,A&fts=all">p.E2680V</a>
FAT4	Missense_Mutation	p.F3056L	T	T		8	Cancer Gene	4	126371337	126371337	104	0.25	NA	NA	NA			355	Cadherin 29. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126371337,T,T&fts=all">p.F3056L</a>
FAT4	Missense_Mutation	p.S3984L	C	C		8	Cancer Gene	4	126389718	126389718	165	0.296969696969697	NA	NA	NA			355	Laminin G-like 1. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126389718,C,C&fts=all">p.S3984L</a>
FAT4	Missense_Mutation	p.H4261Y	C	C		8	Cancer Gene	4	126402858	126402858	114	0.228070175438596	NA	NA	NA			355	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126402858,C,C&fts=all">p.H4261Y</a>
FAT4	Missense_Mutation	p.K4274R	A	A		8	Cancer Gene	4	126408504	126408504	97	0.185567010309278	NA	NA	NA			355	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126408504,A,A&fts=all">p.K4274R</a>
FAT4	Missense_Mutation	p.E4732K	G	G		8	Cancer Gene	4	126412171	126412171	77	0.298701298701299	NA	NA	NA			355	Necessary and sufficient for interaction with MPDZ. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126412171,G,G&fts=all">p.E4732K</a>
FAT4	Missense_Mutation	p.L4953H	T	T		8	Cancer Gene	4	126412835	126412835	60	0.283333333333333	NA	NA	NA			355			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126412835,T,T&fts=all">p.L4953H</a>
FBRS	Missense_Mutation	p.L953F	C	C		8	Cancer Gene	16	30680880	30680880	110	0.281818181818182	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBRS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30680880,C,C&fts=all">p.L953F</a>
FBXL13	Missense_Mutation	p.R139Q	C	C		8	Cancer Gene	7	102665589	102665589	98	0.448979591836735	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXL13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,102665589,C,C&fts=all">p.R139Q</a>
FBXO18	Missense_Mutation	p.L600F	C	C		8	Cancer Gene	10	5959392	5959392	34	0.323529411764706	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,5959392,C,C&fts=all">p.L600F</a>
FBXO30	Nonsense_Mutation	p.Q129*	G	G		8	Cancer Gene	6	146127157	146127157	224	0.428571428571429	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO30&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,146127157,G,G&fts=all">p.Q129*</a>
FBXO38	Missense_Mutation	p.P186S	C	C		8	Cancer Gene	5	147782040	147782040	157	0.426751592356688	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO38&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,147782040,C,C&fts=all">p.P186S</a>
FBXO40	Missense_Mutation	p.E340K	G	G		8	Cancer Gene	3	121341294	121341294	33	0.393939393939394	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,121341294,G,G&fts=all">p.E340K</a>
FBXO45	Nonsense_Mutation	p.R134*	C	C		8	Cancer Gene	3	196304405	196304405	88	0.0568181818181818	NA	NA	NA			7	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO45&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,196304405,C,C&fts=all">p.R134*</a>
FBXW8	Missense_Mutation	p.H294Y	C	C		8	Cancer Gene	12	117423055	117423055	129	0.596899224806202	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXW8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,117423055,C,C&fts=all">p.H294Y</a>
FCRL3	Splice_Site	p.R282K	C	C	rs376853177	8	Cancer Gene	1	157666117	157666117	140	0.707142857142857	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCRL3&recr=Open">Click here</a>	
FCRL5	Missense_Mutation	p.S500F	G	G		8	Cancer Gene	1	157504586	157504586	43	0.767441860465116	NA	NA	NA		p.S500F(1)	85	Ig-like C2-type 5.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCRL5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,157504586,G,G&fts=all">p.S500F</a>
FCRL5	Missense_Mutation	p.H323Y	G	G		8	Cancer Gene	1	157512805	157512805	84	0.261904761904762	NA	NA	NA			85	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCRL5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,157512805,G,G&fts=all">p.H323Y</a>
FERD3L	Missense_Mutation	p.G49R	C	C		8	Cancer Gene	7	19184841	19184841	68	0.382352941176471	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FERD3L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,19184841,C,C&fts=all">p.G49R</a>
FERMT1	Missense_Mutation	p.E450K	C	C		8	Cancer Gene	20	6068447	6068447	151	0.152317880794702	NA	NA	NA			17	FERM.|PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FERMT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,6068447,C,C&fts=all">p.E450K</a>
FERMT1	Missense_Mutation	p.D163N	C	C		8	Cancer Gene	20	6093169	6093169	199	0.231155778894472	NA	NA	NA			17	FERM.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FERMT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,6093169,C,C&fts=all">p.D163N</a>
FEZF2	Missense_Mutation	p.P84L	G	G	rs374201623	8	Cancer Gene	3	62358293	62358293	30	0.2	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FEZF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,62358293,G,G&fts=all">p.P84L</a>
FGD5	Missense_Mutation	p.P429S	C	C		8	Cancer Gene	3	14861863	14861863	44	0.272727272727273	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,14861863,C,C&fts=all">p.P429S</a>
FGD5	Missense_Mutation	p.L523F	C	C		8	Cancer Gene	3	14862145	14862145	33	0.181818181818182	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,14862145,C,C&fts=all">p.L523F</a>
FGFRL1	Missense_Mutation	p.P246S	C	C		8	Cancer Gene	4	1018116	1018116	27	0.296296296296296	NA	NA	NA			13	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGFRL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,1018116,C,C&fts=all">p.P246S</a>
FIBIN	Missense_Mutation	p.R203W	C	C		8	Cancer Gene	11	27016680	27016680	70	0.371428571428571	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FIBIN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,27016680,C,C&fts=all">p.R203W</a>
FIGNL1	Missense_Mutation	p.R483C	G	G	rs144082857	8	Cancer Gene	7	50513539	50513539	216	0.236111111111111	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FIGNL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,50513539,G,G&fts=all">p.R483C</a>
FKBP15	Missense_Mutation	p.P259S	G	G		8	Cancer Gene	9	115959301	115959301	194	0.309278350515464	NA	NA	NA			26	PPIase FKBP-type. {ECO:0000255|PROSITE- ProRule:PRU00277}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FKBP15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,115959301,G,G&fts=all">p.P259S</a>
FLG	Missense_Mutation	p.R3892Q	C	C	rs372348813	8	Cancer Gene	1	152275687	152275687	73	0.232876712328767	NA	NA	NA		p.R3892L(1)|p.R3892Q(1)	424	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152275687,C,C&fts=all">p.R3892Q</a>
FLG	Missense_Mutation	p.R1567W	G	G	rs529239965	8	Cancer Gene	1	152282663	152282663	124	0.5	NA	NA	NA		p.R1567R(1)|p.R1567W(1)	424	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152282663,G,G&fts=all">p.R1567W</a>
FLG	Missense_Mutation	p.V1445M	C	C		8	Cancer Gene	1	152283029	152283029	118	0.23728813559322	NA	NA	NA			424	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152283029,C,C&fts=all">p.V1445M</a>
FLG	Missense_Mutation	p.G1354E	C	C	rs143051055	8	Cancer Gene	1	152283301	152283301	275	0.185454545454545	NA	NA	NA			424	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152283301,C,C&fts=all">p.G1354E</a>
FLG	Missense_Mutation	p.G1030E	C	C		8	Cancer Gene	1	152284273	152284273	263	0.460076045627376	NA	NA	NA			424	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152284273,C,C&fts=all">p.G1030E</a>
FLG	Missense_Mutation	p.G878E	C	C		8	Cancer Gene	1	152284729	152284729	214	0.0327102803738318	NA	NA	NA			424	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152284729,C,C&fts=all">p.G878E</a>
FLG	Missense_Mutation	p.G610E	C	C	rs200858156	8	Cancer Gene	1	152285533	152285533	211	0.644549763033175	NA	NA	NA			424	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152285533,C,C&fts=all">p.G610E</a>
FLG	Missense_Mutation	p.E38K	C	C		8	Cancer Gene	1	152287821	152287821	269	0.605947955390335	NA	NA	NA			424	EF-hand 1. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152287821,C,C&fts=all">p.E38K</a>
FLG2	Missense_Mutation	p.H1764Y	G	G		8	Cancer Gene	1	152324972	152324972	193	0.481865284974093	NA	NA	NA			188			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152324972,G,G&fts=all">p.H1764Y</a>
FLG2	Missense_Mutation	p.G1548E	C	C		8	Cancer Gene	1	152325619	152325619	240	0.1625	NA	NA	NA			188			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152325619,C,C&fts=all">p.G1548E</a>
FLG2	Missense_Mutation	p.S1285L	G	G		8	Cancer Gene	1	152326408	152326408	258	0.434108527131783	NA	NA	NA			188	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152326408,G,G&fts=all">p.S1285L</a>
FLG2	Missense_Mutation	p.H1281P	T	T		8	Cancer Gene	1	152326420	152326420	255	0.219607843137255	NA	NA	NA			188	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152326420,T,T&fts=all">p.H1281P</a>
FMN2	Missense_Mutation	p.E732K	G	G		8	Cancer Gene	1	240370306	240370306	24	0.416666666666667	NA	NA	NA			178			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,240370306,G,G&fts=all">p.E732K</a>
FMN2	Missense_Mutation	p.S795L	C	C		8	Cancer Gene	1	240370496	240370496	46	0.152173913043478	NA	NA	NA			178	FH1.|Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,240370496,C,C&fts=all">p.S795L</a>
FMNL3	Missense_Mutation	p.S705F	G	G		8	Cancer Gene	12	50043290	50043290	75	0.413333333333333	NA	NA	NA			39	FH2. {ECO:0000255|PROSITE- ProRule:PRU00774}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMNL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,50043290,G,G&fts=all">p.S705F</a>
FMO2	Missense_Mutation	p.P230S	C	C		8	Cancer Gene	1	171173064	171173064	140	0.221428571428571	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,171173064,C,C&fts=all">p.P230S</a>
FMR1NB	Splice_Site	p.E212K	G	G		8	Cancer Gene	X	147106386	147106386	167	0.353293413173653	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMR1NB&recr=Open">Click here</a>	
FNDC1	Missense_Mutation	p.R44M	G	G		8	Cancer Gene	6	159618484	159618484	100	0.45	NA	NA	NA			93	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FNDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,159618484,G,G&fts=all">p.R44M</a>
FNDC1	Missense_Mutation	p.G780E	G	G		8	Cancer Gene	6	159653883	159653883	21	0.380952380952381	NA	NA	NA			93			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FNDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,159653883,G,G&fts=all">p.G780E</a>
FNDC1	Missense_Mutation	p.D1361N	G	G		8	Cancer Gene	6	159659598	159659598	14	0.428571428571429	NA	NA	NA			93			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FNDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,159659598,G,G&fts=all">p.D1361N</a>
FNDC1	Missense_Mutation	p.S1803L	C	C	rs62432339	8	Cancer Gene	6	159687239	159687239	96	0.46875	NA	NA	NA		p.S1803*(1)	93			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FNDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,159687239,C,C&fts=all">p.S1803L</a>
FNDC7	Missense_Mutation	p.S562N	G	G		8	Cancer Gene	1	109273356	109273356	203	0.45320197044335	NA	NA	NA			20	Fibronectin type-III 7. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FNDC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,109273356,G,G&fts=all">p.S562N</a>
FOXI2	Missense_Mutation	p.G189E	G	G		8	Cancer Gene	10	129536838	129536838	15	0.666666666666667	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOXI2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,129536838,G,G&fts=all">p.G189E</a>
FOXK1	Missense_Mutation	p.P230L	C	C		8	Cancer Gene	7	4780597	4780597	65	0.215384615384615	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOXK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,4780597,C,C&fts=all">p.P230L</a>
FOXK1	Splice_Site	p.K301K	G	G		8	Cancer Gene	7	4794246	4794246	21	0.428571428571429	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOXK1&recr=Open">Click here</a>	
FOXK1	Missense_Mutation	p.R361C	C	C		8	Cancer Gene	7	4796655	4796655	133	0.18796992481203	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOXK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,4796655,C,C&fts=all">p.R361C</a>
FOXP4	Nonsense_Mutation	p.Q382*	C	C		8	Cancer Gene	6	41557587	41557587	22	0.636363636363636	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOXP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,41557587,C,C&fts=all">p.Q382*</a>
FREM1	Missense_Mutation	p.S1730L	G	G	rs376837215	8	Cancer Gene	9	14769737	14769737	46	0.543478260869565	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FREM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,14769737,G,G&fts=all">p.S1730L</a>
FREM1	Missense_Mutation	p.R114K	C	C		8	Cancer Gene	9	14859471	14859471	98	0.346938775510204	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FREM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,14859471,C,C&fts=all">p.R114K</a>
FREM2	Missense_Mutation	p.P249S	C	C		8	Cancer Gene	13	39262226	39262226	124	0.225806451612903	NA	NA	NA			148			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FREM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,39262226,C,C&fts=all">p.P249S</a>
FREM2	Missense_Mutation	p.P815S	C	C		8	Cancer Gene	13	39263924	39263924	53	0.264150943396226	NA	NA	NA			148			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FREM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,39263924,C,C&fts=all">p.P815S</a>
FREM2	Missense_Mutation	p.L1980P	T	T		8	Cancer Gene	13	39358865	39358865	137	0.284671532846715	NA	NA	NA			148	Calx-beta 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FREM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,39358865,T,T&fts=all">p.L1980P</a>
FRMD3	Missense_Mutation	p.E490K	C	C		8	Cancer Gene	9	85863159	85863159	241	0.307053941908714	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,85863159,C,C&fts=all">p.E490K</a>
FRMD7	Missense_Mutation	p.F223L	A	A		8	Cancer Gene	X	131218590	131218590	132	0.409090909090909	NA	NA	NA			24	FERM. {ECO:0000255|PROSITE- ProRule:PRU00084}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMD7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,131218590,A,A&fts=all">p.F223L</a>
FRMPD1	Missense_Mutation	p.S749F	C	C		8	Cancer Gene	9	37740771	37740771	10	0.4	NA	NA	NA			93			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMPD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,37740771,C,C&fts=all">p.S749F</a>
FRMPD3	Missense_Mutation	p.P393S	C	C		8	Cancer Gene	X	106806392	106806392	68	0.426470588235294	NA	NA	NA			28	FERM. {ECO:0000255|PROSITE- ProRule:PRU00084}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMPD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,106806392,C,C&fts=all">p.P393S</a>
FRMPD3	Missense_Mutation	p.S546L	C	C	rs191464475	8	Cancer Gene	X	106840647	106840647	41	0.536585365853659	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMPD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,106840647,C,C&fts=all">p.S546L</a>
FRMPD3	Missense_Mutation	p.E1138K	G	G		8	Cancer Gene	X	106844582	106844582	12	0.5	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMPD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,106844582,G,G&fts=all">p.E1138K</a>
FRMPD4	Missense_Mutation	p.G1244E	G	G		8	Cancer Gene	X	12736676	12736676	52	0.480769230769231	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMPD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,12736676,G,G&fts=all">p.G1244E</a>
FRY	Missense_Mutation	p.H1704Y	C	C		8	Cancer Gene	13	32800015	32800015	191	0.308900523560209	NA	NA	NA			132			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRY&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,32800015,C,C&fts=all">p.H1704Y</a>
FSCB	Missense_Mutation	p.P342H	G	G		8	Cancer Gene	14	44975166	44975166	66	0.303030303030303	NA	NA	NA			89	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSCB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,44975166,G,G&fts=all">p.P342H</a>
FSD2	Missense_Mutation	p.E160K	C	C		8	Cancer Gene	15	83455665	83455665	65	0.307692307692308	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,83455665,C,C&fts=all">p.E160K</a>
FSHR	Missense_Mutation	p.L502F	G	G		8	Cancer Gene	2	49190456	49190456	17	0.470588235294118	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSHR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,49190456,G,G&fts=all">p.L502F</a>
FSHR	Missense_Mutation	p.L119F	G	G	rs536713398	8	Cancer Gene	2	49244647	49244647	86	0.476744186046512	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSHR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,49244647,G,G&fts=all">p.L119F</a>
FSIP2	Missense_Mutation	p.G6563E	G	G		8	Cancer Gene	2	186673721	186673721	125	0.288	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSIP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,186673721,G,G&fts=all">p.G6563E</a>
FSTL5	Missense_Mutation	p.F662C	A	A		8	Cancer Gene	4	162307458	162307458	86	0.372093023255814	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSTL5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,162307458,A,A&fts=all">p.F662C</a>
FSTL5	Missense_Mutation	p.F662L	A	A		8	Cancer Gene	4	162307459	162307459	86	0.372093023255814	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSTL5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,162307459,A,A&fts=all">p.F662L</a>
FSTL5	Splice_Site		C	C		8	Cancer Gene	4	162307602	162307602	54	0.481481481481481	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSTL5&recr=Open">Click here</a>	
FSTL5	Missense_Mutation	p.K94T	T	T		8	Cancer Gene	4	162841684	162841684	108	0.351851851851852	NA	NA	NA			91	Kazal-like. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSTL5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,162841684,T,T&fts=all">p.K94T</a>
FTMT	Missense_Mutation	p.R141C	C	C	rs531790984	8	Cancer Gene	5	121188079	121188079	45	0.4	NA	NA	NA			33	Ferritin-like diiron. {ECO:0000255|PROSITE-ProRule:PRU00085}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FTMT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,121188079,C,C&fts=all">p.R141C</a>
FYCO1	Missense_Mutation	p.A644V	G	G		8	Cancer Gene	3	46008895	46008895	60	0.25	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FYCO1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,46008895,G,G&fts=all">p.A644V</a>
G3BP1	Missense_Mutation	p.P311S	C	C		8	Cancer Gene	5	151179537	151179537	58	0.448275862068966	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+G3BP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,151179537,C,C&fts=all">p.P311S</a>
G6PC2	Missense_Mutation	p.P313S	C	C		8	Cancer Gene	2	169764458	169764458	235	0.280851063829787	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+G6PC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,169764458,C,C&fts=all">p.P313S</a>
GAB4	Missense_Mutation	p.G118S	C	C		8	Cancer Gene	22	17472889	17472889	342	0.192982456140351	NA	NA	NA			44	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,17472889,C,C&fts=all">p.G118S</a>
GAB4	Nonsense_Mutation	p.E52*	C	C		8	Cancer Gene	22	17488851	17488851	18	0.611111111111111	NA	NA	NA			44	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,17488851,C,C&fts=all">p.E52*</a>
GABRA4	Missense_Mutation	p.P505L	G	G		8	Cancer Gene	4	46930393	46930393	120	0.458333333333333	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,46930393,G,G&fts=all">p.P505L</a>
GABRA4	Missense_Mutation	p.M95I	C	C		8	Cancer Gene	4	46979636	46979636	115	0.339130434782609	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,46979636,C,C&fts=all">p.M95I</a>
GABRG1	Missense_Mutation	p.P230S	G	G		8	Cancer Gene	4	46060577	46060577	88	0.0568181818181818	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,46060577,G,G&fts=all">p.P230S</a>
GABRG1	Nonsense_Mutation	p.W220*	C	C	rs267600166	8	Cancer Gene	4	46060605	46060605	67	0.328358208955224	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,46060605,C,C&fts=all">p.W220*</a>
GABRQ	Missense_Mutation	p.K115R	A	A		8	Cancer Gene	X	151815446	151815446	96	0.5	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRQ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,151815446,A,A&fts=all">p.K115R</a>
GAK	Missense_Mutation	p.R1268C	G	G		8	Cancer Gene	4	843712	843712	9	0.444444444444444	NA	NA	NA			39	J. {ECO:0000255|PROSITE- ProRule:PRU00286}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,843712,G,G&fts=all">p.R1268C</a>
GAL3ST1	Missense_Mutation	p.F416C	A	A		8	Cancer Gene	22	30950965	30950965	33	0.181818181818182	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAL3ST1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,30950965,A,A&fts=all">p.F416C</a>
GALK2	Nonsense_Mutation	p.E299*	G	G		8	Cancer Gene	15	49584662	49584662	76	0.289473684210526	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,49584662,G,G&fts=all">p.E299*</a>
GALK2	Missense_Mutation	p.E299V	A	A		8	Cancer Gene	15	49584663	49584663	73	0.287671232876712	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,49584663,A,A&fts=all">p.E299V</a>
GALNT14	Missense_Mutation	p.P448L	G	G		8	Cancer Gene	2	31147022	31147022	235	0.268085106382979	NA	NA	NA			43	Ricin B-type lectin. {ECO:0000255|PROSITE-ProRule:PRU00174}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,31147022,G,G&fts=all">p.P448L</a>
GALNT14	Missense_Mutation	p.E145K	C	C		8	Cancer Gene	2	31181296	31181296	86	0.209302325581395	NA	NA	NA			43	Catalytic subdomain A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,31181296,C,C&fts=all">p.E145K</a>
GALNT14	Missense_Mutation	p.D51N	C	C		8	Cancer Gene	2	31215852	31215852	19	0.315789473684211	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,31215852,C,C&fts=all">p.D51N</a>
GALNT5	Missense_Mutation	p.E111K	G	G		8	Cancer Gene	2	158114925	158114925	84	0.30952380952381	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,158114925,G,G&fts=all">p.E111K</a>
GALNT5	Missense_Mutation	p.P401S	C	C		8	Cancer Gene	2	158115795	158115795	90	0.266666666666667	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,158115795,C,C&fts=all">p.P401S</a>
GALNT5	Missense_Mutation	p.E530K	G	G		8	Cancer Gene	2	158140927	158140927	60	0.266666666666667	NA	NA	NA			56	Catalytic subdomain A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,158140927,G,G&fts=all">p.E530K</a>
GALNT8	Missense_Mutation	p.M74I	G	G		8	Cancer Gene	12	4835708	4835708	49	0.183673469387755	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,4835708,G,G&fts=all">p.M74I</a>
GALNT8	Missense_Mutation	p.P451H	C	C		8	Cancer Gene	12	4870302	4870302	53	0.320754716981132	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,4870302,C,C&fts=all">p.P451H</a>
GALNT8	Splice_Site	p.G588R	G	G		8	Cancer Gene	12	4881611	4881611	69	0.260869565217391	NA	NA	NA			35	Ricin B-type lectin. {ECO:0000255|PROSITE-ProRule:PRU00174}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT8&recr=Open">Click here</a>	
GALNTL6	Missense_Mutation	p.D232N	G	G		8	Cancer Gene	4	173730652	173730652	49	0.469387755102041	NA	NA	NA			45	Catalytic subdomain A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNTL6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,173730652,G,G&fts=all">p.D232N</a>
GALNTL6	Missense_Mutation	p.P376L	C	C		8	Cancer Gene	4	173852397	173852397	128	0.265625	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNTL6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,173852397,C,C&fts=all">p.P376L</a>
GCN1L1	Missense_Mutation	p.R1017K	C	C		8	Cancer Gene	12	120595690	120595690	49	0.163265306122449	NA	NA	NA			94			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCN1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,120595690,C,C&fts=all">p.R1017K</a>
GCN1L1	Missense_Mutation	p.P891L	G	G		8	Cancer Gene	12	120597706	120597706	48	0.354166666666667	NA	NA	NA			94			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCN1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,120597706,G,G&fts=all">p.P891L</a>
GDF3	Missense_Mutation	p.H180Y	G	G		8	Cancer Gene	12	7843031	7843031	104	0.403846153846154	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7843031,G,G&fts=all">p.H180Y</a>
GDNF	Missense_Mutation	p.T16N	G	G		8	Cancer Gene	5	37834852	37834852	43	0.27906976744186	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDNF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,37834852,G,G&fts=all">p.T16N</a>
GDPD4	Splice_Site	p.D415N	C	C		8	Cancer Gene	11	76944216	76944216	70	0.342857142857143	NA	NA	NA			20	GP-PDE.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDPD4&recr=Open">Click here</a>	
GFRAL	Missense_Mutation	p.G98R	G	G		8	Cancer Gene	6	55198718	55198718	346	0.158959537572254	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GFRAL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,55198718,G,G&fts=all">p.G98R</a>
GFRAL	Splice_Site		G	G		8	Cancer Gene	6	55264166	55264166	191	0.209424083769634	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GFRAL&recr=Open">Click here</a>	
GGA1	Missense_Mutation	p.P514L	C	C		8	Cancer Gene	22	38028015	38028015	51	0.156862745098039	NA	NA	NA			10	GAE. {ECO:0000255|PROSITE- ProRule:PRU00093}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GGA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38028015,C,C&fts=all">p.P514L</a>
GGT5	Missense_Mutation	p.E466K	C	C	rs140052476	8	Cancer Gene	22	24621323	24621323	89	0.168539325842697	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GGT5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,24621323,C,C&fts=all">p.E466K</a>
GGT5	Missense_Mutation	p.D450N	C	C		8	Cancer Gene	22	24621371	24621371	52	0.211538461538462	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GGT5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,24621371,C,C&fts=all">p.D450N</a>
GGTLC2	Splice_Site	p.G102G	G	G		8	Cancer Gene	22	22989454	22989454	89	0.269662921348315	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GGTLC2&recr=Open">Click here</a>	
GIMAP1	Missense_Mutation	p.P96L	C	C		8	Cancer Gene	7	150417379	150417379	12	0.5	NA	NA	NA			28	AIG1-type G.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIMAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,150417379,C,C&fts=all">p.P96L</a>
GIMAP7	Missense_Mutation	p.R103C	C	C	rs115726102	8	Cancer Gene	7	150217369	150217369	32	0.40625	NA	NA	NA			17	AIG1-type G.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIMAP7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,150217369,C,C&fts=all">p.R103C</a>
GIMAP7	Missense_Mutation	p.E259K	G	G		8	Cancer Gene	7	150217837	150217837	32	0.375	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIMAP7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,150217837,G,G&fts=all">p.E259K</a>
GIMAP8	Nonsense_Mutation	p.W293*	G	G		8	Cancer Gene	7	150171296	150171296	50	0.08	NA	NA	NA			62	AIG1-type G 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIMAP8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,150171296,G,G&fts=all">p.W293*</a>
GIPC3	Missense_Mutation	p.T118A	A	A		8	Cancer Gene	19	3586619	3586619	169	0.230769230769231	NA	NA	NA			10	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIPC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,3586619,A,A&fts=all">p.T118A</a>
GIT1	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIT1&recr=Open">Click here</a>	
GJA8	Missense_Mutation	p.D3G	A	A		8	Cancer Gene	1	147380090	147380090	207	0.202898550724638	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GJA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,147380090,A,A&fts=all">p.D3G</a>
GJA8	Missense_Mutation	p.E144K	G	G		8	Cancer Gene	1	147380512	147380512	106	0.216981132075472	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GJA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,147380512,G,G&fts=all">p.E144K</a>
GJB6	Missense_Mutation	p.H234Y	G	G		8	Cancer Gene	13	20796920	20796920	173	0.219653179190751	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GJB6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,20796920,G,G&fts=all">p.H234Y</a>
GLB1L3	Missense_Mutation	p.P411S	C	C		8	Cancer Gene	11	134181008	134181008	98	0.469387755102041	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLB1L3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,134181008,C,C&fts=all">p.P411S</a>
GLB1L3	Missense_Mutation	p.R468C	C	C	rs557506680	8	Cancer Gene	11	134182357	134182357	17	0.823529411764706	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLB1L3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,134182357,C,C&fts=all">p.R468C</a>
GLG1	Missense_Mutation	p.P482S	G	G		8	Cancer Gene	16	74519788	74519788	187	0.294117647058824	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,74519788,G,G&fts=all">p.P482S</a>
GLP2R	Missense_Mutation	p.L69H	T	T		8	Cancer Gene	17	9737140	9737140	51	0.176470588235294	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLP2R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,9737140,T,T&fts=all">p.L69H</a>
GLP2R	Missense_Mutation	p.P311S	C	C		8	Cancer Gene	17	9764461	9764461	134	0.246268656716418	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLP2R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,9764461,C,C&fts=all">p.P311S</a>
GLT6D1	Missense_Mutation	p.R130Q	C	C	rs138281407	8	Cancer Gene	9	138516385	138516385	41	0.341463414634146	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLT6D1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,138516385,C,C&fts=all">p.R130Q</a>
GLT6D1	Missense_Mutation	p.P94L	G	G		8	Cancer Gene	9	138516493	138516493	77	0.311688311688312	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLT6D1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,138516493,G,G&fts=all">p.P94L</a>
GLYATL1	Missense_Mutation	p.G150E	G	G	rs199854361	8	Cancer Gene	11	58722784	58722784	83	0.457831325301205	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLYATL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,58722784,G,G&fts=all">p.G150E</a>
GNAT3	Missense_Mutation	p.G217R	C	C		8	Cancer Gene	7	80091889	80091889	155	0.374193548387097	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GNAT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,80091889,C,C&fts=all">p.G217R</a>
GOLGA2	Missense_Mutation	p.R968C	G	G		8	Cancer Gene	9	131019453	131019453	106	0.358490566037736	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOLGA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,131019453,G,G&fts=all">p.R968C</a>
GOLGA3	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	12	133196162	133354393	NA	NA	79	-1.00781166374669	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOLGA3&recr=Open">Click here</a>	
GOLGA3	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	12	133365878	133779461	NA	NA	33	-1.06793882865658	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOLGA3&recr=Open">Click here</a>	
GOLGB1	Splice_Site	p.S3145S	G	G		8	Cancer Gene	3	121386457	121386457	76	0.0526315789473684	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOLGB1&recr=Open">Click here</a>	
GOLT1A	Missense_Mutation	p.P83L	G	G		8	Cancer Gene	1	204170809	204170809	120	0.241666666666667	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOLT1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,204170809,G,G&fts=all">p.P83L</a>
GORAB	Missense_Mutation	p.R170C	C	C		8	Cancer Gene	1	170511645	170511645	222	0.184684684684685	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GORAB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,170511645,C,C&fts=all">p.R170C</a>
GP6	Missense_Mutation	p.M78I	C	C		8	Cancer Gene	19	55543598	55543598	62	0.241935483870968	NA	NA	NA			19	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55543598,C,C&fts=all">p.M78I</a>
GPAM	Missense_Mutation	p.S405C	G	G		8	Cancer Gene	10	113926167	113926167	193	0.227979274611399	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,113926167,G,G&fts=all">p.S405C</a>
GPBP1	Missense_Mutation	p.P360S	C	C		8	Cancer Gene	5	56546865	56546865	211	0.374407582938389	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,56546865,C,C&fts=all">p.P360S</a>
GPBP1	Nonsense_Mutation	p.Q371*	C	C		8	Cancer Gene	5	56546898	56546898	244	0.233606557377049	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,56546898,C,C&fts=all">p.Q371*</a>
GPHA2	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	64708120	64757286	NA	NA	6	-1.01917037924933	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPHA2&recr=Open">Click here</a>	
GPR110	Splice_Site	p.G831R	C	C		8	Cancer Gene	6	46975031	46975031	133	0.180451127819549	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR110&recr=Open">Click here</a>	
GPR110	Missense_Mutation	p.S331F	G	G		8	Cancer Gene	6	46979867	46979867	294	0.183673469387755	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR110&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,46979867,G,G&fts=all">p.S331F</a>
GPR112	Nonsense_Mutation	p.R2070*	C	C		8	Cancer Gene	X	135432073	135432073	80	0.9	NA	NA	NA			199			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR112&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,135432073,C,C&fts=all">p.R2070*</a>
GPR112	Missense_Mutation	p.S2125F	C	C		8	Cancer Gene	X	135432239	135432239	49	0.387755102040816	NA	NA	NA			199			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR112&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,135432239,C,C&fts=all">p.S2125F</a>
GPR112	Missense_Mutation	p.P2452S	C	C		8	Cancer Gene	X	135445712	135445712	104	0.413461538461538	NA	NA	NA			199			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR112&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,135445712,C,C&fts=all">p.P2452S</a>
GPR115	Missense_Mutation	p.S231F	C	C		8	Cancer Gene	6	47681673	47681673	199	0.231155778894472	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR115&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,47681673,C,C&fts=all">p.S231F</a>
GPR116	Missense_Mutation	p.S1343L	G	G		8	Cancer Gene	6	46821742	46821742	179	0.223463687150838	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR116&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,46821742,G,G&fts=all">p.S1343L</a>
GPR116	Missense_Mutation	p.D742N	C	C		8	Cancer Gene	6	46828607	46828607	136	0.279411764705882	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR116&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,46828607,C,C&fts=all">p.D742N</a>
GPR133	Missense_Mutation	p.E210K	G	G	rs148148477	8	Cancer Gene	12	131471681	131471681	100	0.36	NA	NA	NA		p.E178K(1)	67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR133&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,131471681,G,G&fts=all">p.E210K</a>
GPR149	Missense_Mutation	p.E536K	C	C		8	Cancer Gene	3	154138845	154138845	88	0.318181818181818	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR149&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,154138845,C,C&fts=all">p.E536K</a>
GPR158	Missense_Mutation	p.D566Y	G	G	rs144380617	8	Cancer Gene	10	25861759	25861759	105	0.20952380952381	NA	NA	NA		p.D566N(2)	119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR158&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,25861759,G,G&fts=all">p.D566Y</a>
GPR158	Missense_Mutation	p.P665S	C	C		8	Cancer Gene	10	25883321	25883321	184	0.358695652173913	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR158&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,25883321,C,C&fts=all">p.P665S</a>
GPR158	Missense_Mutation	p.S897L	C	C		8	Cancer Gene	10	25887245	25887245	145	0.16551724137931	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR158&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,25887245,C,C&fts=all">p.S897L</a>
GPR179	Missense_Mutation	p.G826R	C	C		8	Cancer Gene	17	36486976	36486976	19	0.421052631578947	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR179&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,36486976,C,C&fts=all">p.G826R</a>
GPR32	Missense_Mutation	p.D88N	G	G		8	Cancer Gene	19	51274119	51274119	23	0.217391304347826	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR32&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51274119,G,G&fts=all">p.D88N</a>
GPR52	Missense_Mutation	p.G30E	G	G		8	Cancer Gene	1	174417338	174417338	71	0.774647887323944	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR52&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,174417338,G,G&fts=all">p.G30E</a>
GPR52	Missense_Mutation	p.F206S	T	T		8	Cancer Gene	1	174417866	174417866	438	0.445205479452055	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR52&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,174417866,T,T&fts=all">p.F206S</a>
GPR82	Missense_Mutation	p.G182R	G	G		8	Cancer Gene	X	41586823	41586823	194	0.494845360824742	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR82&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,41586823,G,G&fts=all">p.G182R</a>
GPR97	Missense_Mutation	p.P208L	C	C		8	Cancer Gene	16	57713219	57713219	100	0.24	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR97&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,57713219,C,C&fts=all">p.P208L</a>
GPRC6A	Missense_Mutation	p.Q530H	T	T		8	Cancer Gene	6	117116957	117116957	77	0.051948051948052	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPRC6A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,117116957,T,T&fts=all">p.Q530H</a>
GRAMD1C	Missense_Mutation	p.P54L	C	C		8	Cancer Gene	3	113622992	113622992	65	0.292307692307692	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRAMD1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,113622992,C,C&fts=all">p.P54L</a>
GRHL3	Missense_Mutation	p.E412K	G	G	rs371427354	8	Cancer Gene	1	24669211	24669211	91	0.241758241758242	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRHL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,24669211,G,G&fts=all">p.E412K</a>
GRHL3	Missense_Mutation	p.G549R	G	G		8	Cancer Gene	1	24676563	24676563	42	0.214285714285714	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRHL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,24676563,G,G&fts=all">p.G549R</a>
GRIA1	Missense_Mutation	p.M381I	G	G		8	Cancer Gene	5	153065868	153065868	56	0.339285714285714	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,153065868,G,G&fts=all">p.M381I</a>
GRIA1	Missense_Mutation	p.A499V	C	C		8	Cancer Gene	5	153085270	153085270	24	0.375	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,153085270,C,C&fts=all">p.A499V</a>
GRIA1	Missense_Mutation	p.S616P	T	T		8	Cancer Gene	5	153085620	153085620	57	0.368421052631579	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,153085620,T,T&fts=all">p.S616P</a>
GRIA1	Missense_Mutation	p.G763R	G	G		8	Cancer Gene	5	153149962	153149962	48	0.354166666666667	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,153149962,G,G&fts=all">p.G763R</a>
GRID1	Missense_Mutation	p.G503E	C	C		8	Cancer Gene	10	87487637	87487637	98	0.26530612244898	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRID1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,87487637,C,C&fts=all">p.G503E</a>
GRID1	Missense_Mutation	p.G235R	C	C		8	Cancer Gene	10	87898599	87898599	59	0.169491525423729	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRID1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,87898599,C,C&fts=all">p.G235R</a>
GRID2	Missense_Mutation	p.G635R	G	G		8	Cancer Gene	4	94411834	94411834	263	0.273764258555133	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,94411834,G,G&fts=all">p.G635R</a>
GRID2	Missense_Mutation	p.D818N	G	G		8	Cancer Gene	4	94690452	94690452	106	0.292452830188679	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,94690452,G,G&fts=all">p.D818N</a>
GRID2	Missense_Mutation	p.S896F	C	C		8	Cancer Gene	4	94693312	94693312	261	0.329501915708812	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,94693312,C,C&fts=all">p.S896F</a>
GRIK4	Missense_Mutation	p.F386S	T	T	rs372673799	8	Cancer Gene	11	120745945	120745945	33	0.424242424242424	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,120745945,T,T&fts=all">p.F386S</a>
GRIN2B	Missense_Mutation	p.G1170E	C	C		8	Cancer Gene	12	13716663	13716663	40	0.3	NA	NA	NA			143			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,13716663,C,C&fts=all">p.G1170E</a>
GRIN2B	Missense_Mutation	p.E1104K	C	C		8	Cancer Gene	12	13716862	13716862	33	0.424242424242424	NA	NA	NA			143			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,13716862,C,C&fts=all">p.E1104K</a>
GRIN2B	Missense_Mutation	p.T1065I	G	G		8	Cancer Gene	12	13716978	13716978	26	0.461538461538462	NA	NA	NA			143			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,13716978,G,G&fts=all">p.T1065I</a>
GRIN3A	Missense_Mutation	p.T688I	G	G		8	Cancer Gene	9	104432631	104432631	121	0.239669421487603	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,104432631,G,G&fts=all">p.T688I</a>
GRIN3A	Missense_Mutation	p.S556N	C	C		8	Cancer Gene	9	104433027	104433027	124	0.25	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,104433027,C,C&fts=all">p.S556N</a>
GRINA	Missense_Mutation	p.P110S	C	C		8	Cancer Gene	8	145065719	145065719	20	0.25	NA	NA	NA			9	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRINA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,145065719,C,C&fts=all">p.P110S</a>
GRK4	Missense_Mutation	p.P75L	C	C		8	Cancer Gene	4	2990529	2990529	75	0.266666666666667	NA	NA	NA			2	N-terminal.|RGS. {ECO:0000255|PROSITE- ProRule:PRU00171}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,2990529,C,C&fts=all">p.P75L</a>
GRM5	Missense_Mutation	p.S1211L	G	G		8	Cancer Gene	11	88241767	88241767	27	0.37037037037037	NA	NA	NA		p.S1179L(1)	90			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,88241767,G,G&fts=all">p.S1211L</a>
GRM6	Splice_Site		C	C		8	Cancer Gene	5	178416407	178416407	52	0.461538461538462	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM6&recr=Open">Click here</a>	
GRM7	Missense_Mutation	p.T335I	C	C		8	Cancer Gene	3	7348310	7348310	139	0.237410071942446	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,7348310,C,C&fts=all">p.T335I</a>
GRM7	Missense_Mutation	p.R859Q	G	G	rs369197989	8	Cancer Gene	3	7721860	7721860	97	0.164948453608247	NA	NA	NA		p.R859Q(1)	76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,7721860,G,G&fts=all">p.R859Q</a>
GSDMC	Missense_Mutation	p.E243K	C	C		8	Cancer Gene	8	130765061	130765061	94	0.287234042553192	NA	NA	NA		p.E243K(1)	26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSDMC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,130765061,C,C&fts=all">p.E243K</a>
GSG1L	Missense_Mutation	p.A190V	G	G		8	Cancer Gene	16	27856364	27856364	31	0.258064516129032	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSG1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,27856364,G,G&fts=all">p.A190V</a>
GSTA1	Missense_Mutation	p.D101N	C	C		8	Cancer Gene	6	52659036	52659036	265	0.241509433962264	NA	NA	NA			12	GST C-terminal.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSTA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,52659036,C,C&fts=all">p.D101N</a>
GSX1	Nonstop_Mutation	p.*265L	A	A		8	Cancer Gene	13	28368084	28368084	26	0.192307692307692	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSX1&recr=Open">Click here</a>	
GSX2	Copy Number	Amplified	NA	NA	NA	8	Cancer Gene	4	54440169	55161441	NA	NA	26	2.27139579394749	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSX2&recr=Open">Click here</a>	
GTPBP10	Missense_Mutation	p.P63S	C	C		8	Cancer Gene	7	89982283	89982283	140	0.3	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTPBP10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,89982283,C,C&fts=all">p.P63S</a>
GUCA1A	Missense_Mutation	p.G147E	G	G		8	Cancer Gene	6	42146628	42146628	85	0.282352941176471	NA	NA	NA			7	EF-hand 4. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCA1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,42146628,G,G&fts=all">p.G147E</a>
GUCA1C	Missense_Mutation	p.P15S	G	G		8	Cancer Gene	3	108672567	108672567	124	0.32258064516129	NA	NA	NA			14	EF-hand 1. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCA1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,108672567,G,G&fts=all">p.P15S</a>
GYLTL1B	Missense_Mutation	p.D577N	G	G		8	Cancer Gene	11	45949595	45949595	27	0.333333333333333	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GYLTL1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,45949595,G,G&fts=all">p.D577N</a>
GYS1	Missense_Mutation	p.S499F	G	G		8	Cancer Gene	19	49473924	49473924	194	0.15979381443299	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GYS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49473924,G,G&fts=all">p.S499F</a>
HAO2	Missense_Mutation	p.D8N	G	G		8	Cancer Gene	1	119923730	119923730	317	0.0410094637223975	NA	NA	NA			30	FMN hydroxy acid dehydrogenase. {ECO:0000255|PROSITE-ProRule:PRU00683}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,119923730,G,G&fts=all">p.D8N</a>
HBS1L	Missense_Mutation	p.P34S	G	G		8	Cancer Gene	6	135371729	135371729	74	0.527027027027027	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HBS1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,135371729,G,G&fts=all">p.P34S</a>
HCFC2	Missense_Mutation	p.P20S	C	C		8	Cancer Gene	12	104458396	104458396	12	0.416666666666667	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCFC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,104458396,C,C&fts=all">p.P20S</a>
HCFC2	Missense_Mutation	p.P117L	C	C		8	Cancer Gene	12	104461762	104461762	363	0.413223140495868	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCFC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,104461762,C,C&fts=all">p.P117L</a>
HCFC2	Missense_Mutation	p.P157L	C	C		8	Cancer Gene	12	104461882	104461882	249	0.373493975903614	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCFC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,104461882,C,C&fts=all">p.P157L</a>
HCN1	Missense_Mutation	p.L622P	A	A		8	Cancer Gene	5	45262831	45262831	127	0.228346456692913	NA	NA	NA			156			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,45262831,A,A&fts=all">p.L622P</a>
HCN1	Missense_Mutation	p.R593Q	C	C		8	Cancer Gene	5	45267196	45267196	198	0.262626262626263	NA	NA	NA		p.R593Q(1)	156			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,45267196,C,C&fts=all">p.R593Q</a>
HCN1	Missense_Mutation	p.A253T	C	C		8	Cancer Gene	5	45645379	45645379	134	0.470149253731343	NA	NA	NA			156			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,45645379,C,C&fts=all">p.A253T</a>
HCN1	Missense_Mutation	p.E123K	C	C		8	Cancer Gene	5	45695829	45695829	62	0.354838709677419	NA	NA	NA		p.E123*(1)	156	Involved in subunit assembly. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,45695829,C,C&fts=all">p.E123K</a>
HCN2	Missense_Mutation	p.S401F	C	C		8	Cancer Gene	19	605206	605206	49	0.163265306122449	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,605206,C,C&fts=all">p.S401F</a>
HCN4	Missense_Mutation	p.M273I	C	C		8	Cancer Gene	15	73636116	73636116	47	0.276595744680851	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,73636116,C,C&fts=all">p.M273I</a>
HDAC4	Missense_Mutation	p.P296L	G	G		8	Cancer Gene	2	240061471	240061471	94	0.351063829787234	NA	NA	NA			62	Interaction with MEF2A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HDAC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,240061471,G,G&fts=all">p.P296L</a>
HDAC8	Missense_Mutation	p.L366F	G	G		8	Cancer Gene	X	71571598	71571598	74	0.297297297297297	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HDAC8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,71571598,G,G&fts=all">p.L366F</a>
HDHD3	Missense_Mutation	p.P219S	G	G		8	Cancer Gene	9	116135980	116135980	64	0.265625	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HDHD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,116135980,G,G&fts=all">p.P219S</a>
HEATR4	Missense_Mutation	p.S313N	C	C		8	Cancer Gene	14	73987687	73987687	114	0.0350877192982456	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEATR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,73987687,C,C&fts=all">p.S313N</a>
HEATR5B	Missense_Mutation	p.S712F	G	G		8	Cancer Gene	2	37284548	37284548	217	0.253456221198157	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEATR5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,37284548,G,G&fts=all">p.S712F</a>
HECW1	Missense_Mutation	p.E516K	G	G		8	Cancer Gene	7	43484317	43484317	10	0.4	NA	NA	NA			125	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECW1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,43484317,G,G&fts=all">p.E516K</a>
HECW2	Missense_Mutation	p.G1173E	C	C		8	Cancer Gene	2	197080610	197080610	165	0.236363636363636	NA	NA	NA			113			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECW2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,197080610,C,C&fts=all">p.G1173E</a>
HECW2	Missense_Mutation	p.E1021K	C	C		8	Cancer Gene	2	197086952	197086952	177	0.271186440677966	NA	NA	NA			113	Interaction with TP73.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECW2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,197086952,C,C&fts=all">p.E1021K</a>
HECW2	Splice_Site	p.A724T	C	C		8	Cancer Gene	2	197138745	197138745	53	0.377358490566038	NA	NA	NA			113			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECW2&recr=Open">Click here</a>	
HECW2	Missense_Mutation	p.P703S	G	G	rs372804977	8	Cancer Gene	2	197138808	197138808	68	0.352941176470588	NA	NA	NA			113			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECW2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,197138808,G,G&fts=all">p.P703S</a>
HECW2	Missense_Mutation	p.E257K	C	C		8	Cancer Gene	2	197183777	197183777	26	0.230769230769231	NA	NA	NA			113	C2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECW2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,197183777,C,C&fts=all">p.E257K</a>
HELB	Missense_Mutation	p.L267H	T	T		8	Cancer Gene	12	66703508	66703508	206	0.41747572815534	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HELB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,66703508,T,T&fts=all">p.L267H</a>
HELQ	Missense_Mutation	p.C547G	A	A		8	Cancer Gene	4	84358219	84358219	123	0.317073170731707	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HELQ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,84358219,A,A&fts=all">p.C547G</a>
HEMGN	Missense_Mutation	p.H340Y	G	G		8	Cancer Gene	9	100692659	100692659	339	0.221238938053097	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEMGN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,100692659,G,G&fts=all">p.H340Y</a>
HENMT1	Missense_Mutation	p.S90L	G	G	rs189704510	8	Cancer Gene	1	109197467	109197467	234	0.0555555555555556	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HENMT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,109197467,G,G&fts=all">p.S90L</a>
HEPHL1	Missense_Mutation	p.P883L	C	C		8	Cancer Gene	11	93836152	93836152	70	0.414285714285714	NA	NA	NA			61	Plastocyanin-like 5.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEPHL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,93836152,C,C&fts=all">p.P883L</a>
HERC6	Missense_Mutation	p.E73K	G	G		8	Cancer Gene	4	89304390	89304390	50	0.3	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HERC6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,89304390,G,G&fts=all">p.E73K</a>
HFE2	Missense_Mutation	p.E151K	G	G		8	Cancer Gene	1	145415632	145415632	37	0.243243243243243	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HFE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,145415632,G,G&fts=all">p.E151K</a>
HGSNAT	Missense_Mutation	p.L452F	C	C		8	Cancer Gene	8	43047550	43047550	64	0.265625	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HGSNAT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,43047550,C,C&fts=all">p.L452F</a>
HHLA2	Missense_Mutation	p.Q219H	A	A		8	Cancer Gene	3	108074200	108074200	99	0.434343434343434	NA	NA	NA			18	Ig-like C1-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HHLA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,108074200,A,A&fts=all">p.Q219H</a>
HIP1R	Splice_Site		G	G		8	Cancer Gene	12	123344593	123344593	22	0.363636363636364	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIP1R&recr=Open">Click here</a>	
HIP1R	Splice_Site	p.R822R	G	G		8	Cancer Gene	12	123344594	123344594	22	0.363636363636364	NA	NA	NA			26	I/LWEQ. {ECO:0000255|PROSITE- ProRule:PRU00292}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIP1R&recr=Open">Click here</a>	
HIPK4	Missense_Mutation	p.E525K	C	C		8	Cancer Gene	19	40886325	40886325	40	0.525	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIPK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,40886325,C,C&fts=all">p.E525K</a>
HIPK4	Missense_Mutation	p.V450I	C	C		8	Cancer Gene	19	40886550	40886550	89	0.134831460674157	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIPK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,40886550,C,C&fts=all">p.V450I</a>
HIST1H1B	Missense_Mutation	p.G94S	C	C	rs559352119	8	Cancer Gene	6	27835028	27835028	437	0.178489702517162	NA	NA	NA			24	H15. {ECO:0000255|PROSITE- ProRule:PRU00837}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIST1H1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,27835028,C,C&fts=all">p.G94S</a>
HIST1H2AA	Missense_Mutation	p.R36C	G	G		8	Cancer Gene	6	25726650	25726650	58	0.137931034482759	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIST1H2AA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,25726650,G,G&fts=all">p.R36C</a>
HIST1H3B	Frame_Shift_Del	p.G35fs	C	C		8	Cancer Gene	6	26032188	26032188	396	0.202020202020202	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIST1H3B&recr=Open">Click here</a>	
HMCN1	Missense_Mutation	p.E120K	G	G		8	Cancer Gene	1	185833620	185833620	316	0.205696202531646	NA	NA	NA			308	VWFA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMCN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,185833620,G,G&fts=all">p.E120K</a>
HMCN1	Missense_Mutation	p.S1227G	A	A		8	Cancer Gene	1	185964120	185964120	242	0.677685950413223	NA	NA	NA			308	Ig-like C2-type 9.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMCN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,185964120,A,A&fts=all">p.S1227G</a>
HMGB4	Missense_Mutation	p.E74K	G	G		8	Cancer Gene	1	34330012	34330012	99	0.0808080808080808	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMGB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,34330012,G,G&fts=all">p.E74K</a>
HMGCLL1	Missense_Mutation	p.S276F	G	G		8	Cancer Gene	6	55304326	55304326	186	0.198924731182796	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMGCLL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,55304326,G,G&fts=all">p.S276F</a>
HMGCLL1	Missense_Mutation	p.R180Q	C	C		8	Cancer Gene	6	55378849	55378849	209	0.0334928229665072	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMGCLL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,55378849,C,C&fts=all">p.R180Q</a>
HMGCLL1	Missense_Mutation	p.G163R	C	C		8	Cancer Gene	6	55378901	55378901	196	0.0357142857142857	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMGCLL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,55378901,C,C&fts=all">p.G163R</a>
HMGXB4	Missense_Mutation	p.S89L	C	C	rs560951498	8	Cancer Gene	22	35660647	35660647	447	0.190156599552573	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMGXB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,35660647,C,C&fts=all">p.S89L</a>
HMX2	Missense_Mutation	p.D115N	G	G		8	Cancer Gene	10	124909160	124909160	51	0.176470588235294	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124909160,G,G&fts=all">p.D115N</a>
HNRNPF	Missense_Mutation	p.S54N	C	C		8	Cancer Gene	10	43883172	43883172	148	0.391891891891892	NA	NA	NA			19	RRM 1. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNRNPF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,43883172,C,C&fts=all">p.S54N</a>
HNRNPUL1	Missense_Mutation	p.R476C	C	C		8	Cancer Gene	19	41800499	41800499	79	0.177215189873418	NA	NA	NA			29	Necessary for interaction with BRD7 and transcriptional activation.|Necessary for interaction with TP53.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNRNPUL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41800499,C,C&fts=all">p.R476C</a>
HNRNPUL2	Missense_Mutation	p.S323F	G	G		8	Cancer Gene	11	62490299	62490299	91	0.461538461538462	NA	NA	NA			20	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNRNPUL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,62490299,G,G&fts=all">p.S323F</a>
HOGA1	Missense_Mutation	p.E274K	G	G		8	Cancer Gene	10	99361733	99361733	18	0.222222222222222	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOGA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,99361733,G,G&fts=all">p.E274K</a>
HOXD12	Missense_Mutation	p.E216K	G	G		8	Cancer Gene	2	176965321	176965321	18	0.444444444444444	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXD12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,176965321,G,G&fts=all">p.E216K</a>
HPGDS	Missense_Mutation	p.L168F	T	T		8	Cancer Gene	4	95220727	95220727	173	0.300578034682081	NA	NA	NA			7	GST C-terminal.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HPGDS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,95220727,T,T&fts=all">p.L168F</a>
HPS6	Missense_Mutation	p.P277L	C	C		8	Cancer Gene	10	103826061	103826061	61	0.278688524590164	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HPS6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,103826061,C,C&fts=all">p.P277L</a>
HPSE	Missense_Mutation	p.P424S	G	G	rs532481270	8	Cancer Gene	4	84222141	84222141	201	0.293532338308458	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HPSE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,84222141,G,G&fts=all">p.P424S</a>
HPSE2	Missense_Mutation	p.R506Q	C	C		8	Cancer Gene	10	100242489	100242489	188	0.223404255319149	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HPSE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,100242489,C,C&fts=all">p.R506Q</a>
HRASLS2	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	63283187	63342520	NA	NA	10	-1.2222962448729	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRASLS2&recr=Open">Click here</a>	
HRNR	Missense_Mutation	p.R767Q	C	C	rs372523498	8	Cancer Gene	1	152191805	152191805	74	0.0810810810810811	NA	NA	NA			192			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRNR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152191805,C,C&fts=all">p.R767Q</a>
HRNR	Missense_Mutation	p.R448Q	C	C		8	Cancer Gene	1	152192762	152192762	76	0.447368421052632	NA	NA	NA		p.R448Q(1)	192			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRNR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152192762,C,C&fts=all">p.R448Q</a>
HS3ST4	Missense_Mutation	p.R359Q	G	G		8	Cancer Gene	16	26147274	26147274	47	0.74468085106383	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HS3ST4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,26147274,G,G&fts=all">p.R359Q</a>
HS3ST4	Nonsense_Mutation	p.Q448*	C	C		8	Cancer Gene	16	26147540	26147540	26	0.192307692307692	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HS3ST4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,26147540,C,C&fts=all">p.Q448*</a>
HSD17B13	Missense_Mutation	p.R102C	G	G		8	Cancer Gene	4	88239495	88239495	113	0.274336283185841	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD17B13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,88239495,G,G&fts=all">p.R102C</a>
HSD17B14	Missense_Mutation	p.P153S	G	G		8	Cancer Gene	19	49318311	49318311	91	0.142857142857143	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD17B14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49318311,G,G&fts=all">p.P153S</a>
HSD3B1	Missense_Mutation	p.G61R	G	G		8	Cancer Gene	1	120054161	120054161	86	0.186046511627907	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD3B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,120054161,G,G&fts=all">p.G61R</a>
HSD3B1	Missense_Mutation	p.G171R	G	G		8	Cancer Gene	1	120056657	120056657	172	0.354651162790698	NA	NA	NA		p.G171W(1)|p.G171R(1)	32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD3B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,120056657,G,G&fts=all">p.G171R</a>
HSD3B7	Missense_Mutation	p.S349L	C	C		8	Cancer Gene	16	30999440	30999440	18	0.388888888888889	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD3B7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30999440,C,C&fts=all">p.S349L</a>
HSPA12A	Missense_Mutation	p.P637H	G	G		8	Cancer Gene	10	118434410	118434410	87	0.172413793103448	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPA12A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,118434410,G,G&fts=all">p.P637H</a>
HSPB7	Missense_Mutation	p.S19F	G	G		8	Cancer Gene	1	16344403	16344403	41	0.341463414634146	NA	NA	NA			10	Poly-Ser.|Required for localization to SC35 splicing speckles.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPB7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,16344403,G,G&fts=all">p.S19F</a>
HSPBAP1	Missense_Mutation	p.P114L	G	G		8	Cancer Gene	3	122487639	122487639	109	0.486238532110092	NA	NA	NA			16	Interaction with HSPB1. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPBAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,122487639,G,G&fts=all">p.P114L</a>
HTR1A	Missense_Mutation	p.E268D	C	C		8	Cancer Gene	5	63256743	63256743	35	0.4	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,63256743,C,C&fts=all">p.E268D</a>
HTR1B	Missense_Mutation	p.M169I	C	C		8	Cancer Gene	6	78172614	78172614	21	0.476190476190476	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,78172614,C,C&fts=all">p.M169I</a>
HTR1B	Nonsense_Mutation	p.Q41*	G	G		8	Cancer Gene	6	78173000	78173000	52	0.423076923076923	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,78173000,G,G&fts=all">p.Q41*</a>
HTR1E	Missense_Mutation	p.R287Q	G	G	rs61735411	8	Cancer Gene	6	87725912	87725912	87	0.344827586206897	NA	NA	NA		p.R287Q(1)	41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR1E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,87725912,G,G&fts=all">p.R287Q</a>
HTR1F	Missense_Mutation	p.K360T	A	A	rs112317422	8	Cancer Gene	3	88040978	88040978	225	0.408888888888889	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR1F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,88040978,A,A&fts=all">p.K360T</a>
HTR3B	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	113803817	114183201	NA	NA	18	-1.11528487090397	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR3B&recr=Open">Click here</a>	
HTR3C	Missense_Mutation	p.P6L	C	C		8	Cancer Gene	3	183770885	183770885	124	0.25	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR3C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,183770885,C,C&fts=all">p.P6L</a>
HTR3C	Missense_Mutation	p.G368E	G	G		8	Cancer Gene	3	183777793	183777793	21	0.333333333333333	NA	NA	NA		p.G368K(1)	32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR3C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,183777793,G,G&fts=all">p.G368E</a>
HTR3E	Missense_Mutation	p.P42S	C	C		8	Cancer Gene	3	183818329	183818329	143	0.265734265734266	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR3E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,183818329,C,C&fts=all">p.P42S</a>
HTT	Missense_Mutation	p.R1412C	C	C		8	Cancer Gene	4	3176515	3176515	71	0.380281690140845	NA	NA	NA		p.R1412C(1)	87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,3176515,C,C&fts=all">p.R1412C</a>
HYAL4	Nonsense_Mutation	p.K176*	A	A		8	Cancer Gene	7	123508853	123508853	122	0.327868852459016	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HYAL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,123508853,A,A&fts=all">p.K176*</a>
HYAL4	Missense_Mutation	p.G440E	G	G		8	Cancer Gene	7	123517082	123517082	97	0.298969072164948	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HYAL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,123517082,G,G&fts=all">p.G440E</a>
IFIH1	Missense_Mutation	p.A582V	G	G		8	Cancer Gene	2	163134735	163134735	302	0.294701986754967	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFIH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,163134735,G,G&fts=all">p.A582V</a>
IFIT1B	Nonsense_Mutation	p.Q375*	C	C		8	Cancer Gene	10	91144193	91144193	209	0.133971291866029	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFIT1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,91144193,C,C&fts=all">p.Q375*</a>
IFNE	Nonsense_Mutation	p.R149*	G	G	rs147478752	8	Cancer Gene	9	21481249	21481249	231	0.883116883116883	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,21481249,G,G&fts=all">p.R149*</a>
IFT172	Missense_Mutation	p.D1428N	C	C		8	Cancer Gene	2	27672190	27672190	118	0.203389830508475	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT172&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27672190,C,C&fts=all">p.D1428N</a>
IFT172	Nonsense_Mutation	p.W1427*	C	C		8	Cancer Gene	2	27672191	27672191	120	0.208333333333333	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT172&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27672191,C,C&fts=all">p.W1427*</a>
IFT172	Missense_Mutation	p.M582I	C	C		8	Cancer Gene	2	27688696	27688696	406	0.295566502463054	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT172&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27688696,C,C&fts=all">p.M582I</a>
IFT27	Missense_Mutation	p.S95F	G	G		8	Cancer Gene	22	37160028	37160028	60	0.216666666666667	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT27&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,37160028,G,G&fts=all">p.S95F</a>
IGDCC3	Missense_Mutation	p.G222E	C	C		8	Cancer Gene	15	65627649	65627649	54	0.203703703703704	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGDCC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,65627649,C,C&fts=all">p.G222E</a>
IGDCC3	Missense_Mutation	p.G222R	C	C		8	Cancer Gene	15	65627650	65627650	54	0.203703703703704	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGDCC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,65627650,C,C&fts=all">p.G222R</a>
IGF2BP1	Missense_Mutation	p.E11K	G	G		8	Cancer Gene	17	47075138	47075138	54	0.333333333333333	NA	NA	NA		p.E11K(1)	31	RRM 1. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGF2BP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,47075138,G,G&fts=all">p.E11K</a>
IGF2BP1	Missense_Mutation	p.G472S	G	G		8	Cancer Gene	17	47123270	47123270	34	0.323529411764706	NA	NA	NA			31	Necessary for interaction with ELAVL4 and binding to TAU mRNA. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGF2BP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,47123270,G,G&fts=all">p.G472S</a>
IGSF10	Missense_Mutation	p.F1129V	A	A		8	Cancer Gene	3	151164384	151164384	250	0.488	NA	NA	NA			116			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,151164384,A,A&fts=all">p.F1129V</a>
IGSF10	Missense_Mutation	p.E574K	C	C	rs116716539	8	Cancer Gene	3	151166049	151166049	177	0.288135593220339	NA	NA	NA			116	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,151166049,C,C&fts=all">p.E574K</a>
IGSF10	Missense_Mutation	p.H94Y	G	G		8	Cancer Gene	3	151174858	151174858	150	0.246666666666667	NA	NA	NA			116			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,151174858,G,G&fts=all">p.H94Y</a>
IGSF10	Missense_Mutation	p.R46W	G	G		8	Cancer Gene	3	151176362	151176362	65	0.246153846153846	NA	NA	NA			116	LRRNT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,151176362,G,G&fts=all">p.R46W</a>
IGSF11	Missense_Mutation	p.L289I	G	G		8	Cancer Gene	3	118621798	118621798	100	0.35	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,118621798,G,G&fts=all">p.L289I</a>
IGSF11	Missense_Mutation	p.P144S	G	G		8	Cancer Gene	3	118645098	118645098	39	0.41025641025641	NA	NA	NA			34	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,118645098,G,G&fts=all">p.P144S</a>
IGSF22	Missense_Mutation	p.E925K	C	C		8	Cancer Gene	11	18731159	18731159	24	0.458333333333333	NA	NA	NA		p.E925fs*15(1)|p.E824fs*15(1)	56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF22&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,18731159,C,C&fts=all">p.E925K</a>
IGSF8	Missense_Mutation	p.P470S	G	G		8	Cancer Gene	1	160062390	160062390	35	0.4	NA	NA	NA			33	Ig-like C2-type 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,160062390,G,G&fts=all">p.P470S</a>
IKZF2	Missense_Mutation	p.M25I	C	C		8	Cancer Gene	2	214012496	214012496	292	0.246575342465753	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IKZF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,214012496,C,C&fts=all">p.M25I</a>
IKZF3	Missense_Mutation	p.M449I	C	C		8	Cancer Gene	17	37922226	37922226	92	0.380434782608696	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IKZF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,37922226,C,C&fts=all">p.M449I</a>
IKZF3	Missense_Mutation	p.P422S	G	G		8	Cancer Gene	17	37922309	37922309	92	0.380434782608696	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IKZF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,37922309,G,G&fts=all">p.P422S</a>
IL12B	Missense_Mutation	p.E186K	C	C		8	Cancer Gene	5	158747455	158747455	90	0.377777777777778	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL12B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,158747455,C,C&fts=all">p.E186K</a>
IL17D	Missense_Mutation	p.E126K	G	G	rs556994908	8	Cancer Gene	13	21295860	21295860	38	0.131578947368421	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL17D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,21295860,G,G&fts=all">p.E126K</a>
IL17F	Missense_Mutation	p.P81S	G	G	rs530331585	8	Cancer Gene	6	52103541	52103541	86	0.255813953488372	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL17F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,52103541,G,G&fts=all">p.P81S</a>
IL17F	Missense_Mutation	p.R31Q	C	C		8	Cancer Gene	6	52103690	52103690	192	0.223958333333333	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL17F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,52103690,C,C&fts=all">p.R31Q</a>
IL1RAPL2	Nonsense_Mutation	p.Q249*	C	C		8	Cancer Gene	X	104728352	104728352	110	0.4	NA	NA	NA			49	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1RAPL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,104728352,C,C&fts=all">p.Q249*</a>
IL20RA	Missense_Mutation	p.G64R	C	C		8	Cancer Gene	6	137338139	137338139	119	0.420168067226891	NA	NA	NA			27	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL20RA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,137338139,C,C&fts=all">p.G64R</a>
IL36A	Missense_Mutation	p.P41L	C	C		8	Cancer Gene	2	113763662	113763662	39	0.564102564102564	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL36A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,113763662,C,C&fts=all">p.P41L</a>
IL9R	Missense_Mutation	p.P108L	C	C		8	Cancer Gene	X	155233410	155233410	34	0.529411764705882	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL9R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,155233410,C,C&fts=all">p.P108L</a>
ILDR2	Missense_Mutation	p.S322F	G	G		8	Cancer Gene	1	166892019	166892019	132	0.295454545454545	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ILDR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,166892019,G,G&fts=all">p.S322F</a>
ILDR2	Missense_Mutation	p.G133E	C	C		8	Cancer Gene	1	166926071	166926071	163	0.496932515337423	NA	NA	NA			22	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ILDR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,166926071,C,C&fts=all">p.G133E</a>
ILDR2	Missense_Mutation	p.R118K	C	C		8	Cancer Gene	1	166927032	166927032	108	0.481481481481481	NA	NA	NA			22	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ILDR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,166927032,C,C&fts=all">p.R118K</a>
IMPG2	Missense_Mutation	p.D760H	C	C		8	Cancer Gene	3	100962897	100962897	140	0.364285714285714	NA	NA	NA		p.D760Y(1)	64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IMPG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,100962897,C,C&fts=all">p.D760H</a>
IMPG2	Missense_Mutation	p.L6F	G	G		8	Cancer Gene	3	101039201	101039201	124	0.306451612903226	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IMPG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,101039201,G,G&fts=all">p.L6F</a>
IMPG2	Missense_Mutation	p.P5L	G	G		8	Cancer Gene	3	101039203	101039203	120	0.308333333333333	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IMPG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,101039203,G,G&fts=all">p.P5L</a>
INADL	Missense_Mutation	p.R1282C	C	C		8	Cancer Gene	1	62456013	62456013	88	0.386363636363636	NA	NA	NA			103	PDZ 7. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INADL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62456013,C,C&fts=all">p.R1282C</a>
INO80E	Missense_Mutation	p.P126L	C	C		8	Cancer Gene	16	30012342	30012342	44	0.318181818181818	NA	NA	NA			6	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INO80E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30012342,C,C&fts=all">p.P126L</a>
INPP5E	Nonsense_Mutation	p.S623*	G	G		8	Cancer Gene	9	139324194	139324194	157	0.305732484076433	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INPP5E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,139324194,G,G&fts=all">p.S623*</a>
INSIG2	Missense_Mutation	p.L157F	C	C		8	Cancer Gene	2	118864412	118864412	342	0.0321637426900585	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INSIG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,118864412,C,C&fts=all">p.L157F</a>
INTU	Missense_Mutation	p.P429S	C	C		8	Cancer Gene	4	128608858	128608858	236	0.300847457627119	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INTU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,128608858,C,C&fts=all">p.P429S</a>
INTU	Missense_Mutation	p.P429L	C	C		8	Cancer Gene	4	128608859	128608859	237	0.30379746835443	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INTU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,128608859,C,C&fts=all">p.P429L</a>
IPCEF1	Nonsense_Mutation	p.W67*	C	C		8	Cancer Gene	6	154567770	154567770	182	0.406593406593407	NA	NA	NA			12	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IPCEF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,154567770,C,C&fts=all">p.W67*</a>
IQCA1	Missense_Mutation	p.F790S	A	A		8	Cancer Gene	2	237240006	237240006	99	0.343434343434343	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,237240006,A,A&fts=all">p.F790S</a>
IQCA1	Nonsense_Mutation	p.Q690*	G	G		8	Cancer Gene	2	237246914	237246914	46	0.260869565217391	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,237246914,G,G&fts=all">p.Q690*</a>
IQCA1	Missense_Mutation	p.R429Q	C	C		8	Cancer Gene	2	237300918	237300918	30	0.266666666666667	NA	NA	NA			26	Lys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,237300918,C,C&fts=all">p.R429Q</a>
IQCA1	Missense_Mutation	p.M407I	C	C		8	Cancer Gene	2	237300983	237300983	27	0.296296296296296	NA	NA	NA			26	Lys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,237300983,C,C&fts=all">p.M407I</a>
IQCE	Missense_Mutation	p.L393F	C	C		8	Cancer Gene	7	2629673	2629673	70	0.157142857142857	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,2629673,C,C&fts=all">p.L393F</a>
IQSEC2	Missense_Mutation	p.P539L	G	G		8	Cancer Gene	X	53280142	53280142	31	0.935483870967742	NA	NA	NA			29	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQSEC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,53280142,G,G&fts=all">p.P539L</a>
IQSEC2	Missense_Mutation	p.A510V	G	G		8	Cancer Gene	X	53280229	53280229	67	0.358208955223881	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQSEC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,53280229,G,G&fts=all">p.A510V</a>
IREB2	Missense_Mutation	p.D274N	G	G		8	Cancer Gene	15	78764203	78764203	277	0.252707581227437	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IREB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,78764203,G,G&fts=all">p.D274N</a>
IREB2	Missense_Mutation	p.R779C	C	C		8	Cancer Gene	15	78786261	78786261	282	0.542553191489362	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IREB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,78786261,C,C&fts=all">p.R779C</a>
ISM1	Missense_Mutation	p.D185E	C	C	rs377766422	8	Cancer Gene	20	13260457	13260457	54	0.277777777777778	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ISM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,13260457,C,C&fts=all">p.D185E</a>
ITGA11	Nonsense_Mutation	p.R550*	G	G		8	Cancer Gene	15	68624319	68624319	26	0.346153846153846	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,68624319,G,G&fts=all">p.R550*</a>
ITGA11	Splice_Site	p.G89E	C	C		8	Cancer Gene	15	68657136	68657136	36	0.472222222222222	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA11&recr=Open">Click here</a>	
ITIH5	Missense_Mutation	p.L834R	A	A		8	Cancer Gene	10	7608019	7608019	106	0.150943396226415	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,7608019,A,A&fts=all">p.L834R</a>
ITIH5	Missense_Mutation	p.R487P	C	C	rs112992012	8	Cancer Gene	10	7618934	7618934	56	0.392857142857143	NA	NA	NA		p.R487H(1)	75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,7618934,C,C&fts=all">p.R487P</a>
ITIH5	Missense_Mutation	p.K152N	T	T		8	Cancer Gene	10	7679387	7679387	82	0.231707317073171	NA	NA	NA			75	VIT. {ECO:0000255|PROSITE- ProRule:PRU00801}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,7679387,T,T&fts=all">p.K152N</a>
IYD	Nonsense_Mutation	p.R150*	C	C	rs35217099	8	Cancer Gene	6	150713558	150713558	83	0.493975903614458	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IYD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,150713558,C,C&fts=all">p.R150*</a>
IZUMO2	Missense_Mutation	p.D179N	C	C		8	Cancer Gene	19	50657945	50657945	69	0.231884057971014	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IZUMO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50657945,C,C&fts=all">p.D179N</a>
JMJD7-PLA2G4B	Missense_Mutation	p.P108L	C	C		8	Cancer Gene	15	42127272	42127272	99	0.222222222222222	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JMJD7-PLA2G4B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,42127272,C,C&fts=all">p.P108L</a>
JMJD7-PLA2G4B	Missense_Mutation	p.R358C	C	C		8	Cancer Gene	15	42133280	42133280	101	0.316831683168317	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JMJD7-PLA2G4B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,42133280,C,C&fts=all">p.R358C</a>
JMJD7-PLA2G4B	Splice_Site	p.P645L	C	C		8	Cancer Gene	15	42137402	42137402	27	0.592592592592593	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JMJD7-PLA2G4B&recr=Open">Click here</a>	
JPH1	Missense_Mutation	p.G572E	C	C		8	Cancer Gene	8	75156954	75156954	130	0.276923076923077	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JPH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,75156954,C,C&fts=all">p.G572E</a>
KALRN	Missense_Mutation	p.S33F	C	C		8	Cancer Gene	3	123946867	123946867	116	0.413793103448276	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KALRN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,123946867,C,C&fts=all">p.S33F</a>
KALRN	Missense_Mutation	p.E72K	G	G		8	Cancer Gene	3	123953747	123953747	28	0.5	NA	NA	NA			83	CRAL-TRIO. {ECO:0000255|PROSITE- ProRule:PRU00056}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KALRN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,123953747,G,G&fts=all">p.E72K</a>
KALRN	Splice_Site		G	G		8	Cancer Gene	3	123953791	123953791	22	0.363636363636364	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KALRN&recr=Open">Click here</a>	
KALRN	Missense_Mutation	p.D611N	G	G		8	Cancer Gene	3	124103758	124103758	38	0.5	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KALRN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,124103758,G,G&fts=all">p.D611N</a>
KALRN	Missense_Mutation	p.D119N	G	G		8	Cancer Gene	3	124351536	124351536	71	0.450704225352113	NA	NA	NA			83	CRAL-TRIO. {ECO:0000255|PROSITE- ProRule:PRU00056}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KALRN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,124351536,G,G&fts=all">p.D119N</a>
KALRN	Missense_Mutation	p.P562S	C	C		8	Cancer Gene	3	124390581	124390581	73	0.287671232876712	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KALRN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,124390581,C,C&fts=all">p.P562S</a>
KANK4	Missense_Mutation	p.S792L	G	G	rs139968342	8	Cancer Gene	1	62728928	62728928	26	0.346153846153846	NA	NA	NA		p.S792L(1)	81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KANK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62728928,G,G&fts=all">p.S792L</a>
KANK4	Missense_Mutation	p.D411N	C	C		8	Cancer Gene	1	62739545	62739545	121	0.59504132231405	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KANK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62739545,C,C&fts=all">p.D411N</a>
KANK4	Missense_Mutation	p.P30L	G	G		8	Cancer Gene	1	62740687	62740687	143	0.923076923076923	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KANK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62740687,G,G&fts=all">p.P30L</a>
KCNA2	Missense_Mutation	p.P16S	G	G		8	Cancer Gene	1	111147359	111147359	198	0.0353535353535354	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,111147359,G,G&fts=all">p.P16S</a>
KCNA7	Missense_Mutation	p.S387F	G	G		8	Cancer Gene	19	49573531	49573531	48	0.104166666666667	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49573531,G,G&fts=all">p.S387F</a>
KCNC2	Missense_Mutation	p.E137K	C	C		8	Cancer Gene	12	75601355	75601355	24	0.458333333333333	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,75601355,C,C&fts=all">p.E137K</a>
KCND2	Missense_Mutation	p.E486K	G	G		8	Cancer Gene	7	120382645	120382645	89	0.112359550561798	NA	NA	NA			75	Mediates dendritic targeting. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCND2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,120382645,G,G&fts=all">p.E486K</a>
KCND2	Missense_Mutation	p.K536I	A	A		8	Cancer Gene	7	120385973	120385973	97	0.0515463917525773	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCND2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,120385973,A,A&fts=all">p.K536I</a>
KCNH1	Missense_Mutation	p.V853M	C	C		8	Cancer Gene	1	210857036	210857036	90	0.655555555555556	NA	NA	NA			68			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,210857036,C,C&fts=all">p.V853M</a>
KCNH4	Missense_Mutation	p.H957Q	G	G		8	Cancer Gene	17	40312241	40312241	55	0.345454545454545	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,40312241,G,G&fts=all">p.H957Q</a>
KCNH4	Missense_Mutation	p.G691S	C	C		8	Cancer Gene	17	40317481	40317481	59	0.372881355932203	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,40317481,C,C&fts=all">p.G691S</a>
KCNH5	Missense_Mutation	p.E620K	C	C		8	Cancer Gene	14	63246607	63246607	18	0.888888888888889	NA	NA	NA			99			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,63246607,C,C&fts=all">p.E620K</a>
KCNH5	Splice_Site	p.G315E	C	C		8	Cancer Gene	14	63417276	63417276	28	0.464285714285714	NA	NA	NA			99			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH5&recr=Open">Click here</a>	
KCNH5	Missense_Mutation	p.S299F	G	G		8	Cancer Gene	14	63447636	63447636	70	0.885714285714286	NA	NA	NA			99			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,63447636,G,G&fts=all">p.S299F</a>
KCNH7	Missense_Mutation	p.S350L	G	G		8	Cancer Gene	2	163361032	163361032	240	0.2875	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,163361032,G,G&fts=all">p.S350L</a>
KCNH7	Nonsense_Mutation	p.K347*	T	T		8	Cancer Gene	2	163361042	163361042	218	0.279816513761468	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,163361042,T,T&fts=all">p.K347*</a>
KCNJ9	Missense_Mutation	p.V149M	G	G		8	Cancer Gene	1	160054265	160054265	54	0.425925925925926	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,160054265,G,G&fts=all">p.V149M</a>
KCNK13	Nonsense_Mutation	p.Q173*	C	C		8	Cancer Gene	14	90650637	90650637	57	0.614035087719298	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,90650637,C,C&fts=all">p.Q173*</a>
KCNK13	Missense_Mutation	p.S326F	C	C		8	Cancer Gene	14	90651097	90651097	55	0.618181818181818	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,90651097,C,C&fts=all">p.S326F</a>
KCNK17	Missense_Mutation	p.G88E	C	C		8	Cancer Gene	6	39278758	39278758	66	0.106060606060606	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,39278758,C,C&fts=all">p.G88E</a>
KCNK18	Missense_Mutation	p.G347E	G	G		8	Cancer Gene	10	118969695	118969695	225	0.208888888888889	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,118969695,G,G&fts=all">p.G347E</a>
KCNT2	Missense_Mutation	p.D766N	C	C		8	Cancer Gene	1	196288666	196288666	195	0.220512820512821	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,196288666,C,C&fts=all">p.D766N</a>
KCNT2	Missense_Mutation	p.G224E	C	C		8	Cancer Gene	1	196398855	196398855	116	0.629310344827586	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,196398855,C,C&fts=all">p.G224E</a>
KCNT2	Missense_Mutation	p.A187V	G	G		8	Cancer Gene	1	196434501	196434501	229	0.624454148471616	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,196434501,G,G&fts=all">p.A187V</a>
KCNU1	Missense_Mutation	p.R7Q	G	G	rs369264156	8	Cancer Gene	8	36641948	36641948	99	0.252525252525253	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNU1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,36641948,G,G&fts=all">p.R7Q</a>
KCNU1	Nonsense_Mutation	p.W464*	G	G		8	Cancer Gene	8	36694337	36694337	172	0.25	NA	NA	NA			57	RCK N-terminal.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNU1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,36694337,G,G&fts=all">p.W464*</a>
KCNU1	Missense_Mutation	p.R704Q	G	G		8	Cancer Gene	8	36766833	36766833	311	0.241157556270096	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNU1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,36766833,G,G&fts=all">p.R704Q</a>
KCTD11	Missense_Mutation	p.R138W	C	C		8	Cancer Gene	17	7256673	7256673	119	0.0336134453781513	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7256673,C,C&fts=all">p.R138W</a>
KCTD18	Missense_Mutation	p.A311T	C	C		8	Cancer Gene	2	201355173	201355173	69	0.289855072463768	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,201355173,C,C&fts=all">p.A311T</a>
KCTD8	Nonsense_Mutation	p.Y471*	A	A		8	Cancer Gene	4	44176816	44176816	126	0.333333333333333	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,44176816,A,A&fts=all">p.Y471*</a>
KCTD8	Missense_Mutation	p.Y471C	T	T		8	Cancer Gene	4	44176817	44176817	125	0.336	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,44176817,T,T&fts=all">p.Y471C</a>
KCTD8	Missense_Mutation	p.S426F	G	G		8	Cancer Gene	4	44176952	44176952	219	0.397260273972603	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,44176952,G,G&fts=all">p.S426F</a>
KDM1B	Missense_Mutation	p.S80F	C	C		8	Cancer Gene	6	18163089	18163089	229	0.672489082969432	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,18163089,C,C&fts=all">p.S80F</a>
KDM3B	Missense_Mutation	p.R227C	C	C		8	Cancer Gene	5	137715371	137715371	168	0.416666666666667	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,137715371,C,C&fts=all">p.R227C</a>
KDM4C	Missense_Mutation	p.R241C	C	C	rs202012396	8	Cancer Gene	9	6888001	6888001	179	0.871508379888268	NA	NA	NA			43	JmjC. {ECO:0000255|PROSITE- ProRule:PRU00538}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM4C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,6888001,C,C&fts=all">p.R241C</a>
KDM5B	Missense_Mutation	p.F594V	A	A		8	Cancer Gene	1	202719828	202719828	438	0.226027397260274	NA	NA	NA			6	JmjC. {ECO:0000255|PROSITE- ProRule:PRU00538}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,202719828,A,A&fts=all">p.F594V</a>
KDM5B	Missense_Mutation	p.R380C	G	G		8	Cancer Gene	1	202727578	202727578	197	0.472081218274112	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,202727578,G,G&fts=all">p.R380C</a>
KDM6B	Missense_Mutation	p.S30F	C	C		8	Cancer Gene	17	7748961	7748961	134	0.783582089552239	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM6B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7748961,C,C&fts=all">p.S30F</a>
KERA	Missense_Mutation	p.G329E	C	C		8	Cancer Gene	12	91445196	91445196	89	0.235955056179775	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KERA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,91445196,C,C&fts=all">p.G329E</a>
KERA	Missense_Mutation	p.P139L	G	G		8	Cancer Gene	12	91449643	91449643	153	0.73202614379085	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KERA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,91449643,G,G&fts=all">p.P139L</a>
KERA	Missense_Mutation	p.L78F	G	G		8	Cancer Gene	12	91449827	91449827	124	0.314516129032258	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KERA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,91449827,G,G&fts=all">p.L78F</a>
KHDRBS2	Missense_Mutation	p.G340R	C	C	rs139583671	8	Cancer Gene	6	62390900	62390900	71	0.253521126760563	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KHDRBS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,62390900,C,C&fts=all">p.G340R</a>
KHDRBS2	Missense_Mutation	p.D312N	C	C		8	Cancer Gene	6	62407118	62407118	103	0.213592233009709	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KHDRBS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,62407118,C,C&fts=all">p.D312N</a>
KHDRBS2	Missense_Mutation	p.E265K	C	C		8	Cancer Gene	6	62604557	62604557	74	0.22972972972973	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KHDRBS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,62604557,C,C&fts=all">p.E265K</a>
KIAA0226	Nonsense_Mutation	p.Q271*	G	G		8	Cancer Gene	3	197427934	197427934	109	0.256880733944954	NA	NA	NA			31	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0226&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,197427934,G,G&fts=all">p.Q271*</a>
KIAA0232	Missense_Mutation	p.L105P	T	T		8	Cancer Gene	4	6843876	6843876	148	0.432432432432432	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0232&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,6843876,T,T&fts=all">p.L105P</a>
KIAA0408	Missense_Mutation	p.S339Y	G	G		8	Cancer Gene	6	127768448	127768448	169	0.443786982248521	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0408&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,127768448,G,G&fts=all">p.S339Y</a>
KIAA0930	Missense_Mutation	p.H133Y	G	G		8	Cancer Gene	22	45601528	45601528	88	0.170454545454545	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0930&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,45601528,G,G&fts=all">p.H133Y</a>
KIAA0947	Missense_Mutation	p.S1086F	C	C		8	Cancer Gene	5	5462704	5462704	184	0.244565217391304	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0947&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,5462704,C,C&fts=all">p.S1086F</a>
KIAA1024	Missense_Mutation	p.E221K	G	G	rs369106668	8	Cancer Gene	15	79749150	79749150	121	0.289256198347107	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1024&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,79749150,G,G&fts=all">p.E221K</a>
KIAA1024	Missense_Mutation	p.P321L	C	C		8	Cancer Gene	15	79749451	79749451	204	0.338235294117647	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1024&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,79749451,C,C&fts=all">p.P321L</a>
KIAA1109	Missense_Mutation	p.R994C	C	C	rs371237864	8	Cancer Gene	4	123150333	123150333	299	0.311036789297659	NA	NA	NA			172			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1109&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,123150333,C,C&fts=all">p.R994C</a>
KIAA1109	Missense_Mutation	p.P2390S	C	C		8	Cancer Gene	4	123185433	123185433	181	0.50828729281768	NA	NA	NA			172			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1109&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,123185433,C,C&fts=all">p.P2390S</a>
KIAA1109	Missense_Mutation	p.R4674C	C	C		8	Cancer Gene	4	123274229	123274229	180	0.188888888888889	NA	NA	NA			172			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1109&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,123274229,C,C&fts=all">p.R4674C</a>
KIAA1199	Missense_Mutation	p.A128V	C	C		8	Cancer Gene	15	81173243	81173243	204	0.32843137254902	NA	NA	NA			49	G8. {ECO:0000255|PROSITE- ProRule:PRU00817}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1199&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,81173243,C,C&fts=all">p.A128V</a>
KIAA1210	Missense_Mutation	p.P1247S	G	G		8	Cancer Gene	X	118221454	118221454	27	0.592592592592593	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1210&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,118221454,G,G&fts=all">p.P1247S</a>
KIAA1211	Missense_Mutation	p.P214S	C	C		8	Cancer Gene	4	57180308	57180308	28	0.392857142857143	NA	NA	NA			65	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1211&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,57180308,C,C&fts=all">p.P214S</a>
KIAA1217	Splice_Site	p.E279K	G	G		8	Cancer Gene	10	24784077	24784077	135	0.185185185185185	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1217&recr=Open">Click here</a>	
KIAA1324L	Missense_Mutation	p.G743E	C	C		8	Cancer Gene	7	86522373	86522373	209	0.076555023923445	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1324L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,86522373,C,C&fts=all">p.G743E</a>
KIAA1324L	Missense_Mutation	p.G743R	C	C		8	Cancer Gene	7	86522374	86522374	209	0.0813397129186603	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1324L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,86522374,C,C&fts=all">p.G743R</a>
KIAA1377	Missense_Mutation	p.S545F	C	C		8	Cancer Gene	11	101833400	101833400	81	0.0617283950617284	NA	NA	NA		p.S545F(1)	53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1377&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,101833400,C,C&fts=all">p.S545F</a>
KIAA1644	Missense_Mutation	p.G39D	C	C		8	Cancer Gene	22	44692717	44692717	148	0.25	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1644&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,44692717,C,C&fts=all">p.G39D</a>
KIAA1755	Missense_Mutation	p.P423L	G	G		8	Cancer Gene	20	36869265	36869265	151	0.172185430463576	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1755&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,36869265,G,G&fts=all">p.P423L</a>
KIAA1755	Missense_Mutation	p.P423S	G	G		8	Cancer Gene	20	36869266	36869266	154	0.168831168831169	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1755&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,36869266,G,G&fts=all">p.P423S</a>
KIAA1755	Missense_Mutation	p.P20L	G	G		8	Cancer Gene	20	36874473	36874473	53	0.283018867924528	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1755&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,36874473,G,G&fts=all">p.P20L</a>
KIAA1984	Missense_Mutation	p.M89I	G	G		8	Cancer Gene	9	139694239	139694239	27	0.296296296296296	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1984&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,139694239,G,G&fts=all">p.M89I</a>
KIAA2022	Missense_Mutation	p.G1441R	C	C		8	Cancer Gene	X	73960071	73960071	90	0.344444444444444	NA	NA	NA		p.G1441R(1)	109			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA2022&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,73960071,C,C&fts=all">p.G1441R</a>
KIAA2022	Missense_Mutation	p.E376K	C	C		8	Cancer Gene	X	73963266	73963266	76	0.434210526315789	NA	NA	NA			109			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA2022&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,73963266,C,C&fts=all">p.E376K</a>
KIF13B	Missense_Mutation	p.S1430F	G	G	rs373668415	8	Cancer Gene	8	28956685	28956685	326	0.199386503067485	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF13B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,28956685,G,G&fts=all">p.S1430F</a>
KIF13B	Missense_Mutation	p.R1126C	G	G		8	Cancer Gene	8	28980986	28980986	384	0.466145833333333	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF13B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,28980986,G,G&fts=all">p.R1126C</a>
KIF13B	Missense_Mutation	p.R847K	C	C		8	Cancer Gene	8	28997653	28997653	47	0.48936170212766	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF13B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,28997653,C,C&fts=all">p.R847K</a>
KIF16B	Missense_Mutation	p.E893K	C	C	rs550614292	8	Cancer Gene	20	16359970	16359970	115	0.226086956521739	NA	NA	NA			74	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF16B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,16359970,C,C&fts=all">p.E893K</a>
KIF17	Missense_Mutation	p.F576S	A	A		8	Cancer Gene	1	21014092	21014092	53	0.433962264150943	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,21014092,A,A&fts=all">p.F576S</a>
KIF19	Missense_Mutation	p.G970S	G	G		8	Cancer Gene	17	72351362	72351362	44	0.181818181818182	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72351362,G,G&fts=all">p.G970S</a>
KIF2B	Missense_Mutation	p.K122E	A	A		8	Cancer Gene	17	51900758	51900758	75	0.293333333333333	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,51900758,A,A&fts=all">p.K122E</a>
KIF2B	Missense_Mutation	p.K155T	A	A		8	Cancer Gene	17	51900858	51900858	82	0.426829268292683	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,51900858,A,A&fts=all">p.K155T</a>
KIF2B	Missense_Mutation	p.M190I	G	G		8	Cancer Gene	17	51900964	51900964	59	0.101694915254237	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,51900964,G,G&fts=all">p.M190I</a>
KIF4A	Nonsense_Mutation	p.R985*	C	C		8	Cancer Gene	X	69625732	69625732	83	0.530120481927711	NA	NA	NA		p.R985R(1)	51	Interaction with PRC1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF4A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,69625732,C,C&fts=all">p.R985*</a>
KIF4B	Missense_Mutation	p.R156C	C	C		8	Cancer Gene	5	154393885	154393885	125	0.496	NA	NA	NA			58	Kinesin motor. {ECO:0000255|PROSITE- ProRule:PRU00283}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF4B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,154393885,C,C&fts=all">p.R156C</a>
KIF5B	Missense_Mutation	p.L877F	C	C		8	Cancer Gene	10	32306201	32306201	296	0.0202702702702703	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,32306201,C,C&fts=all">p.L877F</a>
KIF6	Missense_Mutation	p.E474K	C	C	rs191227648	8	Cancer Gene	6	39512337	39512337	241	0.244813278008299	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,39512337,C,C&fts=all">p.E474K</a>
KIF6	Missense_Mutation	p.H230Y	G	G	rs199511584	8	Cancer Gene	6	39563988	39563988	239	0.221757322175732	NA	NA	NA			52	Kinesin motor. {ECO:0000255|PROSITE- ProRule:PRU00283}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,39563988,G,G&fts=all">p.H230Y</a>
KIF9	Missense_Mutation	p.P728S	G	G		8	Cancer Gene	3	47277559	47277559	77	0.233766233766234	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,47277559,G,G&fts=all">p.P728S</a>
KIR3DX1	Missense_Mutation	p.A208V	C	C		8	Cancer Gene	19	55047078	55047078	102	0.0882352941176471	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIR3DX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55047078,C,C&fts=all">p.A208V</a>
KIR3DX1	Splice_Site	p.G219G	A	A		8	Cancer Gene	19	55048090	55048090	26	0.153846153846154	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIR3DX1&recr=Open">Click here</a>	
KLB	Missense_Mutation	p.R475C	C	C		8	Cancer Gene	4	39439433	39439433	172	0.383720930232558	NA	NA	NA			29	Glycosyl hydrolase-1 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,39439433,C,C&fts=all">p.R475C</a>
KLF17	Missense_Mutation	p.S198F	C	C		8	Cancer Gene	1	44595536	44595536	57	0.368421052631579	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLF17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,44595536,C,C&fts=all">p.S198F</a>
KLHDC4	Missense_Mutation	p.G513R	C	C	rs143992884	8	Cancer Gene	16	87741983	87741983	54	0.259259259259259	NA	NA	NA		p.G513R(1)	21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHDC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,87741983,C,C&fts=all">p.G513R</a>
KLHDC7A	Missense_Mutation	p.T759I	C	C		8	Cancer Gene	1	18809751	18809751	40	0.35	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHDC7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,18809751,C,C&fts=all">p.T759I</a>
KLHL22	Nonsense_Mutation	p.R364*	G	G		8	Cancer Gene	22	20819167	20819167	115	0.260869565217391	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL22&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,20819167,G,G&fts=all">p.R364*</a>
KLHL36	Missense_Mutation	p.S305F	C	C		8	Cancer Gene	16	84691327	84691327	13	0.538461538461538	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL36&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,84691327,C,C&fts=all">p.S305F</a>
KLK14	Missense_Mutation	p.G207R	C	C		8	Cancer Gene	19	51582104	51582104	131	0.305343511450382	NA	NA	NA			11	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLK14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51582104,C,C&fts=all">p.G207R</a>
KLK7	Missense_Mutation	p.M249I	C	C		8	Cancer Gene	19	51480807	51480807	121	0.15702479338843	NA	NA	NA			19	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51480807,C,C&fts=all">p.M249I</a>
KLK7	Missense_Mutation	p.A95V	G	G		8	Cancer Gene	19	51483681	51483681	36	0.166666666666667	NA	NA	NA			19	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51483681,G,G&fts=all">p.A95V</a>
KLK8	Missense_Mutation	p.R164Q	C	C		8	Cancer Gene	19	51503254	51503254	19	0.421052631578947	NA	NA	NA		p.R209Q(1)	15	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLK8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51503254,C,C&fts=all">p.R164Q</a>
KLK9	Missense_Mutation	p.E85K	C	C		8	Cancer Gene	19	51509927	51509927	22	0.5	NA	NA	NA			7	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLK9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51509927,C,C&fts=all">p.E85K</a>
KPRP	Missense_Mutation	p.S381R	A	A		8	Cancer Gene	1	152733205	152733205	37	0.27027027027027	NA	NA	NA			60	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KPRP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152733205,A,A&fts=all">p.S381R</a>
KPRP	Nonsense_Mutation	p.Q390*	C	C		8	Cancer Gene	1	152733232	152733232	27	0.296296296296296	NA	NA	NA			60	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KPRP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152733232,C,C&fts=all">p.Q390*</a>
KPRP	Missense_Mutation	p.P528S	C	C		8	Cancer Gene	1	152733646	152733646	47	0.170212765957447	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KPRP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152733646,C,C&fts=all">p.P528S</a>
KRT222	Missense_Mutation	p.K106T	T	T		8	Cancer Gene	17	38816368	38816368	148	0.493243243243243	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT222&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,38816368,T,T&fts=all">p.K106T</a>
KRT23	Missense_Mutation	p.D81N	C	C		8	Cancer Gene	17	39092615	39092615	95	0.347368421052632	NA	NA	NA			21	Coil 1A.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT23&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,39092615,C,C&fts=all">p.D81N</a>
KRT24	Missense_Mutation	p.E322K	C	C	rs201916933	8	Cancer Gene	17	38856527	38856527	144	0.402777777777778	NA	NA	NA		p.E322K(1)	29	Coil 2.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT24&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,38856527,C,C&fts=all">p.E322K</a>
KRT25	Missense_Mutation	p.L426R	A	A		8	Cancer Gene	17	38904605	38904605	163	0.460122699386503	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,38904605,A,A&fts=all">p.L426R</a>
KRT25	Missense_Mutation	p.P63S	G	G		8	Cancer Gene	17	38911337	38911337	70	0.414285714285714	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,38911337,G,G&fts=all">p.P63S</a>
KRT37	Missense_Mutation	p.P61L	G	G		8	Cancer Gene	17	39580594	39580594	31	0.483870967741935	NA	NA	NA			25	Head.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT37&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,39580594,G,G&fts=all">p.P61L</a>
KRT38	Missense_Mutation	p.E371K	C	C		8	Cancer Gene	17	39594475	39594475	40	0.55	NA	NA	NA			29	Coil 2.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT38&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,39594475,C,C&fts=all">p.E371K</a>
KRT71	Missense_Mutation	p.V157G	A	A		8	Cancer Gene	12	52943999	52943999	42	0.285714285714286	NA	NA	NA			22	Coil 1A.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT71&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,52943999,A,A&fts=all">p.V157G</a>
KRT72	Missense_Mutation	p.F229L	A	A		8	Cancer Gene	12	52986691	52986691	40	0.525	NA	NA	NA			36	Coil 1B.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT72&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,52986691,A,A&fts=all">p.F229L</a>
KRT79	Missense_Mutation	p.S489F	G	G		8	Cancer Gene	12	53215798	53215798	20	0.45	NA	NA	NA			30	Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT79&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,53215798,G,G&fts=all">p.S489F</a>
KRT79	Missense_Mutation	p.G200S	C	C		8	Cancer Gene	12	53225290	53225290	28	0.321428571428571	NA	NA	NA			30	Coil 1B.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT79&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,53225290,C,C&fts=all">p.G200S</a>
KRTAP10-11	Missense_Mutation	p.P30S	C	C		8	Cancer Gene	21	46066463	46066463	26	0.192307692307692	NA	NA	NA			12	25 X 5 AA repeats of C-C-X(3).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP10-11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,46066463,C,C&fts=all">p.P30S</a>
KRTAP10-11	Missense_Mutation	p.S42F	C	C	rs199930012	8	Cancer Gene	21	46066500	46066500	24	0.166666666666667	NA	NA	NA			12	25 X 5 AA repeats of C-C-X(3).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP10-11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,46066500,C,C&fts=all">p.S42F</a>
KRTAP10-11	Missense_Mutation	p.S125L	C	C		8	Cancer Gene	21	46066749	46066749	71	0.323943661971831	NA	NA	NA			12	25 X 5 AA repeats of C-C-X(3).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP10-11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,46066749,C,C&fts=all">p.S125L</a>
KRTAP15-1	Nonsense_Mutation	p.Q133*	C	C		8	Cancer Gene	21	31813042	31813042	147	0.251700680272109	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP15-1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,31813042,C,C&fts=all">p.Q133*</a>
KRTAP19-3	Nonsense_Mutation	p.G45*	C	C		8	Cancer Gene	21	31864143	31864143	291	0.357388316151203	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP19-3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,31864143,C,C&fts=all">p.G45*</a>
KRTAP19-7	Missense_Mutation	p.G56E	C	C		8	Cancer Gene	21	31933442	31933442	190	0.268421052631579	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP19-7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,31933442,C,C&fts=all">p.G56E</a>
KRTAP26-1	Missense_Mutation	p.E77D	T	T		8	Cancer Gene	21	31692123	31692123	132	0.333333333333333	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP26-1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,31692123,T,T&fts=all">p.E77D</a>
KRTAP26-1	Nonsense_Mutation	p.W51*	C	C		8	Cancer Gene	21	31692201	31692201	192	0.234375	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP26-1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,31692201,C,C&fts=all">p.W51*</a>
L1TD1	Missense_Mutation	p.E120D	A	A		8	Cancer Gene	1	62672660	62672660	175	0.342857142857143	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+L1TD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62672660,A,A&fts=all">p.E120D</a>
L1TD1	Missense_Mutation	p.E416K	G	G	rs137939193	8	Cancer Gene	1	62675692	62675692	35	0.942857142857143	NA	NA	NA			35	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+L1TD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62675692,G,G&fts=all">p.E416K</a>
L1TD1	Missense_Mutation	p.E508K	G	G		8	Cancer Gene	1	62675968	62675968	57	0.929824561403509	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+L1TD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62675968,G,G&fts=all">p.E508K</a>
L1TD1	Nonsense_Mutation	p.E534*	G	G	rs146015306	8	Cancer Gene	1	62676046	62676046	61	0.327868852459016	NA	NA	NA		p.E534K(1)	35	Poly-Glu.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+L1TD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62676046,G,G&fts=all">p.E534*</a>
L1TD1	Missense_Mutation	p.K587E	A	A	rs150779448	8	Cancer Gene	1	62676205	62676205	97	0.278350515463918	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+L1TD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62676205,A,A&fts=all">p.K587E</a>
LAIR2	Missense_Mutation	p.D64N	G	G		8	Cancer Gene	19	55019225	55019225	41	0.0975609756097561	NA	NA	NA			18	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAIR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55019225,G,G&fts=all">p.D64N</a>
LARP1	Missense_Mutation	p.R398C	C	C		8	Cancer Gene	5	154179196	154179196	86	0.36046511627907	NA	NA	NA			33	HTH La-type RNA-binding. {ECO:0000255|PROSITE-ProRule:PRU00332}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LARP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,154179196,C,C&fts=all">p.R398C</a>
LARP4B	Missense_Mutation	p.P561S	G	G		8	Cancer Gene	10	863679	863679	404	0.188118811881188	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LARP4B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,863679,G,G&fts=all">p.P561S</a>
LATS1	Missense_Mutation	p.S267L	G	G		8	Cancer Gene	6	150005425	150005425	213	0.417840375586854	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LATS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,150005425,G,G&fts=all">p.S267L</a>
LCMT2	Missense_Mutation	p.S240F	G	G	rs200675491	8	Cancer Gene	15	43621969	43621969	82	0.292682926829268	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCMT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43621969,G,G&fts=all">p.S240F</a>
LCN8	Splice_Site	p.K8K	C	C		8	Cancer Gene	9	139652359	139652359	19	0.210526315789474	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCN8&recr=Open">Click here</a>	
LCT	Missense_Mutation	p.D1528V	T	T		8	Cancer Gene	2	136561580	136561580	129	0.581395348837209	NA	NA	NA			124	4 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,136561580,T,T&fts=all">p.D1528V</a>
LCT	Missense_Mutation	p.V861I	C	C		8	Cancer Gene	2	136567336	136567336	188	0.265957446808511	NA	NA	NA			124	4 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,136567336,C,C&fts=all">p.V861I</a>
LCT	Missense_Mutation	p.P701S	G	G		8	Cancer Gene	2	136570133	136570133	55	0.218181818181818	NA	NA	NA			124	4 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,136570133,G,G&fts=all">p.P701S</a>
LCTL	Missense_Mutation	p.G257E	C	C		8	Cancer Gene	15	66850212	66850212	165	0.266666666666667	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCTL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,66850212,C,C&fts=all">p.G257E</a>
LDLRAP1	Missense_Mutation	p.S202F	C	C	rs386629678|rs121908326	8	Cancer Gene	1	25889633	25889633	94	0.606382978723404	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LDLRAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,25889633,C,C&fts=all">p.S202F</a>
LDOC1L	Missense_Mutation	p.R111W	G	G		8	Cancer Gene	22	44893106	44893106	55	0.2	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LDOC1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,44893106,G,G&fts=all">p.R111W</a>
LELP1	Missense_Mutation	p.D20N	G	G		8	Cancer Gene	1	153177241	153177241	156	0.185897435897436	NA	NA	NA			19	Cys/Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LELP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,153177241,G,G&fts=all">p.D20N</a>
LEPREL1	Missense_Mutation	p.H652N	G	G		8	Cancer Gene	3	189681827	189681827	172	0.302325581395349	NA	NA	NA			41	Fe2OG dioxygenase. {ECO:0000255|PROSITE- ProRule:PRU00805}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LEPREL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,189681827,G,G&fts=all">p.H652N</a>
LGALS12	Missense_Mutation	p.A317V	C	C		8	Cancer Gene	11	63283801	63283801	19	0.421052631578947	NA	NA	NA			16	Galectin 2. {ECO:0000255|PROSITE- ProRule:PRU00639}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGALS12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,63283801,C,C&fts=all">p.A317V</a>
LGALS12	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	63283187	63342520	NA	NA	10	-1.2222962448729	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGALS12&recr=Open">Click here</a>	
LGI1	Missense_Mutation	p.R330Q	G	G		8	Cancer Gene	10	95556875	95556875	211	0.199052132701422	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,95556875,G,G&fts=all">p.R330Q</a>
LGI1	Missense_Mutation	p.T424S	A	A		8	Cancer Gene	10	95557156	95557156	202	0.0346534653465347	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,95557156,A,A&fts=all">p.T424S</a>
LGI1	Missense_Mutation	p.D467N	G	G		8	Cancer Gene	10	95557285	95557285	115	0.147826086956522	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,95557285,G,G&fts=all">p.D467N</a>
LGSN	Missense_Mutation	p.I212N	A	A	rs550011806	8	Cancer Gene	6	63990821	63990821	88	0.136363636363636	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGSN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,63990821,A,A&fts=all">p.I212N</a>
LGSN	Missense_Mutation	p.M73I	C	C		8	Cancer Gene	6	63995603	63995603	161	0.260869565217391	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGSN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,63995603,C,C&fts=all">p.M73I</a>
LHX6	Missense_Mutation	p.I330T	A	A		8	Cancer Gene	9	124975950	124975950	18	0.666666666666667	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LHX6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,124975950,A,A&fts=all">p.I330T</a>
LHX8	Missense_Mutation	p.S57C	C	C		8	Cancer Gene	1	75602849	75602849	17	0.941176470588235	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LHX8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,75602849,C,C&fts=all">p.S57C</a>
LHX8	Splice_Site	p.G204G	G	G	rs376728766	8	Cancer Gene	1	75609531	75609531	58	0.224137931034483	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LHX8&recr=Open">Click here</a>	
LILRA6	Missense_Mutation	p.G36D	C	C		8	Cancer Gene	19	54746150	54746150	63	0.0952380952380952	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,54746150,C,C&fts=all">p.G36D</a>
LIMA1	Missense_Mutation	p.R335C	G	G	rs373214767	8	Cancer Gene	12	50589640	50589640	59	0.542372881355932	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIMA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,50589640,G,G&fts=all">p.R335C</a>
LIMA1	Missense_Mutation	p.S228N	C	C		8	Cancer Gene	12	50599799	50599799	195	0.425641025641026	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIMA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,50599799,C,C&fts=all">p.S228N</a>
LINGO2	Missense_Mutation	p.P344S	G	G		8	Cancer Gene	9	27949640	27949640	33	0.96969696969697	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LINGO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,27949640,G,G&fts=all">p.P344S</a>
LIPI	Missense_Mutation	p.E404K	C	C		8	Cancer Gene	21	15517092	15517092	258	0.193798449612403	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIPI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,15517092,C,C&fts=all">p.E404K</a>
LIPI	Missense_Mutation	p.P111S	G	G		8	Cancer Gene	21	15561519	15561519	258	0.162790697674419	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIPI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,15561519,G,G&fts=all">p.P111S</a>
LIPK	Missense_Mutation	p.R165Q	G	G	rs200105124	8	Cancer Gene	10	90492006	90492006	192	0.1875	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIPK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,90492006,G,G&fts=all">p.R165Q</a>
LIPK	Missense_Mutation	p.P200L	C	C		8	Cancer Gene	10	90492238	90492238	354	0.242937853107345	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIPK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,90492238,C,C&fts=all">p.P200L</a>
LIPK	Missense_Mutation	p.S311F	C	C		8	Cancer Gene	10	90503050	90503050	58	0.224137931034483	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIPK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,90503050,C,C&fts=all">p.S311F</a>
LMAN2L	Missense_Mutation	p.P316L	G	G		8	Cancer Gene	2	97373126	97373126	19	0.473684210526316	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMAN2L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,97373126,G,G&fts=all">p.P316L</a>
LMBR1L	Missense_Mutation	p.L402I	G	G		8	Cancer Gene	12	49494207	49494207	120	0.316666666666667	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMBR1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,49494207,G,G&fts=all">p.L402I</a>
LMBRD2	Nonsense_Mutation	p.R595*	G	G		8	Cancer Gene	5	36110055	36110055	247	0.190283400809717	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMBRD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,36110055,G,G&fts=all">p.R595*</a>
LMBRD2	Missense_Mutation	p.P210S	G	G		8	Cancer Gene	5	36136530	36136530	246	0.451219512195122	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMBRD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,36136530,G,G&fts=all">p.P210S</a>
LMOD2	Missense_Mutation	p.G181E	G	G		8	Cancer Gene	7	123302182	123302182	16	0.5	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMOD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,123302182,G,G&fts=all">p.G181E</a>
LMX1A	Missense_Mutation	p.A162T	C	C		8	Cancer Gene	1	165218657	165218657	38	0.263157894736842	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMX1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,165218657,C,C&fts=all">p.A162T</a>
LNX1	Nonsense_Mutation	p.R438*	G	G		8	Cancer Gene	4	54362228	54362228	281	0.0782918149466192	NA	NA	NA			32	PDZ 2. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LNX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,54362228,G,G&fts=all">p.R438*</a>
LNX1	Copy Number	Amplified	NA	NA	NA	8	Cancer Gene	4	54440169	55161441	NA	NA	26	2.27139579394749	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LNX1&recr=Open">Click here</a>	
LONP2	Missense_Mutation	p.P465S	C	C		8	Cancer Gene	16	48329935	48329935	467	0.0364025695931477	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LONP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,48329935,C,C&fts=all">p.P465S</a>
LPAR5	Missense_Mutation	p.D169N	C	C		8	Cancer Gene	12	6729910	6729910	25	0.24	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPAR5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,6729910,C,C&fts=all">p.D169N</a>
LPAR5	Missense_Mutation	p.S11F	G	G		8	Cancer Gene	12	6730383	6730383	35	0.171428571428571	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPAR5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,6730383,G,G&fts=all">p.S11F</a>
LPIN3	Missense_Mutation	p.P109S	C	C		8	Cancer Gene	20	39977295	39977295	30	0.433333333333333	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPIN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,39977295,C,C&fts=all">p.P109S</a>
LPO	Splice_Site	p.R148R	G	G		8	Cancer Gene	17	56326927	56326927	36	0.5	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPO&recr=Open">Click here</a>	
LRAT	Missense_Mutation	p.R190C	C	C		8	Cancer Gene	4	155670163	155670163	296	0.290540540540541	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRAT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155670163,C,C&fts=all">p.R190C</a>
LRFN2	Missense_Mutation	p.R746Q	C	C	rs148074361	8	Cancer Gene	6	40359815	40359815	32	0.21875	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRFN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,40359815,C,C&fts=all">p.R746Q</a>
LRFN2	Missense_Mutation	p.I507N	A	A		8	Cancer Gene	6	40360532	40360532	18	0.833333333333333	NA	NA	NA			58	Fibronectin type-III. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRFN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,40360532,A,A&fts=all">p.I507N</a>
LRFN2	Missense_Mutation	p.G331E	C	C		8	Cancer Gene	6	40399861	40399861	32	0.75	NA	NA	NA			58	Ig-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRFN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,40399861,C,C&fts=all">p.G331E</a>
LRFN2	Missense_Mutation	p.S31F	G	G		8	Cancer Gene	6	40400761	40400761	46	0.217391304347826	NA	NA	NA			58	LRRNT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRFN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,40400761,G,G&fts=all">p.S31F</a>
LRFN3	Missense_Mutation	p.A111V	C	C		8	Cancer Gene	19	36430659	36430659	37	0.162162162162162	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRFN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36430659,C,C&fts=all">p.A111V</a>
LRFN5	Missense_Mutation	p.P230S	C	C	rs375396897	8	Cancer Gene	14	42356516	42356516	88	0.352272727272727	NA	NA	NA			120			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRFN5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,42356516,C,C&fts=all">p.P230S</a>
LRGUK	Missense_Mutation	p.P730L	C	C		8	Cancer Gene	7	133933819	133933819	226	0.0530973451327434	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRGUK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,133933819,C,C&fts=all">p.P730L</a>
LRIT2	Missense_Mutation	p.G531S	C	C		8	Cancer Gene	10	85981738	85981738	120	0.175	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRIT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,85981738,C,C&fts=all">p.G531S</a>
LRIT2	Missense_Mutation	p.G210E	C	C		8	Cancer Gene	10	85984352	85984352	42	0.214285714285714	NA	NA	NA			32	LRRCT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRIT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,85984352,C,C&fts=all">p.G210E</a>
LRIT3	Missense_Mutation	p.S390F	C	C		8	Cancer Gene	4	110791074	110791074	125	0.296	NA	NA	NA			16	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRIT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,110791074,C,C&fts=all">p.S390F</a>
LRP10	Nonsense_Mutation	p.Q74*	C	C		8	Cancer Gene	14	23344268	23344268	16	0.6875	NA	NA	NA			32	CUB 1. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,23344268,C,C&fts=all">p.Q74*</a>
LRRC15	Missense_Mutation	p.P424L	G	G		8	Cancer Gene	3	194080502	194080502	27	0.296296296296296	NA	NA	NA			42	LRRCT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,194080502,G,G&fts=all">p.P424L</a>
LRRC15	Missense_Mutation	p.P424S	G	G		8	Cancer Gene	3	194080503	194080503	27	0.259259259259259	NA	NA	NA			42	LRRCT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,194080503,G,G&fts=all">p.P424S</a>
LRRC15	Missense_Mutation	p.P72S	G	G		8	Cancer Gene	3	194081559	194081559	37	0.27027027027027	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,194081559,G,G&fts=all">p.P72S</a>
LRRC16A	Nonsense_Mutation	p.R247*	C	C		8	Cancer Gene	6	25471445	25471445	264	0.193181818181818	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC16A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,25471445,C,C&fts=all">p.R247*</a>
LRRC16A	Missense_Mutation	p.P1273S	C	C		8	Cancer Gene	6	25606471	25606471	56	0.160714285714286	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC16A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,25606471,C,C&fts=all">p.P1273S</a>
LRRC16B	Missense_Mutation	p.L1159F	C	C		8	Cancer Gene	14	24534909	24534909	73	0.835616438356164	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC16B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,24534909,C,C&fts=all">p.L1159F</a>
LRRC31	Missense_Mutation	p.G185E	C	C		8	Cancer Gene	3	169574594	169574594	156	0.25	NA	NA	NA		p.G185V(1)	31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,169574594,C,C&fts=all">p.G185E</a>
LRRC3B	Missense_Mutation	p.R124Q	G	G		8	Cancer Gene	3	26751534	26751534	91	0.263736263736264	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,26751534,G,G&fts=all">p.R124Q</a>
LRRC66	Missense_Mutation	p.K744N	C	C		8	Cancer Gene	4	52860956	52860956	107	0.0373831775700935	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC66&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,52860956,C,C&fts=all">p.K744N</a>
LRRC66	Missense_Mutation	p.P692L	G	G		8	Cancer Gene	4	52861113	52861113	67	0.164179104477612	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC66&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,52861113,G,G&fts=all">p.P692L</a>
LRRC66	Missense_Mutation	p.S675N	C	C		8	Cancer Gene	4	52861164	52861164	53	0.30188679245283	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC66&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,52861164,C,C&fts=all">p.S675N</a>
LRRC7	Missense_Mutation	p.E471K	G	G		8	Cancer Gene	1	70486792	70486792	303	0.488448844884488	NA	NA	NA			162			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,70486792,G,G&fts=all">p.E471K</a>
LRRC7	Missense_Mutation	p.G778E	G	G		8	Cancer Gene	1	70503954	70503954	234	0.918803418803419	NA	NA	NA			162			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,70503954,G,G&fts=all">p.G778E</a>
LRRC7	Missense_Mutation	p.S1178L	C	C		8	Cancer Gene	1	70505154	70505154	90	0.488888888888889	NA	NA	NA			162			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,70505154,C,C&fts=all">p.S1178L</a>
LRRIQ1	Missense_Mutation	p.L955F	C	C		8	Cancer Gene	12	85466852	85466852	92	0.304347826086957	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRIQ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,85466852,C,C&fts=all">p.L955F</a>
LRRIQ1	Missense_Mutation	p.S1484L	C	C	rs371713800	8	Cancer Gene	12	85546833	85546833	299	0.361204013377926	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRIQ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,85546833,C,C&fts=all">p.S1484L</a>
LRRIQ1	Missense_Mutation	p.S1594L	C	C		8	Cancer Gene	12	85554451	85554451	240	0.375	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRIQ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,85554451,C,C&fts=all">p.S1594L</a>
LRRIQ3	Nonsense_Mutation	p.R412*	T	T		8	Cancer Gene	1	74507381	74507381	212	0.320754716981132	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRIQ3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,74507381,T,T&fts=all">p.R412*</a>
LRRIQ3	Missense_Mutation	p.R399Q	C	C	rs202037480	8	Cancer Gene	1	74507419	74507419	200	0.29	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRIQ3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,74507419,C,C&fts=all">p.R399Q</a>
LRRIQ4	Missense_Mutation	p.P134L	C	C		8	Cancer Gene	3	169540110	169540110	52	0.25	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRIQ4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,169540110,C,C&fts=all">p.P134L</a>
LRRK1	Missense_Mutation	p.P1733S	C	C		8	Cancer Gene	15	101605839	101605839	50	0.26	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,101605839,C,C&fts=all">p.P1733S</a>
LRRTM3	Missense_Mutation	p.G245E	G	G		8	Cancer Gene	10	68687408	68687408	95	0.484210526315789	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRTM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,68687408,G,G&fts=all">p.G245E</a>
LSM10	Missense_Mutation	p.P85L	G	G		8	Cancer Gene	1	36859477	36859477	140	0.342857142857143	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LSM10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,36859477,G,G&fts=all">p.P85L</a>
LUZP4	Missense_Mutation	p.L238F	C	C		8	Cancer Gene	X	114541139	114541139	110	0.390909090909091	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LUZP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,114541139,C,C&fts=all">p.L238F</a>
MAB21L1	Missense_Mutation	p.K14I	T	T		8	Cancer Gene	13	36050235	36050235	122	0.647540983606557	NA	NA	NA		p.K14T(1)	20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAB21L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,36050235,T,T&fts=all">p.K14I</a>
MACROD2	Missense_Mutation	p.S241F	C	C		8	Cancer Gene	20	15843466	15843466	141	0.382978723404255	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MACROD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,15843466,C,C&fts=all">p.S241F</a>
MAGEA12	Missense_Mutation	p.S185F	G	G		8	Cancer Gene	X	151900247	151900247	124	0.5	NA	NA	NA			28	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEA12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,151900247,G,G&fts=all">p.S185F</a>
MAGEA8	Missense_Mutation	p.F150L	T	T		8	Cancer Gene	X	149013496	149013496	76	0.473684210526316	NA	NA	NA			20	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,149013496,T,T&fts=all">p.F150L</a>
MAGEB16	Missense_Mutation	p.E82K	G	G		8	Cancer Gene	X	35820557	35820557	19	0.421052631578947	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEB16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,35820557,G,G&fts=all">p.E82K</a>
MAGEB6	Missense_Mutation	p.S120L	C	C		8	Cancer Gene	X	26212322	26212322	60	0.483333333333333	NA	NA	NA			33	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEB6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,26212322,C,C&fts=all">p.S120L</a>
MAGEC2	Missense_Mutation	p.E68K	C	C		8	Cancer Gene	X	141291572	141291572	39	0.358974358974359	NA	NA	NA			47	Poly-Glu.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,141291572,C,C&fts=all">p.E68K</a>
MAGEC3	Missense_Mutation	p.L64F	C	C		8	Cancer Gene	X	140953323	140953323	72	0.444444444444444	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,140953323,C,C&fts=all">p.L64F</a>
MAGEC3	Missense_Mutation	p.E449K	G	G		8	Cancer Gene	X	140984889	140984889	26	0.423076923076923	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,140984889,G,G&fts=all">p.E449K</a>
MAML3	Missense_Mutation	p.R815K	C	C		8	Cancer Gene	4	140641450	140641450	45	0.155555555555556	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAML3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,140641450,C,C&fts=all">p.R815K</a>
MAML3	Missense_Mutation	p.P520L	G	G		8	Cancer Gene	4	140811031	140811031	142	0.323943661971831	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAML3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,140811031,G,G&fts=all">p.P520L</a>
MAN1A2	Missense_Mutation	p.S635L	C	C		8	Cancer Gene	1	118065557	118065557	267	0.689138576779026	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAN1A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,118065557,C,C&fts=all">p.S635L</a>
MAP1LC3B2	Missense_Mutation	p.R37Q	G	G		8	Cancer Gene	12	117013857	117013857	244	0.0245901639344262	NA	NA	NA		p.R37Q(1)	6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP1LC3B2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,117013857,G,G&fts=all">p.R37Q</a>
MAP3K4	Missense_Mutation	p.M117T	T	T	rs373098253	8	Cancer Gene	6	161469654	161469654	80	0.375	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,161469654,T,T&fts=all">p.M117T</a>
MAP3K4	Missense_Mutation	p.L1142F	C	C		8	Cancer Gene	6	161514880	161514880	111	0.522522522522523	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,161514880,C,C&fts=all">p.L1142F</a>
MAP3K9	Missense_Mutation	p.F701S	A	A		8	Cancer Gene	14	71197509	71197509	9	0.333333333333333	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,71197509,A,A&fts=all">p.F701S</a>
MAP7D2	Missense_Mutation	p.P357S	G	G		8	Cancer Gene	X	20044009	20044009	119	0.848739495798319	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP7D2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,20044009,G,G&fts=all">p.P357S</a>
MARCH1	Missense_Mutation	p.R152S	C	C		8	Cancer Gene	4	164466863	164466863	241	0.278008298755187	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,164466863,C,C&fts=all">p.R152S</a>
MARCH1	Missense_Mutation	p.S57N	C	C		8	Cancer Gene	4	164534538	164534538	136	0.294117647058824	NA	NA	NA			36	Responsible for low stability. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,164534538,C,C&fts=all">p.S57N</a>
MARCH10	Missense_Mutation	p.E124K	C	C	rs141415486	8	Cancer Gene	17	60837208	60837208	156	0.173076923076923	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARCH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,60837208,C,C&fts=all">p.E124K</a>
MARCH10	Missense_Mutation	p.E37K	C	C		8	Cancer Gene	17	60865942	60865942	245	0.151020408163265	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARCH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,60865942,C,C&fts=all">p.E37K</a>
MARVELD3	Missense_Mutation	p.S231F	C	C		8	Cancer Gene	16	71674389	71674389	65	0.230769230769231	NA	NA	NA			17	MARVEL. {ECO:0000255|PROSITE- ProRule:PRU00581}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARVELD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,71674389,C,C&fts=all">p.S231F</a>
MASP1	Splice_Site		C	C		8	Cancer Gene	3	186980330	186980330	89	0.280898876404494	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MASP1&recr=Open">Click here</a>	
MASP1	Nonsense_Mutation	p.W22*	C	C		8	Cancer Gene	3	187003706	187003706	173	0.236994219653179	NA	NA	NA			60	CUB 1. {ECO:0000255|PROSITE- ProRule:PRU00059}.|Homodimerization. {ECO:0000250}.|Interaction with FCN2.|Interaction with MBL2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MASP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,187003706,C,C&fts=all">p.W22*</a>
MASP2	Missense_Mutation	p.S312L	G	G		8	Cancer Gene	1	11097823	11097823	146	0.952054794520548	NA	NA	NA			23	Sushi 1. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MASP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,11097823,G,G&fts=all">p.S312L</a>
MAST1	Missense_Mutation	p.L504F	C	C		8	Cancer Gene	19	12975864	12975864	69	0.463768115942029	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAST1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,12975864,C,C&fts=all">p.L504F</a>
MAST4	Missense_Mutation	p.S929F	C	C		8	Cancer Gene	5	66440552	66440552	66	0.439393939393939	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAST4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,66440552,C,C&fts=all">p.S929F</a>
MAST4	Missense_Mutation	p.P1356L	C	C		8	Cancer Gene	5	66459074	66459074	97	0.45360824742268	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAST4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,66459074,C,C&fts=all">p.P1356L</a>
MAST4	Missense_Mutation	p.N2014S	A	A		8	Cancer Gene	5	66461048	66461048	12	0.5	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAST4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,66461048,A,A&fts=all">p.N2014S</a>
MATN2	Missense_Mutation	p.D768N	G	G		8	Cancer Gene	8	99040003	99040003	62	0.258064516129032	NA	NA	NA			31	VWFA 2. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MATN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,99040003,G,G&fts=all">p.D768N</a>
MATN4	Missense_Mutation	p.L520F	G	G	rs552513221	8	Cancer Gene	20	43926579	43926579	37	0.378378378378378	NA	NA	NA			27	VWFA 2. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MATN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,43926579,G,G&fts=all">p.L520F</a>
MAVS	Missense_Mutation	p.P431L	C	C		8	Cancer Gene	20	3846463	3846463	53	0.169811320754717	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAVS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,3846463,C,C&fts=all">p.P431L</a>
MB21D2	Missense_Mutation	p.R453C	G	G	rs368179622	8	Cancer Gene	3	192516294	192516294	167	0.0359281437125748	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MB21D2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,192516294,G,G&fts=all">p.R453C</a>
MBD6	Missense_Mutation	p.G646E	G	G		8	Cancer Gene	12	57920865	57920865	83	0.530120481927711	NA	NA	NA			31	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MBD6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,57920865,G,G&fts=all">p.G646E</a>
MC3R	Missense_Mutation	p.P24S	C	C		8	Cancer Gene	20	54823969	54823969	138	0.355072463768116	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MC3R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,54823969,C,C&fts=all">p.P24S</a>
MCMBP	Missense_Mutation	p.L350F	G	G		8	Cancer Gene	10	121602060	121602060	184	0.152173913043478	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCMBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,121602060,G,G&fts=all">p.L350F</a>
MCTP1	Missense_Mutation	p.R699Q	C	C	rs145448158	8	Cancer Gene	5	94207063	94207063	237	0.434599156118143	NA	NA	NA			41	C2 3. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCTP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,94207063,C,C&fts=all">p.R699Q</a>
MCTP2	Missense_Mutation	p.L23M	T	T		8	Cancer Gene	15	94841561	94841561	116	0.293103448275862	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCTP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,94841561,T,T&fts=all">p.L23M</a>
MCTP2	Missense_Mutation	p.R330Q	G	G	rs139457907	8	Cancer Gene	15	94888377	94888377	151	0.205298013245033	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCTP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,94888377,G,G&fts=all">p.R330Q</a>
MCTP2	Nonsense_Mutation	p.Q379*	C	C		8	Cancer Gene	15	94899495	94899495	91	0.274725274725275	NA	NA	NA			49	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCTP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,94899495,C,C&fts=all">p.Q379*</a>
MDFI	Missense_Mutation	p.P32L	C	C		8	Cancer Gene	6	41617375	41617375	147	0.183673469387755	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MDFI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,41617375,C,C&fts=all">p.P32L</a>
MDN1	Nonsense_Mutation	p.Q5339*	G	G		8	Cancer Gene	6	90360467	90360467	74	0.472972972972973	NA	NA	NA			218			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MDN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,90360467,G,G&fts=all">p.Q5339*</a>
MED13L	Missense_Mutation	p.R1325C	G	G	rs374881943	8	Cancer Gene	12	116425055	116425055	47	0.276595744680851	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED13L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,116425055,G,G&fts=all">p.R1325C</a>
MED16	Missense_Mutation	p.S352L	G	G	rs199592606	8	Cancer Gene	19	881645	881645	84	0.0952380952380952	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,881645,G,G&fts=all">p.S352L</a>
MED17	Missense_Mutation	p.Y256N	T	T		8	Cancer Gene	11	93527022	93527022	143	0.41958041958042	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,93527022,T,T&fts=all">p.Y256N</a>
MEFV	Missense_Mutation	p.E63K	C	C		8	Cancer Gene	16	3306401	3306401	67	0.522388059701492	NA	NA	NA			50	DAPIN. {ECO:0000255|PROSITE- ProRule:PRU00061}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEFV&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,3306401,C,C&fts=all">p.E63K</a>
MEGF10	Missense_Mutation	p.P96S	C	C		8	Cancer Gene	5	126676289	126676289	149	0.469798657718121	NA	NA	NA			68	EMI. {ECO:0000255|PROSITE- ProRule:PRU00384}.|Necessary for interaction with AP2M1, self-assembly and formation of the irregular, mosaic-like adhesion pattern.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGF10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,126676289,C,C&fts=all">p.P96S</a>
MEGF10	Nonsense_Mutation	p.W577*	G	G		8	Cancer Gene	5	126769092	126769092	94	0.425531914893617	NA	NA	NA		p.W577*(1)	68	EGF-like 11. {ECO:0000255|PROSITE- ProRule:PRU00076}.|Necessary for interaction with AP2M1, self-assembly and formation of the irregular, mosaic-like adhesion pattern.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGF10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,126769092,G,G&fts=all">p.W577*</a>
MEGF10	Missense_Mutation	p.F606Y	T	T		8	Cancer Gene	5	126769178	126769178	111	0.558558558558559	NA	NA	NA			68	EGF-like 11. {ECO:0000255|PROSITE- ProRule:PRU00076}.|Necessary for interaction with AP2M1, self-assembly and formation of the irregular, mosaic-like adhesion pattern.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGF10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,126769178,T,T&fts=all">p.F606Y</a>
MEGF6	Splice_Site		A	A		8	Cancer Gene	1	3511900	3511900	17	0.176470588235294	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGF6&recr=Open">Click here</a>	
MEI1	Missense_Mutation	p.P1096S	C	C		8	Cancer Gene	22	42180728	42180728	49	0.530612244897959	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,42180728,C,C&fts=all">p.P1096S</a>
MEP1B	Missense_Mutation	p.G446E	G	G		8	Cancer Gene	18	29793280	29793280	32	0.25	NA	NA	NA			23	MATH. {ECO:0000255|PROSITE- ProRule:PRU00129}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,29793280,G,G&fts=all">p.G446E</a>
MEP1B	Missense_Mutation	p.E566K	G	G		8	Cancer Gene	18	29795161	29795161	38	0.342105263157895	NA	NA	NA			23	MATH. {ECO:0000255|PROSITE- ProRule:PRU00129}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,29795161,G,G&fts=all">p.E566K</a>
METAP2	Missense_Mutation	p.T365I	C	C		8	Cancer Gene	12	95906602	95906602	88	0.477272727272727	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+METAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,95906602,C,C&fts=all">p.T365I</a>
MFSD4	Missense_Mutation	p.S293R	A	A		8	Cancer Gene	1	205554021	205554021	194	0.443298969072165	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MFSD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,205554021,A,A&fts=all">p.S293R</a>
MGAT4B	Missense_Mutation	p.S143L	G	G		8	Cancer Gene	5	179228464	179228464	14	0.642857142857143	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGAT4B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,179228464,G,G&fts=all">p.S143L</a>
MGAT4C	Missense_Mutation	p.S478A	A	A		8	Cancer Gene	12	86373072	86373072	63	0.380952380952381	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGAT4C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,86373072,A,A&fts=all">p.S478A</a>
MGAT4C	Missense_Mutation	p.D191N	C	C		8	Cancer Gene	12	86373933	86373933	136	0.441176470588235	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGAT4C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,86373933,C,C&fts=all">p.D191N</a>
MGAT5B	Missense_Mutation	p.E295V	A	A		8	Cancer Gene	17	74902128	74902128	76	0.631578947368421	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGAT5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,74902128,A,A&fts=all">p.E295V</a>
MGRN1	Missense_Mutation	p.P71S	C	C		8	Cancer Gene	16	4701967	4701967	91	0.263736263736264	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGRN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,4701967,C,C&fts=all">p.P71S</a>
MIA2	Missense_Mutation	p.K423R	A	A		8	Cancer Gene	14	39717046	39717046	120	0.391666666666667	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,39717046,A,A&fts=all">p.K423R</a>
MIA3	Missense_Mutation	p.S298L	C	C		8	Cancer Gene	1	222801455	222801455	267	0.179775280898876	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,222801455,C,C&fts=all">p.S298L</a>
MICALL2	Missense_Mutation	p.E860K	C	C		8	Cancer Gene	7	1476391	1476391	27	0.185185185185185	NA	NA	NA			19	Mediates interaction with RAB13 and is required for transition from the closed to the opened conformation. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MICALL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,1476391,C,C&fts=all">p.E860K</a>
MICALL2	Missense_Mutation	p.S503L	G	G	rs377542505	8	Cancer Gene	7	1482031	1482031	106	0.19811320754717	NA	NA	NA			19	Mediates targeting to the cell plasma membrane. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MICALL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,1482031,G,G&fts=all">p.S503L</a>
MID2	Missense_Mutation	p.R136Q	G	G		8	Cancer Gene	X	107084302	107084302	31	0.419354838709677	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,107084302,G,G&fts=all">p.R136Q</a>
MID2	Missense_Mutation	p.K500N	A	A		8	Cancer Gene	X	107167727	107167727	67	0.462686567164179	NA	NA	NA			19	Fibronectin type-III.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,107167727,A,A&fts=all">p.K500N</a>
MIOX	Missense_Mutation	p.V188I	G	G		8	Cancer Gene	22	50927700	50927700	23	0.217391304347826	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIOX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,50927700,G,G&fts=all">p.V188I</a>
MKRN2	Missense_Mutation	p.H346L	A	A		8	Cancer Gene	3	12623667	12623667	466	0.238197424892704	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKRN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,12623667,A,A&fts=all">p.H346L</a>
MKRN3	Missense_Mutation	p.E12K	G	G		8	Cancer Gene	15	23810963	23810963	18	0.277777777777778	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKRN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,23810963,G,G&fts=all">p.E12K</a>
MKRN3	Missense_Mutation	p.G15R	G	G		8	Cancer Gene	15	23810972	23810972	20	0.3	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKRN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,23810972,G,G&fts=all">p.G15R</a>
MLKL	Missense_Mutation	p.G74E	C	C		8	Cancer Gene	16	74729435	74729435	211	0.274881516587678	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLKL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,74729435,C,C&fts=all">p.G74E</a>
MMP26	Missense_Mutation	p.F61Y	T	T		8	Cancer Gene	11	5010960	5010960	26	0.5	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5010960,T,T&fts=all">p.F61Y</a>
MORC1	Missense_Mutation	p.E679K	C	C		8	Cancer Gene	3	108719493	108719493	208	0.0384615384615385	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MORC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,108719493,C,C&fts=all">p.E679K</a>
MORC1	Missense_Mutation	p.N515S	T	T		8	Cancer Gene	3	108751588	108751588	92	0.0543478260869565	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MORC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,108751588,T,T&fts=all">p.N515S</a>
MORC4	Nonsense_Mutation	p.Q115*	G	G	rs202090135	8	Cancer Gene	X	106229396	106229396	106	0.330188679245283	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MORC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,106229396,G,G&fts=all">p.Q115*</a>
MPHOSPH10	Missense_Mutation	p.P164L	C	C	rs537224547	8	Cancer Gene	2	71360429	71360429	431	0.148491879350348	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPHOSPH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,71360429,C,C&fts=all">p.P164L</a>
MPHOSPH9	Missense_Mutation	p.P845L	G	G		8	Cancer Gene	12	123651259	123651259	334	0.335329341317365	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPHOSPH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,123651259,G,G&fts=all">p.P845L</a>
MPP7	Missense_Mutation	p.S317L	G	G		8	Cancer Gene	10	28408582	28408582	260	0.442307692307692	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPP7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,28408582,G,G&fts=all">p.S317L</a>
MPP7	Missense_Mutation	p.G7E	C	C		8	Cancer Gene	10	28527514	28527514	88	0.204545454545455	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPP7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,28527514,C,C&fts=all">p.G7E</a>
MRPS21	Missense_Mutation	p.E16K	G	G		8	Cancer Gene	1	150266832	150266832	120	0.666666666666667	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRPS21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,150266832,G,G&fts=all">p.E16K</a>
MRVI1	Missense_Mutation	p.G828S	C	C		8	Cancer Gene	11	10602015	10602015	172	0.808139534883721	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRVI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,10602015,C,C&fts=all">p.G828S</a>
MS4A10	Missense_Mutation	p.H86Y	C	C		8	Cancer Gene	11	60558519	60558519	52	0.365384615384615	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MS4A10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,60558519,C,C&fts=all">p.H86Y</a>
MS4A15	Missense_Mutation	p.E64K	G	G		8	Cancer Gene	11	60531396	60531396	13	0.461538461538462	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MS4A15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,60531396,G,G&fts=all">p.E64K</a>
MSR1	Missense_Mutation	p.R326Q	C	C		8	Cancer Gene	8	16007796	16007796	231	0.225108225108225	NA	NA	NA		p.R308L(2)	37	Collagen-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,16007796,C,C&fts=all">p.R326Q</a>
MSR1	Missense_Mutation	p.G260E	C	C	rs369368505	8	Cancer Gene	8	16021666	16021666	173	0.260115606936416	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,16021666,C,C&fts=all">p.G260E</a>
MSR1	Missense_Mutation	p.E193K	C	C		8	Cancer Gene	8	16026074	16026074	229	0.0305676855895196	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,16026074,C,C&fts=all">p.E193K</a>
MSR1	Missense_Mutation	p.S182F	G	G		8	Cancer Gene	8	16026106	16026106	269	0.189591078066914	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,16026106,G,G&fts=all">p.S182F</a>
MSRB2	Missense_Mutation	p.G138R	G	G		8	Cancer Gene	10	23408348	23408348	278	0.0251798561151079	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSRB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,23408348,G,G&fts=all">p.G138R</a>
MSRB3	Missense_Mutation	p.S154L	C	C	rs267603630	8	Cancer Gene	12	65857005	65857005	134	0.328358208955224	NA	NA	NA		p.S161L(1)|p.S154L(1)	13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSRB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,65857005,C,C&fts=all">p.S154L</a>
MST4	Missense_Mutation	p.R290C	C	C		8	Cancer Gene	X	131205181	131205181	207	0.0821256038647343	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MST4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,131205181,C,C&fts=all">p.R290C</a>
MTERFD2	Missense_Mutation	p.S98F	G	G		8	Cancer Gene	2	242039038	242039038	136	0.257352941176471	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTERFD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,242039038,G,G&fts=all">p.S98F</a>
MTMR7	Missense_Mutation	p.G626R	C	C	rs188725371	8	Cancer Gene	8	17157478	17157478	118	0.423728813559322	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTMR7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,17157478,C,C&fts=all">p.G626R</a>
MTMR7	Missense_Mutation	p.N230S	T	T	rs140788515	8	Cancer Gene	8	17198915	17198915	63	0.238095238095238	NA	NA	NA			32	Myotubularin phosphatase. {ECO:0000255|PROSITE-ProRule:PRU00669}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTMR7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,17198915,T,T&fts=all">p.N230S</a>
MTMR7	Missense_Mutation	p.E134K	C	C		8	Cancer Gene	8	17218694	17218694	206	0.252427184466019	NA	NA	NA			32	Myotubularin phosphatase. {ECO:0000255|PROSITE-ProRule:PRU00669}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTMR7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,17218694,C,C&fts=all">p.E134K</a>
MTNR1A	Nonsense_Mutation	p.W93*	C	C		8	Cancer Gene	4	187455618	187455618	34	0.323529411764706	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTNR1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,187455618,C,C&fts=all">p.W93*</a>
MTUS2	Missense_Mutation	p.S20L	C	C		8	Cancer Gene	13	29598864	29598864	53	0.245283018867925	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTUS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,29598864,C,C&fts=all">p.S20L</a>
MTUS2	Missense_Mutation	p.G751E	G	G		8	Cancer Gene	13	29608038	29608038	38	0.210526315789474	NA	NA	NA			20	Mediates interaction with MAPRE1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTUS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,29608038,G,G&fts=all">p.G751E</a>
MTUS2	Missense_Mutation	p.E32K	G	G	rs199840497	8	Cancer Gene	13	30014159	30014159	26	0.307692307692308	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTUS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,30014159,G,G&fts=all">p.E32K</a>
MUC12	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	7	100491855	100693918	NA	NA	16	-1.06099915493049	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC12&recr=Open">Click here</a>	
MUC15	Splice_Site	p.E232K	C	C		8	Cancer Gene	11	26586712	26586712	104	0.855769230769231	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC15&recr=Open">Click here</a>	
MUC17	Missense_Mutation	p.E980K	G	G		8	Cancer Gene	7	100677635	100677635	134	0.395522388059701	NA	NA	NA		p.E980K(1)	343	59 X approximate tandem repeats.|Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,100677635,G,G&fts=all">p.E980K</a>
MUC17	Missense_Mutation	p.P3599L	C	C		8	Cancer Gene	7	100685493	100685493	69	0.420289855072464	NA	NA	NA			343	59 X approximate tandem repeats.|Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,100685493,C,C&fts=all">p.P3599L</a>
MUC17	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	7	100491855	100693918	NA	NA	16	-1.06099915493049	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC17&recr=Open">Click here</a>	
MUL1	Missense_Mutation	p.T185I	G	G		8	Cancer Gene	1	20827688	20827688	125	0.92	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,20827688,G,G&fts=all">p.T185I</a>
MUL1	Missense_Mutation	p.T121I	G	G		8	Cancer Gene	1	20827880	20827880	116	0.258620689655172	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,20827880,G,G&fts=all">p.T121I</a>
MUM1L1	Missense_Mutation	p.K211R	A	A		8	Cancer Gene	X	105450057	105450057	20	0.6	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUM1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,105450057,A,A&fts=all">p.K211R</a>
MYCT1	Missense_Mutation	p.R2Q	G	G		8	Cancer Gene	6	153019042	153019042	86	0.27906976744186	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,153019042,G,G&fts=all">p.R2Q</a>
MYF5	Missense_Mutation	p.E104K	G	G		8	Cancer Gene	12	81111152	81111152	17	0.411764705882353	NA	NA	NA		p.E104K(1)	30	bHLH. {ECO:0000255|PROSITE- ProRule:PRU00981}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYF5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,81111152,G,G&fts=all">p.E104K</a>
MYH13	Missense_Mutation	p.V1256I	C	C	rs373421683	8	Cancer Gene	17	10219315	10219315	56	0.303571428571429	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10219315,C,C&fts=all">p.V1256I</a>
MYH13	Missense_Mutation	p.E1088K	C	C		8	Cancer Gene	17	10223556	10223556	35	0.142857142857143	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10223556,C,C&fts=all">p.E1088K</a>
MYH13	Missense_Mutation	p.E925K	C	C		8	Cancer Gene	17	10227500	10227500	70	0.285714285714286	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10227500,C,C&fts=all">p.E925K</a>
MYH15	Nonsense_Mutation	p.Q622*	G	G		8	Cancer Gene	3	108182018	108182018	195	0.369230769230769	NA	NA	NA			105	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,108182018,G,G&fts=all">p.Q622*</a>
MYH15	Missense_Mutation	p.K69R	T	T		8	Cancer Gene	3	108224619	108224619	178	0.0561797752808989	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,108224619,T,T&fts=all">p.K69R</a>
MYH4	Missense_Mutation	p.E1673K	C	C		8	Cancer Gene	17	10350482	10350482	77	0.337662337662338	NA	NA	NA			149			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10350482,C,C&fts=all">p.E1673K</a>
MYH4	Missense_Mutation	p.G637E	C	C		8	Cancer Gene	17	10359860	10359860	116	0.241379310344828	NA	NA	NA			149	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10359860,C,C&fts=all">p.G637E</a>
MYH4	Missense_Mutation	p.R24Q	C	C		8	Cancer Gene	17	10369992	10369992	102	0.843137254901961	NA	NA	NA			149			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,10369992,C,C&fts=all">p.R24Q</a>
MYLK3	Missense_Mutation	p.P155S	G	G		8	Cancer Gene	16	46764587	46764587	96	0.0520833333333333	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYLK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,46764587,G,G&fts=all">p.P155S</a>
MYO18A	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO18A&recr=Open">Click here</a>	
MYO18B	Missense_Mutation	p.S1006F	C	C		8	Cancer Gene	22	26228921	26228921	107	0.177570093457944	NA	NA	NA			146	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO18B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,26228921,C,C&fts=all">p.S1006F</a>
MYO18B	Missense_Mutation	p.P1018L	C	C		8	Cancer Gene	22	26228957	26228957	88	0.477272727272727	NA	NA	NA			146	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO18B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,26228957,C,C&fts=all">p.P1018L</a>
MYO18B	Missense_Mutation	p.E2343K	G	G	rs370531504	8	Cancer Gene	22	26422964	26422964	66	0.242424242424242	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO18B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,26422964,G,G&fts=all">p.E2343K</a>
MYO18B	Missense_Mutation	p.R2373K	G	G		8	Cancer Gene	22	26423055	26423055	88	0.159090909090909	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO18B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,26423055,G,G&fts=all">p.R2373K</a>
MYO1F	Missense_Mutation	p.P981S	G	G		8	Cancer Gene	19	8587627	8587627	36	0.388888888888889	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8587627,G,G&fts=all">p.P981S</a>
MYO1F	Missense_Mutation	p.E612K	C	C		8	Cancer Gene	19	8601447	8601447	52	0.153846153846154	NA	NA	NA			42	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8601447,C,C&fts=all">p.E612K</a>
MYO1F	Missense_Mutation	p.P435S	G	G		8	Cancer Gene	19	8610587	8610587	121	0.0495867768595041	NA	NA	NA			42	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8610587,G,G&fts=all">p.P435S</a>
MYO1F	Missense_Mutation	p.M42I	C	C	rs373408110	8	Cancer Gene	19	8620558	8620558	54	0.111111111111111	NA	NA	NA			42	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8620558,C,C&fts=all">p.M42I</a>
MYO3B	Missense_Mutation	p.K1040E	A	A		8	Cancer Gene	2	171355205	171355205	120	0.225	NA	NA	NA			59	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,171355205,A,A&fts=all">p.K1040E</a>
MYO7A	Missense_Mutation	p.S295N	G	G		8	Cancer Gene	11	76869357	76869357	15	0.266666666666667	NA	NA	NA			64	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,76869357,G,G&fts=all">p.S295N</a>
MYO7A	Missense_Mutation	p.T1077I	C	C		8	Cancer Gene	11	76893590	76893590	28	0.928571428571429	NA	NA	NA			64	MyTH4 1. {ECO:0000255|PROSITE- ProRule:PRU00359}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,76893590,C,C&fts=all">p.T1077I</a>
MYO7B	Missense_Mutation	p.S183L	C	C		8	Cancer Gene	2	128327441	128327441	23	0.217391304347826	NA	NA	NA			75	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO7B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,128327441,C,C&fts=all">p.S183L</a>
MYO7B	Missense_Mutation	p.P898S	C	C		8	Cancer Gene	2	128366331	128366331	28	0.285714285714286	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO7B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,128366331,C,C&fts=all">p.P898S</a>
MYO7B	Missense_Mutation	p.D1295N	G	G		8	Cancer Gene	2	128381809	128381809	14	0.357142857142857	NA	NA	NA			75	FERM 1. {ECO:0000255|PROSITE- ProRule:PRU00084}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO7B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,128381809,G,G&fts=all">p.D1295N</a>
MYOCD	Splice_Site	p.E325K	G	G	rs138967735	8	Cancer Gene	17	12649237	12649237	121	0.338842975206612	NA	NA	NA		p.E325K(1)	70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOCD&recr=Open">Click here</a>	
MYOCD	Missense_Mutation	p.D373N	G	G		8	Cancer Gene	17	12649381	12649381	121	0.297520661157025	NA	NA	NA			70	SAP. {ECO:0000255|PROSITE- ProRule:PRU00186}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOCD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,12649381,G,G&fts=all">p.D373N</a>
MYPN	Splice_Site		G	G		8	Cancer Gene	10	69908225	69908225	107	0.177570093457944	NA	NA	NA			94			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYPN&recr=Open">Click here</a>	
MYPN	Missense_Mutation	p.T965I	C	C		8	Cancer Gene	10	69948852	69948852	126	0.174603174603175	NA	NA	NA			94	Ig-like 3.|Interaction with ACTN.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYPN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,69948852,C,C&fts=all">p.T965I</a>
MYPN	Missense_Mutation	p.P1188L	C	C		8	Cancer Gene	10	69961655	69961655	120	0.375	NA	NA	NA			94	Ig-like 5.|Interaction with ACTN.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYPN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,69961655,C,C&fts=all">p.P1188L</a>
MYSM1	Missense_Mutation	p.H358Y	G	G	rs201608056	8	Cancer Gene	1	59147644	59147644	400	0.3225	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYSM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,59147644,G,G&fts=all">p.H358Y</a>
N4BP2L2	Missense_Mutation	p.P349L	G	G		8	Cancer Gene	13	33110119	33110119	276	0.619565217391304	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+N4BP2L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,33110119,G,G&fts=all">p.P349L</a>
NAA25	Nonsense_Mutation	p.L631*	A	A		8	Cancer Gene	12	112485583	112485583	398	0.0301507537688442	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAA25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,112485583,A,A&fts=all">p.L631*</a>
NAALADL2	Missense_Mutation	p.G323E	G	G		8	Cancer Gene	3	175041992	175041992	340	0.214705882352941	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAALADL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,175041992,G,G&fts=all">p.G323E</a>
NACA2	Missense_Mutation	p.S117L	G	G		8	Cancer Gene	17	59668192	59668192	374	0.0320855614973262	NA	NA	NA		p.S117L(1)	12	NAC-A/B. {ECO:0000255|PROSITE- ProRule:PRU00507}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NACA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,59668192,G,G&fts=all">p.S117L</a>
NACA2	Nonsense_Mutation	p.W97*	C	C		8	Cancer Gene	17	59668251	59668251	450	0.677777777777778	NA	NA	NA		p.W97*(1)	12	NAC-A/B. {ECO:0000255|PROSITE- ProRule:PRU00507}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NACA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,59668251,C,C&fts=all">p.W97*</a>
NAF1	Missense_Mutation	p.F230I	A	A		8	Cancer Gene	4	164066963	164066963	178	0.258426966292135	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,164066963,A,A&fts=all">p.F230I</a>
NALCN	Missense_Mutation	p.R1650Q	C	C		8	Cancer Gene	13	101710365	101710365	69	0.246376811594203	NA	NA	NA			177			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NALCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,101710365,C,C&fts=all">p.R1650Q</a>
NALCN	Missense_Mutation	p.D1277N	C	C		8	Cancer Gene	13	101733934	101733934	147	0.312925170068027	NA	NA	NA			177			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NALCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,101733934,C,C&fts=all">p.D1277N</a>
NALCN	Missense_Mutation	p.I1124F	T	T		8	Cancer Gene	13	101742217	101742217	400	0.61	NA	NA	NA			177			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NALCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,101742217,T,T&fts=all">p.I1124F</a>
NALCN	Missense_Mutation	p.L1112F	G	G		8	Cancer Gene	13	101742253	101742253	433	0.247113163972286	NA	NA	NA			177			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NALCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,101742253,G,G&fts=all">p.L1112F</a>
NALCN	Missense_Mutation	p.A716T	C	C		8	Cancer Gene	13	101777005	101777005	280	0.257142857142857	NA	NA	NA			177			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NALCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,101777005,C,C&fts=all">p.A716T</a>
NALCN	Missense_Mutation	p.G112E	C	C		8	Cancer Gene	13	102030961	102030961	313	0.293929712460064	NA	NA	NA			177			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NALCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,102030961,C,C&fts=all">p.G112E</a>
NAT10	Missense_Mutation	p.I343M	T	T		8	Cancer Gene	11	34145869	34145869	104	0.807692307692308	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAT10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,34145869,T,T&fts=all">p.I343M</a>
NAV2	Missense_Mutation	p.R848Q	G	G	rs144524855	8	Cancer Gene	11	20005760	20005760	84	0.928571428571429	NA	NA	NA			116			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAV2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,20005760,G,G&fts=all">p.R848Q</a>
NAV3	Missense_Mutation	p.P448L	C	C		8	Cancer Gene	12	78400661	78400661	82	0.451219512195122	NA	NA	NA			236			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAV3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,78400661,C,C&fts=all">p.P448L</a>
NAV3	Missense_Mutation	p.P1218S	C	C		8	Cancer Gene	12	78513628	78513628	73	0.328767123287671	NA	NA	NA			236	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAV3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,78513628,C,C&fts=all">p.P1218S</a>
NAV3	Missense_Mutation	p.D2266E	T	T		8	Cancer Gene	12	78598744	78598744	62	0.516129032258065	NA	NA	NA			236			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAV3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,78598744,T,T&fts=all">p.D2266E</a>
NBAS	Missense_Mutation	p.A9V	G	G	rs541771140	8	Cancer Gene	2	15701403	15701403	232	0.323275862068966	NA	NA	NA			112			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NBAS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,15701403,G,G&fts=all">p.A9V</a>
NCAPH2	Missense_Mutation	p.S208F	C	C	rs139219191	8	Cancer Gene	22	50956684	50956684	81	0.283950617283951	NA	NA	NA		p.S208Y(1)	24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCAPH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,50956684,C,C&fts=all">p.S208F</a>
NCCRP1	Missense_Mutation	p.R188W	C	C	rs140484935	8	Cancer Gene	19	39690999	39690999	132	0.189393939393939	NA	NA	NA			10	FBA. {ECO:0000255|PROSITE- ProRule:PRU00482}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCCRP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39690999,C,C&fts=all">p.R188W</a>
NCK2	Missense_Mutation	p.P205L	C	C		8	Cancer Gene	2	106498171	106498171	101	0.366336633663366	NA	NA	NA			5	SH3 3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,106498171,C,C&fts=all">p.P205L</a>
NCKAP5	Missense_Mutation	p.D1244N	C	C		8	Cancer Gene	2	133540654	133540654	152	0.263157894736842	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCKAP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,133540654,C,C&fts=all">p.D1244N</a>
NCKAP5	Missense_Mutation	p.S928F	G	G		8	Cancer Gene	2	133541601	133541601	28	0.357142857142857	NA	NA	NA			118	Poly-Pro.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCKAP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,133541601,G,G&fts=all">p.S928F</a>
NCKAP5	Missense_Mutation	p.D509N	C	C	rs201204573	8	Cancer Gene	2	133542859	133542859	237	0.278481012658228	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCKAP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,133542859,C,C&fts=all">p.D509N</a>
NCKAP5	Missense_Mutation	p.P450L	G	G		8	Cancer Gene	2	133543035	133543035	63	0.634920634920635	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCKAP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,133543035,G,G&fts=all">p.P450L</a>
NCKAP5L	Missense_Mutation	p.S600I	C	C		8	Cancer Gene	12	50189844	50189844	21	0.428571428571429	NA	NA	NA			18	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCKAP5L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,50189844,C,C&fts=all">p.S600I</a>
NCKAP5L	Missense_Mutation	p.P441S	G	G		8	Cancer Gene	12	50190322	50190322	15	0.333333333333333	NA	NA	NA			18	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCKAP5L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,50190322,G,G&fts=all">p.P441S</a>
NCLN	Missense_Mutation	p.L216P	T	T		8	Cancer Gene	19	3198846	3198846	75	0.16	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCLN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,3198846,T,T&fts=all">p.L216P</a>
NCOA6	Missense_Mutation	p.P1259L	G	G		8	Cancer Gene	20	33330284	33330284	114	0.43859649122807	NA	NA	NA			107	NCOA1-binding region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCOA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,33330284,G,G&fts=all">p.P1259L</a>
NDNF	Missense_Mutation	p.G101E	C	C	rs267600004	8	Cancer Gene	4	121961096	121961096	54	0.222222222222222	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDNF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,121961096,C,C&fts=all">p.G101E</a>
NDST3	Missense_Mutation	p.N794I	A	A		8	Cancer Gene	4	119163286	119163286	251	0.557768924302789	NA	NA	NA			54	Heparan sulfate N-sulfotransferase 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDST3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,119163286,A,A&fts=all">p.N794I</a>
NDUFB9	Missense_Mutation	p.R47W	C	C		8	Cancer Gene	8	125555365	125555365	226	0.407079646017699	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDUFB9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,125555365,C,C&fts=all">p.R47W</a>
NECAB1	Missense_Mutation	p.E240K	G	G		8	Cancer Gene	8	91946556	91946556	7	0.571428571428571	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NECAB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,91946556,G,G&fts=all">p.E240K</a>
NEDD1	Missense_Mutation	p.P197S	C	C		8	Cancer Gene	12	97328853	97328853	188	0.351063829787234	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEDD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,97328853,C,C&fts=all">p.P197S</a>
NEDD1	Missense_Mutation	p.P197L	C	C		8	Cancer Gene	12	97328854	97328854	189	0.338624338624339	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEDD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,97328854,C,C&fts=all">p.P197L</a>
NEDD1	Missense_Mutation	p.R590C	C	C	rs200348451	8	Cancer Gene	12	97339584	97339584	158	0.449367088607595	NA	NA	NA		p.R590C(1)	22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEDD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,97339584,C,C&fts=all">p.R590C</a>
NEDD4L	Splice_Site	p.G17R	G	G		8	Cancer Gene	18	55833020	55833020	41	0.902439024390244	NA	NA	NA			37	C2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEDD4L&recr=Open">Click here</a>	
NEDD4L	Splice_Site	p.G17E	G	G		8	Cancer Gene	18	55833021	55833021	42	0.904761904761905	NA	NA	NA			37	C2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEDD4L&recr=Open">Click here</a>	
NES	Missense_Mutation	p.E1173K	C	C		8	Cancer Gene	1	156640463	156640463	137	0.0364963503649635	NA	NA	NA			64	Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NES&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,156640463,C,C&fts=all">p.E1173K</a>
NEU2	Missense_Mutation	p.T117I	C	C		8	Cancer Gene	2	233898974	233898974	23	0.565217391304348	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEU2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,233898974,C,C&fts=all">p.T117I</a>
NEURL4	Missense_Mutation	p.S1099F	G	G		8	Cancer Gene	17	7224495	7224495	48	0.4375	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEURL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7224495,G,G&fts=all">p.S1099F</a>
NFASC	Missense_Mutation	p.A300T	G	G		8	Cancer Gene	1	204938005	204938005	62	0.580645161290323	NA	NA	NA			81	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFASC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,204938005,G,G&fts=all">p.A300T</a>
NFASC	Missense_Mutation	p.F665C	T	T		8	Cancer Gene	1	204948505	204948505	121	0.603305785123967	NA	NA	NA			81	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFASC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,204948505,T,T&fts=all">p.F665C</a>
NFU1	Missense_Mutation	p.P157S	G	G		8	Cancer Gene	2	69642332	69642332	211	0.483412322274882	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFU1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,69642332,G,G&fts=all">p.P157S</a>
NKAIN2	Missense_Mutation	p.S152F	C	C		8	Cancer Gene	6	124979513	124979513	57	0.368421052631579	NA	NA	NA		p.S152F(1)	19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKAIN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,124979513,C,C&fts=all">p.S152F</a>
NKAIN2	Splice_Site		G	G		8	Cancer Gene	6	125144365	125144365	96	0.375	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKAIN2&recr=Open">Click here</a>	
NKAPL	Missense_Mutation	p.H44Y	C	C		8	Cancer Gene	6	28227279	28227279	89	0.157303370786517	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKAPL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28227279,C,C&fts=all">p.H44Y</a>
NLGN4X	Missense_Mutation	p.M789R	A	A		8	Cancer Gene	X	5810943	5810943	44	0.318181818181818	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLGN4X&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,5810943,A,A&fts=all">p.M789R</a>
NLK	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	25621463	26370357	NA	NA	46	-1.18672159545669	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLK&recr=Open">Click here</a>	
NLRP10	Missense_Mutation	p.A296V	G	G		8	Cancer Gene	11	7982272	7982272	81	0.345679012345679	NA	NA	NA			58	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,7982272,G,G&fts=all">p.A296V</a>
NLRP11	Missense_Mutation	p.D577N	C	C		8	Cancer Gene	19	56320247	56320247	117	0.487179487179487	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56320247,C,C&fts=all">p.D577N</a>
NLRP11	Missense_Mutation	p.R482K	C	C		8	Cancer Gene	19	56320531	56320531	108	0.324074074074074	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56320531,C,C&fts=all">p.R482K</a>
NLRP11	Nonsense_Mutation	p.Q133*	G	G	rs143725072	8	Cancer Gene	19	56321579	56321579	83	0.132530120481928	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56321579,G,G&fts=all">p.Q133*</a>
NLRP13	Missense_Mutation	p.E939K	C	C		8	Cancer Gene	19	56410278	56410278	75	0.44	NA	NA	NA			109			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56410278,C,C&fts=all">p.E939K</a>
NLRP13	Missense_Mutation	p.S675L	G	G		8	Cancer Gene	19	56423159	56423159	126	0.301587301587302	NA	NA	NA			109			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56423159,G,G&fts=all">p.S675L</a>
NLRP4	Missense_Mutation	p.S51F	C	C		8	Cancer Gene	19	56363598	56363598	100	0.22	NA	NA	NA			42	DAPIN. {ECO:0000255|PROSITE- ProRule:PRU00061}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56363598,C,C&fts=all">p.S51F</a>
NLRP4	Missense_Mutation	p.E53K	G	G	rs373426933	8	Cancer Gene	19	56363603	56363603	100	0.2	NA	NA	NA			42	DAPIN. {ECO:0000255|PROSITE- ProRule:PRU00061}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56363603,G,G&fts=all">p.E53K</a>
NLRP4	Missense_Mutation	p.D83N	G	G		8	Cancer Gene	19	56363693	56363693	77	0.103896103896104	NA	NA	NA			42	DAPIN. {ECO:0000255|PROSITE- ProRule:PRU00061}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56363693,G,G&fts=all">p.D83N</a>
NLRP4	Missense_Mutation	p.E511K	G	G		8	Cancer Gene	19	56370290	56370290	90	0.4	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56370290,G,G&fts=all">p.E511K</a>
NLRP4	Missense_Mutation	p.S678F	C	C		8	Cancer Gene	19	56373372	56373372	187	0.176470588235294	NA	NA	NA		p.S678Y(1)	42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56373372,C,C&fts=all">p.S678F</a>
NLRP5	Missense_Mutation	p.G654S	G	G		8	Cancer Gene	19	56539559	56539559	38	0.210526315789474	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56539559,G,G&fts=all">p.G654S</a>
NLRP5	Missense_Mutation	p.G654D	G	G		8	Cancer Gene	19	56539560	56539560	38	0.210526315789474	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56539560,G,G&fts=all">p.G654D</a>
NLRP5	Missense_Mutation	p.G845E	G	G		8	Cancer Gene	19	56544994	56544994	138	0.195652173913043	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56544994,G,G&fts=all">p.G845E</a>
NLRP5	Missense_Mutation	p.G910R	G	G		8	Cancer Gene	19	56549503	56549503	56	0.25	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56549503,G,G&fts=all">p.G910R</a>
NLRP7	Missense_Mutation	p.D860N	C	C		8	Cancer Gene	19	55445001	55445001	56	0.535714285714286	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55445001,C,C&fts=all">p.D860N</a>
NLRP7	Missense_Mutation	p.E593K	C	C		8	Cancer Gene	19	55450410	55450410	52	0.0769230769230769	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55450410,C,C&fts=all">p.E593K</a>
NLRP7	Missense_Mutation	p.E326K	C	C		8	Cancer Gene	19	55451211	55451211	11	0.545454545454545	NA	NA	NA			73	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55451211,C,C&fts=all">p.E326K</a>
NLRP8	Missense_Mutation	p.H502Y	C	C	rs560228163	8	Cancer Gene	19	56466928	56466928	159	0.0880503144654088	NA	NA	NA			35	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56466928,C,C&fts=all">p.H502Y</a>
NLRP8	Missense_Mutation	p.D881N	G	G		8	Cancer Gene	19	56485124	56485124	111	0.198198198198198	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56485124,G,G&fts=all">p.D881N</a>
NLRP9	Missense_Mutation	p.A390T	C	C		8	Cancer Gene	19	56244029	56244029	150	0.306666666666667	NA	NA	NA			74	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56244029,C,C&fts=all">p.A390T</a>
NMNAT3	Missense_Mutation	p.P48S	G	G		8	Cancer Gene	3	139297865	139297865	14	0.5	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NMNAT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,139297865,G,G&fts=all">p.P48S</a>
NOD1	Missense_Mutation	p.S51L	G	G		8	Cancer Gene	7	30496386	30496386	131	0.618320610687023	NA	NA	NA			39	CARD. {ECO:0000255|PROSITE- ProRule:PRU00046}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,30496386,G,G&fts=all">p.S51L</a>
NOP16	Missense_Mutation	p.T135I	G	G		8	Cancer Gene	5	175811274	175811274	88	0.465909090909091	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOP16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,175811274,G,G&fts=all">p.T135I</a>
NOP2	Missense_Mutation	p.R383G	G	G		8	Cancer Gene	12	6670878	6670878	43	0.186046511627907	NA	NA	NA		p.R383W(1)	19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,6670878,G,G&fts=all">p.R383G</a>
NOS1AP	Missense_Mutation	p.S256L	C	C		8	Cancer Gene	1	162326754	162326754	221	0.46606334841629	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOS1AP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,162326754,C,C&fts=all">p.S256L</a>
NOTCH4	Missense_Mutation	p.P1343S	G	G		8	Cancer Gene	6	32169006	32169006	89	0.202247191011236	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOTCH4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,32169006,G,G&fts=all">p.P1343S</a>
NOTCH4	Missense_Mutation	p.G1196E	C	C		8	Cancer Gene	6	32170021	32170021	40	0.225	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOTCH4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,32170021,C,C&fts=all">p.G1196E</a>
NPAS4	Missense_Mutation	p.E607K	G	G		8	Cancer Gene	11	66192180	66192180	69	0.391304347826087	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPAS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,66192180,G,G&fts=all">p.E607K</a>
NPBWR1	Missense_Mutation	p.D278N	G	G		8	Cancer Gene	8	53853299	53853299	20	0.35	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPBWR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,53853299,G,G&fts=all">p.D278N</a>
NPHP1	Missense_Mutation	p.F702L	A	A		8	Cancer Gene	2	110881400	110881400	92	0.630434782608696	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPHP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,110881400,A,A&fts=all">p.F702L</a>
NPSR1	Missense_Mutation	p.M154I	G	G		8	Cancer Gene	7	34851459	34851459	185	0.0594594594594595	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPSR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,34851459,G,G&fts=all">p.M154I</a>
NR1D2	Missense_Mutation	p.S49F	C	C		8	Cancer Gene	3	23996157	23996157	243	0.246913580246914	NA	NA	NA			22	Modulating.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NR1D2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,23996157,C,C&fts=all">p.S49F</a>
NRAP	Nonsense_Mutation	p.Q1537*	G	G		8	Cancer Gene	10	115351988	115351988	72	0.416666666666667	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,115351988,G,G&fts=all">p.Q1537*</a>
NRAP	Missense_Mutation	p.R1280C	G	G		8	Cancer Gene	10	115365598	115365598	274	0.240875912408759	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,115365598,G,G&fts=all">p.R1280C</a>
NRAP	Missense_Mutation	p.G558R	C	C		8	Cancer Gene	10	115391684	115391684	135	0.185185185185185	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,115391684,C,C&fts=all">p.G558R</a>
NUAK2	Missense_Mutation	p.T293I	G	G		8	Cancer Gene	1	205273587	205273587	28	0.5	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUAK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,205273587,G,G&fts=all">p.T293I</a>
NUDT17	Missense_Mutation	p.G233E	C	C		8	Cancer Gene	1	145587382	145587382	77	0.38961038961039	NA	NA	NA			9	Nudix hydrolase. {ECO:0000255|PROSITE- ProRule:PRU00794}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUDT17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,145587382,C,C&fts=all">p.G233E</a>
NVL	Missense_Mutation	p.R403W	G	G	rs549802292	8	Cancer Gene	1	224482087	224482087	125	0.184	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NVL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,224482087,G,G&fts=all">p.R403W</a>
NWD1	Missense_Mutation	p.E264K	G	G	rs373334984	8	Cancer Gene	19	16860243	16860243	36	0.388888888888889	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NWD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,16860243,G,G&fts=all">p.E264K</a>
NWD1	Missense_Mutation	p.S1011Y	C	C		8	Cancer Gene	19	16902252	16902252	57	0.175438596491228	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NWD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,16902252,C,C&fts=all">p.S1011Y</a>
NYNRIN	Missense_Mutation	p.S269F	C	C		8	Cancer Gene	14	24877682	24877682	11	0.909090909090909	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NYNRIN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,24877682,C,C&fts=all">p.S269F</a>
NYNRIN	Splice_Site	p.R915C	C	C		8	Cancer Gene	14	24882303	24882303	4	1	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NYNRIN&recr=Open">Click here</a>	
OBSCN	Missense_Mutation	p.P3486R	C	C		8	Cancer Gene	1	228473944	228473944	14	0.214285714285714	NA	NA	NA			223	Ig-like 35.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,228473944,C,C&fts=all">p.P3486R</a>
OBSCN	Missense_Mutation	p.R6018C	C	C		8	Cancer Gene	1	228509723	228509723	9	0.666666666666667	NA	NA	NA			223	Ig-like 52.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,228509723,C,C&fts=all">p.R6018C</a>
OCIAD2	Missense_Mutation	p.R7C	G	G		8	Cancer Gene	4	48906548	48906548	135	0.0592592592592593	NA	NA	NA			6	OCIA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OCIAD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,48906548,G,G&fts=all">p.R7C</a>
OCRL	Missense_Mutation	p.H174Y	C	C		8	Cancer Gene	X	128692690	128692690	160	0.925	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OCRL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,128692690,C,C&fts=all">p.H174Y</a>
OLFM3	Missense_Mutation	p.M17I	C	C		8	Cancer Gene	1	102312479	102312479	69	0.36231884057971	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OLFM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,102312479,C,C&fts=all">p.M17I</a>
OLFML3	Missense_Mutation	p.G329E	G	G		8	Cancer Gene	1	114524156	114524156	69	0.420289855072464	NA	NA	NA			14	Olfactomedin-like. {ECO:0000255|PROSITE- ProRule:PRU00446}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OLFML3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,114524156,G,G&fts=all">p.G329E</a>
OPN5	Missense_Mutation	p.E31K	G	G	rs146808238	8	Cancer Gene	6	47749893	47749893	247	0.234817813765182	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPN5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,47749893,G,G&fts=all">p.E31K</a>
OPN5	Missense_Mutation	p.D79N	G	G		8	Cancer Gene	6	47754355	47754355	212	0.207547169811321	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPN5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,47754355,G,G&fts=all">p.D79N</a>
OPN5	Missense_Mutation	p.I215L	A	A		8	Cancer Gene	6	47763186	47763186	141	0.269503546099291	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPN5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,47763186,A,A&fts=all">p.I215L</a>
OPN5	Nonsense_Mutation	p.E247*	G	G		8	Cancer Gene	6	47763282	47763282	133	0.639097744360902	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPN5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,47763282,G,G&fts=all">p.E247*</a>
OR10A6	Nonsense_Mutation	p.Q159*	G	G		8	Cancer Gene	11	7949735	7949735	112	0.419642857142857	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10A6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,7949735,G,G&fts=all">p.Q159*</a>
OR10A7	Missense_Mutation	p.A173V	C	C		8	Cancer Gene	12	55615326	55615326	100	0.35	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10A7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,55615326,C,C&fts=all">p.A173V</a>
OR10AG1	Missense_Mutation	p.S139F	G	G		8	Cancer Gene	11	55735524	55735524	57	0.368421052631579	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10AG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55735524,G,G&fts=all">p.S139F</a>
OR10AG1	Missense_Mutation	p.G81E	C	C		8	Cancer Gene	11	55735698	55735698	71	0.830985915492958	NA	NA	NA		p.G81E(1)	40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10AG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55735698,C,C&fts=all">p.G81E</a>
OR10G2	Nonsense_Mutation	p.Q178*	G	G		8	Cancer Gene	14	22102467	22102467	29	0.206896551724138	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10G2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,22102467,G,G&fts=all">p.Q178*</a>
OR10G4	Missense_Mutation	p.R226Q	G	G	rs11219408	8	Cancer Gene	11	123886958	123886958	44	0.863636363636364	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10G4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,123886958,G,G&fts=all">p.R226Q</a>
OR10G8	Missense_Mutation	p.L248F	C	C		8	Cancer Gene	11	123901071	123901071	68	0.308823529411765	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10G8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,123901071,C,C&fts=all">p.L248F</a>
OR10H4	Missense_Mutation	p.L287F	C	C		8	Cancer Gene	19	16060676	16060676	222	0.36036036036036	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10H4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,16060676,C,C&fts=all">p.L287F</a>
OR10J3	Missense_Mutation	p.R140M	C	C		8	Cancer Gene	1	159284031	159284031	94	0.138297872340426	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10J3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,159284031,C,C&fts=all">p.R140M</a>
OR10J5	Missense_Mutation	p.D298N	C	C		8	Cancer Gene	1	159504906	159504906	160	0.45625	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10J5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,159504906,C,C&fts=all">p.D298N</a>
OR10J5	Missense_Mutation	p.H159Y	G	G		8	Cancer Gene	1	159505323	159505323	150	0.453333333333333	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10J5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,159505323,G,G&fts=all">p.H159Y</a>
OR10K1	Missense_Mutation	p.G233E	G	G		8	Cancer Gene	1	158436049	158436049	114	0.192982456140351	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10K1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158436049,G,G&fts=all">p.G233E</a>
OR10K2	Missense_Mutation	p.S67F	G	G		8	Cancer Gene	1	158390457	158390457	149	0.288590604026846	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10K2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158390457,G,G&fts=all">p.S67F</a>
OR10Q1	Missense_Mutation	p.S247F	G	G		8	Cancer Gene	11	57995608	57995608	29	0.482758620689655	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10Q1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,57995608,G,G&fts=all">p.S247F</a>
OR10T2	Missense_Mutation	p.A189V	G	G		8	Cancer Gene	1	158368691	158368691	69	0.27536231884058	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10T2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158368691,G,G&fts=all">p.A189V</a>
OR11H4	Missense_Mutation	p.G106R	G	G		8	Cancer Gene	14	20711266	20711266	81	0.407407407407407	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR11H4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,20711266,G,G&fts=all">p.G106R</a>
OR12D2	Missense_Mutation	p.M160I	G	G		8	Cancer Gene	6	29364956	29364956	185	0.172972972972973	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR12D2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,29364956,G,G&fts=all">p.M160I</a>
OR12D3	Missense_Mutation	p.D178N	C	C		8	Cancer Gene	6	29342533	29342533	182	0.175824175824176	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR12D3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,29342533,C,C&fts=all">p.D178N</a>
OR13C3	Missense_Mutation	p.L144F	G	G		8	Cancer Gene	9	107298665	107298665	205	0.239024390243902	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR13C3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,107298665,G,G&fts=all">p.L144F</a>
OR14A16	Missense_Mutation	p.A293V	G	G	rs111974834	8	Cancer Gene	1	247978154	247978154	301	0.172757475083056	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR14A16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247978154,G,G&fts=all">p.A293V</a>
OR14A16	Missense_Mutation	p.P264H	G	G		8	Cancer Gene	1	247978241	247978241	168	0.547619047619048	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR14A16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247978241,G,G&fts=all">p.P264H</a>
OR14K1	Missense_Mutation	p.M312I	G	G		8	Cancer Gene	1	247902852	247902852	94	0.297872340425532	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR14K1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247902852,G,G&fts=all">p.M312I</a>
OR14K1	Missense_Mutation	p.K313N	A	A		8	Cancer Gene	1	247902855	247902855	90	0.466666666666667	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR14K1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247902855,A,A&fts=all">p.K313N</a>
OR1A1	Missense_Mutation	p.E3K	G	G		8	Cancer Gene	17	3118921	3118921	59	0.593220338983051	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,3118921,G,G&fts=all">p.E3K</a>
OR1A1	Missense_Mutation	p.S91F	C	C		8	Cancer Gene	17	3119186	3119186	48	0.1875	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,3119186,C,C&fts=all">p.S91F</a>
OR1A1	Missense_Mutation	p.R291K	G	G		8	Cancer Gene	17	3119786	3119786	124	0.709677419354839	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,3119786,G,G&fts=all">p.R291K</a>
OR1A2	Missense_Mutation	p.P209L	C	C		8	Cancer Gene	17	3101438	3101438	170	0.247058823529412	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,3101438,C,C&fts=all">p.P209L</a>
OR1C1	Nonsense_Mutation	p.Q143*	G	G		8	Cancer Gene	1	247921282	247921282	75	0.306666666666667	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247921282,G,G&fts=all">p.Q143*</a>
OR1C1	Missense_Mutation	p.L14F	G	G		8	Cancer Gene	1	247921669	247921669	47	0.340425531914894	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247921669,G,G&fts=all">p.L14F</a>
OR1L1	Missense_Mutation	p.P129S	C	C		8	Cancer Gene	9	125424379	125424379	153	0.274509803921569	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,125424379,C,C&fts=all">p.P129S</a>
OR1L1	Missense_Mutation	p.P129L	C	C		8	Cancer Gene	9	125424380	125424380	155	0.283870967741935	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,125424380,C,C&fts=all">p.P129L</a>
OR1L3	Missense_Mutation	p.V173A	T	T		8	Cancer Gene	9	125437926	125437926	185	0.232432432432432	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1L3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,125437926,T,T&fts=all">p.V173A</a>
OR1L3	Missense_Mutation	p.D180N	G	G		8	Cancer Gene	9	125437946	125437946	163	0.294478527607362	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1L3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,125437946,G,G&fts=all">p.D180N</a>
OR1L8	Start_Codon_SNP	p.M1I	C	C		8	Cancer Gene	9	125330754	125330754	40	0.25	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1L8&recr=Open">Click here</a>	
OR1M1	Missense_Mutation	p.L161F	C	C		8	Cancer Gene	19	9204401	9204401	63	0.476190476190476	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1M1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9204401,C,C&fts=all">p.L161F</a>
OR1N2	Missense_Mutation	p.G58E	G	G	rs369746985	8	Cancer Gene	9	125315621	125315621	51	0.176470588235294	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1N2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,125315621,G,G&fts=all">p.G58E</a>
OR1N2	Missense_Mutation	p.L272P	T	T		8	Cancer Gene	9	125316263	125316263	127	0.322834645669291	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1N2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,125316263,T,T&fts=all">p.L272P</a>
OR1Q1	Missense_Mutation	p.P229L	C	C		8	Cancer Gene	9	125377702	125377702	88	0.363636363636364	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1Q1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,125377702,C,C&fts=all">p.P229L</a>
OR2A2	Missense_Mutation	p.L62F	C	C		8	Cancer Gene	7	143806859	143806859	144	0.0555555555555556	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,143806859,C,C&fts=all">p.L62F</a>
OR2A2	Missense_Mutation	p.E159K	G	G		8	Cancer Gene	7	143807150	143807150	58	0.448275862068966	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,143807150,G,G&fts=all">p.E159K</a>
OR2A25	Missense_Mutation	p.G40E	G	G		8	Cancer Gene	7	143771431	143771431	52	0.384615384615385	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2A25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,143771431,G,G&fts=all">p.G40E</a>
OR2A5	Missense_Mutation	p.L154F	C	C		8	Cancer Gene	7	143747954	143747954	108	0.768518518518518	NA	NA	NA		p.L154F(1)|p.L154I(1)	38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,143747954,C,C&fts=all">p.L154F</a>
OR2B11	Missense_Mutation	p.M301I	C	C		8	Cancer Gene	1	247614382	247614382	420	0.39047619047619	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2B11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247614382,C,C&fts=all">p.M301I</a>
OR2B2	Missense_Mutation	p.D70N	C	C		8	Cancer Gene	6	27879890	27879890	127	0.173228346456693	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2B2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,27879890,C,C&fts=all">p.D70N</a>
OR2B6	Missense_Mutation	p.I246S	T	T		8	Cancer Gene	6	27925755	27925755	228	0.0263157894736842	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2B6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,27925755,T,T&fts=all">p.I246S</a>
OR2B6	Missense_Mutation	p.G271R	G	G	rs148039471	8	Cancer Gene	6	27925829	27925829	261	0.241379310344828	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2B6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,27925829,G,G&fts=all">p.G271R</a>
OR2C3	Missense_Mutation	p.S218F	G	G		8	Cancer Gene	1	247695161	247695161	75	0.306666666666667	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2C3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247695161,G,G&fts=all">p.S218F</a>
OR2F2	Missense_Mutation	p.A125V	C	C		8	Cancer Gene	7	143632699	143632699	70	0.5	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2F2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,143632699,C,C&fts=all">p.A125V</a>
OR2F2	Missense_Mutation	p.D175N	G	G		8	Cancer Gene	7	143632848	143632848	62	0.82258064516129	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2F2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,143632848,G,G&fts=all">p.D175N</a>
OR2G2	Missense_Mutation	p.S215L	C	C		8	Cancer Gene	1	247752305	247752305	162	0.154320987654321	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2G2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247752305,C,C&fts=all">p.S215L</a>
OR2G6	Missense_Mutation	p.S242L	C	C		8	Cancer Gene	1	248685672	248685672	215	0.409302325581395	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2G6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,248685672,C,C&fts=all">p.S242L</a>
OR2J2	Missense_Mutation	p.G109E	G	G		8	Cancer Gene	6	29141738	29141738	206	0.189320388349515	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2J2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,29141738,G,G&fts=all">p.G109E</a>
OR2K2	Missense_Mutation	p.G16R	C	C		8	Cancer Gene	9	114090668	114090668	72	0.263888888888889	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2K2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,114090668,C,C&fts=all">p.G16R</a>
OR2L13	Missense_Mutation	p.H164Y	C	C		8	Cancer Gene	1	248263167	248263167	318	0.0220125786163522	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2L13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,248263167,C,C&fts=all">p.H164Y</a>
OR2T1	Missense_Mutation	p.E246K	G	G		8	Cancer Gene	1	248570031	248570031	179	0.391061452513966	NA	NA	NA		p.E246K(1)	39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2T1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,248570031,G,G&fts=all">p.E246K</a>
OR2T10	Missense_Mutation	p.S22L	G	G		8	Cancer Gene	1	248757005	248757005	109	0.357798165137615	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2T10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,248757005,G,G&fts=all">p.S22L</a>
OR2T10	Missense_Mutation	p.T7I	G	G		8	Cancer Gene	1	248757050	248757050	80	0.325	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2T10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,248757050,G,G&fts=all">p.T7I</a>
OR2T6	Missense_Mutation	p.F27L	T	T		8	Cancer Gene	1	248550990	248550990	183	0.666666666666667	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2T6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,248550990,T,T&fts=all">p.F27L</a>
OR2Z1	Missense_Mutation	p.S147F	C	C		8	Cancer Gene	19	8841830	8841830	87	0.448275862068966	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2Z1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8841830,C,C&fts=all">p.S147F</a>
OR3A2	Missense_Mutation	p.Q202K	G	G		8	Cancer Gene	17	3181626	3181626	48	0.270833333333333	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR3A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,3181626,G,G&fts=all">p.Q202K</a>
OR4A15	Missense_Mutation	p.K332I	A	A		8	Cancer Gene	11	55136354	55136354	105	0.342857142857143	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4A15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55136354,A,A&fts=all">p.K332I</a>
OR4B1	Missense_Mutation	p.S91F	C	C	rs146153377	8	Cancer Gene	11	48238633	48238633	135	0.348148148148148	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,48238633,C,C&fts=all">p.S91F</a>
OR4B1	Missense_Mutation	p.P306S	C	C		8	Cancer Gene	11	48239277	48239277	29	0.517241379310345	NA	NA	NA		p.P306T(1)	28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,48239277,C,C&fts=all">p.P306S</a>
OR4C11	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	55371851	55419317	NA	NA	3	-2.52533034083906	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4C11&recr=Open">Click here</a>	
OR4C13	Missense_Mutation	p.F59Y	T	T		8	Cancer Gene	11	49974150	49974150	176	0.0625	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4C13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,49974150,T,T&fts=all">p.F59Y</a>
OR4C13	Missense_Mutation	p.L235F	C	C		8	Cancer Gene	11	49974677	49974677	110	0.381818181818182	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4C13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,49974677,C,C&fts=all">p.L235F</a>
OR4C15	Missense_Mutation	p.P220L	C	C		8	Cancer Gene	11	55322441	55322441	28	0.678571428571429	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4C15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55322441,C,C&fts=all">p.P220L</a>
OR4C6	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	55371851	55419317	NA	NA	3	-2.52533034083906	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4C6&recr=Open">Click here</a>	
OR4D5	Missense_Mutation	p.F251L	T	T		8	Cancer Gene	11	123811076	123811076	78	0.82051282051282	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4D5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,123811076,T,T&fts=all">p.F251L</a>
OR4E2	Missense_Mutation	p.P167L	C	C		8	Cancer Gene	14	22133796	22133796	110	0.381818181818182	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4E2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,22133796,C,C&fts=all">p.P167L</a>
OR4F6	Missense_Mutation	p.M40I	G	G		8	Cancer Gene	15	102346042	102346042	384	0.635416666666667	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4F6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,102346042,G,G&fts=all">p.M40I</a>
OR4K1	Missense_Mutation	p.S20T	T	T		8	Cancer Gene	14	20403883	20403883	468	0.442307692307692	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4K1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,20403883,T,T&fts=all">p.S20T</a>
OR4K1	Missense_Mutation	p.M112I	G	G		8	Cancer Gene	14	20404161	20404161	186	0.381720430107527	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4K1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,20404161,G,G&fts=all">p.M112I</a>
OR4K5	Missense_Mutation	p.D84E	T	T		8	Cancer Gene	14	20389017	20389017	476	0.407563025210084	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4K5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,20389017,T,T&fts=all">p.D84E</a>
OR4K5	Missense_Mutation	p.G252R	G	G		8	Cancer Gene	14	20389519	20389519	266	0.349624060150376	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4K5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,20389519,G,G&fts=all">p.G252R</a>
OR4K5	Missense_Mutation	p.M294I	G	G		8	Cancer Gene	14	20389647	20389647	373	0.428954423592493	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4K5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,20389647,G,G&fts=all">p.M294I</a>
OR4P4	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	55371851	55419317	NA	NA	3	-2.52533034083906	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4P4&recr=Open">Click here</a>	
OR4S1	Missense_Mutation	p.P278L	C	C		8	Cancer Gene	11	48328607	48328607	69	0.492753623188406	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4S1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,48328607,C,C&fts=all">p.P278L</a>
OR4S2	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	55371851	55419317	NA	NA	3	-2.52533034083906	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4S2&recr=Open">Click here</a>	
OR4X1	Missense_Mutation	p.S215F	C	C		8	Cancer Gene	11	48286056	48286056	26	0.769230769230769	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4X1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,48286056,C,C&fts=all">p.S215F</a>
OR51B2	Missense_Mutation	p.R125C	G	G	rs376911782	8	Cancer Gene	11	5345155	5345155	51	0.509803921568627	NA	NA	NA		p.R125S(2)	35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51B2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5345155,G,G&fts=all">p.R125C</a>
OR51B4	Missense_Mutation	p.A310V	G	G		8	Cancer Gene	11	5322248	5322248	43	0.372093023255814	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51B4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5322248,G,G&fts=all">p.A310V</a>
OR51F2	Missense_Mutation	p.N56D	A	A		8	Cancer Gene	11	4842781	4842781	132	0.409090909090909	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51F2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,4842781,A,A&fts=all">p.N56D</a>
OR51G1	Missense_Mutation	p.P97L	G	G		8	Cancer Gene	11	4945280	4945280	26	0.461538461538462	NA	NA	NA		p.P97H(1)|p.P97N(1)	25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51G1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,4945280,G,G&fts=all">p.P97L</a>
OR51G2	Missense_Mutation	p.R156C	G	G		8	Cancer Gene	11	4936428	4936428	41	0.853658536585366	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51G2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,4936428,G,G&fts=all">p.R156C</a>
OR51I1	Missense_Mutation	p.E300K	C	C	rs267602954	8	Cancer Gene	11	5461847	5461847	101	0.405940594059406	NA	NA	NA		p.E300*(1)	30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51I1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5461847,C,C&fts=all">p.E300K</a>
OR52A5	Missense_Mutation	p.L256H	A	A		8	Cancer Gene	11	5153106	5153106	101	0.386138613861386	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5153106,A,A&fts=all">p.L256H</a>
OR52A5	Missense_Mutation	p.E54K	C	C		8	Cancer Gene	11	5153713	5153713	84	0.452380952380952	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5153713,C,C&fts=all">p.E54K</a>
OR52J3	Missense_Mutation	p.H4Y	C	C		8	Cancer Gene	11	5067765	5067765	116	0.353448275862069	NA	NA	NA		p.H4Y(1)	36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52J3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5067765,C,C&fts=all">p.H4Y</a>
OR52J3	Missense_Mutation	p.L276R	T	T		8	Cancer Gene	11	5068582	5068582	129	0.356589147286822	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52J3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5068582,T,T&fts=all">p.L276R</a>
OR52L1	Missense_Mutation	p.G311E	C	C		8	Cancer Gene	11	6007229	6007229	12	0.916666666666667	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,6007229,C,C&fts=all">p.G311E</a>
OR56B1	Frame_Shift_Del	p.L307fs	TT	TT		8	Cancer Gene	11	5758666	5758667	137	0.795620437956204	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR56B1&recr=Open">Click here</a>	
OR5A1	Nonsense_Mutation	p.W90*	G	G		8	Cancer Gene	11	59210910	59210910	71	0.464788732394366	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,59210910,G,G&fts=all">p.W90*</a>
OR5AN1	Missense_Mutation	p.W42R	T	T		8	Cancer Gene	11	59132055	59132055	124	0.411290322580645	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5AN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,59132055,T,T&fts=all">p.W42R</a>
OR5AN1	Missense_Mutation	p.P80S	C	C		8	Cancer Gene	11	59132169	59132169	179	0.407821229050279	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5AN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,59132169,C,C&fts=all">p.P80S</a>
OR5B12	Missense_Mutation	p.G231R	C	C		8	Cancer Gene	11	58206934	58206934	56	0.0714285714285714	NA	NA	NA		p.G231*(1)	40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5B12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,58206934,C,C&fts=all">p.G231R</a>
OR5B12	Missense_Mutation	p.G42E	C	C		8	Cancer Gene	11	58207500	58207500	40	0.35	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5B12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,58207500,C,C&fts=all">p.G42E</a>
OR5H1	Missense_Mutation	p.V311A	T	T		8	Cancer Gene	3	97852473	97852473	71	0.352112676056338	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5H1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,97852473,T,T&fts=all">p.V311A</a>
OR5H14	Missense_Mutation	p.L215F	C	C		8	Cancer Gene	3	97868872	97868872	52	0.346153846153846	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5H14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,97868872,C,C&fts=all">p.L215F</a>
OR5H14	Missense_Mutation	p.R235K	G	G		8	Cancer Gene	3	97868933	97868933	49	0.326530612244898	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5H14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,97868933,G,G&fts=all">p.R235K</a>
OR5H6	Missense_Mutation	p.F118Y	T	T		8	Cancer Gene	3	97983481	97983481	91	0.373626373626374	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5H6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,97983481,T,T&fts=all">p.F118Y</a>
OR5H6	Missense_Mutation	p.P303S	C	C		8	Cancer Gene	3	97984035	97984035	115	0.0347826086956522	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5H6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,97984035,C,C&fts=all">p.P303S</a>
OR5I1	Missense_Mutation	p.F63L	A	A	rs199577612	8	Cancer Gene	11	55703688	55703688	71	0.408450704225352	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5I1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55703688,A,A&fts=all">p.F63L</a>
OR5I1	Missense_Mutation	p.F63S	A	A		8	Cancer Gene	11	55703689	55703689	71	0.408450704225352	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5I1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55703689,A,A&fts=all">p.F63S</a>
OR5K3	Missense_Mutation	p.S74F	C	C		8	Cancer Gene	3	98109730	98109730	233	0.351931330472103	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5K3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,98109730,C,C&fts=all">p.S74F</a>
OR5L1	Missense_Mutation	p.G152R	G	G		8	Cancer Gene	11	55579396	55579396	88	0.363636363636364	NA	NA	NA		p.G152R(1)	78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55579396,G,G&fts=all">p.G152R</a>
OR5L1	Missense_Mutation	p.P283S	C	C	rs368833257	8	Cancer Gene	11	55579789	55579789	60	0.233333333333333	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55579789,C,C&fts=all">p.P283S</a>
OR5L2	Missense_Mutation	p.A116V	C	C		8	Cancer Gene	11	55595041	55595041	93	0.494623655913978	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55595041,C,C&fts=all">p.A116V</a>
OR5M8	Missense_Mutation	p.P282S	G	G		8	Cancer Gene	11	56258003	56258003	111	0.468468468468468	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5M8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,56258003,G,G&fts=all">p.P282S</a>
OR5P2	Missense_Mutation	p.S239F	G	G		8	Cancer Gene	11	7817774	7817774	66	0.363636363636364	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5P2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,7817774,G,G&fts=all">p.S239F</a>
OR5R1	Missense_Mutation	p.P183L	G	G		8	Cancer Gene	11	56185161	56185161	69	0.434782608695652	NA	NA	NA		p.P183H(1)	37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5R1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,56185161,G,G&fts=all">p.P183L</a>
OR5T3	Missense_Mutation	p.N202T	A	A		8	Cancer Gene	11	56020280	56020280	173	0.352601156069364	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5T3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,56020280,A,A&fts=all">p.N202T</a>
OR6C1	Missense_Mutation	p.S70L	C	C		8	Cancer Gene	12	55714592	55714592	66	0.53030303030303	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,55714592,C,C&fts=all">p.S70L</a>
OR6C2	Missense_Mutation	p.M152I	G	G		8	Cancer Gene	12	55846453	55846453	101	0.415841584158416	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,55846453,G,G&fts=all">p.M152I</a>
OR6C2	Missense_Mutation	p.E165K	G	G	rs140332483	8	Cancer Gene	12	55846490	55846490	117	0.35042735042735	NA	NA	NA		p.E165K(1)	23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,55846490,G,G&fts=all">p.E165K</a>
OR6C65	Missense_Mutation	p.P227S	C	C		8	Cancer Gene	12	55794991	55794991	146	0.410958904109589	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C65&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,55794991,C,C&fts=all">p.P227S</a>
OR6C76	Start_Codon_SNP	p.M1I	G	G		8	Cancer Gene	12	55820040	55820040	97	0.43298969072165	NA	NA	NA		p.M1I(1)	14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C76&recr=Open">Click here</a>	
OR6K2	Missense_Mutation	p.H104Y	G	G		8	Cancer Gene	1	158670133	158670133	85	0.223529411764706	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6K2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158670133,G,G&fts=all">p.H104Y</a>
OR6N1	Missense_Mutation	p.S204F	G	G		8	Cancer Gene	1	158735862	158735862	152	0.131578947368421	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6N1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158735862,G,G&fts=all">p.S204F</a>
OR6N1	Missense_Mutation	p.G4R	C	C		8	Cancer Gene	1	158736463	158736463	22	0.681818181818182	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6N1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158736463,C,C&fts=all">p.G4R</a>
OR6N2	Missense_Mutation	p.A117D	G	G		8	Cancer Gene	1	158747076	158747076	98	0.193877551020408	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6N2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158747076,G,G&fts=all">p.A117D</a>
OR6N2	Missense_Mutation	p.S93F	G	G		8	Cancer Gene	1	158747148	158747148	139	0.431654676258993	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6N2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158747148,G,G&fts=all">p.S93F</a>
OR6Q1	Missense_Mutation	p.R126C	C	C		8	Cancer Gene	11	57798800	57798800	89	0.370786516853933	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6Q1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,57798800,C,C&fts=all">p.R126C</a>
OR6S1	Missense_Mutation	p.F260S	A	A		8	Cancer Gene	14	21109072	21109072	42	0.452380952380952	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6S1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,21109072,A,A&fts=all">p.F260S</a>
OR6X1	Missense_Mutation	p.E68K	C	C		8	Cancer Gene	11	123625025	123625025	67	0.358208955223881	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6X1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,123625025,C,C&fts=all">p.E68K</a>
OR7C2	Missense_Mutation	p.M296I	G	G		8	Cancer Gene	19	15053188	15053188	71	0.352112676056338	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7C2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,15053188,G,G&fts=all">p.M296I</a>
OR7D2	Missense_Mutation	p.S161F	C	C	rs202179153	8	Cancer Gene	19	9296939	9296939	132	0.212121212121212	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7D2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9296939,C,C&fts=all">p.S161F</a>
OR7D4	Missense_Mutation	p.G242E	C	C		8	Cancer Gene	19	9324789	9324789	33	0.333333333333333	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7D4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9324789,C,C&fts=all">p.G242E</a>
OR7D4	Missense_Mutation	p.L6F	G	G		8	Cancer Gene	19	9325498	9325498	62	0.193548387096774	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7D4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9325498,G,G&fts=all">p.L6F</a>
OR7E24	Missense_Mutation	p.G271E	G	G		8	Cancer Gene	19	9362531	9362531	42	0.214285714285714	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7E24&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9362531,G,G&fts=all">p.G271E</a>
OR7G2	Missense_Mutation	p.T240I	G	G		8	Cancer Gene	19	9213264	9213264	64	0.328125	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7G2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9213264,G,G&fts=all">p.T240I</a>
OR7G3	Missense_Mutation	p.F311I	A	A		8	Cancer Gene	19	9236696	9236696	44	0.454545454545455	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7G3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9236696,A,A&fts=all">p.F311I</a>
OR7G3	Missense_Mutation	p.K139N	T	T		8	Cancer Gene	19	9237210	9237210	32	0.125	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7G3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9237210,T,T&fts=all">p.K139N</a>
OR7G3	Missense_Mutation	p.C72R	A	A		8	Cancer Gene	19	9237413	9237413	73	0.273972602739726	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7G3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9237413,A,A&fts=all">p.C72R</a>
OR8B4	Missense_Mutation	p.R121C	G	G	rs371189371	8	Cancer Gene	11	124294407	124294407	60	0.816666666666667	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8B4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,124294407,G,G&fts=all">p.R121C</a>
OR8D1	Missense_Mutation	p.G307E	C	C		8	Cancer Gene	11	124179743	124179743	70	0.414285714285714	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8D1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,124179743,C,C&fts=all">p.G307E</a>
OR8D4	Missense_Mutation	p.F153I	T	T		8	Cancer Gene	11	123777595	123777595	106	0.509433962264151	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8D4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,123777595,T,T&fts=all">p.F153I</a>
OR8I2	Missense_Mutation	p.S156L	C	C		8	Cancer Gene	11	55861250	55861250	132	0.424242424242424	NA	NA	NA		p.S156*(1)	53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8I2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55861250,C,C&fts=all">p.S156L</a>
OR8I2	Missense_Mutation	p.S265L	C	C		8	Cancer Gene	11	55861577	55861577	87	0.379310344827586	NA	NA	NA		p.S265*(1)	53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8I2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55861577,C,C&fts=all">p.S265L</a>
OR8K1	Missense_Mutation	p.P268L	C	C		8	Cancer Gene	11	56114317	56114317	122	0.278688524590164	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8K1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,56114317,C,C&fts=all">p.P268L</a>
OR8K5	Missense_Mutation	p.S239F	G	G		8	Cancer Gene	11	55927078	55927078	89	0.460674157303371	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8K5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55927078,G,G&fts=all">p.S239F</a>
OR8K5	Missense_Mutation	p.R139Q	C	C		8	Cancer Gene	11	55927378	55927378	75	0.36	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8K5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55927378,C,C&fts=all">p.R139Q</a>
OR8S1	Splice_Site	p.G297E	G	G		8	Cancer Gene	12	48921696	48921696	23	0.391304347826087	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8S1&recr=Open">Click here</a>	
OSBP2	Missense_Mutation	p.G339S	G	G		8	Cancer Gene	22	31266577	31266577	26	0.115384615384615	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,31266577,G,G&fts=all">p.G339S</a>
OSBP2	Missense_Mutation	p.A893T	G	G		8	Cancer Gene	22	31302252	31302252	95	0.210526315789474	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,31302252,G,G&fts=all">p.A893T</a>
OSBPL5	Splice_Site	p.G46R	C	C		8	Cancer Gene	11	3150243	3150243	4	0.75	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBPL5&recr=Open">Click here</a>	
OSBPL8	Missense_Mutation	p.S342F	G	G		8	Cancer Gene	12	76784342	76784342	222	0.414414414414414	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBPL8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,76784342,G,G&fts=all">p.S342F</a>
OSTC	Missense_Mutation	p.F133V	T	T		8	Cancer Gene	4	109578769	109578769	296	0.317567567567568	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSTC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,109578769,T,T&fts=all">p.F133V</a>
OTOGL	Missense_Mutation	p.P1459S	C	C	rs527599306	8	Cancer Gene	12	80729758	80729758	45	0.422222222222222	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOGL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,80729758,C,C&fts=all">p.P1459S</a>
OTOP1	Missense_Mutation	p.S264F	G	G		8	Cancer Gene	4	4199770	4199770	42	0.30952380952381	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,4199770,G,G&fts=all">p.S264F</a>
OTOP1	Missense_Mutation	p.L184H	A	A		8	Cancer Gene	4	4207847	4207847	64	0.34375	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,4207847,A,A&fts=all">p.L184H</a>
OTOP2	Missense_Mutation	p.H360Y	C	C		8	Cancer Gene	17	72926808	72926808	42	0.642857142857143	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72926808,C,C&fts=all">p.H360Y</a>
OTOP3	Missense_Mutation	p.D184N	G	G		8	Cancer Gene	17	72938055	72938055	38	0.368421052631579	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72938055,G,G&fts=all">p.D184N</a>
OTOS	Missense_Mutation	p.S43F	G	G		8	Cancer Gene	2	241078729	241078729	64	0.203125	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,241078729,G,G&fts=all">p.S43F</a>
OTUD6B	Missense_Mutation	p.T36I	C	C		8	Cancer Gene	8	92082629	92082629	27	0.333333333333333	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTUD6B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,92082629,C,C&fts=all">p.T36I</a>
OTUD7A	Missense_Mutation	p.E573K	C	C		8	Cancer Gene	15	31776561	31776561	26	0.538461538461538	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTUD7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,31776561,C,C&fts=all">p.E573K</a>
OTUD7A	Nonsense_Mutation	p.W410*	C	C		8	Cancer Gene	15	31779691	31779691	42	0.19047619047619	NA	NA	NA			30	Catalytic. {ECO:0000250}.|TRAF-binding. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTUD7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,31779691,C,C&fts=all">p.W410*</a>
OTUD7A	Missense_Mutation	p.G221R	C	C		8	Cancer Gene	15	31819503	31819503	88	0.215909090909091	NA	NA	NA			30	Catalytic. {ECO:0000250}.|OTU. {ECO:0000255|PROSITE- ProRule:PRU00139}.|TRAF-binding. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTUD7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,31819503,C,C&fts=all">p.G221R</a>
OVCH1	Missense_Mutation	p.P981S	G	G		8	Cancer Gene	12	29597154	29597154	266	0.210526315789474	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OVCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,29597154,G,G&fts=all">p.P981S</a>
OVGP1	Missense_Mutation	p.D420E	A	A		8	Cancer Gene	1	111957863	111957863	84	0.404761904761905	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OVGP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,111957863,A,A&fts=all">p.D420E</a>
P2RX2	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	12	133196162	133354393	NA	NA	79	-1.00781166374669	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P2RX2&recr=Open">Click here</a>	
P4HA3	Missense_Mutation	p.S244L	G	G	rs147203342	8	Cancer Gene	11	74000162	74000162	37	0.324324324324324	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P4HA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,74000162,G,G&fts=all">p.S244L</a>
PACRG	Nonsense_Mutation	p.K154*	A	A		8	Cancer Gene	6	163483350	163483350	27	0.407407407407407	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PACRG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,163483350,A,A&fts=all">p.K154*</a>
PACSIN1	Missense_Mutation	p.H98P	A	A		8	Cancer Gene	6	34496491	34496491	154	0.181818181818182	NA	NA	NA			13	F-BAR domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PACSIN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,34496491,A,A&fts=all">p.H98P</a>
PACSIN1	Missense_Mutation	p.E364K	G	G		8	Cancer Gene	6	34499429	34499429	155	0.187096774193548	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PACSIN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,34499429,G,G&fts=all">p.E364K</a>
PADI4	Missense_Mutation	p.D168N	G	G		8	Cancer Gene	1	17664626	17664626	125	0.056	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PADI4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,17664626,G,G&fts=all">p.D168N</a>
PALMD	Missense_Mutation	p.K87I	A	A		8	Cancer Gene	1	100152240	100152240	246	0.345528455284553	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PALMD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,100152240,A,A&fts=all">p.K87I</a>
PANX3	Missense_Mutation	p.R185Q	G	G		8	Cancer Gene	11	124489206	124489206	60	0.35	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PANX3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,124489206,G,G&fts=all">p.R185Q</a>
PANX3	Missense_Mutation	p.D233N	G	G		8	Cancer Gene	11	124489349	124489349	29	0.448275862068966	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PANX3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,124489349,G,G&fts=all">p.D233N</a>
PAPOLB	Missense_Mutation	p.E395K	C	C		8	Cancer Gene	7	4900256	4900256	311	0.247588424437299	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPOLB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,4900256,C,C&fts=all">p.E395K</a>
PAPPA	Missense_Mutation	p.D436N	G	G		8	Cancer Gene	9	118950323	118950323	26	0.346153846153846	NA	NA	NA			98	Metalloprotease.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,118950323,G,G&fts=all">p.D436N</a>
PAPPA	Missense_Mutation	p.P790S	C	C	rs556339934	8	Cancer Gene	9	118997552	118997552	38	0.342105263157895	NA	NA	NA			98			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,118997552,C,C&fts=all">p.P790S</a>
PAPPA	Missense_Mutation	p.P790L	C	C		8	Cancer Gene	9	118997553	118997553	39	0.333333333333333	NA	NA	NA			98			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,118997553,C,C&fts=all">p.P790L</a>
PAPPA	Missense_Mutation	p.D1131N	G	G		8	Cancer Gene	9	119094741	119094741	59	0.271186440677966	NA	NA	NA			98			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,119094741,G,G&fts=all">p.D1131N</a>
PAPPA2	Missense_Mutation	p.G297E	G	G		8	Cancer Gene	1	176526348	176526348	8	0.5	NA	NA	NA			226			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176526348,G,G&fts=all">p.G297E</a>
PAPPA2	Missense_Mutation	p.D646N	G	G	rs550436411	8	Cancer Gene	1	176564676	176564676	30	0.2	NA	NA	NA			226	Metalloprotease.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176564676,G,G&fts=all">p.D646N</a>
PAPPA2	Missense_Mutation	p.G740R	G	G		8	Cancer Gene	1	176659353	176659353	160	0.2	NA	NA	NA			226	Metalloprotease.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176659353,G,G&fts=all">p.G740R</a>
PAPPA2	Missense_Mutation	p.G1097E	G	G		8	Cancer Gene	1	176671796	176671796	97	0.237113402061856	NA	NA	NA			226			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176671796,G,G&fts=all">p.G1097E</a>
PAPPA2	Missense_Mutation	p.S1515F	C	C		8	Cancer Gene	1	176740145	176740145	128	0.125	NA	NA	NA			226	Sushi 2. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176740145,C,C&fts=all">p.S1515F</a>
PAPPA2	Missense_Mutation	p.G1755R	G	G	rs540694699	8	Cancer Gene	1	176809369	176809369	137	0.284671532846715	NA	NA	NA			226			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176809369,G,G&fts=all">p.G1755R</a>
PARK2	Missense_Mutation	p.D274N	C	C		8	Cancer Gene	6	162206855	162206855	29	0.344827586206897	NA	NA	NA			39	SYT11 binding 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PARK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,162206855,C,C&fts=all">p.D274N</a>
PARP15	Missense_Mutation	p.E298K	G	G		8	Cancer Gene	3	122335903	122335903	212	0.367924528301887	NA	NA	NA			24	Macro 2. {ECO:0000255|PROSITE- ProRule:PRU00490}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PARP15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,122335903,G,G&fts=all">p.E298K</a>
PARP6	Missense_Mutation	p.H72Y	G	G		8	Cancer Gene	15	72557777	72557777	144	0.333333333333333	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PARP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,72557777,G,G&fts=all">p.H72Y</a>
PAX1	Missense_Mutation	p.L365F	C	C		8	Cancer Gene	20	21689893	21689893	43	0.186046511627907	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,21689893,C,C&fts=all">p.L365F</a>
PAX1	Missense_Mutation	p.P382S	C	C		8	Cancer Gene	20	21689944	21689944	13	0.307692307692308	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,21689944,C,C&fts=all">p.P382S</a>
PCDH12	Missense_Mutation	p.P14S	G	G		8	Cancer Gene	5	141337377	141337377	85	0.329411764705882	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,141337377,G,G&fts=all">p.P14S</a>
PCDH15	Missense_Mutation	p.E1668K	C	C		8	Cancer Gene	10	55566392	55566392	91	0.208791208791209	NA	NA	NA			237			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55566392,C,C&fts=all">p.E1668K</a>
PCDH15	Missense_Mutation	p.G1775E	C	C		8	Cancer Gene	10	55568486	55568486	67	0.119402985074627	NA	NA	NA			237			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55568486,C,C&fts=all">p.G1775E</a>
PCDH15	Missense_Mutation	p.P1856H	G	G		8	Cancer Gene	10	55581925	55581925	338	0.42603550295858	NA	NA	NA			237			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55581925,G,G&fts=all">p.P1856H</a>
PCDH15	Missense_Mutation	p.S1699F	G	G		8	Cancer Gene	10	55582396	55582396	161	0.260869565217391	NA	NA	NA			237			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55582396,G,G&fts=all">p.S1699F</a>
PCDH15	Missense_Mutation	p.K1178R	T	T		8	Cancer Gene	10	55626607	55626607	188	0.170212765957447	NA	NA	NA			237	Cadherin 11. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55626607,T,T&fts=all">p.K1178R</a>
PCDH15	Missense_Mutation	p.L834V	G	G		8	Cancer Gene	10	55782699	55782699	278	0.402877697841727	NA	NA	NA		p.L832I(2)|p.L827I(2)	237	Cadherin 8. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55782699,G,G&fts=all">p.L834V</a>
PCDH15	Missense_Mutation	p.R666K	C	C		8	Cancer Gene	10	55849765	55849765	239	0.251046025104602	NA	NA	NA			237	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55849765,C,C&fts=all">p.R666K</a>
PCDH15	Nonsense_Mutation	p.R650*	G	G		8	Cancer Gene	10	55849814	55849814	244	0.147540983606557	NA	NA	NA			237	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55849814,G,G&fts=all">p.R650*</a>
PCDH15	Missense_Mutation	p.E634K	C	C		8	Cancer Gene	10	55892673	55892673	82	0.158536585365854	NA	NA	NA			237	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55892673,C,C&fts=all">p.E634K</a>
PCDH15	Missense_Mutation	p.D533N	C	C		8	Cancer Gene	10	55943218	55943218	253	0.268774703557312	NA	NA	NA			237	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55943218,C,C&fts=all">p.D533N</a>
PCDH15	Missense_Mutation	p.S415L	G	G		8	Cancer Gene	10	55955504	55955504	185	0.227027027027027	NA	NA	NA			237	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55955504,G,G&fts=all">p.S415L</a>
PCDH15	Missense_Mutation	p.F395L	A	A		8	Cancer Gene	10	55955565	55955565	159	0.421383647798742	NA	NA	NA			237	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55955565,A,A&fts=all">p.F395L</a>
PCDH15	Missense_Mutation	p.I304S	A	A		8	Cancer Gene	10	55996657	55996657	284	0.221830985915493	NA	NA	NA			237	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55996657,A,A&fts=all">p.I304S</a>
PCDH15	Nonsense_Mutation	p.Q283*	G	G		8	Cancer Gene	10	56077060	56077060	170	0.511764705882353	NA	NA	NA			237	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,56077060,G,G&fts=all">p.Q283*</a>
PCDH15	Missense_Mutation	p.K123N	T	T		8	Cancer Gene	10	56128985	56128985	183	0.469945355191257	NA	NA	NA			237	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,56128985,T,T&fts=all">p.K123N</a>
PCDH15	Missense_Mutation	p.R101K	C	C		8	Cancer Gene	10	56138558	56138558	203	0.206896551724138	NA	NA	NA			237	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,56138558,C,C&fts=all">p.R101K</a>
PCDH15	Missense_Mutation	p.P71S	G	G		8	Cancer Gene	10	56138649	56138649	320	0.04375	NA	NA	NA			237	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,56138649,G,G&fts=all">p.P71S</a>
PCDH15	Missense_Mutation	p.D58N	C	C		8	Cancer Gene	10	56138688	56138688	283	0.208480565371025	NA	NA	NA			237	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,56138688,C,C&fts=all">p.D58N</a>
PCDH18	Missense_Mutation	p.P844S	G	G		8	Cancer Gene	4	138442398	138442398	37	0.27027027027027	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,138442398,G,G&fts=all">p.P844S</a>
PCDH18	Missense_Mutation	p.G705E	C	C		8	Cancer Gene	4	138442814	138442814	130	0.353846153846154	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,138442814,C,C&fts=all">p.G705E</a>
PCDH18	Missense_Mutation	p.F323S	A	A		8	Cancer Gene	4	138451615	138451615	154	0.25974025974026	NA	NA	NA			86	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,138451615,A,A&fts=all">p.F323S</a>
PCDHA1	Missense_Mutation	p.E317K	G	G	rs143010606	8	Cancer Gene	5	140166824	140166824	90	0.311111111111111	NA	NA	NA		p.E317K(1)	70	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140166824,G,G&fts=all">p.E317K</a>
PCDHA10	Missense_Mutation	p.P205L	C	C		8	Cancer Gene	5	140236247	140236247	92	0.423913043478261	NA	NA	NA			79	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140236247,C,C&fts=all">p.P205L</a>
PCDHA11	Missense_Mutation	p.F474L	T	T		8	Cancer Gene	5	140250108	140250108	64	0.328125	NA	NA	NA			2	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140250108,T,T&fts=all">p.F474L</a>
PCDHA11	Missense_Mutation	p.V693M	G	G	rs376198166	8	Cancer Gene	5	140250765	140250765	40	0.3	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140250765,G,G&fts=all">p.V693M</a>
PCDHA12	Missense_Mutation	p.E271K	G	G		8	Cancer Gene	5	140255868	140255868	82	0.304878048780488	NA	NA	NA		p.E271K(2)	78	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140255868,G,G&fts=all">p.E271K</a>
PCDHA12	Missense_Mutation	p.S509L	C	C		8	Cancer Gene	5	140256583	140256583	57	0.385964912280702	NA	NA	NA			78	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140256583,C,C&fts=all">p.S509L</a>
PCDHA12	Missense_Mutation	p.P786S	C	C		8	Cancer Gene	5	140257413	140257413	7	0.571428571428571	NA	NA	NA			78	5 X 4 AA repeats of P-X-X-P.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140257413,C,C&fts=all">p.P786S</a>
PCDHA13	Missense_Mutation	p.E416K	G	G		8	Cancer Gene	5	140263099	140263099	112	0.383928571428571	NA	NA	NA			95	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140263099,G,G&fts=all">p.E416K</a>
PCDHA13	Missense_Mutation	p.P469S	C	C		8	Cancer Gene	5	140263258	140263258	37	0.567567567567568	NA	NA	NA			95	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140263258,C,C&fts=all">p.P469S</a>
PCDHA13	Missense_Mutation	p.P522S	C	C		8	Cancer Gene	5	140263417	140263417	70	0.328571428571429	NA	NA	NA			95	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140263417,C,C&fts=all">p.P522S</a>
PCDHA2	Nonsense_Mutation	p.W12*	G	G		8	Cancer Gene	5	140174584	140174584	52	0.346153846153846	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140174584,G,G&fts=all">p.W12*</a>
PCDHA2	Missense_Mutation	p.P765S	C	C	rs144400963	8	Cancer Gene	5	140176842	140176842	42	0.261904761904762	NA	NA	NA			71	5 X 4 AA repeats of P-X-X-P.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140176842,C,C&fts=all">p.P765S</a>
PCDHA6	Missense_Mutation	p.D7N	G	G	rs375013243|rs17844300	8	Cancer Gene	5	140207695	140207695	117	0.282051282051282	NA	NA	NA			89			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140207695,G,G&fts=all">p.D7N</a>
PCDHA7	Missense_Mutation	p.G53R	G	G		8	Cancer Gene	5	140214125	140214125	64	0.40625	NA	NA	NA			63	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140214125,G,G&fts=all">p.G53R</a>
PCDHA7	Missense_Mutation	p.R623C	C	C		8	Cancer Gene	5	140215835	140215835	39	0.41025641025641	NA	NA	NA			63	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140215835,C,C&fts=all">p.R623C</a>
PCDHA7	Missense_Mutation	p.E656K	G	G		8	Cancer Gene	5	140215934	140215934	30	0.366666666666667	NA	NA	NA			63	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140215934,G,G&fts=all">p.E656K</a>
PCDHA8	Missense_Mutation	p.P643L	C	C		8	Cancer Gene	5	140222834	140222834	67	0.343283582089552	NA	NA	NA			78	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140222834,C,C&fts=all">p.P643L</a>
PCDHB10	Missense_Mutation	p.E276K	G	G		8	Cancer Gene	5	140572951	140572951	114	0.421052631578947	NA	NA	NA			76	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140572951,G,G&fts=all">p.E276K</a>
PCDHB12	Missense_Mutation	p.D342N	G	G		8	Cancer Gene	5	140589503	140589503	90	0.411111111111111	NA	NA	NA		p.D342N(1)	83	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140589503,G,G&fts=all">p.D342N</a>
PCDHB16	Missense_Mutation	p.V722M	G	G		8	Cancer Gene	5	140564298	140564298	74	0.283783783783784	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140564298,G,G&fts=all">p.V722M</a>
PCDHB16	Missense_Mutation	p.G723S	G	G		8	Cancer Gene	5	140564301	140564301	74	0.283783783783784	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140564301,G,G&fts=all">p.G723S</a>
PCDHB3	Missense_Mutation	p.S30L	C	C		8	Cancer Gene	5	140480322	140480322	33	0.545454545454545	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140480322,C,C&fts=all">p.S30L</a>
PCDHB4	Missense_Mutation	p.D215N	G	G	rs374942103	8	Cancer Gene	5	140502223	140502223	65	0.415384615384615	NA	NA	NA			67	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140502223,G,G&fts=all">p.D215N</a>
PCDHB4	Missense_Mutation	p.E309K	G	G		8	Cancer Gene	5	140502505	140502505	141	0.418439716312057	NA	NA	NA			67	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140502505,G,G&fts=all">p.E309K</a>
PCDHB6	Missense_Mutation	p.M781I	G	G		8	Cancer Gene	5	140532181	140532181	42	0.428571428571429	NA	NA	NA			84			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140532181,G,G&fts=all">p.M781I</a>
PCDHGA2	Missense_Mutation	p.F75L	T	T		8	Cancer Gene	5	140718763	140718763	68	0.352941176470588	NA	NA	NA			77	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140718763,T,T&fts=all">p.F75L</a>
PCDHGA2	Missense_Mutation	p.C102F	G	G		8	Cancer Gene	5	140718843	140718843	61	0.573770491803279	NA	NA	NA			77	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140718843,G,G&fts=all">p.C102F</a>
PCDHGB1	Missense_Mutation	p.L488Q	T	T		8	Cancer Gene	5	140731290	140731290	42	0.404761904761905	NA	NA	NA			16	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140731290,T,T&fts=all">p.L488Q</a>
PCDHGC4	Missense_Mutation	p.P779S	C	C		8	Cancer Gene	5	140867075	140867075	79	0.443037974683544	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140867075,C,C&fts=all">p.P779S</a>
PCF11	Missense_Mutation	p.A1185T	G	G		8	Cancer Gene	11	82880930	82880930	48	0.875	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCF11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,82880930,G,G&fts=all">p.A1185T</a>
PCMTD2	Missense_Mutation	p.R283C	C	C		8	Cancer Gene	20	62904714	62904714	143	0.587412587412587	NA	NA	NA			17	Poly-Arg.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCMTD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,62904714,C,C&fts=all">p.R283C</a>
PCSK9	Missense_Mutation	p.L184F	C	C		8	Cancer Gene	1	55517977	55517977	92	0.945652173913043	NA	NA	NA			32	Peptidase S8.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,55517977,C,C&fts=all">p.L184F</a>
PDCD11	Missense_Mutation	p.H1064Y	C	C		8	Cancer Gene	10	105185167	105185167	153	0.0326797385620915	NA	NA	NA			64	S1 motif 9. {ECO:0000255|PROSITE- ProRule:PRU00180}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDCD11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,105185167,C,C&fts=all">p.H1064Y</a>
PDE11A	Missense_Mutation	p.G555E	C	C		8	Cancer Gene	2	178681629	178681629	134	0.26865671641791	NA	NA	NA			58	GAF 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE11A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,178681629,C,C&fts=all">p.G555E</a>
PDE12	Missense_Mutation	p.S400L	C	C		8	Cancer Gene	3	57543305	57543305	188	0.271276595744681	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,57543305,C,C&fts=all">p.S400L</a>
PDE3A	Missense_Mutation	p.D359N	G	G		8	Cancer Gene	12	20766440	20766440	173	0.196531791907514	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,20766440,G,G&fts=all">p.D359N</a>
PDE6C	Splice_Site	p.E289K	G	G		8	Cancer Gene	10	95385332	95385332	89	0.359550561797753	NA	NA	NA			42	GAF 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE6C&recr=Open">Click here</a>	
PDE6C	Missense_Mutation	p.E508K	G	G		8	Cancer Gene	10	95399866	95399866	160	0.18125	NA	NA	NA		p.E508K(1)	42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE6C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,95399866,G,G&fts=all">p.E508K</a>
PDE6C	Missense_Mutation	p.R582K	G	G		8	Cancer Gene	10	95400684	95400684	138	0.217391304347826	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE6C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,95400684,G,G&fts=all">p.R582K</a>
PDHA2	Missense_Mutation	p.R19C	C	C		8	Cancer Gene	4	96761356	96761356	49	0.285714285714286	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDHA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,96761356,C,C&fts=all">p.R19C</a>
PDILT	Missense_Mutation	p.E428K	C	C		8	Cancer Gene	16	20373860	20373860	70	0.285714285714286	NA	NA	NA			61	Thioredoxin. {ECO:0000255|PROSITE- ProRule:PRU00691}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDILT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,20373860,C,C&fts=all">p.E428K</a>
PDILT	Missense_Mutation	p.F198Y	A	A		8	Cancer Gene	16	20386232	20386232	133	0.263157894736842	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDILT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,20386232,A,A&fts=all">p.F198Y</a>
PDZD3	Missense_Mutation	p.E78K	G	G		8	Cancer Gene	11	119057340	119057340	26	0.423076923076923	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,119057340,G,G&fts=all">p.E78K</a>
PDZD3	Missense_Mutation	p.R178Q	G	G		8	Cancer Gene	11	119058324	119058324	6	0.833333333333333	NA	NA	NA			14	PDZ 1. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,119058324,G,G&fts=all">p.R178Q</a>
PDZD9	Missense_Mutation	p.R88Q	C	C	rs375973948	8	Cancer Gene	16	22000061	22000061	94	0.25531914893617	NA	NA	NA			9	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZD9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,22000061,C,C&fts=all">p.R88Q</a>
PGAM5	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	12	133196162	133354393	NA	NA	79	-1.00781166374669	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGAM5&recr=Open">Click here</a>	
PGBD1	Missense_Mutation	p.P108S	C	C		8	Cancer Gene	6	28251912	28251912	163	0.239263803680982	NA	NA	NA			41	SCAN box. {ECO:0000255|PROSITE- ProRule:PRU00187}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGBD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28251912,C,C&fts=all">p.P108S</a>
PGBD1	Missense_Mutation	p.L614F	C	C		8	Cancer Gene	6	28269471	28269471	326	0.223926380368098	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGBD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28269471,C,C&fts=all">p.L614F</a>
PGBD1	Missense_Mutation	p.P659L	C	C		8	Cancer Gene	6	28269607	28269607	166	0.481927710843373	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGBD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28269607,C,C&fts=all">p.P659L</a>
PGK2	Missense_Mutation	p.P283L	G	G		8	Cancer Gene	6	49754053	49754053	265	0.181132075471698	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,49754053,G,G&fts=all">p.P283L</a>
PGK2	Missense_Mutation	p.E193K	C	C		8	Cancer Gene	6	49754324	49754324	138	0.188405797101449	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,49754324,C,C&fts=all">p.E193K</a>
PHACTR3	Missense_Mutation	p.P142L	C	C		8	Cancer Gene	20	58330303	58330303	46	0.239130434782609	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHACTR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,58330303,C,C&fts=all">p.P142L</a>
PHF21B	Missense_Mutation	p.K263T	T	T		8	Cancer Gene	22	45309745	45309745	56	0.178571428571429	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHF21B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,45309745,T,T&fts=all">p.K263T</a>
PHKA1	Missense_Mutation	p.E802K	C	C		8	Cancer Gene	X	71829499	71829499	138	0.463768115942029	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHKA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,71829499,C,C&fts=all">p.E802K</a>
PHKA1	Missense_Mutation	p.E350K	C	C		8	Cancer Gene	X	71873374	71873374	29	0.379310344827586	NA	NA	NA		p.E350K(1)	52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHKA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,71873374,C,C&fts=all">p.E350K</a>
PHLDB3	Missense_Mutation	p.H379Y	G	G		8	Cancer Gene	19	43998868	43998868	31	0.258064516129032	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHLDB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,43998868,G,G&fts=all">p.H379Y</a>
PHLPP2	Nonsense_Mutation	p.R136*	G	G		8	Cancer Gene	16	71736513	71736513	204	0.254901960784314	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHLPP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,71736513,G,G&fts=all">p.R136*</a>
PI15	Missense_Mutation	p.G238E	G	G	rs146938685	8	Cancer Gene	8	75761424	75761424	304	0.273026315789474	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PI15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,75761424,G,G&fts=all">p.G238E</a>
PI4KB	Missense_Mutation	p.P400S	G	G		8	Cancer Gene	1	151278779	151278779	172	0.697674418604651	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PI4KB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,151278779,G,G&fts=all">p.P400S</a>
PIGK	Missense_Mutation	p.P295L	G	G		8	Cancer Gene	1	77620236	77620236	134	0.0373134328358209	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIGK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,77620236,G,G&fts=all">p.P295L</a>
PIGN	Missense_Mutation	p.P293S	G	G		8	Cancer Gene	18	59813187	59813187	47	0.404255319148936	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIGN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,59813187,G,G&fts=all">p.P293S</a>
PIKFYVE	Missense_Mutation	p.P947S	C	C		8	Cancer Gene	2	209190374	209190374	148	0.52027027027027	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIKFYVE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,209190374,C,C&fts=all">p.P947S</a>
PIKFYVE	Missense_Mutation	p.P1302S	C	C		8	Cancer Gene	2	209195359	209195359	308	0.607142857142857	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIKFYVE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,209195359,C,C&fts=all">p.P1302S</a>
PIKFYVE	Missense_Mutation	p.S1886F	C	C		8	Cancer Gene	2	209216121	209216121	382	0.285340314136126	NA	NA	NA			107	Catalytic.|PIPK. {ECO:0000255|PROSITE- ProRule:PRU00781}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIKFYVE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,209216121,C,C&fts=all">p.S1886F</a>
PIP5K1C	Missense_Mutation	p.P623L	G	G		8	Cancer Gene	19	3638934	3638934	29	0.206896551724138	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIP5K1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,3638934,G,G&fts=all">p.P623L</a>
PIP5K1C	Missense_Mutation	p.S544L	G	G		8	Cancer Gene	19	3643259	3643259	45	0.6	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIP5K1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,3643259,G,G&fts=all">p.S544L</a>
PIPOX	Missense_Mutation	p.R333C	C	C		8	Cancer Gene	17	27382861	27382861	89	0.595505617977528	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIPOX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,27382861,C,C&fts=all">p.R333C</a>
PIPOX	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIPOX&recr=Open">Click here</a>	
PISD	Missense_Mutation	p.P99S	G	G		8	Cancer Gene	22	32044113	32044113	61	0.245901639344262	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PISD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,32044113,G,G&fts=all">p.P99S</a>
PIWIL1	Missense_Mutation	p.E297K	G	G		8	Cancer Gene	12	130833938	130833938	70	0.3	NA	NA	NA			57	PAZ. {ECO:0000255|PROSITE- ProRule:PRU00142}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIWIL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,130833938,G,G&fts=all">p.E297K</a>
PIWIL2	Missense_Mutation	p.R648Q	G	G	rs374676378	8	Cancer Gene	8	22168767	22168767	363	0.225895316804408	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIWIL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,22168767,G,G&fts=all">p.R648Q</a>
PIWIL2	Missense_Mutation	p.E968K	G	G		8	Cancer Gene	8	22212998	22212998	81	0.234567901234568	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIWIL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,22212998,G,G&fts=all">p.E968K</a>
PIWIL3	Missense_Mutation	p.A534T	C	C		8	Cancer Gene	22	25131709	25131709	353	0.229461756373938	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIWIL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,25131709,C,C&fts=all">p.A534T</a>
PKD2L2	Missense_Mutation	p.R132C	C	C	rs368989091	8	Cancer Gene	5	137230168	137230168	192	0.463541666666667	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKD2L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,137230168,C,C&fts=all">p.R132C</a>
PKD2L2	Nonsense_Mutation	p.W467*	G	G		8	Cancer Gene	5	137271517	137271517	88	0.454545454545455	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKD2L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,137271517,G,G&fts=all">p.W467*</a>
PKDREJ	Missense_Mutation	p.E1609K	C	C		8	Cancer Gene	22	46654395	46654395	163	0.54601226993865	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKDREJ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,46654395,C,C&fts=all">p.E1609K</a>
PKDREJ	Missense_Mutation	p.G1256E	C	C		8	Cancer Gene	22	46655453	46655453	156	0.230769230769231	NA	NA	NA			73	PLAT. {ECO:0000255|PROSITE- ProRule:PRU00152}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKDREJ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,46655453,C,C&fts=all">p.G1256E</a>
PKDREJ	Missense_Mutation	p.L954F	G	G		8	Cancer Gene	22	46656360	46656360	344	0.444767441860465	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKDREJ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,46656360,G,G&fts=all">p.L954F</a>
PKHD1	Missense_Mutation	p.E1743K	C	C		8	Cancer Gene	6	51889381	51889381	133	0.203007518796992	NA	NA	NA			304			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,51889381,C,C&fts=all">p.E1743K</a>
PKHD1	Missense_Mutation	p.R1173K	C	C		8	Cancer Gene	6	51892996	51892996	283	0.254416961130742	NA	NA	NA			304	IPT/TIG 6; atypical.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,51892996,C,C&fts=all">p.R1173K</a>
PKHD1	Missense_Mutation	p.N874K	A	A		8	Cancer Gene	6	51909857	51909857	132	0.196969696969697	NA	NA	NA			304			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,51909857,A,A&fts=all">p.N874K</a>
PKHD1	Missense_Mutation	p.E434K	C	C		8	Cancer Gene	6	51923333	51923333	119	0.168067226890756	NA	NA	NA			304			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,51923333,C,C&fts=all">p.E434K</a>
PKHD1	Nonsense_Mutation	p.W404*	C	C	rs371245728	8	Cancer Gene	6	51924747	51924747	267	0.224719101123595	NA	NA	NA			304			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,51924747,C,C&fts=all">p.W404*</a>
PKHD1	Missense_Mutation	p.E267D	T	T		8	Cancer Gene	6	51930853	51930853	169	0.254437869822485	NA	NA	NA			304	IPT/TIG 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,51930853,T,T&fts=all">p.E267D</a>
PKHD1L1	Splice_Site		G	G		8	Cancer Gene	8	110416782	110416782	123	0.390243902439024	NA	NA	NA			263			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	
PKHD1L1	Missense_Mutation	p.R548K	G	G		8	Cancer Gene	8	110417333	110417333	19	0.263157894736842	NA	NA	NA			263			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,110417333,G,G&fts=all">p.R548K</a>
PKHD1L1	Missense_Mutation	p.P1978S	C	C		8	Cancer Gene	8	110460527	110460527	62	0.129032258064516	NA	NA	NA			263	IPT/TIG 12.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,110460527,C,C&fts=all">p.P1978S</a>
PKHD1L1	Missense_Mutation	p.L2313I	T	T		8	Cancer Gene	8	110468553	110468553	50	0.22	NA	NA	NA			263			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,110468553,T,T&fts=all">p.L2313I</a>
PKHD1L1	Missense_Mutation	p.S2488F	C	C		8	Cancer Gene	8	110476524	110476524	60	0.233333333333333	NA	NA	NA			263			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,110476524,C,C&fts=all">p.S2488F</a>
PKHD1L1	Missense_Mutation	p.S3535L	C	C		8	Cancer Gene	8	110510695	110510695	103	0.242718446601942	NA	NA	NA			263			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,110510695,C,C&fts=all">p.S3535L</a>
PLA2G16	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	63283187	63342520	NA	NA	10	-1.2222962448729	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2G16&recr=Open">Click here</a>	
PLA2G2F	Missense_Mutation	p.R170Q	G	G	rs202202582	8	Cancer Gene	1	20474767	20474767	81	0.91358024691358	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2G2F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,20474767,G,G&fts=all">p.R170Q</a>
PLA2G4C	Missense_Mutation	p.P427S	G	G		8	Cancer Gene	19	48565263	48565263	102	0.225490196078431	NA	NA	NA			38	PLA2c. {ECO:0000255|PROSITE- ProRule:PRU00555}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2G4C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,48565263,G,G&fts=all">p.P427S</a>
PLA2G4D	Missense_Mutation	p.K347R	T	T		8	Cancer Gene	15	42373249	42373249	50	0.22	NA	NA	NA			27	PLA2c. {ECO:0000255|PROSITE- ProRule:PRU00555}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2G4D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,42373249,T,T&fts=all">p.K347R</a>
PLB1	Missense_Mutation	p.W1122R	T	T		8	Cancer Gene	2	28843180	28843180	199	0.251256281407035	NA	NA	NA			69	4 X 308-326 AA approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,28843180,T,T&fts=all">p.W1122R</a>
PLCB4	Missense_Mutation	p.E223K	G	G		8	Cancer Gene	20	9353031	9353031	98	0.377551020408163	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,9353031,G,G&fts=all">p.E223K</a>
PLCB4	Missense_Mutation	p.K233T	A	A		8	Cancer Gene	20	9353705	9353705	151	0.145695364238411	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,9353705,A,A&fts=all">p.K233T</a>
PLCB4	Missense_Mutation	p.E737K	G	G	rs267606066	8	Cancer Gene	20	9402034	9402034	123	0.528455284552846	NA	NA	NA		p.E737K(1)	87	C2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,9402034,G,G&fts=all">p.E737K</a>
PLCH1	Missense_Mutation	p.D1683N	C	C		8	Cancer Gene	3	155198792	155198792	134	0.350746268656716	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,155198792,C,C&fts=all">p.D1683N</a>
PLCH1	Missense_Mutation	p.L1211F	G	G		8	Cancer Gene	3	155200208	155200208	83	0.301204819277108	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,155200208,G,G&fts=all">p.L1211F</a>
PLCH1	Missense_Mutation	p.S1178F	G	G		8	Cancer Gene	3	155200306	155200306	83	0.204819277108434	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,155200306,G,G&fts=all">p.S1178F</a>
PLCH1	Missense_Mutation	p.A700T	C	C		8	Cancer Gene	3	155211978	155211978	155	0.316129032258064	NA	NA	NA			107	PI-PLC Y-box. {ECO:0000255|PROSITE- ProRule:PRU00271}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,155211978,C,C&fts=all">p.A700T</a>
PLCH1	Missense_Mutation	p.S547F	G	G		8	Cancer Gene	3	155222372	155222372	293	0.283276450511945	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,155222372,G,G&fts=all">p.S547F</a>
PLCXD3	Nonsense_Mutation	p.Q230*	G	G		8	Cancer Gene	5	41382052	41382052	107	0.467289719626168	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCXD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41382052,G,G&fts=all">p.Q230*</a>
PLCXD3	Nonsense_Mutation	p.R98*	G	G		8	Cancer Gene	5	41382448	41382448	122	0.311475409836066	NA	NA	NA		p.R98*(1)	37	PI-PLC X-box. {ECO:0000255|PROSITE- ProRule:PRU00270}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCXD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41382448,G,G&fts=all">p.R98*</a>
PLCXD3	Missense_Mutation	p.R93C	G	G	rs138399387	8	Cancer Gene	5	41382463	41382463	111	0.486486486486487	NA	NA	NA			37	PI-PLC X-box. {ECO:0000255|PROSITE- ProRule:PRU00270}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCXD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41382463,G,G&fts=all">p.R93C</a>
PLCZ1	Missense_Mutation	p.F231C	A	A		8	Cancer Gene	12	18847959	18847959	194	0.206185567010309	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCZ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18847959,A,A&fts=all">p.F231C</a>
PLCZ1	Missense_Mutation	p.H180Y	G	G		8	Cancer Gene	12	18849183	18849183	84	0.297619047619048	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCZ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18849183,G,G&fts=all">p.H180Y</a>
PLCZ1	Missense_Mutation	p.G53D	C	C		8	Cancer Gene	12	18854640	18854640	113	0.185840707964602	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCZ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18854640,C,C&fts=all">p.G53D</a>
PLCZ1	Missense_Mutation	p.E149K	C	C		8	Cancer Gene	12	18872489	18872489	184	0.152173913043478	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCZ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18872489,C,C&fts=all">p.E149K</a>
PLEKHA5	Splice_Site	p.Q104Q	G	G		8	Cancer Gene	12	19407979	19407979	322	0.487577639751553	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHA5&recr=Open">Click here</a>	
PLEKHG2	Missense_Mutation	p.P439L	C	C		8	Cancer Gene	19	39911409	39911409	241	0.323651452282158	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39911409,C,C&fts=all">p.P439L</a>
PLEKHG4B	Missense_Mutation	p.R1146Q	G	G		8	Cancer Gene	5	181731	181731	77	0.285714285714286	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHG4B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,181731,G,G&fts=all">p.R1146Q</a>
PLEKHG6	Missense_Mutation	p.G88R	G	G		8	Cancer Gene	12	6422918	6422918	81	0.234567901234568	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHG6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,6422918,G,G&fts=all">p.G88R</a>
PLIN4	Missense_Mutation	p.G560R	C	C		8	Cancer Gene	19	4512252	4512252	135	0.244444444444444	NA	NA	NA			41	27 X 33 AA approximate tandem repeat.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLIN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4512252,C,C&fts=all">p.G560R</a>
PLIN4	Missense_Mutation	p.D552N	C	C		8	Cancer Gene	19	4512276	4512276	123	0.040650406504065	NA	NA	NA			41	27 X 33 AA approximate tandem repeat.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLIN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4512276,C,C&fts=all">p.D552N</a>
PLIN4	Missense_Mutation	p.D453N	C	C		8	Cancer Gene	19	4512573	4512573	121	0.206611570247934	NA	NA	NA			41	27 X 33 AA approximate tandem repeat.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLIN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4512573,C,C&fts=all">p.D453N</a>
PLIN4	Missense_Mutation	p.D90N	C	C		8	Cancer Gene	19	4513662	4513662	20	0.2	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLIN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4513662,C,C&fts=all">p.D90N</a>
PLIN5	Missense_Mutation	p.R207Q	C	C		8	Cancer Gene	19	4525745	4525745	56	0.160714285714286	NA	NA	NA			10	Interaction with PNPLA2 and ABHD5. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLIN5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4525745,C,C&fts=all">p.R207Q</a>
PLXNA4	Missense_Mutation	p.S1235N	C	C		8	Cancer Gene	7	131864616	131864616	11	0.363636363636364	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXNA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,131864616,C,C&fts=all">p.S1235N</a>
PMFBP1	Missense_Mutation	p.E491K	C	C		8	Cancer Gene	16	72164598	72164598	34	0.382352941176471	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PMFBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,72164598,C,C&fts=all">p.E491K</a>
PMFBP1	Missense_Mutation	p.E363K	C	C	rs374516782	8	Cancer Gene	16	72170463	72170463	92	0.271739130434783	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PMFBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,72170463,C,C&fts=all">p.E363K</a>
PNMAL2	Missense_Mutation	p.E512K	C	C		8	Cancer Gene	19	46997189	46997189	50	0.26	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNMAL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,46997189,C,C&fts=all">p.E512K</a>
PNPLA1	Missense_Mutation	p.G88S	G	G		8	Cancer Gene	6	36261982	36261982	38	0.184210526315789	NA	NA	NA			22	Patatin.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNPLA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,36261982,G,G&fts=all">p.G88S</a>
PNPLA1	Missense_Mutation	p.P334S	C	C		8	Cancer Gene	6	36270120	36270120	91	0.208791208791209	NA	NA	NA			22	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNPLA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,36270120,C,C&fts=all">p.P334S</a>
PNPLA7	Missense_Mutation	p.E1241K	C	C		8	Cancer Gene	9	140356033	140356033	35	0.314285714285714	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNPLA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,140356033,C,C&fts=all">p.E1241K</a>
PNPLA7	Missense_Mutation	p.G934E	C	C		8	Cancer Gene	9	140372492	140372492	7	0.571428571428571	NA	NA	NA			40	Patatin.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNPLA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,140372492,C,C&fts=all">p.G934E</a>
PNPLA7	Missense_Mutation	p.E596K	C	C		8	Cancer Gene	9	140392594	140392594	24	0.25	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNPLA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,140392594,C,C&fts=all">p.E596K</a>
POLL	Missense_Mutation	p.L448F	G	G		8	Cancer Gene	10	103340026	103340026	83	0.228915662650602	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,103340026,G,G&fts=all">p.L448F</a>
POLR1A	Missense_Mutation	p.H1452Y	G	G		8	Cancer Gene	2	86258677	86258677	144	0.166666666666667	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,86258677,G,G&fts=all">p.H1452Y</a>
POLR1B	Missense_Mutation	p.S437F	C	C	rs532394488	8	Cancer Gene	2	113317017	113317017	125	0.336	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,113317017,C,C&fts=all">p.S437F</a>
POLR3A	Missense_Mutation	p.S196F	G	G		8	Cancer Gene	10	79784365	79784365	213	0.258215962441315	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,79784365,G,G&fts=all">p.S196F</a>
POM121L12	Missense_Mutation	p.P103S	C	C		8	Cancer Gene	7	53103671	53103671	9	0.444444444444444	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POM121L12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,53103671,C,C&fts=all">p.P103S</a>
POM121L12	Missense_Mutation	p.Q289P	A	A		8	Cancer Gene	7	53104230	53104230	41	0.219512195121951	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POM121L12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,53104230,A,A&fts=all">p.Q289P</a>
POP1	Missense_Mutation	p.H213Y	C	C		8	Cancer Gene	8	99142356	99142356	144	0.319444444444444	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,99142356,C,C&fts=all">p.H213Y</a>
POU1F1	Missense_Mutation	p.R217Q	C	C	rs374853152	8	Cancer Gene	3	87310438	87310438	179	0.156424581005587	NA	NA	NA		p.R217Q(2)	18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU1F1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,87310438,C,C&fts=all">p.R217Q</a>
PPAPDC1A	Missense_Mutation	p.D101N	G	G		8	Cancer Gene	10	122280493	122280493	370	0.218918918918919	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPAPDC1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,122280493,G,G&fts=all">p.D101N</a>
PPFIBP2	Missense_Mutation	p.P354L	C	C		8	Cancer Gene	11	7662824	7662824	110	0.309090909090909	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPFIBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,7662824,C,C&fts=all">p.P354L</a>
PPHLN1	Missense_Mutation	p.P13L	C	C	rs201787242	8	Cancer Gene	12	42729742	42729742	230	0.421739130434783	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPHLN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,42729742,C,C&fts=all">p.P13L</a>
PPHLN1	Missense_Mutation	p.S353L	C	C		8	Cancer Gene	12	42840085	42840085	58	0.293103448275862	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPHLN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,42840085,C,C&fts=all">p.S353L</a>
PPIP5K1	Missense_Mutation	p.S1172F	G	G		8	Cancer Gene	15	43827578	43827578	71	0.52112676056338	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPIP5K1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43827578,G,G&fts=all">p.S1172F</a>
PPP1R1B	Missense_Mutation	p.G109E	G	G		8	Cancer Gene	17	37790220	37790220	89	0.460674157303371	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,37790220,G,G&fts=all">p.G109E</a>
PPP1R9A	Missense_Mutation	p.A761V	C	C		8	Cancer Gene	7	94879453	94879453	120	0.0833333333333333	NA	NA	NA			71	Interacts with TGN38. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R9A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,94879453,C,C&fts=all">p.A761V</a>
PPP1R9A	Missense_Mutation	p.P1152L	C	C		8	Cancer Gene	7	94913488	94913488	57	0.789473684210526	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R9A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,94913488,C,C&fts=all">p.P1152L</a>
PPP2R5B	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	64708120	64757286	NA	NA	6	-1.01917037924933	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2R5B&recr=Open">Click here</a>	
PRDM12	Missense_Mutation	p.E170K	G	G		8	Cancer Gene	9	133543638	133543638	45	0.2	NA	NA	NA		p.E170K(1)	11	SET. {ECO:0000255|PROSITE- ProRule:PRU00190}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,133543638,G,G&fts=all">p.E170K</a>
PRDM14	Missense_Mutation	p.P433S	G	G		8	Cancer Gene	8	70970964	70970964	72	0.208333333333333	NA	NA	NA		p.P433S(1)	32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,70970964,G,G&fts=all">p.P433S</a>
PRDM2	Missense_Mutation	p.S1057L	C	C		8	Cancer Gene	1	14107460	14107460	42	0.452380952380952	NA	NA	NA			55	Poly-Ser.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,14107460,C,C&fts=all">p.S1057L</a>
PRDM7	Missense_Mutation	p.P104L	G	G		8	Cancer Gene	16	90133309	90133309	430	0.616279069767442	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,90133309,G,G&fts=all">p.P104L</a>
PRDM7	Missense_Mutation	p.P104S	G	G		8	Cancer Gene	16	90133310	90133310	430	0.323255813953488	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,90133310,G,G&fts=all">p.P104S</a>
PRDM9	Missense_Mutation	p.S292F	C	C		8	Cancer Gene	5	23522987	23522987	97	0.45360824742268	NA	NA	NA			172	SET. {ECO:0000255|PROSITE- ProRule:PRU00190}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,23522987,C,C&fts=all">p.S292F</a>
PREX2	Splice_Site	p.E414K	G	G	rs201372935	8	Cancer Gene	8	68972915	68972915	105	0.142857142857143	NA	NA	NA		p.E414K(2)	178	DEP 1. {ECO:0000255|PROSITE- ProRule:PRU00066}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	
PREX2	Missense_Mutation	p.G423R	G	G		8	Cancer Gene	8	68972942	68972942	142	0.147887323943662	NA	NA	NA			178	DEP 1. {ECO:0000255|PROSITE- ProRule:PRU00066}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,68972942,G,G&fts=all">p.G423R</a>
PREX2	Missense_Mutation	p.G423E	G	G		8	Cancer Gene	8	68972943	68972943	143	0.146853146853147	NA	NA	NA			178	DEP 1. {ECO:0000255|PROSITE- ProRule:PRU00066}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,68972943,G,G&fts=all">p.G423E</a>
PREX2	Missense_Mutation	p.G724R	G	G		8	Cancer Gene	8	69002870	69002870	156	0.147435897435897	NA	NA	NA			178	PDZ 2. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,69002870,G,G&fts=all">p.G724R</a>
PREX2	Missense_Mutation	p.F1318L	T	T		8	Cancer Gene	8	69046479	69046479	105	0.161904761904762	NA	NA	NA			178			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,69046479,T,T&fts=all">p.F1318L</a>
PREX2	Missense_Mutation	p.G1553R	G	G		8	Cancer Gene	8	69129903	69129903	27	0.555555555555556	NA	NA	NA			178			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,69129903,G,G&fts=all">p.G1553R</a>
PRKAA2	Missense_Mutation	p.E368D	A	A		8	Cancer Gene	1	57169959	57169959	79	0.443037974683544	NA	NA	NA			23	AIS. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKAA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,57169959,A,A&fts=all">p.E368D</a>
PRKCSH	Missense_Mutation	p.A131V	C	C		8	Cancer Gene	19	11552096	11552096	137	0.255474452554745	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCSH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,11552096,C,C&fts=all">p.A131V</a>
PRKD2	Missense_Mutation	p.S237F	G	G		8	Cancer Gene	19	47207605	47207605	176	0.136363636363636	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,47207605,G,G&fts=all">p.S237F</a>
PRMT10	Missense_Mutation	p.L506F	G	G		8	Cancer Gene	4	148575532	148575532	208	0.274038461538462	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRMT10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,148575532,G,G&fts=all">p.L506F</a>
PRMT2	Missense_Mutation	p.I59S	T	T		8	Cancer Gene	21	48064249	48064249	174	0.270114942528736	NA	NA	NA			16	Interaction with ESR1.|SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRMT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,48064249,T,T&fts=all">p.I59S</a>
PRODH	Missense_Mutation	p.T174K	G	G	rs200030023	8	Cancer Gene	22	18912710	18912710	63	0.206349206349206	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRODH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,18912710,G,G&fts=all">p.T174K</a>
PROKR2	Missense_Mutation	p.Q356K	G	G		8	Cancer Gene	20	5282775	5282775	60	0.15	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROKR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,5282775,G,G&fts=all">p.Q356K</a>
PROM2	Missense_Mutation	p.R807C	C	C	rs35884217	8	Cancer Gene	2	95954315	95954315	65	0.261538461538462	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,95954315,C,C&fts=all">p.R807C</a>
PROM2	Missense_Mutation	p.S815F	C	C		8	Cancer Gene	2	95954683	95954683	62	0.564516129032258	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,95954683,C,C&fts=all">p.S815F</a>
PRPS1L1	Missense_Mutation	p.R301K	C	C		8	Cancer Gene	7	18066504	18066504	496	0.0362903225806452	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRPS1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,18066504,C,C&fts=all">p.R301K</a>
PRR12	Missense_Mutation	p.P1693S	C	C		8	Cancer Gene	19	50119056	50119056	23	0.565217391304348	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRR12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50119056,C,C&fts=all">p.P1693S</a>
PRR14	Missense_Mutation	p.S125F	C	C		8	Cancer Gene	16	30664294	30664294	76	0.381578947368421	NA	NA	NA			18	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRR14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30664294,C,C&fts=all">p.S125F</a>
PRR21	Missense_Mutation	p.S326L	G	G		8	Cancer Gene	2	240981423	240981423	83	0.216867469879518	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRR21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,240981423,G,G&fts=all">p.S326L</a>
PRRC2A	Missense_Mutation	p.P171S	C	C		8	Cancer Gene	6	31592995	31592995	142	0.190140845070423	NA	NA	NA			70	4 X 57 AA type A repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRRC2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31592995,C,C&fts=all">p.P171S</a>
PRRG4	Missense_Mutation	p.G125R	G	G		8	Cancer Gene	11	32861709	32861709	358	0.918994413407821	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRRG4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,32861709,G,G&fts=all">p.G125R</a>
PRSS21	Missense_Mutation	p.L305F	C	C		8	Cancer Gene	16	2871574	2871574	56	0.321428571428571	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRSS21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,2871574,C,C&fts=all">p.L305F</a>
PRSS35	Missense_Mutation	p.E65K	G	G		8	Cancer Gene	6	84233353	84233353	58	0.448275862068966	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRSS35&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,84233353,G,G&fts=all">p.E65K</a>
PRSS38	Missense_Mutation	p.G148E	G	G		8	Cancer Gene	1	228005041	228005041	53	0.132075471698113	NA	NA	NA			23	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRSS38&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,228005041,G,G&fts=all">p.G148E</a>
PRSS42	Missense_Mutation	p.T58I	G	G		8	Cancer Gene	3	46874583	46874583	92	0.206521739130435	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRSS42&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,46874583,G,G&fts=all">p.T58I</a>
PRSS53	Missense_Mutation	p.E286K	C	C		8	Cancer Gene	16	31097312	31097312	107	0.355140186915888	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRSS53&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,31097312,C,C&fts=all">p.E286K</a>
PRSS55	Missense_Mutation	p.E90K	G	G		8	Cancer Gene	8	10387130	10387130	216	0.273148148148148	NA	NA	NA		p.E90*(1)	31	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRSS55&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,10387130,G,G&fts=all">p.E90K</a>
PRSS55	Missense_Mutation	p.P91R	C	C		8	Cancer Gene	8	10387134	10387134	213	0.187793427230047	NA	NA	NA			31	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRSS55&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,10387134,C,C&fts=all">p.P91R</a>
PRSS58	Start_Codon_SNP	p.M1I	C	C		8	Cancer Gene	7	141957525	141957525	65	0.738461538461539	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRSS58&recr=Open">Click here</a>	
PRTG	Missense_Mutation	p.Q503R	T	T		8	Cancer Gene	15	55967755	55967755	226	0.570796460176991	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRTG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,55967755,T,T&fts=all">p.Q503R</a>
PRTG	Missense_Mutation	p.I158N	A	A		8	Cancer Gene	15	55976054	55976054	168	0.321428571428571	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRTG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,55976054,A,A&fts=all">p.I158N</a>
PRUNE2	Missense_Mutation	p.R2151Q	C	C		8	Cancer Gene	9	79320738	79320738	114	0.701754385964912	NA	NA	NA		p.R2151Q(1)	16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRUNE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,79320738,C,C&fts=all">p.R2151Q</a>
PRUNE2	Missense_Mutation	p.S943F	G	G		8	Cancer Gene	9	79324362	79324362	230	0.630434782608696	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRUNE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,79324362,G,G&fts=all">p.S943F</a>
PRUNE2	Missense_Mutation	p.G538R	C	C	rs367647963	8	Cancer Gene	9	79325578	79325578	30	0.2	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRUNE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,79325578,C,C&fts=all">p.G538R</a>
PSAPL1	Missense_Mutation	p.P234L	G	G		8	Cancer Gene	4	7435906	7435906	17	0.294117647058824	NA	NA	NA			4	Saposin B-type 2. {ECO:0000255|PROSITE- ProRule:PRU00415}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSAPL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,7435906,G,G&fts=all">p.P234L</a>
PSD3	Missense_Mutation	p.R766C	G	G	rs149616744	8	Cancer Gene	8	18490237	18490237	239	0.246861924686192	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,18490237,G,G&fts=all">p.R766C</a>
PSG4	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	19	43702429	43757800	NA	NA	4	-1.36178711457659	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG4&recr=Open">Click here</a>	
PSG8	Splice_Site	p.A22T	C	C		8	Cancer Gene	19	43269670	43269670	92	0.152173913043478	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG8&recr=Open">Click here</a>	
PTAR1	Missense_Mutation	p.T311I	G	G		8	Cancer Gene	9	72338257	72338257	205	0.219512195121951	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTAR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,72338257,G,G&fts=all">p.T311I</a>
PTCHD2	Splice_Site		G	G		8	Cancer Gene	1	11591768	11591768	22	0.681818181818182	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCHD2&recr=Open">Click here</a>	
PTCHD3	Missense_Mutation	p.G58R	C	C		8	Cancer Gene	10	27703008	27703008	88	0.431818181818182	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCHD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,27703008,C,C&fts=all">p.G58R</a>
PTER	Missense_Mutation	p.H311Y	C	C		8	Cancer Gene	10	16553136	16553136	164	0.451219512195122	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTER&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,16553136,C,C&fts=all">p.H311Y</a>
PTH1R	Splice_Site		G	G		8	Cancer Gene	3	46939344	46939344	37	0.243243243243243	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTH1R&recr=Open">Click here</a>	
PTPN4	Missense_Mutation	p.R332W	C	C		8	Cancer Gene	2	120677810	120677810	222	0.238738738738739	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,120677810,C,C&fts=all">p.R332W</a>
PTPRA	Missense_Mutation	p.L390F	C	C		8	Cancer Gene	20	3002733	3002733	36	0.25	NA	NA	NA			17	Tyrosine-protein phosphatase 1. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,3002733,C,C&fts=all">p.L390F</a>
PTPRB	Nonsense_Mutation	p.R1780*	G	G		8	Cancer Gene	12	70933795	70933795	25	0.44	NA	NA	NA			107	Tyrosine-protein phosphatase. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,70933795,G,G&fts=all">p.R1780*</a>
PTPRB	Missense_Mutation	p.G407E	C	C		8	Cancer Gene	12	70989867	70989867	33	0.696969696969697	NA	NA	NA			107	Fibronectin type-III 5. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,70989867,C,C&fts=all">p.G407E</a>
PTPRB	Nonsense_Mutation	p.W222*	C	C		8	Cancer Gene	12	71016212	71016212	64	0.390625	NA	NA	NA			107	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,71016212,C,C&fts=all">p.W222*</a>
PTPRB	Nonsense_Mutation	p.Q50*	G	G		8	Cancer Gene	12	71029754	71029754	16	0.5	NA	NA	NA			107	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,71029754,G,G&fts=all">p.Q50*</a>
PTPRJ	Missense_Mutation	p.Y789D	T	T		8	Cancer Gene	11	48161250	48161250	51	0.411764705882353	NA	NA	NA			52	Fibronectin type-III 8. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRJ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,48161250,T,T&fts=all">p.Y789D</a>
PTX4	Missense_Mutation	p.E391K	C	C		8	Cancer Gene	16	1536206	1536206	20	0.35	NA	NA	NA			17	Pentaxin.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,1536206,C,C&fts=all">p.E391K</a>
PXDN	Missense_Mutation	p.K1200R	T	T		8	Cancer Gene	2	1651953	1651953	111	0.252252252252252	NA	NA	NA			112			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXDN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,1651953,T,T&fts=all">p.K1200R</a>
PXDN	Missense_Mutation	p.S759L	G	G	rs200731840	8	Cancer Gene	2	1653276	1653276	69	0.289855072463768	NA	NA	NA			112			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXDN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,1653276,G,G&fts=all">p.S759L</a>
PXDNL	Missense_Mutation	p.K1358R	T	T		8	Cancer Gene	8	52252257	52252257	235	0.204255319148936	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXDNL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,52252257,T,T&fts=all">p.K1358R</a>
PXDNL	Missense_Mutation	p.L1079F	G	G		8	Cancer Gene	8	52320949	52320949	41	0.48780487804878	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXDNL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,52320949,G,G&fts=all">p.L1079F</a>
PXDNL	Missense_Mutation	p.S986F	G	G		8	Cancer Gene	8	52321227	52321227	5	0.8	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXDNL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,52321227,G,G&fts=all">p.S986F</a>
PXDNL	Missense_Mutation	p.G854S	C	C		8	Cancer Gene	8	52321624	52321624	31	0.290322580645161	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXDNL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,52321624,C,C&fts=all">p.G854S</a>
PXDNL	Missense_Mutation	p.P327S	G	G		8	Cancer Gene	8	52370061	52370061	51	0.176470588235294	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXDNL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,52370061,G,G&fts=all">p.P327S</a>
PXDNL	Missense_Mutation	p.L195I	A	A		8	Cancer Gene	8	52387643	52387643	48	0.208333333333333	NA	NA	NA			48	LRRCT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXDNL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,52387643,A,A&fts=all">p.L195I</a>
QRICH1	Nonsense_Mutation	p.Q181*	G	G		8	Cancer Gene	3	49095092	49095092	111	0.18018018018018	NA	NA	NA			25	Gln-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+QRICH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49095092,G,G&fts=all">p.Q181*</a>
RAB11FIP4	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB11FIP4&recr=Open">Click here</a>	
RAB27B	Missense_Mutation	p.L130I	T	T		8	Cancer Gene	18	52555270	52555270	114	0.868421052631579	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB27B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,52555270,T,T&fts=all">p.L130I</a>
RAB37	Missense_Mutation	p.L22V	C	C		8	Cancer Gene	17	72667789	72667789	28	0.392857142857143	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB37&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72667789,C,C&fts=all">p.L22V</a>
RAB37	Missense_Mutation	p.A53V	C	C		8	Cancer Gene	17	72736971	72736971	160	0.25	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB37&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72736971,C,C&fts=all">p.A53V</a>
RAB3B	Missense_Mutation	p.K8E	T	T		8	Cancer Gene	1	52442768	52442768	197	0.0406091370558376	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,52442768,T,T&fts=all">p.K8E</a>
RAB3GAP1	Nonsense_Mutation	p.Q555*	C	C		8	Cancer Gene	2	135893242	135893242	95	0.336842105263158	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB3GAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,135893242,C,C&fts=all">p.Q555*</a>
RAB3IP	Missense_Mutation	p.P331L	C	C		8	Cancer Gene	12	70194092	70194092	87	0.264367816091954	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB3IP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,70194092,C,C&fts=all">p.P331L</a>
RAB40AL	Missense_Mutation	p.P42L	C	C		8	Cancer Gene	X	102192371	102192371	63	0.507936507936508	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB40AL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,102192371,C,C&fts=all">p.P42L</a>
RAB40C	Missense_Mutation	p.P120S	C	C		8	Cancer Gene	16	675914	675914	15	0.733333333333333	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB40C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,675914,C,C&fts=all">p.P120S</a>
RABL5	Missense_Mutation	p.S111F	G	G		8	Cancer Gene	7	100959698	100959698	113	0.0619469026548673	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RABL5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,100959698,G,G&fts=all">p.S111F</a>
RAD18	Missense_Mutation	p.P182S	G	G		8	Cancer Gene	3	8983211	8983211	62	0.193548387096774	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAD18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,8983211,G,G&fts=all">p.P182S</a>
RAD23B	Missense_Mutation	p.S297F	C	C		8	Cancer Gene	9	110086243	110086243	312	0.387820512820513	NA	NA	NA			14	STI1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAD23B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,110086243,C,C&fts=all">p.S297F</a>
RAD51AP2	Missense_Mutation	p.M692I	C	C		8	Cancer Gene	2	17697607	17697607	184	0.217391304347826	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAD51AP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,17697607,C,C&fts=all">p.M692I</a>
RALGAPA2	Missense_Mutation	p.L1840F	G	G		8	Cancer Gene	20	20392770	20392770	191	0.706806282722513	NA	NA	NA			54	Rap-GAP. {ECO:0000255|PROSITE- ProRule:PRU00165}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RALGAPA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,20392770,G,G&fts=all">p.L1840F</a>
RALGAPA2	Missense_Mutation	p.P271S	G	G		8	Cancer Gene	20	20616256	20616256	204	0.279411764705882	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RALGAPA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,20616256,G,G&fts=all">p.P271S</a>
RALYL	Missense_Mutation	p.G171E	G	G		8	Cancer Gene	8	85774629	85774629	46	0.456521739130435	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RALYL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,85774629,G,G&fts=all">p.G171E</a>
RANBP3L	Missense_Mutation	p.E404D	T	T		8	Cancer Gene	5	36253779	36253779	207	0.164251207729469	NA	NA	NA			16	RanBD1. {ECO:0000255|PROSITE- ProRule:PRU00164}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RANBP3L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,36253779,T,T&fts=all">p.E404D</a>
RAP1GAP2	Missense_Mutation	p.G77R	G	G		8	Cancer Gene	17	2865991	2865991	11	0.272727272727273	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAP1GAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,2865991,G,G&fts=all">p.G77R</a>
RAP1GAP2	Splice_Site		G	G		8	Cancer Gene	17	2866723	2866723	96	0.291666666666667	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAP1GAP2&recr=Open">Click here</a>	
RAPH1	Missense_Mutation	p.P919S	G	G		8	Cancer Gene	2	204305158	204305158	62	0.17741935483871	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAPH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,204305158,G,G&fts=all">p.P919S</a>
RASAL1	Missense_Mutation	p.E168K	C	C		8	Cancer Gene	12	113557175	113557175	26	0.307692307692308	NA	NA	NA			43	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASAL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,113557175,C,C&fts=all">p.E168K</a>
RASEF	Missense_Mutation	p.L291S	A	A		8	Cancer Gene	9	85624643	85624643	170	0.252941176470588	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASEF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,85624643,A,A&fts=all">p.L291S</a>
RASEF	Missense_Mutation	p.R175C	G	G	rs373085493	8	Cancer Gene	9	85640745	85640745	325	0.335384615384615	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASEF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,85640745,G,G&fts=all">p.R175C</a>
RASGEF1B	Missense_Mutation	p.L188F	G	G		8	Cancer Gene	4	82369315	82369315	232	0.28448275862069	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGEF1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,82369315,G,G&fts=all">p.L188F</a>
RASGEF1B	Missense_Mutation	p.L114F	G	G		8	Cancer Gene	4	82377903	82377903	192	0.229166666666667	NA	NA	NA			26	N-terminal Ras-GEF. {ECO:0000255|PROSITE- ProRule:PRU00135}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGEF1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,82377903,G,G&fts=all">p.L114F</a>
RASGRF1	Missense_Mutation	p.D198N	C	C	rs150981409	8	Cancer Gene	15	79341870	79341870	83	0.349397590361446	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,79341870,C,C&fts=all">p.D198N</a>
RASGRF2	Missense_Mutation	p.E429K	G	G		8	Cancer Gene	5	80382667	80382667	65	0.507692307692308	NA	NA	NA		p.E429*(1)	75	DH. {ECO:0000255|PROSITE- ProRule:PRU00062}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,80382667,G,G&fts=all">p.E429K</a>
RASGRF2	Nonsense_Mutation	p.R819*	C	C		8	Cancer Gene	5	80409724	80409724	67	0.343283582089552	NA	NA	NA		p.R819*(1)	75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,80409724,C,C&fts=all">p.R819*</a>
RASGRP2	Missense_Mutation	p.E343K	C	C		8	Cancer Gene	11	64504293	64504293	8	0.875	NA	NA	NA			24	Ras-GEF. {ECO:0000255|PROSITE- ProRule:PRU00168}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,64504293,C,C&fts=all">p.E343K</a>
RBFA	Missense_Mutation	p.S145F	C	C		8	Cancer Gene	18	77798560	77798560	77	0.246753246753247	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBFA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,77798560,C,C&fts=all">p.S145F</a>
RBM12B	Missense_Mutation	p.G31R	C	C		8	Cancer Gene	8	94748548	94748548	356	0.23314606741573	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM12B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,94748548,C,C&fts=all">p.G31R</a>
RBM15B	Missense_Mutation	p.P553L	C	C		8	Cancer Gene	3	51430488	51430488	58	0.413793103448276	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM15B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,51430488,C,C&fts=all">p.P553L</a>
RBM17	Missense_Mutation	p.S288F	C	C		8	Cancer Gene	10	6155477	6155477	408	0.20343137254902	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,6155477,C,C&fts=all">p.S288F</a>
RBM26	Missense_Mutation	p.S237L	G	G		8	Cancer Gene	13	79943050	79943050	206	0.29126213592233	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,79943050,G,G&fts=all">p.S237L</a>
RBM43	Missense_Mutation	p.L343R	A	A		8	Cancer Gene	2	152107466	152107466	250	0.28	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM43&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,152107466,A,A&fts=all">p.L343R</a>
RBM44	Missense_Mutation	p.D879N	G	G	rs375782477	8	Cancer Gene	2	238737891	238737891	92	0.304347826086957	NA	NA	NA			33	RRM. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM44&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,238737891,G,G&fts=all">p.D879N</a>
RBM46	Missense_Mutation	p.Y174D	T	T		8	Cancer Gene	4	155719331	155719331	194	0.324742268041237	NA	NA	NA			26	RRM 2. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM46&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155719331,T,T&fts=all">p.Y174D</a>
RBM46	Missense_Mutation	p.E457K	G	G		8	Cancer Gene	4	155720683	155720683	96	0.229166666666667	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM46&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155720683,G,G&fts=all">p.E457K</a>
RBM47	Missense_Mutation	p.E123K	C	C		8	Cancer Gene	4	40440544	40440544	33	0.454545454545455	NA	NA	NA			29	RRM 1. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM47&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,40440544,C,C&fts=all">p.E123K</a>
RBM47	Missense_Mutation	p.G108D	C	C		8	Cancer Gene	4	40440588	40440588	48	0.125	NA	NA	NA			29	RRM 1. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM47&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,40440588,C,C&fts=all">p.G108D</a>
RBP3	Missense_Mutation	p.D1101N	C	C		8	Cancer Gene	10	48383931	48383931	59	0.220338983050847	NA	NA	NA			59	4 X approximate tandem repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,48383931,C,C&fts=all">p.D1101N</a>
RBP3	Missense_Mutation	p.S878F	G	G		8	Cancer Gene	10	48388245	48388245	21	0.333333333333333	NA	NA	NA			59	4 X approximate tandem repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,48388245,G,G&fts=all">p.S878F</a>
RBP3	Missense_Mutation	p.E725K	C	C		8	Cancer Gene	10	48388705	48388705	27	0.148148148148148	NA	NA	NA			59	4 X approximate tandem repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,48388705,C,C&fts=all">p.E725K</a>
RBPMS2	Missense_Mutation	p.F174L	A	A		8	Cancer Gene	15	65040665	65040665	64	0.34375	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBPMS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,65040665,A,A&fts=all">p.F174L</a>
RC3H1	Missense_Mutation	p.P455L	G	G	rs374104801	8	Cancer Gene	1	173934229	173934229	134	0.485074626865672	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RC3H1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,173934229,G,G&fts=all">p.P455L</a>
RCOR1	Missense_Mutation	p.S460F	C	C		8	Cancer Gene	14	103188713	103188713	148	0.243243243243243	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RCOR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,103188713,C,C&fts=all">p.S460F</a>
REG3G	Missense_Mutation	p.D129N	G	G		8	Cancer Gene	2	79255397	79255397	117	0.256410256410256	NA	NA	NA		p.D175H(1)	38	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REG3G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,79255397,G,G&fts=all">p.D129N</a>
RELT	Missense_Mutation	p.P100S	C	C		8	Cancer Gene	11	73102199	73102199	77	0.792207792207792	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,73102199,C,C&fts=all">p.P100S</a>
RERGL	Missense_Mutation	p.E150K	C	C		8	Cancer Gene	12	18234292	18234292	232	0.232758620689655	NA	NA	NA			17	Small GTPase-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RERGL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18234292,C,C&fts=all">p.E150K</a>
RERGL	Missense_Mutation	p.G78E	C	C		8	Cancer Gene	12	18237550	18237550	264	0.162878787878788	NA	NA	NA			17	Small GTPase-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RERGL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18237550,C,C&fts=all">p.G78E</a>
REXO4	Missense_Mutation	p.L364M	G	G		8	Cancer Gene	9	136272990	136272990	19	0.157894736842105	NA	NA	NA			15	Exonuclease.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REXO4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,136272990,G,G&fts=all">p.L364M</a>
REXO4	Missense_Mutation	p.S363F	G	G		8	Cancer Gene	9	136272992	136272992	18	0.166666666666667	NA	NA	NA			15	Exonuclease.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REXO4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,136272992,G,G&fts=all">p.S363F</a>
RFPL2	Missense_Mutation	p.M188I	C	C		8	Cancer Gene	22	32587332	32587332	172	0.232558139534884	NA	NA	NA			21	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFPL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,32587332,C,C&fts=all">p.M188I</a>
RFT1	Missense_Mutation	p.L95H	A	A		8	Cancer Gene	3	53156445	53156445	232	0.228448275862069	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,53156445,A,A&fts=all">p.L95H</a>
RFTN2	Missense_Mutation	p.L397F	G	G		8	Cancer Gene	2	198460759	198460759	178	0.264044943820225	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFTN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,198460759,G,G&fts=all">p.L397F</a>
RFTN2	Nonsense_Mutation	p.W197*	C	C		8	Cancer Gene	2	198498570	198498570	400	0.355	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFTN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,198498570,C,C&fts=all">p.W197*</a>
RFX1	Splice_Site	p.I310I	G	G		8	Cancer Gene	19	14083939	14083939	19	0.473684210526316	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX1&recr=Open">Click here</a>	
RFX1	Missense_Mutation	p.P97L	G	G		8	Cancer Gene	19	14104366	14104366	44	0.545454545454545	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,14104366,G,G&fts=all">p.P97L</a>
RFX6	Missense_Mutation	p.P304L	C	C		8	Cancer Gene	6	117237416	117237416	146	0.383561643835616	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,117237416,C,C&fts=all">p.P304L</a>
RFX6	Missense_Mutation	p.E307K	G	G		8	Cancer Gene	6	117237424	117237424	142	0.450704225352113	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,117237424,G,G&fts=all">p.E307K</a>
RFX6	Missense_Mutation	p.R377Q	G	G		8	Cancer Gene	6	117240407	117240407	133	0.43609022556391	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,117240407,G,G&fts=all">p.R377Q</a>
RFX7	Missense_Mutation	p.H1108Y	G	G		8	Cancer Gene	15	56386313	56386313	205	0.234146341463415	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,56386313,G,G&fts=all">p.H1108Y</a>
RGS11	Missense_Mutation	p.R296C	G	G		8	Cancer Gene	16	321076	321076	13	0.230769230769231	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,321076,G,G&fts=all">p.R296C</a>
RGS11	Missense_Mutation	p.S245F	G	G		8	Cancer Gene	16	321413	321413	28	0.214285714285714	NA	NA	NA			8	G protein gamma.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,321413,G,G&fts=all">p.S245F</a>
RGS12	Missense_Mutation	p.G14R	G	G		8	Cancer Gene	4	3317937	3317937	81	0.432098765432099	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,3317937,G,G&fts=all">p.G14R</a>
RGS12	Missense_Mutation	p.P507L	C	C		8	Cancer Gene	4	3319417	3319417	51	0.490196078431373	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,3319417,C,C&fts=all">p.P507L</a>
RGS17	Missense_Mutation	p.R2Q	C	C		8	Cancer Gene	6	153365149	153365149	171	0.391812865497076	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,153365149,C,C&fts=all">p.R2Q</a>
RGS6	Missense_Mutation	p.G4E	G	G		8	Cancer Gene	14	72431519	72431519	51	0.392156862745098	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,72431519,G,G&fts=all">p.G4E</a>
RGS6	Missense_Mutation	p.R112C	C	C		8	Cancer Gene	14	72925077	72925077	46	0.826086956521739	NA	NA	NA		p.R112C(1)	33	DEP. {ECO:0000255|PROSITE- ProRule:PRU00066}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,72925077,C,C&fts=all">p.R112C</a>
RGS6	Splice_Site	p.E154K	G	G		8	Cancer Gene	14	72936715	72936715	68	0.455882352941176	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS6&recr=Open">Click here</a>	
RHOT2	Missense_Mutation	p.G240S	G	G		8	Cancer Gene	16	720970	720970	37	0.324324324324324	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHOT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,720970,G,G&fts=all">p.G240S</a>
RHPN2	Nonsense_Mutation	p.Q288*	G	G		8	Cancer Gene	19	33493805	33493805	83	0.192771084337349	NA	NA	NA			44	BRO1. {ECO:0000255|PROSITE- ProRule:PRU00526}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHPN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,33493805,G,G&fts=all">p.Q288*</a>
RIC3	Missense_Mutation	p.G92E	C	C		8	Cancer Gene	11	8161590	8161590	94	0.404255319148936	NA	NA	NA			17	Poly-Gly.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,8161590,C,C&fts=all">p.G92E</a>
RICTOR	Missense_Mutation	p.P1550L	G	G		8	Cancer Gene	5	38945155	38945155	181	0.215469613259669	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RICTOR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38945155,G,G&fts=all">p.P1550L</a>
RICTOR	Missense_Mutation	p.S1101L	G	G		8	Cancer Gene	5	38950648	38950648	318	0.235849056603774	NA	NA	NA		p.S1101L(1)	75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RICTOR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38950648,G,G&fts=all">p.S1101L</a>
RICTOR	Missense_Mutation	p.E278K	C	C		8	Cancer Gene	5	38975696	38975696	114	0.184210526315789	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RICTOR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38975696,C,C&fts=all">p.E278K</a>
RIF1	Missense_Mutation	p.R1218K	G	G		8	Cancer Gene	2	152319687	152319687	293	0.593856655290102	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,152319687,G,G&fts=all">p.R1218K</a>
RIMBP2	Missense_Mutation	p.D230N	C	C		8	Cancer Gene	12	130927158	130927158	36	0.222222222222222	NA	NA	NA			96	SH3 1. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,130927158,C,C&fts=all">p.D230N</a>
RLTPR	Missense_Mutation	p.A76V	C	C	rs560546885	8	Cancer Gene	16	67679961	67679961	72	0.222222222222222	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RLTPR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,67679961,C,C&fts=all">p.A76V</a>
RLTPR	Missense_Mutation	p.R326Q	G	G		8	Cancer Gene	16	67681767	67681767	22	0.318181818181818	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RLTPR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,67681767,G,G&fts=all">p.R326Q</a>
RNASE9	Missense_Mutation	p.E68G	T	T		8	Cancer Gene	14	21025041	21025041	158	0.829113924050633	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNASE9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,21025041,T,T&fts=all">p.E68G</a>
RNF113B	Splice_Site		C	C		8	Cancer Gene	13	98828535	98828535	102	0.254901960784314	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF113B&recr=Open">Click here</a>	
RNF113B	Splice_Site	p.G319R	C	C		8	Cancer Gene	13	98828536	98828536	101	0.257425742574257	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF113B&recr=Open">Click here</a>	
RNF128	Splice_Site	p.E269*	G	G		8	Cancer Gene	X	106031148	106031148	161	0.366459627329193	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF128&recr=Open">Click here</a>	
RNF145	Splice_Site	p.S296N	C	C		8	Cancer Gene	5	158600991	158600991	210	0.0476190476190476	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF145&recr=Open">Click here</a>	
RNF157	Missense_Mutation	p.T287I	G	G		8	Cancer Gene	17	74158016	74158016	139	0.287769784172662	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF157&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,74158016,G,G&fts=all">p.T287I</a>
RNF168	Missense_Mutation	p.S394F	G	G		8	Cancer Gene	3	196199225	196199225	225	0.195555555555556	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF168&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,196199225,G,G&fts=all">p.S394F</a>
RNF169	Missense_Mutation	p.A277V	C	C		8	Cancer Gene	11	74528747	74528747	119	0.478991596638655	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF169&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,74528747,C,C&fts=all">p.A277V</a>
RNF17	Missense_Mutation	p.G303E	G	G		8	Cancer Gene	13	25363883	25363883	352	0.275568181818182	NA	NA	NA		p.G303E(2)	36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,25363883,G,G&fts=all">p.G303E</a>
RNF17	Missense_Mutation	p.M646I	G	G		8	Cancer Gene	13	25376698	25376698	123	0.317073170731707	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,25376698,G,G&fts=all">p.M646I</a>
RNF17	Missense_Mutation	p.E1213K	G	G		8	Cancer Gene	13	25433165	25433165	75	0.226666666666667	NA	NA	NA		p.E1213*(1)	36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,25433165,G,G&fts=all">p.E1213K</a>
RNF34	Missense_Mutation	p.C62S	T	T		8	Cancer Gene	12	121854139	121854139	309	0.0420711974110032	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF34&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,121854139,T,T&fts=all">p.C62S</a>
RNF38	Missense_Mutation	p.F52I	A	A		8	Cancer Gene	9	36390472	36390472	121	0.330578512396694	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF38&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,36390472,A,A&fts=all">p.F52I</a>
RNLS	Missense_Mutation	p.S150F	G	G		8	Cancer Gene	10	90332737	90332737	206	0.247572815533981	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNLS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,90332737,G,G&fts=all">p.S150F</a>
RP1L1	Missense_Mutation	p.S2305F	G	G		8	Cancer Gene	8	10464694	10464694	198	0.166666666666667	NA	NA	NA			148	25 X 16 AA approximate tandem repeats of [ED]-[AT]-[PQ]-[ED]-[AVT]-E-[GKE]-[ED]- [AMT]-Q-[EPK]-[EAT]-[TSELP]-[EG]- [EGSQDI]-[AVIE].		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,10464694,G,G&fts=all">p.S2305F</a>
RP1L1	Missense_Mutation	p.E2066K	C	C		8	Cancer Gene	8	10465412	10465412	97	0.422680412371134	NA	NA	NA			148	25 X 16 AA approximate tandem repeats of [ED]-[AT]-[PQ]-[ED]-[AVT]-E-[GKE]-[ED]- [AMT]-Q-[EPK]-[EAT]-[TSELP]-[EG]- [EGSQDI]-[AVIE].		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,10465412,C,C&fts=all">p.E2066K</a>
RP1L1	Missense_Mutation	p.E2061K	C	C		8	Cancer Gene	8	10465427	10465427	88	0.159090909090909	NA	NA	NA			148	25 X 16 AA approximate tandem repeats of [ED]-[AT]-[PQ]-[ED]-[AVT]-E-[GKE]-[ED]- [AMT]-Q-[EPK]-[EAT]-[TSELP]-[EG]- [EGSQDI]-[AVIE].		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,10465427,C,C&fts=all">p.E2061K</a>
RP1L1	Missense_Mutation	p.G984E	C	C		8	Cancer Gene	8	10468657	10468657	62	0.17741935483871	NA	NA	NA			148			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,10468657,C,C&fts=all">p.G984E</a>
RP1L1	Missense_Mutation	p.G767R	C	C		8	Cancer Gene	8	10469309	10469309	50	0.22	NA	NA	NA			148			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,10469309,C,C&fts=all">p.G767R</a>
RP1L1	Missense_Mutation	p.D673N	C	C		8	Cancer Gene	8	10469591	10469591	58	0.103448275862069	NA	NA	NA			148			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,10469591,C,C&fts=all">p.D673N</a>
RPAP2	Missense_Mutation	p.R232S	A	A		8	Cancer Gene	1	92789173	92789173	206	0.330097087378641	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,92789173,A,A&fts=all">p.R232S</a>
RPAP2	Missense_Mutation	p.P233S	C	C		8	Cancer Gene	1	92789174	92789174	204	0.333333333333333	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,92789174,C,C&fts=all">p.P233S</a>
RPGRIP1L	Missense_Mutation	p.E1188K	C	C		8	Cancer Gene	16	53639426	53639426	163	0.251533742331288	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPGRIP1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,53639426,C,C&fts=all">p.E1188K</a>
RPL10L	Missense_Mutation	p.K30N	C	C		8	Cancer Gene	14	47120850	47120850	72	0.430555555555556	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPL10L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,47120850,C,C&fts=all">p.K30N</a>
RPL10L	Missense_Mutation	p.P27L	G	G		8	Cancer Gene	14	47120860	47120860	74	0.864864864864865	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPL10L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,47120860,G,G&fts=all">p.P27L</a>
RPL21P44	Copy Number	Amplified	NA	NA	NA	8	Cancer Gene	4	54440169	55161441	NA	NA	26	2.27139579394749	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPL21P44&recr=Open">Click here</a>	
RPP30	Missense_Mutation	p.S85F	C	C		8	Cancer Gene	10	92635839	92635839	216	0.111111111111111	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPP30&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,92635839,C,C&fts=all">p.S85F</a>
RPRD2	Missense_Mutation	p.S1070F	C	C		8	Cancer Gene	1	150444633	150444633	96	0.416666666666667	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPRD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,150444633,C,C&fts=all">p.S1070F</a>
RPTOR	Missense_Mutation	p.A1258V	C	C		8	Cancer Gene	17	78936341	78936341	75	0.213333333333333	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPTOR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,78936341,C,C&fts=all">p.A1258V</a>
RRBP1	Nonsense_Mutation	p.R97*	G	G		8	Cancer Gene	20	17640864	17640864	19	0.263157894736842	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,17640864,G,G&fts=all">p.R97*</a>
RSL1D1	Missense_Mutation	p.S187F	G	G		8	Cancer Gene	16	11940433	11940433	260	0.288461538461538	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSL1D1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,11940433,G,G&fts=all">p.S187F</a>
RSPH10B2	Missense_Mutation	p.R529C	C	C		8	Cancer Gene	7	6820495	6820495	356	0.0955056179775281	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSPH10B2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,6820495,C,C&fts=all">p.R529C</a>
RSPH6A	Missense_Mutation	p.D508N	C	C		8	Cancer Gene	19	46307641	46307641	51	0.372549019607843	NA	NA	NA			32	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSPH6A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,46307641,C,C&fts=all">p.D508N</a>
RSPO2	Missense_Mutation	p.G67E	C	C		8	Cancer Gene	8	109001367	109001367	118	0.228813559322034	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSPO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,109001367,C,C&fts=all">p.G67E</a>
RSPO3	Missense_Mutation	p.T104I	C	C		8	Cancer Gene	6	127471592	127471592	111	0.252252252252252	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSPO3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,127471592,C,C&fts=all">p.T104I</a>
RSPRY1	Missense_Mutation	p.R82W	C	C	rs200887019	8	Cancer Gene	16	57238814	57238814	74	0.283783783783784	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSPRY1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,57238814,C,C&fts=all">p.R82W</a>
RTF1	Missense_Mutation	p.P694S	C	C		8	Cancer Gene	15	41772832	41772832	68	0.308823529411765	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RTF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,41772832,C,C&fts=all">p.P694S</a>
RTP3	Missense_Mutation	p.M73I	G	G		8	Cancer Gene	3	46541909	46541909	355	0.216901408450704	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RTP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,46541909,G,G&fts=all">p.M73I</a>
RWDD2B	Nonsense_Mutation	p.R256*	G	G	rs373952573	8	Cancer Gene	21	30378932	30378932	212	0.254716981132075	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RWDD2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,30378932,G,G&fts=all">p.R256*</a>
RXFP1	Nonsense_Mutation	p.W608*	G	G		8	Cancer Gene	4	159569817	159569817	185	0.248648648648649	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RXFP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,159569817,G,G&fts=all">p.W608*</a>
RXFP2	Splice_Site	p.D263N	G	G	rs267603797	8	Cancer Gene	13	32355809	32355809	125	0.248	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RXFP2&recr=Open">Click here</a>	
S100A7L2	Missense_Mutation	p.G103R	C	C		8	Cancer Gene	1	153409566	153409566	143	0.216783216783217	NA	NA	NA		p.G103*(1)|p.G92*(1)	8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+S100A7L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,153409566,C,C&fts=all">p.G103R</a>
S1PR4	Missense_Mutation	p.E122K	G	G		8	Cancer Gene	19	3179154	3179154	55	0.0909090909090909	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+S1PR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,3179154,G,G&fts=all">p.E122K</a>
SACS	Missense_Mutation	p.S4289F	G	G		8	Cancer Gene	13	23905149	23905149	148	0.256756756756757	NA	NA	NA			189			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SACS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,23905149,G,G&fts=all">p.S4289F</a>
SACS	Missense_Mutation	p.P3668S	G	G		8	Cancer Gene	13	23907013	23907013	128	0.34375	NA	NA	NA			189			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SACS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,23907013,G,G&fts=all">p.P3668S</a>
SACS	Missense_Mutation	p.S2714L	G	G		8	Cancer Gene	13	23909874	23909874	169	0.236686390532544	NA	NA	NA			189			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SACS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,23909874,G,G&fts=all">p.S2714L</a>
SACS	Missense_Mutation	p.L2458P	A	A		8	Cancer Gene	13	23910642	23910642	191	0.565445026178011	NA	NA	NA			189			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SACS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,23910642,A,A&fts=all">p.L2458P</a>
SAMD4B	Missense_Mutation	p.V401M	G	G	rs138168712	8	Cancer Gene	19	39868221	39868221	75	0.506666666666667	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAMD4B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39868221,G,G&fts=all">p.V401M</a>
SAMD7	Missense_Mutation	p.M100I	G	G		8	Cancer Gene	3	169644350	169644350	63	0.555555555555556	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAMD7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,169644350,G,G&fts=all">p.M100I</a>
SAMD9L	Missense_Mutation	p.E99K	C	C		8	Cancer Gene	7	92764990	92764990	131	0.786259541984733	NA	NA	NA			88			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAMD9L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,92764990,C,C&fts=all">p.E99K</a>
SAP130	Missense_Mutation	p.E982K	C	C		8	Cancer Gene	2	128700066	128700066	198	0.262626262626263	NA	NA	NA			45	Interactions with SIN3A and HDAC1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAP130&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,128700066,C,C&fts=all">p.E982K</a>
SAP130	Missense_Mutation	p.R950C	G	G		8	Cancer Gene	2	128703080	128703080	126	0.261904761904762	NA	NA	NA			45	Interactions with SIN3A and HDAC1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAP130&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,128703080,G,G&fts=all">p.R950C</a>
SAP130	Missense_Mutation	p.P132S	G	G		8	Cancer Gene	2	128774076	128774076	77	0.311688311688312	NA	NA	NA			45	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAP130&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,128774076,G,G&fts=all">p.P132S</a>
SASH1	Missense_Mutation	p.R625K	G	G		8	Cancer Gene	6	148855046	148855046	102	0.382352941176471	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SASH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,148855046,G,G&fts=all">p.R625K</a>
SASH3	Missense_Mutation	p.P14L	C	C		8	Cancer Gene	X	128914114	128914114	13	0.307692307692308	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SASH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,128914114,C,C&fts=all">p.P14L</a>
SBK1	Missense_Mutation	p.G28D	G	G		8	Cancer Gene	16	28328795	28328795	28	0.178571428571429	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SBK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,28328795,G,G&fts=all">p.G28D</a>
SCAF1	Nonsense_Mutation	p.R64*	C	C		8	Cancer Gene	19	50149388	50149388	105	0.152380952380952	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50149388,C,C&fts=all">p.R64*</a>
SCAND3	Missense_Mutation	p.P1272S	G	G		8	Cancer Gene	6	28539852	28539852	147	0.183673469387755	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAND3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28539852,G,G&fts=all">p.P1272S</a>
SCAND3	Nonsense_Mutation	p.W1143*	C	C		8	Cancer Gene	6	28540238	28540238	157	0.089171974522293	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAND3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28540238,C,C&fts=all">p.W1143*</a>
SCAND3	Missense_Mutation	p.F746Y	A	A		8	Cancer Gene	6	28541429	28541429	133	0.172932330827068	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAND3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28541429,A,A&fts=all">p.F746Y</a>
SCAND3	Missense_Mutation	p.R713K	C	C		8	Cancer Gene	6	28541528	28541528	60	0.0666666666666667	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAND3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28541528,C,C&fts=all">p.R713K</a>
SCAND3	Missense_Mutation	p.E609K	C	C		8	Cancer Gene	6	28542657	28542657	99	0.191919191919192	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAND3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28542657,C,C&fts=all">p.E609K</a>
SCARF2	Missense_Mutation	p.S483L	G	G		8	Cancer Gene	22	20783619	20783619	23	0.304347826086957	NA	NA	NA		p.S483L(1)	10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCARF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,20783619,G,G&fts=all">p.S483L</a>
SCD5	Missense_Mutation	p.P183S	G	G		8	Cancer Gene	4	83601882	83601882	106	0.254716981132075	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,83601882,G,G&fts=all">p.P183S</a>
SCN10A	Missense_Mutation	p.G1665S	C	C		8	Cancer Gene	3	38739718	38739718	69	0.246376811594203	NA	NA	NA			150			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN10A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38739718,C,C&fts=all">p.G1665S</a>
SCN10A	Missense_Mutation	p.G1637S	C	C		8	Cancer Gene	3	38739802	38739802	100	0.15	NA	NA	NA			150			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN10A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38739802,C,C&fts=all">p.G1637S</a>
SCN10A	Splice_Site	p.I702I	G	G		8	Cancer Gene	3	38783782	38783782	26	0.230769230769231	NA	NA	NA			150			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN10A&recr=Open">Click here</a>	
SCN10A	Missense_Mutation	p.P555S	G	G		8	Cancer Gene	3	38793802	38793802	70	0.157142857142857	NA	NA	NA			150			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN10A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38793802,G,G&fts=all">p.P555S</a>
SCN10A	Missense_Mutation	p.E423K	C	C		8	Cancer Gene	3	38798188	38798188	118	0.169491525423729	NA	NA	NA		p.E423*(1)	150			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN10A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38798188,C,C&fts=all">p.E423K</a>
SCN10A	Missense_Mutation	p.D321N	C	C		8	Cancer Gene	3	38798640	38798640	78	0.269230769230769	NA	NA	NA			150			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN10A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38798640,C,C&fts=all">p.D321N</a>
SCN10A	Missense_Mutation	p.P230S	G	G	rs147844607	8	Cancer Gene	3	38804999	38804999	173	0.190751445086705	NA	NA	NA			150			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN10A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38804999,G,G&fts=all">p.P230S</a>
SCN10A	Missense_Mutation	p.R209C	G	G	rs138262927	8	Cancer Gene	3	38805062	38805062	125	0.24	NA	NA	NA			150			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN10A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38805062,G,G&fts=all">p.R209C</a>
SCN10A	Missense_Mutation	p.P71S	G	G		8	Cancer Gene	3	38835291	38835291	115	0.2	NA	NA	NA		p.P71S(1)	150			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN10A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38835291,G,G&fts=all">p.P71S</a>
SCN11A	Missense_Mutation	p.N319S	T	T		8	Cancer Gene	3	38961429	38961429	195	0.41025641025641	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN11A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38961429,T,T&fts=all">p.N319S</a>
SCN11A	Missense_Mutation	p.R71C	G	G	rs199820983	8	Cancer Gene	3	38991643	38991643	101	0.227722772277228	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN11A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38991643,G,G&fts=all">p.R71C</a>
SCN1A	Missense_Mutation	p.G1849R	C	C		8	Cancer Gene	2	166848156	166848156	99	0.333333333333333	NA	NA	NA		p.G1866R(1)|p.G1877R(1)	200			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,166848156,C,C&fts=all">p.G1849R</a>
SCN1A	Nonsense_Mutation	p.G994*	C	C		8	Cancer Gene	2	166892923	166892923	231	0.251082251082251	NA	NA	NA			200			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,166892923,C,C&fts=all">p.G994*</a>
SCN1A	Missense_Mutation	p.D978N	C	C		8	Cancer Gene	2	166892971	166892971	173	0.236994219653179	NA	NA	NA			200			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,166892971,C,C&fts=all">p.D978N</a>
SCN1A	Missense_Mutation	p.P37S	G	G		8	Cancer Gene	2	166930023	166930023	333	0.306306306306306	NA	NA	NA			200			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,166930023,G,G&fts=all">p.P37S</a>
SCN3A	Missense_Mutation	p.P816S	G	G		8	Cancer Gene	2	165987873	165987873	305	0.616393442622951	NA	NA	NA			120			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,165987873,G,G&fts=all">p.P816S</a>
SCUBE1	Missense_Mutation	p.E566K	C	C	rs372229798	8	Cancer Gene	22	43614456	43614456	67	0.313432835820896	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCUBE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,43614456,C,C&fts=all">p.E566K</a>
SCUBE1	Missense_Mutation	p.H235Y	G	G		8	Cancer Gene	22	43654249	43654249	53	0.509433962264151	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCUBE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,43654249,G,G&fts=all">p.H235Y</a>
SCUBE2	Missense_Mutation	p.P802S	G	G		8	Cancer Gene	11	9049037	9049037	47	0.51063829787234	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCUBE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,9049037,G,G&fts=all">p.P802S</a>
SDCBP2	Nonsense_Mutation	p.K247*	T	T		8	Cancer Gene	20	1291529	1291529	26	0.153846153846154	NA	NA	NA			7	PDZ 2. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDCBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,1291529,T,T&fts=all">p.K247*</a>
SDK1	Missense_Mutation	p.R500K	G	G		8	Cancer Gene	7	4007019	4007019	245	0.216326530612245	NA	NA	NA			153	Ig-like C2-type 5.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,4007019,G,G&fts=all">p.R500K</a>
SDK1	Missense_Mutation	p.P1581L	C	C		8	Cancer Gene	7	4201430	4201430	99	0.282828282828283	NA	NA	NA			153	Fibronectin type-III 10. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,4201430,C,C&fts=all">p.P1581L</a>
SDK1	Missense_Mutation	p.S1829N	G	G		8	Cancer Gene	7	4259747	4259747	56	0.178571428571429	NA	NA	NA			153	Fibronectin type-III 12. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,4259747,G,G&fts=all">p.S1829N</a>
SDK2	Missense_Mutation	p.E2046K	C	C		8	Cancer Gene	17	71344767	71344767	43	0.255813953488372	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,71344767,C,C&fts=all">p.E2046K</a>
SDK2	Missense_Mutation	p.P736L	G	G		8	Cancer Gene	17	71412111	71412111	27	0.62962962962963	NA	NA	NA			86	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,71412111,G,G&fts=all">p.P736L</a>
SDK2	Missense_Mutation	p.P715L	G	G		8	Cancer Gene	17	71415347	71415347	43	0.162790697674419	NA	NA	NA			86	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,71415347,G,G&fts=all">p.P715L</a>
SDR16C5	Missense_Mutation	p.E252K	C	C		8	Cancer Gene	8	57218238	57218238	105	0.266666666666667	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDR16C5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,57218238,C,C&fts=all">p.E252K</a>
SEC14L4	Missense_Mutation	p.A167V	G	G		8	Cancer Gene	22	30890872	30890872	55	0.4	NA	NA	NA			21	CRAL-TRIO. {ECO:0000255|PROSITE- ProRule:PRU00056}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC14L4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,30890872,G,G&fts=all">p.A167V</a>
SEC14L4	Missense_Mutation	p.N101S	T	T		8	Cancer Gene	22	30891362	30891362	76	0.447368421052632	NA	NA	NA			21	CRAL-TRIO. {ECO:0000255|PROSITE- ProRule:PRU00056}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC14L4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,30891362,T,T&fts=all">p.N101S</a>
SEC14L4	Missense_Mutation	p.S85T	A	A		8	Cancer Gene	22	30891411	30891411	67	0.0895522388059701	NA	NA	NA			21	CRAL-TRIO. {ECO:0000255|PROSITE- ProRule:PRU00056}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC14L4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,30891411,A,A&fts=all">p.S85T</a>
SEC14L5	Missense_Mutation	p.S681L	C	C		8	Cancer Gene	16	5064922	5064922	44	0.522727272727273	NA	NA	NA		p.S681L(1)	29	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC14L5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,5064922,C,C&fts=all">p.S681L</a>
SEC16B	Missense_Mutation	p.D22N	C	C		8	Cancer Gene	1	177937053	177937053	66	0.666666666666667	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC16B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,177937053,C,C&fts=all">p.D22N</a>
SEC23IP	Missense_Mutation	p.L432F	C	C		8	Cancer Gene	10	121671658	121671658	422	0.222748815165877	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC23IP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,121671658,C,C&fts=all">p.L432F</a>
SECISBP2	Missense_Mutation	p.P573S	C	C		8	Cancer Gene	9	91963108	91963108	127	0.582677165354331	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SECISBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,91963108,C,C&fts=all">p.P573S</a>
SEMA3E	Missense_Mutation	p.E594K	C	C		8	Cancer Gene	7	83014705	83014705	186	0.290322580645161	NA	NA	NA			51	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA3E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,83014705,C,C&fts=all">p.E594K</a>
SEMA3E	Missense_Mutation	p.G54E	C	C		8	Cancer Gene	7	83119545	83119545	83	0.325301204819277	NA	NA	NA		p.G54E(1)	51	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA3E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,83119545,C,C&fts=all">p.G54E</a>
SEMA3G	Missense_Mutation	p.R409Q	C	C		8	Cancer Gene	3	52474032	52474032	111	0.18018018018018	NA	NA	NA			18	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA3G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52474032,C,C&fts=all">p.R409Q</a>
SEMA4F	Missense_Mutation	p.E383K	G	G		8	Cancer Gene	2	74902160	74902160	80	0.15	NA	NA	NA			45	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA4F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,74902160,G,G&fts=all">p.E383K</a>
SEMA5A	Missense_Mutation	p.R962S	C	C		8	Cancer Gene	5	9050529	9050529	98	0.387755102040816	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,9050529,C,C&fts=all">p.R962S</a>
SEMA5A	Nonsense_Mutation	p.R730*	G	G		8	Cancer Gene	5	9066644	9066644	220	0.195454545454545	NA	NA	NA			81	TSP type-1 4. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,9066644,G,G&fts=all">p.R730*</a>
SEMA5A	Nonsense_Mutation	p.W710*	C	C		8	Cancer Gene	5	9066702	9066702	202	0.207920792079208	NA	NA	NA			81	TSP type-1 4. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,9066702,C,C&fts=all">p.W710*</a>
SEMA5A	Missense_Mutation	p.Y40H	A	A		8	Cancer Gene	5	9379941	9379941	340	0.447058823529412	NA	NA	NA			81	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,9379941,A,A&fts=all">p.Y40H</a>
SENP2	Missense_Mutation	p.L463F	C	C		8	Cancer Gene	3	185337231	185337231	103	0.262135922330097	NA	NA	NA			12	Protease.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SENP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,185337231,C,C&fts=all">p.L463F</a>
SERINC3	Missense_Mutation	p.R293C	G	G		8	Cancer Gene	20	43132634	43132634	78	0.512820512820513	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERINC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,43132634,G,G&fts=all">p.R293C</a>
SERPINA10	Missense_Mutation	p.R154S	G	G		8	Cancer Gene	14	94756471	94756471	65	0.307692307692308	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINA10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,94756471,G,G&fts=all">p.R154S</a>
SERPINA10	Missense_Mutation	p.G139R	C	C	rs56137907	8	Cancer Gene	14	94756516	94756516	49	0.530612244897959	NA	NA	NA		p.G139R(1)	33	Heparin-binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINA10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,94756516,C,C&fts=all">p.G139R</a>
SERPINA12	Missense_Mutation	p.R28K	C	C		8	Cancer Gene	14	94964652	94964652	204	0.308823529411765	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINA12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,94964652,C,C&fts=all">p.R28K</a>
SERPINB10	Missense_Mutation	p.E286K	G	G		8	Cancer Gene	18	61602138	61602138	80	0.5125	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINB10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,61602138,G,G&fts=all">p.E286K</a>
SETX	Missense_Mutation	p.P2566L	G	G		8	Cancer Gene	9	135139963	135139963	80	0.35	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,135139963,G,G&fts=all">p.P2566L</a>
SETX	Missense_Mutation	p.P2208L	G	G		8	Cancer Gene	9	135156885	135156885	130	0.592307692307692	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,135156885,G,G&fts=all">p.P2208L</a>
SETX	Missense_Mutation	p.R1275C	G	G		8	Cancer Gene	9	135203162	135203162	384	0.3046875	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,135203162,G,G&fts=all">p.R1275C</a>
SF3B2	Missense_Mutation	p.P236S	C	C		8	Cancer Gene	11	65824826	65824826	88	0.545454545454545	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SF3B2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,65824826,C,C&fts=all">p.P236S</a>
SF3B4	Missense_Mutation	p.R206C	G	G		8	Cancer Gene	1	149898358	149898358	155	0.4	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SF3B4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,149898358,G,G&fts=all">p.R206C</a>
SFMBT2	Missense_Mutation	p.S458F	G	G		8	Cancer Gene	10	7247848	7247848	106	0.0849056603773585	NA	NA	NA			99			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SFMBT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,7247848,G,G&fts=all">p.S458F</a>
SGIP1	Missense_Mutation	p.R614W	C	C	rs373240389	8	Cancer Gene	1	67195044	67195044	383	0.879895561357702	NA	NA	NA			71	MHD. {ECO:0000255|PROSITE- ProRule:PRU00404}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGIP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,67195044,C,C&fts=all">p.R614W</a>
SGIP1	Splice_Site	p.G822E	G	G		8	Cancer Gene	1	67208756	67208756	202	0.48019801980198	NA	NA	NA			71	MHD. {ECO:0000255|PROSITE- ProRule:PRU00404}.|Necessary and sufficient to mediate interaction with CANX. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGIP1&recr=Open">Click here</a>	
SGMS2	Missense_Mutation	p.C221R	T	T		8	Cancer Gene	4	108824476	108824476	219	0.607305936073059	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGMS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,108824476,T,T&fts=all">p.C221R</a>
SGOL2	Missense_Mutation	p.F208Y	T	T		8	Cancer Gene	2	201434535	201434535	333	0.297297297297297	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGOL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,201434535,T,T&fts=all">p.F208Y</a>
SGPL1	Missense_Mutation	p.F377L	C	C		8	Cancer Gene	10	72633179	72633179	249	0.0321285140562249	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGPL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,72633179,C,C&fts=all">p.F377L</a>
SGPP2	Nonsense_Mutation	p.W353*	G	G		8	Cancer Gene	2	223423476	223423476	143	0.314685314685315	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGPP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,223423476,G,G&fts=all">p.W353*</a>
SH2D3C	Missense_Mutation	p.R34Q	C	C	rs536578808	8	Cancer Gene	9	130536683	130536683	36	0.666666666666667	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH2D3C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,130536683,C,C&fts=all">p.R34Q</a>
SH3BP5L	Missense_Mutation	p.G16R	C	C		8	Cancer Gene	1	249119089	249119089	154	0.298701298701299	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3BP5L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,249119089,C,C&fts=all">p.G16R</a>
SH3GLB1	Missense_Mutation	p.P146S	C	C		8	Cancer Gene	1	87188315	87188315	491	0.918533604887984	NA	NA	NA			11	BAR. {ECO:0000255|PROSITE- ProRule:PRU00361}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3GLB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,87188315,C,C&fts=all">p.P146S</a>
SH3RF2	Missense_Mutation	p.S82F	C	C		8	Cancer Gene	5	145317736	145317736	39	0.41025641025641	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3RF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,145317736,C,C&fts=all">p.S82F</a>
SH3RF2	Missense_Mutation	p.A304T	G	G		8	Cancer Gene	5	145393475	145393475	83	0.433734939759036	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3RF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,145393475,G,G&fts=all">p.A304T</a>
SH3RF2	Missense_Mutation	p.S467F	C	C	rs371783089	8	Cancer Gene	5	145435621	145435621	173	0.38150289017341	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3RF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,145435621,C,C&fts=all">p.S467F</a>
SH3RF2	Missense_Mutation	p.P580L	C	C		8	Cancer Gene	5	145439612	145439612	41	0.292682926829268	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3RF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,145439612,C,C&fts=all">p.P580L</a>
SH3RF2	Missense_Mutation	p.E684K	G	G		8	Cancer Gene	5	145442124	145442124	28	0.25	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3RF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,145442124,G,G&fts=all">p.E684K</a>
SHANK2	Missense_Mutation	p.P850S	G	G		8	Cancer Gene	11	70332062	70332062	60	0.433333333333333	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHANK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,70332062,G,G&fts=all">p.P850S</a>
SHANK3	Missense_Mutation	p.R300C	C	C	rs376862893	8	Cancer Gene	22	51121780	51121780	28	0.25	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,51121780,C,C&fts=all">p.R300C</a>
SHC4	Missense_Mutation	p.F292L	A	A		8	Cancer Gene	15	49164304	49164304	263	0.262357414448669	NA	NA	NA			29	PID. {ECO:0000255|PROSITE- ProRule:PRU00148}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,49164304,A,A&fts=all">p.F292L</a>
SHCBP1L	Missense_Mutation	p.G374E	C	C		8	Cancer Gene	1	182898843	182898843	407	0.402948402948403	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHCBP1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,182898843,C,C&fts=all">p.G374E</a>
SHKBP1	Missense_Mutation	p.L422F	C	C		8	Cancer Gene	19	41092778	41092778	162	0.172839506172839	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHKBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41092778,C,C&fts=all">p.L422F</a>
SHOX	Missense_Mutation	p.D31N	G	G		8	Cancer Gene	X	591723	591723	70	0.685714285714286	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHOX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,591723,G,G&fts=all">p.D31N</a>
SHROOM3	Missense_Mutation	p.P504S	C	C		8	Cancer Gene	4	77660836	77660836	104	0.240384615384615	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHROOM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,77660836,C,C&fts=all">p.P504S</a>
SHROOM3	Missense_Mutation	p.G522R	G	G		8	Cancer Gene	4	77660890	77660890	121	0.586776859504132	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHROOM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,77660890,G,G&fts=all">p.G522R</a>
SHROOM3	Missense_Mutation	p.E1799Q	G	G		8	Cancer Gene	4	77691824	77691824	75	0.0533333333333333	NA	NA	NA			60	ASD2. {ECO:0000255|PROSITE- ProRule:PRU00638}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHROOM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,77691824,G,G&fts=all">p.E1799Q</a>
SHROOM3	Missense_Mutation	p.L1877F	C	C		8	Cancer Gene	4	77699968	77699968	69	0.27536231884058	NA	NA	NA			60	ASD2. {ECO:0000255|PROSITE- ProRule:PRU00638}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHROOM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,77699968,C,C&fts=all">p.L1877F</a>
SIGLEC1	Missense_Mutation	p.P787S	G	G		8	Cancer Gene	20	3677753	3677753	34	0.352941176470588	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,3677753,G,G&fts=all">p.P787S</a>
SIGLEC1	Missense_Mutation	p.P93L	G	G		8	Cancer Gene	20	3687125	3687125	49	0.306122448979592	NA	NA	NA			70	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,3687125,G,G&fts=all">p.P93L</a>
SIGLEC12	Missense_Mutation	p.A356T	C	C		8	Cancer Gene	19	52002713	52002713	34	0.470588235294118	NA	NA	NA			61	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,52002713,C,C&fts=all">p.A356T</a>
SIGLEC12	Missense_Mutation	p.N51K	A	A	rs562282804	8	Cancer Gene	19	52004835	52004835	46	0.152173913043478	NA	NA	NA			61	Ig-like V-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,52004835,A,A&fts=all">p.N51K</a>
SIGLEC6	Missense_Mutation	p.P281L	G	G		8	Cancer Gene	19	52033148	52033148	47	0.106382978723404	NA	NA	NA			28	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,52033148,G,G&fts=all">p.P281L</a>
SIN3B	Missense_Mutation	p.L220H	T	T		8	Cancer Gene	19	16957857	16957857	54	0.12962962962963	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIN3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,16957857,T,T&fts=all">p.L220H</a>
SIPA1L1	Missense_Mutation	p.G948D	G	G		8	Cancer Gene	14	72139078	72139078	91	0.791208791208791	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIPA1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,72139078,G,G&fts=all">p.G948D</a>
SIPA1L1	Missense_Mutation	p.S1446F	C	C		8	Cancer Gene	14	72190492	72190492	96	0.8125	NA	NA	NA			78	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIPA1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,72190492,C,C&fts=all">p.S1446F</a>
SKA1	Missense_Mutation	p.S3L	C	C		8	Cancer Gene	18	47902208	47902208	191	0.842931937172775	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SKA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,47902208,C,C&fts=all">p.S3L</a>
SLC15A4	Missense_Mutation	p.F494S	A	A		8	Cancer Gene	12	129283896	129283896	69	0.0579710144927536	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC15A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,129283896,A,A&fts=all">p.F494S</a>
SLC16A12	Missense_Mutation	p.H418Y	G	G		8	Cancer Gene	10	91195853	91195853	57	0.228070175438596	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC16A12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,91195853,G,G&fts=all">p.H418Y</a>
SLC17A4	Missense_Mutation	p.S49L	C	C		8	Cancer Gene	6	25769267	25769267	117	0.222222222222222	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,25769267,C,C&fts=all">p.S49L</a>
SLC17A9	Missense_Mutation	p.G414E	G	G		8	Cancer Gene	20	61598782	61598782	95	0.231578947368421	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,61598782,G,G&fts=all">p.G414E</a>
SLC22A15	Missense_Mutation	p.S442Y	C	C		8	Cancer Gene	1	116607089	116607089	125	0.456	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,116607089,C,C&fts=all">p.S442Y</a>
SLC22A25	Missense_Mutation	p.G103E	C	C		8	Cancer Gene	11	62996817	62996817	44	0.431818181818182	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,62996817,C,C&fts=all">p.G103E</a>
SLC22A25	Missense_Mutation	p.R74K	C	C		8	Cancer Gene	11	62996904	62996904	39	0.41025641025641	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,62996904,C,C&fts=all">p.R74K</a>
SLC22A9	Nonsense_Mutation	p.Q182*	C	C		8	Cancer Gene	11	63141153	63141153	56	0.375	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,63141153,C,C&fts=all">p.Q182*</a>
SLC23A3	Missense_Mutation	p.S441F	G	G		8	Cancer Gene	2	220028229	220028229	179	0.268156424581006	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC23A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,220028229,G,G&fts=all">p.S441F</a>
SLC24A4	Missense_Mutation	p.P124S	C	C		8	Cancer Gene	14	92905730	92905730	225	0.253333333333333	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC24A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,92905730,C,C&fts=all">p.P124S</a>
SLC25A20	Missense_Mutation	p.P205S	G	G		8	Cancer Gene	3	48895951	48895951	153	0.477124183006536	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,48895951,G,G&fts=all">p.P205S</a>
SLC25A20	Missense_Mutation	p.P50S	G	G		8	Cancer Gene	3	48929463	48929463	196	0.142857142857143	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,48929463,G,G&fts=all">p.P50S</a>
SLC25A26	Splice_Site	p.A101A	A	A		8	Cancer Gene	3	66413352	66413352	38	0.236842105263158	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A26&recr=Open">Click here</a>	
SLC25A30	Missense_Mutation	p.P23L	G	G		8	Cancer Gene	13	45980104	45980104	96	0.604166666666667	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A30&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,45980104,G,G&fts=all">p.P23L</a>
SLC25A38	Missense_Mutation	p.H63Y	C	C		8	Cancer Gene	3	39431103	39431103	139	0.151079136690647	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A38&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,39431103,C,C&fts=all">p.H63Y</a>
SLC25A47	Missense_Mutation	p.G277E	G	G		8	Cancer Gene	14	100795885	100795885	83	0.614457831325301	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A47&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,100795885,G,G&fts=all">p.G277E</a>
SLC26A11	Missense_Mutation	p.S253F	C	C		8	Cancer Gene	17	78210748	78210748	159	0.207547169811321	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,78210748,C,C&fts=all">p.S253F</a>
SLC26A5	Nonsense_Mutation	p.R399*	G	G		8	Cancer Gene	7	103032107	103032107	48	0.354166666666667	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103032107,G,G&fts=all">p.R399*</a>
SLC26A5	Missense_Mutation	p.S312L	G	G		8	Cancer Gene	7	103038415	103038415	145	0.0620689655172414	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103038415,G,G&fts=all">p.S312L</a>
SLC26A5	Missense_Mutation	p.L10F	G	G		8	Cancer Gene	7	103061934	103061934	93	0.344086021505376	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103061934,G,G&fts=all">p.L10F</a>
SLC26A7	Missense_Mutation	p.P86S	C	C		8	Cancer Gene	8	92301426	92301426	261	0.21455938697318	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,92301426,C,C&fts=all">p.P86S</a>
SLC26A7	Missense_Mutation	p.S152F	C	C		8	Cancer Gene	8	92307909	92307909	80	0.2125	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,92307909,C,C&fts=all">p.S152F</a>
SLC26A9	Missense_Mutation	p.S404Y	G	G		8	Cancer Gene	1	205896624	205896624	66	0.621212121212121	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,205896624,G,G&fts=all">p.S404Y</a>
SLC26A9	Missense_Mutation	p.G402E	C	C		8	Cancer Gene	1	205896630	205896630	73	0.438356164383562	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,205896630,C,C&fts=all">p.G402E</a>
SLC26A9	Missense_Mutation	p.R281C	G	G		8	Cancer Gene	1	205898361	205898361	177	0.418079096045198	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,205898361,G,G&fts=all">p.R281C</a>
SLC27A5	Missense_Mutation	p.A263T	C	C		8	Cancer Gene	19	59022199	59022199	18	0.333333333333333	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC27A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,59022199,C,C&fts=all">p.A263T</a>
SLC28A3	Missense_Mutation	p.L26F	G	G		8	Cancer Gene	9	86928354	86928354	92	0.282608695652174	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC28A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,86928354,G,G&fts=all">p.L26F</a>
SLC29A3	Missense_Mutation	p.P391S	C	C		8	Cancer Gene	10	73122108	73122108	79	0.189873417721519	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC29A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,73122108,C,C&fts=all">p.P391S</a>
SLC2A14	Missense_Mutation	p.S81F	G	G		8	Cancer Gene	12	7984230	7984230	92	0.130434782608696	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC2A14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7984230,G,G&fts=all">p.S81F</a>
SLC30A8	Missense_Mutation	p.P169S	C	C		8	Cancer Gene	8	118170016	118170016	166	0.433734939759036	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC30A8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,118170016,C,C&fts=all">p.P169S</a>
SLC34A2	Missense_Mutation	p.G126R	G	G		8	Cancer Gene	4	25665949	25665949	65	0.384615384615385	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC34A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,25665949,G,G&fts=all">p.G126R</a>
SLC34A2	Missense_Mutation	p.T669I	C	C		8	Cancer Gene	4	25678304	25678304	36	0.25	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC34A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,25678304,C,C&fts=all">p.T669I</a>
SLC35F3	Missense_Mutation	p.G303S	G	G		8	Cancer Gene	1	234452426	234452426	84	0.214285714285714	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC35F3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,234452426,G,G&fts=all">p.G303S</a>
SLC35F3	Missense_Mutation	p.S378L	C	C		8	Cancer Gene	1	234454675	234454675	205	0.0390243902439024	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC35F3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,234454675,C,C&fts=all">p.S378L</a>
SLC36A3	Missense_Mutation	p.D432N	C	C		8	Cancer Gene	5	150657073	150657073	120	0.541666666666667	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC36A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,150657073,C,C&fts=all">p.D432N</a>
SLC38A10	Missense_Mutation	p.R514Q	C	C		8	Cancer Gene	17	79226399	79226399	94	0.202127659574468	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC38A10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,79226399,C,C&fts=all">p.R514Q</a>
SLC38A4	Missense_Mutation	p.P351S	G	G		8	Cancer Gene	12	47172094	47172094	57	0.421052631578947	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC38A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,47172094,G,G&fts=all">p.P351S</a>
SLC38A4	Missense_Mutation	p.S214L	G	G		8	Cancer Gene	12	47173580	47173580	65	0.369230769230769	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC38A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,47173580,G,G&fts=all">p.S214L</a>
SLC38A4	Missense_Mutation	p.S76F	G	G		8	Cancer Gene	12	47181798	47181798	33	0.393939393939394	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC38A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,47181798,G,G&fts=all">p.S76F</a>
SLC44A5	Missense_Mutation	p.M490I	C	C	rs138689403	8	Cancer Gene	1	75684234	75684234	172	0.0290697674418605	NA	NA	NA		p.M490I(1)	61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC44A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,75684234,C,C&fts=all">p.M490I</a>
SLC44A5	Nonsense_Mutation	p.E359*	C	C		8	Cancer Gene	1	75688056	75688056	112	0.5	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC44A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,75688056,C,C&fts=all">p.E359*</a>
SLC45A1	Missense_Mutation	p.G259R	G	G		8	Cancer Gene	1	8390328	8390328	96	0.0416666666666667	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC45A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,8390328,G,G&fts=all">p.G259R</a>
SLC46A2	Missense_Mutation	p.V250I	C	C		8	Cancer Gene	9	115652214	115652214	69	0.27536231884058	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC46A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,115652214,C,C&fts=all">p.V250I</a>
SLC47A2	Missense_Mutation	p.V23A	A	A		8	Cancer Gene	17	19619801	19619801	12	0.5	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC47A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,19619801,A,A&fts=all">p.V23A</a>
SLC4A8	Missense_Mutation	p.S513F	C	C		8	Cancer Gene	12	51864189	51864189	107	0.355140186915888	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,51864189,C,C&fts=all">p.S513F</a>
SLC4A8	Splice_Site		G	G		8	Cancer Gene	12	51883483	51883483	82	0.463414634146341	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A8&recr=Open">Click here</a>	
SLC5A11	Splice_Site		G	G		8	Cancer Gene	16	24888578	24888578	209	0.239234449760766	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A11&recr=Open">Click here</a>	
SLC5A11	Nonsense_Mutation	p.W405*	G	G		8	Cancer Gene	16	24918445	24918445	88	0.272727272727273	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,24918445,G,G&fts=all">p.W405*</a>
SLC6A19	Missense_Mutation	p.R97Q	G	G		8	Cancer Gene	5	1208948	1208948	27	0.259259259259259	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,1208948,G,G&fts=all">p.R97Q</a>
SLC6A19	Nonsense_Mutation	p.W481*	G	G		8	Cancer Gene	5	1219683	1219683	21	0.285714285714286	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,1219683,G,G&fts=all">p.W481*</a>
SLC6A20	Missense_Mutation	p.F256L	A	A		8	Cancer Gene	3	45812878	45812878	71	0.52112676056338	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,45812878,A,A&fts=all">p.F256L</a>
SLC6A20	Missense_Mutation	p.P82S	G	G		8	Cancer Gene	3	45823593	45823593	11	0.545454545454545	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,45823593,G,G&fts=all">p.P82S</a>
SLC6A5	Missense_Mutation	p.P232S	C	C		8	Cancer Gene	11	20628567	20628567	51	0.392156862745098	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,20628567,C,C&fts=all">p.P232S</a>
SLC6A5	Missense_Mutation	p.R743K	G	G		8	Cancer Gene	11	20673992	20673992	119	0.420168067226891	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,20673992,G,G&fts=all">p.R743K</a>
SLC7A13	Missense_Mutation	p.L456V	A	A		8	Cancer Gene	8	87226689	87226689	83	0.373493975903614	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,87226689,A,A&fts=all">p.L456V</a>
SLC7A14	Missense_Mutation	p.L427S	A	A		8	Cancer Gene	3	170198791	170198791	73	0.273972602739726	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,170198791,A,A&fts=all">p.L427S</a>
SLC7A3	Missense_Mutation	p.E454K	C	C		8	Cancer Gene	X	70146818	70146818	30	0.5	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,70146818,C,C&fts=all">p.E454K</a>
SLC7A3	Missense_Mutation	p.P92L	G	G		8	Cancer Gene	X	70149573	70149573	13	0.615384615384615	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,70149573,G,G&fts=all">p.P92L</a>
SLC8A1	Missense_Mutation	p.R6Q	C	C	rs202097070	8	Cancer Gene	2	40657404	40657404	105	0.219047619047619	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC8A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,40657404,C,C&fts=all">p.R6Q</a>
SLC9A2	Missense_Mutation	p.H304Y	C	C		8	Cancer Gene	2	103281715	103281715	107	0.214953271028037	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,103281715,C,C&fts=all">p.H304Y</a>
SLCO1B1	Missense_Mutation	p.G119E	G	G		8	Cancer Gene	12	21327640	21327640	181	0.209944751381215	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO1B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,21327640,G,G&fts=all">p.G119E</a>
SLCO4A1	Missense_Mutation	p.E292K	G	G		8	Cancer Gene	20	61290106	61290106	16	0.25	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO4A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,61290106,G,G&fts=all">p.E292K</a>
SLCO4C1	Missense_Mutation	p.S417F	G	G		8	Cancer Gene	5	101593670	101593670	166	0.427710843373494	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO4C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,101593670,G,G&fts=all">p.S417F</a>
SLCO4C1	Missense_Mutation	p.P59L	G	G		8	Cancer Gene	5	101631791	101631791	41	0.390243902439024	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO4C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,101631791,G,G&fts=all">p.P59L</a>
SLCO5A1	Missense_Mutation	p.L655F	G	G		8	Cancer Gene	8	70591674	70591674	188	0.0319148936170213	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO5A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,70591674,G,G&fts=all">p.L655F</a>
SLCO6A1	Missense_Mutation	p.F405Y	A	A		8	Cancer Gene	5	101774383	101774383	201	0.442786069651741	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO6A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,101774383,A,A&fts=all">p.F405Y</a>
SLFN13	Missense_Mutation	p.P358S	G	G		8	Cancer Gene	17	33770934	33770934	78	0.41025641025641	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLFN13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,33770934,G,G&fts=all">p.P358S</a>
SLITRK2	Missense_Mutation	p.G207E	G	G		8	Cancer Gene	X	144904563	144904563	99	0.94949494949495	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,144904563,G,G&fts=all">p.G207E</a>
SLITRK4	Missense_Mutation	p.F750C	A	A		8	Cancer Gene	X	142716676	142716676	132	0.416666666666667	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,142716676,A,A&fts=all">p.F750C</a>
SLITRK4	Missense_Mutation	p.G402R	C	C		8	Cancer Gene	X	142717721	142717721	130	0.461538461538462	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,142717721,C,C&fts=all">p.G402R</a>
SLITRK6	Missense_Mutation	p.L823H	A	A		8	Cancer Gene	13	86368176	86368176	158	0.348101265822785	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,86368176,A,A&fts=all">p.L823H</a>
SLITRK6	Missense_Mutation	p.G453E	C	C		8	Cancer Gene	13	86369286	86369286	183	0.245901639344262	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,86369286,C,C&fts=all">p.G453E</a>
SMARCAL1	Missense_Mutation	p.I207N	T	T		8	Cancer Gene	2	217280047	217280047	76	0.276315789473684	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMARCAL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,217280047,T,T&fts=all">p.I207N</a>
SMG6	Missense_Mutation	p.P122S	G	G		8	Cancer Gene	17	2203683	2203683	452	0.661504424778761	NA	NA	NA			45	Interaction with telomeric DNA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMG6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,2203683,G,G&fts=all">p.P122S</a>
SMG8	Missense_Mutation	p.P78S	C	C		8	Cancer Gene	17	57287644	57287644	34	0.117647058823529	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMG8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,57287644,C,C&fts=all">p.P78S</a>
SNCAIP	Missense_Mutation	p.S695F	C	C		8	Cancer Gene	5	121786485	121786485	24	0.416666666666667	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNCAIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,121786485,C,C&fts=all">p.S695F</a>
SNF8	Splice_Site	p.Q35Q	C	C		8	Cancer Gene	17	47021287	47021287	92	0.521739130434783	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNF8&recr=Open">Click here</a>	
SNRNP200	Missense_Mutation	p.P1182L	G	G		8	Cancer Gene	2	96952838	96952838	162	0.209876543209877	NA	NA	NA			90	SEC63 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNRNP200&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,96952838,G,G&fts=all">p.P1182L</a>
SNTB1	Missense_Mutation	p.G386E	C	C	rs141740285	8	Cancer Gene	8	121561178	121561178	52	0.192307692307692	NA	NA	NA			24	PH 2. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNTB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,121561178,C,C&fts=all">p.G386E</a>
SNTB1	Missense_Mutation	p.G204E	C	C		8	Cancer Gene	8	121706109	121706109	145	0.23448275862069	NA	NA	NA			24	PH 1. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNTB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,121706109,C,C&fts=all">p.G204E</a>
SNX13	Missense_Mutation	p.S710L	G	G		8	Cancer Gene	7	17843172	17843172	63	0.174603174603175	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNX13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,17843172,G,G&fts=all">p.S710L</a>
SNX13	Missense_Mutation	p.S71L	G	G	rs200885761	8	Cancer Gene	7	17932971	17932971	40	0.425	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNX13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,17932971,G,G&fts=all">p.S71L</a>
SNX29	Missense_Mutation	p.T776I	C	C		8	Cancer Gene	16	12662371	12662371	28	0.321428571428571	NA	NA	NA			7	PX. {ECO:0000255|PROSITE- ProRule:PRU00147}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNX29&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,12662371,C,C&fts=all">p.T776I</a>
SORCS2	Missense_Mutation	p.N830S	A	A		8	Cancer Gene	4	7725488	7725488	52	0.288461538461538	NA	NA	NA			42	PKD. {ECO:0000255|PROSITE- ProRule:PRU00151}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,7725488,A,A&fts=all">p.N830S</a>
SORCS2	Missense_Mutation	p.S929L	C	C		8	Cancer Gene	4	7728547	7728547	67	0.343283582089552	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,7728547,C,C&fts=all">p.S929L</a>
SORCS3	Missense_Mutation	p.V655G	T	T		8	Cancer Gene	10	106937886	106937886	87	0.425287356321839	NA	NA	NA			131			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,106937886,T,T&fts=all">p.V655G</a>
SORCS3	Missense_Mutation	p.M664I	G	G		8	Cancer Gene	10	106937914	106937914	69	0.173913043478261	NA	NA	NA			131			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,106937914,G,G&fts=all">p.M664I</a>
SORCS3	Missense_Mutation	p.E876K	G	G		8	Cancer Gene	10	106976772	106976772	89	0.292134831460674	NA	NA	NA			131	PKD. {ECO:0000255|PROSITE- ProRule:PRU00151}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,106976772,G,G&fts=all">p.E876K</a>
SORCS3	Missense_Mutation	p.H997Y	C	C		8	Cancer Gene	10	107005420	107005420	55	0.218181818181818	NA	NA	NA			131			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,107005420,C,C&fts=all">p.H997Y</a>
SORCS3	Splice_Site		G	G		8	Cancer Gene	10	107022088	107022088	93	0.182795698924731	NA	NA	NA			131			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS3&recr=Open">Click here</a>	
SORCS3	Splice_Site	p.R1148R	G	G		8	Cancer Gene	10	107022089	107022089	92	0.16304347826087	NA	NA	NA		p.R1148S(1)	131			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS3&recr=Open">Click here</a>	
SOX7	Missense_Mutation	p.S304F	G	G		8	Cancer Gene	8	10583504	10583504	23	0.434782608695652	NA	NA	NA			20	Sox C-terminal. {ECO:0000255|PROSITE- ProRule:PRU00849}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOX7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,10583504,G,G&fts=all">p.S304F</a>
SPACA1	Missense_Mutation	p.E182K	G	G	rs371980319	8	Cancer Gene	6	88769240	88769240	79	0.443037974683544	NA	NA	NA		p.E182K(1)	20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPACA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,88769240,G,G&fts=all">p.E182K</a>
SPACA7	Missense_Mutation	p.D96N	G	G		8	Cancer Gene	13	113055412	113055412	212	0.193396226415094	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPACA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,113055412,G,G&fts=all">p.D96N</a>
SPAG16	Missense_Mutation	p.P100S	C	C		8	Cancer Gene	2	214174801	214174801	177	0.570621468926554	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPAG16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,214174801,C,C&fts=all">p.P100S</a>
SPAG16	Missense_Mutation	p.S412L	C	C		8	Cancer Gene	2	214794704	214794704	145	0.303448275862069	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPAG16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,214794704,C,C&fts=all">p.S412L</a>
SPAG17	Missense_Mutation	p.E955K	C	C		8	Cancer Gene	1	118584617	118584617	358	0.251396648044693	NA	NA	NA			123			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPAG17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,118584617,C,C&fts=all">p.E955K</a>
SPANXN3	Missense_Mutation	p.K110Q	T	T		8	Cancer Gene	X	142596742	142596742	87	0.425287356321839	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPANXN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,142596742,T,T&fts=all">p.K110Q</a>
SPAST	Missense_Mutation	p.P33S	C	C		8	Cancer Gene	2	32288997	32288997	14	0.357142857142857	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPAST&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,32288997,C,C&fts=all">p.P33S</a>
SPAST	Missense_Mutation	p.P233L	C	C		8	Cancer Gene	2	32339722	32339722	174	0.28735632183908	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPAST&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,32339722,C,C&fts=all">p.P233L</a>
SPATA16	Missense_Mutation	p.K304Q	T	T		8	Cancer Gene	3	172694781	172694781	83	0.27710843373494	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATA16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,172694781,T,T&fts=all">p.K304Q</a>
SPATA16	Missense_Mutation	p.R267C	G	G	rs141658177	8	Cancer Gene	3	172737325	172737325	269	0.282527881040892	NA	NA	NA		p.R267C(1)	43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATA16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,172737325,G,G&fts=all">p.R267C</a>
SPATA19	Missense_Mutation	p.L11F	G	G		8	Cancer Gene	11	133715311	133715311	34	0.411764705882353	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATA19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,133715311,G,G&fts=all">p.L11F</a>
SPATA7	Missense_Mutation	p.L60F	C	C		8	Cancer Gene	14	88859820	88859820	117	0.188034188034188	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,88859820,C,C&fts=all">p.L60F</a>
SPATS2	Missense_Mutation	p.R449Q	G	G		8	Cancer Gene	12	49919746	49919746	57	0.228070175438596	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,49919746,G,G&fts=all">p.R449Q</a>
SPEM1	Missense_Mutation	p.R94W	C	C		8	Cancer Gene	17	7324274	7324274	61	0.639344262295082	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7324274,C,C&fts=all">p.R94W</a>
SPEM1	Missense_Mutation	p.A129T	G	G		8	Cancer Gene	17	7324379	7324379	22	0.681818181818182	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7324379,G,G&fts=all">p.A129T</a>
SPERT	Missense_Mutation	p.D186N	G	G		8	Cancer Gene	13	46287824	46287824	24	0.375	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPERT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,46287824,G,G&fts=all">p.D186N</a>
SPHKAP	Missense_Mutation	p.L1583F	G	G		8	Cancer Gene	2	228856017	228856017	141	0.269503546099291	NA	NA	NA			185			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPHKAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,228856017,G,G&fts=all">p.L1583F</a>
SPHKAP	Missense_Mutation	p.E852K	C	C		8	Cancer Gene	2	228883016	228883016	225	0.284444444444444	NA	NA	NA			185			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPHKAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,228883016,C,C&fts=all">p.E852K</a>
SPHKAP	Missense_Mutation	p.E740K	C	C		8	Cancer Gene	2	228883352	228883352	116	0.293103448275862	NA	NA	NA			185			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPHKAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,228883352,C,C&fts=all">p.E740K</a>
SPHKAP	Missense_Mutation	p.E226K	C	C	rs143438723	8	Cancer Gene	2	228886448	228886448	67	0.223880597014925	NA	NA	NA		p.E226K(1)	185			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPHKAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,228886448,C,C&fts=all">p.E226K</a>
SPHKAP	Splice_Site		C	C		8	Cancer Gene	2	228892260	228892260	96	0.260416666666667	NA	NA	NA			185			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPHKAP&recr=Open">Click here</a>	
SPNS3	Missense_Mutation	p.P354S	C	C	rs373657415	8	Cancer Gene	17	4356447	4356447	56	0.267857142857143	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPNS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,4356447,C,C&fts=all">p.P354S</a>
SPRED1	Nonsense_Mutation	p.R251*	C	C		8	Cancer Gene	15	38643281	38643281	157	0.286624203821656	NA	NA	NA			25	KBD. {ECO:0000255|PROSITE- ProRule:PRU00821}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPRED1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,38643281,C,C&fts=all">p.R251*</a>
SPRY2	Missense_Mutation	p.R4K	C	C		8	Cancer Gene	13	80911830	80911830	85	0.317647058823529	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPRY2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,80911830,C,C&fts=all">p.R4K</a>
SPRY3	Missense_Mutation	p.S43F	C	C		8	Cancer Gene	X	155003661	155003661	134	0.23134328358209	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPRY3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,155003661,C,C&fts=all">p.S43F</a>
SPRY3	Missense_Mutation	p.C158G	T	T		8	Cancer Gene	X	155004005	155004005	99	0.222222222222222	NA	NA	NA		p.C158S(1)		Cys-rich.|SPR. {ECO:0000255|PROSITE- ProRule:PRU00572}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPRY3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,155004005,T,T&fts=all">p.C158G</a>
SPTBN5	Missense_Mutation	p.E1272K	C	C	rs374105901	8	Cancer Gene	15	42169044	42169044	23	0.434782608695652	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTBN5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,42169044,C,C&fts=all">p.E1272K</a>
SREK1IP1	Splice_Site	p.KR92fs	CCTTT	CCTTT		8	Cancer Gene	5	64023933	64023937	16	0.25	NA	NA	NA			6	Lys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SREK1IP1&recr=Open">Click here</a>	
SRFBP1	Missense_Mutation	p.S215F	C	C		8	Cancer Gene	5	121356074	121356074	118	0.533898305084746	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRFBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,121356074,C,C&fts=all">p.S215F</a>
SRGAP1	Missense_Mutation	p.H690Y	C	C		8	Cancer Gene	12	64505690	64505690	126	0.26984126984127	NA	NA	NA			65	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRGAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,64505690,C,C&fts=all">p.H690Y</a>
SRRT	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	7	100491855	100693918	NA	NA	16	-1.06099915493049	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRRT&recr=Open">Click here</a>	
STAB2	Missense_Mutation	p.L571F	C	C		8	Cancer Gene	12	104049336	104049336	75	0.266666666666667	NA	NA	NA			174			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,104049336,C,C&fts=all">p.L571F</a>
STAB2	Nonsense_Mutation	p.W1914*	G	G		8	Cancer Gene	12	104133233	104133233	54	0.333333333333333	NA	NA	NA			174			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,104133233,G,G&fts=all">p.W1914*</a>
STAB2	Splice_Site	p.G1919D	G	G		8	Cancer Gene	12	104134409	104134409	38	0.342105263157895	NA	NA	NA			174			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB2&recr=Open">Click here</a>	
STAB2	Missense_Mutation	p.K2087T	A	A		8	Cancer Gene	12	104142756	104142756	28	0.464285714285714	NA	NA	NA			174			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,104142756,A,A&fts=all">p.K2087T</a>
STAC3	Missense_Mutation	p.T358I	G	G		8	Cancer Gene	12	57637617	57637617	29	0.379310344827586	NA	NA	NA			18	SH3 2. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,57637617,G,G&fts=all">p.T358I</a>
STARD3NL	Missense_Mutation	p.L203F	C	C		8	Cancer Gene	7	38259219	38259219	248	0.229838709677419	NA	NA	NA			10	MENTAL. {ECO:0000255|PROSITE- ProRule:PRU00770}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STARD3NL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,38259219,C,C&fts=all">p.L203F</a>
STARD6	Missense_Mutation	p.N70S	T	T		8	Cancer Gene	18	51851144	51851144	124	0.370967741935484	NA	NA	NA			8	START. {ECO:0000255|PROSITE- ProRule:PRU00197}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STARD6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,51851144,T,T&fts=all">p.N70S</a>
STARD6	Missense_Mutation	p.N70Y	T	T		8	Cancer Gene	18	51851145	51851145	124	0.370967741935484	NA	NA	NA			8	START. {ECO:0000255|PROSITE- ProRule:PRU00197}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STARD6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,51851145,T,T&fts=all">p.N70Y</a>
STARD8	Missense_Mutation	p.P55S	C	C		8	Cancer Gene	X	67935147	67935147	14	0.428571428571429	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STARD8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,67935147,C,C&fts=all">p.P55S</a>
STAU2	Missense_Mutation	p.P182S	G	G		8	Cancer Gene	8	74495023	74495023	283	0.441696113074205	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAU2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,74495023,G,G&fts=all">p.P182S</a>
STEAP2	Nonsense_Mutation	p.Q155*	C	C		8	Cancer Gene	7	89854859	89854859	189	0.788359788359788	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STEAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,89854859,C,C&fts=all">p.Q155*</a>
STK11IP	Missense_Mutation	p.T649I	C	C		8	Cancer Gene	2	220474104	220474104	44	0.386363636363636	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK11IP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,220474104,C,C&fts=all">p.T649I</a>
STON1	Missense_Mutation	p.S576L	C	C		8	Cancer Gene	2	48809499	48809499	119	0.302521008403361	NA	NA	NA			37	MHD. {ECO:0000255|PROSITE- ProRule:PRU00404}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STON1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,48809499,C,C&fts=all">p.S576L</a>
STON1-GTF2A1L	Splice_Site		G	G		8	Cancer Gene	2	48872171	48872171	118	0.211864406779661	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STON1-GTF2A1L&recr=Open">Click here</a>	
STON1-GTF2A1L	Splice_Site	p.G806S	G	G		8	Cancer Gene	2	48872172	48872172	124	0.225806451612903	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STON1-GTF2A1L&recr=Open">Click here</a>	
STOX2	Missense_Mutation	p.H889N	C	C		8	Cancer Gene	4	184938321	184938321	31	0.161290322580645	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STOX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,184938321,C,C&fts=all">p.H889N</a>
STRN4	Missense_Mutation	p.P334S	G	G		8	Cancer Gene	19	47231914	47231914	64	0.21875	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STRN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,47231914,G,G&fts=all">p.P334S</a>
STXBP4	Missense_Mutation	p.A307V	C	C		8	Cancer Gene	17	53120661	53120661	359	0.175487465181058	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STXBP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,53120661,C,C&fts=all">p.A307V</a>
STXBP5L	Missense_Mutation	p.R931K	G	G	rs558213185	8	Cancer Gene	3	121126222	121126222	89	0.348314606741573	NA	NA	NA			68			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STXBP5L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,121126222,G,G&fts=all">p.R931K</a>
STYK1	Missense_Mutation	p.E51D	T	T		8	Cancer Gene	12	10786623	10786623	312	0.467948717948718	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STYK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,10786623,T,T&fts=all">p.E51D</a>
SUGP2	Missense_Mutation	p.P907L	G	G		8	Cancer Gene	19	19115186	19115186	18	0.222222222222222	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUGP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,19115186,G,G&fts=all">p.P907L</a>
SUGP2	Missense_Mutation	p.P725S	G	G		8	Cancer Gene	19	19120829	19120829	134	0.470149253731343	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUGP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,19120829,G,G&fts=all">p.P725S</a>
SULF2	Missense_Mutation	p.D380N	C	C		8	Cancer Gene	20	46307475	46307475	50	0.36	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,46307475,C,C&fts=all">p.D380N</a>
SUSD2	Missense_Mutation	p.P621L	C	C		8	Cancer Gene	22	24583389	24583389	29	0.448275862068966	NA	NA	NA			26	VWFD. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUSD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,24583389,C,C&fts=all">p.P621L</a>
SUSD5	Missense_Mutation	p.G198E	C	C		8	Cancer Gene	3	33216383	33216383	90	0.233333333333333	NA	NA	NA			24	Sushi. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUSD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,33216383,C,C&fts=all">p.G198E</a>
SUZ12P	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUZ12P&recr=Open">Click here</a>	
SYBU	Missense_Mutation	p.E332K	C	C		8	Cancer Gene	8	110588130	110588130	177	0.225988700564972	NA	NA	NA			30	Sufficient for interaction with KIF5B.|Sufficient for interaction with STX1A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYBU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,110588130,C,C&fts=all">p.E332K</a>
SYCP2L	Missense_Mutation	p.R435K	G	G		8	Cancer Gene	6	10926657	10926657	174	0.224137931034483	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYCP2L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,10926657,G,G&fts=all">p.R435K</a>
SYT10	Missense_Mutation	p.D307N	C	C		8	Cancer Gene	12	33559882	33559882	167	0.18562874251497	NA	NA	NA			42	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,33559882,C,C&fts=all">p.D307N</a>
SYT10	Missense_Mutation	p.L275F	G	G		8	Cancer Gene	12	33559978	33559978	129	0.193798449612403	NA	NA	NA			42	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,33559978,G,G&fts=all">p.L275F</a>
SYT10	Missense_Mutation	p.S267F	G	G		8	Cancer Gene	12	33560001	33560001	135	0.392592592592593	NA	NA	NA			42	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,33560001,G,G&fts=all">p.S267F</a>
SYT10	Missense_Mutation	p.K254E	T	T		8	Cancer Gene	12	33560041	33560041	120	0.2	NA	NA	NA			42	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,33560041,T,T&fts=all">p.K254E</a>
SYT3	Missense_Mutation	p.S313L	G	G		8	Cancer Gene	19	51133165	51133165	46	0.239130434782609	NA	NA	NA			35	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51133165,G,G&fts=all">p.S313L</a>
SYT3	Missense_Mutation	p.S166L	G	G		8	Cancer Gene	19	51135720	51135720	24	0.125	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51135720,G,G&fts=all">p.S166L</a>
SYT9	Missense_Mutation	p.E299K	G	G		8	Cancer Gene	11	7335023	7335023	184	0.858695652173913	NA	NA	NA			38	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,7335023,G,G&fts=all">p.E299K</a>
TAAR1	Missense_Mutation	p.L161M	G	G		8	Cancer Gene	6	132966662	132966662	132	0.416666666666667	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAAR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,132966662,G,G&fts=all">p.L161M</a>
TAAR6	Missense_Mutation	p.L51F	C	C		8	Cancer Gene	6	132891611	132891611	168	0.470238095238095	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAAR6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,132891611,C,C&fts=all">p.L51F</a>
TAB3	Frame_Shift_Del	p.P61fs	T	T		8	Cancer Gene	X	30873599	30873599	82	0.853658536585366	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAB3&recr=Open">Click here</a>	
TADA2A	Nonsense_Mutation	p.R172*	C	C		8	Cancer Gene	17	35802736	35802736	115	0.4	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TADA2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,35802736,C,C&fts=all">p.R172*</a>
TAF1L	Missense_Mutation	p.R1710K	C	C		8	Cancer Gene	9	32630449	32630449	113	0.884955752212389	NA	NA	NA			159			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,32630449,C,C&fts=all">p.R1710K</a>
TAF1L	Missense_Mutation	p.E936K	C	C		8	Cancer Gene	9	32632772	32632772	132	0.446969696969697	NA	NA	NA			159			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,32632772,C,C&fts=all">p.E936K</a>
TAF1L	Missense_Mutation	p.E705K	C	C		8	Cancer Gene	9	32633465	32633465	127	0.417322834645669	NA	NA	NA			159			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,32633465,C,C&fts=all">p.E705K</a>
TAOK1	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAOK1&recr=Open">Click here</a>	
TAPBP	Missense_Mutation	p.A148V	G	G		8	Cancer Gene	6	33272930	33272930	140	0.164285714285714	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAPBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,33272930,G,G&fts=all">p.A148V</a>
TAPT1	Missense_Mutation	p.S454L	G	G		8	Cancer Gene	4	16168369	16168369	88	0.454545454545455	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAPT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,16168369,G,G&fts=all">p.S454L</a>
TARSL2	Missense_Mutation	p.D416N	C	C		8	Cancer Gene	15	102241363	102241363	339	0.572271386430678	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TARSL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,102241363,C,C&fts=all">p.D416N</a>
TAS2R1	Missense_Mutation	p.G214D	C	C		8	Cancer Gene	5	9629504	9629504	62	0.145161290322581	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,9629504,C,C&fts=all">p.G214D</a>
TAS2R14	Missense_Mutation	p.S42F	G	G		8	Cancer Gene	12	11091682	11091682	107	0.11214953271028	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,11091682,G,G&fts=all">p.S42F</a>
TAS2R20	Missense_Mutation	p.S273L	G	G		8	Cancer Gene	12	11149657	11149657	164	0.225609756097561	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,11149657,G,G&fts=all">p.S273L</a>
TAS2R3	Missense_Mutation	p.L184F	C	C		8	Cancer Gene	7	141464508	141464508	65	0.307692307692308	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,141464508,C,C&fts=all">p.L184F</a>
TAS2R38	Missense_Mutation	p.S251F	G	G		8	Cancer Gene	7	141672738	141672738	28	0.214285714285714	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R38&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,141672738,G,G&fts=all">p.S251F</a>
TAS2R40	Missense_Mutation	p.F103C	T	T		8	Cancer Gene	7	142919479	142919479	179	0.106145251396648	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,142919479,T,T&fts=all">p.F103C</a>
TAS2R40	Missense_Mutation	p.R305K	G	G		8	Cancer Gene	7	142920085	142920085	75	0.333333333333333	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,142920085,G,G&fts=all">p.R305K</a>
TAS2R43	Missense_Mutation	p.S10F	G	G		8	Cancer Gene	12	11244800	11244800	111	0.234234234234234	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R43&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,11244800,G,G&fts=all">p.S10F</a>
TAS2R5	Missense_Mutation	p.R79C	C	C	rs148686585	8	Cancer Gene	7	141490396	141490396	51	0.470588235294118	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,141490396,C,C&fts=all">p.R79C</a>
TBC1D29	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D29&recr=Open">Click here</a>	
TBX15	Missense_Mutation	p.P372S	G	G		8	Cancer Gene	1	119428050	119428050	44	0.363636363636364	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBX15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,119428050,G,G&fts=all">p.P372S</a>
TBX18	Missense_Mutation	p.P538L	G	G		8	Cancer Gene	6	85446614	85446614	115	0.260869565217391	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBX18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,85446614,G,G&fts=all">p.P538L</a>
TCF20	Missense_Mutation	p.L836S	A	A		8	Cancer Gene	22	42608805	42608805	190	0.236842105263158	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCF20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,42608805,A,A&fts=all">p.L836S</a>
TCF25	Missense_Mutation	p.Y194S	A	A	rs376171364	8	Cancer Gene	16	89954092	89954092	157	0.292993630573248	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCF25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,89954092,A,A&fts=all">p.Y194S</a>
TCHHL1	Missense_Mutation	p.S90L	G	G		8	Cancer Gene	1	152059889	152059889	120	0.133333333333333	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCHHL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152059889,G,G&fts=all">p.S90L</a>
TCP11	Missense_Mutation	p.L96F	G	G		8	Cancer Gene	6	35089997	35089997	290	0.710344827586207	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCP11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,35089997,G,G&fts=all">p.L96F</a>
TDRD5	Nonsense_Mutation	p.L145*	T	T		8	Cancer Gene	1	179562796	179562796	180	0.25	NA	NA	NA			77	HTH OST-type 2. {ECO:0000255|PROSITE- ProRule:PRU00975}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDRD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,179562796,T,T&fts=all">p.L145*</a>
TDRD6	Missense_Mutation	p.S319F	C	C		8	Cancer Gene	6	46656821	46656821	44	0.363636363636364	NA	NA	NA			80	Tudor 2. {ECO:0000255|PROSITE- ProRule:PRU00211}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDRD6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,46656821,C,C&fts=all">p.S319F</a>
TDRD6	Missense_Mutation	p.L1462F	C	C		8	Cancer Gene	6	46660249	46660249	235	0.246808510638298	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDRD6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,46660249,C,C&fts=all">p.L1462F</a>
TDRD9	Nonsense_Mutation	p.Q1329*	C	C		8	Cancer Gene	14	104515955	104515955	12	0.416666666666667	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDRD9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,104515955,C,C&fts=all">p.Q1329*</a>
TECRL	Missense_Mutation	p.M358I	C	C		8	Cancer Gene	4	65145808	65145808	159	0.144654088050314	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TECRL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,65145808,C,C&fts=all">p.M358I</a>
TECTA	Missense_Mutation	p.L267F	C	C		8	Cancer Gene	11	120989023	120989023	31	0.32258064516129	NA	NA	NA			135	VWFC.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TECTA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,120989023,C,C&fts=all">p.L267F</a>
TECTA	Missense_Mutation	p.E1469K	G	G		8	Cancer Gene	11	121028649	121028649	18	0.388888888888889	NA	NA	NA		p.E1469Q(1)	135			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TECTA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,121028649,G,G&fts=all">p.E1469K</a>
TECTA	Missense_Mutation	p.H1725Y	C	C		8	Cancer Gene	11	121032980	121032980	27	0.222222222222222	NA	NA	NA			135			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TECTA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,121032980,C,C&fts=all">p.H1725Y</a>
TECTA	Missense_Mutation	p.D1844E	T	T		8	Cancer Gene	11	121037435	121037435	37	0.405405405405405	NA	NA	NA			135	ZP. {ECO:0000255|PROSITE- ProRule:PRU00375}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TECTA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,121037435,T,T&fts=all">p.D1844E</a>
TEDDM1	Missense_Mutation	p.P248L	G	G		8	Cancer Gene	1	182368878	182368878	89	0.438202247191011	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEDDM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,182368878,G,G&fts=all">p.P248L</a>
TEKT5	Missense_Mutation	p.R88C	G	G	rs138237208	8	Cancer Gene	16	10788469	10788469	47	0.297872340425532	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEKT5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,10788469,G,G&fts=all">p.R88C</a>
TET3	Missense_Mutation	p.P566S	C	C		8	Cancer Gene	2	74275145	74275145	74	0.351351351351351	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TET3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,74275145,C,C&fts=all">p.P566S</a>
TET3	Missense_Mutation	p.G1316D	G	G		8	Cancer Gene	2	74328267	74328267	34	0.382352941176471	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TET3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,74328267,G,G&fts=all">p.G1316D</a>
TEX11	Missense_Mutation	p.E70K	C	C		8	Cancer Gene	X	70093154	70093154	80	0.5	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,70093154,C,C&fts=all">p.E70K</a>
TEX15	Missense_Mutation	p.D1550N	C	C		8	Cancer Gene	8	30701886	30701886	306	0.401960784313726	NA	NA	NA			138			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,30701886,C,C&fts=all">p.D1550N</a>
TEX15	Missense_Mutation	p.E1387K	C	C		8	Cancer Gene	8	30702375	30702375	221	0.262443438914027	NA	NA	NA			138			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,30702375,C,C&fts=all">p.E1387K</a>
TEX15	Missense_Mutation	p.K1219N	T	T		8	Cancer Gene	8	30702877	30702877	129	0.178294573643411	NA	NA	NA			138			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,30702877,T,T&fts=all">p.K1219N</a>
TEX15	Missense_Mutation	p.S870P	A	A		8	Cancer Gene	8	30703926	30703926	189	0.44973544973545	NA	NA	NA			138			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,30703926,A,A&fts=all">p.S870P</a>
TEX15	Missense_Mutation	p.D506N	C	C		8	Cancer Gene	8	30705018	30705018	252	0.202380952380952	NA	NA	NA			138			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,30705018,C,C&fts=all">p.D506N</a>
TEX15	Missense_Mutation	p.G368R	C	C		8	Cancer Gene	8	30705432	30705432	205	0.185365853658537	NA	NA	NA			138			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,30705432,C,C&fts=all">p.G368R</a>
TEX264	Missense_Mutation	p.G8S	G	G		8	Cancer Gene	3	51708342	51708342	120	0.45	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX264&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,51708342,G,G&fts=all">p.G8S</a>
TFAP2D	Missense_Mutation	p.L221F	C	C		8	Cancer Gene	6	50696631	50696631	178	0.202247191011236	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TFAP2D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,50696631,C,C&fts=all">p.L221F</a>
TFIP11	Missense_Mutation	p.E535K	C	C		8	Cancer Gene	22	26892689	26892689	213	0.36150234741784	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TFIP11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,26892689,C,C&fts=all">p.E535K</a>
TFIP11	Nonsense_Mutation	p.Q158*	G	G		8	Cancer Gene	22	26902317	26902317	215	0.209302325581395	NA	NA	NA			25	G-patch. {ECO:0000255|PROSITE- ProRule:PRU00092}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TFIP11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,26902317,G,G&fts=all">p.Q158*</a>
TGM6	Missense_Mutation	p.G593R	G	G		8	Cancer Gene	20	2411190	2411190	56	0.160714285714286	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGM6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,2411190,G,G&fts=all">p.G593R</a>
THADA	Missense_Mutation	p.R1399W	G	G	rs182266798	8	Cancer Gene	2	43625142	43625142	205	0.0390243902439024	NA	NA	NA		p.R1399W(1)	66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THADA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,43625142,G,G&fts=all">p.R1399W</a>
THADA	Missense_Mutation	p.P972S	G	G		8	Cancer Gene	2	43778961	43778961	132	0.242424242424242	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THADA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,43778961,G,G&fts=all">p.P972S</a>
THSD4	Missense_Mutation	p.G234R	G	G		8	Cancer Gene	15	71535223	71535223	74	0.243243243243243	NA	NA	NA			42	TSP type-1 1. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,71535223,G,G&fts=all">p.G234R</a>
THSD4	Missense_Mutation	p.G234E	G	G	rs376771879	8	Cancer Gene	15	71535224	71535224	75	0.253333333333333	NA	NA	NA			42	TSP type-1 1. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,71535224,G,G&fts=all">p.G234E</a>
THSD4	Missense_Mutation	p.T746I	C	C		8	Cancer Gene	15	72039377	72039377	10	0.4	NA	NA	NA			42	TSP type-1 3. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,72039377,C,C&fts=all">p.T746I</a>
THSD7A	Missense_Mutation	p.Y1540N	A	A		8	Cancer Gene	7	11418880	11418880	200	0.4	NA	NA	NA			113			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,11418880,A,A&fts=all">p.Y1540N</a>
THSD7A	Missense_Mutation	p.S1327F	G	G	rs372808276	8	Cancer Gene	7	11446619	11446619	58	0.431034482758621	NA	NA	NA			113	TSP type-1 13. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,11446619,G,G&fts=all">p.S1327F</a>
THSD7A	Missense_Mutation	p.G71E	C	C		8	Cancer Gene	7	11676567	11676567	129	0.217054263565891	NA	NA	NA			113	TSP type-1 1. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,11676567,C,C&fts=all">p.G71E</a>
THSD7B	Nonsense_Mutation	p.W67*	G	G		8	Cancer Gene	2	137814051	137814051	63	0.698412698412698	NA	NA	NA		p.W67C(1)|p.W36C(1)	134	TSP type-1 1. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,137814051,G,G&fts=all">p.W67*</a>
THSD7B	Missense_Mutation	p.A134T	G	G		8	Cancer Gene	2	137814250	137814250	33	0.363636363636364	NA	NA	NA			134	TSP type-1 2. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,137814250,G,G&fts=all">p.A134T</a>
THSD7B	Missense_Mutation	p.K285I	A	A		8	Cancer Gene	2	137814704	137814704	82	0.317073170731707	NA	NA	NA			134			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,137814704,A,A&fts=all">p.K285I</a>
THSD7B	Missense_Mutation	p.G640E	G	G	rs187887961	8	Cancer Gene	2	137990472	137990472	56	0.285714285714286	NA	NA	NA			134	TSP type-1 7. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,137990472,G,G&fts=all">p.G640E</a>
THSD7B	Missense_Mutation	p.S793F	C	C		8	Cancer Gene	2	138030214	138030214	54	0.222222222222222	NA	NA	NA			134	TSP type-1 9. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,138030214,C,C&fts=all">p.S793F</a>
THSD7B	Splice_Site	p.G899E	G	G		8	Cancer Gene	2	138169179	138169179	88	0.204545454545455	NA	NA	NA			134	TSP type-1 11. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7B&recr=Open">Click here</a>	
THSD7B	Nonsense_Mutation	p.Q1407*	C	C		8	Cancer Gene	2	138414479	138414479	147	0.312925170068027	NA	NA	NA			134	TSP type-1 18. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,138414479,C,C&fts=all">p.Q1407*</a>
THSD7B	Splice_Site	p.D1551V	A	A		8	Cancer Gene	2	138425344	138425344	28	0.178571428571429	NA	NA	NA			134			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7B&recr=Open">Click here</a>	
TKTL1	Missense_Mutation	p.G99E	G	G		8	Cancer Gene	X	153537740	153537740	301	0.93687707641196	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TKTL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,153537740,G,G&fts=all">p.G99E</a>
TLR4	Missense_Mutation	p.P34S	C	C		8	Cancer Gene	9	120470847	120470847	121	0.190082644628099	NA	NA	NA		p.P34S(1)	103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,120470847,C,C&fts=all">p.P34S</a>
TLR4	Missense_Mutation	p.G111E	G	G		8	Cancer Gene	9	120474738	120474738	106	0.30188679245283	NA	NA	NA			103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,120474738,G,G&fts=all">p.G111E</a>
TLR4	Missense_Mutation	p.L380F	C	C		8	Cancer Gene	9	120475544	120475544	132	0.333333333333333	NA	NA	NA			103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,120475544,C,C&fts=all">p.L380F</a>
TLR4	Nonsense_Mutation	p.Q430*	C	C		8	Cancer Gene	9	120475694	120475694	146	0.582191780821918	NA	NA	NA			103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,120475694,C,C&fts=all">p.Q430*</a>
TLR4	Missense_Mutation	p.G825E	G	G		8	Cancer Gene	9	120476880	120476880	85	0.235294117647059	NA	NA	NA			103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,120476880,G,G&fts=all">p.G825E</a>
TLR8	Missense_Mutation	p.S378F	C	C		8	Cancer Gene	X	12938238	12938238	208	0.884615384615385	NA	NA	NA		p.S378F(1)	50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,12938238,C,C&fts=all">p.S378F</a>
TM9SF4	Missense_Mutation	p.P89S	C	C		8	Cancer Gene	20	30729335	30729335	63	0.396825396825397	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TM9SF4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,30729335,C,C&fts=all">p.P89S</a>
TMC3	Missense_Mutation	p.E848K	C	C		8	Cancer Gene	15	81625521	81625521	200	0.28	NA	NA	NA		p.E852K(1)	34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,81625521,C,C&fts=all">p.E848K</a>
TMCO4	Missense_Mutation	p.R259Q	C	C		8	Cancer Gene	1	20072126	20072126	144	0.479166666666667	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMCO4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,20072126,C,C&fts=all">p.R259Q</a>
TMEM108	Missense_Mutation	p.H108Y	C	C		8	Cancer Gene	3	133098877	133098877	13	0.461538461538462	NA	NA	NA			38	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM108&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,133098877,C,C&fts=all">p.H108Y</a>
TMEM108	Missense_Mutation	p.M492I	G	G		8	Cancer Gene	3	133109049	133109049	165	0.448484848484848	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM108&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,133109049,G,G&fts=all">p.M492I</a>
TMEM108	Missense_Mutation	p.P559L	C	C		8	Cancer Gene	3	133114778	133114778	115	0.234782608695652	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM108&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,133114778,C,C&fts=all">p.P559L</a>
TMEM110	Nonsense_Mutation	p.Q177*	G	G		8	Cancer Gene	3	52878856	52878856	116	0.181034482758621	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM110&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52878856,G,G&fts=all">p.Q177*</a>
TMEM131	Missense_Mutation	p.P214L	G	G		8	Cancer Gene	2	98458360	98458360	23	0.173913043478261	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM131&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,98458360,G,G&fts=all">p.P214L</a>
TMEM132B	Missense_Mutation	p.P157L	C	C		8	Cancer Gene	12	125834415	125834415	69	0.666666666666667	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM132B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,125834415,C,C&fts=all">p.P157L</a>
TMEM132B	Missense_Mutation	p.T353I	C	C		8	Cancer Gene	12	125900190	125900190	32	0.34375	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM132B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,125900190,C,C&fts=all">p.T353I</a>
TMEM132B	Missense_Mutation	p.D1069N	G	G		8	Cancer Gene	12	126139224	126139224	127	0.480314960629921	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM132B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,126139224,G,G&fts=all">p.D1069N</a>
TMEM132D	Missense_Mutation	p.P514S	G	G		8	Cancer Gene	12	129569151	129569151	39	0.230769230769231	NA	NA	NA			152			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM132D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,129569151,G,G&fts=all">p.P514S</a>
TMEM132D	Missense_Mutation	p.P263L	G	G		8	Cancer Gene	12	130184535	130184535	45	0.666666666666667	NA	NA	NA			152			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM132D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,130184535,G,G&fts=all">p.P263L</a>
TMEM139	Nonsense_Mutation	p.G154*	G	G		8	Cancer Gene	7	142983731	142983731	58	0.327586206896552	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM139&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,142983731,G,G&fts=all">p.G154*</a>
TMEM154	Missense_Mutation	p.K169Q	T	T		8	Cancer Gene	4	153562111	153562111	131	0.229007633587786	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM154&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,153562111,T,T&fts=all">p.K169Q</a>
TMEM176B	Missense_Mutation	p.A267V	G	G		8	Cancer Gene	7	150488632	150488632	31	0.548387096774194	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM176B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,150488632,G,G&fts=all">p.A267V</a>
TMEM176B	Nonsense_Mutation	p.E190*	C	C		8	Cancer Gene	7	150490208	150490208	36	0.5	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM176B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,150490208,C,C&fts=all">p.E190*</a>
TMEM184A	Missense_Mutation	p.G32E	C	C		8	Cancer Gene	7	1595026	1595026	57	0.228070175438596	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM184A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,1595026,C,C&fts=all">p.G32E</a>
TMEM201	Missense_Mutation	p.P140S	C	C		8	Cancer Gene	1	9657100	9657100	57	0.912280701754386	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM201&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,9657100,C,C&fts=all">p.P140S</a>
TMEM205	Missense_Mutation	p.P137L	G	G		8	Cancer Gene	19	11453651	11453651	98	0.112244897959184	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM205&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,11453651,G,G&fts=all">p.P137L</a>
TMEM214	Nonsense_Mutation	p.Q526*	C	C		8	Cancer Gene	2	27262659	27262659	194	0.324742268041237	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM214&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27262659,C,C&fts=all">p.Q526*</a>
TMEM217	Missense_Mutation	p.H151Y	G	G		8	Cancer Gene	6	37186356	37186356	373	0.201072386058981	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM217&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,37186356,G,G&fts=all">p.H151Y</a>
TMEM225	Missense_Mutation	p.S192L	G	G		8	Cancer Gene	11	123753948	123753948	60	0.35	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM225&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,123753948,G,G&fts=all">p.S192L</a>
TMEM25	Missense_Mutation	p.M321I	G	G		8	Cancer Gene	11	118405006	118405006	14	0.857142857142857	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,118405006,G,G&fts=all">p.M321I</a>
TMEM43	Missense_Mutation	p.A42V	C	C		8	Cancer Gene	3	14171024	14171024	167	0.239520958083832	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM43&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,14171024,C,C&fts=all">p.A42V</a>
TMEM71	Missense_Mutation	p.H205Y	G	G		8	Cancer Gene	8	133740050	133740050	107	0.149532710280374	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM71&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,133740050,G,G&fts=all">p.H205Y</a>
TMEM99	Frame_Shift_Del	p.Q164fs	A	A		8	Cancer Gene	17	38991259	38991259	249	0.413654618473896	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM99&recr=Open">Click here</a>	
TMIGD1	Missense_Mutation	p.N148S	T	T		8	Cancer Gene	17	28652031	28652031	119	0.739495798319328	NA	NA	NA			12	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMIGD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,28652031,T,T&fts=all">p.N148S</a>
TMIGD1	Missense_Mutation	p.V115L	C	C		8	Cancer Gene	17	28656287	28656287	49	0.857142857142857	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMIGD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,28656287,C,C&fts=all">p.V115L</a>
TMIGD1	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMIGD1&recr=Open">Click here</a>	
TMPRSS11B	Missense_Mutation	p.E63K	C	C		8	Cancer Gene	4	69101922	69101922	116	0.344827586206897	NA	NA	NA			27	SEA. {ECO:0000255|PROSITE- ProRule:PRU00188}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS11B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,69101922,C,C&fts=all">p.E63K</a>
TMPRSS11E	Missense_Mutation	p.E129K	G	G		8	Cancer Gene	4	69337236	69337236	491	0.044806517311609	NA	NA	NA			24	SEA. {ECO:0000255|PROSITE- ProRule:PRU00188}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS11E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,69337236,G,G&fts=all">p.E129K</a>
TMPRSS15	Missense_Mutation	p.L418V	A	A		8	Cancer Gene	21	19716297	19716297	258	0.182170542635659	NA	NA	NA			85	MAM. {ECO:0000255|PROSITE- ProRule:PRU00128}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,19716297,A,A&fts=all">p.L418V</a>
TMPRSS3	Nonsense_Mutation	p.W443*	C	C		8	Cancer Gene	21	43795843	43795843	56	0.339285714285714	NA	NA	NA			13	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,43795843,C,C&fts=all">p.W443*</a>
TMPRSS6	Nonsense_Mutation	p.R590*	G	G	rs137853123	8	Cancer Gene	22	37466597	37466597	54	0.444444444444444	NA	NA	NA			40	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,37466597,G,G&fts=all">p.R590*</a>
TMPRSS6	Missense_Mutation	p.G589D	C	C		8	Cancer Gene	22	37466599	37466599	51	0.196078431372549	NA	NA	NA			40	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,37466599,C,C&fts=all">p.G589D</a>
TMTC1	Missense_Mutation	p.R862G	T	T		8	Cancer Gene	12	29667447	29667447	264	0.253787878787879	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMTC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,29667447,T,T&fts=all">p.R862G</a>
TMTC1	Missense_Mutation	p.S182L	G	G	rs367577245	8	Cancer Gene	12	29911646	29911646	118	0.245762711864407	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMTC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,29911646,G,G&fts=all">p.S182L</a>
TMTC1	Missense_Mutation	p.F176I	A	A		8	Cancer Gene	12	29911665	29911665	136	0.125	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMTC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,29911665,A,A&fts=all">p.F176I</a>
TMTC4	Missense_Mutation	p.P572L	G	G		8	Cancer Gene	13	101258641	101258641	110	0.309090909090909	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMTC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,101258641,G,G&fts=all">p.P572L</a>
TMTC4	Missense_Mutation	p.P402S	G	G		8	Cancer Gene	13	101278139	101278139	88	0.227272727272727	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMTC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,101278139,G,G&fts=all">p.P402S</a>
TNKS	Missense_Mutation	p.P324S	C	C		8	Cancer Gene	8	9567662	9567662	128	0.1875	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNKS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,9567662,C,C&fts=all">p.P324S</a>
TNKS1BP1	Missense_Mutation	p.L569F	G	G		8	Cancer Gene	11	57080457	57080457	40	0.4	NA	NA	NA			64	Acidic.|Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNKS1BP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,57080457,G,G&fts=all">p.L569F</a>
TNKS2	Missense_Mutation	p.H1122Y	C	C		8	Cancer Gene	10	93621838	93621838	320	0.3	NA	NA	NA			48	PARP catalytic. {ECO:0000255|PROSITE- ProRule:PRU00397}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNKS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,93621838,C,C&fts=all">p.H1122Y</a>
TNNI3K	Missense_Mutation	p.R826Q	G	G	rs138299635	8	Cancer Gene	1	75009635	75009635	97	0.319587628865979	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNNI3K&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,75009635,G,G&fts=all">p.R826Q</a>
TNRC6A	Missense_Mutation	p.P156S	C	C		8	Cancer Gene	16	24788556	24788556	275	0.32	NA	NA	NA			64	Interaction with argonaute family proteins.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNRC6A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,24788556,C,C&fts=all">p.P156S</a>
TNRC6A	Missense_Mutation	p.F1508Y	T	T		8	Cancer Gene	16	24818088	24818088	57	0.280701754385965	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNRC6A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,24818088,T,T&fts=all">p.F1508Y</a>
TNRC6B	Missense_Mutation	p.H785Y	C	C		8	Cancer Gene	22	40711373	40711373	135	0.162962962962963	NA	NA	NA			1	Interaction with argonaute proteins.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNRC6B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,40711373,C,C&fts=all">p.H785Y</a>
TNS4	Nonsense_Mutation	p.R499*	G	G	rs267604851	8	Cancer Gene	17	38640742	38640742	31	0.387096774193548	NA	NA	NA			30	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,38640742,G,G&fts=all">p.R499*</a>
TONSL	Missense_Mutation	p.P328S	G	G		8	Cancer Gene	8	145666378	145666378	96	0.270833333333333	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TONSL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,145666378,G,G&fts=all">p.P328S</a>
TOP2B	Missense_Mutation	p.F404S	A	A		8	Cancer Gene	3	25673977	25673977	74	0.256756756756757	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TOP2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,25673977,A,A&fts=all">p.F404S</a>
TOX3	Missense_Mutation	p.K312I	T	T		8	Cancer Gene	16	52478240	52478240	19	0.210526315789474	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TOX3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,52478240,T,T&fts=all">p.K312I</a>
TP53BP2	Splice_Site	p.V97L	C	C		8	Cancer Gene	1	224001942	224001942	203	0.25615763546798	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TP53BP2&recr=Open">Click here</a>	
TPCN1	Splice_Site	p.M608I	G	G		8	Cancer Gene	12	113729482	113729482	16	0.3125	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPCN1&recr=Open">Click here</a>	
TPCN1	Splice_Site		G	G		8	Cancer Gene	12	113729483	113729483	17	0.352941176470588	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPCN1&recr=Open">Click here</a>	
TPH2	Missense_Mutation	p.P284L	C	C		8	Cancer Gene	12	72372777	72372777	89	0.460674157303371	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,72372777,C,C&fts=all">p.P284L</a>
TRA2B	Missense_Mutation	p.F166I	A	A		8	Cancer Gene	3	185641610	185641610	217	0.308755760368664	NA	NA	NA			18	RRM. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRA2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,185641610,A,A&fts=all">p.F166I</a>
TRANK1	Missense_Mutation	p.A2123T	C	C		8	Cancer Gene	3	36872925	36872925	28	0.178571428571429	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,36872925,C,C&fts=all">p.A2123T</a>
TRANK1	Missense_Mutation	p.S1962L	G	G	rs267599779	8	Cancer Gene	3	36873407	36873407	90	0.177777777777778	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,36873407,G,G&fts=all">p.S1962L</a>
TRANK1	Missense_Mutation	p.P1305S	G	G		8	Cancer Gene	3	36875379	36875379	59	0.406779661016949	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,36875379,G,G&fts=all">p.P1305S</a>
TRANK1	Missense_Mutation	p.R1101W	G	G	rs535162660	8	Cancer Gene	3	36887847	36887847	121	0.132231404958678	NA	NA	NA			73	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,36887847,G,G&fts=all">p.R1101W</a>
TRANK1	Missense_Mutation	p.M392I	C	C		8	Cancer Gene	3	36898255	36898255	175	0.222857142857143	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,36898255,C,C&fts=all">p.M392I</a>
TRAPPC4	Missense_Mutation	p.L77F	C	C		8	Cancer Gene	11	118892523	118892523	121	0.487603305785124	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAPPC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,118892523,C,C&fts=all">p.L77F</a>
TRAPPC8	Missense_Mutation	p.F921Y	A	A		8	Cancer Gene	18	29437929	29437929	196	0.846938775510204	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAPPC8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,29437929,A,A&fts=all">p.F921Y</a>
TRAPPC9	Nonsense_Mutation	p.R712*	G	G		8	Cancer Gene	8	141301106	141301106	169	0.307692307692308	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAPPC9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,141301106,G,G&fts=all">p.R712*</a>
TREML1	Missense_Mutation	p.M105I	C	C		8	Cancer Gene	6	41121557	41121557	55	0.272727272727273	NA	NA	NA			13	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TREML1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,41121557,C,C&fts=all">p.M105I</a>
TRERF1	Missense_Mutation	p.P198S	G	G		8	Cancer Gene	6	42236737	42236737	44	0.25	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRERF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,42236737,G,G&fts=all">p.P198S</a>
TRHDE	Missense_Mutation	p.N610K	T	T		8	Cancer Gene	12	72956743	72956743	265	0.415094339622642	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRHDE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,72956743,T,T&fts=all">p.N610K</a>
TRHR	Missense_Mutation	p.K143E	A	A		8	Cancer Gene	8	110100168	110100168	144	0.486111111111111	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRHR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,110100168,A,A&fts=all">p.K143E</a>
TRIM11	Missense_Mutation	p.P266L	G	G		8	Cancer Gene	1	228584710	228584710	37	0.675675675675676	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,228584710,G,G&fts=all">p.P266L</a>
TRIM25	Missense_Mutation	p.P538S	G	G		8	Cancer Gene	17	54969342	54969342	142	0.183098591549296	NA	NA	NA			21	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,54969342,G,G&fts=all">p.P538S</a>
TRIM31	Missense_Mutation	p.C114R	A	A		8	Cancer Gene	6	30080243	30080243	114	0.184210526315789	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,30080243,A,A&fts=all">p.C114R</a>
TRIM31	Missense_Mutation	p.E45K	C	C		8	Cancer Gene	6	30080450	30080450	179	0.206703910614525	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,30080450,C,C&fts=all">p.E45K</a>
TRIM32	Missense_Mutation	p.A267S	G	G		8	Cancer Gene	9	119460820	119460820	57	0.315789473684211	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM32&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,119460820,G,G&fts=all">p.A267S</a>
TRIM42	Missense_Mutation	p.P43S	C	C		8	Cancer Gene	3	140397198	140397198	108	0.407407407407407	NA	NA	NA			69	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM42&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,140397198,C,C&fts=all">p.P43S</a>
TRIM42	Missense_Mutation	p.G686S	G	G		8	Cancer Gene	3	140410005	140410005	137	0.0656934306569343	NA	NA	NA			69	Fibronectin type-III. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM42&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,140410005,G,G&fts=all">p.G686S</a>
TRIM58	Missense_Mutation	p.G355E	G	G		8	Cancer Gene	1	248039394	248039394	62	0.193548387096774	NA	NA	NA			63	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM58&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,248039394,G,G&fts=all">p.G355E</a>
TRIM58	Missense_Mutation	p.H485Y	C	C		8	Cancer Gene	1	248039783	248039783	49	0.244897959183673	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM58&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,248039783,C,C&fts=all">p.H485Y</a>
TRIM60	Missense_Mutation	p.E12K	G	G		8	Cancer Gene	4	165961258	165961258	76	0.210526315789474	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM60&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,165961258,G,G&fts=all">p.E12K</a>
TRIM67	Missense_Mutation	p.G357E	G	G		8	Cancer Gene	1	231333142	231333142	165	0.278787878787879	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM67&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,231333142,G,G&fts=all">p.G357E</a>
TRIM71	Missense_Mutation	p.G853E	G	G		8	Cancer Gene	3	32933254	32933254	174	0.442528735632184	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM71&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,32933254,G,G&fts=all">p.G853E</a>
TRIML2	Missense_Mutation	p.M120I	C	C		8	Cancer Gene	4	189020300	189020300	108	0.25	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIML2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,189020300,C,C&fts=all">p.M120I</a>
TRIOBP	Missense_Mutation	p.P1039S	C	C		8	Cancer Gene	22	38121678	38121678	136	0.264705882352941	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIOBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38121678,C,C&fts=all">p.P1039S</a>
TRIOBP	Missense_Mutation	p.P1105L	C	C		8	Cancer Gene	22	38121877	38121877	153	0.228758169934641	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIOBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38121877,C,C&fts=all">p.P1105L</a>
TRIOBP	Missense_Mutation	p.P1192S	C	C		8	Cancer Gene	22	38122137	38122137	86	0.302325581395349	NA	NA	NA		p.P1192S(1)	12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIOBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38122137,C,C&fts=all">p.P1192S</a>
TRIOBP	Missense_Mutation	p.P1376S	C	C		8	Cancer Gene	22	38130469	38130469	45	0.155555555555556	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIOBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38130469,C,C&fts=all">p.P1376S</a>
TRPC5	Missense_Mutation	p.S451F	G	G		8	Cancer Gene	X	111095551	111095551	103	0.912621359223301	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,111095551,G,G&fts=all">p.S451F</a>
TRPM3	Nonsense_Mutation	p.Q1312*	G	G		8	Cancer Gene	9	73152059	73152059	131	0.251908396946565	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,73152059,G,G&fts=all">p.Q1312*</a>
TRPM3	Missense_Mutation	p.H238Y	G	G		8	Cancer Gene	9	73458008	73458008	117	0.273504273504274	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,73458008,G,G&fts=all">p.H238Y</a>
TRPM3	Missense_Mutation	p.G28E	C	C		8	Cancer Gene	9	73736188	73736188	67	0.283582089552239	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,73736188,C,C&fts=all">p.G28E</a>
TRPM7	Missense_Mutation	p.R660C	G	G		8	Cancer Gene	15	50904819	50904819	264	0.268939393939394	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,50904819,G,G&fts=all">p.R660C</a>
TRPV3	Missense_Mutation	p.E332Q	C	C		8	Cancer Gene	17	3436022	3436022	47	0.212765957446809	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPV3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,3436022,C,C&fts=all">p.E332Q</a>
TRPV6	Missense_Mutation	p.P552L	G	G		8	Cancer Gene	7	142571334	142571334	38	0.263157894736842	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPV6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,142571334,G,G&fts=all">p.P552L</a>
TSHZ3	Missense_Mutation	p.S636A	A	A		8	Cancer Gene	19	31768793	31768793	39	0.256410256410256	NA	NA	NA			123			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSHZ3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,31768793,A,A&fts=all">p.S636A</a>
TSHZ3	Missense_Mutation	p.P446L	G	G		8	Cancer Gene	19	31769362	31769362	54	0.185185185185185	NA	NA	NA			123			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSHZ3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,31769362,G,G&fts=all">p.P446L</a>
TSHZ3	Missense_Mutation	p.S114N	C	C		8	Cancer Gene	19	31770358	31770358	74	0.148648648648649	NA	NA	NA			123			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSHZ3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,31770358,C,C&fts=all">p.S114N</a>
TSNARE1	Missense_Mutation	p.S277F	G	G		8	Cancer Gene	8	143412325	143412325	26	0.192307692307692	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSNARE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,143412325,G,G&fts=all">p.S277F</a>
TSPAN17	Nonsense_Mutation	p.R99*	C	C	rs536743163	8	Cancer Gene	5	176079822	176079822	114	0.517543859649123	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPAN17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,176079822,C,C&fts=all">p.R99*</a>
TSPAN5	Missense_Mutation	p.S48F	G	G		8	Cancer Gene	4	99408025	99408025	91	0.263736263736264	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPAN5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,99408025,G,G&fts=all">p.S48F</a>
TSTD2	Missense_Mutation	p.P392S	G	G		8	Cancer Gene	9	100367087	100367087	150	0.24	NA	NA	NA			15	Rhodanese. {ECO:0000255|PROSITE- ProRule:PRU00173}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSTD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,100367087,G,G&fts=all">p.P392S</a>
TTBK1	Missense_Mutation	p.E733K	G	G	rs543120452	8	Cancer Gene	6	43250675	43250675	17	0.705882352941177	NA	NA	NA			53	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTBK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,43250675,G,G&fts=all">p.E733K</a>
TTBK1	Missense_Mutation	p.E1004G	A	A		8	Cancer Gene	6	43251489	43251489	35	0.142857142857143	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTBK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,43251489,A,A&fts=all">p.E1004G</a>
TTC18	Missense_Mutation	p.P126S	G	G		8	Cancer Gene	10	75107967	75107967	242	0.239669421487603	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,75107967,G,G&fts=all">p.P126S</a>
TTLL11	Missense_Mutation	p.S481F	G	G		8	Cancer Gene	9	124751571	124751571	93	0.193548387096774	NA	NA	NA			18	TTL. {ECO:0000255|PROSITE- ProRule:PRU00568}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTLL11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,124751571,G,G&fts=all">p.S481F</a>
TTYH1	Missense_Mutation	p.D427N	G	G		8	Cancer Gene	19	54947018	54947018	63	0.428571428571429	NA	NA	NA			17	Poly-Asp.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTYH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,54947018,G,G&fts=all">p.D427N</a>
TTYH3	Missense_Mutation	p.R302C	C	C		8	Cancer Gene	7	2691853	2691853	65	0.261538461538462	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTYH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,2691853,C,C&fts=all">p.R302C</a>
TTYH3	Missense_Mutation	p.P410S	C	C		8	Cancer Gene	7	2696146	2696146	138	0.152173913043478	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTYH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,2696146,C,C&fts=all">p.P410S</a>
TXNRD2	Missense_Mutation	p.E57G	T	T		8	Cancer Gene	22	19918555	19918555	81	0.185185185185185	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TXNRD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,19918555,T,T&fts=all">p.E57G</a>
UBASH3A	Missense_Mutation	p.E470K	G	G		8	Cancer Gene	21	43862597	43862597	103	0.271844660194175	NA	NA	NA			28	Phosphatase-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBASH3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,43862597,G,G&fts=all">p.E470K</a>
UBE2NL	Missense_Mutation	p.H36Y	C	C	rs267606376	8	Cancer Gene	X	142967308	142967308	123	0.455284552845528	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBE2NL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,142967308,C,C&fts=all">p.H36Y</a>
UBE2Q2	Missense_Mutation	p.P279S	C	C		8	Cancer Gene	15	76175716	76175716	227	0.26431718061674	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBE2Q2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,76175716,C,C&fts=all">p.P279S</a>
UBE2U	Missense_Mutation	p.P124L	C	C		8	Cancer Gene	1	64680529	64680529	260	0.0384615384615385	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBE2U&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,64680529,C,C&fts=all">p.P124L</a>
UBE3A	Missense_Mutation	p.P294L	G	G		8	Cancer Gene	15	25616380	25616380	217	0.230414746543779	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBE3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,25616380,G,G&fts=all">p.P294L</a>
UBR2	Missense_Mutation	p.S703F	C	C		8	Cancer Gene	6	42611962	42611962	316	0.215189873417722	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,42611962,C,C&fts=all">p.S703F</a>
UBR2	Missense_Mutation	p.S1569L	C	C		8	Cancer Gene	6	42647558	42647558	135	0.244444444444444	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,42647558,C,C&fts=all">p.S1569L</a>
UBR4	Missense_Mutation	p.R325C	G	G		8	Cancer Gene	1	19523680	19523680	220	0.318181818181818	NA	NA	NA			171			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,19523680,G,G&fts=all">p.R325C</a>
UFSP1	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	7	100491855	100693918	NA	NA	16	-1.06099915493049	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UFSP1&recr=Open">Click here</a>	
UGGT1	Missense_Mutation	p.L1271F	C	C		8	Cancer Gene	2	128936139	128936139	112	0.294642857142857	NA	NA	NA			63	Glucosyltransferase. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGGT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,128936139,C,C&fts=all">p.L1271F</a>
UGT1A5	Missense_Mutation	p.S145F	C	C		8	Cancer Gene	2	234622071	234622071	249	0.309236947791165	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT1A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,234622071,C,C&fts=all">p.S145F</a>
UGT2B11	Missense_Mutation	p.F514L	A	A		8	Cancer Gene	4	70066208	70066208	225	0.542222222222222	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2B11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70066208,A,A&fts=all">p.F514L</a>
UGT3A1	Missense_Mutation	p.L13F	G	G		8	Cancer Gene	5	35991306	35991306	92	0.239130434782609	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT3A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,35991306,G,G&fts=all">p.L13F</a>
UGT3A2	Missense_Mutation	p.G432E	C	C		8	Cancer Gene	5	36035975	36035975	29	0.137931034482759	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT3A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,36035975,C,C&fts=all">p.G432E</a>
UGT3A2	Nonsense_Mutation	p.W164*	C	C	rs373202259	8	Cancer Gene	5	36049241	36049241	96	0.15625	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT3A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,36049241,C,C&fts=all">p.W164*</a>
UGT3A2	Missense_Mutation	p.F163I	A	A		8	Cancer Gene	5	36049245	36049245	100	0.25	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT3A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,36049245,A,A&fts=all">p.F163I</a>
ULK2	Missense_Mutation	p.L1002I	G	G		8	Cancer Gene	17	19680942	19680942	105	0.342857142857143	NA	NA	NA			6	CTD-like region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ULK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,19680942,G,G&fts=all">p.L1002I</a>
UMODL1	Missense_Mutation	p.T664I	C	C		8	Cancer Gene	21	43531707	43531707	54	0.240740740740741	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UMODL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,43531707,C,C&fts=all">p.T664I</a>
UNC13C	Missense_Mutation	p.E287K	G	G		8	Cancer Gene	15	54305959	54305959	157	0.292993630573248	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,54305959,G,G&fts=all">p.E287K</a>
UNC13C	Missense_Mutation	p.G399R	G	G	rs375027743	8	Cancer Gene	15	54306295	54306295	72	0.236111111111111	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,54306295,G,G&fts=all">p.G399R</a>
UNC13C	Missense_Mutation	p.S655P	T	T		8	Cancer Gene	15	54307063	54307063	101	0.227722772277228	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,54307063,T,T&fts=all">p.S655P</a>
UNC13C	Nonsense_Mutation	p.W657*	G	G		8	Cancer Gene	15	54307070	54307070	97	0.556701030927835	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,54307070,G,G&fts=all">p.W657*</a>
UNC13C	Nonsense_Mutation	p.W657*	G	G		8	Cancer Gene	15	54307071	54307071	96	0.5625	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,54307071,G,G&fts=all">p.W657*</a>
UNC13C	Missense_Mutation	p.S850F	C	C		8	Cancer Gene	15	54307649	54307649	55	0.327272727272727	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,54307649,C,C&fts=all">p.S850F</a>
UNC45A	Missense_Mutation	p.L461Q	T	T		8	Cancer Gene	15	91490026	91490026	58	0.172413793103448	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC45A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,91490026,T,T&fts=all">p.L461Q</a>
UNC45B	Missense_Mutation	p.G490D	G	G		8	Cancer Gene	17	33496872	33496872	28	0.357142857142857	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC45B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,33496872,G,G&fts=all">p.G490D</a>
UNC5CL	Missense_Mutation	p.E421K	C	C		8	Cancer Gene	6	40998200	40998200	56	0.125	NA	NA	NA			13	Death. {ECO:0000255|PROSITE- ProRule:PRU00064}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC5CL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,40998200,C,C&fts=all">p.E421K</a>
UNC80	Missense_Mutation	p.L120I	C	C		8	Cancer Gene	2	210642041	210642041	115	0.226086956521739	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC80&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,210642041,C,C&fts=all">p.L120I</a>
UPK2	Missense_Mutation	p.G124E	G	G		8	Cancer Gene	11	118828331	118828331	45	0.377777777777778	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UPK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,118828331,G,G&fts=all">p.G124E</a>
UPK2	Splice_Site	p.R140Q	G	G		8	Cancer Gene	11	118828807	118828807	36	0.361111111111111	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UPK2&recr=Open">Click here</a>	
UPP2	Missense_Mutation	p.H133Y	C	C		8	Cancer Gene	2	158974393	158974393	196	0.321428571428571	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UPP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,158974393,C,C&fts=all">p.H133Y</a>
USH1G	Missense_Mutation	p.K218R	T	T		8	Cancer Gene	17	72916278	72916278	56	0.678571428571429	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH1G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72916278,T,T&fts=all">p.K218R</a>
USH1G	Missense_Mutation	p.M111I	C	C		8	Cancer Gene	17	72916598	72916598	61	0.245901639344262	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH1G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72916598,C,C&fts=all">p.M111I</a>
USP20	Splice_Site	p.A426A	C	C		8	Cancer Gene	9	132631590	132631590	103	0.233009708737864	NA	NA	NA			11	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP20&recr=Open">Click here</a>	
USP21	Missense_Mutation	p.R55W	C	C		8	Cancer Gene	1	161130593	161130593	169	0.218934911242604	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,161130593,C,C&fts=all">p.R55W</a>
USP26	Missense_Mutation	p.G630R	C	C		8	Cancer Gene	X	132160361	132160361	65	0.461538461538462	NA	NA	NA			60	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,132160361,C,C&fts=all">p.G630R</a>
USP26	Missense_Mutation	p.E410K	C	C		8	Cancer Gene	X	132161021	132161021	131	0.0916030534351145	NA	NA	NA			60	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,132161021,C,C&fts=all">p.E410K</a>
USP29	Nonsense_Mutation	p.Q104*	C	C		8	Cancer Gene	19	57640353	57640353	84	0.452380952380952	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP29&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57640353,C,C&fts=all">p.Q104*</a>
USP31	Missense_Mutation	p.P311A	G	G		8	Cancer Gene	16	23117556	23117556	96	0.229166666666667	NA	NA	NA			57	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,23117556,G,G&fts=all">p.P311A</a>
USP32	Missense_Mutation	p.P1134S	G	G		8	Cancer Gene	17	58275655	58275655	255	0.235294117647059	NA	NA	NA			62	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP32&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,58275655,G,G&fts=all">p.P1134S</a>
USP34	Missense_Mutation	p.G2616E	C	C		8	Cancer Gene	2	61448689	61448689	243	0.0246913580246914	NA	NA	NA			138			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP34&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,61448689,C,C&fts=all">p.G2616E</a>
USP34	Missense_Mutation	p.G2616R	C	C		8	Cancer Gene	2	61448690	61448690	243	0.0329218106995885	NA	NA	NA			138			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP34&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,61448690,C,C&fts=all">p.G2616R</a>
USP38	Missense_Mutation	p.P406S	C	C		8	Cancer Gene	4	144127192	144127192	266	0.221804511278195	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP38&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,144127192,C,C&fts=all">p.P406S</a>
USP38	Missense_Mutation	p.F620C	T	T		8	Cancer Gene	4	144134988	144134988	192	0.348958333333333	NA	NA	NA			33	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP38&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,144134988,T,T&fts=all">p.F620C</a>
USP38	Missense_Mutation	p.P651L	C	C		8	Cancer Gene	4	144135081	144135081	385	0.254545454545455	NA	NA	NA			33	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP38&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,144135081,C,C&fts=all">p.P651L</a>
USP39	Missense_Mutation	p.H375Y	C	C		8	Cancer Gene	2	85866353	85866353	156	0.25	NA	NA	NA			19	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,85866353,C,C&fts=all">p.H375Y</a>
USP40	Missense_Mutation	p.L141F	G	G		8	Cancer Gene	2	234465626	234465626	201	0.243781094527363	NA	NA	NA			30	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,234465626,G,G&fts=all">p.L141F</a>
USP44	Missense_Mutation	p.K26I	T	T		8	Cancer Gene	12	95927956	95927956	141	0.390070921985816	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP44&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,95927956,T,T&fts=all">p.K26I</a>
USP53	Nonsense_Mutation	p.Q399*	C	C		8	Cancer Gene	4	120189482	120189482	137	0.248175182481752	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP53&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,120189482,C,C&fts=all">p.Q399*</a>
USP53	Missense_Mutation	p.P409S	C	C		8	Cancer Gene	4	120189512	120189512	138	0.304347826086957	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP53&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,120189512,C,C&fts=all">p.P409S</a>
USP54	Missense_Mutation	p.S152F	G	G		8	Cancer Gene	10	75302810	75302810	431	0.255220417633411	NA	NA	NA			30	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP54&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,75302810,G,G&fts=all">p.S152F</a>
UTP6	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	27370359	30228648	NA	NA	296	-1.2894745576614	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UTP6&recr=Open">Click here</a>	
UVRAG	Missense_Mutation	p.P163S	C	C		8	Cancer Gene	11	75851960	75851960	65	0.323076923076923	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UVRAG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,75851960,C,C&fts=all">p.P163S</a>
VEZF1	Missense_Mutation	p.S453F	G	G		8	Cancer Gene	17	56052042	56052042	317	0.220820189274448	NA	NA	NA			10	4 X 7 AA repeats of P-[LV]-T-[IL]-T-[ST]- P.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VEZF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56052042,G,G&fts=all">p.S453F</a>
VEZF1	Missense_Mutation	p.H188Y	G	G		8	Cancer Gene	17	56060226	56060226	124	0.298387096774194	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VEZF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56060226,G,G&fts=all">p.H188Y</a>
VPREB3	Missense_Mutation	p.R63W	G	G		8	Cancer Gene	22	24095200	24095200	54	0.222222222222222	NA	NA	NA			3	Ig-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPREB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,24095200,G,G&fts=all">p.R63W</a>
VPS13A	Missense_Mutation	p.L1686I	T	T		8	Cancer Gene	9	79933250	79933250	302	0.622516556291391	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,79933250,T,T&fts=all">p.L1686I</a>
VPS13A	Missense_Mutation	p.P3172S	C	C		8	Cancer Gene	9	80030911	80030911	201	0.313432835820896	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,80030911,C,C&fts=all">p.P3172S</a>
VPS13B	Missense_Mutation	p.P8S	C	C	rs386834076	8	Cancer Gene	8	100026038	100026038	261	0.203065134099617	NA	NA	NA			193			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,100026038,C,C&fts=all">p.P8S</a>
VPS13B	Nonsense_Mutation	p.Q1190*	C	C		8	Cancer Gene	8	100479764	100479764	301	0.259136212624585	NA	NA	NA			193			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,100479764,C,C&fts=all">p.Q1190*</a>
VPS13B	Missense_Mutation	p.L1493F	C	C	rs386834088	8	Cancer Gene	8	100523509	100523509	209	0.244019138755981	NA	NA	NA			193			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,100523509,C,C&fts=all">p.L1493F</a>
VPS13B	Splice_Site		T	T		8	Cancer Gene	8	100588014	100588014	152	0.203947368421053	NA	NA	NA			193			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13B&recr=Open">Click here</a>	
VPS13B	Missense_Mutation	p.E2880K	G	G		8	Cancer Gene	8	100831058	100831058	243	0.218106995884774	NA	NA	NA			193			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,100831058,G,G&fts=all">p.E2880K</a>
VPS13B	Missense_Mutation	p.S2942L	C	C	rs139732310	8	Cancer Gene	8	100831768	100831768	157	0.222929936305732	NA	NA	NA			193			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,100831768,C,C&fts=all">p.S2942L</a>
VPS13C	Splice_Site	p.E3161E	C	C		8	Cancer Gene	15	62176327	62176327	123	0.536585365853659	NA	NA	NA			117			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13C&recr=Open">Click here</a>	
VPS35	Missense_Mutation	p.R781Q	C	C		8	Cancer Gene	16	46694433	46694433	263	0.638783269961977	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS35&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,46694433,C,C&fts=all">p.R781Q</a>
VPS35	Nonsense_Mutation	p.R751*	G	G		8	Cancer Gene	16	46694524	46694524	223	0.408071748878924	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS35&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,46694524,G,G&fts=all">p.R751*</a>
VRTN	Missense_Mutation	p.E22K	G	G		8	Cancer Gene	14	74823550	74823550	14	0.428571428571429	NA	NA	NA		p.E22K(1)	41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VRTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,74823550,G,G&fts=all">p.E22K</a>
VSTM1	Missense_Mutation	p.D122N	C	C	rs147285202	8	Cancer Gene	19	54554694	54554694	73	0.0958904109589041	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VSTM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,54554694,C,C&fts=all">p.D122N</a>
VSTM4	Missense_Mutation	p.E131K	C	C		8	Cancer Gene	10	50315705	50315705	45	0.133333333333333	NA	NA	NA			31	Ig-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VSTM4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,50315705,C,C&fts=all">p.E131K</a>
VWA3A	Missense_Mutation	p.G761R	G	G		8	Cancer Gene	16	22149822	22149822	25	0.72	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWA3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,22149822,G,G&fts=all">p.G761R</a>
VWA3A	Splice_Site	p.E864E	G	G		8	Cancer Gene	16	22154086	22154086	11	0.272727272727273	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWA3A&recr=Open">Click here</a>	
VWA3A	Missense_Mutation	p.S1105F	C	C		8	Cancer Gene	16	22163864	22163864	26	0.269230769230769	NA	NA	NA			7	VWFA 2. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWA3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,22163864,C,C&fts=all">p.S1105F</a>
VWA3A	Missense_Mutation	p.S1169F	C	C		8	Cancer Gene	16	22167174	22167174	55	0.254545454545455	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWA3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,22167174,C,C&fts=all">p.S1169F</a>
VWA5A	Splice_Site	p.P356L	C	C	rs202052765	8	Cancer Gene	11	123994161	123994161	126	0.404761904761905	NA	NA	NA			47	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWA5A&recr=Open">Click here</a>	
VWA5A	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	123988263	123989417	NA	NA	4	-1.26015189730067	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWA5A&recr=Open">Click here</a>	
VWC2	Missense_Mutation	p.Q324H	A	A		8	Cancer Gene	7	49951775	49951775	48	0.270833333333333	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,49951775,A,A&fts=all">p.Q324H</a>
WAPAL	Missense_Mutation	p.H834Y	G	G		8	Cancer Gene	10	88220236	88220236	212	0.188679245283019	NA	NA	NA			31	WAPL. {ECO:0000255|PROSITE- ProRule:PRU00603}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WAPAL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,88220236,G,G&fts=all">p.H834Y</a>
WBSCR17	Missense_Mutation	p.G425E	G	G		8	Cancer Gene	7	71134964	71134964	36	0.694444444444444	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WBSCR17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,71134964,G,G&fts=all">p.G425E</a>
WDFY3	Nonsense_Mutation	p.Q2644*	G	G		8	Cancer Gene	4	85636482	85636482	207	0.570048309178744	NA	NA	NA			134	Interaction with SQSTM1.|Sufficient for translocalization to p62 bodies/ALIS.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDFY3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,85636482,G,G&fts=all">p.Q2644*</a>
WDFY3	Missense_Mutation	p.H1037Y	G	G		8	Cancer Gene	4	85717732	85717732	84	0.357142857142857	NA	NA	NA			134			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDFY3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,85717732,G,G&fts=all">p.H1037Y</a>
WDR11	Missense_Mutation	p.P844S	C	C		8	Cancer Gene	10	122659555	122659555	185	0.189189189189189	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,122659555,C,C&fts=all">p.P844S</a>
WDR11	Missense_Mutation	p.P844L	C	C		8	Cancer Gene	10	122659556	122659556	188	0.186170212765957	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,122659556,C,C&fts=all">p.P844L</a>
WDR16	Splice_Site	p.G252R	G	G		8	Cancer Gene	17	9511436	9511436	35	0.314285714285714	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR16&recr=Open">Click here</a>	
WDR17	Missense_Mutation	p.G351R	G	G		8	Cancer Gene	4	177052842	177052842	386	0.269430051813472	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,177052842,G,G&fts=all">p.G351R</a>
WDR27	Missense_Mutation	p.P795L	G	G		8	Cancer Gene	6	170002355	170002355	8	0.375	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR27&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,170002355,G,G&fts=all">p.P795L</a>
WDR33	Missense_Mutation	p.G1159E	C	C		8	Cancer Gene	2	128467153	128467153	118	0.61864406779661	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR33&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,128467153,C,C&fts=all">p.G1159E</a>
WDR49	Missense_Mutation	p.P395L	G	G		8	Cancer Gene	3	167320006	167320006	104	0.596153846153846	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR49&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,167320006,G,G&fts=all">p.P395L</a>
WDR53	Missense_Mutation	p.S86F	G	G		8	Cancer Gene	3	196281425	196281425	219	0.0273972602739726	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR53&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,196281425,G,G&fts=all">p.S86F</a>
WDR62	Missense_Mutation	p.V216F	G	G		8	Cancer Gene	19	36558292	36558292	130	0.307692307692308	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR62&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36558292,G,G&fts=all">p.V216F</a>
WDR62	Missense_Mutation	p.S669F	C	C		8	Cancer Gene	19	36581394	36581394	102	0.117647058823529	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR62&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36581394,C,C&fts=all">p.S669F</a>
WDR62	Missense_Mutation	p.P794L	C	C	rs149431376	8	Cancer Gene	19	36584980	36584980	150	0.426666666666667	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR62&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36584980,C,C&fts=all">p.P794L</a>
WDR65	Missense_Mutation	p.A114V	C	C		8	Cancer Gene	1	43647388	43647388	192	0.520833333333333	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR65&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,43647388,C,C&fts=all">p.A114V</a>
WDR65	Missense_Mutation	p.G473E	G	G	rs200428342	8	Cancer Gene	1	43664307	43664307	151	0.470198675496689	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR65&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,43664307,G,G&fts=all">p.G473E</a>
WDR72	Missense_Mutation	p.G607R	C	C		8	Cancer Gene	15	53957942	53957942	116	0.25	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR72&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,53957942,C,C&fts=all">p.G607R</a>
WDR72	Splice_Site	p.K533I	T	T		8	Cancer Gene	15	53994332	53994332	293	0.245733788395904	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR72&recr=Open">Click here</a>	
WDR72	Missense_Mutation	p.P521S	G	G		8	Cancer Gene	15	53994369	53994369	424	0.283018867924528	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR72&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,53994369,G,G&fts=all">p.P521S</a>
WDR72	Missense_Mutation	p.G357E	C	C		8	Cancer Gene	15	53998186	53998186	144	0.270833333333333	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR72&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,53998186,C,C&fts=all">p.G357E</a>
WDR96	Missense_Mutation	p.S1192Y	G	G		8	Cancer Gene	10	105912450	105912450	242	0.223140495867769	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR96&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,105912450,G,G&fts=all">p.S1192Y</a>
WDYHV1	Missense_Mutation	p.P160S	C	C		8	Cancer Gene	8	124449544	124449544	92	0.228260869565217	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDYHV1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,124449544,C,C&fts=all">p.P160S</a>
WFIKKN2	Missense_Mutation	p.P301L	C	C	rs201598038	8	Cancer Gene	17	48917551	48917551	41	0.170731707317073	NA	NA	NA			29	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WFIKKN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,48917551,C,C&fts=all">p.P301L</a>
WNK2	Missense_Mutation	p.P881S	C	C		8	Cancer Gene	9	96021471	96021471	17	0.529411764705882	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,96021471,C,C&fts=all">p.P881S</a>
WNK4	Missense_Mutation	p.G538E	G	G		8	Cancer Gene	17	40939432	40939432	24	0.625	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,40939432,G,G&fts=all">p.G538E</a>
WNK4	Splice_Site		G	G	rs199890441	8	Cancer Gene	17	40945609	40945609	86	0.430232558139535	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNK4&recr=Open">Click here</a>	
WNK4	Missense_Mutation	p.G1088E	G	G		8	Cancer Gene	17	40947883	40947883	46	0.260869565217391	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,40947883,G,G&fts=all">p.G1088E</a>
WWC2	Missense_Mutation	p.L950F	C	C		8	Cancer Gene	4	184204024	184204024	15	0.533333333333333	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WWC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,184204024,C,C&fts=all">p.L950F</a>
XIRP1	Missense_Mutation	p.P1111L	G	G		8	Cancer Gene	3	39227605	39227605	79	0.139240506329114	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,39227605,G,G&fts=all">p.P1111L</a>
XIRP1	Missense_Mutation	p.G1108E	C	C		8	Cancer Gene	3	39227614	39227614	77	0.519480519480519	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,39227614,C,C&fts=all">p.G1108E</a>
XIRP1	Missense_Mutation	p.P449S	G	G		8	Cancer Gene	3	39229592	39229592	201	0.233830845771144	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,39229592,G,G&fts=all">p.P449S</a>
XKR3	Missense_Mutation	p.S19L	G	G		8	Cancer Gene	22	17288908	17288908	209	0.411483253588517	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XKR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,17288908,G,G&fts=all">p.S19L</a>
XKR9	Missense_Mutation	p.H344Y	C	C		8	Cancer Gene	8	71646567	71646567	210	0.157142857142857	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XKR9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,71646567,C,C&fts=all">p.H344Y</a>
XPO5	Nonsense_Mutation	p.Q658*	G	G		8	Cancer Gene	6	43516086	43516086	219	0.200913242009132	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XPO5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,43516086,G,G&fts=all">p.Q658*</a>
XYLT1	Missense_Mutation	p.R337C	G	G	rs267604424	8	Cancer Gene	16	17294416	17294416	118	0.26271186440678	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XYLT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,17294416,G,G&fts=all">p.R337C</a>
YARS2	Missense_Mutation	p.T275S	T	T		8	Cancer Gene	12	32906976	32906976	437	0.494279176201373	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YARS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,32906976,T,T&fts=all">p.T275S</a>
YTHDC1	Missense_Mutation	p.R665C	G	G		8	Cancer Gene	4	69180008	69180008	82	0.207317073170732	NA	NA	NA			30	Arg-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YTHDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,69180008,G,G&fts=all">p.R665C</a>
YTHDC1	Missense_Mutation	p.S277F	G	G		8	Cancer Gene	4	69202798	69202798	220	0.263636363636364	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YTHDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,69202798,G,G&fts=all">p.S277F</a>
YTHDC2	Missense_Mutation	p.R641C	C	C		8	Cancer Gene	5	112889340	112889340	251	0.434262948207171	NA	NA	NA			43	Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YTHDC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,112889340,C,C&fts=all">p.R641C</a>
YY2	Missense_Mutation	p.H283Y	C	C		8	Cancer Gene	X	21875449	21875449	149	0.912751677852349	NA	NA	NA			19	Mediates transcriptional repression.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YY2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,21875449,C,C&fts=all">p.H283Y</a>
ZAP70	Missense_Mutation	p.P224S	C	C		8	Cancer Gene	2	98349452	98349452	36	0.305555555555556	NA	NA	NA			29	SH2 2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZAP70&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,98349452,C,C&fts=all">p.P224S</a>
ZBBX	Missense_Mutation	p.E503D	T	T		8	Cancer Gene	3	167023647	167023647	124	0.258064516129032	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBBX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,167023647,T,T&fts=all">p.E503D</a>
ZBBX	Missense_Mutation	p.G70E	C	C		8	Cancer Gene	3	167083738	167083738	316	0.25	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBBX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,167083738,C,C&fts=all">p.G70E</a>
ZBP1	Missense_Mutation	p.G281S	C	C		8	Cancer Gene	20	56186816	56186816	8	0.875	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,56186816,C,C&fts=all">p.G281S</a>
ZBTB11	Missense_Mutation	p.H745Y	G	G		8	Cancer Gene	3	101373624	101373624	114	0.368421052631579	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,101373624,G,G&fts=all">p.H745Y</a>
ZC3H12B	Missense_Mutation	p.H227Y	C	C		8	Cancer Gene	X	64717082	64717082	41	0.463414634146341	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3H12B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,64717082,C,C&fts=all">p.H227Y</a>
ZC3H12C	Missense_Mutation	p.P561S	C	C	rs369802092	8	Cancer Gene	11	110035488	110035488	128	0.921875	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3H12C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,110035488,C,C&fts=all">p.P561S</a>
ZC3H13	Missense_Mutation	p.R681W	G	G		8	Cancer Gene	13	46549845	46549845	69	0.289855072463768	NA	NA	NA			79	Arg/Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3H13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,46549845,G,G&fts=all">p.R681W</a>
ZC3H13	Missense_Mutation	p.R540C	G	G		8	Cancer Gene	13	46559534	46559534	199	0.261306532663317	NA	NA	NA			79	Arg/Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3H13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,46559534,G,G&fts=all">p.R540C</a>
ZC3H6	Missense_Mutation	p.L429F	C	C		8	Cancer Gene	2	113080424	113080424	238	0.584033613445378	NA	NA	NA			35	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3H6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,113080424,C,C&fts=all">p.L429F</a>
ZC3HAV1L	Missense_Mutation	p.L184F	G	G		8	Cancer Gene	7	138713658	138713658	98	0.0816326530612245	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3HAV1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,138713658,G,G&fts=all">p.L184F</a>
ZC4H2	Missense_Mutation	p.E77K	C	C		8	Cancer Gene	X	64140130	64140130	64	0.515625	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC4H2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,64140130,C,C&fts=all">p.E77K</a>
ZC4H2	Nonsense_Mutation	p.R67*	G	G		8	Cancer Gene	X	64141723	64141723	22	0.863636363636364	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC4H2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,64141723,G,G&fts=all">p.R67*</a>
ZCCHC12	Missense_Mutation	p.R341Q	G	G		8	Cancer Gene	X	117960229	117960229	63	0.380952380952381	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCCHC12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,117960229,G,G&fts=all">p.R341Q</a>
ZCCHC16	Missense_Mutation	p.E35K	G	G		8	Cancer Gene	X	111698059	111698059	33	0.575757575757576	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCCHC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,111698059,G,G&fts=all">p.E35K</a>
ZCCHC4	Missense_Mutation	p.L371F	C	C		8	Cancer Gene	4	25363580	25363580	105	0.0380952380952381	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCCHC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,25363580,C,C&fts=all">p.L371F</a>
ZCCHC5	Missense_Mutation	p.E372K	C	C		8	Cancer Gene	X	77912804	77912804	65	0.430769230769231	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCCHC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,77912804,C,C&fts=all">p.E372K</a>
ZCCHC5	Missense_Mutation	p.F361Y	A	A		8	Cancer Gene	X	77912836	77912836	51	0.490196078431373	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCCHC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,77912836,A,A&fts=all">p.F361Y</a>
ZCCHC5	Missense_Mutation	p.R53Q	C	C		8	Cancer Gene	X	77913760	77913760	18	0.5	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCCHC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,77913760,C,C&fts=all">p.R53Q</a>
ZCCHC5	Missense_Mutation	p.A35T	C	C		8	Cancer Gene	X	77913815	77913815	32	0.34375	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCCHC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,77913815,C,C&fts=all">p.A35T</a>
ZCWPW1	Missense_Mutation	p.E92K	C	C		8	Cancer Gene	7	100013715	100013715	89	0.359550561797753	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCWPW1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,100013715,C,C&fts=all">p.E92K</a>
ZFAT	Missense_Mutation	p.R930C	G	G		8	Cancer Gene	8	135596174	135596174	23	0.434782608695652	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFAT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,135596174,G,G&fts=all">p.R930C</a>
ZFHX4	Missense_Mutation	p.G890R	G	G		8	Cancer Gene	8	77619858	77619858	66	0.242424242424242	NA	NA	NA			432			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,77619858,G,G&fts=all">p.G890R</a>
ZFHX4	Missense_Mutation	p.S1044F	C	C		8	Cancer Gene	8	77690481	77690481	133	0.225563909774436	NA	NA	NA			432			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,77690481,C,C&fts=all">p.S1044F</a>
ZFHX4	Missense_Mutation	p.F1099Y	T	T		8	Cancer Gene	8	77690646	77690646	128	0.4765625	NA	NA	NA			432			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,77690646,T,T&fts=all">p.F1099Y</a>
ZFHX4	Missense_Mutation	p.P2630S	C	C		8	Cancer Gene	8	77767045	77767045	38	0.131578947368421	NA	NA	NA			432			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,77767045,C,C&fts=all">p.P2630S</a>
ZFHX4	Missense_Mutation	p.E2722D	A	A		8	Cancer Gene	8	77767323	77767323	33	0.212121212121212	NA	NA	NA			432			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,77767323,A,A&fts=all">p.E2722D</a>
ZFHX4	Missense_Mutation	p.L2944V	C	C		8	Cancer Gene	8	77767987	77767987	54	0.166666666666667	NA	NA	NA			432			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,77767987,C,C&fts=all">p.L2944V</a>
ZFHX4	Missense_Mutation	p.P3170S	C	C		8	Cancer Gene	8	77775458	77775458	4	0.75	NA	NA	NA		p.P3154N(1)|p.P3154T(1)	432			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,77775458,C,C&fts=all">p.P3170S</a>
ZFHX4	Missense_Mutation	p.F3266L	T	T		8	Cancer Gene	8	77775748	77775748	160	0.1875	NA	NA	NA			432			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,77775748,T,T&fts=all">p.F3266L</a>
ZFHX4	Missense_Mutation	p.P3598L	C	C		8	Cancer Gene	8	77776743	77776743	34	0.205882352941176	NA	NA	NA			432			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,77776743,C,C&fts=all">p.P3598L</a>
ZFP42	Missense_Mutation	p.P158R	C	C		8	Cancer Gene	4	188924434	188924434	120	0.241666666666667	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFP42&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,188924434,C,C&fts=all">p.P158R</a>
ZFP57	Missense_Mutation	p.K120T	T	T		8	Cancer Gene	6	29641529	29641529	172	0.22093023255814	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFP57&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,29641529,T,T&fts=all">p.K120T</a>
ZFPM1	Missense_Mutation	p.A274T	G	G		8	Cancer Gene	16	88598517	88598517	28	0.178571428571429	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFPM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,88598517,G,G&fts=all">p.A274T</a>
ZFYVE26	Missense_Mutation	p.L1027F	G	G		8	Cancer Gene	14	68252891	68252891	99	0.868686868686869	NA	NA	NA			94			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFYVE26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,68252891,G,G&fts=all">p.L1027F</a>
ZFYVE28	Missense_Mutation	p.P540L	G	G		8	Cancer Gene	4	2306448	2306448	16	0.375	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFYVE28&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,2306448,G,G&fts=all">p.P540L</a>
ZIM2	Missense_Mutation	p.R281K	C	C	rs146296476	8	Cancer Gene	19	57286798	57286798	169	0.201183431952663	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZIM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57286798,C,C&fts=all">p.R281K</a>
ZIM2	Missense_Mutation	p.E237K	C	C	rs375870865	8	Cancer Gene	19	57290778	57290778	147	0.299319727891156	NA	NA	NA			44	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZIM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57290778,C,C&fts=all">p.E237K</a>
ZIM2	Missense_Mutation	p.M236I	C	C		8	Cancer Gene	19	57290779	57290779	147	0.292517006802721	NA	NA	NA			44	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZIM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57290779,C,C&fts=all">p.M236I</a>
ZIM3	Missense_Mutation	p.T371I	G	G		8	Cancer Gene	19	57646593	57646593	148	0.344594594594595	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZIM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57646593,G,G&fts=all">p.T371I</a>
ZKSCAN2	Nonsense_Mutation	p.R903*	G	G		8	Cancer Gene	16	25251334	25251334	81	0.296296296296296	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZKSCAN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,25251334,G,G&fts=all">p.R903*</a>
ZKSCAN4	Missense_Mutation	p.N435D	T	T		8	Cancer Gene	6	28213229	28213229	172	0.209302325581395	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZKSCAN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28213229,T,T&fts=all">p.N435D</a>
ZNF100	Missense_Mutation	p.R252K	C	C		8	Cancer Gene	19	21910359	21910359	149	0.416107382550336	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF100&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,21910359,C,C&fts=all">p.R252K</a>
ZNF114	Missense_Mutation	p.H126Y	C	C		8	Cancer Gene	19	48789257	48789257	178	0.247191011235955	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF114&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,48789257,C,C&fts=all">p.H126Y</a>
ZNF135	Missense_Mutation	p.H298Y	C	C		8	Cancer Gene	19	58578870	58578870	30	0.333333333333333	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF135&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58578870,C,C&fts=all">p.H298Y</a>
ZNF140	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	12	133365878	133779461	NA	NA	33	-1.06793882865658	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF140&recr=Open">Click here</a>	
ZNF154	Missense_Mutation	p.G185R	C	C		8	Cancer Gene	19	58213764	58213764	183	0.120218579234973	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF154&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58213764,C,C&fts=all">p.G185R</a>
ZNF155	Missense_Mutation	p.Y309F	A	A		8	Cancer Gene	19	44500902	44500902	173	0.543352601156069	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF155&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44500902,A,A&fts=all">p.Y309F</a>
ZNF169	Missense_Mutation	p.T37I	C	C		8	Cancer Gene	9	97054699	97054699	97	0.505154639175258	NA	NA	NA			24	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF169&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,97054699,C,C&fts=all">p.T37I</a>
ZNF213	Missense_Mutation	p.E100K	G	G		8	Cancer Gene	16	3187579	3187579	54	0.277777777777778	NA	NA	NA			16	SCAN box. {ECO:0000255|PROSITE- ProRule:PRU00187}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF213&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,3187579,G,G&fts=all">p.E100K</a>
ZNF229	Missense_Mutation	p.G674E	C	C		8	Cancer Gene	19	44932917	44932917	139	0.0719424460431655	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF229&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44932917,C,C&fts=all">p.G674E</a>
ZNF229	Missense_Mutation	p.H389Y	G	G		8	Cancer Gene	19	44933773	44933773	109	0.357798165137615	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF229&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44933773,G,G&fts=all">p.H389Y</a>
ZNF229	Missense_Mutation	p.R226K	C	C		8	Cancer Gene	19	44934261	44934261	184	0.173913043478261	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF229&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44934261,C,C&fts=all">p.R226K</a>
ZNF229	Missense_Mutation	p.G139E	C	C		8	Cancer Gene	19	44934522	44934522	148	0.168918918918919	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF229&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44934522,C,C&fts=all">p.G139E</a>
ZNF232	Missense_Mutation	p.P271S	G	G		8	Cancer Gene	17	5009643	5009643	137	0.248175182481752	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF232&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,5009643,G,G&fts=all">p.P271S</a>
ZNF234	Missense_Mutation	p.R332C	C	C		8	Cancer Gene	19	44661163	44661163	144	0.409722222222222	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF234&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44661163,C,C&fts=all">p.R332C</a>
ZNF235	Missense_Mutation	p.S360L	G	G		8	Cancer Gene	19	44792509	44792509	71	0.225352112676056	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF235&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44792509,G,G&fts=all">p.S360L</a>
ZNF268	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	12	133365878	133779461	NA	NA	33	-1.06793882865658	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF268&recr=Open">Click here</a>	
ZNF283	Missense_Mutation	p.R144K	G	G		8	Cancer Gene	19	44351601	44351601	158	0.474683544303797	NA	NA	NA			8	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF283&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44351601,G,G&fts=all">p.R144K</a>
ZNF283	Missense_Mutation	p.H174Y	C	C		8	Cancer Gene	19	44351690	44351690	151	0.185430463576159	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF283&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44351690,C,C&fts=all">p.H174Y</a>
ZNF311	Missense_Mutation	p.T515I	G	G		8	Cancer Gene	6	28963235	28963235	135	0.244444444444444	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF311&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28963235,G,G&fts=all">p.T515I</a>
ZNF311	Missense_Mutation	p.L241P	A	A		8	Cancer Gene	6	28964057	28964057	160	0.7125	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF311&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28964057,A,A&fts=all">p.L241P</a>
ZNF317	Missense_Mutation	p.S5F	C	C		8	Cancer Gene	19	9266706	9266706	64	0.109375	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF317&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9266706,C,C&fts=all">p.S5F</a>
ZNF319	Missense_Mutation	p.S89F	G	G		8	Cancer Gene	16	58031904	58031904	65	0.323076923076923	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF319&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,58031904,G,G&fts=all">p.S89F</a>
ZNF319	Missense_Mutation	p.S2L	G	G		8	Cancer Gene	16	58032165	58032165	122	0.278688524590164	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF319&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,58032165,G,G&fts=all">p.S2L</a>
ZNF320	Missense_Mutation	p.H407Y	G	G		8	Cancer Gene	19	53384160	53384160	114	0.175438596491228	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF320&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,53384160,G,G&fts=all">p.H407Y</a>
ZNF334	Missense_Mutation	p.H315Y	G	G		8	Cancer Gene	20	45131035	45131035	127	0.425196850393701	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF334&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,45131035,G,G&fts=all">p.H315Y</a>
ZNF334	Missense_Mutation	p.M3I	C	C		8	Cancer Gene	20	45140733	45140733	72	0.458333333333333	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF334&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,45140733,C,C&fts=all">p.M3I</a>
ZNF335	Missense_Mutation	p.S1020F	G	G		8	Cancer Gene	20	44580916	44580916	21	0.523809523809524	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF335&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,44580916,G,G&fts=all">p.S1020F</a>
ZNF335	Missense_Mutation	p.R720C	G	G		8	Cancer Gene	20	44587935	44587935	35	0.371428571428571	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF335&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,44587935,G,G&fts=all">p.R720C</a>
ZNF33B	Missense_Mutation	p.L262F	G	G		8	Cancer Gene	10	43089614	43089614	193	0.160621761658031	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF33B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,43089614,G,G&fts=all">p.L262F</a>
ZNF37A	Missense_Mutation	p.P74S	C	C		8	Cancer Gene	10	38404200	38404200	67	0.17910447761194	NA	NA	NA			28	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF37A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,38404200,C,C&fts=all">p.P74S</a>
ZNF382	Missense_Mutation	p.L261P	T	T		8	Cancer Gene	19	37117584	37117584	150	0.553333333333333	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF382&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,37117584,T,T&fts=all">p.L261P</a>
ZNF391	Nonsense_Mutation	p.Q238*	C	C		8	Cancer Gene	6	27368861	27368861	105	0.19047619047619	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF391&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,27368861,C,C&fts=all">p.Q238*</a>
ZNF396	Missense_Mutation	p.P83S	G	G		8	Cancer Gene	18	32954010	32954010	67	0.462686567164179	NA	NA	NA			7	SCAN box. {ECO:0000255|PROSITE- ProRule:PRU00187}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF396&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,32954010,G,G&fts=all">p.P83S</a>
ZNF398	Missense_Mutation	p.S273L	C	C		8	Cancer Gene	7	148875782	148875782	163	0.411042944785276	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF398&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,148875782,C,C&fts=all">p.S273L</a>
ZNF418	Missense_Mutation	p.C230W	A	A	rs560874349	8	Cancer Gene	19	58438859	58438859	257	0.175097276264591	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF418&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58438859,A,A&fts=all">p.C230W</a>
ZNF419	Missense_Mutation	p.H154Y	C	C		8	Cancer Gene	19	58004382	58004382	85	0.211764705882353	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF419&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58004382,C,C&fts=all">p.H154Y</a>
ZNF429	Missense_Mutation	p.S181L	C	C		8	Cancer Gene	19	21719397	21719397	132	0.462121212121212	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF429&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,21719397,C,C&fts=all">p.S181L</a>
ZNF430	Missense_Mutation	p.S386L	C	C		8	Cancer Gene	19	21240271	21240271	83	0.144578313253012	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF430&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,21240271,C,C&fts=all">p.S386L</a>
ZNF439	Missense_Mutation	p.P241L	C	C	rs374360870	8	Cancer Gene	19	11978606	11978606	176	0.488636363636364	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF439&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,11978606,C,C&fts=all">p.P241L</a>
ZNF439	Nonsense_Mutation	p.R398*	C	C		8	Cancer Gene	19	11979076	11979076	128	0.4140625	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF439&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,11979076,C,C&fts=all">p.R398*</a>
ZNF439	Missense_Mutation	p.R454Q	G	G	rs77098353	8	Cancer Gene	19	11979245	11979245	112	0.151785714285714	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF439&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,11979245,G,G&fts=all">p.R454Q</a>
ZNF441	Missense_Mutation	p.K365T	A	A		8	Cancer Gene	19	11891733	11891733	230	0.382608695652174	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF441&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,11891733,A,A&fts=all">p.K365T</a>
ZNF460	Missense_Mutation	p.P8S	C	C		8	Cancer Gene	19	57792196	57792196	79	0.151898734177215	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF460&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57792196,C,C&fts=all">p.P8S</a>
ZNF460	Missense_Mutation	p.H330Y	C	C		8	Cancer Gene	19	57802897	57802897	196	0.443877551020408	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF460&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57802897,C,C&fts=all">p.H330Y</a>
ZNF460	Nonsense_Mutation	p.R465*	C	C		8	Cancer Gene	19	57803302	57803302	166	0.174698795180723	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF460&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57803302,C,C&fts=all">p.R465*</a>
ZNF473	Missense_Mutation	p.H668Y	C	C		8	Cancer Gene	19	50549702	50549702	82	0.207317073170732	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF473&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50549702,C,C&fts=all">p.H668Y</a>
ZNF484	Missense_Mutation	p.H490Y	G	G		8	Cancer Gene	9	95609601	95609601	136	0.294117647058824	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF484&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,95609601,G,G&fts=all">p.H490Y</a>
ZNF485	Missense_Mutation	p.S144F	C	C		8	Cancer Gene	10	44111922	44111922	155	0.193548387096774	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF485&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,44111922,C,C&fts=all">p.S144F</a>
ZNF488	Missense_Mutation	p.R120G	A	A		8	Cancer Gene	10	48370890	48370890	12	0.25	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF488&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,48370890,A,A&fts=all">p.R120G</a>
ZNF492	Missense_Mutation	p.M88I	G	G		8	Cancer Gene	19	22846735	22846735	56	0.196428571428571	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF492&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,22846735,G,G&fts=all">p.M88I</a>
ZNF496	Missense_Mutation	p.S358F	G	G		8	Cancer Gene	1	247464512	247464512	59	0.271186440677966	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF496&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247464512,G,G&fts=all">p.S358F</a>
ZNF496	Missense_Mutation	p.L357F	G	G		8	Cancer Gene	1	247464516	247464516	56	0.553571428571429	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF496&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247464516,G,G&fts=all">p.L357F</a>
ZNF503	Splice_Site	p.E105E	C	C		8	Cancer Gene	10	77160863	77160863	41	0.195121951219512	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF503&recr=Open">Click here</a>	
ZNF546	Missense_Mutation	p.H267Y	C	C		8	Cancer Gene	19	40519976	40519976	238	0.340336134453782	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF546&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,40519976,C,C&fts=all">p.H267Y</a>
ZNF549	Missense_Mutation	p.P13S	C	C		8	Cancer Gene	19	58042441	58042441	151	0.291390728476821	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF549&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58042441,C,C&fts=all">p.P13S</a>
ZNF555	Missense_Mutation	p.P379S	C	C		8	Cancer Gene	19	2853201	2853201	80	0.2375	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF555&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,2853201,C,C&fts=all">p.P379S</a>
ZNF560	Missense_Mutation	p.K517R	T	T		8	Cancer Gene	19	9578073	9578073	104	0.0673076923076923	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF560&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9578073,T,T&fts=all">p.K517R</a>
ZNF560	Missense_Mutation	p.H454Y	G	G		8	Cancer Gene	19	9578263	9578263	154	0.214285714285714	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF560&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9578263,G,G&fts=all">p.H454Y</a>
ZNF560	Missense_Mutation	p.R284K	C	C		8	Cancer Gene	19	9578772	9578772	123	0.203252032520325	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF560&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9578772,C,C&fts=all">p.R284K</a>
ZNF560	Missense_Mutation	p.E212K	C	C		8	Cancer Gene	19	9578989	9578989	105	0.180952380952381	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF560&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9578989,C,C&fts=all">p.E212K</a>
ZNF563	Missense_Mutation	p.P308L	G	G		8	Cancer Gene	19	12429916	12429916	224	0.294642857142857	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF563&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,12429916,G,G&fts=all">p.P308L</a>
ZNF564	Missense_Mutation	p.P532L	G	G		8	Cancer Gene	19	12637327	12637327	163	0.226993865030675	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF564&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,12637327,G,G&fts=all">p.P532L</a>
ZNF564	Missense_Mutation	p.P532S	G	G		8	Cancer Gene	19	12637328	12637328	164	0.225609756097561	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF564&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,12637328,G,G&fts=all">p.P532S</a>
ZNF568	Missense_Mutation	p.S35F	C	C		8	Cancer Gene	19	37416129	37416129	121	0.148760330578512	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF568&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,37416129,C,C&fts=all">p.S35F</a>
ZNF568	Missense_Mutation	p.H300Y	C	C		8	Cancer Gene	19	37440953	37440953	127	0.149606299212598	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF568&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,37440953,C,C&fts=all">p.H300Y</a>
ZNF568	Missense_Mutation	p.H552Y	C	C		8	Cancer Gene	19	37441709	37441709	124	0.185483870967742	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF568&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,37441709,C,C&fts=all">p.H552Y</a>
ZNF569	Missense_Mutation	p.H488Y	G	G		8	Cancer Gene	19	37904098	37904098	102	0.343137254901961	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF569&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,37904098,G,G&fts=all">p.H488Y</a>
ZNF569	Missense_Mutation	p.H208Y	G	G		8	Cancer Gene	19	37904938	37904938	150	0.386666666666667	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF569&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,37904938,G,G&fts=all">p.H208Y</a>
ZNF577	Missense_Mutation	p.C93S	A	A		8	Cancer Gene	19	52380541	52380541	108	0.166666666666667	NA	NA	NA			21	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF577&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,52380541,A,A&fts=all">p.C93S</a>
ZNF580	Missense_Mutation	p.P27S	C	C		8	Cancer Gene	19	56153953	56153953	27	0.185185185185185	NA	NA	NA			2	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF580&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56153953,C,C&fts=all">p.P27S</a>
ZNF581	Missense_Mutation	p.S15F	C	C		8	Cancer Gene	19	56155981	56155981	29	0.206896551724138	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF581&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56155981,C,C&fts=all">p.S15F</a>
ZNF582	Missense_Mutation	p.E218K	C	C		8	Cancer Gene	19	56896134	56896134	165	0.139393939393939	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF582&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56896134,C,C&fts=all">p.E218K</a>
ZNF583	Missense_Mutation	p.F15I	T	T		8	Cancer Gene	19	56925361	56925361	176	0.403409090909091	NA	NA	NA			26	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF583&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56925361,T,T&fts=all">p.F15I</a>
ZNF585B	Missense_Mutation	p.S143L	G	G		8	Cancer Gene	19	37678011	37678011	194	0.170103092783505	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF585B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,37678011,G,G&fts=all">p.S143L</a>
ZNF597	Missense_Mutation	p.G403E	C	C		8	Cancer Gene	16	3486491	3486491	163	0.177914110429448	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF597&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,3486491,C,C&fts=all">p.G403E</a>
ZNF605	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	12	133365878	133779461	NA	NA	33	-1.06793882865658	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF605&recr=Open">Click here</a>	
ZNF607	Missense_Mutation	p.H667Y	G	G		8	Cancer Gene	19	38189033	38189033	261	0.114942528735632	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF607&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,38189033,G,G&fts=all">p.H667Y</a>
ZNF609	Missense_Mutation	p.S90F	C	C		8	Cancer Gene	15	64791887	64791887	82	0.560975609756098	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF609&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,64791887,C,C&fts=all">p.S90F</a>
ZNF609	Missense_Mutation	p.P567S	C	C		8	Cancer Gene	15	64966752	64966752	117	0.299145299145299	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF609&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,64966752,C,C&fts=all">p.P567S</a>
ZNF609	Missense_Mutation	p.P1314L	C	C		8	Cancer Gene	15	64972555	64972555	70	0.285714285714286	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF609&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,64972555,C,C&fts=all">p.P1314L</a>
ZNF616	Missense_Mutation	p.D103N	C	C		8	Cancer Gene	19	52620110	52620110	260	0.169230769230769	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF616&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,52620110,C,C&fts=all">p.D103N</a>
ZNF618	Missense_Mutation	p.G454S	G	G		8	Cancer Gene	9	116810942	116810942	98	0.714285714285714	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF618&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,116810942,G,G&fts=all">p.G454S</a>
ZNF621	Missense_Mutation	p.S62F	C	C	rs374336887	8	Cancer Gene	3	40571733	40571733	127	0.244094488188976	NA	NA	NA			21	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF621&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,40571733,C,C&fts=all">p.S62F</a>
ZNF626	Missense_Mutation	p.L244F	G	G		8	Cancer Gene	19	20807953	20807953	120	0.2	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF626&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,20807953,G,G&fts=all">p.L244F</a>
ZNF641	Missense_Mutation	p.P413L	G	G		8	Cancer Gene	12	48736793	48736793	47	0.404255319148936	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF641&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,48736793,G,G&fts=all">p.P413L</a>
ZNF648	Missense_Mutation	p.P94L	G	G		8	Cancer Gene	1	182026865	182026865	79	0.455696202531646	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF648&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,182026865,G,G&fts=all">p.P94L</a>
ZNF653	Missense_Mutation	p.P610L	G	G		8	Cancer Gene	19	11594516	11594516	39	0.358974358974359	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF653&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,11594516,G,G&fts=all">p.P610L</a>
ZNF653	Missense_Mutation	p.S172L	G	G		8	Cancer Gene	19	11606809	11606809	37	0.108108108108108	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF653&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,11606809,G,G&fts=all">p.S172L</a>
ZNF658	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	40775038	40789281	NA	NA	4	-1.47272944312266	FALSE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF658&recr=Open">Click here</a>	
ZNF660	Missense_Mutation	p.A86T	G	G		8	Cancer Gene	3	44635941	44635941	122	0.516393442622951	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF660&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,44635941,G,G&fts=all">p.A86T</a>
ZNF665	Missense_Mutation	p.R638C	G	G		8	Cancer Gene	19	53667831	53667831	152	0.210526315789474	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF665&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,53667831,G,G&fts=all">p.R638C</a>
ZNF665	Missense_Mutation	p.H526Y	G	G		8	Cancer Gene	19	53668167	53668167	234	0.363247863247863	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF665&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,53668167,G,G&fts=all">p.H526Y</a>
ZNF669	Missense_Mutation	p.G386R	C	C		8	Cancer Gene	1	247263915	247263915	264	0.556818181818182	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF669&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247263915,C,C&fts=all">p.G386R</a>
ZNF669	Missense_Mutation	p.P305L	G	G		8	Cancer Gene	1	247264157	247264157	281	0.185053380782918	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF669&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247264157,G,G&fts=all">p.P305L</a>
ZNF675	Missense_Mutation	p.H530Y	G	G		8	Cancer Gene	19	23836147	23836147	108	0.166666666666667	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF675&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,23836147,G,G&fts=all">p.H530Y</a>
ZNF676	Missense_Mutation	p.S128L	G	G		8	Cancer Gene	19	22364136	22364136	193	0.49740932642487	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF676&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,22364136,G,G&fts=all">p.S128L</a>
ZNF676	Missense_Mutation	p.K100T	T	T		8	Cancer Gene	19	22364220	22364220	241	0.20746887966805	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF676&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,22364220,T,T&fts=all">p.K100T</a>
ZNF676	Missense_Mutation	p.M66I	C	C		8	Cancer Gene	19	22364321	22364321	85	0.235294117647059	NA	NA	NA		p.M66I(1)	67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF676&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,22364321,C,C&fts=all">p.M66I</a>
ZNF677	Missense_Mutation	p.I151L	T	T		8	Cancer Gene	19	53741529	53741529	160	0.3125	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF677&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,53741529,T,T&fts=all">p.I151L</a>
ZNF678	Missense_Mutation	p.S446L	C	C		8	Cancer Gene	1	227843288	227843288	173	0.265895953757225	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF678&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,227843288,C,C&fts=all">p.S446L</a>
ZNF682	Missense_Mutation	p.H267Y	G	G		8	Cancer Gene	19	20117512	20117512	136	0.316176470588235	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF682&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,20117512,G,G&fts=all">p.H267Y</a>
ZNF689	Missense_Mutation	p.E124K	C	C		8	Cancer Gene	16	30616718	30616718	264	0.314393939393939	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF689&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30616718,C,C&fts=all">p.E124K</a>
ZNF692	Missense_Mutation	p.L41F	G	G		8	Cancer Gene	1	249152388	249152388	47	0.361702127659574	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF692&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,249152388,G,G&fts=all">p.L41F</a>
ZNF705A	Missense_Mutation	p.H166Y	C	C	rs140239317	8	Cancer Gene	12	8329772	8329772	351	0.216524216524217	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF705A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,8329772,C,C&fts=all">p.H166Y</a>
ZNF709	Missense_Mutation	p.S462F	G	G		8	Cancer Gene	19	12575351	12575351	233	0.502145922746781	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF709&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,12575351,G,G&fts=all">p.S462F</a>
ZNF709	Missense_Mutation	p.F6L	A	A		8	Cancer Gene	19	12577652	12577652	138	0.0869565217391304	NA	NA	NA			6	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF709&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,12577652,A,A&fts=all">p.F6L</a>
ZNF711	Missense_Mutation	p.E480K	G	G		8	Cancer Gene	X	84525848	84525848	31	0.451612903225806	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF711&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,84525848,G,G&fts=all">p.E480K</a>
ZNF711	Missense_Mutation	p.Y497N	T	T		8	Cancer Gene	X	84525899	84525899	34	0.882352941176471	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF711&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,84525899,T,T&fts=all">p.Y497N</a>
ZNF711	Nonsense_Mutation	p.R790*	A	A		8	Cancer Gene	X	84526778	84526778	87	0.402298850574713	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF711&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,84526778,A,A&fts=all">p.R790*</a>
ZNF750	Missense_Mutation	p.P619L	G	G		8	Cancer Gene	17	80788334	80788334	49	0.693877551020408	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF750&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,80788334,G,G&fts=all">p.P619L</a>
ZNF750	Missense_Mutation	p.L40F	G	G		8	Cancer Gene	17	80790213	80790213	161	0.503105590062112	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF750&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,80790213,G,G&fts=all">p.L40F</a>
ZNF773	Missense_Mutation	p.F387S	T	T		8	Cancer Gene	19	58018623	58018623	314	0.178343949044586	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF773&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58018623,T,T&fts=all">p.F387S</a>
ZNF785	Missense_Mutation	p.C289R	A	A		8	Cancer Gene	16	30594234	30594234	49	0.346938775510204	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF785&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30594234,A,A&fts=all">p.C289R</a>
ZNF785	Missense_Mutation	p.R122K	C	C		8	Cancer Gene	16	30594734	30594734	160	0.55	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF785&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,30594734,C,C&fts=all">p.R122K</a>
ZNF799	Missense_Mutation	p.R573S	G	G		8	Cancer Gene	19	12501495	12501495	166	0.180722891566265	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF799&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,12501495,G,G&fts=all">p.R573S</a>
ZNF799	Missense_Mutation	p.K368R	T	T		8	Cancer Gene	19	12502109	12502109	329	0.0577507598784195	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF799&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,12502109,T,T&fts=all">p.K368R</a>
ZNF80	Nonsense_Mutation	p.K252*	T	T		8	Cancer Gene	3	113955168	113955168	66	0.242424242424242	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF80&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,113955168,T,T&fts=all">p.K252*</a>
ZNF80	Missense_Mutation	p.R251K	C	C		8	Cancer Gene	3	113955170	113955170	66	0.242424242424242	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF80&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,113955170,C,C&fts=all">p.R251K</a>
ZNF804A	Missense_Mutation	p.K225Q	A	A		8	Cancer Gene	2	185800796	185800796	212	0.221698113207547	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,185800796,A,A&fts=all">p.K225Q</a>
ZNF804A	Missense_Mutation	p.P280L	C	C		8	Cancer Gene	2	185800962	185800962	176	0.625	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,185800962,C,C&fts=all">p.P280L</a>
ZNF804A	Missense_Mutation	p.K815I	A	A		8	Cancer Gene	2	185802567	185802567	162	0.259259259259259	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,185802567,A,A&fts=all">p.K815I</a>
ZNF804A	Nonsense_Mutation	p.E938*	G	G		8	Cancer Gene	2	185802935	185802935	195	0.282051282051282	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,185802935,G,G&fts=all">p.E938*</a>
ZNF804B	Missense_Mutation	p.P403L	C	C	rs189494355	8	Cancer Gene	7	88963504	88963504	55	0.4	NA	NA	NA			144			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,88963504,C,C&fts=all">p.P403L</a>
ZNF804B	Nonsense_Mutation	p.Q456*	C	C		8	Cancer Gene	7	88963662	88963662	89	0.0674157303370786	NA	NA	NA			144			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,88963662,C,C&fts=all">p.Q456*</a>
ZNF804B	Missense_Mutation	p.P578S	C	C		8	Cancer Gene	7	88964028	88964028	114	0.219298245614035	NA	NA	NA			144			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,88964028,C,C&fts=all">p.P578S</a>
ZNF804B	Missense_Mutation	p.I896T	T	T		8	Cancer Gene	7	88964983	88964983	79	0.10126582278481	NA	NA	NA			144			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,88964983,T,T&fts=all">p.I896T</a>
ZNF804B	Missense_Mutation	p.G918E	G	G		8	Cancer Gene	7	88965049	88965049	144	0.409722222222222	NA	NA	NA			144			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,88965049,G,G&fts=all">p.G918E</a>
ZNF813	Missense_Mutation	p.S200L	C	C		8	Cancer Gene	19	53994085	53994085	180	0.138888888888889	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF813&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,53994085,C,C&fts=all">p.S200L</a>
ZNF813	Missense_Mutation	p.H485Y	C	C		8	Cancer Gene	19	53994939	53994939	91	0.384615384615385	NA	NA	NA		p.H485D(1)	1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF813&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,53994939,C,C&fts=all">p.H485Y</a>
ZNF827	Missense_Mutation	p.G371E	C	C	rs199562651	8	Cancer Gene	4	146813549	146813549	141	0.297872340425532	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF827&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,146813549,C,C&fts=all">p.G371E</a>
ZNF831	Missense_Mutation	p.G136S	G	G		8	Cancer Gene	20	57766480	57766480	38	0.236842105263158	NA	NA	NA			125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF831&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,57766480,G,G&fts=all">p.G136S</a>
ZNF831	Missense_Mutation	p.D1502N	G	G		8	Cancer Gene	20	57829268	57829268	57	0.333333333333333	NA	NA	NA			125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF831&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,57829268,G,G&fts=all">p.D1502N</a>
ZNF84	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	12	133365878	133779461	NA	NA	33	-1.06793882865658	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF84&recr=Open">Click here</a>	
ZNF98	Missense_Mutation	p.K185R	T	T		8	Cancer Gene	19	22575483	22575483	29	0.275862068965517	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,22575483,T,T&fts=all">p.K185R</a>
ZNF99	Missense_Mutation	p.F350Y	A	A		8	Cancer Gene	19	22941662	22941662	123	0.121951219512195	NA	NA	NA			124			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF99&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,22941662,A,A&fts=all">p.F350Y</a>
ZSCAN10	Missense_Mutation	p.E96K	C	C		8	Cancer Gene	16	3142263	3142263	52	0.211538461538462	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,3142263,C,C&fts=all">p.E96K</a>
ZSCAN18	Missense_Mutation	p.P90L	G	G		8	Cancer Gene	19	58601534	58601534	50	0.18	NA	NA	NA			19	SCAN box. {ECO:0000255|PROSITE- ProRule:PRU00187}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58601534,G,G&fts=all">p.P90L</a>
ZSCAN18	Missense_Mutation	p.P73S	G	G		8	Cancer Gene	19	58601586	58601586	74	0.148648648648649	NA	NA	NA			19	SCAN box. {ECO:0000255|PROSITE- ProRule:PRU00187}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58601586,G,G&fts=all">p.P73S</a>
ZSCAN29	Missense_Mutation	p.P170L	G	G		8	Cancer Gene	15	43661135	43661135	424	0.278301886792453	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN29&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43661135,G,G&fts=all">p.P170L</a>
ZSCAN4	Missense_Mutation	p.E207K	G	G		8	Cancer Gene	19	58189590	58189590	100	0.21	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58189590,G,G&fts=all">p.E207K</a>
ZSCAN5A	Missense_Mutation	p.P296S	G	G		8	Cancer Gene	19	56733546	56733546	81	0.0864197530864197	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56733546,G,G&fts=all">p.P296S</a>
ZSCAN5A	Missense_Mutation	p.S14F	G	G		8	Cancer Gene	19	56736375	56736375	84	0.0952380952380952	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56736375,G,G&fts=all">p.S14F</a>
ZSWIM2	Missense_Mutation	p.R411K	C	C		8	Cancer Gene	2	187693381	187693381	142	0.23943661971831	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSWIM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,187693381,C,C&fts=all">p.R411K</a>
ZSWIM2	Missense_Mutation	p.S325L	G	G		8	Cancer Gene	2	187694575	187694575	174	0.281609195402299	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSWIM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,187694575,G,G&fts=all">p.S325L</a>
ZZEF1	Missense_Mutation	p.R2909C	G	G		8	Cancer Gene	17	3912906	3912906	49	0.428571428571429	NA	NA	NA			84			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZZEF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,3912906,G,G&fts=all">p.R2909C</a>
ZZEF1	Missense_Mutation	p.P2055S	G	G	rs144040894	8	Cancer Gene	17	3947521	3947521	123	0.203252032520325	NA	NA	NA			84			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZZEF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,3947521,G,G&fts=all">p.P2055S</a>
C17orf108	Copy Number	Deleted	NA	NA	NA	9	VUS	17	25621463	26370357	NA	NA	46	-1.18672159545669	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf108&recr=Open">Click here</a>	
CCDC55	Copy Number	Deleted	NA	NA	NA	9	VUS	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC55&recr=Open">Click here</a>	
DPRXP4	Copy Number	Deleted	NA	NA	NA	9	VUS	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPRXP4&recr=Open">Click here</a>	
LOC284344	Copy Number	Deleted	NA	NA	NA	9	VUS	19	43702429	43757800	NA	NA	4	-1.36178711457659	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LOC284344&recr=Open">Click here</a>	
LOC440419	Copy Number	Deleted	NA	NA	NA	9	VUS	17	25621463	26370357	NA	NA	46	-1.18672159545669	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LOC440419&recr=Open">Click here</a>	
LRRC37B2	Copy Number	Deleted	NA	NA	NA	9	VUS	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC37B2&recr=Open">Click here</a>	
MIR193A	Copy Number	Deleted	NA	NA	NA	9	VUS	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR193A&recr=Open">Click here</a>	
MIR3184	Copy Number	Deleted	NA	NA	NA	9	VUS	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR3184&recr=Open">Click here</a>	
MIR365-2	Copy Number	Deleted	NA	NA	NA	9	VUS	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR365-2&recr=Open">Click here</a>	
MIR423	Copy Number	Deleted	NA	NA	NA	9	VUS	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR423&recr=Open">Click here</a>	
MIR4298	Copy Number	Deleted	NA	NA	NA	9	VUS	11	1860936	1955677	NA	NA	21	-1.13511063553025	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR4298&recr=Open">Click here</a>	
SH3GL1P2	Copy Number	Deleted	NA	NA	NA	9	VUS	17	27370359	30228648	NA	NA	296	-1.2894745576614	TRUE		NA	NA	NA		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3GL1P2&recr=Open">Click here</a>	
MAP3K19	Missense_Mutation	p.E1104K	C	C		9.75	SNP	2	135739001	135739001	181	0.596685082872928	NA	NA	NA				Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,135739001,C,C&fts=all">p.E1104K</a>
NIM1	Missense_Mutation	p.R75Q	G	G	rs140198619	9.75	SNP	5	43246101	43246101	77	0.324675324675325	NA	NA	NA				Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,43246101,G,G&fts=all">p.R75Q</a>
NIM1	Missense_Mutation	p.L158F	C	C		9.75	SNP	5	43277338	43277338	69	0.27536231884058	NA	NA	NA				Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,43277338,C,C&fts=all">p.L158F</a>
ACSM4	Missense_Mutation	p.G95S	G	G		10	SNP	12	7459210	7459210	11	0.454545454545455	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSM4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7459210,G,G&fts=all">p.G95S</a>
ACSM4	Missense_Mutation	p.E418K	G	G	rs573991806	10	SNP	12	7476100	7476100	96	0.177083333333333	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSM4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7476100,G,G&fts=all">p.E418K</a>
AF064858.6	lincRNA		C	C		10	SNP	21	40250706	40250706	155	0.516129032258065	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AF064858.6&recr=Open">Click here</a>	
AF064858.6	lincRNA		G	G		10	SNP	21	40250739	40250739	162	0.216049382716049	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AF064858.6&recr=Open">Click here</a>	
AGO1	Missense_Mutation	p.R88C	C	C		10	SNP	1	36358210	36358210	81	0.283950617283951	NA	NA	NA		p.R88C(1)				MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGO1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,36358210,C,C&fts=all">p.R88C</a>
AGO2	Missense_Mutation	p.H466Y	G	G		10	SNP	8	141561409	141561409	115	0.104347826086957	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,141561409,G,G&fts=all">p.H466Y</a>
AGO4	Missense_Mutation	p.S626F	C	C		10	SNP	1	36306918	36306918	67	0.895522388059702	NA	NA	NA				Piwi. {ECO:0000255|HAMAP-Rule:MF_03033}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGO4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,36306918,C,C&fts=all">p.S626F</a>
AP5Z1	Missense_Mutation	p.S117F	C	C		10	SNP	7	4821369	4821369	43	0.255813953488372	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP5Z1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,4821369,C,C&fts=all">p.S117F</a>
AP5Z1	Missense_Mutation	p.L418F	C	C	rs370339182	10	SNP	7	4826000	4826000	192	0.177083333333333	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP5Z1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,4826000,C,C&fts=all">p.L418F</a>
ARHGAP35	Missense_Mutation	p.S56F	C	C		10	SNP	19	47422099	47422099	132	0.575757575757576	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP35&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,47422099,C,C&fts=all">p.S56F</a>
ARHGAP35	Nonsense_Mutation	p.Q1061*	C	C		10	SNP	19	47425113	47425113	79	0.40506329113924	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP35&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,47425113,C,C&fts=all">p.Q1061*</a>
ARHGEF28	Missense_Mutation	p.G210E	G	G		10	SNP	5	73069833	73069833	24	0.291666666666667	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF28&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,73069833,G,G&fts=all">p.G210E</a>
ASIC1	Missense_Mutation	p.R501W	C	C		10	SNP	12	50475346	50475346	33	0.393939393939394	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASIC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,50475346,C,C&fts=all">p.R501W</a>
ASIC5	Missense_Mutation	p.R61C	G	G		10	SNP	4	156784766	156784766	106	0.292452830188679	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASIC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,156784766,G,G&fts=all">p.R61C</a>
BIVM-ERCC5	Missense_Mutation	p.H1043Y	C	C		10	SNP	13	103515350	103515350	188	0.329787234042553	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BIVM-ERCC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,103515350,C,C&fts=all">p.H1043Y</a>
BLOC1S5-TXNDC5	Nonsense_Mutation	p.R67*	G	G		10	SNP	6	8041486	8041486	227	0.167400881057269	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BLOC1S5-TXNDC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,8041486,G,G&fts=all">p.R67*</a>
BOD1L1	Missense_Mutation	p.P2204S	G	G		10	SNP	4	13601914	13601914	50	0.4	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BOD1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,13601914,G,G&fts=all">p.P2204S</a>
BPIFB1	Missense_Mutation	p.E301K	G	G		10	SNP	20	31889192	31889192	39	0.461538461538462	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,31889192,G,G&fts=all">p.E301K</a>
BPIFB2	Nonsense_Mutation	p.Q261*	C	C		10	SNP	20	31606554	31606554	28	0.714285714285714	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,31606554,C,C&fts=all">p.Q261*</a>
BPIFC	Splice_Site		C	C		10	SNP	22	32827402	32827402	203	0.270935960591133	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFC&recr=Open">Click here</a>	
BPIFC	Missense_Mutation	p.E188K	C	C		10	SNP	22	32841654	32841654	291	0.219931271477663	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,32841654,C,C&fts=all">p.E188K</a>
BRINP1	Missense_Mutation	p.D701N	C	C		10	SNP	9	121929547	121929547	55	0.636363636363636	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,121929547,C,C&fts=all">p.D701N</a>
BRINP1	Missense_Mutation	p.S690L	G	G	rs201389326	10	SNP	9	121929579	121929579	57	0.298245614035088	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,121929579,G,G&fts=all">p.S690L</a>
BRINP1	Nonsense_Mutation	p.R380*	T	T		10	SNP	9	121971004	121971004	30	0.3	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,121971004,T,T&fts=all">p.R380*</a>
BRINP1	Missense_Mutation	p.S212F	G	G		10	SNP	9	122000983	122000983	55	0.254545454545455	NA	NA	NA				MACPF.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,122000983,G,G&fts=all">p.S212F</a>
BRINP1	Missense_Mutation	p.L97F	G	G		10	SNP	9	122011358	122011358	39	0.564102564102564	NA	NA	NA				MACPF.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,122011358,G,G&fts=all">p.L97F</a>
BRINP2	Missense_Mutation	p.D655N	G	G		10	SNP	1	177250275	177250275	79	0.139240506329114	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,177250275,G,G&fts=all">p.D655N</a>
BRINP3	Missense_Mutation	p.P715S	G	G		10	SNP	1	190067306	190067306	134	0.664179104477612	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,190067306,G,G&fts=all">p.P715S</a>
BRINP3	Missense_Mutation	p.K531Q	T	T		10	SNP	1	190067858	190067858	162	0.265432098765432	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,190067858,T,T&fts=all">p.K531Q</a>
BRINP3	Missense_Mutation	p.E489D	T	T		10	SNP	1	190067982	190067982	218	0.224770642201835	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,190067982,T,T&fts=all">p.E489D</a>
BRINP3	Splice_Site	p.E80K	C	C		10	SNP	1	190250879	190250879	95	0.221052631578947	NA	NA	NA				MACPF.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP3&recr=Open">Click here</a>	
C16orf90	Nonsense_Mutation	p.R124*	G	G		10	SNP	16	3544554	3544554	38	0.210526315789474	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C16orf90&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,3544554,G,G&fts=all">p.R124*</a>
C5AR2	Missense_Mutation	p.P168S	C	C		10	SNP	19	47844558	47844558	27	0.37037037037037	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C5AR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,47844558,C,C&fts=all">p.P168S</a>
C7orf65	Missense_Mutation	p.G11R	G	G		10	SNP	7	47694907	47694907	59	0.152542372881356	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C7orf65&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,47694907,G,G&fts=all">p.G11R</a>
C8orf74	Splice_Site	p.G81D	G	G		10	SNP	8	10555109	10555109	65	0.476923076923077	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8orf74&recr=Open">Click here</a>	
CACTIN	Missense_Mutation	p.S296F	G	G		10	SNP	19	3619238	3619238	31	0.290322580645161	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACTIN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,3619238,G,G&fts=all">p.S296F</a>
CAMSAP3	Missense_Mutation	p.R236Q	G	G		10	SNP	19	7673016	7673016	21	0.19047619047619	NA	NA	NA			19	CH.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMSAP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,7673016,G,G&fts=all">p.R236Q</a>
CAMSAP3	Missense_Mutation	p.T1076N	C	C		10	SNP	19	7681442	7681442	42	0.404761904761905	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMSAP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,7681442,C,C&fts=all">p.T1076N</a>
CATSPERD	Missense_Mutation	p.L83F	C	C		10	SNP	19	5729926	5729926	253	0.245059288537549	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPERD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,5729926,C,C&fts=all">p.L83F</a>
CCDC129	Missense_Mutation	p.S314L	C	C		10	SNP	7	31622794	31622794	181	0.237569060773481	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC129&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,31622794,C,C&fts=all">p.S314L</a>
CCDC129	Missense_Mutation	p.P552S	C	C		10	SNP	7	31682914	31682914	77	0.272727272727273	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC129&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,31682914,C,C&fts=all">p.P552S</a>
CCDC129	Missense_Mutation	p.P559L	C	C		10	SNP	7	31682936	31682936	74	0.216216216216216	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC129&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,31682936,C,C&fts=all">p.P559L</a>
CCDC173	Missense_Mutation	p.E68K	C	C		10	SNP	2	170537609	170537609	224	0.285714285714286	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC173&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,170537609,C,C&fts=all">p.E68K</a>
CCDC180	Missense_Mutation	p.P55L	C	C		10	SNP	9	100070377	100070377	32	0.5	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC180&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,100070377,C,C&fts=all">p.P55L</a>
CCDC181	Missense_Mutation	p.E45K	C	C		10	SNP	1	169391536	169391536	133	0.255639097744361	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC181&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,169391536,C,C&fts=all">p.E45K</a>
CCDC64B	Missense_Mutation	p.E177K	C	C		10	SNP	16	3080783	3080783	20	0.4	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC64B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,3080783,C,C&fts=all">p.E177K</a>
CCER1	Missense_Mutation	p.E376K	C	C		10	SNP	12	91347394	91347394	116	0.370689655172414	NA	NA	NA				Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCER1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,91347394,C,C&fts=all">p.E376K</a>
CCER1	Missense_Mutation	p.E302K	C	C		10	SNP	12	91347616	91347616	33	0.424242424242424	NA	NA	NA		p.E302K(1)		Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCER1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,91347616,C,C&fts=all">p.E302K</a>
CCER1	Nonsense_Mutation	p.Y176*	A	A		10	SNP	12	91347992	91347992	28	0.464285714285714	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCER1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,91347992,A,A&fts=all">p.Y176*</a>
CCSER2	Missense_Mutation	p.E136K	G	G		10	SNP	10	86131214	86131214	260	0.461538461538462	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCSER2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,86131214,G,G&fts=all">p.E136K</a>
CHDC2	Missense_Mutation	p.L96F	C	C		10	SNP	X	36091351	36091351	81	0.432098765432099	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHDC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,36091351,C,C&fts=all">p.L96F</a>
CHRM4	Missense_Mutation	p.A322V	G	G		10	SNP	11	46407143	46407143	91	0.43956043956044	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRM4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,46407143,G,G&fts=all">p.A322V</a>
CNBD2	Missense_Mutation	p.E455K	G	G		10	SNP	20	34611629	34611629	129	0.418604651162791	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNBD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,34611629,G,G&fts=all">p.E455K</a>
CNBD2	Missense_Mutation	p.M463I	G	G		10	SNP	20	34611655	34611655	143	0.265734265734266	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNBD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,34611655,G,G&fts=all">p.M463I</a>
COL6A5	Missense_Mutation	p.G2164R	G	G		10	SNP	3	130162322	130162322	58	0.310344827586207	NA	NA	NA			44	Nonhelical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,130162322,G,G&fts=all">p.G2164R</a>
CPED1	Nonsense_Mutation	p.R998*	C	C	rs573221210	10	SNP	7	120935617	120935617	112	0.348214285714286	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPED1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,120935617,C,C&fts=all">p.R998*</a>
CPLX1	Missense_Mutation	p.P103S	G	G		10	SNP	4	780387	780387	9	0.555555555555556	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPLX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,780387,G,G&fts=all">p.P103S</a>
CRYM-AS1	lincRNA		G	G	rs372456362	10	SNP	16	21328282	21328282	441	0.281179138321995	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRYM-AS1&recr=Open">Click here</a>	
DACT3	Missense_Mutation	p.R619C	G	G		10	SNP	19	47151774	47151774	567	0.437389770723104	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DACT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,47151774,G,G&fts=all">p.R619C</a>
DAW1	Missense_Mutation	p.E211A	A	A		10	SNP	2	228767809	228767809	99	0.313131313131313	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAW1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,228767809,A,A&fts=all">p.E211A</a>
DHRS7C	Missense_Mutation	p.R188C	G	G		10	SNP	17	9680519	9680519	49	0.204081632653061	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHRS7C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,9680519,G,G&fts=all">p.R188C</a>
DNAAF3	Missense_Mutation	p.K9I	T	T		10	SNP	19	55677991	55677991	133	0.56390977443609	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAAF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55677991,T,T&fts=all">p.K9I</a>
DSCR10	lincRNA		C	C		10	SNP	21	39580285	39580285	47	0.212765957446809	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCR10&recr=Open">Click here</a>	
DZANK1	Splice_Site	p.P673S	G	G		10	SNP	20	18370346	18370346	58	0.172413793103448	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DZANK1&recr=Open">Click here</a>	
DZANK1	Missense_Mutation	p.S124L	G	G		10	SNP	20	18435898	18435898	27	0.259259259259259	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DZANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,18435898,G,G&fts=all">p.S124L</a>
EOGT	Nonsense_Mutation	p.R366*	G	G		10	SNP	3	69036652	69036652	205	0.224390243902439	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EOGT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,69036652,G,G&fts=all">p.R366*</a>
ERCC6-PGBD3	Missense_Mutation	p.L579F	G	G		10	SNP	10	50724830	50724830	182	0.137362637362637	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERCC6-PGBD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,50724830,G,G&fts=all">p.L579F</a>
EXD2	Missense_Mutation	p.S407F	C	C		10	SNP	14	69703187	69703187	79	0.835443037974684	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,69703187,C,C&fts=all">p.S407F</a>
FAM150B	Splice_Site	p.K151N	C	C		10	SNP	2	283111	283111	31	0.354838709677419	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM150B&recr=Open">Click here</a>	
FAM211B	Missense_Mutation	p.T190M	G	G	rs189889936	10	SNP	22	24982233	24982233	94	0.0425531914893617	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM211B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,24982233,G,G&fts=all">p.T190M</a>
FAM214A	Nonsense_Mutation	p.R139*	G	G		10	SNP	15	52903442	52903442	105	0.342857142857143	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM214A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,52903442,G,G&fts=all">p.R139*</a>
FAM216B	Missense_Mutation	p.P106L	C	C	rs139228134	10	SNP	13	43362823	43362823	155	0.309677419354839	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM216B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,43362823,C,C&fts=all">p.P106L</a>
FAM217A	Missense_Mutation	p.S492L	G	G	rs144438667	10	SNP	6	4068982	4068982	280	0.210714285714286	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM217A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,4068982,G,G&fts=all">p.S492L</a>
FAM227B	Missense_Mutation	p.S229L	G	G		10	SNP	15	49860503	49860503	130	0.253846153846154	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM227B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,49860503,G,G&fts=all">p.S229L</a>
FAXDC2	Missense_Mutation	p.G3E	C	C		10	SNP	5	154217731	154217731	74	0.567567567567568	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAXDC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,154217731,C,C&fts=all">p.G3E</a>
FDCSP	Missense_Mutation	p.E36K	G	G		10	SNP	4	71099752	71099752	491	0.285132382892057	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FDCSP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,71099752,G,G&fts=all">p.E36K</a>
FDCSP	Missense_Mutation	p.E84K	G	G	rs144614996	10	SNP	4	71099896	71099896	151	0.278145695364238	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FDCSP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,71099896,G,G&fts=all">p.E84K</a>
FFAR4	Missense_Mutation	p.S237L	C	C		10	SNP	10	95346990	95346990	40	0.225	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FFAR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,95346990,C,C&fts=all">p.S237L</a>
FPGT-TNNI3K	Missense_Mutation	p.Q725P	A	A		10	SNP	1	74902203	74902203	157	0.318471337579618	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FPGT-TNNI3K&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,74902203,A,A&fts=all">p.Q725P</a>
FPGT-TNNI3K	Missense_Mutation	p.P765S	C	C	rs199988336	10	SNP	1	74905285	74905285	229	0.480349344978166	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FPGT-TNNI3K&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,74905285,C,C&fts=all">p.P765S</a>
GALNT15	Missense_Mutation	p.E92K	G	G		10	SNP	3	16216932	16216932	37	0.135135135135135	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,16216932,G,G&fts=all">p.E92K</a>
GALNT15	Missense_Mutation	p.P191L	C	C		10	SNP	3	16237299	16237299	76	0.486842105263158	NA	NA	NA				Catalytic subdomain A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,16237299,C,C&fts=all">p.P191L</a>
GAREM	Missense_Mutation	p.S812F	G	G		10	SNP	18	29848030	29848030	52	0.384615384615385	NA	NA	NA				SAM.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAREM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,29848030,G,G&fts=all">p.S812F</a>
GAREM	Missense_Mutation	p.P646S	G	G		10	SNP	18	29848529	29848529	33	0.484848484848485	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAREM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,29848529,G,G&fts=all">p.P646S</a>
GCSAM	Missense_Mutation	p.N3Y	T	T		10	SNP	3	111851961	111851961	115	0.382608695652174	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCSAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,111851961,T,T&fts=all">p.N3Y</a>
GCSAML	Missense_Mutation	p.E27K	G	G		10	SNP	1	247719758	247719758	84	0.392857142857143	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCSAML&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247719758,G,G&fts=all">p.E27K</a>
GDPGP1	Missense_Mutation	p.R137C	C	C		10	SNP	15	90784549	90784549	119	0.285714285714286	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDPGP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,90784549,C,C&fts=all">p.R137C</a>
GSE1	Missense_Mutation	p.P11S	C	C	rs143102373	10	SNP	16	85667543	85667543	40	0.65	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,85667543,C,C&fts=all">p.P11S</a>
HCG17	lincRNA		C	C		10	SNP	6	30231145	30231145	350	0.751428571428571	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCG17&recr=Open">Click here</a>	
HECTD4	Missense_Mutation	p.P2768L	G	G		10	SNP	12	112632697	112632697	10	0.3	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECTD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,112632697,G,G&fts=all">p.P2768L</a>
HID1	Missense_Mutation	p.G80R	C	C		10	SNP	17	72959984	72959984	51	0.176470588235294	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HID1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72959984,C,C&fts=all">p.G80R</a>
HSH2D	Missense_Mutation	p.S55F	C	C		10	SNP	19	16263400	16263400	20	0.3	NA	NA	NA			4	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSH2D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,16263400,C,C&fts=all">p.S55F</a>
IFNL1	Nonsense_Mutation	p.Q154*	C	C		10	SNP	19	39788919	39788919	50	0.16	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39788919,C,C&fts=all">p.Q154*</a>
IGFL1	Missense_Mutation	p.S101L	C	C		10	SNP	19	46733753	46733753	116	0.379310344827586	NA	NA	NA		p.S101*(1)	5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGFL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,46733753,C,C&fts=all">p.S101L</a>
IGFL2	Missense_Mutation	p.P31S	C	C		10	SNP	19	46663710	46663710	36	0.222222222222222	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGFL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,46663710,C,C&fts=all">p.P31S</a>
IGLON5	Missense_Mutation	p.S37F	C	C		10	SNP	19	51825348	51825348	63	0.111111111111111	NA	NA	NA			12	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGLON5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51825348,C,C&fts=all">p.S37F</a>
IGLON5	Missense_Mutation	p.P38L	C	C		10	SNP	19	51825351	51825351	65	0.123076923076923	NA	NA	NA			12	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGLON5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51825351,C,C&fts=all">p.P38L</a>
KANSL1	Missense_Mutation	p.P77S	G	G		10	SNP	17	44249281	44249281	391	0.0230179028132992	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KANSL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,44249281,G,G&fts=all">p.P77S</a>
KAT6A	Missense_Mutation	p.P1566S	G	G		10	SNP	8	41791042	41791042	52	0.153846153846154	NA	NA	NA				Interaction with PML.|Interaction with RUNX1-2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KAT6A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,41791042,G,G&fts=all">p.P1566S</a>
KAT6A	Missense_Mutation	p.P895S	G	G		10	SNP	8	41798716	41798716	206	0.393203883495146	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KAT6A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,41798716,G,G&fts=all">p.P895S</a>
KAT6B	Missense_Mutation	p.K1130M	A	A		10	SNP	10	76784732	76784732	139	0.0359712230215827	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KAT6B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,76784732,A,A&fts=all">p.K1130M</a>
KIAA1551	Missense_Mutation	p.E842K	G	G		10	SNP	12	32136413	32136413	127	0.236220472440945	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1551&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,32136413,G,G&fts=all">p.E842K</a>
KLHL41	Missense_Mutation	p.R155C	C	C	rs200210332	10	SNP	2	170366751	170366751	428	0.280373831775701	NA	NA	NA				BACK.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL41&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,170366751,C,C&fts=all">p.R155C</a>
KMT2C	Missense_Mutation	p.V4616M	C	C		10	SNP	7	151845166	151845166	62	0.403225806451613	NA	NA	NA				FYR C-terminal. {ECO:0000255|PROSITE- ProRule:PRU00876}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,151845166,C,C&fts=all">p.V4616M</a>
KMT2C	Nonsense_Mutation	p.Q2903*	G	G		10	SNP	7	151873831	151873831	83	0.530120481927711	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,151873831,G,G&fts=all">p.Q2903*</a>
KMT2C	Missense_Mutation	p.S2835F	G	G		10	SNP	7	151874034	151874034	187	0.0374331550802139	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,151874034,G,G&fts=all">p.S2835F</a>
KMT2C	Nonsense_Mutation	p.R1906*	G	G		10	SNP	7	151879229	151879229	83	0.795180722891566	NA	NA	NA		p.R1906*(1)		Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,151879229,G,G&fts=all">p.R1906*</a>
KMT2C	Missense_Mutation	p.L694F	G	G		10	SNP	7	151945439	151945439	123	0.430894308943089	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,151945439,G,G&fts=all">p.L694F</a>
KMT2D	Missense_Mutation	p.P790S	G	G	rs376911077	10	SNP	12	49445098	49445098	24	0.416666666666667	NA	NA	NA				Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,49445098,G,G&fts=all">p.P790S</a>
KMT2E	Nonsense_Mutation	p.R283*	C	C		10	SNP	7	104717488	104717488	169	0.0591715976331361	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,104717488,C,C&fts=all">p.R283*</a>
KRTAP10-9	Missense_Mutation	p.Q164R	A	A		10	SNP	21	46047579	46047579	103	0.252427184466019	NA	NA	NA		p.Q164L(1)	9	25 X 5 AA repeats of C-C-X(3).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP10-9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,46047579,A,A&fts=all">p.Q164R</a>
KRTAP12-2	Missense_Mutation	p.S7F	G	G		10	SNP	21	46086784	46086784	16	0.25	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP12-2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,46086784,G,G&fts=all">p.S7F</a>
KXD1	Missense_Mutation	p.R82C	C	C		10	SNP	19	18675821	18675821	121	0.181818181818182	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KXD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,18675821,C,C&fts=all">p.R82C</a>
LDLRAD4	Nonsense_Mutation	p.Q148*	C	C		10	SNP	18	13645177	13645177	48	0.5625	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LDLRAD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,13645177,C,C&fts=all">p.Q148*</a>
LDLRAD4	Missense_Mutation	p.P252L	C	C		10	SNP	18	13645490	13645490	49	0.387755102040816	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LDLRAD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,13645490,C,C&fts=all">p.P252L</a>
LINC00477	lincRNA		G	G		10	SNP	12	24737004	24737004	194	0.417525773195876	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LINC00477&recr=Open">Click here</a>	
LINC00669	lincRNA		G	G		10	SNP	18	37202081	37202081	47	0.297872340425532	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LINC00669&recr=Open">Click here</a>	
LPPR1	Missense_Mutation	p.R9Q	G	G	rs200860367	10	SNP	9	103947802	103947802	175	0.297142857142857	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPPR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,103947802,G,G&fts=all">p.R9Q</a>
LPPR1	Missense_Mutation	p.Y116H	T	T		10	SNP	9	104048479	104048479	130	0.207692307692308	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPPR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,104048479,T,T&fts=all">p.Y116H</a>
LRRC58	Missense_Mutation	p.E238K	C	C		10	SNP	3	120053904	120053904	80	0.0625	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC58&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,120053904,C,C&fts=all">p.E238K</a>
LY75-CD302	Missense_Mutation	p.E1053K	C	C		10	SNP	2	160698879	160698879	119	0.277310924369748	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LY75-CD302&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,160698879,C,C&fts=all">p.E1053K</a>
LZTS3	Missense_Mutation	p.G302S	C	C		10	SNP	20	3146562	3146562	37	0.351351351351351	NA	NA	NA				Poly-Gly.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LZTS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,3146562,C,C&fts=all">p.G302S</a>
MALAT1	lincRNA		C	C		10	SNP	11	65272980	65272980	225	0.906666666666667	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MALAT1&recr=Open">Click here</a>	
MAP3K19	Missense_Mutation	p.E151K	C	C		10	SNP	2	135756431	135756431	121	0.31404958677686	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,135756431,C,C&fts=all">p.E151K</a>
METTL25	Nonsense_Mutation	p.Q292*	C	C		10	SNP	12	82792916	82792916	162	0.395061728395062	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+METTL25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,82792916,C,C&fts=all">p.Q292*</a>
MIR205HG	lincRNA		G	G		10	SNP	1	209603799	209603799	105	0.2	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR205HG&recr=Open">Click here</a>	
MLK4	Missense_Mutation	p.R977C	C	C	rs56065162	10	SNP	1	233518275	233518275	62	0.209677419354839	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,233518275,C,C&fts=all">p.R977C</a>
MMP24	Missense_Mutation	p.D318N	G	G		10	SNP	20	33851728	33851728	42	0.380952380952381	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP24&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,33851728,G,G&fts=all">p.D318N</a>
MOB3A	Missense_Mutation	p.P143L	G	G		10	SNP	19	2077006	2077006	14	0.5	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MOB3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,2077006,G,G&fts=all">p.P143L</a>
MROH2B	Missense_Mutation	p.E1500K	C	C		10	SNP	5	40999866	40999866	84	0.428571428571429	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,40999866,C,C&fts=all">p.E1500K</a>
MROH2B	Missense_Mutation	p.P1444S	G	G		10	SNP	5	41000800	41000800	30	0.5	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41000800,G,G&fts=all">p.P1444S</a>
MROH2B	Missense_Mutation	p.E294K	C	C		10	SNP	5	41057250	41057250	74	0.148648648648649	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41057250,C,C&fts=all">p.E294K</a>
MROH2B	Nonsense_Mutation	p.W197*	C	C		10	SNP	5	41061697	41061697	188	0.388297872340426	NA	NA	NA		p.W197L(1)				MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41061697,C,C&fts=all">p.W197*</a>
MS4A8	Missense_Mutation	p.G111R	G	G		10	SNP	11	60470962	60470962	86	0.395348837209302	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MS4A8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,60470962,G,G&fts=all">p.G111R</a>
MUC5B	Missense_Mutation	p.E963K	G	G		10	SNP	11	1257622	1257622	15	0.466666666666667	NA	NA	NA			137	VWFD 3. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,1257622,G,G&fts=all">p.E963K</a>
MUC5B	Missense_Mutation	p.G3872S	G	G		10	SNP	11	1269724	1269724	36	0.416666666666667	NA	NA	NA			137	11 X approximate tandem repeats, Ser/Thr- rich.|7 X Cys-rich subdomain repeats.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,1269724,G,G&fts=all">p.G3872S</a>
MVB12B	Missense_Mutation	p.S224F	C	C	rs267602133	10	SNP	9	129184141	129184141	109	0.26605504587156	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MVB12B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,129184141,C,C&fts=all">p.S224F</a>
MYRF	Missense_Mutation	p.P299L	C	C		10	SNP	11	61539127	61539127	48	0.25	NA	NA	NA				Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYRF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,61539127,C,C&fts=all">p.P299L</a>
MYZAP	Missense_Mutation	p.D410N	G	G		10	SNP	15	57967190	57967190	95	0.0421052631578947	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYZAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,57967190,G,G&fts=all">p.D410N</a>
MYZAP	Missense_Mutation	p.P434S	C	C		10	SNP	15	57967262	57967262	67	0.597014925373134	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYZAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,57967262,C,C&fts=all">p.P434S</a>
MYZAP	Missense_Mutation	p.P452L	C	C		10	SNP	15	57976650	57976650	264	0.238636363636364	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYZAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,57976650,C,C&fts=all">p.P452L</a>
NBPF1	Missense_Mutation	p.S1005A	A	A		10	SNP	1	16892179	16892179	2799	0.0392997499106824	NA	NA	NA				NBPF 6. {ECO:0000255|PROSITE- ProRule:PRU00647}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NBPF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,16892179,A,A&fts=all">p.S1005A</a>
NIM1	Missense_Mutation	p.S56F	C	C		10	SNP	5	43246044	43246044	96	0.208333333333333	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,43246044,C,C&fts=all">p.S56F</a>
NIM1	Missense_Mutation	p.G72S	G	G		10	SNP	5	43246091	43246091	76	0.210526315789474	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,43246091,G,G&fts=all">p.G72S</a>
NME8	Missense_Mutation	p.D137N	G	G		10	SNP	7	37903019	37903019	254	0.196850393700787	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NME8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,37903019,G,G&fts=all">p.D137N</a>
NPAP1	Missense_Mutation	p.R76Q	G	G		10	SNP	15	24921241	24921241	15	0.333333333333333	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,24921241,G,G&fts=all">p.R76Q</a>
NPAP1	Missense_Mutation	p.R103Q	G	G		10	SNP	15	24921322	24921322	19	0.684210526315789	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,24921322,G,G&fts=all">p.R103Q</a>
NPIPB15	Missense_Mutation	p.A350V	C	C		10	SNP	16	74425695	74425695	31	0.193548387096774	NA	NA	NA				Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPIPB15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,74425695,C,C&fts=all">p.A350V</a>
NPY4R	Start_Codon_SNP	p.M1I	G	G		10	SNP	10	47086786	47086786	137	0.0437956204379562	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPY4R&recr=Open">Click here</a>	
NPY4R	Missense_Mutation	p.D105N	G	G		10	SNP	10	47087096	47087096	161	0.0683229813664596	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPY4R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,47087096,G,G&fts=all">p.D105N</a>
NT5C1B-RDH14	Nonsense_Mutation	p.K413*	T	T		10	SNP	2	18758126	18758126	177	0.271186440677966	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NT5C1B-RDH14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,18758126,T,T&fts=all">p.K413*</a>
NTMT1	Missense_Mutation	p.I72F	A	A		10	SNP	9	132396384	132396384	68	0.191176470588235	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NTMT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,132396384,A,A&fts=all">p.I72F</a>
NUGGC	Missense_Mutation	p.G720E	C	C		10	SNP	8	27884565	27884565	145	0.262068965517241	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUGGC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,27884565,C,C&fts=all">p.G720E</a>
NUGGC	Missense_Mutation	p.S658F	G	G		10	SNP	8	27887871	27887871	12	0.333333333333333	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUGGC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,27887871,G,G&fts=all">p.S658F</a>
NUTM1	Missense_Mutation	p.R381K	G	G		10	SNP	15	34646713	34646713	83	0.590361445783133	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUTM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,34646713,G,G&fts=all">p.R381K</a>
NUTM2D	Missense_Mutation	p.G50E	G	G		10	SNP	10	89118171	89118171	278	0.161870503597122	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUTM2D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,89118171,G,G&fts=all">p.G50E</a>
NUTM2F	Missense_Mutation	p.E368K	C	C		10	SNP	9	97082756	97082756	28	0.428571428571429	NA	NA	NA				Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUTM2F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,97082756,C,C&fts=all">p.E368K</a>
NXPE3	Missense_Mutation	p.S184F	C	C		10	SNP	3	101520536	101520536	68	0.426470588235294	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NXPE3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,101520536,C,C&fts=all">p.S184F</a>
NXPE4	Missense_Mutation	p.P441S	G	G		10	SNP	11	114441974	114441974	116	0.0517241379310345	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NXPE4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,114441974,G,G&fts=all">p.P441S</a>
OSER1	Missense_Mutation	p.P224S	G	G		10	SNP	20	42825901	42825901	44	0.840909090909091	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSER1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,42825901,G,G&fts=all">p.P224S</a>
OSER1	Missense_Mutation	p.H88Y	G	G		10	SNP	20	42826309	42826309	106	0.415094339622642	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSER1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,42826309,G,G&fts=all">p.H88Y</a>
PAPL	Splice_Site		G	G		10	SNP	19	39591927	39591927	164	0.170731707317073	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPL&recr=Open">Click here</a>	
PAPL	Missense_Mutation	p.H409Y	C	C		10	SNP	19	39597698	39597698	121	0.206611570247934	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39597698,C,C&fts=all">p.H409Y</a>
PBOV1	Missense_Mutation	p.F48I	A	A		10	SNP	6	138539391	138539391	15	0.266666666666667	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PBOV1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,138539391,A,A&fts=all">p.F48I</a>
PCDHGA4	Missense_Mutation	p.S179T	T	T		10	SNP	5	140735302	140735302	36	0.388888888888889	NA	NA	NA			5	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140735302,T,T&fts=all">p.S179T</a>
PCDHGA4	Missense_Mutation	p.H208Y	C	C		10	SNP	5	140735389	140735389	14	0.428571428571429	NA	NA	NA			5	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140735389,C,C&fts=all">p.H208Y</a>
PCDHGA7	Missense_Mutation	p.E310K	G	G		10	SNP	5	140763394	140763394	46	0.434782608695652	NA	NA	NA			49	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140763394,G,G&fts=all">p.E310K</a>
PCDHGA9	Missense_Mutation	p.P462L	C	C		10	SNP	5	140783904	140783904	34	0.470588235294118	NA	NA	NA			5	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140783904,C,C&fts=all">p.P462L</a>
PCDHGB4	Missense_Mutation	p.M325I	G	G		10	SNP	5	140768426	140768426	20	0.5	NA	NA	NA			37	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140768426,G,G&fts=all">p.M325I</a>
PCDP1	Missense_Mutation	p.D744N	G	G	rs376715639	10	SNP	2	120404538	120404538	176	0.272727272727273	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,120404538,G,G&fts=all">p.D744N</a>
PCDP1	Nonsense_Mutation	p.Q810*	C	C		10	SNP	2	120413951	120413951	58	0.310344827586207	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,120413951,C,C&fts=all">p.Q810*</a>
PCED1B	Missense_Mutation	p.G304R	G	G		10	SNP	12	47629756	47629756	12	0.416666666666667	NA	NA	NA				Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCED1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,47629756,G,G&fts=all">p.G304R</a>
PIEZO2	Missense_Mutation	p.S2533L	G	G		10	SNP	18	10680211	10680211	107	0.392523364485981	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIEZO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,10680211,G,G&fts=all">p.S2533L</a>
PLEKHS1	Missense_Mutation	p.E389K	G	G		10	SNP	10	115537016	115537016	54	0.574074074074074	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,115537016,G,G&fts=all">p.E389K</a>
PPP1R17	Missense_Mutation	p.E96K	G	G	rs147297649	10	SNP	7	31746868	31746868	68	0.0735294117647059	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,31746868,G,G&fts=all">p.E96K</a>
PRRC2C	Missense_Mutation	p.S2409F	C	C	rs143032286	10	SNP	1	171548565	171548565	148	0.277027027027027	NA	NA	NA				Gln-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRRC2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,171548565,C,C&fts=all">p.S2409F</a>
PRRC2C	Missense_Mutation	p.G2419D	G	G		10	SNP	1	171548595	171548595	108	0.583333333333333	NA	NA	NA				Gln-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRRC2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,171548595,G,G&fts=all">p.G2419D</a>
PSMB11	Missense_Mutation	p.P30S	C	C		10	SNP	14	23511522	23511522	44	0.840909090909091	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSMB11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,23511522,C,C&fts=all">p.P30S</a>
PSMB11	Missense_Mutation	p.D195N	G	G	rs372279769	10	SNP	14	23512017	23512017	28	0.392857142857143	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSMB11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,23512017,G,G&fts=all">p.D195N</a>
PSMB11	Missense_Mutation	p.A203V	C	C		10	SNP	14	23512042	23512042	30	0.833333333333333	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSMB11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,23512042,C,C&fts=all">p.A203V</a>
PTCHD4	Missense_Mutation	p.L34P	A	A		10	SNP	6	48036291	48036291	16	0.375	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCHD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,48036291,A,A&fts=all">p.L34P</a>
RABL6	Missense_Mutation	p.P344L	C	C		10	SNP	9	139732019	139732019	9	0.444444444444444	NA	NA	NA				Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RABL6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,139732019,C,C&fts=all">p.P344L</a>
RBMXL1	Missense_Mutation	p.R172C	G	G		10	SNP	1	89448996	89448996	354	0.0451977401129944	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBMXL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,89448996,G,G&fts=all">p.R172C</a>
REEP3	Missense_Mutation	p.P48L	C	C		10	SNP	10	65357789	65357789	245	0.204081632653061	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REEP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,65357789,C,C&fts=all">p.P48L</a>
RP11-35J10.5	lincRNA		C	C		10	SNP	11	7726181	7726181	20	0.35	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-35J10.5&recr=Open">Click here</a>	
RP11-35J10.5	lincRNA		A	A		10	SNP	11	7727895	7727895	28	0.285714285714286	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-35J10.5&recr=Open">Click here</a>	
RP11-379F12.4	lincRNA		A	A		10	SNP	10	8093020	8093020	21	0.285714285714286	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-379F12.4&recr=Open">Click here</a>	
RP11-58C22.1	Missense_Mutation	p.H30Y	C	C		10	SNP	16	76587735	76587735	64	0.328125	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-58C22.1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,76587735,C,C&fts=all">p.H30Y</a>
RP11-909M7.3	lincRNA		C	C		10	SNP	14	101439005	101439005	159	0.314465408805031	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-909M7.3&recr=Open">Click here</a>	
RPS4Y2	Missense_Mutation	p.S32L	C	C		10	SNP	Y	22921767	22921767	27	0.814814814814815	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPS4Y2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,Y,22921767,C,C&fts=all">p.S32L</a>
RTCB	Missense_Mutation	p.F148L	A	A		10	SNP	22	32797787	32797787	201	0.27363184079602	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RTCB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,32797787,A,A&fts=all">p.F148L</a>
SCGB2B2	Missense_Mutation	p.S59F	G	G		10	SNP	19	35085150	35085150	57	0.350877192982456	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCGB2B2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,35085150,G,G&fts=all">p.S59F</a>
SEL1L3	Nonsense_Mutation	p.W499*	C	C		10	SNP	4	25819827	25819827	17	0.352941176470588	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEL1L3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,25819827,C,C&fts=all">p.W499*</a>
SELT	Missense_Mutation	p.S111F	C	C		10	SNP	3	150344839	150344839	171	0.298245614035088	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SELT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,150344839,C,C&fts=all">p.S111F</a>
SERTM1	Missense_Mutation	p.S11L	C	C		10	SNP	13	37269247	37269247	114	0.578947368421053	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERTM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,37269247,C,C&fts=all">p.S11L</a>
SFTA3	Nonsense_Mutation	p.G33*	C	C		10	SNP	14	36960442	36960442	12	0.25	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SFTA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,36960442,C,C&fts=all">p.G33*</a>
SLC52A1	Missense_Mutation	p.P141L	G	G		10	SNP	17	4937362	4937362	56	0.267857142857143	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC52A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,4937362,G,G&fts=all">p.P141L</a>
SLC9C1	Missense_Mutation	p.R81C	G	G		10	SNP	3	111997653	111997653	300	0.333333333333333	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,111997653,G,G&fts=all">p.R81C</a>
SLC9C2	Missense_Mutation	p.S824L	G	G		10	SNP	1	173493961	173493961	223	0.210762331838565	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9C2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,173493961,G,G&fts=all">p.S824L</a>
SLC9C2	Missense_Mutation	p.R203W	G	G		10	SNP	1	173552678	173552678	311	0.0353697749196141	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9C2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,173552678,G,G&fts=all">p.R203W</a>
SMDT1	Missense_Mutation	p.P58L	C	C		10	SNP	22	42475945	42475945	166	0.162650602409639	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMDT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,42475945,C,C&fts=all">p.P58L</a>
SMIM14	Missense_Mutation	p.P43L	G	G	rs370566309	10	SNP	4	39558187	39558187	65	0.415384615384615	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMIM14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,39558187,G,G&fts=all">p.P43L</a>
SNORA71B	lincRNA		G	G		10	SNP	20	37053872	37053872	214	0.383177570093458	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNORA71B&recr=Open">Click here</a>	
SOGA2	Missense_Mutation	p.D730N	G	G		10	SNP	18	8784218	8784218	18	0.166666666666667	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOGA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,8784218,G,G&fts=all">p.D730N</a>
SOWAHA	Missense_Mutation	p.T549A	A	A		10	SNP	5	132150958	132150958	32	0.5	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOWAHA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,132150958,A,A&fts=all">p.T549A</a>
SPATA31E1	Missense_Mutation	p.P186L	C	C		10	SNP	9	90499959	90499959	31	0.258064516129032	NA	NA	NA				Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATA31E1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,90499959,C,C&fts=all">p.P186L</a>
SPATA31E1	Nonsense_Mutation	p.W1172*	G	G		10	SNP	9	90502917	90502917	19	0.684210526315789	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATA31E1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,90502917,G,G&fts=all">p.W1172*</a>
SPATA6L	Missense_Mutation	p.T107I	G	G		10	SNP	9	4625502	4625502	157	0.471337579617834	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATA6L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,4625502,G,G&fts=all">p.T107I</a>
SPPL2C	Missense_Mutation	p.L162F	C	C		10	SNP	17	43922756	43922756	30	0.3	NA	NA	NA				PA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPPL2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,43922756,C,C&fts=all">p.L162F</a>
SPPL3	Missense_Mutation	p.H373Y	G	G		10	SNP	12	121202840	121202840	119	0.243697478991597	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPPL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,121202840,G,G&fts=all">p.H373Y</a>
STPG2	Missense_Mutation	p.G448E	C	C		10	SNP	4	98480246	98480246	210	0.252380952380952	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STPG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,98480246,C,C&fts=all">p.G448E</a>
SVOP	Missense_Mutation	p.R463K	C	C	rs535655235	10	SNP	12	109306374	109306374	83	0.385542168674699	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SVOP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,109306374,C,C&fts=all">p.R463K</a>
SVOP	Missense_Mutation	p.P246L	G	G		10	SNP	12	109331078	109331078	167	0.437125748502994	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SVOP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,109331078,G,G&fts=all">p.P246L</a>
TBATA	Missense_Mutation	p.G189E	C	C		10	SNP	10	72537033	72537033	47	0.170212765957447	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBATA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,72537033,C,C&fts=all">p.G189E</a>
TBC1D32	Missense_Mutation	p.S492F	G	G		10	SNP	6	121602823	121602823	197	0.436548223350254	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D32&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,121602823,G,G&fts=all">p.S492F</a>
TENM1	Nonsense_Mutation	p.R2195*	G	G		10	SNP	X	123518177	123518177	100	0.32	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,123518177,G,G&fts=all">p.R2195*</a>
TENM1	Missense_Mutation	p.P1667S	G	G		10	SNP	X	123540302	123540302	119	0.403361344537815	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,123540302,G,G&fts=all">p.P1667S</a>
TENM1	Missense_Mutation	p.P820S	G	G		10	SNP	X	123680917	123680917	58	0.5	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,123680917,G,G&fts=all">p.P820S</a>
TENM1	Splice_Site	p.A755V	G	G		10	SNP	X	123697622	123697622	64	0.484375	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM1&recr=Open">Click here</a>	
TENM2	Missense_Mutation	p.D410N	G	G		10	SNP	5	167545407	167545407	122	0.352459016393443	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,167545407,G,G&fts=all">p.D410N</a>
TENM2	Missense_Mutation	p.P723S	C	C		10	SNP	5	167622263	167622263	25	0.28	NA	NA	NA				EGF-like 5. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,167622263,C,C&fts=all">p.P723S</a>
TENM2	Missense_Mutation	p.M1488I	G	G		10	SNP	5	167653165	167653165	29	0.413793103448276	NA	NA	NA		p.M1560>?(1)				MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,167653165,G,G&fts=all">p.M1488I</a>
TENM3	Missense_Mutation	p.E163K	G	G		10	SNP	4	183268058	183268058	47	0.340425531914894	NA	NA	NA				Teneurin N-terminal. {ECO:0000255|PROSITE-ProRule:PRU00694}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,183268058,G,G&fts=all">p.E163K</a>
TENM3	Missense_Mutation	p.A221V	C	C		10	SNP	4	183522227	183522227	145	0.268965517241379	NA	NA	NA				Teneurin N-terminal. {ECO:0000255|PROSITE-ProRule:PRU00694}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,183522227,C,C&fts=all">p.A221V</a>
TENM3	Missense_Mutation	p.P674S	C	C		10	SNP	4	183603152	183603152	112	0.241071428571429	NA	NA	NA				EGF-like 5. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,183603152,C,C&fts=all">p.P674S</a>
TENM3	Missense_Mutation	p.S2268L	C	C	rs369153629	10	SNP	4	183714628	183714628	57	0.350877192982456	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,183714628,C,C&fts=all">p.S2268L</a>
TENM4	Missense_Mutation	p.M2761I	C	C	rs369408263	10	SNP	11	78369130	78369130	137	0.474452554744526	NA	NA	NA		p.M2761I(2)				MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,78369130,C,C&fts=all">p.M2761I</a>
TESPA1	Missense_Mutation	p.R309K	C	C		10	SNP	12	55356756	55356756	42	0.333333333333333	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TESPA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,55356756,C,C&fts=all">p.R309K</a>
TESPA1	Missense_Mutation	p.V205E	A	A		10	SNP	12	55357567	55357567	20	0.35	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TESPA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,55357567,A,A&fts=all">p.V205E</a>
TEX33	Missense_Mutation	p.G110E	C	C		10	SNP	22	37398038	37398038	32	0.21875	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX33&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,37398038,C,C&fts=all">p.G110E</a>
TLDC2	Missense_Mutation	p.G87D	G	G		10	SNP	20	35507514	35507514	52	0.442307692307692	NA	NA	NA				TLD.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLDC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,35507514,G,G&fts=all">p.G87D</a>
TMEM239	Missense_Mutation	p.P15L	C	C		10	SNP	20	2795874	2795874	73	0.219178082191781	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM239&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,2795874,C,C&fts=all">p.P15L</a>
TMEM255B	Missense_Mutation	p.F126L	T	T		10	SNP	13	114502347	114502347	50	0.3	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM255B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,114502347,T,T&fts=all">p.F126L</a>
TSIX	lincRNA		C	C		10	SNP	X	73041107	73041107	15	0.333333333333333	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSIX&recr=Open">Click here</a>	
TSIX	lincRNA		C	C		10	SNP	X	73042609	73042609	40	0.5	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSIX&recr=Open">Click here</a>	
TSIX	lincRNA		G	G		10	SNP	X	73045964	73045964	69	0.420289855072464	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSIX&recr=Open">Click here</a>	
TSIX	lincRNA		C	C		10	SNP	X	73046088	73046088	111	0.36036036036036	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSIX&recr=Open">Click here</a>	
TSIX	lincRNA		C	C		10	SNP	X	73046089	73046089	112	0.366071428571429	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSIX&recr=Open">Click here</a>	
TTC40	Missense_Mutation	p.K2199Q	T	T		10	SNP	10	134649664	134649664	20	0.4	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC40&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,134649664,T,T&fts=all">p.K2199Q</a>
UNC79	Missense_Mutation	p.G369E	G	G		10	SNP	14	94008924	94008924	175	0.262857142857143	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC79&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,94008924,G,G&fts=all">p.G369E</a>
UNC79	Missense_Mutation	p.P586S	C	C		10	SNP	14	94044263	94044263	239	0.552301255230126	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC79&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,94044263,C,C&fts=all">p.P586S</a>
UNC79	Missense_Mutation	p.R588W	C	C		10	SNP	14	94044269	94044269	226	0.309734513274336	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC79&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,94044269,C,C&fts=all">p.R588W</a>
UNC79	Missense_Mutation	p.A1030V	C	C		10	SNP	14	94069630	94069630	140	0.564285714285714	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC79&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,94069630,C,C&fts=all">p.A1030V</a>
VCX3B	Missense_Mutation	p.E217K	G	G		10	SNP	X	8434332	8434332	148	0.0743243243243243	NA	NA	NA			11	14 X 10 AA tandem repeats of L-S-Q-E-S- [EQ]-V-E-E-P.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VCX3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,8434332,G,G&fts=all">p.E217K</a>
VOPP1	Missense_Mutation	p.P49L	G	G	rs369962600	10	SNP	7	55540720	55540720	23	0.608695652173913	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VOPP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,55540720,G,G&fts=all">p.P49L</a>
VPS9D1	Missense_Mutation	p.P485S	G	G		10	SNP	16	89775779	89775779	45	0.288888888888889	NA	NA	NA				VPS9. {ECO:0000255|PROSITE- ProRule:PRU00550}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS9D1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,89775779,G,G&fts=all">p.P485S</a>
XIST	lincRNA		G	G		10	SNP	X	73065043	73065043	60	0.433333333333333	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIST&recr=Open">Click here</a>	
XIST	lincRNA		G	G		10	SNP	X	73065931	73065931	72	0.416666666666667	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIST&recr=Open">Click here</a>	
XIST	lincRNA		T	T		10	SNP	X	73066332	73066332	73	0.534246575342466	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIST&recr=Open">Click here</a>	
XIST	lincRNA		C	C		10	SNP	X	73070815	73070815	30	0.333333333333333	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIST&recr=Open">Click here</a>	
XIST	lincRNA		C	C		10	SNP	X	73072019	73072019	11	0.363636363636364	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIST&recr=Open">Click here</a>	
XXbac-BPG308J9.3	lincRNA		G	G		10	SNP	6	29230735	29230735	96	0.166666666666667	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XXbac-BPG308J9.3&recr=Open">Click here</a>	
ZBTB14	Missense_Mutation	p.I117N	A	A		10	SNP	18	5291857	5291857	187	0.0588235294117647	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,5291857,A,A&fts=all">p.I117N</a>
ZBTB21	Missense_Mutation	p.P631L	G	G		10	SNP	21	43411710	43411710	206	0.320388349514563	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,43411710,G,G&fts=all">p.P631L</a>
ZNF404	Missense_Mutation	p.P119S	G	G		10	SNP	19	44378011	44378011	305	0.20655737704918	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF404&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44378011,G,G&fts=all">p.P119S</a>
ZNF578	Missense_Mutation	p.P370L	C	C		10	SNP	19	53014743	53014743	152	0.0394736842105263	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF578&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,53014743,C,C&fts=all">p.P370L</a>
ZNF683	Missense_Mutation	p.G482E	C	C		10	SNP	1	26688212	26688212	144	0.194444444444444	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF683&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,26688212,C,C&fts=all">p.G482E</a>
ZNF683	Missense_Mutation	p.G482R	C	C		10	SNP	1	26688213	26688213	143	0.202797202797203	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF683&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,26688213,C,C&fts=all">p.G482R</a>
ZNF778	Missense_Mutation	p.A48V	C	C		10	SNP	16	89289590	89289590	87	0.229885057471264	NA	NA	NA			24	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF778&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,89289590,C,C&fts=all">p.A48V</a>
ZNF778	Missense_Mutation	p.P276S	C	C		10	SNP	16	89293606	89293606	33	0.242424242424242	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF778&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,89293606,C,C&fts=all">p.P276S</a>
ZNF808	Missense_Mutation	p.A883V	C	C		10	SNP	19	53058817	53058817	134	0.365671641791045	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF808&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,53058817,C,C&fts=all">p.A883V</a>
ZNF883	lincRNA		G	G		10	SNP	9	115760017	115760017	111	0.225225225225225	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF883&recr=Open">Click here</a>	
hsa-mir-125a	lincRNA		C	C		10	SNP	19	52196112	52196112	30	0.133333333333333	NA	NA	NA						MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+hsa-mir-125a&recr=Open">Click here</a>	
A1CF	Silent	p.G428G	C	C		11	Filtered Calls	10	52573680	52573680	235	0.2	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+A1CF&recr=Open">Click here</a>	
A2M	Intron		G	G		11	Filtered Calls	12	9227389	9227389	23	0.217391304347826	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+A2M&recr=Open">Click here</a>	
A2M	Silent	p.G257G	C	C		11	Filtered Calls	12	9260228	9260228	286	0.48951048951049	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+A2M&recr=Open">Click here</a>	
A2ML1	Intron		G	G		11	Filtered Calls	12	8988272	8988272	32	0.25	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+A2ML1&recr=Open">Click here</a>	
A2ML1	Silent	p.E1260E	G	G		11	Filtered Calls	12	9020500	9020500	171	0.233918128654971	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+A2ML1&recr=Open">Click here</a>	
AANAT	Intron		C	C		11	Filtered Calls	17	74465002	74465002	46	0.195652173913043	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AANAT&recr=Open">Click here</a>	
AAR2	Silent	p.T343T	C	C		11	Filtered Calls	20	34843541	34843541	203	0.359605911330049	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AAR2&recr=Open">Click here</a>	
AARS2	Silent	p.F528F	G	G		11	Filtered Calls	6	44272550	44272550	55	0.181818181818182	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AARS2&recr=Open">Click here</a>	
AARS2	Silent	p.S170S	G	G		11	Filtered Calls	6	44279198	44279198	138	0.210144927536232	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AARS2&recr=Open">Click here</a>	
AASDHPPT	3'UTR		C	C		11	Filtered Calls	11	105967641	105967641	62	0.387096774193548	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AASDHPPT&recr=Open">Click here</a>	
AATK	Silent	p.L1217L	G	G		11	Filtered Calls	17	79094087	79094087	52	0.230769230769231	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AATK&recr=Open">Click here</a>	
ABCA1	Silent	p.L2034L	G	G	rs113373258	11	Filtered Calls	9	107550303	107550303	218	0.31651376146789	NA	NA	NA			115	ABC transporter 2. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA1&recr=Open">Click here</a>	
ABCA1	Intron		C	C		11	Filtered Calls	9	107556661	107556661	148	0.344594594594595	NA	NA	NA			115			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA1&recr=Open">Click here</a>	
ABCA1	Intron		G	G		11	Filtered Calls	9	107584958	107584958	55	0.236363636363636	NA	NA	NA			115			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA1&recr=Open">Click here</a>	
ABCA1	Silent	p.I673I	G	G		11	Filtered Calls	9	107591293	107591293	71	0.197183098591549	NA	NA	NA			115			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA1&recr=Open">Click here</a>	
ABCA10	Intron		G	G		11	Filtered Calls	17	67146215	67146215	199	0.185929648241206	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA10&recr=Open">Click here</a>	
ABCA10	Silent	p.F1129F	G	G		11	Filtered Calls	17	67153041	67153041	166	0.156626506024096	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA10&recr=Open">Click here</a>	
ABCA12	Intron		G	G	rs545331857	11	Filtered Calls	2	215834986	215834986	99	0.181818181818182	NA	NA	NA			139			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA12&recr=Open">Click here</a>	
ABCA13	Silent	p.P2494P	C	C		11	Filtered Calls	7	48318273	48318273	443	0.209932279909707	NA	NA	NA			270			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	
ABCA2	Silent	p.L2042L	G	G		11	Filtered Calls	9	139905120	139905120	93	0.247311827956989	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA2&recr=Open">Click here</a>	
ABCA3	Silent	p.A414A	G	G		11	Filtered Calls	16	2354021	2354021	54	0.296296296296296	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA3&recr=Open">Click here</a>	
ABCA4	Silent	p.F780F	G	G		11	Filtered Calls	1	94522199	94522199	32	1	NA	NA	NA			147			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA4&recr=Open">Click here</a>	
ABCA5	Silent	p.S192S	A	A		11	Filtered Calls	17	67303078	67303078	295	0.210169491525424	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA5&recr=Open">Click here</a>	
ABCA6	Silent	p.S1045S	G	G		11	Filtered Calls	17	67092928	67092928	141	0.212765957446809	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA6&recr=Open">Click here</a>	
ABCA7	5'Flank		C	C		11	Filtered Calls	19	1042366	1042366	75	0.32	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA7&recr=Open">Click here</a>	
ABCA7	Silent	p.Q782Q	G	G		11	Filtered Calls	19	1051229	1051229	30	0.166666666666667	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA7&recr=Open">Click here</a>	
ABCA7	Silent	p.P1289P	C	C		11	Filtered Calls	19	1056107	1056107	38	0.105263157894737	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA7&recr=Open">Click here</a>	
ABCA7	Silent	p.V1424V	C	C		11	Filtered Calls	19	1057005	1057005	46	0.108695652173913	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA7&recr=Open">Click here</a>	
ABCA8	Intron		C	C		11	Filtered Calls	17	66872759	66872759	111	0.684684684684685	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA8&recr=Open">Click here</a>	
ABCA8	Silent	p.R66R	C	C		11	Filtered Calls	17	66937002	66937002	263	0.475285171102662	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA8&recr=Open">Click here</a>	
ABCA9	Silent	p.L345L	G	G		11	Filtered Calls	17	67031482	67031482	218	0.660550458715596	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA9&recr=Open">Click here</a>	
ABCA9	Silent	p.I344I	G	G		11	Filtered Calls	17	67031483	67031483	222	0.666666666666667	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA9&recr=Open">Click here</a>	
ABCA9	Intron		C	C		11	Filtered Calls	17	67040635	67040635	156	0.192307692307692	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA9&recr=Open">Click here</a>	
ABCB1	Silent	p.L1082L	G	G		11	Filtered Calls	7	87144583	87144583	43	0.534883720930233	NA	NA	NA			111	ABC transporter 2. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB1&recr=Open">Click here</a>	
ABCB1	Intron		A	A		11	Filtered Calls	7	87179755	87179755	45	0.355555555555556	NA	NA	NA			111			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB1&recr=Open">Click here</a>	
ABCB10	Silent	p.F513F	G	G		11	Filtered Calls	1	229666052	229666052	276	0.231884057971014	NA	NA	NA			31	ABC transporter. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB10&recr=Open">Click here</a>	
ABCB11	Silent	p.I991I	G	G		11	Filtered Calls	2	169791777	169791777	114	0.307017543859649	NA	NA	NA			57	ABC transmembrane type-1 2. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB11&recr=Open">Click here</a>	
ABCB4	Silent	p.I1114I	G	G		11	Filtered Calls	7	87035748	87035748	121	0.380165289256198	NA	NA	NA			77	ABC transporter 2. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB4&recr=Open">Click here</a>	
ABCB4	Intron		C	C		11	Filtered Calls	7	87035826	87035826	58	0.775862068965517	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB4&recr=Open">Click here</a>	
ABCC11	Intron		G	G		11	Filtered Calls	16	48231988	48231988	84	0.25	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC11&recr=Open">Click here</a>	
ABCC3	Silent	p.L976L	C	C		11	Filtered Calls	17	48753312	48753312	50	0.28	NA	NA	NA			33	ABC transmembrane type-1 2. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC3&recr=Open">Click here</a>	
ABCC4	Silent	p.F716F	G	G		11	Filtered Calls	13	95816659	95816659	110	0.354545454545455	NA	NA	NA			43	ABC transmembrane type-1 2. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC4&recr=Open">Click here</a>	
ABCC6	Silent	p.S1049S	G	G		11	Filtered Calls	16	16259639	16259639	96	0.229166666666667	NA	NA	NA			43	ABC transmembrane type-1 2. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC6&recr=Open">Click here</a>	
ABCC6	Intron		G	G		11	Filtered Calls	16	16269758	16269758	32	0.40625	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC6&recr=Open">Click here</a>	
ABCC6	Silent	p.L556L	G	G		11	Filtered Calls	16	16282801	16282801	52	0.288461538461538	NA	NA	NA			43	ABC transmembrane type-1 1. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC6&recr=Open">Click here</a>	
ABCC8	Silent	p.G322G	C	C		11	Filtered Calls	11	17482080	17482080	62	0.370967741935484	NA	NA	NA			67	ABC transmembrane type-1 1. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC8&recr=Open">Click here</a>	
ABCC9	Intron		C	C		11	Filtered Calls	12	21958225	21958225	130	0.238461538461538	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC9&recr=Open">Click here</a>	
ABCC9	Intron		G	G	rs573503531	11	Filtered Calls	12	21968839	21968839	143	0.153846153846154	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC9&recr=Open">Click here</a>	
ABCC9	Silent	p.S1243S	C	C	rs140182559	11	Filtered Calls	12	21971126	21971126	229	0.22707423580786	NA	NA	NA			118	ABC transmembrane type-1 2. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC9&recr=Open">Click here</a>	
ABCC9	Silent	p.F1135F	G	G		11	Filtered Calls	12	21995316	21995316	154	0.233766233766234	NA	NA	NA			118	ABC transmembrane type-1 2. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC9&recr=Open">Click here</a>	
ABCC9	Silent	p.R934R	C	C		11	Filtered Calls	12	22001148	22001148	126	0.142857142857143	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC9&recr=Open">Click here</a>	
ABCG1	Silent	p.D81D	C	C		11	Filtered Calls	21	43645981	43645981	164	0.225609756097561	NA	NA	NA			29	ABC transporter. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCG1&recr=Open">Click here</a>	
ABCG5	Intron		G	G		11	Filtered Calls	2	44053672	44053672	121	0.644628099173554	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCG5&recr=Open">Click here</a>	
ABHD14B	Silent	p.F205F	G	G		11	Filtered Calls	3	52003460	52003460	130	0.507692307692308	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABHD14B&recr=Open">Click here</a>	
ABHD16A	Intron		G	G		11	Filtered Calls	6	31669100	31669100	126	0.19047619047619	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABHD16A&recr=Open">Click here</a>	
ABHD2	Intron		C	C	rs367650390	11	Filtered Calls	15	89728648	89728648	58	0.568965517241379	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABHD2&recr=Open">Click here</a>	
ABI2	Intron		C	C		11	Filtered Calls	2	204259413	204259413	122	0.30327868852459	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABI2&recr=Open">Click here</a>	
ABI3BP	Silent	p.F138F	G	G		11	Filtered Calls	3	100617674	100617674	106	0.462264150943396	NA	NA	NA			50	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABI3BP&recr=Open">Click here</a>	
ABL1	Silent	p.S620S	C	C		11	Filtered Calls	9	133759537	133759537	65	0.723076923076923	NA	NA	NA			1195			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABL1&recr=Open">Click here</a>	
ABLIM3	Intron		C	C		11	Filtered Calls	5	148637851	148637851	38	0.394736842105263	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABLIM3&recr=Open">Click here</a>	
ABRA	Silent	p.R215R	C	C		11	Filtered Calls	8	107781774	107781774	172	0.197674418604651	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABRA&recr=Open">Click here</a>	
AC004076.7	Intron		C	C		11	Filtered Calls	19	57910478	57910478	83	0.337349397590361	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AC004076.7&recr=Open">Click here</a>	
AC006538.4	Intron		G	G		11	Filtered Calls	19	2733091	2733091	59	0.135593220338983	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AC006538.4&recr=Open">Click here</a>	
AC009892.10	Intron		G	G	rs562284717	11	Filtered Calls	19	55148276	55148276	30	0.233333333333333	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AC009892.10&recr=Open">Click here</a>	
AC113607.3	RNA		C	C		11	Filtered Calls	2	905859	905859	228	0.166666666666667	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AC113607.3&recr=Open">Click here</a>	
AC113607.3	RNA		T	T		11	Filtered Calls	2	905899	905899	231	0.108225108225108	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AC113607.3&recr=Open">Click here</a>	
AC113607.3	RNA		C	C		11	Filtered Calls	2	905943	905943	155	0.212903225806452	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AC113607.3&recr=Open">Click here</a>	
ACAA1	Silent	p.L304L	G	G	rs4345105	11	Filtered Calls	3	38167740	38167740	97	0.216494845360825	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACAA1&recr=Open">Click here</a>	
ACAD10	Silent	p.F123F	C	C		11	Filtered Calls	12	112143574	112143574	139	0.215827338129496	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACAD10&recr=Open">Click here</a>	
ACAN	Silent	p.V1481V	C	C	rs370647891	11	Filtered Calls	15	89400259	89400259	110	0.363636363636364	NA	NA	NA			93	29 X 19 AA approximate tandem repeats of E-[IVDG]-[LV]-[EV]-[GTI]-[STA]-[ATV]- [SP]-[GA]-[VIFAD]-[GEDL]-[DE]-[LVI]-[SG]- [GERK]-[LV]-P-S-G.|CS-1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACAN&recr=Open">Click here</a>	
ACAN	Silent	p.L1555L	C	C		11	Filtered Calls	15	89400479	89400479	44	0.113636363636364	NA	NA	NA			93	CS-2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACAN&recr=Open">Click here</a>	
ACBD7	Silent	p.T72T	C	C	rs144913185	11	Filtered Calls	10	15120580	15120580	261	0.168582375478927	NA	NA	NA			6	ACB. {ECO:0000255|PROSITE- ProRule:PRU00573}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACBD7&recr=Open">Click here</a>	
ACE	Silent	p.F207F	C	C		11	Filtered Calls	17	61557239	61557239	29	0.551724137931034	NA	NA	NA			51	Peptidase M2 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACE&recr=Open">Click here</a>	
ACO1	Silent	p.F281F	C	C		11	Filtered Calls	9	32420898	32420898	198	0.378787878787879	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACO1&recr=Open">Click here</a>	
ACOT11	Silent	p.S376S	C	C		11	Filtered Calls	1	55069586	55069586	105	0.323809523809524	NA	NA	NA			17	START. {ECO:0000255|PROSITE- ProRule:PRU00197}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACOT11&recr=Open">Click here</a>	
ACOX2	Intron		G	G		11	Filtered Calls	3	58514691	58514691	89	0.146067415730337	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACOX2&recr=Open">Click here</a>	
ACOXL	Intron		C	C		11	Filtered Calls	2	111850551	111850551	194	0.350515463917526	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACOXL&recr=Open">Click here</a>	
ACR	Intron		T	T		11	Filtered Calls	22	51182645	51182645	55	0.181818181818182	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACR&recr=Open">Click here</a>	
ACSF3	Intron		C	C		11	Filtered Calls	16	89167156	89167156	34	0.205882352941176	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSF3&recr=Open">Click here</a>	
ACSL3	Silent	p.Y709Y	C	C		11	Filtered Calls	2	223806336	223806336	331	0.0332326283987915	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSL3&recr=Open">Click here</a>	
ACSL5	Intron		G	G		11	Filtered Calls	10	114182204	114182204	102	0.127450980392157	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSL5&recr=Open">Click here</a>	
ACSL6	Intron		C	C		11	Filtered Calls	5	131326538	131326538	24	0.25	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSL6&recr=Open">Click here</a>	
ACSM1	Silent	p.F329F	G	G		11	Filtered Calls	16	20673121	20673121	119	0.226890756302521	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSM1&recr=Open">Click here</a>	
ACSM2A	Silent	p.K566K	G	G	rs376006052	11	Filtered Calls	16	20497964	20497964	226	0.238938053097345	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSM2A&recr=Open">Click here</a>	
ACSM2B	Intron		A	A		11	Filtered Calls	16	20570777	20570777	17	0.411764705882353	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSM2B&recr=Open">Click here</a>	
ACSM5	Intron		C	C		11	Filtered Calls	16	20423018	20423018	21	0.19047619047619	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSM5&recr=Open">Click here</a>	
ACTA1	Silent	p.T91T	G	G		11	Filtered Calls	1	229568484	229568484	139	0.215827338129496	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTA1&recr=Open">Click here</a>	
ACTG1	Silent	p.A174A	G	G		11	Filtered Calls	17	79478494	79478494	122	0.237704918032787	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTG1&recr=Open">Click here</a>	
ACTG1	Silent	p.P130P	C	C	rs561518636	11	Filtered Calls	17	79478626	79478626	265	0.754716981132076	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTG1&recr=Open">Click here</a>	
ACTN2	Silent	p.L888L	C	C		11	Filtered Calls	1	236925898	236925898	54	0.240740740740741	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTN2&recr=Open">Click here</a>	
ACTN4	Silent	p.T839T	C	C		11	Filtered Calls	19	39219734	39219734	163	0.171779141104294	NA	NA	NA			30	EF-hand 2. {ECO:0000255|PROSITE- ProRule:PRU00448}.|Mediates interaction with MICALL2. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTN4&recr=Open">Click here</a>	
ACTR2	Silent	p.F133F	T	T		11	Filtered Calls	2	65478184	65478184	581	0.189328743545611	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTR2&recr=Open">Click here</a>	
AD000671.6	3'UTR		G	G		11	Filtered Calls	19	36234735	36234735	52	0.211538461538462	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AD000671.6&recr=Open">Click here</a>	
ADAD2	Intron		C	C		11	Filtered Calls	16	84229415	84229415	17	0.294117647058824	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAD2&recr=Open">Click here</a>	
ADAM11	Silent	p.V227V	C	C		11	Filtered Calls	17	42850227	42850227	42	0.19047619047619	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM11&recr=Open">Click here</a>	
ADAM18	Silent	p.F2F	C	C		11	Filtered Calls	8	39442147	39442147	77	0.272727272727273	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM18&recr=Open">Click here</a>	
ADAM18	Intron		G	G		11	Filtered Calls	8	39442208	39442208	61	0.377049180327869	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM18&recr=Open">Click here</a>	
ADAM18	Intron		G	G		11	Filtered Calls	8	39581435	39581435	332	0.234939759036145	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM18&recr=Open">Click here</a>	
ADAM19	Silent	p.F176F	G	G	rs199763273	11	Filtered Calls	5	156946919	156946919	143	0.41958041958042	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM19&recr=Open">Click here</a>	
ADAM2	Intron		G	G		11	Filtered Calls	8	39618803	39618803	201	0.223880597014925	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM2&recr=Open">Click here</a>	
ADAM2	Silent	p.G194G	C	C		11	Filtered Calls	8	39634612	39634612	165	0.16969696969697	NA	NA	NA			53	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM2&recr=Open">Click here</a>	
ADAM23	Silent	p.F824F	C	C		11	Filtered Calls	2	207482324	207482324	49	0.224489795918367	NA	NA	NA		p.S794L(1)|p.F824F(1)	51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM23&recr=Open">Click here</a>	
ADAM28	Silent	p.L2L	T	T		11	Filtered Calls	8	24151666	24151666	115	0.173913043478261	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM28&recr=Open">Click here</a>	
ADAM28	Silent	p.L284L	C	C		11	Filtered Calls	8	24181478	24181478	180	0.255555555555556	NA	NA	NA			42	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM28&recr=Open">Click here</a>	
ADAM29	Silent	p.F289F	C	C		11	Filtered Calls	4	175897543	175897543	133	0.315789473684211	NA	NA	NA			93	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM29&recr=Open">Click here</a>	
ADAM29	Silent	p.Q749Q	G	G		11	Filtered Calls	4	175898923	175898923	128	0.296875	NA	NA	NA			93	9 X 9 AA approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM29&recr=Open">Click here</a>	
ADAM29	Silent	p.Q812Q	G	G		11	Filtered Calls	4	175899112	175899112	100	0.05	NA	NA	NA			93	9 X 9 AA approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM29&recr=Open">Click here</a>	
ADAM7	Intron		C	C		11	Filtered Calls	8	24333942	24333942	114	0.219298245614035	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM7&recr=Open">Click here</a>	
ADAM7	Silent	p.A235A	G	G	rs371892053	11	Filtered Calls	8	24349448	24349448	35	0.171428571428571	NA	NA	NA			64	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM7&recr=Open">Click here</a>	
ADAM7	Silent	p.G274G	G	G		11	Filtered Calls	8	24349565	24349565	180	0.411111111111111	NA	NA	NA			64	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM7&recr=Open">Click here</a>	
ADAMTS1	Silent	p.I704I	G	G		11	Filtered Calls	21	28210850	28210850	224	0.321428571428571	NA	NA	NA			42	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS1&recr=Open">Click here</a>	
ADAMTS1	Silent	p.G275G	G	G	rs142764880	11	Filtered Calls	21	28214910	28214910	222	0.274774774774775	NA	NA	NA			42	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS1&recr=Open">Click here</a>	
ADAMTS10	Silent	p.L757L	C	C		11	Filtered Calls	19	8651574	8651574	47	0.25531914893617	NA	NA	NA			53	Spacer.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS10&recr=Open">Click here</a>	
ADAMTS12	Silent	p.I46I	G	G		11	Filtered Calls	5	33881575	33881575	155	0.154838709677419	NA	NA	NA			216			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS12&recr=Open">Click here</a>	
ADAMTS16	Intron		AACTCTTTAAGCT	AACTCTTTAAGCT	rs199821240|rs76694171	11	Filtered Calls	5	5200388	5200400	177	0.129943502824859	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS16&recr=Open">Click here</a>	
ADAMTS18	Silent	p.I149I	G	G		11	Filtered Calls	16	77465240	77465240	78	0.256410256410256	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS18&recr=Open">Click here</a>	
ADAMTS19	Silent	p.E867E	G	G		11	Filtered Calls	5	129015569	129015569	130	0.361538461538462	NA	NA	NA			91	Spacer.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS19&recr=Open">Click here</a>	
ADAMTS2	Silent	p.G880G	G	G		11	Filtered Calls	5	178553109	178553109	43	0.441860465116279	NA	NA	NA			72	TSP type-1 2. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS2&recr=Open">Click here</a>	
ADAMTS20	Silent	p.G1673G	C	C		11	Filtered Calls	12	43770433	43770433	72	0.402777777777778	NA	NA	NA			95	TSP type-1 15. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS20&recr=Open">Click here</a>	
ADAMTS20	Silent	p.G1214G	C	C		11	Filtered Calls	12	43822450	43822450	13	0.384615384615385	NA	NA	NA			95	TSP type-1 8. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS20&recr=Open">Click here</a>	
ADAMTS3	Intron		G	G		11	Filtered Calls	4	73414608	73414608	77	0.168831168831169	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS3&recr=Open">Click here</a>	
ADAMTS5	Silent	p.F463F	G	G		11	Filtered Calls	21	28315715	28315715	85	0.247058823529412	NA	NA	NA			72	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS5&recr=Open">Click here</a>	
ADAMTS8	Silent	p.I763I	G	G		11	Filtered Calls	11	130275834	130275834	61	0.426229508196721	NA	NA	NA			10	Spacer.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS8&recr=Open">Click here</a>	
ADAMTS9	Silent	p.L1763L	G	G		11	Filtered Calls	3	64527207	64527207	177	0.401129943502825	NA	NA	NA			100	GON. {ECO:0000255|PROSITE- ProRule:PRU00383}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS9&recr=Open">Click here</a>	
ADAMTS9	Silent	p.F486F	A	A		11	Filtered Calls	3	64636698	64636698	157	0.21656050955414	NA	NA	NA			100	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS9&recr=Open">Click here</a>	
ADAMTSL3	Silent	p.I1394I	C	C	rs199898161	11	Filtered Calls	15	84685160	84685160	70	0.214285714285714	NA	NA	NA			130			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTSL3&recr=Open">Click here</a>	
ADAMTSL4	Silent	p.K502K	G	G		11	Filtered Calls	1	150528772	150528772	116	0.189655172413793	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTSL4&recr=Open">Click here</a>	
ADAR	Silent	p.F514F	G	G		11	Filtered Calls	1	154573576	154573576	199	0.50251256281407	NA	NA	NA			51	DRBM 1. {ECO:0000255|PROSITE- ProRule:PRU00266}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAR&recr=Open">Click here</a>	
ADARB1	Silent	p.F142F	C	C		11	Filtered Calls	21	46596042	46596042	74	0.243243243243243	NA	NA	NA			17	DRBM 1. {ECO:0000255|PROSITE- ProRule:PRU00266}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADARB1&recr=Open">Click here</a>	
ADARB2	Silent	p.E375E	C	C		11	Filtered Calls	10	1313217	1313217	35	0.371428571428571	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADARB2&recr=Open">Click here</a>	
ADAT1	Intron		A	A		11	Filtered Calls	16	75636973	75636973	352	0.306818181818182	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAT1&recr=Open">Click here</a>	
ADAT2	Silent	p.A111A	T	T	rs181238804	11	Filtered Calls	6	143754987	143754987	48	0.479166666666667	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAT2&recr=Open">Click here</a>	
ADCK5	Silent	p.I139I	C	C		11	Filtered Calls	8	145616130	145616130	74	0.472972972972973	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCK5&recr=Open">Click here</a>	
ADCY1	Silent	p.F745F	C	C	rs529111774	11	Filtered Calls	7	45725722	45725722	117	0.581196581196581	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY1&recr=Open">Click here</a>	
ADCY1	Silent	p.F849F	C	C		11	Filtered Calls	7	45743067	45743067	34	0.264705882352941	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY1&recr=Open">Click here</a>	
ADCY1	Silent	p.T921T	C	C		11	Filtered Calls	7	45744161	45744161	96	0.239583333333333	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY1&recr=Open">Click here</a>	
ADCY10	Silent	p.S671S	G	G		11	Filtered Calls	1	167825561	167825561	246	0.207317073170732	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY10&recr=Open">Click here</a>	
ADCY10	Silent	p.G434G	C	C		11	Filtered Calls	1	167847788	167847788	234	0.209401709401709	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY10&recr=Open">Click here</a>	
ADCY10	Silent	p.I384I	G	G		11	Filtered Calls	1	167849417	167849417	55	0.509090909090909	NA	NA	NA			63	Guanylate cyclase 2. {ECO:0000255|PROSITE-ProRule:PRU00099}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY10&recr=Open">Click here</a>	
ADCY10	Silent	p.T293T	C	C		11	Filtered Calls	1	167852816	167852816	209	0.210526315789474	NA	NA	NA			63	Guanylate cyclase 2. {ECO:0000255|PROSITE-ProRule:PRU00099}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY10&recr=Open">Click here</a>	
ADCY2	Intron		C	C		11	Filtered Calls	5	7727271	7727271	139	0.172661870503597	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY2&recr=Open">Click here</a>	
ADCY2	Silent	p.G1069G	G	G		11	Filtered Calls	5	7826915	7826915	154	0.441558441558442	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY2&recr=Open">Click here</a>	
ADCY4	Silent	p.F800F	G	G		11	Filtered Calls	14	24791857	24791857	17	0.823529411764706	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY4&recr=Open">Click here</a>	
ADCY5	Silent	p.F732F	G	G		11	Filtered Calls	3	123010065	123010065	30	0.233333333333333	NA	NA	NA		p.F1074L(1)	60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY5&recr=Open">Click here</a>	
ADCY5	Silent	p.I270I	G	G		11	Filtered Calls	3	123046501	123046501	12	0.5	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY5&recr=Open">Click here</a>	
ADCY5	Silent	p.I239I	G	G		11	Filtered Calls	3	123046594	123046594	43	0.372093023255814	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY5&recr=Open">Click here</a>	
ADCY8	Silent	p.I582I	G	G	rs377395326	11	Filtered Calls	8	131916183	131916183	183	0.245901639344262	NA	NA	NA			134			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY8&recr=Open">Click here</a>	
ADCY8	Silent	p.F154F	G	G		11	Filtered Calls	8	132052118	132052118	33	0.242424242424242	NA	NA	NA			134			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY8&recr=Open">Click here</a>	
ADCYAP1R1	Intron		C	C		11	Filtered Calls	7	31126552	31126552	98	0.26530612244898	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCYAP1R1&recr=Open">Click here</a>	
ADH1A	5'UTR		C	C		11	Filtered Calls	4	100212079	100212079	235	0.25531914893617	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADH1A&recr=Open">Click here</a>	
ADH1B	Intron		G	G		11	Filtered Calls	4	100229031	100229031	64	0.28125	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADH1B&recr=Open">Click here</a>	
ADH1C	RNA		C	C		11	Filtered Calls	4	100260740	100260740	36	0.194444444444444	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADH1C&recr=Open">Click here</a>	
ADH4	Silent	p.I135I	G	G		11	Filtered Calls	4	100060214	100060214	80	0.2625	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADH4&recr=Open">Click here</a>	
ADK	Silent	p.L116L	C	C		11	Filtered Calls	10	76153971	76153971	273	0.157509157509158	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADK&recr=Open">Click here</a>	
ADORA3	Silent	p.L128L	G	G		11	Filtered Calls	1	112033353	112033353	148	0.432432432432432	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADORA3&recr=Open">Click here</a>	
ADRA1A	Intron		A	A		11	Filtered Calls	8	26628189	26628189	61	0.311475409836066	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADRA1A&recr=Open">Click here</a>	
ADRBK2	Intron		C	C	rs202119424	11	Filtered Calls	22	26068254	26068254	327	0.480122324159021	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADRBK2&recr=Open">Click here</a>	
AEBP1	Silent	p.P367P	C	C		11	Filtered Calls	7	44148891	44148891	10	0.6	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AEBP1&recr=Open">Click here</a>	
AF196779.12	Intron		G	G		11	Filtered Calls	X	48932577	48932577	74	0.391891891891892	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AF196779.12&recr=Open">Click here</a>	
AF196779.12	Intron		G	G		11	Filtered Calls	X	48932578	48932578	70	0.4	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AF196779.12&recr=Open">Click here</a>	
AFF2	Intron		C	C		11	Filtered Calls	X	147733517	147733517	159	0.962264150943396	NA	NA	NA			109			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFF2&recr=Open">Click here</a>	
AFF2	Silent	p.V1196V	C	C		11	Filtered Calls	X	148062285	148062285	200	0.375	NA	NA	NA		p.V1196V(1)	109			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFF2&recr=Open">Click here</a>	
AFF3	Silent	p.S442S	G	G		11	Filtered Calls	2	100217942	100217942	11	0.272727272727273	NA	NA	NA			86	Poly-Ser.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFF3&recr=Open">Click here</a>	
AFM	Silent	p.K2K	A	A		11	Filtered Calls	4	74347498	74347498	87	0.35632183908046	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFM&recr=Open">Click here</a>	
AFM	Intron		A	A	rs368253144	11	Filtered Calls	4	74350116	74350116	104	0.278846153846154	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFM&recr=Open">Click here</a>	
AFMID	Intron		C	C		11	Filtered Calls	17	76201676	76201676	52	0.192307692307692	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFMID&recr=Open">Click here</a>	
AFTPH	Silent	p.S835S	C	C		11	Filtered Calls	2	64812605	64812605	572	0.125874125874126	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFTPH&recr=Open">Click here</a>	
AGAP1	Silent	p.V618V	C	C	rs147314067	11	Filtered Calls	2	236957824	236957824	114	0.298245614035088	NA	NA	NA			41	Arf-GAP. {ECO:0000255|PROSITE- ProRule:PRU00288}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGAP1&recr=Open">Click here</a>	
AGAP11	RNA		C	C		11	Filtered Calls	10	88768116	88768116	271	0.199261992619926	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGAP11&recr=Open">Click here</a>	
AGAP11	RNA		C	C		11	Filtered Calls	10	88768739	88768739	115	0.2	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGAP11&recr=Open">Click here</a>	
AGAP7	Silent	p.G523G	C	C		11	Filtered Calls	10	51464887	51464887	144	0.222222222222222	NA	NA	NA			11	Arf-GAP. {ECO:0000255|PROSITE- ProRule:PRU00288}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGAP7&recr=Open">Click here</a>	
AGBL1	Intron		C	C		11	Filtered Calls	15	86768139	86768139	293	0.283276450511945	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGBL1&recr=Open">Click here</a>	
AGBL1	Silent	p.R431R	G	G		11	Filtered Calls	15	86807833	86807833	150	0.36	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGBL1&recr=Open">Click here</a>	
AGBL2	Intron		G	G		11	Filtered Calls	11	47698964	47698964	58	0.448275862068966	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGBL2&recr=Open">Click here</a>	
AGMO	Silent	p.S378S	G	G		11	Filtered Calls	7	15405788	15405788	76	0.276315789473684	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGMO&recr=Open">Click here</a>	
AGO2	Silent	p.P590P	G	G		11	Filtered Calls	8	141554381	141554381	116	0.189655172413793	NA	NA	NA			NA	Interaction with GW182 family members. {ECO:0000255}.|Piwi. {ECO:0000255|HAMAP-Rule:MF_03031}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGO2&recr=Open">Click here</a>	
AGO2	Silent	p.V465V	G	G		11	Filtered Calls	8	141561410	141561410	115	0.11304347826087	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGO2&recr=Open">Click here</a>	
AGO3	Silent	p.G525G	G	G		11	Filtered Calls	1	36492883	36492883	64	0.921875	NA	NA	NA			NA	Piwi. {ECO:0000255|HAMAP-Rule:MF_03032}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGO3&recr=Open">Click here</a>	
AGO4	Silent	p.S626S	C	C		11	Filtered Calls	1	36306919	36306919	68	0.897058823529412	NA	NA	NA			NA	Piwi. {ECO:0000255|HAMAP-Rule:MF_03033}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGO4&recr=Open">Click here</a>	
AGTR2	Silent	p.I135I	C	C		11	Filtered Calls	X	115303938	115303938	165	0.490909090909091	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGTR2&recr=Open">Click here</a>	
AGXT2	Silent	p.R20R	C	C	rs528259406	11	Filtered Calls	5	35047938	35047938	56	0.142857142857143	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGXT2&recr=Open">Click here</a>	
AHCYL1	Silent	p.I364I	C	C		11	Filtered Calls	1	110560607	110560607	256	0.3359375	NA	NA	NA			18	NAD binding. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHCYL1&recr=Open">Click here</a>	
AHNAK2	Intron		G	G		11	Filtered Calls	14	105410832	105410832	169	0.337278106508876	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHNAK2&recr=Open">Click here</a>	
AHNAK2	Intron		G	G		11	Filtered Calls	14	105416133	105416133	78	0.333333333333333	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHNAK2&recr=Open">Click here</a>	
AHRR	Silent	p.A99A	C	C		11	Filtered Calls	5	376765	376765	23	0.217391304347826	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHRR&recr=Open">Click here</a>	
AIFM3	Silent	p.V162V	G	G		11	Filtered Calls	22	21328543	21328543	40	0.225	NA	NA	NA			21	Rieske. {ECO:0000255|PROSITE- ProRule:PRU00628}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AIFM3&recr=Open">Click here</a>	
AIM1L	5'Flank		C	C		11	Filtered Calls	1	26672363	26672363	38	0.421052631578947	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AIM1L&recr=Open">Click here</a>	
AIPL1	Silent	p.L100L	G	G		11	Filtered Calls	17	6331805	6331805	27	0.296296296296296	NA	NA	NA			12	PPIase FKBP-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AIPL1&recr=Open">Click here</a>	
AIRE	Silent	p.R113R	G	G		11	Filtered Calls	21	45706892	45706892	29	0.137931034482759	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AIRE&recr=Open">Click here</a>	
AK7	Intron		C	C		11	Filtered Calls	14	96917747	96917747	127	0.307086614173228	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AK7&recr=Open">Click here</a>	
AK8	Intron		G	G		11	Filtered Calls	9	135730319	135730319	31	0.290322580645161	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AK8&recr=Open">Click here</a>	
AK8	Silent	p.I47I	G	G		11	Filtered Calls	9	135750530	135750530	39	0.282051282051282	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AK8&recr=Open">Click here</a>	
AK9	Silent	p.F23F	G	G		11	Filtered Calls	6	109871425	109871425	185	0.372972972972973	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AK9&recr=Open">Click here</a>	
AKAP13	Silent	p.L847L	C	C		11	Filtered Calls	15	86123838	86123838	114	0.166666666666667	NA	NA	NA			98			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP13&recr=Open">Click here</a>	
AKAP3	Silent	p.F474F	G	G		11	Filtered Calls	12	4736646	4736646	55	0.2	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP3&recr=Open">Click here</a>	
AKAP3	Silent	p.R395R	C	C		11	Filtered Calls	12	4736883	4736883	227	0.193832599118943	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP3&recr=Open">Click here</a>	
AKNA	Intron		G	G		11	Filtered Calls	9	117119256	117119256	43	0.232558139534884	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKNA&recr=Open">Click here</a>	
AKNA	Silent	p.A745A	G	G		11	Filtered Calls	9	117122232	117122232	52	0.211538461538462	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKNA&recr=Open">Click here</a>	
AKR1CL1	5'Flank		C	C		11	Filtered Calls	10	5204836	5204836	287	0.0313588850174216	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKR1CL1&recr=Open">Click here</a>	
AL590867.1	Intron		C	C		11	Filtered Calls	6	153603531	153603531	77	0.350649350649351	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AL590867.1&recr=Open">Click here</a>	
ALAD	Intron		G	G		11	Filtered Calls	9	116151814	116151814	28	0.285714285714286	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALAD&recr=Open">Click here</a>	
ALB	De_novo_Start_InFrame		T	T		11	Filtered Calls	4	74272359	74272359	164	0.207317073170732	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALB&recr=Open">Click here</a>	
ALDH1B1	Silent	p.K226K	G	G		11	Filtered Calls	9	38396423	38396423	53	0.415094339622642	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH1B1&recr=Open">Click here</a>	
ALDH1L1	Silent	p.I100I	G	G		11	Filtered Calls	3	125877340	125877340	24	0.375	NA	NA	NA			52	GART.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH1L1&recr=Open">Click here</a>	
ALDH4A1	Silent	p.T474T	G	G		11	Filtered Calls	1	19201914	19201914	63	0.444444444444444	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH4A1&recr=Open">Click here</a>	
ALDOB	Silent	p.V104V	C	C		11	Filtered Calls	9	104192049	104192049	221	0.298642533936652	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDOB&recr=Open">Click here</a>	
ALG5	Silent	p.F45F	G	G		11	Filtered Calls	13	37569665	37569665	237	0.286919831223629	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALG5&recr=Open">Click here</a>	
ALG8	Silent	p.L407L	G	G		11	Filtered Calls	11	77815459	77815459	31	0.451612903225806	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALG8&recr=Open">Click here</a>	
ALLC	Silent	p.A348A	C	C		11	Filtered Calls	2	3750021	3750021	18	0.277777777777778	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALLC&recr=Open">Click here</a>	
ALMS1	Silent	p.S664S	C	C		11	Filtered Calls	2	73675649	73675649	137	0.211678832116788	NA	NA	NA			147	34 X 47 AA approximate tandem repeat.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALMS1&recr=Open">Click here</a>	
ALMS1	Intron		C	C		11	Filtered Calls	2	73827797	73827797	209	0.076555023923445	NA	NA	NA			147			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALMS1&recr=Open">Click here</a>	
ALOX5	Silent	p.G280G	G	G		11	Filtered Calls	10	45924071	45924071	56	0.196428571428571	NA	NA	NA			37	Lipoxygenase. {ECO:0000255|PROSITE- ProRule:PRU00726}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALOX5&recr=Open">Click here</a>	
ALOXE3	Silent	p.K650K	C	C		11	Filtered Calls	17	8006647	8006647	73	0.301369863013699	NA	NA	NA			31	Lipoxygenase. {ECO:0000255|PROSITE- ProRule:PRU00726}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALOXE3&recr=Open">Click here</a>	
ALOXE3	Intron		G	G		11	Filtered Calls	17	8019018	8019018	85	0.235294117647059	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALOXE3&recr=Open">Click here</a>	
ALPK1	Silent	p.I455I	C	C		11	Filtered Calls	4	113352068	113352068	130	0.561538461538462	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPK1&recr=Open">Click here</a>	
ALPK2	Silent	p.S623S	G	G	rs577915999	11	Filtered Calls	18	56246139	56246139	137	0.386861313868613	NA	NA	NA			84			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPK2&recr=Open">Click here</a>	
ALPK3	Silent	p.S525S	C	C		11	Filtered Calls	15	85383479	85383479	36	0.361111111111111	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPK3&recr=Open">Click here</a>	
ALPK3	Silent	p.F967F	C	C		11	Filtered Calls	15	85400264	85400264	142	0.323943661971831	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPK3&recr=Open">Click here</a>	
AMELX	Silent	p.I66I	C	C		11	Filtered Calls	X	11316721	11316721	71	0.450704225352113	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMELX&recr=Open">Click here</a>	
AMER3	Silent	p.R337R	G	G		11	Filtered Calls	2	131520656	131520656	21	0.142857142857143	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMER3&recr=Open">Click here</a>	
AMFR	Silent	p.V257V	G	G		11	Filtered Calls	16	56438890	56438890	183	0.349726775956284	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMFR&recr=Open">Click here</a>	
AMOT	Silent	p.S839S	G	G		11	Filtered Calls	X	112022865	112022865	63	0.444444444444444	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMOT&recr=Open">Click here</a>	
AMPH	Silent	p.F359F	G	G		11	Filtered Calls	7	38475929	38475929	80	0.5875	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMPH&recr=Open">Click here</a>	
ANAPC4	Intron		A	A		11	Filtered Calls	4	25404652	25404652	89	0.303370786516854	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANAPC4&recr=Open">Click here</a>	
ANAPC5	Silent	p.D406D	G	G		11	Filtered Calls	12	121766205	121766205	76	0.276315789473684	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANAPC5&recr=Open">Click here</a>	
ANGPT4	Silent	p.L441L	G	G		11	Filtered Calls	20	854955	854955	42	0.928571428571429	NA	NA	NA			27	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANGPT4&recr=Open">Click here</a>	
ANGPTL5	Intron		C	C		11	Filtered Calls	11	101776469	101776469	87	0.448275862068966	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANGPTL5&recr=Open">Click here</a>	
ANK1	Silent	p.S1292S	G	G		11	Filtered Calls	8	41548100	41548100	69	0.347826086956522	NA	NA	NA			122	UPA domain. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK1&recr=Open">Click here</a>	
ANK1	Silent	p.I749I	G	G		11	Filtered Calls	8	41561607	41561607	89	0.213483146067416	NA	NA	NA			122	89 kDa domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK1&recr=Open">Click here</a>	
ANK2	Silent	p.L582L	C	C		11	Filtered Calls	4	114199055	114199055	160	0.3125	NA	NA	NA			248			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK2&recr=Open">Click here</a>	
ANK3	Silent	p.S3143S	A	A		11	Filtered Calls	10	61831210	61831210	155	0.225806451612903	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	
ANK3	Silent	p.A57A	G	G		11	Filtered Calls	10	62039341	62039341	359	0.233983286908078	NA	NA	NA			196			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	
ANKFN1	Intron		C	C		11	Filtered Calls	17	54428116	54428116	200	0.04	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKFN1&recr=Open">Click here</a>	
ANKFN1	Silent	p.L722L	C	C		11	Filtered Calls	17	54559782	54559782	252	0.214285714285714	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKFN1&recr=Open">Click here</a>	
ANKIB1	Silent	p.F645F	C	C		11	Filtered Calls	7	92019313	92019313	208	0.0817307692307692	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKIB1&recr=Open">Click here</a>	
ANKRD1	Intron		G	G		11	Filtered Calls	10	92679034	92679034	77	0.415584415584416	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD1&recr=Open">Click here</a>	
ANKRD10	Silent	p.P320P	C	C		11	Filtered Calls	13	111532287	111532287	242	0.181818181818182	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD10&recr=Open">Click here</a>	
ANKRD30A	Silent	p.T125T	G	G		11	Filtered Calls	10	37421200	37421200	372	0.182795698924731	NA	NA	NA		p.T125T(1)	158			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD30A&recr=Open">Click here</a>	
ANKRD30A	Silent	p.F294F	C	C	rs202098264	11	Filtered Calls	10	37430875	37430875	109	0.220183486238532	NA	NA	NA			158			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD30A&recr=Open">Click here</a>	
ANKRD30A	Silent	p.I361I	C	C	rs267602478	11	Filtered Calls	10	37431076	37431076	132	0.0454545454545455	NA	NA	NA			158			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD30A&recr=Open">Click here</a>	
ANKRD30A	Silent	p.L841L	G	G		11	Filtered Calls	10	37486383	37486383	301	0.209302325581395	NA	NA	NA			158			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD30A&recr=Open">Click here</a>	
ANKRD40	Intron		G	G		11	Filtered Calls	17	48777922	48777922	244	0.30327868852459	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD40&recr=Open">Click here</a>	
ANKRD42	Intron		C	C		11	Filtered Calls	11	82935885	82935885	59	0.440677966101695	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD42&recr=Open">Click here</a>	
ANKS1A	Intron		C	C		11	Filtered Calls	6	35054717	35054717	101	0.188118811881188	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKS1A&recr=Open">Click here</a>	
ANKS1B	Silent	p.L536L	C	C		11	Filtered Calls	12	99793557	99793557	102	0.431372549019608	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKS1B&recr=Open">Click here</a>	
ANKS1B	Intron		G	G		11	Filtered Calls	12	100041993	100041993	36	0.388888888888889	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKS1B&recr=Open">Click here</a>	
ANKS6	Intron		G	G		11	Filtered Calls	9	101498792	101498792	19	0.263157894736842	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKS6&recr=Open">Click here</a>	
ANO1	Silent	p.K390K	G	G		11	Filtered Calls	11	69978097	69978097	17	0.411764705882353	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO1&recr=Open">Click here</a>	
ANO1	Silent	p.L891L	G	G		11	Filtered Calls	11	70031780	70031780	46	0.347826086956522	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO1&recr=Open">Click here</a>	
ANO10	Silent	p.G264G	G	G		11	Filtered Calls	3	43618554	43618554	119	0.277310924369748	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO10&recr=Open">Click here</a>	
ANO2	Silent	p.V752V	G	G		11	Filtered Calls	12	5687665	5687665	24	0.291666666666667	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO2&recr=Open">Click here</a>	
ANO2	Silent	p.P609P	C	C		11	Filtered Calls	12	5724456	5724456	38	0.157894736842105	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO2&recr=Open">Click here</a>	
ANO2	Silent	p.I371I	G	G		11	Filtered Calls	12	5860070	5860070	50	0.36	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO2&recr=Open">Click here</a>	
ANO2	Silent	p.R326R	C	C	rs370576663	11	Filtered Calls	12	5915221	5915221	70	0.4	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO2&recr=Open">Click here</a>	
ANO4	Silent	p.F203F	C	C		11	Filtered Calls	12	101381428	101381428	66	0.454545454545455	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO4&recr=Open">Click here</a>	
ANO4	Silent	p.K906K	G	G		11	Filtered Calls	12	101520803	101520803	21	0.238095238095238	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO4&recr=Open">Click here</a>	
ANPEP	Intron		G	G		11	Filtered Calls	15	90342648	90342648	29	0.551724137931034	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANPEP&recr=Open">Click here</a>	
ANTXR1	Intron		C	C		11	Filtered Calls	2	69317984	69317984	358	0.142458100558659	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANTXR1&recr=Open">Click here</a>	
ANXA1	Intron		C	C		11	Filtered Calls	9	75781010	75781010	99	0.272727272727273	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANXA1&recr=Open">Click here</a>	
ANXA10	Intron		C	C		11	Filtered Calls	4	169049229	169049229	95	0.2	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANXA10&recr=Open">Click here</a>	
ANXA11	Intron		G	G	rs537447272	11	Filtered Calls	10	81923906	81923906	115	0.260869565217391	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANXA11&recr=Open">Click here</a>	
ANXA7	Silent	p.C305C	G	G		11	Filtered Calls	10	75142936	75142936	219	0.388127853881279	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANXA7&recr=Open">Click here</a>	
ANXA7	Silent	p.I157I	G	G		11	Filtered Calls	10	75148137	75148137	254	0.240157480314961	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANXA7&recr=Open">Click here</a>	
ANXA8L2	Silent	p.A179A	C	C	rs375281576	11	Filtered Calls	10	47756077	47756077	154	0.227272727272727	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANXA8L2&recr=Open">Click here</a>	
AP1B1	Silent	p.L207L	G	G		11	Filtered Calls	22	29752512	29752512	64	0.234375	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP1B1&recr=Open">Click here</a>	
AP1G1	Intron		G	G		11	Filtered Calls	16	71782284	71782284	76	0.302631578947368	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP1G1&recr=Open">Click here</a>	
AP3B1	Intron		A	A		11	Filtered Calls	5	77473271	77473271	122	0.360655737704918	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP3B1&recr=Open">Click here</a>	
AP4E1	Silent	p.S121S	C	C		11	Filtered Calls	15	51216144	51216144	130	0.230769230769231	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP4E1&recr=Open">Click here</a>	
APBA1	Silent	p.A345A	G	G	rs373701291	11	Filtered Calls	9	72131092	72131092	52	0.25	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APBA1&recr=Open">Click here</a>	
APBA2	Silent	p.A177A	C	C		11	Filtered Calls	15	29346618	29346618	24	0.25	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APBA2&recr=Open">Click here</a>	
APBA2	Intron		G	G		11	Filtered Calls	15	29406224	29406224	26	0.269230769230769	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APBA2&recr=Open">Click here</a>	
APC	Silent	p.T1430T	C	C		11	Filtered Calls	5	112175581	112175581	38	0.368421052631579	NA	NA	NA		p.M1431fs*42(4)|p.Y1376fs*41(1)|p.?(1)|p.P1424fs*19(1)|p.S1411fs*41(1)|p.K1192fs*3(1)|p.Q1429fs*41(1)	3261	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APC&recr=Open">Click here</a>	
APLP1	Silent	p.A435A	C	C		11	Filtered Calls	19	36365732	36365732	31	0.0967741935483871	NA	NA	NA			33	Heparin-binding. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APLP1&recr=Open">Click here</a>	
APOA5	Silent	p.T133T	C	C		11	Filtered Calls	11	116661546	116661546	45	0.4	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOA5&recr=Open">Click here</a>	
APOB	Silent	p.K4145K	C	C		11	Filtered Calls	2	21225859	21225859	124	0.25	NA	NA	NA			305			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOB&recr=Open">Click here</a>	
APOB	Silent	p.G2116G	T	T		11	Filtered Calls	2	21233392	21233392	108	0.527777777777778	NA	NA	NA			305	Heparin-binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOB&recr=Open">Click here</a>	
APOB	Silent	p.T1360T	C	C	rs374558307	11	Filtered Calls	2	21236168	21236168	156	0.282051282051282	NA	NA	NA			305			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOB&recr=Open">Click here</a>	
APOBEC3C	Intron		C	C		11	Filtered Calls	22	39413759	39413759	224	0.232142857142857	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOBEC3C&recr=Open">Click here</a>	
AQP12B	Silent	p.F77F	G	G		11	Filtered Calls	2	241622024	241622024	22	0.318181818181818	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AQP12B&recr=Open">Click here</a>	
ARAP2	Silent	p.I970I	G	G		11	Filtered Calls	4	36150117	36150117	106	0.0849056603773585	NA	NA	NA			82	PH 3. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARAP2&recr=Open">Click here</a>	
ARAP2	Silent	p.E959E	C	C		11	Filtered Calls	4	36152542	36152542	226	0.0752212389380531	NA	NA	NA			82	PH 3. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARAP2&recr=Open">Click here</a>	
ARAP3	Silent	p.P1362P	G	G		11	Filtered Calls	5	141033559	141033559	91	0.32967032967033	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARAP3&recr=Open">Click here</a>	
ARFGEF1	Silent	p.S31S	G	G		11	Filtered Calls	8	68255430	68255430	63	0.238095238095238	NA	NA	NA			65	DCB; DCB:DCB domain and DCB:HUS domain interaction.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARFGEF1&recr=Open">Click here</a>	
ARHGAP15	Silent	p.I28I	C	C		11	Filtered Calls	2	143913143	143913143	83	0.253012048192771	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP15&recr=Open">Click here</a>	
ARHGAP15	3'UTR		A	A		11	Filtered Calls	2	144525748	144525748	91	0.307692307692308	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP15&recr=Open">Click here</a>	
ARHGAP15	3'UTR		G	G		11	Filtered Calls	2	144525749	144525749	89	0.303370786516854	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP15&recr=Open">Click here</a>	
ARHGAP17	Intron		G	G		11	Filtered Calls	16	24970981	24970981	66	0.560606060606061	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP17&recr=Open">Click here</a>	
ARHGAP17	Silent	p.L29L	G	G	rs144434477	11	Filtered Calls	16	24990295	24990295	104	0.25	NA	NA	NA			30	BAR. {ECO:0000255|PROSITE- ProRule:PRU00361}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP17&recr=Open">Click here</a>	
ARHGAP19	Intron		G	G		11	Filtered Calls	10	98985900	98985900	116	0.21551724137931	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP19&recr=Open">Click here</a>	
ARHGAP25	Silent	p.R353R	G	G		11	Filtered Calls	2	69046430	69046430	155	0.180645161290323	NA	NA	NA			52	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP25&recr=Open">Click here</a>	
ARHGAP26	Intron		C	C	rs10077444	11	Filtered Calls	5	142500542	142500542	150	0.313333333333333	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP26&recr=Open">Click here</a>	
ARHGAP30	Silent	p.L284L	C	C		11	Filtered Calls	1	161022318	161022318	212	0.273584905660377	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP30&recr=Open">Click here</a>	
ARHGAP30	Intron		G	G		11	Filtered Calls	1	161022406	161022406	26	0.5	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP30&recr=Open">Click here</a>	
ARHGAP33	Silent	p.V862V	C	C		11	Filtered Calls	19	36278536	36278536	53	0.283018867924528	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP33&recr=Open">Click here</a>	
ARHGAP33	Silent	p.S898S	C	C		11	Filtered Calls	19	36278644	36278644	38	0.157894736842105	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP33&recr=Open">Click here</a>	
ARHGAP35	Silent	p.I881I	C	C		11	Filtered Calls	19	47424575	47424575	251	0.342629482071713	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP35&recr=Open">Click here</a>	
ARHGAP39	Silent	p.S2S	G	G		11	Filtered Calls	8	145830994	145830994	72	0.166666666666667	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP39&recr=Open">Click here</a>	
ARHGAP44	3'UTR		C	C		11	Filtered Calls	17	12883517	12883517	13	0.384615384615385	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP44&recr=Open">Click here</a>	
ARHGAP8	3'UTR		C	C		11	Filtered Calls	22	45258447	45258447	39	0.358974358974359	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP8&recr=Open">Click here</a>	
ARHGEF1	Silent	p.I483I	C	C		11	Filtered Calls	19	42406173	42406173	25	0.16	NA	NA	NA			37	DH. {ECO:0000255|PROSITE- ProRule:PRU00062}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF1&recr=Open">Click here</a>	
ARHGEF10L	Silent	p.F395F	C	C		11	Filtered Calls	1	17950983	17950983	38	0.447368421052632	NA	NA	NA			43	DH. {ECO:0000255|PROSITE- ProRule:PRU00062}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF10L&recr=Open">Click here</a>	
ARHGEF10L	Silent	p.L1021L	C	C		11	Filtered Calls	1	18014236	18014236	20	0.2	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF10L&recr=Open">Click here</a>	
ARHGEF15	Intron		C	C		11	Filtered Calls	17	8216816	8216816	149	0.261744966442953	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF15&recr=Open">Click here</a>	
ARHGEF15	Silent	p.G811G	G	G		11	Filtered Calls	17	8224218	8224218	54	0.314814814814815	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF15&recr=Open">Click here</a>	
ARHGEF28	Silent	p.T714T	C	C		11	Filtered Calls	5	73161828	73161828	97	0.463917525773196	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF28&recr=Open">Click here</a>	
ARHGEF3	Silent	p.P12P	G	G		11	Filtered Calls	3	56807818	56807818	46	0.173913043478261	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF3&recr=Open">Click here</a>	
ARHGEF4	Silent	p.F247F	C	C		11	Filtered Calls	2	131796599	131796599	17	0.235294117647059	NA	NA	NA			29	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF4&recr=Open">Click here</a>	
ARHGEF4	Silent	p.R623R	G	G		11	Filtered Calls	2	131802967	131802967	30	0.7	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF4&recr=Open">Click here</a>	
ARHGEF7	Intron		C	C		11	Filtered Calls	13	111857628	111857628	269	0.197026022304833	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF7&recr=Open">Click here</a>	
ARID3A	Silent	p.Y323Y	C	C		11	Filtered Calls	19	964851	964851	60	0.1	NA	NA	NA			10	ARID. {ECO:0000255|PROSITE- ProRule:PRU00355}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARID3A&recr=Open">Click here</a>	
ARID4B	Silent	p.E435E	C	C		11	Filtered Calls	1	235383719	235383719	168	0.196428571428571	NA	NA	NA			8	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARID4B&recr=Open">Click here</a>	
ARID5A	5'UTR		C	C	rs577859323	11	Filtered Calls	2	97215062	97215062	40	0.25	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARID5A&recr=Open">Click here</a>	
ARID5A	5'UTR		C	C		11	Filtered Calls	2	97215063	97215063	38	0.263157894736842	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARID5A&recr=Open">Click here</a>	
ARID5B	Silent	p.L722L	C	C		11	Filtered Calls	10	63851386	63851386	203	0.201970443349754	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARID5B&recr=Open">Click here</a>	
ARL13A	Intron		G	G		11	Filtered Calls	X	100243396	100243396	34	0.352941176470588	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARL13A&recr=Open">Click here</a>	
ARL16	5'Flank		C	C		11	Filtered Calls	17	79653333	79653333	73	0.219178082191781	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARL16&recr=Open">Click here</a>	
ARL6	Intron		T	T		11	Filtered Calls	3	97506830	97506830	74	0.364864864864865	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARL6&recr=Open">Click here</a>	
ARMC4	Silent	p.N810N	G	G		11	Filtered Calls	10	28224004	28224004	237	0.282700421940928	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMC4&recr=Open">Click here</a>	
ARMC5	Silent	p.L415L	C	C		11	Filtered Calls	16	31474113	31474113	71	0.28169014084507	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMC5&recr=Open">Click here</a>	
ARMC5	Intron		C	C		11	Filtered Calls	16	31476313	31476313	46	0.391304347826087	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMC5&recr=Open">Click here</a>	
ARMC6	Intron		T	T		11	Filtered Calls	19	19168578	19168578	44	0.227272727272727	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMC6&recr=Open">Click here</a>	
ARNT2	3'UTR		C	C		11	Filtered Calls	15	80762690	80762690	57	0.315789473684211	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARNT2&recr=Open">Click here</a>	
ARR3	IGR		G	G		11	Filtered Calls	X	69504154	69504154	88	0.340909090909091	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARR3&recr=Open">Click here</a>	
ARRDC5	Intron		C	C		11	Filtered Calls	19	4896673	4896673	37	0.189189189189189	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARRDC5&recr=Open">Click here</a>	
ASB11	Silent	p.F319F	G	G		11	Filtered Calls	X	15301642	15301642	211	0.928909952606635	NA	NA	NA			16	SOCS box. {ECO:0000255|PROSITE- ProRule:PRU00194}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASB11&recr=Open">Click here</a>	
ASB5	Silent	p.L152L	G	G		11	Filtered Calls	4	177142361	177142361	90	0.255555555555556	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASB5&recr=Open">Click here</a>	
ASCC2	Silent	p.S313S	G	G		11	Filtered Calls	22	30202863	30202863	66	0.151515151515152	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASCC2&recr=Open">Click here</a>	
ASCC3	Silent	p.T2023T	C	C		11	Filtered Calls	6	100964062	100964062	166	0.367469879518072	NA	NA	NA			92	SEC63 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASCC3&recr=Open">Click here</a>	
ASF1B	Silent	p.P21P	G	G	rs267605303	11	Filtered Calls	19	14247206	14247206	69	0.246376811594203	NA	NA	NA			7	Interaction with CHAF1B.|Interaction with histone H3. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASF1B&recr=Open">Click here</a>	
ASH1L	Intron		G	G		11	Filtered Calls	1	155309170	155309170	233	0.248927038626609	NA	NA	NA			124			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASH1L&recr=Open">Click here</a>	
ASIC5	Intron		T	T		11	Filtered Calls	4	156784595	156784595	106	0.283018867924528	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASIC5&recr=Open">Click here</a>	
ASIC5	5'UTR		C	C		11	Filtered Calls	4	156787388	156787388	300	0.31	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASIC5&recr=Open">Click here</a>	
ASMTL	Silent	p.P215P	G	G		11	Filtered Calls	X	1546879	1546879	21	0.238095238095238	NA	NA	NA			23	MAF-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASMTL&recr=Open">Click here</a>	
ASNA1	Silent	p.A135A	C	C		11	Filtered Calls	19	12856286	12856286	59	0.220338983050847	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASNA1&recr=Open">Click here</a>	
ASPHD2	Intron		C	C		11	Filtered Calls	22	26839056	26839056	198	0.272727272727273	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASPHD2&recr=Open">Click here</a>	
ASTN1	Silent	p.L297L	C	C		11	Filtered Calls	1	177000063	177000063	83	0.409638554216867	NA	NA	NA			153			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN1&recr=Open">Click here</a>	
ASTN2	Intron		G	G	rs374060452	11	Filtered Calls	9	119380759	119380759	43	0.372093023255814	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN2&recr=Open">Click here</a>	
ASTN2	Intron		G	G		11	Filtered Calls	9	119858311	119858311	43	0.186046511627907	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN2&recr=Open">Click here</a>	
ASTN2	Intron		G	G	rs140458736	11	Filtered Calls	9	119903672	119903672	50	0.12	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN2&recr=Open">Click here</a>	
ASXL3	Silent	p.S667S	C	C		11	Filtered Calls	18	31319369	31319369	18	0.277777777777778	NA	NA	NA			43	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASXL3&recr=Open">Click here</a>	
ASXL3	Silent	p.P1575P	C	C		11	Filtered Calls	18	31324537	31324537	9	0.555555555555556	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASXL3&recr=Open">Click here</a>	
ATAD2	5'UTR		G	G		11	Filtered Calls	8	124359537	124359537	264	0.261363636363636	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATAD2&recr=Open">Click here</a>	
ATE1	Silent	p.I350I	G	G		11	Filtered Calls	10	123600704	123600704	114	0.254385964912281	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATE1&recr=Open">Click here</a>	
ATE1	Intron		G	G		11	Filtered Calls	10	123659391	123659391	323	0.185758513931889	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATE1&recr=Open">Click here</a>	
ATF2	Silent	p.V189V	T	T		11	Filtered Calls	2	175979477	175979477	388	0.280927835051546	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATF2&recr=Open">Click here</a>	
ATG10	Silent	p.T168T	G	G		11	Filtered Calls	5	81548431	81548431	179	0.379888268156425	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATG10&recr=Open">Click here</a>	
ATG4D	Intron		G	G		11	Filtered Calls	19	10655545	10655545	140	0.242857142857143	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATG4D&recr=Open">Click here</a>	
ATG9B	5'UTR		G	G		11	Filtered Calls	7	150721284	150721284	14	0.5	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATG9B&recr=Open">Click here</a>	
ATMIN	Intron		C	C		11	Filtered Calls	16	81075992	81075992	110	0.281818181818182	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATMIN&recr=Open">Click here</a>	
ATMIN	Intron		C	C		11	Filtered Calls	16	81075993	81075993	107	0.271028037383178	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATMIN&recr=Open">Click here</a>	
ATP10A	Intron		G	G		11	Filtered Calls	15	25928422	25928422	25	0.4	NA	NA	NA			103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP10A&recr=Open">Click here</a>	
ATP11B	Intron		T	T		11	Filtered Calls	3	182590134	182590134	267	0.318352059925094	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP11B&recr=Open">Click here</a>	
ATP13A4	Silent	p.F960F	G	G		11	Filtered Calls	3	193132502	193132502	75	0.266666666666667	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP13A4&recr=Open">Click here</a>	
ATP1A4	Intron		G	G		11	Filtered Calls	1	160144061	160144061	80	0.2	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP1A4&recr=Open">Click here</a>	
ATP2A2	Intron		C	C		11	Filtered Calls	12	110760788	110760788	280	0.546428571428571	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2A2&recr=Open">Click here</a>	
ATP2A3	Silent	p.I635I	G	G		11	Filtered Calls	17	3844460	3844460	27	0.185185185185185	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2A3&recr=Open">Click here</a>	
ATP2B2	Silent	p.R938R	C	C		11	Filtered Calls	3	10382357	10382357	94	0.51063829787234	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2B2&recr=Open">Click here</a>	
ATP2B2	Silent	p.E176E	C	C		11	Filtered Calls	3	10443902	10443902	157	0.222929936305732	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2B2&recr=Open">Click here</a>	
ATP2B2	Silent	p.L98L	G	G	rs35276601|rs61734386	11	Filtered Calls	3	10452405	10452405	255	0.164705882352941	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2B2&recr=Open">Click here</a>	
ATP2B4	Silent	p.F843F	C	C		11	Filtered Calls	1	203689799	203689799	156	0.205128205128205	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2B4&recr=Open">Click here</a>	
ATP6V1A	Silent	p.I109I	C	C		11	Filtered Calls	3	113503186	113503186	174	0.402298850574713	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP6V1A&recr=Open">Click here</a>	
ATP6V1B1	Silent	p.F126F	C	C		11	Filtered Calls	2	71186158	71186158	74	0.337837837837838	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP6V1B1&recr=Open">Click here</a>	
ATP6V1B1	Silent	p.A300A	C	C		11	Filtered Calls	2	71190021	71190021	65	0.369230769230769	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP6V1B1&recr=Open">Click here</a>	
ATP6V1C1	Silent	p.T100T	T	T		11	Filtered Calls	8	104063291	104063291	230	0.191304347826087	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP6V1C1&recr=Open">Click here</a>	
ATP6V1C1	Intron		T	T		11	Filtered Calls	8	104076933	104076933	224	0.196428571428571	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP6V1C1&recr=Open">Click here</a>	
ATP8A1	Intron		G	G		11	Filtered Calls	4	42558064	42558064	50	0.32	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8A1&recr=Open">Click here</a>	
ATP8A2	Silent	p.L817L	C	C		11	Filtered Calls	13	26343250	26343250	67	0.238805970149254	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8A2&recr=Open">Click here</a>	
ATP8B2	Silent	p.P8P	C	C		11	Filtered Calls	1	154300299	154300299	431	0.180974477958237	NA	NA	NA		p.P8P(1)	51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8B2&recr=Open">Click here</a>	
ATP8B3	Silent	p.L335L	G	G		11	Filtered Calls	19	1802544	1802544	43	0.348837209302326	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8B3&recr=Open">Click here</a>	
ATR	Intron		G	G		11	Filtered Calls	3	142188418	142188418	102	0.401960784313726	NA	NA	NA			122			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATR&recr=Open">Click here</a>	
ATRN	Silent	p.F1260F	C	C		11	Filtered Calls	20	3584888	3584888	213	0.300469483568075	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATRN&recr=Open">Click here</a>	
ATRNL1	Silent	p.I429I	C	C		11	Filtered Calls	10	116930989	116930989	422	0.201421800947867	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATRNL1&recr=Open">Click here</a>	
AXIN2	Intron		C	C		11	Filtered Calls	17	63533110	63533110	20	0.65	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AXIN2&recr=Open">Click here</a>	
AXL	Intron		C	C		11	Filtered Calls	19	41748780	41748780	120	0.108333333333333	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AXL&recr=Open">Click here</a>	
AZU1	Intron		C	C		11	Filtered Calls	19	828220	828220	82	0.207317073170732	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AZU1&recr=Open">Click here</a>	
B3GALT1	Silent	p.L117L	C	C	rs142541144	11	Filtered Calls	2	168725900	168725900	114	0.403508771929825	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+B3GALT1&recr=Open">Click here</a>	
B3GNT9	Silent	p.F224F	G	G	rs267604595	11	Filtered Calls	16	67183717	67183717	49	0.244897959183673	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+B3GNT9&recr=Open">Click here</a>	
B4GALNT2	Intron		G	G		11	Filtered Calls	17	47210386	47210386	12	0.333333333333333	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+B4GALNT2&recr=Open">Click here</a>	
B4GALT4	Intron		G	G		11	Filtered Calls	3	118937623	118937623	98	0.357142857142857	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+B4GALT4&recr=Open">Click here</a>	
BAG3	Silent	p.F225F	C	C		11	Filtered Calls	10	121431934	121431934	105	0.238095238095238	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAG3&recr=Open">Click here</a>	
BAGE2	RNA		G	G		11	Filtered Calls	21	11097619	11097619	76	0.0789473684210526	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAGE2&recr=Open">Click here</a>	
BAI2	Silent	p.I858I	G	G		11	Filtered Calls	1	32204460	32204460	119	0.26890756302521	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAI2&recr=Open">Click here</a>	
BAI3	Silent	p.S298S	C	C	rs369473087	11	Filtered Calls	6	69646436	69646436	43	0.441860465116279	NA	NA	NA			210	TSP type-1 1. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAI3&recr=Open">Click here</a>	
BAI3	Silent	p.T699T	T	T		11	Filtered Calls	6	69728381	69728381	86	0.0581395348837209	NA	NA	NA			210			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAI3&recr=Open">Click here</a>	
BAI3	Silent	p.Q1439Q	A	A		11	Filtered Calls	6	70092764	70092764	62	0.403225806451613	NA	NA	NA			210			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAI3&recr=Open">Click here</a>	
BAIAP2L2	Intron		G	G		11	Filtered Calls	22	38494195	38494195	47	0.148936170212766	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAIAP2L2&recr=Open">Click here</a>	
BAIAP2L2	Intron		G	G		11	Filtered Calls	22	38494196	38494196	47	0.148936170212766	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAIAP2L2&recr=Open">Click here</a>	
BANK1	Silent	p.F649F	C	C		11	Filtered Calls	4	102965042	102965042	419	0.295942720763723	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BANK1&recr=Open">Click here</a>	
BAP1	Intron		G	G		11	Filtered Calls	3	52436697	52436697	113	0.247787610619469	NA	NA	NA			180			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAP1&recr=Open">Click here</a>	
BATF2	3'UTR		G	G		11	Filtered Calls	11	64756591	64756591	26	0.346153846153846	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BATF2&recr=Open">Click here</a>	
BAZ1A	Silent	p.P1539P	G	G		11	Filtered Calls	14	35222768	35222768	102	0.823529411764706	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAZ1A&recr=Open">Click here</a>	
BAZ1B	Intron		A	A		11	Filtered Calls	7	72874057	72874057	39	0.358974358974359	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAZ1B&recr=Open">Click here</a>	
BBS12	Silent	p.F22F	C	C	rs150546366	11	Filtered Calls	4	123663113	123663113	237	0.345991561181435	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BBS12&recr=Open">Click here</a>	
BBS9	Silent	p.F684F	C	C		11	Filtered Calls	7	33427693	33427693	342	0.672514619883041	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BBS9&recr=Open">Click here</a>	
BBX	Silent	p.E484E	G	G		11	Filtered Calls	3	107492020	107492020	90	0.344444444444444	NA	NA	NA			49	Lys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BBX&recr=Open">Click here</a>	
BCAS3	Silent	p.S503S	C	C		11	Filtered Calls	17	59093134	59093134	557	0.224416517055655	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCAS3&recr=Open">Click here</a>	
BCAS3	Silent	p.E884E	G	G		11	Filtered Calls	17	59469351	59469351	180	0.516666666666667	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCAS3&recr=Open">Click here</a>	
BCHE	Silent	p.F474F	A	A		11	Filtered Calls	3	165547400	165547400	278	0.0503597122302158	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCHE&recr=Open">Click here</a>	
BCL2L14	Intron		G	G		11	Filtered Calls	12	12243788	12243788	94	0.425531914893617	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL2L14&recr=Open">Click here</a>	
BCL2L2-PABPN1	Silent	p.S189S	C	C		11	Filtered Calls	14	23792227	23792227	250	0.88	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL2L2-PABPN1&recr=Open">Click here</a>	
BCL7B	Silent	p.S148S	G	G		11	Filtered Calls	7	72952336	72952336	69	0.420289855072464	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL7B&recr=Open">Click here</a>	
BCL7B	Silent	p.A67A	G	G		11	Filtered Calls	7	72957942	72957942	163	0.0429447852760736	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL7B&recr=Open">Click here</a>	
BCL9L	5'UTR		G	G		11	Filtered Calls	11	118769201	118769201	20	0.35	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL9L&recr=Open">Click here</a>	
BCL9L	5'UTR		C	C		11	Filtered Calls	11	118769367	118769367	21	0.238095238095238	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL9L&recr=Open">Click here</a>	
BCL9L	5'UTR		G	G		11	Filtered Calls	11	118769574	118769574	41	0.853658536585366	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL9L&recr=Open">Click here</a>	
BCL9L	5'UTR		G	G	rs189893252	11	Filtered Calls	11	118769575	118769575	42	0.857142857142857	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL9L&recr=Open">Click here</a>	
BCMO1	Silent	p.V393V	C	C		11	Filtered Calls	16	81314539	81314539	69	0.333333333333333	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCMO1&recr=Open">Click here</a>	
BCOR	Silent	p.V1701V	A	A		11	Filtered Calls	X	39911527	39911527	53	0.962264150943396	NA	NA	NA			126	Necessary and sufficient for interaction with PCGF1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCOR&recr=Open">Click here</a>	
BCORL1	Silent	p.A247A	T	T		11	Filtered Calls	X	129147489	129147489	70	0.414285714285714	NA	NA	NA			75	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCORL1&recr=Open">Click here</a>	
BCORL1	Silent	p.F895F	C	C		11	Filtered Calls	X	129149433	129149433	25	0.44	NA	NA	NA		p.S894fs*26(1)	75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCORL1&recr=Open">Click here</a>	
BDKRB2	Silent	p.I247I	C	C		11	Filtered Calls	14	96707406	96707406	9	0.333333333333333	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BDKRB2&recr=Open">Click here</a>	
BFSP1	Silent	p.I645I	G	G	rs201721549	11	Filtered Calls	20	17474782	17474782	228	0.276315789473684	NA	NA	NA			18	Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BFSP1&recr=Open">Click here</a>	
BFSP1	Silent	p.G440G	G	G		11	Filtered Calls	20	17475397	17475397	144	0.263888888888889	NA	NA	NA			18	Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BFSP1&recr=Open">Click here</a>	
BGLAP	IGR		C	C		11	Filtered Calls	1	156214069	156214069	51	0.254901960784314	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BGLAP&recr=Open">Click here</a>	
BGLAP	IGR		G	G		11	Filtered Calls	1	156214628	156214628	38	0.789473684210526	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BGLAP&recr=Open">Click here</a>	
BICC1	Silent	p.T666T	G	G		11	Filtered Calls	10	60560789	60560789	160	0.475	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BICC1&recr=Open">Click here</a>	
BIRC3	Silent	p.T498T	G	G		11	Filtered Calls	11	102206866	102206866	252	0.404761904761905	NA	NA	NA			21	CARD. {ECO:0000255|PROSITE- ProRule:PRU00046}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BIRC3&recr=Open">Click here</a>	
BMP2	Intron		C	C		11	Filtered Calls	20	6758884	6758884	136	0.176470588235294	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMP2&recr=Open">Click here</a>	
BMP2	Silent	p.F186F	C	C		11	Filtered Calls	20	6759103	6759103	79	0.177215189873418	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMP2&recr=Open">Click here</a>	
BMPER	Silent	p.P361P	C	C		11	Filtered Calls	7	34118473	34118473	84	0.273809523809524	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMPER&recr=Open">Click here</a>	
BMPR1A	Silent	p.F291F	C	C		11	Filtered Calls	10	88678933	88678933	391	0.248081841432225	NA	NA	NA			24	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMPR1A&recr=Open">Click here</a>	
BMX	Silent	p.L601L	G	G		11	Filtered Calls	X	15567970	15567970	153	0.431372549019608	NA	NA	NA			30	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMX&recr=Open">Click here</a>	
BNIP3L	Intron		C	C		11	Filtered Calls	8	26267873	26267873	132	0.507575757575758	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BNIP3L&recr=Open">Click here</a>	
BNIPL	3'UTR		A	A		11	Filtered Calls	1	151019167	151019167	127	0.149606299212598	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BNIPL&recr=Open">Click here</a>	
BOD1L1	Silent	p.L855L	G	G		11	Filtered Calls	4	13605961	13605961	108	0.416666666666667	NA	NA	NA			NA	Lys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BOD1L1&recr=Open">Click here</a>	
BOLL	Silent	p.F77F	G	G		11	Filtered Calls	2	198641828	198641828	316	0.215189873417722	NA	NA	NA			13	RRM. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BOLL&recr=Open">Click here</a>	
BPIFA1	Intron		C	C		11	Filtered Calls	20	31825857	31825857	21	0.428571428571429	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFA1&recr=Open">Click here</a>	
BPIFB2	Silent	p.S260S	C	C		11	Filtered Calls	20	31606553	31606553	30	0.733333333333333	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFB2&recr=Open">Click here</a>	
BPIFB2	Silent	p.L428L	C	C		11	Filtered Calls	20	31609554	31609554	52	0.25	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFB2&recr=Open">Click here</a>	
BPIFB2	Silent	p.I441I	C	C		11	Filtered Calls	20	31609593	31609593	49	0.26530612244898	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFB2&recr=Open">Click here</a>	
BPIFB4	Silent	p.D344D	C	C		11	Filtered Calls	20	31677345	31677345	36	0.361111111111111	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFB4&recr=Open">Click here</a>	
BPIFC	Silent	p.T377T	G	G		11	Filtered Calls	22	32828378	32828378	134	0.417910447761194	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFC&recr=Open">Click here</a>	
BPIFC	Silent	p.F13F	G	G		11	Filtered Calls	22	32853335	32853335	147	0.462585034013605	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFC&recr=Open">Click here</a>	
BRAT1	Silent	p.L722L	G	G	rs372332387	11	Filtered Calls	7	2578003	2578003	52	0.230769230769231	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRAT1&recr=Open">Click here</a>	
BRD1	Silent	p.P1008P	G	G		11	Filtered Calls	22	50168034	50168034	215	0.213953488372093	NA	NA	NA			37	PWWP. {ECO:0000255|PROSITE- ProRule:PRU00162}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRD1&recr=Open">Click here</a>	
BRD2	Intron		C	C		11	Filtered Calls	6	32940714	32940714	178	0.162921348314607	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRD2&recr=Open">Click here</a>	
BRINP1	Silent	p.F612F	G	G		11	Filtered Calls	9	121929812	121929812	75	0.253333333333333	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP1&recr=Open">Click here</a>	
BRINP1	Silent	p.F11F	G	G		11	Filtered Calls	9	122075601	122075601	61	0.311475409836066	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP1&recr=Open">Click here</a>	
BRINP2	Silent	p.I323I	C	C		11	Filtered Calls	1	177245527	177245527	41	0.121951219512195	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP2&recr=Open">Click here</a>	
BRK1	Intron		C	C		11	Filtered Calls	3	10167943	10167943	27	0.222222222222222	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRK1&recr=Open">Click here</a>	
BRPF3	Intron		C	C		11	Filtered Calls	6	36181650	36181650	226	0.63716814159292	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRPF3&recr=Open">Click here</a>	
BRSK1	Intron		C	C		11	Filtered Calls	19	55823271	55823271	24	0.166666666666667	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRSK1&recr=Open">Click here</a>	
BSN	Silent	p.R2606R	G	G		11	Filtered Calls	3	49694807	49694807	21	0.238095238095238	NA	NA	NA			106	Poly-Arg.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BSN&recr=Open">Click here</a>	
BSND	Silent	p.L307L	C	C		11	Filtered Calls	1	55474259	55474259	86	0.465116279069767	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BSND&recr=Open">Click here</a>	
BTAF1	Silent	p.R52R	G	G		11	Filtered Calls	10	93699726	93699726	125	0.544	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTAF1&recr=Open">Click here</a>	
BTBD11	Silent	p.V10V	G	G		11	Filtered Calls	12	107712747	107712747	11	0.545454545454545	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTBD11&recr=Open">Click here</a>	
BTC	Intron		C	C		11	Filtered Calls	4	75695376	75695376	94	0.308510638297872	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTC&recr=Open">Click here</a>	
BTK	Silent	p.G419G	C	C		11	Filtered Calls	X	100611864	100611864	299	0.511705685618729	NA	NA	NA			50	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTK&recr=Open">Click here</a>	
BTK	Silent	p.L402L	C	C		11	Filtered Calls	X	100611915	100611915	287	0.463414634146341	NA	NA	NA			50	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTK&recr=Open">Click here</a>	
BTN1A1	Intron		C	C		11	Filtered Calls	6	26505147	26505147	218	0.220183486238532	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTN1A1&recr=Open">Click here</a>	
BTN2A2	Intron		C	C		11	Filtered Calls	6	26388410	26388410	248	0.254032258064516	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTN2A2&recr=Open">Click here</a>	
BTN2A3P	RNA		T	T		11	Filtered Calls	6	26431768	26431768	273	0.216117216117216	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTN2A3P&recr=Open">Click here</a>	
BTN3A2	Silent	p.L308L	C	C		11	Filtered Calls	6	26373511	26373511	431	0.0208816705336427	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTN3A2&recr=Open">Click here</a>	
BTNL8	Silent	p.K124K	G	G		11	Filtered Calls	5	180335908	180335908	156	0.397435897435897	NA	NA	NA			28	Ig-like V-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTNL8&recr=Open">Click here</a>	
BTRC	Silent	p.S595S	C	C		11	Filtered Calls	10	103310584	103310584	161	0.22360248447205	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTRC&recr=Open">Click here</a>	
BYSL	Intron		G	G		11	Filtered Calls	6	41895278	41895278	88	0.784090909090909	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BYSL&recr=Open">Click here</a>	
BZRAP1	Silent	p.G1638G	C	C		11	Filtered Calls	17	56384219	56384219	31	0.129032258064516	NA	NA	NA			54	SH3 2. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BZRAP1&recr=Open">Click here</a>	
BZRAP1	Silent	p.G1349G	C	C		11	Filtered Calls	17	56386406	56386406	103	0.349514563106796	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BZRAP1&recr=Open">Click here</a>	
C10orf12	Silent	p.F196F	C	C		11	Filtered Calls	10	98741735	98741735	202	0.247524752475248	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf12&recr=Open">Click here</a>	
C10orf128	Intron		C	C		11	Filtered Calls	10	50374907	50374907	80	0.3625	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf128&recr=Open">Click here</a>	
C10orf25	Silent	p.L106L	G	G		11	Filtered Calls	10	45495990	45495990	27	0.222222222222222	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf25&recr=Open">Click here</a>	
C10orf68	Intron		C	C		11	Filtered Calls	10	33093937	33093937	378	0.195767195767196	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf68&recr=Open">Click here</a>	
C10orf76	Intron		G	G		11	Filtered Calls	10	103792938	103792938	238	0.180672268907563	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf76&recr=Open">Click here</a>	
C10orf90	Intron		G	G		11	Filtered Calls	10	128118423	128118423	173	0.254335260115607	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf90&recr=Open">Click here</a>	
C10orf90	Silent	p.P499P	G	G		11	Filtered Calls	10	128150051	128150051	46	0.217391304347826	NA	NA	NA		p.P546P(1)|p.P546Q(1)	65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf90&recr=Open">Click here</a>	
C10orf90	5'UTR		C	C		11	Filtered Calls	10	128202484	128202484	278	0.215827338129496	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf90&recr=Open">Click here</a>	
C11orf30	Intron		C	C	rs370445987	11	Filtered Calls	11	76248934	76248934	141	0.822695035460993	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C11orf30&recr=Open">Click here</a>	
C11orf42	IGR		G	G		11	Filtered Calls	11	6232947	6232947	32	0.5	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C11orf42&recr=Open">Click here</a>	
C11orf52	Silent	p.F108F	C	C		11	Filtered Calls	11	111796875	111796875	71	0.859154929577465	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C11orf52&recr=Open">Click here</a>	
C11orf53	Intron		C	C		11	Filtered Calls	11	111156373	111156373	41	0.902439024390244	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C11orf53&recr=Open">Click here</a>	
C11orf82	Silent	p.F727F	C	C		11	Filtered Calls	11	82644561	82644561	131	0.396946564885496	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C11orf82&recr=Open">Click here</a>	
C11orf84	Silent	p.P214P	C	C		11	Filtered Calls	11	63586033	63586033	65	0.369230769230769	NA	NA	NA			8	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C11orf84&recr=Open">Click here</a>	
C12orf10	5'Flank		C	C		11	Filtered Calls	12	53693537	53693537	17	0.470588235294118	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf10&recr=Open">Click here</a>	
C12orf44	Silent	p.I155I	C	C	rs373128893	11	Filtered Calls	12	52470782	52470782	46	0.434782608695652	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf44&recr=Open">Click here</a>	
C12orf50	Intron		C	C		11	Filtered Calls	12	88383035	88383035	43	0.511627906976744	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf50&recr=Open">Click here</a>	
C12orf55	Intron		C	C		11	Filtered Calls	12	97159031	97159031	81	0.382716049382716	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf55&recr=Open">Click here</a>	
C16orf59	Silent	p.S120S	C	C	rs200109457	11	Filtered Calls	16	2510980	2510980	62	0.596774193548387	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C16orf59&recr=Open">Click here</a>	
C17orf47	Silent	p.A262A	G	G		11	Filtered Calls	17	56620762	56620762	296	0.182432432432432	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf47&recr=Open">Click here</a>	
C17orf64	Silent	p.K207K	G	G		11	Filtered Calls	17	58506914	58506914	68	0.147058823529412	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf64&recr=Open">Click here</a>	
C17orf80	Silent	p.F565F	C	C		11	Filtered Calls	17	71239108	71239108	105	0.504761904761905	NA	NA	NA		p.F565F(1)	14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf80&recr=Open">Click here</a>	
C19orf18	Intron		A	A		11	Filtered Calls	19	58478010	58478010	95	0.410526315789474	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C19orf18&recr=Open">Click here</a>	
C19orf71	Intron		G	G		11	Filtered Calls	19	3542875	3542875	100	0.14	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C19orf71&recr=Open">Click here</a>	
C1QTNF2	Silent	p.F232F	G	G		11	Filtered Calls	5	159776472	159776472	53	0.452830188679245	NA	NA	NA			13	C1q. {ECO:0000255|PROSITE- ProRule:PRU00368}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1QTNF2&recr=Open">Click here</a>	
C1QTNF6	Silent	p.L95L	G	G		11	Filtered Calls	22	37581264	37581264	76	0.460526315789474	NA	NA	NA			11	Collagen-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1QTNF6&recr=Open">Click here</a>	
C1RL	Intron		G	G		11	Filtered Calls	12	7249485	7249485	138	0.217391304347826	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1RL&recr=Open">Click here</a>	
C1RL	Intron		G	G		11	Filtered Calls	12	7261062	7261062	63	0.19047619047619	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1RL&recr=Open">Click here</a>	
C1S	5'UTR		C	C		11	Filtered Calls	12	7171629	7171629	298	0.25503355704698	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1S&recr=Open">Click here</a>	
C1orf101	Silent	p.S738S	G	G	rs200656739	11	Filtered Calls	1	244756721	244756721	229	0.22707423580786	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf101&recr=Open">Click here</a>	
C1orf106	5'UTR		C	C	rs530365199	11	Filtered Calls	1	200867495	200867495	103	0.155339805825243	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf106&recr=Open">Click here</a>	
C1orf110	Intron		A	A		11	Filtered Calls	1	162825156	162825156	256	0.4296875	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf110&recr=Open">Click here</a>	
C1orf131	Intron		A	A		11	Filtered Calls	1	231364964	231364964	266	0.43984962406015	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf131&recr=Open">Click here</a>	
C1orf158	Silent	p.R35R	G	G		11	Filtered Calls	1	12806483	12806483	121	0.322314049586777	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf158&recr=Open">Click here</a>	
C1orf168	Silent	p.F320F	G	G		11	Filtered Calls	1	57233605	57233605	107	0.289719626168224	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf168&recr=Open">Click here</a>	
C1orf172	Silent	p.L226L	G	G		11	Filtered Calls	1	27278196	27278196	51	0.431372549019608	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf172&recr=Open">Click here</a>	
C1orf172	Silent	p.S222S	C	C	rs572491048	11	Filtered Calls	1	27278206	27278206	53	0.452830188679245	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf172&recr=Open">Click here</a>	
C1orf173	Silent	p.A1493A	C	C		11	Filtered Calls	1	75036915	75036915	111	0.396396396396396	NA	NA	NA			184			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf173&recr=Open">Click here</a>	
C1orf177	Intron		C	C	rs201772369	11	Filtered Calls	1	55280582	55280582	53	0.39622641509434	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf177&recr=Open">Click here</a>	
C1orf204	3'UTR		G	G		11	Filtered Calls	1	159804987	159804987	120	0.416666666666667	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf204&recr=Open">Click here</a>	
C1orf216	Silent	p.S106S	G	G		11	Filtered Calls	1	36181605	36181605	78	0.487179487179487	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf216&recr=Open">Click here</a>	
C1orf216	5'Flank		G	G		11	Filtered Calls	1	36186589	36186589	49	0.591836734693878	NA	NA	NA		p.?(1)	8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf216&recr=Open">Click here</a>	
C20orf166-AS1	RNA		C	C		11	Filtered Calls	20	61143707	61143707	26	0.269230769230769	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C20orf166-AS1&recr=Open">Click here</a>	
C20orf26	Silent	p.A66A	C	C		11	Filtered Calls	20	20051552	20051552	109	0.192660550458716	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C20orf26&recr=Open">Click here</a>	
C20orf26	Intron		G	G		11	Filtered Calls	20	20066137	20066137	208	0.317307692307692	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C20orf26&recr=Open">Click here</a>	
C20orf26	Silent	p.L1151L	C	C		11	Filtered Calls	20	20322503	20322503	61	0.295081967213115	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C20orf26&recr=Open">Click here</a>	
C2CD2	Silent	p.F167F	G	G	rs531119471	11	Filtered Calls	21	43339061	43339061	106	0.245283018867925	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2CD2&recr=Open">Click here</a>	
C2CD3	Intron		G	G		11	Filtered Calls	11	73825646	73825646	77	0.103896103896104	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2CD3&recr=Open">Click here</a>	
C2CD5	Silent	p.L830L	G	G		11	Filtered Calls	12	22622688	22622688	185	0.513513513513513	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2CD5&recr=Open">Click here</a>	
C2CD5	Silent	p.T445T	G	G		11	Filtered Calls	12	22643080	22643080	185	0.2	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2CD5&recr=Open">Click here</a>	
C2orf16	Silent	p.R1324R	G	G		11	Filtered Calls	2	27803411	27803411	84	0.273809523809524	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf16&recr=Open">Click here</a>	
C2orf40	Silent	p.D38D	C	C		11	Filtered Calls	2	106690436	106690436	114	0.324561403508772	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf40&recr=Open">Click here</a>	
C2orf42	Silent	p.E521E	C	C		11	Filtered Calls	2	70377650	70377650	135	0.2	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf42&recr=Open">Click here</a>	
C2orf54	Silent	p.R277R	C	C		11	Filtered Calls	2	241829485	241829485	33	0.151515151515152	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf54&recr=Open">Click here</a>	
C2orf54	Silent	p.S132S	G	G		11	Filtered Calls	2	241835019	241835019	15	0.266666666666667	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf54&recr=Open">Click here</a>	
C2orf78	Silent	p.P455P	G	G		11	Filtered Calls	2	74042715	74042715	123	0.170731707317073	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf78&recr=Open">Click here</a>	
C2orf78	Silent	p.K572K	G	G		11	Filtered Calls	2	74043066	74043066	39	0.256410256410256	NA	NA	NA			34	Lys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf78&recr=Open">Click here</a>	
C3	Intron		C	C		11	Filtered Calls	19	6684780	6684780	73	0.219178082191781	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3&recr=Open">Click here</a>	
C3P1	RNA		C	C	rs559605380	11	Filtered Calls	19	10158037	10158037	136	0.397058823529412	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3P1&recr=Open">Click here</a>	
C3orf20	Silent	p.F385F	C	C		11	Filtered Calls	3	14746120	14746120	164	0.0365853658536585	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3orf20&recr=Open">Click here</a>	
C3orf20	Silent	p.E543E	G	G		11	Filtered Calls	3	14768470	14768470	88	0.284090909090909	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3orf20&recr=Open">Click here</a>	
C3orf20	Silent	p.F700F	C	C		11	Filtered Calls	3	14799037	14799037	44	0.431818181818182	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3orf20&recr=Open">Click here</a>	
C3orf36	Silent	p.S131S	A	A		11	Filtered Calls	3	133647255	133647255	27	0.37037037037037	NA	NA	NA			6	Poly-Ser.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3orf36&recr=Open">Click here</a>	
C3orf55	3'UTR		G	G		11	Filtered Calls	3	157296089	157296089	73	0.452054794520548	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3orf55&recr=Open">Click here</a>	
C3orf67	Silent	p.F260F	G	G		11	Filtered Calls	3	58849443	58849443	219	0.17351598173516	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3orf67&recr=Open">Click here</a>	
C3orf67	Silent	p.F23F	G	G	rs143276468	11	Filtered Calls	3	58870302	58870302	495	0.212121212121212	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3orf67&recr=Open">Click here</a>	
C4orf17	Silent	p.K147K	G	G		11	Filtered Calls	4	100451010	100451010	156	0.282051282051282	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C4orf17&recr=Open">Click here</a>	
C5AR1	Silent	p.L117L	C	C		11	Filtered Calls	19	47823383	47823383	41	0.707317073170732	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C5AR1&recr=Open">Click here</a>	
C5orf42	Intron		A	A		11	Filtered Calls	5	37108384	37108384	105	0.428571428571429	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C5orf42&recr=Open">Click here</a>	
C5orf42	Intron		G	G		11	Filtered Calls	5	37198974	37198974	43	0.348837209302326	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C5orf42&recr=Open">Click here</a>	
C6	Silent	p.G276G	C	C	rs372345940	11	Filtered Calls	5	41181560	41181560	237	0.210970464135021	NA	NA	NA			96	MACPF. {ECO:0000255|PROSITE- ProRule:PRU00745}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6&recr=Open">Click here</a>	
C6orf118	Silent	p.L333L	G	G		11	Filtered Calls	6	165711528	165711528	45	0.444444444444444	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6orf118&recr=Open">Click here</a>	
C6orf118	Silent	p.K327K	C	C		11	Filtered Calls	6	165711546	165711546	43	0.488372093023256	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6orf118&recr=Open">Click here</a>	
C6orf165	Intron		C	C		11	Filtered Calls	6	88127915	88127915	41	0.365853658536585	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6orf165&recr=Open">Click here</a>	
C6orf222	Silent	p.P424P	C	C		11	Filtered Calls	6	36291269	36291269	215	0.237209302325581	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6orf222&recr=Open">Click here</a>	
C6orf89	Silent	p.S115S	C	C		11	Filtered Calls	6	36870131	36870131	191	0.633507853403141	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6orf89&recr=Open">Click here</a>	
C6orf89	Silent	p.T328T	C	C		11	Filtered Calls	6	36891136	36891136	121	0.231404958677686	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6orf89&recr=Open">Click here</a>	
C7	Intron		C	C		11	Filtered Calls	5	40950000	40950000	24	0.291666666666667	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C7&recr=Open">Click here</a>	
C7	Silent	p.G532G	G	G		11	Filtered Calls	5	40959657	40959657	58	0.46551724137931	NA	NA	NA			NA	TSP type-1 2. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C7&recr=Open">Click here</a>	
C7orf10	Silent	p.G216G	C	C		11	Filtered Calls	7	40314162	40314162	106	0.226415094339623	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C7orf10&recr=Open">Click here</a>	
C8A	Silent	p.F287F	C	C		11	Filtered Calls	1	57351605	57351605	122	0.377049180327869	NA	NA	NA			43	MACPF. {ECO:0000255|PROSITE- ProRule:PRU00745}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8A&recr=Open">Click here</a>	
C8orf22	Intron		C	C		11	Filtered Calls	8	49986611	49986611	161	0.161490683229814	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8orf22&recr=Open">Click here</a>	
C9orf9	Silent	p.R131R	G	G		11	Filtered Calls	9	135763722	135763722	32	0.1875	NA	NA	NA		p.?(1)	4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9orf9&recr=Open">Click here</a>	
C9orf96	Silent	p.L245L	C	C		11	Filtered Calls	9	136260759	136260759	40	0.625	NA	NA	NA			25	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9orf96&recr=Open">Click here</a>	
CA1	Silent	p.S51S	G	G		11	Filtered Calls	8	86250563	86250563	312	0.227564102564103	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CA1&recr=Open">Click here</a>	
CA10	Silent	p.S42S	G	G		11	Filtered Calls	17	50149689	50149689	217	0.225806451612903	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CA10&recr=Open">Click here</a>	
CA3	Intron		T	T		11	Filtered Calls	8	86351934	86351934	39	0.256410256410256	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CA3&recr=Open">Click here</a>	
CA4	Intron		G	G		11	Filtered Calls	17	58235815	58235815	19	0.473684210526316	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CA4&recr=Open">Click here</a>	
CABIN1	Silent	p.V460V	C	C	rs553443541	11	Filtered Calls	22	24456517	24456517	68	0.161764705882353	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CABIN1&recr=Open">Click here</a>	
CABIN1	Silent	p.L1217L	C	C		11	Filtered Calls	22	24491908	24491908	178	0.432584269662921	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CABIN1&recr=Open">Click here</a>	
CABIN1	Silent	p.V1599V	C	C		11	Filtered Calls	22	24562633	24562633	209	0.229665071770335	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CABIN1&recr=Open">Click here</a>	
CABS1	Silent	p.S105S	C	C		11	Filtered Calls	4	71201071	71201071	106	0.264150943396226	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CABS1&recr=Open">Click here</a>	
CACFD1	5'Flank		C	C		11	Filtered Calls	9	136323137	136323137	39	0.282051282051282	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACFD1&recr=Open">Click here</a>	
CACHD1	Intron		C	C		11	Filtered Calls	1	65016269	65016269	167	0.293413173652695	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACHD1&recr=Open">Click here</a>	
CACNA1A	Silent	p.P1176P	G	G		11	Filtered Calls	19	13397342	13397342	29	0.448275862068966	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1A&recr=Open">Click here</a>	
CACNA1A	Silent	p.F523F	G	G		11	Filtered Calls	19	13423582	13423582	46	0.173913043478261	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1A&recr=Open">Click here</a>	
CACNA1B	Silent	p.S675S	G	G	rs202184196	11	Filtered Calls	9	140901269	140901269	13	0.307692307692308	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1B&recr=Open">Click here</a>	
CACNA1B	Intron		C	C		11	Filtered Calls	9	140911638	140911638	27	0.814814814814815	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1B&recr=Open">Click here</a>	
CACNA1B	Silent	p.I1508I	C	C	rs199889289	11	Filtered Calls	9	140953581	140953581	22	0.5	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1B&recr=Open">Click here</a>	
CACNA1B	Intron		C	C		11	Filtered Calls	9	140997159	140997159	28	0.214285714285714	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1B&recr=Open">Click here</a>	
CACNA1C	Silent	p.P112P	C	C		11	Filtered Calls	12	2224676	2224676	56	0.339285714285714	NA	NA	NA			132			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1C&recr=Open">Click here</a>	
CACNA1C	Silent	p.R114R	G	G		11	Filtered Calls	12	2224682	2224682	51	0.117647058823529	NA	NA	NA			132			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1C&recr=Open">Click here</a>	
CACNA1C	Silent	p.G1959G	G	G		11	Filtered Calls	12	2795384	2795384	85	0.352941176470588	NA	NA	NA			132			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1C&recr=Open">Click here</a>	
CACNA1D	Intron		C	C		11	Filtered Calls	3	53806851	53806851	107	0.14018691588785	NA	NA	NA			90			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1D&recr=Open">Click here</a>	
CACNA1E	Silent	p.F180F	C	C		11	Filtered Calls	1	181546929	181546929	30	0.233333333333333	NA	NA	NA			204			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1E&recr=Open">Click here</a>	
CACNA1E	Intron		C	C		11	Filtered Calls	1	181687310	181687310	27	0.444444444444444	NA	NA	NA			204			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1E&recr=Open">Click here</a>	
CACNA1E	Silent	p.P894P	G	G	rs376991322	11	Filtered Calls	1	181701904	181701904	32	0.53125	NA	NA	NA			204			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1E&recr=Open">Click here</a>	
CACNA1E	Silent	p.F1547F	C	C		11	Filtered Calls	1	181731745	181731745	71	0.0563380281690141	NA	NA	NA			204			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1E&recr=Open">Click here</a>	
CACNA1E	Intron		C	C		11	Filtered Calls	1	181735675	181735675	34	0.176470588235294	NA	NA	NA			204			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1E&recr=Open">Click here</a>	
CACNA1E	Silent	p.Q2155Q	A	A		11	Filtered Calls	1	181767622	181767622	41	0.170731707317073	NA	NA	NA			204			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1E&recr=Open">Click here</a>	
CACNA1F	3'UTR		G	G		11	Filtered Calls	X	49061593	49061593	9	0.333333333333333	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1F&recr=Open">Click here</a>	
CACNA1F	Intron		C	C		11	Filtered Calls	X	49063177	49063177	29	0.482758620689655	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1F&recr=Open">Click here</a>	
CACNA1G	Silent	p.F225F	C	C	rs377069021	11	Filtered Calls	17	48649327	48649327	60	0.3	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1G&recr=Open">Click here</a>	
CACNA1G	Silent	p.F944F	C	C		11	Filtered Calls	17	48669375	48669375	32	0.625	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1G&recr=Open">Click here</a>	
CACNA1G	Intron		G	G		11	Filtered Calls	17	48683403	48683403	59	0.186440677966102	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1G&recr=Open">Click here</a>	
CACNA1G	Intron		C	C		11	Filtered Calls	17	48697038	48697038	14	0.285714285714286	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1G&recr=Open">Click here</a>	
CACNA1G	3'UTR		C	C		11	Filtered Calls	17	48704116	48704116	129	0.0387596899224806	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1G&recr=Open">Click here</a>	
CACNA1I	Silent	p.K74K	G	G	rs371813934	11	Filtered Calls	22	39966979	39966979	82	0.536585365853659	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1I&recr=Open">Click here</a>	
CACNA1I	Silent	p.I636I	C	C		11	Filtered Calls	22	40045846	40045846	28	0.214285714285714	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1I&recr=Open">Click here</a>	
CACNA1S	Silent	p.R1389R	C	C		11	Filtered Calls	1	201019591	201019591	78	0.217948717948718	NA	NA	NA			102	Dihydropyridine binding. {ECO:0000250}.|Phenylalkylamine binding. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1S&recr=Open">Click here</a>	
CACNA1S	Silent	p.D1180D	G	G		11	Filtered Calls	1	201027605	201027605	121	0.504132231404959	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1S&recr=Open">Click here</a>	
CACNA2D2	Silent	p.S427S	G	G	rs150534078	11	Filtered Calls	3	50416404	50416404	55	0.4	NA	NA	NA			31	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA2D2&recr=Open">Click here</a>	
CACNA2D3	Silent	p.T176T	G	G		11	Filtered Calls	3	54537665	54537665	54	0.296296296296296	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA2D3&recr=Open">Click here</a>	
CACNA2D3	Silent	p.E429E	G	G		11	Filtered Calls	3	54798285	54798285	184	0.46195652173913	NA	NA	NA			59	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA2D3&recr=Open">Click here</a>	
CACNA2D3	Silent	p.I1003I	C	C		11	Filtered Calls	3	55107493	55107493	82	0.182926829268293	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA2D3&recr=Open">Click here</a>	
CACNG3	Intron		C	C		11	Filtered Calls	16	24358146	24358146	33	0.181818181818182	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNG3&recr=Open">Click here</a>	
CACNG3	Silent	p.L279L	C	C		11	Filtered Calls	16	24373073	24373073	50	0.28	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNG3&recr=Open">Click here</a>	
CACNG6	Silent	p.A259A	C	C		11	Filtered Calls	19	54515437	54515437	80	0.3125	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNG6&recr=Open">Click here</a>	
CAD	Silent	p.A175A	C	C		11	Filtered Calls	2	27445416	27445416	91	0.252747252747253	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAD&recr=Open">Click here</a>	
CAD	Silent	p.P245P	C	C		11	Filtered Calls	2	27445831	27445831	162	0.271604938271605	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAD&recr=Open">Click here</a>	
CAD	Silent	p.S1055S	C	C		11	Filtered Calls	2	27456631	27456631	82	0.268292682926829	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAD&recr=Open">Click here</a>	
CADM1	Silent	p.E161E	C	C		11	Filtered Calls	11	115102152	115102152	145	0.448275862068966	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CADM1&recr=Open">Click here</a>	
CADPS	Intron		G	G		11	Filtered Calls	3	62499355	62499355	46	0.260869565217391	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CADPS&recr=Open">Click here</a>	
CADPS	Silent	p.I418I	G	G		11	Filtered Calls	3	62631468	62631468	271	0.191881918819188	NA	NA	NA			92	C2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CADPS&recr=Open">Click here</a>	
CADPS2	Silent	p.S757S	G	G		11	Filtered Calls	7	122091436	122091436	82	0.317073170731707	NA	NA	NA			43	Interaction with DRD2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CADPS2&recr=Open">Click here</a>	
CADPS2	Intron		G	G		11	Filtered Calls	7	122153377	122153377	11	0.545454545454545	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CADPS2&recr=Open">Click here</a>	
CALCRL	Silent	p.F262F	A	A		11	Filtered Calls	2	188223995	188223995	16	0.4375	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CALCRL&recr=Open">Click here</a>	
CALCRL	Silent	p.A244A	G	G		11	Filtered Calls	2	188225374	188225374	188	0.276595744680851	NA	NA	NA		p.A244A(1)	32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CALCRL&recr=Open">Click here</a>	
CALCRL	Silent	p.F142F	A	A		11	Filtered Calls	2	188243741	188243741	307	0.218241042345277	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CALCRL&recr=Open">Click here</a>	
CALCRL	Intron		G	G		11	Filtered Calls	2	188248038	188248038	74	0.297297297297297	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CALCRL&recr=Open">Click here</a>	
CALHM1	Silent	p.C161C	G	G		11	Filtered Calls	10	105218026	105218026	57	0.192982456140351	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CALHM1&recr=Open">Click here</a>	
CALN1	Silent	p.L115L	A	A		11	Filtered Calls	7	71488672	71488672	45	0.8	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CALN1&recr=Open">Click here</a>	
CAMK1	Intron		G	G		11	Filtered Calls	3	9804746	9804746	28	0.428571428571429	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMK1&recr=Open">Click here</a>	
CAMK1G	Silent	p.R20R	G	G		11	Filtered Calls	1	209768388	209768388	145	0.303448275862069	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMK1G&recr=Open">Click here</a>	
CAMK2A	Silent	p.G316G	C	C		11	Filtered Calls	5	149624760	149624760	76	0.355263157894737	NA	NA	NA			15	Interaction with BAALC. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMK2A&recr=Open">Click here</a>	
CAMK2B	Intron		G	G		11	Filtered Calls	7	44281949	44281949	42	0.19047619047619	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMK2B&recr=Open">Click here</a>	
CAMK2D	Intron		A	A		11	Filtered Calls	4	114434534	114434534	150	0.28	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMK2D&recr=Open">Click here</a>	
CAMSAP2	Intron		C	C	rs183635737	11	Filtered Calls	1	200811114	200811114	288	0.222222222222222	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMSAP2&recr=Open">Click here</a>	
CAMSAP2	Intron		C	C	rs527737880	11	Filtered Calls	1	200821660	200821660	225	0.248888888888889	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMSAP2&recr=Open">Click here</a>	
CAP1	Silent	p.A140A	C	C		11	Filtered Calls	1	40530024	40530024	176	0.0284090909090909	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAP1&recr=Open">Click here</a>	
CAPN1	Silent	p.F675F	C	C		11	Filtered Calls	11	64977889	64977889	20	0.25	NA	NA	NA			13	Domain IV.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN1&recr=Open">Click here</a>	
CAPN10	Silent	p.F367F	C	C		11	Filtered Calls	2	241534544	241534544	89	0.258426966292135	NA	NA	NA			27	Domain III 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN10&recr=Open">Click here</a>	
CAPN11	Silent	p.E354E	G	G		11	Filtered Calls	6	44144378	44144378	102	0.186274509803922	NA	NA	NA			36	Calpain catalytic. {ECO:0000255|PROSITE- ProRule:PRU00239}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN11&recr=Open">Click here</a>	
CAPN5	Intron		G	G		11	Filtered Calls	11	76814212	76814212	15	0.466666666666667	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN5&recr=Open">Click here</a>	
CAPN9	Silent	p.I193I	C	C	rs372361365	11	Filtered Calls	1	230903329	230903329	164	0.195121951219512	NA	NA	NA			25	Calpain catalytic. {ECO:0000255|PROSITE- ProRule:PRU00239}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN9&recr=Open">Click here</a>	
CAPN9	Silent	p.F370F	C	C		11	Filtered Calls	1	230914875	230914875	52	0.423076923076923	NA	NA	NA			25	Domain III.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN9&recr=Open">Click here</a>	
CAPN9	Silent	p.Q477Q	G	G		11	Filtered Calls	1	230916404	230916404	542	0.232472324723247	NA	NA	NA			25	Domain III.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN9&recr=Open">Click here</a>	
CARD10	Silent	p.L772L	G	G		11	Filtered Calls	22	37891581	37891581	18	0.166666666666667	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CARD10&recr=Open">Click here</a>	
CARD11	Silent	p.D224D	G	G		11	Filtered Calls	7	2983858	2983858	45	0.2	NA	NA	NA			150			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CARD11&recr=Open">Click here</a>	
CARD14	Intron		C	C		11	Filtered Calls	17	78171890	78171890	150	0.273333333333333	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CARD14&recr=Open">Click here</a>	
CARD6	Intron		C	C		11	Filtered Calls	5	40853794	40853794	236	0.23728813559322	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CARD6&recr=Open">Click here</a>	
CARD6	Intron		C	C		11	Filtered Calls	5	40853995	40853995	150	0.56	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CARD6&recr=Open">Click here</a>	
CARM1	Silent	p.L247L	C	C		11	Filtered Calls	19	11024624	11024624	55	0.236363636363636	NA	NA	NA			13	SAM-dependent MTase PRMT-type. {ECO:0000255|PROSITE-ProRule:PRU01015}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CARM1&recr=Open">Click here</a>	
CARS2	Intron		G	G		11	Filtered Calls	13	111340375	111340375	59	0.169491525423729	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CARS2&recr=Open">Click here</a>	
CASKIN2	Intron		G	G		11	Filtered Calls	17	73501626	73501626	240	0.216666666666667	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASKIN2&recr=Open">Click here</a>	
CASP8AP2	RNA		C	C		11	Filtered Calls	6	90572606	90572606	81	0.481481481481481	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASP8AP2&recr=Open">Click here</a>	
CASQ2	Intron		G	G		11	Filtered Calls	1	116287539	116287539	241	0.033195020746888	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASQ2&recr=Open">Click here</a>	
CASS4	Intron		C	C		11	Filtered Calls	20	55012211	55012211	210	0.238095238095238	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASS4&recr=Open">Click here</a>	
CASS4	Intron		G	G		11	Filtered Calls	20	55025744	55025744	38	0.289473684210526	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASS4&recr=Open">Click here</a>	
CASZ1	Silent	p.Q328Q	C	C		11	Filtered Calls	1	10720115	10720115	110	0.3	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASZ1&recr=Open">Click here</a>	
CATSPERB	Silent	p.G1056G	T	T		11	Filtered Calls	14	92047416	92047416	69	0.231884057971014	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPERB&recr=Open">Click here</a>	
CATSPERB	Intron		C	C		11	Filtered Calls	14	92140515	92140515	119	0.168067226890756	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPERB&recr=Open">Click here</a>	
CATSPERD	Intron		C	C		11	Filtered Calls	19	5748166	5748166	70	0.385714285714286	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPERD&recr=Open">Click here</a>	
CBLB	Silent	p.R463R	C	C		11	Filtered Calls	3	105438909	105438909	91	0.263736263736264	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CBLB&recr=Open">Click here</a>	
CBLN4	Silent	p.F199F	G	G		11	Filtered Calls	20	54573622	54573622	107	0.252336448598131	NA	NA	NA			17	C1q. {ECO:0000255|PROSITE- ProRule:PRU00368}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CBLN4&recr=Open">Click here</a>	
CBX8	Silent	p.S118S	G	G		11	Filtered Calls	17	77769250	77769250	35	0.171428571428571	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CBX8&recr=Open">Click here</a>	
CC2D1A	Intron		C	C	rs534395579	11	Filtered Calls	19	14040978	14040978	53	0.207547169811321	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CC2D1A&recr=Open">Click here</a>	
CCDC108	Silent	p.F197F	G	G		11	Filtered Calls	2	219897246	219897246	21	0.285714285714286	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC108&recr=Open">Click here</a>	
CCDC112	Intron		G	G	rs548537744	11	Filtered Calls	5	114615471	114615471	59	0.423728813559322	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC112&recr=Open">Click here</a>	
CCDC113	Silent	p.R343R	G	G		11	Filtered Calls	16	58312523	58312523	73	0.287671232876712	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC113&recr=Open">Click here</a>	
CCDC116	Silent	p.S50S	C	C		11	Filtered Calls	22	21988388	21988388	113	0.176991150442478	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC116&recr=Open">Click here</a>	
CCDC129	Intron		T	T		11	Filtered Calls	7	31692123	31692123	12	0.333333333333333	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC129&recr=Open">Click here</a>	
CCDC135	Silent	p.E289E	G	G		11	Filtered Calls	16	57741380	57741380	20	0.2	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC135&recr=Open">Click here</a>	
CCDC141	5'UTR		G	G		11	Filtered Calls	2	179701639	179701639	147	0.26530612244898	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC141&recr=Open">Click here</a>	
CCDC141	5'UTR		G	G		11	Filtered Calls	2	179701852	179701852	34	0.323529411764706	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC141&recr=Open">Click here</a>	
CCDC141	5'UTR		C	C		11	Filtered Calls	2	179702466	179702466	106	0.330188679245283	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC141&recr=Open">Click here</a>	
CCDC147	Silent	p.K96K	G	G		11	Filtered Calls	10	106118377	106118377	213	0.248826291079812	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC147&recr=Open">Click here</a>	
CCDC147	Silent	p.E313E	G	G		11	Filtered Calls	10	106130661	106130661	166	0.126506024096386	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC147&recr=Open">Click here</a>	
CCDC147	Silent	p.K660K	G	G		11	Filtered Calls	10	106160602	106160602	92	0.260869565217391	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC147&recr=Open">Click here</a>	
CCDC15	Silent	p.D589D	C	C		11	Filtered Calls	11	124857889	124857889	181	0.353591160220994	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC15&recr=Open">Click here</a>	
CCDC151	Silent	p.K332K	C	C		11	Filtered Calls	19	11533470	11533470	41	0.439024390243902	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC151&recr=Open">Click here</a>	
CCDC160	Silent	p.L187L	A	A		11	Filtered Calls	X	133379391	133379391	20	0.95	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC160&recr=Open">Click here</a>	
CCDC167	3'UTR		C	C		11	Filtered Calls	6	37450961	37450961	61	0.262295081967213	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC167&recr=Open">Click here</a>	
CCDC18	Intron		C	C		11	Filtered Calls	1	93646076	93646076	72	0.930555555555556	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC18&recr=Open">Click here</a>	
CCDC180	Intron		C	C		11	Filtered Calls	9	100070100	100070100	118	0.406779661016949	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC180&recr=Open">Click here</a>	
CCDC180	Intron		A	A		11	Filtered Calls	9	100070258	100070258	55	0.181818181818182	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC180&recr=Open">Click here</a>	
CCDC19	Intron		A	A		11	Filtered Calls	1	159842364	159842364	67	0.208955223880597	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC19&recr=Open">Click here</a>	
CCDC19	Silent	p.Q427Q	C	C		11	Filtered Calls	1	159846417	159846417	69	0.260869565217391	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC19&recr=Open">Click here</a>	
CCDC28A	Silent	p.G21G	G	G		11	Filtered Calls	6	139094874	139094874	169	0.408284023668639	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC28A&recr=Open">Click here</a>	
CCDC28A	Silent	p.I164I	C	C		11	Filtered Calls	6	139101022	139101022	122	0.426229508196721	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC28A&recr=Open">Click here</a>	
CCDC3	Intron		G	G		11	Filtered Calls	10	13040522	13040522	138	0.130434782608696	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC3&recr=Open">Click here</a>	
CCDC37	Intron		C	C		11	Filtered Calls	3	126132925	126132925	109	0.036697247706422	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC37&recr=Open">Click here</a>	
CCDC38	Intron		T	T		11	Filtered Calls	12	96284607	96284607	57	0.421052631578947	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC38&recr=Open">Click here</a>	
CCDC39	Intron		G	G		11	Filtered Calls	3	180359772	180359772	125	0.544	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC39&recr=Open">Click here</a>	
CCDC60	Silent	p.G109G	G	G		11	Filtered Calls	12	119909955	119909955	156	0.275641025641026	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC60&recr=Open">Click here</a>	
CCDC60	Silent	p.E529E	G	G		11	Filtered Calls	12	119978454	119978454	80	0.275	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC60&recr=Open">Click here</a>	
CCDC68	Silent	p.D99D	G	G		11	Filtered Calls	18	52605236	52605236	73	0.424657534246575	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC68&recr=Open">Click here</a>	
CCDC69	Intron		C	C		11	Filtered Calls	5	150564971	150564971	64	0.34375	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC69&recr=Open">Click here</a>	
CCDC69	Intron		G	G	rs200423694	11	Filtered Calls	5	150567027	150567027	25	0.64	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC69&recr=Open">Click here</a>	
CCDC81	Silent	p.Q584Q	G	G		11	Filtered Calls	11	86131030	86131030	89	0.438202247191011	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC81&recr=Open">Click here</a>	
CCDC85A	Silent	p.R528R	G	G		11	Filtered Calls	2	56611412	56611412	145	0.124137931034483	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC85A&recr=Open">Click here</a>	
CCDC88C	Silent	p.R1423R	C	C		11	Filtered Calls	14	91755621	91755621	200	0.46	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC88C&recr=Open">Click here</a>	
CCL4	Intron		G	G		11	Filtered Calls	17	34431967	34431967	30	0.366666666666667	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCL4&recr=Open">Click here</a>	
CCM2	Silent	p.L369L	C	C		11	Filtered Calls	7	45115426	45115426	38	0.263157894736842	NA	NA	NA			19	Harmonin homology domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCM2&recr=Open">Click here</a>	
CCNB3	Silent	p.S419S	C	C		11	Filtered Calls	X	50052426	50052426	53	0.377358490566038	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCNB3&recr=Open">Click here</a>	
CCND1	3'UTR		C	C		11	Filtered Calls	11	69462898	69462898	56	0.285714285714286	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCND1&recr=Open">Click here</a>	
CCND2	Intron		C	C		11	Filtered Calls	12	4398000	4398000	167	0.161676646706587	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCND2&recr=Open">Click here</a>	
CCND2	Silent	p.L258L	C	C		11	Filtered Calls	12	4409077	4409077	79	0.379746835443038	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCND2&recr=Open">Click here</a>	
CCNT2	Silent	p.S641S	A	A		11	Filtered Calls	2	135711948	135711948	251	0.223107569721116	NA	NA	NA			25	Poly-Ser.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCNT2&recr=Open">Click here</a>	
CCR1	Silent	p.L160L	G	G		11	Filtered Calls	3	46245327	46245327	91	0.21978021978022	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCR1&recr=Open">Click here</a>	
CCR10	5'Flank		C	C		11	Filtered Calls	17	40837272	40837272	49	0.489795918367347	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCR10&recr=Open">Click here</a>	
CCR3	Silent	p.F123F	C	C		11	Filtered Calls	3	46307018	46307018	182	0.21978021978022	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCR3&recr=Open">Click here</a>	
CCR3	Silent	p.I289I	C	C		11	Filtered Calls	3	46307516	46307516	93	0.225806451612903	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCR3&recr=Open">Click here</a>	
CCR3	Silent	p.E348E	G	G		11	Filtered Calls	3	46307693	46307693	77	0.220779220779221	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCR3&recr=Open">Click here</a>	
CCR5	Silent	p.R232R	G	G		11	Filtered Calls	3	46415089	46415089	413	0.239709443099274	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCR5&recr=Open">Click here</a>	
CD109	Intron		C	C		11	Filtered Calls	6	74432967	74432967	519	0.344894026974952	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD109&recr=Open">Click here</a>	
CD109	Intron		C	C		11	Filtered Calls	6	74433012	74433012	459	0.396514161220044	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD109&recr=Open">Click here</a>	
CD109	Silent	p.L1221L	C	C		11	Filtered Calls	6	74520829	74520829	103	0.427184466019417	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD109&recr=Open">Click here</a>	
CD14	Silent	p.S46S	G	G		11	Filtered Calls	5	140012431	140012431	36	0.361111111111111	NA	NA	NA			6	Ligand-binding pocket rim.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD14&recr=Open">Click here</a>	
CD14	Silent	p.F32F	G	G		11	Filtered Calls	5	140012473	140012473	29	0.448275862068966	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD14&recr=Open">Click here</a>	
CD163	5'Flank		G	G		11	Filtered Calls	12	7635291	7635291	186	0.258064516129032	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163&recr=Open">Click here</a>	
CD163	5'Flank		C	C	rs267603679	11	Filtered Calls	12	7640083	7640083	152	0.190789473684211	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163&recr=Open">Click here</a>	
CD163	5'Flank		C	C		11	Filtered Calls	12	7640410	7640410	112	0.0535714285714286	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163&recr=Open">Click here</a>	
CD163	5'Flank		G	G		11	Filtered Calls	12	7640523	7640523	78	0.243589743589744	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163&recr=Open">Click here</a>	
CD163	5'Flank		C	C		11	Filtered Calls	12	7640656	7640656	38	0.368421052631579	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163&recr=Open">Click here</a>	
CD163	Silent	p.G154G	T	T		11	Filtered Calls	12	7651780	7651780	220	0.222727272727273	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163&recr=Open">Click here</a>	
CD163L1	Silent	p.F1093F	G	G		11	Filtered Calls	12	7527198	7527198	84	0.452380952380952	NA	NA	NA			96	SRCR 10. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163L1&recr=Open">Click here</a>	
CD163L1	Silent	p.V690V	C	C		11	Filtered Calls	12	7548701	7548701	62	0.258064516129032	NA	NA	NA			96	SRCR 7. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163L1&recr=Open">Click here</a>	
CD163L1	Intron		A	A		11	Filtered Calls	12	7559452	7559452	100	0.26	NA	NA	NA			96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163L1&recr=Open">Click here</a>	
CD180	Silent	p.N609N	G	G		11	Filtered Calls	5	66478844	66478844	144	0.305555555555556	NA	NA	NA			34	LRRCT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD180&recr=Open">Click here</a>	
CD19	Silent	p.L468L	G	G		11	Filtered Calls	16	28948976	28948976	74	0.256756756756757	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD19&recr=Open">Click here</a>	
CD1C	Silent	p.G260G	G	G		11	Filtered Calls	1	158262555	158262555	90	0.344444444444444	NA	NA	NA			39	Ig-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD1C&recr=Open">Click here</a>	
CD22	Intron		C	C		11	Filtered Calls	19	35829064	35829064	28	0.178571428571429	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD22&recr=Open">Click here</a>	
CD226	Silent	p.F94F	G	G	rs564043368	11	Filtered Calls	18	67614070	67614070	127	0.409448818897638	NA	NA	NA			24	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD226&recr=Open">Click here</a>	
CD300LB	Silent	p.T127T	G	G		11	Filtered Calls	17	72521987	72521987	132	0.371212121212121	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD300LB&recr=Open">Click here</a>	
CD33	Silent	p.F216F	C	C	rs141510568	11	Filtered Calls	19	51729288	51729288	25	0.2	NA	NA	NA			24	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD33&recr=Open">Click here</a>	
CD7	5'UTR		C	C		11	Filtered Calls	17	80274657	80274657	128	0.2109375	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD7&recr=Open">Click here</a>	
CD70	Silent	p.G164G	C	C		11	Filtered Calls	19	6586121	6586121	32	0.21875	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD70&recr=Open">Click here</a>	
CD81	Silent	p.A130A	C	C		11	Filtered Calls	11	2416681	2416681	42	0.5	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD81&recr=Open">Click here</a>	
CD86	Silent	p.F12F	C	C		11	Filtered Calls	3	121810487	121810487	208	0.307692307692308	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD86&recr=Open">Click here</a>	
CD86	Silent	p.L20L	C	C		11	Filtered Calls	3	121822370	121822370	61	0.278688524590164	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD86&recr=Open">Click here</a>	
CD86	Silent	p.S74S	C	C		11	Filtered Calls	3	121822534	121822534	126	0.436507936507937	NA	NA	NA			23	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD86&recr=Open">Click here</a>	
CD86	Silent	p.F130F	C	C		11	Filtered Calls	3	121825052	121825052	23	0.826086956521739	NA	NA	NA			23	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD86&recr=Open">Click here</a>	
CD96	Silent	p.I358I	C	C		11	Filtered Calls	3	111319748	111319748	87	0.0689655172413793	NA	NA	NA			35	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD96&recr=Open">Click here</a>	
CD97	Silent	p.F464F	C	C		11	Filtered Calls	19	14513617	14513617	159	0.19496855345912	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD97&recr=Open">Click here</a>	
CDA	Silent	p.G78G	G	G		11	Filtered Calls	1	20931500	20931500	42	0.333333333333333	NA	NA	NA			7	CMP/dCMP deaminase zinc-binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDA&recr=Open">Click here</a>	
CDAN1	Intron		A	A		11	Filtered Calls	15	43026250	43026250	73	0.397260273972603	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDAN1&recr=Open">Click here</a>	
CDAN1	Intron		A	A		11	Filtered Calls	15	43026251	43026251	73	0.397260273972603	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDAN1&recr=Open">Click here</a>	
CDC20B	Silent	p.S215S	G	G		11	Filtered Calls	5	54429292	54429292	198	0.101010101010101	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDC20B&recr=Open">Click here</a>	
CDC42BPA	Silent	p.S1532S	G	G		11	Filtered Calls	1	227204666	227204666	301	0.186046511627907	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDC42BPA&recr=Open">Click here</a>	
CDC42BPA	Intron		A	A		11	Filtered Calls	1	227316943	227316943	181	0.408839779005525	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDC42BPA&recr=Open">Click here</a>	
CDC42BPB	Silent	p.S1044S	G	G		11	Filtered Calls	14	103418875	103418875	33	0.303030303030303	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDC42BPB&recr=Open">Click here</a>	
CDC42EP2	Silent	p.S109S	C	C		11	Filtered Calls	11	65088696	65088696	36	0.361111111111111	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDC42EP2&recr=Open">Click here</a>	
CDH10	Silent	p.L506L	T	T		11	Filtered Calls	5	24493032	24493032	362	0.187845303867403	NA	NA	NA			185	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH10&recr=Open">Click here</a>	
CDH11	3'UTR		C	C	rs376269667	11	Filtered Calls	16	64981498	64981498	237	0.552742616033755	NA	NA	NA			88			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH11&recr=Open">Click here</a>	
CDH13	Intron		C	C		11	Filtered Calls	16	83158981	83158981	24	0.208333333333333	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH13&recr=Open">Click here</a>	
CDH16	Silent	p.K669K	C	C		11	Filtered Calls	16	66944257	66944257	78	0.217948717948718	NA	NA	NA			41	Ectodomain G.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH16&recr=Open">Click here</a>	
CDH18	IGR		G	G		11	Filtered Calls	5	19473415	19473415	105	0.466666666666667	NA	NA	NA			138			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH18&recr=Open">Click here</a>	
CDH18	IGR		G	G		11	Filtered Calls	5	19473530	19473530	86	0.174418604651163	NA	NA	NA			138			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH18&recr=Open">Click here</a>	
CDH18	Silent	p.V401V	G	G		11	Filtered Calls	5	19571738	19571738	190	0.278947368421053	NA	NA	NA			138	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH18&recr=Open">Click here</a>	
CDH18	Silent	p.I328I	G	G		11	Filtered Calls	5	19591181	19591181	143	0.174825174825175	NA	NA	NA			138	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH18&recr=Open">Click here</a>	
CDH2	Silent	p.F804F	G	G		11	Filtered Calls	18	25543330	25543330	21	0.619047619047619	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH2&recr=Open">Click here</a>	
CDH23	Silent	p.I288I	C	C		11	Filtered Calls	10	73375277	73375277	61	0.19672131147541	NA	NA	NA			133	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH23&recr=Open">Click here</a>	
CDH23	Intron		C	C		11	Filtered Calls	10	73406381	73406381	100	0.22	NA	NA	NA			133			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH23&recr=Open">Click here</a>	
CDH23	Silent	p.G2302G	G	G		11	Filtered Calls	10	73558172	73558172	73	0.150684931506849	NA	NA	NA			133	Cadherin 22. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH23&recr=Open">Click here</a>	
CDH3	Intron		C	C		11	Filtered Calls	16	68732082	68732082	51	0.274509803921569	NA	NA	NA		p.?(2)	25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH3&recr=Open">Click here</a>	
CDH4	Silent	p.V415V	G	G		11	Filtered Calls	20	60485534	60485534	26	0.307692307692308	NA	NA	NA			74	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH4&recr=Open">Click here</a>	
CDH6	Silent	p.S443S	G	G	rs142200699	11	Filtered Calls	5	31313500	31313500	196	0.255102040816327	NA	NA	NA		p.S443S(1)	77	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH6&recr=Open">Click here</a>	
CDH7	Silent	p.P167P	C	C		11	Filtered Calls	18	63477230	63477230	142	0.380281690140845	NA	NA	NA			80	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH7&recr=Open">Click here</a>	
CDH8	Silent	p.K548K	C	C		11	Filtered Calls	16	61747755	61747755	129	0.271317829457364	NA	NA	NA			112	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH8&recr=Open">Click here</a>	
CDH8	Silent	p.L262L	A	A		11	Filtered Calls	16	61858965	61858965	82	0.317073170731707	NA	NA	NA			112	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH8&recr=Open">Click here</a>	
CDH8	Silent	p.L10L	A	A		11	Filtered Calls	16	62055280	62055280	156	0.288461538461538	NA	NA	NA			112			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH8&recr=Open">Click here</a>	
CDH9	Silent	p.L756L	G	G		11	Filtered Calls	5	26881347	26881347	254	0.196850393700787	NA	NA	NA			137			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH9&recr=Open">Click here</a>	
CDH9	Intron		G	G	rs373625166	11	Filtered Calls	5	26890074	26890074	222	0.193693693693694	NA	NA	NA			137			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH9&recr=Open">Click here</a>	
CDH9	Silent	p.A166A	G	G		11	Filtered Calls	5	26915763	26915763	235	0.204255319148936	NA	NA	NA			137	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH9&recr=Open">Click here</a>	
CDK5RAP1	Silent	p.I254I	G	G		11	Filtered Calls	20	31973570	31973570	54	0.444444444444444	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDK5RAP1&recr=Open">Click here</a>	
CDK5RAP3	Intron		C	C	rs374073867	11	Filtered Calls	17	46054198	46054198	70	0.657142857142857	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDK5RAP3&recr=Open">Click here</a>	
CDKAL1	Intron		C	C		11	Filtered Calls	6	20739739	20739739	90	0.177777777777778	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDKAL1&recr=Open">Click here</a>	
CDKN1A	Silent	p.T145T	C	C		11	Filtered Calls	6	36652313	36652313	57	0.614035087719298	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDKN1A&recr=Open">Click here</a>	
CEACAM18	Silent	p.P301P	C	C	rs529356930	11	Filtered Calls	19	51986500	51986500	49	0.306122448979592	NA	NA	NA			17	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEACAM18&recr=Open">Click here</a>	
CEACAM20	RNA		G	G		11	Filtered Calls	19	45015204	45015204	81	0.135802469135802	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEACAM20&recr=Open">Click here</a>	
CEACAM4	Silent	p.I90I	G	G		11	Filtered Calls	19	42132129	42132129	141	0.198581560283688	NA	NA	NA			16	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEACAM4&recr=Open">Click here</a>	
CEACAM5	Silent	p.T351T	A	A		11	Filtered Calls	19	42221471	42221471	135	0.0962962962962963	NA	NA	NA			34	Ig-like 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEACAM5&recr=Open">Click here</a>	
CECR1	Silent	p.S205S	C	C	rs373985143	11	Filtered Calls	22	17684591	17684591	77	0.220779220779221	NA	NA	NA			25	Substrate binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CECR1&recr=Open">Click here</a>	
CECR1	Intron		C	C		11	Filtered Calls	22	17690235	17690235	78	0.166666666666667	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CECR1&recr=Open">Click here</a>	
CECR5	Silent	p.P94P	G	G	rs575125213	11	Filtered Calls	22	17622002	17622002	59	0.186440677966102	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CECR5&recr=Open">Click here</a>	
CECR5	Intron		G	G		11	Filtered Calls	22	17630549	17630549	176	0.25	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CECR5&recr=Open">Click here</a>	
CELA3B	Intron		C	C	rs201720180	11	Filtered Calls	1	22304853	22304853	109	0.165137614678899	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELA3B&recr=Open">Click here</a>	
CELA3B	Silent	p.T80T	C	C		11	Filtered Calls	1	22307543	22307543	55	0.363636363636364	NA	NA	NA			8	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELA3B&recr=Open">Click here</a>	
CELA3B	Silent	p.S189S	C	C		11	Filtered Calls	1	22310749	22310749	51	0.372549019607843	NA	NA	NA			8	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELA3B&recr=Open">Click here</a>	
CELSR2	Silent	p.L387L	T	T		11	Filtered Calls	1	109793862	109793862	113	0.530973451327434	NA	NA	NA			82	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELSR2&recr=Open">Click here</a>	
CELSR2	Silent	p.Y1913Y	C	C		11	Filtered Calls	1	109808368	109808368	59	0.949152542372881	NA	NA	NA			82	EGF-like 7; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELSR2&recr=Open">Click here</a>	
CENPC	Intron		G	G		11	Filtered Calls	4	68406778	68406778	74	0.175675675675676	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CENPC&recr=Open">Click here</a>	
CENPJ	Silent	p.T424T	G	G		11	Filtered Calls	13	25480904	25480904	317	0.271293375394322	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CENPJ&recr=Open">Click here</a>	
CENPT	IGR		G	G		11	Filtered Calls	16	67860743	67860743	146	0.232876712328767	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CENPT&recr=Open">Click here</a>	
CEP170B	Silent	p.T1067T	C	C		11	Filtered Calls	14	105353777	105353777	16	0.1875	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP170B&recr=Open">Click here</a>	
CEP89	Intron		G	G		11	Filtered Calls	19	33409121	33409121	186	0.188172043010753	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP89&recr=Open">Click here</a>	
CERS3	Silent	p.S90S	G	G		11	Filtered Calls	15	101031040	101031040	145	0.0482758620689655	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CERS3&recr=Open">Click here</a>	
CERS4	Intron		G	G		11	Filtered Calls	19	8320619	8320619	16	0.3125	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CERS4&recr=Open">Click here</a>	
CES3	5'Flank		C	C		11	Filtered Calls	16	66998641	66998641	19	0.315789473684211	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CES3&recr=Open">Click here</a>	
CES3	Silent	p.A88A	G	G	rs138538405	11	Filtered Calls	16	67006314	67006314	201	0.228855721393035	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CES3&recr=Open">Click here</a>	
CES5A	Silent	p.G257G	T	T		11	Filtered Calls	16	55899896	55899896	66	0.287878787878788	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CES5A&recr=Open">Click here</a>	
CETN1	Silent	p.K51K	G	G		11	Filtered Calls	18	580561	580561	20	0.5	NA	NA	NA			25	EF-hand 1. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CETN1&recr=Open">Click here</a>	
CFB	Silent	p.T687T	G	G		11	Filtered Calls	6	31916261	31916261	166	0.240963855421687	NA	NA	NA			21	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFB&recr=Open">Click here</a>	
CFHR4	Intron		T	T		11	Filtered Calls	1	196887336	196887336	69	0.231884057971014	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFHR4&recr=Open">Click here</a>	
CFI	Silent	p.R345R	C	C		11	Filtered Calls	4	110670688	110670688	185	0.248648648648649	NA	NA	NA			27	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFI&recr=Open">Click here</a>	
CFI	Intron		T	T		11	Filtered Calls	4	110678915	110678915	61	0.229508196721311	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFI&recr=Open">Click here</a>	
CFI	Intron		G	G		11	Filtered Calls	4	110681804	110681804	77	0.25974025974026	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFI&recr=Open">Click here</a>	
CFTR	Intron		C	C		11	Filtered Calls	7	117170941	117170941	58	0.344827586206897	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFTR&recr=Open">Click here</a>	
CFTR	Intron		A	A		11	Filtered Calls	7	117199713	117199713	82	0.365853658536585	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFTR&recr=Open">Click here</a>	
CFTR	Silent	p.F1052F	C	C		11	Filtered Calls	7	117251651	117251651	56	0.357142857142857	NA	NA	NA			69	ABC transmembrane type-1 2. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFTR&recr=Open">Click here</a>	
CFTR	Silent	p.S1188S	G	G	rs146804928	11	Filtered Calls	7	117267671	117267671	105	0.4	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFTR&recr=Open">Click here</a>	
CGN	Silent	p.R412R	G	G		11	Filtered Calls	1	151496005	151496005	41	0.195121951219512	NA	NA	NA			45	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CGN&recr=Open">Click here</a>	
CGNL1	Silent	p.H265H	C	C		11	Filtered Calls	15	57730992	57730992	52	0.0769230769230769	NA	NA	NA			60	Head.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CGNL1&recr=Open">Click here</a>	
CHAF1B	Intron		T	T		11	Filtered Calls	21	37771811	37771811	228	0.37719298245614	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHAF1B&recr=Open">Click here</a>	
CHD5	Silent	p.Q1080Q	C	C		11	Filtered Calls	1	6191713	6191713	22	0.636363636363636	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD5&recr=Open">Click here</a>	
CHD6	Silent	p.I515I	G	G	rs149970572	11	Filtered Calls	20	40118553	40118553	90	0.422222222222222	NA	NA	NA		p.I515I(1)	129	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.|Required for DNA-dependent ATPase activity.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD6&recr=Open">Click here</a>	
CHD8	Intron		G	G		11	Filtered Calls	14	21868471	21868471	54	0.314814814814815	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD8&recr=Open">Click here</a>	
CHIT1	Intron		G	G		11	Filtered Calls	1	203195009	203195009	23	0.608695652173913	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHIT1&recr=Open">Click here</a>	
CHKA	5'Flank		G	G		11	Filtered Calls	11	67831980	67831980	29	0.586206896551724	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHKA&recr=Open">Click here</a>	
CHMP4B	Silent	p.L66L	C	C		11	Filtered Calls	20	32436280	32436280	39	0.717948717948718	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHMP4B&recr=Open">Click here</a>	
CHMP7	Intron		C	C		11	Filtered Calls	8	23114118	23114118	180	0.238888888888889	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHMP7&recr=Open">Click here</a>	
CHPF2	Silent	p.V261V	C	C	rs140913168	11	Filtered Calls	7	150932677	150932677	78	0.0512820512820513	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHPF2&recr=Open">Click here</a>	
CHRM3	Silent	p.F222F	C	C		11	Filtered Calls	1	240071417	240071417	196	0.459183673469388	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRM3&recr=Open">Click here</a>	
CHRM3	Silent	p.I429I	C	C		11	Filtered Calls	1	240072038	240072038	23	0.173913043478261	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRM3&recr=Open">Click here</a>	
CHRNA2	Silent	p.F192F	G	G	rs148009259	11	Filtered Calls	8	27321384	27321384	117	0.35042735042735	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRNA2&recr=Open">Click here</a>	
CHRNA2	Silent	p.R87R	G	G		11	Filtered Calls	8	27327311	27327311	79	0.253164556962025	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRNA2&recr=Open">Click here</a>	
CHRNA3	Silent	p.F108F	G	G		11	Filtered Calls	15	78909419	78909419	68	0.382352941176471	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRNA3&recr=Open">Click here</a>	
CHRNA4	Silent	p.A567A	C	C		11	Filtered Calls	20	61981062	61981062	34	0.235294117647059	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRNA4&recr=Open">Click here</a>	
CHRNB3	Silent	p.F160F	C	C		11	Filtered Calls	8	42586930	42586930	50	0.12	NA	NA	NA		p.F160F(1)	25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRNB3&recr=Open">Click here</a>	
CHRNB4	Intron		G	G		11	Filtered Calls	15	78921729	78921729	36	0.277777777777778	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRNB4&recr=Open">Click here</a>	
CHRNB4	Intron		C	C		11	Filtered Calls	15	78921863	78921863	64	0.3125	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRNB4&recr=Open">Click here</a>	
CHRND	Silent	p.F268F	C	C		11	Filtered Calls	2	233394833	233394833	70	0.285714285714286	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRND&recr=Open">Click here</a>	
CHST1	Silent	p.S280S	G	G		11	Filtered Calls	11	45671634	45671634	50	0.34	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHST1&recr=Open">Click here</a>	
CHST10	Silent	p.F240F	G	G		11	Filtered Calls	2	101010058	101010058	203	0.285714285714286	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHST10&recr=Open">Click here</a>	
CHST12	Silent	p.F338F	C	C		11	Filtered Calls	7	2473288	2473288	68	0.455882352941176	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHST12&recr=Open">Click here</a>	
CHST5	Silent	p.F285F	G	G	rs375851697	11	Filtered Calls	16	75563428	75563428	58	0.137931034482759	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHST5&recr=Open">Click here</a>	
CHST8	Silent	p.L31L	C	C		11	Filtered Calls	19	34180258	34180258	60	0.166666666666667	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHST8&recr=Open">Click here</a>	
CHST8	Silent	p.T250T	C	C		11	Filtered Calls	19	34263443	34263443	54	0.425925925925926	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHST8&recr=Open">Click here</a>	
CHTF18	Silent	p.S624S	C	C		11	Filtered Calls	16	844123	844123	39	0.307692307692308	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHTF18&recr=Open">Click here</a>	
CIB4	Silent	p.V63V	G	G		11	Filtered Calls	2	26818183	26818183	36	0.277777777777778	NA	NA	NA			10	EF-hand 1. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CIB4&recr=Open">Click here</a>	
CIC	Silent	p.P1423P	C	C		11	Filtered Calls	19	42794462	42794462	143	0.223776223776224	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CIC&recr=Open">Click here</a>	
CIITA	Intron		C	C		11	Filtered Calls	16	10989131	10989131	52	0.230769230769231	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CIITA&recr=Open">Click here</a>	
CKLF-CMTM1	IGR		G	G	rs9925443	11	Filtered Calls	16	66613691	66613691	95	0.221052631578947	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CKLF-CMTM1&recr=Open">Click here</a>	
CLASP1	Silent	p.S1463S	G	G		11	Filtered Calls	2	122098464	122098464	26	0.153846153846154	NA	NA	NA			47	Interaction with CLIP2. {ECO:0000250}.|Interaction with PHLDB2 and RSN.|Localization to kinetochores.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLASP1&recr=Open">Click here</a>	
CLASP2	Silent	p.L114L	G	G		11	Filtered Calls	3	33731359	33731359	44	0.136363636363636	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLASP2&recr=Open">Click here</a>	
CLCA4	Intron		T	T		11	Filtered Calls	1	87041012	87041012	187	0.0213903743315508	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCA4&recr=Open">Click here</a>	
CLCN1	Intron		C	C		11	Filtered Calls	7	143020397	143020397	46	0.717391304347826	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCN1&recr=Open">Click here</a>	
CLCN1	Silent	p.F341F	C	C		11	Filtered Calls	7	143028368	143028368	82	0.0731707317073171	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCN1&recr=Open">Click here</a>	
CLCN2	Silent	p.P52P	G	G		11	Filtered Calls	3	184076827	184076827	78	0.243589743589744	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCN2&recr=Open">Click here</a>	
CLCN4	Silent	p.L90L	C	C		11	Filtered Calls	X	10162976	10162976	118	0.38135593220339	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCN4&recr=Open">Click here</a>	
CLCNKB	Intron		G	G		11	Filtered Calls	1	16377102	16377102	35	0.428571428571429	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCNKB&recr=Open">Click here</a>	
CLDN10	Silent	p.S94S	C	C		11	Filtered Calls	13	96212447	96212447	226	0.234513274336283	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLDN10&recr=Open">Click here</a>	
CLDND1	Intron		G	G	rs370921810	11	Filtered Calls	3	98217208	98217208	105	0.371428571428571	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLDND1&recr=Open">Click here</a>	
CLEC3A	Silent	p.F97F	C	C		11	Filtered Calls	16	78064408	78064408	102	0.323529411764706	NA	NA	NA			18	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC3A&recr=Open">Click here</a>	
CLEC4D	Silent	p.C39C	T	T		11	Filtered Calls	12	8667920	8667920	138	0.297101449275362	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC4D&recr=Open">Click here</a>	
CLEC4D	Intron		G	G		11	Filtered Calls	12	8671768	8671768	60	0.116666666666667	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC4D&recr=Open">Click here</a>	
CLEC4E	Intron		G	G		11	Filtered Calls	12	8689784	8689784	140	0.235714285714286	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC4E&recr=Open">Click here</a>	
CLEC5A	Intron		G	G		11	Filtered Calls	7	141635707	141635707	74	0.418918918918919	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC5A&recr=Open">Click here</a>	
CLIC5	3'UTR		G	G		11	Filtered Calls	6	45870818	45870818	117	0.188034188034188	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLIC5&recr=Open">Click here</a>	
CLIP2	Silent	p.F279F	C	C	rs147879287	11	Filtered Calls	7	73770773	73770773	64	0.4375	NA	NA	NA			30	CAP-Gly 2. {ECO:0000255|PROSITE- ProRule:PRU00045}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLIP2&recr=Open">Click here</a>	
CLMN	Silent	p.F326F	G	G	rs111287470	11	Filtered Calls	14	95670708	95670708	216	0.615740740740741	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLMN&recr=Open">Click here</a>	
CLMP	5'UTR		G	G		11	Filtered Calls	11	122945495	122945495	73	0.835616438356164	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLMP&recr=Open">Click here</a>	
CLN3	5'Flank		G	G		11	Filtered Calls	16	28507256	28507256	19	0.210526315789474	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLN3&recr=Open">Click here</a>	
CLN6	Intron		G	G	rs371705916	11	Filtered Calls	15	68506731	68506731	46	0.304347826086957	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLN6&recr=Open">Click here</a>	
CLNK	Silent	p.V134V	C	C		11	Filtered Calls	4	10560074	10560074	245	0.440816326530612	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLNK&recr=Open">Click here</a>	
CLPTM1	Silent	p.F403F	C	C	rs144674984	11	Filtered Calls	19	45493771	45493771	149	0.51006711409396	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLPTM1&recr=Open">Click here</a>	
CLRN3	Silent	p.G58G	C	C		11	Filtered Calls	10	129690875	129690875	240	0.258333333333333	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLRN3&recr=Open">Click here</a>	
CLRN3	Silent	p.F15F	G	G		11	Filtered Calls	10	129691004	129691004	242	0.239669421487603	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLRN3&recr=Open">Click here</a>	
CLSTN2	Silent	p.K870K	G	G		11	Filtered Calls	3	140282930	140282930	65	0.384615384615385	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLSTN2&recr=Open">Click here</a>	
CLUL1	Silent	p.K402K	G	G		11	Filtered Calls	18	641463	641463	123	0.373983739837398	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLUL1&recr=Open">Click here</a>	
CLVS1	Silent	p.R138R	G	G	rs267601963	11	Filtered Calls	8	62212800	62212800	71	0.225352112676056	NA	NA	NA			41	CRAL-TRIO. {ECO:0000255|PROSITE- ProRule:PRU00056}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLVS1&recr=Open">Click here</a>	
CLVS1	Silent	p.L267L	T	T		11	Filtered Calls	8	62370923	62370923	200	0.175	NA	NA	NA			41	CRAL-TRIO. {ECO:0000255|PROSITE- ProRule:PRU00056}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLVS1&recr=Open">Click here</a>	
CLVS2	Silent	p.S293S	C	C		11	Filtered Calls	6	123377154	123377154	15	0.533333333333333	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLVS2&recr=Open">Click here</a>	
CMIP	Intron		C	C		11	Filtered Calls	16	81691429	81691429	19	0.157894736842105	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMIP&recr=Open">Click here</a>	
CMTR1	Silent	p.L827L	C	C		11	Filtered Calls	6	37447894	37447894	92	0.184782608695652	NA	NA	NA			NA	Interaction with POLR2A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMTR1&recr=Open">Click here</a>	
CMYA5	Silent	p.K2383K	G	G		11	Filtered Calls	5	79031737	79031737	82	0.414634146341463	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMYA5&recr=Open">Click here</a>	
CMYA5	Silent	p.F2723F	C	C		11	Filtered Calls	5	79032757	79032757	55	0.381818181818182	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMYA5&recr=Open">Click here</a>	
CMYA5	Silent	p.E3050E	G	G		11	Filtered Calls	5	79033738	79033738	83	0.0602409638554217	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMYA5&recr=Open">Click here</a>	
CNDP1	Silent	p.I16I	C	C	rs11538622	11	Filtered Calls	18	72226581	72226581	74	0.932432432432432	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNDP1&recr=Open">Click here</a>	
CNDP1	Silent	p.L90L	G	G		11	Filtered Calls	18	72228186	72228186	124	0.387096774193548	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNDP1&recr=Open">Click here</a>	
CNDP2	Silent	p.S387S	C	C	rs560774464	11	Filtered Calls	18	72185826	72185826	148	0.898648648648649	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNDP2&recr=Open">Click here</a>	
CNGA3	Silent	p.V311V	C	C		11	Filtered Calls	2	99012554	99012554	108	0.342592592592593	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNGA3&recr=Open">Click here</a>	
CNGB1	Silent	p.S494S	A	A		11	Filtered Calls	16	57965673	57965673	30	0.3	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNGB1&recr=Open">Click here</a>	
CNKSR2	Silent	p.R106R	G	G		11	Filtered Calls	X	21450819	21450819	175	0.422857142857143	NA	NA	NA			61	CRIC. {ECO:0000255|PROSITE- ProRule:PRU00621}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNKSR2&recr=Open">Click here</a>	
CNKSR2	Intron		C	C		11	Filtered Calls	X	21609129	21609129	234	0.94017094017094	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNKSR2&recr=Open">Click here</a>	
CNN1	Intron		G	G		11	Filtered Calls	19	11660293	11660293	16	0.1875	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNN1&recr=Open">Click here</a>	
CNN3	Silent	p.G45G	G	G		11	Filtered Calls	1	95369003	95369003	144	0.555555555555556	NA	NA	NA			18	CH. {ECO:0000255|PROSITE- ProRule:PRU00044}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNN3&recr=Open">Click here</a>	
CNOT1	Silent	p.I1397I	A	A		11	Filtered Calls	16	58577754	58577754	81	0.234567901234568	NA	NA	NA			87	Interaction with CNOT6, CNOT6L, CNOT7 and CNOT8.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNOT1&recr=Open">Click here</a>	
CNOT7	Silent	p.I168I	G	G		11	Filtered Calls	8	17092339	17092339	216	0.212962962962963	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNOT7&recr=Open">Click here</a>	
CNPPD1	Intron		G	G		11	Filtered Calls	2	220039834	220039834	68	0.264705882352941	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNPPD1&recr=Open">Click here</a>	
CNTD1	5'Flank		G	G		11	Filtered Calls	17	40948512	40948512	58	0.431034482758621	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTD1&recr=Open">Click here</a>	
CNTLN	Silent	p.L1020L	C	C		11	Filtered Calls	9	17416133	17416133	179	0.379888268156425	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTLN&recr=Open">Click here</a>	
CNTN3	Intron		G	G		11	Filtered Calls	3	74548947	74548947	147	0.469387755102041	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN3&recr=Open">Click here</a>	
CNTN4	Intron		A	A		11	Filtered Calls	3	2787391	2787391	121	0.173553719008264	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN4&recr=Open">Click here</a>	
CNTN4	Silent	p.R499R	G	G		11	Filtered Calls	3	3067796	3067796	131	0.541984732824427	NA	NA	NA			61	Ig-like C2-type 6.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN4&recr=Open">Click here</a>	
CNTN5	Intron		C	C		11	Filtered Calls	11	99690268	99690268	85	0.329411764705882	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN5&recr=Open">Click here</a>	
CNTN5	Silent	p.I701I	C	C		11	Filtered Calls	11	100126589	100126589	64	0.484375	NA	NA	NA			81	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN5&recr=Open">Click here</a>	
CNTN6	Intron		C	C	rs371457244	11	Filtered Calls	3	1320092	1320092	181	0.265193370165746	NA	NA	NA			90			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN6&recr=Open">Click here</a>	
CNTN6	Silent	p.V186V	G	G		11	Filtered Calls	3	1337388	1337388	130	0.246153846153846	NA	NA	NA			90	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN6&recr=Open">Click here</a>	
CNTN6	Intron		T	T		11	Filtered Calls	3	1371465	1371465	245	0.212244897959184	NA	NA	NA			90			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN6&recr=Open">Click here</a>	
CNTNAP2	Silent	p.K354K	G	G		11	Filtered Calls	7	146825907	146825907	173	0.352601156069364	NA	NA	NA			188	Laminin G-like 1. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP2&recr=Open">Click here</a>	
CNTNAP2	Silent	p.F959F	C	C		11	Filtered Calls	7	147869437	147869437	40	0.175	NA	NA	NA			188	Laminin G-like 3. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP2&recr=Open">Click here</a>	
CNTROB	Silent	p.P180P	C	C		11	Filtered Calls	17	7838409	7838409	143	0.272727272727273	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTROB&recr=Open">Click here</a>	
CNTROB	Intron		C	C		11	Filtered Calls	17	7851464	7851464	101	0.267326732673267	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTROB&recr=Open">Click here</a>	
COASY	3'UTR		C	C		11	Filtered Calls	17	40717993	40717993	142	0.492957746478873	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COASY&recr=Open">Click here</a>	
COG1	Silent	p.L291L	C	C		11	Filtered Calls	17	71193495	71193495	163	0.220858895705521	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COG1&recr=Open">Click here</a>	
COIL	Silent	p.P261P	G	G		11	Filtered Calls	17	55027820	55027820	246	0.252032520325203	NA	NA	NA			15	2 X 4 AA repeats of A-R-N-S.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COIL&recr=Open">Click here</a>	
COL11A1	Silent	p.F929F	G	G		11	Filtered Calls	1	103440407	103440407	146	0.0479452054794521	NA	NA	NA			258	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL11A1&recr=Open">Click here</a>	
COL11A1	Intron		G	G		11	Filtered Calls	1	103445163	103445163	34	0.529411764705882	NA	NA	NA			258			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL11A1&recr=Open">Click here</a>	
COL11A1	Silent	p.T187T	C	C	rs368813913	11	Filtered Calls	1	103540264	103540264	184	0.934782608695652	NA	NA	NA			258	Laminin G-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL11A1&recr=Open">Click here</a>	
COL13A1	Silent	p.L132L	C	C		11	Filtered Calls	10	71631963	71631963	81	0.172839506172839	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL13A1&recr=Open">Click here</a>	
COL14A1	Intron		T	T		11	Filtered Calls	8	121301838	121301838	253	0.201581027667984	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL14A1&recr=Open">Click here</a>	
COL15A1	Silent	p.I83I	C	C		11	Filtered Calls	9	101747995	101747995	46	0.695652173913043	NA	NA	NA			107	Laminin G-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL15A1&recr=Open">Click here</a>	
COL15A1	Silent	p.V127V	G	G		11	Filtered Calls	9	101748127	101748127	64	0.28125	NA	NA	NA			107	Laminin G-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL15A1&recr=Open">Click here</a>	
COL18A1	Intron		C	C	rs374650058	11	Filtered Calls	21	46902702	46902702	56	0.321428571428571	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL18A1&recr=Open">Click here</a>	
COL19A1	Silent	p.G1054G	G	G		11	Filtered Calls	6	70909379	70909379	94	0.468085106382979	NA	NA	NA			109	Triple-helical region 6 (COL6).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL19A1&recr=Open">Click here</a>	
COL1A2	Intron		G	G		11	Filtered Calls	7	94029422	94029422	110	0.0545454545454545	NA	NA	NA			115			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL1A2&recr=Open">Click here</a>	
COL1A2	Silent	p.F257F	C	C		11	Filtered Calls	7	94038114	94038114	45	0.688888888888889	NA	NA	NA			115			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL1A2&recr=Open">Click here</a>	
COL1A2	Intron		C	C		11	Filtered Calls	7	94055300	94055300	93	0.709677419354839	NA	NA	NA			115			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL1A2&recr=Open">Click here</a>	
COL20A1	Silent	p.I1040I	C	C	rs369267534	11	Filtered Calls	20	61951666	61951666	31	0.32258064516129	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL20A1&recr=Open">Click here</a>	
COL22A1	Intron		G	G		11	Filtered Calls	8	139603749	139603749	50	0.38	NA	NA	NA			211			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL22A1&recr=Open">Click here</a>	
COL22A1	Silent	p.F609F	G	G	rs551548894	11	Filtered Calls	8	139774686	139774686	60	0.116666666666667	NA	NA	NA			211	Collagen-like 3.|Gly-rich.|Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL22A1&recr=Open">Click here</a>	
COL25A1	Silent	p.G625G	C	C		11	Filtered Calls	4	109740456	109740456	117	0.256410256410256	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL25A1&recr=Open">Click here</a>	
COL25A1	Intron		C	C		11	Filtered Calls	4	109765735	109765735	79	0.341772151898734	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL25A1&recr=Open">Click here</a>	
COL28A1	Silent	p.S479S	G	G		11	Filtered Calls	7	7493074	7493074	312	0.230769230769231	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL28A1&recr=Open">Click here</a>	
COL2A1	Silent	p.F898F	G	G		11	Filtered Calls	12	48373333	48373333	26	0.423076923076923	NA	NA	NA			64	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL2A1&recr=Open">Click here</a>	
COL3A1	Intron		T	T		11	Filtered Calls	2	189857607	189857607	216	0.314814814814815	NA	NA	NA			126			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL3A1&recr=Open">Click here</a>	
COL3A1	Intron		C	C	rs587779700|rs368416786	11	Filtered Calls	2	189863396	189863396	85	0.247058823529412	NA	NA	NA			126			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL3A1&recr=Open">Click here</a>	
COL3A1	Silent	p.K740K	G	G	rs541557925	11	Filtered Calls	2	189864294	189864294	88	0.193181818181818	NA	NA	NA			126	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL3A1&recr=Open">Click here</a>	
COL4A1	Silent	p.P694P	G	G		11	Filtered Calls	13	110835353	110835353	23	0.173913043478261	NA	NA	NA			105	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A1&recr=Open">Click here</a>	
COL4A1	Intron		G	G		11	Filtered Calls	13	110859070	110859070	345	0.536231884057971	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A1&recr=Open">Click here</a>	
COL4A2	Intron		C	C		11	Filtered Calls	13	111160273	111160273	111	0.774774774774775	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A2&recr=Open">Click here</a>	
COL4A3	Silent	p.L1043L	C	C		11	Filtered Calls	2	228155521	228155521	72	0.708333333333333	NA	NA	NA			55	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A3&recr=Open">Click here</a>	
COL4A3	Silent	p.P1278P	A	A		11	Filtered Calls	2	228163480	228163480	82	0.341463414634146	NA	NA	NA			55	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A3&recr=Open">Click here</a>	
COL4A4	Silent	p.I758I	G	G		11	Filtered Calls	2	227924230	227924230	103	0.330097087378641	NA	NA	NA			98	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A4&recr=Open">Click here</a>	
COL4A5	Intron		G	G		11	Filtered Calls	X	107869034	107869034	52	0.480769230769231	NA	NA	NA			99			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A5&recr=Open">Click here</a>	
COL4A5	Silent	p.G1351G	C	C		11	Filtered Calls	X	107924152	107924152	92	0.380434782608696	NA	NA	NA			99	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A5&recr=Open">Click here</a>	
COL4A5	Intron		A	A		11	Filtered Calls	X	107930936	107930936	105	0.895238095238095	NA	NA	NA			99			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A5&recr=Open">Click here</a>	
COL4A6	Intron		A	A		11	Filtered Calls	X	107449621	107449621	94	0.478723404255319	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A6&recr=Open">Click here</a>	
COL5A1	Intron		C	C		11	Filtered Calls	9	137630312	137630312	31	0.451612903225806	NA	NA	NA			115			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A1&recr=Open">Click here</a>	
COL5A1	Intron		C	C		11	Filtered Calls	9	137648607	137648607	21	0.571428571428571	NA	NA	NA			115			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A1&recr=Open">Click here</a>	
COL5A2	Silent	p.G684G	C	C		11	Filtered Calls	2	189925489	189925489	172	0.215116279069767	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A2&recr=Open">Click here</a>	
COL5A3	Silent	p.P1563P	G	G	rs368569500	11	Filtered Calls	19	10077083	10077083	33	0.151515151515152	NA	NA	NA			116	Fibrillar collagen NC1. {ECO:0000255|PROSITE-ProRule:PRU00793}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A3&recr=Open">Click here</a>	
COL5A3	Silent	p.E1251E	C	C		11	Filtered Calls	19	10083616	10083616	28	0.25	NA	NA	NA			116	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A3&recr=Open">Click here</a>	
COL5A3	Intron		G	G		11	Filtered Calls	19	10091817	10091817	87	0.425287356321839	NA	NA	NA			116			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A3&recr=Open">Click here</a>	
COL5A3	Intron		G	G	rs536011022	11	Filtered Calls	19	10114393	10114393	29	0.379310344827586	NA	NA	NA			116			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A3&recr=Open">Click here</a>	
COL6A3	Silent	p.F1692F	G	G		11	Filtered Calls	2	238275754	238275754	72	0.277777777777778	NA	NA	NA			217	Nonhelical region.|VWFA 9. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A3&recr=Open">Click here</a>	
COL6A5	Silent	p.S2439S	C	C		11	Filtered Calls	3	130188165	130188165	35	0.428571428571429	NA	NA	NA			44	Nonhelical region.|VWFA 10. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A5&recr=Open">Click here</a>	
COL6A6	Silent	p.G1860G	G	G		11	Filtered Calls	3	130368253	130368253	18	0.5	NA	NA	NA			134	Nonhelical region.|VWFA 8. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A6&recr=Open">Click here</a>	
COL7A1	Silent	p.G1501G	G	G		11	Filtered Calls	3	48620461	48620461	107	0.205607476635514	NA	NA	NA			137	Triple-helical region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL7A1&recr=Open">Click here</a>	
COL7A1	Intron		G	G		11	Filtered Calls	3	48629909	48629909	72	0.125	NA	NA	NA			137			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL7A1&recr=Open">Click here</a>	
COL9A1	Silent	p.G864G	G	G		11	Filtered Calls	6	70926774	70926774	26	0.384615384615385	NA	NA	NA			80	Collagen-like 10.|Triple-helical region (COL1).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL9A1&recr=Open">Click here</a>	
COL9A3	Intron		C	C	rs201781331	11	Filtered Calls	20	61453452	61453452	50	0.16	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL9A3&recr=Open">Click here</a>	
COL9A3	Silent	p.A342A	G	G		11	Filtered Calls	20	61460824	61460824	35	0.285714285714286	NA	NA	NA			28	Triple-helical region 3 (COL3).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL9A3&recr=Open">Click here</a>	
COLEC12	Silent	p.S408S	C	C		11	Filtered Calls	18	346398	346398	90	0.4	NA	NA	NA		p.S408S(1)	46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COLEC12&recr=Open">Click here</a>	
COLEC12	Silent	p.L394L	C	C		11	Filtered Calls	18	346440	346440	62	0.32258064516129	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COLEC12&recr=Open">Click here</a>	
COLGALT2	Intron		G	G		11	Filtered Calls	1	183908182	183908182	39	0.794871794871795	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COLGALT2&recr=Open">Click here</a>	
COLGALT2	Silent	p.A155A	C	C	rs150587929	11	Filtered Calls	1	183944258	183944258	443	0.460496613995485	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COLGALT2&recr=Open">Click here</a>	
COPA	Silent	p.I709I	G	G		11	Filtered Calls	1	160267386	160267386	405	0.212345679012346	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COPA&recr=Open">Click here</a>	
COPA	Silent	p.T697T	G	G		11	Filtered Calls	1	160267422	160267422	356	0.48314606741573	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COPA&recr=Open">Click here</a>	
COPG1	Silent	p.I47I	C	C		11	Filtered Calls	3	128971174	128971174	154	0.415584415584416	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COPG1&recr=Open">Click here</a>	
COPG1	Silent	p.L84L	C	C		11	Filtered Calls	3	128971727	128971727	188	0.457446808510638	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COPG1&recr=Open">Click here</a>	
COPS5	5'UTR		C	C		11	Filtered Calls	8	67976725	67976725	49	0.26530612244898	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COPS5&recr=Open">Click here</a>	
COQ7	Intron		C	C		11	Filtered Calls	16	19087191	19087191	60	0.0666666666666667	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COQ7&recr=Open">Click here</a>	
COQ9	Intron		T	T		11	Filtered Calls	16	57493958	57493958	54	0.333333333333333	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COQ9&recr=Open">Click here</a>	
CORIN	Silent	p.I64I	G	G		11	Filtered Calls	4	47808936	47808936	45	0.377777777777778	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CORIN&recr=Open">Click here</a>	
COX5A	Silent	p.G107G	G	G		11	Filtered Calls	15	75216013	75216013	100	0.22	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COX5A&recr=Open">Click here</a>	
COX8C	5'UTR		G	G		11	Filtered Calls	14	93813612	93813612	42	0.214285714285714	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COX8C&recr=Open">Click here</a>	
CPAMD8	Silent	p.G131G	C	C		11	Filtered Calls	19	17131156	17131156	242	0.446280991735537	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPAMD8&recr=Open">Click here</a>	
CPE	Intron		C	C		11	Filtered Calls	4	166307420	166307420	216	0.305555555555556	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPE&recr=Open">Click here</a>	
CPEB1	Intron		C	C		11	Filtered Calls	15	83221372	83221372	112	0.330357142857143	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPEB1&recr=Open">Click here</a>	
CPED1	Intron		-	-	rs375379705	11	Filtered Calls	7	120774001	120774002	25	0.84	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPED1&recr=Open">Click here</a>	
CPED1	Silent	p.L876L	G	G		11	Filtered Calls	7	120906857	120906857	111	0.0720720720720721	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPED1&recr=Open">Click here</a>	
CPM	Silent	p.F76F	G	G		11	Filtered Calls	12	69279602	69279602	142	0.436619718309859	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPM&recr=Open">Click here</a>	
CPNE3	Intron		C	C		11	Filtered Calls	8	87558816	87558816	214	0.457943925233645	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPNE3&recr=Open">Click here</a>	
CPNE4	Silent	p.I417I	G	G		11	Filtered Calls	3	131268842	131268842	76	0.368421052631579	NA	NA	NA		p.I417I(1)	39	VWFA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPNE4&recr=Open">Click here</a>	
CPNE4	Silent	p.S326S	G	G		11	Filtered Calls	3	131283143	131283143	86	0.0813953488372093	NA	NA	NA			39	VWFA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPNE4&recr=Open">Click here</a>	
CPNE4	Silent	p.F314F	G	G	rs138712970	11	Filtered Calls	3	131283179	131283179	69	0.318840579710145	NA	NA	NA			39	VWFA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPNE4&recr=Open">Click here</a>	
CPNE5	Silent	p.F379F	G	G		11	Filtered Calls	6	36714236	36714236	61	0.229508196721311	NA	NA	NA			25	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPNE5&recr=Open">Click here</a>	
CPPED1	Silent	p.L307L	G	G		11	Filtered Calls	16	12758767	12758767	124	0.25	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPPED1&recr=Open">Click here</a>	
CPQ	Intron		A	A		11	Filtered Calls	8	98078442	98078442	46	0.282608695652174	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPQ&recr=Open">Click here</a>	
CPSF7	Silent	p.H281H	G	G		11	Filtered Calls	11	61183672	61183672	69	0.420289855072464	NA	NA	NA			22	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPSF7&recr=Open">Click here</a>	
CPT1B	Intron		G	G		11	Filtered Calls	22	51015475	51015475	60	0.166666666666667	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPT1B&recr=Open">Click here</a>	
CPT1C	Silent	p.L101L	C	C		11	Filtered Calls	19	50203962	50203962	144	0.194444444444444	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPT1C&recr=Open">Click here</a>	
CPXCR1	Silent	p.I76I	C	C		11	Filtered Calls	X	88008643	88008643	27	0.333333333333333	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPXCR1&recr=Open">Click here</a>	
CPXM2	Intron		G	G		11	Filtered Calls	10	125639837	125639837	61	0.229508196721311	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPXM2&recr=Open">Click here</a>	
CPZ	Silent	p.T49T	C	C		11	Filtered Calls	4	8602908	8602908	18	0.277777777777778	NA	NA	NA			46	FZ. {ECO:0000255|PROSITE- ProRule:PRU00090}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPZ&recr=Open">Click here</a>	
CPZ	Silent	p.Y249Y	C	C		11	Filtered Calls	4	8607786	8607786	22	0.545454545454545	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPZ&recr=Open">Click here</a>	
CR1	Silent	p.T1858T	G	G	rs201955068	11	Filtered Calls	1	207760774	207760774	151	0.450331125827815	NA	NA	NA			82	Sushi 29. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CR1&recr=Open">Click here</a>	
CR2	Silent	p.F767F	C	C		11	Filtered Calls	1	207647646	207647646	191	0.261780104712042	NA	NA	NA			69	Sushi 12. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CR2&recr=Open">Click here</a>	
CRB1	Intron		C	C		11	Filtered Calls	1	197403830	197403830	153	0.169934640522876	NA	NA	NA			132			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRB1&recr=Open">Click here</a>	
CRB1	IGR		G	G		11	Filtered Calls	1	197447010	197447010	81	0.222222222222222	NA	NA	NA			132			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRB1&recr=Open">Click here</a>	
CREB3	IGR		G	G		11	Filtered Calls	9	35738628	35738628	111	0.423423423423423	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CREB3&recr=Open">Click here</a>	
CREB3L1	Silent	p.N454N	C	C		11	Filtered Calls	11	46341918	46341918	13	0.307692307692308	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CREB3L1&recr=Open">Click here</a>	
CREB3L2	Silent	p.F520F	G	G		11	Filtered Calls	7	137565225	137565225	29	0.827586206896552	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CREB3L2&recr=Open">Click here</a>	
CREB3L2	Intron		G	G		11	Filtered Calls	7	137597831	137597831	55	0.436363636363636	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CREB3L2&recr=Open">Click here</a>	
CREB5	Silent	p.I479I	C	C		11	Filtered Calls	7	28858806	28858806	145	0.282758620689655	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CREB5&recr=Open">Click here</a>	
CREBBP	Intron		G	G		11	Filtered Calls	16	3790555	3790555	53	0.584905660377358	NA	NA	NA			295			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CREBBP&recr=Open">Click here</a>	
CRHR2	Silent	p.F280F	G	G	rs149909822	11	Filtered Calls	7	30695620	30695620	70	0.3	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRHR2&recr=Open">Click here</a>	
CRIM1	Silent	p.T115T	T	T		11	Filtered Calls	2	36623770	36623770	148	0.466216216216216	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRIM1&recr=Open">Click here</a>	
CRKL	Silent	p.I243I	C	C		11	Filtered Calls	22	21288484	21288484	202	0.173267326732673	NA	NA	NA			14	SH3 2. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRKL&recr=Open">Click here</a>	
CRLF2	5'UTR		G	G		11	Filtered Calls	X	1321372	1321372	123	0.219512195121951	NA	NA	NA		p.S128L(1)	20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRLF2&recr=Open">Click here</a>	
CROCC	Silent	p.D1106D	C	C		11	Filtered Calls	1	17280849	17280849	40	0.375	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CROCC&recr=Open">Click here</a>	
CROT	Intron		C	C		11	Filtered Calls	7	86988518	86988518	119	0.0672268907563025	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CROT&recr=Open">Click here</a>	
CRYBB1	Silent	p.E165E	C	C		11	Filtered Calls	22	26997923	26997923	101	0.207920792079208	NA	NA	NA			31	Beta/gamma crystallin 'Greek key' 3. {ECO:0000255|PROSITE-ProRule:PRU00028}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRYBB1&recr=Open">Click here</a>	
CRYBB3	Silent	p.G76G	G	G		11	Filtered Calls	22	25599763	25599763	116	0.198275862068966	NA	NA	NA			5	Beta/gamma crystallin 'Greek key' 2. {ECO:0000255|PROSITE-ProRule:PRU00028}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRYBB3&recr=Open">Click here</a>	
CRYGN	Silent	p.F62F	G	G		11	Filtered Calls	7	151135166	151135166	37	0.891891891891892	NA	NA	NA			8	Beta/gamma crystallin 'Greek key' 2. {ECO:0000255|PROSITE-ProRule:PRU00028}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRYGN&recr=Open">Click here</a>	
CSAD	Intron		G	G		11	Filtered Calls	12	53554111	53554111	23	0.478260869565217	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSAD&recr=Open">Click here</a>	
CSAD	Silent	p.I120I	G	G		11	Filtered Calls	12	53565757	53565757	27	0.333333333333333	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSAD&recr=Open">Click here</a>	
CSAD	Silent	p.S40S	G	G		11	Filtered Calls	12	53567135	53567135	21	0.333333333333333	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSAD&recr=Open">Click here</a>	
CSAG1	Intron		G	G		11	Filtered Calls	X	151908934	151908934	101	0.475247524752475	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSAG1&recr=Open">Click here</a>	
CSDE1	Silent	p.I506I	G	G	rs560545162	11	Filtered Calls	1	115263304	115263304	257	0.272373540856031	NA	NA	NA			51	CSD 6.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSDE1&recr=Open">Click here</a>	
CSF1R	Silent	p.S225S	T	T		11	Filtered Calls	5	149457729	149457729	66	0.454545454545455	NA	NA	NA			93	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSF1R&recr=Open">Click here</a>	
CSF2RA	Silent	p.T63T	T	T		11	Filtered Calls	X	1404783	1404783	151	0.225165562913907	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSF2RA&recr=Open">Click here</a>	
CSF2RA	Intron		G	G		11	Filtered Calls	X	1424429	1424429	72	0.25	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSF2RA&recr=Open">Click here</a>	
CSF3R	Silent	p.R478R	C	C		11	Filtered Calls	1	36935293	36935293	144	0.930555555555556	NA	NA	NA			38	Fibronectin type-III 4. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSF3R&recr=Open">Click here</a>	
CSK	Silent	p.F310F	C	C		11	Filtered Calls	15	75094078	75094078	24	0.583333333333333	NA	NA	NA			3	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSK&recr=Open">Click here</a>	
CSMD1	Silent	p.G3367G	C	C		11	Filtered Calls	8	2808739	2808739	22	0.409090909090909	NA	NA	NA		p.G3095G(1)|p.G3366G(1)	25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	
CSMD1	Silent	p.F2112F	G	G	rs371752238	11	Filtered Calls	8	2976018	2976018	152	0.539473684210526	NA	NA	NA			25	Sushi 12. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	
CSMD1	Intron		G	G		11	Filtered Calls	8	3063145	3063145	29	0.172413793103448	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	
CSMD1	Intron		G	G		11	Filtered Calls	8	3200978	3200978	38	0.210526315789474	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	
CSMD1	Silent	p.P429P	C	C	rs372720663	11	Filtered Calls	8	3432527	3432527	74	0.486486486486487	NA	NA	NA			25	CUB 3. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	
CSMD1	Silent	p.F365F	G	G		11	Filtered Calls	8	3474234	3474234	59	0.186440677966102	NA	NA	NA			25	Sushi 2. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	
CSMD2	Intron		G	G		11	Filtered Calls	1	33992867	33992867	45	0.355555555555556	NA	NA	NA			246			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD2&recr=Open">Click here</a>	
CSMD2	Silent	p.A1115A	G	G		11	Filtered Calls	1	34180248	34180248	86	0.0581395348837209	NA	NA	NA			246	CUB 7. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD2&recr=Open">Click here</a>	
CSMD2	Silent	p.F870F	G	G		11	Filtered Calls	1	34191035	34191035	36	0.305555555555556	NA	NA	NA			246	Sushi 5. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD2&recr=Open">Click here</a>	
CSMD2	Silent	p.F761F	G	G		11	Filtered Calls	1	34204826	34204826	37	0.891891891891892	NA	NA	NA			246	CUB 5. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD2&recr=Open">Click here</a>	
CSMD3	Intron		A	A		11	Filtered Calls	8	113256614	113256614	120	0.3	NA	NA	NA			646			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	
CSMD3	Silent	p.L3183L	C	C		11	Filtered Calls	8	113277779	113277779	264	0.231060606060606	NA	NA	NA			646	Sushi 24. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	
CSMD3	Intron		G	G		11	Filtered Calls	8	113326653	113326653	113	0.389380530973451	NA	NA	NA			646			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	
CSMD3	Silent	p.F1630F	G	G		11	Filtered Calls	8	113518925	113518925	262	0.217557251908397	NA	NA	NA			646	CUB 9. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	
CSMD3	Silent	p.T1246T	C	C		11	Filtered Calls	8	113599442	113599442	337	0.231454005934718	NA	NA	NA			646	CUB 7. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	
CSN2	Intron		T	T		11	Filtered Calls	4	70824623	70824623	279	0.455197132616487	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSN2&recr=Open">Click here</a>	
CSN3	Silent	p.T167T	G	G	rs201406795	11	Filtered Calls	4	71115128	71115128	89	0.370786516853933	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSN3&recr=Open">Click here</a>	
CSNK1G2	Silent	p.P198P	C	C		11	Filtered Calls	19	1979004	1979004	24	0.375	NA	NA	NA			8	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSNK1G2&recr=Open">Click here</a>	
CSNK1G3	Intron		C	C		11	Filtered Calls	5	122950024	122950024	104	0.413461538461538	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSNK1G3&recr=Open">Click here</a>	
CSNK2B	5'Flank		G	G		11	Filtered Calls	6	31630499	31630499	83	0.168674698795181	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSNK2B&recr=Open">Click here</a>	
CST11	Silent	p.T100T	C	C		11	Filtered Calls	20	23432486	23432486	88	0.284090909090909	NA	NA	NA		p.T100T(1)	14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CST11&recr=Open">Click here</a>	
CT62	3'UTR		G	G		11	Filtered Calls	15	71403563	71403563	28	0.25	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CT62&recr=Open">Click here</a>	
CTBP2	Silent	p.P49P	G	G		11	Filtered Calls	10	126691973	126691973	83	0.265060240963855	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTBP2&recr=Open">Click here</a>	
CTBP2	Intron		G	G	rs373594497	11	Filtered Calls	10	126714827	126714827	58	0.224137931034483	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTBP2&recr=Open">Click here</a>	
CTC1	Silent	p.A565A	G	G		11	Filtered Calls	17	8137896	8137896	14	0.714285714285714	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTC1&recr=Open">Click here</a>	
CTCFL	Silent	p.F56F	G	G		11	Filtered Calls	20	56099094	56099094	110	0.281818181818182	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTCFL&recr=Open">Click here</a>	
CTCFL	Silent	p.R42R	C	C		11	Filtered Calls	20	56099136	56099136	172	0.331395348837209	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTCFL&recr=Open">Click here</a>	
CTD-2207O23.3	Silent	p.A273A	C	C		11	Filtered Calls	19	7509239	7509239	42	0.214285714285714	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTD-2207O23.3&recr=Open">Click here</a>	
CTD-2215E18.1	Intron		C	C	rs77316058	11	Filtered Calls	5	96500850	96500850	93	0.43010752688172	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTD-2215E18.1&recr=Open">Click here</a>	
CTD-2278I10.6	IGR		C	C	rs370761881	11	Filtered Calls	19	17394462	17394462	68	0.279411764705882	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTD-2278I10.6&recr=Open">Click here</a>	
CTD-2330K9.3	Intron		G	G		11	Filtered Calls	3	49947603	49947603	127	0.488188976377953	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTD-2330K9.3&recr=Open">Click here</a>	
CTD-2545M3.6	Silent	p.P191P	C	C		11	Filtered Calls	19	50926125	50926125	74	0.243243243243243	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTD-2545M3.6&recr=Open">Click here</a>	
CTD-3074O7.11	Silent	p.L332L	T	T		11	Filtered Calls	11	66290981	66290981	46	0.804347826086957	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTD-3074O7.11&recr=Open">Click here</a>	
CTD-3222D19.2	3'UTR		G	G		11	Filtered Calls	19	16606600	16606600	184	0.260869565217391	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTD-3222D19.2&recr=Open">Click here</a>	
CTD-3222D19.2	Intron		C	C		11	Filtered Calls	19	16612034	16612034	121	0.454545454545455	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTD-3222D19.2&recr=Open">Click here</a>	
CTD-3222D19.2	3'UTR		G	G		11	Filtered Calls	19	16664601	16664601	151	0.218543046357616	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTD-3222D19.2&recr=Open">Click here</a>	
CTD-3222D19.2	3'UTR		G	G		11	Filtered Calls	19	16664634	16664634	93	0.505376344086022	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTD-3222D19.2&recr=Open">Click here</a>	
CTNNA2	Silent	p.D325D	C	C		11	Filtered Calls	2	80136842	80136842	127	0.173228346456693	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA2&recr=Open">Click here</a>	
CTNNA2	Silent	p.I331I	C	C	rs112183183	11	Filtered Calls	2	80136860	80136860	119	0.34453781512605	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA2&recr=Open">Click here</a>	
CTNNA2	Intron		C	C		11	Filtered Calls	2	80620328	80620328	273	0.465201465201465	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA2&recr=Open">Click here</a>	
CTNNA3	Silent	p.A416A	C	C		11	Filtered Calls	10	68526055	68526055	275	0.170909090909091	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA3&recr=Open">Click here</a>	
CTNNA3	Intron		C	C		11	Filtered Calls	10	69106476	69106476	26	0.307692307692308	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA3&recr=Open">Click here</a>	
CTNNB1	IGR		C	C		11	Filtered Calls	3	41279547	41279547	897	0.244147157190635	NA	NA	NA			3893			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNB1&recr=Open">Click here</a>	
CTNND2	Silent	p.V746V	C	C		11	Filtered Calls	5	11117601	11117601	205	0.229268292682927	NA	NA	NA			136			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNND2&recr=Open">Click here</a>	
CTNND2	Silent	p.I688I	G	G		11	Filtered Calls	5	11159783	11159783	118	0.279661016949153	NA	NA	NA			136			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNND2&recr=Open">Click here</a>	
CTNND2	Silent	p.F166F	G	G		11	Filtered Calls	5	11397257	11397257	53	0.377358490566038	NA	NA	NA			136			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNND2&recr=Open">Click here</a>	
CTRC	Silent	p.F68F	C	C		11	Filtered Calls	1	15767060	15767060	55	0.563636363636364	NA	NA	NA			13	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTRC&recr=Open">Click here</a>	
CTSE	3'UTR		G	G		11	Filtered Calls	1	206331186	206331186	99	0.202020202020202	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTSE&recr=Open">Click here</a>	
CTSF	IGR		G	G		11	Filtered Calls	11	66330608	66330608	22	0.545454545454545	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTSF&recr=Open">Click here</a>	
CTSZ	Silent	p.I275I	G	G	rs370129546	11	Filtered Calls	20	57570791	57570791	98	0.275510204081633	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTSZ&recr=Open">Click here</a>	
CTTNBP2	Silent	p.S1440S	G	G		11	Filtered Calls	7	117364728	117364728	109	0.458715596330275	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTTNBP2&recr=Open">Click here</a>	
CUBN	Silent	p.I2845I	G	G		11	Filtered Calls	10	16941058	16941058	496	0.189516129032258	NA	NA	NA			241	CUB 21. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUBN&recr=Open">Click here</a>	
CUBN	Silent	p.L855L	G	G		11	Filtered Calls	10	17113485	17113485	447	0.427293064876958	NA	NA	NA			241	CUB 4. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUBN&recr=Open">Click here</a>	
CUBN	Intron		T	T		11	Filtered Calls	10	17113607	17113607	218	0.119266055045872	NA	NA	NA			241			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUBN&recr=Open">Click here</a>	
CUBN	Intron		A	A		11	Filtered Calls	10	17113608	17113608	215	0.116279069767442	NA	NA	NA			241			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUBN&recr=Open">Click here</a>	
CUBN	Intron		A	A		11	Filtered Calls	10	17113609	17113609	211	0.118483412322275	NA	NA	NA			241			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUBN&recr=Open">Click here</a>	
CUL2	Intron		G	G		11	Filtered Calls	10	35317823	35317823	139	0.525179856115108	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUL2&recr=Open">Click here</a>	
CUL7	Silent	p.L715L	G	G		11	Filtered Calls	6	43015912	43015912	33	0.181818181818182	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUL7&recr=Open">Click here</a>	
CUL7	Intron		A	A		11	Filtered Calls	6	43016312	43016312	47	0.170212765957447	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUL7&recr=Open">Click here</a>	
CUL9	Silent	p.P157P	C	C		11	Filtered Calls	6	43152519	43152519	92	0.217391304347826	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUL9&recr=Open">Click here</a>	
CUX1	Intron		C	C		11	Filtered Calls	7	101840560	101840560	46	0.0869565217391304	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUX1&recr=Open">Click here</a>	
CWC22	Intron		G	G		11	Filtered Calls	2	180815662	180815662	10	0.4	NA	NA	NA		p.?(1)	30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CWC22&recr=Open">Click here</a>	
CWF19L1	Intron		C	C		11	Filtered Calls	10	101996598	101996598	327	0.434250764525994	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CWF19L1&recr=Open">Click here</a>	
CX3CL1	Silent	p.K111K	G	G		11	Filtered Calls	16	57416065	57416065	77	0.220779220779221	NA	NA	NA			5	Mucin-like stalk.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CX3CL1&recr=Open">Click here</a>	
CXCL5	Silent	p.K88K	C	C	rs200883747	11	Filtered Calls	4	74863791	74863791	248	0.310483870967742	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXCL5&recr=Open">Click here</a>	
CXCR4	Silent	p.F308F	G	G		11	Filtered Calls	2	136872586	136872586	112	0.0446428571428571	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXCR4&recr=Open">Click here</a>	
CXXC4	Silent	p.E187E	C	C		11	Filtered Calls	4	105412399	105412399	124	0.266129032258065	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXXC4&recr=Open">Click here</a>	
CXorf21	Silent	p.K260K	C	C		11	Filtered Calls	X	30577693	30577693	77	0.415584415584416	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXorf21&recr=Open">Click here</a>	
CXorf38	Intron		G	G		11	Filtered Calls	X	40490032	40490032	81	0.444444444444444	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXorf38&recr=Open">Click here</a>	
CYB561D2	IGR		G	G		11	Filtered Calls	3	50385784	50385784	121	0.421487603305785	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYB561D2&recr=Open">Click here</a>	
CYB5R4	Silent	p.F78F	C	C		11	Filtered Calls	6	84603245	84603245	89	0.348314606741573	NA	NA	NA		p.F78F(1)	23	Cytochrome b5 heme-binding. {ECO:0000255|PROSITE-ProRule:PRU00279}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYB5R4&recr=Open">Click here</a>	
CYBB	Silent	p.A55A	C	C		11	Filtered Calls	X	37642766	37642766	73	0.438356164383562	NA	NA	NA			32	Ferric oxidoreductase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYBB&recr=Open">Click here</a>	
CYBB	Intron		G	G		11	Filtered Calls	X	37663395	37663395	44	0.431818181818182	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYBB&recr=Open">Click here</a>	
CYFIP2	Intron		G	G		11	Filtered Calls	5	156721804	156721804	31	0.483870967741935	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYFIP2&recr=Open">Click here</a>	
CYFIP2	Silent	p.F445F	C	C		11	Filtered Calls	5	156746826	156746826	66	0.545454545454545	NA	NA	NA		p.F471F(3)	38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYFIP2&recr=Open">Click here</a>	
CYFIP2	Intron		C	C		11	Filtered Calls	5	156760328	156760328	139	0.467625899280576	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYFIP2&recr=Open">Click here</a>	
CYLC1	Silent	p.F213F	C	C	rs199676239	11	Filtered Calls	X	83128355	83128355	41	0.902439024390244	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYLC1&recr=Open">Click here</a>	
CYLC2	Silent	p.K316K	G	G	rs532036391	11	Filtered Calls	9	105767861	105767861	19	0.210526315789474	NA	NA	NA			41	31 X 3 AA repeats of K-K-X.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYLC2&recr=Open">Click here</a>	
CYP11A1	5'UTR		C	C		11	Filtered Calls	15	74640289	74640289	59	0.23728813559322	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP11A1&recr=Open">Click here</a>	
CYP11A1	Intron		G	G		11	Filtered Calls	15	74640403	74640403	22	0.590909090909091	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP11A1&recr=Open">Click here</a>	
CYP11B1	Silent	p.F488F	G	G		11	Filtered Calls	8	143956520	143956520	47	0.191489361702128	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP11B1&recr=Open">Click here</a>	
CYP11B1	Silent	p.F189F	G	G		11	Filtered Calls	8	143959214	143959214	34	0.235294117647059	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP11B1&recr=Open">Click here</a>	
CYP1A1	Silent	p.F477F	G	G		11	Filtered Calls	15	75012851	75012851	98	0.285714285714286	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP1A1&recr=Open">Click here</a>	
CYP1A2	Silent	p.F408F	C	C	rs528804804	11	Filtered Calls	15	75045582	75045582	49	0.306122448979592	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP1A2&recr=Open">Click here</a>	
CYP27B1	Intron		G	G		11	Filtered Calls	12	58158525	58158525	30	0.3	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP27B1&recr=Open">Click here</a>	
CYP2A13	Silent	p.F314F	C	C		11	Filtered Calls	19	41599645	41599645	82	0.109756097560976	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2A13&recr=Open">Click here</a>	
CYP2A7	Intron		G	G		11	Filtered Calls	19	41384658	41384658	32	0.1875	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2A7&recr=Open">Click here</a>	
CYP2B6	Intron		C	C		11	Filtered Calls	19	41510190	41510190	82	0.195121951219512	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2B6&recr=Open">Click here</a>	
CYP2C18	Silent	p.R433R	G	G		11	Filtered Calls	10	96495027	96495027	154	0.38961038961039	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C18&recr=Open">Click here</a>	
CYP2C8	Silent	p.*491*	C	C		11	Filtered Calls	10	96796886	96796886	74	0.256756756756757	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C8&recr=Open">Click here</a>	
CYP2E1	5'UTR		C	C		11	Filtered Calls	10	135340893	135340893	98	0.142857142857143	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2E1&recr=Open">Click here</a>	
CYP39A1	Silent	p.G410G	C	C		11	Filtered Calls	6	46554834	46554834	79	0.253164556962025	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP39A1&recr=Open">Click here</a>	
CYP4A22	Silent	p.L412L	C	C	rs150951823	11	Filtered Calls	1	47611551	47611551	265	0.381132075471698	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4A22&recr=Open">Click here</a>	
CYP4B1	Silent	p.S12S	C	C		11	Filtered Calls	1	47264789	47264789	28	0.428571428571429	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4B1&recr=Open">Click here</a>	
CYP4B1	Intron		C	C		11	Filtered Calls	1	47283632	47283632	100	0.17	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4B1&recr=Open">Click here</a>	
CYP4F2	Silent	p.L246L	G	G		11	Filtered Calls	19	16000415	16000415	78	0.294871794871795	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4F2&recr=Open">Click here</a>	
CYP4F2	Intron		G	G		11	Filtered Calls	19	16006312	16006312	85	0.447058823529412	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4F2&recr=Open">Click here</a>	
CYP4F2	Silent	p.A32A	G	G	rs554886092	11	Filtered Calls	19	16008326	16008326	46	0.108695652173913	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4F2&recr=Open">Click here</a>	
CYP4F3	Intron		C	C		11	Filtered Calls	19	15769295	15769295	100	0.08	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4F3&recr=Open">Click here</a>	
CYP4F8	RNA		C	C		11	Filtered Calls	19	15728951	15728951	87	0.494252873563218	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4F8&recr=Open">Click here</a>	
CYP4X1	Intron		C	C		11	Filtered Calls	1	47515091	47515091	110	0.454545454545455	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4X1&recr=Open">Click here</a>	
CYP8B1	Intron		C	C		11	Filtered Calls	3	42906138	42906138	141	0.24113475177305	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP8B1&recr=Open">Click here</a>	
CYTH3	Silent	p.T289T	G	G	rs552487948	11	Filtered Calls	7	6205398	6205398	113	0.168141592920354	NA	NA	NA			19	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYTH3&recr=Open">Click here</a>	
CYTH4	Intron		C	C		11	Filtered Calls	22	37707490	37707490	54	0.12962962962963	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYTH4&recr=Open">Click here</a>	
CYTIP	Silent	p.V337V	G	G		11	Filtered Calls	2	158272258	158272258	75	0.32	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYTIP&recr=Open">Click here</a>	
CYTIP	Intron		A	A		11	Filtered Calls	2	158287366	158287366	75	0.213333333333333	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYTIP&recr=Open">Click here</a>	
DAB1	Intron		A	A		11	Filtered Calls	1	57476325	57476325	65	0.2	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAB1&recr=Open">Click here</a>	
DAB1	Intron		G	G		11	Filtered Calls	1	57481115	57481115	21	0.619047619047619	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAB1&recr=Open">Click here</a>	
DAB2	Silent	p.F295F	G	G		11	Filtered Calls	5	39383176	39383176	239	0.271966527196653	NA	NA	NA			47	Required for localization to clathrin- coated pits. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAB2&recr=Open">Click here</a>	
DAB2	Silent	p.K26K	C	C		11	Filtered Calls	5	39394345	39394345	191	0.465968586387435	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAB2&recr=Open">Click here</a>	
DAGLA	Silent	p.F515F	C	C	rs202095436	11	Filtered Calls	11	61505189	61505189	30	0.8	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAGLA&recr=Open">Click here</a>	
DAPK2	Silent	p.F53F	G	G		11	Filtered Calls	15	64275887	64275887	33	0.181818181818182	NA	NA	NA			11	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAPK2&recr=Open">Click here</a>	
DAPK3	Silent	p.F217F	G	G		11	Filtered Calls	19	3961138	3961138	19	0.315789473684211	NA	NA	NA			21	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAPK3&recr=Open">Click here</a>	
DARS2	Silent	p.F162F	C	C		11	Filtered Calls	1	173800762	173800762	335	0.432835820895522	NA	NA	NA		p.F162L(1)	30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DARS2&recr=Open">Click here</a>	
DAW1	Intron		T	T		11	Filtered Calls	2	228767835	228767835	71	0.23943661971831	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAW1&recr=Open">Click here</a>	
DAW1	3'UTR		G	G		11	Filtered Calls	2	228783561	228783561	120	0.283333333333333	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAW1&recr=Open">Click here</a>	
DAZL	5'UTR		G	G		11	Filtered Calls	3	16646723	16646723	140	0.192857142857143	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAZL&recr=Open">Click here</a>	
DBN1	Silent	p.Q240Q	C	C		11	Filtered Calls	5	176893824	176893824	142	0.345070422535211	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DBN1&recr=Open">Click here</a>	
DCC	Silent	p.K12K	G	G		11	Filtered Calls	18	49867193	49867193	67	0.373134328358209	NA	NA	NA			148			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCC&recr=Open">Click here</a>	
DCD	3'UTR		C	C		11	Filtered Calls	12	55038489	55038489	46	0.456521739130435	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCD&recr=Open">Click here</a>	
DCDC1	Silent	p.R1025R	C	C		11	Filtered Calls	11	30944108	30944108	83	0.91566265060241	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCDC1&recr=Open">Click here</a>	
DCDC1	Silent	p.R963R	C	C		11	Filtered Calls	11	30953326	30953326	72	0.430555555555556	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCDC1&recr=Open">Click here</a>	
DCHS2	Silent	p.F2149F	G	G		11	Filtered Calls	4	155157992	155157992	186	0.263440860215054	NA	NA	NA		p.F2149L(2)	176	Cadherin 19. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCHS2&recr=Open">Click here</a>	
DCLK1	Silent	p.F263F	G	G		11	Filtered Calls	13	36521529	36521529	106	0.349056603773585	NA	NA	NA			64	Doublecortin 2. {ECO:0000255|PROSITE- ProRule:PRU00072}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCLK1&recr=Open">Click here</a>	
DCLRE1C	Intron		G	G		11	Filtered Calls	10	14987196	14987196	276	0.195652173913043	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCLRE1C&recr=Open">Click here</a>	
DCN	Silent	p.L241L	G	G		11	Filtered Calls	12	91546898	91546898	114	0.37719298245614	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCN&recr=Open">Click here</a>	
DCST2	Intron		G	G		11	Filtered Calls	1	155002722	155002722	14	0.642857142857143	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCST2&recr=Open">Click here</a>	
DCSTAMP	Intron		C	C		11	Filtered Calls	8	105367173	105367173	324	0.191358024691358	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCSTAMP&recr=Open">Click here</a>	
DCTN1	Silent	p.I341I	G	G		11	Filtered Calls	2	74597773	74597773	133	0.142857142857143	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCTN1&recr=Open">Click here</a>	
DCTN2	Intron		G	G		11	Filtered Calls	12	57926812	57926812	23	0.391304347826087	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCTN2&recr=Open">Click here</a>	
DCTN4	Intron		G	G		11	Filtered Calls	5	150136057	150136057	126	0.404761904761905	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCTN4&recr=Open">Click here</a>	
DDAH2	Silent	p.F137F	G	G		11	Filtered Calls	6	31696288	31696288	100	0.25	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDAH2&recr=Open">Click here</a>	
DDB1	Intron		G	G		11	Filtered Calls	11	61094371	61094371	110	0.409090909090909	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDB1&recr=Open">Click here</a>	
DDHD2	5'Flank		C	C		11	Filtered Calls	8	38107265	38107265	190	0.0368421052631579	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDHD2&recr=Open">Click here</a>	
DDI2	Silent	p.S150S	C	C		11	Filtered Calls	1	15957001	15957001	200	0.03	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDI2&recr=Open">Click here</a>	
DDO	Intron		G	G		11	Filtered Calls	6	110734679	110734679	51	0.411764705882353	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDO&recr=Open">Click here</a>	
DDR2	Silent	p.T283T	C	C		11	Filtered Calls	1	162729763	162729763	174	0.241379310344828	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDR2&recr=Open">Click here</a>	
DDX23	Intron		G	G		11	Filtered Calls	12	49225109	49225109	113	0.327433628318584	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX23&recr=Open">Click here</a>	
DDX25	Silent	p.F167F	C	C		11	Filtered Calls	11	125778392	125778392	132	0.553030303030303	NA	NA	NA			10	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX25&recr=Open">Click here</a>	
DDX31	Silent	p.L353L	G	G		11	Filtered Calls	9	135523935	135523935	236	0.194915254237288	NA	NA	NA			27	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX31&recr=Open">Click here</a>	
DDX52	Silent	p.F339F	G	G		11	Filtered Calls	17	35986060	35986060	111	0.45045045045045	NA	NA	NA			17	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX52&recr=Open">Click here</a>	
DDX60L	Intron		C	C		11	Filtered Calls	4	169340448	169340448	24	0.25	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX60L&recr=Open">Click here</a>	
DEDD2	Silent	p.A177A	G	G		11	Filtered Calls	19	42713910	42713910	117	0.393162393162393	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEDD2&recr=Open">Click here</a>	
DEFB112	Silent	p.T6T	G	G	rs371555913	11	Filtered Calls	6	50016347	50016347	156	0.224358974358974	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEFB112&recr=Open">Click here</a>	
DEFB113	Silent	p.I75I	G	G		11	Filtered Calls	6	49936414	49936414	20	0.3	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEFB113&recr=Open">Click here</a>	
DEFB116	Intron		A	A		11	Filtered Calls	20	29891263	29891263	49	0.73469387755102	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEFB116&recr=Open">Click here</a>	
DEFB119	Intron		C	C		11	Filtered Calls	20	29966177	29966177	53	0.320754716981132	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEFB119&recr=Open">Click here</a>	
DEFB127	Silent	p.R34R	G	G		11	Filtered Calls	20	139467	139467	86	0.348837209302326	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEFB127&recr=Open">Click here</a>	
DEFB134	Silent	p.F12F	G	G		11	Filtered Calls	8	11853725	11853725	434	0.518433179723502	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEFB134&recr=Open">Click here</a>	
DENND1A	Intron		G	G		11	Filtered Calls	9	126164872	126164872	38	0.184210526315789	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DENND1A&recr=Open">Click here</a>	
DENND1A	Intron		G	G		11	Filtered Calls	9	126438991	126438991	102	0.294117647058824	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DENND1A&recr=Open">Click here</a>	
DENND1C	IGR		C	C	rs558971348	11	Filtered Calls	19	6465602	6465602	219	0.118721461187215	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DENND1C&recr=Open">Click here</a>	
DENND1C	Silent	p.I161I	G	G		11	Filtered Calls	19	6477259	6477259	28	0.285714285714286	NA	NA	NA			10	DENN. {ECO:0000255|PROSITE- ProRule:PRU00304}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DENND1C&recr=Open">Click here</a>	
DENND2A	Silent	p.F933F	G	G		11	Filtered Calls	7	140221767	140221767	16	0.4375	NA	NA	NA			49	dDENN. {ECO:0000255|PROSITE- ProRule:PRU00306}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DENND2A&recr=Open">Click here</a>	
DENND4B	Intron		G	G		11	Filtered Calls	1	153910097	153910097	93	0.204301075268817	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DENND4B&recr=Open">Click here</a>	
DEPDC1B	Intron		G	G		11	Filtered Calls	5	59938693	59938693	175	0.32	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEPDC1B&recr=Open">Click here</a>	
DFNB59	Silent	p.I295I	C	C		11	Filtered Calls	2	179325827	179325827	380	0.286842105263158	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DFNB59&recr=Open">Click here</a>	
DGAT2L6	Silent	p.G139G	G	G		11	Filtered Calls	X	69420254	69420254	74	0.445945945945946	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGAT2L6&recr=Open">Click here</a>	
DGAT2L6	3'UTR		G	G		11	Filtered Calls	X	69424959	69424959	23	0.521739130434783	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGAT2L6&recr=Open">Click here</a>	
DHODH	Silent	p.Q293Q	G	G		11	Filtered Calls	16	72057123	72057123	30	0.233333333333333	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHODH&recr=Open">Click here</a>	
DHRS7C	Silent	p.*312*	T	T		11	Filtered Calls	17	9674805	9674805	20	0.85	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHRS7C&recr=Open">Click here</a>	
DHRS9	Silent	p.I57I	C	C		11	Filtered Calls	2	169938262	169938262	107	0.242990654205607	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHRS9&recr=Open">Click here</a>	
DHX16	Intron		G	G		11	Filtered Calls	6	30624544	30624544	60	0.15	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX16&recr=Open">Click here</a>	
DHX16	Silent	p.A180A	G	G		11	Filtered Calls	6	30638636	30638636	139	0.697841726618705	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX16&recr=Open">Click here</a>	
DHX30	Intron		C	C		11	Filtered Calls	3	47870635	47870635	29	0.275862068965517	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX30&recr=Open">Click here</a>	
DHX34	Silent	p.F384F	C	C		11	Filtered Calls	19	47861257	47861257	60	0.15	NA	NA	NA			36	Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX34&recr=Open">Click here</a>	
DHX37	Silent	p.I772I	G	G	rs61757600	11	Filtered Calls	12	125435264	125435264	62	0.145161290322581	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX37&recr=Open">Click here</a>	
DHX57	Intron		G	G		11	Filtered Calls	2	39053839	39053839	103	0.378640776699029	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX57&recr=Open">Click here</a>	
DIAPH3	Intron		G	G		11	Filtered Calls	13	60240991	60240991	107	0.252336448598131	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIAPH3&recr=Open">Click here</a>	
DIAPH3	Silent	p.S271S	G	G		11	Filtered Calls	13	60584762	60584762	200	0.275	NA	NA	NA			46	GBD/FH3. {ECO:0000255|PROSITE- ProRule:PRU00579}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIAPH3&recr=Open">Click here</a>	
DICER1	Silent	p.G1341G	G	G		11	Filtered Calls	14	95569710	95569710	198	0.595959595959596	NA	NA	NA			75	RNase III 1. {ECO:0000255|PROSITE- ProRule:PRU00177}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DICER1&recr=Open">Click here</a>	
DIDO1	Silent	p.L181L	G	G		11	Filtered Calls	20	61542424	61542424	64	0.25	NA	NA	NA			99			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIDO1&recr=Open">Click here</a>	
DIO2	3'UTR		C	C		11	Filtered Calls	14	80668703	80668703	87	0.586206896551724	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIO2&recr=Open">Click here</a>	
DIO3	Silent	p.F146F	C	C		11	Filtered Calls	14	102028271	102028271	22	0.227272727272727	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIO3&recr=Open">Click here</a>	
DIRAS3	Silent	p.H158H	G	G		11	Filtered Calls	1	68512507	68512507	194	0.474226804123711	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIRAS3&recr=Open">Click here</a>	
DIS3	Silent	p.A698A	G	G		11	Filtered Calls	13	73336219	73336219	126	0.317460317460317	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIS3&recr=Open">Click here</a>	
DIS3	Silent	p.T357T	G	G		11	Filtered Calls	13	73347900	73347900	283	0.293286219081272	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIS3&recr=Open">Click here</a>	
DIS3L2	Silent	p.I238I	C	C		11	Filtered Calls	2	233001193	233001193	217	0.258064516129032	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIS3L2&recr=Open">Click here</a>	
DIXDC1	Intron		T	T		11	Filtered Calls	11	111855948	111855948	33	0.939393939393939	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIXDC1&recr=Open">Click here</a>	
DLEC1	Silent	p.L1195L	G	G		11	Filtered Calls	3	38153771	38153771	112	0.348214285714286	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLEC1&recr=Open">Click here</a>	
DLG5	Silent	p.F623F	G	G	rs556899023	11	Filtered Calls	10	79590511	79590511	127	0.236220472440945	NA	NA	NA		p.F623F(1)	60	PDZ 1. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLG5&recr=Open">Click here</a>	
DLGAP1	Silent	p.S27S	G	G	rs200480488	11	Filtered Calls	18	3879988	3879988	32	0.46875	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLGAP1&recr=Open">Click here</a>	
DLGAP2	Intron		C	C		11	Filtered Calls	8	1626371	1626371	65	0.369230769230769	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLGAP2&recr=Open">Click here</a>	
DLGAP3	Silent	p.Q485Q	C	C		11	Filtered Calls	1	35351818	35351818	13	0.461538461538462	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLGAP3&recr=Open">Click here</a>	
DLGAP4	Silent	p.P271P	C	C		11	Filtered Calls	20	35060933	35060933	20	0.35	NA	NA	NA			37	Poly-Pro.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLGAP4&recr=Open">Click here</a>	
DLK1	Silent	p.V132V	G	G		11	Filtered Calls	14	101198512	101198512	61	0.213114754098361	NA	NA	NA			29	EGF-like 4. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLK1&recr=Open">Click here</a>	
DMBT1	Silent	p.S835S	C	C		11	Filtered Calls	10	124353089	124353089	204	0.0343137254901961	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMBT1&recr=Open">Click here</a>	
DMBT1	Silent	p.I2319I	C	C		11	Filtered Calls	10	124399957	124399957	28	0.214285714285714	NA	NA	NA			72	ZP. {ECO:0000255|PROSITE- ProRule:PRU00375}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMBT1&recr=Open">Click here</a>	
DMD	Silent	p.L2724L	G	G		11	Filtered Calls	X	31645835	31645835	80	0.925	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMD&recr=Open">Click here</a>	
DMPK	Intron		G	G		11	Filtered Calls	19	46274662	46274662	93	0.387096774193548	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMPK&recr=Open">Click here</a>	
DMRTB1	Silent	p.F283F	C	C		11	Filtered Calls	1	53930408	53930408	44	0.886363636363636	NA	NA	NA			10	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMRTB1&recr=Open">Click here</a>	
DMXL1	Intron		C	C		11	Filtered Calls	5	118454505	118454505	176	0.477272727272727	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMXL1&recr=Open">Click here</a>	
DMXL1	Intron		T	T		11	Filtered Calls	5	118503288	118503288	14	0.428571428571429	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMXL1&recr=Open">Click here</a>	
DNA2	Silent	p.L836L	A	A		11	Filtered Calls	10	70182173	70182173	147	0.210884353741497	NA	NA	NA			20	Helicase activity. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNA2&recr=Open">Click here</a>	
DNAAF1	Silent	p.F522F	C	C		11	Filtered Calls	16	84205903	84205903	66	0.303030303030303	NA	NA	NA		p.F522F(1)	41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAAF1&recr=Open">Click here</a>	
DNAAF3	Silent	p.E149E	C	C		11	Filtered Calls	19	55676817	55676817	118	0.220338983050847	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAAF3&recr=Open">Click here</a>	
DNAH1	Silent	p.F659F	C	C		11	Filtered Calls	3	52381861	52381861	10	0.4	NA	NA	NA			62	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH1&recr=Open">Click here</a>	
DNAH1	Silent	p.I808I	C	C		11	Filtered Calls	3	52383334	52383334	45	0.155555555555556	NA	NA	NA			62	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH1&recr=Open">Click here</a>	
DNAH1	Silent	p.V1788V	G	G		11	Filtered Calls	3	52398881	52398881	53	0.30188679245283	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH1&recr=Open">Click here</a>	
DNAH1	Intron		C	C		11	Filtered Calls	3	52428474	52428474	39	0.102564102564103	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH1&recr=Open">Click here</a>	
DNAH1	Silent	p.L3829L	G	G		11	Filtered Calls	3	52430690	52430690	95	0.157894736842105	NA	NA	NA			62	AAA 6. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH1&recr=Open">Click here</a>	
DNAH1	Silent	p.I3841I	C	C		11	Filtered Calls	3	52430726	52430726	169	0.414201183431953	NA	NA	NA			62	AAA 6. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH1&recr=Open">Click here</a>	
DNAH10	Silent	p.I110I	C	C		11	Filtered Calls	12	124258703	124258703	144	0.229166666666667	NA	NA	NA			52	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH10&recr=Open">Click here</a>	
DNAH10OS	IGR		C	C		11	Filtered Calls	12	124409692	124409692	95	0.305263157894737	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH10OS&recr=Open">Click here</a>	
DNAH11	Intron		T	T		11	Filtered Calls	7	21646038	21646038	22	0.363636363636364	NA	NA	NA			230			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	
DNAH11	Intron		G	G		11	Filtered Calls	7	21659705	21659705	26	0.230769230769231	NA	NA	NA			230			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	
DNAH11	Silent	p.K2946K	G	G		11	Filtered Calls	7	21789880	21789880	24	0.208333333333333	NA	NA	NA			230	AAA 4. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	
DNAH17	Silent	p.F3225F	G	G		11	Filtered Calls	17	76455254	76455254	242	0.0371900826446281	NA	NA	NA			116	Stalk. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH17&recr=Open">Click here</a>	
DNAH17	Intron		G	G		11	Filtered Calls	17	76511112	76511112	68	0.205882352941176	NA	NA	NA			116			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH17&recr=Open">Click here</a>	
DNAH17	Intron		G	G		11	Filtered Calls	17	76557790	76557790	17	0.235294117647059	NA	NA	NA			116			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH17&recr=Open">Click here</a>	
DNAH2	Intron		G	G		11	Filtered Calls	17	7721622	7721622	103	0.223300970873786	NA	NA	NA			189			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH2&recr=Open">Click here</a>	
DNAH2	Silent	p.I4312I	C	C		11	Filtered Calls	17	7736204	7736204	368	0.317934782608696	NA	NA	NA			189			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH2&recr=Open">Click here</a>	
DNAH3	Silent	p.E3391E	C	C		11	Filtered Calls	16	20975033	20975033	19	0.263157894736842	NA	NA	NA			202			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH3&recr=Open">Click here</a>	
DNAH3	Silent	p.F2489F	G	G		11	Filtered Calls	16	20996597	20996597	77	0.246753246753247	NA	NA	NA			202	AAA 4. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH3&recr=Open">Click here</a>	
DNAH3	Intron		C	C		11	Filtered Calls	16	21035913	21035913	52	0.576923076923077	NA	NA	NA			202			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH3&recr=Open">Click here</a>	
DNAH5	Intron		G	G		11	Filtered Calls	5	13716804	13716804	67	0.492537313432836	NA	NA	NA			378			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH5	Silent	p.I3612I	G	G		11	Filtered Calls	5	13753378	13753378	158	0.227848101265823	NA	NA	NA			378	AAA 5. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH5	Silent	p.K3611K	C	C		11	Filtered Calls	5	13753381	13753381	159	0.150943396226415	NA	NA	NA			378	AAA 5. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH5	Silent	p.T3595T	C	C	rs144055129	11	Filtered Calls	5	13753429	13753429	190	0.247368421052632	NA	NA	NA			378	AAA 5. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH5	Silent	p.L2222L	C	C		11	Filtered Calls	5	13823393	13823393	236	0.207627118644068	NA	NA	NA			378			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH5	Intron		G	G		11	Filtered Calls	5	13830332	13830332	89	0.426966292134831	NA	NA	NA			378			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH5	Silent	p.G1998G	C	C		11	Filtered Calls	5	13830773	13830773	126	0.206349206349206	NA	NA	NA			378	AAA 1. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH5	Silent	p.L1696L	C	C		11	Filtered Calls	5	13850787	13850787	77	0.246753246753247	NA	NA	NA			378	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH5	Silent	p.K1461K	C	C		11	Filtered Calls	5	13864719	13864719	73	0.191780821917808	NA	NA	NA			378	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH5	Silent	p.Q845Q	C	C		11	Filtered Calls	5	13891127	13891127	243	0.493827160493827	NA	NA	NA			378	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH5	Intron		G	G		11	Filtered Calls	5	13891237	13891237	141	0.24113475177305	NA	NA	NA			378			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH7	Silent	p.L2424L	G	G		11	Filtered Calls	2	196729107	196729107	120	0.266666666666667	NA	NA	NA			205	AAA 4. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	
DNAH7	Silent	p.E2420E	C	C		11	Filtered Calls	2	196729119	196729119	122	0.286885245901639	NA	NA	NA			205	AAA 4. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	
DNAH7	Intron		G	G	rs540152428	11	Filtered Calls	2	196922847	196922847	133	0.263157894736842	NA	NA	NA			205			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	
DNAH8	Intron		G	G	rs201672902	11	Filtered Calls	6	38697704	38697704	43	0.186046511627907	NA	NA	NA			260			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	
DNAH8	Intron		C	C		11	Filtered Calls	6	38704840	38704840	254	0.240157480314961	NA	NA	NA			260			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	
DNAH8	Silent	p.K724K	G	G		11	Filtered Calls	6	38759372	38759372	98	0.204081632653061	NA	NA	NA			260			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	
DNAH8	Intron		A	A		11	Filtered Calls	6	38831845	38831845	68	0.617647058823529	NA	NA	NA			260			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	
DNAH8	Intron		C	C		11	Filtered Calls	6	38905747	38905747	181	0.18232044198895	NA	NA	NA			260			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	
DNAH9	Silent	p.Y226Y	C	C		11	Filtered Calls	17	11513776	11513776	59	0.322033898305085	NA	NA	NA			290	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	
DNAH9	Silent	p.E1196E	G	G		11	Filtered Calls	17	11584051	11584051	25	0.2	NA	NA	NA			290	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	
DNAH9	Silent	p.I1546I	C	C		11	Filtered Calls	17	11597208	11597208	70	0.328571428571429	NA	NA	NA		p.I1546I(1)	290	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	
DNAH9	Silent	p.K1651K	G	G		11	Filtered Calls	17	11603128	11603128	47	0.170212765957447	NA	NA	NA			290	Stem. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	
DNAH9	Silent	p.R2967R	G	G		11	Filtered Calls	17	11725805	11725805	100	0.33	NA	NA	NA			290	AAA 4. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	
DNAI2	Silent	p.I29I	C	C		11	Filtered Calls	17	72278043	72278043	167	0.431137724550898	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAI2&recr=Open">Click here</a>	
DNAJB1	5'UTR		C	C		11	Filtered Calls	19	14629165	14629165	50	0.34	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJB1&recr=Open">Click here</a>	
DNAJB13	Silent	p.L257L	C	C		11	Filtered Calls	11	73680341	73680341	33	0.303030303030303	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJB13&recr=Open">Click here</a>	
DNAJB13	Intron		C	C		11	Filtered Calls	11	73680996	73680996	69	0.376811594202899	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJB13&recr=Open">Click here</a>	
DNAJB2	Intron		C	C		11	Filtered Calls	2	220147663	220147663	133	0.263157894736842	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJB2&recr=Open">Click here</a>	
DNAJC13	Intron		C	C		11	Filtered Calls	3	132213920	132213920	127	0.393700787401575	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJC13&recr=Open">Click here</a>	
DNAJC6	Silent	p.Y281Y	C	C		11	Filtered Calls	1	65851437	65851437	91	0.505494505494505	NA	NA	NA			39	C2 tensin-type. {ECO:0000255|PROSITE- ProRule:PRU00589}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJC6&recr=Open">Click here</a>	
DNER	Silent	p.G572G	C	C		11	Filtered Calls	2	230271955	230271955	162	0.253086419753086	NA	NA	NA			63	EGF-like 9. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNER&recr=Open">Click here</a>	
DNHD1	Silent	p.L193L	C	C		11	Filtered Calls	11	6520022	6520022	65	0.430769230769231	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNHD1&recr=Open">Click here</a>	
DNHD1	Silent	p.F360F	C	C		11	Filtered Calls	11	6530269	6530269	189	0.407407407407407	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNHD1&recr=Open">Click here</a>	
DNM1	Intron		C	C		11	Filtered Calls	9	131010225	131010225	174	0.28735632183908	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNM1&recr=Open">Click here</a>	
DNM2	Silent	p.I687I	C	C		11	Filtered Calls	19	10939726	10939726	23	0.260869565217391	NA	NA	NA			42	GED. {ECO:0000255|PROSITE- ProRule:PRU00720}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNM2&recr=Open">Click here</a>	
DNM3	3'UTR		G	G		11	Filtered Calls	1	172376984	172376984	247	0.230769230769231	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNM3&recr=Open">Click here</a>	
DNMBP	Silent	p.L1302L	A	A	rs567734686	11	Filtered Calls	10	101643861	101643861	144	0.229166666666667	NA	NA	NA			61	SH3 5. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNMBP&recr=Open">Click here</a>	
DNPEP	Silent	p.A346A	G	G		11	Filtered Calls	2	220246760	220246760	40	0.425	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNPEP&recr=Open">Click here</a>	
DNTT	Silent	p.Q18Q	G	G		11	Filtered Calls	10	98064308	98064308	91	0.197802197802198	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNTT&recr=Open">Click here</a>	
DOCK10	Silent	p.V598V	T	T		11	Filtered Calls	2	225721591	225721591	99	0.535353535353535	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK10&recr=Open">Click here</a>	
DOCK11	Intron		C	C		11	Filtered Calls	X	117788857	117788857	270	0.388888888888889	NA	NA	NA			84			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK11&recr=Open">Click here</a>	
DOCK2	Silent	p.V407V	G	G		11	Filtered Calls	5	169127106	169127106	100	0.3	NA	NA	NA			160			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK2&recr=Open">Click here</a>	
DOCK3	Silent	p.I854I	C	C		11	Filtered Calls	3	51312523	51312523	277	0.187725631768953	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK3&recr=Open">Click here</a>	
DOCK3	Intron		C	C		11	Filtered Calls	3	51393830	51393830	87	0.183908045977011	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK3&recr=Open">Click here</a>	
DOCK3	Intron		C	C		11	Filtered Calls	3	51393831	51393831	88	0.181818181818182	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK3&recr=Open">Click here</a>	
DOCK4	Intron		G	G		11	Filtered Calls	7	111398675	111398675	35	0.457142857142857	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK4&recr=Open">Click here</a>	
DOCK4	Silent	p.F1070F	G	G		11	Filtered Calls	7	111430618	111430618	30	0.166666666666667	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK4&recr=Open">Click here</a>	
DOCK4	Intron		-	-		11	Filtered Calls	7	111541651	111541652	32	0.3125	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK4&recr=Open">Click here</a>	
DOCK8	Intron		C	C	rs546247187	11	Filtered Calls	9	464148	464148	91	0.252747252747253	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK8&recr=Open">Click here</a>	
DOCK9	Silent	p.I1492I	G	G		11	Filtered Calls	13	99483692	99483692	18	0.611111111111111	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK9&recr=Open">Click here</a>	
DOK2	Silent	p.T171T	G	G		11	Filtered Calls	8	21768289	21768289	17	0.294117647058824	NA	NA	NA			26	IRS-type PTB. {ECO:0000255|PROSITE- ProRule:PRU00389}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOK2&recr=Open">Click here</a>	
DOK3	Intron		G	G	rs558150906	11	Filtered Calls	5	176936847	176936847	25	0.32	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOK3&recr=Open">Click here</a>	
DOPEY2	Intron		C	C		11	Filtered Calls	21	37605094	37605094	128	0.59375	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOPEY2&recr=Open">Click here</a>	
DOT1L	Silent	p.A894A	C	C		11	Filtered Calls	19	2217908	2217908	25	0.52	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOT1L&recr=Open">Click here</a>	
DOT1L	Silent	p.P988P	C	C		11	Filtered Calls	19	2222132	2222132	39	0.41025641025641	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOT1L&recr=Open">Click here</a>	
DPEP2	Intron		G	G		11	Filtered Calls	16	68021669	68021669	103	0.601941747572815	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPEP2&recr=Open">Click here</a>	
DPEP2	Intron		G	G		11	Filtered Calls	16	68021670	68021670	100	0.59	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPEP2&recr=Open">Click here</a>	
DPEP2	Intron		G	G		11	Filtered Calls	16	68023214	68023214	45	0.311111111111111	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPEP2&recr=Open">Click here</a>	
DPEP3	Silent	p.S444S	G	G		11	Filtered Calls	16	68009878	68009878	33	0.303030303030303	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPEP3&recr=Open">Click here</a>	
DPF2	Intron		C	C		11	Filtered Calls	11	65113839	65113839	30	0.833333333333333	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPF2&recr=Open">Click here</a>	
DPF2	Intron		C	C		11	Filtered Calls	11	65113840	65113840	30	0.833333333333333	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPF2&recr=Open">Click here</a>	
DPF3	Intron		G	G	rs534653616	11	Filtered Calls	14	73137904	73137904	32	0.84375	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPF3&recr=Open">Click here</a>	
DPF3	Intron		G	G		11	Filtered Calls	14	73137905	73137905	32	0.875	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPF3&recr=Open">Click here</a>	
DPH1	Intron		G	G		11	Filtered Calls	17	1939988	1939988	24	0.291666666666667	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPH1&recr=Open">Click here</a>	
DPP3	Silent	p.I392I	C	C		11	Filtered Calls	11	66260374	66260374	36	0.5	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPP3&recr=Open">Click here</a>	
DPP3	Silent	p.F621F	C	C	rs34191382	11	Filtered Calls	11	66264933	66264933	34	0.382352941176471	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPP3&recr=Open">Click here</a>	
DPP6	Intron		G	G		11	Filtered Calls	7	154379603	154379603	35	0.285714285714286	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPP6&recr=Open">Click here</a>	
DPP6	Intron		C	C		11	Filtered Calls	7	154379621	154379621	39	0.102564102564103	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPP6&recr=Open">Click here</a>	
DPPA4	Silent	p.H280H	G	G		11	Filtered Calls	3	109047775	109047775	50	0.28	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPPA4&recr=Open">Click here</a>	
DPPA5	Intron		G	G		11	Filtered Calls	6	74063827	74063827	45	0.444444444444444	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPPA5&recr=Open">Click here</a>	
DPT	Silent	p.F186F	G	G		11	Filtered Calls	1	168665835	168665835	147	0.210884353741497	NA	NA	NA			12	2 X 53-55 AA tandem repeats.|3 X 6 AA repeats of D-R-[EQ]-W-[NQK]- [FY].		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPT&recr=Open">Click here</a>	
DPT	Silent	p.L12L	G	G		11	Filtered Calls	1	168698379	168698379	41	0.317073170731707	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPT&recr=Open">Click here</a>	
DPYD	Silent	p.V1021V	C	C		11	Filtered Calls	1	97544547	97544547	311	0.559485530546624	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPYD&recr=Open">Click here</a>	
DPYSL4	Intron		C	C		11	Filtered Calls	10	134008344	134008344	65	0.215384615384615	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPYSL4&recr=Open">Click here</a>	
DRD2	Intron		G	G		11	Filtered Calls	11	113283266	113283266	16	0.3125	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DRD2&recr=Open">Click here</a>	
DRD3	Silent	p.L81L	C	C		11	Filtered Calls	3	113890597	113890597	42	0.333333333333333	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DRD3&recr=Open">Click here</a>	
DROSHA	Silent	p.P194P	G	G		11	Filtered Calls	5	31526458	31526458	139	0.244604316546763	NA	NA	NA			66	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DROSHA&recr=Open">Click here</a>	
DRP2	Silent	p.H530H	C	C		11	Filtered Calls	X	100505461	100505461	95	0.547368421052632	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DRP2&recr=Open">Click here</a>	
DRP2	Intron		G	G		11	Filtered Calls	X	100506078	100506078	71	0.436619718309859	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DRP2&recr=Open">Click here</a>	
DSC2	Silent	p.V35V	C	C		11	Filtered Calls	18	28673571	28673571	141	0.375886524822695	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSC2&recr=Open">Click here</a>	
DSC2	Intron		A	A		11	Filtered Calls	18	28673611	28673611	83	0.397590361445783	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSC2&recr=Open">Click here</a>	
DSC3	Silent	p.T519T	G	G		11	Filtered Calls	18	28588088	28588088	81	0.407407407407407	NA	NA	NA			56	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSC3&recr=Open">Click here</a>	
DSCAM	Silent	p.F1181F	G	G		11	Filtered Calls	21	41505800	41505800	67	0.26865671641791	NA	NA	NA			142	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCAM&recr=Open">Click here</a>	
DSCAM	Silent	p.V75V	G	G		11	Filtered Calls	21	42080516	42080516	62	0.387096774193548	NA	NA	NA			142	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCAM&recr=Open">Click here</a>	
DSCAML1	Silent	p.G534G	G	G		11	Filtered Calls	11	117389269	117389269	40	0.475	NA	NA	NA			110	Ig-like C2-type 6.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCAML1&recr=Open">Click here</a>	
DSG1	Silent	p.V949V	C	C		11	Filtered Calls	18	28935006	28935006	137	0.386861313868613	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSG1&recr=Open">Click here</a>	
DSG2	Intron		T	T		11	Filtered Calls	18	29100755	29100755	50	0.36	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSG2&recr=Open">Click here</a>	
DSG2	Intron		G	G		11	Filtered Calls	18	29101054	29101054	93	0.817204301075269	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSG2&recr=Open">Click here</a>	
DSG3	Silent	p.S970S	C	C		11	Filtered Calls	18	29056133	29056133	95	0.442105263157895	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSG3&recr=Open">Click here</a>	
DSP	Silent	p.A1521A	G	G		11	Filtered Calls	6	7580986	7580986	174	0.028735632183908	NA	NA	NA			101	Central fibrous rod domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSP&recr=Open">Click here</a>	
DSP	Silent	p.F2011F	C	C		11	Filtered Calls	6	7583528	7583528	105	0.20952380952381	NA	NA	NA			101	4.5 X 38 AA tandem repeats (Domain A).|Globular 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSP&recr=Open">Click here</a>	
DSPP	Intron		T	T		11	Filtered Calls	4	88533468	88533468	51	0.156862745098039	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSPP&recr=Open">Click here</a>	
DST	Silent	p.A7285A	G	G		11	Filtered Calls	6	56328507	56328507	238	0.0252100840336134	NA	NA	NA			105	GAR. {ECO:0000255|PROSITE- ProRule:PRU00792}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DST&recr=Open">Click here</a>	
DST	Silent	p.K4502K	C	C		11	Filtered Calls	6	56426277	56426277	254	0.62992125984252	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DST&recr=Open">Click here</a>	
DST	Silent	p.S2162S	G	G	rs567020753	11	Filtered Calls	6	56472307	56472307	50	0.16	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DST&recr=Open">Click here</a>	
DST	Silent	p.L1991L	T	T		11	Filtered Calls	6	56472820	56472820	107	0.233644859813084	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DST&recr=Open">Click here</a>	
DST	Intron		G	G		11	Filtered Calls	6	56483488	56483488	370	0.248648648648649	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DST&recr=Open">Click here</a>	
DTX1	IGR		C	C		11	Filtered Calls	12	113537732	113537732	73	0.0821917808219178	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DTX1&recr=Open">Click here</a>	
DUOX2	Intron		G	G		11	Filtered Calls	15	45393483	45393483	39	0.230769230769231	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUOX2&recr=Open">Click here</a>	
DUOXA2	3'UTR		C	C		11	Filtered Calls	15	45410127	45410127	96	0.291666666666667	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUOXA2&recr=Open">Click here</a>	
DUSP13	Intron		C	C		11	Filtered Calls	10	76861700	76861700	117	0.205128205128205	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP13&recr=Open">Click here</a>	
DUSP26	Silent	p.S18S	G	G		11	Filtered Calls	8	33454980	33454980	53	0.132075471698113	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP26&recr=Open">Click here</a>	
DUSP5	Silent	p.P145P	C	C		11	Filtered Calls	10	112262534	112262534	395	0.217721518987342	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP5&recr=Open">Click here</a>	
DUXA	Intron		G	G		11	Filtered Calls	19	57669847	57669847	30	0.6	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUXA&recr=Open">Click here</a>	
DVL3	Silent	p.I395I	C	C		11	Filtered Calls	3	183884750	183884750	113	0.274336283185841	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DVL3&recr=Open">Click here</a>	
DYNC1H1	Silent	p.L3833L	C	C	rs200735835	11	Filtered Calls	14	102505785	102505785	55	0.581818181818182	NA	NA	NA			166			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYNC1H1&recr=Open">Click here</a>	
DYNC1LI1	Silent	p.L131L	G	G		11	Filtered Calls	3	32586543	32586543	237	0.232067510548523	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYNC1LI1&recr=Open">Click here</a>	
DYNC2LI1	3'UTR		C	C		11	Filtered Calls	2	44021769	44021769	240	0.4875	NA	NA	NA		p.P165L(1)	26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYNC2LI1&recr=Open">Click here</a>	
DYRK1B	Silent	p.Q77Q	C	C		11	Filtered Calls	19	40321156	40321156	104	0.576923076923077	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYRK1B&recr=Open">Click here</a>	
DYRK4	Silent	p.I151I	C	C		11	Filtered Calls	12	4705788	4705788	60	0.466666666666667	NA	NA	NA			27	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYRK4&recr=Open">Click here</a>	
DYSF	Silent	p.G910G	G	G		11	Filtered Calls	2	71795334	71795334	141	0.205673758865248	NA	NA	NA			111			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYSF&recr=Open">Click here</a>	
DYSF	Intron		G	G	rs372900372	11	Filtered Calls	2	71883431	71883431	298	0.204697986577181	NA	NA	NA			111			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYSF&recr=Open">Click here</a>	
DYTN	Intron		A	A		11	Filtered Calls	2	207530760	207530760	95	0.263157894736842	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYTN&recr=Open">Click here</a>	
DZIP1	Intron		G	G		11	Filtered Calls	13	96238252	96238252	132	0.234848484848485	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DZIP1&recr=Open">Click here</a>	
DZIP1	Silent	p.V741V	G	G		11	Filtered Calls	13	96238386	96238386	165	0.236363636363636	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DZIP1&recr=Open">Click here</a>	
E2F3	Silent	p.F190F	C	C		11	Filtered Calls	6	20481501	20481501	236	0.211864406779661	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+E2F3&recr=Open">Click here</a>	
E2F6	Silent	p.P62P	A	A		11	Filtered Calls	2	11593902	11593902	194	0.56701030927835	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+E2F6&recr=Open">Click here</a>	
EBF2	Intron		G	G		11	Filtered Calls	8	25745500	25745500	58	0.155172413793103	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EBF2&recr=Open">Click here</a>	
ECE1	Intron		G	G		11	Filtered Calls	1	21548249	21548249	189	0.0529100529100529	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ECE1&recr=Open">Click here</a>	
ECE2	Intron		C	C		11	Filtered Calls	3	184008822	184008822	104	0.0673076923076923	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ECE2&recr=Open">Click here</a>	
EDC4	Silent	p.L717L	C	C		11	Filtered Calls	16	67914511	67914511	118	0.279661016949153	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EDC4&recr=Open">Click here</a>	
EDC4	Silent	p.F1372F	C	C	rs140860932	11	Filtered Calls	16	67917961	67917961	50	0.34	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EDC4&recr=Open">Click here</a>	
EDDM3B	Silent	p.E108E	G	G		11	Filtered Calls	14	21238633	21238633	80	0.375	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EDDM3B&recr=Open">Click here</a>	
EDN1	Silent	p.G152G	G	G		11	Filtered Calls	6	12294560	12294560	104	0.221153846153846	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EDN1&recr=Open">Click here</a>	
EDN2	Silent	p.R169R	C	C	rs5799	11	Filtered Calls	1	41945110	41945110	62	0.419354838709677	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EDN2&recr=Open">Click here</a>	
EEF2K	Silent	p.L373L	C	C		11	Filtered Calls	16	22269904	22269904	72	0.347222222222222	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EEF2K&recr=Open">Click here</a>	
EEPD1	Silent	p.P519P	G	G	rs534483874	11	Filtered Calls	7	36338662	36338662	129	0.325581395348837	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EEPD1&recr=Open">Click here</a>	
EFCAB4B	Intron		G	G	rs371753815	11	Filtered Calls	12	3763574	3763574	60	0.333333333333333	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFCAB4B&recr=Open">Click here</a>	
EFCAB6	Intron		A	A		11	Filtered Calls	22	44011808	44011808	65	0.476923076923077	NA	NA	NA			68			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFCAB6&recr=Open">Click here</a>	
EFHC1	Intron		C	C		11	Filtered Calls	6	52354930	52354930	87	0.218390804597701	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFHC1&recr=Open">Click here</a>	
EFHD2	Silent	p.I156I	C	C		11	Filtered Calls	1	15753657	15753657	17	0.294117647058824	NA	NA	NA			2	EF-hand 2. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFHD2&recr=Open">Click here</a>	
EFR3A	Intron		C	C		11	Filtered Calls	8	132980535	132980535	73	0.164383561643836	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFR3A&recr=Open">Click here</a>	
EHD2	Silent	p.P92P	C	C		11	Filtered Calls	19	48220145	48220145	38	0.184210526315789	NA	NA	NA			19	Dynamin-type G.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EHD2&recr=Open">Click here</a>	
EHMT2	Silent	p.S342S	G	G		11	Filtered Calls	6	31860193	31860193	99	0.242424242424242	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EHMT2&recr=Open">Click here</a>	
EIF1AX	Intron		G	G		11	Filtered Calls	X	20156645	20156645	195	0.933333333333333	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF1AX&recr=Open">Click here</a>	
EIF2AK4	Silent	p.F575F	C	C		11	Filtered Calls	15	40265857	40265857	304	0.276315789473684	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF2AK4&recr=Open">Click here</a>	
EIF2B3	Silent	p.E307E	C	C	rs531541564	11	Filtered Calls	1	45345544	45345544	136	0.0367647058823529	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF2B3&recr=Open">Click here</a>	
EIF4E	Silent	p.P66P	G	G		11	Filtered Calls	4	99823038	99823038	236	0.279661016949153	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF4E&recr=Open">Click here</a>	
EIF4E2	Intron		C	C		11	Filtered Calls	2	233422589	233422589	299	0.264214046822742	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF4E2&recr=Open">Click here</a>	
EIF4G3	Silent	p.E1586E	C	C		11	Filtered Calls	1	21133830	21133830	304	0.911184210526316	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF4G3&recr=Open">Click here</a>	
ELAVL1	Silent	p.Q29Q	C	C		11	Filtered Calls	19	8056613	8056613	240	0.25	NA	NA	NA			20	RRM 1. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELAVL1&recr=Open">Click here</a>	
ELAVL4	Silent	p.I158I	C	C		11	Filtered Calls	1	50659556	50659556	223	0.394618834080717	NA	NA	NA			32	RRM 2. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELAVL4&recr=Open">Click here</a>	
ELMO1	Silent	p.F59F	G	G		11	Filtered Calls	7	37354469	37354469	184	0.304347826086957	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELMO1&recr=Open">Click here</a>	
ELMO3	Intron		C	C		11	Filtered Calls	16	67233916	67233916	39	0.307692307692308	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELMO3&recr=Open">Click here</a>	
EMCN	5'UTR		C	C	rs377577086	11	Filtered Calls	4	101439078	101439078	107	0.252336448598131	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMCN&recr=Open">Click here</a>	
EMID1	Silent	p.S113S	C	C		11	Filtered Calls	22	29621141	29621141	64	0.28125	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMID1&recr=Open">Click here</a>	
EMILIN1	Silent	p.E711E	G	G		11	Filtered Calls	2	27306572	27306572	151	0.0529801324503311	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMILIN1&recr=Open">Click here</a>	
EML4	Silent	p.F287F	C	C		11	Filtered Calls	2	42510032	42510032	328	0.274390243902439	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EML4&recr=Open">Click here</a>	
EMP2	Intron		A	A		11	Filtered Calls	16	10631940	10631940	59	0.23728813559322	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMP2&recr=Open">Click here</a>	
EMR3	Intron		G	G		11	Filtered Calls	19	14730294	14730294	233	0.240343347639485	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMR3&recr=Open">Click here</a>	
EMR3	Intron		T	T		11	Filtered Calls	19	14755095	14755095	96	0.5	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMR3&recr=Open">Click here</a>	
EMR4P	RNA		C	C		11	Filtered Calls	19	6981766	6981766	39	0.307692307692308	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMR4P&recr=Open">Click here</a>	
EMR4P	RNA		C	C	rs35247280	11	Filtered Calls	19	6984797	6984797	34	0.176470588235294	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMR4P&recr=Open">Click here</a>	
ENGASE	Intron		C	C		11	Filtered Calls	17	77082008	77082008	30	0.166666666666667	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENGASE&recr=Open">Click here</a>	
ENPEP	Silent	p.P94P	G	G		11	Filtered Calls	4	111397852	111397852	59	0.220338983050847	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPEP&recr=Open">Click here</a>	
ENPEP	Silent	p.I349I	C	C		11	Filtered Calls	4	111430816	111430816	191	0.282722513089005	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPEP&recr=Open">Click here</a>	
ENPEP	Silent	p.E496E	G	G	rs267599982	11	Filtered Calls	4	111436577	111436577	312	0.21474358974359	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPEP&recr=Open">Click here</a>	
ENPP2	Intron		G	G		11	Filtered Calls	8	120596054	120596054	212	0.268867924528302	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPP2&recr=Open">Click here</a>	
ENPP3	Silent	p.E312E	A	A		11	Filtered Calls	6	131997939	131997939	141	0.347517730496454	NA	NA	NA			53	Phosphodiesterase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPP3&recr=Open">Click here</a>	
ENTHD2	Silent	p.P480P	G	G		11	Filtered Calls	17	79202866	79202866	57	0.175438596491228	NA	NA	NA		p.P480P(1)	NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENTHD2&recr=Open">Click here</a>	
ENTPD1	Silent	p.E173E	G	G		11	Filtered Calls	10	97604338	97604338	190	0.189473684210526	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENTPD1&recr=Open">Click here</a>	
ENTPD4	Silent	p.T519T	G	G	rs369592406	11	Filtered Calls	8	23291871	23291871	196	0.239795918367347	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENTPD4&recr=Open">Click here</a>	
EPB41	Silent	p.E676E	G	G		11	Filtered Calls	1	29391514	29391514	102	0.588235294117647	NA	NA	NA			14	Spectrin--actin-binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPB41&recr=Open">Click here</a>	
EPB41L3	Silent	p.S587S	G	G		11	Filtered Calls	18	5416123	5416123	36	0.388888888888889	NA	NA	NA			105	Spectrin--actin-binding. {ECO:0000255}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPB41L3&recr=Open">Click here</a>	
EPG5	Silent	p.P2307P	G	G		11	Filtered Calls	18	43440157	43440157	69	0.391304347826087	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPG5&recr=Open">Click here</a>	
EPG5	Intron		G	G		11	Filtered Calls	18	43508986	43508986	94	0.48936170212766	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPG5&recr=Open">Click here</a>	
EPHA10	Silent	p.F275F	G	G		11	Filtered Calls	1	38227102	38227102	22	0.5	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA10&recr=Open">Click here</a>	
EPHA3	Silent	p.S222S	C	C		11	Filtered Calls	3	89259522	89259522	211	0.218009478672986	NA	NA	NA			139	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA3&recr=Open">Click here</a>	
EPHA3	Silent	p.E307E	G	G		11	Filtered Calls	3	89390172	89390172	248	0.209677419354839	NA	NA	NA			139	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA3&recr=Open">Click here</a>	
EPHA3	Silent	p.T519T	G	G		11	Filtered Calls	3	89448593	89448593	129	0.263565891472868	NA	NA	NA			139	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA3&recr=Open">Click here</a>	
EPHA4	Silent	p.V208V	G	G		11	Filtered Calls	2	222428650	222428650	146	0.267123287671233	NA	NA	NA			49	Cys-rich.|Eph LBD. {ECO:0000255|PROSITE- ProRule:PRU00883}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA4&recr=Open">Click here</a>	
EPHA6	5'UTR		G	G		11	Filtered Calls	3	97167412	97167412	76	0.328947368421053	NA	NA	NA			101			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA6&recr=Open">Click here</a>	
EPHA6	Intron		C	C		11	Filtered Calls	3	97185257	97185257	49	0.448979591836735	NA	NA	NA			101			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA6&recr=Open">Click here</a>	
EPHA7	Silent	p.E396E	C	C		11	Filtered Calls	6	94066571	94066571	32	0.5	NA	NA	NA			112	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA7&recr=Open">Click here</a>	
EPHA7	Silent	p.R136R	C	C		11	Filtered Calls	6	94120643	94120643	124	0.338709677419355	NA	NA	NA			112	Eph LBD. {ECO:0000255|PROSITE- ProRule:PRU00883}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA7&recr=Open">Click here</a>	
EPHB1	Intron		C	C		11	Filtered Calls	3	134884925	134884925	56	0.107142857142857	NA	NA	NA			130			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHB1&recr=Open">Click here</a>	
EPHB1	Silent	p.F716F	C	C		11	Filtered Calls	3	134920333	134920333	159	0.440251572327044	NA	NA	NA			130	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHB1&recr=Open">Click here</a>	
EPHB2	Silent	p.F260F	C	C		11	Filtered Calls	1	23111538	23111538	50	0.08	NA	NA	NA			56	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHB2&recr=Open">Click here</a>	
EPHB2	Intron		C	C		11	Filtered Calls	1	23221962	23221962	53	0.490566037735849	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHB2&recr=Open">Click here</a>	
EPHX2	Silent	p.A29A	G	G		11	Filtered Calls	8	27361219	27361219	118	0.211864406779661	NA	NA	NA			27	Phosphatase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHX2&recr=Open">Click here</a>	
EPHX3	Silent	p.L332L	G	G		11	Filtered Calls	19	15338337	15338337	67	0.17910447761194	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHX3&recr=Open">Click here</a>	
EPS15L1	Intron		G	G		11	Filtered Calls	19	16503259	16503259	73	0.123287671232877	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPS15L1&recr=Open">Click here</a>	
ERBB3	Intron		T	T		11	Filtered Calls	12	56482320	56482320	227	0.405286343612335	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERBB3&recr=Open">Click here</a>	
ERBB3	Intron		C	C		11	Filtered Calls	12	56490527	56490527	207	0.405797101449275	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERBB3&recr=Open">Click here</a>	
ERBB4	Silent	p.K968K	C	C		11	Filtered Calls	2	212286792	212286792	173	0.300578034682081	NA	NA	NA			179	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERBB4&recr=Open">Click here</a>	
ERC1	Silent	p.H32H	C	C		11	Filtered Calls	12	1137165	1137165	174	0.270114942528736	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERC1&recr=Open">Click here</a>	
ERCC6	Intron		A	A		11	Filtered Calls	10	50679172	50679172	241	0.161825726141079	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERCC6&recr=Open">Click here</a>	
ERCC6	Intron		G	G		11	Filtered Calls	10	50684361	50684361	139	0.23021582733813	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERCC6&recr=Open">Click here</a>	
ERCC6	Intron		G	G		11	Filtered Calls	10	50684366	50684366	131	0.229007633587786	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERCC6&recr=Open">Click here</a>	
ERCC6-PGBD3	Silent	p.T605T	G	G		11	Filtered Calls	10	50724750	50724750	293	0.436860068259386	NA	NA	NA		p.T137T(1)	NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERCC6-PGBD3&recr=Open">Click here</a>	
ERCC6L2	Intron		C	C		11	Filtered Calls	9	98685535	98685535	208	0.5625	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERCC6L2&recr=Open">Click here</a>	
ERG	Silent	p.R309R	G	G		11	Filtered Calls	21	39762930	39762930	221	0.271493212669683	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERG&recr=Open">Click here</a>	
ERICH1	Silent	p.I425I	G	G	rs113707327	11	Filtered Calls	8	614660	614660	174	0.241379310344828	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERICH1&recr=Open">Click here</a>	
ERMARD	5'UTR		G	G		11	Filtered Calls	6	170156461	170156461	145	0.0413793103448276	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERMARD&recr=Open">Click here</a>	
ERMARD	Silent	p.S237S	C	C		11	Filtered Calls	6	170169695	170169695	72	0.347222222222222	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERMARD&recr=Open">Click here</a>	
ERN2	Silent	p.F297F	G	G		11	Filtered Calls	16	23713987	23713987	85	0.235294117647059	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERN2&recr=Open">Click here</a>	
ERN2	Silent	p.G291G	C	C		11	Filtered Calls	16	23714005	23714005	73	0.301369863013699	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERN2&recr=Open">Click here</a>	
ESR1	Silent	p.L466L	C	C		11	Filtered Calls	6	152415546	152415546	147	0.421768707482993	NA	NA	NA			49	Interaction with AKAP13.|Self-association.|Steroid-binding.|Transactivation AF-2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESR1&recr=Open">Click here</a>	
ESRP2	Silent	p.R307R	T	T		11	Filtered Calls	16	68266307	68266307	48	0.645833333333333	NA	NA	NA			16	RRM 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESRP2&recr=Open">Click here</a>	
ESRP2	Intron		C	C	rs201523758	11	Filtered Calls	16	68266654	68266654	149	0.302013422818792	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESRP2&recr=Open">Click here</a>	
ESYT2	Silent	p.L585L	G	G		11	Filtered Calls	7	158536342	158536342	16	0.1875	NA	NA	NA			32	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESYT2&recr=Open">Click here</a>	
ESYT3	Intron		T	T		11	Filtered Calls	3	138183180	138183180	18	0.388888888888889	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESYT3&recr=Open">Click here</a>	
ETNK1	Intron		T	T		11	Filtered Calls	12	22811941	22811941	290	0.0241379310344828	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ETNK1&recr=Open">Click here</a>	
EVA1A	3'UTR		C	C		11	Filtered Calls	2	75720361	75720361	475	0.437894736842105	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EVA1A&recr=Open">Click here</a>	
EVI5	Silent	p.A470A	G	G		11	Filtered Calls	1	93101828	93101828	261	0.471264367816092	NA	NA	NA			38	Dimerization.|Interaction with alpha-tubulin, gamma- tubulin, BIRC5 and FBXO5.|Targeting to the centrosomes.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EVI5&recr=Open">Click here</a>	
EVPL	Silent	p.G1733G	C	C		11	Filtered Calls	17	74004087	74004087	37	0.243243243243243	NA	NA	NA			54	Globular 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EVPL&recr=Open">Click here</a>	
EVPL	Silent	p.E1160E	C	C		11	Filtered Calls	17	74005806	74005806	42	0.380952380952381	NA	NA	NA			54	Central fibrous rod domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EVPL&recr=Open">Click here</a>	
EVPL	Silent	p.R597R	C	C		11	Filtered Calls	17	74011629	74011629	39	0.230769230769231	NA	NA	NA			54	Globular 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EVPL&recr=Open">Click here</a>	
EXD3	Silent	p.F630F	G	G		11	Filtered Calls	9	140242631	140242631	17	0.705882352941177	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXD3&recr=Open">Click here</a>	
EXOC1	Intron		T	T		11	Filtered Calls	4	56749979	56749979	60	0.566666666666667	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXOC1&recr=Open">Click here</a>	
EXOSC2	Intron		C	C		11	Filtered Calls	9	133579071	133579071	259	0.200772200772201	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXOSC2&recr=Open">Click here</a>	
EXOSC9	Silent	p.L102L	T	T		11	Filtered Calls	4	122724092	122724092	212	0.283018867924528	NA	NA	NA			16	ARE binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXOSC9&recr=Open">Click here</a>	
EXPH5	Silent	p.R328R	C	C		11	Filtered Calls	11	108385250	108385250	60	0.0666666666666667	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXPH5&recr=Open">Click here</a>	
EXTL3	Silent	p.A124A	C	C		11	Filtered Calls	8	28573948	28573948	19	0.210526315789474	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXTL3&recr=Open">Click here</a>	
EYS	Silent	p.L51L	C	C		11	Filtered Calls	6	66205151	66205151	163	0.355828220858896	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EYS&recr=Open">Click here</a>	
F11	Silent	p.V16V	T	T		11	Filtered Calls	4	187188338	187188338	100	0.28	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F11&recr=Open">Click here</a>	
F13A1	Intron		G	G		11	Filtered Calls	6	6152187	6152187	101	0.207920792079208	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F13A1&recr=Open">Click here</a>	
F13A1	Silent	p.L578L	C	C		11	Filtered Calls	6	6174826	6174826	130	0.684615384615385	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F13A1&recr=Open">Click here</a>	
F5	Silent	p.Q1372Q	C	C		11	Filtered Calls	1	169510212	169510212	290	0.248275862068966	NA	NA	NA			128	35 X 9 AA approximate tandem repeats of [TNP]-L-S-P-D-L-S-Q-T.|B.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F5&recr=Open">Click here</a>	
F5	Silent	p.P1002P	A	A		11	Filtered Calls	1	169511322	169511322	277	0.642599277978339	NA	NA	NA			128	B.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F5&recr=Open">Click here</a>	
F7	Silent	p.R139R	G	G		11	Filtered Calls	13	113768261	113768261	26	0.384615384615385	NA	NA	NA			16	EGF-like 1; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F7&recr=Open">Click here</a>	
F8	Silent	p.G821G	C	C		11	Filtered Calls	X	154159602	154159602	117	0.418803418803419	NA	NA	NA			120	B.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F8&recr=Open">Click here</a>	
FAAH2	Intron		T	T		11	Filtered Calls	X	57515183	57515183	33	0.909090909090909	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAAH2&recr=Open">Click here</a>	
FAM107B	Silent	p.L118L	G	G		11	Filtered Calls	10	14563231	14563231	189	0.105820105820106	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM107B&recr=Open">Click here</a>	
FAM117A	Silent	p.F90F	G	G	rs377253020	11	Filtered Calls	17	47810009	47810009	29	0.275862068965517	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM117A&recr=Open">Click here</a>	
FAM120C	Intron		G	G		11	Filtered Calls	X	54177814	54177814	19	0.947368421052632	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM120C&recr=Open">Click here</a>	
FAM124B	Silent	p.P108P	G	G		11	Filtered Calls	2	225266162	225266162	18	0.222222222222222	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM124B&recr=Open">Click here</a>	
FAM127C	Silent	p.D38D	G	G		11	Filtered Calls	X	134156376	134156376	112	0.446428571428571	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM127C&recr=Open">Click here</a>	
FAM129A	Silent	p.A757A	G	G		11	Filtered Calls	1	184764627	184764627	279	0.186379928315412	NA	NA	NA			45	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM129A&recr=Open">Click here</a>	
FAM129A	Silent	p.F219F	G	G		11	Filtered Calls	1	184801041	184801041	273	0.538461538461538	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM129A&recr=Open">Click here</a>	
FAM129B	Silent	p.T21T	G	G	rs111851615	11	Filtered Calls	9	130294050	130294050	55	0.272727272727273	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM129B&recr=Open">Click here</a>	
FAM131A	Intron		C	C		11	Filtered Calls	3	184060522	184060522	20	0.6	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM131A&recr=Open">Click here</a>	
FAM134C	Silent	p.S325S	G	G		11	Filtered Calls	17	40734257	40734257	50	0.38	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM134C&recr=Open">Click here</a>	
FAM135B	Silent	p.L911L	C	C		11	Filtered Calls	8	139163985	139163985	147	0.156462585034014	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	
FAM135B	Intron		G	G		11	Filtered Calls	8	139165474	139165474	59	0.338983050847458	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	
FAM135B	Silent	p.G224G	T	T		11	Filtered Calls	8	139209910	139209910	64	0.1875	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	
FAM135B	Silent	p.R125R	C	C		11	Filtered Calls	8	139263251	139263251	59	0.169491525423729	NA	NA	NA			238			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	
FAM151A	Silent	p.I112I	G	G	rs139479416	11	Filtered Calls	1	55081772	55081772	118	0.584745762711864	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM151A&recr=Open">Click here</a>	
FAM153A	Intron		G	G		11	Filtered Calls	5	177166150	177166150	87	0.540229885057471	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM153A&recr=Open">Click here</a>	
FAM160B1	Intron		A	A		11	Filtered Calls	10	116605855	116605855	546	0.214285714285714	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM160B1&recr=Open">Click here</a>	
FAM170A	Intron		C	C		11	Filtered Calls	5	118969646	118969646	33	0.454545454545455	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM170A&recr=Open">Click here</a>	
FAM170A	Intron		T	T		11	Filtered Calls	5	118969647	118969647	34	0.441176470588235	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM170A&recr=Open">Click here</a>	
FAM170A	Silent	p.S115S	C	C		11	Filtered Calls	5	118969788	118969788	51	0.431372549019608	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM170A&recr=Open">Click here</a>	
FAM171B	Intron		C	C		11	Filtered Calls	2	187626200	187626200	208	0.293269230769231	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM171B&recr=Open">Click here</a>	
FAM172A	Silent	p.F289F	G	G		11	Filtered Calls	5	93159893	93159893	175	0.314285714285714	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM172A&recr=Open">Click here</a>	
FAM179A	Intron		G	G		11	Filtered Calls	2	29221129	29221129	15	0.2	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM179A&recr=Open">Click here</a>	
FAM183B	Silent	p.P41P	G	G		11	Filtered Calls	7	38725483	38725483	71	0.23943661971831	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM183B&recr=Open">Click here</a>	
FAM193A	Silent	p.E935E	G	G		11	Filtered Calls	4	2701511	2701511	23	0.391304347826087	NA	NA	NA			40	Poly-Lys.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM193A&recr=Open">Click here</a>	
FAM209B	Silent	p.Y157Y	C	C		11	Filtered Calls	20	55111449	55111449	155	0.290322580645161	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM209B&recr=Open">Click here</a>	
FAM211A	IGR		C	C		11	Filtered Calls	17	16344384	16344384	419	0.157517899761337	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM211A&recr=Open">Click here</a>	
FAM35A	Intron		C	C		11	Filtered Calls	10	88930229	88930229	182	0.384615384615385	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM35A&recr=Open">Click here</a>	
FAM3D	Intron		G	G		11	Filtered Calls	3	58622959	58622959	36	0.472222222222222	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM3D&recr=Open">Click here</a>	
FAM46D	Silent	p.I125I	C	C		11	Filtered Calls	X	79698413	79698413	169	0.437869822485207	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM46D&recr=Open">Click here</a>	
FAM47C	Silent	p.S352S	C	C		11	Filtered Calls	X	37027539	37027539	25	0.48	NA	NA	NA			120			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM47C&recr=Open">Click here</a>	
FAM49A	Silent	p.A320A	T	T		11	Filtered Calls	2	16734216	16734216	99	0.222222222222222	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM49A&recr=Open">Click here</a>	
FAM53B	Silent	p.P293P	A	A		11	Filtered Calls	10	126370203	126370203	70	0.2	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM53B&recr=Open">Click here</a>	
FAM69C	Silent	p.F369F	G	G		11	Filtered Calls	18	72103889	72103889	40	0.45	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM69C&recr=Open">Click here</a>	
FAM83B	Intron		C	C		11	Filtered Calls	6	54792438	54792438	282	0.184397163120567	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM83B&recr=Open">Click here</a>	
FAM90A1	Silent	p.T350T	C	C		11	Filtered Calls	12	8374763	8374763	17	0.294117647058824	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM90A1&recr=Open">Click here</a>	
FARP1	Silent	p.I22I	C	C		11	Filtered Calls	13	98865562	98865562	240	0.304166666666667	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FARP1&recr=Open">Click here</a>	
FARP1	Silent	p.P100P	C	C		11	Filtered Calls	13	99017672	99017672	271	0.250922509225092	NA	NA	NA			49	FERM. {ECO:0000255|PROSITE- ProRule:PRU00084}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FARP1&recr=Open">Click here</a>	
FARP1	Intron		T	T		11	Filtered Calls	13	99036980	99036980	61	0.295081967213115	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FARP1&recr=Open">Click here</a>	
FAS	Silent	p.K204K	G	G		11	Filtered Calls	10	90771799	90771799	280	0.364285714285714	NA	NA	NA			18	Beta-ketoacyl synthase. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAS&recr=Open">Click here</a>	
FAT1	Silent	p.V810V	G	G	rs146355594	11	Filtered Calls	4	187628552	187628552	273	0.256410256410256	NA	NA	NA			228	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT1&recr=Open">Click here</a>	
FAT2	Silent	p.I1019I	G	G	rs147733173	11	Filtered Calls	5	150945436	150945436	16	0.5	NA	NA	NA			196	Cadherin 8. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT2&recr=Open">Click here</a>	
FAT3	Silent	p.A452A	G	G		11	Filtered Calls	11	92087084	92087084	36	0.444444444444444	NA	NA	NA		p.A602A(2)	85	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT3&recr=Open">Click here</a>	
FAT3	Silent	p.L1628L	C	C		11	Filtered Calls	11	92531511	92531511	13	0.384615384615385	NA	NA	NA		p.L1778V(2)	85	Cadherin 15. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT3&recr=Open">Click here</a>	
FAT4	Silent	p.S2243S	C	C	rs368872163	11	Filtered Calls	4	126336847	126336847	105	0.238095238095238	NA	NA	NA			355	Cadherin 21. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	
FAT4	Silent	p.T3000T	G	G	rs142357260	11	Filtered Calls	4	126371171	126371171	121	0.223140495867769	NA	NA	NA			355	Cadherin 29. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	
FAT4	Silent	p.K3062K	G	G		11	Filtered Calls	4	126371357	126371357	109	0.293577981651376	NA	NA	NA			355	Cadherin 29. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	
FAT4	Silent	p.S3650S	C	C		11	Filtered Calls	4	126373121	126373121	126	0.293650793650794	NA	NA	NA			355			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	
FAT4	Intron		C	C		11	Filtered Calls	4	126389986	126389986	153	0.300653594771242	NA	NA	NA			355			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	
FAT4	Silent	p.G4310G	G	G		11	Filtered Calls	4	126408613	126408613	183	0.322404371584699	NA	NA	NA			355	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	
FBLIM1	Intron		C	C		11	Filtered Calls	1	16096900	16096900	55	0.363636363636364	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBLIM1&recr=Open">Click here</a>	
FBLL1	Silent	p.S173S	C	C		11	Filtered Calls	5	167957028	167957028	12	0.583333333333333	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBLL1&recr=Open">Click here</a>	
FBLN5	5'Flank		C	C	rs374737765	11	Filtered Calls	14	92343859	92343859	71	0.295774647887324	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBLN5&recr=Open">Click here</a>	
FBN3	Silent	p.H1656H	G	G		11	Filtered Calls	19	8167729	8167729	91	0.208791208791209	NA	NA	NA			132	TB 7.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBN3&recr=Open">Click here</a>	
FBXL12	IGR		G	G		11	Filtered Calls	19	9921600	9921600	67	0.26865671641791	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXL12&recr=Open">Click here</a>	
FBXL4	Silent	p.L532L	G	G		11	Filtered Calls	6	99323397	99323397	92	0.41304347826087	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXL4&recr=Open">Click here</a>	
FBXL7	Intron		C	C		11	Filtered Calls	5	15935299	15935299	115	0.478260869565217	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXL7&recr=Open">Click here</a>	
FBXL8	IGR		C	C	rs184475114	11	Filtered Calls	16	67199458	67199458	147	0.285714285714286	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXL8&recr=Open">Click here</a>	
FBXO16	Silent	p.F91F	G	G		11	Filtered Calls	8	28321162	28321162	95	0.221052631578947	NA	NA	NA			3	F-box. {ECO:0000255|PROSITE- ProRule:PRU00080}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO16&recr=Open">Click here</a>	
FBXO28	Silent	p.I169I	C	C		11	Filtered Calls	1	224321905	224321905	229	0.672489082969432	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO28&recr=Open">Click here</a>	
FBXO3	Intron		G	G		11	Filtered Calls	11	33790364	33790364	127	0.354330708661417	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO3&recr=Open">Click here</a>	
FBXO41	Silent	p.F561F	G	G		11	Filtered Calls	2	73491529	73491529	139	0.23021582733813	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO41&recr=Open">Click here</a>	
FBXW7	Intron		-	-		11	Filtered Calls	4	153244306	153244307	91	0.274725274725275	NA	NA	NA		p.?(1)	462			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXW7&recr=Open">Click here</a>	
FCAMR	Silent	p.F60F	G	G	rs369525141	11	Filtered Calls	1	207139193	207139193	38	0.315789473684211	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCAMR&recr=Open">Click here</a>	
FCER1A	Silent	p.F129F	C	C		11	Filtered Calls	1	159275833	159275833	91	0.197802197802198	NA	NA	NA			33	Ig-like 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCER1A&recr=Open">Click here</a>	
FCER1G	5'Flank		C	C	rs142586717	11	Filtered Calls	1	161182186	161182186	102	0.323529411764706	NA	NA	NA		p.I344I(1)	6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCER1G&recr=Open">Click here</a>	
FCGBP	Silent	p.L1451L	C	C		11	Filtered Calls	19	40408486	40408486	42	0.404761904761905	NA	NA	NA			165	VWFD 3. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCGBP&recr=Open">Click here</a>	
FCGBP	Silent	p.A107A	C	C		11	Filtered Calls	19	40433948	40433948	89	0.146067415730337	NA	NA	NA			165	IgGFc-binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCGBP&recr=Open">Click here</a>	
FCGRT	Silent	p.S297S	C	C		11	Filtered Calls	19	50028733	50028733	118	0.296610169491525	NA	NA	NA			9	Connecting peptide.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCGRT&recr=Open">Click here</a>	
FCHO1	Silent	p.F349F	C	C	rs147287381	11	Filtered Calls	19	17886835	17886835	36	0.25	NA	NA	NA			22	Mediates interaction with the adaptor protein complex AP-2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCHO1&recr=Open">Click here</a>	
FCHO1	Silent	p.Y871Y	C	C	rs571990005	11	Filtered Calls	19	17898621	17898621	15	0.2	NA	NA	NA			22	MHD. {ECO:0000255|PROSITE- ProRule:PRU00404}.|Mediates interaction with AGFG1, CALM, DAB2, EPS15, EPS15R, ITSN1 and clathrin.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCHO1&recr=Open">Click here</a>	
FCN1	Intron		G	G		11	Filtered Calls	9	137804997	137804997	13	0.384615384615385	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCN1&recr=Open">Click here</a>	
FCN2	Intron		T	T		11	Filtered Calls	9	137774363	137774363	35	0.257142857142857	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCN2&recr=Open">Click here</a>	
FCN2	Silent	p.G263G	A	A		11	Filtered Calls	9	137779108	137779108	81	0.320987654320988	NA	NA	NA			20	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCN2&recr=Open">Click here</a>	
FCRL1	Silent	p.I22I	T	T		11	Filtered Calls	1	157773888	157773888	64	0.234375	NA	NA	NA			42	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCRL1&recr=Open">Click here</a>	
FCRL2	Silent	p.V408V	G	G		11	Filtered Calls	1	157736700	157736700	103	0.16504854368932	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCRL2&recr=Open">Click here</a>	
FCRL3	Silent	p.T84T	G	G		11	Filtered Calls	1	157668220	157668220	135	0.62962962962963	NA	NA	NA			69	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCRL3&recr=Open">Click here</a>	
FCRL4	Silent	p.S179S	T	T		11	Filtered Calls	1	157557680	157557680	58	0.172413793103448	NA	NA	NA			40	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCRL4&recr=Open">Click here</a>	
FCRL6	Intron		C	C	rs376774970	11	Filtered Calls	1	159779873	159779873	193	0.212435233160622	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCRL6&recr=Open">Click here</a>	
FDPS	Silent	p.I328I	C	C		11	Filtered Calls	1	155289644	155289644	262	0.251908396946565	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FDPS&recr=Open">Click here</a>	
FER1L6	Silent	p.F1657F	C	C		11	Filtered Calls	8	125113425	125113425	128	0.125	NA	NA	NA			118	C2 6. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FER1L6&recr=Open">Click here</a>	
FERD3L	Silent	p.F16F	G	G		11	Filtered Calls	7	19184938	19184938	48	0.604166666666667	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FERD3L&recr=Open">Click here</a>	
FERMT2	Silent	p.L443L	G	G		11	Filtered Calls	14	53331516	53331516	249	0.883534136546185	NA	NA	NA			20	FERM.|PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FERMT2&recr=Open">Click here</a>	
FES	Silent	p.T128T	C	C		11	Filtered Calls	15	91428812	91428812	32	0.15625	NA	NA	NA			3	Important for interaction with membranes containing phosphoinositides.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FES&recr=Open">Click here</a>	
FES	Intron		C	C		11	Filtered Calls	15	91432740	91432740	92	0.543478260869565	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FES&recr=Open">Click here</a>	
FES	Silent	p.L512L	C	C		11	Filtered Calls	15	91434787	91434787	80	0.225	NA	NA	NA			3	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FES&recr=Open">Click here</a>	
FFAR4	Silent	p.S357S	G	G	rs539781267	11	Filtered Calls	10	95347351	95347351	165	0.2	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FFAR4&recr=Open">Click here</a>	
FGD3	Silent	p.A241A	C	C		11	Filtered Calls	9	95768348	95768348	113	0.20353982300885	NA	NA	NA			17	DH. {ECO:0000255|PROSITE- ProRule:PRU00062}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGD3&recr=Open">Click here</a>	
FGD3	Silent	p.Q473Q	G	G		11	Filtered Calls	9	95782631	95782631	25	0.16	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGD3&recr=Open">Click here</a>	
FGF1	Silent	p.G21G	C	C		11	Filtered Calls	5	141993630	141993630	71	0.394366197183099	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF1&recr=Open">Click here</a>	
FGF12	Silent	p.P200P	C	C		11	Filtered Calls	3	191888260	191888260	133	0.210526315789474	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF12&recr=Open">Click here</a>	
FGF13	Silent	p.L233L	C	C		11	Filtered Calls	X	137715050	137715050	145	0.393103448275862	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF13&recr=Open">Click here</a>	
FGF20	Silent	p.K182K	C	C		11	Filtered Calls	8	16850671	16850671	287	0.184668989547038	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF20&recr=Open">Click here</a>	
FGF23	Silent	p.R196R	C	C		11	Filtered Calls	12	4479677	4479677	28	0.214285714285714	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF23&recr=Open">Click here</a>	
FGF9	Silent	p.P49P	C	C		11	Filtered Calls	13	22246198	22246198	57	0.315789473684211	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF9&recr=Open">Click here</a>	
FGF9	Silent	p.G117G	G	G		11	Filtered Calls	13	22255254	22255254	26	0.153846153846154	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF9&recr=Open">Click here</a>	
FGFR1	Intron		G	G		11	Filtered Calls	8	38286845	38286845	16	0.25	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGFR1&recr=Open">Click here</a>	
FGFR2	Intron		C	C		11	Filtered Calls	10	123245050	123245050	37	0.189189189189189	NA	NA	NA		p.?(3)	181			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGFR2&recr=Open">Click here</a>	
FGFR2	Intron		C	C		11	Filtered Calls	10	123279487	123279487	90	0.377777777777778	NA	NA	NA			181			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGFR2&recr=Open">Click here</a>	
FGFR2	Intron		C	C		11	Filtered Calls	10	123279488	123279488	92	0.369565217391304	NA	NA	NA			181			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGFR2&recr=Open">Click here</a>	
FGGY	Silent	p.F524F	C	C	rs115951404	11	Filtered Calls	1	60139793	60139793	53	0.377358490566038	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGGY&recr=Open">Click here</a>	
FGL1	Silent	p.R18R	C	C		11	Filtered Calls	8	17743010	17743010	219	0.200913242009132	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGL1&recr=Open">Click here</a>	
FIG4	Intron		C	C		11	Filtered Calls	6	110036391	110036391	115	0.452173913043478	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FIG4&recr=Open">Click here</a>	
FILIP1	Silent	p.K1101K	C	C		11	Filtered Calls	6	76022245	76022245	84	0.380952380952381	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FILIP1&recr=Open">Click here</a>	
FILIP1L	Silent	p.K769K	C	C		11	Filtered Calls	3	99568213	99568213	179	0.35195530726257	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FILIP1L&recr=Open">Click here</a>	
FIP1L1	Silent	p.S285S	C	C	rs375304698	11	Filtered Calls	4	54280821	54280821	96	0.34375	NA	NA	NA			6	Necessary for stimulating PAPOLA activity.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FIP1L1&recr=Open">Click here</a>	
FIP1L1	Intron		C	C		11	Filtered Calls	4	54294341	54294341	246	0.300813008130081	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FIP1L1&recr=Open">Click here</a>	
FLG	Silent	p.Q838Q	C	C		11	Filtered Calls	1	152284848	152284848	159	0.283018867924528	NA	NA	NA			424	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	
FLG2	Silent	p.R1876R	C	C		11	Filtered Calls	1	152324634	152324634	216	0.212962962962963	NA	NA	NA			188			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG2&recr=Open">Click here</a>	
FLG2	Silent	p.S1138S	G	G		11	Filtered Calls	1	152326848	152326848	217	0.663594470046083	NA	NA	NA		p.S1138S(1)	188	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG2&recr=Open">Click here</a>	
FLII	Silent	p.L194L	G	G		11	Filtered Calls	17	18157490	18157490	17	1	NA	NA	NA			32	Interaction with LRRFIP1 and LRRFIP2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLII&recr=Open">Click here</a>	
FLNB	Silent	p.F570F	C	C	rs551771569	11	Filtered Calls	3	58090906	58090906	164	0.457317073170732	NA	NA	NA			120			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLNB&recr=Open">Click here</a>	
FLNB	Intron		C	C		11	Filtered Calls	3	58131637	58131637	253	0.197628458498024	NA	NA	NA			120			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLNB&recr=Open">Click here</a>	
FLNB	Silent	p.I1897I	C	C		11	Filtered Calls	3	58132590	58132590	92	0.304347826086957	NA	NA	NA			120	Interaction with the cytoplasmic tail of GP1BA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLNB&recr=Open">Click here</a>	
FLNB	Silent	p.I2055I	C	C	rs144036986	11	Filtered Calls	3	58134560	58134560	86	0.27906976744186	NA	NA	NA			120	Interaction with the cytoplasmic tail of GP1BA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLNB&recr=Open">Click here</a>	
FLOT2	Intron		G	G		11	Filtered Calls	17	27209260	27209260	86	0.36046511627907	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLOT2&recr=Open">Click here</a>	
FLRT2	Silent	p.T362T	C	C		11	Filtered Calls	14	86088944	86088944	89	0.191011235955056	NA	NA	NA			73	LRRCT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLRT2&recr=Open">Click here</a>	
FLT1	Intron		A	A		11	Filtered Calls	13	28896919	28896919	166	0.301204819277108	NA	NA	NA			115			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLT1&recr=Open">Click here</a>	
FLT4	Silent	p.I776I	G	G	rs139263798	11	Filtered Calls	5	180047687	180047687	36	0.444444444444444	NA	NA	NA		p.I776I(2)|p.I586I(1)	71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLT4&recr=Open">Click here</a>	
FLT4	Intron		C	C		11	Filtered Calls	5	180056247	180056247	24	0.541666666666667	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLT4&recr=Open">Click here</a>	
FLYWCH1	Silent	p.F429F	C	C		11	Filtered Calls	16	2983757	2983757	40	0.2	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLYWCH1&recr=Open">Click here</a>	
FMN1	Intron		G	G		11	Filtered Calls	15	33359674	33359674	223	0.488789237668161	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMN1&recr=Open">Click here</a>	
FMN2	Silent	p.Q672Q	G	G		11	Filtered Calls	1	240370128	240370128	84	0.416666666666667	NA	NA	NA			178			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMN2&recr=Open">Click here</a>	
FMNL1	Intron		C	C		11	Filtered Calls	17	43321149	43321149	22	0.272727272727273	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMNL1&recr=Open">Click here</a>	
FMNL2	Silent	p.A179A	G	G		11	Filtered Calls	2	153486181	153486181	42	0.333333333333333	NA	NA	NA			23	GBD/FH3. {ECO:0000255|PROSITE- ProRule:PRU00579}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMNL2&recr=Open">Click here</a>	
FMNL3	IGR		C	C		11	Filtered Calls	12	50037733	50037733	71	0.464788732394366	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMNL3&recr=Open">Click here</a>	
FMO1	Silent	p.F337F	C	C		11	Filtered Calls	1	171251300	171251300	219	0.132420091324201	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMO1&recr=Open">Click here</a>	
FMO2	Silent	p.L361L	G	G	rs151070773	11	Filtered Calls	1	171174673	171174673	105	0.257142857142857	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMO2&recr=Open">Click here</a>	
FMO4	Intron		T	T		11	Filtered Calls	1	171289105	171289105	292	0.400684931506849	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMO4&recr=Open">Click here</a>	
FNDC1	Silent	p.K1649K	G	G		11	Filtered Calls	6	159672446	159672446	20	0.35	NA	NA	NA			93			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FNDC1&recr=Open">Click here</a>	
FNDC3A	Intron		C	C		11	Filtered Calls	13	49741450	49741450	159	0.220125786163522	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FNDC3A&recr=Open">Click here</a>	
FNDC9	IGR		G	G		11	Filtered Calls	5	156766065	156766065	19	0.473684210526316	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FNDC9&recr=Open">Click here</a>	
FNTA	Intron		C	C		11	Filtered Calls	8	42932353	42932353	164	0.414634146341463	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FNTA&recr=Open">Click here</a>	
FOLR4	Silent	p.K34K	G	G		11	Filtered Calls	11	94038904	94038904	20	0.4	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOLR4&recr=Open">Click here</a>	
FOLR4	Silent	p.F219F	C	C	rs367878279	11	Filtered Calls	11	94040783	94040783	71	0.549295774647887	NA	NA	NA		p.F220fs*>22(1)	14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOLR4&recr=Open">Click here</a>	
FOXK1	Silent	p.I222I	C	C		11	Filtered Calls	7	4780574	4780574	109	0.18348623853211	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOXK1&recr=Open">Click here</a>	
FOXN3	Silent	p.K332K	C	C		11	Filtered Calls	14	89629235	89629235	35	0.2	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOXN3&recr=Open">Click here</a>	
FPGT-TNNI3K	Intron		C	C		11	Filtered Calls	1	74835072	74835072	65	0.461538461538462	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FPGT-TNNI3K&recr=Open">Click here</a>	
FPGT-TNNI3K	Intron		C	C		11	Filtered Calls	1	74902151	74902151	112	0.285714285714286	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FPGT-TNNI3K&recr=Open">Click here</a>	
FPR2	Silent	p.L39L	C	C		11	Filtered Calls	19	52272028	52272028	97	0.195876288659794	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FPR2&recr=Open">Click here</a>	
FPR3	Silent	p.F243F	C	C		11	Filtered Calls	19	52327730	52327730	32	0.3125	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FPR3&recr=Open">Click here</a>	
FPR3	Silent	p.E347E	G	G		11	Filtered Calls	19	52328042	52328042	16	0.25	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FPR3&recr=Open">Click here</a>	
FRAS1	Silent	p.I2256I	C	C		11	Filtered Calls	4	79385179	79385179	140	0.564285714285714	NA	NA	NA			103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRAS1&recr=Open">Click here</a>	
FREM1	Silent	p.F1544F	G	G		11	Filtered Calls	9	14776012	14776012	61	0.377049180327869	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FREM1&recr=Open">Click here</a>	
FREM1	Intron		C	C		11	Filtered Calls	9	14857547	14857547	90	0.322222222222222	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FREM1&recr=Open">Click here</a>	
FREM2	Silent	p.K2590K	G	G		11	Filtered Calls	13	39438530	39438530	163	0.276073619631902	NA	NA	NA			148			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FREM2&recr=Open">Click here</a>	
FRMD1	Silent	p.F137F	G	G	rs140475200	11	Filtered Calls	6	168467485	168467485	28	0.392857142857143	NA	NA	NA		p.F137F(1)	19	FERM. {ECO:0000255|PROSITE- ProRule:PRU00084}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMD1&recr=Open">Click here</a>	
FRMD3	Intron		G	G	rs377323266	11	Filtered Calls	9	85926791	85926791	138	0.260869565217391	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMD3&recr=Open">Click here</a>	
FRMPD1	Silent	p.S675S	C	C	rs533913734	11	Filtered Calls	9	37740550	37740550	19	0.421052631578947	NA	NA	NA		p.S675S(1)	93			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMPD1&recr=Open">Click here</a>	
FRMPD2	Silent	p.G335G	C	C		11	Filtered Calls	10	49440321	49440321	30	0.133333333333333	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMPD2&recr=Open">Click here</a>	
FRMPD3	Silent	p.L801L	G	G		11	Filtered Calls	X	106843573	106843573	18	0.888888888888889	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMPD3&recr=Open">Click here</a>	
FRMPD4	Silent	p.L760L	C	C		11	Filtered Calls	X	12734858	12734858	80	0.5	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMPD4&recr=Open">Click here</a>	
FRMPD4	Silent	p.L932L	C	C		11	Filtered Calls	X	12735741	12735741	97	0.515463917525773	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMPD4&recr=Open">Click here</a>	
FRS3	Intron		G	G		11	Filtered Calls	6	41740701	41740701	60	0.666666666666667	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRS3&recr=Open">Click here</a>	
FRY	Silent	p.F1703F	C	C		11	Filtered Calls	13	32800014	32800014	195	0.302564102564103	NA	NA	NA			132			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRY&recr=Open">Click here</a>	
FRY	Silent	p.F2461F	C	C		11	Filtered Calls	13	32828498	32828498	213	0.323943661971831	NA	NA	NA		p.F2461F(1)	132			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRY&recr=Open">Click here</a>	
FSD1	Silent	p.G333G	G	G		11	Filtered Calls	19	4318908	4318908	65	0.169230769230769	NA	NA	NA			21	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSD1&recr=Open">Click here</a>	
FSD2	Silent	p.E159E	C	C		11	Filtered Calls	15	83455666	83455666	64	0.3125	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSD2&recr=Open">Click here</a>	
FSHR	Silent	p.R569R	C	C		11	Filtered Calls	2	49190253	49190253	29	0.275862068965517	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSHR&recr=Open">Click here</a>	
FSIP1	Intron		G	G		11	Filtered Calls	15	40030408	40030408	143	0.265734265734266	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSIP1&recr=Open">Click here</a>	
FSIP1	Intron		G	G		11	Filtered Calls	15	40056126	40056126	254	0.311023622047244	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSIP1&recr=Open">Click here</a>	
FSIP2	Silent	p.L6586L	A	A		11	Filtered Calls	2	186673791	186673791	124	0.32258064516129	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSIP2&recr=Open">Click here</a>	
FSTL5	Silent	p.Q518Q	C	C		11	Filtered Calls	4	162402226	162402226	222	0.247747747747748	NA	NA	NA			91			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSTL5&recr=Open">Click here</a>	
FSTL5	Silent	p.E236E	T	T		11	Filtered Calls	4	162680582	162680582	171	0.538011695906433	NA	NA	NA			91	EF-hand 2. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSTL5&recr=Open">Click here</a>	
FSTL5	Silent	p.V203V	C	C		11	Filtered Calls	4	162680681	162680681	142	0.21830985915493	NA	NA	NA			91	EF-hand 1. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSTL5&recr=Open">Click here</a>	
FUK	Intron		C	C		11	Filtered Calls	16	70500069	70500069	95	0.684210526315789	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FUK&recr=Open">Click here</a>	
FUT10	Silent	p.P124P	C	C	rs142312018	11	Filtered Calls	8	33247237	33247237	196	0.178571428571429	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FUT10&recr=Open">Click here</a>	
FUT7	Silent	p.T238T	C	C		11	Filtered Calls	9	139925477	139925477	127	0.267716535433071	NA	NA	NA		p.T238T(1)	8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FUT7&recr=Open">Click here</a>	
FZD2	Silent	p.F403F	C	C		11	Filtered Calls	17	42636265	42636265	119	0.361344537815126	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FZD2&recr=Open">Click here</a>	
FZD8	Silent	p.T295T	G	G		11	Filtered Calls	10	35929473	35929473	22	0.181818181818182	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FZD8&recr=Open">Click here</a>	
FZD8	Silent	p.L88L	G	G		11	Filtered Calls	10	35930096	35930096	27	0.407407407407407	NA	NA	NA			11	FZ. {ECO:0000255|PROSITE- ProRule:PRU00090}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FZD8&recr=Open">Click here</a>	
FZD8	Silent	p.F86F	G	G		11	Filtered Calls	10	35930100	35930100	27	0.407407407407407	NA	NA	NA			11	FZ. {ECO:0000255|PROSITE- ProRule:PRU00090}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FZD8&recr=Open">Click here</a>	
GAB4	Intron		G	G		11	Filtered Calls	22	17473072	17473072	145	0.227586206896552	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAB4&recr=Open">Click here</a>	
GABBR2	Silent	p.R435R	C	C		11	Filtered Calls	9	101156530	101156530	56	0.25	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABBR2&recr=Open">Click here</a>	
GABBR2	Silent	p.R418R	C	C	rs534738651	11	Filtered Calls	9	101168406	101168406	114	0.175438596491228	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABBR2&recr=Open">Click here</a>	
GABBR2	Silent	p.R304R	C	C		11	Filtered Calls	9	101235515	101235515	44	0.272727272727273	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABBR2&recr=Open">Click here</a>	
GABRA1	Silent	p.V41V	C	C		11	Filtered Calls	5	161281212	161281212	128	0.3203125	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA1&recr=Open">Click here</a>	
GABRA1	Intron		C	C		11	Filtered Calls	5	161300118	161300118	158	0.481012658227848	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA1&recr=Open">Click here</a>	
GABRA2	Silent	p.G346G	C	C		11	Filtered Calls	4	46263964	46263964	94	0.372340425531915	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA2&recr=Open">Click here</a>	
GABRA3	Intron		G	G		11	Filtered Calls	X	151562937	151562937	63	0.952380952380952	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA3&recr=Open">Click here</a>	
GABRA5	Silent	p.F330F	C	C		11	Filtered Calls	15	27188474	27188474	15	0.2	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA5&recr=Open">Click here</a>	
GABRA6	Silent	p.S258S	C	C		11	Filtered Calls	5	161117307	161117307	151	0.364238410596026	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA6&recr=Open">Click here</a>	
GABRB1	Silent	p.T288T	C	C		11	Filtered Calls	4	47408727	47408727	57	0.315789473684211	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRB1&recr=Open">Click here</a>	
GABRB2	Silent	p.K239K	C	C		11	Filtered Calls	5	160761874	160761874	72	0.333333333333333	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRB2&recr=Open">Click here</a>	
GABRG1	Silent	p.L4L	C	C		11	Filtered Calls	4	46125919	46125919	63	0.0634920634920635	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRG1&recr=Open">Click here</a>	
GABRG2	Intron		T	T		11	Filtered Calls	5	161576608	161576608	36	0.305555555555556	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRG2&recr=Open">Click here</a>	
GABRP	Intron		C	C		11	Filtered Calls	5	170222207	170222207	98	0.377551020408163	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRP&recr=Open">Click here</a>	
GABRP	Intron		C	C	rs77629881	11	Filtered Calls	5	170222208	170222208	98	0.377551020408163	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRP&recr=Open">Click here</a>	
GAD2	Silent	p.V122V	G	G	rs201248117	11	Filtered Calls	10	26508051	26508051	126	0.222222222222222	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAD2&recr=Open">Click here</a>	
GAD2	Silent	p.G463G	G	G	rs575617728	11	Filtered Calls	10	26581396	26581396	104	0.423076923076923	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAD2&recr=Open">Click here</a>	
GAL3ST1	Silent	p.F106F	G	G		11	Filtered Calls	22	30951894	30951894	66	0.393939393939394	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAL3ST1&recr=Open">Click here</a>	
GAL3ST4	Silent	p.A404A	C	C	rs267601670	11	Filtered Calls	7	99757800	99757800	84	0.464285714285714	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAL3ST4&recr=Open">Click here</a>	
GALNT12	Silent	p.K204K	G	G		11	Filtered Calls	9	101589104	101589104	12	0.833333333333333	NA	NA	NA			17	Catalytic subdomain A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT12&recr=Open">Click here</a>	
GALNT13	Silent	p.L262L	G	G		11	Filtered Calls	2	155102424	155102424	140	0.242857142857143	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT13&recr=Open">Click here</a>	
GALNT14	Silent	p.S261S	G	G		11	Filtered Calls	2	31167768	31167768	69	0.188405797101449	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT14&recr=Open">Click here</a>	
GALNT15	Silent	p.R550R	G	G		11	Filtered Calls	3	16264142	16264142	259	0.482625482625483	NA	NA	NA			NA	Ricin B-type lectin. {ECO:0000255|PROSITE-ProRule:PRU00174}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT15&recr=Open">Click here</a>	
GALNT16	Silent	p.P104P	C	C		11	Filtered Calls	14	69787562	69787562	17	0.882352941176471	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT16&recr=Open">Click here</a>	
GALNT5	Silent	p.E564E	G	G		11	Filtered Calls	2	158142597	158142597	118	0.559322033898305	NA	NA	NA			56	Catalytic subdomain A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT5&recr=Open">Click here</a>	
GALNT6	Silent	p.A260A	T	T		11	Filtered Calls	12	51759248	51759248	32	0.375	NA	NA	NA			27	Catalytic subdomain A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT6&recr=Open">Click here</a>	
GALNT8	Silent	p.L247L	G	G		11	Filtered Calls	12	4853747	4853747	59	0.305084745762712	NA	NA	NA			35	Catalytic subdomain A.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT8&recr=Open">Click here</a>	
GALNTL5	3'UTR		G	G		11	Filtered Calls	7	151699851	151699851	44	0.386363636363636	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNTL5&recr=Open">Click here</a>	
GALNTL6	Silent	p.G63G	T	T		11	Filtered Calls	4	173150857	173150857	50	0.22	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNTL6&recr=Open">Click here</a>	
GAN	Silent	p.T539T	C	C		11	Filtered Calls	16	81411024	81411024	148	0.209459459459459	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAN&recr=Open">Click here</a>	
GAPVD1	Intron		T	T		11	Filtered Calls	9	128099292	128099292	77	0.376623376623377	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAPVD1&recr=Open">Click here</a>	
GART	Silent	p.K452K	C	C		11	Filtered Calls	21	34894532	34894532	332	0.310240963855422	NA	NA	NA			31	AIRS.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GART&recr=Open">Click here</a>	
GAS2	Intron		C	C		11	Filtered Calls	11	22707211	22707211	138	0.282608695652174	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAS2&recr=Open">Click here</a>	
GAS2L2	Silent	p.I503I	G	G		11	Filtered Calls	17	34073007	34073007	28	0.392857142857143	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAS2L2&recr=Open">Click here</a>	
GATA2	Silent	p.P470P	G	G		11	Filtered Calls	3	128199895	128199895	9	0.333333333333333	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GATA2&recr=Open">Click here</a>	
GATA3	Silent	p.S110S	C	C	rs111978415	11	Filtered Calls	10	8100356	8100356	45	0.244444444444444	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GATA3&recr=Open">Click here</a>	
GATA3	Silent	p.P158P	G	G		11	Filtered Calls	10	8100500	8100500	35	0.2	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GATA3&recr=Open">Click here</a>	
GATA4	Intron		C	C		11	Filtered Calls	8	11612552	11612552	89	0.438202247191011	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GATA4&recr=Open">Click here</a>	
GATAD2A	Silent	p.I627I	C	C		11	Filtered Calls	19	19616259	19616259	101	0.247524752475248	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GATAD2A&recr=Open">Click here</a>	
GATSL3	Intron		G	G		11	Filtered Calls	22	30682943	30682943	108	0.203703703703704	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GATSL3&recr=Open">Click here</a>	
GBA	Silent	p.P328P	G	G		11	Filtered Calls	1	155207147	155207147	64	0.21875	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBA&recr=Open">Click here</a>	
GBA3	RNA		C	C		11	Filtered Calls	4	22694638	22694638	19	0.315789473684211	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBA3&recr=Open">Click here</a>	
GBA3	RNA		C	C		11	Filtered Calls	4	22750579	22750579	13	0.538461538461538	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBA3&recr=Open">Click here</a>	
GBAS	Intron		C	C		11	Filtered Calls	7	56052500	56052500	97	0.134020618556701	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBAS&recr=Open">Click here</a>	
GBE1	Silent	p.F579F	G	G		11	Filtered Calls	3	81586128	81586128	136	0.25	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBE1&recr=Open">Click here</a>	
GBF1	Intron		C	C	rs199716243	11	Filtered Calls	10	104120768	104120768	296	0.260135135135135	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBF1&recr=Open">Click here</a>	
GBF1	Silent	p.T1796T	C	C		11	Filtered Calls	10	104141901	104141901	94	0.170212765957447	NA	NA	NA			71	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBF1&recr=Open">Click here</a>	
GBP4	Silent	p.L593L	C	C		11	Filtered Calls	1	89651081	89651081	209	0.37799043062201	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBP4&recr=Open">Click here</a>	
GBP5	Silent	p.I113I	G	G	rs371813081	11	Filtered Calls	1	89733189	89733189	131	0.862595419847328	NA	NA	NA			24	GB1/RHD3-type G.|GTPase domain (Globular). {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBP5&recr=Open">Click here</a>	
GBP6	Silent	p.R451R	G	G	rs267598761	11	Filtered Calls	1	89848423	89848423	60	0.333333333333333	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBP6&recr=Open">Click here</a>	
GBP6	Silent	p.L530L	G	G		11	Filtered Calls	1	89849773	89849773	47	0.553191489361702	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBP6&recr=Open">Click here</a>	
GCA	Intron		C	C		11	Filtered Calls	2	163204077	163204077	87	0.505747126436782	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCA&recr=Open">Click here</a>	
GCAT	Intron		T	T		11	Filtered Calls	22	38211125	38211125	87	0.183908045977011	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCAT&recr=Open">Click here</a>	
GCDH	Silent	p.R234R	G	G		11	Filtered Calls	19	13007085	13007085	115	0.426086956521739	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCDH&recr=Open">Click here</a>	
GCK	Silent	p.I110I	G	G		11	Filtered Calls	7	44191903	44191903	68	0.323529411764706	NA	NA	NA			37	Hexokinase type-1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCK&recr=Open">Click here</a>	
GCKR	Silent	p.L538L	C	C	rs372400697	11	Filtered Calls	2	27745368	27745368	73	0.301369863013699	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCKR&recr=Open">Click here</a>	
GCLC	Silent	p.I452I	G	G		11	Filtered Calls	6	53370229	53370229	130	0.238461538461538	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCLC&recr=Open">Click here</a>	
GCN1L1	Intron		G	G		11	Filtered Calls	12	120587531	120587531	24	0.375	NA	NA	NA		p.?(1)	94			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCN1L1&recr=Open">Click here</a>	
GCN1L1	Intron		G	G		11	Filtered Calls	12	120621364	120621364	118	0.220338983050847	NA	NA	NA			94			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCN1L1&recr=Open">Click here</a>	
GDAP2	Intron		G	G		11	Filtered Calls	1	118454716	118454716	239	0.355648535564854	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDAP2&recr=Open">Click here</a>	
GDF2	Silent	p.V403V	G	G		11	Filtered Calls	10	48413659	48413659	21	0.19047619047619	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDF2&recr=Open">Click here</a>	
GDF2	Silent	p.E294E	C	C	rs200196714	11	Filtered Calls	10	48413986	48413986	47	0.148936170212766	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDF2&recr=Open">Click here</a>	
GDF3	Silent	p.I324I	G	G		11	Filtered Calls	12	7842597	7842597	54	0.185185185185185	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDF3&recr=Open">Click here</a>	
GDF3	5'UTR		G	G		11	Filtered Calls	12	7848333	7848333	30	0.466666666666667	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDF3&recr=Open">Click here</a>	
GDF7	Silent	p.V356V	G	G		11	Filtered Calls	2	20870900	20870900	17	0.294117647058824	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDF7&recr=Open">Click here</a>	
GDNF	Silent	p.T16T	G	G		11	Filtered Calls	5	37834851	37834851	42	0.285714285714286	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDNF&recr=Open">Click here</a>	
GDPD4	Silent	p.R325R	T	T		11	Filtered Calls	11	76956439	76956439	162	0.364197530864198	NA	NA	NA			20	GP-PDE.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GDPD4&recr=Open">Click here</a>	
GEM	Silent	p.S68S	G	G		11	Filtered Calls	8	95272528	95272528	90	0.4	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GEM&recr=Open">Click here</a>	
GEMIN2	Intron		C	C		11	Filtered Calls	14	39587737	39587737	189	0.301587301587302	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GEMIN2&recr=Open">Click here</a>	
GEMIN5	Silent	p.P483P	G	G		11	Filtered Calls	5	154300916	154300916	93	0.483870967741935	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GEMIN5&recr=Open">Click here</a>	
GEMIN8	Silent	p.I139I	G	G		11	Filtered Calls	X	14038252	14038252	249	0.534136546184739	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GEMIN8&recr=Open">Click here</a>	
GGA1	Silent	p.S480S	C	C		11	Filtered Calls	22	38027018	38027018	136	0.125	NA	NA	NA			10	Unstructured hinge.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GGA1&recr=Open">Click here</a>	
GGTLC2	Silent	p.I133I	C	C		11	Filtered Calls	22	22989547	22989547	80	0.225	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GGTLC2&recr=Open">Click here</a>	
GHDC	Silent	p.T170T	G	G		11	Filtered Calls	17	40344638	40344638	28	0.535714285714286	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GHDC&recr=Open">Click here</a>	
GHITM	Silent	p.L254L	C	C	rs374622091	11	Filtered Calls	10	85909980	85909980	113	0.238938053097345	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GHITM&recr=Open">Click here</a>	
GIF	Silent	p.T100T	G	G		11	Filtered Calls	11	59610571	59610571	63	0.333333333333333	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIF&recr=Open">Click here</a>	
GIMAP5	Silent	p.F4F	C	C		11	Filtered Calls	7	150437984	150437984	82	0.292682926829268	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIMAP5&recr=Open">Click here</a>	
GIMAP8	Silent	p.L344L	G	G		11	Filtered Calls	7	150171449	150171449	63	0.0952380952380952	NA	NA	NA			62	AIG1-type G 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIMAP8&recr=Open">Click here</a>	
GIP	5'UTR		C	C		11	Filtered Calls	17	47044599	47044599	60	0.15	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIP&recr=Open">Click here</a>	
GIPR	Silent	p.P237P	C	C		11	Filtered Calls	19	46180606	46180606	38	0.105263157894737	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIPR&recr=Open">Click here</a>	
GJA10	Silent	p.R109R	G	G		11	Filtered Calls	6	90604514	90604514	45	0.288888888888889	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GJA10&recr=Open">Click here</a>	
GJA5	Silent	p.R352R	C	C		11	Filtered Calls	1	147230291	147230291	90	0.7	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GJA5&recr=Open">Click here</a>	
GJB2	Silent	p.T8T	C	C	rs533231493	11	Filtered Calls	13	20763697	20763697	185	0.275675675675676	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GJB2&recr=Open">Click here</a>	
GJB5	Silent	p.A108A	C	C		11	Filtered Calls	1	35223255	35223255	71	0.309859154929577	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GJB5&recr=Open">Click here</a>	
GLB1L	Silent	p.Q584Q	C	C		11	Filtered Calls	2	220102007	220102007	93	0.279569892473118	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLB1L&recr=Open">Click here</a>	
GLB1L	Intron		G	G		11	Filtered Calls	2	220102460	220102460	74	0.540540540540541	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLB1L&recr=Open">Click here</a>	
GLB1L	Intron		G	G		11	Filtered Calls	2	220102461	220102461	74	0.554054054054054	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLB1L&recr=Open">Click here</a>	
GLB1L3	Intron		C	C		11	Filtered Calls	11	134182235	134182235	34	0.382352941176471	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLB1L3&recr=Open">Click here</a>	
GLE1	Intron		T	T		11	Filtered Calls	9	131271383	131271383	63	0.26984126984127	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLE1&recr=Open">Click here</a>	
GLI2	Silent	p.Q179Q	G	G		11	Filtered Calls	2	121712900	121712900	39	0.230769230769231	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLI2&recr=Open">Click here</a>	
GLI2	Silent	p.A630A	C	C		11	Filtered Calls	2	121742253	121742253	26	0.346153846153846	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLI2&recr=Open">Click here</a>	
GLIS3	Intron		G	G		11	Filtered Calls	9	3828412	3828412	28	0.321428571428571	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLIS3&recr=Open">Click here</a>	
GLRA1	Silent	p.F235F	G	G		11	Filtered Calls	5	151231158	151231158	38	0.368421052631579	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLRA1&recr=Open">Click here</a>	
GLTP	Silent	p.F103F	G	G		11	Filtered Calls	12	110293562	110293562	83	0.265060240963855	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLTP&recr=Open">Click here</a>	
GLYATL1	Silent	p.L211L	C	C	rs147236321	11	Filtered Calls	11	58723224	58723224	38	0.421052631578947	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLYATL1&recr=Open">Click here</a>	
GMCL1	Silent	p.I429I	C	C		11	Filtered Calls	2	70096919	70096919	347	0.178674351585014	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GMCL1&recr=Open">Click here</a>	
GML	Silent	p.I151I	C	C		11	Filtered Calls	8	143928082	143928082	104	0.278846153846154	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GML&recr=Open">Click here</a>	
GNA13	5'Flank		G	G		11	Filtered Calls	17	63052700	63052700	149	0.214765100671141	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GNA13&recr=Open">Click here</a>	
GNA15	Silent	p.I192I	C	C		11	Filtered Calls	19	3151795	3151795	220	0.0318181818181818	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GNA15&recr=Open">Click here</a>	
GNA15	Silent	p.I206I	C	C	rs140382547	11	Filtered Calls	19	3155824	3155824	44	0.0909090909090909	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GNA15&recr=Open">Click here</a>	
GNAZ	Silent	p.L37L	C	C		11	Filtered Calls	22	23437993	23437993	59	0.152542372881356	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GNAZ&recr=Open">Click here</a>	
GNS	Silent	p.L193L	C	C		11	Filtered Calls	12	65137074	65137074	55	0.4	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GNS&recr=Open">Click here</a>	
GOLGA2	5'Flank		G	G		11	Filtered Calls	9	131038413	131038413	146	0.0479452054794521	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOLGA2&recr=Open">Click here</a>	
GOLGA2	5'Flank		C	C		11	Filtered Calls	9	131038500	131038500	37	0.702702702702703	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOLGA2&recr=Open">Click here</a>	
GOLGA2B	RNA		C	C		11	Filtered Calls	12	100551832	100551832	8	0.75	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOLGA2B&recr=Open">Click here</a>	
GOLM1	Intron		G	G		11	Filtered Calls	9	88692514	88692514	70	0.585714285714286	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOLM1&recr=Open">Click here</a>	
GOPC	Intron		G	G		11	Filtered Calls	6	117894806	117894806	174	0.408045977011494	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOPC&recr=Open">Click here</a>	
GORASP2	Silent	p.L358L	C	C		11	Filtered Calls	2	171822355	171822355	88	0.329545454545455	NA	NA	NA			14	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GORASP2&recr=Open">Click here</a>	
GOT1L1	Intron		G	G		11	Filtered Calls	8	37794395	37794395	33	0.242424242424242	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOT1L1&recr=Open">Click here</a>	
GP2	Silent	p.E433E	C	C		11	Filtered Calls	16	20328661	20328661	152	0.282894736842105	NA	NA	NA			48	ZP. {ECO:0000255|PROSITE- ProRule:PRU00375}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GP2&recr=Open">Click here</a>	
GP6	Intron		A	A		11	Filtered Calls	19	55530087	55530087	79	0.569620253164557	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GP6&recr=Open">Click here</a>	
GP6	Silent	p.L198L	C	C		11	Filtered Calls	19	55538962	55538962	57	0.210526315789474	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GP6&recr=Open">Click here</a>	
GP9	Silent	p.P75P	C	C		11	Filtered Calls	3	128780807	128780807	22	0.136363636363636	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GP9&recr=Open">Click here</a>	
GPA33	Silent	p.I80I	G	G		11	Filtered Calls	1	167038334	167038334	79	0.278481012658228	NA	NA	NA			15	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPA33&recr=Open">Click here</a>	
GPATCH2	Intron		G	G		11	Filtered Calls	1	217688238	217688238	88	0.590909090909091	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPATCH2&recr=Open">Click here</a>	
GPATCH8	Silent	p.S956S	G	G		11	Filtered Calls	17	42476577	42476577	130	0.230769230769231	NA	NA	NA			50	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPATCH8&recr=Open">Click here</a>	
GPBP1	Silent	p.F13F	C	C		11	Filtered Calls	5	56509996	56509996	288	0.256944444444444	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPBP1&recr=Open">Click here</a>	
GPC5	Intron		C	C		11	Filtered Calls	13	92560181	92560181	118	0.584745762711864	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPC5&recr=Open">Click here</a>	
GPC6	Silent	p.P314P	G	G	rs138238361	11	Filtered Calls	13	94938667	94938667	85	0.317647058823529	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPC6&recr=Open">Click here</a>	
GPLD1	Silent	p.P105P	G	G		11	Filtered Calls	6	24476424	24476424	32	0.25	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPLD1&recr=Open">Click here</a>	
GPM6A	Intron		G	G		11	Filtered Calls	4	176556218	176556218	107	0.233644859813084	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPM6A&recr=Open">Click here</a>	
GPNMB	Silent	p.P260P	C	C		11	Filtered Calls	7	23300154	23300154	489	0.276073619631902	NA	NA	NA			41	PKD. {ECO:0000255|PROSITE- ProRule:PRU00151}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPNMB&recr=Open">Click here</a>	
GPR101	Silent	p.N361N	A	A		11	Filtered Calls	X	136112751	136112751	51	0.509803921568627	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR101&recr=Open">Click here</a>	
GPR111	Silent	p.T362T	C	C		11	Filtered Calls	6	47649585	47649585	189	0.19047619047619	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR111&recr=Open">Click here</a>	
GPR112	Silent	p.K1281K	G	G	rs202020116	11	Filtered Calls	X	135429708	135429708	27	0.37037037037037	NA	NA	NA			199			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR112&recr=Open">Click here</a>	
GPR114	Intron		G	G		11	Filtered Calls	16	57599073	57599073	112	0.267857142857143	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR114&recr=Open">Click here</a>	
GPR116	Silent	p.I446I	G	G		11	Filtered Calls	6	46839653	46839653	158	0.177215189873418	NA	NA	NA			59	Ig-like 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR116&recr=Open">Click here</a>	
GPR116	Silent	p.E61E	T	T		11	Filtered Calls	6	46856217	46856217	192	0.239583333333333	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR116&recr=Open">Click here</a>	
GPR119	Silent	p.R319R	C	C		11	Filtered Calls	X	129518465	129518465	85	0.411764705882353	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR119&recr=Open">Click here</a>	
GPR124	Silent	p.L896L	C	C	rs534668249	11	Filtered Calls	8	37698308	37698308	98	0.459183673469388	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR124&recr=Open">Click here</a>	
GPR125	Intron		C	C		11	Filtered Calls	4	22446589	22446589	84	0.404761904761905	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR125&recr=Open">Click here</a>	
GPR155	Silent	p.S393S	G	G		11	Filtered Calls	2	175333643	175333643	397	0.269521410579345	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR155&recr=Open">Click here</a>	
GPR158	Silent	p.T457T	G	G		11	Filtered Calls	10	25755615	25755615	218	0.146788990825688	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR158&recr=Open">Click here</a>	
GPR158	Silent	p.Q971Q	G	G		11	Filtered Calls	10	25887468	25887468	182	0.214285714285714	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR158&recr=Open">Click here</a>	
GPR158	Silent	p.K1200K	G	G		11	Filtered Calls	10	25888155	25888155	100	0.38	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR158&recr=Open">Click here</a>	
GPR161	Silent	p.S168S	G	G	rs537492326	11	Filtered Calls	1	168065945	168065945	74	0.256756756756757	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR161&recr=Open">Click here</a>	
GPR171	Silent	p.F25F	G	G		11	Filtered Calls	3	150917099	150917099	215	0.581395348837209	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR171&recr=Open">Click here</a>	
GPR176	Silent	p.S199S	G	G		11	Filtered Calls	15	40094284	40094284	52	0.615384615384615	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR176&recr=Open">Click here</a>	
GPR19	Silent	p.I114I	G	G		11	Filtered Calls	12	12815041	12815041	104	0.538461538461538	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR19&recr=Open">Click here</a>	
GPR25	Silent	p.R240R	G	G		11	Filtered Calls	1	200842885	200842885	61	0.344262295081967	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR25&recr=Open">Click here</a>	
GPR39	Silent	p.V290V	G	G		11	Filtered Calls	2	133402687	133402687	101	0.396039603960396	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR39&recr=Open">Click here</a>	
GPR4	5'UTR		G	G		11	Filtered Calls	19	46095130	46095130	59	0.135593220338983	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR4&recr=Open">Click here</a>	
GPR45	Silent	p.I127I	C	C		11	Filtered Calls	2	105858696	105858696	37	0.324324324324324	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR45&recr=Open">Click here</a>	
GPR55	Silent	p.L191L	G	G		11	Filtered Calls	2	231775105	231775105	117	0.316239316239316	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR55&recr=Open">Click here</a>	
GPR63	Silent	p.L359L	G	G		11	Filtered Calls	6	97246531	97246531	67	0.477611940298507	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR63&recr=Open">Click here</a>	
GPR75	Silent	p.F68F	G	G	rs542225785	11	Filtered Calls	2	54081690	54081690	29	0.241379310344828	NA	NA	NA			18	Phe-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR75&recr=Open">Click here</a>	
GPR83	Silent	p.S362S	G	G		11	Filtered Calls	11	94113375	94113375	17	0.411764705882353	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR83&recr=Open">Click here</a>	
GPR98	Intron		C	C		11	Filtered Calls	5	89920939	89920939	20	0.25	NA	NA	NA			269			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	
GPR98	Silent	p.L642L	G	G		11	Filtered Calls	5	89931017	89931017	121	0.413223140495868	NA	NA	NA			269			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	
GPR98	Silent	p.F2847F	C	C		11	Filtered Calls	5	90001371	90001371	119	0.34453781512605	NA	NA	NA			269	Calx-beta 20. {ECO:0000255}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	
GPR98	Silent	p.P3107P	T	T		11	Filtered Calls	5	90012420	90012420	46	0.41304347826087	NA	NA	NA			269	Calx-beta 22. {ECO:0000255}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	
GPR98	Silent	p.F4960F	C	C		11	Filtered Calls	5	90103462	90103462	33	0.151515151515152	NA	NA	NA			269			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	
GPRC5C	Intron		C	C	rs141898092	11	Filtered Calls	17	72436296	72436296	88	0.25	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPRC5C&recr=Open">Click here</a>	
GPRC5C	Intron		C	C	rs374834578	11	Filtered Calls	17	72436456	72436456	32	0.28125	NA	NA	NA		p.R226W(1)	17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPRC5C&recr=Open">Click here</a>	
GPRC5C	Intron		C	C		11	Filtered Calls	17	72436695	72436695	43	0.232558139534884	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPRC5C&recr=Open">Click here</a>	
GPRC6A	Silent	p.R394R	C	C		11	Filtered Calls	6	117127686	117127686	62	0.451612903225806	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPRC6A&recr=Open">Click here</a>	
GPX5	Silent	p.F186F	C	C		11	Filtered Calls	6	28501836	28501836	88	0.261363636363636	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPX5&recr=Open">Click here</a>	
GPX5	3'UTR		G	G		11	Filtered Calls	6	28501945	28501945	36	0.25	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPX5&recr=Open">Click here</a>	
GPX6	Silent	p.F5F	G	G		11	Filtered Calls	6	28483506	28483506	68	0.132352941176471	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPX6&recr=Open">Click here</a>	
GRAMD1C	Intron		C	C		11	Filtered Calls	3	113649689	113649689	65	0.584615384615385	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRAMD1C&recr=Open">Click here</a>	
GRAMD4	Intron		C	C	rs549571285	11	Filtered Calls	22	47062778	47062778	83	0.156626506024096	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRAMD4&recr=Open">Click here</a>	
GRB14	Silent	p.S375S	G	G		11	Filtered Calls	2	165353980	165353980	220	0.190909090909091	NA	NA	NA		p.S375S(1)	32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRB14&recr=Open">Click here</a>	
GRB7	Silent	p.L224L	G	G		11	Filtered Calls	17	37900331	37900331	64	0.40625	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRB7&recr=Open">Click here</a>	
GRHL2	Intron		G	G		11	Filtered Calls	8	102565017	102565017	24	0.125	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRHL2&recr=Open">Click here</a>	
GRHL2	Silent	p.C288C	C	C		11	Filtered Calls	8	102586025	102586025	56	0.142857142857143	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRHL2&recr=Open">Click here</a>	
GRHL2	Intron		C	C		11	Filtered Calls	8	102589625	102589625	21	0.19047619047619	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRHL2&recr=Open">Click here</a>	
GRHL2	Silent	p.V299V	G	G		11	Filtered Calls	8	102589641	102589641	28	0.285714285714286	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRHL2&recr=Open">Click here</a>	
GRIA1	Silent	p.L114L	C	C		11	Filtered Calls	5	153026579	153026579	103	0.359223300970874	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA1&recr=Open">Click here</a>	
GRIA1	Silent	p.G908G	G	G		11	Filtered Calls	5	153190758	153190758	30	0.433333333333333	NA	NA	NA		p.G898G(1)	81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA1&recr=Open">Click here</a>	
GRIA2	Intron		C	C		11	Filtered Calls	4	158283945	158283945	120	0.291666666666667	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA2&recr=Open">Click here</a>	
GRIA2	Silent	p.G872G	T	T		11	Filtered Calls	4	158284160	158284160	213	0.328638497652582	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA2&recr=Open">Click here</a>	
GRID1	Silent	p.R969R	C	C		11	Filtered Calls	10	87362153	87362153	54	0.166666666666667	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRID1&recr=Open">Click here</a>	
GRIFIN	RNA		G	G	rs560495418	11	Filtered Calls	7	2517281	2517281	42	0.428571428571429	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIFIN&recr=Open">Click here</a>	
GRIK1	Silent	p.G816G	C	C		11	Filtered Calls	21	30927532	30927532	189	0.322751322751323	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK1&recr=Open">Click here</a>	
GRIK2	Intron		C	C		11	Filtered Calls	6	102307380	102307380	49	0.448979591836735	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK2&recr=Open">Click here</a>	
GRIK3	Silent	p.F704F	G	G		11	Filtered Calls	1	37271907	37271907	45	0.644444444444444	NA	NA	NA			89			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK3&recr=Open">Click here</a>	
GRIN1	Intron		G	G		11	Filtered Calls	9	140052984	140052984	32	0.125	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN1&recr=Open">Click here</a>	
GRIN2A	Silent	p.F1128F	G	G		11	Filtered Calls	16	9858017	9858017	84	0.333333333333333	NA	NA	NA			198			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2A&recr=Open">Click here</a>	
GRIN2A	Silent	p.V1101V	G	G		11	Filtered Calls	16	9858098	9858098	84	0.226190476190476	NA	NA	NA		p.V1101V(2)	198			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2A&recr=Open">Click here</a>	
GRIN2A	Silent	p.E1040E	C	C		11	Filtered Calls	16	9858281	9858281	115	0.278260869565217	NA	NA	NA		p.E1040D(1)	198			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2A&recr=Open">Click here</a>	
GRIN2B	Silent	p.L335L	G	G		11	Filtered Calls	12	13906258	13906258	124	0.25	NA	NA	NA			143			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2B&recr=Open">Click here</a>	
GRIN2D	Silent	p.E648E	G	G		11	Filtered Calls	19	48922924	48922924	216	0.356481481481481	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2D&recr=Open">Click here</a>	
GRIP1	Silent	p.K74K	C	C	rs368349433	11	Filtered Calls	12	66935645	66935645	171	0.391812865497076	NA	NA	NA			50	Galectin 1. {ECO:0000255|PROSITE- ProRule:PRU00639}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIP1&recr=Open">Click here</a>	
GRIP1	Intron		G	G		11	Filtered Calls	12	66935740	66935740	99	0.373737373737374	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIP1&recr=Open">Click here</a>	
GRIP2	RNA		G	G		11	Filtered Calls	3	14558648	14558648	28	0.535714285714286	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIP2&recr=Open">Click here</a>	
GRIP2	RNA		C	C		11	Filtered Calls	3	14565150	14565150	51	0.235294117647059	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIP2&recr=Open">Click here</a>	
GRIPAP1	Silent	p.A431A	G	G		11	Filtered Calls	X	48839832	48839832	66	0.5	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIPAP1&recr=Open">Click here</a>	
GRK5	Intron		C	C		11	Filtered Calls	10	121199287	121199287	161	0.236024844720497	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRK5&recr=Open">Click here</a>	
GRM2	Silent	p.L651L	C	C		11	Filtered Calls	3	51749742	51749742	40	0.25	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM2&recr=Open">Click here</a>	
GRM3	Silent	p.V394V	G	G		11	Filtered Calls	7	86416290	86416290	52	0.365384615384615	NA	NA	NA			109			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM3&recr=Open">Click here</a>	
GRM4	Silent	p.A415A	G	G		11	Filtered Calls	6	34008449	34008449	34	0.235294117647059	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM4&recr=Open">Click here</a>	
GRM7	Silent	p.E290E	G	G		11	Filtered Calls	3	7340504	7340504	96	0.46875	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM7&recr=Open">Click here</a>	
GRM7	Intron		C	C		11	Filtered Calls	3	7494503	7494503	23	0.347826086956522	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM7&recr=Open">Click here</a>	
GRM7	Silent	p.T675T	G	G	rs267599934	11	Filtered Calls	3	7620618	7620618	116	0.232758620689655	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM7&recr=Open">Click here</a>	
GRM8	Silent	p.R854R	C	C		11	Filtered Calls	7	126086295	126086295	125	0.056	NA	NA	NA			125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM8&recr=Open">Click here</a>	
GRM8	Silent	p.Q251Q	C	C		11	Filtered Calls	7	126544712	126544712	136	0.0514705882352941	NA	NA	NA		p.Q251H(1)	125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM8&recr=Open">Click here</a>	
GRWD1	Silent	p.P147P	C	C		11	Filtered Calls	19	48950073	48950073	106	0.179245283018868	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRWD1&recr=Open">Click here</a>	
GSDMA	Silent	p.L15L	C	C		11	Filtered Calls	17	38121983	38121983	14	0.285714285714286	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSDMA&recr=Open">Click here</a>	
GSDMA	Intron		C	C		11	Filtered Calls	17	38130521	38130521	25	0.36	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSDMA&recr=Open">Click here</a>	
GSDMA	Silent	p.P360P	C	C		11	Filtered Calls	17	38132235	38132235	15	0.2	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSDMA&recr=Open">Click here</a>	
GSDMA	Silent	p.F374F	C	C		11	Filtered Calls	17	38133095	38133095	147	0.306122448979592	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSDMA&recr=Open">Click here</a>	
GSDMC	Silent	p.L399L	G	G		11	Filtered Calls	8	130762252	130762252	173	0.439306358381503	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSDMC&recr=Open">Click here</a>	
GSG1L	Intron		C	C		11	Filtered Calls	16	27895802	27895802	26	0.192307692307692	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSG1L&recr=Open">Click here</a>	
GSTA1	Silent	p.E115E	C	C	rs149877285	11	Filtered Calls	6	52658992	52658992	402	0.427860696517413	NA	NA	NA			12	GST C-terminal.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSTA1&recr=Open">Click here</a>	
GSTA5	Intron		C	C		11	Filtered Calls	6	52701029	52701029	367	0.223433242506812	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSTA5&recr=Open">Click here</a>	
GSTM3	Intron		G	G		11	Filtered Calls	1	110280704	110280704	79	0.253164556962025	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSTM3&recr=Open">Click here</a>	
GUCY1A2	Intron		G	G		11	Filtered Calls	11	106617343	106617343	35	0.371428571428571	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCY1A2&recr=Open">Click here</a>	
GUCY1A2	Intron		G	G		11	Filtered Calls	11	106617344	106617344	35	0.371428571428571	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCY1A2&recr=Open">Click here</a>	
GUCY1A2	Silent	p.F364F	G	G	rs200299084	11	Filtered Calls	11	106810300	106810300	63	0.285714285714286	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCY1A2&recr=Open">Click here</a>	
GUCY2C	Intron		G	G		11	Filtered Calls	12	14769665	14769665	118	0.152542372881356	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCY2C&recr=Open">Click here</a>	
GYS1	5'UTR		C	C		11	Filtered Calls	19	49490504	49490504	55	0.2	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GYS1&recr=Open">Click here</a>	
H2AFY2	Silent	p.A301A	G	G	rs41277966	11	Filtered Calls	10	71868913	71868913	69	0.304347826086957	NA	NA	NA		p.A301A(1)	15	Macro. {ECO:0000255|PROSITE- ProRule:PRU00490}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+H2AFY2&recr=Open">Click here</a>	
HAL	Intron		G	G		11	Filtered Calls	12	96370368	96370368	60	0.433333333333333	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAL&recr=Open">Click here</a>	
HAO1	Intron		G	G		11	Filtered Calls	20	7866248	7866248	131	0.183206106870229	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAO1&recr=Open">Click here</a>	
HAO2	Silent	p.I75I	C	C	rs138723642	11	Filtered Calls	1	119925631	119925631	35	0.285714285714286	NA	NA	NA			30	FMN hydroxy acid dehydrogenase. {ECO:0000255|PROSITE-ProRule:PRU00683}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAO2&recr=Open">Click here</a>	
HAPLN4	Silent	p.Y112Y	G	G		11	Filtered Calls	19	19371770	19371770	33	0.212121212121212	NA	NA	NA			16	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAPLN4&recr=Open">Click here</a>	
HAUS5	Silent	p.P146P	C	C		11	Filtered Calls	19	36106241	36106241	23	0.565217391304348	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAUS5&recr=Open">Click here</a>	
HAUS5	Intron		C	C		11	Filtered Calls	19	36110905	36110905	201	0.303482587064677	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAUS5&recr=Open">Click here</a>	
HAVCR1	Intron		G	G		11	Filtered Calls	5	156476164	156476164	66	0.393939393939394	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAVCR1&recr=Open">Click here</a>	
HBEGF	Intron		C	C		11	Filtered Calls	5	139715445	139715445	54	0.37037037037037	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HBEGF&recr=Open">Click here</a>	
HBG2	Intron		C	C		11	Filtered Calls	11	5602096	5602096	90	0.288888888888889	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HBG2&recr=Open">Click here</a>	
HCAR3	Silent	p.F25F	G	G		11	Filtered Calls	12	123201210	123201210	171	0.298245614035088	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCAR3&recr=Open">Click here</a>	
HCFC1	Intron		G	G		11	Filtered Calls	X	153221865	153221865	38	0.447368421052632	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCFC1&recr=Open">Click here</a>	
HCFC1R1	5'Flank		C	C	rs147432065	11	Filtered Calls	16	3076890	3076890	47	0.234042553191489	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCFC1R1&recr=Open">Click here</a>	
HCG27	3'UTR		C	C		11	Filtered Calls	6	31170599	31170599	238	0.243697478991597	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCG27&recr=Open">Click here</a>	
HCK	Silent	p.I435I	C	C		11	Filtered Calls	20	30686928	30686928	87	0.390804597701149	NA	NA	NA			36	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCK&recr=Open">Click here</a>	
HCLS1	Silent	p.F477F	G	G		11	Filtered Calls	3	121350723	121350723	37	0.459459459459459	NA	NA	NA			35	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCLS1&recr=Open">Click here</a>	
HCN1	Silent	p.A486A	G	G		11	Filtered Calls	5	45303861	45303861	250	0.228	NA	NA	NA			156			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCN1&recr=Open">Click here</a>	
HCN3	Intron		C	C		11	Filtered Calls	1	155252192	155252192	98	0.642857142857143	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCN3&recr=Open">Click here</a>	
HCN3	Intron		C	C		11	Filtered Calls	1	155252193	155252193	103	0.631067961165049	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCN3&recr=Open">Click here</a>	
HCP5	RNA		G	G		11	Filtered Calls	6	31431497	31431497	124	0.258064516129032	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCP5&recr=Open">Click here</a>	
HCRTR2	Silent	p.R300R	G	G		11	Filtered Calls	6	55142315	55142315	107	0.233644859813084	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCRTR2&recr=Open">Click here</a>	
HDAC11	Silent	p.F76F	C	C		11	Filtered Calls	3	13538295	13538295	89	0.292134831460674	NA	NA	NA			13	Histone deacetylase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HDAC11&recr=Open">Click here</a>	
HDAC11	Silent	p.T93T	C	C		11	Filtered Calls	3	13538346	13538346	38	0.184210526315789	NA	NA	NA			13	Histone deacetylase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HDAC11&recr=Open">Click here</a>	
HDC	Silent	p.K199K	C	C		11	Filtered Calls	15	50546450	50546450	68	0.117647058823529	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HDC&recr=Open">Click here</a>	
HEATR6	Intron		G	G		11	Filtered Calls	17	58148175	58148175	233	0.210300429184549	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEATR6&recr=Open">Click here</a>	
HEATR6	Intron		A	A		11	Filtered Calls	17	58150647	58150647	135	0.644444444444444	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEATR6&recr=Open">Click here</a>	
HECTD4	Silent	p.I1880I	G	G	rs575275148	11	Filtered Calls	12	112669439	112669439	54	0.592592592592593	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECTD4&recr=Open">Click here</a>	
HECTD4	Silent	p.I1748I	G	G		11	Filtered Calls	12	112673351	112673351	50	0.18	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECTD4&recr=Open">Click here</a>	
HECTD4	Silent	p.R1467R	C	C		11	Filtered Calls	12	112681276	112681276	17	0.294117647058824	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECTD4&recr=Open">Click here</a>	
HECW2	Silent	p.G1173G	C	C	rs376055248	11	Filtered Calls	2	197080609	197080609	166	0.234939759036145	NA	NA	NA		p.G1529G(1)	113			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECW2&recr=Open">Click here</a>	
HELT	Silent	p.G47G	G	G		11	Filtered Calls	4	185940909	185940909	13	0.692307692307692	NA	NA	NA			14	bHLH. {ECO:0000255|PROSITE- ProRule:PRU00981}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HELT&recr=Open">Click here</a>	
HEPH	Intron		G	G		11	Filtered Calls	X	65417682	65417682	17	0.529411764705882	NA	NA	NA			89			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEPH&recr=Open">Click here</a>	
HERC5	Silent	p.P483P	C	C		11	Filtered Calls	4	89397048	89397048	231	0.242424242424242	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HERC5&recr=Open">Click here</a>	
HERC6	Intron		C	C		11	Filtered Calls	4	89317997	89317997	244	0.266393442622951	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HERC6&recr=Open">Click here</a>	
HERPUD2	Intron		A	A		11	Filtered Calls	7	35707210	35707210	92	0.228260869565217	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HERPUD2&recr=Open">Click here</a>	
HGFAC	Silent	p.A51A	G	G		11	Filtered Calls	4	3444494	3444494	69	0.376811594202899	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HGFAC&recr=Open">Click here</a>	
HHAT	Silent	p.T455T	C	C		11	Filtered Calls	1	210796989	210796989	357	0.0392156862745098	NA	NA	NA			27	GTP-binding. {ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HHAT&recr=Open">Click here</a>	
HHIP	Silent	p.R340R	A	A		11	Filtered Calls	4	145628273	145628273	139	0.330935251798561	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HHIP&recr=Open">Click here</a>	
HHIP	Silent	p.F518F	C	C		11	Filtered Calls	4	145636458	145636458	126	0.595238095238095	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HHIP&recr=Open">Click here</a>	
HHIPL2	Silent	p.T166T	G	G		11	Filtered Calls	1	222717355	222717355	61	0.639344262295082	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HHIPL2&recr=Open">Click here</a>	
HHLA2	Silent	p.G102G	G	G		11	Filtered Calls	3	108072515	108072515	62	0.419354838709677	NA	NA	NA			18	Ig-like V-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HHLA2&recr=Open">Click here</a>	
HIF1AN	Silent	p.F128F	C	C		11	Filtered Calls	10	102296374	102296374	297	0.279461279461279	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIF1AN&recr=Open">Click here</a>	
HIGD1B	IGR		G	G		11	Filtered Calls	17	42929853	42929853	70	0.2	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIGD1B&recr=Open">Click here</a>	
HINFP	Intron		T	T		11	Filtered Calls	11	119002237	119002237	79	0.417721518987342	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HINFP&recr=Open">Click here</a>	
HIP1	Intron		G	G		11	Filtered Calls	7	75190710	75190710	102	0.0490196078431373	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIP1&recr=Open">Click here</a>	
HIP1	Silent	p.A303A	G	G	rs368435923	11	Filtered Calls	7	75192350	75192350	38	0.842105263157895	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIP1&recr=Open">Click here</a>	
HIPK1	Intron		C	C		11	Filtered Calls	1	114506151	114506151	151	0.23841059602649	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIPK1&recr=Open">Click here</a>	
HIPK2	Intron		G	G		11	Filtered Calls	7	139258148	139258148	28	0.75	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIPK2&recr=Open">Click here</a>	
HIPK2	Silent	p.S597S	G	G		11	Filtered Calls	7	139299231	139299231	31	0.741935483870968	NA	NA	NA			43	Interaction with SKI and SMAD1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIPK2&recr=Open">Click here</a>	
HIST1H1B	Silent	p.K93K	C	C		11	Filtered Calls	6	27835029	27835029	441	0.17687074829932	NA	NA	NA			24	H15. {ECO:0000255|PROSITE- ProRule:PRU00837}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIST1H1B&recr=Open">Click here</a>	
HIST1H2BA	Silent	p.E95E	G	G		11	Filtered Calls	6	25727421	25727421	89	0.179775280898876	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIST1H2BA&recr=Open">Click here</a>	
HIST1H2BI	Silent	p.G105G	G	G	rs375240174	11	Filtered Calls	6	26273518	26273518	114	0.254385964912281	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIST1H2BI&recr=Open">Click here</a>	
HIST1H3G	Silent	p.I75I	G	G		11	Filtered Calls	6	26271388	26271388	182	0.208791208791209	NA	NA	NA		p.I75I(1)	12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIST1H3G&recr=Open">Click here</a>	
HIVEP2	Silent	p.S980S	G	G		11	Filtered Calls	6	143092936	143092936	82	0.317073170731707	NA	NA	NA			100	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIVEP2&recr=Open">Click here</a>	
HK2	Intron		C	C		11	Filtered Calls	2	75113416	75113416	117	0.170940170940171	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HK2&recr=Open">Click here</a>	
HK3	Intron		G	G		11	Filtered Calls	5	176311139	176311139	23	0.391304347826087	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HK3&recr=Open">Click here</a>	
HLA-DOA	Intron		T	T		11	Filtered Calls	6	32974625	32974625	85	0.670588235294118	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HLA-DOA&recr=Open">Click here</a>	
HLA-DPA1	Silent	p.A211A	G	G		11	Filtered Calls	6	33036577	33036577	129	0.147286821705426	NA	NA	NA			15	Connecting peptide.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HLA-DPA1&recr=Open">Click here</a>	
HLA-DQA2	Silent	p.E56E	G	G		11	Filtered Calls	6	32713021	32713021	183	0.224043715846995	NA	NA	NA			13	Alpha-1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HLA-DQA2&recr=Open">Click here</a>	
HLCS	Silent	p.S546S	G	G	rs536830110	11	Filtered Calls	21	38137355	38137355	87	0.32183908045977	NA	NA	NA			24	BPL/LPL catalytic. {ECO:0000255|PROSITE- ProRule:PRU01067}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HLCS&recr=Open">Click here</a>	
HLTF	Intron		A	A		11	Filtered Calls	3	148792143	148792143	319	0.536050156739812	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HLTF&recr=Open">Click here</a>	
HMBOX1	Intron		T	T		11	Filtered Calls	8	28866582	28866582	205	0.2	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMBOX1&recr=Open">Click here</a>	
HMCN1	Silent	p.F496F	C	C		11	Filtered Calls	1	185897735	185897735	509	0.699410609037328	NA	NA	NA			308	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMCN1&recr=Open">Click here</a>	
HMCN1	Silent	p.I3178I	C	C		11	Filtered Calls	1	186057365	186057365	193	0.419689119170984	NA	NA	NA			308	Ig-like C2-type 30.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMCN1&recr=Open">Click here</a>	
HMCN1	Intron		G	G		11	Filtered Calls	1	186099237	186099237	228	0.644736842105263	NA	NA	NA			308			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMCN1&recr=Open">Click here</a>	
HMCN1	Silent	p.D4484D	C	C		11	Filtered Calls	1	186105939	186105939	144	0.243055555555556	NA	NA	NA			308	Ig-like C2-type 44.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMCN1&recr=Open">Click here</a>	
HMGCS2	Silent	p.E60E	C	C		11	Filtered Calls	1	120307174	120307174	62	0.290322580645161	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMGCS2&recr=Open">Click here</a>	
HMHA1	Silent	p.E212E	G	G		11	Filtered Calls	19	1073563	1073563	89	0.235955056179775	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMHA1&recr=Open">Click here</a>	
HMHA1	Silent	p.Q520Q	G	G		11	Filtered Calls	19	1079962	1079962	122	0.163934426229508	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMHA1&recr=Open">Click here</a>	
HMOX1	Intron		C	C		11	Filtered Calls	22	35782666	35782666	40	0.375	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMOX1&recr=Open">Click here</a>	
HNF4G	Intron		G	G		11	Filtered Calls	8	76463739	76463739	55	0.327272727272727	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNF4G&recr=Open">Click here</a>	
HNF4G	Silent	p.I335I	C	C		11	Filtered Calls	8	76471184	76471184	189	0.206349206349206	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNF4G&recr=Open">Click here</a>	
HNMT	Intron		C	C		11	Filtered Calls	2	138762693	138762693	185	0.345945945945946	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNMT&recr=Open">Click here</a>	
HNMT	Intron		C	C		11	Filtered Calls	2	138762694	138762694	189	0.349206349206349	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNMT&recr=Open">Click here</a>	
HNRNPUL1	Intron		C	C		11	Filtered Calls	19	41798146	41798146	338	0.313609467455621	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNRNPUL1&recr=Open">Click here</a>	
HNRNPUL2	Silent	p.G140G	C	C		11	Filtered Calls	11	62494209	62494209	34	0.235294117647059	NA	NA	NA			20	Glu-rich. {ECO:0000255}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNRNPUL2&recr=Open">Click here</a>	
HOMER2	Silent	p.I61I	G	G		11	Filtered Calls	15	83544136	83544136	46	0.239130434782609	NA	NA	NA			9	WH1. {ECO:0000255|PROSITE- ProRule:PRU00410}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOMER2&recr=Open">Click here</a>	
HOOK2	Intron		G	G		11	Filtered Calls	19	12883867	12883867	162	0.290123456790123	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOOK2&recr=Open">Click here</a>	
HOXA6	5'UTR		G	G		11	Filtered Calls	7	27186956	27186956	191	0.204188481675393	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXA6&recr=Open">Click here</a>	
HOXA7	Silent	p.N180N	G	G		11	Filtered Calls	7	27194681	27194681	334	0.287425149700599	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXA7&recr=Open">Click here</a>	
HOXB2	Silent	p.S337S	G	G	rs563859485	11	Filtered Calls	17	46620490	46620490	185	0.275675675675676	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXB2&recr=Open">Click here</a>	
HOXB2	Silent	p.P58P	G	G		11	Filtered Calls	17	46622100	46622100	61	0.19672131147541	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXB2&recr=Open">Click here</a>	
HOXD10	3'UTR		C	C		11	Filtered Calls	2	176973861	176973861	121	0.256198347107438	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXD10&recr=Open">Click here</a>	
HPN	5'UTR		G	G		11	Filtered Calls	19	35532748	35532748	17	0.294117647058824	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HPN&recr=Open">Click here</a>	
HPN	5'UTR		G	G		11	Filtered Calls	19	35532749	35532749	17	0.294117647058824	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HPN&recr=Open">Click here</a>	
HPS4	Silent	p.V243V	G	G		11	Filtered Calls	22	26861495	26861495	208	0.192307692307692	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HPS4&recr=Open">Click here</a>	
HPSE2	Silent	p.V417V	G	G		11	Filtered Calls	10	100374730	100374730	359	0.261838440111421	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HPSE2&recr=Open">Click here</a>	
HRC	Silent	p.P23P	G	G		11	Filtered Calls	19	49658426	49658426	84	0.357142857142857	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRC&recr=Open">Click here</a>	
HRG	3'UTR		C	C		11	Filtered Calls	3	186395682	186395682	72	0.277777777777778	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRG&recr=Open">Click here</a>	
HRH2	Silent	p.L340L	C	C		11	Filtered Calls	5	175111254	175111254	88	0.397727272727273	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRH2&recr=Open">Click here</a>	
HRH4	Silent	p.A138A	C	C		11	Filtered Calls	18	22056767	22056767	156	0.358974358974359	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRH4&recr=Open">Click here</a>	
HS3ST6	Silent	p.T191T	C	C		11	Filtered Calls	16	1962098	1962098	16	0.4375	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HS3ST6&recr=Open">Click here</a>	
HSPA12A	Silent	p.P637P	G	G		11	Filtered Calls	10	118434409	118434409	87	0.172413793103448	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPA12A&recr=Open">Click here</a>	
HSPA8	Silent	p.Q347Q	C	C		11	Filtered Calls	11	122930260	122930260	226	0.438053097345133	NA	NA	NA			36	Interaction with BAG1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPA8&recr=Open">Click here</a>	
HSPB8	Silent	p.A77A	C	C		11	Filtered Calls	12	119617348	119617348	23	0.478260869565217	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPB8&recr=Open">Click here</a>	
HSPG2	Intron		G	G		11	Filtered Calls	1	22183700	22183700	121	0.487603305785124	NA	NA	NA			127			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPG2&recr=Open">Click here</a>	
HSPG2	Intron		G	G		11	Filtered Calls	1	22216983	22216983	58	0.827586206896552	NA	NA	NA			127			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPG2&recr=Open">Click here</a>	
HTR1A	Silent	p.D180D	G	G	rs143826173	11	Filtered Calls	5	63257007	63257007	103	0.436893203883495	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR1A&recr=Open">Click here</a>	
HTR3B	Intron		C	C		11	Filtered Calls	11	113815285	113815285	21	0.523809523809524	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR3B&recr=Open">Click here</a>	
HTR3E	Intron		G	G		11	Filtered Calls	3	183819322	183819322	149	0.187919463087248	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR3E&recr=Open">Click here</a>	
HTR3E	Silent	p.V320V	G	G		11	Filtered Calls	3	183823950	183823950	66	0.53030303030303	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR3E&recr=Open">Click here</a>	
HTR4	Intron		G	G		11	Filtered Calls	5	147900530	147900530	129	0.286821705426357	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR4&recr=Open">Click here</a>	
HTRA1	Intron		T	T		11	Filtered Calls	10	124248926	124248926	109	0.275229357798165	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTRA1&recr=Open">Click here</a>	
HTRA1	Silent	p.F278F	C	C	rs141130635	11	Filtered Calls	10	124266263	124266263	77	0.233766233766234	NA	NA	NA			17	Serine protease.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTRA1&recr=Open">Click here</a>	
HTRA1	Silent	p.I296I	C	C		11	Filtered Calls	10	124266317	124266317	58	0.241379310344828	NA	NA	NA			17	Serine protease.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTRA1&recr=Open">Click here</a>	
HVCN1	Intron		C	C		11	Filtered Calls	12	111070305	111070305	268	0.261194029850746	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HVCN1&recr=Open">Click here</a>	
HVCN1	Intron		C	C	rs376544711	11	Filtered Calls	12	111070323	111070323	264	0.261363636363636	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HVCN1&recr=Open">Click here</a>	
ICAM1	Silent	p.K469K	G	G		11	Filtered Calls	19	10395685	10395685	37	0.378378378378378	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ICAM1&recr=Open">Click here</a>	
ICAM5	5'Flank		C	C		11	Filtered Calls	19	10397937	10397937	27	0.259259259259259	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ICAM5&recr=Open">Click here</a>	
ICAM5	5'Flank		C	C		11	Filtered Calls	19	10397938	10397938	27	0.259259259259259	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ICAM5&recr=Open">Click here</a>	
ICOS	Silent	p.G58G	G	G		11	Filtered Calls	2	204820474	204820474	249	0.305220883534137	NA	NA	NA			6	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ICOS&recr=Open">Click here</a>	
IDE	Intron		G	G		11	Filtered Calls	10	94225605	94225605	122	0.262295081967213	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IDE&recr=Open">Click here</a>	
IDH3B	5'UTR		G	G		11	Filtered Calls	20	2644846	2644846	35	0.4	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IDH3B&recr=Open">Click here</a>	
IDO1	Silent	p.S341S	C	C		11	Filtered Calls	8	39785515	39785515	21	0.380952380952381	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IDO1&recr=Open">Click here</a>	
IDO1	Silent	p.F387F	C	C		11	Filtered Calls	8	39785653	39785653	51	0.196078431372549	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IDO1&recr=Open">Click here</a>	
IDS	Intron		G	G		11	Filtered Calls	X	148571981	148571981	65	0.523076923076923	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IDS&recr=Open">Click here</a>	
IFNAR2	Silent	p.L229L	C	C		11	Filtered Calls	21	34625113	34625113	241	0.228215767634855	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNAR2&recr=Open">Click here</a>	
IFNLR1	Silent	p.S107S	G	G	rs141902174	11	Filtered Calls	1	24495953	24495953	45	0.0888888888888889	NA	NA	NA			NA	Fibronectin type-III. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNLR1&recr=Open">Click here</a>	
IFT140	Intron		G	G		11	Filtered Calls	16	1614170	1614170	22	0.318181818181818	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT140&recr=Open">Click here</a>	
IFT57	3'UTR		A	A		11	Filtered Calls	3	107881319	107881319	154	0.396103896103896	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT57&recr=Open">Click here</a>	
IFT88	Silent	p.I807I	C	C		11	Filtered Calls	13	21265260	21265260	182	0.21978021978022	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT88&recr=Open">Click here</a>	
IGF2BP1	Silent	p.R93R	C	C		11	Filtered Calls	17	47103020	47103020	80	0.2375	NA	NA	NA			31	RRM 2. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGF2BP1&recr=Open">Click here</a>	
IGF2BP3	Silent	p.S187S	G	G		11	Filtered Calls	7	23391046	23391046	123	0.308943089430894	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGF2BP3&recr=Open">Click here</a>	
IGFBP1	Intron		C	C		11	Filtered Calls	7	45931618	45931618	85	0.270588235294118	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGFBP1&recr=Open">Click here</a>	
IGFN1	Intron		C	C		11	Filtered Calls	1	201196002	201196002	186	0.21505376344086	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGFN1&recr=Open">Click here</a>	
IGFN1	Silent	p.F3616F	C	C		11	Filtered Calls	1	201196071	201196071	103	0.436893203883495	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGFN1&recr=Open">Click here</a>	
IGHD	RNA		G	G		11	Filtered Calls	14	106311979	106311979	27	0.222222222222222	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHD&recr=Open">Click here</a>	
IGHD5-12	RNA		C	C	rs529992693	11	Filtered Calls	14	106366503	106366503	45	0.244444444444444	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHD5-12&recr=Open">Click here</a>	
IGHM	RNA		C	C		11	Filtered Calls	14	106321919	106321919	15	0.666666666666667	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHM&recr=Open">Click here</a>	
IGHV1-58	RNA		C	C		11	Filtered Calls	14	107078758	107078758	73	0.301369863013699	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV1-58&recr=Open">Click here</a>	
IGHV1-58	RNA		C	C		11	Filtered Calls	14	107078800	107078800	69	0.27536231884058	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV1-58&recr=Open">Click here</a>	
IGHV2-26	RNA		G	G		11	Filtered Calls	14	106757951	106757951	31	0.354838709677419	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV2-26&recr=Open">Click here</a>	
IGHV3-35	RNA		T	T		11	Filtered Calls	14	106845473	106845473	159	0.232704402515723	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV3-35&recr=Open">Click here</a>	
IGHV3-35	RNA		A	A		11	Filtered Calls	14	106845474	106845474	159	0.245283018867925	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV3-35&recr=Open">Click here</a>	
IGHV3-35	RNA		G	G		11	Filtered Calls	14	106845530	106845530	134	0.253731343283582	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV3-35&recr=Open">Click here</a>	
IGHV3-49	RNA		A	A	rs190464058	11	Filtered Calls	14	107013166	107013166	69	0.304347826086957	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV3-49&recr=Open">Click here</a>	
IGHV3-7	RNA		A	A		11	Filtered Calls	14	106518633	106518633	121	0.528925619834711	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV3-7&recr=Open">Click here</a>	
IGHV4-34	RNA		G	G		11	Filtered Calls	14	106829704	106829704	92	0.619565217391304	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV4-34&recr=Open">Click here</a>	
IGKV1-5	RNA		C	C		11	Filtered Calls	2	89247032	89247032	186	0.381720430107527	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGKV1-5&recr=Open">Click here</a>	
IGKV1D-42	RNA		G	G		11	Filtered Calls	2	90229480	90229480	41	0.439024390243902	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGKV1D-42&recr=Open">Click here</a>	
IGKV5-2	RNA		C	C		11	Filtered Calls	2	89197297	89197297	105	0.171428571428571	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGKV5-2&recr=Open">Click here</a>	
IGLC7	RNA		A	A		11	Filtered Calls	22	23264913	23264913	40	0.2	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGLC7&recr=Open">Click here</a>	
IGLV1-47	RNA		G	G		11	Filtered Calls	22	22712589	22712589	170	0.0470588235294118	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGLV1-47&recr=Open">Click here</a>	
IGLV11-55	RNA		G	G	rs374063016	11	Filtered Calls	22	22556541	22556541	77	0.181818181818182	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGLV11-55&recr=Open">Click here</a>	
IGLV3-25	RNA		C	C	rs531194021	11	Filtered Calls	22	23029745	23029745	102	0.215686274509804	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGLV3-25&recr=Open">Click here</a>	
IGLV6-57	RNA		C	C		11	Filtered Calls	22	22550514	22550514	42	0.30952380952381	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGLV6-57&recr=Open">Click here</a>	
IGSF1	Silent	p.G1251G	C	C		11	Filtered Calls	X	130408152	130408152	63	0.26984126984127	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF1&recr=Open">Click here</a>	
IGSF1	Intron		C	C		11	Filtered Calls	X	130415632	130415632	51	0.411764705882353	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF1&recr=Open">Click here</a>	
IGSF10	Silent	p.S1726S	G	G		11	Filtered Calls	3	151161557	151161557	89	0.247191011235955	NA	NA	NA			116	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF10&recr=Open">Click here</a>	
IGSF21	Silent	p.L305L	C	C		11	Filtered Calls	1	18692091	18692091	30	0.5	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF21&recr=Open">Click here</a>	
IGSF9B	Silent	p.I827I	G	G		11	Filtered Calls	11	133791139	133791139	18	0.5	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF9B&recr=Open">Click here</a>	
IHH	Silent	p.L230L	G	G		11	Filtered Calls	2	219920477	219920477	40	0.3	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IHH&recr=Open">Click here</a>	
IKBKAP	Silent	p.F282F	G	G		11	Filtered Calls	9	111679845	111679845	307	0.335504885993485	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IKBKAP&recr=Open">Click here</a>	
IKBKE	Silent	p.E57E	G	G	rs368487957	11	Filtered Calls	1	206647757	206647757	69	0.260869565217391	NA	NA	NA			32	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IKBKE&recr=Open">Click here</a>	
IKZF3	Silent	p.T32T	G	G		11	Filtered Calls	17	37985707	37985707	140	0.428571428571429	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IKZF3&recr=Open">Click here</a>	
IL12A	Silent	p.V170V	G	G		11	Filtered Calls	3	159711535	159711535	222	0.252252252252252	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL12A&recr=Open">Click here</a>	
IL12B	Silent	p.I58I	G	G		11	Filtered Calls	5	158750252	158750252	63	0.333333333333333	NA	NA	NA			11	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL12B&recr=Open">Click here</a>	
IL12RB1	Intron		G	G		11	Filtered Calls	19	18186684	18186684	82	0.134146341463415	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL12RB1&recr=Open">Click here</a>	
IL17RB	Intron		C	C	rs376984504	11	Filtered Calls	3	53886020	53886020	92	0.108695652173913	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL17RB&recr=Open">Click here</a>	
IL17RC	Intron		C	C		11	Filtered Calls	3	9969977	9969977	102	0.450980392156863	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL17RC&recr=Open">Click here</a>	
IL17RE	Intron		C	C		11	Filtered Calls	3	9948639	9948639	36	0.222222222222222	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL17RE&recr=Open">Click here</a>	
IL17RE	IGR		C	C		11	Filtered Calls	3	9959638	9959638	76	0.210526315789474	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL17RE&recr=Open">Click here</a>	
IL17REL	Silent	p.R67R	C	C		11	Filtered Calls	22	50439201	50439201	16	0.25	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL17REL&recr=Open">Click here</a>	
IL18	5'Flank		C	C	rs199505901	11	Filtered Calls	11	112014327	112014327	35	0.742857142857143	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL18&recr=Open">Click here</a>	
IL18RAP	5'UTR		G	G		11	Filtered Calls	2	103039782	103039782	223	0.251121076233184	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL18RAP&recr=Open">Click here</a>	
IL1B	Intron		C	C		11	Filtered Calls	2	113590231	113590231	94	0.382978723404255	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1B&recr=Open">Click here</a>	
IL1RAP	Silent	p.I245I	C	C		11	Filtered Calls	3	190341164	190341164	217	0.258064516129032	NA	NA	NA			20	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1RAP&recr=Open">Click here</a>	
IL1RAPL2	Intron		G	G		11	Filtered Calls	X	104463950	104463950	23	0.347826086956522	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1RAPL2&recr=Open">Click here</a>	
IL1RAPL2	Intron		C	C		11	Filtered Calls	X	104464367	104464367	32	0.4375	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1RAPL2&recr=Open">Click here</a>	
IL1RL1	Silent	p.L405L	C	C		11	Filtered Calls	2	102965634	102965634	163	0.196319018404908	NA	NA	NA			16	TIR. {ECO:0000255|PROSITE- ProRule:PRU00204}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1RL1&recr=Open">Click here</a>	
IL1RN	Silent	p.F89F	C	C		11	Filtered Calls	2	113890283	113890283	75	0.24	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1RN&recr=Open">Click here</a>	
IL20RA	Silent	p.L348L	G	G		11	Filtered Calls	6	137323315	137323315	65	0.307692307692308	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL20RA&recr=Open">Click here</a>	
IL21R	Silent	p.S209S	C	C		11	Filtered Calls	16	27455982	27455982	59	0.23728813559322	NA	NA	NA			8	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL21R&recr=Open">Click here</a>	
IL21R	Silent	p.L242L	C	C		11	Filtered Calls	16	27456538	27456538	41	0.390243902439024	NA	NA	NA		p.L242L(2)	8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL21R&recr=Open">Click here</a>	
IL36G	Silent	p.T36T	C	C	rs148181448	11	Filtered Calls	2	113736850	113736850	91	0.296703296703297	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL36G&recr=Open">Click here</a>	
IL37	Intron		G	G		11	Filtered Calls	2	113672762	113672762	42	0.19047619047619	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL37&recr=Open">Click here</a>	
ILDR1	Silent	p.I517I	G	G		11	Filtered Calls	3	121712045	121712045	14	0.571428571428571	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ILDR1&recr=Open">Click here</a>	
ILDR1	Silent	p.R106R	C	C		11	Filtered Calls	3	121724152	121724152	18	0.333333333333333	NA	NA	NA			25	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ILDR1&recr=Open">Click here</a>	
ILF3	Silent	p.L253L	C	C		11	Filtered Calls	19	10790503	10790503	49	0.183673469387755	NA	NA	NA			31	DZF. {ECO:0000255|PROSITE- ProRule:PRU01040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ILF3&recr=Open">Click here</a>	
ILF3	Silent	p.Q564Q	G	G		11	Filtered Calls	19	10794059	10794059	42	0.214285714285714	NA	NA	NA			31	DRBM 2. {ECO:0000255|PROSITE- ProRule:PRU00266}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ILF3&recr=Open">Click here</a>	
IMMP2L	Intron		A	A		11	Filtered Calls	7	110763545	110763545	144	0.0486111111111111	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IMMP2L&recr=Open">Click here</a>	
IMMP2L	Intron		G	G		11	Filtered Calls	7	110763660	110763660	142	0.0704225352112676	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IMMP2L&recr=Open">Click here</a>	
IMMT	Silent	p.V158V	G	G	rs368629905	11	Filtered Calls	2	86398416	86398416	73	0.273972602739726	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IMMT&recr=Open">Click here</a>	
IMPA2	Intron		C	C		11	Filtered Calls	18	12030337	12030337	16	0.25	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IMPA2&recr=Open">Click here</a>	
IMPDH2	Intron		G	G		11	Filtered Calls	3	49066251	49066251	137	0.233576642335766	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IMPDH2&recr=Open">Click here</a>	
IMPG1	Silent	p.L369L	C	C		11	Filtered Calls	6	76715032	76715032	114	0.342105263157895	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IMPG1&recr=Open">Click here</a>	
IMPG1	Silent	p.E133E	C	C		11	Filtered Calls	6	76744407	76744407	63	0.285714285714286	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IMPG1&recr=Open">Click here</a>	
IMPG2	Intron		G	G		11	Filtered Calls	3	100994594	100994594	66	0.515151515151515	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IMPG2&recr=Open">Click here</a>	
INADL	Intron		C	C		11	Filtered Calls	1	62366944	62366944	84	0.0476190476190476	NA	NA	NA			103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INADL&recr=Open">Click here</a>	
INADL	Intron		G	G		11	Filtered Calls	1	62593773	62593773	113	0.31858407079646	NA	NA	NA			103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INADL&recr=Open">Click here</a>	
INHBA	Silent	p.K45K	C	C		11	Filtered Calls	7	41739838	41739838	211	0.322274881516588	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INHBA&recr=Open">Click here</a>	
INPP4A	Silent	p.L917L	C	C		11	Filtered Calls	2	99204003	99204003	97	0.278350515463918	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INPP4A&recr=Open">Click here</a>	
INPP5D	3'UTR		G	G	rs569172731	11	Filtered Calls	2	233990561	233990561	18	0.444444444444444	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INPP5D&recr=Open">Click here</a>	
INPP5D	Silent	p.K616K	G	G		11	Filtered Calls	2	234079234	234079234	39	0.230769230769231	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INPP5D&recr=Open">Click here</a>	
INPP5J	Silent	p.R330R	G	G		11	Filtered Calls	22	31524541	31524541	49	0.408163265306122	NA	NA	NA			12	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INPP5J&recr=Open">Click here</a>	
INSRR	Intron		G	G	rs189068345	11	Filtered Calls	1	156815916	156815916	51	0.431372549019608	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INSRR&recr=Open">Click here</a>	
INTS1	Silent	p.I126I	G	G		11	Filtered Calls	7	1539974	1539974	22	0.181818181818182	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INTS1&recr=Open">Click here</a>	
INTS3	Silent	p.P1005P	C	C		11	Filtered Calls	1	153745521	153745521	257	0.132295719844358	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INTS3&recr=Open">Click here</a>	
INTS3	IGR		G	G		11	Filtered Calls	1	153748400	153748400	24	0.291666666666667	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INTS3&recr=Open">Click here</a>	
INTS7	Intron		G	G		11	Filtered Calls	1	212120052	212120052	185	0.448648648648649	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INTS7&recr=Open">Click here</a>	
INTS7	Intron		G	G		11	Filtered Calls	1	212139843	212139843	283	0.247349823321555	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INTS7&recr=Open">Click here</a>	
INVS	Intron		T	T		11	Filtered Calls	9	103062844	103062844	93	0.32258064516129	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INVS&recr=Open">Click here</a>	
IP6K2	Silent	p.R93R	G	G	rs201009012	11	Filtered Calls	3	48732623	48732623	198	0.474747474747475	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IP6K2&recr=Open">Click here</a>	
IPO13	Silent	p.I738I	C	C		11	Filtered Calls	1	44426652	44426652	95	0.0421052631578947	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IPO13&recr=Open">Click here</a>	
IPO4	Silent	p.I683I	G	G		11	Filtered Calls	14	24652810	24652810	56	0.875	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IPO4&recr=Open">Click here</a>	
IPO9	Silent	p.L190L	C	C		11	Filtered Calls	1	201821287	201821287	264	0.0227272727272727	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IPO9&recr=Open">Click here</a>	
IQCA1	Silent	p.S600S	G	G		11	Filtered Calls	2	237272492	237272492	109	0.311926605504587	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCA1&recr=Open">Click here</a>	
IQCD	Silent	p.S54S	G	G		11	Filtered Calls	12	113645810	113645810	281	0.281138790035587	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCD&recr=Open">Click here</a>	
IQCE	Intron		C	C	rs201129204	11	Filtered Calls	7	2617998	2617998	36	0.222222222222222	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCE&recr=Open">Click here</a>	
IQCF3	Silent	p.S98S	C	C	rs377100769	11	Filtered Calls	3	51864646	51864646	92	0.271739130434783	NA	NA	NA			6	IQ. {ECO:0000255|PROSITE- ProRule:PRU00116}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCF3&recr=Open">Click here</a>	
IQCH	Silent	p.E35E	G	G		11	Filtered Calls	15	67553663	67553663	225	0.253333333333333	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCH&recr=Open">Click here</a>	
IQCJ-SCHIP1	Silent	p.L43L	C	C		11	Filtered Calls	3	158970568	158970568	118	0.338983050847458	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCJ-SCHIP1&recr=Open">Click here</a>	
IQCJ-SCHIP1	Silent	p.G68G	G	G		11	Filtered Calls	3	158980385	158980385	139	0.309352517985612	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCJ-SCHIP1&recr=Open">Click here</a>	
IQGAP1	Silent	p.T446T	C	C		11	Filtered Calls	15	90996375	90996375	207	0.27536231884058	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQGAP1&recr=Open">Click here</a>	
IQUB	Silent	p.L576L	G	G		11	Filtered Calls	7	123104919	123104919	135	0.814814814814815	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQUB&recr=Open">Click here</a>	
IREB2	Silent	p.I381I	C	C		11	Filtered Calls	15	78768649	78768649	162	0.283950617283951	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IREB2&recr=Open">Click here</a>	
IREB2	3'UTR		C	C		11	Filtered Calls	15	78790497	78790497	135	0.274074074074074	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IREB2&recr=Open">Click here</a>	
IRF1	Intron		G	G		11	Filtered Calls	5	131822826	131822826	176	0.414772727272727	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IRF1&recr=Open">Click here</a>	
IRF2	Silent	p.L311L	G	G		11	Filtered Calls	4	185310029	185310029	58	0.275862068965517	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IRF2&recr=Open">Click here</a>	
IRF6	Silent	p.I168I	G	G		11	Filtered Calls	1	209968639	209968639	153	0.666666666666667	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IRF6&recr=Open">Click here</a>	
IRX1	Intron		C	C		11	Filtered Calls	5	3601089	3601089	55	0.254545454545455	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IRX1&recr=Open">Click here</a>	
IRX4	Silent	p.S281S	G	G		11	Filtered Calls	5	1878800	1878800	3	0.666666666666667	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IRX4&recr=Open">Click here</a>	
ISX	Silent	p.E22E	G	G		11	Filtered Calls	22	35463146	35463146	23	0.173913043478261	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ISX&recr=Open">Click here</a>	
ITFG1	Silent	p.V367V	G	G		11	Filtered Calls	16	47294576	47294576	195	0.297435897435897	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITFG1&recr=Open">Click here</a>	
ITGA1	Silent	p.L509L	C	C		11	Filtered Calls	5	52204797	52204797	216	0.444444444444444	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA1&recr=Open">Click here</a>	
ITGA4	Silent	p.P597P	A	A		11	Filtered Calls	2	182374480	182374480	252	0.226190476190476	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA4&recr=Open">Click here</a>	
ITGA4	Intron		T	T		11	Filtered Calls	2	182388153	182388153	119	0.277310924369748	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA4&recr=Open">Click here</a>	
ITGA5	Silent	p.L955L	G	G		11	Filtered Calls	12	54792461	54792461	30	0.566666666666667	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA5&recr=Open">Click here</a>	
ITGA5	Silent	p.T397T	G	G		11	Filtered Calls	12	54798984	54798984	83	0.0843373493975904	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA5&recr=Open">Click here</a>	
ITGA8	Intron		G	G		11	Filtered Calls	10	15697414	15697414	164	0.213414634146341	NA	NA	NA			96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA8&recr=Open">Click here</a>	
ITGA8	Intron		G	G	rs184753978	11	Filtered Calls	10	15720790	15720790	119	0.142857142857143	NA	NA	NA			96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA8&recr=Open">Click here</a>	
ITGAD	Silent	p.G528G	G	G	rs201597756	11	Filtered Calls	16	31422715	31422715	115	0.295652173913043	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGAD&recr=Open">Click here</a>	
ITGAE	Silent	p.S71S	G	G		11	Filtered Calls	17	3667197	3667197	42	0.30952380952381	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGAE&recr=Open">Click here</a>	
ITGAM	Intron		G	G		11	Filtered Calls	16	31289435	31289435	24	0.416666666666667	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGAM&recr=Open">Click here</a>	
ITGAM	Silent	p.S463S	C	C	rs374020608	11	Filtered Calls	16	31308867	31308867	179	0.324022346368715	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGAM&recr=Open">Click here</a>	
ITGB4	Silent	p.P195P	C	C		11	Filtered Calls	17	73725364	73725364	66	0.136363636363636	NA	NA	NA			43	VWFA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB4&recr=Open">Click here</a>	
ITGB4	Silent	p.A266A	C	C		11	Filtered Calls	17	73726381	73726381	60	0.25	NA	NA	NA			43	VWFA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB4&recr=Open">Click here</a>	
ITGB4	Silent	p.I366I	C	C		11	Filtered Calls	17	73727332	73727332	39	0.307692307692308	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB4&recr=Open">Click here</a>	
ITGB6	5'UTR		C	C		11	Filtered Calls	2	161056576	161056576	209	0.320574162679426	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB6&recr=Open">Click here</a>	
ITGB8	Silent	p.E232E	G	G		11	Filtered Calls	7	20420349	20420349	265	0.252830188679245	NA	NA	NA			37	VWFA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB8&recr=Open">Click here</a>	
ITIH1	Silent	p.L381L	G	G		11	Filtered Calls	3	52817273	52817273	93	0.548387096774194	NA	NA	NA			52	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH1&recr=Open">Click here</a>	
ITIH2	Silent	p.Q133Q	G	G		11	Filtered Calls	10	7755213	7755213	19	0.210526315789474	NA	NA	NA			64	VIT. {ECO:0000255|PROSITE- ProRule:PRU00801}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH2&recr=Open">Click here</a>	
ITIH2	Silent	p.P665P	C	C	rs146607033	11	Filtered Calls	10	7780654	7780654	99	0.232323232323232	NA	NA	NA			64	O-glycosylated at three sites.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH2&recr=Open">Click here</a>	
ITIH2	Silent	p.T895T	G	G		11	Filtered Calls	10	7791174	7791174	277	0.1985559566787	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH2&recr=Open">Click here</a>	
ITIH2	Silent	p.R934R	G	G		11	Filtered Calls	10	7791291	7791291	224	0.401785714285714	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH2&recr=Open">Click here</a>	
ITIH5	Silent	p.L943L	C	C		11	Filtered Calls	10	7605046	7605046	170	0.211764705882353	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH5&recr=Open">Click here</a>	
ITIH5	Silent	p.I191I	G	G		11	Filtered Calls	10	7679270	7679270	54	0.203703703703704	NA	NA	NA		p.I191I(2)	75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH5&recr=Open">Click here</a>	
ITIH6	Silent	p.Q378Q	C	C		11	Filtered Calls	X	54785373	54785373	12	0.666666666666667	NA	NA	NA			NA	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH6&recr=Open">Click here</a>	
ITIH6	Silent	p.T304T	C	C		11	Filtered Calls	X	54786352	54786352	76	0.447368421052632	NA	NA	NA			NA	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH6&recr=Open">Click here</a>	
ITIH6	5'UTR		G	G		11	Filtered Calls	X	54814991	54814991	31	0.258064516129032	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH6&recr=Open">Click here</a>	
ITK	Intron		C	C		11	Filtered Calls	5	156672727	156672727	48	0.5	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITK&recr=Open">Click here</a>	
ITLN1	Silent	p.V192V	C	C		11	Filtered Calls	1	160850487	160850487	203	0.226600985221675	NA	NA	NA			21	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITLN1&recr=Open">Click here</a>	
ITM2C	Silent	p.G127G	G	G		11	Filtered Calls	2	231742120	231742120	39	0.205128205128205	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITM2C&recr=Open">Click here</a>	
ITPK1	5'UTR		T	T		11	Filtered Calls	14	93581514	93581514	35	0.628571428571429	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPK1&recr=Open">Click here</a>	
ITPKB	Silent	p.S456S	G	G		11	Filtered Calls	1	226923792	226923792	120	0.716666666666667	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPKB&recr=Open">Click here</a>	
ITPR1	Intron		C	C		11	Filtered Calls	3	4718293	4718293	52	0.192307692307692	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPR1&recr=Open">Click here</a>	
ITPR1	Silent	p.I1120I	C	C		11	Filtered Calls	3	4725389	4725389	157	0.210191082802548	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPR1&recr=Open">Click here</a>	
ITPR3	Intron		C	C	rs200489534	11	Filtered Calls	6	33608342	33608342	138	0.681159420289855	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPR3&recr=Open">Click here</a>	
IWS1	5'Flank		G	G		11	Filtered Calls	2	128262743	128262743	305	0.272131147540984	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IWS1&recr=Open">Click here</a>	
IZUMO1	Intron		C	C		11	Filtered Calls	19	49248871	49248871	135	0.4	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IZUMO1&recr=Open">Click here</a>	
JAG1	Silent	p.R1116R	C	C		11	Filtered Calls	20	10620455	10620455	65	0.6	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAG1&recr=Open">Click here</a>	
JAK3	Silent	p.K1026K	T	T		11	Filtered Calls	19	17941330	17941330	22	0.318181818181818	NA	NA	NA			147	Protein kinase 2. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAK3&recr=Open">Click here</a>	
JAKMIP1	Silent	p.L725L	G	G		11	Filtered Calls	4	6042368	6042368	24	0.416666666666667	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAKMIP1&recr=Open">Click here</a>	
JAKMIP3	Silent	p.Q59Q	G	G		11	Filtered Calls	10	133930622	133930622	33	0.151515151515152	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAKMIP3&recr=Open">Click here</a>	
JAZF1	Silent	p.S75S	G	G		11	Filtered Calls	7	27934999	27934999	106	0.235849056603774	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAZF1&recr=Open">Click here</a>	
JPH1	Silent	p.A386A	C	C		11	Filtered Calls	8	75171720	75171720	25	0.24	NA	NA	NA			24	Ala-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JPH1&recr=Open">Click here</a>	
JPH3	Silent	p.I164I	C	C		11	Filtered Calls	16	87677973	87677973	60	0.266666666666667	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JPH3&recr=Open">Click here</a>	
JPH4	Silent	p.I232I	G	G	rs528868041	11	Filtered Calls	14	24040239	24040239	18	0.888888888888889	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JPH4&recr=Open">Click here</a>	
JTB	IGR		G	G		11	Filtered Calls	1	153945479	153945479	162	0.58641975308642	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JTB&recr=Open">Click here</a>	
JTB	IGR		G	G		11	Filtered Calls	1	153945480	153945480	164	0.591463414634146	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JTB&recr=Open">Click here</a>	
JUP	Silent	p.A48A	G	G		11	Filtered Calls	17	39927963	39927963	47	0.382978723404255	NA	NA	NA		p.K40_Y53del(1)	23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JUP&recr=Open">Click here</a>	
KALRN	Silent	p.S189S	C	C		11	Filtered Calls	3	123987706	123987706	17	0.411764705882353	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KALRN&recr=Open">Click here</a>	
KALRN	5'Flank		C	C		11	Filtered Calls	3	124393374	124393374	15	0.4	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KALRN&recr=Open">Click here</a>	
KAT6A	Silent	p.V1425V	T	T		11	Filtered Calls	8	41791463	41791463	128	0.3125	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KAT6A&recr=Open">Click here</a>	
KAT6A	Silent	p.V980V	G	G		11	Filtered Calls	8	41798459	41798459	148	0.527027027027027	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KAT6A&recr=Open">Click here</a>	
KAT6B	Silent	p.K1130K	G	G		11	Filtered Calls	10	76784733	76784733	143	0.034965034965035	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KAT6B&recr=Open">Click here</a>	
KATNAL2	Intron		C	C	rs3833182|rs199906751	11	Filtered Calls	18	44559919	44559919	22	0.272727272727273	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KATNAL2&recr=Open">Click here</a>	
KATNAL2	Intron		C	C	rs113388488	11	Filtered Calls	18	44584642	44584642	62	0.306451612903226	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KATNAL2&recr=Open">Click here</a>	
KATNAL2	Silent	p.I31I	C	C		11	Filtered Calls	18	44601689	44601689	19	0.894736842105263	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KATNAL2&recr=Open">Click here</a>	
KATNBL1	Silent	p.F21F	G	G		11	Filtered Calls	15	34455815	34455815	170	0.323529411764706	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KATNBL1&recr=Open">Click here</a>	
KCNA1	Silent	p.F73F	C	C		11	Filtered Calls	12	5020763	5020763	62	0.258064516129032	NA	NA	NA		p.F73F(1)	63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNA1&recr=Open">Click here</a>	
KCNA1	Silent	p.V202V	C	C		11	Filtered Calls	12	5021150	5021150	29	0.241379310344828	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNA1&recr=Open">Click here</a>	
KCNA2	Intron		G	G		11	Filtered Calls	1	111146397	111146397	84	0.583333333333333	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNA2&recr=Open">Click here</a>	
KCNB1	Silent	p.F337F	G	G		11	Filtered Calls	20	47991086	47991086	18	0.222222222222222	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNB1&recr=Open">Click here</a>	
KCNB2	Silent	p.G394G	G	G		11	Filtered Calls	8	73848772	73848772	128	0.3984375	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNB2&recr=Open">Click here</a>	
KCNC2	Silent	p.K494K	C	C		11	Filtered Calls	12	75444303	75444303	83	0.506024096385542	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNC2&recr=Open">Click here</a>	
KCNC4	Silent	p.F351F	C	C		11	Filtered Calls	1	110765960	110765960	15	0.6	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNC4&recr=Open">Click here</a>	
KCND2	Silent	p.Y99Y	C	C		11	Filtered Calls	7	119914983	119914983	111	0.351351351351351	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCND2&recr=Open">Click here</a>	
KCNF1	Silent	p.Q208Q	G	G		11	Filtered Calls	2	11053176	11053176	16	0.6875	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNF1&recr=Open">Click here</a>	
KCNF1	Silent	p.F250F	C	C		11	Filtered Calls	2	11053302	11053302	34	0.117647058823529	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNF1&recr=Open">Click here</a>	
KCNH4	Silent	p.F432F	G	G		11	Filtered Calls	17	40322219	40322219	16	0.3125	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH4&recr=Open">Click here</a>	
KCNH7	Silent	p.E142E	C	C	rs143755583	11	Filtered Calls	2	163393472	163393472	274	0.233576642335766	NA	NA	NA		p.E142E(1)	108	PAC.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH7&recr=Open">Click here</a>	
KCNH8	Silent	p.P762P	C	C		11	Filtered Calls	3	19554668	19554668	132	0.303030303030303	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH8&recr=Open">Click here</a>	
KCNJ14	Silent	p.F63F	C	C		11	Filtered Calls	19	48965170	48965170	40	0.3	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ14&recr=Open">Click here</a>	
KCNJ3	Silent	p.V117V	C	C		11	Filtered Calls	2	155555638	155555638	62	0.451612903225806	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ3&recr=Open">Click here</a>	
KCNJ3	Intron		A	A		11	Filtered Calls	2	155566339	155566339	75	0.213333333333333	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ3&recr=Open">Click here</a>	
KCNJ6	Silent	p.G216G	C	C		11	Filtered Calls	21	39086812	39086812	64	0.40625	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ6&recr=Open">Click here</a>	
KCNJ8	Silent	p.S422S	C	C		11	Filtered Calls	12	21918666	21918666	176	0.278409090909091	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ8&recr=Open">Click here</a>	
KCNJ8	Silent	p.S326S	G	G		11	Filtered Calls	12	21918954	21918954	112	0.1875	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ8&recr=Open">Click here</a>	
KCNJ8	Silent	p.S79S	G	G		11	Filtered Calls	12	21926314	21926314	52	0.25	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ8&recr=Open">Click here</a>	
KCNK13	Silent	p.F276F	C	C		11	Filtered Calls	14	90650948	90650948	75	0.253333333333333	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK13&recr=Open">Click here</a>	
KCNK18	Silent	p.K91K	G	G		11	Filtered Calls	10	118960719	118960719	205	0.224390243902439	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK18&recr=Open">Click here</a>	
KCNK5	Silent	p.E268E	C	C		11	Filtered Calls	6	39159362	39159362	108	0.194444444444444	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK5&recr=Open">Click here</a>	
KCNK5	Silent	p.F180F	G	G		11	Filtered Calls	6	39162039	39162039	82	0.182926829268293	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK5&recr=Open">Click here</a>	
KCNK5	Intron		G	G		11	Filtered Calls	6	39162542	39162542	55	0.290909090909091	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK5&recr=Open">Click here</a>	
KCNK9	Silent	p.F109F	G	G		11	Filtered Calls	8	140631299	140631299	29	0.482758620689655	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK9&recr=Open">Click here</a>	
KCNMB1	Silent	p.T115T	C	C	rs200802497	11	Filtered Calls	5	169805939	169805939	35	0.342857142857143	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNMB1&recr=Open">Click here</a>	
KCNT1	Silent	p.I818I	C	C	rs149452823	11	Filtered Calls	9	138669288	138669288	28	0.214285714285714	NA	NA	NA		p.I818I(1)	50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNT1&recr=Open">Click here</a>	
KCNT2	Intron		A	A	rs550636021	11	Filtered Calls	1	196251497	196251497	126	0.261904761904762	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNT2&recr=Open">Click here</a>	
KCNT2	Silent	p.L229L	G	G		11	Filtered Calls	1	196398839	196398839	136	0.411764705882353	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNT2&recr=Open">Click here</a>	
KCNU1	Silent	p.S902S	C	C	rs186727015	11	Filtered Calls	8	36780117	36780117	51	0.470588235294118	NA	NA	NA		p.S902S(1)	57	Segment S10.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNU1&recr=Open">Click here</a>	
KCTD1	Intron		A	A		11	Filtered Calls	18	24039897	24039897	82	0.731707317073171	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD1&recr=Open">Click here</a>	
KCTD16	3'UTR		G	G		11	Filtered Calls	5	143853687	143853687	60	0.5	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD16&recr=Open">Click here</a>	
KCTD19	Silent	p.K611K	C	C		11	Filtered Calls	16	67327832	67327832	173	0.260115606936416	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD19&recr=Open">Click here</a>	
KCTD19	Silent	p.V182V	C	C		11	Filtered Calls	16	67337146	67337146	55	0.272727272727273	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD19&recr=Open">Click here</a>	
KCTD6	IGR		T	T		11	Filtered Calls	3	58486880	58486880	283	0.45583038869258	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD6&recr=Open">Click here</a>	
KCTD8	Intron		A	A		11	Filtered Calls	4	44177272	44177272	45	0.311111111111111	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD8&recr=Open">Click here</a>	
KDM2B	Intron		A	A		11	Filtered Calls	12	122012446	122012446	138	0.333333333333333	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM2B&recr=Open">Click here</a>	
KDM2B	Intron		G	G		11	Filtered Calls	12	122012503	122012503	102	0.303921568627451	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM2B&recr=Open">Click here</a>	
KDM5A	Intron		A	A		11	Filtered Calls	12	475280	475280	357	0.263305322128852	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM5A&recr=Open">Click here</a>	
KDM5C	Silent	p.F697F	G	G		11	Filtered Calls	X	53228311	53228311	83	0.542168674698795	NA	NA	NA			82			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM5C&recr=Open">Click here</a>	
KDM8	Silent	p.I263I	C	C		11	Filtered Calls	16	27226320	27226320	65	0.276923076923077	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM8&recr=Open">Click here</a>	
KDR	Silent	p.V1088V	G	G	rs139806698	11	Filtered Calls	4	55955898	55955898	202	0.331683168316832	NA	NA	NA			135	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDR&recr=Open">Click here</a>	
KDR	Silent	p.S265S	C	C	rs189635816	11	Filtered Calls	4	55980296	55980296	254	0.299212598425197	NA	NA	NA			135	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDR&recr=Open">Click here</a>	
KDR	Intron		C	C		11	Filtered Calls	4	55984761	55984761	99	0.323232323232323	NA	NA	NA			135			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDR&recr=Open">Click here</a>	
KHNYN	5'Flank		C	C		11	Filtered Calls	14	24901549	24901549	39	0.871794871794872	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KHNYN&recr=Open">Click here</a>	
KIAA0100	Silent	p.S980S	G	G	rs555946279	11	Filtered Calls	17	26961665	26961665	74	0.459459459459459	NA	NA	NA			68			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0100&recr=Open">Click here</a>	
KIAA0195	Silent	p.S1027S	C	C		11	Filtered Calls	17	73492390	73492390	38	0.631578947368421	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0195&recr=Open">Click here</a>	
KIAA0196	Intron		G	G		11	Filtered Calls	8	126087356	126087356	217	0.230414746543779	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0196&recr=Open">Click here</a>	
KIAA0226	Silent	p.C75C	G	G		11	Filtered Calls	3	197432041	197432041	118	0.652542372881356	NA	NA	NA			31	RUN. {ECO:0000255|PROSITE- ProRule:PRU00178}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0226&recr=Open">Click here</a>	
KIAA0232	Silent	p.L1219L	C	C		11	Filtered Calls	4	6865764	6865764	88	0.420454545454545	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0232&recr=Open">Click here</a>	
KIAA0355	Intron		C	C		11	Filtered Calls	19	34818782	34818782	177	0.23728813559322	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0355&recr=Open">Click here</a>	
KIAA0368	Silent	p.L335L	G	G		11	Filtered Calls	9	114190367	114190367	125	0.096	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0368&recr=Open">Click here</a>	
KIAA0753	Intron		G	G		11	Filtered Calls	17	6538324	6538324	148	0.141891891891892	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0753&recr=Open">Click here</a>	
KIAA1217	Intron		G	G		11	Filtered Calls	10	24832109	24832109	112	0.241071428571429	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1217&recr=Open">Click here</a>	
KIAA1217	Intron		G	G		11	Filtered Calls	10	24832493	24832493	87	0.229885057471264	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1217&recr=Open">Click here</a>	
KIAA1217	Intron		G	G		11	Filtered Calls	10	24832676	24832676	24	0.25	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1217&recr=Open">Click here</a>	
KIAA1217	IGR		C	C		11	Filtered Calls	10	24834904	24834904	163	0.184049079754601	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1217&recr=Open">Click here</a>	
KIAA1324	Intron		C	C		11	Filtered Calls	1	109732315	109732315	41	0.48780487804878	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1324&recr=Open">Click here</a>	
KIAA1407	Silent	p.F330F	G	G		11	Filtered Calls	3	113737698	113737698	213	0.366197183098592	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1407&recr=Open">Click here</a>	
KIAA1429	Intron		G	G		11	Filtered Calls	8	95527188	95527188	140	0.3	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1429&recr=Open">Click here</a>	
KIAA1429	Silent	p.F84F	G	G	rs369924461	11	Filtered Calls	8	95550502	95550502	422	0.220379146919431	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1429&recr=Open">Click here</a>	
KIAA1432	Intron		T	T		11	Filtered Calls	9	5754938	5754938	136	0.426470588235294	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1432&recr=Open">Click here</a>	
KIAA1462	Silent	p.V399V	C	C		11	Filtered Calls	10	30317880	30317880	71	0.323943661971831	NA	NA	NA			75	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1462&recr=Open">Click here</a>	
KIAA1462	Silent	p.G80G	C	C		11	Filtered Calls	10	30336502	30336502	49	0.530612244897959	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1462&recr=Open">Click here</a>	
KIAA1755	Intron		G	G		11	Filtered Calls	20	36854055	36854055	34	0.470588235294118	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1755&recr=Open">Click here</a>	
KIAA1755	Silent	p.K133K	C	C		11	Filtered Calls	20	36870134	36870134	333	0.15015015015015	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1755&recr=Open">Click here</a>	
KIAA1958	Silent	p.E669E	G	G		11	Filtered Calls	9	115422205	115422205	14	0.285714285714286	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1958&recr=Open">Click here</a>	
KIAA2018	Intron		A	A	rs143667618	11	Filtered Calls	3	113374812	113374812	109	0.0642201834862385	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA2018&recr=Open">Click here</a>	
KIF12	Silent	p.L510L	G	G		11	Filtered Calls	9	116854153	116854153	51	0.254901960784314	NA	NA	NA			17	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF12&recr=Open">Click here</a>	
KIF13B	Intron		G	G		11	Filtered Calls	8	29006291	29006291	205	0.146341463414634	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF13B&recr=Open">Click here</a>	
KIF15	Intron		T	T		11	Filtered Calls	3	44882742	44882742	177	0.214689265536723	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF15&recr=Open">Click here</a>	
KIF16B	Silent	p.L850L	G	G		11	Filtered Calls	20	16360099	16360099	222	0.274774774774775	NA	NA	NA			74	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF16B&recr=Open">Click here</a>	
KIF16B	Intron		G	G		11	Filtered Calls	20	16493575	16493575	88	0.693181818181818	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF16B&recr=Open">Click here</a>	
KIF16B	Intron		G	G		11	Filtered Calls	20	16506858	16506858	203	0.374384236453202	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF16B&recr=Open">Click here</a>	
KIF1A	Silent	p.F882F	G	G	rs375672100	11	Filtered Calls	2	241689874	241689874	17	0.235294117647059	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF1A&recr=Open">Click here</a>	
KIF1A	Intron		G	G		11	Filtered Calls	2	241710526	241710526	30	0.2	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF1A&recr=Open">Click here</a>	
KIF1B	Silent	p.I483I	C	C		11	Filtered Calls	1	10351154	10351154	193	0.310880829015544	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF1B&recr=Open">Click here</a>	
KIF1B	Intron		C	C		11	Filtered Calls	1	10363826	10363826	149	0.536912751677852	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF1B&recr=Open">Click here</a>	
KIF1B	Intron		C	C		11	Filtered Calls	1	10425715	10425715	50	0.34	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF1B&recr=Open">Click here</a>	
KIF21B	Silent	p.K1291K	C	C		11	Filtered Calls	1	200950194	200950194	46	0.282608695652174	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF21B&recr=Open">Click here</a>	
KIF21B	Intron		G	G		11	Filtered Calls	1	200959175	200959175	38	0.210526315789474	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF21B&recr=Open">Click here</a>	
KIF2B	Silent	p.K371K	G	G		11	Filtered Calls	17	51901507	51901507	106	0.264150943396226	NA	NA	NA			104	Kinesin motor. {ECO:0000255|PROSITE- ProRule:PRU00283}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF2B&recr=Open">Click here</a>	
KIF2B	Silent	p.I432I	C	C		11	Filtered Calls	17	51901690	51901690	57	0.263157894736842	NA	NA	NA			104	Kinesin motor. {ECO:0000255|PROSITE- ProRule:PRU00283}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF2B&recr=Open">Click here</a>	
KIF3B	Silent	p.I109I	C	C	rs575298577	11	Filtered Calls	20	30897907	30897907	72	0.416666666666667	NA	NA	NA			36	Kinesin motor. {ECO:0000255|PROSITE- ProRule:PRU00283}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF3B&recr=Open">Click here</a>	
KIF4A	Silent	p.I1041I	C	C		11	Filtered Calls	X	69626793	69626793	134	0.417910447761194	NA	NA	NA			51	Globular.|Interaction with PRC1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF4A&recr=Open">Click here</a>	
KIF4A	Intron		C	C		11	Filtered Calls	X	69639907	69639907	33	0.393939393939394	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF4A&recr=Open">Click here</a>	
KIF4A	Intron		C	C		11	Filtered Calls	X	69639908	69639908	34	0.382352941176471	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF4A&recr=Open">Click here</a>	
KIF4B	Silent	p.L829L	C	C		11	Filtered Calls	5	154395906	154395906	26	0.384615384615385	NA	NA	NA			58	Interaction with PRC1. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF4B&recr=Open">Click here</a>	
KIF5A	Intron		C	C		11	Filtered Calls	12	57958231	57958231	178	0.320224719101124	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF5A&recr=Open">Click here</a>	
KIF5B	Intron		G	G		11	Filtered Calls	10	32304595	32304595	173	0.312138728323699	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF5B&recr=Open">Click here</a>	
KIF5C	Intron		C	C		11	Filtered Calls	2	149840290	149840290	35	0.657142857142857	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF5C&recr=Open">Click here</a>	
KIF6	3'UTR		G	G		11	Filtered Calls	6	39304303	39304303	83	0.144578313253012	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF6&recr=Open">Click here</a>	
KIFC3	Silent	p.L300L	G	G	rs370271657	11	Filtered Calls	16	57800799	57800799	60	0.35	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIFC3&recr=Open">Click here</a>	
KIR3DX1	Silent	p.T59T	A	A		11	Filtered Calls	19	55045057	55045057	49	0.183673469387755	NA	NA	NA			24	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIR3DX1&recr=Open">Click here</a>	
KIR3DX1	Intron		G	G		11	Filtered Calls	19	55053749	55053749	36	0.277777777777778	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIR3DX1&recr=Open">Click here</a>	
KIRREL2	Silent	p.V278V	C	C		11	Filtered Calls	19	36351475	36351475	68	0.308823529411765	NA	NA	NA			48	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIRREL2&recr=Open">Click here</a>	
KIT	Silent	p.T90T	C	C		11	Filtered Calls	4	55561880	55561880	1449	0.0082815734989648	NA	NA	NA			6411	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIT&recr=Open">Click here</a>	
KL	Intron		C	C		11	Filtered Calls	13	33629174	33629174	83	0.204819277108434	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KL&recr=Open">Click here</a>	
KLF17	Intron		T	T		11	Filtered Calls	1	44595014	44595014	123	0.398373983739837	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLF17&recr=Open">Click here</a>	
KLF17	Silent	p.F127F	C	C		11	Filtered Calls	1	44595324	44595324	69	0.449275362318841	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLF17&recr=Open">Click here</a>	
KLF17	Intron		G	G	rs12739968	11	Filtered Calls	1	44595875	44595875	70	0.314285714285714	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLF17&recr=Open">Click here</a>	
KLHDC7A	Silent	p.E271E	G	G	rs372156529	11	Filtered Calls	1	18808288	18808288	48	0.4375	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHDC7A&recr=Open">Click here</a>	
KLHDC8B	Silent	p.A143A	C	C		11	Filtered Calls	3	49211724	49211724	131	0.16030534351145	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHDC8B&recr=Open">Click here</a>	
KLHL15	Silent	p.I147I	G	G		11	Filtered Calls	X	24024370	24024370	150	0.473333333333333	NA	NA	NA			22	BACK.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL15&recr=Open">Click here</a>	
KLHL26	Silent	p.F201F	C	C		11	Filtered Calls	19	18778810	18778810	49	0.183673469387755	NA	NA	NA			17	BACK.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL26&recr=Open">Click here</a>	
KLHL26	Silent	p.L202L	C	C		11	Filtered Calls	19	18778811	18778811	48	0.1875	NA	NA	NA			17	BACK.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL26&recr=Open">Click here</a>	
KLHL28	5'Flank		C	C		11	Filtered Calls	14	45432202	45432202	118	0.830508474576271	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL28&recr=Open">Click here</a>	
KLHL31	Silent	p.I21I	G	G		11	Filtered Calls	6	53520008	53520008	249	0.21285140562249	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL31&recr=Open">Click here</a>	
KLHL4	Silent	p.P68P	T	T		11	Filtered Calls	X	86773100	86773100	17	0.411764705882353	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL4&recr=Open">Click here</a>	
KLHL4	Intron		T	T		11	Filtered Calls	X	86877200	86877200	28	0.428571428571429	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL4&recr=Open">Click here</a>	
KLHL4	Silent	p.S535S	C	C		11	Filtered Calls	X	86888804	86888804	73	0.410958904109589	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL4&recr=Open">Click here</a>	
KLHL40	Intron		C	C		11	Filtered Calls	3	42730095	42730095	37	0.216216216216216	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL40&recr=Open">Click here</a>	
KLHL41	Silent	p.A154A	C	C		11	Filtered Calls	2	170366750	170366750	427	0.285714285714286	NA	NA	NA			NA	BACK.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL41&recr=Open">Click here</a>	
KLHL6	Silent	p.V458V	G	G		11	Filtered Calls	3	183210472	183210472	100	0.28	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL6&recr=Open">Click here</a>	
KLK12	Intron		C	C		11	Filtered Calls	19	51532585	51532585	70	0.157142857142857	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLK12&recr=Open">Click here</a>	
KLK3	Intron		C	C		11	Filtered Calls	19	51362836	51362836	64	0.296875	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLK3&recr=Open">Click here</a>	
KLK3	Silent	p.V218V	C	C		11	Filtered Calls	19	51363251	51363251	92	0.326086956521739	NA	NA	NA			24	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLK3&recr=Open">Click here</a>	
KLK5	Silent	p.S254S	G	G		11	Filtered Calls	19	51447007	51447007	24	0.458333333333333	NA	NA	NA			15	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLK5&recr=Open">Click here</a>	
KLRD1	Silent	p.L31L	G	G		11	Filtered Calls	12	10462072	10462072	183	0.251366120218579	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLRD1&recr=Open">Click here</a>	
KLRK1	Intron		A	A		11	Filtered Calls	12	10539620	10539620	110	0.190909090909091	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLRK1&recr=Open">Click here</a>	
KMO	Intron		C	C		11	Filtered Calls	1	241723954	241723954	131	0.0381679389312977	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMO&recr=Open">Click here</a>	
KMT2D	5'Flank		G	G		11	Filtered Calls	12	49431838	49431838	15	0.4	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2D&recr=Open">Click here</a>	
KRBA1	Silent	p.P413P	C	C		11	Filtered Calls	7	149422518	149422518	16	0.25	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRBA1&recr=Open">Click here</a>	
KRI1	Intron		G	G		11	Filtered Calls	19	10672530	10672530	211	0.175355450236967	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRI1&recr=Open">Click here</a>	
KRT15	Silent	p.K136K	C	C		11	Filtered Calls	17	39674672	39674672	66	0.424242424242424	NA	NA	NA			16	Coil 1A.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT15&recr=Open">Click here</a>	
KRT17	Silent	p.L377L	C	C		11	Filtered Calls	17	39776961	39776961	33	0.363636363636364	NA	NA	NA			12	Coil 2.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT17&recr=Open">Click here</a>	
KRT18P55	RNA		C	C		11	Filtered Calls	17	26603970	26603970	56	0.25	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT18P55&recr=Open">Click here</a>	
KRT2	Intron		G	G		11	Filtered Calls	12	53040756	53040756	24	0.416666666666667	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT2&recr=Open">Click here</a>	
KRT23	Silent	p.S3S	G	G		11	Filtered Calls	17	39092847	39092847	41	0.414634146341463	NA	NA	NA			21	Head.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT23&recr=Open">Click here</a>	
KRT25	Silent	p.I144I	G	G		11	Filtered Calls	17	38910718	38910718	93	0.419354838709677	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT25&recr=Open">Click here</a>	
KRT33B	Intron		G	G		11	Filtered Calls	17	39521261	39521261	12	0.416666666666667	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT33B&recr=Open">Click here</a>	
KRT35	5'UTR		C	C		11	Filtered Calls	17	39637291	39637291	44	0.159090909090909	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT35&recr=Open">Click here</a>	
KRT39	Silent	p.L206L	G	G		11	Filtered Calls	17	39119971	39119971	107	0.457943925233645	NA	NA	NA			17	Coil 1B.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT39&recr=Open">Click here</a>	
KRT40	Silent	p.L246L	C	C		11	Filtered Calls	17	39137353	39137353	89	0.404494382022472	NA	NA	NA			9	Linker 12.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT40&recr=Open">Click here</a>	
KRT6B	Intron		T	T		11	Filtered Calls	12	52841554	52841554	60	0.316666666666667	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT6B&recr=Open">Click here</a>	
KRT72	Silent	p.I118I	G	G		11	Filtered Calls	12	52994883	52994883	37	0.378378378378378	NA	NA	NA			36	Head.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT72&recr=Open">Click here</a>	
KRT73	Silent	p.L48L	A	A		11	Filtered Calls	12	53012165	53012165	40	0.6	NA	NA	NA			44	Gly-rich.|Head.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT73&recr=Open">Click here</a>	
KRT74	Silent	p.I59I	A	A		11	Filtered Calls	12	52967385	52967385	16	0.4375	NA	NA	NA			28	Gly-rich.|Head.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT74&recr=Open">Click here</a>	
KRT79	Silent	p.A335A	G	G		11	Filtered Calls	12	53217997	53217997	30	0.333333333333333	NA	NA	NA			30	Coil 2.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT79&recr=Open">Click here</a>	
KRT86	Silent	p.E235E	G	G	rs200085173	11	Filtered Calls	12	52698781	52698781	76	0.513157894736842	NA	NA	NA			10	Coil 1B.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT86&recr=Open">Click here</a>	
KRTAP6-3	Silent	p.G76G	C	C		11	Filtered Calls	21	31965013	31965013	29	0.517241379310345	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP6-3&recr=Open">Click here</a>	
KRTAP9-8	5'Flank		C	C		11	Filtered Calls	17	39394294	39394294	53	0.264150943396226	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP9-8&recr=Open">Click here</a>	
KSR2	Silent	p.L924L	G	G		11	Filtered Calls	12	117907541	117907541	31	0.258064516129032	NA	NA	NA			67	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KSR2&recr=Open">Click here</a>	
KSR2	Silent	p.F575F	G	G		11	Filtered Calls	12	117969475	117969475	60	0.266666666666667	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KSR2&recr=Open">Click here</a>	
KSR2	Silent	p.V258V	G	G		11	Filtered Calls	12	118199028	118199028	66	0.621212121212121	NA	NA	NA			67	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KSR2&recr=Open">Click here</a>	
KYNU	Silent	p.R43R	G	G		11	Filtered Calls	2	143643065	143643065	66	0.227272727272727	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KYNU&recr=Open">Click here</a>	
LAIR1	Silent	p.K232K	C	C		11	Filtered Calls	19	54867584	54867584	84	0.166666666666667	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAIR1&recr=Open">Click here</a>	
LAIR1	Intron		G	G		11	Filtered Calls	19	54872825	54872825	93	0.193548387096774	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAIR1&recr=Open">Click here</a>	
LAIR2	Intron		C	C		11	Filtered Calls	19	55014175	55014175	69	0.231884057971014	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAIR2&recr=Open">Click here</a>	
LAIR2	Silent	p.E63E	G	G		11	Filtered Calls	19	55019224	55019224	42	0.119047619047619	NA	NA	NA			18	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAIR2&recr=Open">Click here</a>	
LAMA1	Silent	p.V2318V	C	C		11	Filtered Calls	18	6966242	6966242	25	0.4	NA	NA	NA			205	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA1&recr=Open">Click here</a>	
LAMA2	Intron		T	T		11	Filtered Calls	6	129470247	129470247	66	0.409090909090909	NA	NA	NA			194			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA2&recr=Open">Click here</a>	
LAMA2	Silent	p.P485P	C	C		11	Filtered Calls	6	129498999	129498999	54	0.259259259259259	NA	NA	NA			194	Laminin EGF-like 4. {ECO:0000255|PROSITE- ProRule:PRU00460}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA2&recr=Open">Click here</a>	
LAMA3	Silent	p.I383I	C	C		11	Filtered Calls	18	21343454	21343454	135	0.903703703703704	NA	NA	NA			128	Domain V.|Laminin EGF-like 2. {ECO:0000255|PROSITE- ProRule:PRU00460}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA3&recr=Open">Click here</a>	
LAMA3	Silent	p.V960V	C	C		11	Filtered Calls	18	21413848	21413848	253	0.41897233201581	NA	NA	NA			128	Domain IV 1 (domain IV B).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA3&recr=Open">Click here</a>	
LAMA3	Silent	p.S2075S	C	C		11	Filtered Calls	18	21482996	21482996	143	0.79020979020979	NA	NA	NA			128	Domain II and I.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA3&recr=Open">Click here</a>	
LAMA4	Silent	p.L320L	G	G		11	Filtered Calls	6	112508658	112508658	66	0.424242424242424	NA	NA	NA			100	Domain II and I.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA4&recr=Open">Click here</a>	
LAMB2	Silent	p.A361A	G	G		11	Filtered Calls	3	49167806	49167806	96	0.520833333333333	NA	NA	NA			61	Laminin EGF-like 2. {ECO:0000255|PROSITE- ProRule:PRU00460}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMB2&recr=Open">Click here</a>	
LAMB3	Silent	p.F898F	G	G	rs267598350	11	Filtered Calls	1	209795888	209795888	132	0.265151515151515	NA	NA	NA			45	Domain I.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMB3&recr=Open">Click here</a>	
LAMC1	Silent	p.I1579I	C	C	rs139212722	11	Filtered Calls	1	183111832	183111832	103	0.514563106796116	NA	NA	NA			76	Domain II and I.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMC1&recr=Open">Click here</a>	
LAMC2	Silent	p.Q1133Q	G	G		11	Filtered Calls	1	183212352	183212352	108	0.231481481481481	NA	NA	NA			55	Domain II and I.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMC2&recr=Open">Click here</a>	
LAMP5	Silent	p.I47I	A	A		11	Filtered Calls	20	9496176	9496176	79	0.240506329113924	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMP5&recr=Open">Click here</a>	
LAMP5	Silent	p.L239L	G	G		11	Filtered Calls	20	9510341	9510341	59	0.288135593220339	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMP5&recr=Open">Click here</a>	
LARGE	Silent	p.F695F	G	G		11	Filtered Calls	22	33670599	33670599	77	0.168831168831169	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LARGE&recr=Open">Click here</a>	
LAS1L	Intron		G	G		11	Filtered Calls	X	64738357	64738357	18	0.388888888888889	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAS1L&recr=Open">Click here</a>	
LATS2	Intron		G	G		11	Filtered Calls	13	21563451	21563451	43	0.302325581395349	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LATS2&recr=Open">Click here</a>	
LBP	Silent	p.S10S	C	C		11	Filtered Calls	20	36974949	36974949	90	0.133333333333333	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LBP&recr=Open">Click here</a>	
LCE1C	Silent	p.G108G	C	C	rs372400123	11	Filtered Calls	1	152777631	152777631	46	0.434782608695652	NA	NA	NA			9	Gly-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCE1C&recr=Open">Click here</a>	
LCE3D	3'UTR		G	G		11	Filtered Calls	1	152552126	152552126	101	0.237623762376238	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCE3D&recr=Open">Click here</a>	
LCLAT1	Silent	p.T52T	C	C		11	Filtered Calls	2	30748612	30748612	170	0.282352941176471	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCLAT1&recr=Open">Click here</a>	
LCP1	Intron		G	G		11	Filtered Calls	13	46701866	46701866	156	0.294871794871795	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCP1&recr=Open">Click here</a>	
LCP2	Silent	p.L489L	G	G		11	Filtered Calls	5	169677746	169677746	164	0.432926829268293	NA	NA	NA			23	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCP2&recr=Open">Click here</a>	
LDHD	Silent	p.P254P	G	G		11	Filtered Calls	16	75147931	75147931	29	0.275862068965517	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LDHD&recr=Open">Click here</a>	
LDLRAD1	Intron		C	C		11	Filtered Calls	1	54483043	54483043	23	0.391304347826087	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LDLRAD1&recr=Open">Click here</a>	
LECT2	Intron		G	G	rs183819927	11	Filtered Calls	5	135290470	135290470	133	0.338345864661654	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LECT2&recr=Open">Click here</a>	
LEP	Intron		C	C		11	Filtered Calls	7	127894446	127894446	134	0.0447761194029851	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LEP&recr=Open">Click here</a>	
LEPREL1	Silent	p.E624E	C	C		11	Filtered Calls	3	189688626	189688626	152	0.223684210526316	NA	NA	NA			41	Fe2OG dioxygenase. {ECO:0000255|PROSITE- ProRule:PRU00805}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LEPREL1&recr=Open">Click here</a>	
LEPREL1	Intron		C	C		11	Filtered Calls	3	189700934	189700934	116	0.301724137931034	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LEPREL1&recr=Open">Click here</a>	
LEPREL1	Intron		C	C		11	Filtered Calls	3	189704569	189704569	276	0.278985507246377	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LEPREL1&recr=Open">Click here</a>	
LEPREL1	Silent	p.F233F	G	G	rs114077778	11	Filtered Calls	3	189712007	189712007	142	0.345070422535211	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LEPREL1&recr=Open">Click here</a>	
LEPREL2	RNA		C	C		11	Filtered Calls	12	6946182	6946182	76	0.25	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LEPREL2&recr=Open">Click here</a>	
LETM2	Silent	p.L265L	C	C		11	Filtered Calls	8	38258523	38258523	132	0.151515151515152	NA	NA	NA			7	LETM1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LETM2&recr=Open">Click here</a>	
LFNG	Silent	p.S65S	C	C		11	Filtered Calls	7	2552938	2552938	28	0.464285714285714	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LFNG&recr=Open">Click here</a>	
LGALS2	Silent	p.S126S	G	G		11	Filtered Calls	22	37966291	37966291	142	0.204225352112676	NA	NA	NA			11	Galectin. {ECO:0000255|PROSITE- ProRule:PRU00639}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGALS2&recr=Open">Click here</a>	
LGALSL	Intron		C	C		11	Filtered Calls	2	64683596	64683596	296	0.0304054054054054	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGALSL&recr=Open">Click here</a>	
LGI1	Silent	p.K35K	G	G		11	Filtered Calls	10	95518006	95518006	185	0.291891891891892	NA	NA	NA			29	LRRNT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGI1&recr=Open">Click here</a>	
LGI2	Silent	p.G441G	C	C		11	Filtered Calls	4	25005388	25005388	225	0.417777777777778	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGI2&recr=Open">Click here</a>	
LGR4	IGR		A	A		11	Filtered Calls	11	27403808	27403808	82	0.414634146341463	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGR4&recr=Open">Click here</a>	
LGR5	Silent	p.S271S	G	G	rs149089340	11	Filtered Calls	12	71955588	71955588	89	0.539325842696629	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGR5&recr=Open">Click here</a>	
LGR5	Silent	p.L330L	G	G		11	Filtered Calls	12	71960472	71960472	151	0.350993377483444	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGR5&recr=Open">Click here</a>	
LHCGR	Silent	p.Q290Q	C	C		11	Filtered Calls	2	48921440	48921440	54	0.240740740740741	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LHCGR&recr=Open">Click here</a>	
LHFPL1	Silent	p.I203I	G	G		11	Filtered Calls	X	111874702	111874702	73	0.424657534246575	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LHFPL1&recr=Open">Click here</a>	
LHX9	Silent	p.V310V	T	T		11	Filtered Calls	1	197896917	197896917	64	0.125	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LHX9&recr=Open">Click here</a>	
LIG1	Silent	p.L722L	G	G		11	Filtered Calls	19	48626259	48626259	255	0.207843137254902	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIG1&recr=Open">Click here</a>	
LIG3	Intron		C	C		11	Filtered Calls	17	33323585	33323585	128	0.421875	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIG3&recr=Open">Click here</a>	
LILRA1	Silent	p.F382F	C	C		11	Filtered Calls	19	55107841	55107841	78	0.128205128205128	NA	NA	NA			47	Ig-like C2-type 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRA1&recr=Open">Click here</a>	
LILRA2	5'UTR		G	G		11	Filtered Calls	19	55085340	55085340	48	0.25	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRA2&recr=Open">Click here</a>	
LILRA5	Silent	p.L133L	G	G		11	Filtered Calls	19	54823146	54823146	44	0.204545454545455	NA	NA	NA			20	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRA5&recr=Open">Click here</a>	
LILRB5	Silent	p.T186T	G	G		11	Filtered Calls	19	54760003	54760003	59	0.423728813559322	NA	NA	NA			56	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRB5&recr=Open">Click here</a>	
LIM2	Intron		C	C		11	Filtered Calls	19	51890456	51890456	56	0.285714285714286	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIM2&recr=Open">Click here</a>	
LIM2	Intron		C	C		11	Filtered Calls	19	51890457	51890457	55	0.290909090909091	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIM2&recr=Open">Click here</a>	
LIMA1	Silent	p.I413I	G	G		11	Filtered Calls	12	50575725	50575725	103	0.456310679611651	NA	NA	NA			44	LIM zinc-binding. {ECO:0000255|PROSITE- ProRule:PRU00125}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIMA1&recr=Open">Click here</a>	
LIMA1	Silent	p.V334V	G	G		11	Filtered Calls	12	50589641	50589641	53	0.528301886792453	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIMA1&recr=Open">Click here</a>	
LIN28A	Silent	p.P69P	A	A		11	Filtered Calls	1	26738052	26738052	81	0.0740740740740741	NA	NA	NA			8	CSD.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIN28A&recr=Open">Click here</a>	
LIN7A	Silent	p.A86A	C	C		11	Filtered Calls	12	81242045	81242045	79	0.379746835443038	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIN7A&recr=Open">Click here</a>	
LINGO2	Silent	p.K415K	C	C		11	Filtered Calls	9	27949425	27949425	98	0.438775510204082	NA	NA	NA			44	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LINGO2&recr=Open">Click here</a>	
LINGO4	Silent	p.L469L	C	C		11	Filtered Calls	1	151773774	151773774	120	0.2	NA	NA	NA			21	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LINGO4&recr=Open">Click here</a>	
LIPC	Silent	p.F250F	C	C		11	Filtered Calls	15	58838116	58838116	156	0.269230769230769	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIPC&recr=Open">Click here</a>	
LIPH	Intron		G	G		11	Filtered Calls	3	185245263	185245263	102	0.0392156862745098	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIPH&recr=Open">Click here</a>	
LIPK	Silent	p.L5L	T	T		11	Filtered Calls	10	90484313	90484313	32	0.125	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIPK&recr=Open">Click here</a>	
LLGL2	Silent	p.L490L	C	C		11	Filtered Calls	17	73565206	73565206	9	0.555555555555556	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LLGL2&recr=Open">Click here</a>	
LLGL2	Intron		C	C		11	Filtered Calls	17	73566420	73566420	13	0.384615384615385	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LLGL2&recr=Open">Click here</a>	
LLGL2	Intron		C	C		11	Filtered Calls	17	73567024	73567024	51	0.333333333333333	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LLGL2&recr=Open">Click here</a>	
LLGL2	Intron		C	C		11	Filtered Calls	17	73569556	73569556	146	0.219178082191781	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LLGL2&recr=Open">Click here</a>	
LMAN2L	IGR		G	G		11	Filtered Calls	2	97369299	97369299	46	0.347826086956522	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMAN2L&recr=Open">Click here</a>	
LMBR1	Intron		G	G		11	Filtered Calls	7	156619445	156619445	43	0.395348837209302	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMBR1&recr=Open">Click here</a>	
LMBR1L	Silent	p.I326I	G	G		11	Filtered Calls	12	49495285	49495285	23	0.173913043478261	NA	NA	NA		p.I326M(1)|p.I321M(1)	15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMBR1L&recr=Open">Click here</a>	
LMBRD2	Silent	p.F492F	G	G		11	Filtered Calls	5	36115183	36115183	179	0.195530726256983	NA	NA	NA		p.F492L(1)	35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMBRD2&recr=Open">Click here</a>	
LMNA	Silent	p.F206F	C	C	rs267607629	11	Filtered Calls	1	156104298	156104298	108	0.222222222222222	NA	NA	NA			10	Coil 1B.|Rod.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMNA&recr=Open">Click here</a>	
LMNB1	Intron		C	C		11	Filtered Calls	5	126156593	126156593	50	0.3	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMNB1&recr=Open">Click here</a>	
LMO2	Intron		G	G		11	Filtered Calls	11	33886144	33886144	9	0.444444444444444	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMO2&recr=Open">Click here</a>	
LMO3	Intron		C	C		11	Filtered Calls	12	16753599	16753599	59	0.23728813559322	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMO3&recr=Open">Click here</a>	
LNX1	Intron		G	G		11	Filtered Calls	4	54344915	54344915	77	0.324675324675325	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LNX1&recr=Open">Click here</a>	
LNX1	Silent	p.R140R	C	C		11	Filtered Calls	4	54374355	54374355	272	0.143382352941176	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LNX1&recr=Open">Click here</a>	
LONRF3	Silent	p.S339S	C	C		11	Filtered Calls	X	118116864	118116864	91	0.934065934065934	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LONRF3&recr=Open">Click here</a>	
LOXL2	Intron		G	G		11	Filtered Calls	8	23177387	23177387	24	0.25	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LOXL2&recr=Open">Click here</a>	
LPA	3'UTR		C	C		11	Filtered Calls	6	160952752	160952752	60	0.316666666666667	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPA&recr=Open">Click here</a>	
LPA	Silent	p.V1365V	G	G		11	Filtered Calls	6	161007515	161007515	72	0.430555555555556	NA	NA	NA			107	Kringle 12. {ECO:0000255|PROSITE- ProRule:PRU00121}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPA&recr=Open">Click here</a>	
LPA	Intron		G	G		11	Filtered Calls	6	161027694	161027694	140	0.428571428571429	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPA&recr=Open">Click here</a>	
LPCAT1	Silent	p.S76S	G	G		11	Filtered Calls	5	1501626	1501626	42	0.404761904761905	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPCAT1&recr=Open">Click here</a>	
LPHN2	Intron		C	C		11	Filtered Calls	1	82431732	82431732	173	0.46242774566474	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPHN2&recr=Open">Click here</a>	
LPHN3	Intron		C	C		11	Filtered Calls	4	62800551	62800551	38	0.289473684210526	NA	NA	NA			125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPHN3&recr=Open">Click here</a>	
LPHN3	Silent	p.G962G	G	G		11	Filtered Calls	4	62849175	62849175	78	0.358974358974359	NA	NA	NA			125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPHN3&recr=Open">Click here</a>	
LPHN3	Intron		C	C		11	Filtered Calls	4	62862085	62862085	150	0.253333333333333	NA	NA	NA			125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPHN3&recr=Open">Click here</a>	
LPIN1	Silent	p.F580F	C	C		11	Filtered Calls	2	11964794	11964794	113	0.292035398230089	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPIN1&recr=Open">Click here</a>	
LPL	Silent	p.L15L	C	C		11	Filtered Calls	8	19796996	19796996	27	0.555555555555556	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPL&recr=Open">Click here</a>	
LPL	Intron		C	C		11	Filtered Calls	8	19805682	19805682	187	0.155080213903743	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPL&recr=Open">Click here</a>	
LPO	Silent	p.F303F	C	C		11	Filtered Calls	17	56329671	56329671	41	0.146341463414634	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPO&recr=Open">Click here</a>	
LPPR1	Intron		C	C		11	Filtered Calls	9	104048376	104048376	102	0.215686274509804	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPPR1&recr=Open">Click here</a>	
LRAT	3'UTR		C	C		11	Filtered Calls	4	155670292	155670292	308	0.262987012987013	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRAT&recr=Open">Click here</a>	
LRFN2	Silent	p.I507I	G	G		11	Filtered Calls	6	40360531	40360531	18	0.833333333333333	NA	NA	NA			58	Fibronectin type-III. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRFN2&recr=Open">Click here</a>	
LRFN2	Silent	p.D315D	G	G		11	Filtered Calls	6	40399908	40399908	29	0.241379310344828	NA	NA	NA			58	Ig-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRFN2&recr=Open">Click here</a>	
LRFN5	Silent	p.R68R	G	G		11	Filtered Calls	14	42356032	42356032	84	0.80952380952381	NA	NA	NA			120			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRFN5&recr=Open">Click here</a>	
LRIT3	Silent	p.L585L	C	C	rs191105415	11	Filtered Calls	4	110791660	110791660	228	0.565789473684211	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRIT3&recr=Open">Click here</a>	
LRP1	Silent	p.I300I	C	C	rs202134358	11	Filtered Calls	12	57548049	57548049	97	0.34020618556701	NA	NA	NA			184			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1&recr=Open">Click here</a>	
LRP1B	Silent	p.L3453L	G	G		11	Filtered Calls	2	141200130	141200130	149	0.241610738255034	NA	NA	NA			606	LDL-receptor class A 24. {ECO:0000255|PROSITE-ProRule:PRU00124}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	
LRP1B	Silent	p.L3289L	A	A		11	Filtered Calls	2	141214120	141214120	189	0.343915343915344	NA	NA	NA			606	EGF-like 13. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	
LRP1B	Silent	p.V3168V	G	G		11	Filtered Calls	2	141232828	141232828	239	0.0292887029288703	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	
LRP1B	Intron		G	G		11	Filtered Calls	2	141272346	141272346	68	0.367647058823529	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	
LRP1B	Intron		A	A		11	Filtered Calls	2	141356413	141356413	64	0.3125	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	
LRP1B	Silent	p.L1903L	C	C		11	Filtered Calls	2	141526831	141526831	134	0.238805970149254	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	
LRP1B	Intron		-	-		11	Filtered Calls	2	141528350	141528351	39	0.307692307692308	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	
LRP1B	Silent	p.Q894Q	C	C		11	Filtered Calls	2	141747189	141747189	160	0.55	NA	NA	NA			606	LDL-receptor class A 4. {ECO:0000255|PROSITE-ProRule:PRU00124}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	
LRP1B	Silent	p.G346G	C	C		11	Filtered Calls	2	141819818	141819818	76	0.302631578947368	NA	NA	NA			606			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	
LRP2	Intron		C	C		11	Filtered Calls	2	170081814	170081814	123	0.300813008130081	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP2&recr=Open">Click here</a>	
LRP2	Silent	p.G1758G	T	T		11	Filtered Calls	2	170083052	170083052	163	0.269938650306748	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP2&recr=Open">Click here</a>	
LRP2	Intron		G	G		11	Filtered Calls	2	170092583	170092583	18	0.388888888888889	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP2&recr=Open">Click here</a>	
LRP5	Intron		T	T		11	Filtered Calls	11	68190945	68190945	33	0.363636363636364	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP5&recr=Open">Click here</a>	
LRP6	Silent	p.E631E	C	C		11	Filtered Calls	12	12317366	12317366	278	0.453237410071942	NA	NA	NA			85	Beta-propeller 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP6&recr=Open">Click here</a>	
LRP6	Silent	p.C310C	G	G		11	Filtered Calls	12	12336960	12336960	288	0.4375	NA	NA	NA			85	EGF-like 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP6&recr=Open">Click here</a>	
LRR1	IGR		G	G		11	Filtered Calls	14	50074636	50074636	117	0.333333333333333	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRR1&recr=Open">Click here</a>	
LRRC1	Silent	p.F81F	C	C		11	Filtered Calls	6	53706991	53706991	238	0.243697478991597	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC1&recr=Open">Click here</a>	
LRRC1	Silent	p.A457A	G	G		11	Filtered Calls	6	53785514	53785514	141	0.24822695035461	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC1&recr=Open">Click here</a>	
LRRC15	Silent	p.Q232Q	C	C		11	Filtered Calls	3	194081077	194081077	97	0.34020618556701	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC15&recr=Open">Click here</a>	
LRRC16A	Intron		T	T		11	Filtered Calls	6	25510933	25510933	29	0.172413793103448	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC16A&recr=Open">Click here</a>	
LRRC16A	Silent	p.S1049S	C	C		11	Filtered Calls	6	25600569	25600569	188	0.25	NA	NA	NA			50	Inhibits capping activity of CAPZA2. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC16A&recr=Open">Click here</a>	
LRRC20	Intron		A	A		11	Filtered Calls	10	72061274	72061274	139	0.438848920863309	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC20&recr=Open">Click here</a>	
LRRC3	Silent	p.L71L	C	C		11	Filtered Calls	21	45876740	45876740	42	0.238095238095238	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC3&recr=Open">Click here</a>	
LRRC49	Silent	p.R368R	G	G		11	Filtered Calls	15	71341876	71341876	233	0.231759656652361	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC49&recr=Open">Click here</a>	
LRRC4B	Silent	p.G646G	C	C		11	Filtered Calls	19	51021032	51021032	8	0.625	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC4B&recr=Open">Click here</a>	
LRRC4C	Silent	p.S197S	G	G		11	Filtered Calls	11	40137252	40137252	111	0.378378378378378	NA	NA	NA		p.S197S(1)	86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC4C&recr=Open">Click here</a>	
LRRC4C	Intron		-	-	rs532955654	11	Filtered Calls	11	40137899	40137900	43	0.465116279069767	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC4C&recr=Open">Click here</a>	
LRRC7	Silent	p.L191L	A	A		11	Filtered Calls	1	70397229	70397229	102	0.92156862745098	NA	NA	NA			162			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC7&recr=Open">Click here</a>	
LRRC7	Silent	p.S403S	C	C		11	Filtered Calls	1	70484404	70484404	221	0.334841628959276	NA	NA	NA			162			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC7&recr=Open">Click here</a>	
LRRC7	Silent	p.S933S	C	C		11	Filtered Calls	1	70504420	70504420	148	0.864864864864865	NA	NA	NA			162			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC7&recr=Open">Click here</a>	
LRRIQ1	Silent	p.F954F	C	C		11	Filtered Calls	12	85466851	85466851	93	0.311827956989247	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRIQ1&recr=Open">Click here</a>	
LRRIQ3	Intron		G	G		11	Filtered Calls	1	74621560	74621560	64	0.9375	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRIQ3&recr=Open">Click here</a>	
LRRIQ4	Silent	p.L93L	C	C		11	Filtered Calls	3	169539986	169539986	74	0.189189189189189	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRIQ4&recr=Open">Click here</a>	
LRRIQ4	Silent	p.P134P	C	C	rs377497941	11	Filtered Calls	3	169540111	169540111	54	0.240740740740741	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRIQ4&recr=Open">Click here</a>	
LRRK1	Silent	p.L906L	C	C		11	Filtered Calls	15	101569190	101569190	132	0.212121212121212	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRK1&recr=Open">Click here</a>	
LRRK2	Silent	p.L839L	A	A		11	Filtered Calls	12	40681169	40681169	113	0.380530973451327	NA	NA	NA			181			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRK2&recr=Open">Click here</a>	
LRRK2	Silent	p.I1606I	C	C		11	Filtered Calls	12	40709093	40709093	237	0.383966244725738	NA	NA	NA		p.I1606I(2)	181			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRK2&recr=Open">Click here</a>	
LRRN1	Silent	p.R65R	G	G		11	Filtered Calls	3	3886520	3886520	182	0.456043956043956	NA	NA	NA			26	LRRNT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRN1&recr=Open">Click here</a>	
LRRN4	Silent	p.G428G	C	C		11	Filtered Calls	20	6022607	6022607	36	0.333333333333333	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRN4&recr=Open">Click here</a>	
LRRTM3	Silent	p.A372A	C	C		11	Filtered Calls	10	68687790	68687790	83	0.132530120481928	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRTM3&recr=Open">Click here</a>	
LRRTM3	Silent	p.L375L	C	C		11	Filtered Calls	10	68687799	68687799	77	0.12987012987013	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRTM3&recr=Open">Click here</a>	
LRTM1	Silent	p.I290I	G	G		11	Filtered Calls	3	54952654	54952654	56	0.25	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRTM1&recr=Open">Click here</a>	
LRTM1	Silent	p.E126E	C	C		11	Filtered Calls	3	54958872	54958872	77	0.194805194805195	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRTM1&recr=Open">Click here</a>	
LRTOMT	IGR		T	T		11	Filtered Calls	11	71821254	71821254	243	0.423868312757202	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRTOMT&recr=Open">Click here</a>	
LSM10	Silent	p.I84I	G	G		11	Filtered Calls	1	36859479	36859479	138	0.318840579710145	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LSM10&recr=Open">Click here</a>	
LSS	Silent	p.F618F	G	G		11	Filtered Calls	21	47614539	47614539	30	0.333333333333333	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LSS&recr=Open">Click here</a>	
LST3	Intron		C	C		11	Filtered Calls	12	21028279	21028279	138	0.22463768115942	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LST3&recr=Open">Click here</a>	
LST3	Intron		C	C		11	Filtered Calls	12	21028280	21028280	136	0.220588235294118	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LST3&recr=Open">Click here</a>	
LTA4H	Intron		C	C		11	Filtered Calls	12	96397778	96397778	20	0.35	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LTA4H&recr=Open">Click here</a>	
LTBP1	Silent	p.Q531Q	G	G		11	Filtered Calls	2	33498835	33498835	184	0.298913043478261	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LTBP1&recr=Open">Click here</a>	
LTBP1	Silent	p.N1109N	C	C		11	Filtered Calls	2	33589353	33589353	249	0.626506024096386	NA	NA	NA			108	EGF-like 9; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LTBP1&recr=Open">Click here</a>	
LTBP3	Silent	p.L294L	G	G		11	Filtered Calls	11	65320984	65320984	21	0.285714285714286	NA	NA	NA			23	TB 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LTBP3&recr=Open">Click here</a>	
LTBP4	Intron		G	G		11	Filtered Calls	19	41112222	41112222	31	0.354838709677419	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LTBP4&recr=Open">Click here</a>	
LTBP4	3'UTR		C	C		11	Filtered Calls	19	41117850	41117850	38	0.131578947368421	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LTBP4&recr=Open">Click here</a>	
LTK	Intron		G	G		11	Filtered Calls	15	41796450	41796450	34	0.235294117647059	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LTK&recr=Open">Click here</a>	
LTK	Silent	p.G378G	C	C		11	Filtered Calls	15	41797051	41797051	45	0.288888888888889	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LTK&recr=Open">Click here</a>	
LY6G6C	5'Flank		G	G		11	Filtered Calls	6	31691447	31691447	55	0.127272727272727	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LY6G6C&recr=Open">Click here</a>	
LY6G6C	5'Flank		C	C		11	Filtered Calls	6	31691504	31691504	75	0.266666666666667	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LY6G6C&recr=Open">Click here</a>	
LY75-CD302	Intron		C	C		11	Filtered Calls	2	160737589	160737589	183	0.251366120218579	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LY75-CD302&recr=Open">Click here</a>	
LYAR	Silent	p.I136I	G	G		11	Filtered Calls	4	4281195	4281195	154	0.279220779220779	NA	NA	NA		p.I136I(1)	17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LYAR&recr=Open">Click here</a>	
LYG2	Silent	p.F163F	G	G		11	Filtered Calls	2	99860493	99860493	136	0.227941176470588	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LYG2&recr=Open">Click here</a>	
LYPD4	Silent	p.L187L	G	G		11	Filtered Calls	19	42341397	42341397	142	0.176056338028169	NA	NA	NA			12	UPAR/Ly6.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LYPD4&recr=Open">Click here</a>	
LYST	Silent	p.A2755A	G	G		11	Filtered Calls	1	235904815	235904815	336	0.696428571428571	NA	NA	NA			162			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LYST&recr=Open">Click here</a>	
LYZL4	Intron		G	G		11	Filtered Calls	3	42448495	42448495	42	0.452380952380952	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LYZL4&recr=Open">Click here</a>	
LYZL4	Silent	p.S4S	G	G	rs372342313	11	Filtered Calls	3	42448732	42448732	43	0.209302325581395	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LYZL4&recr=Open">Click here</a>	
LZTS1	Silent	p.S522S	G	G		11	Filtered Calls	8	20107458	20107458	106	0.452830188679245	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LZTS1&recr=Open">Click here</a>	
M1AP	IGR		C	C		11	Filtered Calls	2	74782463	74782463	83	0.385542168674699	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+M1AP&recr=Open">Click here</a>	
MAB21L3	Silent	p.L144L	C	C		11	Filtered Calls	1	116666927	116666927	133	0.330827067669173	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAB21L3&recr=Open">Click here</a>	
MACF1	Intron		C	C		11	Filtered Calls	1	39878983	39878983	36	0.5	NA	NA	NA			203			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MACF1&recr=Open">Click here</a>	
MADD	Intron		C	C		11	Filtered Calls	11	47312155	47312155	62	0.387096774193548	NA	NA	NA			84			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MADD&recr=Open">Click here</a>	
MAEL	Silent	p.F154F	C	C		11	Filtered Calls	1	166962059	166962059	227	0.220264317180617	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAEL&recr=Open">Click here</a>	
MAF1	Silent	p.P176P	C	C		11	Filtered Calls	8	145161485	145161485	82	0.219512195121951	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAF1&recr=Open">Click here</a>	
MAG	Silent	p.T153T	G	G		11	Filtered Calls	19	35790500	35790500	27	0.481481481481481	NA	NA	NA			34	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAG&recr=Open">Click here</a>	
MAGEA4	Silent	p.R235R	G	G		11	Filtered Calls	X	151092841	151092841	47	0.51063829787234	NA	NA	NA			27	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEA4&recr=Open">Click here</a>	
MAGEA4	Silent	p.E312E	G	G		11	Filtered Calls	X	151093072	151093072	36	0.638888888888889	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEA4&recr=Open">Click here</a>	
MAGEB16	Silent	p.L16L	T	T		11	Filtered Calls	X	35820361	35820361	19	0.473684210526316	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEB16&recr=Open">Click here</a>	
MAGEB18	Silent	p.L164L	G	G	rs138520878	11	Filtered Calls	X	26157594	26157594	14	0.928571428571429	NA	NA	NA			33	Interaction with LNX1.|MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEB18&recr=Open">Click here</a>	
MAGEB2	Silent	p.E221E	A	A		11	Filtered Calls	X	30237360	30237360	21	0.380952380952381	NA	NA	NA			23	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEB2&recr=Open">Click here</a>	
MAGEC1	Silent	p.S348S	T	T	rs57133902	11	Filtered Calls	X	140994234	140994234	101	0.425742574257426	NA	NA	NA			127			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC1&recr=Open">Click here</a>	
MAGEC1	Silent	p.S383S	C	C		11	Filtered Calls	X	140994339	140994339	84	0.476190476190476	NA	NA	NA			127			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC1&recr=Open">Click here</a>	
MAGEC1	Silent	p.T983T	C	C	rs371741859	11	Filtered Calls	X	140996139	140996139	89	0.471910112359551	NA	NA	NA			127	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC1&recr=Open">Click here</a>	
MAGEC2	Silent	p.L321L	C	C		11	Filtered Calls	X	141290811	141290811	77	0.272727272727273	NA	NA	NA			47	Interaction with TRIM28.|MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC2&recr=Open">Click here</a>	
MAGEC2	Silent	p.E272E	C	C		11	Filtered Calls	X	141290958	141290958	86	0.895348837209302	NA	NA	NA			47	Interaction with TRIM28.|MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC2&recr=Open">Click here</a>	
MAGEC2	Silent	p.S58S	G	G		11	Filtered Calls	X	141291600	141291600	62	0.258064516129032	NA	NA	NA			47	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC2&recr=Open">Click here</a>	
MAGI1	Silent	p.E1324E	C	C		11	Filtered Calls	3	65342470	65342470	51	0.176470588235294	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	
MAGI1	Intron		G	G		11	Filtered Calls	3	65342815	65342815	28	0.535714285714286	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	
MAGI1	Intron		C	C	rs200026736	11	Filtered Calls	3	65372837	65372837	104	0.201923076923077	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	
MAGI1	Silent	p.L176L	A	A		11	Filtered Calls	3	65479209	65479209	87	0.172413793103448	NA	NA	NA			51	Guanylate kinase-like. {ECO:0000255|PROSITE-ProRule:PRU00100}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	
MAGOHB	Silent	p.P30P	C	C		11	Filtered Calls	12	10766042	10766042	255	0.207843137254902	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGOHB&recr=Open">Click here</a>	
MAL2	3'UTR		G	G		11	Filtered Calls	8	120252444	120252444	164	0.0670731707317073	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAL2&recr=Open">Click here</a>	
MAMDC2	Intron		C	C		11	Filtered Calls	9	72783615	72783615	111	0.288288288288288	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAMDC2&recr=Open">Click here</a>	
MAN1A1	Intron		G	G		11	Filtered Calls	6	119526053	119526053	43	0.395348837209302	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAN1A1&recr=Open">Click here</a>	
MAN1C1	Silent	p.F346F	C	C		11	Filtered Calls	1	26085191	26085191	106	0.471698113207547	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAN1C1&recr=Open">Click here</a>	
MAN2A2	Silent	p.L455L	C	C		11	Filtered Calls	15	91452725	91452725	112	0.616071428571429	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAN2A2&recr=Open">Click here</a>	
MAN2A2	Silent	p.P671P	C	C		11	Filtered Calls	15	91454684	91454684	114	0.228070175438596	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAN2A2&recr=Open">Click here</a>	
MAN2C1	Intron		G	G		11	Filtered Calls	15	75653375	75653375	10	0.4	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAN2C1&recr=Open">Click here</a>	
MANBA	Silent	p.V824V	G	G		11	Filtered Calls	4	103553382	103553382	160	0.30625	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MANBA&recr=Open">Click here</a>	
MAP1A	Silent	p.P496P	C	C		11	Filtered Calls	15	43814445	43814445	69	0.623188405797101	NA	NA	NA			66	9 X 3 AA repeats of K-K-[DE].|Lys-rich (basic).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP1A&recr=Open">Click here</a>	
MAP1A	Silent	p.L2552L	G	G		11	Filtered Calls	15	43820613	43820613	26	0.384615384615385	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP1A&recr=Open">Click here</a>	
MAP3K1	Silent	p.S588S	C	C		11	Filtered Calls	5	56170936	56170936	244	0.262295081967213	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K1&recr=Open">Click here</a>	
MAP3K13	Intron		-	-		11	Filtered Calls	3	185155440	185155441	91	0.241758241758242	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K13&recr=Open">Click here</a>	
MAP3K19	Silent	p.I224I	G	G		11	Filtered Calls	2	135745770	135745770	237	0.172995780590717	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K19&recr=Open">Click here</a>	
MAP4K2	Silent	p.A446A	G	G		11	Filtered Calls	11	64564603	64564603	16	0.625	NA	NA	NA			8	PEST3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP4K2&recr=Open">Click here</a>	
MAP4K4	Silent	p.L138L	C	C		11	Filtered Calls	2	102441886	102441886	56	0.571428571428571	NA	NA	NA			41	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP4K4&recr=Open">Click here</a>	
MAP4K4	Intron		C	C		11	Filtered Calls	2	102480326	102480326	353	0.308781869688385	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP4K4&recr=Open">Click here</a>	
MAP7	Intron		C	C		11	Filtered Calls	6	136686868	136686868	64	0.453125	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP7&recr=Open">Click here</a>	
MAPK15	Silent	p.F218F	C	C		11	Filtered Calls	8	144801585	144801585	35	0.342857142857143	NA	NA	NA			12	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPK15&recr=Open">Click here</a>	
MAPK8IP2	Intron		C	C	rs559694012	11	Filtered Calls	22	51044170	51044170	24	0.333333333333333	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPK8IP2&recr=Open">Click here</a>	
MAPK8IP3	Silent	p.P281P	C	C		11	Filtered Calls	16	1797128	1797128	66	0.227272727272727	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPK8IP3&recr=Open">Click here</a>	
MAPK8IP3	Silent	p.F1144F	C	C	rs185930912	11	Filtered Calls	16	1817831	1817831	70	0.242857142857143	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPK8IP3&recr=Open">Click here</a>	
MAPKAPK3	Silent	p.S227S	C	C		11	Filtered Calls	3	50683193	50683193	55	0.272727272727273	NA	NA	NA			2	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPKAPK3&recr=Open">Click here</a>	
MAPT	Silent	p.V674V	A	A		11	Filtered Calls	17	44096003	44096003	145	0.572413793103448	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPT&recr=Open">Click here</a>	
MARCH8	Silent	p.P92P	G	G		11	Filtered Calls	10	45956826	45956826	47	0.340425531914894	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARCH8&recr=Open">Click here</a>	
MARCO	Intron		T	T		11	Filtered Calls	2	119735037	119735037	71	0.309859154929577	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARCO&recr=Open">Click here</a>	
MARVELD3	Intron		C	C		11	Filtered Calls	16	71668220	71668220	113	0.327433628318584	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARVELD3&recr=Open">Click here</a>	
MAS1L	Silent	p.L25L	G	G		11	Filtered Calls	6	29455605	29455605	131	0.251908396946565	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAS1L&recr=Open">Click here</a>	
MASP1	Silent	p.A478A	G	G		11	Filtered Calls	3	186953886	186953886	92	0.5	NA	NA	NA			60	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MASP1&recr=Open">Click here</a>	
MAST1	Silent	p.T72T	C	C		11	Filtered Calls	19	12951848	12951848	105	0.380952380952381	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAST1&recr=Open">Click here</a>	
MAST1	Silent	p.L503L	C	C		11	Filtered Calls	19	12975863	12975863	68	0.470588235294118	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAST1&recr=Open">Click here</a>	
MAST1	Silent	p.A830A	G	G		11	Filtered Calls	19	12978715	12978715	30	0.5	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAST1&recr=Open">Click here</a>	
MAST4	Silent	p.F439F	C	C		11	Filtered Calls	5	66400364	66400364	48	0.395833333333333	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAST4&recr=Open">Click here</a>	
MAST4	Silent	p.P2053P	C	C		11	Filtered Calls	5	66461166	66461166	34	0.382352941176471	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAST4&recr=Open">Click here</a>	
MAT2A	5'Flank		C	C		11	Filtered Calls	2	85766498	85766498	60	0.45	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAT2A&recr=Open">Click here</a>	
MAVS	Silent	p.T205T	C	C		11	Filtered Calls	20	3843050	3843050	40	0.25	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAVS&recr=Open">Click here</a>	
MBTPS2	Intron		T	T		11	Filtered Calls	X	21899004	21899004	126	0.404761904761905	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MBTPS2&recr=Open">Click here</a>	
MC3R	5'UTR		C	C	rs376616332	11	Filtered Calls	20	54823878	54823878	191	0.56020942408377	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MC3R&recr=Open">Click here</a>	
MCF2	Silent	p.L390L	G	G		11	Filtered Calls	X	138699681	138699681	167	0.419161676646707	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCF2&recr=Open">Click here</a>	
MCHR2	Silent	p.V35V	G	G		11	Filtered Calls	6	100403919	100403919	106	0.490566037735849	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCHR2&recr=Open">Click here</a>	
MCM3	Intron		G	G		11	Filtered Calls	6	52138532	52138532	125	0.224	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCM3&recr=Open">Click here</a>	
MCM3	Intron		G	G	rs146699762	11	Filtered Calls	6	52146983	52146983	300	0.25	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCM3&recr=Open">Click here</a>	
MCM3AP	Silent	p.C1208C	G	G		11	Filtered Calls	21	47678963	47678963	98	0.0408163265306122	NA	NA	NA			72	CID.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCM3AP&recr=Open">Click here</a>	
MCM8	Intron		C	C		11	Filtered Calls	20	5958516	5958516	111	0.0540540540540541	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCM8&recr=Open">Click here</a>	
MCPH1	Intron		C	C	rs139251288	11	Filtered Calls	8	6385144	6385144	317	0.17981072555205	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCPH1&recr=Open">Click here</a>	
MCTP2	Silent	p.V219V	G	G	rs267604395	11	Filtered Calls	15	94882538	94882538	219	0.237442922374429	NA	NA	NA			49	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCTP2&recr=Open">Click here</a>	
MCUR1	Silent	p.V208V	G	G		11	Filtered Calls	6	13802490	13802490	263	0.163498098859316	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCUR1&recr=Open">Click here</a>	
MDFI	Silent	p.P32P	C	C		11	Filtered Calls	6	41617376	41617376	143	0.174825174825175	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MDFI&recr=Open">Click here</a>	
MDGA2	Intron		C	C		11	Filtered Calls	14	47426565	47426565	58	0.275862068965517	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MDGA2&recr=Open">Click here</a>	
MDH1B	Silent	p.L196L	G	G		11	Filtered Calls	2	207619763	207619763	139	0.244604316546763	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MDH1B&recr=Open">Click here</a>	
MECOM	Silent	p.S376S	G	G		11	Filtered Calls	3	168833968	168833968	96	0.0520833333333333	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MECOM&recr=Open">Click here</a>	
MECOM	Intron		G	G		11	Filtered Calls	3	168839004	168839004	44	0.363636363636364	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MECOM&recr=Open">Click here</a>	
MECOM	5'UTR		C	C		11	Filtered Calls	3	168861611	168861611	235	0.285106382978723	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MECOM&recr=Open">Click here</a>	
MED12L	Intron		C	C		11	Filtered Calls	3	151105591	151105591	152	0.210526315789474	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED12L&recr=Open">Click here</a>	
MED12L	Silent	p.Q2070Q	G	G		11	Filtered Calls	3	151134117	151134117	108	0.259259259259259	NA	NA	NA			128	Gln-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED12L&recr=Open">Click here</a>	
MED13	Silent	p.T165T	G	G	rs576429960	11	Filtered Calls	17	60112945	60112945	210	0.233333333333333	NA	NA	NA			88			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED13&recr=Open">Click here</a>	
MED13L	Silent	p.I1338I	G	G		11	Filtered Calls	12	116425014	116425014	99	0.202020202020202	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED13L&recr=Open">Click here</a>	
MED13L	Intron		G	G		11	Filtered Calls	12	116425097	116425097	20	0.3	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED13L&recr=Open">Click here</a>	
MED16	Silent	p.A231A	C	C		11	Filtered Calls	19	885956	885956	33	0.121212121212121	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED16&recr=Open">Click here</a>	
MED24	IGR		G	G		11	Filtered Calls	17	38172605	38172605	10	0.4	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED24&recr=Open">Click here</a>	
MED24	Silent	p.I100I	G	G		11	Filtered Calls	17	38192001	38192001	43	0.558139534883721	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED24&recr=Open">Click here</a>	
MED25	Intron		C	C	rs370255278	11	Filtered Calls	19	50335348	50335348	55	0.345454545454545	NA	NA	NA		p.?(2)	17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED25&recr=Open">Click here</a>	
MEF2B	Intron		G	G		11	Filtered Calls	19	19258646	19258646	16	0.3125	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEF2B&recr=Open">Click here</a>	
MEF2B	Intron		G	G		11	Filtered Calls	19	19258647	19258647	16	0.3125	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEF2B&recr=Open">Click here</a>	
MEF2C	Silent	p.G438G	T	T		11	Filtered Calls	5	88018499	88018499	267	0.445692883895131	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEF2C&recr=Open">Click here</a>	
MEFV	Intron		G	G		11	Filtered Calls	16	3304364	3304364	61	0.213114754098361	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEFV&recr=Open">Click here</a>	
MEGF6	Intron		G	G		11	Filtered Calls	1	3407527	3407527	9	0.888888888888889	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGF6&recr=Open">Click here</a>	
MEGF6	Intron		G	G		11	Filtered Calls	1	3407530	3407530	9	0.888888888888889	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGF6&recr=Open">Click here</a>	
MEGF6	Intron		G	G		11	Filtered Calls	1	3407531	3407531	9	0.888888888888889	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGF6&recr=Open">Click here</a>	
MEGT1	Intron		G	G		11	Filtered Calls	6	31678136	31678136	381	0.230971128608924	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGT1&recr=Open">Click here</a>	
MEGT1	IGR		G	G		11	Filtered Calls	6	31686945	31686945	162	0.240740740740741	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGT1&recr=Open">Click here</a>	
MEI1	Silent	p.I585I	C	C	rs201012229	11	Filtered Calls	22	42144185	42144185	90	0.222222222222222	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEI1&recr=Open">Click here</a>	
MEIS1	Silent	p.F358F	C	C		11	Filtered Calls	2	66795848	66795848	479	0.196242171189979	NA	NA	NA			24	Required for transcriptional activation. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEIS1&recr=Open">Click here</a>	
MEP1A	Silent	p.Q341Q	G	G		11	Filtered Calls	6	46797187	46797187	246	0.247967479674797	NA	NA	NA			42	MAM. {ECO:0000255|PROSITE- ProRule:PRU00128}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEP1A&recr=Open">Click here</a>	
MEPE	IGR		G	G		11	Filtered Calls	4	88767368	88767368	124	0.241935483870968	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEPE&recr=Open">Click here</a>	
METAP1	Intron		C	C		11	Filtered Calls	4	99966323	99966323	45	0.311111111111111	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+METAP1&recr=Open">Click here</a>	
METTL1	Silent	p.F256F	G	G		11	Filtered Calls	12	58162842	58162842	49	0.346938775510204	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+METTL1&recr=Open">Click here</a>	
METTL21B	5'UTR		C	C		11	Filtered Calls	12	58174204	58174204	74	0.391891891891892	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+METTL21B&recr=Open">Click here</a>	
METTL22	Intron		C	C		11	Filtered Calls	16	8729017	8729017	52	0.288461538461538	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+METTL22&recr=Open">Click here</a>	
METTL22	Intron		C	C		11	Filtered Calls	16	8729018	8729018	51	0.274509803921569	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+METTL22&recr=Open">Click here</a>	
METTL7B	IGR		G	G		11	Filtered Calls	12	56078838	56078838	10	0.3	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+METTL7B&recr=Open">Click here</a>	
MEX3A	Intron		G	G		11	Filtered Calls	1	156047478	156047478	54	0.240740740740741	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEX3A&recr=Open">Click here</a>	
MEX3C	5'UTR		G	G		11	Filtered Calls	18	48703890	48703890	149	0.402684563758389	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEX3C&recr=Open">Click here</a>	
MFI2	Intron		G	G		11	Filtered Calls	3	196749994	196749994	54	0.314814814814815	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MFI2&recr=Open">Click here</a>	
MFN2	Intron		C	C		11	Filtered Calls	1	12064872	12064872	29	0.310344827586207	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MFN2&recr=Open">Click here</a>	
MFSD11	Intron		A	A		11	Filtered Calls	17	74738252	74738252	211	0.251184834123223	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MFSD11&recr=Open">Click here</a>	
MFSD4	Intron		T	T		11	Filtered Calls	1	205569527	205569527	122	0.213114754098361	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MFSD4&recr=Open">Click here</a>	
MFSD9	Silent	p.F180F	G	G		11	Filtered Calls	2	103340256	103340256	93	0.580645161290323	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MFSD9&recr=Open">Click here</a>	
MGAM	Silent	p.L726L	C	C		11	Filtered Calls	7	141736724	141736724	155	0.335483870967742	NA	NA	NA			13	Maltase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGAM&recr=Open">Click here</a>	
MGAM	Silent	p.G1112G	C	C		11	Filtered Calls	7	141755379	141755379	67	0.0895522388059701	NA	NA	NA			13	Glucoamylase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGAM&recr=Open">Click here</a>	
MGARP	Silent	p.S217S	T	T		11	Filtered Calls	4	140187825	140187825	60	0.6	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGARP&recr=Open">Click here</a>	
MGMT	Silent	p.L64L	C	C		11	Filtered Calls	10	131334615	131334615	94	0.223404255319149	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGMT&recr=Open">Click here</a>	
MIB1	Silent	p.V686V	C	C		11	Filtered Calls	18	19424061	19424061	111	0.414414414414414	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIB1&recr=Open">Click here</a>	
MICAL2	Intron		C	C		11	Filtered Calls	11	12241736	12241736	59	0.406779661016949	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MICAL2&recr=Open">Click here</a>	
MICALL1	Silent	p.A411A	C	C		11	Filtered Calls	22	38321818	38321818	45	0.311111111111111	NA	NA	NA			24	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MICALL1&recr=Open">Click here</a>	
MID1	Silent	p.N226N	G	G		11	Filtered Calls	X	10491210	10491210	155	0.483870967741935	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MID1&recr=Open">Click here</a>	
MIDN	Silent	p.A248A	C	C		11	Filtered Calls	19	1254948	1254948	141	0.276595744680851	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIDN&recr=Open">Click here</a>	
MIEF2	IGR		C	C		11	Filtered Calls	17	18167754	18167754	66	0.257575757575758	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIEF2&recr=Open">Click here</a>	
MIP	Silent	p.S8S	G	G		11	Filtered Calls	12	56848374	56848374	43	0.325581395348837	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIP&recr=Open">Click here</a>	
MIR1302-3	RNA		C	C		11	Filtered Calls	2	114340673	114340673	877	0.172177879133409	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR1302-3&recr=Open">Click here</a>	
MIR377	RNA		T	T		11	Filtered Calls	14	101527005	101527005	53	0.245283018867925	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR377&recr=Open">Click here</a>	
MIR412	RNA		A	A		11	Filtered Calls	14	101531699	101531699	53	0.283018867924528	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR412&recr=Open">Click here</a>	
MIR412	RNA		G	G		11	Filtered Calls	14	101531941	101531941	95	0.2	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR412&recr=Open">Click here</a>	
MIR412	RNA		G	G		11	Filtered Calls	14	101531942	101531942	95	0.210526315789474	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR412&recr=Open">Click here</a>	
MIR450A1	RNA		G	G		11	Filtered Calls	X	133674430	133674430	184	0.451086956521739	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR450A1&recr=Open">Click here</a>	
MIR513A2	RNA		C	C		11	Filtered Calls	X	146307338	146307338	59	0.898305084745763	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR513A2&recr=Open">Click here</a>	
MIR515-1	RNA		A	A		11	Filtered Calls	19	54182254	54182254	186	0.102150537634409	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR515-1&recr=Open">Click here</a>	
MIR515-2	RNA		G	G	rs201544531	11	Filtered Calls	19	54189746	54189746	226	0.13716814159292	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR515-2&recr=Open">Click here</a>	
MIR516A2	RNA		T	T		11	Filtered Calls	19	54261550	54261550	114	0.149122807017544	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR516A2&recr=Open">Click here</a>	
MIR517C	RNA		G	G		11	Filtered Calls	19	54245838	54245838	97	0.175257731958763	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR517C&recr=Open">Click here</a>	
MIR518A1	RNA		C	C		11	Filtered Calls	19	54234320	54234320	90	0.122222222222222	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR518A1&recr=Open">Click here</a>	
MIR518F	RNA		T	T		11	Filtered Calls	19	54200851	54200851	112	0.151785714285714	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR518F&recr=Open">Click here</a>	
MIR518F	RNA		A	A		11	Filtered Calls	19	54201636	54201636	159	0.138364779874214	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR518F&recr=Open">Click here</a>	
MIR520A	RNA		G	G		11	Filtered Calls	19	54194157	54194157	215	0.162790697674419	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR520A&recr=Open">Click here</a>	
MIR520A	RNA		G	G		11	Filtered Calls	19	54194179	54194179	181	0.18232044198895	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR520A&recr=Open">Click here</a>	
MIR548H4	RNA		G	G		11	Filtered Calls	8	26906368	26906368	197	0.213197969543147	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR548H4&recr=Open">Click here</a>	
MIR7-2	RNA		C	C	rs200523177	11	Filtered Calls	15	89155082	89155082	25	0.24	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR7-2&recr=Open">Click here</a>	
MIS18A	Intron		G	G		11	Filtered Calls	21	33642117	33642117	187	0.288770053475936	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIS18A&recr=Open">Click here</a>	
MISP	Silent	p.R295R	G	G		11	Filtered Calls	19	757831	757831	51	0.117647058823529	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MISP&recr=Open">Click here</a>	
MITD1	Silent	p.R209R	C	C		11	Filtered Calls	2	99786040	99786040	397	0.206549118387909	NA	NA	NA			6	Important for association with membranes.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MITD1&recr=Open">Click here</a>	
MITF	Intron		C	C		11	Filtered Calls	3	69928278	69928278	112	0.25	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MITF&recr=Open">Click here</a>	
MITF	Intron		C	C		11	Filtered Calls	3	70008419	70008419	231	0.458874458874459	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MITF&recr=Open">Click here</a>	
MKI67	Silent	p.S3128S	G	G		11	Filtered Calls	10	129899843	129899843	188	0.25531914893617	NA	NA	NA			159			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKI67&recr=Open">Click here</a>	
MKI67	Silent	p.S1880S	G	G		11	Filtered Calls	10	129904464	129904464	248	0.310483870967742	NA	NA	NA			159	16 X 122 AA approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKI67&recr=Open">Click here</a>	
MKL1	Intron		G	G		11	Filtered Calls	22	40819698	40819698	53	0.264150943396226	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKL1&recr=Open">Click here</a>	
MKRN3	Intron		C	C		11	Filtered Calls	15	23811429	23811429	35	0.685714285714286	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKRN3&recr=Open">Click here</a>	
MKRN3	Intron		C	C		11	Filtered Calls	15	23811689	23811689	80	0.1875	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKRN3&recr=Open">Click here</a>	
MKS1	Silent	p.I176I	G	G		11	Filtered Calls	17	56291736	56291736	98	0.214285714285714	NA	NA	NA		p.I176I(2)	26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKS1&recr=Open">Click here</a>	
MLC1	Silent	p.G213G	C	C		11	Filtered Calls	22	50512720	50512720	21	0.19047619047619	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLC1&recr=Open">Click here</a>	
MLEC	Intron		C	C		11	Filtered Calls	12	121132619	121132619	250	0.644	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLEC&recr=Open">Click here</a>	
MLH3	Silent	p.K743K	C	C		11	Filtered Calls	14	75514130	75514130	210	0.395238095238095	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLH3&recr=Open">Click here</a>	
MLK4	Silent	p.F985F	C	C		11	Filtered Calls	1	233518301	233518301	79	0.20253164556962	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLK4&recr=Open">Click here</a>	
MLKL	Silent	p.F257F	G	G	rs568554020	11	Filtered Calls	16	74719433	74719433	177	0.310734463276836	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLKL&recr=Open">Click here</a>	
MLLT6	Intron		C	C		11	Filtered Calls	17	36868279	36868279	16	0.9375	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLLT6&recr=Open">Click here</a>	
MLLT6	Intron		C	C		11	Filtered Calls	17	36871854	36871854	21	0.333333333333333	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLLT6&recr=Open">Click here</a>	
MLTK	Silent	p.F170F	C	C		11	Filtered Calls	2	174055833	174055833	247	0.295546558704453	NA	NA	NA		p.F170L(1)	NA	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLTK&recr=Open">Click here</a>	
MLTK	Intron		C	C		11	Filtered Calls	2	174123423	174123423	52	0.230769230769231	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLTK&recr=Open">Click here</a>	
MLYCD	Silent	p.S262S	C	C		11	Filtered Calls	16	83941875	83941875	166	0.295180722891566	NA	NA	NA			12	Catalytic domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLYCD&recr=Open">Click here</a>	
MME	Silent	p.V246V	G	G		11	Filtered Calls	3	154855908	154855908	280	0.0428571428571429	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MME&recr=Open">Click here</a>	
MMP1	Silent	p.I270I	G	G		11	Filtered Calls	11	102665994	102665994	98	0.418367346938776	NA	NA	NA			30	Metalloprotease.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP1&recr=Open">Click here</a>	
MMP10	Silent	p.K394K	C	C		11	Filtered Calls	11	102643622	102643622	267	0.382022471910112	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP10&recr=Open">Click here</a>	
MMP16	Silent	p.R589R	C	C		11	Filtered Calls	8	89053746	89053746	207	0.188405797101449	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP16&recr=Open">Click here</a>	
MMP20	Silent	p.G309G	C	C	rs145529899	11	Filtered Calls	11	102477292	102477292	49	0.428571428571429	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP20&recr=Open">Click here</a>	
MMP26	Intron		G	G		11	Filtered Calls	11	4790237	4790237	108	0.0648148148148148	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP26&recr=Open">Click here</a>	
MMP26	Intron		C	C		11	Filtered Calls	11	4903321	4903321	88	0.454545454545455	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP26&recr=Open">Click here</a>	
MMRN1	5'UTR		G	G		11	Filtered Calls	4	90830475	90830475	332	0.325301204819277	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMRN1&recr=Open">Click here</a>	
MN1	Silent	p.P59P	C	C		11	Filtered Calls	22	28196355	28196355	36	0.638888888888889	NA	NA	NA		p.P59P(1)	45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MN1&recr=Open">Click here</a>	
MOG	Intron		G	G		11	Filtered Calls	6	29637994	29637994	105	0.19047619047619	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MOG&recr=Open">Click here</a>	
MOK	Silent	p.T164T	G	G		11	Filtered Calls	14	102717247	102717247	223	0.282511210762332	NA	NA	NA			NA	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MOK&recr=Open">Click here</a>	
MON2	Silent	p.F269F	C	C		11	Filtered Calls	12	62902083	62902083	155	0.451612903225806	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MON2&recr=Open">Click here</a>	
MORC1	Silent	p.F482F	G	G		11	Filtered Calls	3	108754200	108754200	162	0.0679012345679012	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MORC1&recr=Open">Click here</a>	
MORC1	Intron		A	A		11	Filtered Calls	3	108788615	108788615	100	0.47	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MORC1&recr=Open">Click here</a>	
MORC2	Intron		G	G		11	Filtered Calls	22	31324201	31324201	50	0.24	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MORC2&recr=Open">Click here</a>	
MOV10L1	Intron		C	C		11	Filtered Calls	22	50553538	50553538	94	0.127659574468085	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MOV10L1&recr=Open">Click here</a>	
MOV10L1	Intron		C	C		11	Filtered Calls	22	50572429	50572429	196	0.209183673469388	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MOV10L1&recr=Open">Click here</a>	
MPHOSPH10	Silent	p.I658I	C	C		11	Filtered Calls	2	71377073	71377073	270	0.240740740740741	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPHOSPH10&recr=Open">Click here</a>	
MPO	Silent	p.V53V	G	G		11	Filtered Calls	17	56357816	56357816	17	0.235294117647059	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPO&recr=Open">Click here</a>	
MPP2	Intron		C	C		11	Filtered Calls	17	41956638	41956638	88	0.329545454545455	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPP2&recr=Open">Click here</a>	
MPP3	3'UTR		A	A		11	Filtered Calls	17	41879065	41879065	128	0.3125	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPP3&recr=Open">Click here</a>	
MPRIP	Intron		C	C		11	Filtered Calls	17	16979020	16979020	144	0.236111111111111	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPRIP&recr=Open">Click here</a>	
MPZ	Silent	p.P70P	G	G	rs545129173	11	Filtered Calls	1	161277072	161277072	83	0.662650602409639	NA	NA	NA			10	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPZ&recr=Open">Click here</a>	
MRAP2	Silent	p.V57V	G	G		11	Filtered Calls	6	84772655	84772655	84	0.44047619047619	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRAP2&recr=Open">Click here</a>	
MRGPRX1	Silent	p.I200I	G	G		11	Filtered Calls	11	18955732	18955732	44	0.409090909090909	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRGPRX1&recr=Open">Click here</a>	
MROH2B	Intron		G	G		11	Filtered Calls	5	40999890	40999890	80	0.175	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH2B&recr=Open">Click here</a>	
MROH2B	Silent	p.L1480L	G	G		11	Filtered Calls	5	41000366	41000366	76	0.210526315789474	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH2B&recr=Open">Click here</a>	
MROH2B	Silent	p.V729V	G	G		11	Filtered Calls	5	41038865	41038865	33	0.212121212121212	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH2B&recr=Open">Click here</a>	
MROH5	RNA		C	C		11	Filtered Calls	8	142506529	142506529	30	0.366666666666667	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH5&recr=Open">Click here</a>	
MROH7	Silent	p.K1110K	G	G		11	Filtered Calls	1	55167807	55167807	13	0.846153846153846	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH7&recr=Open">Click here</a>	
MROH9	Silent	p.Q355Q	G	G		11	Filtered Calls	1	170961341	170961341	59	0.423728813559322	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH9&recr=Open">Click here</a>	
MROH9	Silent	p.K470K	G	G		11	Filtered Calls	1	170965720	170965720	279	0.025089605734767	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH9&recr=Open">Click here</a>	
MRPL10	Silent	p.L146L	A	A		11	Filtered Calls	17	45904097	45904097	106	0.292452830188679	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRPL10&recr=Open">Click here</a>	
MRPL53	5'Flank		G	G	rs201575358	11	Filtered Calls	2	74701858	74701858	82	0.195121951219512	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRPL53&recr=Open">Click here</a>	
MRPS12	5'UTR		G	G		11	Filtered Calls	19	39421288	39421288	147	0.360544217687075	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRPS12&recr=Open">Click here</a>	
MRS2	Intron		T	T		11	Filtered Calls	6	24423808	24423808	109	0.293577981651376	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRS2&recr=Open">Click here</a>	
MS4A12	Silent	p.S210S	C	C		11	Filtered Calls	11	60274242	60274242	121	0.363636363636364	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MS4A12&recr=Open">Click here</a>	
MS4A2	Silent	p.P241P	C	C	rs535377676	11	Filtered Calls	11	59863117	59863117	83	0.843373493975904	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MS4A2&recr=Open">Click here</a>	
MS4A6A	Intron		A	A		11	Filtered Calls	11	59943090	59943090	48	0.354166666666667	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MS4A6A&recr=Open">Click here</a>	
MS4A6A	Intron		G	G		11	Filtered Calls	11	59943091	59943091	44	0.386363636363636	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MS4A6A&recr=Open">Click here</a>	
MSGN1	IGR		T	T		11	Filtered Calls	2	17998374	17998374	32	0.28125	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSGN1&recr=Open">Click here</a>	
MSI1	Silent	p.G133G	C	C		11	Filtered Calls	12	120800849	120800849	187	0.0374331550802139	NA	NA	NA			19	RRM 2. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSI1&recr=Open">Click here</a>	
MSI2	Silent	p.F222F	C	C	rs549686242	11	Filtered Calls	17	55704603	55704603	209	0.210526315789474	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSI2&recr=Open">Click here</a>	
MSLN	IGR		C	C		11	Filtered Calls	16	819508	819508	30	0.333333333333333	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSLN&recr=Open">Click here</a>	
MSMO1	Silent	p.T218T	C	C		11	Filtered Calls	4	166261495	166261495	194	0.262886597938144	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSMO1&recr=Open">Click here</a>	
MSR1	Silent	p.T98T	C	C		11	Filtered Calls	8	16026357	16026357	170	0.217647058823529	NA	NA	NA			37	Spacer. {ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSR1&recr=Open">Click here</a>	
MSS51	Intron		G	G		11	Filtered Calls	10	75184536	75184536	66	0.287878787878788	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSS51&recr=Open">Click here</a>	
MST1R	Silent	p.L1011L	G	G		11	Filtered Calls	3	49932913	49932913	96	0.197916666666667	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MST1R&recr=Open">Click here</a>	
MST4	IGR		C	C		11	Filtered Calls	X	131212126	131212126	134	0.455223880597015	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MST4&recr=Open">Click here</a>	
MSX2	IGR		C	C		11	Filtered Calls	5	174156325	174156325	31	0.354838709677419	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSX2&recr=Open">Click here</a>	
MTA1	Intron		C	C		11	Filtered Calls	14	105926685	105926685	13	0.307692307692308	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTA1&recr=Open">Click here</a>	
MTA1	Intron		C	C		11	Filtered Calls	14	105930358	105930358	36	0.388888888888889	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTA1&recr=Open">Click here</a>	
MTHFR	Intron		G	G		11	Filtered Calls	1	11854929	11854929	44	0.227272727272727	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTHFR&recr=Open">Click here</a>	
MTHFSD	Silent	p.V186V	G	G		11	Filtered Calls	16	86575426	86575426	20	0.7	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTHFSD&recr=Open">Click here</a>	
MTM1	Intron		C	C		11	Filtered Calls	X	149807407	149807407	104	0.932692307692308	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTM1&recr=Open">Click here</a>	
MTMR3	Intron		C	C		11	Filtered Calls	22	30374532	30374532	118	0.228813559322034	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTMR3&recr=Open">Click here</a>	
MTRR	Silent	p.F596F	C	C		11	Filtered Calls	5	7897196	7897196	202	0.227722772277228	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTRR&recr=Open">Click here</a>	
MTUS1	Silent	p.F239F	G	G	rs367638294	11	Filtered Calls	8	17513504	17513504	285	0.242105263157895	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTUS1&recr=Open">Click here</a>	
MTUS1	Silent	p.I166I	G	G		11	Filtered Calls	8	17541918	17541918	248	0.185483870967742	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTUS1&recr=Open">Click here</a>	
MUC16	Silent	p.E12134E	C	C		11	Filtered Calls	19	9028390	9028390	50	0.4	NA	NA	NA			590	SEA 1. {ECO:0000255|PROSITE- ProRule:PRU00188}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC16	Silent	p.S11868S	G	G		11	Filtered Calls	19	9046027	9046027	80	0.1625	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC16	Silent	p.R10307R	C	C		11	Filtered Calls	19	9056525	9056525	49	0.224489795918367	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC16	Silent	p.K9767K	C	C		11	Filtered Calls	19	9058145	9058145	46	0.152173913043478	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC16	Silent	p.E6673E	C	C		11	Filtered Calls	19	9067427	9067427	73	0.232876712328767	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC16	Silent	p.I5793I	G	G		11	Filtered Calls	19	9070067	9070067	48	0.354166666666667	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC16	Silent	p.S3539S	G	G		11	Filtered Calls	19	9076829	9076829	85	0.211764705882353	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC16	Silent	p.S3366S	G	G		11	Filtered Calls	19	9077348	9077348	170	0.270588235294118	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC16	Silent	p.T3294T	G	G		11	Filtered Calls	19	9077564	9077564	76	0.407894736842105	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC16	Silent	p.E1617E	C	C		11	Filtered Calls	19	9086964	9086964	105	0.266666666666667	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC16	Silent	p.S1493S	G	G		11	Filtered Calls	19	9087336	9087336	149	0.194630872483221	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC16	Silent	p.T1328T	C	C		11	Filtered Calls	19	9087831	9087831	36	0.305555555555556	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC17	Silent	p.E803E	A	A		11	Filtered Calls	7	100677106	100677106	136	0.0441176470588235	NA	NA	NA			343	59 X approximate tandem repeats.|Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC17&recr=Open">Click here</a>	
MUC17	Silent	p.T2193T	C	C		11	Filtered Calls	7	100681276	100681276	172	0.75	NA	NA	NA			343	59 X approximate tandem repeats.|Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC17&recr=Open">Click here</a>	
MUC17	Silent	p.V3946V	C	C		11	Filtered Calls	7	100686535	100686535	104	0.423076923076923	NA	NA	NA			343			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC17&recr=Open">Click here</a>	
MUC2	Intron		C	C		11	Filtered Calls	11	1075646	1075646	22	0.409090909090909	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC2&recr=Open">Click here</a>	
MUC2	Intron		C	C		11	Filtered Calls	11	1104036	1104036	8	1	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC2&recr=Open">Click here</a>	
MUC2	3'UTR		T	T		11	Filtered Calls	11	1104361	1104361	9	0.777777777777778	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC2&recr=Open">Click here</a>	
MUC4	Intron		G	G		11	Filtered Calls	3	195515825	195515825	18	0.277777777777778	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC4&recr=Open">Click here</a>	
MUC4	Intron		C	C		11	Filtered Calls	3	195516064	195516064	76	0.223684210526316	NA	NA	NA		p.R796Q(1)	51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC4&recr=Open">Click here</a>	
MUC4	Intron		G	G		11	Filtered Calls	3	195516547	195516547	109	0.532110091743119	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC4&recr=Open">Click here</a>	
MUC5AC	Silent	p.I511I	C	C		11	Filtered Calls	11	1161862	1161862	16	0.5625	NA	NA	NA			203	VWFD 2. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC5AC&recr=Open">Click here</a>	
MUC6	Silent	p.T2277T	G	G		11	Filtered Calls	11	1015970	1015970	77	0.818181818181818	NA	NA	NA			80	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC6&recr=Open">Click here</a>	
MUSK	Intron		T	T		11	Filtered Calls	9	113468428	113468428	22	0.363636363636364	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUSK&recr=Open">Click here</a>	
MUSK	Silent	p.L667L	C	C		11	Filtered Calls	9	113562659	113562659	105	0.619047619047619	NA	NA	NA			49	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUSK&recr=Open">Click here</a>	
MUT	Silent	p.F607F	G	G		11	Filtered Calls	6	49408054	49408054	238	0.218487394957983	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUT&recr=Open">Click here</a>	
MVB12A	3'UTR		C	C		11	Filtered Calls	19	17535812	17535812	113	0.283185840707965	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MVB12A&recr=Open">Click here</a>	
MVK	Silent	p.N199N	C	C		11	Filtered Calls	12	110023896	110023896	42	0.452380952380952	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MVK&recr=Open">Click here</a>	
MX2	Intron		C	C		11	Filtered Calls	21	42751937	42751937	55	0.272727272727273	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MX2&recr=Open">Click here</a>	
MXRA5	Silent	p.L2279L	G	G		11	Filtered Calls	X	3229407	3229407	35	0.428571428571429	NA	NA	NA			157	Ig-like C2-type 7.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MXRA5&recr=Open">Click here</a>	
MXRA7	Intron		G	G		11	Filtered Calls	17	74679981	74679981	121	0.173553719008264	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MXRA7&recr=Open">Click here</a>	
MYADM	Silent	p.G19G	C	C		11	Filtered Calls	19	54376840	54376840	58	0.344827586206897	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYADM&recr=Open">Click here</a>	
MYBBP1A	Intron		G	G		11	Filtered Calls	17	4451615	4451615	64	0.171875	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYBBP1A&recr=Open">Click here</a>	
MYCBP2	5'UTR		G	G		11	Filtered Calls	13	77692537	77692537	43	0.302325581395349	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCBP2&recr=Open">Click here</a>	
MYCBP2	Silent	p.I1614I	G	G		11	Filtered Calls	13	77754439	77754439	227	0.3215859030837	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCBP2&recr=Open">Click here</a>	
MYCBP2	Silent	p.L203L	G	G		11	Filtered Calls	13	77852918	77852918	96	0.260416666666667	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCBP2&recr=Open">Click here</a>	
MYCBP2	Silent	p.S182S	G	G		11	Filtered Calls	13	77852981	77852981	132	0.287878787878788	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCBP2&recr=Open">Click here</a>	
MYCN	Silent	p.R286R	T	T		11	Filtered Calls	2	16085682	16085682	32	0.28125	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCN&recr=Open">Click here</a>	
MYF5	5'UTR		G	G		11	Filtered Calls	12	81110842	81110842	22	0.409090909090909	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYF5&recr=Open">Click here</a>	
MYH1	Silent	p.R1645R	C	C		11	Filtered Calls	17	10399588	10399588	92	0.293478260869565	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH1&recr=Open">Click here</a>	
MYH1	Intron		C	C		11	Filtered Calls	17	10404899	10404899	58	0.46551724137931	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH1&recr=Open">Click here</a>	
MYH1	Silent	p.K1056K	C	C		11	Filtered Calls	17	10405172	10405172	68	0.294117647058824	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH1&recr=Open">Click here</a>	
MYH1	Intron		G	G		11	Filtered Calls	17	10411192	10411192	91	0.318681318681319	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH1&recr=Open">Click here</a>	
MYH10	Intron		G	G		11	Filtered Calls	17	8422118	8422118	148	0.189189189189189	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH10&recr=Open">Click here</a>	
MYH11	Silent	p.I457I	G	G		11	Filtered Calls	16	15853463	15853463	126	0.333333333333333	NA	NA	NA			123	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH11&recr=Open">Click here</a>	
MYH11	Silent	p.Y117Y	G	G		11	Filtered Calls	16	15917263	15917263	69	0.304347826086957	NA	NA	NA			123	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH11&recr=Open">Click here</a>	
MYH13	Intron		G	G		11	Filtered Calls	17	10204288	10204288	112	0.285714285714286	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH13&recr=Open">Click here</a>	
MYH13	Intron		A	A		11	Filtered Calls	17	10204290	10204290	111	0.297297297297297	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH13&recr=Open">Click here</a>	
MYH14	Silent	p.V48V	G	G		11	Filtered Calls	19	50713766	50713766	8	0.625	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH14&recr=Open">Click here</a>	
MYH14	Silent	p.R183R	G	G		11	Filtered Calls	19	50721015	50721015	37	0.135135135135135	NA	NA	NA			46	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH14&recr=Open">Click here</a>	
MYH14	Silent	p.F273F	C	C	rs568322917	11	Filtered Calls	19	50730168	50730168	57	0.280701754385965	NA	NA	NA			46	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH14&recr=Open">Click here</a>	
MYH15	Silent	p.F656F	G	G		11	Filtered Calls	3	108179171	108179171	67	0.313432835820896	NA	NA	NA			105	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH15&recr=Open">Click here</a>	
MYH2	Intron		T	T		11	Filtered Calls	17	10426850	10426850	69	0.130434782608696	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH2&recr=Open">Click here</a>	
MYH2	Intron		G	G		11	Filtered Calls	17	10426881	10426881	78	0.346153846153846	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH2&recr=Open">Click here</a>	
MYH2	Intron		C	C		11	Filtered Calls	17	10428640	10428640	109	0.26605504587156	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH2&recr=Open">Click here</a>	
MYH2	Intron		G	G	rs537925112	11	Filtered Calls	17	10428858	10428858	81	0.567901234567901	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH2&recr=Open">Click here</a>	
MYH2	Intron		G	G		11	Filtered Calls	17	10435060	10435060	135	0.296296296296296	NA	NA	NA		p.?(1)	176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH2&recr=Open">Click here</a>	
MYH3	Intron		G	G		11	Filtered Calls	17	10542796	10542796	82	0.219512195121951	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH3&recr=Open">Click here</a>	
MYH3	Silent	p.F813F	G	G		11	Filtered Calls	17	10543556	10543556	77	0.181818181818182	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH3&recr=Open">Click here</a>	
MYH4	Silent	p.L1692L	G	G		11	Filtered Calls	17	10350423	10350423	85	0.235294117647059	NA	NA	NA			149			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH4&recr=Open">Click here</a>	
MYH6	Intron		G	G		11	Filtered Calls	14	23851282	23851282	59	0.830508474576271	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH6&recr=Open">Click here</a>	
MYH7	Silent	p.Q1422Q	C	C		11	Filtered Calls	14	23886799	23886799	45	0.888888888888889	NA	NA	NA			137			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH7&recr=Open">Click here</a>	
MYH8	Silent	p.V1455V	G	G		11	Filtered Calls	17	10300033	10300033	83	0.0481927710843374	NA	NA	NA			134			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH8&recr=Open">Click here</a>	
MYLK	Intron		G	G		11	Filtered Calls	3	123366283	123366283	70	0.442857142857143	NA	NA	NA			113			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYLK&recr=Open">Click here</a>	
MYLK3	Intron		C	C		11	Filtered Calls	16	46764501	46764501	68	0.279411764705882	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYLK3&recr=Open">Click here</a>	
MYLK3	Intron		G	G	rs374905189	11	Filtered Calls	16	46771758	46771758	84	0.226190476190476	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYLK3&recr=Open">Click here</a>	
MYO15A	Silent	p.E1247E	A	A		11	Filtered Calls	17	18028530	18028530	77	0.194805194805195	NA	NA	NA			99	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO15A&recr=Open">Click here</a>	
MYO16	Intron		T	T		11	Filtered Calls	13	109704833	109704833	133	0.203007518796992	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO16&recr=Open">Click here</a>	
MYO18A	Intron		G	G		11	Filtered Calls	17	27413600	27413600	8	1	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO18A&recr=Open">Click here</a>	
MYO18B	Silent	p.A802A	C	C		11	Filtered Calls	22	26193949	26193949	90	0.166666666666667	NA	NA	NA			146	Myosin motor.|Poly-Ala.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO18B&recr=Open">Click here</a>	
MYO18B	Silent	p.K1608K	G	G		11	Filtered Calls	22	26294426	26294426	111	0.486486486486487	NA	NA	NA			146	Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO18B&recr=Open">Click here</a>	
MYO18B	Silent	p.I2117I	C	C		11	Filtered Calls	22	26400699	26400699	54	0.333333333333333	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO18B&recr=Open">Click here</a>	
MYO1A	Silent	p.F61F	G	G		11	Filtered Calls	12	57441820	57441820	73	0.273972602739726	NA	NA	NA			50	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1A&recr=Open">Click here</a>	
MYO1B	Intron		T	T		11	Filtered Calls	2	192272834	192272834	160	0.30625	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1B&recr=Open">Click here</a>	
MYO1C	Silent	p.L620L	G	G		11	Filtered Calls	17	1375259	1375259	90	0.155555555555556	NA	NA	NA			17	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1C&recr=Open">Click here</a>	
MYO1C	Intron		G	G	rs201086772	11	Filtered Calls	17	1381701	1381701	96	0.21875	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1C&recr=Open">Click here</a>	
MYO1F	Silent	p.S1076S	C	C		11	Filtered Calls	19	8586481	8586481	81	0.185185185185185	NA	NA	NA			42	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1F&recr=Open">Click here</a>	
MYO1F	Silent	p.K611K	C	C		11	Filtered Calls	19	8601448	8601448	50	0.22	NA	NA	NA			42	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1F&recr=Open">Click here</a>	
MYO1F	Intron		G	G	rs374274277	11	Filtered Calls	19	8604824	8604824	40	0.4	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1F&recr=Open">Click here</a>	
MYO1F	Intron		G	G		11	Filtered Calls	19	8610628	8610628	62	0.193548387096774	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1F&recr=Open">Click here</a>	
MYO3A	Intron		C	C		11	Filtered Calls	10	26443670	26443670	70	0.185714285714286	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO3A&recr=Open">Click here</a>	
MYO3A	Silent	p.R1367R	G	G		11	Filtered Calls	10	26463294	26463294	135	0.222222222222222	NA	NA	NA			146	IQ 3. {ECO:0000255|PROSITE- ProRule:PRU00116}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO3A&recr=Open">Click here</a>	
MYO3A	Silent	p.F1440F	C	C		11	Filtered Calls	10	26465656	26465656	59	0.406779661016949	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO3A&recr=Open">Click here</a>	
MYO3A	Silent	p.L1490L	G	G		11	Filtered Calls	10	26482165	26482165	144	0.229166666666667	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO3A&recr=Open">Click here</a>	
MYO3B	Intron		C	C		11	Filtered Calls	2	171240213	171240213	56	0.357142857142857	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO3B&recr=Open">Click here</a>	
MYO3B	Silent	p.R590R	G	G		11	Filtered Calls	2	171248984	171248984	104	0.221153846153846	NA	NA	NA			59	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO3B&recr=Open">Click here</a>	
MYO3B	Intron		C	C	rs555076873	11	Filtered Calls	2	171371544	171371544	17	0.235294117647059	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO3B&recr=Open">Click here</a>	
MYO5B	Intron		C	C		11	Filtered Calls	18	47402047	47402047	126	0.373015873015873	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5B&recr=Open">Click here</a>	
MYO5B	Silent	p.R1014R	C	C		11	Filtered Calls	18	47421314	47421314	19	0.421052631578947	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5B&recr=Open">Click here</a>	
MYO5B	Silent	p.S427S	G	G		11	Filtered Calls	18	47500761	47500761	28	0.357142857142857	NA	NA	NA			87	Myosin motor.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5B&recr=Open">Click here</a>	
MYO5B	Intron		C	C	rs370144130	11	Filtered Calls	18	47566506	47566506	53	0.490566037735849	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5B&recr=Open">Click here</a>	
MYO5C	Intron		G	G		11	Filtered Calls	15	52510894	52510894	96	0.270833333333333	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5C&recr=Open">Click here</a>	
MYO7A	Silent	p.F1004F	C	C	rs544100095	11	Filtered Calls	11	76893104	76893104	37	0.675675675675676	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO7A&recr=Open">Click here</a>	
MYO7B	Silent	p.V1242V	C	C		11	Filtered Calls	2	128380935	128380935	7	0.428571428571429	NA	NA	NA			75	FERM 1. {ECO:0000255|PROSITE- ProRule:PRU00084}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO7B&recr=Open">Click here</a>	
MYO9A	Silent	p.S2066S	G	G		11	Filtered Calls	15	72146866	72146866	203	0.310344827586207	NA	NA	NA			88	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.|Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO9A&recr=Open">Click here</a>	
MYO9B	Silent	p.R2061R	G	G		11	Filtered Calls	19	17322828	17322828	30	0.566666666666667	NA	NA	NA			39	Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO9B&recr=Open">Click here</a>	
MYOC	Silent	p.P276P	G	G		11	Filtered Calls	1	171605752	171605752	102	0.333333333333333	NA	NA	NA			28	Olfactomedin-like. {ECO:0000255|PROSITE- ProRule:PRU00446}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOC&recr=Open">Click here</a>	
MYOCD	Silent	p.R288R	G	G		11	Filtered Calls	17	12647646	12647646	35	0.228571428571429	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOCD&recr=Open">Click here</a>	
MYOCD	Silent	p.L471L	C	C		11	Filtered Calls	17	12656016	12656016	33	0.787878787878788	NA	NA	NA			70	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOCD&recr=Open">Click here</a>	
MYOF	Silent	p.T1909T	C	C	rs370918123	11	Filtered Calls	10	95072939	95072939	97	0.185567010309278	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOF&recr=Open">Click here</a>	
MYOF	Intron		G	G	rs374472012	11	Filtered Calls	10	95072977	95072977	65	0.461538461538462	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOF&recr=Open">Click here</a>	
MYOM1	5'UTR		C	C		11	Filtered Calls	18	3215223	3215223	7	0.428571428571429	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOM1&recr=Open">Click here</a>	
MYOM2	Intron		C	C		11	Filtered Calls	8	2033392	2033392	36	0.166666666666667	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOM2&recr=Open">Click here</a>	
MYOT	Intron		C	C	rs142382856	11	Filtered Calls	5	137206526	137206526	133	0.43609022556391	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOT&recr=Open">Click here</a>	
MYPN	Silent	p.S779S	C	C		11	Filtered Calls	10	69934186	69934186	88	0.261363636363636	NA	NA	NA			94			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYPN&recr=Open">Click here</a>	
MYRIP	Intron		G	G		11	Filtered Calls	3	40275549	40275549	95	0.347368421052632	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYRIP&recr=Open">Click here</a>	
MYSM1	Intron		G	G		11	Filtered Calls	1	59155933	59155933	179	0.284916201117318	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYSM1&recr=Open">Click here</a>	
MYT1L	Silent	p.T1093T	C	C		11	Filtered Calls	2	1796228	1796228	22	0.318181818181818	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYT1L&recr=Open">Click here</a>	
MYT1L	Silent	p.A400A	C	C	rs373977335	11	Filtered Calls	2	1926341	1926341	40	0.175	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYT1L&recr=Open">Click here</a>	
MYT1L	Silent	p.R349R	C	C		11	Filtered Calls	2	1926494	1926494	21	0.523809523809524	NA	NA	NA		p.R349R(1)	97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYT1L&recr=Open">Click here</a>	
MYT1L	Silent	p.I211I	G	G		11	Filtered Calls	2	1926908	1926908	48	0.583333333333333	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYT1L&recr=Open">Click here</a>	
NAA35	Intron		C	C		11	Filtered Calls	9	88633163	88633163	170	0.229411764705882	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAA35&recr=Open">Click here</a>	
NAALAD2	Intron		T	T		11	Filtered Calls	11	89891307	89891307	151	0.847682119205298	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAALAD2&recr=Open">Click here</a>	
NAALAD2	Silent	p.L432L	C	C		11	Filtered Calls	11	89902114	89902114	119	0.394957983193277	NA	NA	NA			59	NAALADase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAALAD2&recr=Open">Click here</a>	
NAALADL2	Silent	p.L308L	G	G		11	Filtered Calls	3	174974304	174974304	134	0.529850746268657	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAALADL2&recr=Open">Click here</a>	
NACA	Intron		G	G		11	Filtered Calls	12	57111860	57111860	132	0.378787878787879	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NACA&recr=Open">Click here</a>	
NACA	Intron		G	G		11	Filtered Calls	12	57112402	57112402	70	0.457142857142857	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NACA&recr=Open">Click here</a>	
NADSYN1	Silent	p.I566I	C	C		11	Filtered Calls	11	71202883	71202883	26	0.384615384615385	NA	NA	NA			25	Ligase. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NADSYN1&recr=Open">Click here</a>	
NAGA	Silent	p.T161T	G	G		11	Filtered Calls	22	42463136	42463136	220	0.459090909090909	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAGA&recr=Open">Click here</a>	
NAGK	Intron		C	C		11	Filtered Calls	2	71305440	71305440	120	0.183333333333333	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAGK&recr=Open">Click here</a>	
NALCN	Silent	p.E1457E	C	C		11	Filtered Calls	13	101720345	101720345	122	0.237704918032787	NA	NA	NA			177			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NALCN&recr=Open">Click here</a>	
NALCN	Silent	p.K812K	C	C		11	Filtered Calls	13	101760069	101760069	87	0.275862068965517	NA	NA	NA			177			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NALCN&recr=Open">Click here</a>	
NALCN	Silent	p.E763E	C	C		11	Filtered Calls	13	101763481	101763481	274	0.277372262773723	NA	NA	NA			177			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NALCN&recr=Open">Click here</a>	
NALCN	Intron		G	G	rs369043342	11	Filtered Calls	13	101833451	101833451	111	0.297297297297297	NA	NA	NA			177			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NALCN&recr=Open">Click here</a>	
NALCN	Silent	p.R146R	G	G		11	Filtered Calls	13	102029347	102029347	139	0.223021582733813	NA	NA	NA			177			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NALCN&recr=Open">Click here</a>	
NANOS3	IGR		C	C		11	Filtered Calls	19	13993641	13993641	94	0.319148936170213	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NANOS3&recr=Open">Click here</a>	
NAP1L2	Silent	p.E230E	C	C		11	Filtered Calls	X	72433639	72433639	52	0.384615384615385	NA	NA	NA			29	Glu-rich (acidic).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAP1L2&recr=Open">Click here</a>	
NAP1L3	Silent	p.D240D	G	G		11	Filtered Calls	X	92927584	92927584	128	0.4296875	NA	NA	NA			34	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAP1L3&recr=Open">Click here</a>	
NAT2	Silent	p.R117R	G	G		11	Filtered Calls	8	18257864	18257864	169	0.165680473372781	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAT2&recr=Open">Click here</a>	
NAV3	Silent	p.S1217S	C	C		11	Filtered Calls	12	78513627	78513627	72	0.347222222222222	NA	NA	NA			236	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAV3&recr=Open">Click here</a>	
NBAS	Silent	p.S672S	G	G		11	Filtered Calls	2	15607790	15607790	90	0.3	NA	NA	NA		p.S672S(1)	112			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NBAS&recr=Open">Click here</a>	
NBEA	Silent	p.K1709K	G	G		11	Filtered Calls	13	35770209	35770209	128	0.3515625	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NBEA&recr=Open">Click here</a>	
NBEAL2	Silent	p.L303L	C	C		11	Filtered Calls	3	47033162	47033162	18	0.333333333333333	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NBEAL2&recr=Open">Click here</a>	
NCALD	Silent	p.V12V	G	G		11	Filtered Calls	8	102731822	102731822	117	0.196581196581197	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCALD&recr=Open">Click here</a>	
NCAM2	Silent	p.S217S	T	T		11	Filtered Calls	21	22696734	22696734	148	0.317567567567568	NA	NA	NA			108	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCAM2&recr=Open">Click here</a>	
NCAM2	Silent	p.S598S	C	C		11	Filtered Calls	21	22841002	22841002	120	0.491666666666667	NA	NA	NA			108	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCAM2&recr=Open">Click here</a>	
NCAN	Silent	p.G924G	G	G		11	Filtered Calls	19	19339201	19339201	67	0.223880597014925	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCAN&recr=Open">Click here</a>	
NCAPD2	Silent	p.G373G	C	C		11	Filtered Calls	12	6626125	6626125	301	0.252491694352159	NA	NA	NA			48	Interactions with SMC2 and SMC4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCAPD2&recr=Open">Click here</a>	
NCAPD3	Silent	p.S316S	G	G		11	Filtered Calls	11	134076562	134076562	136	0.463235294117647	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCAPD3&recr=Open">Click here</a>	
NCAPD3	5'UTR		C	C		11	Filtered Calls	11	134093825	134093825	13	0.615384615384615	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCAPD3&recr=Open">Click here</a>	
NCF4	Intron		C	C		11	Filtered Calls	22	37260076	37260076	173	0.196531791907514	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCF4&recr=Open">Click here</a>	
NCF4	Silent	p.F41F	C	C	rs369350039	11	Filtered Calls	22	37260966	37260966	48	0.1875	NA	NA	NA			16	PX. {ECO:0000255|PROSITE- ProRule:PRU00147}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCF4&recr=Open">Click here</a>	
NCK2	Silent	p.F280F	C	C	rs374552067	11	Filtered Calls	2	106498397	106498397	63	0.317460317460317	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCK2&recr=Open">Click here</a>	
NCKAP1L	Intron		G	G		11	Filtered Calls	12	54893254	54893254	41	0.317073170731707	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCKAP1L&recr=Open">Click here</a>	
NCOR1	Silent	p.F2194F	G	G		11	Filtered Calls	17	15950362	15950362	253	0.284584980237154	NA	NA	NA			107	Interaction with C1D. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCOR1&recr=Open">Click here</a>	
NCOR1	Silent	p.S1164S	A	A		11	Filtered Calls	17	15983287	15983287	192	0.6875	NA	NA	NA			107	Interaction with ETO.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCOR1&recr=Open">Click here</a>	
NCR1	Intron		C	C		11	Filtered Calls	19	55421369	55421369	104	0.134615384615385	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCR1&recr=Open">Click here</a>	
NDNF	Silent	p.G101G	C	C		11	Filtered Calls	4	121961095	121961095	54	0.222222222222222	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDNF&recr=Open">Click here</a>	
NDOR1	Silent	p.I399I	C	C	rs199703256	11	Filtered Calls	9	140109882	140109882	71	0.28169014084507	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDOR1&recr=Open">Click here</a>	
NDRG2	Intron		G	G		11	Filtered Calls	14	21490663	21490663	40	0.15	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDRG2&recr=Open">Click here</a>	
NDRG3	Silent	p.P102P	G	G		11	Filtered Calls	20	35315909	35315909	119	0.361344537815126	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDRG3&recr=Open">Click here</a>	
NDST1	Intron		C	C		11	Filtered Calls	5	149919634	149919634	30	0.433333333333333	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDST1&recr=Open">Click here</a>	
NDST4	Silent	p.F564F	G	G	rs189562045	11	Filtered Calls	4	115791951	115791951	95	0.242105263157895	NA	NA	NA			81	Heparan sulfate N-deacetylase 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDST4&recr=Open">Click here</a>	
NDST4	Silent	p.F516F	G	G		11	Filtered Calls	4	115792095	115792095	65	0.153846153846154	NA	NA	NA			81	Heparan sulfate N-deacetylase 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDST4&recr=Open">Click here</a>	
NDST4	Intron		G	G		11	Filtered Calls	4	115898433	115898433	147	0.510204081632653	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDST4&recr=Open">Click here</a>	
NDUFA12	Intron		G	G		11	Filtered Calls	12	95365408	95365408	65	0.461538461538462	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDUFA12&recr=Open">Click here</a>	
NDUFS1	Silent	p.S143S	G	G		11	Filtered Calls	2	207012377	207012377	112	0.258928571428571	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDUFS1&recr=Open">Click here</a>	
NDUFV3	Intron		C	C		11	Filtered Calls	21	44323513	44323513	314	0.312101910828025	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDUFV3&recr=Open">Click here</a>	
NDUFV3	Intron		C	C		11	Filtered Calls	21	44324172	44324172	40	0.275	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDUFV3&recr=Open">Click here</a>	
NEB	Silent	p.Q1494Q	C	C		11	Filtered Calls	2	152527561	152527561	110	0.3	NA	NA	NA			301			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEB&recr=Open">Click here</a>	
NEB	Silent	p.A1396A	G	G		11	Filtered Calls	2	152528994	152528994	94	0.276595744680851	NA	NA	NA			301			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEB&recr=Open">Click here</a>	
NEB	Silent	p.P828P	G	G		11	Filtered Calls	2	152544179	152544179	18	0.333333333333333	NA	NA	NA			301			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEB&recr=Open">Click here</a>	
NEBL	Intron		T	T		11	Filtered Calls	10	21124518	21124518	252	0.154761904761905	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEBL&recr=Open">Click here</a>	
NEBL	Intron		A	A		11	Filtered Calls	10	21141582	21141582	47	0.191489361702128	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEBL&recr=Open">Click here</a>	
NECAP1	Silent	p.Q124Q	G	G		11	Filtered Calls	12	8244435	8244435	76	0.157894736842105	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NECAP1&recr=Open">Click here</a>	
NEDD4	Silent	p.L863L	G	G		11	Filtered Calls	15	56141054	56141054	406	0.283251231527094	NA	NA	NA			43	Mediates interaction with TNIK. {ECO:0000250}.|WW 3. {ECO:0000255|PROSITE- ProRule:PRU00224}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEDD4&recr=Open">Click here</a>	
NEFH	Silent	p.T642T	G	G		11	Filtered Calls	22	29885555	29885555	67	0.164179104477612	NA	NA	NA			30	30 X 6 AA repeats of K-S-P-[AEPV]-[EAK]- [AEVK].|Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEFH&recr=Open">Click here</a>	
NEFH	Silent	p.S648S	C	C		11	Filtered Calls	22	29885573	29885573	94	0.351063829787234	NA	NA	NA			30	30 X 6 AA repeats of K-S-P-[AEPV]-[EAK]- [AEVK].|Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEFH&recr=Open">Click here</a>	
NEFL	RNA		G	G		11	Filtered Calls	8	24811156	24811156	121	0.239669421487603	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEFL&recr=Open">Click here</a>	
NEFM	Silent	p.V448V	C	C		11	Filtered Calls	8	24774712	24774712	85	0.129411764705882	NA	NA	NA			36	Tail.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEFM&recr=Open">Click here</a>	
NEIL3	Silent	p.I453I	C	C		11	Filtered Calls	4	178274781	178274781	168	0.238095238095238	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEIL3&recr=Open">Click here</a>	
NEK10	Intron		G	G		11	Filtered Calls	3	27182970	27182970	155	0.154838709677419	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEK10&recr=Open">Click here</a>	
NEK10	Intron		G	G		11	Filtered Calls	3	27346469	27346469	32	0.28125	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEK10&recr=Open">Click here</a>	
NEK2	Silent	p.I67I	G	G		11	Filtered Calls	1	211847751	211847751	352	0.198863636363636	NA	NA	NA			3	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEK2&recr=Open">Click here</a>	
NEK8	Silent	p.L123L	C	C		11	Filtered Calls	17	27061905	27061905	137	0.474452554744526	NA	NA	NA			35	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEK8&recr=Open">Click here</a>	
NEO1	Intron		C	C		11	Filtered Calls	15	73594948	73594948	20	0.3	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEO1&recr=Open">Click here</a>	
NES	3'UTR		C	C		11	Filtered Calls	1	156639113	156639113	60	0.283333333333333	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NES&recr=Open">Click here</a>	
NEURL	Silent	p.F35F	C	C		11	Filtered Calls	10	105330648	105330648	181	0.209944751381215	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEURL&recr=Open">Click here</a>	
NEUROD6	Silent	p.Y287Y	G	G		11	Filtered Calls	7	31378022	31378022	71	0.253521126760563	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEUROD6&recr=Open">Click here</a>	
NF1	Intron		C	C		11	Filtered Calls	17	29548865	29548865	112	0.6875	NA	NA	NA		p.0?(8)|p.?(4)	599			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NF1&recr=Open">Click here</a>	
NFAM1	Intron		G	G		11	Filtered Calls	22	42783091	42783091	31	0.225806451612903	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFAM1&recr=Open">Click here</a>	
NFASC	Silent	p.L690L	C	C		11	Filtered Calls	1	204948581	204948581	133	0.729323308270677	NA	NA	NA			81	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFASC&recr=Open">Click here</a>	
NFASC	Silent	p.F1130F	C	C		11	Filtered Calls	1	204978785	204978785	27	0.592592592592593	NA	NA	NA			81	Fibronectin type-III 5. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFASC&recr=Open">Click here</a>	
NFATC2	Intron		G	G		11	Filtered Calls	20	50049301	50049301	60	0.933333333333333	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFATC2&recr=Open">Click here</a>	
NFATC2IP	Silent	p.D274D	C	C		11	Filtered Calls	16	28967634	28967634	33	0.242424242424242	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFATC2IP&recr=Open">Click here</a>	
NFE2L1	Silent	p.S490S	C	C		11	Filtered Calls	17	46136187	46136187	63	0.317460317460317	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFE2L1&recr=Open">Click here</a>	
NFKBIB	Silent	p.P353P	C	C		11	Filtered Calls	19	39399460	39399460	124	0.0403225806451613	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFKBIB&recr=Open">Click here</a>	
NFKBIZ	Silent	p.S319S	C	C	rs202168485	11	Filtered Calls	3	101572327	101572327	150	0.426666666666667	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFKBIZ&recr=Open">Click here</a>	
NFRKB	Silent	p.S581S	A	A		11	Filtered Calls	11	129746620	129746620	47	0.74468085106383	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFRKB&recr=Open">Click here</a>	
NGEF	Silent	p.R344R	C	C		11	Filtered Calls	2	233752782	233752782	116	0.241379310344828	NA	NA	NA			35	DH. {ECO:0000255|PROSITE- ProRule:PRU00062}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NGEF&recr=Open">Click here</a>	
NGEF	Intron		G	G	rs548487043	11	Filtered Calls	2	233757765	233757765	30	0.2	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NGEF&recr=Open">Click here</a>	
NHLRC2	Silent	p.S337S	C	C		11	Filtered Calls	10	115644111	115644111	213	0.215962441314554	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NHLRC2&recr=Open">Click here</a>	
NINJ2	Silent	p.F171F	G	G		11	Filtered Calls	12	674455	674455	91	0.208791208791209	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NINJ2&recr=Open">Click here</a>	
NIPAL4	Intron		C	C		11	Filtered Calls	5	156890349	156890349	19	0.263157894736842	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIPAL4&recr=Open">Click here</a>	
NIPAL4	Silent	p.I464I	C	C		11	Filtered Calls	5	156899959	156899959	62	0.274193548387097	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIPAL4&recr=Open">Click here</a>	
NIPBL	Intron		C	C		11	Filtered Calls	5	36995715	36995715	222	0.207207207207207	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIPBL&recr=Open">Click here</a>	
NIPBL	Intron		C	C		11	Filtered Calls	5	37006698	37006698	90	0.133333333333333	NA	NA	NA			128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIPBL&recr=Open">Click here</a>	
NIPBL	Silent	p.T2695T	G	G	rs201036501	11	Filtered Calls	5	37064664	37064664	417	0.237410071942446	NA	NA	NA		p.T2695T(1)	128			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIPBL&recr=Open">Click here</a>	
NISCH	Silent	p.V236V	C	C	rs370837747	11	Filtered Calls	3	52507788	52507788	84	0.535714285714286	NA	NA	NA			33	Necessary for homooligomerization and targeting to endosomes.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NISCH&recr=Open">Click here</a>	
NKAIN3	Silent	p.F29F	C	C		11	Filtered Calls	8	63492130	63492130	241	0.240663900414938	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKAIN3&recr=Open">Click here</a>	
NKAPL	Silent	p.I13I	C	C		11	Filtered Calls	6	28227188	28227188	58	0.706896551724138	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKAPL&recr=Open">Click here</a>	
NKD1	Silent	p.L262L	C	C	rs570585869	11	Filtered Calls	16	50666282	50666282	32	0.15625	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKD1&recr=Open">Click here</a>	
NKG2-E	Intron		G	G		11	Filtered Calls	12	10583736	10583736	366	0.193989071038251	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKG2-E&recr=Open">Click here</a>	
NKG2-E	Silent	p.P104P	C	C		11	Filtered Calls	12	10587104	10587104	575	0.0869565217391304	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKG2-E&recr=Open">Click here</a>	
NKX3-1	Silent	p.V211V	G	G		11	Filtered Calls	8	23538806	23538806	75	0.266666666666667	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKX3-1&recr=Open">Click here</a>	
NLGN1	Silent	p.F562F	C	C		11	Filtered Calls	3	173998307	173998307	196	0.198979591836735	NA	NA	NA		p.F562L(1)	83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLGN1&recr=Open">Click here</a>	
NLGN3	Silent	p.I129I	C	C		11	Filtered Calls	X	70367986	70367986	75	0.0933333333333333	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLGN3&recr=Open">Click here</a>	
NLGN3	Silent	p.V556V	C	C		11	Filtered Calls	X	70387615	70387615	107	0.467289719626168	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLGN3&recr=Open">Click here</a>	
NLGN3	Silent	p.F720F	C	C		11	Filtered Calls	X	70389560	70389560	16	0.3125	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLGN3&recr=Open">Click here</a>	
NLGN4Y	3'UTR		C	C		11	Filtered Calls	Y	16734068	16734068	24	0.833333333333333	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLGN4Y&recr=Open">Click here</a>	
NLGN4Y	3'UTR		C	C		11	Filtered Calls	Y	16936177	16936177	33	0.909090909090909	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLGN4Y&recr=Open">Click here</a>	
NLRC5	5'UTR		C	C		11	Filtered Calls	16	57054624	57054624	93	0.172043010752688	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRC5&recr=Open">Click here</a>	
NLRP1	Silent	p.I1253I	G	G		11	Filtered Calls	17	5424868	5424868	46	0.630434782608696	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP1&recr=Open">Click here</a>	
NLRP1	Silent	p.S179S	G	G		11	Filtered Calls	17	5485294	5485294	27	0.333333333333333	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP1&recr=Open">Click here</a>	
NLRP12	Silent	p.D676D	G	G		11	Filtered Calls	19	54312885	54312885	25	0.16	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP12&recr=Open">Click here</a>	
NLRP12	Silent	p.I595I	G	G		11	Filtered Calls	19	54313128	54313128	48	0.104166666666667	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP12&recr=Open">Click here</a>	
NLRP12	Silent	p.L475L	G	G		11	Filtered Calls	19	54313490	54313490	52	0.384615384615385	NA	NA	NA			80	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP12&recr=Open">Click here</a>	
NLRP13	Silent	p.F534F	G	G	rs531168183	11	Filtered Calls	19	56423581	56423581	84	0.261904761904762	NA	NA	NA			109	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP13&recr=Open">Click here</a>	
NLRP14	Silent	p.L232L	G	G		11	Filtered Calls	11	7063953	7063953	129	0.372093023255814	NA	NA	NA			21	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP14&recr=Open">Click here</a>	
NLRP2	Silent	p.Q6Q	G	G		11	Filtered Calls	19	55481401	55481401	52	0.0961538461538462	NA	NA	NA			11	DAPIN. {ECO:0000255|PROSITE- ProRule:PRU00061}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP2&recr=Open">Click here</a>	
NLRP4	Silent	p.G145G	G	G		11	Filtered Calls	19	56369194	56369194	94	0.191489361702128	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP4&recr=Open">Click here</a>	
NLRP5	Silent	p.E577E	G	G		11	Filtered Calls	19	56539330	56539330	19	0.421052631578947	NA	NA	NA			25	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP5&recr=Open">Click here</a>	
NLRP5	Silent	p.I832I	C	C		11	Filtered Calls	19	56544956	56544956	121	0.140495867768595	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP5&recr=Open">Click here</a>	
NLRP7	Silent	p.S428S	G	G		11	Filtered Calls	19	55450903	55450903	20	0.3	NA	NA	NA			73	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP7&recr=Open">Click here</a>	
NLRP7	Silent	p.G271G	C	C		11	Filtered Calls	19	55451374	55451374	38	0.105263157894737	NA	NA	NA			73	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP7&recr=Open">Click here</a>	
NLRP8	Silent	p.F243F	C	C		11	Filtered Calls	19	56466153	56466153	82	0.378048780487805	NA	NA	NA			35	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP8&recr=Open">Click here</a>	
NLRP8	Silent	p.L747L	G	G		11	Filtered Calls	19	56477606	56477606	109	0.155963302752294	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP8&recr=Open">Click here</a>	
NLRP9	Silent	p.A810A	G	G		11	Filtered Calls	19	56226492	56226492	64	0.390625	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP9&recr=Open">Click here</a>	
NLRP9	Silent	p.P753P	G	G		11	Filtered Calls	19	56228165	56228165	71	0.140845070422535	NA	NA	NA		p.P753P(1)	74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP9&recr=Open">Click here</a>	
NLRP9	Silent	p.L109L	G	G		11	Filtered Calls	19	56244870	56244870	172	0.38953488372093	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP9&recr=Open">Click here</a>	
NME3	5'Flank		C	C		11	Filtered Calls	16	1823359	1823359	9	0.444444444444444	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NME3&recr=Open">Click here</a>	
NMS	Silent	p.L101L	C	C		11	Filtered Calls	2	101095856	101095856	77	0.25974025974026	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NMS&recr=Open">Click here</a>	
NMUR2	Silent	p.I212I	G	G		11	Filtered Calls	5	151784039	151784039	89	0.460674157303371	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NMUR2&recr=Open">Click here</a>	
NOL9	Intron		G	G		11	Filtered Calls	1	6589241	6589241	59	0.457627118644068	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOL9&recr=Open">Click here</a>	
NOP16	5'Flank		C	C		11	Filtered Calls	5	175815937	175815937	116	0.474137931034483	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOP16&recr=Open">Click here</a>	
NOP2	3'UTR		G	G	rs551573004	11	Filtered Calls	12	6666664	6666664	132	0.234848484848485	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOP2&recr=Open">Click here</a>	
NOP2	Intron		G	G		11	Filtered Calls	12	6672775	6672775	50	0.28	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOP2&recr=Open">Click here</a>	
NOP56	Silent	p.S171S	C	C		11	Filtered Calls	20	2635537	2635537	271	0.232472324723247	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOP56&recr=Open">Click here</a>	
NOS1	Intron		G	G		11	Filtered Calls	12	117662952	117662952	41	0.24390243902439	NA	NA	NA			117			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOS1&recr=Open">Click here</a>	
NOS3	Silent	p.F468F	C	C		11	Filtered Calls	7	150698489	150698489	37	0.351351351351351	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOS3&recr=Open">Click here</a>	
NOSIP	Silent	p.D261D	G	G		11	Filtered Calls	19	50059625	50059625	36	0.277777777777778	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOSIP&recr=Open">Click here</a>	
NOTCH2	Intron		G	G		11	Filtered Calls	1	120478238	120478238	71	0.352112676056338	NA	NA	NA			158			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOTCH2&recr=Open">Click here</a>	
NOTCH4	Silent	p.Q292Q	C	C		11	Filtered Calls	6	32188579	32188579	112	0.339285714285714	NA	NA	NA			100	EGF-like 7; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOTCH4&recr=Open">Click here</a>	
NOX4	Silent	p.I71I	G	G		11	Filtered Calls	11	89185004	89185004	96	0.395833333333333	NA	NA	NA			44	Ferric oxidoreductase.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOX4&recr=Open">Click here</a>	
NPAP1	Silent	p.A153A	C	C		11	Filtered Calls	15	24921473	24921473	15	0.333333333333333	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPAP1&recr=Open">Click here</a>	
NPAS2	Intron		T	T		11	Filtered Calls	2	101564690	101564690	278	0.0431654676258993	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPAS2&recr=Open">Click here</a>	
NPAS3	Intron		C	C		11	Filtered Calls	14	33684735	33684735	45	0.777777777777778	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPAS3&recr=Open">Click here</a>	
NPAS4	Silent	p.F436F	C	C		11	Filtered Calls	11	66191669	66191669	91	0.846153846153846	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPAS4&recr=Open">Click here</a>	
NPBWR2	Silent	p.F201F	G	G		11	Filtered Calls	20	62737582	62737582	21	0.333333333333333	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPBWR2&recr=Open">Click here</a>	
NPC1L1	Silent	p.S1167S	G	G		11	Filtered Calls	7	44556320	44556320	15	0.2	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPC1L1&recr=Open">Click here</a>	
NPL	Silent	p.F174F	C	C		11	Filtered Calls	1	182787740	182787740	199	0.42713567839196	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPL&recr=Open">Click here</a>	
NPNT	Intron		T	T		11	Filtered Calls	4	106879617	106879617	52	0.365384615384615	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPNT&recr=Open">Click here</a>	
NPR2	Silent	p.S113S	C	C		11	Filtered Calls	9	35792744	35792744	81	0.358024691358025	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPR2&recr=Open">Click here</a>	
NPR2	Silent	p.S328S	C	C		11	Filtered Calls	9	35799725	35799725	63	0.333333333333333	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPR2&recr=Open">Click here</a>	
NPRL2	IGR		G	G		11	Filtered Calls	3	50382549	50382549	71	0.23943661971831	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPRL2&recr=Open">Click here</a>	
NPSR1	Silent	p.I314I	C	C		11	Filtered Calls	7	34888192	34888192	157	0.337579617834395	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPSR1&recr=Open">Click here</a>	
NPSR1	Silent	p.L321L	G	G		11	Filtered Calls	7	34888213	34888213	155	0.032258064516129	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPSR1&recr=Open">Click here</a>	
NPTN	Silent	p.I352I	G	G		11	Filtered Calls	15	73862549	73862549	129	0.310077519379845	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPTN&recr=Open">Click here</a>	
NPTX2	Silent	p.E372E	G	G		11	Filtered Calls	7	98257761	98257761	11	0.454545454545455	NA	NA	NA			18	Pentaxin.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPTX2&recr=Open">Click here</a>	
NPY	3'UTR		G	G		11	Filtered Calls	7	24331308	24331308	120	0.241666666666667	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPY&recr=Open">Click here</a>	
NPY2R	Silent	p.K79K	G	G		11	Filtered Calls	4	156135328	156135328	59	0.305084745762712	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPY2R&recr=Open">Click here</a>	
NPY2R	Silent	p.F88F	C	C		11	Filtered Calls	4	156135355	156135355	49	0.428571428571429	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPY2R&recr=Open">Click here</a>	
NR1H2	Silent	p.V116V	C	C		11	Filtered Calls	19	50881572	50881572	194	0.149484536082474	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NR1H2&recr=Open">Click here</a>	
NR1H3	Intron		C	C		11	Filtered Calls	11	47290091	47290091	195	0.830769230769231	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NR1H3&recr=Open">Click here</a>	
NR1I2	Silent	p.H398H	C	C	rs267599559	11	Filtered Calls	3	119534595	119534595	15	0.266666666666667	NA	NA	NA			23	Ligand-binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NR1I2&recr=Open">Click here</a>	
NR2E1	Intron		C	C		11	Filtered Calls	6	108492812	108492812	98	0.489795918367347	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NR2E1&recr=Open">Click here</a>	
NR3C2	5'UTR		G	G		11	Filtered Calls	4	149115973	149115973	266	0.319548872180451	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NR3C2&recr=Open">Click here</a>	
NR5A2	Intron		C	C		11	Filtered Calls	1	200014724	200014724	180	0.0388888888888889	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NR5A2&recr=Open">Click here</a>	
NRAP	Silent	p.I1563I	G	G	rs556650136	11	Filtered Calls	10	115350604	115350604	56	0.535714285714286	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRAP&recr=Open">Click here</a>	
NRAP	Silent	p.K1158K	C	C		11	Filtered Calls	10	115372017	115372017	104	0.182692307692308	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRAP&recr=Open">Click here</a>	
NRBP1	Intron		C	C		11	Filtered Calls	2	27659608	27659608	89	0.325842696629214	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRBP1&recr=Open">Click here</a>	
NRD1	Silent	p.F716F	G	G	rs142972588	11	Filtered Calls	1	52275033	52275033	595	0.0285714285714286	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRD1&recr=Open">Click here</a>	
NRG1	Silent	p.S316S	C	C		11	Filtered Calls	8	32616850	32616850	201	0.208955223880597	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRG1&recr=Open">Click here</a>	
NRK	Silent	p.F212F	C	C		11	Filtered Calls	X	105142632	105142632	25	0.44	NA	NA	NA			76	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRK&recr=Open">Click here</a>	
NRK	Intron		G	G	rs373104815	11	Filtered Calls	X	105190013	105190013	14	0.571428571428571	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRK&recr=Open">Click here</a>	
NRP1	Intron		C	C		11	Filtered Calls	10	33495149	33495149	108	0.231481481481481	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRP1&recr=Open">Click here</a>	
NRP1	Intron		G	G		11	Filtered Calls	10	33538431	33538431	86	0.232558139534884	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRP1&recr=Open">Click here</a>	
NRP1	Intron		G	G		11	Filtered Calls	10	33538459	33538459	86	0.162790697674419	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRP1&recr=Open">Click here</a>	
NRP1	Silent	p.I213I	G	G		11	Filtered Calls	10	33552593	33552593	90	0.188888888888889	NA	NA	NA			48	CUB 2. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRP1&recr=Open">Click here</a>	
NRP2	Intron		C	C		11	Filtered Calls	2	206607916	206607916	155	0.554838709677419	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRP2&recr=Open">Click here</a>	
NRXN1	Silent	p.P1409P	C	C	rs183440866	11	Filtered Calls	2	50280430	50280430	207	0.328502415458937	NA	NA	NA			58	Poly-Ala.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN1&recr=Open">Click here</a>	
NRXN1	Silent	p.R350R	C	C		11	Filtered Calls	2	50850635	50850635	147	0.224489795918367	NA	NA	NA			58	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN1&recr=Open">Click here</a>	
NRXN1	Intron		G	G		11	Filtered Calls	2	51149023	51149023	86	0.186046511627907	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN1&recr=Open">Click here</a>	
NRXN1	Intron		C	C		11	Filtered Calls	2	51254630	51254630	16	0.25	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN1&recr=Open">Click here</a>	
NRXN2	Intron		G	G		11	Filtered Calls	11	64444518	64444518	36	0.388888888888889	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN2&recr=Open">Click here</a>	
NRXN3	5'UTR		C	C		11	Filtered Calls	14	79111529	79111529	8	0.625	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN3&recr=Open">Click here</a>	
NRXN3	5'UTR		C	C		11	Filtered Calls	14	79111665	79111665	29	0.482758620689655	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN3&recr=Open">Click here</a>	
NRXN3	Silent	p.L313L	G	G		11	Filtered Calls	14	79269976	79269976	77	0.467532467532468	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN3&recr=Open">Click here</a>	
NRXN3	Intron		C	C		11	Filtered Calls	14	80319910	80319910	113	0.548672566371681	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN3&recr=Open">Click here</a>	
NSD1	Intron		C	C		11	Filtered Calls	5	176696819	176696819	76	0.5	NA	NA	NA			96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NSD1&recr=Open">Click here</a>	
NT5C1B-RDH14	Silent	p.F564F	G	G		11	Filtered Calls	2	18745203	18745203	144	0.305555555555556	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NT5C1B-RDH14&recr=Open">Click here</a>	
NT5C1B-RDH14	Intron		G	G		11	Filtered Calls	2	18767662	18767662	48	0.4375	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NT5C1B-RDH14&recr=Open">Click here</a>	
NT5C1B-RDH14	Intron		C	C		11	Filtered Calls	2	18768761	18768761	133	0.210526315789474	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NT5C1B-RDH14&recr=Open">Click here</a>	
NT5E	Silent	p.T376T	G	G	rs138566130	11	Filtered Calls	6	86199235	86199235	88	0.431818181818182	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NT5E&recr=Open">Click here</a>	
NTM	Intron		T	T		11	Filtered Calls	11	132204929	132204929	37	0.324324324324324	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NTM&recr=Open">Click here</a>	
NTN1	Intron		C	C		11	Filtered Calls	17	9124475	9124475	75	0.173333333333333	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NTN1&recr=Open">Click here</a>	
NTNG1	Intron		C	C		11	Filtered Calls	1	107950300	107950300	152	0.835526315789474	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NTNG1&recr=Open">Click here</a>	
NTNG1	Intron		G	G		11	Filtered Calls	1	107998250	107998250	17	0.352941176470588	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NTNG1&recr=Open">Click here</a>	
NTRK3	Silent	p.S335S	G	G		11	Filtered Calls	15	88669599	88669599	58	0.310344827586207	NA	NA	NA			119	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NTRK3&recr=Open">Click here</a>	
NUAK1	Silent	p.R437R	C	C		11	Filtered Calls	12	106461255	106461255	36	0.277777777777778	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUAK1&recr=Open">Click here</a>	
NUAK1	Silent	p.S85S	G	G	rs540624410	11	Filtered Calls	12	106500289	106500289	67	0.223880597014925	NA	NA	NA			37	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUAK1&recr=Open">Click here</a>	
NUBP1	Silent	p.V261V	C	C		11	Filtered Calls	16	10855679	10855679	47	0.276595744680851	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUBP1&recr=Open">Click here</a>	
NUCB1	3'UTR		C	C		11	Filtered Calls	19	49425686	49425686	74	0.175675675675676	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUCB1&recr=Open">Click here</a>	
NUDCD3	Intron		G	G		11	Filtered Calls	7	44507898	44507898	144	0.361111111111111	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUDCD3&recr=Open">Click here</a>	
NUP153	Silent	p.T1248T	G	G		11	Filtered Calls	6	17626196	17626196	115	0.191304347826087	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP153&recr=Open">Click here</a>	
NUP155	Silent	p.F573F	G	G		11	Filtered Calls	5	37330145	37330145	108	0.194444444444444	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP155&recr=Open">Click here</a>	
NUP188	Silent	p.K344K	G	G	rs143388445	11	Filtered Calls	9	131733156	131733156	119	0.613445378151261	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP188&recr=Open">Click here</a>	
NUP188	Silent	p.F921F	C	C		11	Filtered Calls	9	131755598	131755598	99	0.292929292929293	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP188&recr=Open">Click here</a>	
NUP205	Silent	p.Q602Q	G	G		11	Filtered Calls	7	135277916	135277916	119	0.369747899159664	NA	NA	NA			93			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP205&recr=Open">Click here</a>	
NUP210	Silent	p.A612A	G	G		11	Filtered Calls	3	13407542	13407542	34	0.352941176470588	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP210&recr=Open">Click here</a>	
NUP210L	Intron		C	C	rs374684249	11	Filtered Calls	1	154090194	154090194	207	0.202898550724638	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP210L&recr=Open">Click here</a>	
NUP214	Silent	p.S509S	C	C	rs142073749	11	Filtered Calls	9	134019899	134019899	133	0.360902255639098	NA	NA	NA			86	11 X 5 AA approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP214&recr=Open">Click here</a>	
NUP98	Intron		G	G		11	Filtered Calls	11	3716843	3716843	37	0.891891891891892	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP98&recr=Open">Click here</a>	
NUSAP1	Intron		C	C		11	Filtered Calls	15	41663717	41663717	148	0.236486486486486	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUSAP1&recr=Open">Click here</a>	
NVL	Silent	p.A402A	G	G		11	Filtered Calls	1	224482088	224482088	124	0.185483870967742	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NVL&recr=Open">Click here</a>	
NWD1	Silent	p.Q1055Q	G	G		11	Filtered Calls	19	16902385	16902385	96	0.427083333333333	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NWD1&recr=Open">Click here</a>	
NXF3	Silent	p.T292T	G	G		11	Filtered Calls	X	102337197	102337197	63	0.873015873015873	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NXF3&recr=Open">Click here</a>	
NXN	Silent	p.F371F	G	G		11	Filtered Calls	17	706934	706934	48	0.270833333333333	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NXN&recr=Open">Click here</a>	
NXPE3	Silent	p.L495L	T	T		11	Filtered Calls	3	101540603	101540603	128	0.4765625	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NXPE3&recr=Open">Click here</a>	
NXPH2	Silent	p.L177L	C	C		11	Filtered Calls	2	139428756	139428756	56	0.339285714285714	NA	NA	NA			22	IV (linker domain).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NXPH2&recr=Open">Click here</a>	
NYAP2	Silent	p.V249V	G	G		11	Filtered Calls	2	226446880	226446880	85	0.247058823529412	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NYAP2&recr=Open">Click here</a>	
NYNRIN	Silent	p.G1361G	C	C		11	Filtered Calls	14	24885038	24885038	40	0.8	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NYNRIN&recr=Open">Click here</a>	
OARD1	Intron		C	C		11	Filtered Calls	6	41038860	41038860	262	0.240458015267176	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OARD1&recr=Open">Click here</a>	
OAS1	Intron		C	C	rs143035510	11	Filtered Calls	12	113354553	113354553	90	0.333333333333333	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OAS1&recr=Open">Click here</a>	
OAS3	Intron		C	C		11	Filtered Calls	12	113388488	113388488	126	0.30952380952381	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OAS3&recr=Open">Click here</a>	
OBSCN	Silent	p.P3486P	C	C		11	Filtered Calls	1	228473945	228473945	13	0.230769230769231	NA	NA	NA			223	Ig-like 35.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	
OBSCN	Silent	p.Q4999Q	G	G		11	Filtered Calls	1	228494801	228494801	28	0.178571428571429	NA	NA	NA			223			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	
OBSCN	Intron		C	C		11	Filtered Calls	1	228548271	228548271	14	0.285714285714286	NA	NA	NA			223			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	
OBSCN	Silent	p.A8047A	A	A		11	Filtered Calls	1	228559749	228559749	24	0.208333333333333	NA	NA	NA			223			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	
OCLN	Silent	p.I181I	C	C		11	Filtered Calls	5	68805460	68805460	250	0.476	NA	NA	NA			6	MARVEL. {ECO:0000255|PROSITE- ProRule:PRU00581}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OCLN&recr=Open">Click here</a>	
ODF3L1	Silent	p.I34I	C	C		11	Filtered Calls	15	76016642	76016642	66	0.287878787878788	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ODF3L1&recr=Open">Click here</a>	
ODF3L1	Silent	p.L47L	C	C		11	Filtered Calls	15	76017471	76017471	84	0.261904761904762	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ODF3L1&recr=Open">Click here</a>	
ODF4	Intron		G	G		11	Filtered Calls	17	8243696	8243696	20	0.65	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ODF4&recr=Open">Click here</a>	
OFCC1	5'UTR		A	A		11	Filtered Calls	6	9897232	9897232	21	0.19047619047619	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OFCC1&recr=Open">Click here</a>	
OFCC1	5'UTR		C	C		11	Filtered Calls	6	9900605	9900605	253	0.217391304347826	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OFCC1&recr=Open">Click here</a>	
OFD1	Intron		C	C		11	Filtered Calls	X	13780451	13780451	337	0.421364985163205	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OFD1&recr=Open">Click here</a>	
OGDHL	Silent	p.Q223Q	C	C		11	Filtered Calls	10	50959953	50959953	117	0.478632478632479	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OGDHL&recr=Open">Click here</a>	
OGDHL	Silent	p.F209F	G	G		11	Filtered Calls	10	50959995	50959995	128	0.1953125	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OGDHL&recr=Open">Click here</a>	
OLFML2A	Silent	p.R428R	G	G		11	Filtered Calls	9	127570175	127570175	98	0.295918367346939	NA	NA	NA			25	Olfactomedin-like. {ECO:0000255|PROSITE- ProRule:PRU00446}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OLFML2A&recr=Open">Click here</a>	
OOEP	Intron		G	G	rs368582382	11	Filtered Calls	6	74079467	74079467	63	0.507936507936508	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OOEP&recr=Open">Click here</a>	
OPLAH	5'UTR		C	C		11	Filtered Calls	8	145108285	145108285	78	0.294871794871795	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPLAH&recr=Open">Click here</a>	
OPLAH	5'UTR		G	G		11	Filtered Calls	8	145112553	145112553	25	0.48	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPLAH&recr=Open">Click here</a>	
OPRK1	Silent	p.A159A	G	G	rs199574345	11	Filtered Calls	8	54147452	54147452	34	0.117647058823529	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPRK1&recr=Open">Click here</a>	
OPRM1	Silent	p.F10F	C	C		11	Filtered Calls	6	154411000	154411000	69	0.492753623188406	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPRM1&recr=Open">Click here</a>	
OPRM1	Silent	p.N259N	C	C		11	Filtered Calls	6	154412520	154412520	69	0.405797101449275	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPRM1&recr=Open">Click here</a>	
OPTC	Silent	p.V130V	C	C		11	Filtered Calls	1	203467828	203467828	99	0.393939393939394	NA	NA	NA			20	Cys-rich.|LRRNT.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPTC&recr=Open">Click here</a>	
OR10AD1	Silent	p.I46I	G	G		11	Filtered Calls	12	48596938	48596938	26	0.692307692307692	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10AD1&recr=Open">Click here</a>	
OR10C1	Silent	p.F167F	C	C		11	Filtered Calls	6	29408293	29408293	163	0.226993865030675	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10C1&recr=Open">Click here</a>	
OR10C1	Silent	p.T172T	C	C		11	Filtered Calls	6	29408308	29408308	174	0.172413793103448	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10C1&recr=Open">Click here</a>	
OR10H4	Silent	p.F29F	C	C		11	Filtered Calls	19	16059904	16059904	164	0.25609756097561	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10H4&recr=Open">Click here</a>	
OR10J1	Silent	p.L141L	G	G		11	Filtered Calls	1	159409971	159409971	169	0.42603550295858	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10J1&recr=Open">Click here</a>	
OR10K2	IGR		T	T	rs374710976	11	Filtered Calls	1	158389712	158389712	67	0.656716417910448	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10K2&recr=Open">Click here</a>	
OR10K2	Silent	p.S277S	G	G		11	Filtered Calls	1	158389826	158389826	159	0.257861635220126	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10K2&recr=Open">Click here</a>	
OR10K2	Silent	p.F14F	G	G		11	Filtered Calls	1	158390615	158390615	64	0.296875	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10K2&recr=Open">Click here</a>	
OR10Q1	Silent	p.S247S	G	G		11	Filtered Calls	11	57995607	57995607	29	0.482758620689655	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10Q1&recr=Open">Click here</a>	
OR10S1	Silent	p.L199L	G	G		11	Filtered Calls	11	123847804	123847804	32	0.8125	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10S1&recr=Open">Click here</a>	
OR10S1	Silent	p.V198V	G	G		11	Filtered Calls	11	123847805	123847805	33	0.818181818181818	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10S1&recr=Open">Click here</a>	
OR10T2	Silent	p.I229I	G	G		11	Filtered Calls	1	158368570	158368570	87	0.206896551724138	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10T2&recr=Open">Click here</a>	
OR10Z1	Silent	p.S210S	C	C		11	Filtered Calls	1	158576858	158576858	194	0.257731958762887	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10Z1&recr=Open">Click here</a>	
OR10Z1	Silent	p.F305F	C	C		11	Filtered Calls	1	158577143	158577143	179	0.240223463687151	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10Z1&recr=Open">Click here</a>	
OR11H4	Silent	p.K32K	G	G		11	Filtered Calls	14	20711046	20711046	36	0.888888888888889	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR11H4&recr=Open">Click here</a>	
OR11L1	Silent	p.F104F	G	G	rs564443240	11	Filtered Calls	1	248004887	248004887	21	0.238095238095238	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR11L1&recr=Open">Click here</a>	
OR12D3	3'UTR		C	C		11	Filtered Calls	6	29342104	29342104	206	0.20873786407767	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR12D3&recr=Open">Click here</a>	
OR13C4	Silent	p.I181I	G	G		11	Filtered Calls	9	107288948	107288948	83	0.216867469879518	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR13C4&recr=Open">Click here</a>	
OR13C5	Silent	p.L294L	A	A		11	Filtered Calls	9	107360815	107360815	153	0.34640522875817	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR13C5&recr=Open">Click here</a>	
OR13C5	Silent	p.P289P	G	G		11	Filtered Calls	9	107360828	107360828	150	0.253333333333333	NA	NA	NA		p.P289P(1)	28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR13C5&recr=Open">Click here</a>	
OR13C5	Silent	p.E232E	C	C		11	Filtered Calls	9	107360999	107360999	98	0.214285714285714	NA	NA	NA		p.E232D(1)	28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR13C5&recr=Open">Click here</a>	
OR13C8	Silent	p.F27F	C	C		11	Filtered Calls	9	107331529	107331529	203	0.344827586206897	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR13C8&recr=Open">Click here</a>	
OR13H1	Silent	p.L291L	C	C		11	Filtered Calls	X	130678918	130678918	116	0.879310344827586	NA	NA	NA		p.L291M(1)	15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR13H1&recr=Open">Click here</a>	
OR14A16	Silent	p.A293A	G	G		11	Filtered Calls	1	247978153	247978153	300	0.173333333333333	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR14A16&recr=Open">Click here</a>	
OR14A16	Silent	p.V99V	G	G		11	Filtered Calls	1	247978735	247978735	103	0.349514563106796	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR14A16&recr=Open">Click here</a>	
OR14I1	Silent	p.R163R	C	C		11	Filtered Calls	1	248845117	248845117	52	0.192307692307692	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR14I1&recr=Open">Click here</a>	
OR1A2	Silent	p.S222S	C	C		11	Filtered Calls	17	3101478	3101478	162	0.203703703703704	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1A2&recr=Open">Click here</a>	
OR1A2	Silent	p.L262L	G	G		11	Filtered Calls	17	3101598	3101598	100	0.69	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1A2&recr=Open">Click here</a>	
OR1F1	Silent	p.F62F	C	C		11	Filtered Calls	16	3254432	3254432	71	0.267605633802817	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1F1&recr=Open">Click here</a>	
OR1G1	3'UTR		C	C		11	Filtered Calls	17	3029901	3029901	67	0.149253731343284	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1G1&recr=Open">Click here</a>	
OR1G1	Silent	p.I225I	G	G		11	Filtered Calls	17	3030171	3030171	37	0.27027027027027	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1G1&recr=Open">Click here</a>	
OR1J4	IGR		C	C		11	Filtered Calls	9	125282370	125282370	21	0.142857142857143	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1J4&recr=Open">Click here</a>	
OR1M1	Silent	p.I13I	C	C		11	Filtered Calls	19	9203959	9203959	42	0.166666666666667	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1M1&recr=Open">Click here</a>	
OR1M1	Silent	p.I160I	C	C		11	Filtered Calls	19	9204400	9204400	63	0.492063492063492	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1M1&recr=Open">Click here</a>	
OR1M1	Silent	p.R234R	G	G		11	Filtered Calls	19	9204622	9204622	42	0.19047619047619	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1M1&recr=Open">Click here</a>	
OR1N1	Silent	p.F112F	G	G		11	Filtered Calls	9	125289237	125289237	42	0.523809523809524	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1N1&recr=Open">Click here</a>	
OR1N2	Silent	p.F48F	C	C		11	Filtered Calls	9	125315592	125315592	39	0.641025641025641	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1N2&recr=Open">Click here</a>	
OR1Q1	Silent	p.F103F	C	C		11	Filtered Calls	9	125377325	125377325	197	0.228426395939086	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1Q1&recr=Open">Click here</a>	
OR2A12	Silent	p.A73A	C	C		11	Filtered Calls	7	143792419	143792419	106	0.452830188679245	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2A12&recr=Open">Click here</a>	
OR2AG1	Silent	p.A83A	G	G	rs144825471	11	Filtered Calls	11	6806517	6806517	76	0.355263157894737	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2AG1&recr=Open">Click here</a>	
OR2AG2	Silent	p.F206F	G	G		11	Filtered Calls	11	6789571	6789571	34	0.382352941176471	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2AG2&recr=Open">Click here</a>	
OR2B11	Silent	p.F210F	G	G	rs199665492	11	Filtered Calls	1	247614655	247614655	38	0.184210526315789	NA	NA	NA		p.F210F(1)	60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2B11&recr=Open">Click here</a>	
OR2C3	Silent	p.A301A	G	G		11	Filtered Calls	1	247694911	247694911	74	0.378378378378378	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2C3&recr=Open">Click here</a>	
OR2C3	Silent	p.K237K	C	C		11	Filtered Calls	1	247695103	247695103	106	0.132075471698113	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2C3&recr=Open">Click here</a>	
OR2C3	Silent	p.I175I	G	G		11	Filtered Calls	1	247695289	247695289	13	0.538461538461538	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2C3&recr=Open">Click here</a>	
OR2F2	Silent	p.V46V	C	C		11	Filtered Calls	7	143632463	143632463	149	0.315436241610738	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2F2&recr=Open">Click here</a>	
OR2G2	Silent	p.I95I	C	C		11	Filtered Calls	1	247751946	247751946	132	0.340909090909091	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2G2&recr=Open">Click here</a>	
OR2K2	Silent	p.I218I	G	G		11	Filtered Calls	9	114090060	114090060	70	0.671428571428571	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2K2&recr=Open">Click here</a>	
OR2L13	Silent	p.V247V	G	G		11	Filtered Calls	1	248263418	248263418	203	0.29064039408867	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2L13&recr=Open">Click here</a>	
OR2L2	Silent	p.L46L	T	T		11	Filtered Calls	1	248201707	248201707	391	0.388746803069054	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2L2&recr=Open">Click here</a>	
OR2L2	Silent	p.C126C	C	C		11	Filtered Calls	1	248201947	248201947	233	0.377682403433476	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2L2&recr=Open">Click here</a>	
OR2M3	Silent	p.F26F	C	C		11	Filtered Calls	1	248366447	248366447	317	0.195583596214511	NA	NA	NA		p.F26L(1)	50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2M3&recr=Open">Click here</a>	
OR2T1	Silent	p.F64F	C	C		11	Filtered Calls	1	248569487	248569487	290	0.2	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2T1&recr=Open">Click here</a>	
OR2T11	Silent	p.V48V	C	C		11	Filtered Calls	1	248790286	248790286	74	0.351351351351351	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2T11&recr=Open">Click here</a>	
OR2T4	Silent	p.F198F	C	C		11	Filtered Calls	1	248525476	248525476	239	0.209205020920502	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2T4&recr=Open">Click here</a>	
OR2W3	Silent	p.V201V	C	C		11	Filtered Calls	1	248059491	248059491	136	0.147058823529412	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2W3&recr=Open">Click here</a>	
OR2W5	RNA		C	C		11	Filtered Calls	1	247654515	247654515	79	0.20253164556962	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2W5&recr=Open">Click here</a>	
OR2W5	RNA		G	G	rs368780486	11	Filtered Calls	1	247654688	247654688	97	0.298969072164948	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2W5&recr=Open">Click here</a>	
OR4A15	Silent	p.G180G	C	C		11	Filtered Calls	11	55135899	55135899	193	0.440414507772021	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4A15&recr=Open">Click here</a>	
OR4A15	Silent	p.G260G	G	G		11	Filtered Calls	11	55136139	55136139	96	0.427083333333333	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4A15&recr=Open">Click here</a>	
OR4B1	3'UTR		G	G		11	Filtered Calls	11	48239299	48239299	21	0.476190476190476	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4B1&recr=Open">Click here</a>	
OR4C13	Silent	p.V45V	C	C		11	Filtered Calls	11	49974109	49974109	166	0.397590361445783	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4C13&recr=Open">Click here</a>	
OR4C16	Silent	p.V99V	C	C		11	Filtered Calls	11	55339900	55339900	149	0.328859060402685	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4C16&recr=Open">Click here</a>	
OR4C16	Silent	p.I114I	C	C		11	Filtered Calls	11	55339945	55339945	121	0.363636363636364	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4C16&recr=Open">Click here</a>	
OR4D11	Silent	p.R290R	G	G		11	Filtered Calls	11	59271918	59271918	46	0.304347826086957	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4D11&recr=Open">Click here</a>	
OR4F15	Silent	p.A236A	C	C	rs201625205	11	Filtered Calls	15	102359097	102359097	293	0.249146757679181	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4F15&recr=Open">Click here</a>	
OR4K1	Silent	p.F31F	C	C		11	Filtered Calls	14	20403918	20403918	358	0.0307262569832402	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4K1&recr=Open">Click here</a>	
OR4M2	Silent	p.Q19Q	G	G		11	Filtered Calls	15	22368632	22368632	378	0.158730158730159	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4M2&recr=Open">Click here</a>	
OR4N5	Silent	p.L114L	C	C		11	Filtered Calls	14	20612236	20612236	99	0.373737373737374	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4N5&recr=Open">Click here</a>	
OR4N5	Silent	p.S238S	C	C		11	Filtered Calls	14	20612608	20612608	121	0.421487603305785	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4N5&recr=Open">Click here</a>	
OR51A7	Silent	p.F161F	C	C		11	Filtered Calls	11	4929082	4929082	81	0.37037037037037	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51A7&recr=Open">Click here</a>	
OR51B4	Silent	p.L37L	A	A		11	Filtered Calls	11	5323066	5323066	69	0.405797101449275	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51B4&recr=Open">Click here</a>	
OR51B5	Silent	p.F281F	G	G		11	Filtered Calls	11	5363912	5363912	63	0.380952380952381	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51B5&recr=Open">Click here</a>	
OR51B5	Silent	p.S106S	G	G		11	Filtered Calls	11	5364437	5364437	26	0.5	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51B5&recr=Open">Click here</a>	
OR51D1	Silent	p.K93K	G	G		11	Filtered Calls	11	4661299	4661299	39	0.230769230769231	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51D1&recr=Open">Click here</a>	
OR51I2	Silent	p.E21E	G	G	rs147328747	11	Filtered Calls	11	5474781	5474781	46	0.260869565217391	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51I2&recr=Open">Click here</a>	
OR51M1	Silent	p.F162F	C	C		11	Filtered Calls	11	5411114	5411114	130	0.407692307692308	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51M1&recr=Open">Click here</a>	
OR52E8	Silent	p.F18F	G	G		11	Filtered Calls	11	5878879	5878879	147	0.870748299319728	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52E8&recr=Open">Click here</a>	
OR52K1	5'UTR		C	C		11	Filtered Calls	11	4510122	4510122	51	0.470588235294118	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52K1&recr=Open">Click here</a>	
OR52M1	Silent	p.S178S	C	C		11	Filtered Calls	11	4566954	4566954	56	0.839285714285714	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52M1&recr=Open">Click here</a>	
OR52N2	Silent	p.I137I	C	C		11	Filtered Calls	11	5841976	5841976	34	0.5	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52N2&recr=Open">Click here</a>	
OR56A3	Silent	p.F102F	C	C		11	Filtered Calls	11	5968882	5968882	109	0.348623853211009	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR56A3&recr=Open">Click here</a>	
OR56A4	Silent	p.L91L	G	G		11	Filtered Calls	11	6024106	6024106	13	0.538461538461538	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR56A4&recr=Open">Click here</a>	
OR56B1	3'UTR		C	C		11	Filtered Calls	11	5758732	5758732	75	0.746666666666667	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR56B1&recr=Open">Click here</a>	
OR5AP2	Silent	p.K301K	C	C		11	Filtered Calls	11	56409013	56409013	93	0.827956989247312	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5AP2&recr=Open">Click here</a>	
OR5AS1	Silent	p.K303K	G	G		11	Filtered Calls	11	55798803	55798803	89	0.415730337078652	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5AS1&recr=Open">Click here</a>	
OR5B12	Silent	p.G42G	C	C		11	Filtered Calls	11	58207499	58207499	40	0.35	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5B12&recr=Open">Click here</a>	
OR5B3	Silent	p.L209L	G	G		11	Filtered Calls	11	58170256	58170256	64	0.421875	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5B3&recr=Open">Click here</a>	
OR5D14	Silent	p.V88V	A	A		11	Filtered Calls	11	55563295	55563295	72	0.319444444444444	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5D14&recr=Open">Click here</a>	
OR5D14	Silent	p.I215I	C	C	rs267602975	11	Filtered Calls	11	55563676	55563676	119	0.0504201680672269	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5D14&recr=Open">Click here</a>	
OR5D14	Silent	p.R295R	G	G		11	Filtered Calls	11	55563916	55563916	81	0.407407407407407	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5D14&recr=Open">Click here</a>	
OR5D16	Silent	p.F64F	C	C		11	Filtered Calls	11	55606419	55606419	164	0.884146341463415	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5D16&recr=Open">Click here</a>	
OR5D18	3'UTR		C	C		11	Filtered Calls	11	55588049	55588049	29	0.448275862068966	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5D18&recr=Open">Click here</a>	
OR5F1	Silent	p.S217S	G	G		11	Filtered Calls	11	55761451	55761451	29	0.344827586206897	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5F1&recr=Open">Click here</a>	
OR5F1	5'Flank		G	G		11	Filtered Calls	11	55762106	55762106	58	0.327586206896552	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5F1&recr=Open">Click here</a>	
OR5H2	Silent	p.F262F	C	C		11	Filtered Calls	3	98002517	98002517	86	0.0813953488372093	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5H2&recr=Open">Click here</a>	
OR5K1	Silent	p.E83E	G	G		11	Filtered Calls	3	98188669	98188669	209	0.0478468899521531	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5K1&recr=Open">Click here</a>	
OR5K4	Silent	p.F226F	C	C		11	Filtered Calls	3	98073375	98073375	85	0.435294117647059	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5K4&recr=Open">Click here</a>	
OR5K4	Silent	p.V294V	C	C		11	Filtered Calls	3	98073579	98073579	215	0.316279069767442	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5K4&recr=Open">Click here</a>	
OR5M8	Silent	p.F84F	G	G		11	Filtered Calls	11	56258595	56258595	61	0.344262295081967	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5M8&recr=Open">Click here</a>	
OR5M9	Silent	p.R259R	C	C		11	Filtered Calls	11	56230101	56230101	54	0.796296296296296	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5M9&recr=Open">Click here</a>	
OR5P2	Silent	p.G249G	C	C	rs148357349	11	Filtered Calls	11	7817743	7817743	74	0.445945945945946	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5P2&recr=Open">Click here</a>	
OR5T2	Silent	p.T117T	G	G		11	Filtered Calls	11	56000311	56000311	56	0.339285714285714	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5T2&recr=Open">Click here</a>	
OR6C2	Silent	p.F226F	C	C		11	Filtered Calls	12	55846675	55846675	141	0.390070921985816	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C2&recr=Open">Click here</a>	
OR6C3	Silent	p.F59F	C	C		11	Filtered Calls	12	55725661	55725661	108	0.37962962962963	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C3&recr=Open">Click here</a>	
OR6C3	Silent	p.L147L	C	C		11	Filtered Calls	12	55725923	55725923	132	0.462121212121212	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C3&recr=Open">Click here</a>	
OR6C4	Silent	p.S115S	C	C		11	Filtered Calls	12	55945355	55945355	91	0.406593406593407	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C4&recr=Open">Click here</a>	
OR6C6	Silent	p.F10F	G	G		11	Filtered Calls	12	55688987	55688987	95	0.421052631578947	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C6&recr=Open">Click here</a>	
OR6C65	Silent	p.R62R	G	G		11	Filtered Calls	12	55794498	55794498	81	0.493827160493827	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C65&recr=Open">Click here</a>	
OR6C65	Silent	p.N140N	T	T		11	Filtered Calls	12	55794732	55794732	167	0.37125748502994	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C65&recr=Open">Click here</a>	
OR6C70	Silent	p.L46L	G	G	rs200802708	11	Filtered Calls	12	55863785	55863785	64	0.453125	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C70&recr=Open">Click here</a>	
OR6F1	Silent	p.L85L	G	G		11	Filtered Calls	1	247875805	247875805	121	0.429752066115702	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6F1&recr=Open">Click here</a>	
OR6F1	Silent	p.F68F	G	G		11	Filtered Calls	1	247875854	247875854	118	0.584745762711864	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6F1&recr=Open">Click here</a>	
OR6K2	Silent	p.F252F	G	G		11	Filtered Calls	1	158669687	158669687	46	0.239130434782609	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6K2&recr=Open">Click here</a>	
OR6M1	Silent	p.L84L	G	G	rs147909339	11	Filtered Calls	11	123676808	123676808	69	0.405797101449275	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6M1&recr=Open">Click here</a>	
OR6T1	Silent	p.P159P	G	G		11	Filtered Calls	11	123814069	123814069	31	0.32258064516129	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6T1&recr=Open">Click here</a>	
OR6T1	Silent	p.S148S	G	G		11	Filtered Calls	11	123814102	123814102	27	0.296296296296296	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6T1&recr=Open">Click here</a>	
OR6X1	Silent	p.L113L	G	G		11	Filtered Calls	11	123624888	123624888	32	0.34375	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6X1&recr=Open">Click here</a>	
OR7D2	Silent	p.F62F	C	C		11	Filtered Calls	19	9296643	9296643	65	0.276923076923077	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7D2&recr=Open">Click here</a>	
OR7E24	Silent	p.R287R	G	G		11	Filtered Calls	19	9362580	9362580	61	0.311475409836066	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7E24&recr=Open">Click here</a>	
OR7G2	Silent	p.T98T	C	C	rs377637744	11	Filtered Calls	19	9213689	9213689	69	0.159420289855072	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7G2&recr=Open">Click here</a>	
OR7G3	Silent	p.L66L	G	G		11	Filtered Calls	19	9237431	9237431	65	0.2	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7G3&recr=Open">Click here</a>	
OR8D2	Silent	p.V83V	C	C		11	Filtered Calls	11	124189845	124189845	77	0.831168831168831	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8D2&recr=Open">Click here</a>	
OR8G5	Silent	p.I84I	T	T		11	Filtered Calls	11	124134974	124134974	51	0.392156862745098	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8G5&recr=Open">Click here</a>	
OR8H1	Silent	p.L225L	G	G		11	Filtered Calls	11	56057866	56057866	118	0.372881355932203	NA	NA	NA		p.L225M(1)	43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8H1&recr=Open">Click here</a>	
OR8S1	Silent	p.R327R	G	G		11	Filtered Calls	12	48921787	48921787	14	0.214285714285714	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8S1&recr=Open">Click here</a>	
OR9A2	Silent	p.A296A	G	G		11	Filtered Calls	7	142723332	142723332	103	0.728155339805825	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR9A2&recr=Open">Click here</a>	
OR9G4	Silent	p.L42L	G	G		11	Filtered Calls	11	56511164	56511164	76	0.289473684210526	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR9G4&recr=Open">Click here</a>	
OR9I1	Silent	p.S230S	A	A		11	Filtered Calls	11	57886227	57886227	51	0.784313725490196	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR9I1&recr=Open">Click here</a>	
OR9Q1	Silent	p.I222I	C	C	rs139135884	11	Filtered Calls	11	57947582	57947582	114	0.333333333333333	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR9Q1&recr=Open">Click here</a>	
OR9Q2	Silent	p.R302R	G	G		11	Filtered Calls	11	57958868	57958868	41	0.292682926829268	NA	NA	NA		p.R302S(1)	41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR9Q2&recr=Open">Click here</a>	
ORAI1	Silent	p.Y117Y	C	C		11	Filtered Calls	12	122078988	122078988	23	0.608695652173913	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ORAI1&recr=Open">Click here</a>	
ORAI2	Silent	p.R180R	C	C		11	Filtered Calls	7	102087274	102087274	49	0.551020408163265	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ORAI2&recr=Open">Click here</a>	
OSBP	Silent	p.S485S	G	G		11	Filtered Calls	11	59361585	59361585	52	0.865384615384615	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBP&recr=Open">Click here</a>	
OSBPL1A	IGR		G	G		11	Filtered Calls	18	21739685	21739685	56	0.428571428571429	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBPL1A&recr=Open">Click here</a>	
OSBPL3	Intron		G	G		11	Filtered Calls	7	24843930	24843930	195	0.220512820512821	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBPL3&recr=Open">Click here</a>	
OSBPL6	Intron		C	C	rs62176090	11	Filtered Calls	2	179247141	179247141	55	0.454545454545455	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBPL6&recr=Open">Click here</a>	
OSBPL6	Intron		C	C		11	Filtered Calls	2	179247142	179247142	55	0.472727272727273	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBPL6&recr=Open">Click here</a>	
OSMR	Silent	p.I229I	C	C	rs571295169	11	Filtered Calls	5	38884197	38884197	321	0.186915887850467	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSMR&recr=Open">Click here</a>	
OSMR	Silent	p.R317R	G	G		11	Filtered Calls	5	38886252	38886252	201	0.203980099502488	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSMR&recr=Open">Click here</a>	
OTOA	Silent	p.Q589Q	G	G		11	Filtered Calls	16	21730786	21730786	111	0.216216216216216	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOA&recr=Open">Click here</a>	
OTOGL	Silent	p.E1922E	A	A		11	Filtered Calls	12	80750218	80750218	144	0.416666666666667	NA	NA	NA			23	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOGL&recr=Open">Click here</a>	
OTOP2	Silent	p.V523V	G	G		11	Filtered Calls	17	72929520	72929520	66	0.257575757575758	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOP2&recr=Open">Click here</a>	
OTOP3	Silent	p.K523K	G	G		11	Filtered Calls	17	72943519	72943519	36	0.25	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOP3&recr=Open">Click here</a>	
OTUD6A	Silent	p.S197S	C	C		11	Filtered Calls	X	69282965	69282965	25	0.44	NA	NA	NA			23	OTU. {ECO:0000255|PROSITE- ProRule:PRU00139}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTUD6A&recr=Open">Click here</a>	
OTUD7A	Intron		G	G		11	Filtered Calls	15	31851397	31851397	21	0.142857142857143	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTUD7A&recr=Open">Click here</a>	
OTUD7A	Intron		G	G	rs537614284	11	Filtered Calls	15	31851398	31851398	21	0.142857142857143	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTUD7A&recr=Open">Click here</a>	
OVCH1	Silent	p.I746I	G	G		11	Filtered Calls	12	29614829	29614829	192	0.208333333333333	NA	NA	NA		p.I746I(1)	92	Peptidase S1 2. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OVCH1&recr=Open">Click here</a>	
OXSR1	Silent	p.S5S	G	G		11	Filtered Calls	3	38207382	38207382	30	0.433333333333333	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OXSR1&recr=Open">Click here</a>	
P2RX1	Silent	p.H224H	G	G		11	Filtered Calls	17	3806571	3806571	42	0.285714285714286	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P2RX1&recr=Open">Click here</a>	
P2RX5-TAX1BP3	Silent	p.L415L	G	G		11	Filtered Calls	17	3582898	3582898	30	0.166666666666667	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P2RX5-TAX1BP3&recr=Open">Click here</a>	
P2RX5-TAX1BP3	Intron		A	A		11	Filtered Calls	17	3593455	3593455	53	0.716981132075472	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P2RX5-TAX1BP3&recr=Open">Click here</a>	
P2RX6	Intron		G	G		11	Filtered Calls	22	21377708	21377708	56	0.25	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P2RX6&recr=Open">Click here</a>	
P2RX6	Intron		G	G		11	Filtered Calls	22	21377709	21377709	56	0.25	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P2RX6&recr=Open">Click here</a>	
P2RY12	Silent	p.I197I	A	A		11	Filtered Calls	3	151056043	151056043	205	0.0292682926829268	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P2RY12&recr=Open">Click here</a>	
P2RY2	3'UTR		G	G		11	Filtered Calls	11	72946339	72946339	51	0.392156862745098	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P2RY2&recr=Open">Click here</a>	
P2RY8	5'UTR		G	G		11	Filtered Calls	X	1585460	1585460	13	0.230769230769231	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P2RY8&recr=Open">Click here</a>	
PACS1	Silent	p.I159I	C	C		11	Filtered Calls	11	65977865	65977865	79	0.873417721518987	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PACS1&recr=Open">Click here</a>	
PACS1	Intron		C	C		11	Filtered Calls	11	66001247	66001247	45	0.866666666666667	NA	NA	NA		p.?(1)	37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PACS1&recr=Open">Click here</a>	
PADI3	Silent	p.E614E	G	G		11	Filtered Calls	1	17609421	17609421	18	0.5	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PADI3&recr=Open">Click here</a>	
PADI4	Silent	p.S370S	T	T		11	Filtered Calls	1	17674498	17674498	51	0.411764705882353	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PADI4&recr=Open">Click here</a>	
PADI6	RNA		C	C		11	Filtered Calls	1	17698794	17698794	138	0.86231884057971	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PADI6&recr=Open">Click here</a>	
PADI6	RNA		G	G		11	Filtered Calls	1	17727764	17727764	46	0.565217391304348	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PADI6&recr=Open">Click here</a>	
PAIP1	Intron		G	G		11	Filtered Calls	5	43548021	43548021	105	0.152380952380952	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAIP1&recr=Open">Click here</a>	
PAK7	Silent	p.V624V	C	C		11	Filtered Calls	20	9523365	9523365	71	0.338028169014085	NA	NA	NA			81	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAK7&recr=Open">Click here</a>	
PALB2	Silent	p.S572S	G	G		11	Filtered Calls	16	23641759	23641759	101	0.277227722772277	NA	NA	NA			55	DNA-binding (with the preference D loop > dsDNA > ssDNA).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PALB2&recr=Open">Click here</a>	
PALLD	Silent	p.A534A	C	C		11	Filtered Calls	4	169630279	169630279	85	0.247058823529412	NA	NA	NA			48	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PALLD&recr=Open">Click here</a>	
PALM2-AKAP2	Intron		G	G		11	Filtered Calls	9	112705607	112705607	86	0.209302325581395	NA	NA	NA		p.E348K(1)	44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PALM2-AKAP2&recr=Open">Click here</a>	
PAN2	Silent	p.I278I	G	G		11	Filtered Calls	12	56721233	56721233	59	0.440677966101695	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAN2&recr=Open">Click here</a>	
PAOX	Silent	p.I284I	C	C		11	Filtered Calls	10	135195147	135195147	84	0.154761904761905	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAOX&recr=Open">Click here</a>	
PAPLN	Silent	p.F1115F	C	C	rs376299144	11	Filtered Calls	14	73733290	73733290	33	0.787878787878788	NA	NA	NA			42	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPLN&recr=Open">Click here</a>	
PAPOLB	Silent	p.I227I	G	G	rs376442403	11	Filtered Calls	7	4900758	4900758	196	0.255102040816327	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPOLB&recr=Open">Click here</a>	
PAPPA2	Silent	p.F428F	C	C		11	Filtered Calls	1	176564024	176564024	110	0.263636363636364	NA	NA	NA			226			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA2&recr=Open">Click here</a>	
PAPPA2	Silent	p.P1040P	C	C		11	Filtered Calls	1	176668609	176668609	87	0.206896551724138	NA	NA	NA			226			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA2&recr=Open">Click here</a>	
PAPPA2	Silent	p.G1755G	G	G		11	Filtered Calls	1	176809371	176809371	137	0.408759124087591	NA	NA	NA			226			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA2&recr=Open">Click here</a>	
PAPSS1	Silent	p.G273G	A	A		11	Filtered Calls	4	108578128	108578128	252	0.0357142857142857	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPSS1&recr=Open">Click here</a>	
PARD3B	Silent	p.A1102A	C	C		11	Filtered Calls	2	206480432	206480432	69	0.347826086956522	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PARD3B&recr=Open">Click here</a>	
PARN	Silent	p.S484S	G	G		11	Filtered Calls	16	14645906	14645906	310	0.267741935483871	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PARN&recr=Open">Click here</a>	
PARP16	Intron		G	G		11	Filtered Calls	15	65559061	65559061	45	0.222222222222222	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PARP16&recr=Open">Click here</a>	
PARP4	Silent	p.T698T	G	G	rs202099337	11	Filtered Calls	13	25043201	25043201	134	0.276119402985075	NA	NA	NA			63	VIT. {ECO:0000255|PROSITE- ProRule:PRU00801}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PARP4&recr=Open">Click here</a>	
PARP4	Silent	p.P441P	A	A		11	Filtered Calls	13	25060335	25060335	222	0.31981981981982	NA	NA	NA			63	PARP catalytic. {ECO:0000255|PROSITE- ProRule:PRU00397}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PARP4&recr=Open">Click here</a>	
PARVG	3'UTR		C	C	rs200144612	11	Filtered Calls	22	44602313	44602313	24	0.208333333333333	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PARVG&recr=Open">Click here</a>	
PASK	Silent	p.I1141I	G	G	rs200314136	11	Filtered Calls	2	242051786	242051786	82	0.268292682926829	NA	NA	NA			53	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PASK&recr=Open">Click here</a>	
PATL1	Intron		G	G		11	Filtered Calls	11	59420303	59420303	49	0.510204081632653	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PATL1&recr=Open">Click here</a>	
PATZ1	Intron		A	A		11	Filtered Calls	22	31737674	31737674	78	0.192307692307692	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PATZ1&recr=Open">Click here</a>	
PAX8	Silent	p.S322S	G	G		11	Filtered Calls	2	113993092	113993092	32	0.1875	NA	NA	NA			20	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAX8&recr=Open">Click here</a>	
PBX1	Silent	p.S187S	C	C		11	Filtered Calls	1	164768986	164768986	92	0.108695652173913	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PBX1&recr=Open">Click here</a>	
PBX1	Intron		C	C		11	Filtered Calls	1	164776769	164776769	228	0.745614035087719	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PBX1&recr=Open">Click here</a>	
PBX1	Intron		T	T		11	Filtered Calls	1	164789399	164789399	140	0.228571428571429	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PBX1&recr=Open">Click here</a>	
PCDH10	Silent	p.F147F	C	C		11	Filtered Calls	4	134071736	134071736	46	0.347826086956522	NA	NA	NA			136	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH10&recr=Open">Click here</a>	
PCDH12	Silent	p.V535V	C	C		11	Filtered Calls	5	141335812	141335812	62	0.435483870967742	NA	NA	NA			38	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH12&recr=Open">Click here</a>	
PCDH15	Silent	p.E1633E	C	C		11	Filtered Calls	10	55568911	55568911	102	0.274509803921569	NA	NA	NA			237			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	
PCDH15	Silent	p.S1699S	G	G		11	Filtered Calls	10	55582395	55582395	163	0.214723926380368	NA	NA	NA			237			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	
PCDH15	Silent	p.L1253L	C	C		11	Filtered Calls	10	55617003	55617003	270	0.42962962962963	NA	NA	NA		p.L1251L(2)|p.L1246L(2)	237	Cadherin 11. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	
PCDH15	Silent	p.D750D	G	G		11	Filtered Calls	10	55782949	55782949	136	0.227941176470588	NA	NA	NA			237	Cadherin 7. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	
PCDH15	Silent	p.V667V	A	A		11	Filtered Calls	10	55849761	55849761	232	0.202586206896552	NA	NA	NA			237	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	
PCDH15	Intron		G	G		11	Filtered Calls	10	55943363	55943363	201	0.203980099502488	NA	NA	NA		p.?(4)	237			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	
PCDH15	Silent	p.L470L	G	G		11	Filtered Calls	10	55944945	55944945	293	0.433447098976109	NA	NA	NA			237	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	
PCDH15	Silent	p.Q359Q	C	C		11	Filtered Calls	10	55973717	55973717	154	0.188311688311688	NA	NA	NA			237	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	
PCDH17	Silent	p.R379R	G	G		11	Filtered Calls	13	58207817	58207817	20	0.3	NA	NA	NA			120	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH17&recr=Open">Click here</a>	
PCDH18	Silent	p.S485S	G	G		11	Filtered Calls	4	138451128	138451128	143	0.272727272727273	NA	NA	NA			86	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH18&recr=Open">Click here</a>	
PCDH18	Silent	p.I456I	G	G		11	Filtered Calls	4	138451215	138451215	191	0.324607329842932	NA	NA	NA			86	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH18&recr=Open">Click here</a>	
PCDH18	Silent	p.G221G	C	C		11	Filtered Calls	4	138451920	138451920	182	0.335164835164835	NA	NA	NA			86	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH18&recr=Open">Click here</a>	
PCDH18	Intron		C	C		11	Filtered Calls	4	138453002	138453002	208	0.269230769230769	NA	NA	NA		p.E81*(1)	86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH18&recr=Open">Click here</a>	
PCDH18	Intron		G	G	rs553566034	11	Filtered Calls	4	138453244	138453244	106	0.283018867924528	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH18&recr=Open">Click here</a>	
PCDH7	Silent	p.S851S	C	C	rs369895898	11	Filtered Calls	4	30725597	30725597	59	0.372881355932203	NA	NA	NA			55	Cadherin 7. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH7&recr=Open">Click here</a>	
PCDH8	Silent	p.G86G	C	C		11	Filtered Calls	13	53422314	53422314	28	0.25	NA	NA	NA			36	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH8&recr=Open">Click here</a>	
PCDH9	3'UTR		T	T		11	Filtered Calls	13	66878782	66878782	107	0.252336448598131	NA	NA	NA			103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH9&recr=Open">Click here</a>	
PCDH9	3'UTR		T	T		11	Filtered Calls	13	66878783	66878783	107	0.252336448598131	NA	NA	NA			103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH9&recr=Open">Click here</a>	
PCDHA10	Silent	p.F43F	C	C	rs200004763	11	Filtered Calls	5	140235762	140235762	60	0.85	NA	NA	NA			79	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA10&recr=Open">Click here</a>	
PCDHA10	Silent	p.F454F	C	C		11	Filtered Calls	5	140236995	140236995	45	0.511111111111111	NA	NA	NA			79	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA10&recr=Open">Click here</a>	
PCDHA12	Silent	p.V448V	G	G		11	Filtered Calls	5	140256401	140256401	56	0.428571428571429	NA	NA	NA			78	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA12&recr=Open">Click here</a>	
PCDHA13	Silent	p.V585V	G	G		11	Filtered Calls	5	140263608	140263608	60	0.333333333333333	NA	NA	NA			95	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA13&recr=Open">Click here</a>	
PCDHA13	Intron		C	C		11	Filtered Calls	5	140307184	140307184	38	0.342105263157895	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA13&recr=Open">Click here</a>	
PCDHA13	Intron		C	C	rs137957181	11	Filtered Calls	5	140308012	140308012	85	0.352941176470588	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA13&recr=Open">Click here</a>	
PCDHA13	Intron		C	C		11	Filtered Calls	5	140308316	140308316	73	0.287671232876712	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA13&recr=Open">Click here</a>	
PCDHA13	Intron		C	C		11	Filtered Calls	5	140348247	140348247	41	0.560975609756098	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA13&recr=Open">Click here</a>	
PCDHA2	Intron		G	G		11	Filtered Calls	5	140182360	140182360	67	0.552238805970149	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA2&recr=Open">Click here</a>	
PCDHA2	Intron		C	C		11	Filtered Calls	5	140182444	140182444	80	0.45	NA	NA	NA		p.F554F(2)	71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA2&recr=Open">Click here</a>	
PCDHA2	IGR		C	C		11	Filtered Calls	5	140186812	140186812	96	0.375	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA2&recr=Open">Click here</a>	
PCDHA2	IGR		G	G		11	Filtered Calls	5	140187331	140187331	63	0.587301587301587	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA2&recr=Open">Click here</a>	
PCDHA4	Silent	p.S505S	G	G		11	Filtered Calls	5	140188287	140188287	42	0.404761904761905	NA	NA	NA			78	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA4&recr=Open">Click here</a>	
PCDHA4	Silent	p.Q534Q	G	G		11	Filtered Calls	5	140188374	140188374	52	0.346153846153846	NA	NA	NA			78	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA4&recr=Open">Click here</a>	
PCDHA6	Silent	p.E6E	G	G	rs17844300	11	Filtered Calls	5	140207694	140207694	119	0.277310924369748	NA	NA	NA			89			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA6&recr=Open">Click here</a>	
PCDHA7	Silent	p.F463F	C	C	rs141459004	11	Filtered Calls	5	140215357	140215357	36	0.5	NA	NA	NA			63	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA7&recr=Open">Click here</a>	
PCDHA7	Silent	p.A482A	G	G		11	Filtered Calls	5	140215414	140215414	35	0.628571428571429	NA	NA	NA			63	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA7&recr=Open">Click here</a>	
PCDHA7	Silent	p.I620I	C	C		11	Filtered Calls	5	140215828	140215828	42	0.380952380952381	NA	NA	NA			63	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA7&recr=Open">Click here</a>	
PCDHA7	Silent	p.F622F	C	C		11	Filtered Calls	5	140215834	140215834	42	0.404761904761905	NA	NA	NA			63	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA7&recr=Open">Click here</a>	
PCDHA8	Silent	p.V303V	G	G		11	Filtered Calls	5	140221815	140221815	66	0.393939393939394	NA	NA	NA			78	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA8&recr=Open">Click here</a>	
PCDHB1	Silent	p.L334L	C	C		11	Filtered Calls	5	140432055	140432055	67	0.402985074626866	NA	NA	NA			53	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB1&recr=Open">Click here</a>	
PCDHB10	5'Flank		C	C		11	Filtered Calls	5	140569214	140569214	87	0.471264367816092	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB10&recr=Open">Click here</a>	
PCDHB13	Silent	p.I421I	C	C		11	Filtered Calls	5	140594958	140594958	37	0.486486486486487	NA	NA	NA			66	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB13&recr=Open">Click here</a>	
PCDHB15	Silent	p.D91D	C	C		11	Filtered Calls	5	140625419	140625419	78	0.0769230769230769	NA	NA	NA			61	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB15&recr=Open">Click here</a>	
PCDHB16	Silent	p.F701F	C	C		11	Filtered Calls	5	140564237	140564237	74	0.337837837837838	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB16&recr=Open">Click here</a>	
PCDHB4	Silent	p.F765F	C	C		11	Filtered Calls	5	140503875	140503875	111	0.432432432432432	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB4&recr=Open">Click here</a>	
PCDHGA11	Silent	p.S702S	C	C		11	Filtered Calls	5	140802900	140802900	43	0.209302325581395	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA11&recr=Open">Click here</a>	
PCDHGA2	Silent	p.L103L	C	C		11	Filtered Calls	5	140718845	140718845	60	0.566666666666667	NA	NA	NA			77	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA2&recr=Open">Click here</a>	
PCDHGA2	Silent	p.T336T	G	G		11	Filtered Calls	5	140719546	140719546	134	0.425373134328358	NA	NA	NA			77	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA2&recr=Open">Click here</a>	
PCDHGA2	Silent	p.P579P	C	C	rs200779662	11	Filtered Calls	5	140720275	140720275	62	0.370967741935484	NA	NA	NA			77	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA2&recr=Open">Click here</a>	
PCDHGA3	Silent	p.I142I	T	T	rs374905915	11	Filtered Calls	5	140724026	140724026	35	0.342857142857143	NA	NA	NA			1	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA3&recr=Open">Click here</a>	
PCDHGA3	Silent	p.F242F	T	T		11	Filtered Calls	5	140724326	140724326	44	0.431818181818182	NA	NA	NA			1	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA3&recr=Open">Click here</a>	
PCDHGA4	Silent	p.L432L	C	C		11	Filtered Calls	5	140736061	140736061	34	0.264705882352941	NA	NA	NA			5	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA4&recr=Open">Click here</a>	
PCDHGA6	Silent	p.I31I	C	C		11	Filtered Calls	5	140753743	140753743	10	0.6	NA	NA	NA			2	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA6&recr=Open">Click here</a>	
PCDHGA6	Silent	p.F707F	C	C	rs185484474	11	Filtered Calls	5	140755771	140755771	45	0.466666666666667	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA6&recr=Open">Click here</a>	
PCDHGA6	Silent	p.S754S	C	C		11	Filtered Calls	5	140755912	140755912	43	0.232558139534884	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA6&recr=Open">Click here</a>	
PCDHGA8	Silent	p.F44F	C	C		11	Filtered Calls	5	140772512	140772512	38	0.5	NA	NA	NA			51	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA8&recr=Open">Click here</a>	
PCDHGA8	Silent	p.F551F	C	C		11	Filtered Calls	5	140774033	140774033	88	0.465909090909091	NA	NA	NA			51	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA8&recr=Open">Click here</a>	
PCDHGB3	Intron		C	C		11	Filtered Calls	5	140778104	140778104	51	0.411764705882353	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGB3&recr=Open">Click here</a>	
PCDHGC3	Silent	p.S657S	C	C		11	Filtered Calls	5	140857654	140857654	133	0.383458646616541	NA	NA	NA			29	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGC3&recr=Open">Click here</a>	
PCDP1	Silent	p.A507A	G	G		11	Filtered Calls	2	120385233	120385233	228	0.31140350877193	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDP1&recr=Open">Click here</a>	
PCDP1	Intron		C	C		11	Filtered Calls	2	120388140	120388140	59	0.288135593220339	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDP1&recr=Open">Click here</a>	
PCK1	Silent	p.P214P	G	G	rs138176491	11	Filtered Calls	20	56138115	56138115	44	0.295454545454545	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCK1&recr=Open">Click here</a>	
PCLO	Silent	p.L4782L	G	G		11	Filtered Calls	7	82455974	82455974	80	0.45	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	
PCLO	Silent	p.K4192K	C	C		11	Filtered Calls	7	82544726	82544726	49	0.408163265306122	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	
PCLO	Silent	p.V4108V	C	C		11	Filtered Calls	7	82544978	82544978	32	0.125	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	
PCLO	Silent	p.V3088V	A	A		11	Filtered Calls	7	82580640	82580640	16	0.25	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	
PCLO	Silent	p.R2837R	C	C		11	Filtered Calls	7	82581758	82581758	25	0.88	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	
PCLO	Silent	p.S2556S	G	G		11	Filtered Calls	7	82582601	82582601	52	0.346153846153846	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	
PCLO	Silent	p.V1171V	G	G		11	Filtered Calls	7	82595591	82595591	72	0.0555555555555556	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	
PCLO	Silent	p.Q393Q	C	C		11	Filtered Calls	7	82784778	82784778	41	0.609756097560976	NA	NA	NA			259			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	
PCM1	Intron		C	C		11	Filtered Calls	8	17819534	17819534	72	0.180555555555556	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCM1&recr=Open">Click here</a>	
PCMTD1	Silent	p.A32A	G	G		11	Filtered Calls	8	52773616	52773616	135	0.222222222222222	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCMTD1&recr=Open">Click here</a>	
PCNT	Silent	p.S472S	C	C		11	Filtered Calls	21	47771414	47771414	90	0.311111111111111	NA	NA	NA			104	Glu-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCNT&recr=Open">Click here</a>	
PCNT	Silent	p.S1142S	C	C		11	Filtered Calls	21	47805860	47805860	87	0.310344827586207	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCNT&recr=Open">Click here</a>	
PCNT	Silent	p.F2314F	T	T		11	Filtered Calls	21	47838138	47838138	96	0.260416666666667	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCNT&recr=Open">Click here</a>	
PCNT	Silent	p.S2486S	C	C		11	Filtered Calls	21	47847673	47847673	31	0.709677419354839	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCNT&recr=Open">Click here</a>	
PCNT	Silent	p.L2487L	C	C	rs201185279	11	Filtered Calls	21	47847674	47847674	31	0.709677419354839	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCNT&recr=Open">Click here</a>	
PCNXL2	Intron		G	G		11	Filtered Calls	1	233296184	233296184	63	0.349206349206349	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCNXL2&recr=Open">Click here</a>	
PCNXL3	Intron		C	C	rs147000329	11	Filtered Calls	11	65387908	65387908	26	0.615384615384615	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCNXL3&recr=Open">Click here</a>	
PCNXL4	Silent	p.L651L	C	C		11	Filtered Calls	14	60587922	60587922	185	0.875675675675676	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCNXL4&recr=Open">Click here</a>	
PCNXL4	Silent	p.S806S	C	C		11	Filtered Calls	14	60591307	60591307	267	0.831460674157303	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCNXL4&recr=Open">Click here</a>	
PCOLCE	Silent	p.V396V	C	C	rs140161433	11	Filtered Calls	7	100205564	100205564	105	0.39047619047619	NA	NA	NA			23	NTR. {ECO:0000255|PROSITE- ProRule:PRU00295}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCOLCE&recr=Open">Click here</a>	
PCSK1	Silent	p.V620V	C	C		11	Filtered Calls	5	95730592	95730592	127	0.377952755905512	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK1&recr=Open">Click here</a>	
PCSK1	Intron		G	G		11	Filtered Calls	5	95761641	95761641	41	0.463414634146341	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK1&recr=Open">Click here</a>	
PCSK1	Silent	p.I39I	G	G		11	Filtered Calls	5	95768630	95768630	76	0.315789473684211	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK1&recr=Open">Click here</a>	
PCSK5	Silent	p.P262P	C	C		11	Filtered Calls	9	78686706	78686706	117	0.273504273504274	NA	NA	NA			55	Peptidase S8.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	
PCSK5	Intron		C	C		11	Filtered Calls	9	78722163	78722163	27	0.555555555555556	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	
PCSK5	Silent	p.K683K	G	G		11	Filtered Calls	9	78796359	78796359	57	0.192982456140351	NA	NA	NA			55	CRM (Cys-rich motif).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	
PCSK5	Silent	p.R687R	G	G		11	Filtered Calls	9	78796371	78796371	62	0.225806451612903	NA	NA	NA			55	CRM (Cys-rich motif).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	
PCSK5	Silent	p.Q1167Q	G	G		11	Filtered Calls	9	78911759	78911759	58	0.293103448275862	NA	NA	NA			55	CRM (Cys-rich motif).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	
PCSK5	Intron		G	G		11	Filtered Calls	9	78943158	78943158	37	0.324324324324324	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	
PCSK5	Silent	p.A1691A	C	C		11	Filtered Calls	9	78969035	78969035	13	0.538461538461538	NA	NA	NA			55	CRM (Cys-rich motif).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	
PCSK6	5'UTR		C	C		11	Filtered Calls	15	101845512	101845512	19	0.263157894736842	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK6&recr=Open">Click here</a>	
PCSK6	5'UTR		C	C	rs45492198	11	Filtered Calls	15	101862731	101862731	54	0.296296296296296	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK6&recr=Open">Click here</a>	
PCSK9	Silent	p.L123L	C	C		11	Filtered Calls	1	55509675	55509675	45	0.288888888888889	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK9&recr=Open">Click here</a>	
PDCD11	Silent	p.F406F	C	C		11	Filtered Calls	10	105173755	105173755	170	0.270588235294118	NA	NA	NA			64	S1 motif 4. {ECO:0000255|PROSITE- ProRule:PRU00180}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDCD11&recr=Open">Click here</a>	
PDCD11	Silent	p.I579I	C	C		11	Filtered Calls	10	105176466	105176466	161	0.397515527950311	NA	NA	NA			64	S1 motif 6. {ECO:0000255|PROSITE- ProRule:PRU00180}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDCD11&recr=Open">Click here</a>	
PDCD11	Intron		C	C		11	Filtered Calls	10	105178189	105178189	113	0.176991150442478	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDCD11&recr=Open">Click here</a>	
PDE10A	Intron		G	G		11	Filtered Calls	6	165752855	165752855	146	0.363013698630137	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE10A&recr=Open">Click here</a>	
PDE10A	Silent	p.F300F	G	G		11	Filtered Calls	6	165832221	165832221	143	0.482517482517482	NA	NA	NA			71	GAF 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE10A&recr=Open">Click here</a>	
PDE11A	Silent	p.R861R	C	C		11	Filtered Calls	2	178528657	178528657	195	0.256410256410256	NA	NA	NA			58	Catalytic. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE11A&recr=Open">Click here</a>	
PDE1C	Silent	p.S528S	C	C	rs140362011	11	Filtered Calls	7	31864483	31864483	124	0.266129032258065	NA	NA	NA		p.S468S(3)	81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE1C&recr=Open">Click here</a>	
PDE3A	Silent	p.E743E	G	G		11	Filtered Calls	12	20792869	20792869	246	0.170731707317073	NA	NA	NA			58	Catalytic. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE3A&recr=Open">Click here</a>	
PDE3B	Intron		C	C		11	Filtered Calls	11	14808086	14808086	199	0.447236180904523	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE3B&recr=Open">Click here</a>	
PDE6B	Silent	p.K579K	G	G		11	Filtered Calls	4	656312	656312	23	0.521739130434783	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE6B&recr=Open">Click here</a>	
PDE6C	Intron		C	C	rs561489310	11	Filtered Calls	10	95395246	95395246	108	0.231481481481481	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE6C&recr=Open">Click here</a>	
PDE6G	Silent	p.A82A	G	G		11	Filtered Calls	17	79618122	79618122	90	0.0777777777777778	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE6G&recr=Open">Click here</a>	
PDE6H	Intron		T	T		11	Filtered Calls	12	15132105	15132105	112	0.214285714285714	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE6H&recr=Open">Click here</a>	
PDE8B	Silent	p.S440S	C	C		11	Filtered Calls	5	76703237	76703237	43	0.418604651162791	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE8B&recr=Open">Click here</a>	
PDGFA	Silent	p.R159R	C	C		11	Filtered Calls	7	540856	540856	145	0.227586206896552	NA	NA	NA			16	Receptor binding site. {ECO:0000255}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFA&recr=Open">Click here</a>	
PDGFD	Silent	p.F173F	G	G		11	Filtered Calls	11	103818444	103818444	81	0.358024691358025	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFD&recr=Open">Click here</a>	
PDGFRB	Silent	p.V261V	C	C	rs142649064	11	Filtered Calls	5	149513300	149513300	71	0.394366197183099	NA	NA	NA			75	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFRB&recr=Open">Click here</a>	
PDGFRL	Intron		G	G		11	Filtered Calls	8	17500187	17500187	142	0.204225352112676	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFRL&recr=Open">Click here</a>	
PDGFRL	IGR		G	G		11	Filtered Calls	8	17503462	17503462	35	0.142857142857143	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFRL&recr=Open">Click here</a>	
PDIA4	Silent	p.D593D	G	G		11	Filtered Calls	7	148701045	148701045	21	0.571428571428571	NA	NA	NA			24	Thioredoxin 3. {ECO:0000255|PROSITE- ProRule:PRU00691}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDIA4&recr=Open">Click here</a>	
PDIA5	Silent	p.P390P	C	C		11	Filtered Calls	3	122869108	122869108	49	0.346938775510204	NA	NA	NA			21	Thioredoxin 3. {ECO:0000255|PROSITE- ProRule:PRU00691}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDIA5&recr=Open">Click here</a>	
PDILT	Silent	p.I307I	G	G		11	Filtered Calls	16	20381009	20381009	55	0.272727272727273	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDILT&recr=Open">Click here</a>	
PDK3	Silent	p.V234V	G	G		11	Filtered Calls	X	24544343	24544343	232	0.418103448275862	NA	NA	NA			23	Histidine kinase. {ECO:0000255|PROSITE- ProRule:PRU00107}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDK3&recr=Open">Click here</a>	
PDK3	Silent	p.V292V	C	C		11	Filtered Calls	X	24546216	24546216	74	0.337837837837838	NA	NA	NA			23	Histidine kinase. {ECO:0000255|PROSITE- ProRule:PRU00107}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDK3&recr=Open">Click here</a>	
PDLIM1	Silent	p.I222I	G	G		11	Filtered Calls	10	97006991	97006991	226	0.243362831858407	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDLIM1&recr=Open">Click here</a>	
PDLIM7	Silent	p.A84A	G	G		11	Filtered Calls	5	176919433	176919433	22	0.545454545454545	NA	NA	NA			10	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDLIM7&recr=Open">Click here</a>	
PDZD11	Silent	p.F102F	G	G		11	Filtered Calls	X	69507603	69507603	162	0.45679012345679	NA	NA	NA			9	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZD11&recr=Open">Click here</a>	
PDZD2	Silent	p.T2455T	G	G		11	Filtered Calls	5	32090919	32090919	94	0.159574468085106	NA	NA	NA			148			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZD2&recr=Open">Click here</a>	
PDZD3	Silent	p.R178R	G	G		11	Filtered Calls	11	119058325	119058325	6	0.833333333333333	NA	NA	NA			14	PDZ 1. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZD3&recr=Open">Click here</a>	
PDZD7	Silent	p.R482R	C	C		11	Filtered Calls	10	102777932	102777932	123	0.471544715447154	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZD7&recr=Open">Click here</a>	
PDZK1IP1	Silent	p.E58E	C	C		11	Filtered Calls	1	47652993	47652993	19	0.473684210526316	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZK1IP1&recr=Open">Click here</a>	
PDZRN3	Silent	p.P506P	C	C	rs200099704	11	Filtered Calls	3	73433350	73433350	49	0.285714285714286	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZRN3&recr=Open">Click here</a>	
PDZRN3	Silent	p.I355I	G	G	rs374714693	11	Filtered Calls	3	73433803	73433803	108	0.222222222222222	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZRN3&recr=Open">Click here</a>	
PDZRN3	Silent	p.F342F	G	G	rs573137126	11	Filtered Calls	3	73433842	73433842	101	0.267326732673267	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZRN3&recr=Open">Click here</a>	
PEA15	Intron		C	C		11	Filtered Calls	1	160183205	160183205	100	0.1	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEA15&recr=Open">Click here</a>	
PEA15	Intron		C	C		11	Filtered Calls	1	160183209	160183209	104	0.115384615384615	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEA15&recr=Open">Click here</a>	
PEAK1	Silent	p.I1570I	G	G		11	Filtered Calls	15	77407029	77407029	182	0.258241758241758	NA	NA	NA			NA	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEAK1&recr=Open">Click here</a>	
PEAK1	Silent	p.Y1510Y	G	G		11	Filtered Calls	15	77407209	77407209	60	0.333333333333333	NA	NA	NA			NA	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEAK1&recr=Open">Click here</a>	
PEAR1	Intron		C	C		11	Filtered Calls	1	156879910	156879910	96	0.166666666666667	NA	NA	NA		p.?(1)	43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEAR1&recr=Open">Click here</a>	
PEAR1	Silent	p.L998L	C	C		11	Filtered Calls	1	156884468	156884468	90	0.322222222222222	NA	NA	NA			43	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEAR1&recr=Open">Click here</a>	
PEG3	Intron		G	G		11	Filtered Calls	19	57335054	57335054	60	0.3	NA	NA	NA			170			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEG3&recr=Open">Click here</a>	
PEG3	Silent	p.L117L	G	G	rs527606019	11	Filtered Calls	19	57335673	57335673	64	0.125	NA	NA	NA			170	SCAN box. {ECO:0000255|PROSITE- ProRule:PRU00187}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEG3&recr=Open">Click here</a>	
PELI3	Intron		C	C		11	Filtered Calls	11	66235761	66235761	41	0.341463414634146	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PELI3&recr=Open">Click here</a>	
PEPD	Silent	p.T266T	C	C		11	Filtered Calls	19	33902598	33902598	23	0.217391304347826	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEPD&recr=Open">Click here</a>	
PER2	Silent	p.S540S	G	G		11	Filtered Calls	2	239168617	239168617	62	0.274193548387097	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PER2&recr=Open">Click here</a>	
PER3	Intron		C	C		11	Filtered Calls	1	7869946	7869946	34	1	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PER3&recr=Open">Click here</a>	
PEX26	Silent	p.L85L	C	C	rs61752133	11	Filtered Calls	22	18562662	18562662	257	0.424124513618677	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEX26&recr=Open">Click here</a>	
PEX5L	Silent	p.G340G	C	C		11	Filtered Calls	3	179533712	179533712	118	0.279661016949153	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEX5L&recr=Open">Click here</a>	
PFN2	Intron		C	C		11	Filtered Calls	3	149700345	149700345	439	0.309794988610478	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PFN2&recr=Open">Click here</a>	
PFN3	Silent	p.K123K	C	C		11	Filtered Calls	5	176827209	176827209	36	0.305555555555556	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PFN3&recr=Open">Click here</a>	
PGAP1	Silent	p.I725I	G	G		11	Filtered Calls	2	197710717	197710717	247	0.307692307692308	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGAP1&recr=Open">Click here</a>	
PGAP1	Intron		G	G		11	Filtered Calls	2	197791245	197791245	483	0.608695652173913	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGAP1&recr=Open">Click here</a>	
PGAP2	Intron		T	T		11	Filtered Calls	11	3838668	3838668	58	0.896551724137931	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGAP2&recr=Open">Click here</a>	
PGBD2	Silent	p.F156F	C	C		11	Filtered Calls	1	249211251	249211251	374	0.382352941176471	NA	NA	NA		p.F156F(1)	14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGBD2&recr=Open">Click here</a>	
PGC	Silent	p.F367F	G	G		11	Filtered Calls	6	41704656	41704656	66	0.303030303030303	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGC&recr=Open">Click here</a>	
PGC	Intron		C	C		11	Filtered Calls	6	41711004	41711004	76	0.131578947368421	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGC&recr=Open">Click here</a>	
PGK2	Silent	p.I407I	G	G		11	Filtered Calls	6	49753680	49753680	76	0.631578947368421	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGK2&recr=Open">Click here</a>	
PGK2	Silent	p.R39R	C	C	rs372733132	11	Filtered Calls	6	49754784	49754784	207	0.256038647342995	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGK2&recr=Open">Click here</a>	
PGLS	Intron		C	C		11	Filtered Calls	19	17628086	17628086	190	0.136842105263158	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGLS&recr=Open">Click here</a>	
PGLYRP2	Intron		C	C	rs569124526	11	Filtered Calls	19	15586343	15586343	82	0.268292682926829	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGLYRP2&recr=Open">Click here</a>	
PGLYRP2	Silent	p.E150E	C	C		11	Filtered Calls	19	15587031	15587031	30	0.266666666666667	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGLYRP2&recr=Open">Click here</a>	
PGLYRP3	Intron		G	G		11	Filtered Calls	1	153276497	153276497	37	0.135135135135135	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGLYRP3&recr=Open">Click here</a>	
PGR	Silent	p.T839T	G	G		11	Filtered Calls	11	100912805	100912805	90	0.455555555555556	NA	NA	NA			36	Steroid-binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGR&recr=Open">Click here</a>	
PGR	Silent	p.G585G	C	C		11	Filtered Calls	11	100996772	100996772	86	0.395348837209302	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGR&recr=Open">Click here</a>	
PHACTR1	Intron		C	C		11	Filtered Calls	6	13185068	13185068	206	0.174757281553398	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHACTR1&recr=Open">Click here</a>	
PHF23	Silent	p.L10L	G	G		11	Filtered Calls	17	7139828	7139828	147	0.36734693877551	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHF23&recr=Open">Click here</a>	
PHF3	Intron		T	T		11	Filtered Calls	6	64404464	64404464	361	0.484764542936288	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHF3&recr=Open">Click here</a>	
PHIP	Intron		G	G		11	Filtered Calls	6	79679897	79679897	118	0.330508474576271	NA	NA	NA			68			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHIP&recr=Open">Click here</a>	
PHKA1	Silent	p.P247P	G	G		11	Filtered Calls	X	71886124	71886124	108	0.416666666666667	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHKA1&recr=Open">Click here</a>	
PHKB	Silent	p.F573F	C	C		11	Filtered Calls	16	47683058	47683058	290	0.310344827586207	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHKB&recr=Open">Click here</a>	
PHLDA3	Silent	p.T46T	C	C		11	Filtered Calls	1	201437777	201437777	60	0.2	NA	NA	NA			2	PH.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHLDA3&recr=Open">Click here</a>	
PHLDB1	Intron		C	C		11	Filtered Calls	11	118527383	118527383	42	0.476190476190476	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHLDB1&recr=Open">Click here</a>	
PHOX2B	Silent	p.E183E	C	C		11	Filtered Calls	4	41748220	41748220	29	0.413793103448276	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHOX2B&recr=Open">Click here</a>	
PHOX2B	Silent	p.S59S	G	G		11	Filtered Calls	4	41750451	41750451	16	0.25	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHOX2B&recr=Open">Click here</a>	
PHRF1	Silent	p.S898S	C	C		11	Filtered Calls	11	608153	608153	55	0.8	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHRF1&recr=Open">Click here</a>	
PHYHIP	Silent	p.H305H	G	G		11	Filtered Calls	8	22078944	22078944	107	0.205607476635514	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHYHIP&recr=Open">Click here</a>	
PHYHIPL	Intron		T	T		11	Filtered Calls	10	60998340	60998340	294	0.231292517006803	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHYHIPL&recr=Open">Click here</a>	
PI4KA	Silent	p.I2003I	G	G		11	Filtered Calls	22	21065061	21065061	64	0.28125	NA	NA	NA			79	PI3K/PI4K. {ECO:0000255|PROSITE- ProRule:PRU00269}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PI4KA&recr=Open">Click here</a>	
PIEZO2	Silent	p.L2347L	G	G		11	Filtered Calls	18	10689772	10689772	33	0.515151515151515	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIEZO2&recr=Open">Click here</a>	
PIGR	Intron		G	G		11	Filtered Calls	1	207105793	207105793	224	0.191964285714286	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIGR&recr=Open">Click here</a>	
PIK3AP1	Silent	p.E109E	C	C		11	Filtered Calls	10	98469427	98469427	152	0.177631578947368	NA	NA	NA			52	Necessary and sufficent to mediate inhibition of NF-kappa-B downstream of activated TLRs; may mediate interaction with MYD88 and TIRAP. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3AP1&recr=Open">Click here</a>	
PIK3C2B	Intron		G	G		11	Filtered Calls	1	204410702	204410702	78	0.525641025641026	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3C2B&recr=Open">Click here</a>	
PIK3C2G	Silent	p.F89F	C	C		11	Filtered Calls	12	18435282	18435282	280	0.228571428571429	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3C2G&recr=Open">Click here</a>	
PIK3C2G	Silent	p.T120T	G	G		11	Filtered Calls	12	18435375	18435375	138	0.41304347826087	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3C2G&recr=Open">Click here</a>	
PIK3C2G	Intron		C	C		11	Filtered Calls	12	18691254	18691254	105	0.542857142857143	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3C2G&recr=Open">Click here</a>	
PIK3C2G	Silent	p.K1157K	A	A		11	Filtered Calls	12	18715640	18715640	21	0.142857142857143	NA	NA	NA			66	PI3K/PI4K. {ECO:0000255|PROSITE- ProRule:PRU00269}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3C2G&recr=Open">Click here</a>	
PIK3C3	Intron		T	T		11	Filtered Calls	18	39661078	39661078	84	0.416666666666667	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3C3&recr=Open">Click here</a>	
PIK3R5	Intron		C	C		11	Filtered Calls	17	8784210	8784210	59	0.220338983050847	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3R5&recr=Open">Click here</a>	
PIK3R6	5'UTR		G	G		11	Filtered Calls	17	8707438	8707438	41	0.24390243902439	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3R6&recr=Open">Click here</a>	
PIK3R6	5'UTR		C	C		11	Filtered Calls	17	8738630	8738630	14	0.214285714285714	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3R6&recr=Open">Click here</a>	
PIP4K2A	Silent	p.S126S	G	G		11	Filtered Calls	10	22880672	22880672	201	0.238805970149254	NA	NA	NA			29	PIPK. {ECO:0000255|PROSITE- ProRule:PRU00781}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIP4K2A&recr=Open">Click here</a>	
PIPOX	Intron		C	C		11	Filtered Calls	17	27383188	27383188	38	0.157894736842105	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIPOX&recr=Open">Click here</a>	
PITPNC1	Silent	p.P91P	C	C		11	Filtered Calls	17	65548448	65548448	146	0.308219178082192	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PITPNC1&recr=Open">Click here</a>	
PITPNM3	Silent	p.L161L	C	C		11	Filtered Calls	17	6386941	6386941	29	0.310344827586207	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PITPNM3&recr=Open">Click here</a>	
PKD1L1	Intron		G	G		11	Filtered Calls	7	47857728	47857728	114	0.350877192982456	NA	NA	NA			142			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKD1L1&recr=Open">Click here</a>	
PKD1L2	RNA		G	G		11	Filtered Calls	16	81161490	81161490	41	0.390243902439024	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKD1L2&recr=Open">Click here</a>	
PKD1L2	RNA		G	G		11	Filtered Calls	16	81241186	81241186	164	0.280487804878049	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKD1L2&recr=Open">Click here</a>	
PKD1L2	RNA		A	A		11	Filtered Calls	16	81253754	81253754	102	0.0490196078431373	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKD1L2&recr=Open">Click here</a>	
PKD2L2	Silent	p.S332S	C	C		11	Filtered Calls	5	137243451	137243451	267	0.415730337078652	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKD2L2&recr=Open">Click here</a>	
PKDREJ	Silent	p.Y953Y	G	G		11	Filtered Calls	22	46656361	46656361	343	0.446064139941691	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKDREJ&recr=Open">Click here</a>	
PKHD1	Silent	p.F253F	G	G		11	Filtered Calls	6	51934274	51934274	233	0.248927038626609	NA	NA	NA			304			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1&recr=Open">Click here</a>	
PKHD1L1	Silent	p.F169F	C	C		11	Filtered Calls	8	110397797	110397797	103	0.300970873786408	NA	NA	NA			263	IPT/TIG 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	
PKHD1L1	Silent	p.R187R	G	G		11	Filtered Calls	8	110397851	110397851	84	0.130952380952381	NA	NA	NA			263	IPT/TIG 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	
PKHD1L1	Silent	p.G617G	G	G		11	Filtered Calls	8	110420315	110420315	125	0.2	NA	NA	NA			263			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	
PKHD1L1	Silent	p.T1752T	A	A		11	Filtered Calls	8	110457354	110457354	112	0.0535714285714286	NA	NA	NA			263	IPT/TIG 10.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	
PKHD1L1	Silent	p.L1776L	G	G		11	Filtered Calls	8	110457426	110457426	96	0.291666666666667	NA	NA	NA			263	IPT/TIG 10.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	
PKLR	Silent	p.A394A	G	G		11	Filtered Calls	1	155263129	155263129	62	0.0967741935483871	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKLR&recr=Open">Click here</a>	
PKM	Intron		G	G		11	Filtered Calls	15	72502205	72502205	122	0.30327868852459	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKM&recr=Open">Click here</a>	
PKN1	Silent	p.I736I	C	C		11	Filtered Calls	19	14580618	14580618	157	0.140127388535032	NA	NA	NA			31	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKN1&recr=Open">Click here</a>	
PKN3	Intron		C	C		11	Filtered Calls	9	131469168	131469168	32	0.75	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKN3&recr=Open">Click here</a>	
PKN3	Silent	p.F656F	C	C		11	Filtered Calls	9	131479185	131479185	77	0.701298701298701	NA	NA	NA			24	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKN3&recr=Open">Click here</a>	
PKP2	3'UTR		C	C		11	Filtered Calls	12	32945356	32945356	138	0.239130434782609	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKP2&recr=Open">Click here</a>	
PKP2	Silent	p.E580E	C	C	rs370219248	11	Filtered Calls	12	32975500	32975500	141	0.212765957446809	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKP2&recr=Open">Click here</a>	
PKP2	Intron		C	C		11	Filtered Calls	12	32996229	32996229	57	0.228070175438596	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKP2&recr=Open">Click here</a>	
PKP3	Silent	p.S238S	C	C		11	Filtered Calls	11	397215	397215	17	0.411764705882353	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKP3&recr=Open">Click here</a>	
PKP4	Silent	p.S891S	C	C	rs201008561	11	Filtered Calls	2	159523020	159523020	204	0.259803921568627	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKP4&recr=Open">Click here</a>	
PLA2G4A	Silent	p.N682N	T	T		11	Filtered Calls	1	186948532	186948532	239	0.514644351464435	NA	NA	NA			53	PLA2c. {ECO:0000255|PROSITE- ProRule:PRU00555}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2G4A&recr=Open">Click here</a>	
PLA2G6	Intron		C	C		11	Filtered Calls	22	38522370	38522370	50	0.18	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2G6&recr=Open">Click here</a>	
PLB1	Intron		C	C		11	Filtered Calls	2	28748130	28748130	35	0.285714285714286	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLB1&recr=Open">Click here</a>	
PLB1	Silent	p.L298L	C	C		11	Filtered Calls	2	28766093	28766093	14	0.428571428571429	NA	NA	NA			69	4 X 308-326 AA approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLB1&recr=Open">Click here</a>	
PLB1	Silent	p.T302T	C	C		11	Filtered Calls	2	28766105	28766105	15	0.2	NA	NA	NA			69	4 X 308-326 AA approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLB1&recr=Open">Click here</a>	
PLB1	Intron		C	C	rs577795705	11	Filtered Calls	2	28847915	28847915	133	0.165413533834586	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLB1&recr=Open">Click here</a>	
PLBD2	Silent	p.F452F	C	C	rs139158811	11	Filtered Calls	12	113825561	113825561	209	0.0382775119617225	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLBD2&recr=Open">Click here</a>	
PLCB1	Silent	p.G93G	G	G		11	Filtered Calls	20	8608973	8608973	139	0.266187050359712	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCB1&recr=Open">Click here</a>	
PLCB1	Silent	p.F756F	C	C		11	Filtered Calls	20	8719967	8719967	131	0.129770992366412	NA	NA	NA			95	C2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCB1&recr=Open">Click here</a>	
PLCB2	IGR		C	C		11	Filtered Calls	15	40590845	40590845	31	0.516129032258065	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCB2&recr=Open">Click here</a>	
PLCB2	Silent	p.F115F	G	G		11	Filtered Calls	15	40594697	40594697	64	0.296875	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCB2&recr=Open">Click here</a>	
PLCB4	Intron		G	G	rs369645694	11	Filtered Calls	20	9457409	9457409	88	0.125	NA	NA	NA			87			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCB4&recr=Open">Click here</a>	
PLCD3	5'UTR		C	C		11	Filtered Calls	17	43195492	43195492	32	0.5625	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCD3&recr=Open">Click here</a>	
PLCE1	Silent	p.S1173S	C	C		11	Filtered Calls	10	96014771	96014771	247	0.408906882591093	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCE1&recr=Open">Click here</a>	
PLCE1	Silent	p.L1768L	C	C		11	Filtered Calls	10	96058270	96058270	132	0.21969696969697	NA	NA	NA			8	PI-PLC Y-box. {ECO:0000255|PROSITE- ProRule:PRU00271}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCE1&recr=Open">Click here</a>	
PLCG2	Silent	p.F832F	C	C		11	Filtered Calls	16	81960765	81960765	143	0.300699300699301	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCG2&recr=Open">Click here</a>	
PLCH2	Silent	p.S523S	C	C		11	Filtered Calls	1	2422684	2422684	25	0.4	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCH2&recr=Open">Click here</a>	
PLCL1	Silent	p.F135F	C	C		11	Filtered Calls	2	198948646	198948646	74	0.22972972972973	NA	NA	NA			80	Interaction with PPP1C.|PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCL1&recr=Open">Click here</a>	
PLCL2	Silent	p.L163L	C	C		11	Filtered Calls	3	17051703	17051703	296	0.0472972972972973	NA	NA	NA			43	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCL2&recr=Open">Click here</a>	
PLCXD2	3'UTR		C	C		11	Filtered Calls	3	111432806	111432806	99	0.414141414141414	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCXD2&recr=Open">Click here</a>	
PLCXD3	Silent	p.F141F	G	G		11	Filtered Calls	5	41382317	41382317	251	0.195219123505976	NA	NA	NA			37	PI-PLC X-box. {ECO:0000255|PROSITE- ProRule:PRU00270}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCXD3&recr=Open">Click here</a>	
PLD1	Silent	p.S671S	T	T		11	Filtered Calls	3	171392392	171392392	199	0.0452261306532663	NA	NA	NA			63	Catalytic.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLD1&recr=Open">Click here</a>	
PLD2	Intron		C	C	rs548280693	11	Filtered Calls	17	4717705	4717705	26	0.192307692307692	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLD2&recr=Open">Click here</a>	
PLD3	Silent	p.Y291Y	C	C		11	Filtered Calls	19	40877774	40877774	70	0.157142857142857	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLD3&recr=Open">Click here</a>	
PLEK	Silent	p.F81F	C	C		11	Filtered Calls	2	68607899	68607899	292	0.178082191780822	NA	NA	NA			24	PH 1. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEK&recr=Open">Click here</a>	
PLEKHA8P1	RNA		G	G		11	Filtered Calls	12	45567467	45567467	171	0.47953216374269	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHA8P1&recr=Open">Click here</a>	
PLEKHA8P1	RNA		G	G		11	Filtered Calls	12	45567947	45567947	117	0.376068376068376	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHA8P1&recr=Open">Click here</a>	
PLEKHA8P1	RNA		G	G		11	Filtered Calls	12	45567948	45567948	117	0.376068376068376	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHA8P1&recr=Open">Click here</a>	
PLEKHG1	Intron		C	C	rs554078892	11	Filtered Calls	6	151130773	151130773	48	0.4375	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHG1&recr=Open">Click here</a>	
PLEKHM1	Silent	p.A56A	G	G	rs202204663	11	Filtered Calls	17	43555394	43555394	34	0.264705882352941	NA	NA	NA			26	RUN. {ECO:0000255|PROSITE- ProRule:PRU00178}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHM1&recr=Open">Click here</a>	
PLG	Silent	p.E145E	G	G		11	Filtered Calls	6	161134045	161134045	91	0.395604395604396	NA	NA	NA			59	Kringle 1. {ECO:0000255|PROSITE- ProRule:PRU00121}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLG&recr=Open">Click here</a>	
PLIN4	Silent	p.K452K	C	C		11	Filtered Calls	19	4512574	4512574	122	0.19672131147541	NA	NA	NA			41	27 X 33 AA approximate tandem repeat.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLIN4&recr=Open">Click here</a>	
PLK2	Silent	p.T620T	G	G		11	Filtered Calls	5	57750744	57750744	440	0.35	NA	NA	NA			26	POLO box 2. {ECO:0000255|PROSITE- ProRule:PRU00154}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLK2&recr=Open">Click here</a>	
PLK3	Silent	p.F192F	C	C		11	Filtered Calls	1	45267527	45267527	241	0.560165975103734	NA	NA	NA			19	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLK3&recr=Open">Click here</a>	
PLRG1	Intron		G	G		11	Filtered Calls	4	155467087	155467087	68	0.352941176470588	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLRG1&recr=Open">Click here</a>	
PLVAP	Silent	p.K183K	C	C		11	Filtered Calls	19	17476725	17476725	52	0.153846153846154	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLVAP&recr=Open">Click here</a>	
PLXNA2	Intron		G	G		11	Filtered Calls	1	208206653	208206653	146	0.39041095890411	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXNA2&recr=Open">Click here</a>	
PLXNA4	Silent	p.V305V	C	C		11	Filtered Calls	7	132192538	132192538	14	0.785714285714286	NA	NA	NA			45	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXNA4&recr=Open">Click here</a>	
PLXND1	Intron		G	G		11	Filtered Calls	3	129289784	129289784	134	0.507462686567164	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXND1&recr=Open">Click here</a>	
PMFBP1	Intron		C	C		11	Filtered Calls	16	72198657	72198657	109	0.623853211009174	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PMFBP1&recr=Open">Click here</a>	
PML	Intron		C	C		11	Filtered Calls	15	74327995	74327995	84	0.285714285714286	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PML&recr=Open">Click here</a>	
PMS1	Silent	p.V697V	A	A		11	Filtered Calls	2	190728703	190728703	219	0.242009132420091	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PMS1&recr=Open">Click here</a>	
PNLIPRP2	RNA		G	G		11	Filtered Calls	10	118383456	118383456	99	0.141414141414141	NA	NA	NA		p.?(2)	16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNLIPRP2&recr=Open">Click here</a>	
PNLIPRP2	RNA		G	G		11	Filtered Calls	10	118383457	118383457	99	0.131313131313131	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNLIPRP2&recr=Open">Click here</a>	
PNLIPRP3	Intron		C	C		11	Filtered Calls	10	118231268	118231268	208	0.0336538461538462	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNLIPRP3&recr=Open">Click here</a>	
PNMA3	Silent	p.I23I	C	C		11	Filtered Calls	X	152225481	152225481	61	0.426229508196721	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNMA3&recr=Open">Click here</a>	
PNMAL1	Silent	p.K298K	C	C		11	Filtered Calls	19	46973399	46973399	223	0.139013452914798	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNMAL1&recr=Open">Click here</a>	
PNMAL2	Silent	p.L434L	G	G		11	Filtered Calls	19	46997421	46997421	48	0.4375	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNMAL2&recr=Open">Click here</a>	
PNPLA1	Silent	p.P67P	C	C		11	Filtered Calls	6	36260885	36260885	86	0.0930232558139535	NA	NA	NA			22	Patatin.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNPLA1&recr=Open">Click here</a>	
PNPLA7	Intron		C	C		11	Filtered Calls	9	140355080	140355080	38	0.342105263157895	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNPLA7&recr=Open">Click here</a>	
PNPLA7	Silent	p.L137L	G	G		11	Filtered Calls	9	140437906	140437906	81	0.345679012345679	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNPLA7&recr=Open">Click here</a>	
PODXL	Silent	p.S204S	C	C	rs553481012	11	Filtered Calls	7	131195681	131195681	32	0.78125	NA	NA	NA		p.S204S(1)	24	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PODXL&recr=Open">Click here</a>	
POFUT1	Intron		C	C		11	Filtered Calls	20	30804844	30804844	69	0.391304347826087	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POFUT1&recr=Open">Click here</a>	
POFUT2	Silent	p.G285G	C	C		11	Filtered Calls	21	46689911	46689911	79	0.227848101265823	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POFUT2&recr=Open">Click here</a>	
POLR1A	Silent	p.P1451P	G	G		11	Filtered Calls	2	86258678	86258678	143	0.160839160839161	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR1A&recr=Open">Click here</a>	
POLR1A	Silent	p.L173L	G	G		11	Filtered Calls	2	86316966	86316966	277	0.534296028880866	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR1A&recr=Open">Click here</a>	
POLR2A	Silent	p.L567L	C	C		11	Filtered Calls	17	7403985	7403985	60	0.283333333333333	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR2A&recr=Open">Click here</a>	
POLR3B	Silent	p.F50F	C	C		11	Filtered Calls	12	106760338	106760338	76	0.434210526315789	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR3B&recr=Open">Click here</a>	
POLR3B	Silent	p.L471L	C	C		11	Filtered Calls	12	106824200	106824200	121	0.388429752066116	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR3B&recr=Open">Click here</a>	
POLR3E	Silent	p.F355F	C	C		11	Filtered Calls	16	22334249	22334249	18	0.388888888888889	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR3E&recr=Open">Click here</a>	
POM121	Silent	p.V752V	C	C		11	Filtered Calls	7	72413583	72413583	104	0.173076923076923	NA	NA	NA			41	Pore side. {ECO:0000255}.|Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POM121&recr=Open">Click here</a>	
POMT1	Intron		C	C		11	Filtered Calls	9	134395463	134395463	23	0.173913043478261	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POMT1&recr=Open">Click here</a>	
PON1	Intron		G	G		11	Filtered Calls	7	94946034	94946034	193	0.0466321243523316	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PON1&recr=Open">Click here</a>	
POSTN	Silent	p.I562I	G	G		11	Filtered Calls	13	38153471	38153471	272	0.220588235294118	NA	NA	NA			59	FAS1 4. {ECO:0000255|PROSITE- ProRule:PRU00082, ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POSTN&recr=Open">Click here</a>	
POTEA	RNA		C	C	rs551447996	11	Filtered Calls	8	43147723	43147723	71	0.225352112676056	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POTEA&recr=Open">Click here</a>	
POU2AF1	Silent	p.P209P	G	G		11	Filtered Calls	11	111225130	111225130	28	0.392857142857143	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU2AF1&recr=Open">Click here</a>	
POU2AF1	Silent	p.L200L	G	G		11	Filtered Calls	11	111225159	111225159	20	0.8	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU2AF1&recr=Open">Click here</a>	
POU2F1	Silent	p.F688F	C	C		11	Filtered Calls	1	167384843	167384843	107	0.205607476635514	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU2F1&recr=Open">Click here</a>	
POU2F2	Intron		C	C		11	Filtered Calls	19	42597975	42597975	231	0.324675324675325	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU2F2&recr=Open">Click here</a>	
POU2F3	Intron		C	C		11	Filtered Calls	11	120176341	120176341	84	0.857142857142857	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU2F3&recr=Open">Click here</a>	
POU4F2	Silent	p.E344E	G	G		11	Filtered Calls	4	147561762	147561762	69	0.565217391304348	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU4F2&recr=Open">Click here</a>	
PPAN-P2RY11	IGR		C	C		11	Filtered Calls	19	10227468	10227468	100	0.09	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPAN-P2RY11&recr=Open">Click here</a>	
PPAP2C	Silent	p.D80D	G	G		11	Filtered Calls	19	287716	287716	172	0.255813953488372	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPAP2C&recr=Open">Click here</a>	
PPAPDC1A	Silent	p.F146F	C	C		11	Filtered Calls	10	122334665	122334665	176	0.232954545454545	NA	NA	NA			20	Phosphatase sequence motif II.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPAPDC1A&recr=Open">Click here</a>	
PPARG	Intron		G	G	rs530007199	11	Filtered Calls	3	12458437	12458437	91	0.274725274725275	NA	NA	NA		p.E352K(1)	20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPARG&recr=Open">Click here</a>	
PPARG	Intron		G	G		11	Filtered Calls	3	12458479	12458479	68	0.220588235294118	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPARG&recr=Open">Click here</a>	
PPEF1	Silent	p.I22I	C	C		11	Filtered Calls	X	18748318	18748318	110	0.390909090909091	NA	NA	NA		p.I22I(1)	43	IQ. {ECO:0000255|PROSITE- ProRule:PRU00116}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPEF1&recr=Open">Click here</a>	
PPFIBP1	Silent	p.E128E	G	G		11	Filtered Calls	12	27800688	27800688	581	0.222030981067126	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPFIBP1&recr=Open">Click here</a>	
PPIL1	Silent	p.Q150Q	C	C		11	Filtered Calls	6	36823640	36823640	198	0.202020202020202	NA	NA	NA			2	PPIase cyclophilin-type. {ECO:0000255|PROSITE-ProRule:PRU00156}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPIL1&recr=Open">Click here</a>	
PPIP5K1	Silent	p.S1172S	G	G		11	Filtered Calls	15	43827577	43827577	70	0.514285714285714	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPIP5K1&recr=Open">Click here</a>	
PPM1E	Silent	p.A202A	C	C		11	Filtered Calls	17	57043077	57043077	653	0.223583460949464	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPM1E&recr=Open">Click here</a>	
PPP1R12B	Intron		C	C		11	Filtered Calls	1	202407391	202407391	84	0.416666666666667	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R12B&recr=Open">Click here</a>	
PPP1R13L	Silent	p.S183S	G	G		11	Filtered Calls	19	45899966	45899966	13	0.538461538461538	NA	NA	NA			26	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R13L&recr=Open">Click here</a>	
PPP1R14A	Silent	p.S136S	G	G		11	Filtered Calls	19	38741994	38741994	15	0.2	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R14A&recr=Open">Click here</a>	
PPP1R17	Silent	p.E93E	A	A		11	Filtered Calls	7	31746861	31746861	66	0.303030303030303	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R17&recr=Open">Click here</a>	
PPP1R32	Silent	p.L5L	C	C		11	Filtered Calls	11	61249296	61249296	9	0.666666666666667	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R32&recr=Open">Click here</a>	
PPP1R3A	Silent	p.F534F	G	G	rs267601240	11	Filtered Calls	7	113519545	113519545	56	0.392857142857143	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R3A&recr=Open">Click here</a>	
PPP1R9A	Intron		C	C		11	Filtered Calls	7	94881266	94881266	76	0.355263157894737	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R9A&recr=Open">Click here</a>	
PPP2R1B	Silent	p.R330R	T	T		11	Filtered Calls	11	111625264	111625264	103	0.844660194174757	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2R1B&recr=Open">Click here</a>	
PPP2R2B	Silent	p.F80F	G	G		11	Filtered Calls	5	146077636	146077636	255	0.447058823529412	NA	NA	NA		p.F69F(1)|p.F80F(1)|p.F83F(1)|p.F138F(1)	32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2R2B&recr=Open">Click here</a>	
PPP2R5C	Intron		C	C		11	Filtered Calls	14	102391474	102391474	344	0.595930232558139	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2R5C&recr=Open">Click here</a>	
PPP4R4	Silent	p.L117L	C	C		11	Filtered Calls	14	94696978	94696978	122	0.344262295081967	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP4R4&recr=Open">Click here</a>	
PPP4R4	Silent	p.L259L	T	T		11	Filtered Calls	14	94703947	94703947	203	0.522167487684729	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP4R4&recr=Open">Click here</a>	
PPP4R4	Silent	p.P839P	G	G		11	Filtered Calls	14	94741778	94741778	218	0.527522935779816	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP4R4&recr=Open">Click here</a>	
PPP5C	Intron		C	C		11	Filtered Calls	19	46890346	46890346	44	0.159090909090909	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP5C&recr=Open">Click here</a>	
PPTC7	Silent	p.V196V	G	G		11	Filtered Calls	12	110983699	110983699	217	0.235023041474654	NA	NA	NA			9	PP2C-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPTC7&recr=Open">Click here</a>	
PRAMENP	RNA		T	T		11	Filtered Calls	22	22385642	22385642	49	0.244897959183673	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRAMENP&recr=Open">Click here</a>	
PRDM1	Silent	p.R49R	G	G		11	Filtered Calls	6	106536288	106536288	107	0.373831775700935	NA	NA	NA		p.?(1)	94			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM1&recr=Open">Click here</a>	
PRDM1	Silent	p.P495P	C	C		11	Filtered Calls	6	106553628	106553628	25	0.36	NA	NA	NA			94			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM1&recr=Open">Click here</a>	
PRDM10	Silent	p.F856F	G	G		11	Filtered Calls	11	129784872	129784872	51	0.313725490196078	NA	NA	NA		p.F856F(1)	48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM10&recr=Open">Click here</a>	
PRDM10	Silent	p.P119P	A	A		11	Filtered Calls	11	129817203	129817203	31	0.838709677419355	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM10&recr=Open">Click here</a>	
PRDM13	Silent	p.T545T	G	G		11	Filtered Calls	6	100062146	100062146	15	0.4	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM13&recr=Open">Click here</a>	
PRDM16	Intron		C	C		11	Filtered Calls	1	3350232	3350232	83	0.650602409638554	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM16&recr=Open">Click here</a>	
PRDM8	Silent	p.L117L	C	C		11	Filtered Calls	4	81122575	81122575	64	0.25	NA	NA	NA			10	SET. {ECO:0000255|PROSITE- ProRule:PRU00190}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM8&recr=Open">Click here</a>	
PRDM9	Silent	p.Q338Q	G	G	rs373277404	11	Filtered Calls	5	23524506	23524506	82	0.219512195121951	NA	NA	NA			172	SET. {ECO:0000255|PROSITE- ProRule:PRU00190}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM9&recr=Open">Click here</a>	
PRDM9	Silent	p.G548G	G	G		11	Filtered Calls	5	23526841	23526841	107	0.514018691588785	NA	NA	NA		p.G548G(1)	172			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM9&recr=Open">Click here</a>	
PREB	5'Flank		C	C		11	Filtered Calls	2	27353403	27353403	144	0.277777777777778	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREB&recr=Open">Click here</a>	
PREX1	Intron		G	G	rs199817612	11	Filtered Calls	20	47248934	47248934	39	0.487179487179487	NA	NA	NA			110			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX1&recr=Open">Click here</a>	
PREX2	Silent	p.Q1260Q	G	G		11	Filtered Calls	8	69046307	69046307	145	0.406896551724138	NA	NA	NA			178			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	
PREX2	Intron		C	C		11	Filtered Calls	8	69058436	69058436	80	0.25	NA	NA	NA			178			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	
PRKACG	Silent	p.V86V	G	G	rs556702322	11	Filtered Calls	9	71628751	71628751	83	0.289156626506024	NA	NA	NA			22	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKACG&recr=Open">Click here</a>	
PRKAG3	Intron		G	G		11	Filtered Calls	2	219693335	219693335	29	0.379310344827586	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKAG3&recr=Open">Click here</a>	
PRKAR1A	Silent	p.I226I	C	C	rs200592054	11	Filtered Calls	17	66522023	66522023	212	0.419811320754717	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKAR1A&recr=Open">Click here</a>	
PRKAR1A	Intron		C	C		11	Filtered Calls	17	66537012	66537012	51	0.137254901960784	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKAR1A&recr=Open">Click here</a>	
PRKCB	Intron		C	C		11	Filtered Calls	16	24226094	24226094	141	0.290780141843972	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCB&recr=Open">Click here</a>	
PRKCD	Silent	p.P601P	C	C		11	Filtered Calls	3	53223948	53223948	337	0.198813056379822	NA	NA	NA			26	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCD&recr=Open">Click here</a>	
PRKCE	Silent	p.R156R	G	G		11	Filtered Calls	2	46203623	46203623	103	0.320388349514563	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCE&recr=Open">Click here</a>	
PRKCQ	Intron		G	G		11	Filtered Calls	10	6539085	6539085	182	0.214285714285714	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCQ&recr=Open">Click here</a>	
PRKCZ	Intron		C	C		11	Filtered Calls	1	2082219	2082219	93	0.32258064516129	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCZ&recr=Open">Click here</a>	
PRKD2	Silent	p.A507A	G	G		11	Filtered Calls	19	47197187	47197187	84	0.607142857142857	NA	NA	NA			41	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKD2&recr=Open">Click here</a>	
PRKDC	5'UTR		C	C		11	Filtered Calls	8	48691313	48691313	81	0.234567901234568	NA	NA	NA			147			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKDC&recr=Open">Click here</a>	
PRKG1	Intron		C	C	rs371409852	11	Filtered Calls	10	52912912	52912912	356	0.207865168539326	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKG1&recr=Open">Click here</a>	
PRKG1	Silent	p.Q128Q	G	G		11	Filtered Calls	10	52912996	52912996	253	0.237154150197628	NA	NA	NA			53	cGMP-binding, high affinity.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKG1&recr=Open">Click here</a>	
PRKG1	Intron		C	C	rs374171830	11	Filtered Calls	10	53921639	53921639	248	0.185483870967742	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKG1&recr=Open">Click here</a>	
PRKG2	Silent	p.V105V	G	G		11	Filtered Calls	4	82125887	82125887	114	0.254385964912281	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKG2&recr=Open">Click here</a>	
PRMT3	Silent	p.L336L	C	C		11	Filtered Calls	11	20473688	20473688	147	0.816326530612245	NA	NA	NA			17	SAM-dependent MTase PRMT-type. {ECO:0000255|PROSITE-ProRule:PRU01015}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRMT3&recr=Open">Click here</a>	
PRMT7	Silent	p.I151I	C	C		11	Filtered Calls	16	68371423	68371423	82	0.365853658536585	NA	NA	NA			20	SAM-dependent MTase PRMT-type 1. {ECO:0000255|PROSITE-ProRule:PRU01015}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRMT7&recr=Open">Click here</a>	
PRND	Silent	p.P56P	G	G		11	Filtered Calls	20	4705365	4705365	28	0.535714285714286	NA	NA	NA			13	Globular.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRND&recr=Open">Click here</a>	
PROKR1	Silent	p.I84I	C	C	rs111648620	11	Filtered Calls	2	68873205	68873205	206	0.169902912621359	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROKR1&recr=Open">Click here</a>	
PROKR1	Silent	p.I193I	C	C		11	Filtered Calls	2	68882105	68882105	212	0.174528301886792	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROKR1&recr=Open">Click here</a>	
PROM2	Silent	p.V436V	C	C		11	Filtered Calls	2	95945626	95945626	56	0.232142857142857	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROM2&recr=Open">Click here</a>	
PROM2	Silent	p.R733R	G	G		11	Filtered Calls	2	95953167	95953167	37	0.378378378378378	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROM2&recr=Open">Click here</a>	
PROS1	Silent	p.L255L	A	A		11	Filtered Calls	3	93617376	93617376	188	0.404255319148936	NA	NA	NA			46	EGF-like 4; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROS1&recr=Open">Click here</a>	
PROS1	Intron		G	G		11	Filtered Calls	3	93646258	93646258	96	0.375	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROS1&recr=Open">Click here</a>	
PRPF3	Intron		C	C		11	Filtered Calls	1	150310625	150310625	226	0.464601769911504	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRPF3&recr=Open">Click here</a>	
PRPF4	Silent	p.L265L	C	C		11	Filtered Calls	9	116048554	116048554	317	0.305993690851735	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRPF4&recr=Open">Click here</a>	
PRPF8	Intron		G	G		11	Filtered Calls	17	1563302	1563302	176	0.215909090909091	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRPF8&recr=Open">Click here</a>	
PRPS1L1	Silent	p.R301R	C	C		11	Filtered Calls	7	18066503	18066503	495	0.0343434343434343	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRPS1L1&recr=Open">Click here</a>	
PRR12	Silent	p.F599F	C	C		11	Filtered Calls	19	50099389	50099389	96	0.21875	NA	NA	NA			11	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRR12&recr=Open">Click here</a>	
PRR4	5'UTR		G	G		11	Filtered Calls	12	11036823	11036823	73	0.219178082191781	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRR4&recr=Open">Click here</a>	
PRRC2A	Intron		C	C		11	Filtered Calls	6	31593226	31593226	249	0.168674698795181	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRRC2A&recr=Open">Click here</a>	
PRRC2B	Intron		G	G		11	Filtered Calls	9	134351053	134351053	13	0.461538461538462	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRRC2B&recr=Open">Click here</a>	
PRRC2B	Intron		C	C		11	Filtered Calls	9	134351115	134351115	12	0.5	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRRC2B&recr=Open">Click here</a>	
PRRC2B	Intron		C	C		11	Filtered Calls	9	134351116	134351116	11	0.545454545454545	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRRC2B&recr=Open">Click here</a>	
PRRC2C	Intron		C	C	rs373271797	11	Filtered Calls	1	171484867	171484867	44	0.204545454545455	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRRC2C&recr=Open">Click here</a>	
PRRC2C	Silent	p.S2409S	C	C		11	Filtered Calls	1	171548566	171548566	149	0.281879194630872	NA	NA	NA			NA	Gln-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRRC2C&recr=Open">Click here</a>	
PRRX1	Intron		C	C		11	Filtered Calls	1	170699427	170699427	350	0.182857142857143	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRRX1&recr=Open">Click here</a>	
PRSS12	Silent	p.K532K	C	C		11	Filtered Calls	4	119229626	119229626	261	0.264367816091954	NA	NA	NA			29	SRCR 4. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRSS12&recr=Open">Click here</a>	
PRSS36	Intron		G	G		11	Filtered Calls	16	31151805	31151805	43	0.13953488372093	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRSS36&recr=Open">Click here</a>	
PRSS54	Silent	p.L237L	G	G		11	Filtered Calls	16	58314607	58314607	46	0.304347826086957	NA	NA	NA			25	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRSS54&recr=Open">Click here</a>	
PSAT1	Intron		T	T		11	Filtered Calls	9	80932589	80932589	211	0.270142180094787	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSAT1&recr=Open">Click here</a>	
PSD	Silent	p.P448P	G	G		11	Filtered Calls	10	104173735	104173735	81	0.703703703703704	NA	NA	NA			34	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSD&recr=Open">Click here</a>	
PSD2	Silent	p.L90L	G	G		11	Filtered Calls	5	139189295	139189295	84	0.511904761904762	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSD2&recr=Open">Click here</a>	
PSD3	Intron		G	G		11	Filtered Calls	8	18457954	18457954	226	0.168141592920354	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSD3&recr=Open">Click here</a>	
PSD3	Intron		G	G		11	Filtered Calls	8	18490114	18490114	199	0.226130653266332	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSD3&recr=Open">Click here</a>	
PSD3	Silent	p.G239G	C	C		11	Filtered Calls	8	18729657	18729657	128	0.3046875	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSD3&recr=Open">Click here</a>	
PSD3	Silent	p.L134L	C	C		11	Filtered Calls	8	18729972	18729972	278	0.194244604316547	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSD3&recr=Open">Click here</a>	
PSEN2	Silent	p.L385L	G	G		11	Filtered Calls	1	227079529	227079529	99	0.404040404040404	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSEN2&recr=Open">Click here</a>	
PSENEN	5'UTR		G	G		11	Filtered Calls	19	36236241	36236241	417	0.182254196642686	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSENEN&recr=Open">Click here</a>	
PSG3	Silent	p.I381I	G	G		11	Filtered Calls	19	43233375	43233375	272	0.143382352941176	NA	NA	NA			36	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG3&recr=Open">Click here</a>	
PSG3	5'UTR		G	G		11	Filtered Calls	19	43244537	43244537	116	0.21551724137931	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG3&recr=Open">Click here</a>	
PSG5	Intron		G	G		11	Filtered Calls	19	43674299	43674299	79	0.329113924050633	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG5&recr=Open">Click here</a>	
PSG9	Silent	p.L187L	G	G		11	Filtered Calls	19	43766160	43766160	249	0.180722891566265	NA	NA	NA			41	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG9&recr=Open">Click here</a>	
PSMB11	Silent	p.A203A	C	C		11	Filtered Calls	14	23512043	23512043	30	0.866666666666667	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSMB11&recr=Open">Click here</a>	
PSTK	Silent	p.P104P	C	C		11	Filtered Calls	10	124742344	124742344	307	0.0195439739413681	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSTK&recr=Open">Click here</a>	
PTCD3	Silent	p.D384D	C	C		11	Filtered Calls	2	86357775	86357775	501	0.119760479041916	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCD3&recr=Open">Click here</a>	
PTCH1	Silent	p.F1177F	G	G	rs587780702	11	Filtered Calls	9	98212141	98212141	77	0.285714285714286	NA	NA	NA		p.L1170_P1180>WT(1)	490			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCH1&recr=Open">Click here</a>	
PTCH1	Intron		A	A		11	Filtered Calls	9	98239149	98239149	53	0.30188679245283	NA	NA	NA			490			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCH1&recr=Open">Click here</a>	
PTCHD1	Silent	p.R400R	G	G		11	Filtered Calls	X	23410835	23410835	112	0.392857142857143	NA	NA	NA			42	SSD. {ECO:0000255|PROSITE- ProRule:PRU00199}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCHD1&recr=Open">Click here</a>	
PTCHD3	Silent	p.I384I	G	G		11	Filtered Calls	10	27700796	27700796	158	0.278481012658228	NA	NA	NA			55	SSD. {ECO:0000255|PROSITE- ProRule:PRU00199}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCHD3&recr=Open">Click here</a>	
PTCHD3	Silent	p.T126T	G	G		11	Filtered Calls	10	27702802	27702802	14	0.571428571428571	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCHD3&recr=Open">Click here</a>	
PTCHD4	Silent	p.I641I	G	G		11	Filtered Calls	6	47846657	47846657	192	0.255208333333333	NA	NA	NA		p.I641I(1)	NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCHD4&recr=Open">Click here</a>	
PTDSS2	Intron		C	C		11	Filtered Calls	11	488521	488521	23	0.91304347826087	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTDSS2&recr=Open">Click here</a>	
PTDSS2	Intron		C	C		11	Filtered Calls	11	488522	488522	22	0.909090909090909	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTDSS2&recr=Open">Click here</a>	
PTGER3	Intron		C	C		11	Filtered Calls	1	71328080	71328080	149	0.295302013422819	NA	NA	NA		p.R417K(1)	25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGER3&recr=Open">Click here</a>	
PTGER3	Silent	p.S258S	G	G		11	Filtered Calls	1	71512487	71512487	42	0.357142857142857	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGER3&recr=Open">Click here</a>	
PTGFR	Intron		A	A		11	Filtered Calls	1	78963585	78963585	94	0.319148936170213	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGFR&recr=Open">Click here</a>	
PTGIR	Intron		G	G		11	Filtered Calls	19	47124939	47124939	26	0.115384615384615	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGIR&recr=Open">Click here</a>	
PTGIS	Silent	p.F388F	G	G		11	Filtered Calls	20	48129659	48129659	70	0.385714285714286	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGIS&recr=Open">Click here</a>	
PTGS1	Silent	p.P541P	G	G	rs374665506	11	Filtered Calls	9	125154646	125154646	135	0.192592592592593	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGS1&recr=Open">Click here</a>	
PTH1R	Silent	p.L309L	C	C		11	Filtered Calls	3	46940885	46940885	57	0.157894736842105	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTH1R&recr=Open">Click here</a>	
PTH2R	Silent	p.P529P	T	T		11	Filtered Calls	2	209358318	209358318	94	0.308510638297872	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTH2R&recr=Open">Click here</a>	
PTHLH	Silent	p.H61H	G	G		11	Filtered Calls	12	28116622	28116622	258	0.232558139534884	NA	NA	NA			10	Important for receptor binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTHLH&recr=Open">Click here</a>	
PTK2B	Silent	p.T673T	C	C	rs149334019	11	Filtered Calls	8	27297938	27297938	55	0.272727272727273	NA	NA	NA			47	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTK2B&recr=Open">Click here</a>	
PTN	3'UTR		C	C		11	Filtered Calls	7	136912784	136912784	147	0.319727891156463	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTN&recr=Open">Click here</a>	
PTN	3'UTR		C	C		11	Filtered Calls	7	136912799	136912799	114	0.333333333333333	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTN&recr=Open">Click here</a>	
PTPDC1	Silent	p.I690I	C	C		11	Filtered Calls	9	96863910	96863910	251	0.278884462151394	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPDC1&recr=Open">Click here</a>	
PTPN6	Silent	p.I93I	C	C		11	Filtered Calls	12	7061293	7061293	188	0.212765957446809	NA	NA	NA			18	SH2 1. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPN6&recr=Open">Click here</a>	
PTPN9	Intron		G	G	rs148342575	11	Filtered Calls	15	75782654	75782654	113	0.327433628318584	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPN9&recr=Open">Click here</a>	
PTPRA	Intron		G	G		11	Filtered Calls	20	2945004	2945004	233	0.300429184549356	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRA&recr=Open">Click here</a>	
PTPRA	Intron		T	T		11	Filtered Calls	20	2945005	2945005	230	0.3	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRA&recr=Open">Click here</a>	
PTPRB	Silent	p.P352P	A	A		11	Filtered Calls	12	70990031	70990031	40	0.3	NA	NA	NA			107	Fibronectin type-III 4. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRB&recr=Open">Click here</a>	
PTPRD	Intron		G	G	rs375789438	11	Filtered Calls	9	8376102	8376102	40	0.4	NA	NA	NA			168			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRD&recr=Open">Click here</a>	
PTPRD	Intron		G	G		11	Filtered Calls	9	8376596	8376596	54	0.37037037037037	NA	NA	NA			168			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRD&recr=Open">Click here</a>	
PTPRD	Intron		C	C		11	Filtered Calls	9	8460281	8460281	22	0.181818181818182	NA	NA	NA			168			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRD&recr=Open">Click here</a>	
PTPRD	Silent	p.V310V	G	G		11	Filtered Calls	9	8521308	8521308	90	0.288888888888889	NA	NA	NA			168	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRD&recr=Open">Click here</a>	
PTPRG	Silent	p.V322V	C	C		11	Filtered Calls	3	62153770	62153770	147	0.27891156462585	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRG&recr=Open">Click here</a>	
PTPRG	Silent	p.A923A	C	C		11	Filtered Calls	3	62253389	62253389	438	0.0410958904109589	NA	NA	NA			62	Tyrosine-protein phosphatase 1. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRG&recr=Open">Click here</a>	
PTPRJ	Silent	p.S788S	G	G		11	Filtered Calls	11	48161249	48161249	51	0.431372549019608	NA	NA	NA			52	Fibronectin type-III 8. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRJ&recr=Open">Click here</a>	
PTPRK	Intron		G	G		11	Filtered Calls	6	128324384	128324384	26	0.269230769230769	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRK&recr=Open">Click here</a>	
PTPRM	Silent	p.S1082S	C	C		11	Filtered Calls	18	8376157	8376157	21	0.428571428571429	NA	NA	NA			90	Tyrosine-protein phosphatase 1. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRM&recr=Open">Click here</a>	
PTPRN	Intron		G	G		11	Filtered Calls	2	220162164	220162164	39	0.102564102564103	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRN&recr=Open">Click here</a>	
PTPRN	Intron		G	G		11	Filtered Calls	2	220163844	220163844	103	0.592233009708738	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRN&recr=Open">Click here</a>	
PTPRN	Intron		G	G		11	Filtered Calls	2	220166301	220166301	91	0.296703296703297	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRN&recr=Open">Click here</a>	
PTPRN	Silent	p.D43D	G	G		11	Filtered Calls	2	220172551	220172551	158	0.658227848101266	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRN&recr=Open">Click here</a>	
PTPRO	Silent	p.V979V	G	G		11	Filtered Calls	12	15732989	15732989	249	0.192771084337349	NA	NA	NA			74	Tyrosine-protein phosphatase. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRO&recr=Open">Click here</a>	
PTPRS	Silent	p.F1231F	G	G		11	Filtered Calls	19	5220022	5220022	82	0.5	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRS&recr=Open">Click here</a>	
PTPRT	Silent	p.L695L	G	G		11	Filtered Calls	20	40944417	40944417	39	0.435897435897436	NA	NA	NA		p.L695L(1)	176	Fibronectin type-III 4. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRT&recr=Open">Click here</a>	
PTPRT	Silent	p.G540G	C	C		11	Filtered Calls	20	40980866	40980866	52	0.288461538461538	NA	NA	NA			176	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRT&recr=Open">Click here</a>	
PTPRU	Intron		C	C		11	Filtered Calls	1	29605962	29605962	37	0.891891891891892	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRU&recr=Open">Click here</a>	
PTPRZ1	Intron		C	C		11	Filtered Calls	7	121651887	121651887	100	0.45	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRZ1&recr=Open">Click here</a>	
PTRF	Silent	p.I375I	G	G		11	Filtered Calls	17	40556753	40556753	9	0.444444444444444	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTRF&recr=Open">Click here</a>	
PTX4	Silent	p.R281R	C	C		11	Filtered Calls	16	1536534	1536534	25	0.2	NA	NA	NA			17	Pentaxin.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTX4&recr=Open">Click here</a>	
PURG	Silent	p.F195F	G	G		11	Filtered Calls	8	30889714	30889714	130	0.230769230769231	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PURG&recr=Open">Click here</a>	
PVR	Silent	p.I345I	C	C		11	Filtered Calls	19	45162053	45162053	191	0.18848167539267	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PVR&recr=Open">Click here</a>	
PVRIG	Intron		G	G		11	Filtered Calls	7	99818097	99818097	8	1	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PVRIG&recr=Open">Click here</a>	
PXDC1	Silent	p.P224P	G	G		11	Filtered Calls	6	3723877	3723877	132	0.189393939393939	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXDC1&recr=Open">Click here</a>	
PXDN	Intron		A	A		11	Filtered Calls	2	1642759	1642759	19	0.368421052631579	NA	NA	NA			112			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXDN&recr=Open">Click here</a>	
PXDN	Intron		G	G		11	Filtered Calls	2	1642760	1642760	19	0.368421052631579	NA	NA	NA			112			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXDN&recr=Open">Click here</a>	
PXDNL	Silent	p.R853R	C	C		11	Filtered Calls	8	52321625	52321625	31	0.290322580645161	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXDNL&recr=Open">Click here</a>	
PXMP4	Intron		G	G		11	Filtered Calls	20	32298352	32298352	66	0.363636363636364	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PXMP4&recr=Open">Click here</a>	
PYGM	Silent	p.L64L	G	G		11	Filtered Calls	11	64527179	64527179	105	0.428571428571429	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PYGM&recr=Open">Click here</a>	
PYHIN1	Silent	p.K302K	G	G		11	Filtered Calls	1	158912093	158912093	185	0.681081081081081	NA	NA	NA			60	HIN-200. {ECO:0000255|PROSITE- ProRule:PRU00106}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PYHIN1&recr=Open">Click here</a>	
PZP	Intron		A	A		11	Filtered Calls	12	9334549	9334549	116	0.21551724137931	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PZP&recr=Open">Click here</a>	
PZP	Intron		C	C		11	Filtered Calls	12	9355111	9355111	297	0.175084175084175	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PZP&recr=Open">Click here</a>	
QARS	Silent	p.I590I	G	G		11	Filtered Calls	3	49136411	49136411	88	0.227272727272727	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+QARS&recr=Open">Click here</a>	
QRICH2	Silent	p.T1201T	G	G		11	Filtered Calls	17	74278107	74278107	18	0.166666666666667	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+QRICH2&recr=Open">Click here</a>	
QRICH2	Silent	p.S1186S	G	G		11	Filtered Calls	17	74278152	74278152	35	0.228571428571429	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+QRICH2&recr=Open">Click here</a>	
QRICH2	Intron		G	G		11	Filtered Calls	17	74278207	74278207	32	0.15625	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+QRICH2&recr=Open">Click here</a>	
QRSL1	Intron		C	C		11	Filtered Calls	6	107096891	107096891	115	0.382608695652174	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+QRSL1&recr=Open">Click here</a>	
QRSL1	Intron		-	-		11	Filtered Calls	6	107103474	107103475	114	0.421052631578947	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+QRSL1&recr=Open">Click here</a>	
QTRTD1	Intron		A	A		11	Filtered Calls	3	113786908	113786908	240	0.4125	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+QTRTD1&recr=Open">Click here</a>	
R3HDM1	Silent	p.Q49Q	G	G		11	Filtered Calls	2	136379075	136379075	71	0.338028169014085	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+R3HDM1&recr=Open">Click here</a>	
RAB25	Silent	p.I118I	C	C		11	Filtered Calls	1	156038175	156038175	148	0.72972972972973	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB25&recr=Open">Click here</a>	
RAB27B	Silent	p.F38F	C	C		11	Filtered Calls	18	52544930	52544930	97	0.402061855670103	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB27B&recr=Open">Click here</a>	
RAB37	Silent	p.F222F	C	C		11	Filtered Calls	17	72741544	72741544	76	0.236842105263158	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB37&recr=Open">Click here</a>	
RAB3GAP1	Intron		T	T		11	Filtered Calls	2	135872781	135872781	220	0.0409090909090909	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB3GAP1&recr=Open">Click here</a>	
RAB3GAP1	Silent	p.F490F	C	C		11	Filtered Calls	2	135891574	135891574	282	0.265957446808511	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB3GAP1&recr=Open">Click here</a>	
RAB3GAP2	Intron		G	G		11	Filtered Calls	1	220373901	220373901	322	0.726708074534162	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB3GAP2&recr=Open">Click here</a>	
RAB40C	Silent	p.V119V	C	C		11	Filtered Calls	16	675913	675913	14	0.714285714285714	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB40C&recr=Open">Click here</a>	
RAB4B-EGLN2	Silent	p.L163L	C	C		11	Filtered Calls	19	41292628	41292628	63	0.142857142857143	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB4B-EGLN2&recr=Open">Click here</a>	
RABGAP1L	3'UTR		C	C		11	Filtered Calls	1	174927050	174927050	227	0.383259911894273	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RABGAP1L&recr=Open">Click here</a>	
RAD51AP1	Silent	p.L55L	C	C		11	Filtered Calls	12	4653026	4653026	295	0.4	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAD51AP1&recr=Open">Click here</a>	
RAD51AP2	Silent	p.E390E	T	T		11	Filtered Calls	2	17698513	17698513	245	0.289795918367347	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAD51AP2&recr=Open">Click here</a>	
RAD51AP2	Silent	p.I356I	G	G		11	Filtered Calls	2	17698615	17698615	143	0.335664335664336	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAD51AP2&recr=Open">Click here</a>	
RALA	Intron		C	C		11	Filtered Calls	7	39729972	39729972	88	0.272727272727273	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RALA&recr=Open">Click here</a>	
RALGAPA2	Silent	p.I1649I	G	G		11	Filtered Calls	20	20486160	20486160	75	0.173333333333333	NA	NA	NA			54	Rap-GAP. {ECO:0000255|PROSITE- ProRule:PRU00165}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RALGAPA2&recr=Open">Click here</a>	
RAP1GAP2	Silent	p.L202L	G	G		11	Filtered Calls	17	2883590	2883590	38	0.447368421052632	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAP1GAP2&recr=Open">Click here</a>	
RAPGEF4	Silent	p.R904R	G	G		11	Filtered Calls	2	173900864	173900864	98	0.26530612244898	NA	NA	NA			47	Ras-GEF. {ECO:0000255|PROSITE- ProRule:PRU00168}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAPGEF4&recr=Open">Click here</a>	
RARG	Silent	p.F39F	G	G	rs556025298	11	Filtered Calls	12	53621213	53621213	41	0.317073170731707	NA	NA	NA			20	Modulating.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RARG&recr=Open">Click here</a>	
RARRES3	Silent	p.K132K	G	G		11	Filtered Calls	11	63313629	63313629	113	0.283185840707965	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RARRES3&recr=Open">Click here</a>	
RASD2	Silent	p.F234F	C	C	rs562482100	11	Filtered Calls	22	35947980	35947980	49	0.244897959183673	NA	NA	NA			13	Interaction with GNB1, GNB2 and GNB3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASD2&recr=Open">Click here</a>	
RASGRF1	Silent	p.L291L	C	C		11	Filtered Calls	15	79339093	79339093	113	0.0530973451327434	NA	NA	NA			71	DH. {ECO:0000255|PROSITE- ProRule:PRU00062}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRF1&recr=Open">Click here</a>	
RASGRF2	Silent	p.I446I	C	C		11	Filtered Calls	5	80382720	80382720	72	0.0694444444444444	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRF2&recr=Open">Click here</a>	
RASGRF2	Silent	p.L487L	G	G	rs34329522	11	Filtered Calls	5	80388690	80388690	158	0.512658227848101	NA	NA	NA			75	PH 2. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRF2&recr=Open">Click here</a>	
RASGRF2	Intron		C	C		11	Filtered Calls	5	80511687	80511687	135	0.414814814814815	NA	NA	NA			75			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRF2&recr=Open">Click here</a>	
RASGRP2	Silent	p.I607I	G	G		11	Filtered Calls	11	64494783	64494783	72	0.361111111111111	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRP2&recr=Open">Click here</a>	
RASSF2	Silent	p.F278F	G	G	rs200418178	11	Filtered Calls	20	4766954	4766954	244	0.290983606557377	NA	NA	NA		p.F278F(2)	34	SARAH. {ECO:0000255|PROSITE- ProRule:PRU00310}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASSF2&recr=Open">Click here</a>	
RASSF5	Silent	p.T188T	C	C	rs138095666	11	Filtered Calls	1	206711607	206711607	143	0.188811188811189	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASSF5&recr=Open">Click here</a>	
RBBP6	Silent	p.L1521L	T	T		11	Filtered Calls	16	24582948	24582948	87	0.252873563218391	NA	NA	NA			46	Interaction with p53. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBBP6&recr=Open">Click here</a>	
RBBP8	Intron		C	C		11	Filtered Calls	18	20529575	20529575	185	0.324324324324324	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBBP8&recr=Open">Click here</a>	
RBBP8NL	Intron		G	G		11	Filtered Calls	20	60987814	60987814	38	0.184210526315789	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBBP8NL&recr=Open">Click here</a>	
RBBP8NL	Silent	p.S524S	G	G		11	Filtered Calls	20	60988560	60988560	28	0.214285714285714	NA	NA	NA			NA	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBBP8NL&recr=Open">Click here</a>	
RBFA	Silent	p.L259L	C	C	rs148332133	11	Filtered Calls	18	77805900	77805900	47	0.468085106382979	NA	NA	NA		p.L259L(1)	15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBFA&recr=Open">Click here</a>	
RBFOX1	Intron		G	G		11	Filtered Calls	16	7383001	7383001	167	0.287425149700599	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBFOX1&recr=Open">Click here</a>	
RBKS	Intron		G	G		11	Filtered Calls	2	28070892	28070892	79	0.253164556962025	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBKS&recr=Open">Click here</a>	
RBM28	Silent	p.C125C	A	A		11	Filtered Calls	7	127978853	127978853	179	0.810055865921788	NA	NA	NA			21	RRM 2. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM28&recr=Open">Click here</a>	
RBM46	3'UTR		C	C		11	Filtered Calls	4	155749058	155749058	314	0.235668789808917	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM46&recr=Open">Click here</a>	
RBM4B	Intron		G	G	rs146095184	11	Filtered Calls	11	66436496	66436496	39	0.384615384615385	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM4B&recr=Open">Click here</a>	
RBM4B	Intron		G	G		11	Filtered Calls	11	66436497	66436497	37	0.378378378378378	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM4B&recr=Open">Click here</a>	
RBMS3	Intron		C	C		11	Filtered Calls	3	30029721	30029721	72	0.222222222222222	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBMS3&recr=Open">Click here</a>	
RBMXL3	5'Flank		A	A		11	Filtered Calls	X	114422863	114422863	23	0.521739130434783	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBMXL3&recr=Open">Click here</a>	
RBP3	Silent	p.I1111I	G	G		11	Filtered Calls	10	48383899	48383899	62	0.193548387096774	NA	NA	NA			59	4 X approximate tandem repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBP3&recr=Open">Click here</a>	
RBP3	Silent	p.G945G	C	C		11	Filtered Calls	10	48388043	48388043	33	0.151515151515152	NA	NA	NA			59	4 X approximate tandem repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBP3&recr=Open">Click here</a>	
RC3H1	Intron		G	G		11	Filtered Calls	1	173952046	173952046	300	0.21	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RC3H1&recr=Open">Click here</a>	
RCAN2	5'UTR		G	G		11	Filtered Calls	6	46293227	46293227	34	0.235294117647059	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RCAN2&recr=Open">Click here</a>	
RCBTB1	Silent	p.L246L	G	G		11	Filtered Calls	13	50125580	50125580	114	0.324561403508772	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RCBTB1&recr=Open">Click here</a>	
RCHY1	Intron		A	A		11	Filtered Calls	4	76439398	76439398	101	0.257425742574257	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RCHY1&recr=Open">Click here</a>	
RDH8	Silent	p.V139V	C	C		11	Filtered Calls	19	10129501	10129501	67	0.134328358208955	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RDH8&recr=Open">Click here</a>	
RDH8	Silent	p.F180F	C	C	rs142648928	11	Filtered Calls	19	10131422	10131422	104	0.153846153846154	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RDH8&recr=Open">Click here</a>	
RECQL5	Silent	p.A781A	G	G		11	Filtered Calls	17	73625160	73625160	46	0.195652173913043	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RECQL5&recr=Open">Click here</a>	
REG1B	Silent	p.A82A	G	G		11	Filtered Calls	2	79313568	79313568	132	0.196969696969697	NA	NA	NA			51	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REG1B&recr=Open">Click here</a>	
REG3A	Intron		G	G		11	Filtered Calls	2	79385907	79385907	22	0.545454545454545	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REG3A&recr=Open">Click here</a>	
RELB	Intron		C	C		11	Filtered Calls	19	45506199	45506199	36	0.194444444444444	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELB&recr=Open">Click here</a>	
RELN	Silent	p.G804G	C	C		11	Filtered Calls	7	103275925	103275925	118	0.0508474576271186	NA	NA	NA			227			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	
RELN	Silent	p.N140N	G	G		11	Filtered Calls	7	103474037	103474037	67	0.388059701492537	NA	NA	NA			227	Reelin. {ECO:0000255|PROSITE- ProRule:PRU00363}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	
RETNLB	Silent	p.L7L	G	G	rs141416455	11	Filtered Calls	3	108476012	108476012	29	0.413793103448276	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RETNLB&recr=Open">Click here</a>	
REV3L	Intron		G	G		11	Filtered Calls	6	111654577	111654577	112	0.4375	NA	NA	NA			88			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REV3L&recr=Open">Click here</a>	
REV3L	Silent	p.P1120P	G	G		11	Filtered Calls	6	111696198	111696198	211	0.402843601895735	NA	NA	NA			88			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REV3L&recr=Open">Click here</a>	
RFPL4B	Silent	p.I182I	C	C		11	Filtered Calls	6	112671456	112671456	55	0.363636363636364	NA	NA	NA			14	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFPL4B&recr=Open">Click here</a>	
RFT1	Silent	p.F487F	G	G		11	Filtered Calls	3	53125967	53125967	122	0.229508196721311	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFT1&recr=Open">Click here</a>	
RFWD2	Intron		G	G		11	Filtered Calls	1	176012961	176012961	450	0.233333333333333	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFWD2&recr=Open">Click here</a>	
RFX5	Silent	p.A371A	G	G	rs377016578	11	Filtered Calls	1	151315400	151315400	175	0.211428571428571	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX5&recr=Open">Click here</a>	
RFX6	Silent	p.F617F	C	C		11	Filtered Calls	6	117246788	117246788	31	0.419354838709677	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX6&recr=Open">Click here</a>	
RFX7	5'UTR		G	G		11	Filtered Calls	15	56535387	56535387	35	0.228571428571429	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX7&recr=Open">Click here</a>	
RGS14	Intron		C	C		11	Filtered Calls	5	176795152	176795152	44	0.568181818181818	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS14&recr=Open">Click here</a>	
RGS14	Silent	p.R372R	G	G		11	Filtered Calls	5	176797654	176797654	65	0.384615384615385	NA	NA	NA			12	Necessary for interaction with RABGEF1. {ECO:0000250}.|RBD 1. {ECO:0000255|PROSITE- ProRule:PRU00262}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS14&recr=Open">Click here</a>	
RGS18	Silent	p.S63S	C	C		11	Filtered Calls	1	192128419	192128419	241	0.16597510373444	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS18&recr=Open">Click here</a>	
RGS22	Silent	p.F876F	G	G		11	Filtered Calls	8	101014556	101014556	128	0.2109375	NA	NA	NA			68	RGS 1. {ECO:0000255|PROSITE- ProRule:PRU00171}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS22&recr=Open">Click here</a>	
RGS3	Silent	p.F631F	C	C		11	Filtered Calls	9	116291523	116291523	184	0.0380434782608696	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS3&recr=Open">Click here</a>	
RGS7	Intron		T	T		11	Filtered Calls	1	240990393	240990393	121	0.421487603305785	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS7&recr=Open">Click here</a>	
RGS7	Silent	p.R33R	C	C		11	Filtered Calls	1	241262042	241262042	119	0.19327731092437	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS7&recr=Open">Click here</a>	
RGS8	5'UTR		C	C		11	Filtered Calls	1	182640806	182640806	118	0.186440677966102	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS8&recr=Open">Click here</a>	
RGS9	Silent	p.P548P	C	C		11	Filtered Calls	17	63221356	63221356	98	0.173469387755102	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS9&recr=Open">Click here</a>	
RHAG	Intron		G	G		11	Filtered Calls	6	49586883	49586883	95	0.273684210526316	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHAG&recr=Open">Click here</a>	
RHBDD2	Intron		G	G	rs201214533	11	Filtered Calls	7	75513163	75513163	105	0.828571428571429	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHBDD2&recr=Open">Click here</a>	
RHBDF2	Intron		A	A		11	Filtered Calls	17	74468758	74468758	47	0.191489361702128	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHBDF2&recr=Open">Click here</a>	
RHCG	Silent	p.F311F	G	G		11	Filtered Calls	15	90021110	90021110	25	0.32	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHCG&recr=Open">Click here</a>	
RHO	Silent	p.K67K	G	G		11	Filtered Calls	3	129247777	129247777	37	0.486486486486487	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHO&recr=Open">Click here</a>	
RHOT2	Silent	p.G240G	C	C		11	Filtered Calls	16	720972	720972	40	0.325	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHOT2&recr=Open">Click here</a>	
RHPN1	Silent	p.I110I	C	C		11	Filtered Calls	8	144459574	144459574	31	0.161290322580645	NA	NA	NA			9	BRO1. {ECO:0000255|PROSITE- ProRule:PRU00526}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHPN1&recr=Open">Click here</a>	
RIBC2	Intron		C	C		11	Filtered Calls	22	45826772	45826772	28	0.535714285714286	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIBC2&recr=Open">Click here</a>	
RIBC2	Intron		C	C		11	Filtered Calls	22	45826773	45826773	29	0.551724137931034	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIBC2&recr=Open">Click here</a>	
RIMBP2	Silent	p.I292I	G	G	rs145945316	11	Filtered Calls	12	130926970	130926970	81	0.234567901234568	NA	NA	NA			96			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMBP2&recr=Open">Click here</a>	
RIMBP2	Silent	p.G167G	C	C		11	Filtered Calls	12	130934774	130934774	16	0.1875	NA	NA	NA			96	SH3 1. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMBP2&recr=Open">Click here</a>	
RIMS1	Silent	p.H993H	C	C		11	Filtered Calls	6	72968740	72968740	131	0.389312977099237	NA	NA	NA			102			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMS1&recr=Open">Click here</a>	
RIMS4	Intron		G	G		11	Filtered Calls	20	43386301	43386301	34	0.441176470588235	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMS4&recr=Open">Click here</a>	
RIN3	Silent	p.S533S	C	C		11	Filtered Calls	14	93118993	93118993	14	0.214285714285714	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIN3&recr=Open">Click here</a>	
RIPK4	Intron		G	G		11	Filtered Calls	21	43166940	43166940	96	0.25	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIPK4&recr=Open">Click here</a>	
RLBP1	Intron		G	G		11	Filtered Calls	15	89758480	89758480	40	0.35	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RLBP1&recr=Open">Click here</a>	
RLTPR	Intron		C	C		11	Filtered Calls	16	67681947	67681947	16	0.75	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RLTPR&recr=Open">Click here</a>	
RLTPR	Intron		C	C		11	Filtered Calls	16	67681948	67681948	16	0.75	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RLTPR&recr=Open">Click here</a>	
RNF113B	Silent	p.R27R	C	C		11	Filtered Calls	13	98829410	98829410	62	0.274193548387097	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF113B&recr=Open">Click here</a>	
RNF122	Intron		G	G		11	Filtered Calls	8	33416298	33416298	77	0.233766233766234	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF122&recr=Open">Click here</a>	
RNF123	Silent	p.L1018L	C	C		11	Filtered Calls	3	49753051	49753051	41	0.536585365853659	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF123&recr=Open">Click here</a>	
RNF148	Silent	p.T49T	C	C		11	Filtered Calls	7	122342364	122342364	174	0.764367816091954	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF148&recr=Open">Click here</a>	
RNF149	Intron		G	G		11	Filtered Calls	2	101911650	101911650	98	0.244897959183673	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF149&recr=Open">Click here</a>	
RNF165	Silent	p.F220F	C	C	rs146872731	11	Filtered Calls	18	44030303	44030303	55	0.563636363636364	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF165&recr=Open">Click here</a>	
RNF165	3'UTR		G	G		11	Filtered Calls	18	44036605	44036605	27	0.296296296296296	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF165&recr=Open">Click here</a>	
RNF168	Silent	p.S386S	G	G		11	Filtered Calls	3	196199248	196199248	241	0.224066390041494	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF168&recr=Open">Click here</a>	
RNF175	Silent	p.T97T	C	C		11	Filtered Calls	4	154649469	154649469	251	0.235059760956175	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF175&recr=Open">Click here</a>	
RNF19B	Silent	p.I663I	G	G		11	Filtered Calls	1	33402617	33402617	192	0.958333333333333	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF19B&recr=Open">Click here</a>	
RNF213	Silent	p.I869I	T	T		11	Filtered Calls	17	78280960	78280960	470	0.504255319148936	NA	NA	NA			130			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF213&recr=Open">Click here</a>	
RNF216	Silent	p.L340L	G	G	rs376378022	11	Filtered Calls	7	5780628	5780628	271	0.029520295202952	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF216&recr=Open">Click here</a>	
RNF219	Silent	p.S461S	G	G		11	Filtered Calls	13	79190513	79190513	148	0.236486486486486	NA	NA	NA			32	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF219&recr=Open">Click here</a>	
RNF220	Silent	p.V52V	C	C		11	Filtered Calls	1	44877925	44877925	191	0.602094240837696	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF220&recr=Open">Click here</a>	
ROBO1	Silent	p.V862V	T	T		11	Filtered Calls	3	78706276	78706276	41	0.317073170731707	NA	NA	NA			44	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROBO1&recr=Open">Click here</a>	
ROBO2	Silent	p.I41I	C	C		11	Filtered Calls	3	77147226	77147226	45	0.133333333333333	NA	NA	NA			117	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROBO2&recr=Open">Click here</a>	
ROBO2	Silent	p.L50L	G	G		11	Filtered Calls	3	77147253	77147253	42	0.214285714285714	NA	NA	NA			117	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROBO2&recr=Open">Click here</a>	
ROBO2	Intron		C	C		11	Filtered Calls	3	77684206	77684206	36	0.444444444444444	NA	NA	NA			117			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROBO2&recr=Open">Click here</a>	
ROBO3	Silent	p.E383E	G	G		11	Filtered Calls	11	124741025	124741025	12	0.333333333333333	NA	NA	NA			35	Ig-like C2-type 4.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROBO3&recr=Open">Click here</a>	
ROBO4	Intron		G	G		11	Filtered Calls	11	124765590	124765590	29	0.379310344827586	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROBO4&recr=Open">Click here</a>	
ROR1	Silent	p.F352F	C	C		11	Filtered Calls	1	64608215	64608215	130	0.507692307692308	NA	NA	NA			51	Kringle. {ECO:0000255|PROSITE- ProRule:PRU00121}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROR1&recr=Open">Click here</a>	
ROS1	Silent	p.L2337L	G	G		11	Filtered Calls	6	117609688	117609688	79	0.430379746835443	NA	NA	NA			162			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROS1&recr=Open">Click here</a>	
ROS1	Silent	p.K1984K	C	C		11	Filtered Calls	6	117639404	117639404	58	0.258620689655172	NA	NA	NA			162	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROS1&recr=Open">Click here</a>	
ROS1	Silent	p.R1497R	C	C		11	Filtered Calls	6	117665256	117665256	94	0.468085106382979	NA	NA	NA			162	Fibronectin type-III 6. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROS1&recr=Open">Click here</a>	
RP1	Silent	p.V842V	G	G		11	Filtered Calls	8	55538968	55538968	158	0.069620253164557	NA	NA	NA			169			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	
RP1	Silent	p.L895L	T	T		11	Filtered Calls	8	55539125	55539125	131	0.374045801526718	NA	NA	NA			169			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	
RP1-170O19.20	Silent	p.N84N	G	G	rs370546155	11	Filtered Calls	7	27203309	27203309	162	0.0432098765432099	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1-170O19.20&recr=Open">Click here</a>	
RP11-1035H13.3	Silent	p.S94S	G	G		11	Filtered Calls	16	18809255	18809255	373	0.300268096514745	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-1035H13.3&recr=Open">Click here</a>	
RP11-1055B8.7	IGR		C	C		11	Filtered Calls	17	79408918	79408918	110	0.427272727272727	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-1055B8.7&recr=Open">Click here</a>	
RP11-108K14.8	Intron		C	C		11	Filtered Calls	10	135233524	135233524	62	0.241935483870968	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-108K14.8&recr=Open">Click here</a>	
RP11-131H24.4	5'Flank		C	C		11	Filtered Calls	14	94405716	94405716	24	0.291666666666667	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-131H24.4&recr=Open">Click here</a>	
RP11-144F15.1	Intron		C	C		11	Filtered Calls	12	107075789	107075789	112	0.482142857142857	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-144F15.1&recr=Open">Click here</a>	
RP11-287D1.3	3'UTR		G	G	rs369807491	11	Filtered Calls	2	74460607	74460607	83	0.590361445783133	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-287D1.3&recr=Open">Click here</a>	
RP11-287D1.3	3'UTR		G	G		11	Filtered Calls	2	74466528	74466528	134	0.567164179104478	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-287D1.3&recr=Open">Click here</a>	
RP11-287D1.3	3'UTR		G	G		11	Filtered Calls	2	74466560	74466560	137	0.299270072992701	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-287D1.3&recr=Open">Click here</a>	
RP11-287D1.3	3'UTR		C	C		11	Filtered Calls	2	74475553	74475553	65	0.0615384615384615	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-287D1.3&recr=Open">Click here</a>	
RP11-287D1.3	3'UTR		G	G		11	Filtered Calls	2	74477509	74477509	168	0.345238095238095	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-287D1.3&recr=Open">Click here</a>	
RP11-287D1.3	3'UTR		G	G		11	Filtered Calls	2	74477510	74477510	170	0.347058823529412	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-287D1.3&recr=Open">Click here</a>	
RP11-295K3.1	5'Flank		C	C		11	Filtered Calls	11	1780741	1780741	53	0.377358490566038	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-295K3.1&recr=Open">Click here</a>	
RP11-321M21.3	Intron		C	C		11	Filtered Calls	18	73130753	73130753	307	0.254071661237785	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-321M21.3&recr=Open">Click here</a>	
RP11-422N16.3	5'Flank		G	G		11	Filtered Calls	8	110655107	110655107	137	0.408759124087591	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-422N16.3&recr=Open">Click here</a>	
RP11-565P22.6	IGR		C	C		11	Filtered Calls	1	162352964	162352964	69	0.173913043478261	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-565P22.6&recr=Open">Click here</a>	
RP11-64J4.2	RNA		C	C		11	Filtered Calls	17	3213760	3213760	49	0.612244897959184	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-64J4.2&recr=Open">Click here</a>	
RP11-690P14.4	Intron		G	G		11	Filtered Calls	10	97778959	97778959	133	0.142857142857143	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-690P14.4&recr=Open">Click here</a>	
RP11-690P14.4	Intron		G	G		11	Filtered Calls	10	97778960	97778960	132	0.136363636363636	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-690P14.4&recr=Open">Click here</a>	
RP11-761B3.1	3'UTR		G	G	rs141614874	11	Filtered Calls	2	47357121	47357121	132	0.272727272727273	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-761B3.1&recr=Open">Click here</a>	
RP11-81K2.1	Intron		G	G		11	Filtered Calls	17	47486842	47486842	86	0.523255813953488	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-81K2.1&recr=Open">Click here</a>	
RP13-279N23.2	Intron		G	G		11	Filtered Calls	1	19209176	19209176	61	0.131147540983607	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP13-279N23.2&recr=Open">Click here</a>	
RP1L1	Silent	p.S2301S	G	G		11	Filtered Calls	8	10464705	10464705	174	0.258620689655172	NA	NA	NA			148	25 X 16 AA approximate tandem repeats of [ED]-[AT]-[PQ]-[ED]-[AVT]-E-[GKE]-[ED]- [AMT]-Q-[EPK]-[EAT]-[TSELP]-[EG]- [EGSQDI]-[AVIE].		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1L1&recr=Open">Click here</a>	
RP4-576H24.4	Intron		G	G		11	Filtered Calls	20	1552404	1552404	41	0.195121951219512	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP4-576H24.4&recr=Open">Click here</a>	
RP5-1139I1.2	RNA		G	G		11	Filtered Calls	X	118513710	118513710	54	0.555555555555556	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP5-1139I1.2&recr=Open">Click here</a>	
RP5-966M1.6	3'UTR		G	G		11	Filtered Calls	3	52853425	52853425	43	0.325581395348837	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP5-966M1.6&recr=Open">Click here</a>	
RP5-966M1.6	3'UTR		G	G	rs377222475	11	Filtered Calls	3	52858972	52858972	63	0.428571428571429	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP5-966M1.6&recr=Open">Click here</a>	
RPA2	Silent	p.N210N	G	G		11	Filtered Calls	1	28220804	28220804	174	0.298850574712644	NA	NA	NA			11	Interaction with RAD52, TIPIN, UNG and XPA.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPA2&recr=Open">Click here</a>	
RPE	5'UTR		G	G		11	Filtered Calls	2	210867383	210867383	74	0.351351351351351	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPE&recr=Open">Click here</a>	
RPGRIP1L	Silent	p.F844F	G	G		11	Filtered Calls	16	53679688	53679688	159	0.238993710691824	NA	NA	NA			46	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPGRIP1L&recr=Open">Click here</a>	
RPH3AL	Silent	p.T194T	G	G		11	Filtered Calls	17	96933	96933	44	0.318181818181818	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPH3AL&recr=Open">Click here</a>	
RPH3AL	Silent	p.I5I	G	G		11	Filtered Calls	17	177320	177320	24	0.125	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPH3AL&recr=Open">Click here</a>	
RPL10	Intron		G	G	rs368589203	11	Filtered Calls	X	153627940	153627940	91	0.461538461538462	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPL10&recr=Open">Click here</a>	
RPL10L	Silent	p.V148V	C	C		11	Filtered Calls	14	47120496	47120496	61	0.39344262295082	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPL10L&recr=Open">Click here</a>	
RPL17-C18orf32	Intron		A	A	rs146036347	11	Filtered Calls	18	47017667	47017667	556	0.0161870503597122	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPL17-C18orf32&recr=Open">Click here</a>	
RPL18	Silent	p.I67I	G	G		11	Filtered Calls	19	49120079	49120079	242	0.161157024793388	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPL18&recr=Open">Click here</a>	
RPL36	Silent	p.L70L	C	C		11	Filtered Calls	19	5691446	5691446	119	0.403361344537815	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPL36&recr=Open">Click here</a>	
RPL4	Intron		C	C		11	Filtered Calls	15	66816081	66816081	237	0.274261603375527	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPL4&recr=Open">Click here</a>	
RPN1	Intron		G	G		11	Filtered Calls	3	128351008	128351008	74	0.0810810810810811	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPN1&recr=Open">Click here</a>	
RPS15	Silent	p.K14K	G	G		11	Filtered Calls	19	1438823	1438823	21	0.428571428571429	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPS15&recr=Open">Click here</a>	
RPS27A	5'UTR		C	C		11	Filtered Calls	2	55459957	55459957	36	0.166666666666667	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPS27A&recr=Open">Click here</a>	
RPS6KB2	Silent	p.P197P	C	C		11	Filtered Calls	11	67200283	67200283	46	0.456521739130435	NA	NA	NA			25	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPS6KB2&recr=Open">Click here</a>	
RPS9	Silent	p.I130I	C	C	rs200897465	11	Filtered Calls	19	54710313	54710313	88	0.136363636363636	NA	NA	NA			20	S4 RNA-binding. {ECO:0000255|PROSITE- ProRule:PRU00182}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPS9&recr=Open">Click here</a>	
RPTOR	Intron		T	T		11	Filtered Calls	17	78919455	78919455	94	0.212765957446809	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPTOR&recr=Open">Click here</a>	
RPTOR	Intron		C	C		11	Filtered Calls	17	78931536	78931536	50	0.24	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPTOR&recr=Open">Click here</a>	
RPTOR	Silent	p.A1258A	C	C		11	Filtered Calls	17	78936342	78936342	75	0.2	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPTOR&recr=Open">Click here</a>	
RPUSD4	Intron		G	G		11	Filtered Calls	11	126079626	126079626	86	0.430232558139535	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPUSD4&recr=Open">Click here</a>	
RRAD	Silent	p.F177F	G	G		11	Filtered Calls	16	66957537	66957537	83	0.590361445783133	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRAD&recr=Open">Click here</a>	
RRBP1	Intron		G	G		11	Filtered Calls	20	17601460	17601460	19	0.684210526315789	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRBP1&recr=Open">Click here</a>	
RRBP1	Silent	p.L215L	G	G		11	Filtered Calls	20	17623741	17623741	34	0.205882352941176	NA	NA	NA			28	41 X 10 AA approximate tandem repeats of [TN]-Q-[GSA]-[KRQT]-K-[ATGSV]-[ED]- [GTAS]-[ATIS]-[PQTAS].		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRBP1&recr=Open">Click here</a>	
RREB1	Silent	p.A1519A	G	G		11	Filtered Calls	6	7247240	7247240	12	0.75	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RREB1&recr=Open">Click here</a>	
RRM1	Intron		T	T		11	Filtered Calls	11	4128621	4128621	69	0.318840579710145	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRM1&recr=Open">Click here</a>	
RRP12	Intron		G	G		11	Filtered Calls	10	99131931	99131931	32	0.1875	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRP12&recr=Open">Click here</a>	
RRP12	Silent	p.R510R	C	C	rs375727600	11	Filtered Calls	10	99140559	99140559	41	0.439024390243902	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRP12&recr=Open">Click here</a>	
RRP8	Intron		C	C		11	Filtered Calls	11	6622551	6622551	11	0.818181818181818	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRP8&recr=Open">Click here</a>	
RRP8	Intron		C	C		11	Filtered Calls	11	6622552	6622552	11	0.818181818181818	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRP8&recr=Open">Click here</a>	
RRP9	Silent	p.I161I	G	G		11	Filtered Calls	3	51971242	51971242	93	0.204301075268817	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRP9&recr=Open">Click here</a>	
RSAD2	Silent	p.I154I	C	C		11	Filtered Calls	2	7023617	7023617	78	0.217948717948718	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSAD2&recr=Open">Click here</a>	
RSF1	Intron		T	T		11	Filtered Calls	11	77386077	77386077	96	0.458333333333333	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSF1&recr=Open">Click here</a>	
RSPH3	Silent	p.A93A	G	G		11	Filtered Calls	6	159407379	159407379	232	0.375	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSPH3&recr=Open">Click here</a>	
RSRC2	Silent	p.G311G	T	T		11	Filtered Calls	12	122992867	122992867	291	0.281786941580756	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSRC2&recr=Open">Click here</a>	
RSU1	Silent	p.L169L	G	G		11	Filtered Calls	10	16794631	16794631	202	0.242574257425743	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSU1&recr=Open">Click here</a>	
RTCB	Intron		G	G		11	Filtered Calls	22	32791208	32791208	78	0.141025641025641	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RTCB&recr=Open">Click here</a>	
RTF1	Intron		C	C		11	Filtered Calls	15	41772408	41772408	78	0.320512820512821	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RTF1&recr=Open">Click here</a>	
RTKN	IGR		C	C		11	Filtered Calls	2	74651994	74651994	325	0.206153846153846	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RTKN&recr=Open">Click here</a>	
RTKN2	Intron		A	A		11	Filtered Calls	10	63977951	63977951	206	0.169902912621359	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RTKN2&recr=Open">Click here</a>	
RUFY1	Intron		C	C		11	Filtered Calls	5	179004069	179004069	147	0.360544217687075	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RUFY1&recr=Open">Click here</a>	
RUFY2	Intron		G	G		11	Filtered Calls	10	70138312	70138312	99	0.303030303030303	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RUFY2&recr=Open">Click here</a>	
RUNDC1	Silent	p.G579G	C	C		11	Filtered Calls	17	41143628	41143628	39	0.41025641025641	NA	NA	NA			8	RUN. {ECO:0000255|PROSITE- ProRule:PRU00178}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RUNDC1&recr=Open">Click here</a>	
RUNX1T1	Silent	p.T602T	G	G		11	Filtered Calls	8	92972479	92972479	12	0.333333333333333	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RUNX1T1&recr=Open">Click here</a>	
RUNX1T1	Silent	p.V456V	C	C		11	Filtered Calls	8	92983057	92983057	47	0.276595744680851	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RUNX1T1&recr=Open">Click here</a>	
RUNX1T1	Intron		G	G		11	Filtered Calls	8	92998562	92998562	103	0.310679611650485	NA	NA	NA			86			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RUNX1T1&recr=Open">Click here</a>	
RYR1	Intron		G	G		11	Filtered Calls	19	38933099	38933099	33	0.121212121212121	NA	NA	NA			285			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	
RYR1	Silent	p.L368L	C	C		11	Filtered Calls	19	38939435	38939435	25	0.16	NA	NA	NA			285	MIR 5. {ECO:0000255|PROSITE- ProRule:PRU00131}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	
RYR1	Silent	p.L589L	G	G		11	Filtered Calls	19	38946367	38946367	44	0.204545454545455	NA	NA	NA			285	B30.2/SPRY 1. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	
RYR1	Intron		G	G		11	Filtered Calls	19	38954496	38954496	43	0.581395348837209	NA	NA	NA			285			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	
RYR1	Silent	p.I1649I	C	C		11	Filtered Calls	19	38976242	38976242	55	0.181818181818182	NA	NA	NA			285	6 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	
RYR1	Silent	p.I2182I	C	C		11	Filtered Calls	19	38985263	38985263	66	0.151515151515152	NA	NA	NA			285	6 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	
RYR2	Silent	p.A165A	C	C		11	Filtered Calls	1	237540654	237540654	73	0.136986301369863	NA	NA	NA			586	MIR 1. {ECO:0000255|PROSITE- ProRule:PRU00131}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	
RYR2	Silent	p.I755I	C	C		11	Filtered Calls	1	237664072	237664072	377	0.175066312997347	NA	NA	NA			586	B30.2/SPRY 1. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	
RYR2	Intron		G	G		11	Filtered Calls	1	237872876	237872876	26	0.692307692307692	NA	NA	NA			586			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	
RYR2	Silent	p.G3894G	G	G		11	Filtered Calls	1	237936855	237936855	129	0.410852713178295	NA	NA	NA			586			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	
RYR2	Silent	p.V4854V	T	T		11	Filtered Calls	1	237982464	237982464	147	0.659863945578231	NA	NA	NA			586			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	
RYR3	Silent	p.S405S	C	C		11	Filtered Calls	15	33858947	33858947	131	0.312977099236641	NA	NA	NA			311			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	
RYR3	Silent	p.L2614L	G	G		11	Filtered Calls	15	34034588	34034588	120	0.558333333333333	NA	NA	NA			311	4 X approximate repeats.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	
RYR3	Silent	p.I3172I	C	C		11	Filtered Calls	15	34078110	34078110	195	0.297435897435897	NA	NA	NA			311			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	
RYR3	Silent	p.L4162L	C	C		11	Filtered Calls	15	34130665	34130665	60	0.666666666666667	NA	NA	NA			311			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	
S100A6	5'UTR		G	G		11	Filtered Calls	1	153507816	153507816	141	0.205673758865248	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+S100A6&recr=Open">Click here</a>	
S100A7	Silent	p.S97S	G	G		11	Filtered Calls	1	153430297	153430297	78	0.205128205128205	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+S100A7&recr=Open">Click here</a>	
S1PR1	Silent	p.L278L	G	G		11	Filtered Calls	1	101705374	101705374	176	0.323863636363636	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+S1PR1&recr=Open">Click here</a>	
SACS	Silent	p.H1315H	G	G		11	Filtered Calls	13	23914070	23914070	115	0.252173913043478	NA	NA	NA			189			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SACS&recr=Open">Click here</a>	
SACS	Silent	p.F524F	G	G		11	Filtered Calls	13	23929179	23929179	136	0.316176470588235	NA	NA	NA			189			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SACS&recr=Open">Click here</a>	
SALL1	5'Flank		G	G	rs79975375	11	Filtered Calls	16	51175566	51175566	54	0.333333333333333	NA	NA	NA			126			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SALL1&recr=Open">Click here</a>	
SALL1	5'Flank		T	T	rs28643388	11	Filtered Calls	16	51175841	51175841	120	0.3	NA	NA	NA			126			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SALL1&recr=Open">Click here</a>	
SALL3	Silent	p.S662S	G	G		11	Filtered Calls	18	76753977	76753977	5	0.6	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SALL3&recr=Open">Click here</a>	
SAMD11	Intron		G	G		11	Filtered Calls	1	866476	866476	28	0.285714285714286	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAMD11&recr=Open">Click here</a>	
SAMD3	Silent	p.V129V	C	C		11	Filtered Calls	6	130505759	130505759	44	0.409090909090909	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAMD3&recr=Open">Click here</a>	
SAMM50	Silent	p.I353I	C	C		11	Filtered Calls	22	44379864	44379864	209	0.172248803827751	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAMM50&recr=Open">Click here</a>	
SAMSN1	Silent	p.P49P	G	G		11	Filtered Calls	21	15889345	15889345	106	0.160377358490566	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAMSN1&recr=Open">Click here</a>	
SAPCD1	5'Flank		C	C		11	Filtered Calls	6	31730243	31730243	226	0.221238938053097	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAPCD1&recr=Open">Click here</a>	
SART1	Silent	p.L426L	C	C	rs201336410	11	Filtered Calls	11	65734819	65734819	144	0.416666666666667	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SART1&recr=Open">Click here</a>	
SATL1	Silent	p.G391G	C	C		11	Filtered Calls	X	84362802	84362802	17	0.529411764705882	NA	NA	NA			29	N-acetyltransferase. {ECO:0000255|PROSITE-ProRule:PRU00532}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SATL1&recr=Open">Click here</a>	
SCAF1	Silent	p.P139P	C	C		11	Filtered Calls	19	50150026	50150026	45	0.266666666666667	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAF1&recr=Open">Click here</a>	
SCAF4	Silent	p.P880P	G	G		11	Filtered Calls	21	33044516	33044516	96	0.635416666666667	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAF4&recr=Open">Click here</a>	
SCAND3	Silent	p.F794F	G	G		11	Filtered Calls	6	28541284	28541284	144	0.208333333333333	NA	NA	NA			71			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAND3&recr=Open">Click here</a>	
SCARF1	Silent	p.F505F	G	G		11	Filtered Calls	17	1540121	1540121	133	0.390977443609023	NA	NA	NA			20	Pro/Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCARF1&recr=Open">Click here</a>	
SCD5	Intron		A	A		11	Filtered Calls	4	83582085	83582085	293	0.273037542662116	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCD5&recr=Open">Click here</a>	
SCD5	Silent	p.F125F	G	G		11	Filtered Calls	4	83602054	83602054	86	0.27906976744186	NA	NA	NA		p.F125F(4)	13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCD5&recr=Open">Click here</a>	
SCEL	Intron		C	C		11	Filtered Calls	13	78133927	78133927	170	0.258823529411765	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCEL&recr=Open">Click here</a>	
SCFD2	Silent	p.D676D	G	G		11	Filtered Calls	4	53740163	53740163	139	0.23021582733813	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCFD2&recr=Open">Click here</a>	
SCFD2	Silent	p.L628L	G	G		11	Filtered Calls	4	53751992	53751992	60	0.483333333333333	NA	NA	NA		p.L628L(1)	30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCFD2&recr=Open">Click here</a>	
SCG2	Silent	p.L463L	G	G		11	Filtered Calls	2	224462614	224462614	228	0.592105263157895	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCG2&recr=Open">Click here</a>	
SCIN	Intron		C	C		11	Filtered Calls	7	12691463	12691463	36	0.444444444444444	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCIN&recr=Open">Click here</a>	
SCLY	Silent	p.F122F	C	C		11	Filtered Calls	2	238977976	238977976	66	0.212121212121212	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCLY&recr=Open">Click here</a>	
SCMH1	Intron		G	G		11	Filtered Calls	1	41512275	41512275	60	0.4	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCMH1&recr=Open">Click here</a>	
SCMH1	Silent	p.F139F	G	G		11	Filtered Calls	1	41582648	41582648	68	0.264705882352941	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCMH1&recr=Open">Click here</a>	
SCN10A	Silent	p.V1300V	C	C		11	Filtered Calls	3	38753841	38753841	154	0.253246753246753	NA	NA	NA			150			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN10A&recr=Open">Click here</a>	
SCN10A	Intron		G	G		11	Filtered Calls	3	38766811	38766811	19	0.368421052631579	NA	NA	NA			150			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN10A&recr=Open">Click here</a>	
SCN10A	Silent	p.S341S	G	G		11	Filtered Calls	3	38798578	38798578	60	0.1	NA	NA	NA			150			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN10A&recr=Open">Click here</a>	
SCN11A	Intron		G	G		11	Filtered Calls	3	38927607	38927607	137	0.218978102189781	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN11A&recr=Open">Click here</a>	
SCN11A	Silent	p.L230L	C	C		11	Filtered Calls	3	38966928	38966928	95	0.168421052631579	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN11A&recr=Open">Click here</a>	
SCN2A	Intron		C	C		11	Filtered Calls	2	166153524	166153524	90	0.2	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN2A&recr=Open">Click here</a>	
SCN2A	Silent	p.L656L	C	C		11	Filtered Calls	2	166179960	166179960	39	0.230769230769231	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN2A&recr=Open">Click here</a>	
SCN2A	Silent	p.G1191G	G	G	rs267598962	11	Filtered Calls	2	166223779	166223779	162	0.234567901234568	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN2A&recr=Open">Click here</a>	
SCN3A	Silent	p.R1317R	C	C		11	Filtered Calls	2	165956827	165956827	283	0.229681978798587	NA	NA	NA			120			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN3A&recr=Open">Click here</a>	
SCN4A	Silent	p.L1489L	G	G	rs374297500	11	Filtered Calls	17	62019175	62019175	75	0.453333333333333	NA	NA	NA			101			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN4A&recr=Open">Click here</a>	
SCN5A	Silent	p.E1554E	C	C		11	Filtered Calls	3	38595918	38595918	108	0.453703703703704	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN5A&recr=Open">Click here</a>	
SCN7A	Silent	p.E815E	C	C		11	Filtered Calls	2	167288975	167288975	285	0.621052631578947	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN7A&recr=Open">Click here</a>	
SCN7A	Silent	p.L522L	C	C		11	Filtered Calls	2	167301332	167301332	37	0.243243243243243	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN7A&recr=Open">Click here</a>	
SCN7A	Intron		G	G		11	Filtered Calls	2	167301518	167301518	25	0.32	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN7A&recr=Open">Click here</a>	
SCN7A	Intron		A	A		11	Filtered Calls	2	167322047	167322047	26	0.346153846153846	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN7A&recr=Open">Click here</a>	
SCN7A	Silent	p.F175F	G	G		11	Filtered Calls	2	167328874	167328874	60	0.25	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN7A&recr=Open">Click here</a>	
SCN7A	Silent	p.F120F	G	G		11	Filtered Calls	2	167330392	167330392	131	0.267175572519084	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN7A&recr=Open">Click here</a>	
SCN9A	Silent	p.I1636I	G	G		11	Filtered Calls	2	167056208	167056208	131	0.290076335877863	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN9A&recr=Open">Click here</a>	
SCN9A	Silent	p.T1244T	G	G	rs201040437	11	Filtered Calls	2	167094640	167094640	43	0.441860465116279	NA	NA	NA			108			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN9A&recr=Open">Click here</a>	
SCTR	Silent	p.I348I	G	G	rs202090092	11	Filtered Calls	2	120204431	120204431	78	0.384615384615385	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCTR&recr=Open">Click here</a>	
SCUBE1	Intron		G	G	rs373325677	11	Filtered Calls	22	43619227	43619227	115	0.217391304347826	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCUBE1&recr=Open">Click here</a>	
SCUBE1	Silent	p.C59C	G	G		11	Filtered Calls	22	43735153	43735153	56	0.464285714285714	NA	NA	NA			31	EGF-like 1; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCUBE1&recr=Open">Click here</a>	
SCYL2	Silent	p.L233L	T	T		11	Filtered Calls	12	100706276	100706276	91	0.505494505494505	NA	NA	NA			41	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCYL2&recr=Open">Click here</a>	
SDCCAG8	Silent	p.N277N	C	C		11	Filtered Calls	1	243471381	243471381	343	0.425655976676385	NA	NA	NA			29	Sufficient for homodimerization. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDCCAG8&recr=Open">Click here</a>	
SDK1	Silent	p.R500R	G	G		11	Filtered Calls	7	4007020	4007020	242	0.214876033057851	NA	NA	NA			153	Ig-like C2-type 5.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDK1&recr=Open">Click here</a>	
SDK1	Intron		C	C		11	Filtered Calls	7	4088971	4088971	39	0.282051282051282	NA	NA	NA			153			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDK1&recr=Open">Click here</a>	
SDK1	Silent	p.V1676V	C	C	rs145808805	11	Filtered Calls	7	4218208	4218208	96	0.3125	NA	NA	NA			153	Fibronectin type-III 10. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDK1&recr=Open">Click here</a>	
SDK1	Silent	p.S1801S	C	C		11	Filtered Calls	7	4249718	4249718	99	0.161616161616162	NA	NA	NA			153			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDK1&recr=Open">Click here</a>	
SDK2	Silent	p.P817P	G	G		11	Filtered Calls	17	71410816	71410816	89	0.224719101123595	NA	NA	NA			86	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDK2&recr=Open">Click here</a>	
SEC14L3	Silent	p.G201G	G	G		11	Filtered Calls	22	30860868	30860868	118	0.203389830508475	NA	NA	NA			19	CRAL-TRIO. {ECO:0000255|PROSITE- ProRule:PRU00056}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC14L3&recr=Open">Click here</a>	
SEC14L3	Silent	p.L160L	C	C	rs142636401	11	Filtered Calls	22	30863008	30863008	224	0.1875	NA	NA	NA			19	CRAL-TRIO. {ECO:0000255|PROSITE- ProRule:PRU00056}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC14L3&recr=Open">Click here</a>	
SEC16B	Intron		C	C		11	Filtered Calls	1	177902615	177902615	23	0.217391304347826	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC16B&recr=Open">Click here</a>	
SEC24C	Silent	p.I453I	C	C		11	Filtered Calls	10	75525340	75525340	110	0.218181818181818	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC24C&recr=Open">Click here</a>	
SEC61A2	Intron		T	T		11	Filtered Calls	10	12199896	12199896	123	0.260162601626016	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC61A2&recr=Open">Click here</a>	
SEH1L	3'UTR		C	C		11	Filtered Calls	18	12986867	12986867	28	0.5	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEH1L&recr=Open">Click here</a>	
SEL1L2	Silent	p.L68L	G	G		11	Filtered Calls	20	13912330	13912330	191	0.209424083769634	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEL1L2&recr=Open">Click here</a>	
SELP	Intron		C	C		11	Filtered Calls	1	169562835	169562835	120	0.241666666666667	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SELP&recr=Open">Click here</a>	
SELPLG	Silent	p.L408L	C	C		11	Filtered Calls	12	109016908	109016908	5	1	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SELPLG&recr=Open">Click here</a>	
SEMA3A	Silent	p.R359R	C	C		11	Filtered Calls	7	83636732	83636732	118	0.440677966101695	NA	NA	NA			53	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA3A&recr=Open">Click here</a>	
SEMA3E	Silent	p.E730E	C	C		11	Filtered Calls	7	82997040	82997040	180	0.4	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA3E&recr=Open">Click here</a>	
SEMA3E	Intron		C	C		11	Filtered Calls	7	83029336	83029336	244	0.0778688524590164	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA3E&recr=Open">Click here</a>	
SEMA3E	Intron		A	A		11	Filtered Calls	7	83029570	83029570	81	0.271604938271605	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA3E&recr=Open">Click here</a>	
SEMA4F	Intron		T	T		11	Filtered Calls	2	74889849	74889849	549	0.53551912568306	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA4F&recr=Open">Click here</a>	
SEMA4F	Silent	p.S595S	C	C		11	Filtered Calls	2	74906808	74906808	186	0.241935483870968	NA	NA	NA			45	Ig-like C2-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA4F&recr=Open">Click here</a>	
SEMA4F	Silent	p.L671L	C	C	rs372248795	11	Filtered Calls	2	74907036	74907036	63	0.111111111111111	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA4F&recr=Open">Click here</a>	
SEMA5A	Silent	p.F729F	G	G		11	Filtered Calls	5	9066645	9066645	217	0.188940092165899	NA	NA	NA			81	TSP type-1 4. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA5A&recr=Open">Click here</a>	
SEMA5B	Intron		G	G		11	Filtered Calls	3	122632855	122632855	21	0.571428571428571	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA5B&recr=Open">Click here</a>	
SEMA6B	Silent	p.F285F	G	G		11	Filtered Calls	19	4552568	4552568	43	0.534883720930233	NA	NA	NA		p.F285F(1)	21	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA6B&recr=Open">Click here</a>	
SEMA6C	Intron		G	G		11	Filtered Calls	1	151106926	151106926	12	0.5	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA6C&recr=Open">Click here</a>	
SEMA6C	Silent	p.T141T	C	C		11	Filtered Calls	1	151111139	151111139	96	0.270833333333333	NA	NA	NA			28	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA6C&recr=Open">Click here</a>	
SEMA6D	Intron		C	C		11	Filtered Calls	15	48060953	48060953	110	0.245454545454545	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA6D&recr=Open">Click here</a>	
SEMG2	Silent	p.L166L	C	C		11	Filtered Calls	20	43850769	43850769	103	0.281553398058252	NA	NA	NA			36	Repeat-rich region.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMG2&recr=Open">Click here</a>	
SENP6	Intron		C	C		11	Filtered Calls	6	76423221	76423221	182	0.373626373626374	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SENP6&recr=Open">Click here</a>	
SEPP1	Intron		G	G		11	Filtered Calls	5	42804880	42804880	83	0.180722891566265	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEPP1&recr=Open">Click here</a>	
SEPT4	Intron		G	G		11	Filtered Calls	17	56603154	56603154	94	0.521276595744681	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEPT4&recr=Open">Click here</a>	
SEPT4	Silent	p.G9G	C	C		11	Filtered Calls	17	56606509	56606509	132	0.053030303030303	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEPT4&recr=Open">Click here</a>	
SEPT6	Silent	p.S190S	C	C		11	Filtered Calls	X	118784020	118784020	117	0.341880341880342	NA	NA	NA			17	Septin-type G.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEPT6&recr=Open">Click here</a>	
SEPT9	Silent	p.L45L	C	C		11	Filtered Calls	17	75398220	75398220	71	0.225352112676056	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEPT9&recr=Open">Click here</a>	
SERINC5	Intron		G	G		11	Filtered Calls	5	79454652	79454652	105	0.323809523809524	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERINC5&recr=Open">Click here</a>	
SERPINA1	Intron		G	G		11	Filtered Calls	14	94845793	94845793	69	0.347826086956522	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINA1&recr=Open">Click here</a>	
SERPINA3	Silent	p.L47L	C	C	rs201175080	11	Filtered Calls	14	95080919	95080919	53	0.245283018867925	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINA3&recr=Open">Click here</a>	
SERPINB10	Silent	p.I99I	C	C		11	Filtered Calls	18	61585261	61585261	106	0.39622641509434	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINB10&recr=Open">Click here</a>	
SERPINB6	Silent	p.A37A	G	G		11	Filtered Calls	6	2959456	2959456	200	0.205	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINB6&recr=Open">Click here</a>	
SERPINC1	Silent	p.L343L	C	C		11	Filtered Calls	1	173878814	173878814	136	0.397058823529412	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINC1&recr=Open">Click here</a>	
SERPINE3	Silent	p.L59L	C	C		11	Filtered Calls	13	51915404	51915404	51	0.607843137254902	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINE3&recr=Open">Click here</a>	
SERPINI2	Silent	p.I354I	G	G		11	Filtered Calls	3	167164259	167164259	245	0.244897959183673	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINI2&recr=Open">Click here</a>	
SERTAD3	Silent	p.P111P	G	G		11	Filtered Calls	19	40947655	40947655	176	0.272727272727273	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERTAD3&recr=Open">Click here</a>	
SESN2	Silent	p.D346D	C	C		11	Filtered Calls	1	28601353	28601353	99	0.404040404040404	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SESN2&recr=Open">Click here</a>	
SETBP1	Silent	p.G1037G	G	G		11	Filtered Calls	18	42532416	42532416	16	0.375	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETBP1&recr=Open">Click here</a>	
SETD1A	Silent	p.C114C	C	C		11	Filtered Calls	16	30972683	30972683	142	0.309859154929577	NA	NA	NA			59	RRM. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETD1A&recr=Open">Click here</a>	
SETX	Intron		G	G		11	Filtered Calls	9	135150819	135150819	86	0.197674418604651	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETX&recr=Open">Click here</a>	
SETX	Silent	p.F837F	G	G		11	Filtered Calls	9	135204474	135204474	145	0.317241379310345	NA	NA	NA			97			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETX&recr=Open">Click here</a>	
SF3B2	Silent	p.P235P	C	C		11	Filtered Calls	11	65824825	65824825	89	0.561797752808989	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SF3B2&recr=Open">Click here</a>	
SFTA2	Silent	p.L28L	C	C		11	Filtered Calls	6	30899550	30899550	109	0.192660550458716	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SFTA2&recr=Open">Click here</a>	
SFTPA1	Intron		G	G		11	Filtered Calls	10	81372190	81372190	93	0.193548387096774	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SFTPA1&recr=Open">Click here</a>	
SFTPD	Silent	p.T275T	C	C	rs200300388	11	Filtered Calls	10	81697911	81697911	109	0.220183486238532	NA	NA	NA			17	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SFTPD&recr=Open">Click here</a>	
SGCZ	Intron		A	A		11	Filtered Calls	8	13960019	13960019	32	0.125	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGCZ&recr=Open">Click here</a>	
SGK223	Silent	p.P354P	G	G		11	Filtered Calls	8	8234857	8234857	15	0.266666666666667	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGK223&recr=Open">Click here</a>	
SGK223	Silent	p.S93S	G	G		11	Filtered Calls	8	8238979	8238979	142	0.204225352112676	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGK223&recr=Open">Click here</a>	
SGK223	Silent	p.R68R	G	G		11	Filtered Calls	8	8239054	8239054	66	0.166666666666667	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGK223&recr=Open">Click here</a>	
SGPP2	Intron		C	C		11	Filtered Calls	2	223389655	223389655	74	0.324324324324324	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGPP2&recr=Open">Click here</a>	
SGSM1	Intron		C	C		11	Filtered Calls	22	25272535	25272535	137	0.328467153284672	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGSM1&recr=Open">Click here</a>	
SGSM1	Silent	p.V738V	C	C		11	Filtered Calls	22	25294130	25294130	65	0.261538461538462	NA	NA	NA			41	Rab-GAP TBC. {ECO:0000255|PROSITE- ProRule:PRU00163}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGSM1&recr=Open">Click here</a>	
SH2D7	Silent	p.P40P	C	C		11	Filtered Calls	15	78385046	78385046	23	0.391304347826087	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH2D7&recr=Open">Click here</a>	
SH3BGRL	Silent	p.A93A	C	C		11	Filtered Calls	X	80533877	80533877	77	0.506493506493506	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3BGRL&recr=Open">Click here</a>	
SH3BP2	Silent	p.Q70Q	G	G		11	Filtered Calls	4	2824735	2824735	27	0.333333333333333	NA	NA	NA			20	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3BP2&recr=Open">Click here</a>	
SH3GL3	Intron		A	A		11	Filtered Calls	15	84159628	84159628	160	0.275	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3GL3&recr=Open">Click here</a>	
SH3RF1	Silent	p.A705A	T	T		11	Filtered Calls	4	170037444	170037444	188	0.276595744680851	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3RF1&recr=Open">Click here</a>	
SH3TC1	Intron		C	C		11	Filtered Calls	4	8234222	8234222	23	0.260869565217391	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3TC1&recr=Open">Click here</a>	
SH3TC2	Intron		C	C		11	Filtered Calls	5	148441883	148441883	121	0.43801652892562	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3TC2&recr=Open">Click here</a>	
SHANK1	Silent	p.P2130P	G	G		11	Filtered Calls	19	51165318	51165318	40	0.15	NA	NA	NA			64	SAM. {ECO:0000255|PROSITE- ProRule:PRU00184}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHANK1&recr=Open">Click here</a>	
SHARPIN	Silent	p.L135L	C	C		11	Filtered Calls	8	145154944	145154944	172	0.232558139534884	NA	NA	NA			7	Self-association. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHARPIN&recr=Open">Click here</a>	
SHD	3'UTR		C	C		11	Filtered Calls	19	4290638	4290638	15	0.333333333333333	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHD&recr=Open">Click here</a>	
SHMT1	Intron		G	G		11	Filtered Calls	17	18251836	18251836	96	0.364583333333333	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHMT1&recr=Open">Click here</a>	
SHROOM1	Silent	p.G825G	G	G		11	Filtered Calls	5	132158572	132158572	25	0.44	NA	NA	NA			17	ASD2. {ECO:0000255|PROSITE- ProRule:PRU00638}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHROOM1&recr=Open">Click here</a>	
SI	Intron		T	T		11	Filtered Calls	3	164755683	164755683	87	0.275862068965517	NA	NA	NA			218			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SI&recr=Open">Click here</a>	
SI	Intron		T	T		11	Filtered Calls	3	164755684	164755684	88	0.272727272727273	NA	NA	NA			218			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SI&recr=Open">Click here</a>	
SIDT1	Intron		C	C	rs566409278	11	Filtered Calls	3	113344943	113344943	124	0.379032258064516	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIDT1&recr=Open">Click here</a>	
SIDT2	Intron		C	C		11	Filtered Calls	11	117063532	117063532	36	0.861111111111111	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIDT2&recr=Open">Click here</a>	
SIGLEC1	Intron		G	G		11	Filtered Calls	20	3674355	3674355	26	0.269230769230769	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC1&recr=Open">Click here</a>	
SIGLEC1	Intron		C	C		11	Filtered Calls	20	3687715	3687715	41	0.439024390243902	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC1&recr=Open">Click here</a>	
SIGLEC10	Silent	p.I413I	G	G		11	Filtered Calls	19	51917717	51917717	40	0.275	NA	NA	NA			58	Ig-like C2-type 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC10&recr=Open">Click here</a>	
SIGLEC10	Intron		C	C		11	Filtered Calls	19	51920331	51920331	47	0.234042553191489	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC10&recr=Open">Click here</a>	
SIGLEC5	3'UTR		C	C		11	Filtered Calls	19	52115482	52115482	85	0.117647058823529	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC5&recr=Open">Click here</a>	
SIGLEC5	Intron		G	G	rs549022941	11	Filtered Calls	19	52131352	52131352	31	0.161290322580645	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC5&recr=Open">Click here</a>	
SIGLEC6	Intron		G	G		11	Filtered Calls	19	52033743	52033743	27	0.518518518518518	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC6&recr=Open">Click here</a>	
SIGLEC6	Silent	p.R101R	C	C		11	Filtered Calls	19	52034538	52034538	64	0.09375	NA	NA	NA			28	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC6&recr=Open">Click here</a>	
SIGLEC9	Silent	p.F118F	C	C		11	Filtered Calls	19	51628585	51628585	51	0.0980392156862745	NA	NA	NA			45	Ig-like V-type.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC9&recr=Open">Click here</a>	
SIK3	Silent	p.G770G	G	G		11	Filtered Calls	11	116730292	116730292	56	0.392857142857143	NA	NA	NA			57	Gln-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIK3&recr=Open">Click here</a>	
SIM1	Silent	p.A221A	G	G		11	Filtered Calls	6	100896435	100896435	19	0.210526315789474	NA	NA	NA		p.A221A(1)	79	PAS 2. {ECO:0000255|PROSITE- ProRule:PRU00140}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIM1&recr=Open">Click here</a>	
SIM2	Silent	p.N507N	T	T		11	Filtered Calls	21	38117382	38117382	24	0.291666666666667	NA	NA	NA			16	Single-minded C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00632}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIM2&recr=Open">Click here</a>	
SIN3A	Silent	p.T996T	G	G		11	Filtered Calls	15	75682026	75682026	218	0.247706422018349	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIN3A&recr=Open">Click here</a>	
SIN3B	Silent	p.I629I	C	C		11	Filtered Calls	19	16980351	16980351	43	0.27906976744186	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIN3B&recr=Open">Click here</a>	
SIPA1L1	Silent	p.L552L	C	C		11	Filtered Calls	14	72090789	72090789	185	0.454054054054054	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIPA1L1&recr=Open">Click here</a>	
SIPA1L1	Silent	p.P1088P	C	C		11	Filtered Calls	14	72152238	72152238	18	0.277777777777778	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIPA1L1&recr=Open">Click here</a>	
SIPA1L2	Silent	p.S379S	G	G		11	Filtered Calls	1	232649949	232649949	247	0.263157894736842	NA	NA	NA			103			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIPA1L2&recr=Open">Click here</a>	
SIPA1L3	Silent	p.L559L	C	C		11	Filtered Calls	19	38590611	38590611	77	0.103896103896104	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIPA1L3&recr=Open">Click here</a>	
SIPA1L3	Silent	p.A601A	C	C		11	Filtered Calls	19	38590739	38590739	48	0.1875	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIPA1L3&recr=Open">Click here</a>	
SIPA1L3	Silent	p.I886I	C	C	rs199695282	11	Filtered Calls	19	38610312	38610312	92	0.141304347826087	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIPA1L3&recr=Open">Click here</a>	
SIPA1L3	Silent	p.T1317T	C	C		11	Filtered Calls	19	38655289	38655289	17	0.470588235294118	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIPA1L3&recr=Open">Click here</a>	
SIRT6	IGR		C	C		11	Filtered Calls	19	4171373	4171373	25	0.2	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIRT6&recr=Open">Click here</a>	
SIRT7	Silent	p.L186L	G	G		11	Filtered Calls	17	79872501	79872501	169	0.710059171597633	NA	NA	NA			13	Deacetylase sirtuin-type. {ECO:0000255|PROSITE-ProRule:PRU00236}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIRT7&recr=Open">Click here</a>	
SIVA1	Silent	p.F47F	C	C		11	Filtered Calls	14	105221989	105221989	123	0.382113821138211	NA	NA	NA			3	Interaction with BCL2L1 isoform Bcl-x(L) and inhibition of BCL2L1 anti-apoptotic activity.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIVA1&recr=Open">Click here</a>	
SKIV2L	Intron		C	C		11	Filtered Calls	6	31927991	31927991	305	0.186885245901639	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SKIV2L&recr=Open">Click here</a>	
SLA	Silent	p.E182E	C	C	rs528805748	11	Filtered Calls	8	134050973	134050973	46	0.217391304347826	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLA&recr=Open">Click here</a>	
SLAMF9	Silent	p.L271L	G	G		11	Filtered Calls	1	159921508	159921508	231	0.186147186147186	NA	NA	NA		p.L271L(1)	13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLAMF9&recr=Open">Click here</a>	
SLBP	Silent	p.I148I	G	G		11	Filtered Calls	4	1697997	1697997	103	0.398058252427184	NA	NA	NA			5	RNA-binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLBP&recr=Open">Click here</a>	
SLC10A7	Silent	p.G315G	T	T		11	Filtered Calls	4	147179892	147179892	169	0.266272189349112	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC10A7&recr=Open">Click here</a>	
SLC12A1	Silent	p.A232A	G	G	rs138091124	11	Filtered Calls	15	48518740	48518740	84	0.535714285714286	NA	NA	NA			59			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC12A1&recr=Open">Click here</a>	
SLC12A3	Silent	p.S577S	C	C	rs374923985	11	Filtered Calls	16	56918022	56918022	43	0.255813953488372	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC12A3&recr=Open">Click here</a>	
SLC12A5	Silent	p.S988S	C	C		11	Filtered Calls	20	44685057	44685057	11	0.363636363636364	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC12A5&recr=Open">Click here</a>	
SLC12A6	Silent	p.A870A	G	G		11	Filtered Calls	15	34531188	34531188	335	0.26865671641791	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC12A6&recr=Open">Click here</a>	
SLC12A9	Intron		C	C		11	Filtered Calls	7	100457502	100457502	59	0.305084745762712	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC12A9&recr=Open">Click here</a>	
SLC13A4	Silent	p.V90V	C	C		11	Filtered Calls	7	135392957	135392957	109	0.055045871559633	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC13A4&recr=Open">Click here</a>	
SLC17A2	Intron		A	A		11	Filtered Calls	6	25916902	25916902	107	0.205607476635514	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A2&recr=Open">Click here</a>	
SLC17A2	Intron		G	G		11	Filtered Calls	6	25918808	25918808	93	0.623655913978495	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A2&recr=Open">Click here</a>	
SLC17A7	Silent	p.F510F	G	G		11	Filtered Calls	19	49933929	49933929	67	0.17910447761194	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A7&recr=Open">Click here</a>	
SLC17A7	Silent	p.A282A	C	C		11	Filtered Calls	19	49937004	49937004	34	0.235294117647059	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A7&recr=Open">Click here</a>	
SLC17A8	Silent	p.V198V	G	G		11	Filtered Calls	12	100790113	100790113	61	0.360655737704918	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A8&recr=Open">Click here</a>	
SLC17A9	Intron		G	G		11	Filtered Calls	20	61598091	61598091	53	0.415094339622642	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A9&recr=Open">Click here</a>	
SLC18A1	Silent	p.A450A	G	G		11	Filtered Calls	8	20004883	20004883	45	0.333333333333333	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC18A1&recr=Open">Click here</a>	
SLC18A1	Silent	p.T330T	G	G		11	Filtered Calls	8	20022405	20022405	66	0.151515151515152	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC18A1&recr=Open">Click here</a>	
SLC18A1	Silent	p.I168I	G	G		11	Filtered Calls	8	20035989	20035989	66	0.106060606060606	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC18A1&recr=Open">Click here</a>	
SLC1A1	Silent	p.L324L	C	C		11	Filtered Calls	9	4576097	4576097	51	0.803921568627451	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC1A1&recr=Open">Click here</a>	
SLC1A3	Silent	p.E229E	G	G		11	Filtered Calls	5	36677113	36677113	136	0.213235294117647	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC1A3&recr=Open">Click here</a>	
SLC1A3	Intron		C	C		11	Filtered Calls	5	36680494	36680494	46	0.108695652173913	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC1A3&recr=Open">Click here</a>	
SLC1A6	Intron		C	C		11	Filtered Calls	19	15064944	15064944	28	0.178571428571429	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC1A6&recr=Open">Click here</a>	
SLC1A6	Intron		G	G		11	Filtered Calls	19	15073160	15073160	63	0.285714285714286	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC1A6&recr=Open">Click here</a>	
SLC1A7	Silent	p.P324P	G	G		11	Filtered Calls	1	53558285	53558285	25	0.72	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC1A7&recr=Open">Click here</a>	
SLC22A11	Silent	p.F386F	C	C		11	Filtered Calls	11	64335170	64335170	39	0.897435897435897	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A11&recr=Open">Click here</a>	
SLC22A14	Silent	p.F279F	C	C	rs201940470	11	Filtered Calls	3	38350506	38350506	224	0.178571428571429	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A14&recr=Open">Click here</a>	
SLC22A3	Silent	p.T251T	C	C		11	Filtered Calls	6	160829849	160829849	119	0.428571428571429	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A3&recr=Open">Click here</a>	
SLC22A3	Silent	p.R545R	G	G		11	Filtered Calls	6	160872052	160872052	15	0.2	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A3&recr=Open">Click here</a>	
SLC22A7	Silent	p.F150F	C	C		11	Filtered Calls	6	43267184	43267184	77	0.25974025974026	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A7&recr=Open">Click here</a>	
SLC22A9	Silent	p.L181L	C	C		11	Filtered Calls	11	63141152	63141152	53	0.39622641509434	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A9&recr=Open">Click here</a>	
SLC25A13	Intron		A	A		11	Filtered Calls	7	95820568	95820568	95	0.326315789473684	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A13&recr=Open">Click here</a>	
SLC25A15	Silent	p.V130V	G	G		11	Filtered Calls	13	41379329	41379329	55	0.345454545454545	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A15&recr=Open">Click here</a>	
SLC25A20	Silent	p.S191S	G	G		11	Filtered Calls	3	48895991	48895991	208	0.0432692307692308	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A20&recr=Open">Click here</a>	
SLC25A30	Silent	p.P23P	G	G	rs554601944	11	Filtered Calls	13	45980103	45980103	95	0.6	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A30&recr=Open">Click here</a>	
SLC25A34	Intron		C	C		11	Filtered Calls	1	16065713	16065713	73	0.246575342465753	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A34&recr=Open">Click here</a>	
SLC25A36	Intron		C	C		11	Filtered Calls	3	140681958	140681958	95	0.389473684210526	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A36&recr=Open">Click here</a>	
SLC25A37	Silent	p.F216F	C	C		11	Filtered Calls	8	23428999	23428999	68	0.176470588235294	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A37&recr=Open">Click here</a>	
SLC25A46	Silent	p.L77L	C	C		11	Filtered Calls	5	110097093	110097093	192	0.494791666666667	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A46&recr=Open">Click here</a>	
SLC25A47	Silent	p.G277G	G	G		11	Filtered Calls	14	100795886	100795886	84	0.619047619047619	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A47&recr=Open">Click here</a>	
SLC26A1	5'Flank		C	C		11	Filtered Calls	4	983009	983009	14	0.642857142857143	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A1&recr=Open">Click here</a>	
SLC26A5	Silent	p.V529V	C	C		11	Filtered Calls	7	103019780	103019780	65	0.307692307692308	NA	NA	NA			43	STAS. {ECO:0000255|PROSITE- ProRule:PRU00198}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A5&recr=Open">Click here</a>	
SLC26A7	Silent	p.F389F	C	C		11	Filtered Calls	8	92364064	92364064	358	0.270949720670391	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A7&recr=Open">Click here</a>	
SLC26A8	Silent	p.S638S	G	G		11	Filtered Calls	6	35923247	35923247	101	0.227722772277228	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A8&recr=Open">Click here</a>	
SLC26A8	Silent	p.S365S	A	A		11	Filtered Calls	6	35945059	35945059	126	0.126984126984127	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A8&recr=Open">Click here</a>	
SLC26A9	Silent	p.S404S	G	G		11	Filtered Calls	1	205896623	205896623	60	0.6	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A9&recr=Open">Click here</a>	
SLC26A9	Silent	p.F116F	G	G		11	Filtered Calls	1	205901858	205901858	74	0.22972972972973	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A9&recr=Open">Click here</a>	
SLC27A3	Silent	p.A792A	C	C		11	Filtered Calls	1	153752418	153752418	53	0.169811320754717	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC27A3&recr=Open">Click here</a>	
SLC27A4	Intron		C	C		11	Filtered Calls	9	131117322	131117322	16	0.5	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC27A4&recr=Open">Click here</a>	
SLC27A5	Silent	p.G262G	C	C		11	Filtered Calls	19	59022200	59022200	20	0.35	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC27A5&recr=Open">Click here</a>	
SLC27A6	Silent	p.F123F	C	C		11	Filtered Calls	5	128302199	128302199	24	0.208333333333333	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC27A6&recr=Open">Click here</a>	
SLC29A3	Silent	p.F393F	C	C		11	Filtered Calls	10	73122116	73122116	77	0.220779220779221	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC29A3&recr=Open">Click here</a>	
SLC2A13	Intron		-	-		11	Filtered Calls	12	40345191	40345192	34	0.264705882352941	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC2A13&recr=Open">Click here</a>	
SLC2A2	Intron		C	C		11	Filtered Calls	3	170723720	170723720	154	0.0324675324675325	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC2A2&recr=Open">Click here</a>	
SLC2A4	Silent	p.A111A	C	C		11	Filtered Calls	17	7187066	7187066	27	0.222222222222222	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC2A4&recr=Open">Click here</a>	
SLC2A8	Intron		C	C		11	Filtered Calls	9	130165928	130165928	48	0.583333333333333	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC2A8&recr=Open">Click here</a>	
SLC30A10	Silent	p.S252S	G	G	rs143340726	11	Filtered Calls	1	220091799	220091799	140	0.15	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC30A10&recr=Open">Click here</a>	
SLC30A2	Intron		G	G		11	Filtered Calls	1	26370780	26370780	82	0.451219512195122	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC30A2&recr=Open">Click here</a>	
SLC30A3	Intron		C	C		11	Filtered Calls	2	27481611	27481611	90	0.188888888888889	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC30A3&recr=Open">Click here</a>	
SLC30A3	Silent	p.L10L	A	A		11	Filtered Calls	2	27485747	27485747	28	0.392857142857143	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC30A3&recr=Open">Click here</a>	
SLC33A1	Silent	p.I412I	G	G		11	Filtered Calls	3	155551287	155551287	220	0.254545454545455	NA	NA	NA		p.I412M(1)	22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC33A1&recr=Open">Click here</a>	
SLC34A2	Silent	p.K400K	G	G		11	Filtered Calls	4	25674860	25674860	56	0.446428571428571	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC34A2&recr=Open">Click here</a>	
SLC34A2	Silent	p.T466T	C	C		11	Filtered Calls	4	25676191	25676191	66	0.333333333333333	NA	NA	NA			41	Poly-Thr.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC34A2&recr=Open">Click here</a>	
SLC35A3	Silent	p.D291D	T	T		11	Filtered Calls	1	100483357	100483357	344	0.520348837209302	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC35A3&recr=Open">Click here</a>	
SLC35B3	Silent	p.S233S	G	G		11	Filtered Calls	6	8419894	8419894	346	0.234104046242775	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC35B3&recr=Open">Click here</a>	
SLC35F4	5'UTR		C	C		11	Filtered Calls	14	58063571	58063571	29	0.413793103448276	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC35F4&recr=Open">Click here</a>	
SLC35G1	Silent	p.F131F	C	C		11	Filtered Calls	10	95660545	95660545	371	0.21832884097035	NA	NA	NA			NA	EamA 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC35G1&recr=Open">Click here</a>	
SLC38A8	Intron		G	G	rs79490100	11	Filtered Calls	16	84046668	84046668	73	0.191780821917808	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC38A8&recr=Open">Click here</a>	
SLC38A8	Silent	p.I374I	G	G		11	Filtered Calls	16	84050164	84050164	29	0.275862068965517	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC38A8&recr=Open">Click here</a>	
SLC39A12	Intron		C	C	rs368197868	11	Filtered Calls	10	18289762	18289762	33	0.242424242424242	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC39A12&recr=Open">Click here</a>	
SLC39A6	Silent	p.H385H	G	G		11	Filtered Calls	18	33702219	33702219	255	0.905882352941176	NA	NA	NA			41	His-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC39A6&recr=Open">Click here</a>	
SLC39A7	Silent	p.V364V	C	C		11	Filtered Calls	6	33170838	33170838	379	0.25065963060686	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC39A7&recr=Open">Click here</a>	
SLC3A1	Silent	p.I88I	C	C		11	Filtered Calls	2	44502938	44502938	55	0.290909090909091	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC3A1&recr=Open">Click here</a>	
SLC44A2	Intron		G	G		11	Filtered Calls	19	10742431	10742431	21	0.19047619047619	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC44A2&recr=Open">Click here</a>	
SLC44A4	Silent	p.G567G	C	C		11	Filtered Calls	6	31833151	31833151	196	0.209183673469388	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC44A4&recr=Open">Click here</a>	
SLC45A1	5'UTR		C	C		11	Filtered Calls	1	8384383	8384383	70	0.371428571428571	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC45A1&recr=Open">Click here</a>	
SLC45A3	Silent	p.F431F	G	G		11	Filtered Calls	1	205628731	205628731	43	0.767441860465116	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC45A3&recr=Open">Click here</a>	
SLC4A10	Intron		T	T		11	Filtered Calls	2	162833394	162833394	20	0.3	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A10&recr=Open">Click here</a>	
SLC4A3	Intron		C	C		11	Filtered Calls	2	220496976	220496976	21	0.19047619047619	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A3&recr=Open">Click here</a>	
SLC4A4	Intron		C	C		11	Filtered Calls	4	72263290	72263290	179	0.279329608938547	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A4&recr=Open">Click here</a>	
SLC4A4	Silent	p.K671K	G	G		11	Filtered Calls	4	72363256	72363256	178	0.202247191011236	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A4&recr=Open">Click here</a>	
SLC52A1	Silent	p.A72A	G	G		11	Filtered Calls	17	4937568	4937568	26	0.692307692307692	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC52A1&recr=Open">Click here</a>	
SLC5A1	Intron		T	T		11	Filtered Calls	22	32498001	32498001	91	0.153846153846154	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A1&recr=Open">Click here</a>	
SLC5A3	Silent	p.L248L	C	C		11	Filtered Calls	21	35468239	35468239	202	0.50990099009901	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A3&recr=Open">Click here</a>	
SLC5A3	Silent	p.V281V	C	C		11	Filtered Calls	21	35468340	35468340	108	0.611111111111111	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A3&recr=Open">Click here</a>	
SLC5A6	Silent	p.F298F	G	G	rs267599311	11	Filtered Calls	2	27427440	27427440	70	0.257142857142857	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A6&recr=Open">Click here</a>	
SLC5A8	Intron		G	G		11	Filtered Calls	12	101576702	101576702	70	0.385714285714286	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A8&recr=Open">Click here</a>	
SLC5A9	Intron		G	G	rs372721066	11	Filtered Calls	1	48698183	48698183	96	0.96875	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A9&recr=Open">Click here</a>	
SLC6A11	Silent	p.Q464Q	G	G		11	Filtered Calls	3	10974857	10974857	42	0.333333333333333	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A11&recr=Open">Click here</a>	
SLC6A12	Silent	p.L25L	A	A		11	Filtered Calls	12	319080	319080	101	0.475247524752475	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A12&recr=Open">Click here</a>	
SLC6A14	Silent	p.F414F	C	C		11	Filtered Calls	X	115584264	115584264	108	0.37962962962963	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A14&recr=Open">Click here</a>	
SLC6A18	Silent	p.L405L	C	C		11	Filtered Calls	5	1243753	1243753	34	0.411764705882353	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A18&recr=Open">Click here</a>	
SLC6A19	Intron		C	C		11	Filtered Calls	5	1212410	1212410	30	0.2	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A19&recr=Open">Click here</a>	
SLC6A19	Silent	p.I401I	C	C		11	Filtered Calls	5	1219047	1219047	34	0.176470588235294	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A19&recr=Open">Click here</a>	
SLC6A2	Intron		C	C		11	Filtered Calls	16	55719044	55719044	16	0.8125	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A2&recr=Open">Click here</a>	
SLC6A2	Silent	p.F275F	C	C		11	Filtered Calls	16	55725871	55725871	28	0.178571428571429	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A2&recr=Open">Click here</a>	
SLC6A2	Silent	p.F528F	C	C		11	Filtered Calls	16	55733560	55733560	30	0.266666666666667	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A2&recr=Open">Click here</a>	
SLC6A20	Silent	p.I242I	G	G		11	Filtered Calls	3	45812918	45812918	58	0.189655172413793	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A20&recr=Open">Click here</a>	
SLC6A5	Intron		C	C		11	Filtered Calls	11	20628548	20628548	44	0.340909090909091	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A5&recr=Open">Click here</a>	
SLC7A6OS	Silent	p.A17A	C	C		11	Filtered Calls	16	68344779	68344779	10	0.3	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A6OS&recr=Open">Click here</a>	
SLC7A7	Silent	p.I196I	G	G		11	Filtered Calls	14	23249172	23249172	182	0.324175824175824	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A7&recr=Open">Click here</a>	
SLC8A2	Silent	p.G631G	C	C	rs576007468	11	Filtered Calls	19	47941223	47941223	78	0.179487179487179	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC8A2&recr=Open">Click here</a>	
SLC8A3	5'UTR		C	C		11	Filtered Calls	14	70527628	70527628	86	0.36046511627907	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC8A3&recr=Open">Click here</a>	
SLC9A3	Silent	p.F437F	G	G		11	Filtered Calls	5	482708	482708	66	0.242424242424242	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9A3&recr=Open">Click here</a>	
SLC9A4	Silent	p.L175L	C	C		11	Filtered Calls	2	103095566	103095566	29	0.172413793103448	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9A4&recr=Open">Click here</a>	
SLC9A4	Silent	p.V517V	G	G		11	Filtered Calls	2	103128724	103128724	123	0.284552845528455	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9A4&recr=Open">Click here</a>	
SLC9A5	3'UTR		G	G		11	Filtered Calls	16	67283095	67283095	14	0.5	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9A5&recr=Open">Click here</a>	
SLC9A8	Silent	p.F127F	C	C		11	Filtered Calls	20	48461605	48461605	119	0.420168067226891	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9A8&recr=Open">Click here</a>	
SLC9C2	Intron		G	G		11	Filtered Calls	1	173486853	173486853	125	0.248	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9C2&recr=Open">Click here</a>	
SLC9C2	Silent	p.L694L	C	C		11	Filtered Calls	1	173502829	173502829	418	0.267942583732057	NA	NA	NA			NA	Ion transport-like. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9C2&recr=Open">Click here</a>	
SLC9C2	Silent	p.I375I	G	G		11	Filtered Calls	1	173526569	173526569	456	0.236842105263158	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9C2&recr=Open">Click here</a>	
SLCO1B1	Silent	p.S273S	C	C		11	Filtered Calls	12	21349971	21349971	296	0.422297297297297	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO1B1&recr=Open">Click here</a>	
SLCO1C1	Intron		C	C		11	Filtered Calls	12	20870056	20870056	205	0.180487804878049	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO1C1&recr=Open">Click here</a>	
SLCO2A1	Silent	p.F341F	G	G		11	Filtered Calls	3	133666144	133666144	36	0.222222222222222	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO2A1&recr=Open">Click here</a>	
SLCO2B1	Intron		C	C		11	Filtered Calls	11	74880450	74880450	18	0.944444444444444	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO2B1&recr=Open">Click here</a>	
SLCO2B1	Silent	p.I117I	C	C	rs528967109	11	Filtered Calls	11	74904303	74904303	53	0.433962264150943	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO2B1&recr=Open">Click here</a>	
SLCO3A1	Silent	p.L465L	C	C		11	Filtered Calls	15	92671600	92671600	178	0.247191011235955	NA	NA	NA			25	Kazal-like. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO3A1&recr=Open">Click here</a>	
SLCO4A1	Intron		C	C		11	Filtered Calls	20	61303096	61303096	116	0.318965517241379	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO4A1&recr=Open">Click here</a>	
SLCO4C1	3'UTR		C	C		11	Filtered Calls	5	101572556	101572556	128	0.359375	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO4C1&recr=Open">Click here</a>	
SLCO4C1	Intron		G	G		11	Filtered Calls	5	101631604	101631604	25	0.32	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO4C1&recr=Open">Click here</a>	
SLCO5A1	3'UTR		C	C		11	Filtered Calls	8	70585235	70585235	75	0.2	NA	NA	NA		p.E806*(1)	53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO5A1&recr=Open">Click here</a>	
SLCO5A1	3'UTR		G	G		11	Filtered Calls	8	70585448	70585448	197	0.182741116751269	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO5A1&recr=Open">Click here</a>	
SLCO5A1	Silent	p.L211L	G	G		11	Filtered Calls	8	70744276	70744276	14	0.285714285714286	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO5A1&recr=Open">Click here</a>	
SLCO6A1	Intron		C	C		11	Filtered Calls	5	101834182	101834182	22	0.409090909090909	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO6A1&recr=Open">Click here</a>	
SLIT1	Silent	p.G1461G	C	C		11	Filtered Calls	10	98761091	98761091	70	0.228571428571429	NA	NA	NA			78	CTCK. {ECO:0000255|PROSITE- ProRule:PRU00039}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT1&recr=Open">Click here</a>	
SLIT1	Silent	p.G1244G	C	C		11	Filtered Calls	10	98763958	98763958	164	0.25609756097561	NA	NA	NA			78	Laminin G-like. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT1&recr=Open">Click here</a>	
SLIT1	Intron		C	C		11	Filtered Calls	10	98807725	98807725	103	0.203883495145631	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT1&recr=Open">Click here</a>	
SLIT1	Intron		G	G		11	Filtered Calls	10	98924651	98924651	87	0.275862068965517	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT1&recr=Open">Click here</a>	
SLIT2	Silent	p.L217L	C	C		11	Filtered Calls	4	20490479	20490479	182	0.406593406593407	NA	NA	NA			116	LRRCT 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT2&recr=Open">Click here</a>	
SLIT2	Intron		T	T		11	Filtered Calls	4	20541054	20541054	138	0.492753623188406	NA	NA	NA			116			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT2&recr=Open">Click here</a>	
SLIT2	Silent	p.I1196I	C	C		11	Filtered Calls	4	20599914	20599914	104	0.384615384615385	NA	NA	NA			116	Laminin G-like. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT2&recr=Open">Click here</a>	
SLIT2	Silent	p.T1525T	G	G		11	Filtered Calls	4	20620617	20620617	85	0.305882352941176	NA	NA	NA			116	CTCK. {ECO:0000255|PROSITE- ProRule:PRU00039, ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT2&recr=Open">Click here</a>	
SLIT3	Silent	p.G1399G	C	C		11	Filtered Calls	5	168096927	168096927	52	0.230769230769231	NA	NA	NA		p.G1399G(2)	100	EGF-like 8. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT3&recr=Open">Click here</a>	
SLIT3	Silent	p.A1150A	G	G		11	Filtered Calls	5	168112797	168112797	16	0.5	NA	NA	NA			100	EGF-like 6. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT3&recr=Open">Click here</a>	
SLIT3	Silent	p.N809N	G	G		11	Filtered Calls	5	168149317	168149317	21	0.333333333333333	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT3&recr=Open">Click here</a>	
SLIT3	Silent	p.R679R	C	C		11	Filtered Calls	5	168176577	168176577	73	0.36986301369863	NA	NA	NA			100	LRRCT 3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT3&recr=Open">Click here</a>	
SLITRK1	Silent	p.Y508Y	G	G		11	Filtered Calls	13	84454119	84454119	33	0.515151515151515	NA	NA	NA			80			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK1&recr=Open">Click here</a>	
SLITRK1	Silent	p.F53F	G	G		11	Filtered Calls	13	84455484	84455484	74	0.216216216216216	NA	NA	NA			80	LRRNT 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK1&recr=Open">Click here</a>	
SLITRK5	Silent	p.L158L	C	C		11	Filtered Calls	13	88328115	88328115	118	0.364406779661017	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK5&recr=Open">Click here</a>	
SLITRK5	Silent	p.L207L	C	C		11	Filtered Calls	13	88328264	88328264	77	0.38961038961039	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK5&recr=Open">Click here</a>	
SLITRK5	Silent	p.S542S	C	C		11	Filtered Calls	13	88329269	88329269	74	0.0540540540540541	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK5&recr=Open">Click here</a>	
SLITRK6	Silent	p.V246V	G	G		11	Filtered Calls	13	86369906	86369906	170	0.270588235294118	NA	NA	NA			51	LRRCT 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK6&recr=Open">Click here</a>	
SLX4	Silent	p.L153L	G	G		11	Filtered Calls	16	3658507	3658507	151	0.291390728476821	NA	NA	NA			76	Interaction with SLX4IP, ERCC4 and MSH2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLX4&recr=Open">Click here</a>	
SMAP2	3'UTR		C	C		11	Filtered Calls	1	40879826	40879826	104	0.0480769230769231	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMAP2&recr=Open">Click here</a>	
SMAP2	IGR		C	C		11	Filtered Calls	1	40882779	40882779	16	0.5	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMAP2&recr=Open">Click here</a>	
SMARCA4	Silent	p.P159P	C	C		11	Filtered Calls	19	11096986	11096986	20	0.2	NA	NA	NA		p.?(1)	163	Necessary for interaction with SS18L1/CREST. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMARCA4&recr=Open">Click here</a>	
SMARCAL1	Intron		C	C		11	Filtered Calls	2	217280249	217280249	123	0.365853658536585	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMARCAL1&recr=Open">Click here</a>	
SMARCAL1	Silent	p.I710I	C	C		11	Filtered Calls	2	217329379	217329379	244	0.278688524590164	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMARCAL1&recr=Open">Click here</a>	
SMARCB1	Intron		G	G		11	Filtered Calls	22	24143148	24143148	120	0.0333333333333333	NA	NA	NA		p.?(5)	458			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMARCB1&recr=Open">Click here</a>	
SMARCB1	Intron		G	G		11	Filtered Calls	22	24143149	24143149	120	0.0333333333333333	NA	NA	NA		p.?(5)	458			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMARCB1&recr=Open">Click here</a>	
SMARCC1	Silent	p.L1067L	G	G		11	Filtered Calls	3	47632172	47632172	62	0.225806451612903	NA	NA	NA			33	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMARCC1&recr=Open">Click here</a>	
SMC2	Intron		T	T		11	Filtered Calls	9	106875760	106875760	55	0.254545454545455	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMC2&recr=Open">Click here</a>	
SMG1	Silent	p.I2864I	G	G		11	Filtered Calls	16	18844462	18844462	84	0.321428571428571	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMG1&recr=Open">Click here</a>	
SMG1	Intron		G	G		11	Filtered Calls	16	18859363	18859363	110	0.290909090909091	NA	NA	NA			92			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMG1&recr=Open">Click here</a>	
SMG7	Intron		T	T		11	Filtered Calls	1	183495726	183495726	367	0.258855585831063	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMG7&recr=Open">Click here</a>	
SMIM1	5'Flank		C	C		11	Filtered Calls	1	3686446	3686446	69	0.91304347826087	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMIM1&recr=Open">Click here</a>	
SMOC1	Intron		T	T		11	Filtered Calls	14	70480099	70480099	30	0.8	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMOC1&recr=Open">Click here</a>	
SMOC2	Intron		C	C		11	Filtered Calls	6	169067093	169067093	65	0.384615384615385	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMOC2&recr=Open">Click here</a>	
SMR3A	Silent	p.G61G	G	G		11	Filtered Calls	4	71232489	71232489	95	0.294736842105263	NA	NA	NA		p.G61E(1)	15	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMR3A&recr=Open">Click here</a>	
SMTN	Silent	p.F324F	C	C		11	Filtered Calls	22	31486981	31486981	86	0.5	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMTN&recr=Open">Click here</a>	
SMTN	Silent	p.A375A	C	C		11	Filtered Calls	22	31487134	31487134	43	0.465116279069767	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMTN&recr=Open">Click here</a>	
SMTNL2	Intron		G	G		11	Filtered Calls	17	4495748	4495748	31	0.225806451612903	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMTNL2&recr=Open">Click here</a>	
SMYD1	Intron		T	T		11	Filtered Calls	2	88383830	88383830	133	0.308270676691729	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMYD1&recr=Open">Click here</a>	
SMYD3	Silent	p.F157F	G	G		11	Filtered Calls	1	246091287	246091287	178	0.308988764044944	NA	NA	NA			17	SET. {ECO:0000255|PROSITE- ProRule:PRU00190}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMYD3&recr=Open">Click here</a>	
SMYD4	Intron		G	G		11	Filtered Calls	17	1690097	1690097	98	0.0510204081632653	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMYD4&recr=Open">Click here</a>	
SNAP25	Silent	p.L160L	C	C		11	Filtered Calls	20	10279988	10279988	67	0.194029850746269	NA	NA	NA			18	t-SNARE coiled-coil homology 2. {ECO:0000255|PROSITE-ProRule:PRU00202}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNAP25&recr=Open">Click here</a>	
SNAP47	5'UTR		C	C		11	Filtered Calls	1	227923013	227923013	20	0.55	NA	NA	NA		p.E34K(1)	17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNAP47&recr=Open">Click here</a>	
SNCAIP	Silent	p.K217K	G	G		11	Filtered Calls	5	121758942	121758942	106	0.377358490566038	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNCAIP&recr=Open">Click here</a>	
SNCB	Intron		C	C		11	Filtered Calls	5	176053392	176053392	60	0.35	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNCB&recr=Open">Click here</a>	
SNED1	Silent	p.I228I	C	C		11	Filtered Calls	2	241974026	241974026	25	0.32	NA	NA	NA			24	NIDO. {ECO:0000255|PROSITE- ProRule:PRU00570}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNED1&recr=Open">Click here</a>	
SNED1	Silent	p.T677T	G	G		11	Filtered Calls	2	241991833	241991833	38	0.157894736842105	NA	NA	NA			24	EGF-like 10. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNED1&recr=Open">Click here</a>	
SNHG14	RNA		G	G		11	Filtered Calls	15	25310257	25310257	175	0.605714285714286	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNHG14&recr=Open">Click here</a>	
SNHG14	RNA		C	C	rs200534027	11	Filtered Calls	15	25315583	25315583	111	0.216216216216216	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNHG14&recr=Open">Click here</a>	
SNHG14	RNA		G	G		11	Filtered Calls	15	25315615	25315615	182	0.236263736263736	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNHG14&recr=Open">Click here</a>	
SNHG14	RNA		C	C		11	Filtered Calls	15	25318326	25318326	174	0.649425287356322	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNHG14&recr=Open">Click here</a>	
SNHG14	RNA		G	G		11	Filtered Calls	15	25351757	25351757	62	0.225806451612903	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNHG14&recr=Open">Click here</a>	
SNHG14	RNA		C	C		11	Filtered Calls	15	25427583	25427583	142	0.309859154929577	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNHG14&recr=Open">Click here</a>	
SNHG14	RNA		C	C	rs371282740	11	Filtered Calls	15	25446487	25446487	115	0.217391304347826	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNHG14&recr=Open">Click here</a>	
SNHG14	RNA		A	A		11	Filtered Calls	15	25488775	25488775	119	0.285714285714286	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNHG14&recr=Open">Click here</a>	
SNHG14	RNA		T	T		11	Filtered Calls	15	25488830	25488830	132	0.295454545454545	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNHG14&recr=Open">Click here</a>	
SNHG14	RNA		G	G		11	Filtered Calls	15	25494411	25494411	152	0.243421052631579	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNHG14&recr=Open">Click here</a>	
SNORD113-6	RNA		G	G		11	Filtered Calls	14	101404610	101404610	155	0.283870967741935	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNORD113-6&recr=Open">Click here</a>	
SNRNP200	Intron		G	G		11	Filtered Calls	2	96942732	96942732	55	0.272727272727273	NA	NA	NA			90			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNRNP200&recr=Open">Click here</a>	
SNRNP200	Silent	p.T1008T	G	G		11	Filtered Calls	2	96955034	96955034	128	0.25	NA	NA	NA			90	SEC63 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNRNP200&recr=Open">Click here</a>	
SNRNP35	Silent	p.I136I	C	C		11	Filtered Calls	12	123950495	123950495	212	0.0377358490566038	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNRNP35&recr=Open">Click here</a>	
SNRPN	5'UTR		C	C		11	Filtered Calls	15	25207265	25207265	99	0.212121212121212	NA	NA	NA		p.R7G(1)	24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNRPN&recr=Open">Click here</a>	
SNTB1	Intron		G	G		11	Filtered Calls	8	121561210	121561210	36	0.138888888888889	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNTB1&recr=Open">Click here</a>	
SNX16	Intron		A	A	rs201585684	11	Filtered Calls	8	82715474	82715474	157	0.445859872611465	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNX16&recr=Open">Click here</a>	
SNX29	Silent	p.S38S	C	C	rs531027822	11	Filtered Calls	16	12096892	12096892	170	0.582352941176471	NA	NA	NA			7	RUN. {ECO:0000255|PROSITE- ProRule:PRU00178}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNX29&recr=Open">Click here</a>	
SNX29	Silent	p.P663P	C	C		11	Filtered Calls	16	12497338	12497338	31	0.225806451612903	NA	NA	NA			7	PX. {ECO:0000255|PROSITE- ProRule:PRU00147}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNX29&recr=Open">Click here</a>	
SNX29	Silent	p.T776T	C	C		11	Filtered Calls	16	12662372	12662372	27	0.333333333333333	NA	NA	NA			7	PX. {ECO:0000255|PROSITE- ProRule:PRU00147}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNX29&recr=Open">Click here</a>	
SON	Silent	p.K122K	G	G		11	Filtered Calls	21	34921903	34921903	134	0.559701492537313	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SON&recr=Open">Click here</a>	
SORBS1	Silent	p.F918F	G	G		11	Filtered Calls	10	97099001	97099001	93	0.21505376344086	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORBS1&recr=Open">Click here</a>	
SORBS2	Intron		G	G		11	Filtered Calls	4	186541316	186541316	223	0.295964125560538	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORBS2&recr=Open">Click here</a>	
SORBS2	Intron		C	C		11	Filtered Calls	4	186544411	186544411	244	0.30327868852459	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORBS2&recr=Open">Click here</a>	
SORBS2	Intron		G	G		11	Filtered Calls	4	186544847	186544847	77	0.545454545454545	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORBS2&recr=Open">Click here</a>	
SORBS3	Intron		C	C		11	Filtered Calls	8	22428413	22428413	51	0.196078431372549	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORBS3&recr=Open">Click here</a>	
SORCS1	3'UTR		C	C		11	Filtered Calls	10	108336975	108336975	130	0.184615384615385	NA	NA	NA			127			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS1&recr=Open">Click here</a>	
SORCS1	Intron		G	G		11	Filtered Calls	10	108338838	108338838	44	0.272727272727273	NA	NA	NA			127			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS1&recr=Open">Click here</a>	
SORCS1	Silent	p.V596V	G	G		11	Filtered Calls	10	108437115	108437115	109	0.36697247706422	NA	NA	NA			127			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS1&recr=Open">Click here</a>	
SORCS1	Silent	p.I550I	G	G		11	Filtered Calls	10	108439403	108439403	89	0.426966292134831	NA	NA	NA			127			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS1&recr=Open">Click here</a>	
SORCS1	Silent	p.G460G	G	G		11	Filtered Calls	10	108459005	108459005	155	0.270967741935484	NA	NA	NA			127			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS1&recr=Open">Click here</a>	
SORCS2	Silent	p.T195T	C	C		11	Filtered Calls	4	7533293	7533293	15	0.466666666666667	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS2&recr=Open">Click here</a>	
SORCS3	Silent	p.I593I	C	C		11	Filtered Calls	10	106924107	106924107	85	0.235294117647059	NA	NA	NA			131			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS3&recr=Open">Click here</a>	
SOS1	Silent	p.E970E	C	C		11	Filtered Calls	2	39224448	39224448	755	0.0344370860927152	NA	NA	NA			75	Ras-GEF. {ECO:0000255|PROSITE- ProRule:PRU00168}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOS1&recr=Open">Click here</a>	
SOX30	Silent	p.F617F	G	G		11	Filtered Calls	5	157065267	157065267	88	0.363636363636364	NA	NA	NA			23	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOX30&recr=Open">Click here</a>	
SOX5	Intron		G	G		11	Filtered Calls	12	23687468	23687468	39	0.41025641025641	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOX5&recr=Open">Click here</a>	
SOX7	Silent	p.L323L	G	G		11	Filtered Calls	8	10583446	10583446	31	0.258064516129032	NA	NA	NA			20	Sox C-terminal. {ECO:0000255|PROSITE- ProRule:PRU00849}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOX7&recr=Open">Click here</a>	
SP140	Intron		C	C		11	Filtered Calls	2	231108435	231108435	204	0.313725490196078	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SP140&recr=Open">Click here</a>	
SPAG16	Silent	p.V568V	G	G		11	Filtered Calls	2	215013974	215013974	282	0.24468085106383	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPAG16&recr=Open">Click here</a>	
SPAG17	Intron		G	G		11	Filtered Calls	1	118635951	118635951	36	0.25	NA	NA	NA			123			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPAG17&recr=Open">Click here</a>	
SPAG7	Silent	p.I25I	G	G	rs202121641	11	Filtered Calls	17	4863768	4863768	172	0.22093023255814	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPAG7&recr=Open">Click here</a>	
SPATA16	5'UTR		C	C		11	Filtered Calls	3	172835526	172835526	91	0.241758241758242	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATA16&recr=Open">Click here</a>	
SPATA18	Silent	p.V343V	C	C		11	Filtered Calls	4	52945005	52945005	184	0.255434782608696	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATA18&recr=Open">Click here</a>	
SPATA31E1	Silent	p.G814G	G	G		11	Filtered Calls	9	90501844	90501844	34	0.264705882352941	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATA31E1&recr=Open">Click here</a>	
SPATA8	Silent	p.L28L	C	C		11	Filtered Calls	15	97328233	97328233	103	0.203883495145631	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATA8&recr=Open">Click here</a>	
SPATC1	Silent	p.P434P	C	C		11	Filtered Calls	8	145096004	145096004	16	0.5	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATC1&recr=Open">Click here</a>	
SPECC1L	Intron		C	C		11	Filtered Calls	22	24807545	24807545	193	0.16580310880829	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPECC1L&recr=Open">Click here</a>	
SPEG	Intron		C	C		11	Filtered Calls	2	220333294	220333294	34	0.264705882352941	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEG&recr=Open">Click here</a>	
SPEG	Silent	p.I1398I	C	C		11	Filtered Calls	2	220338272	220338272	95	0.189473684210526	NA	NA	NA		p.I1398I(1)|p.I1398M(1)	100	Ig-like 7.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEG&recr=Open">Click here</a>	
SPEG	Intron		C	C		11	Filtered Calls	2	220352909	220352909	57	0.298245614035088	NA	NA	NA			100			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEG&recr=Open">Click here</a>	
SPERT	Silent	p.E394E	G	G		11	Filtered Calls	13	46288450	46288450	13	0.230769230769231	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPERT&recr=Open">Click here</a>	
SPHKAP	3'UTR		C	C		11	Filtered Calls	2	228846429	228846429	115	0.31304347826087	NA	NA	NA			185			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPHKAP&recr=Open">Click here</a>	
SPHKAP	Intron		G	G		11	Filtered Calls	2	228855903	228855903	44	0.318181818181818	NA	NA	NA			185			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPHKAP&recr=Open">Click here</a>	
SPHKAP	Silent	p.I1465I	G	G		11	Filtered Calls	2	228881175	228881175	103	0.368932038834951	NA	NA	NA			185			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPHKAP&recr=Open">Click here</a>	
SPHKAP	Silent	p.L1078L	C	C		11	Filtered Calls	2	228882336	228882336	29	0.482758620689655	NA	NA	NA			185			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPHKAP&recr=Open">Click here</a>	
SPHKAP	Intron		G	G		11	Filtered Calls	2	229046274	229046274	86	0.255813953488372	NA	NA	NA		p.?(4)	185			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPHKAP&recr=Open">Click here</a>	
SPINK5	Intron		C	C		11	Filtered Calls	5	147480909	147480909	60	0.466666666666667	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPINK5&recr=Open">Click here</a>	
SPINK5	3'UTR		G	G	rs564723902	11	Filtered Calls	5	147516557	147516557	196	0.392857142857143	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPINK5&recr=Open">Click here</a>	
SPINK6	Intron		T	T		11	Filtered Calls	5	147582727	147582727	126	0.357142857142857	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPINK6&recr=Open">Click here</a>	
SPINK6	Silent	p.K63K	G	G		11	Filtered Calls	5	147593580	147593580	32	0.25	NA	NA	NA			2	Kazal-like. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPINK6&recr=Open">Click here</a>	
SPINK9	Silent	p.Q25Q	G	G		11	Filtered Calls	5	147716004	147716004	181	0.353591160220994	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPINK9&recr=Open">Click here</a>	
SPINT1	Silent	p.L291L	T	T		11	Filtered Calls	15	41146039	41146039	181	0.342541436464088	NA	NA	NA			16	BPTI/Kunitz inhibitor 1. {ECO:0000255|PROSITE-ProRule:PRU00031}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPINT1&recr=Open">Click here</a>	
SPINT2	Intron		C	C		11	Filtered Calls	19	38779840	38779840	80	0.1375	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPINT2&recr=Open">Click here</a>	
SPIRE2	Intron		C	C		11	Filtered Calls	16	89924923	89924923	37	0.486486486486487	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPIRE2&recr=Open">Click here</a>	
SPN	Silent	p.L194L	C	C		11	Filtered Calls	16	29675629	29675629	143	0.223776223776224	NA	NA	NA			15	SAND. {ECO:0000255|PROSITE- ProRule:PRU00185}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPN&recr=Open">Click here</a>	
SPOCK1	Silent	p.Q143Q	C	C		11	Filtered Calls	5	136448169	136448169	80	0.525	NA	NA	NA			18	Kazal-like. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPOCK1&recr=Open">Click here</a>	
SPON1	RNA		C	C		11	Filtered Calls	11	14280857	14280857	21	0.142857142857143	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPON1&recr=Open">Click here</a>	
SPPL2B	RNA		G	G		11	Filtered Calls	19	2338840	2338840	25	0.12	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPPL2B&recr=Open">Click here</a>	
SPPL3	Silent	p.C135C	G	G		11	Filtered Calls	12	121220555	121220555	61	0.655737704918033	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPPL3&recr=Open">Click here</a>	
SPRN	Intron		G	G		11	Filtered Calls	10	135367827	135367827	128	0.21875	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPRN&recr=Open">Click here</a>	
SPRN	Intron		G	G		11	Filtered Calls	10	135372383	135372383	51	0.274509803921569	NA	NA	NA		p.S54L(1)|p.S90L(1)	NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPRN&recr=Open">Click here</a>	
SPRR2B	Silent	p.V57V	C	C		11	Filtered Calls	1	153043145	153043145	185	0.216216216216216	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPRR2B&recr=Open">Click here</a>	
SPRR2E	5'UTR		C	C		11	Filtered Calls	1	153066229	153066229	69	0.144927536231884	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPRR2E&recr=Open">Click here</a>	
SPRTN	5'Flank		G	G		11	Filtered Calls	1	231472028	231472028	86	0.465116279069767	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPRTN&recr=Open">Click here</a>	
SPRY1	Silent	p.L258L	C	C		11	Filtered Calls	4	124323518	124323518	197	0.294416243654822	NA	NA	NA			11	Cys-rich.|SPR. {ECO:0000255|PROSITE- ProRule:PRU00572}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPRY1&recr=Open">Click here</a>	
SPRY4	5'UTR		G	G		11	Filtered Calls	5	141694699	141694699	22	0.227272727272727	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPRY4&recr=Open">Click here</a>	
SPTA1	Silent	p.L1733L	C	C		11	Filtered Calls	1	158606542	158606542	173	0.184971098265896	NA	NA	NA			307			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	
SPTA1	Silent	p.E1247E	C	C		11	Filtered Calls	1	158617484	158617484	43	0.209302325581395	NA	NA	NA			307			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	
SPTA1	Silent	p.E917E	C	C		11	Filtered Calls	1	158627321	158627321	165	0.23030303030303	NA	NA	NA			307			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	
SPTA1	Silent	p.L594L	G	G		11	Filtered Calls	1	158639251	158639251	285	0.189473684210526	NA	NA	NA			307			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	
SPTA1	Intron		C	C		11	Filtered Calls	1	158645927	158645927	124	0.443548387096774	NA	NA	NA			307			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	
SPTA1	Intron		A	A		11	Filtered Calls	1	158651467	158651467	43	0.418604651162791	NA	NA	NA			307			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	
SPTB	Silent	p.L1782L	G	G		11	Filtered Calls	14	65239505	65239505	24	0.75	NA	NA	NA			106			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTB&recr=Open">Click here</a>	
SPTBN4	Silent	p.T207T	C	C		11	Filtered Calls	19	41000837	41000837	51	0.215686274509804	NA	NA	NA			73	Actin-binding.|CH 2. {ECO:0000255|PROSITE- ProRule:PRU00044}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTBN4&recr=Open">Click here</a>	
SPTBN4	Intron		C	C		11	Filtered Calls	19	41081310	41081310	47	0.191489361702128	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTBN4&recr=Open">Click here</a>	
SPTBN5	Silent	p.I1597I	G	G		11	Filtered Calls	15	42166142	42166142	34	0.323529411764706	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTBN5&recr=Open">Click here</a>	
SPTBN5	Silent	p.L215L	G	G		11	Filtered Calls	15	42180140	42180140	18	0.222222222222222	NA	NA	NA			62	Actin-binding.|CH 2. {ECO:0000255|PROSITE- ProRule:PRU00044}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTBN5&recr=Open">Click here</a>	
SPTBN5	Silent	p.I134I	G	G		11	Filtered Calls	15	42182386	42182386	13	0.230769230769231	NA	NA	NA			62	Actin-binding.|CH 1. {ECO:0000255|PROSITE- ProRule:PRU00044}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTBN5&recr=Open">Click here</a>	
SRCIN1	Silent	p.L840L	G	G		11	Filtered Calls	17	36708329	36708329	49	0.36734693877551	NA	NA	NA			19	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRCIN1&recr=Open">Click here</a>	
SREK1	3'UTR		C	C		11	Filtered Calls	5	65474699	65474699	119	0.403361344537815	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SREK1&recr=Open">Click here</a>	
SRL	Silent	p.I215I	G	G	rs550013235	11	Filtered Calls	16	4242931	4242931	74	0.324324324324324	NA	NA	NA			21	Acidic domain, probably binds calcium. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRL&recr=Open">Click here</a>	
SRRM2	IGR		C	C	rs202144562	11	Filtered Calls	16	2815952	2815952	40	0.625	NA	NA	NA			105			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRRM2&recr=Open">Click here</a>	
SRRM4	Silent	p.S192S	C	C		11	Filtered Calls	12	119563246	119563246	42	0.642857142857143	NA	NA	NA			24	Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRRM4&recr=Open">Click here</a>	
SRRM4	Silent	p.R508R	G	G		11	Filtered Calls	12	119592180	119592180	21	0.428571428571429	NA	NA	NA			24	Arg-rich.|Ser-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRRM4&recr=Open">Click here</a>	
SSPO	RNA		C	C		11	Filtered Calls	7	149480591	149480591	12	0.333333333333333	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSPO&recr=Open">Click here</a>	
SSPO	RNA		G	G		11	Filtered Calls	7	149483193	149483193	7	0.428571428571429	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSPO&recr=Open">Click here</a>	
SSPO	RNA		C	C	rs373074929	11	Filtered Calls	7	149492719	149492719	69	0.565217391304348	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSPO&recr=Open">Click here</a>	
SSTR2	Silent	p.V235V	G	G		11	Filtered Calls	17	71166163	71166163	211	0.180094786729858	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSTR2&recr=Open">Click here</a>	
SSTR3	Silent	p.F266F	G	G		11	Filtered Calls	22	37603045	37603045	53	0.283018867924528	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSTR3&recr=Open">Click here</a>	
ST14	Silent	p.K119K	G	G		11	Filtered Calls	11	130058540	130058540	42	0.428571428571429	NA	NA	NA			32	SEA. {ECO:0000255|PROSITE- ProRule:PRU00188}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST14&recr=Open">Click here</a>	
ST14	Silent	p.F416F	C	C	rs138855512	11	Filtered Calls	11	130066489	130066489	19	0.473684210526316	NA	NA	NA			32	CUB 2. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST14&recr=Open">Click here</a>	
ST14	Silent	p.K600K	G	G		11	Filtered Calls	11	130068957	130068957	14	0.5	NA	NA	NA			32	LDL-receptor class A 4. {ECO:0000255|PROSITE-ProRule:PRU00124}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST14&recr=Open">Click here</a>	
ST3GAL1	Silent	p.F18F	G	G		11	Filtered Calls	8	134488214	134488214	72	0.277777777777778	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST3GAL1&recr=Open">Click here</a>	
ST3GAL3	Silent	p.F123F	C	C		11	Filtered Calls	1	44360121	44360121	132	0.484848484848485	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST3GAL3&recr=Open">Click here</a>	
ST6GAL2	Silent	p.E187E	C	C	rs4676092	11	Filtered Calls	2	107459873	107459873	31	0.419354838709677	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST6GAL2&recr=Open">Click here</a>	
ST6GALNAC4	3'UTR		G	G		11	Filtered Calls	9	130670663	130670663	45	0.555555555555556	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST6GALNAC4&recr=Open">Click here</a>	
ST8SIA4	Intron		A	A		11	Filtered Calls	5	100152177	100152177	129	0.348837209302326	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST8SIA4&recr=Open">Click here</a>	
STAB1	Intron		C	C		11	Filtered Calls	3	52538466	52538466	33	0.181818181818182	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB1&recr=Open">Click here</a>	
STAB1	Silent	p.A514A	C	C		11	Filtered Calls	3	52539358	52539358	40	0.425	NA	NA	NA			76	FAS1 2. {ECO:0000255|PROSITE- ProRule:PRU00082, ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB1&recr=Open">Click here</a>	
STAB1	Silent	p.S866S	C	C		11	Filtered Calls	3	52544221	52544221	83	0.385542168674699	NA	NA	NA			76	EGF-like 7. {ECO:0000255|PROSITE- ProRule:PRU00076, ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB1&recr=Open">Click here</a>	
STAB1	Silent	p.A1386A	C	C		11	Filtered Calls	3	52550385	52550385	70	0.171428571428571	NA	NA	NA			76	Laminin EGF-like 1. {ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB1&recr=Open">Click here</a>	
STAB2	Silent	p.F1091F	C	C		11	Filtered Calls	12	104084292	104084292	70	0.257142857142857	NA	NA	NA			174			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB2&recr=Open">Click here</a>	
STAB2	Silent	p.S1227S	C	C		11	Filtered Calls	12	104092972	104092972	25	0.44	NA	NA	NA			174			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB2&recr=Open">Click here</a>	
STAC	Intron		C	C		11	Filtered Calls	3	36527750	36527750	36	0.25	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAC&recr=Open">Click here</a>	
STAC3	Silent	p.S154S	G	G		11	Filtered Calls	12	57641952	57641952	114	0.403508771929825	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAC3&recr=Open">Click here</a>	
STARD13	Intron		T	T		11	Filtered Calls	13	33712980	33712980	25	0.2	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STARD13&recr=Open">Click here</a>	
STARD13	Intron		G	G		11	Filtered Calls	13	33716518	33716518	201	0.278606965174129	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STARD13&recr=Open">Click here</a>	
STARD8	Intron		G	G		11	Filtered Calls	X	67940760	67940760	14	1	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STARD8&recr=Open">Click here</a>	
STC2	5'Flank		C	C	rs146441603	11	Filtered Calls	5	172752907	172752907	303	0.386138613861386	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STC2&recr=Open">Click here</a>	
STK11IP	Silent	p.H269H	C	C		11	Filtered Calls	2	220470739	220470739	21	0.428571428571429	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK11IP&recr=Open">Click here</a>	
STK16	Silent	p.A183A	C	C		11	Filtered Calls	2	220111942	220111942	73	0.328767123287671	NA	NA	NA			1	Activation loop.|Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK16&recr=Open">Click here</a>	
STK31	Intron		C	C		11	Filtered Calls	7	23810617	23810617	207	0.0434782608695652	NA	NA	NA			67			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK31&recr=Open">Click here</a>	
STK32C	5'UTR		G	G		11	Filtered Calls	10	134059436	134059436	65	0.246153846153846	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK32C&recr=Open">Click here</a>	
STK32C	5'UTR		G	G		11	Filtered Calls	10	134059437	134059437	65	0.307692307692308	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK32C&recr=Open">Click here</a>	
STK36	Intron		C	C		11	Filtered Calls	2	219538594	219538594	100	0.31	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK36&recr=Open">Click here</a>	
STK36	Intron		C	C		11	Filtered Calls	2	219554573	219554573	68	0.264705882352941	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK36&recr=Open">Click here</a>	
STK38	Silent	p.L120L	G	G		11	Filtered Calls	6	36489541	36489541	528	0.174242424242424	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK38&recr=Open">Click here</a>	
STK4	Intron		C	C		11	Filtered Calls	20	43703650	43703650	98	0.469387755102041	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK4&recr=Open">Click here</a>	
STOML1	Intron		G	G		11	Filtered Calls	15	74277049	74277049	55	0.0909090909090909	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STOML1&recr=Open">Click here</a>	
STOX2	Silent	p.F137F	C	C		11	Filtered Calls	4	184930402	184930402	29	0.206896551724138	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STOX2&recr=Open">Click here</a>	
STOX2	Silent	p.F145F	C	C	rs545310273	11	Filtered Calls	4	184930426	184930426	34	0.294117647058824	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STOX2&recr=Open">Click here</a>	
STRN4	Intron		G	G		11	Filtered Calls	19	47228910	47228910	40	0.4	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STRN4&recr=Open">Click here</a>	
STS	Silent	p.Q577Q	G	G		11	Filtered Calls	X	7268281	7268281	21	0.523809523809524	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STS&recr=Open">Click here</a>	
STX12	Intron		C	C		11	Filtered Calls	1	28144357	28144357	163	0.0613496932515337	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STX12&recr=Open">Click here</a>	
STX4	Silent	p.F134F	C	C		11	Filtered Calls	16	31049270	31049270	87	0.264367816091954	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STX4&recr=Open">Click here</a>	
STXBP4	Intron		C	C		11	Filtered Calls	17	53084860	53084860	746	0.197050938337802	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STXBP4&recr=Open">Click here</a>	
STXBP5	Intron		A	A		11	Filtered Calls	6	147632675	147632675	65	0.0615384615384615	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STXBP5&recr=Open">Click here</a>	
STXBP5	Silent	p.I506I	C	C		11	Filtered Calls	6	147636766	147636766	181	0.414364640883978	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STXBP5&recr=Open">Click here</a>	
STYXL1	Intron		G	G		11	Filtered Calls	7	75658030	75658030	58	0.103448275862069	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STYXL1&recr=Open">Click here</a>	
SUCO	5'Flank		G	G		11	Filtered Calls	1	172501620	172501620	94	0.170212765957447	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUCO&recr=Open">Click here</a>	
SUCO	5'Flank		C	C		11	Filtered Calls	1	172501624	172501624	94	0.75531914893617	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUCO&recr=Open">Click here</a>	
SUCO	Intron		C	C		11	Filtered Calls	1	172569199	172569199	122	0.442622950819672	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUCO&recr=Open">Click here</a>	
SULF1	Silent	p.I358I	C	C		11	Filtered Calls	8	70515439	70515439	173	0.190751445086705	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULF1&recr=Open">Click here</a>	
SULT1A2	IGR		C	C		11	Filtered Calls	16	28602121	28602121	42	0.333333333333333	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULT1A2&recr=Open">Click here</a>	
SULT1A2	Silent	p.L28L	C	C		11	Filtered Calls	16	28607168	28607168	36	0.388888888888889	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULT1A2&recr=Open">Click here</a>	
SUMF1	Intron		G	G		11	Filtered Calls	3	4494741	4494741	35	0.257142857142857	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUMF1&recr=Open">Click here</a>	
SUPT16H	Intron		G	G		11	Filtered Calls	14	21828697	21828697	81	0.888888888888889	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUPT16H&recr=Open">Click here</a>	
SUPT3H	Intron		A	A		11	Filtered Calls	6	45333042	45333042	347	0.204610951008646	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUPT3H&recr=Open">Click here</a>	
SUSD2	Silent	p.T491T	G	G		11	Filtered Calls	22	24582117	24582117	21	0.238095238095238	NA	NA	NA			26	VWFD. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUSD2&recr=Open">Click here</a>	
SUSD2	Intron		C	C		11	Filtered Calls	22	24584187	24584187	46	0.478260869565217	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUSD2&recr=Open">Click here</a>	
SUSD5	Silent	p.P451P	G	G		11	Filtered Calls	3	33194771	33194771	96	0.260416666666667	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUSD5&recr=Open">Click here</a>	
SUSD5	Silent	p.L151L	G	G		11	Filtered Calls	3	33216525	33216525	69	0.289855072463768	NA	NA	NA			24	Sushi. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUSD5&recr=Open">Click here</a>	
SV2B	Intron		C	C		11	Filtered Calls	15	91835587	91835587	100	0.21	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SV2B&recr=Open">Click here</a>	
SV2C	Intron		C	C	rs190515855	11	Filtered Calls	5	75469932	75469932	100	0.29	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SV2C&recr=Open">Click here</a>	
SVEP1	Silent	p.F3010F	G	G		11	Filtered Calls	9	113168781	113168781	27	0.222222222222222	NA	NA	NA			147	Sushi 27. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SVEP1&recr=Open">Click here</a>	
SVEP1	Silent	p.P703P	G	G		11	Filtered Calls	9	113243709	113243709	35	0.257142857142857	NA	NA	NA			147	HYR 2. {ECO:0000255|PROSITE- ProRule:PRU00113}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SVEP1&recr=Open">Click here</a>	
SVEP1	Silent	p.T500T	C	C	rs3737156	11	Filtered Calls	9	113261433	113261433	63	0.285714285714286	NA	NA	NA			147	Sushi 3. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SVEP1&recr=Open">Click here</a>	
SVOP	Silent	p.R306R	C	C		11	Filtered Calls	12	109316508	109316508	17	0.176470588235294	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SVOP&recr=Open">Click here</a>	
SYCN	Silent	p.S127S	G	G		11	Filtered Calls	19	39694514	39694514	25	0.16	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYCN&recr=Open">Click here</a>	
SYCP1	Silent	p.E454E	G	G		11	Filtered Calls	1	115453059	115453059	275	0.36	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYCP1&recr=Open">Click here</a>	
SYMPK	Silent	p.Q21Q	T	T		11	Filtered Calls	19	46357691	46357691	90	0.333333333333333	NA	NA	NA			45	Interaction with HSF1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYMPK&recr=Open">Click here</a>	
SYN3	Silent	p.F161F	G	G		11	Filtered Calls	22	33265091	33265091	54	0.166666666666667	NA	NA	NA		p.F161F(1)	33	C; actin-binding and synaptic-vesicle binding.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYN3&recr=Open">Click here</a>	
SYNE1	Silent	p.I7622I	G	G		11	Filtered Calls	6	152527456	152527456	67	0.447761194029851	NA	NA	NA			524			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE1&recr=Open">Click here</a>	
SYNE1	Intron		A	A		11	Filtered Calls	6	152552712	152552712	65	0.276923076923077	NA	NA	NA			524			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE1&recr=Open">Click here</a>	
SYNE1	Silent	p.A5695A	G	G		11	Filtered Calls	6	152631087	152631087	62	0.0967741935483871	NA	NA	NA			524			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE1&recr=Open">Click here</a>	
SYNE1	Intron		G	G		11	Filtered Calls	6	152639206	152639206	185	0.4	NA	NA	NA			524			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE1&recr=Open">Click here</a>	
SYNE1	Silent	p.F2770F	G	G		11	Filtered Calls	6	152708384	152708384	174	0.390804597701149	NA	NA	NA		p.F2770F(2)	524			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE1&recr=Open">Click here</a>	
SYNE1	Silent	p.A2492A	G	G		11	Filtered Calls	6	152717990	152717990	194	0.402061855670103	NA	NA	NA			524			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE1&recr=Open">Click here</a>	
SYNGAP1	Silent	p.R248R	G	G		11	Filtered Calls	6	33403372	33403372	205	0.68780487804878	NA	NA	NA			43	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNGAP1&recr=Open">Click here</a>	
SYNGR1	Silent	p.A104A	C	C		11	Filtered Calls	22	39770533	39770533	70	0.414285714285714	NA	NA	NA		p.A104A(1)	7	MARVEL. {ECO:0000255|PROSITE- ProRule:PRU00581}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNGR1&recr=Open">Click here</a>	
SYNGR1	IGR		C	C		11	Filtered Calls	22	39772123	39772123	157	0.197452229299363	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNGR1&recr=Open">Click here</a>	
SYNPO2	Silent	p.N59N	C	C		11	Filtered Calls	4	119944656	119944656	198	0.333333333333333	NA	NA	NA			64	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNPO2&recr=Open">Click here</a>	
SYS1	3'UTR		C	C		11	Filtered Calls	20	44003692	44003692	74	0.472972972972973	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYS1&recr=Open">Click here</a>	
SYT15	Silent	p.F196F	G	G		11	Filtered Calls	10	46967489	46967489	175	0.0628571428571429	NA	NA	NA			13	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT15&recr=Open">Click here</a>	
SYT15	Silent	p.T37T	G	G		11	Filtered Calls	10	46969350	46969350	97	0.0515463917525773	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT15&recr=Open">Click here</a>	
SYT5	Silent	p.V250V	G	G		11	Filtered Calls	19	55686326	55686326	117	0.393162393162393	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT5&recr=Open">Click here</a>	
SYT7	Silent	p.E246E	C	C		11	Filtered Calls	11	61295403	61295403	45	0.333333333333333	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT7&recr=Open">Click here</a>	
SYTL3	Silent	p.L550L	G	G		11	Filtered Calls	6	159184468	159184468	75	0.36	NA	NA	NA			20	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYTL3&recr=Open">Click here</a>	
SYTL4	Silent	p.L613L	G	G		11	Filtered Calls	X	99933418	99933418	43	0.395348837209302	NA	NA	NA			27	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYTL4&recr=Open">Click here</a>	
SYVN1	Silent	p.F240F	G	G		11	Filtered Calls	11	64898783	64898783	71	0.352112676056338	NA	NA	NA			22	Interaction with p53/TP53.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYVN1&recr=Open">Click here</a>	
SZT2	Intron		C	C		11	Filtered Calls	1	43885402	43885402	31	0.419354838709677	NA	NA	NA			113			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SZT2&recr=Open">Click here</a>	
TAAR5	Silent	p.F325F	G	G		11	Filtered Calls	6	132909851	132909851	55	0.381818181818182	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAAR5&recr=Open">Click here</a>	
TAB1	Intron		C	C	rs370788651	11	Filtered Calls	22	39811501	39811501	90	0.233333333333333	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAB1&recr=Open">Click here</a>	
TACC2	Silent	p.P293P	C	C		11	Filtered Calls	10	123970585	123970585	32	0.28125	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	
TACC2	Intron		C	C		11	Filtered Calls	10	123989856	123989856	161	0.291925465838509	NA	NA	NA			83			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	
TACC3	Silent	p.I675I	C	C		11	Filtered Calls	4	1741692	1741692	49	0.489795918367347	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC3&recr=Open">Click here</a>	
TACR1	Silent	p.I221I	G	G	rs201060197	11	Filtered Calls	2	75280804	75280804	98	0.244897959183673	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACR1&recr=Open">Click here</a>	
TAF1B	Silent	p.F376F	C	C	rs369161786	11	Filtered Calls	2	10051037	10051037	204	0.264705882352941	NA	NA	NA		p.F376F(1)	14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF1B&recr=Open">Click here</a>	
TAF1C	Intron		G	G		11	Filtered Calls	16	84214799	84214799	79	0.278481012658228	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF1C&recr=Open">Click here</a>	
TAF1C	Intron		G	G		11	Filtered Calls	16	84215521	84215521	104	0.278846153846154	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF1C&recr=Open">Click here</a>	
TAF1L	Silent	p.V566V	G	G		11	Filtered Calls	9	32633880	32633880	228	0.381578947368421	NA	NA	NA			159			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF1L&recr=Open">Click here</a>	
TAF2	Silent	p.S248S	G	G	rs370215970	11	Filtered Calls	8	120814082	120814082	270	0.437037037037037	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF2&recr=Open">Click here</a>	
TAF3	Silent	p.A440A	G	G	rs201095393	11	Filtered Calls	10	8006793	8006793	133	0.150375939849624	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF3&recr=Open">Click here</a>	
TALDO1	Intron		C	C	rs373190351	11	Filtered Calls	11	764281	764281	60	0.9	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TALDO1&recr=Open">Click here</a>	
TANC1	Silent	p.F24F	T	T		11	Filtered Calls	2	159954159	159954159	238	0.264705882352941	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TANC1&recr=Open">Click here</a>	
TANC1	Silent	p.I483I	C	C	rs6729871	11	Filtered Calls	2	160028729	160028729	138	0.268115942028986	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TANC1&recr=Open">Click here</a>	
TANC1	Silent	p.L529L	C	C		11	Filtered Calls	2	160031547	160031547	213	0.333333333333333	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TANC1&recr=Open">Click here</a>	
TANC2	Intron		C	C		11	Filtered Calls	17	61151385	61151385	27	0.259259259259259	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TANC2&recr=Open">Click here</a>	
TANGO2	Intron		C	C	rs369261835	11	Filtered Calls	22	20030869	20030869	167	0.221556886227545	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TANGO2&recr=Open">Click here</a>	
TAOK2	Silent	p.I157I	C	C		11	Filtered Calls	16	29990537	29990537	75	0.333333333333333	NA	NA	NA			22	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAOK2&recr=Open">Click here</a>	
TAOK3	Silent	p.I124I	G	G		11	Filtered Calls	12	118675943	118675943	223	0.286995515695067	NA	NA	NA			7	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAOK3&recr=Open">Click here</a>	
TAPBP	Silent	p.A148A	G	G	rs146422093	11	Filtered Calls	6	33272929	33272929	141	0.163120567375887	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAPBP&recr=Open">Click here</a>	
TAPBPL	5'Flank		G	G		11	Filtered Calls	12	6560495	6560495	95	0.189473684210526	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAPBPL&recr=Open">Click here</a>	
TARBP1	Silent	p.I1069I	G	G		11	Filtered Calls	1	234563366	234563366	250	0.272	NA	NA	NA			55			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TARBP1&recr=Open">Click here</a>	
TARS	Intron		C	C		11	Filtered Calls	5	33455680	33455680	278	0.197841726618705	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TARS&recr=Open">Click here</a>	
TARS2	Silent	p.S495S	C	C		11	Filtered Calls	1	150471456	150471456	203	0.512315270935961	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TARS2&recr=Open">Click here</a>	
TAS1R2	Silent	p.Q634Q	C	C		11	Filtered Calls	1	19166711	19166711	53	0.30188679245283	NA	NA	NA			45			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS1R2&recr=Open">Click here</a>	
TAS2R3	Silent	p.S141S	C	C		11	Filtered Calls	7	141464381	141464381	76	0.407894736842105	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R3&recr=Open">Click here</a>	
TAS2R42	Silent	p.G23G	C	C		11	Filtered Calls	12	11339475	11339475	229	0.441048034934498	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R42&recr=Open">Click here</a>	
TAS2R50	Silent	p.L202L	G	G		11	Filtered Calls	12	11138856	11138856	270	0.211111111111111	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R50&recr=Open">Click here</a>	
TAS2R7	Silent	p.F87F	G	G		11	Filtered Calls	12	10954909	10954909	162	0.388888888888889	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R7&recr=Open">Click here</a>	
TAS2R8	Silent	p.N72N	G	G	rs552836587	11	Filtered Calls	12	10959364	10959364	224	0.200892857142857	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R8&recr=Open">Click here</a>	
TAT	Intron		C	C		11	Filtered Calls	16	71605499	71605499	137	0.255474452554745	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAT&recr=Open">Click here</a>	
TBATA	Silent	p.E187E	C	C		11	Filtered Calls	10	72537038	72537038	44	0.159090909090909	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBATA&recr=Open">Click here</a>	
TBC1D17	Intron		C	C		11	Filtered Calls	19	50384519	50384519	87	0.172413793103448	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D17&recr=Open">Click here</a>	
TBC1D17	Silent	p.L469L	C	C	rs138109191	11	Filtered Calls	19	50387978	50387978	68	0.323529411764706	NA	NA	NA			15	Rab-GAP TBC. {ECO:0000255|PROSITE- ProRule:PRU00163}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D17&recr=Open">Click here</a>	
TBC1D22A	Silent	p.T173T	C	C		11	Filtered Calls	22	47193399	47193399	87	0.172413793103448	NA	NA	NA		p.T173T(1)	22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D22A&recr=Open">Click here</a>	
TBC1D2B	Silent	p.T561T	G	G		11	Filtered Calls	15	78308980	78308980	37	0.324324324324324	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D2B&recr=Open">Click here</a>	
TBC1D5	Silent	p.F191F	G	G		11	Filtered Calls	3	17425444	17425444	468	0.202991452991453	NA	NA	NA			36	Rab-GAP TBC. {ECO:0000255|PROSITE- ProRule:PRU00163}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D5&recr=Open">Click here</a>	
TBC1D8	IGR		C	C		11	Filtered Calls	2	101622440	101622440	186	0.553763440860215	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D8&recr=Open">Click here</a>	
TBC1D8	Intron		G	G		11	Filtered Calls	2	101650223	101650223	42	0.261904761904762	NA	NA	NA		p.?(2)	32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D8&recr=Open">Click here</a>	
TBC1D8B	Intron		G	G		11	Filtered Calls	X	106091407	106091407	69	0.463768115942029	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D8B&recr=Open">Click here</a>	
TBC1D8B	Intron		G	G		11	Filtered Calls	X	106109271	106109271	71	0.436619718309859	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D8B&recr=Open">Click here</a>	
TBC1D9	Intron		G	G		11	Filtered Calls	4	141590228	141590228	80	0.1875	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D9&recr=Open">Click here</a>	
TBL3	Silent	p.S257S	C	C		11	Filtered Calls	16	2025405	2025405	95	0.326315789473684	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBL3&recr=Open">Click here</a>	
TBRG4	Silent	p.P471P	G	G		11	Filtered Calls	7	45141578	45141578	90	0.577777777777778	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBRG4&recr=Open">Click here</a>	
TBX21	Intron		C	C		11	Filtered Calls	17	45821840	45821840	76	0.263157894736842	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBX21&recr=Open">Click here</a>	
TBX3	Intron		C	C		11	Filtered Calls	12	115117708	115117708	88	0.170454545454545	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBX3&recr=Open">Click here</a>	
TBX5	Silent	p.Q43Q	C	C		11	Filtered Calls	12	114841575	114841575	61	0.19672131147541	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBX5&recr=Open">Click here</a>	
TCERG1	Silent	p.I409I	C	C		11	Filtered Calls	5	145849135	145849135	374	0.390374331550802	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCERG1&recr=Open">Click here</a>	
TCERG1	Intron		C	C		11	Filtered Calls	5	145858051	145858051	295	0.4	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCERG1&recr=Open">Click here</a>	
TCERG1	Silent	p.I983I	C	C		11	Filtered Calls	5	145887474	145887474	73	0.356164383561644	NA	NA	NA			46	FF 5.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCERG1&recr=Open">Click here</a>	
TCF20	Silent	p.S1801S	G	G		11	Filtered Calls	22	42605909	42605909	99	0.121212121212121	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCF20&recr=Open">Click here</a>	
TCF25	Intron		C	C		11	Filtered Calls	16	89949756	89949756	144	0.277777777777778	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCF25&recr=Open">Click here</a>	
TCL1B	Silent	p.V36V	C	C		11	Filtered Calls	14	96152912	96152912	18	0.555555555555556	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCL1B&recr=Open">Click here</a>	
TCOF1	Silent	p.T1429T	C	C		11	Filtered Calls	5	149777972	149777972	76	0.381578947368421	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCOF1&recr=Open">Click here</a>	
TCP1	Intron		G	G		11	Filtered Calls	6	160206664	160206664	250	0.508	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCP1&recr=Open">Click here</a>	
TCP11	Silent	p.S206S	G	G		11	Filtered Calls	6	35088332	35088332	98	0.173469387755102	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCP11&recr=Open">Click here</a>	
TCP11	Silent	p.G131G	C	C		11	Filtered Calls	6	35088819	35088819	165	0.181818181818182	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCP11&recr=Open">Click here</a>	
TCP11L1	IGR		G	G		11	Filtered Calls	11	33080602	33080602	216	0.37037037037037	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCP11L1&recr=Open">Click here</a>	
TCTE1	Silent	p.L78L	G	G		11	Filtered Calls	6	44255329	44255329	83	0.433734939759036	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCTE1&recr=Open">Click here</a>	
TCTN2	Silent	p.E109E	G	G		11	Filtered Calls	12	124158221	124158221	245	0.579591836734694	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCTN2&recr=Open">Click here</a>	
TDO2	Intron		T	T		11	Filtered Calls	4	156838538	156838538	103	0.29126213592233	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDO2&recr=Open">Click here</a>	
TDO2	Silent	p.T342T	C	C		11	Filtered Calls	4	156839350	156839350	156	0.192307692307692	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDO2&recr=Open">Click here</a>	
TDP1	Intron		T	T		11	Filtered Calls	14	90509406	90509406	123	0.642276422764228	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDP1&recr=Open">Click here</a>	
TDRD1	Silent	p.K261K	G	G		11	Filtered Calls	10	115962917	115962917	112	0.196428571428571	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDRD1&recr=Open">Click here</a>	
TDRD5	Silent	p.L747L	C	C		11	Filtered Calls	1	179631317	179631317	147	0.36734693877551	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDRD5&recr=Open">Click here</a>	
TDRD5	Intron		C	C		11	Filtered Calls	1	179632475	179632475	236	0.169491525423729	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDRD5&recr=Open">Click here</a>	
TDRD5	Silent	p.L934L	G	G	rs371987660	11	Filtered Calls	1	179659934	179659934	94	0.319148936170213	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDRD5&recr=Open">Click here</a>	
TDRD5	3'UTR		G	G	rs567800134	11	Filtered Calls	1	179660080	179660080	40	0.5	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDRD5&recr=Open">Click here</a>	
TDRKH	Silent	p.D351D	G	G		11	Filtered Calls	1	151748736	151748736	145	0.386206896551724	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDRKH&recr=Open">Click here</a>	
TECPR2	Silent	p.F1239F	C	C		11	Filtered Calls	14	102931554	102931554	153	0.568627450980392	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TECPR2&recr=Open">Click here</a>	
TECRL	Intron		A	A		11	Filtered Calls	4	65188514	65188514	130	0.338461538461538	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TECRL&recr=Open">Click here</a>	
TECTA	Silent	p.C283C	C	C		11	Filtered Calls	11	120989073	120989073	38	0.368421052631579	NA	NA	NA			135	VWFC.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TECTA&recr=Open">Click here</a>	
TECTA	3'UTR		G	G		11	Filtered Calls	11	121016354	121016354	62	0.435483870967742	NA	NA	NA			135			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TECTA&recr=Open">Click here</a>	
TEK	Intron		G	G		11	Filtered Calls	9	27157971	27157971	50	0.48	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEK&recr=Open">Click here</a>	
TEK	Intron		C	C		11	Filtered Calls	9	27180314	27180314	80	0.45	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEK&recr=Open">Click here</a>	
TEKT1	Silent	p.E293E	C	C		11	Filtered Calls	17	6704236	6704236	70	0.114285714285714	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEKT1&recr=Open">Click here</a>	
TEKT5	Silent	p.L364L	G	G		11	Filtered Calls	16	10729772	10729772	100	0.63	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEKT5&recr=Open">Click here</a>	
TENM1	Silent	p.G2569G	C	C		11	Filtered Calls	X	123514857	123514857	65	0.415384615384615	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM1&recr=Open">Click here</a>	
TENM1	Silent	p.V2257V	G	G	rs184919933	11	Filtered Calls	X	123517989	123517989	99	0.424242424242424	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM1&recr=Open">Click here</a>	
TENM1	Intron		G	G		11	Filtered Calls	X	123556498	123556498	111	0.477477477477477	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM1&recr=Open">Click here</a>	
TENM1	Intron		G	G		11	Filtered Calls	X	123699417	123699417	73	0.26027397260274	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM1&recr=Open">Click here</a>	
TENM1	Intron		G	G		11	Filtered Calls	X	123699418	123699418	71	0.366197183098592	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM1&recr=Open">Click here</a>	
TENM2	Silent	p.G1690G	G	G		11	Filtered Calls	5	167671691	167671691	36	0.444444444444444	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM2&recr=Open">Click here</a>	
TENM3	Silent	p.P714P	C	C		11	Filtered Calls	4	183609425	183609425	114	0.307017543859649	NA	NA	NA			NA	EGF-like 7. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM3&recr=Open">Click here</a>	
TENM3	Silent	p.I2204I	C	C		11	Filtered Calls	4	183714437	183714437	98	0.295918367346939	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM3&recr=Open">Click here</a>	
TENM3	Silent	p.I2324I	C	C		11	Filtered Calls	4	183714797	183714797	83	0.650602409638554	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM3&recr=Open">Click here</a>	
TEPP	Silent	p.C8C	T	T		11	Filtered Calls	16	58010399	58010399	104	0.269230769230769	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEPP&recr=Open">Click here</a>	
TEX13B	Silent	p.G207G	C	C		11	Filtered Calls	X	107224628	107224628	66	0.484848484848485	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX13B&recr=Open">Click here</a>	
TEX14	3'UTR		C	C		11	Filtered Calls	17	56634369	56634369	291	0.223367697594502	NA	NA	NA			81			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX14&recr=Open">Click here</a>	
TEX2	Silent	p.I886I	G	G		11	Filtered Calls	17	62248494	62248494	286	0.206293706293706	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX2&recr=Open">Click here</a>	
TEX264	Silent	p.I112I	C	C	rs532705370	11	Filtered Calls	3	51718506	51718506	62	0.241935483870968	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX264&recr=Open">Click here</a>	
TFAP2B	Silent	p.S277S	G	G		11	Filtered Calls	6	50805697	50805697	231	0.151515151515152	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TFAP2B&recr=Open">Click here</a>	
TFAP2B	Silent	p.A407A	C	C		11	Filtered Calls	6	50810943	50810943	71	0.140845070422535	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TFAP2B&recr=Open">Click here</a>	
TFB2M	3'UTR		AGTTTTCAAATTTGGTTTTCATGTCAT	AGTTTTCAAATTTGGTTTTCATGTCAT	rs144556168	11	Filtered Calls	1	246704259	246704285	171	0.169590643274854	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TFB2M&recr=Open">Click here</a>	
TFEB	Silent	p.L314L	G	G		11	Filtered Calls	6	41653837	41653837	111	0.216216216216216	NA	NA	NA			11	Leucine-zipper.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TFEB&recr=Open">Click here</a>	
TFG	Silent	p.S153S	T	T		11	Filtered Calls	3	100451395	100451395	215	0.0976744186046512	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TFG&recr=Open">Click here</a>	
TFPI	Silent	p.F75F	G	G		11	Filtered Calls	2	188361702	188361702	171	0.245614035087719	NA	NA	NA			9	BPTI/Kunitz inhibitor 1. {ECO:0000255|PROSITE-ProRule:PRU00031}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TFPI&recr=Open">Click here</a>	
TG	Silent	p.T621T	G	G	rs148739204	11	Filtered Calls	8	133899480	133899480	177	0.231638418079096	NA	NA	NA			168	Thyroglobulin type-1 5. {ECO:0000255|PROSITE-ProRule:PRU00500}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TG&recr=Open">Click here</a>	
TG	Silent	p.E1078E	G	G		11	Filtered Calls	8	133911059	133911059	59	0.203389830508475	NA	NA	NA			168	Thyroglobulin type-1 9. {ECO:0000255|PROSITE-ProRule:PRU00500}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TG&recr=Open">Click here</a>	
TG	Intron		T	T		11	Filtered Calls	8	133978798	133978798	172	0.226744186046512	NA	NA	NA			168			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TG&recr=Open">Click here</a>	
TGDS	Silent	p.N256N	G	G		11	Filtered Calls	13	95230316	95230316	274	0.313868613138686	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGDS&recr=Open">Click here</a>	
TGDS	Silent	p.L21L	G	G		11	Filtered Calls	13	95248330	95248330	80	0.3	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGDS&recr=Open">Click here</a>	
TGFBR1	Intron		T	T		11	Filtered Calls	9	101908762	101908762	249	0.365461847389558	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGFBR1&recr=Open">Click here</a>	
TGM1	Silent	p.I182I	G	G		11	Filtered Calls	14	24729867	24729867	43	0.348837209302326	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGM1&recr=Open">Click here</a>	
TGM5	Silent	p.F167F	G	G		11	Filtered Calls	15	43548820	43548820	173	0.341040462427746	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGM5&recr=Open">Click here</a>	
TGM5	Silent	p.F136F	G	G		11	Filtered Calls	15	43552278	43552278	72	0.236111111111111	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGM5&recr=Open">Click here</a>	
TGOLN2	Silent	p.I401I	G	G		11	Filtered Calls	2	85553652	85553652	220	0.404545454545455	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGOLN2&recr=Open">Click here</a>	
THADA	Intron		G	G		11	Filtered Calls	2	43625282	43625282	127	0.338582677165354	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THADA&recr=Open">Click here</a>	
THAP6	5'UTR		C	C		11	Filtered Calls	4	76441985	76441985	205	0.258536585365854	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THAP6&recr=Open">Click here</a>	
THBS1	Silent	p.P629P	C	C		11	Filtered Calls	15	39881516	39881516	93	0.516129032258065	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THBS1&recr=Open">Click here</a>	
THBS1	Silent	p.A709A	G	G		11	Filtered Calls	15	39882206	39882206	14	0.214285714285714	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THBS1&recr=Open">Click here</a>	
THBS2	Silent	p.I458I	G	G		11	Filtered Calls	6	169637368	169637368	28	0.5	NA	NA	NA			111	TSP type-1 2. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THBS2&recr=Open">Click here</a>	
THBS4	Silent	p.T698T	C	C		11	Filtered Calls	5	79374937	79374937	151	0.437086092715232	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THBS4&recr=Open">Click here</a>	
THEG	Intron		G	G		11	Filtered Calls	19	367232	367232	42	0.0952380952380952	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THEG&recr=Open">Click here</a>	
THEMIS	5'UTR		G	G		11	Filtered Calls	6	128222067	128222067	99	0.404040404040404	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THEMIS&recr=Open">Click here</a>	
THRB	Silent	p.F68F	G	G		11	Filtered Calls	3	24231644	24231644	208	0.413461538461538	NA	NA	NA			19	Modulating.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THRB&recr=Open">Click here</a>	
THSD7A	Silent	p.Q1581Q	T	T		11	Filtered Calls	7	11418755	11418755	98	0.255102040816327	NA	NA	NA			113			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7A&recr=Open">Click here</a>	
THSD7A	Intron		G	G		11	Filtered Calls	7	11422139	11422139	45	0.244444444444444	NA	NA	NA			113			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7A&recr=Open">Click here</a>	
THSD7A	Silent	p.K481K	C	C		11	Filtered Calls	7	11630097	11630097	117	0.333333333333333	NA	NA	NA			113	TSP type-1 4. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD7A&recr=Open">Click here</a>	
TIAM2	Silent	p.L499L	C	C		11	Filtered Calls	6	155458613	155458613	87	0.390804597701149	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TIAM2&recr=Open">Click here</a>	
TIAM2	Silent	p.K987K	G	G		11	Filtered Calls	6	155578078	155578078	30	0.333333333333333	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TIAM2&recr=Open">Click here</a>	
TICAM1	Silent	p.P422P	G	G		11	Filtered Calls	19	4817124	4817124	66	0.151515151515152	NA	NA	NA			26	TIR.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TICAM1&recr=Open">Click here</a>	
TIE1	Silent	p.G473G	G	G		11	Filtered Calls	1	43777427	43777427	39	0.487179487179487	NA	NA	NA			70	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TIE1&recr=Open">Click here</a>	
TIGIT	Intron		C	C		11	Filtered Calls	3	114018437	114018437	40	0.3	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TIGIT&recr=Open">Click here</a>	
TIMP1	Intron		C	C		11	Filtered Calls	X	47444419	47444419	17	0.352941176470588	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TIMP1&recr=Open">Click here</a>	
TINAG	Silent	p.Y56Y	C	C		11	Filtered Calls	6	54173516	54173516	251	0.195219123505976	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TINAG&recr=Open">Click here</a>	
TKTL1	Silent	p.S551S	C	C		11	Filtered Calls	X	153557900	153557900	158	0.936708860759494	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TKTL1&recr=Open">Click here</a>	
TLK1	3'UTR		G	G	rs143671860	11	Filtered Calls	2	171850282	171850282	182	0.230769230769231	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLK1&recr=Open">Click here</a>	
TLL1	Silent	p.L111L	T	T		11	Filtered Calls	4	166914008	166914008	140	0.335714285714286	NA	NA	NA			77			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLL1&recr=Open">Click here</a>	
TLL2	Intron		G	G		11	Filtered Calls	10	98145979	98145979	109	0.165137614678899	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLL2&recr=Open">Click here</a>	
TLL2	Intron		A	A		11	Filtered Calls	10	98146846	98146846	76	0.184210526315789	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLL2&recr=Open">Click here</a>	
TLN1	Silent	p.K138K	C	C		11	Filtered Calls	9	35724666	35724666	107	0.831775700934579	NA	NA	NA			85	FERM. {ECO:0000255|PROSITE- ProRule:PRU00084}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLN1&recr=Open">Click here</a>	
TLR2	Silent	p.S692S	C	C		11	Filtered Calls	4	154626135	154626135	272	0.231617647058824	NA	NA	NA			29	TIR. {ECO:0000255|PROSITE- ProRule:PRU00204}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR2&recr=Open">Click here</a>	
TLR3	5'UTR		T	T		11	Filtered Calls	4	187003512	187003512	273	0.197802197802198	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR3&recr=Open">Click here</a>	
TLR3	Silent	p.L2L	C	C		11	Filtered Calls	4	187003677	187003677	178	0.235955056179775	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR3&recr=Open">Click here</a>	
TLR5	Silent	p.L712L	G	G		11	Filtered Calls	1	223284238	223284238	96	0.270833333333333	NA	NA	NA			32	TIR. {ECO:0000255|PROSITE- ProRule:PRU00204}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR5&recr=Open">Click here</a>	
TLR8	Silent	p.F33F	C	C		11	Filtered Calls	X	12937204	12937204	150	0.4	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR8&recr=Open">Click here</a>	
TLR9	Silent	p.G718G	C	C		11	Filtered Calls	3	52256638	52256638	24	0.291666666666667	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR9&recr=Open">Click here</a>	
TLR9	Intron		G	G		11	Filtered Calls	3	52263665	52263665	56	0.214285714285714	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR9&recr=Open">Click here</a>	
TM4SF18	Silent	p.I200I	G	G		11	Filtered Calls	3	149039271	149039271	434	0.26036866359447	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TM4SF18&recr=Open">Click here</a>	
TM4SF2	Intron		C	C		11	Filtered Calls	X	37955477	37955477	224	0.459821428571429	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TM4SF2&recr=Open">Click here</a>	
TM4SF2	Intron		C	C		11	Filtered Calls	X	38145076	38145076	84	0.571428571428571	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TM4SF2&recr=Open">Click here</a>	
TMC2	Silent	p.S716S	C	C		11	Filtered Calls	20	2597925	2597925	40	0.675	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMC2&recr=Open">Click here</a>	
TMC4	Intron		G	G		11	Filtered Calls	19	54667447	54667447	83	0.27710843373494	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMC4&recr=Open">Click here</a>	
TMC4	Silent	p.I426I	G	G		11	Filtered Calls	19	54667473	54667473	83	0.108433734939759	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMC4&recr=Open">Click here</a>	
TMC5	Intron		C	C		11	Filtered Calls	16	19460858	19460858	67	0.253731343283582	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMC5&recr=Open">Click here</a>	
TMC5	Intron		G	G		11	Filtered Calls	16	19468315	19468315	53	0.245283018867925	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMC5&recr=Open">Click here</a>	
TMC7	Silent	p.V693V	C	C		11	Filtered Calls	16	19070789	19070789	157	0.0573248407643312	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMC7&recr=Open">Click here</a>	
TMC8	Silent	p.S391S	C	C		11	Filtered Calls	17	76133361	76133361	57	0.192982456140351	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMC8&recr=Open">Click here</a>	
TMCO3	Silent	p.F560F	C	C	rs147612090	11	Filtered Calls	13	114193812	114193812	43	0.162790697674419	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMCO3&recr=Open">Click here</a>	
TMCO5A	Silent	p.I38I	C	C		11	Filtered Calls	15	38228638	38228638	147	0.346938775510204	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMCO5A&recr=Open">Click here</a>	
TMCO5A	Intron		C	C		11	Filtered Calls	15	38239853	38239853	200	0.23	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMCO5A&recr=Open">Click here</a>	
TMED6	Silent	p.F68F	G	G		11	Filtered Calls	16	69385453	69385453	137	0.569343065693431	NA	NA	NA			9	GOLD. {ECO:0000255|PROSITE- ProRule:PRU00096}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMED6&recr=Open">Click here</a>	
TMEM104	Intron		C	C		11	Filtered Calls	17	72781686	72781686	96	0.572916666666667	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM104&recr=Open">Click here</a>	
TMEM104	Silent	p.I139I	C	C		11	Filtered Calls	17	72787126	72787126	123	0.260162601626016	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM104&recr=Open">Click here</a>	
TMEM108	Silent	p.P107P	C	C	rs201002405	11	Filtered Calls	3	133098876	133098876	13	0.461538461538462	NA	NA	NA			38	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM108&recr=Open">Click here</a>	
TMEM117	Silent	p.G163G	G	G		11	Filtered Calls	12	44537406	44537406	102	0.382352941176471	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM117&recr=Open">Click here</a>	
TMEM119	Silent	p.F83F	G	G		11	Filtered Calls	12	108985911	108985911	39	0.307692307692308	NA	NA	NA		p.F83F(1)	7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM119&recr=Open">Click here</a>	
TMEM131	Silent	p.T258T	C	C		11	Filtered Calls	2	98453570	98453570	158	0.40506329113924	NA	NA	NA			57			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM131&recr=Open">Click here</a>	
TMEM132B	Silent	p.E239E	G	G		11	Filtered Calls	12	125834662	125834662	29	0.241379310344828	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM132B&recr=Open">Click here</a>	
TMEM132B	Silent	p.V734V	G	G		11	Filtered Calls	12	126138221	126138221	126	0.26984126984127	NA	NA	NA			107			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM132B&recr=Open">Click here</a>	
TMEM132D	Silent	p.I642I	G	G		11	Filtered Calls	12	129563268	129563268	50	0.1	NA	NA	NA			152			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM132D&recr=Open">Click here</a>	
TMEM143	Silent	p.L169L	C	C		11	Filtered Calls	19	48848474	48848474	131	0.312977099236641	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM143&recr=Open">Click here</a>	
TMEM144	Intron		T	T		11	Filtered Calls	4	159156582	159156582	188	0.319148936170213	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM144&recr=Open">Click here</a>	
TMEM161A	Silent	p.F82F	G	G		11	Filtered Calls	19	19243506	19243506	53	0.358490566037736	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM161A&recr=Open">Click here</a>	
TMEM174	Silent	p.L222L	C	C		11	Filtered Calls	5	72469924	72469924	70	0.485714285714286	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM174&recr=Open">Click here</a>	
TMEM184B	5'UTR		G	G		11	Filtered Calls	22	38617549	38617549	50	0.24	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM184B&recr=Open">Click here</a>	
TMEM2	Intron		G	G		11	Filtered Calls	9	74355156	74355156	195	0.338461538461538	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM2&recr=Open">Click here</a>	
TMEM207	Silent	p.P80P	G	G		11	Filtered Calls	3	190158097	190158097	100	0.27	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM207&recr=Open">Click here</a>	
TMEM231	Silent	p.F290F	G	G	rs541349898	11	Filtered Calls	16	75573973	75573973	32	0.3125	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM231&recr=Open">Click here</a>	
TMEM234	5'Flank		G	G	rs375062766	11	Filtered Calls	1	32681071	32681071	101	0.316831683168317	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM234&recr=Open">Click here</a>	
TMEM234	5'Flank		G	G	rs369087066	11	Filtered Calls	1	32681075	32681075	103	0.058252427184466	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM234&recr=Open">Click here</a>	
TMEM234	Silent	p.L17L	G	G		11	Filtered Calls	1	32687587	32687587	61	0.557377049180328	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM234&recr=Open">Click here</a>	
TMEM239	Intron		C	C		11	Filtered Calls	20	2796172	2796172	28	0.214285714285714	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM239&recr=Open">Click here</a>	
TMEM241	Silent	p.L131L	G	G		11	Filtered Calls	18	20953718	20953718	50	0.44	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM241&recr=Open">Click here</a>	
TMEM37	Silent	p.E202E	A	A		11	Filtered Calls	2	120195013	120195013	92	0.282608695652174	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM37&recr=Open">Click here</a>	
TMEM40	Silent	p.G96G	C	C		11	Filtered Calls	3	12785412	12785412	131	0.442748091603053	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM40&recr=Open">Click here</a>	
TMEM53	IGR		T	T		11	Filtered Calls	1	45116367	45116367	46	0.434782608695652	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM53&recr=Open">Click here</a>	
TMEM53	Silent	p.L241L	G	G		11	Filtered Calls	1	45120344	45120344	73	0.410958904109589	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM53&recr=Open">Click here</a>	
TMEM53	Silent	p.V240V	G	G		11	Filtered Calls	1	45120345	45120345	72	0.402777777777778	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM53&recr=Open">Click here</a>	
TMEM71	Silent	p.I174I	G	G		11	Filtered Calls	8	133740141	133740141	143	0.181818181818182	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM71&recr=Open">Click here</a>	
TMEM74	Silent	p.L246L	G	G		11	Filtered Calls	8	109796592	109796592	47	0.212765957446809	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM74&recr=Open">Click here</a>	
TMEM91	Intron		G	G	rs548296403	11	Filtered Calls	19	41860650	41860650	73	0.164383561643836	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM91&recr=Open">Click here</a>	
TMEM98	Intron		C	C		11	Filtered Calls	17	31267798	31267798	125	0.464	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM98&recr=Open">Click here</a>	
TMEM98	Intron		C	C		11	Filtered Calls	17	31267799	31267799	128	0.4609375	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM98&recr=Open">Click here</a>	
TMIGD1	Silent	p.S114S	C	C		11	Filtered Calls	17	28656288	28656288	49	0.877551020408163	NA	NA	NA			12	Ig-like C2-type 1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMIGD1&recr=Open">Click here</a>	
TMPRSS11A	Intron		G	G		11	Filtered Calls	4	68795586	68795586	149	0.275167785234899	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS11A&recr=Open">Click here</a>	
TMPRSS11E	Silent	p.I192I	C	C		11	Filtered Calls	4	69342025	69342025	153	0.326797385620915	NA	NA	NA			24	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS11E&recr=Open">Click here</a>	
TMPRSS11E	Silent	p.L298L	C	C		11	Filtered Calls	4	69343273	69343273	317	0.290220820189274	NA	NA	NA			24	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS11E&recr=Open">Click here</a>	
TMPRSS12	Silent	p.S40S	T	T		11	Filtered Calls	12	51236867	51236867	8	0.375	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS12&recr=Open">Click here</a>	
TMPRSS15	Silent	p.L814L	G	G	rs369366818	11	Filtered Calls	21	19666631	19666631	85	0.294117647058824	NA	NA	NA			85	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS15&recr=Open">Click here</a>	
TMPRSS15	Intron		G	G		11	Filtered Calls	21	19732192	19732192	200	0.305	NA	NA	NA			85			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS15&recr=Open">Click here</a>	
TMPRSS3	Silent	p.F147F	G	G		11	Filtered Calls	21	43808517	43808517	102	0.323529411764706	NA	NA	NA			13	SRCR. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS3&recr=Open">Click here</a>	
TMTC4	Intron		G	G		11	Filtered Calls	13	101316505	101316505	27	0.259259259259259	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMTC4&recr=Open">Click here</a>	
TMX4	Intron		G	G		11	Filtered Calls	20	7964508	7964508	79	0.367088607594937	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMX4&recr=Open">Click here</a>	
TNC	Intron		G	G		11	Filtered Calls	9	117810767	117810767	75	0.693333333333333	NA	NA	NA			120			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNC&recr=Open">Click here</a>	
TNC	Silent	p.G755G	T	T		11	Filtered Calls	9	117844190	117844190	212	0.235849056603774	NA	NA	NA			120	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNC&recr=Open">Click here</a>	
TNFRSF10A	Silent	p.V103V	G	G		11	Filtered Calls	8	23069723	23069723	124	0.0967741935483871	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFRSF10A&recr=Open">Click here</a>	
TNFRSF10D	Silent	p.S109S	G	G		11	Filtered Calls	8	23005994	23005994	134	0.17910447761194	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFRSF10D&recr=Open">Click here</a>	
TNFRSF13B	5'Flank		A	A		11	Filtered Calls	17	16843647	16843647	72	0.708333333333333	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFRSF13B&recr=Open">Click here</a>	
TNFRSF13B	5'Flank		G	G		11	Filtered Calls	17	16843648	16843648	72	0.708333333333333	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFRSF13B&recr=Open">Click here</a>	
TNFRSF25	5'Flank		C	C		11	Filtered Calls	1	6528627	6528627	46	0.0869565217391304	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFRSF25&recr=Open">Click here</a>	
TNFRSF4	Intron		G	G		11	Filtered Calls	1	1147011	1147011	18	0.277777777777778	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFRSF4&recr=Open">Click here</a>	
TNFRSF8	Intron		C	C		11	Filtered Calls	1	12195680	12195680	66	0.46969696969697	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFRSF8&recr=Open">Click here</a>	
TNFSF12-TNFSF13	IGR		C	C		11	Filtered Calls	17	7467051	7467051	54	0.759259259259259	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFSF12-TNFSF13&recr=Open">Click here</a>	
TNFSF18	Silent	p.F197F	G	G		11	Filtered Calls	1	173010516	173010516	92	0.41304347826087	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFSF18&recr=Open">Click here</a>	
TNKS	Intron		T	T		11	Filtered Calls	8	9605525	9605525	171	0.233918128654971	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNKS&recr=Open">Click here</a>	
TNKS1BP1	Silent	p.I1115I	G	G	rs113027859	11	Filtered Calls	11	57076840	57076840	53	0.39622641509434	NA	NA	NA			64	Acidic.|Gly-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNKS1BP1&recr=Open">Click here</a>	
TNKS2	Silent	p.S540S	C	C		11	Filtered Calls	10	93600410	93600410	306	0.26797385620915	NA	NA	NA		p.S540S(1)	48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNKS2&recr=Open">Click here</a>	
TNKS2	Intron		C	C		11	Filtered Calls	10	93622687	93622687	200	0.315	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNKS2&recr=Open">Click here</a>	
TNR	Silent	p.G212G	C	C		11	Filtered Calls	1	175372616	175372616	134	0.582089552238806	NA	NA	NA			177	Cys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNR&recr=Open">Click here</a>	
TNRC6B	Intron		C	C		11	Filtered Calls	22	40708499	40708499	96	0.166666666666667	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNRC6B&recr=Open">Click here</a>	
TNRC6C	Silent	p.P917P	C	C		11	Filtered Calls	17	76063986	76063986	93	0.204301075268817	NA	NA	NA			40	Sufficient for interaction with argonaute family proteins.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNRC6C&recr=Open">Click here</a>	
TNRC6C	Silent	p.S1055S	C	C		11	Filtered Calls	17	76073379	76073379	20	0.2	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNRC6C&recr=Open">Click here</a>	
TNS1	Intron		G	G		11	Filtered Calls	2	218682401	218682401	29	0.275862068965517	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNS1&recr=Open">Click here</a>	
TNS3	3'UTR		G	G		11	Filtered Calls	7	47317668	47317668	46	0.260869565217391	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNS3&recr=Open">Click here</a>	
TNS3	Silent	p.F809F	G	G		11	Filtered Calls	7	47385809	47385809	57	0.210526315789474	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNS3&recr=Open">Click here</a>	
TNS3	Silent	p.T757T	G	G	rs373110561	11	Filtered Calls	7	47407972	47407972	184	0.630434782608696	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNS3&recr=Open">Click here</a>	
TNS3	Silent	p.F191F	G	G	rs368113552	11	Filtered Calls	7	47454705	47454705	39	0.538461538461538	NA	NA	NA		p.F191fs*10(2)	64	C2 tensin-type. {ECO:0000255|PROSITE- ProRule:PRU00589}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNS3&recr=Open">Click here</a>	
TNXB	Silent	p.L3234L	G	G		11	Filtered Calls	6	32017104	32017104	42	0.261904761904762	NA	NA	NA			8	Fibronectin type-III 24. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNXB&recr=Open">Click here</a>	
TNXB	Silent	p.E2527E	C	C		11	Filtered Calls	6	32026079	32026079	72	0.208333333333333	NA	NA	NA			8	Fibronectin type-III 17. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNXB&recr=Open">Click here</a>	
TNXB	Silent	p.P1107P	G	G		11	Filtered Calls	6	32052314	32052314	33	0.303030303030303	NA	NA	NA			8	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNXB&recr=Open">Click here</a>	
TOLLIP	Silent	p.I249I	G	G	rs375043112	11	Filtered Calls	11	1298347	1298347	68	0.323529411764706	NA	NA	NA			6	CUE. {ECO:0000255|PROSITE- ProRule:PRU00468}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TOLLIP&recr=Open">Click here</a>	
TOMM22	Intron		C	C		11	Filtered Calls	22	39078875	39078875	456	0.0219298245614035	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TOMM22&recr=Open">Click here</a>	
TONSL	Intron		G	G		11	Filtered Calls	8	145668051	145668051	149	0.429530201342282	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TONSL&recr=Open">Click here</a>	
TONSL	Intron		G	G		11	Filtered Calls	8	145668052	145668052	151	0.437086092715232	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TONSL&recr=Open">Click here</a>	
TOP1MT	Intron		G	G		11	Filtered Calls	8	144400015	144400015	22	0.363636363636364	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TOP1MT&recr=Open">Click here</a>	
TP63	Intron		C	C		11	Filtered Calls	3	189455520	189455520	137	0.0656934306569343	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TP63&recr=Open">Click here</a>	
TP63	Silent	p.G585G	G	G		11	Filtered Calls	3	189612285	189612285	57	0.263157894736842	NA	NA	NA			61	SAM.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TP63&recr=Open">Click here</a>	
TPCN1	Intron		C	C		11	Filtered Calls	12	113698165	113698165	176	0.0397727272727273	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPCN1&recr=Open">Click here</a>	
TPCN1	Silent	p.I368I	C	C		11	Filtered Calls	12	113717966	113717966	96	0.489583333333333	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPCN1&recr=Open">Click here</a>	
TPK1	Intron		G	G		11	Filtered Calls	7	144228164	144228164	15	0.266666666666667	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPK1&recr=Open">Click here</a>	
TPM1	Intron		C	C		11	Filtered Calls	15	63349180	63349180	338	0.284023668639053	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPM1&recr=Open">Click here</a>	
TPMT	Silent	p.I232I	A	A		11	Filtered Calls	6	18130941	18130941	350	0.165714285714286	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPMT&recr=Open">Click here</a>	
TPO	Silent	p.G903G	G	G		11	Filtered Calls	2	1544456	1544456	19	0.368421052631579	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPO&recr=Open">Click here</a>	
TPPP3	3'UTR		A	A		11	Filtered Calls	16	67424072	67424072	35	0.628571428571429	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPPP3&recr=Open">Click here</a>	
TPR	Intron		T	T		11	Filtered Calls	1	186306142	186306142	502	0.213147410358566	NA	NA	NA			123			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPR&recr=Open">Click here</a>	
TPRA1	Silent	p.I128I	G	G		11	Filtered Calls	3	127295698	127295698	18	0.444444444444444	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPRA1&recr=Open">Click here</a>	
TPSD1	Silent	p.S69S	C	C		11	Filtered Calls	16	1306641	1306641	41	0.24390243902439	NA	NA	NA			20	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPSD1&recr=Open">Click here</a>	
TPST1	Silent	p.I146I	C	C	rs142645304	11	Filtered Calls	7	65705850	65705850	80	0.0625	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPST1&recr=Open">Click here</a>	
TPTE	Silent	p.E534E	C	C		11	Filtered Calls	21	10906959	10906959	92	0.141304347826087	NA	NA	NA			130	C2 tensin-type. {ECO:0000255|PROSITE- ProRule:PRU00589}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPTE&recr=Open">Click here</a>	
TPTE	Silent	p.L17L	G	G		11	Filtered Calls	21	10971306	10971306	43	0.186046511627907	NA	NA	NA			130			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPTE&recr=Open">Click here</a>	
TRAF5	Silent	p.S71S	C	C		11	Filtered Calls	1	211526794	211526794	20	0.25	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAF5&recr=Open">Click here</a>	
TRAJ28	RNA		T	T		11	Filtered Calls	14	22981880	22981880	42	0.571428571428571	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAJ28&recr=Open">Click here</a>	
TRAJ28	RNA		C	C		11	Filtered Calls	14	22981884	22981884	44	0.318181818181818	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAJ28&recr=Open">Click here</a>	
TRAJ53	RNA		G	G		11	Filtered Calls	14	22952034	22952034	125	0.904	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAJ53&recr=Open">Click here</a>	
TRAK1	Silent	p.S730S	C	C		11	Filtered Calls	3	42264557	42264557	74	0.175675675675676	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAK1&recr=Open">Click here</a>	
TRAM1	Intron		A	A		11	Filtered Calls	8	71499243	71499243	113	0.265486725663717	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAM1&recr=Open">Click here</a>	
TRANK1	Silent	p.L1737L	C	C		11	Filtered Calls	3	36874081	36874081	63	0.174603174603175	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRANK1&recr=Open">Click here</a>	
TRANK1	Silent	p.V109V	G	G		11	Filtered Calls	3	36899104	36899104	65	0.384615384615385	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRANK1&recr=Open">Click here</a>	
TRAPPC11	Intron		C	C		11	Filtered Calls	4	184588205	184588205	207	0.323671497584541	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAPPC11&recr=Open">Click here</a>	
TRAPPC9	Silent	p.I619I	G	G		11	Filtered Calls	8	141321406	141321406	96	0.260416666666667	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAPPC9&recr=Open">Click here</a>	
TRAV12-1	RNA		C	C	rs367744964	11	Filtered Calls	14	22309874	22309874	86	0.465116279069767	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAV12-1&recr=Open">Click here</a>	
TRAV14DV4	RNA		A	A		11	Filtered Calls	14	22392549	22392549	52	0.461538461538462	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAV14DV4&recr=Open">Click here</a>	
TRAV2	RNA		C	C		11	Filtered Calls	14	22180985	22180985	96	0.322916666666667	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAV2&recr=Open">Click here</a>	
TRAV26-1	RNA		G	G		11	Filtered Calls	14	22592010	22592010	95	0.715789473684211	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAV26-1&recr=Open">Click here</a>	
TRAV30	RNA		G	G		11	Filtered Calls	14	22636748	22636748	42	0.785714285714286	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAV30&recr=Open">Click here</a>	
TRAV4	RNA		C	C		11	Filtered Calls	14	22205204	22205204	20	0.7	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAV4&recr=Open">Click here</a>	
TRBV10-2	RNA		G	G		11	Filtered Calls	7	142206932	142206932	41	0.414634146341463	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRBV10-2&recr=Open">Click here</a>	
TRBV2	RNA		C	C		11	Filtered Calls	7	142000816	142000816	68	0.294117647058824	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRBV2&recr=Open">Click here</a>	
TRBV28	RNA		T	T		11	Filtered Calls	7	142428755	142428755	28	0.75	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRBV28&recr=Open">Click here</a>	
TRBV6-1	RNA		G	G		11	Filtered Calls	7	142028452	142028452	75	0.386666666666667	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRBV6-1&recr=Open">Click here</a>	
TRBV6-4	RNA		C	C		11	Filtered Calls	7	142250815	142250815	37	0.297297297297297	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRBV6-4&recr=Open">Click here</a>	
TRBV6-4	RNA		C	C		11	Filtered Calls	7	142250981	142250981	35	0.228571428571429	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRBV6-4&recr=Open">Click here</a>	
TRBV7-3	RNA		C	C	rs371743471	11	Filtered Calls	7	142247280	142247280	34	0.441176470588235	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRBV7-3&recr=Open">Click here</a>	
TRBV7-8	RNA		G	G		11	Filtered Calls	7	142099733	142099733	31	0.258064516129032	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRBV7-8&recr=Open">Click here</a>	
TRDC	RNA		C	C		11	Filtered Calls	14	22934585	22934585	46	0.782608695652174	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRDC&recr=Open">Click here</a>	
TRDV1	RNA		C	C		11	Filtered Calls	14	22564592	22564592	110	0.881818181818182	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRDV1&recr=Open">Click here</a>	
TREX2	5'UTR		C	C		11	Filtered Calls	X	152730472	152730472	203	0.448275862068966	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TREX2&recr=Open">Click here</a>	
TRGC1	RNA		G	G		11	Filtered Calls	7	38305167	38305167	352	0.0369318181818182	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRGC1&recr=Open">Click here</a>	
TRGV3	RNA		C	C	rs372759223	11	Filtered Calls	7	38398389	38398389	167	0.275449101796407	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRGV3&recr=Open">Click here</a>	
TRGV8	RNA		C	C		11	Filtered Calls	7	38370231	38370231	95	0.242105263157895	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRGV8&recr=Open">Click here</a>	
TRHDE	Silent	p.A202A	T	T		11	Filtered Calls	12	72667164	72667164	24	0.5	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRHDE&recr=Open">Click here</a>	
TRHDE	Intron		C	C		11	Filtered Calls	12	72956624	72956624	133	0.338345864661654	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRHDE&recr=Open">Click here</a>	
TRHDE	Silent	p.R696R	G	G		11	Filtered Calls	12	72969126	72969126	128	0.296875	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRHDE&recr=Open">Click here</a>	
TRHR	Silent	p.K358K	G	G		11	Filtered Calls	8	110131561	110131561	206	0.383495145631068	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRHR&recr=Open">Click here</a>	
TRIM10	Silent	p.L250L	G	G		11	Filtered Calls	6	30126182	30126182	135	0.222222222222222	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM10&recr=Open">Click here</a>	
TRIM17	Silent	p.F448F	G	G		11	Filtered Calls	1	228595992	228595992	81	0.395061728395062	NA	NA	NA			10	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM17&recr=Open">Click here</a>	
TRIM24	Intron		T	T		11	Filtered Calls	7	138262103	138262103	46	0.891304347826087	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM24&recr=Open">Click here</a>	
TRIM28	Intron		C	C	rs377351986	11	Filtered Calls	19	59061093	59061093	397	0.52896725440806	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM28&recr=Open">Click here</a>	
TRIM29	5'Flank		T	T		11	Filtered Calls	11	119999136	119999136	30	0.433333333333333	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM29&recr=Open">Click here</a>	
TRIM33	Intron		G	G		11	Filtered Calls	1	114969923	114969923	310	0.225806451612903	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM33&recr=Open">Click here</a>	
TRIM36	Silent	p.I422I	G	G		11	Filtered Calls	5	114469825	114469825	87	0.471264367816092	NA	NA	NA			37	Fibronectin type-III. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM36&recr=Open">Click here</a>	
TRIM37	Silent	p.S412S	G	G		11	Filtered Calls	17	57128653	57128653	259	0.181467181467181	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM37&recr=Open">Click here</a>	
TRIM5	Silent	p.F418F	G	G	rs200373739	11	Filtered Calls	11	5686267	5686267	97	0.474226804123711	NA	NA	NA			21	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM5&recr=Open">Click here</a>	
TRIM58	Intron		C	C		11	Filtered Calls	1	248023911	248023911	54	0.314814814814815	NA	NA	NA		p.?(1)	63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM58&recr=Open">Click here</a>	
TRIM67	Silent	p.A485A	G	G		11	Filtered Calls	1	231337184	231337184	43	0.162790697674419	NA	NA	NA			29	COS. {ECO:0000255|PROSITE- ProRule:PRU00586}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM67&recr=Open">Click here</a>	
TRIM69	Silent	p.K138K	G	G		11	Filtered Calls	15	45047505	45047505	87	0.310344827586207	NA	NA	NA			20	Necessary for nuclear localization. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM69&recr=Open">Click here</a>	
TRIML1	Silent	p.F17F	C	C		11	Filtered Calls	4	189060763	189060763	112	0.294642857142857	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIML1&recr=Open">Click here</a>	
TRIML1	Silent	p.G339G	G	G		11	Filtered Calls	4	189068136	189068136	38	0.236842105263158	NA	NA	NA			60	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIML1&recr=Open">Click here</a>	
TRIO	Intron		C	C		11	Filtered Calls	5	14489133	14489133	59	0.203389830508475	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIO&recr=Open">Click here</a>	
TRIP11	Silent	p.N1446N	G	G		11	Filtered Calls	14	92469982	92469982	265	0.260377358490566	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIP11&recr=Open">Click here</a>	
TRMT10A	Intron		G	G		11	Filtered Calls	4	100472036	100472036	113	0.230088495575221	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRMT10A&recr=Open">Click here</a>	
TRMT13	Intron		C	C		11	Filtered Calls	1	100598881	100598881	34	0.323529411764706	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRMT13&recr=Open">Click here</a>	
TRMT6	Intron		G	G		11	Filtered Calls	20	5927183	5927183	69	0.36231884057971	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRMT6&recr=Open">Click here</a>	
TRMT6	Intron		G	G		11	Filtered Calls	20	5927185	5927185	66	0.348484848484849	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRMT6&recr=Open">Click here</a>	
TROAP	Intron		C	C	rs199891545	11	Filtered Calls	12	49717617	49717617	95	0.452631578947368	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TROAP&recr=Open">Click here</a>	
TRPC7	Silent	p.K186K	C	C		11	Filtered Calls	5	135692518	135692518	59	0.0677966101694915	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPC7&recr=Open">Click here</a>	
TRPM2	Silent	p.Q1054Q	G	G		11	Filtered Calls	21	45837825	45837825	24	0.333333333333333	NA	NA	NA			76			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM2&recr=Open">Click here</a>	
TRPM3	Intron		G	G		11	Filtered Calls	9	73151288	73151288	136	0.235294117647059	NA	NA	NA			95			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM3&recr=Open">Click here</a>	
TRPM4	Silent	p.I922I	C	C		11	Filtered Calls	19	49703677	49703677	63	0.222222222222222	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM4&recr=Open">Click here</a>	
TRPM6	Silent	p.E1901E	C	C		11	Filtered Calls	9	77353396	77353396	72	0.347222222222222	NA	NA	NA			126	Alpha-type protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00501}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM6&recr=Open">Click here</a>	
TRPM7	Silent	p.R819R	C	C		11	Filtered Calls	15	50901901	50901901	156	0.621794871794872	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM7&recr=Open">Click here</a>	
TRPM8	Silent	p.L385L	C	C		11	Filtered Calls	2	234862575	234862575	140	0.292857142857143	NA	NA	NA			66			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM8&recr=Open">Click here</a>	
TRPS1	Silent	p.Q150Q	T	T		11	Filtered Calls	8	116631875	116631875	98	0.153061224489796	NA	NA	NA			111			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPS1&recr=Open">Click here</a>	
TRPV1	Intron		G	G		11	Filtered Calls	17	3495354	3495354	16	0.5625	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPV1&recr=Open">Click here</a>	
TRPV3	Intron		G	G		11	Filtered Calls	17	3419866	3419866	44	0.272727272727273	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPV3&recr=Open">Click here</a>	
TRPV3	Intron		G	G		11	Filtered Calls	17	3419869	3419869	41	0.268292682926829	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPV3&recr=Open">Click here</a>	
TRPV3	Intron		G	G		11	Filtered Calls	17	3430226	3430226	11	0.727272727272727	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPV3&recr=Open">Click here</a>	
TRPV3	Intron		G	G		11	Filtered Calls	17	3447966	3447966	24	0.25	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPV3&recr=Open">Click here</a>	
TRPV4	Silent	p.R160R	C	C		11	Filtered Calls	12	110246180	110246180	72	0.222222222222222	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPV4&recr=Open">Click here</a>	
TRRAP	Intron		G	G		11	Filtered Calls	7	98513262	98513262	23	0.347826086956522	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRRAP&recr=Open">Click here</a>	
TRRAP	Silent	p.A1392A	C	C		11	Filtered Calls	7	98534846	98534846	217	0.327188940092166	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRRAP&recr=Open">Click here</a>	
TRRAP	Silent	p.F2596F	C	C		11	Filtered Calls	7	98573795	98573795	63	0.0634920634920635	NA	NA	NA			176			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRRAP&recr=Open">Click here</a>	
TRUB1	Intron		G	G		11	Filtered Calls	10	116710920	116710920	313	0.517571884984026	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRUB1&recr=Open">Click here</a>	
TSEN15	Intron		C	C		11	Filtered Calls	1	184023485	184023485	382	0.201570680628272	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSEN15&recr=Open">Click here</a>	
TSFM	Intron		G	G		11	Filtered Calls	12	58197066	58197066	200	0.42	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSFM&recr=Open">Click here</a>	
TSFM	IGR		G	G		11	Filtered Calls	12	58203449	58203449	152	0.421052631578947	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSFM&recr=Open">Click here</a>	
TSHB	Silent	p.L89L	C	C		11	Filtered Calls	1	115576698	115576698	329	0.224924012158055	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSHB&recr=Open">Click here</a>	
TSHR	Intron		C	C		11	Filtered Calls	14	81557402	81557402	162	0.327160493827161	NA	NA	NA			337			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSHR&recr=Open">Click here</a>	
TSHR	Silent	p.R710R	G	G		11	Filtered Calls	14	81610532	81610532	114	0.263157894736842	NA	NA	NA			337			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSHR&recr=Open">Click here</a>	
TSHZ1	Silent	p.S865S	C	C		11	Filtered Calls	18	72999957	72999957	35	0.228571428571429	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSHZ1&recr=Open">Click here</a>	
TSHZ3	Silent	p.I923I	G	G		11	Filtered Calls	19	31767930	31767930	27	0.148148148148148	NA	NA	NA		p.I740I(1)|p.I923I(1)	123			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSHZ3&recr=Open">Click here</a>	
TSHZ3	Silent	p.Q399Q	C	C		11	Filtered Calls	19	31769502	31769502	113	0.20353982300885	NA	NA	NA			123			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSHZ3&recr=Open">Click here</a>	
TSPAN1	Intron		C	C		11	Filtered Calls	1	46650890	46650890	378	0.468253968253968	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPAN1&recr=Open">Click here</a>	
TSPAN1	3'UTR		C	C		11	Filtered Calls	1	46651209	46651209	274	0.478102189781022	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPAN1&recr=Open">Click here</a>	
TSPAN16	Silent	p.F191F	C	C		11	Filtered Calls	19	11422859	11422859	65	0.169230769230769	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPAN16&recr=Open">Click here</a>	
TSPAN5	Silent	p.S48S	G	G		11	Filtered Calls	4	99408024	99408024	93	0.268817204301075	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPAN5&recr=Open">Click here</a>	
TSPAN9	Intron		C	C		11	Filtered Calls	12	3390895	3390895	17	0.294117647058824	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPAN9&recr=Open">Click here</a>	
TSPEAR	Intron		G	G		11	Filtered Calls	21	45978152	45978152	64	0.328125	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPEAR&recr=Open">Click here</a>	
TSPEAR	5'Flank		C	C		11	Filtered Calls	21	45994835	45994835	15	0.466666666666667	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPEAR&recr=Open">Click here</a>	
TSPO2	Intron		G	G		11	Filtered Calls	6	41011320	41011320	98	0.255102040816327	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPO2&recr=Open">Click here</a>	
TSPYL5	Silent	p.F304F	G	G		11	Filtered Calls	8	98289161	98289161	203	0.472906403940887	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPYL5&recr=Open">Click here</a>	
TST	Silent	p.R281R	G	G		11	Filtered Calls	22	37407119	37407119	76	0.460526315789474	NA	NA	NA			7	Rhodanese 2. {ECO:0000255|PROSITE- ProRule:PRU00173}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TST&recr=Open">Click here</a>	
TTBK1	5'Flank		G	G		11	Filtered Calls	6	43214453	43214453	51	0.176470588235294	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTBK1&recr=Open">Click here</a>	
TTBK1	Intron		C	C	rs377494173	11	Filtered Calls	6	43220628	43220628	74	0.756756756756757	NA	NA	NA			53			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTBK1&recr=Open">Click here</a>	
TTC12	Silent	p.L367L	C	C	rs377423064	11	Filtered Calls	11	113215109	113215109	99	0.353535353535354	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC12&recr=Open">Click here</a>	
TTC18	Intron		G	G		11	Filtered Calls	10	75072404	75072404	280	0.232142857142857	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC18&recr=Open">Click here</a>	
TTC18	5'UTR		G	G		11	Filtered Calls	10	75082759	75082759	240	0.241666666666667	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC18&recr=Open">Click here</a>	
TTC27	Silent	p.L271L	G	G		11	Filtered Calls	2	32891709	32891709	159	0.226415094339623	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC27&recr=Open">Click here</a>	
TTLL2	Silent	p.L248L	T	T		11	Filtered Calls	6	167754132	167754132	103	0.378640776699029	NA	NA	NA			39	TTL. {ECO:0000255|PROSITE- ProRule:PRU00568}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTLL2&recr=Open">Click here</a>	
TTLL4	Silent	p.L1002L	C	C		11	Filtered Calls	2	219617513	219617513	265	0.358490566037736	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTLL4&recr=Open">Click here</a>	
TTLL6	Silent	p.G810G	C	C		11	Filtered Calls	17	46846597	46846597	43	0.0930232558139535	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTLL6&recr=Open">Click here</a>	
TTN	Silent	p.S34065S	C	C		11	Filtered Calls	2	179399147	179399147	144	0.631944444444444	NA	NA	NA		p.S25192S(1)|p.S31497S(1)|p.S25000S(1)|p.S25125S(1)|p.S31495S(1)	1448	Ig-like 151.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Intron		T	T		11	Filtered Calls	2	179410424	179410424	127	0.322834645669291	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Silent	p.I26968I	G	G	rs539234338	11	Filtered Calls	2	179429955	179429955	130	0.369230769230769	NA	NA	NA		p.I24400I(1)|p.I18095I(1)|p.I18028I(1)|p.I17903I(1)|p.I24398I(1)	1448	Fibronectin type-III 96. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Silent	p.Q23678Q	C	C		11	Filtered Calls	2	179439825	179439825	58	0.241379310344828	NA	NA	NA			1448	Fibronectin type-III 72. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Intron		A	A		11	Filtered Calls	2	179501534	179501534	84	0.380952380952381	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Silent	p.K13194K	C	C		11	Filtered Calls	2	179516013	179516013	145	0.275862068965517	NA	NA	NA			1448	Ig-like 87.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Silent	p.E10246E	C	C		11	Filtered Calls	2	179563586	179563586	20	0.35	NA	NA	NA			1448	Glu-rich.|Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Silent	p.V9410V	C	C		11	Filtered Calls	2	179575594	179575594	93	0.247311827956989	NA	NA	NA			1448	Ig-like 77.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Silent	p.G7999G	C	C		11	Filtered Calls	2	179584120	179584120	98	0.63265306122449	NA	NA	NA			1448	Ig-like 62.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Silent	p.E7819E	C	C		11	Filtered Calls	2	179584912	179584912	79	0.240506329113924	NA	NA	NA			1448	Ig-like 60.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Silent	p.I6926I	G	G		11	Filtered Calls	2	179590153	179590153	37	0.324324324324324	NA	NA	NA			1448	Ig-like 51.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Intron		G	G		11	Filtered Calls	2	179597084	179597084	113	0.256637168141593	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Intron		C	C		11	Filtered Calls	2	179611376	179611376	129	0.271317829457364	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Intron		T	T		11	Filtered Calls	2	179611387	179611387	152	0.282894736842105	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Intron		G	G		11	Filtered Calls	2	179611768	179611768	126	0.349206349206349	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Intron		G	G		11	Filtered Calls	2	179611872	179611872	111	0.333333333333333	NA	NA	NA		p.T5086A(1)	1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Intron		G	G	rs368249743	11	Filtered Calls	2	179611964	179611964	100	0.2	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Intron		C	C	rs576478273	11	Filtered Calls	2	179615486	179615486	155	0.27741935483871	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Intron		C	C		11	Filtered Calls	2	179615774	179615774	217	0.248847926267281	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Silent	p.R3224R	C	C		11	Filtered Calls	2	179631139	179631139	151	0.549668874172185	NA	NA	NA			1448			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Silent	p.I2677I	G	G		11	Filtered Calls	2	179636023	179636023	95	0.231578947368421	NA	NA	NA			1448	Ig-like 15.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Silent	p.A2431A	G	G		11	Filtered Calls	2	179638602	179638602	127	0.31496062992126	NA	NA	NA			1448	Ig-like 13.|Ig-like 14.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Silent	p.F2427F	G	G		11	Filtered Calls	2	179638614	179638614	121	0.247933884297521	NA	NA	NA			1448	Ig-like 13.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTYH2	Silent	p.S353S	C	C		11	Filtered Calls	17	72246439	72246439	48	0.208333333333333	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTYH2&recr=Open">Click here</a>	
TUB	Intron		C	C		11	Filtered Calls	11	8118221	8118221	43	0.86046511627907	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TUB&recr=Open">Click here</a>	
TUBA3E	Silent	p.I332I	G	G		11	Filtered Calls	2	130951419	130951419	68	0.441176470588235	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TUBA3E&recr=Open">Click here</a>	
TUBA8	Intron		C	C		11	Filtered Calls	22	18604239	18604239	75	0.24	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TUBA8&recr=Open">Click here</a>	
TUBB1	Silent	p.V313V	G	G		11	Filtered Calls	20	57599421	57599421	60	0.233333333333333	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TUBB1&recr=Open">Click here</a>	
TUBB8	Silent	p.G146G	C	C		11	Filtered Calls	10	93894	93894	164	0.0975609756097561	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TUBB8&recr=Open">Click here</a>	
TUFT1	Intron		C	C		11	Filtered Calls	1	151536377	151536377	108	0.194444444444444	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TUFT1&recr=Open">Click here</a>	
TULP1	Intron		G	G		11	Filtered Calls	6	35480406	35480406	85	0.188235294117647	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TULP1&recr=Open">Click here</a>	
TWISTNB	Intron		G	G	rs554776089	11	Filtered Calls	7	19739908	19739908	125	0.312	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TWISTNB&recr=Open">Click here</a>	
TXNDC11	Silent	p.S102S	G	G		11	Filtered Calls	16	11830038	11830038	39	0.333333333333333	NA	NA	NA			21	Thioredoxin 1. {ECO:0000255|PROSITE- ProRule:PRU00691}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TXNDC11&recr=Open">Click here</a>	
TXNRD2	Silent	p.L102L	C	C		11	Filtered Calls	22	19906451	19906451	38	0.131578947368421	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TXNRD2&recr=Open">Click here</a>	
TYR	5'UTR		G	G	rs13312738	11	Filtered Calls	11	88911117	88911117	139	0.956834532374101	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TYR&recr=Open">Click here</a>	
TYRO3	Intron		C	C		11	Filtered Calls	15	41862215	41862215	50	0.12	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TYRO3&recr=Open">Click here</a>	
TYROBP	Intron		C	C		11	Filtered Calls	19	36398345	36398345	99	0.313131313131313	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TYROBP&recr=Open">Click here</a>	
U2AF2	Intron		C	C		11	Filtered Calls	19	56173860	56173860	49	0.183673469387755	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+U2AF2&recr=Open">Click here</a>	
U2AF2	Intron		C	C		11	Filtered Calls	19	56173862	56173862	52	0.269230769230769	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+U2AF2&recr=Open">Click here</a>	
UBASH3A	Intron		C	C		11	Filtered Calls	21	43833532	43833532	53	0.188679245283019	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBASH3A&recr=Open">Click here</a>	
UBASH3A	Silent	p.G570G	G	G		11	Filtered Calls	21	43864729	43864729	80	0.3625	NA	NA	NA			28	Phosphatase-like.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBASH3A&recr=Open">Click here</a>	
UBE2D3	Silent	p.P61P	G	G		11	Filtered Calls	4	103723733	103723733	310	0.274193548387097	NA	NA	NA			5			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBE2D3&recr=Open">Click here</a>	
UBE2F	Intron		T	T		11	Filtered Calls	2	238940853	238940853	123	0.634146341463415	NA	NA	NA			2			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBE2F&recr=Open">Click here</a>	
UBE2O	Silent	p.P762P	G	G		11	Filtered Calls	17	74392732	74392732	117	0.247863247863248	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBE2O&recr=Open">Click here</a>	
UBE2O	Silent	p.I397I	G	G		11	Filtered Calls	17	74395967	74395967	130	0.284615384615385	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBE2O&recr=Open">Click here</a>	
UBE3C	Silent	p.T248T	T	T		11	Filtered Calls	7	156974339	156974339	190	0.0526315789473684	NA	NA	NA			63			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBE3C&recr=Open">Click here</a>	
UBE4A	Silent	p.P754P	C	C		11	Filtered Calls	11	118255393	118255393	102	0.431372549019608	NA	NA	NA			56			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBE4A&recr=Open">Click here</a>	
UBE4B	Intron		C	C		11	Filtered Calls	1	10166495	10166495	107	0.0560747663551402	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBE4B&recr=Open">Click here</a>	
UBN1	Silent	p.A223A	C	C		11	Filtered Calls	16	4909967	4909967	65	0.553846153846154	NA	NA	NA			38	Lys-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBN1&recr=Open">Click here</a>	
UBQLN3	Silent	p.P385P	G	G		11	Filtered Calls	11	5529634	5529634	91	0.483516483516484	NA	NA	NA			39			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBQLN3&recr=Open">Click here</a>	
UBR1	Intron		G	G		11	Filtered Calls	15	43242568	43242568	112	0.3125	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBR1&recr=Open">Click here</a>	
UBR1	Intron		G	G		11	Filtered Calls	15	43242570	43242570	108	0.37962962962963	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBR1&recr=Open">Click here</a>	
UBR2	Intron		C	C		11	Filtered Calls	6	42580037	42580037	315	0.187301587301587	NA	NA	NA			64			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBR2&recr=Open">Click here</a>	
UBR5	Silent	p.G2211G	A	A		11	Filtered Calls	8	103287827	103287827	294	0.173469387755102	NA	NA	NA			124			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBR5&recr=Open">Click here</a>	
UBXN2B	Silent	p.V98V	C	C		11	Filtered Calls	8	59343183	59343183	130	0.438461538461538	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBXN2B&recr=Open">Click here</a>	
UBXN4	Intron		C	C		11	Filtered Calls	2	136527402	136527402	140	0.3	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBXN4&recr=Open">Click here</a>	
UCP1	Silent	p.G156G	C	C		11	Filtered Calls	4	141484530	141484530	212	0.297169811320755	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UCP1&recr=Open">Click here</a>	
UGT1A6	Intron		C	C		11	Filtered Calls	2	234676491	234676491	93	0.301075268817204	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT1A6&recr=Open">Click here</a>	
UGT2A1	Silent	p.I370I	G	G		11	Filtered Calls	4	70460389	70460389	105	0.171428571428571	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2A1&recr=Open">Click here</a>	
UGT2A1	Silent	p.E390E	C	C		11	Filtered Calls	4	70504792	70504792	83	0.168674698795181	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2A1&recr=Open">Click here</a>	
UGT2A1	Silent	p.F90F	G	G	rs145072098	11	Filtered Calls	4	70513093	70513093	220	0.15	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2A1&recr=Open">Click here</a>	
UGT2B28	Silent	p.I42I	C	C		11	Filtered Calls	4	70146344	70146344	246	0.532520325203252	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2B28&recr=Open">Click here</a>	
UGT2B7	Intron		G	G		11	Filtered Calls	4	69968661	69968661	313	0.300319488817891	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2B7&recr=Open">Click here</a>	
UGT3A1	IGR		G	G		11	Filtered Calls	5	35954487	35954487	32	0.25	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT3A1&recr=Open">Click here</a>	
UGT3A1	Silent	p.L378L	C	C		11	Filtered Calls	5	35955806	35955806	188	0.372340425531915	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT3A1&recr=Open">Click here</a>	
UGT3A1	Silent	p.F115F	G	G		11	Filtered Calls	5	35965884	35965884	126	0.198412698412698	NA	NA	NA			46			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT3A1&recr=Open">Click here</a>	
UGT3A2	Intron		G	G		11	Filtered Calls	5	36064438	36064438	126	0.468253968253968	NA	NA	NA			43			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT3A2&recr=Open">Click here</a>	
UGT8	Silent	p.V540V	G	G		11	Filtered Calls	4	115597438	115597438	185	0.545945945945946	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT8&recr=Open">Click here</a>	
UHMK1	Silent	p.D279D	C	C		11	Filtered Calls	1	162473627	162473627	174	0.683908045977011	NA	NA	NA			11	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159, ECO:0000305}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UHMK1&recr=Open">Click here</a>	
UHRF1BP1	Intron		T	T		11	Filtered Calls	6	34791132	34791132	307	0.218241042345277	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UHRF1BP1&recr=Open">Click here</a>	
ULK1	Silent	p.R553R	C	C		11	Filtered Calls	12	132400485	132400485	52	0.326923076923077	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ULK1&recr=Open">Click here</a>	
UMODL1	Silent	p.K182K	G	G		11	Filtered Calls	21	43505465	43505465	162	0.222222222222222	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UMODL1&recr=Open">Click here</a>	
UMODL1	Silent	p.K795K	G	G		11	Filtered Calls	21	43536005	43536005	122	0.565573770491803	NA	NA	NA			47	SEA 2. {ECO:0000255|PROSITE- ProRule:PRU00188}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UMODL1&recr=Open">Click here</a>	
UMODL1	Silent	p.S1223S	C	C		11	Filtered Calls	21	43547920	43547920	142	0.584507042253521	NA	NA	NA			47	ZP. {ECO:0000255|PROSITE- ProRule:PRU00375}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UMODL1&recr=Open">Click here</a>	
UNC13A	Silent	p.F649F	G	G		11	Filtered Calls	19	17758171	17758171	13	0.307692307692308	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13A&recr=Open">Click here</a>	
UNC13A	Silent	p.V401V	C	C		11	Filtered Calls	19	17766772	17766772	9	0.333333333333333	NA	NA	NA			61			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13A&recr=Open">Click here</a>	
UNC13C	Silent	p.L1374L	G	G		11	Filtered Calls	15	54592425	54592425	25	0.2	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13C&recr=Open">Click here</a>	
UNC13C	Silent	p.F1784F	C	C		11	Filtered Calls	15	54799365	54799365	45	0.288888888888889	NA	NA	NA			121			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13C&recr=Open">Click here</a>	
UNC13D	Intron		G	G		11	Filtered Calls	17	73831151	73831151	65	0.246153846153846	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13D&recr=Open">Click here</a>	
UNC5B	Silent	p.F515F	C	C	rs150389249	11	Filtered Calls	10	73051439	73051439	34	0.264705882352941	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC5B&recr=Open">Click here</a>	
UNC5D	Silent	p.G605G	G	G		11	Filtered Calls	8	35608186	35608186	167	0.215568862275449	NA	NA	NA			112	ZU5. {ECO:0000255|PROSITE- ProRule:PRU00485}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC5D&recr=Open">Click here</a>	
UNC79	Intron		C	C	rs374564401	11	Filtered Calls	14	94089195	94089195	82	0.25609756097561	NA	NA	NA			118			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC79&recr=Open">Click here</a>	
UPF1	Intron		C	C		11	Filtered Calls	19	18963785	18963785	95	0.252631578947368	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UPF1&recr=Open">Click here</a>	
UPF1	Silent	p.F685F	C	C	rs149225517	11	Filtered Calls	19	18968215	18968215	47	0.51063829787234	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UPF1&recr=Open">Click here</a>	
UPF3A	Intron		C	C		11	Filtered Calls	13	115070257	115070257	169	0.29585798816568	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UPF3A&recr=Open">Click here</a>	
UPK3B	Intron		G	G		11	Filtered Calls	7	76140105	76140105	9	0.333333333333333	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UPK3B&recr=Open">Click here</a>	
URB1	3'UTR		G	G		11	Filtered Calls	21	33684286	33684286	68	0.220588235294118	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+URB1&recr=Open">Click here</a>	
URB2	Silent	p.L86L	C	C		11	Filtered Calls	1	229768147	229768147	230	0.191304347826087	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+URB2&recr=Open">Click here</a>	
URGCP-MRPS24	Intron		G	G		11	Filtered Calls	7	43918597	43918597	121	0.28099173553719	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+URGCP-MRPS24&recr=Open">Click here</a>	
USB1	Silent	p.S124S	C	C		11	Filtered Calls	16	58043939	58043939	74	0.22972972972973	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USB1&recr=Open">Click here</a>	
USH1C	Silent	p.I748I	G	G		11	Filtered Calls	11	17523065	17523065	32	0.53125	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH1C&recr=Open">Click here</a>	
USH1C	Silent	p.F730F	G	G		11	Filtered Calls	11	17523522	17523522	43	0.418604651162791	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH1C&recr=Open">Click here</a>	
USH1C	Silent	p.L58L	G	G	rs200525985	11	Filtered Calls	11	17553022	17553022	15	0.333333333333333	NA	NA	NA			48	N-terminal domain.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH1C&recr=Open">Click here</a>	
USH2A	Silent	p.T4425T	C	C	rs377063327	11	Filtered Calls	1	215847978	215847978	119	0.218487394957983	NA	NA	NA			527	Fibronectin type-III 29. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH2A&recr=Open">Click here</a>	
USH2A	Silent	p.T3450T	G	G		11	Filtered Calls	1	215960049	215960049	179	0.430167597765363	NA	NA	NA			527	Fibronectin type-III 19. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH2A&recr=Open">Click here</a>	
USH2A	Intron		C	C		11	Filtered Calls	1	215972243	215972243	111	0.387387387387387	NA	NA	NA			527			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH2A&recr=Open">Click here</a>	
USH2A	Silent	p.F1755F	G	G	rs147371835	11	Filtered Calls	1	216256831	216256831	666	0.208708708708709	NA	NA	NA			527	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH2A&recr=Open">Click here</a>	
USP10	Intron		C	C	rs546799570	11	Filtered Calls	16	84796587	84796587	166	0.289156626506024	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP10&recr=Open">Click here</a>	
USP10	Intron		T	T	rs546799570	11	Filtered Calls	16	84796588	84796588	169	0.289940828402367	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP10&recr=Open">Click here</a>	
USP17L2	Silent	p.R511R	C	C		11	Filtered Calls	8	11994737	11994737	83	0.216867469879518	NA	NA	NA			29	Mediates interaction with SUDS3.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP17L2&recr=Open">Click here</a>	
USP29	Silent	p.G352G	G	G		11	Filtered Calls	19	57641099	57641099	164	0.115853658536585	NA	NA	NA			85	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP29&recr=Open">Click here</a>	
USP29	Silent	p.K447K	G	G		11	Filtered Calls	19	57641384	57641384	188	0.335106382978723	NA	NA	NA			85	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP29&recr=Open">Click here</a>	
USP34	Silent	p.V2668V	G	G		11	Filtered Calls	2	61447488	61447488	1110	0.184684684684685	NA	NA	NA			138			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP34&recr=Open">Click here</a>	
USP36	Intron		G	G		11	Filtered Calls	17	76816003	76816003	456	0.192982456140351	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP36&recr=Open">Click here</a>	
USP40	Silent	p.F931F	G	G		11	Filtered Calls	2	234402192	234402192	35	0.4	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP40&recr=Open">Click here</a>	
USP5	Silent	p.V542V	C	C		11	Filtered Calls	12	6970734	6970734	118	0.177966101694915	NA	NA	NA			36	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP5&recr=Open">Click here</a>	
USP6	Silent	p.T74T	G	G		11	Filtered Calls	17	5036231	5036231	101	0.207920792079208	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP6&recr=Open">Click here</a>	
USP6	Intron		C	C	rs372541359	11	Filtered Calls	17	5044713	5044713	145	0.227586206896552	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP6&recr=Open">Click here</a>	
USP7	Silent	p.N470N	G	G		11	Filtered Calls	16	9000301	9000301	180	0.272222222222222	NA	NA	NA			48	USP.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP7&recr=Open">Click here</a>	
UTP20	Silent	p.V589V	G	G		11	Filtered Calls	12	101696317	101696317	112	0.4375	NA	NA	NA			88			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UTP20&recr=Open">Click here</a>	
UTP20	Silent	p.L2228L	G	G		11	Filtered Calls	12	101764338	101764338	158	0.424050632911392	NA	NA	NA			88			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UTP20&recr=Open">Click here</a>	
Unknown	IGR		T	T		11	Filtered Calls	1	1987966	1987966	24	0.5	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		C	C	rs551836552	11	Filtered Calls	1	197479746	197479746	190	0.173684210526316	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		C	C		11	Filtered Calls	1	247419787	247419787	97	0.381443298969072	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		G	G		11	Filtered Calls	1	247420013	247420013	378	0.153439153439153	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		C	C		11	Filtered Calls	2	177465731	177465731	346	0.271676300578035	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		C	C		11	Filtered Calls	4	165980675	165980675	56	0.625	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		C	C		11	Filtered Calls	4	174537290	174537290	197	0.319796954314721	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		G	G		11	Filtered Calls	5	21121266	21121266	57	0.403508771929825	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		C	C		11	Filtered Calls	7	121081059	121081059	63	0.73015873015873	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		C	C		11	Filtered Calls	7	124116736	124116736	42	0.642857142857143	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		A	A		11	Filtered Calls	7	144707322	144707322	120	0.325	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		G	G		11	Filtered Calls	7	144707486	144707486	91	0.450549450549451	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		C	C		11	Filtered Calls	9	84675994	84675994	155	0.206451612903226	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		C	C		11	Filtered Calls	11	124095622	124095622	115	0.817391304347826	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		G	G		11	Filtered Calls	12	66501811	66501811	33	0.181818181818182	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		C	C		11	Filtered Calls	15	22482999	22482999	339	0.300884955752212	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		A	A		11	Filtered Calls	15	22483291	22483291	111	0.162162162162162	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		G	G		11	Filtered Calls	16	51098417	51098417	212	0.0613207547169811	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		C	C		11	Filtered Calls	20	56063612	56063612	115	0.330434782608696	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		G	G	rs188270369	11	Filtered Calls	X	26179943	26179943	77	0.519480519480519	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		C	C		11	Filtered Calls	X	47663207	47663207	32	0.375	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		G	G		11	Filtered Calls	X	47663257	47663257	39	0.41025641025641	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
VAT1	Silent	p.E31E	T	T		11	Filtered Calls	17	41170709	41170709	109	0.440366972477064	NA	NA	NA			9			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VAT1&recr=Open">Click here</a>	
VAV1	Silent	p.E354E	G	G		11	Filtered Calls	19	6828468	6828468	21	0.238095238095238	NA	NA	NA			62	DH. {ECO:0000255|PROSITE- ProRule:PRU00062}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VAV1&recr=Open">Click here</a>	
VAV1	Silent	p.P608P	A	A		11	Filtered Calls	19	6836489	6836489	30	0.366666666666667	NA	NA	NA			62			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VAV1&recr=Open">Click here</a>	
VAV1	Silent	p.F744F	T	T		11	Filtered Calls	19	6852990	6852990	67	0.17910447761194	NA	NA	NA			62	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VAV1&recr=Open">Click here</a>	
VAV3	Intron		G	G		11	Filtered Calls	1	108138969	108138969	194	0.278350515463918	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VAV3&recr=Open">Click here</a>	
VAV3	Intron		G	G		11	Filtered Calls	1	108292227	108292227	231	0.0303030303030303	NA	NA	NA			58			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VAV3&recr=Open">Click here</a>	
VCAN	Intron		C	C		11	Filtered Calls	5	82815464	82815464	81	0.333333333333333	NA	NA	NA			190			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VCAN&recr=Open">Click here</a>	
VCAN	Intron		G	G		11	Filtered Calls	5	82834132	82834132	152	0.467105263157895	NA	NA	NA			190			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VCAN&recr=Open">Click here</a>	
VCAN	Intron		A	A		11	Filtered Calls	5	82835405	82835405	187	0.475935828877005	NA	NA	NA			190			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VCAN&recr=Open">Click here</a>	
VCAN	Intron		G	G		11	Filtered Calls	5	82837328	82837328	98	0.377551020408163	NA	NA	NA			190			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VCAN&recr=Open">Click here</a>	
VCAN	Intron		C	C		11	Filtered Calls	5	82838004	82838004	137	0.0510948905109489	NA	NA	NA		p.S3061F(1)	190			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VCAN&recr=Open">Click here</a>	
VDAC1	Silent	p.S137S	G	G		11	Filtered Calls	5	133316560	133316560	150	0.44	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VDAC1&recr=Open">Click here</a>	
VEGFC	Silent	p.F399F	A	A		11	Filtered Calls	4	177605143	177605143	188	0.319148936170213	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VEGFC&recr=Open">Click here</a>	
VEGFC	Silent	p.L119L	C	C		11	Filtered Calls	4	177650691	177650691	143	0.237762237762238	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VEGFC&recr=Open">Click here</a>	
VEPH1	Silent	p.R780R	C	C		11	Filtered Calls	3	156979085	156979085	125	0.376	NA	NA	NA			48	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VEPH1&recr=Open">Click here</a>	
VEPH1	Intron		C	C		11	Filtered Calls	3	157131665	157131665	91	0.362637362637363	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VEPH1&recr=Open">Click here</a>	
VEPH1	Intron		T	T		11	Filtered Calls	3	157146108	157146108	173	0.341040462427746	NA	NA	NA			48			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VEPH1&recr=Open">Click here</a>	
VILL	Silent	p.A528A	C	C		11	Filtered Calls	3	38043991	38043991	182	0.214285714285714	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VILL&recr=Open">Click here</a>	
VIM	Silent	p.S51S	C	C		11	Filtered Calls	10	17271574	17271574	36	0.222222222222222	NA	NA	NA			38	Head.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VIM&recr=Open">Click here</a>	
VIP	Intron		T	T		11	Filtered Calls	6	153075291	153075291	72	0.430555555555556	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VIP&recr=Open">Click here</a>	
VIPR1	Silent	p.T76T	C	C		11	Filtered Calls	3	42560758	42560758	40	0.35	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VIPR1&recr=Open">Click here</a>	
VIPR1	Intron		C	C		11	Filtered Calls	3	42573372	42573372	56	0.232142857142857	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VIPR1&recr=Open">Click here</a>	
VIPR2	Silent	p.F166F	G	G		11	Filtered Calls	7	158835825	158835825	18	0.555555555555556	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VIPR2&recr=Open">Click here</a>	
VIT	Silent	p.E313E	G	G		11	Filtered Calls	2	37028513	37028513	238	0.239495798319328	NA	NA	NA			57	VWFA 1. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VIT&recr=Open">Click here</a>	
VN1R2	Silent	p.F219F	C	C		11	Filtered Calls	19	53762285	53762285	66	0.136363636363636	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VN1R2&recr=Open">Click here</a>	
VNN2	Silent	p.K130K	C	C		11	Filtered Calls	6	133077129	133077129	57	0.456140350877193	NA	NA	NA		p.K130N(1)	36	CN hydrolase. {ECO:0000255|PROSITE- ProRule:PRU00054}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VNN2&recr=Open">Click here</a>	
VNN3	3'UTR		C	C		11	Filtered Calls	6	133046014	133046014	96	0.333333333333333	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VNN3&recr=Open">Click here</a>	
VNN3	Intron		A	A		11	Filtered Calls	6	133055382	133055382	104	0.528846153846154	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VNN3&recr=Open">Click here</a>	
VPRBP	Intron		G	G		11	Filtered Calls	3	51467652	51467652	89	0.258426966292135	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPRBP&recr=Open">Click here</a>	
VPS13B	Silent	p.P893P	C	C		11	Filtered Calls	8	100287337	100287337	85	0.141176470588235	NA	NA	NA			193			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13B&recr=Open">Click here</a>	
VPS13B	Intron		C	C		11	Filtered Calls	8	100519994	100519994	160	0.175	NA	NA	NA			193			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13B&recr=Open">Click here</a>	
VPS13D	Silent	p.S2079S	C	C		11	Filtered Calls	1	12364583	12364583	28	0.107142857142857	NA	NA	NA			130			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13D&recr=Open">Click here</a>	
VPS35	Silent	p.R781R	C	C		11	Filtered Calls	16	46694432	46694432	262	0.648854961832061	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS35&recr=Open">Click here</a>	
VPS39	Intron		G	G		11	Filtered Calls	15	42458025	42458025	70	0.214285714285714	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS39&recr=Open">Click here</a>	
VPS8	Intron		C	C		11	Filtered Calls	3	184657982	184657982	36	0.222222222222222	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS8&recr=Open">Click here</a>	
VPS8	Silent	p.L1154L	C	C		11	Filtered Calls	3	184700399	184700399	154	0.538961038961039	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS8&recr=Open">Click here</a>	
VRTN	Silent	p.S505S	C	C		11	Filtered Calls	14	74825001	74825001	34	0.470588235294118	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VRTN&recr=Open">Click here</a>	
VSIG1	Silent	p.A213A	C	C		11	Filtered Calls	X	107316550	107316550	309	0.394822006472492	NA	NA	NA			17	Ig-like C2-type 2.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VSIG1&recr=Open">Click here</a>	
VSTM4	Silent	p.I199I	G	G	rs146407836	11	Filtered Calls	10	50285301	50285301	59	0.271186440677966	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VSTM4&recr=Open">Click here</a>	
VSTM4	Intron		A	A		11	Filtered Calls	10	50294072	50294072	125	0.192	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VSTM4&recr=Open">Click here</a>	
VTI1A	Intron		C	C		11	Filtered Calls	10	114224295	114224295	95	0.378947368421053	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VTI1A&recr=Open">Click here</a>	
VWA7	Silent	p.G647G	C	C		11	Filtered Calls	6	31734483	31734483	80	0.2125	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWA7&recr=Open">Click here</a>	
VWC2	Silent	p.E305E	G	G		11	Filtered Calls	7	49951718	49951718	77	0.246753246753247	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWC2&recr=Open">Click here</a>	
VWC2	Silent	p.A315A	C	C		11	Filtered Calls	7	49951748	49951748	62	0.258064516129032	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWC2&recr=Open">Click here</a>	
VWCE	Silent	p.T805T	C	C	rs148487281	11	Filtered Calls	11	61026600	61026600	19	0.421052631578947	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWCE&recr=Open">Click here</a>	
VWF	Silent	p.T2298T	C	C	rs147523582	11	Filtered Calls	12	6094736	6094736	40	0.2	NA	NA	NA			129	VWFC 1. {ECO:0000255|PROSITE- ProRule:PRU00220}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWF&recr=Open">Click here</a>	
VWF	Silent	p.F1966F	G	G		11	Filtered Calls	12	6105333	6105333	60	0.316666666666667	NA	NA	NA			129	VWFD 4. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWF&recr=Open">Click here</a>	
VWF	Silent	p.S424S	G	G		11	Filtered Calls	12	6174324	6174324	52	0.25	NA	NA	NA			129	VWFD 2. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWF&recr=Open">Click here</a>	
VWF	Silent	p.S422S	G	G		11	Filtered Calls	12	6174330	6174330	52	0.25	NA	NA	NA			129	VWFD 2. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWF&recr=Open">Click here</a>	
VWF	Intron		C	C		11	Filtered Calls	12	6182779	6182779	171	0.210526315789474	NA	NA	NA			129			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWF&recr=Open">Click here</a>	
WASF2	Silent	p.T60T	G	G		11	Filtered Calls	1	27745540	27745540	357	0.0476190476190476	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WASF2&recr=Open">Click here</a>	
WBP1	5'Flank		C	C		11	Filtered Calls	2	74683372	74683372	285	0.189473684210526	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WBP1&recr=Open">Click here</a>	
WBSCR17	Silent	p.F330F	C	C		11	Filtered Calls	7	71036297	71036297	57	0.473684210526316	NA	NA	NA			100	Catalytic subdomain B.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WBSCR17&recr=Open">Click here</a>	
WDFY2	Intron		C	C		11	Filtered Calls	13	52277723	52277723	80	0.2125	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDFY2&recr=Open">Click here</a>	
WDR11	Silent	p.L373L	C	C	rs143915270	11	Filtered Calls	10	122626205	122626205	346	0.208092485549133	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR11&recr=Open">Click here</a>	
WDR11	Intron		C	C		11	Filtered Calls	10	122626687	122626687	180	0.177777777777778	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR11&recr=Open">Click here</a>	
WDR11	Silent	p.P844P	C	C		11	Filtered Calls	10	122659557	122659557	190	0.2	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR11&recr=Open">Click here</a>	
WDR11	Intron		T	T		11	Filtered Calls	10	122662754	122662754	87	0.229885057471264	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR11&recr=Open">Click here</a>	
WDR18	Intron		C	C	rs145613963	11	Filtered Calls	19	990841	990841	25	0.16	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR18&recr=Open">Click here</a>	
WDR38	Intron		C	C		11	Filtered Calls	9	127618610	127618610	63	0.317460317460317	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR38&recr=Open">Click here</a>	
WDR4	Intron		G	G		11	Filtered Calls	21	44283714	44283714	66	0.257575757575758	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR4&recr=Open">Click here</a>	
WDR49	Intron		G	G		11	Filtered Calls	3	167254799	167254799	133	0.218045112781955	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR49&recr=Open">Click here</a>	
WDR49	Intron		G	G		11	Filtered Calls	3	167272560	167272560	231	0.0346320346320346	NA	NA	NA			50			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR49&recr=Open">Click here</a>	
WDR59	Silent	p.P535P	G	G		11	Filtered Calls	16	74943436	74943436	112	0.196428571428571	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR59&recr=Open">Click here</a>	
WDR59	Intron		A	A		11	Filtered Calls	16	74985447	74985447	8	0.625	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR59&recr=Open">Click here</a>	
WDR64	Intron		T	T		11	Filtered Calls	1	241959547	241959547	107	0.224299065420561	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR64&recr=Open">Click here</a>	
WDR64	Silent	p.L1071L	C	C		11	Filtered Calls	1	241964482	241964482	394	0.195431472081218	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR64&recr=Open">Click here</a>	
WDR65	Intron		C	C		11	Filtered Calls	1	43665054	43665054	139	0.23021582733813	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR65&recr=Open">Click here</a>	
WDR7	Silent	p.P401P	C	C		11	Filtered Calls	18	54362275	54362275	132	0.371212121212121	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR7&recr=Open">Click here</a>	
WDR7	Silent	p.T1273T	C	C		11	Filtered Calls	18	54603124	54603124	72	0.347222222222222	NA	NA	NA			78			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR7&recr=Open">Click here</a>	
WDR70	Intron		T	T		11	Filtered Calls	5	37392084	37392084	81	0.407407407407407	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR70&recr=Open">Click here</a>	
WDR70	Intron		C	C		11	Filtered Calls	5	37721209	37721209	292	0.452054794520548	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR70&recr=Open">Click here</a>	
WDR78	Silent	p.L404L	A	A		11	Filtered Calls	1	67313248	67313248	178	0.337078651685393	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR78&recr=Open">Click here</a>	
WDR88	Silent	p.R40R	G	G		11	Filtered Calls	19	33623195	33623195	73	0.150684931506849	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR88&recr=Open">Click here</a>	
WDR96	Intron		C	C		11	Filtered Calls	10	105921716	105921716	549	0.216757741347905	NA	NA	NA			72			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR96&recr=Open">Click here</a>	
WFDC12	Silent	p.V8V	G	G		11	Filtered Calls	20	43753065	43753065	46	0.847826086956522	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WFDC12&recr=Open">Click here</a>	
WFDC8	Intron		G	G		11	Filtered Calls	20	44190866	44190866	18	0.333333333333333	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WFDC8&recr=Open">Click here</a>	
WFS1	Silent	p.F374F	C	C		11	Filtered Calls	4	6302644	6302644	39	0.307692307692308	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WFS1&recr=Open">Click here</a>	
WIF1	Silent	p.F138F	G	G		11	Filtered Calls	12	65462668	65462668	121	0.43801652892562	NA	NA	NA			21	WIF. {ECO:0000255|PROSITE- ProRule:PRU00222}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WIF1&recr=Open">Click here</a>	
WIPI2	Intron		C	C		11	Filtered Calls	7	5269231	5269231	19	0.315789473684211	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WIPI2&recr=Open">Click here</a>	
WIPI2	Intron		C	C		11	Filtered Calls	7	5270456	5270456	43	0.302325581395349	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WIPI2&recr=Open">Click here</a>	
WNK1	Silent	p.L2313L	C	C		11	Filtered Calls	12	1017746	1017746	76	0.434210526315789	NA	NA	NA			104			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNK1&recr=Open">Click here</a>	
WNK2	Silent	p.I810I	C	C		11	Filtered Calls	9	96021260	96021260	34	0.117647058823529	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNK2&recr=Open">Click here</a>	
WNK4	Intron		C	C		11	Filtered Calls	17	40946627	40946627	22	0.409090909090909	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNK4&recr=Open">Click here</a>	
WNK4	Silent	p.R994R	G	G		11	Filtered Calls	17	40947499	40947499	101	0.495049504950495	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNK4&recr=Open">Click here</a>	
WNT16	Silent	p.Q274Q	G	G		11	Filtered Calls	7	120979123	120979123	35	0.485714285714286	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNT16&recr=Open">Click here</a>	
WRB	Intron		T	T		11	Filtered Calls	21	40765085	40765085	79	0.30379746835443	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WRB&recr=Open">Click here</a>	
WSCD1	Silent	p.F149F	C	C		11	Filtered Calls	17	5991329	5991329	56	0.285714285714286	NA	NA	NA			35	WSC 1. {ECO:0000255|PROSITE- ProRule:PRU00558}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WSCD1&recr=Open">Click here</a>	
WSCD1	Silent	p.S229S	C	C		11	Filtered Calls	17	5993785	5993785	13	0.384615384615385	NA	NA	NA			35	WSC 1. {ECO:0000255|PROSITE- ProRule:PRU00558}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WSCD1&recr=Open">Click here</a>	
WWOX	Silent	p.T359T	C	C	rs150912992	11	Filtered Calls	16	79245525	79245525	61	0.655737704918033	NA	NA	NA			7	Interaction with MAPT. {ECO:0000250}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WWOX&recr=Open">Click here</a>	
XAB2	Silent	p.I520I	G	G	rs373175532	11	Filtered Calls	19	7687274	7687274	144	0.194444444444444	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XAB2&recr=Open">Click here</a>	
XAB2	Silent	p.T288T	G	G		11	Filtered Calls	19	7689290	7689290	42	0.30952380952381	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XAB2&recr=Open">Click here</a>	
XCR1	Silent	p.S64S	G	G		11	Filtered Calls	3	46063248	46063248	44	0.431818181818182	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XCR1&recr=Open">Click here</a>	
XDH	Silent	p.I1236I	G	G		11	Filtered Calls	2	31562421	31562421	46	0.304347826086957	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XDH&recr=Open">Click here</a>	
XDH	Silent	p.L713L	C	C		11	Filtered Calls	2	31590885	31590885	172	0.366279069767442	NA	NA	NA			74			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XDH&recr=Open">Click here</a>	
XIRP2	Silent	p.K166K	G	G		11	Filtered Calls	2	167992508	167992508	154	0.298701298701299	NA	NA	NA		p.K166N(2)	315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		A	A		11	Filtered Calls	2	168099547	168099547	69	0.318840579710145	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		T	T		11	Filtered Calls	2	168099559	168099559	72	0.333333333333333	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G		11	Filtered Calls	2	168099604	168099604	76	0.263157894736842	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G		11	Filtered Calls	2	168099621	168099621	92	0.173913043478261	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		C	C		11	Filtered Calls	2	168101234	168101234	108	0.574074074074074	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G	rs374306778	11	Filtered Calls	2	168101241	168101241	108	0.287037037037037	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G		11	Filtered Calls	2	168101381	168101381	149	0.570469798657718	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G		11	Filtered Calls	2	168101488	168101488	80	0.25	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G		11	Filtered Calls	2	168102490	168102490	188	0.329787234042553	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G		11	Filtered Calls	2	168103531	168103531	158	0.259493670886076	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		C	C		11	Filtered Calls	2	168103957	168103957	90	0.266666666666667	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G	rs200547698	11	Filtered Calls	2	168104739	168104739	87	0.597701149425287	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		C	C		11	Filtered Calls	2	168104881	168104881	174	0.293103448275862	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G		11	Filtered Calls	2	168105143	168105143	110	0.245454545454545	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		A	A		11	Filtered Calls	2	168105145	168105145	111	0.342342342342342	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G	rs563915541	11	Filtered Calls	2	168105217	168105217	127	0.669291338582677	NA	NA	NA		p.D2439N(1)	315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		C	C		11	Filtered Calls	2	168105225	168105225	127	0.188976377952756	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		A	A		11	Filtered Calls	2	168105300	168105300	77	0.376623376623377	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G		11	Filtered Calls	2	168105894	168105894	77	0.207792207792208	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G	rs267598987	11	Filtered Calls	2	168105895	168105895	78	0.205128205128205	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G		11	Filtered Calls	2	168105922	168105922	81	0.185185185185185	NA	NA	NA		p.E2674K(1)	315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		G	G		11	Filtered Calls	2	168106341	168106341	87	0.275862068965517	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		C	C		11	Filtered Calls	2	168106977	168106977	145	0.572413793103448	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		C	C		11	Filtered Calls	2	168107416	168107416	112	0.285714285714286	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		C	C		11	Filtered Calls	2	168108159	168108159	128	0.3046875	NA	NA	NA			315			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XKR4	IGR		C	C		11	Filtered Calls	8	56436052	56436052	164	0.207317073170732	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XKR4&recr=Open">Click here</a>	
XKR4	IGR		C	C		11	Filtered Calls	8	56436243	56436243	76	0.25	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XKR4&recr=Open">Click here</a>	
XKR4	IGR		A	A		11	Filtered Calls	8	56436785	56436785	47	0.0638297872340425	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XKR4&recr=Open">Click here</a>	
XKR5	RNA		G	G		11	Filtered Calls	8	6673434	6673434	15	0.2	NA	NA	NA			3			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XKR5&recr=Open">Click here</a>	
XKR7	Silent	p.V579V	G	G		11	Filtered Calls	20	30585257	30585257	9	0.888888888888889	NA	NA	NA			34			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XKR7&recr=Open">Click here</a>	
XPA	Intron		G	G		11	Filtered Calls	9	100451931	100451931	77	0.194805194805195	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XPA&recr=Open">Click here</a>	
XPNPEP3	Silent	p.I456I	T	T		11	Filtered Calls	22	41322283	41322283	271	0.265682656826568	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XPNPEP3&recr=Open">Click here</a>	
XPO1	Silent	p.F181F	G	G		11	Filtered Calls	2	61726895	61726895	386	0.0181347150259067	NA	NA	NA			39	Necessary for HTLV-1 Rex-mediated mRNA export.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XPO1&recr=Open">Click here</a>	
XPO4	Silent	p.L651L	G	G		11	Filtered Calls	13	21374996	21374996	352	0.215909090909091	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XPO4&recr=Open">Click here</a>	
XPO7	Intron		C	C		11	Filtered Calls	8	21843087	21843087	191	0.18848167539267	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XPO7&recr=Open">Click here</a>	
XPR1	Silent	p.L77L	C	C	rs372023037	11	Filtered Calls	1	180772531	180772531	170	0.170588235294118	NA	NA	NA		p.L77L(1)	35	SPX. {ECO:0000255|PROSITE- ProRule:PRU00714}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XPR1&recr=Open">Click here</a>	
XPR1	Silent	p.T250T	C	C		11	Filtered Calls	1	180780611	180780611	273	0.168498168498169	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XPR1&recr=Open">Click here</a>	
XRCC2	Intron		A	A		11	Filtered Calls	7	152346457	152346457	77	0.701298701298701	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XRCC2&recr=Open">Click here</a>	
XYLB	Intron		C	C		11	Filtered Calls	3	38436988	38436988	115	0.426086956521739	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XYLB&recr=Open">Click here</a>	
YEATS2	Silent	p.S414S	C	C		11	Filtered Calls	3	183472005	183472005	234	0.282051282051282	NA	NA	NA			49			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YEATS2&recr=Open">Click here</a>	
YIF1B	Silent	p.P302P	A	A		11	Filtered Calls	19	38796031	38796031	25	0.32	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YIF1B&recr=Open">Click here</a>	
YIPF2	IGR		C	C		11	Filtered Calls	19	11031155	11031155	33	0.181818181818182	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YIPF2&recr=Open">Click here</a>	
YTHDC1	Intron		G	G		11	Filtered Calls	4	69198507	69198507	202	0.212871287128713	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YTHDC1&recr=Open">Click here</a>	
ZAN	RNA		G	G	rs375614439	11	Filtered Calls	7	100334177	100334177	76	0.486842105263158	NA	NA	NA			139			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZAN&recr=Open">Click here</a>	
ZAN	RNA		A	A		11	Filtered Calls	7	100348820	100348820	27	0.259259259259259	NA	NA	NA			139			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZAN&recr=Open">Click here</a>	
ZAN	RNA		C	C		11	Filtered Calls	7	100352931	100352931	77	0.714285714285714	NA	NA	NA			139			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZAN&recr=Open">Click here</a>	
ZBBX	Intron		G	G		11	Filtered Calls	3	167034898	167034898	163	0.239263803680982	NA	NA	NA			70			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBBX&recr=Open">Click here</a>	
ZBED4	Silent	p.S108S	C	C		11	Filtered Calls	22	50277634	50277634	99	0.171717171717172	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBED4&recr=Open">Click here</a>	
ZBED6CL	5'UTR		C	C		11	Filtered Calls	7	150027485	150027485	32	0.25	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBED6CL&recr=Open">Click here</a>	
ZBTB10	Silent	p.V383V	T	T		11	Filtered Calls	8	81411905	81411905	208	0.3125	NA	NA	NA			20	BTB. {ECO:0000255|PROSITE- ProRule:PRU00037}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB10&recr=Open">Click here</a>	
ZBTB11	Silent	p.V200V	G	G		11	Filtered Calls	3	101390152	101390152	293	0.361774744027304	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB11&recr=Open">Click here</a>	
ZBTB38	Silent	p.F525F	C	C		11	Filtered Calls	3	141162805	141162805	161	0.031055900621118	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB38&recr=Open">Click here</a>	
ZBTB4	Silent	p.L234L	G	G		11	Filtered Calls	17	7369419	7369419	51	0.411764705882353	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB4&recr=Open">Click here</a>	
ZBTB40	Silent	p.T1166T	C	C		11	Filtered Calls	1	22850910	22850910	16	0.75	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB40&recr=Open">Click here</a>	
ZBTB7C	Silent	p.K288K	C	C		11	Filtered Calls	18	45566615	45566615	28	0.785714285714286	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB7C&recr=Open">Click here</a>	
ZBTB9	5'UTR		C	C		11	Filtered Calls	6	33422868	33422868	59	0.288135593220339	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB9&recr=Open">Click here</a>	
ZC3H12B	Silent	p.Q93Q	G	G		11	Filtered Calls	X	64708960	64708960	57	0.403508771929825	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3H12B&recr=Open">Click here</a>	
ZC3H12D	IGR		G	G		11	Filtered Calls	6	149777981	149777981	44	0.340909090909091	NA	NA	NA			6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3H12D&recr=Open">Click here</a>	
ZC3H13	Silent	p.D1074D	G	G		11	Filtered Calls	13	46543457	46543457	242	0.628099173553719	NA	NA	NA			79			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3H13&recr=Open">Click here</a>	
ZC3H7A	Intron		G	G		11	Filtered Calls	16	11856609	11856609	217	0.276497695852535	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3H7A&recr=Open">Click here</a>	
ZC3H7A	Intron		A	A		11	Filtered Calls	16	11873227	11873227	162	0.271604938271605	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3H7A&recr=Open">Click here</a>	
ZCCHC17	Silent	p.I35I	C	C		11	Filtered Calls	1	31791994	31791994	292	0.5	NA	NA	NA			6	S1 motif. {ECO:0000255|PROSITE- ProRule:PRU00180}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCCHC17&recr=Open">Click here</a>	
ZCWPW1	Intron		G	G		11	Filtered Calls	7	99999561	99999561	88	0.761363636363636	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCWPW1&recr=Open">Click here</a>	
ZCWPW1	Intron		G	G		11	Filtered Calls	7	99999562	99999562	89	0.764044943820225	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCWPW1&recr=Open">Click here</a>	
ZCWPW1	5'UTR		A	A		11	Filtered Calls	7	100017480	100017480	112	0.366071428571429	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCWPW1&recr=Open">Click here</a>	
ZDHHC14	Silent	p.Q364Q	G	G		11	Filtered Calls	6	158093779	158093779	32	0.3125	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZDHHC14&recr=Open">Click here</a>	
ZDHHC19	Silent	p.A253A	T	T		11	Filtered Calls	3	195925674	195925674	86	0.255813953488372	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZDHHC19&recr=Open">Click here</a>	
ZDHHC2	Silent	p.I126I	C	C		11	Filtered Calls	8	17055095	17055095	220	0.204545454545455	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZDHHC2&recr=Open">Click here</a>	
ZDHHC23	3'UTR		G	G		11	Filtered Calls	3	113676663	113676663	42	0.404761904761905	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZDHHC23&recr=Open">Click here</a>	
ZDHHC3	Silent	p.F228F	G	G		11	Filtered Calls	3	44974638	44974638	64	0.4375	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZDHHC3&recr=Open">Click here</a>	
ZDHHC7	Silent	p.S73S	G	G		11	Filtered Calls	16	85024006	85024006	31	0.516129032258065	NA	NA	NA			10			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZDHHC7&recr=Open">Click here</a>	
ZEB2	Silent	p.F1160F	G	G		11	Filtered Calls	2	145147183	145147183	308	0.337662337662338	NA	NA	NA			107	Glu-rich (acidic).		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZEB2&recr=Open">Click here</a>	
ZFAND4	3'UTR		G	G		11	Filtered Calls	10	46111877	46111877	189	0.169312169312169	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFAND4&recr=Open">Click here</a>	
ZFAND4	Silent	p.F331F	G	G		11	Filtered Calls	10	46122278	46122278	122	0.188524590163934	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFAND4&recr=Open">Click here</a>	
ZFAT	Intron		G	G		11	Filtered Calls	8	135649964	135649964	137	0.240875912408759	NA	NA	NA			54			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFAT&recr=Open">Click here</a>	
ZFC3H1	Silent	p.F144F	G	G		11	Filtered Calls	12	72056959	72056959	117	0.461538461538462	NA	NA	NA			69			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFC3H1&recr=Open">Click here</a>	
ZFHX4	Silent	p.V1343V	A	A		11	Filtered Calls	8	77763186	77763186	28	0.285714285714286	NA	NA	NA			432			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX4&recr=Open">Click here</a>	
ZFP37	Silent	p.L150L	G	G		11	Filtered Calls	9	115806493	115806493	285	0.242105263157895	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFP37&recr=Open">Click here</a>	
ZFP42	5'UTR		G	G		11	Filtered Calls	4	188923956	188923956	58	0.206896551724138	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFP42&recr=Open">Click here</a>	
ZFP82	Silent	p.L521L	A	A		11	Filtered Calls	19	36883679	36883679	145	0.144827586206897	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFP82&recr=Open">Click here</a>	
ZFYVE1	Silent	p.S6S	G	G		11	Filtered Calls	14	73491199	73491199	114	0.043859649122807	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFYVE1&recr=Open">Click here</a>	
ZFYVE20	Silent	p.S548S	G	G		11	Filtered Calls	3	15116000	15116000	111	0.243243243243243	NA	NA	NA			26	Necessary for the interaction with EHD1.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFYVE20&recr=Open">Click here</a>	
ZFYVE27	Silent	p.S372S	C	C		11	Filtered Calls	10	99517446	99517446	167	0.44311377245509	NA	NA	NA			8			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFYVE27&recr=Open">Click here</a>	
ZHX2	Silent	p.T215T	C	C	rs184731017	11	Filtered Calls	8	123964395	123964395	97	0.185567010309278	NA	NA	NA		p.T215T(1)	45	Required for homodimerization.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZHX2&recr=Open">Click here</a>	
ZIM3	Silent	p.R187R	C	C		11	Filtered Calls	19	57647144	57647144	169	0.14792899408284	NA	NA	NA			52			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZIM3&recr=Open">Click here</a>	
ZKSCAN1	Silent	p.I229I	C	C		11	Filtered Calls	7	99627886	99627886	82	0.0487804878048781	NA	NA	NA			25	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZKSCAN1&recr=Open">Click here</a>	
ZKSCAN5	Silent	p.F227F	C	C		11	Filtered Calls	7	99117836	99117836	134	0.41044776119403	NA	NA	NA			21	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZKSCAN5&recr=Open">Click here</a>	
ZKSCAN8	Silent	p.L395L	C	C		11	Filtered Calls	6	28121241	28121241	272	0.213235294117647	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZKSCAN8&recr=Open">Click here</a>	
ZMAT4	Intron		G	G		11	Filtered Calls	8	40625258	40625258	58	0.448275862068966	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZMAT4&recr=Open">Click here</a>	
ZMIZ1	Intron		C	C		11	Filtered Calls	10	81065370	81065370	75	0.226666666666667	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZMIZ1&recr=Open">Click here</a>	
ZMIZ2	Silent	p.S898S	C	C		11	Filtered Calls	7	44807153	44807153	56	0.196428571428571	NA	NA	NA			35	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZMIZ2&recr=Open">Click here</a>	
ZMYM1	Silent	p.V179V	T	T		11	Filtered Calls	1	35570013	35570013	162	0.327160493827161	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZMYM1&recr=Open">Click here</a>	
ZMYM5	Silent	p.I139I	G	G	rs146800619	11	Filtered Calls	13	20425904	20425904	224	0.575892857142857	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZMYM5&recr=Open">Click here</a>	
ZNF107	Silent	p.S383S	C	C		11	Filtered Calls	7	64167831	64167831	53	0.754716981132076	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF107&recr=Open">Click here</a>	
ZNF12	Intron		G	G		11	Filtered Calls	7	6732159	6732159	495	0.0262626262626263	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF12&recr=Open">Click here</a>	
ZNF12	Intron		A	A		11	Filtered Calls	7	6737643	6737643	57	0.192982456140351	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF12&recr=Open">Click here</a>	
ZNF131	Silent	p.Y221Y	C	C		11	Filtered Calls	5	43161642	43161642	108	0.240740740740741	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF131&recr=Open">Click here</a>	
ZNF131	Silent	p.K277K	G	G		11	Filtered Calls	5	43161810	43161810	118	0.474576271186441	NA	NA	NA			17			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF131&recr=Open">Click here</a>	
ZNF135	Silent	p.I64I	A	A		11	Filtered Calls	19	58578170	58578170	99	0.171717171717172	NA	NA	NA			41	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF135&recr=Open">Click here</a>	
ZNF135	Silent	p.I188I	C	C		11	Filtered Calls	19	58578542	58578542	142	0.288732394366197	NA	NA	NA			41			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF135&recr=Open">Click here</a>	
ZNF154	Silent	p.G185G	T	T		11	Filtered Calls	19	58213762	58213762	178	0.117977528089888	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF154&recr=Open">Click here</a>	
ZNF16	Silent	p.A273A	G	G		11	Filtered Calls	8	146157354	146157354	178	0.117977528089888	NA	NA	NA			29	Required for nuclear localization.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF16&recr=Open">Click here</a>	
ZNF208	Intron		G	G		11	Filtered Calls	19	22157617	22157617	30	0.433333333333333	NA	NA	NA			113			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF208&recr=Open">Click here</a>	
ZNF239	Silent	p.G185G	C	C		11	Filtered Calls	10	44052973	44052973	236	0.216101694915254	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF239&recr=Open">Click here</a>	
ZNF257	Silent	p.G116G	C	C		11	Filtered Calls	19	22270900	22270900	107	0.186915887850467	NA	NA	NA		p.G116G(1)	6			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF257&recr=Open">Click here</a>	
ZNF264	Silent	p.L246L	C	C		11	Filtered Calls	19	57723203	57723203	115	0.408695652173913	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF264&recr=Open">Click here</a>	
ZNF274	3'UTR		C	C		11	Filtered Calls	19	58718456	58718456	31	0.516129032258065	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF274&recr=Open">Click here</a>	
ZNF274	3'UTR		C	C		11	Filtered Calls	19	58723761	58723761	89	0.134831460674157	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF274&recr=Open">Click here</a>	
ZNF274	3'UTR		C	C		11	Filtered Calls	19	58724270	58724270	73	0.136986301369863	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF274&recr=Open">Click here</a>	
ZNF285	Silent	p.E397E	C	C		11	Filtered Calls	19	44891216	44891216	82	0.109756097560976	NA	NA	NA			44			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF285&recr=Open">Click here</a>	
ZNF287	Silent	p.L523L	A	A		11	Filtered Calls	17	16455887	16455887	209	0.349282296650718	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF287&recr=Open">Click here</a>	
ZNF287	Intron		A	A		11	Filtered Calls	17	16456749	16456749	108	0.0740740740740741	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF287&recr=Open">Click here</a>	
ZNF296	5'UTR		C	C		11	Filtered Calls	19	45579636	45579636	32	0.25	NA	NA	NA			7			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF296&recr=Open">Click here</a>	
ZNF335	Silent	p.R719R	G	G		11	Filtered Calls	20	44587936	44587936	33	0.393939393939394	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF335&recr=Open">Click here</a>	
ZNF335	Silent	p.S426S	G	G		11	Filtered Calls	20	44592454	44592454	43	0.813953488372093	NA	NA	NA			51			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF335&recr=Open">Click here</a>	
ZNF33B	Silent	p.F561F	G	G		11	Filtered Calls	10	43088715	43088715	305	0.186885245901639	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF33B&recr=Open">Click here</a>	
ZNF34	Intron		G	G		11	Filtered Calls	8	146003553	146003553	66	0.257575757575758	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF34&recr=Open">Click here</a>	
ZNF343	Silent	p.L480L	G	G		11	Filtered Calls	20	2464167	2464167	98	0.23469387755102	NA	NA	NA			25			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF343&recr=Open">Click here</a>	
ZNF345	Silent	p.A322A	C	C		11	Filtered Calls	19	37368698	37368698	114	0.350877192982456	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF345&recr=Open">Click here</a>	
ZNF365	Silent	p.F165F	C	C		11	Filtered Calls	10	64136447	64136447	208	0.225961538461538	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF365&recr=Open">Click here</a>	
ZNF385B	Silent	p.T191T	C	C		11	Filtered Calls	2	180348096	180348096	126	0.277777777777778	NA	NA	NA		p.T191T(1)	26	Interaction with p53/TP53.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF385B&recr=Open">Click here</a>	
ZNF385D	Silent	p.I173I	G	G		11	Filtered Calls	3	21478616	21478616	214	0.205607476635514	NA	NA	NA			46	Thr-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF385D&recr=Open">Click here</a>	
ZNF397	Silent	p.S182S	C	C		11	Filtered Calls	18	32823247	32823247	157	0.477707006369427	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF397&recr=Open">Click here</a>	
ZNF415	Silent	p.F477F	G	G		11	Filtered Calls	19	53611867	53611867	315	0.0380952380952381	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF415&recr=Open">Click here</a>	
ZNF415	Silent	p.F281F	G	G		11	Filtered Calls	19	53612455	53612455	132	0.128787878787879	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF415&recr=Open">Click here</a>	
ZNF423	Silent	p.L447L	C	C	rs548578929	11	Filtered Calls	16	49671722	49671722	52	0.269230769230769	NA	NA	NA			89			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF423&recr=Open">Click here</a>	
ZNF423	Silent	p.V303V	G	G		11	Filtered Calls	16	49672154	49672154	35	0.428571428571429	NA	NA	NA			89			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF423&recr=Open">Click here</a>	
ZNF426	Silent	p.F145F	G	G		11	Filtered Calls	19	9640172	9640172	101	0.108910891089109	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF426&recr=Open">Click here</a>	
ZNF445	Silent	p.L282L	G	G		11	Filtered Calls	3	44491092	44491092	53	0.547169811320755	NA	NA	NA			31	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF445&recr=Open">Click here</a>	
ZNF451	Intron		TTATTCA	TTATTCA		11	Filtered Calls	6	57017163	57017169	304	0.0394736842105263	NA	NA	NA			32			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF451&recr=Open">Click here</a>	
ZNF462	Silent	p.F790F	C	C		11	Filtered Calls	9	109692028	109692028	96	0.208333333333333	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF462&recr=Open">Click here</a>	
ZNF462	Silent	p.P1189P	C	C		11	Filtered Calls	9	109746483	109746483	149	0.228187919463087	NA	NA	NA			119			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF462&recr=Open">Click here</a>	
ZNF471	Intron		A	A		11	Filtered Calls	19	57035747	57035747	174	0.137931034482759	NA	NA	NA			36			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF471&recr=Open">Click here</a>	
ZNF48	Silent	p.F389F	C	C		11	Filtered Calls	16	30409738	30409738	53	0.207547169811321	NA	NA	NA			21			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF48&recr=Open">Click here</a>	
ZNF480	3'UTR		C	C		11	Filtered Calls	19	52825555	52825555	128	0.5078125	NA	NA	NA			12			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF480&recr=Open">Click here</a>	
ZNF486	Silent	p.L120L	T	T		11	Filtered Calls	19	20307877	20307877	192	0.28125	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF486&recr=Open">Click here</a>	
ZNF488	5'UTR		G	G		11	Filtered Calls	10	48370524	48370524	53	0.188679245283019	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF488&recr=Open">Click here</a>	
ZNF488	5'UTR		C	C		11	Filtered Calls	10	48370526	48370526	55	0.2	NA	NA	NA			14			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF488&recr=Open">Click here</a>	
ZNF493	Silent	p.E207E	G	G		11	Filtered Calls	19	21606082	21606082	203	0.403940886699507	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF493&recr=Open">Click here</a>	
ZNF512	Intron		C	C		11	Filtered Calls	2	27824215	27824215	142	0.295774647887324	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF512&recr=Open">Click here</a>	
ZNF518A	RNA		C	C		11	Filtered Calls	10	97917841	97917841	63	0.333333333333333	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF518A&recr=Open">Click here</a>	
ZNF521	Silent	p.T1032T	G	G		11	Filtered Calls	18	22804786	22804786	33	0.757575757575758	NA	NA	NA			149			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF521&recr=Open">Click here</a>	
ZNF526	Silent	p.V83V	C	C		11	Filtered Calls	19	42728804	42728804	88	0.488636363636364	NA	NA	NA			22			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF526&recr=Open">Click here</a>	
ZNF530	Intron		C	C		11	Filtered Calls	19	58117047	58117047	109	0.541284403669725	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF530&recr=Open">Click here</a>	
ZNF534	Intron		G	G		11	Filtered Calls	19	52941496	52941496	56	0.339285714285714	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF534&recr=Open">Click here</a>	
ZNF534	Intron		G	G		11	Filtered Calls	19	52941621	52941621	42	0.142857142857143	NA	NA	NA			4			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF534&recr=Open">Click here</a>	
ZNF536	Silent	p.F105F	C	C		11	Filtered Calls	19	30934784	30934784	22	0.272727272727273	NA	NA	NA			182			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF536&recr=Open">Click here</a>	
ZNF536	Silent	p.G1125G	G	G		11	Filtered Calls	19	31039901	31039901	59	0.186440677966102	NA	NA	NA			182			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF536&recr=Open">Click here</a>	
ZNF543	Intron		C	C		11	Filtered Calls	19	57839064	57839064	135	0.118518518518519	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF543&recr=Open">Click here</a>	
ZNF549	Silent	p.L43L	C	C	rs371630660	11	Filtered Calls	19	58046568	58046568	134	0.358208955223881	NA	NA	NA			21	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF549&recr=Open">Click here</a>	
ZNF554	Silent	p.S41S	C	C		11	Filtered Calls	19	2823107	2823107	47	0.51063829787234	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF554&recr=Open">Click here</a>	
ZNF555	Silent	p.S381S	C	C		11	Filtered Calls	19	2853209	2853209	83	0.530120481927711	NA	NA	NA			23			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF555&recr=Open">Click here</a>	
ZNF556	Silent	p.F267F	C	C		11	Filtered Calls	19	2877760	2877760	41	0.24390243902439	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF556&recr=Open">Click here</a>	
ZNF560	Silent	p.G718G	C	C		11	Filtered Calls	19	9577469	9577469	137	0.204379562043796	NA	NA	NA			65			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF560&recr=Open">Click here</a>	
ZNF577	Silent	p.I92I	G	G		11	Filtered Calls	19	52380542	52380542	108	0.166666666666667	NA	NA	NA			21	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF577&recr=Open">Click here</a>	
ZNF578	IGR		C	C		11	Filtered Calls	19	53015412	53015412	62	0.193548387096774	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF578&recr=Open">Click here</a>	
ZNF580	Silent	p.K25K	G	G		11	Filtered Calls	19	56153949	56153949	29	0.448275862068966	NA	NA	NA			2	Pro-rich.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF580&recr=Open">Click here</a>	
ZNF582	Silent	p.Q358Q	C	C		11	Filtered Calls	19	56895712	56895712	172	0.168604651162791	NA	NA	NA		p.Q358H(1)	26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF582&recr=Open">Click here</a>	
ZNF582	Silent	p.I143I	G	G	rs138147752	11	Filtered Calls	19	56896357	56896357	217	0.36405529953917	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF582&recr=Open">Click here</a>	
ZNF583	Silent	p.R470R	G	G		11	Filtered Calls	19	56935437	56935437	154	0.188311688311688	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF583&recr=Open">Click here</a>	
ZNF585A	Silent	p.F135F	A	A		11	Filtered Calls	19	37644396	37644396	311	0.231511254019293	NA	NA	NA			42			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF585A&recr=Open">Click here</a>	
ZNF648	Silent	p.T556T	G	G		11	Filtered Calls	1	182025478	182025478	45	0.2	NA	NA	NA			40			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF648&recr=Open">Click here</a>	
ZNF652	Silent	p.S330S	G	G		11	Filtered Calls	17	47390118	47390118	237	0.236286919831224	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF652&recr=Open">Click here</a>	
ZNF655	Silent	p.P56P	C	C		11	Filtered Calls	7	99159542	99159542	28	0.214285714285714	NA	NA	NA			16			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF655&recr=Open">Click here</a>	
ZNF662	Silent	p.E221E	G	G		11	Filtered Calls	3	42956150	42956150	166	0.174698795180723	NA	NA	NA			15			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF662&recr=Open">Click here</a>	
ZNF664	Silent	p.L214L	C	C		11	Filtered Calls	12	124497331	124497331	153	0.254901960784314	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF664&recr=Open">Click here</a>	
ZNF667	3'UTR		C	C		11	Filtered Calls	19	56952812	56952812	82	0.158536585365854	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF667&recr=Open">Click here</a>	
ZNF667	3'UTR		G	G		11	Filtered Calls	19	56953055	56953055	142	0.161971830985915	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF667&recr=Open">Click here</a>	
ZNF667	3'UTR		G	G		11	Filtered Calls	19	56953852	56953852	117	0.162393162393162	NA	NA	NA			38			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF667&recr=Open">Click here</a>	
ZNF676	Silent	p.I21I	G	G		11	Filtered Calls	19	22375885	22375885	157	0.426751592356688	NA	NA	NA			67	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF676&recr=Open">Click here</a>	
ZNF682	Silent	p.D8D	A	A		11	Filtered Calls	19	20135165	20135165	106	0.30188679245283	NA	NA	NA			14	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF682&recr=Open">Click here</a>	
ZNF695	Silent	p.A360A	G	G		11	Filtered Calls	1	247150737	247150737	90	0.444444444444444	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF695&recr=Open">Click here</a>	
ZNF695	Silent	p.P74P	G	G		11	Filtered Calls	1	247162687	247162687	136	0.191176470588235	NA	NA	NA			13	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF695&recr=Open">Click here</a>	
ZNF695	Intron		G	G		11	Filtered Calls	1	247163379	247163379	102	0.294117647058824	NA	NA	NA			13			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF695&recr=Open">Click here</a>	
ZNF699	Silent	p.S601S	G	G		11	Filtered Calls	19	9406277	9406277	107	0.14018691588785	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF699&recr=Open">Click here</a>	
ZNF700	Silent	p.T327T	C	C		11	Filtered Calls	19	12059820	12059820	144	0.284722222222222	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF700&recr=Open">Click here</a>	
ZNF704	Silent	p.V364V	G	G		11	Filtered Calls	8	81555305	81555305	101	0.158415841584158	NA	NA	NA			11			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF704&recr=Open">Click here</a>	
ZNF711	Silent	p.I244I	A	A		11	Filtered Calls	X	84519390	84519390	74	0.391891891891892	NA	NA	NA		p.I224M(1)	28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF711&recr=Open">Click here</a>	
ZNF714	Intron		T	T		11	Filtered Calls	19	21299605	21299605	89	0.370786516853933	NA	NA	NA			18			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF714&recr=Open">Click here</a>	
ZNF721	Silent	p.A649A	G	G		11	Filtered Calls	4	436309	436309	164	0.469512195121951	NA	NA	NA			33			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF721&recr=Open">Click here</a>	
ZNF761	RNA		C	C		11	Filtered Calls	19	53959187	53959187	142	0.197183098591549	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF761&recr=Open">Click here</a>	
ZNF761	RNA		C	C		11	Filtered Calls	19	53959391	53959391	177	0.0508474576271186	NA	NA	NA			30			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF761&recr=Open">Click here</a>	
ZNF776	IGR		C	C		11	Filtered Calls	19	58264920	58264920	157	0.363057324840764	NA	NA	NA			31			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF776&recr=Open">Click here</a>	
ZNF777	Silent	p.G54G	G	G		11	Filtered Calls	7	149152952	149152952	56	0.464285714285714	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF777&recr=Open">Click here</a>	
ZNF778	Silent	p.H275H	C	C		11	Filtered Calls	16	89293605	89293605	32	0.21875	NA	NA	NA			24			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF778&recr=Open">Click here</a>	
ZNF799	Silent	p.L269L	T	T		11	Filtered Calls	19	12502405	12502405	168	0.196428571428571	NA	NA	NA			19			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF799&recr=Open">Click here</a>	
ZNF804A	Silent	p.S664S	C	C		11	Filtered Calls	2	185802115	185802115	276	0.318840579710145	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804A&recr=Open">Click here</a>	
ZNF804A	Silent	p.R959R	G	G		11	Filtered Calls	2	185803000	185803000	219	0.255707762557078	NA	NA	NA			146			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804A&recr=Open">Click here</a>	
ZNF804B	Silent	p.S405S	C	C		11	Filtered Calls	7	88963511	88963511	60	0.8	NA	NA	NA			144			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804B&recr=Open">Click here</a>	
ZNF823	Silent	p.A59A	G	G		11	Filtered Calls	19	11835023	11835023	60	0.183333333333333	NA	NA	NA			26	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF823&recr=Open">Click here</a>	
ZNF831	Silent	p.E215E	G	G	rs183980006	11	Filtered Calls	20	57766719	57766719	21	0.428571428571429	NA	NA	NA			125			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF831&recr=Open">Click here</a>	
ZNF835	5'UTR		C	C		11	Filtered Calls	19	57176570	57176570	35	0.285714285714286	NA	NA	NA			47			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF835&recr=Open">Click here</a>	
ZNF836	3'UTR		G	G		11	Filtered Calls	19	52658122	52658122	18	0.388888888888889	NA	NA	NA			26			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF836&recr=Open">Click here</a>	
ZNFX1	Silent	p.Y1088Y	G	G		11	Filtered Calls	20	47868112	47868112	75	0.44	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNFX1&recr=Open">Click here</a>	
ZNFX1	Silent	p.L465L	A	A		11	Filtered Calls	20	47886954	47886954	144	0.395833333333333	NA	NA	NA			60			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNFX1&recr=Open">Click here</a>	
ZNRF3	Intron		C	C		11	Filtered Calls	22	29438566	29438566	80	0.275	NA	NA	NA			28			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNRF3&recr=Open">Click here</a>	
ZP2	Silent	p.F417F	G	G		11	Filtered Calls	16	21213461	21213461	55	0.254545454545455	NA	NA	NA			41	ZP. {ECO:0000255|PROSITE- ProRule:PRU00375}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZP2&recr=Open">Click here</a>	
ZP4	Silent	p.S504S	C	C		11	Filtered Calls	1	238045833	238045833	107	0.158878504672897	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZP4&recr=Open">Click here</a>	
ZP4	Intron		G	G		11	Filtered Calls	1	238048627	238048627	21	0.19047619047619	NA	NA	NA			73			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZP4&recr=Open">Click here</a>	
ZP4	Silent	p.V265V	C	C		11	Filtered Calls	1	238050115	238050115	116	0.241379310344828	NA	NA	NA			73	ZP. {ECO:0000255|PROSITE- ProRule:PRU00375}.		MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZP4&recr=Open">Click here</a>	
ZPBP	Silent	p.I187I	A	A		11	Filtered Calls	7	50070830	50070830	223	0.560538116591928	NA	NA	NA			29			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZPBP&recr=Open">Click here</a>	
ZPLD1	Intron		T	T		11	Filtered Calls	3	102171759	102171759	102	0.362745098039216	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZPLD1&recr=Open">Click here</a>	
ZPLD1	Intron		C	C		11	Filtered Calls	3	102181116	102181116	82	0.329268292682927	NA	NA	NA			35			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZPLD1&recr=Open">Click here</a>	
ZSCAN31	5'Flank		G	G		11	Filtered Calls	6	28295313	28295313	208	0.230769230769231	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN31&recr=Open">Click here</a>	
ZSCAN32	IGR		G	G		11	Filtered Calls	16	3433494	3433494	155	0.529032258064516	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN32&recr=Open">Click here</a>	
ZSCAN5A	Silent	p.T220T	G	G		11	Filtered Calls	19	56734039	56734039	177	0.19774011299435	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN5A&recr=Open">Click here</a>	
ZSCAN5B	Silent	p.L398L	G	G	rs370425792	11	Filtered Calls	19	56701490	56701490	57	0.491228070175439	NA	NA	NA			37			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN5B&recr=Open">Click here</a>	
ZSWIM4	Silent	p.S152S	C	C		11	Filtered Calls	19	13915706	13915706	48	0.25	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSWIM4&recr=Open">Click here</a>	
ZSWIM4	Silent	p.D589D	C	C		11	Filtered Calls	19	13934217	13934217	26	0.346153846153846	NA	NA	NA			27			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSWIM4&recr=Open">Click here</a>	
ZSWIM7	3'UTR		C	C		11	Filtered Calls	17	15881379	15881379	151	0.28476821192053	NA	NA	NA			1			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSWIM7&recr=Open">Click here</a>	
ZSWIM8	Silent	p.P1134P	T	T	rs375324786	11	Filtered Calls	10	75557013	75557013	103	0.233009708737864	NA	NA	NA			NA			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSWIM8&recr=Open">Click here</a>	
ZWINT	Silent	p.S262S	G	G		11	Filtered Calls	10	58118323	58118323	151	0.264900662251656	NA	NA	NA			20			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZWINT&recr=Open">Click here</a>	
ZZEF1	Intron		G	G		11	Filtered Calls	17	3959650	3959650	48	0.270833333333333	NA	NA	NA			84			MEL-IPI_Pat110-Tumor-SM-4CU6X	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZZEF1&recr=Open">Click here</a>	
